data_2hr9_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2hr9 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.404 ' CD1' ' HB3' ' A' ' 169' ' ' MET . 5.0 tt . . . . . 0 N--CA 1.456 -0.151 0 CA-C-O 120.755 0.312 . . . . 0.0 110.912 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.9 mm -106.78 159.06 6.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.523 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.504 ' CD2' ' CE2' ' A' ' 14' ' ' PHE . 4.9 m-85 -121.27 104.73 9.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.427 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 20.9 ptt180 -118.09 146.77 43.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.9 0.381 . . . . 0.0 111.365 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.426 ' O ' ' HA ' ' A' ' 10' ' ' HIS . 47.0 t0 -55.55 152.02 9.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.813 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 49.0 tp -81.6 -18.36 45.03 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.505 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.1 mp -91.36 -48.95 13.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -96.63 -17.75 20.19 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -179.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.426 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 36.1 m170 63.18 29.9 15.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.889 0.376 . . . . 0.0 110.71 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -100.4 121.02 40.85 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.661 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.18 94.84 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.372 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 14.7 mtt -72.13 -20.22 61.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.528 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.504 ' CE2' ' CD2' ' A' ' 4' ' ' TYR . 8.6 p90 -173.07 179.76 2.18 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.325 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -132.74 -170.26 2.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.836 0.35 . . . . 0.0 111.159 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -96.28 24.69 5.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.068 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.422 HG13 ' CD2' ' A' ' 18' ' ' TYR . 41.8 pt -89.03 -9.54 10.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.72 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.426 ' CZ ' HG21 ' A' ' 72' ' ' ILE . 73.6 m-85 -111.34 177.63 4.6 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.765 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -86.76 90.23 8.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.872 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.6 mp -87.93 129.27 39.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.94 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 -123.3 121.04 34.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.979 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -73.32 115.79 13.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.768 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.8 pt -108.86 171.6 2.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.996 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 57.95 31.82 21.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.06 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 65.66 46.95 2.27 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.228 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.35 -11.38 63.52 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.756 -0.735 . . . . 0.0 113.345 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.25 -55.22 37.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.905 0.352 . . . . 0.0 111.141 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 35.0 m -120.17 167.79 11.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.057 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.6 132.46 44.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.785 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -100.43 112.98 25.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.101 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 33.3 t -90.69 111.97 24.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.387 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -84.04 115.9 22.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.284 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -100.63 -138.96 10.51 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.042 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.8 pttp -174.56 125.55 0.3 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.814 0.34 . . . . 0.0 111.08 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 65.3 mtp -70.95 120.43 16.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.529 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.5 m . . . . . 0 C--N 1.33 -0.278 0 CA-C-O 120.914 0.387 . . . . 0.0 111.54 -179.572 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.375 0 N-CA-C 112.563 -0.215 . . . . 0.0 112.563 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.434 ' CG1' HG12 ' A' ' 72' ' ' ILE . 47.6 t -71.96 134.14 30.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.847 0.356 . . . . 0.0 110.868 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -61.04 -57.47 12.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.837 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.44 ' HB ' ' CE1' ' A' ' 76' ' ' HIS . 10.1 pt -53.61 -33.8 22.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.642 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.401 ' CG2' ' HB ' ' A' ' 70' ' ' VAL . 90.2 t -71.7 -32.73 46.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.898 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.4 mtm -78.32 -40.29 37.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.554 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.406 ' OD1' ' CD2' ' A' ' 76' ' ' HIS . 16.9 p30 -82.11 -29.92 31.47 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.829 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.44 ' CE1' ' HB ' ' A' ' 72' ' ' ILE . 27.4 m170 -91.94 -2.54 56.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.808 0.337 . . . . 0.0 110.914 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 28.1 m-70 57.29 34.08 24.24 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.808 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 29.7 mt -55.43 148.63 14.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.865 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -128.35 128.02 43.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.922 0.392 . . . . 0.0 110.897 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.412 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 1.4 tt0 -89.9 122.16 32.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.075 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.3 t -108.6 178.88 4.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.817 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 50.5 p -115.85 163.77 15.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.004 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.457 ' CE2' ' CE2' ' A' ' 91' ' ' TYR . 0.6 OUTLIER -171.64 153.87 3.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.806 -179.973 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 13.0 p -101.44 176.34 5.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.969 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.67 -52.55 24.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.944 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -65.36 -41.83 93.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.702 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.29 -38.42 83.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.027 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.473 ' CD2' HD13 ' A' ' 122' ' ' ILE . 0.6 OUTLIER -61.97 -36.76 82.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.673 179.936 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 17.5 mttm -57.68 -46.41 84.33 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.064 0.459 . . . . 0.0 110.225 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.62 -27.95 55.93 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.64 178.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.457 ' CE2' ' CE2' ' A' ' 83' ' ' PHE . 2.8 t80 -66.15 -44.94 82.7 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.745 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.471 ' CD1' ' CE2' ' A' ' 95' ' ' TYR . 3.9 tp -62.08 -45.61 98.34 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.752 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 15.0 ttpt -60.51 -37.95 82.78 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.883 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.478 ' HA ' ' HG2' ' A' ' 97' ' ' LYS . 31.3 t70 -74.67 -42.57 58.22 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.841 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.528 ' CD1' ' C ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -77.05 -40.26 46.95 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.999 -0.281 . . . . 0.0 111.065 -179.35 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.436 ' HG2' ' O ' ' A' ' 92' ' ' ILE . 8.8 ptt? -66.23 -32.11 73.33 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.855 0.36 . . . . 0.0 110.298 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.483 ' HG3' ' N ' ' A' ' 98' ' ' SER . 4.2 ptmt -70.48 -33.74 71.59 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.529 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.483 ' N ' ' HG3' ' A' ' 97' ' ' LYS . 1.8 m -63.92 -40.1 95.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.266 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 8.4 mt -79.76 -41.47 21.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.211 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.9 tmtt? -56.95 -52.1 66.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.266 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -59.21 -48.02 87.97 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.002 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.1 tppm? -62.79 -38.75 91.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.981 0.42 . . . . 0.0 110.122 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.455 ' O ' ' N ' ' A' ' 107' ' ' ARG . 14.3 tp -67.95 -36.87 80.84 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.975 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.405 ' HA ' ' HA ' ' A' ' 108' ' ' PRO . 36.0 mt-10 -55.96 -32.38 63.81 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.752 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -85.61 -19.99 30.18 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.567 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -105.18 -62.95 1.28 Allowed 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.773 0.32 . . . . 0.0 111.517 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.455 ' N ' ' O ' ' A' ' 103' ' ' LEU . 16.5 mmt180 -129.36 64.42 71.2 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.844 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.405 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 9.6 Cg_endo -50.64 -24.02 12.12 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 123.01 2.473 . . . . 0.0 112.596 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -74.13 -9.02 58.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.1 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.408 ' C ' ' HD2' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -108.79 -1.71 19.08 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.5 -179.683 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 27.6 m -72.13 -26.96 25.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.713 0.292 . . . . 0.0 111.299 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.545 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 0.8 OUTLIER -68.47 -56.03 10.92 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.37 -179.398 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.545 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 41.6 Cg_exo -55.67 -40.76 83.4 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 121.921 1.747 . . . . 0.0 111.641 179.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.428 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 56.9 t80 -62.02 -39.9 93.86 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.866 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 4.4 mmm -59.7 -45.3 92.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.829 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 63.1 m -74.82 -44.65 48.14 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.876 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -66.18 -39.44 94.53 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.938 -0.648 . . . . 0.0 112.688 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.63 -51.7 68.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.943 0.401 . . . . 0.0 111.074 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.68 -28.11 68.19 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.37 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -75.39 -57.14 4.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.229 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -58.44 -43.09 88.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.278 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.473 HD13 ' CD2' ' A' ' 88' ' ' TYR . 0.3 OUTLIER -58.79 -46.33 90.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.269 -179.801 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.457 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 25.6 mttt -60.43 -31.52 70.5 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.262 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -67.39 -54.33 21.43 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.715 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 11.8 pt -61.59 -41.05 88.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.149 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.404 ' HG ' ' CD1' ' A' ' 122' ' ' ILE . 11.1 mt -53.88 -35.96 62.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.761 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -68.6 -11.52 60.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.357 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -136.3 32.31 2.85 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.934 0.397 . . . . 0.0 110.522 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -48.23 -32.73 7.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.253 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -69.18 -24.35 64.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.274 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 21.5 m-20 -94.06 -36.43 12.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.419 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.418 ' CE1' ' OD2' ' A' ' 150' ' ' ASP . 3.5 m-85 -92.23 141.39 28.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.175 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.2 mm100 -121.35 145.74 47.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.877 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.427 ' CE2' ' HB2' ' A' ' 83' ' ' PHE . 2.9 m-85 -83.24 125.25 31.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.169 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.412 ' CE2' ' HB2' ' A' ' 80' ' ' GLU . 32.9 m-85 -127.5 150.16 49.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.679 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.438 ' HB ' ' HA ' ' A' ' 140' ' ' MET . 0.7 OUTLIER -140.05 159.97 26.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.719 179.893 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -57.57 -168.81 0.13 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.562 -0.828 . . . . 0.0 111.94 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -71.59 -8.9 56.92 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.622 0.248 . . . . 0.0 111.402 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 -94.09 -31.25 14.27 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.62 -0.263 . . . . 0.0 111.493 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' MET . . . . . 0.438 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 77.7 mtm 58.87 49.95 9.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.821 0.343 . . . . 0.0 111.017 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . 0.417 ' ND2' ' HA3' ' A' ' 144' ' ' GLY . 14.3 p-10 -72.11 114.62 30.8 Favored Pre-proline 0 N--CA 1.452 -0.357 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.987 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -64.98 -29.25 57.55 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.642 2.228 . . . . 0.0 112.288 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -84.59 -3.28 58.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.336 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.417 ' HA3' ' ND2' ' A' ' 141' ' ' ASN . . . -90.61 -155.17 31.07 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.535 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 2.8 ptp -94.75 -176.97 4.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.814 0.34 . . . . 0.0 110.895 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 53.4 t -128.97 151.13 35.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.085 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -111.71 115.85 29.77 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.67 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.517 ' HB2' ' HB ' ' A' ' 161' ' ' ILE . 4.6 mt -92.26 106.24 18.28 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.96 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.8 tp -89.29 119.63 29.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.248 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.427 ' HB3' ' CE1' ' A' ' 159' ' ' TYR . 0.6 OUTLIER -133.12 172.52 12.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.701 179.658 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -116.01 140.84 48.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.763 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 19.2 mmm180 -55.56 -178.66 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.115 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.23 -31.59 53.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.018 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 37.4 p30 -76.69 -15.2 59.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.104 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 71.27 17.47 75.99 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.708 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 93.9 t -111.89 -65.75 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.817 0.342 . . . . 0.0 110.846 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 35.8 m -56.95 109.17 1.53 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.097 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -82.17 122.85 3.83 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.522 2.148 . . . . 0.0 112.406 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.427 ' CE1' ' HB3' ' A' ' 150' ' ' ASP . 12.7 p90 -123.49 146.71 47.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.772 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' MET . . . . . 0.422 ' HE3' ' CZ ' ' A' ' 162' ' ' PHE . 1.1 mtm -112.22 142.53 44.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.949 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.517 ' HB ' ' HB2' ' A' ' 148' ' ' LEU . 46.0 mt -95.45 117.58 39.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.226 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . 0.422 ' CZ ' ' HE3' ' A' ' 160' ' ' MET . 48.4 m-85 -116.34 152.48 33.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.837 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.505 ' CE2' ' CZ ' ' A' ' 95' ' ' TYR . 11.5 m-85 -97.16 120.4 37.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.885 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 9.9 ttpt -65.26 -50.12 66.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.023 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.428 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 52.8 m-20 -57.69 -30.74 65.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.96 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -104.72 26.3 22.94 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.446 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.1 tt -142.69 142.23 31.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.759 0.314 . . . . 0.0 110.911 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -116.66 159.51 22.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.928 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' MET . . . . . 0.404 ' HB3' ' CD1' ' A' ' 2' ' ' ILE . 0.1 OUTLIER -115.48 159.96 20.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.776 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.908 -179.974 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.519 HG21 ' HB2' ' A' ' 16' ' ' ASP . 3.2 tt . . . . . 0 N--CA 1.456 -0.138 0 CA-C-O 120.848 0.356 . . . . 0.0 110.945 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 21.5 mm -99.64 154.02 4.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.292 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.512 ' CD2' ' CZ ' ' A' ' 14' ' ' PHE . 3.3 m-85 -123.67 110.06 14.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.602 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.57 145.78 49.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.906 0.384 . . . . 0.0 111.282 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.453 ' O ' ' HA ' ' A' ' 10' ' ' HIS . 44.3 t0 -55.68 152.17 9.83 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.862 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 57.3 tp -80.2 -23.5 40.91 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.305 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.3 mp -91.3 -45.48 14.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.26 -21.24 19.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.799 -179.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.453 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 14.5 m170 61.78 27.89 17.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.809 0.337 . . . . 0.0 110.731 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -100.77 122.15 42.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.751 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -56.93 89.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.366 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.407 ' O ' ' CD2' ' A' ' 76' ' ' HIS . 25.2 mtt -67.53 -19.24 65.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.644 179.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.512 ' CZ ' ' CD2' ' A' ' 4' ' ' TYR . 12.5 p90 -177.64 175.87 1.32 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.817 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.28 -169.92 2.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.734 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.519 ' HB2' HG21 ' A' ' 2' ' ' ILE . 19.0 t0 -95.76 31.87 1.98 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.148 0.499 . . . . 0.0 110.817 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.433 HD13 ' CE2' ' A' ' 18' ' ' TYR . 35.6 pt -89.66 -13.41 9.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.437 178.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.433 ' CE2' HD13 ' A' ' 17' ' ' ILE . 61.3 m-85 -110.07 178.92 4.25 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.463 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.43 91.55 8.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.75 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.2 mp -88.35 135.61 25.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.178 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 10.7 mtm180 -129.26 117.67 21.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.015 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -71.07 116.33 11.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.71 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.9 pt -109.5 171.07 2.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.162 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 57.91 30.97 19.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.178 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 66.56 42.56 2.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.095 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.89 -17.48 54.97 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.996 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.13 -49.37 60.94 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.852 0.358 . . . . 0.0 111.168 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 6.7 m -128.48 167.07 17.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.727 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.1 mt -129.37 135.08 48.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.878 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -99.62 112.78 24.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.8 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 159' ' ' TYR . 22.0 t -94.24 111.75 25.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.541 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -86.53 110.57 19.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.357 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -92.91 -134.21 6.76 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.212 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 9.3 ptpt -174.49 123.23 0.28 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.802 0.334 . . . . 0.0 111.023 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 15.1 mtt -67.16 121.54 15.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.641 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.4 m . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.495 -179.696 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 N-CA-C 112.401 -0.28 . . . . 0.0 112.401 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.42 ' HB ' ' CG2' ' A' ' 73' ' ' VAL . 48.4 t -72.34 140.54 17.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.806 0.336 . . . . 0.0 110.967 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.411 ' O ' ' ND2' ' A' ' 75' ' ' ASN . 35.4 t70 -67.75 -59.63 3.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.363 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.434 ' HB ' ' CD2' ' A' ' 76' ' ' HIS . 10.3 pt -53.62 -34.44 24.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.594 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.42 ' CG2' ' HB ' ' A' ' 70' ' ' VAL . 58.7 t -71.18 -33.04 49.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.826 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.6 mtm -78.25 -40.03 38.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.62 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.411 ' ND2' ' O ' ' A' ' 71' ' ' ASP . 15.3 p30 -82.02 -28.44 32.54 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.582 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.434 ' CD2' ' HB ' ' A' ' 72' ' ' ILE . 8.1 m-70 -91.49 -0.77 57.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.928 0.394 . . . . 0.0 110.753 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 10.7 m170 57.61 28.14 15.23 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.131 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 57.1 mt -56.82 137.98 54.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.371 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -122.12 137.01 54.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.973 0.416 . . . . 0.0 111.271 -179.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.424 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 1.5 tt0 -92.09 130.64 37.77 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.961 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.3 t -117.77 165.62 13.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.83 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 40.3 m -96.17 161.39 13.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.963 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.447 ' HB2' ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -171.7 149.94 2.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.013 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -101.54 164.76 11.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.906 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.11 -52.48 65.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.992 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -65.62 -44.9 85.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.785 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.79 -37.61 76.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.07 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.493 ' CZ ' ' CE1' ' A' ' 134' ' ' PHE . 0.5 OUTLIER -62.96 -35.79 81.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.799 179.9 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 52.8 mttt -59.61 -43.65 93.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.475 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.5 tttt -77.72 -27.91 50.72 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.75 178.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.442 ' CG ' ' CZ ' ' A' ' 83' ' ' PHE . 7.8 t80 -67.75 -46.84 70.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.702 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.426 HD11 ' CE2' ' A' ' 95' ' ' TYR . 5.8 tp -60.49 -42.73 92.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 CA-C-O 120.84 0.352 . . . . 0.0 110.668 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.458 ' O ' ' HB3' ' A' ' 97' ' ' LYS . 7.9 ttpp -63.94 -39.73 94.83 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.799 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.43 ' O ' ' HG3' ' A' ' 97' ' ' LYS . 29.1 t70 -75.85 -37.99 58.42 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.769 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.478 ' CD1' ' C ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -78.46 -42.78 28.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.607 0.242 . . . . 0.0 110.619 -179.736 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.419 ' HG3' ' N ' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -67.53 -32.09 72.64 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.035 179.569 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.458 ' HB3' ' O ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -70.91 -34.5 71.6 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.899 0.38 . . . . 0.0 110.656 179.807 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.4 ' N ' ' HG3' ' A' ' 97' ' ' LYS . 1.0 OUTLIER -61.27 -41.03 96.26 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.152 179.446 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.3 mt -79.81 -41.16 21.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.488 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.8 tttt -55.57 -53.16 59.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.462 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -60.64 -46.97 93.4 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.162 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.9 tppt? -62.5 -37.94 87.98 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.878 0.37 . . . . 0.0 110.403 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.44 ' O ' ' N ' ' A' ' 107' ' ' ARG . 3.4 tp -69.55 -34.24 73.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.032 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 108' ' ' PRO . 29.4 mt-10 -59.19 -30.99 68.6 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.691 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -87.38 -20.17 27.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.707 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -107.36 -62.3 1.44 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.833 0.349 . . . . 0.0 111.593 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 103' ' ' LEU . 22.0 mtm180 -128.03 63.52 62.27 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.92 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.414 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 10.0 Cg_endo -50.74 -21.24 7.82 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 123.144 2.562 . . . . 0.0 112.965 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -72.04 -9.22 58.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.584 0.23 . . . . 0.0 111.433 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.515 ' C ' ' HD2' ' A' ' 113' ' ' PRO . 19.0 mmt85 -112.12 -1.27 15.34 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.64 -0.255 . . . . 0.0 111.677 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 33.8 m -71.33 -32.54 47.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.546 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 15.5 mttm -69.81 -49.95 18.98 Favored Pre-proline 0 CA--C 1.53 0.192 0 C-N-CA 121.047 -0.261 . . . . 0.0 111.57 -179.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.546 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 31.4 Cg_exo -58.98 -36.13 97.35 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.183 1.922 . . . . 0.0 111.936 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.442 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 89.9 t80 -71.09 -35.38 71.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.923 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 10.8 mtp -58.61 -52.44 65.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.761 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 63.0 m -73.89 -44.06 56.49 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.552 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.58 -38.71 96.29 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.391 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.99 -51.6 68.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.002 0.429 . . . . 0.0 110.961 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.08 -28.22 65.25 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.129 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -75.88 -44.01 42.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.009 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -71.34 -38.12 71.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.001 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.449 HD12 ' CD2' ' A' ' 88' ' ' TYR . 0.4 OUTLIER -63.89 -46.82 93.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.269 -179.916 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.448 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 6.1 ptmt -60.72 -31.07 70.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.338 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -66.49 -52.37 46.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.996 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.431 HD11 HG23 ' A' ' 125' ' ' ILE . 11.9 pt -65.3 -40.44 88.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.283 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 11.9 mt -53.88 -35.5 61.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.882 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -72.75 -9.9 59.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.3 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -142.93 32.1 1.4 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.985 0.422 . . . . 0.0 110.615 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.495 ' CE1' ' CZ ' ' A' ' 134' ' ' PHE . 5.9 t80 -51.49 -25.32 6.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.22 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 5.7 tttp -62.74 -29.2 70.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.744 0.307 . . . . 0.0 110.915 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 32.8 m-20 -94.09 -39.17 10.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.263 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -89.87 145.59 25.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.086 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 -132.55 145.37 51.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.147 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.495 ' CZ ' ' CE1' ' A' ' 129' ' ' PHE . 1.4 m-85 -78.27 124.78 28.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.858 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.424 ' CE2' ' HB2' ' A' ' 80' ' ' GLU . 38.0 m-85 -129.9 135.96 48.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.767 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.421 ' HB ' ' HA ' ' A' ' 140' ' ' MET . 0.6 OUTLIER -120.99 159.65 22.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.858 179.905 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.68 -165.69 0.38 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.215 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -71.78 -8.93 57.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.573 0.225 . . . . 0.0 111.502 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 -96.97 -28.29 14.24 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' MET . . . . . 0.421 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 62.0 mtm 55.37 37.71 29.28 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.853 0.359 . . . . 0.0 110.93 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -61.87 115.25 14.43 Favored Pre-proline 0 N--CA 1.451 -0.386 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.933 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.21 -30.64 91.71 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.498 2.132 . . . . 0.0 112.183 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -84.59 -3.14 58.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.102 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -87.24 -169.29 45.6 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.472 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 2.3 ptp -86.58 -176.5 5.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.728 0.299 . . . . 0.0 110.91 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 48.9 t -128.17 148.85 32.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.962 0.41 . . . . 0.0 111.164 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -111.64 115.2 28.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.599 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.472 ' HB2' ' HB ' ' A' ' 161' ' ' ILE . 3.2 mt -89.77 106.28 18.36 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.332 -179.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.1 tp -88.83 121.15 30.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.922 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.454 ' HB3' ' CE1' ' A' ' 159' ' ' TYR . 31.2 t70 -134.67 164.01 28.48 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.547 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -110.36 148.52 31.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.051 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.66 -178.01 0.66 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.826 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -61.48 -31.07 71.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.94 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -84.66 -15.03 46.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.289 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 64.59 27.55 72.04 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.468 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 77.9 t -110.06 -42.47 5.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.846 0.355 . . . . 0.0 111.044 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 96.2 m -100.33 106.76 44.25 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.327 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.72 130.74 12.81 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.385 2.057 . . . . 0.0 111.609 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.454 ' CE1' ' HB3' ' A' ' 150' ' ' ASP . 6.1 p90 -127.09 146.43 50.38 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.913 0.387 . . . . 0.0 111.18 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' MET . . . . . 0.412 ' HE3' ' CG ' ' A' ' 135' ' ' PHE . 0.1 OUTLIER -113.12 145.4 40.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.041 -179.827 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.472 ' HB ' ' HB2' ' A' ' 148' ' ' LEU . 59.7 mt -101.78 110.61 29.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.267 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -110.93 154.0 24.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.523 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -102.14 115.14 29.92 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.944 0.402 . . . . 0.0 110.861 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.94 -46.5 87.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.168 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.442 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 56.5 m-20 -51.56 -31.84 25.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.987 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -106.45 25.99 21.42 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.395 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -139.88 146.93 39.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.821 0.343 . . . . 0.0 110.941 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.23 150.79 29.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.843 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.59 142.92 49.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.986 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.948 179.955 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.492 HG21 ' HB2' ' A' ' 16' ' ' ASP . 3.5 tt . . . . . 0 N--CA 1.457 -0.097 0 CA-C-O 120.806 0.336 . . . . 0.0 110.952 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.3 mm -99.72 155.04 4.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.374 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.501 ' CD2' ' CZ ' ' A' ' 14' ' ' PHE . 4.6 m-85 -124.43 107.29 10.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.669 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -123.8 144.93 49.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.153 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -54.88 140.62 36.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.856 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 43.1 tp -72.31 -20.29 61.52 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.362 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.1 mp -91.39 -46.3 14.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.51 -18.38 19.86 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -179.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.1 m80 62.2 29.28 17.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.864 0.364 . . . . 0.0 110.756 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -101.94 118.36 36.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.762 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -56.79 94.07 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.377 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 9.8 mtt -71.7 -19.24 62.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.695 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.501 ' CZ ' ' CD2' ' A' ' 4' ' ' TYR . 9.4 p90 -177.15 175.84 1.47 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.821 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.86 -171.13 2.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.593 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.492 ' HB2' HG21 ' A' ' 2' ' ' ILE . 21.1 t0 -95.52 36.24 1.28 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.113 0.482 . . . . 0.0 110.785 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.423 HG13 ' CD2' ' A' ' 18' ' ' TYR . 37.4 pt -94.5 -11.77 8.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.571 179.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.423 ' CD2' HG13 ' A' ' 17' ' ' ILE . 43.5 m-85 -109.41 -166.85 1.14 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.573 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.7 mtpp -98.96 89.46 4.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.838 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.8 mp -88.03 124.68 41.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.881 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 11.0 mtp180 -115.78 121.16 41.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.158 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -74.0 116.36 14.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.803 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.1 pt -116.08 171.51 5.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.19 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 56.58 33.45 22.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.167 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 64.57 38.32 7.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.249 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.74 -13.84 66.6 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.737 -0.744 . . . . 0.0 113.113 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -53.57 -48.09 69.48 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.749 0.309 . . . . 0.0 111.368 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 18.8 m -126.0 167.27 15.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.272 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.8 123.83 30.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.76 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -92.0 112.8 24.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.885 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.402 HG22 ' CD2' ' A' ' 14' ' ' PHE . 20.2 t -100.63 111.91 31.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.956 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -87.6 118.77 27.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.029 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -99.9 -128.49 6.3 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.299 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.48 125.89 0.31 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.856 0.36 . . . . 0.0 110.903 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 81.4 mtp -73.21 119.42 17.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.941 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.9 m . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.152 179.944 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.45 0 N-CA-C 112.321 -0.312 . . . . 0.0 112.321 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.429 ' CG1' HG12 ' A' ' 72' ' ' ILE . 51.0 t -71.29 148.66 10.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.775 0.322 . . . . 0.0 110.793 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -73.8 -56.35 5.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.453 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.429 HG12 ' CG1' ' A' ' 70' ' ' VAL . 11.2 pt -53.72 -33.97 23.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.349 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.409 ' CG1' ' HB2' ' A' ' 78' ' ' LEU . 59.7 t -71.6 -33.57 49.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.812 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.8 mtt -78.47 -39.6 37.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.693 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.2 p30 -82.04 -28.46 32.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.545 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.416 ' CG ' ' O ' ' A' ' 72' ' ' ILE . 7.2 m-70 -90.28 -2.59 58.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.845 0.355 . . . . 0.0 110.582 179.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.432 ' HB2' ' HB3' ' A' ' 138' ' ' GLU . 8.9 m-70 59.87 28.24 17.7 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.892 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.409 ' HB2' ' CG1' ' A' ' 73' ' ' VAL . 64.2 mt -58.55 144.51 42.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.555 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -128.63 138.06 51.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.891 0.377 . . . . 0.0 111.251 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.413 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 18.4 tt0 -92.84 123.28 36.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.04 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.4 t -108.97 165.05 11.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.76 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.5 m -95.44 160.5 14.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.874 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.503 ' CE2' ' CE2' ' A' ' 91' ' ' TYR . 0.6 OUTLIER -171.66 148.56 2.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.908 -179.884 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.52 167.09 10.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.791 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.66 -52.43 64.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.896 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -63.39 -43.71 96.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.916 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.77 -36.61 79.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.156 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.457 ' CD2' HD11 ' A' ' 122' ' ' ILE . 0.2 OUTLIER -64.16 -33.82 76.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.833 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.496 ' O ' HG21 ' A' ' 92' ' ' ILE . 23.4 mttt -61.62 -45.33 94.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.012 0.434 . . . . 0.0 110.369 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.55 -27.9 45.94 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.834 178.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.503 ' CE2' ' CE2' ' A' ' 83' ' ' PHE . 12.6 t80 -67.77 -47.09 70.18 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.848 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.496 HG21 ' O ' ' A' ' 89' ' ' LYS . 1.6 tp -62.46 -41.61 92.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.828 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.425 ' O ' ' CG ' ' A' ' 97' ' ' LYS . 17.5 ttmt -59.07 -46.36 88.47 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.045 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -66.42 -43.75 84.85 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.149 -179.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.541 ' CD1' ' C ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -73.24 -42.46 62.54 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.943 -179.088 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 23.0 ptm -61.0 -32.16 71.74 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.303 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.425 ' CG ' ' O ' ' A' ' 93' ' ' LYS . 6.4 mmtp -66.91 -43.91 82.13 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.511 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.2 m -56.19 -41.37 75.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.735 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.7 mt -79.79 -41.7 21.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.701 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 13.2 tttt -53.76 -56.29 18.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.532 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -59.97 -45.2 96.3 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.189 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.03 -41.93 97.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.903 0.383 . . . . 0.0 110.378 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.444 ' O ' ' N ' ' A' ' 107' ' ' ARG . 9.2 tp -66.36 -34.2 77.43 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.259 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 108' ' ' PRO . 31.3 mt-10 -60.11 -29.07 68.37 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.617 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -88.19 -18.76 28.01 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.548 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -107.05 -58.49 1.93 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.775 0.322 . . . . 0.0 111.693 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.444 ' N ' ' O ' ' A' ' 103' ' ' LEU . 46.1 mtt180 -134.04 66.4 71.81 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.809 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.4 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 9.1 Cg_endo -50.46 -22.68 9.3 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 123.141 2.561 . . . . 0.0 112.729 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -73.68 -9.3 58.53 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.735 0.302 . . . . 0.0 111.176 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.487 ' C ' ' HD2' ' A' ' 113' ' ' PRO . 3.0 mmt180 -110.91 -0.16 16.91 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.616 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 32.9 m -72.67 -33.43 44.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.575 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 13.9 mttt -66.87 -50.38 43.7 Favored Pre-proline 0 C--N 1.331 -0.21 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.555 -179.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.575 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 32.8 Cg_exo -59.05 -39.36 80.88 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 121.967 1.778 . . . . 0.0 111.724 179.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.426 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 67.3 t80 -64.25 -37.89 89.1 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.887 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 4.1 mmm -58.57 -50.13 74.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.728 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 66.4 m -74.33 -44.34 52.92 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.742 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.47 -40.0 98.31 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.516 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.42 -51.55 69.34 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.006 0.431 . . . . 0.0 110.948 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.6 -31.42 65.17 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.088 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -72.12 -41.33 67.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.106 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -73.53 -36.71 65.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.078 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.457 HD11 ' CD2' ' A' ' 88' ' ' TYR . 0.4 OUTLIER -67.12 -46.08 85.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.247 -179.765 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.451 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 1.2 ptpm? -61.42 -31.41 71.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.083 0.468 . . . . 0.0 110.223 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -67.1 -53.66 28.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.705 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 15.0 pt -62.28 -41.71 92.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.249 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 12.3 mt -53.85 -35.85 61.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.922 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -68.05 -13.82 62.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.14 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -139.98 32.37 1.97 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.011 0.434 . . . . 0.0 110.628 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.514 ' CE1' ' CZ ' ' A' ' 134' ' ' PHE . 2.8 t80 -49.47 -28.87 5.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.096 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.49 -27.04 65.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.986 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -94.22 -35.97 12.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.476 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -94.44 140.52 29.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.923 0.392 . . . . 0.0 111.373 -179.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.2 mm100 -124.13 145.49 49.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.805 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.514 ' CZ ' ' CE1' ' A' ' 129' ' ' PHE . 0.5 OUTLIER -80.47 123.87 28.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.069 -179.787 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.413 ' CE2' ' HB2' ' A' ' 80' ' ' GLU . 36.6 m-85 -126.76 151.94 47.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.499 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -138.7 160.04 30.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.001 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.05 -159.25 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.2 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.432 ' HB3' ' HB2' ' A' ' 77' ' ' HIS . 5.7 pt-20 -76.79 -8.77 57.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.609 0.242 . . . . 0.0 111.436 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 20.4 m-80 -96.58 -29.75 13.68 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 31.1 mtm 57.44 37.73 27.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.907 0.384 . . . . 0.0 110.854 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . 0.407 ' ND2' ' HA3' ' A' ' 144' ' ' GLY . 15.0 p-10 -66.22 115.01 19.45 Favored Pre-proline 0 N--CA 1.452 -0.352 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.164 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -62.73 -28.96 76.75 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.505 2.137 . . . . 0.0 112.17 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -84.55 -3.9 58.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.148 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.407 ' HA3' ' ND2' ' A' ' 141' ' ' ASN . . . -87.05 -146.52 10.5 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.381 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 2.3 ptp -104.9 179.86 4.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.765 0.317 . . . . 0.0 110.768 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 43.7 t -128.98 149.31 33.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.136 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.43 ' HB3' ' CE1' ' A' ' 162' ' ' PHE . . . -111.75 115.86 29.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.663 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.482 ' HB2' ' HB ' ' A' ' 161' ' ' ILE . 4.6 mt -90.57 106.14 18.3 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.86 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 5.2 tp -88.56 120.64 30.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.192 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.463 ' HB3' ' CE1' ' A' ' 159' ' ' TYR . 47.9 t0 -138.06 164.35 29.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.442 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -105.98 146.99 29.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.889 0.376 . . . . 0.0 111.026 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.71 -177.66 0.62 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.863 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -60.46 -41.21 93.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.858 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -79.19 -15.11 58.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.16 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 60.51 33.79 83.0 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.537 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 91.2 t -107.08 -24.08 4.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.78 0.324 . . . . 0.0 111.039 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.4 t -132.22 124.23 19.24 Favored Pre-proline 0 CA--C 1.531 0.241 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.136 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -79.93 135.42 11.21 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.529 2.152 . . . . 0.0 112.079 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.463 ' CE1' ' HB3' ' A' ' 150' ' ' ASP . 8.0 p90 -124.61 136.02 53.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.862 0.363 . . . . 0.0 111.016 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' MET . . . . . . . . . . . . . 24.7 mtp -104.43 140.51 37.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.958 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.482 ' HB ' ' HB2' ' A' ' 148' ' ' LEU . 53.1 mt -99.67 113.67 35.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.16 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . 0.43 ' CE1' ' HB3' ' A' ' 147' ' ' ALA . 92.6 m-85 -110.15 158.14 18.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.705 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.414 ' CZ ' ' OH ' ' A' ' 95' ' ' TYR . 24.2 m-85 -99.18 114.64 27.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.852 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 33.0 tttm -57.98 -51.9 67.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.136 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.426 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 37.8 m-20 -54.55 -35.63 63.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.038 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -96.94 28.51 13.46 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.397 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -147.34 143.6 28.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.878 0.37 . . . . 0.0 110.801 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -105.11 162.58 13.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.803 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.31 138.32 44.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.976 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.845 -179.953 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.403 HG23 ' HB2' ' A' ' 16' ' ' ASP . 2.4 tt . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.837 0.351 . . . . 0.0 111.008 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 21.2 mm -101.77 157.88 4.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.353 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.508 ' CD2' ' CE2' ' A' ' 14' ' ' PHE . 5.5 m-85 -126.58 95.22 4.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.423 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 10.0 ptt180 -110.67 148.59 31.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.955 0.407 . . . . 0.0 111.183 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.441 ' O ' ' HA ' ' A' ' 10' ' ' HIS . 31.8 t0 -56.96 152.2 13.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.741 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 36.1 tp -81.31 -24.05 37.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.225 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.9 mp -91.36 -44.61 14.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.827 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.0 t -94.13 -21.09 19.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.756 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.441 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 25.5 m-70 62.34 26.63 15.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.86 0.362 . . . . 0.0 110.812 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -101.96 124.6 47.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.798 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -58.03 104.06 0.18 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.386 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 19.7 mtt -82.82 -18.68 39.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.62 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.508 ' CE2' ' CD2' ' A' ' 4' ' ' TYR . 16.0 p90 -178.64 176.74 0.96 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.68 179.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.66 -170.73 2.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.824 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.403 ' HB2' HG23 ' A' ' 2' ' ' ILE . 34.5 t70 -95.91 28.53 3.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.114 0.483 . . . . 0.0 110.877 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.418 HD11 ' CZ ' ' A' ' 18' ' ' TYR . 45.9 pt -89.31 -11.34 10.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.731 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.42 ' CZ ' HG22 ' A' ' 72' ' ' ILE . 62.9 m-85 -109.45 -171.09 1.77 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.67 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.1 mttt -94.13 86.97 5.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.702 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.7 mp -88.66 127.06 41.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.203 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -119.87 148.36 43.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.612 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -94.25 117.09 29.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.01 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.1 pt -113.71 166.63 7.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.087 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 57.53 29.99 18.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.203 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 64.56 39.66 6.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.203 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.37 -16.09 61.82 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.593 -0.813 . . . . 0.0 113.071 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.57 -30.14 53.37 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.829 0.347 . . . . 0.0 111.083 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 56.6 m -149.4 164.66 34.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.877 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.32 128.97 44.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.962 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.46 ' HA ' ' O ' ' A' ' 160' ' ' MET . 67.7 mt-10 -91.27 117.25 29.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.306 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 23.0 t -98.79 111.94 29.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.605 179.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -90.74 116.28 28.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.303 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -100.78 -130.52 7.07 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.228 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.2 pttm -174.46 125.98 0.32 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.919 0.39 . . . . 0.0 110.893 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 35.8 mtp -70.37 123.46 21.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.745 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.0 m . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.229 -179.879 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.249 -0.34 . . . . 0.0 112.249 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.436 ' CG1' HG12 ' A' ' 72' ' ' ILE . 47.7 t -72.58 142.73 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-O 120.801 0.334 . . . . 0.0 110.801 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -69.04 -56.61 7.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.551 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.44 ' HB ' ' CE1' ' A' ' 76' ' ' HIS . 9.5 pt -53.66 -33.83 23.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.816 0.341 . . . . 0.0 111.409 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.403 ' CG1' ' HB2' ' A' ' 78' ' ' LEU . 98.6 t -71.2 -33.08 49.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.037 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.0 mtm -78.27 -39.73 39.18 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.634 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.43 ' OD1' ' CD2' ' A' ' 76' ' ' HIS . 15.2 p30 -82.17 -28.24 32.19 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.609 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.44 ' CE1' ' HB ' ' A' ' 72' ' ' ILE . 28.1 m170 -93.07 0.99 57.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.852 0.358 . . . . 0.0 110.801 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.417 ' HB2' ' HB3' ' A' ' 138' ' ' GLU . 7.8 m170 56.58 28.53 14.06 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.314 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.403 ' HB2' ' CG1' ' A' ' 73' ' ' VAL . 71.0 mt -56.99 129.13 40.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.512 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 -112.82 130.58 56.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.254 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.412 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 30.1 tt0 -83.86 129.66 34.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.074 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.6 t -116.57 -179.75 3.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.856 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 69.9 m -121.4 165.67 15.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.96 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.501 ' CE2' ' CE2' ' A' ' 91' ' ' TYR . 3.2 m-85 -171.71 154.01 3.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.043 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.2 m -101.58 166.98 10.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.694 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.0 mtpp -57.73 -52.47 65.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.891 0.377 . . . . 0.0 110.996 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.72 -37.14 76.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.959 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.31 -44.28 88.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.158 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.512 ' CZ ' ' CE1' ' A' ' 134' ' ' PHE . 1.0 OUTLIER -60.98 -32.93 72.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.814 179.876 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 18.2 mttm -61.97 -43.41 98.91 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.549 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.1 mtmt -78.09 -28.02 48.61 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.663 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.501 ' CE2' ' CE2' ' A' ' 83' ' ' PHE . 8.8 t80 -65.48 -47.41 76.15 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.616 179.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.446 ' O ' ' HG2' ' A' ' 96' ' ' MET . 4.7 tp -61.18 -45.91 97.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.956 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 16.6 tttp -58.42 -38.33 77.18 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.252 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.475 ' HA ' ' HG2' ' A' ' 97' ' ' LYS . 19.6 t70 -75.06 -43.64 52.19 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.903 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.46 ' CD1' ' C ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -75.22 -40.07 59.46 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 121.074 -0.25 . . . . 0.0 111.119 -179.368 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.446 ' HG2' ' O ' ' A' ' 92' ' ' ILE . 3.1 ptt? -67.7 -32.27 72.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.734 0.302 . . . . 0.0 110.707 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.475 ' HG2' ' HA ' ' A' ' 94' ' ' ASP . 5.4 ptpt -69.23 -34.32 74.66 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.705 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.469 ' N ' ' HG3' ' A' ' 97' ' ' LYS . 2.1 m -62.71 -41.28 99.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.295 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 5.9 mt -79.89 -39.08 19.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.352 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.97 -57.79 10.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.578 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -59.44 -43.53 97.39 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.625 -0.797 . . . . 0.0 111.914 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.4 tmtt? -61.51 -42.11 98.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.978 0.418 . . . . 0.0 110.276 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.452 ' O ' ' N ' ' A' ' 107' ' ' ARG . 8.7 tp -66.69 -33.35 75.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.1 179.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.406 ' HA ' ' HA ' ' A' ' 108' ' ' PRO . 39.6 mt-10 -60.5 -28.98 68.8 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.611 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -87.24 -20.24 27.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.436 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -104.95 -58.87 1.83 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.779 0.323 . . . . 0.0 111.703 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.452 ' N ' ' O ' ' A' ' 103' ' ' LEU . 23.8 mtt85 -136.43 67.39 60.02 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.027 0.441 . . . . 0.0 110.894 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 9.5 Cg_endo -50.58 -21.71 8.16 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 123.275 2.65 . . . . 0.0 112.733 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -71.07 -9.12 57.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.608 0.242 . . . . 0.0 111.245 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -112.44 -3.4 14.47 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 34.7 m -71.74 -27.19 27.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.659 0.266 . . . . 0.0 111.656 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.551 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 0.9 OUTLIER -68.68 -55.54 11.2 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.574 -179.194 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.551 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 37.1 Cg_exo -59.87 -31.82 94.38 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 121.868 1.712 . . . . 0.0 111.429 179.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.44 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 73.5 t80 -68.15 -42.78 79.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.958 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -56.02 -51.9 66.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.887 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 60.2 m -76.57 -43.82 37.25 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.675 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -55.3 -53.84 38.19 Favored Glycine 0 N--CA 1.452 -0.277 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.761 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.62 -51.78 67.39 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.052 0.453 . . . . 0.0 111.09 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.78 -28.05 69.18 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.182 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -75.49 -57.86 3.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.229 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -60.12 -39.66 87.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.399 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.454 ' CG2' ' N ' ' A' ' 123' ' ' LYS . 0.4 OUTLIER -58.27 -46.5 88.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.897 0.38 . . . . 0.0 111.165 -179.777 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.454 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 20.0 mttm -62.02 -29.98 70.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.229 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -70.88 -54.79 10.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.709 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 15.4 pt -60.41 -43.8 94.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.277 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 11.6 mt -54.36 -37.58 65.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.944 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -72.55 -9.54 58.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.441 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 -142.47 31.68 1.5 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.899 0.381 . . . . 0.0 110.765 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.518 ' CE1' ' CZ ' ' A' ' 134' ' ' PHE . 6.3 t80 -54.11 -24.36 17.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.074 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 40.5 mtmt -57.92 -23.68 54.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.052 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 16.3 m-20 -94.23 -49.22 5.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.447 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.438 ' CD1' ' N ' ' A' ' 132' ' ' TYR . 0.6 OUTLIER -88.21 154.07 20.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.932 0.396 . . . . 0.0 111.212 -179.404 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.427 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 1.7 mm100 -131.29 143.32 50.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.945 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.518 ' CZ ' ' CE1' ' A' ' 129' ' ' PHE . 2.5 m-85 -77.75 121.28 23.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.055 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.412 ' CE2' ' HB2' ' A' ' 80' ' ' GLU . 32.9 m-85 -126.47 134.97 50.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.708 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.454 ' HB ' ' HA ' ' A' ' 140' ' ' MET . 0.7 OUTLIER -120.91 160.99 21.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.785 179.989 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -58.31 -165.5 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.272 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.417 ' HB3' ' HB2' ' A' ' 77' ' ' HIS . 7.1 pm0 -72.54 -9.01 58.04 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.544 0.212 . . . . 0.0 111.371 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 22.5 m-80 -96.92 -35.4 10.9 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.504 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' MET . . . . . 0.454 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 37.0 mtp 60.86 36.91 18.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.701 0.286 . . . . 0.0 111.234 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -66.0 122.21 79.92 Favored Pre-proline 0 N--CA 1.453 -0.297 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.733 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -61.89 -23.46 75.98 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.246 1.964 . . . . 0.0 111.824 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -84.64 -12.24 54.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.672 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -79.27 -160.46 19.01 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.237 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -100.31 -177.38 3.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.766 0.317 . . . . 0.0 110.93 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 46.9 t -126.67 148.92 31.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.135 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.415 ' HB1' ' CE2' ' A' ' 162' ' ' PHE . . . -116.27 110.58 18.94 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.555 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.514 ' HB2' ' HB ' ' A' ' 161' ' ' ILE . 3.9 mt -84.58 115.25 22.52 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.139 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 12.4 tp -88.27 123.62 33.05 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.764 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.474 ' HB2' ' CZ ' ' A' ' 159' ' ' TYR . 24.2 m-20 -127.72 158.69 36.94 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.885 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -117.22 148.84 41.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.907 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -75.48 178.57 5.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.822 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.8 -37.94 80.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.976 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -75.62 -15.11 60.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.302 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 64.05 23.69 68.0 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.492 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 65.3 t -112.0 -38.38 3.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.753 0.311 . . . . 0.0 110.89 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 86.9 m -98.58 103.01 16.34 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.226 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -77.93 127.55 8.65 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.395 2.063 . . . . 0.0 112.057 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.474 ' CZ ' ' HB2' ' A' ' 150' ' ' ASP . 12.1 p90 -124.58 133.17 53.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.668 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' MET . . . . . 0.46 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 0.3 OUTLIER -99.98 169.01 9.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.761 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.514 ' HB ' ' HB2' ' A' ' 148' ' ' LEU . 89.6 mt -123.94 110.7 26.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.175 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . 0.415 ' CE2' ' HB1' ' A' ' 147' ' ' ALA . 87.6 m-85 -114.38 156.71 23.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.729 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -99.21 123.59 43.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.852 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.32 -55.31 29.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.189 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.44 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 0.8 OUTLIER -51.23 -34.92 34.34 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.071 -179.855 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -96.86 27.9 16.03 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.366 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.66 144.05 29.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.777 0.322 . . . . 0.0 110.793 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -112.85 156.82 22.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.811 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.51 149.98 41.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.005 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.926 179.945 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.403 ' CD1' ' HB3' ' A' ' 169' ' ' MET . 1.7 tt . . . . . 0 N--CA 1.456 -0.158 0 CA-C-O 120.854 0.359 . . . . 0.0 111.036 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 11.7 mm -106.6 155.61 7.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.136 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.502 ' CD2' ' CE2' ' A' ' 14' ' ' PHE . 3.7 m-85 -123.73 104.71 9.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.665 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.73 156.31 32.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.9 0.381 . . . . 0.0 111.277 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.441 ' O ' ' HA ' ' A' ' 10' ' ' HIS . 27.0 t0 -61.64 152.18 31.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.767 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 67.1 tp -80.45 -22.11 41.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.234 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.0 mp -91.23 -46.53 14.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.966 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -93.05 -28.77 16.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.705 -179.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.441 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER 68.72 30.88 4.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.907 0.384 . . . . 0.0 110.747 -179.681 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -102.73 125.06 49.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.806 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.12 96.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.311 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 42.2 mtp -79.71 -16.97 54.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.606 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.502 ' CE2' ' CD2' ' A' ' 4' ' ' TYR . 23.7 p90 -178.98 172.73 1.25 Allowed 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.706 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -133.05 -169.91 2.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.19 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 54.3 p30 -89.3 15.56 8.84 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.521 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 44.6 pt -82.69 -9.31 11.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.816 0.341 . . . . 0.0 111.229 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.432 ' CE2' HG21 ' A' ' 72' ' ' ILE . 74.3 m-85 -111.65 -178.06 3.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.819 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.7 mtmt -94.48 91.45 6.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.683 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.3 mp -87.84 129.94 38.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.11 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.7 mtm180 -120.89 126.0 48.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.892 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -74.36 116.19 14.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.84 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.6 pt -109.6 165.37 5.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.025 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 59.5 32.69 21.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.092 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 64.78 45.01 3.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.301 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.52 -12.4 63.22 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.744 -0.741 . . . . 0.0 113.272 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.89 -39.48 71.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.938 0.369 . . . . 0.0 111.191 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 96.6 m -137.32 170.96 15.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.081 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.74 131.25 40.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.86 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.404 ' OE1' ' CD2' ' A' ' 159' ' ' TYR . 63.3 mt-10 -97.49 113.8 25.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.04 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 23.5 t -90.58 112.08 24.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.904 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -85.53 120.63 27.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.994 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.46 -142.34 11.14 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.457 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.0 ptmm? -165.31 124.73 1.77 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.787 0.327 . . . . 0.0 110.795 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 52.4 mtm -72.04 123.8 23.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.94 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.0 m . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.133 -179.953 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 112.117 -0.393 . . . . 0.0 112.117 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.436 ' CG1' HG12 ' A' ' 72' ' ' ILE . 53.2 t -70.8 147.58 11.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.791 0.329 . . . . 0.0 110.987 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -73.57 -55.56 6.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.306 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.459 ' HB ' ' CE1' ' A' ' 76' ' ' HIS . 8.9 pt -53.62 -33.72 22.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.183 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 84.1 t -71.5 -33.62 50.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.091 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.8 mtm -78.07 -39.2 42.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.585 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.409 ' OD1' ' CD2' ' A' ' 76' ' ' HIS . 15.8 p30 -82.11 -28.38 32.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.508 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.459 ' CE1' ' HB ' ' A' ' 72' ' ' ILE . 24.4 m170 -94.93 1.69 55.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.778 0.323 . . . . 0.0 110.936 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.7 m80 54.98 32.22 17.65 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.344 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 54.6 mt -59.13 139.11 57.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.383 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -124.77 137.44 54.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.93 0.395 . . . . 0.0 111.239 -179.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.411 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 2.5 tt0 -92.86 124.14 36.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.926 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.5 t -115.19 127.35 55.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.888 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 89.3 p -68.91 159.67 32.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.941 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -165.32 164.22 19.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.748 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -101.58 167.84 9.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.835 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.5 mtpt -67.02 -52.46 42.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.838 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.7 tp10 -64.89 -42.82 94.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.511 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.88 -39.37 81.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.931 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.51 ' CZ ' ' CE1' ' A' ' 134' ' ' PHE . 1.3 t80 -59.94 -38.66 83.04 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.786 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 70.7 mttt -56.82 -45.72 82.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.112 0.482 . . . . 0.0 110.591 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.79 -27.77 50.28 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.641 178.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -66.77 -44.6 80.95 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.743 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.446 ' HB ' HG13 ' A' ' 122' ' ' ILE . 5.4 tp -63.15 -44.3 99.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.014 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -62.63 -37.15 85.2 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.067 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.449 ' HA ' ' HG2' ' A' ' 97' ' ' LYS . 29.3 t70 -75.76 -42.95 48.97 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.662 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.478 ' CD1' ' C ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -77.8 -40.86 39.26 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 121.013 -0.275 . . . . 0.0 110.863 -179.476 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.444 ' HG3' ' N ' ' A' ' 97' ' ' LYS . 0.1 OUTLIER -65.12 -31.85 73.26 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.249 179.418 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.482 ' HG3' ' N ' ' A' ' 98' ' ' SER . 15.1 pttt -70.64 -34.13 71.74 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 120.945 0.402 . . . . 0.0 110.178 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.482 ' N ' ' HG3' ' A' ' 97' ' ' LYS . 2.0 m -59.47 -37.41 78.12 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.761 179.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.7 mt -79.78 -40.88 21.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.102 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.75 -51.33 70.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.22 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -59.54 -47.69 89.69 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.64 -0.79 . . . . 0.0 111.91 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.6 -41.27 97.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.921 0.391 . . . . 0.0 110.086 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.457 ' O ' ' N ' ' A' ' 107' ' ' ARG . 8.3 tp -65.37 -37.88 88.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.958 179.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 108' ' ' PRO . 76.4 mt-10 -56.62 -29.95 62.75 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.767 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -86.62 -20.19 28.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.531 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -106.84 -60.9 1.61 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.763 0.316 . . . . 0.0 111.602 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.457 ' N ' ' O ' ' A' ' 103' ' ' LEU . 4.0 mtt85 -129.37 65.23 73.92 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.816 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.441 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 9.7 Cg_endo -50.4 -22.5 8.85 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 123.22 2.613 . . . . 0.0 112.745 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -75.69 -6.92 52.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.653 0.263 . . . . 0.0 111.136 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.495 ' C ' ' HD2' ' A' ' 113' ' ' PRO . 13.9 mmt180 -112.38 -1.53 15.02 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.654 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 33.7 m -70.77 -36.24 63.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -179.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.559 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 25.8 mttm -66.65 -50.29 46.37 Favored Pre-proline 0 CA--C 1.529 0.16 0 C-N-CA 121.049 -0.261 . . . . 0.0 111.502 -179.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.559 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 37.0 Cg_exo -59.97 -32.04 94.47 Favored 'Trans proline' 0 C--N 1.347 0.447 0 C-N-CA 121.993 1.796 . . . . 0.0 111.568 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.476 ' CE1' ' HB2' ' A' ' 165' ' ' ASP . 76.0 t80 -69.99 -47.71 61.11 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.852 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -50.97 -42.03 59.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.02 0.438 . . . . 0.0 110.769 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.8 m -76.65 -44.29 34.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.717 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.43 -52.47 52.39 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.679 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.04 -51.74 66.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.937 0.399 . . . . 0.0 111.134 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.58 -28.2 68.97 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.363 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -77.87 -45.69 23.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.9 0.381 . . . . 0.0 111.194 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -70.49 -36.45 73.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.208 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.465 ' CG2' ' N ' ' A' ' 123' ' ' LYS . 0.3 OUTLIER -61.89 -47.37 93.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.326 -179.765 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.465 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 13.4 pttt -61.76 -31.19 71.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.017 0.437 . . . . 0.0 110.072 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -67.9 -53.65 24.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.621 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.419 HG23 ' CD2' ' A' ' 132' ' ' TYR . 15.5 pt -62.01 -42.04 93.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.291 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.404 ' HG ' ' CD1' ' A' ' 122' ' ' ILE . 11.3 mt -53.9 -35.9 62.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.944 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.99 -14.29 62.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.087 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -140.5 33.15 1.85 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.073 0.463 . . . . 0.0 110.398 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.504 ' CE1' ' CZ ' ' A' ' 134' ' ' PHE . 5.5 t80 -49.02 -27.59 3.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.224 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 2.8 ttpp -60.57 -27.78 67.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.791 0.329 . . . . 0.0 110.867 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 30.8 m-20 -94.27 -32.19 13.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.322 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.419 ' CD2' HG23 ' A' ' 125' ' ' ILE . 3.6 m-85 -98.36 131.97 44.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.199 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.7 mm100 -117.33 143.72 45.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.803 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.51 ' CE1' ' CZ ' ' A' ' 88' ' ' TYR . 2.1 m-85 -80.01 124.11 28.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.062 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.411 ' CE2' ' HB2' ' A' ' 80' ' ' GLU . 43.1 m-85 -127.88 145.84 50.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.686 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.411 ' HB ' ' HA ' ' A' ' 140' ' ' MET . 0.7 OUTLIER -131.59 163.64 36.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.042 179.958 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -64.56 -159.55 0.38 Allowed Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.298 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -75.97 -8.89 58.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.597 0.237 . . . . 0.0 111.512 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -97.24 -31.75 12.27 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.583 0.23 . . . . 0.0 111.563 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' MET . . . . . 0.411 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 56.0 mtp 58.26 37.39 26.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.809 0.338 . . . . 0.0 110.945 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 19.6 p-10 -64.35 115.0 16.18 Favored Pre-proline 0 N--CA 1.452 -0.372 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.934 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.92 -29.7 90.04 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.514 2.142 . . . . 0.0 112.287 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -84.55 -6.63 59.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.059 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -79.08 -141.12 2.05 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.413 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 3.2 ptp -113.36 -178.55 3.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.752 0.311 . . . . 0.0 110.919 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.406 ' CG1' ' HB3' ' A' ' 134' ' ' PHE . 42.2 t -128.06 144.95 36.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.283 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -111.67 114.73 27.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.681 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.51 ' HB2' ' HB ' ' A' ' 161' ' ' ILE . 3.3 mt -88.53 106.3 18.2 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.068 -179.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.7 tp -88.93 119.62 29.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.219 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.44 ' HB2' ' CZ ' ' A' ' 159' ' ' TYR . 0.9 OUTLIER -129.08 165.91 20.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.695 179.517 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -111.88 146.15 38.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.96 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 21.9 mmt180 -67.32 -177.46 0.7 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.879 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.41 -31.94 68.17 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.899 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 38.1 p-10 -77.35 -15.05 59.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.23 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 71.83 17.21 76.66 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.72 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 91.1 t -112.93 -70.4 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.841 0.353 . . . . 0.0 110.733 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 86.4 m -55.07 107.86 0.99 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.08 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -84.25 128.22 4.16 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.586 2.19 . . . . 0.0 112.334 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.44 ' CZ ' ' HB2' ' A' ' 150' ' ' ASP . 9.4 p90 -124.22 136.05 53.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.821 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -107.08 136.73 46.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.992 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.51 ' HB ' ' HB2' ' A' ' 148' ' ' LEU . 62.3 mt -91.55 112.65 25.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.103 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -110.24 152.18 26.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.833 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.42 ' CE2' ' OH ' ' A' ' 95' ' ' TYR . 3.1 m-85 -96.28 124.7 40.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.617 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -65.96 -56.36 12.08 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.355 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.476 ' HB2' ' CE1' ' A' ' 114' ' ' PHE . 7.0 m-20 -50.1 -36.29 28.98 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.859 0.362 . . . . 0.0 111.071 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -95.87 24.76 28.3 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.24 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -139.99 145.07 37.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.754 0.311 . . . . 0.0 110.841 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -119.23 143.45 47.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.796 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' MET . . . . . 0.403 ' HB3' ' CD1' ' A' ' 2' ' ' ILE . 0.6 OUTLIER -110.51 146.41 36.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.022 -179.918 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.958 -179.944 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.417 HG22 ' HB2' ' A' ' 16' ' ' ASP . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.741 0.305 . . . . 0.0 110.983 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 169' ' ' MET . 14.8 mm -100.14 137.75 26.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.723 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.485 ' CD2' ' CZ ' ' A' ' 14' ' ' PHE . 6.1 m-85 -106.36 105.37 15.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.457 179.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -122.44 145.76 47.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.839 0.352 . . . . 0.0 111.231 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.46 ' O ' ' HA ' ' A' ' 10' ' ' HIS . 43.5 t0 -56.21 152.08 11.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.723 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 57.9 tp -78.8 -26.71 44.38 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.2 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.4 mp -91.34 -44.12 14.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -179.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.473 ' O ' ' CG ' ' A' ' 10' ' ' HIS . 30.0 t -95.33 -10.19 30.84 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -178.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.473 ' CG ' ' O ' ' A' ' 9' ' ' SER . 25.5 p80 48.31 27.62 1.4 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.952 0.406 . . . . 0.0 111.267 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -98.21 122.59 41.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.705 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.47 84.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.362 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.413 ' O ' ' CD2' ' A' ' 76' ' ' HIS . 7.0 mtp -64.34 -18.57 64.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.588 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.485 ' CZ ' ' CD2' ' A' ' 4' ' ' TYR . 8.8 p90 -178.94 179.7 0.66 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.634 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -136.99 -169.9 2.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.91 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.417 ' HB2' HG22 ' A' ' 2' ' ' ILE . 37.8 t70 -93.55 26.18 3.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.027 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.424 HG13 ' CD2' ' A' ' 18' ' ' TYR . 46.0 pt -84.77 -13.28 11.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.754 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.428 ' CZ ' HG22 ' A' ' 72' ' ' ILE . 79.0 m-85 -110.72 168.64 9.32 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.618 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.44 94.01 4.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.864 0.364 . . . . 0.0 110.581 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.2 mp -87.79 139.41 17.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.12 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -127.35 119.53 26.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.036 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -71.77 114.7 10.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.859 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.9 pt -111.49 167.1 5.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.203 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 59.29 30.17 19.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.236 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 64.38 36.67 8.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.152 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.12 -15.32 61.64 Favored Glycine 0 CA--C 1.518 0.245 0 C-N-CA 120.556 -0.831 . . . . 0.0 112.986 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.04 -43.39 73.74 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.811 0.338 . . . . 0.0 110.917 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 9.0 m -135.66 165.05 26.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.912 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.02 139.09 52.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.785 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -103.51 113.01 26.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.086 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 23.5 t -91.56 112.05 24.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.721 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -82.12 114.39 20.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.229 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.43 -137.13 8.84 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.288 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -174.51 128.24 0.33 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.885 0.374 . . . . 0.0 110.809 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 8.3 mtt -72.3 124.26 24.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.921 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 28.0 m . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.208 -179.899 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.466 0 N-CA-C 111.891 -0.484 . . . . 0.0 111.891 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.433 ' CG1' HG12 ' A' ' 72' ' ' ILE . 46.8 t -73.25 141.89 15.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.75 0.309 . . . . 0.0 110.754 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -68.59 -56.17 9.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.725 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.439 ' HB ' ' CD2' ' A' ' 76' ' ' HIS . 8.5 pt -53.58 -33.77 22.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.868 0.366 . . . . 0.0 111.32 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.423 ' CG2' ' HB ' ' A' ' 70' ' ' VAL . 92.9 t -70.8 -32.0 47.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.83 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.5 mtm -78.3 -40.64 36.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.539 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -82.07 -28.46 32.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.621 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.439 ' CD2' ' HB ' ' A' ' 72' ' ' ILE . 7.2 m-70 -90.22 -5.68 56.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.857 0.36 . . . . 0.0 110.676 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 9.0 m80 62.45 29.93 17.19 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.103 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.406 ' HB2' ' CG1' ' A' ' 73' ' ' VAL . 34.5 mt -59.53 147.1 38.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.499 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -127.71 137.24 52.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.86 0.362 . . . . 0.0 111.042 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.43 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 2.9 tt0 -99.96 124.11 44.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.056 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.6 t -123.69 135.18 53.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.769 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 9.1 m -68.01 160.58 28.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.092 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.43 ' HB2' ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -156.8 154.54 30.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.866 179.975 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.9 m -99.13 157.08 16.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.786 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.67 -52.39 65.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.904 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -66.51 -43.09 86.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.683 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.6 -37.8 82.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.05 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.461 ' CD2' HD11 ' A' ' 122' ' ' ILE . 1.3 t80 -62.87 -35.13 79.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.745 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 24.4 mttt -59.99 -45.5 92.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.051 0.453 . . . . 0.0 110.443 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.65 -27.93 55.81 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.629 178.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -66.21 -47.47 73.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.638 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.457 ' O ' ' HG2' ' A' ' 96' ' ' MET . 4.7 tp -60.3 -43.93 94.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.968 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 8.6 ttmt -60.08 -43.64 95.36 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.214 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.445 ' HA ' ' HG2' ' A' ' 97' ' ' LYS . 12.0 t70 -72.75 -39.72 66.6 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.819 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.471 ' CD1' ' C ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -76.46 -41.62 46.69 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 121.004 -0.279 . . . . 0.0 110.855 -179.497 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.457 ' HG2' ' O ' ' A' ' 92' ' ' ILE . 2.9 ptt? -67.95 -32.75 73.4 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.73 0.3 . . . . 0.0 110.844 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.445 ' HG2' ' HA ' ' A' ' 94' ' ' ASP . 0.3 OUTLIER -70.68 -35.58 72.89 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.894 0.378 . . . . 0.0 110.577 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.9 m -60.52 -40.49 91.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.144 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 6.6 mt -79.85 -41.63 21.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.445 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.5 tmtt? -54.44 -54.07 45.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.502 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -58.69 -45.93 94.07 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.192 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 10.4 tptp -61.69 -41.28 97.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.806 0.336 . . . . 0.0 110.461 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.446 ' O ' ' N ' ' A' ' 107' ' ' ARG . 5.0 tp -67.4 -34.1 76.57 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.132 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -59.81 -29.83 68.51 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.828 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -87.84 -19.39 27.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.561 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -105.44 -58.17 1.93 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.736 0.303 . . . . 0.0 111.611 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.446 ' N ' ' O ' ' A' ' 103' ' ' LEU . 87.5 mtt180 -138.5 67.91 45.22 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 120.919 0.39 . . . . 0.0 110.858 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.408 ' HA ' HG11 ' A' ' 111' ' ' VAL . 10.3 Cg_endo -50.88 -20.97 7.71 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 123.254 2.636 . . . . 0.0 112.888 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -67.69 -9.72 46.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.592 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.447 ' C ' ' HD2' ' A' ' 113' ' ' PRO . 31.0 mmt-85 -114.23 -4.82 13.02 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.408 HG11 ' HA ' ' A' ' 108' ' ' PRO . 35.6 m -69.52 -27.74 35.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.565 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 4.3 mmtp -71.99 -54.32 6.08 Favored Pre-proline 0 CA--C 1.532 0.257 0 C-N-CA 121.078 -0.249 . . . . 0.0 111.416 -179.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.565 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 37.2 Cg_exo -56.08 -35.89 95.47 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 121.772 1.648 . . . . 0.0 111.547 179.061 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.461 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 87.5 t80 -65.8 -43.18 89.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.904 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.54 -52.36 55.19 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.08 0.467 . . . . 0.0 110.741 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 61.7 m -75.8 -44.19 42.49 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.695 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -56.21 -51.39 56.19 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.687 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.16 -51.67 67.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.994 0.426 . . . . 0.0 110.985 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.55 -28.07 69.07 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.229 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -77.94 -48.54 16.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.859 0.362 . . . . 0.0 111.048 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -67.31 -34.99 78.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.025 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.461 HD11 ' CD2' ' A' ' 88' ' ' TYR . 0.3 OUTLIER -67.03 -45.1 87.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.064 -179.865 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.439 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 26.3 mttt -61.47 -29.94 70.29 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.411 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -70.19 -53.96 14.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.764 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.428 HG22 ' CD2' ' A' ' 132' ' ' TYR . 14.5 pt -60.52 -41.86 89.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.273 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 12.4 mt -55.23 -38.41 68.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.89 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -71.39 -10.82 60.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.317 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -140.59 33.48 1.83 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.859 0.361 . . . . 0.0 110.648 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.511 ' CE1' ' CE2' ' A' ' 134' ' ' PHE . 2.2 t80 -50.13 -29.96 10.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.99 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.6 ttpt -60.1 -29.68 68.75 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.935 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 21.3 m-20 -94.17 -35.73 12.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.436 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.428 ' CD2' HG22 ' A' ' 125' ' ' ILE . 4.7 m-85 -94.84 136.31 35.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.897 0.38 . . . . 0.0 111.211 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.2 mm100 -119.83 145.68 46.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.745 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.511 ' CE2' ' CE1' ' A' ' 129' ' ' PHE . 0.6 OUTLIER -83.35 121.82 27.64 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.989 -179.759 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.459 ' CG ' ' CE ' ' A' ' 160' ' ' MET . 46.5 m-85 -125.46 134.85 51.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.761 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.467 ' HB ' ' HA ' ' A' ' 140' ' ' MET . 0.3 OUTLIER -123.87 164.77 21.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.784 179.989 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.53 -173.05 1.25 Allowed Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.447 -0.882 . . . . 0.0 111.899 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -67.36 -13.68 62.23 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.564 0.221 . . . . 0.0 111.22 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -92.75 -28.66 16.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.723 0.297 . . . . 0.0 111.366 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' MET . . . . . 0.467 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 53.8 mtm 54.69 43.08 30.7 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.811 0.339 . . . . 0.0 111.201 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -67.29 122.28 82.26 Favored Pre-proline 0 N--CA 1.453 -0.279 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.67 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -59.74 -27.23 84.45 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.351 2.034 . . . . 0.0 111.881 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -84.76 -15.99 43.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.814 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.99 -173.45 24.78 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.347 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -88.84 -177.99 5.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.737 0.303 . . . . 0.0 110.881 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 41.6 t -127.6 153.84 37.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.222 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -118.54 115.74 25.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.691 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.533 ' HB2' ' HB ' ' A' ' 161' ' ' ILE . 3.6 mt -90.18 106.7 18.66 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.948 -179.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.6 tp -88.5 119.61 29.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.409 -179.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.445 ' HB3' ' CE1' ' A' ' 159' ' ' TYR . 0.7 OUTLIER -129.49 172.24 11.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.525 179.4 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -117.76 144.41 45.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.847 0.356 . . . . 0.0 111.008 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.41 -177.71 0.05 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.933 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.36 -34.97 71.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.017 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -76.54 -15.14 59.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.218 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 69.17 26.04 74.95 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.711 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 94.5 t -112.83 -69.81 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.932 0.396 . . . . 0.0 110.885 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 73.4 m -63.77 111.23 4.86 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.01 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -81.73 131.17 7.08 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.462 2.108 . . . . 0.0 112.192 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.445 ' CE1' ' HB3' ' A' ' 150' ' ' ASP . 13.9 p90 -125.62 144.59 50.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.92 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' MET . . . . . 0.459 ' CE ' ' CG ' ' A' ' 135' ' ' PHE . 0.2 OUTLIER -110.7 142.65 42.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.137 -179.792 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.533 ' HB ' ' HB2' ' A' ' 148' ' ' LEU . 58.7 mt -97.68 116.34 39.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.974 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -118.6 132.82 56.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.798 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -78.0 123.0 26.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.867 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.46 -54.48 35.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.327 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.461 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 1.6 m-20 -49.54 -36.2 22.75 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.285 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -96.55 27.92 15.49 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.366 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.49 143.96 29.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.814 0.34 . . . . 0.0 110.925 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -113.66 147.76 37.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.725 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' MET . . . . . 0.409 ' HA ' ' O ' ' A' ' 3' ' ' ILE . 0.7 OUTLIER -120.08 140.3 51.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.975 -179.816 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.914 179.955 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.435 ' CD1' ' HB3' ' A' ' 169' ' ' MET . 4.5 tt . . . . . 0 N--CA 1.456 -0.139 0 CA-C-O 120.892 0.377 . . . . 0.0 111.038 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.2 mm -100.98 155.25 4.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.317 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.516 ' CD2' ' CE2' ' A' ' 14' ' ' PHE . 2.8 m-85 -122.8 105.94 10.47 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.424 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 17.5 ptt180 -120.8 150.29 41.25 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.937 0.398 . . . . 0.0 111.469 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.425 ' O ' ' HA ' ' A' ' 10' ' ' HIS . 37.6 t0 -62.38 152.18 34.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.616 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 56.6 tp -81.23 -22.6 38.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.395 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.1 mp -91.27 -45.9 14.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 93.1 p -93.14 -21.39 19.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.616 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.425 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 1.6 m-70 62.23 29.78 17.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.865 0.364 . . . . 0.0 110.805 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -106.1 124.62 49.87 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.804 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -58.44 93.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.207 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 7.3 mtt -70.08 -18.42 63.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.847 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.516 ' CE2' ' CD2' ' A' ' 4' ' ' TYR . 14.3 p90 -177.44 177.33 1.19 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.899 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -136.67 -169.88 2.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.975 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 34.5 p-10 -87.83 13.93 9.75 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.615 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 46.5 pt -78.9 -4.96 7.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.816 0.341 . . . . 0.0 111.13 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.46 ' CE2' HG21 ' A' ' 72' ' ' ILE . 65.3 m-85 -119.56 -179.07 3.77 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.728 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -91.39 88.71 6.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.748 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.0 mp -87.84 123.96 40.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.928 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 8.9 mtt180 -114.85 135.91 53.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.934 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -81.56 114.82 20.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.868 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.3 pt -110.23 162.59 7.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.21 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 60.01 29.77 19.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.251 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 64.42 50.81 2.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.423 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.65 -4.25 74.86 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 120.732 -0.747 . . . . 0.0 113.441 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.65 -29.36 69.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 117.036 0.418 . . . . 0.0 111.0 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 92.4 m -147.59 171.52 15.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.119 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -134.79 129.57 34.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.874 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.414 ' OE1' ' CD2' ' A' ' 159' ' ' TYR . 61.7 mt-10 -97.52 116.36 29.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.166 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.9 t -92.41 111.97 25.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.698 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -83.0 116.77 22.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.172 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -99.98 -144.51 16.22 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.201 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.0 pttm -174.53 126.01 0.31 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.829 0.347 . . . . 0.0 111.02 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 21.7 mtt -70.03 121.93 18.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.778 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.4 m . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.29 -179.775 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 N-CA-C 112.356 -0.298 . . . . 0.0 112.356 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.452 ' CG1' HG12 ' A' ' 72' ' ' ILE . 47.9 t -69.02 124.27 24.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.913 0.387 . . . . 0.0 110.756 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -54.28 -57.31 11.68 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.833 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.46 HG21 ' CE2' ' A' ' 18' ' ' TYR . 5.4 pt -53.74 -34.13 24.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.842 0.353 . . . . 0.0 111.364 -179.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 97.5 t -73.67 -29.97 27.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.055 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.7 mtt -78.24 -42.25 31.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.82 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.428 ' OD1' ' CD2' ' A' ' 76' ' ' HIS . 19.6 p30 -82.05 -29.68 31.78 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 -179.18 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.428 ' CD2' ' OD1' ' A' ' 75' ' ' ASN . 34.1 m170 -88.99 -5.39 57.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.862 0.363 . . . . 0.0 110.626 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 61.43 30.3 18.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.032 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 60.0 mt -58.57 148.56 28.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.49 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -131.75 136.47 47.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.854 0.359 . . . . 0.0 111.109 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.42 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 2.5 tm-20 -89.81 135.21 33.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.104 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.2 t -120.21 171.85 8.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.725 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 30.2 m -114.56 161.23 18.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.978 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.457 ' HB2' ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -171.62 159.81 5.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.039 -179.898 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 8.6 m -101.54 162.41 12.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.815 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 17.1 mtpt -58.39 -51.95 67.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.104 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -65.64 -46.44 79.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.842 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.46 -36.4 73.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.185 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.444 ' CZ ' ' CE1' ' A' ' 134' ' ' PHE . 1.0 OUTLIER -62.57 -37.9 87.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.809 179.874 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 28.1 mttm -58.58 -44.9 89.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.649 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.1 tttm -77.96 -27.9 49.33 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.652 178.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.4 ' CE2' ' CE2' ' A' ' 83' ' ' PHE . 12.4 t80 -66.9 -46.6 74.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.711 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.451 ' HB ' HG13 ' A' ' 122' ' ' ILE . 6.0 tp -61.9 -42.61 95.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.107 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.475 ' O ' ' CG ' ' A' ' 97' ' ' LYS . 11.3 ttpp -62.0 -45.28 94.32 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.92 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -70.56 -38.14 74.08 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.945 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.447 ' CD1' ' C ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -78.24 -43.51 28.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.742 -0.208 . . . . 0.0 110.839 -179.458 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.42 ' HG3' ' N ' ' A' ' 97' ' ' LYS . 0.3 OUTLIER -62.07 -31.77 72.22 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 178.778 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.475 ' CG ' ' O ' ' A' ' 93' ' ' LYS . 1.4 mmmp? -65.61 -41.87 92.23 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.35 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.7 m -52.85 -40.31 63.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.146 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 8.7 mt -79.76 -42.71 22.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.443 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.69 -49.05 74.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.376 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -60.89 -49.66 76.15 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.013 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.5 -40.53 91.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.86 0.362 . . . . 0.0 110.262 179.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.447 ' O ' ' N ' ' A' ' 107' ' ' ARG . 7.3 tp -65.17 -38.31 90.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.095 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.426 ' HA ' ' HA ' ' A' ' 108' ' ' PRO . 78.7 mt-10 -56.88 -29.54 63.06 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.725 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -87.03 -19.66 28.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.635 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -107.8 -61.77 1.53 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.882 0.372 . . . . 0.0 111.527 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.447 ' N ' ' O ' ' A' ' 103' ' ' LEU . 43.5 mtt-85 -131.11 65.41 76.57 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.715 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.426 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 9.8 Cg_endo -50.49 -22.82 9.58 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 123.19 2.594 . . . . 0.0 112.75 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -70.6 -10.46 59.36 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.217 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.493 ' C ' ' HD2' ' A' ' 113' ' ' PRO . 0.0 OUTLIER -108.89 -1.24 19.28 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -179.482 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 26.5 m -71.81 -34.41 51.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.56 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 23.9 mtmt -68.99 -49.57 24.95 Favored Pre-proline 0 C--N 1.332 -0.178 0 C-N-CA 120.949 -0.301 . . . . 0.0 111.633 -179.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.56 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 37.0 Cg_exo -60.56 -32.07 93.04 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.153 1.902 . . . . 0.0 111.686 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.469 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 36.7 t80 -72.16 -47.09 53.43 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.096 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 15.0 mmm -49.42 -43.25 44.45 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.021 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 69.1 m -76.01 -45.14 36.08 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.842 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.45 -54.78 34.3 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.803 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -52.62 -51.63 59.11 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.897 0.38 . . . . 0.0 111.434 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.424 ' O ' HG22 ' A' ' 122' ' ' ILE . . . -68.58 -29.05 67.51 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.662 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -72.87 -55.87 6.02 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.865 0.364 . . . . 0.0 111.214 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -60.83 -31.51 70.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.487 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.451 HG13 ' HB ' ' A' ' 92' ' ' ILE . 0.4 OUTLIER -63.71 -45.19 98.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.322 -179.532 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.436 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 15.5 mttp -61.45 -30.89 70.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.059 0.457 . . . . 0.0 110.196 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -69.34 -54.78 12.79 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.764 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 15.0 pt -60.26 -42.79 91.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.386 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 12.0 mt -53.98 -38.18 64.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.886 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.58 -15.18 63.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.212 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -137.98 32.32 2.42 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.941 0.401 . . . . 0.0 110.751 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.499 ' CE1' ' CZ ' ' A' ' 134' ' ' PHE . 4.2 t80 -51.93 -27.99 14.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.065 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.59 -18.87 65.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.296 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 15.8 m-80 -94.14 -36.25 12.15 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.325 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.442 ' CD1' ' N ' ' A' ' 132' ' ' TYR . 1.1 m-30 -102.7 162.32 13.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.829 0.347 . . . . 0.0 111.151 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.7 mm100 -138.0 147.57 44.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.889 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.499 ' CZ ' ' CE1' ' A' ' 129' ' ' PHE . 2.8 m-85 -78.62 129.74 35.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.955 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.42 ' CE2' ' HB2' ' A' ' 80' ' ' GLU . 33.2 m-85 -134.71 134.59 41.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.629 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.436 ' HB ' ' HA ' ' A' ' 140' ' ' MET . 0.8 OUTLIER -123.18 161.2 25.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.931 -179.977 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.51 -163.44 0.24 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.207 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -72.49 -8.88 57.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.554 0.216 . . . . 0.0 111.531 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -95.7 -35.34 11.61 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.607 0.241 . . . . 0.0 111.566 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' MET . . . . . 0.436 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 10.3 mtp 58.85 40.77 22.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.695 0.283 . . . . 0.0 111.217 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -69.67 117.64 55.18 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.633 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -62.54 -24.26 75.18 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.345 2.03 . . . . 0.0 111.78 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -84.8 -15.23 45.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.758 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -74.17 -136.11 0.37 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.317 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 5.6 ptp -120.29 -175.87 3.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.86 0.362 . . . . 0.0 110.712 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 57.5 t -129.09 144.78 37.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.338 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -111.39 117.8 34.08 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.378 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.468 ' HB2' ' HB ' ' A' ' 161' ' ' ILE . 5.8 mt -91.53 107.77 19.44 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.323 -179.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.3 tp -88.05 120.67 29.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.552 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.506 ' HB2' ' CZ ' ' A' ' 159' ' ' TYR . 18.3 m-20 -122.0 145.28 48.28 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.056 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 0.421 ' CE1' ' HB3' ' A' ' 158' ' ' PRO . 64.7 m-85 -100.75 135.44 42.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.933 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 15.2 mmm-85 -60.89 -178.64 0.1 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.943 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -59.88 -41.24 91.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.999 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -77.68 -15.08 59.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.287 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 67.49 25.14 73.86 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.522 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 71.6 t -110.21 -37.05 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.851 0.358 . . . . 0.0 110.964 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 94.3 m -103.41 96.63 8.81 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.225 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.421 ' HB3' ' CE1' ' A' ' 151' ' ' TYR . 71.8 Cg_endo -76.02 128.12 10.47 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.521 2.148 . . . . 0.0 112.169 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.506 ' CZ ' ' HB2' ' A' ' 150' ' ' ASP . 7.7 p90 -120.04 130.56 54.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.73 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' MET . . . . . . . . . . . . . 20.9 mtp -102.2 134.66 45.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.546 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.468 ' HB ' ' HB2' ' A' ' 148' ' ' LEU . 96.4 mt -90.45 113.06 25.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.861 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -109.82 154.54 22.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.921 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.419 ' CD2' ' OH ' ' A' ' 95' ' ' TYR . 3.4 m-30 -95.46 126.26 40.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.717 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.98 -54.91 11.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.306 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.469 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 3.2 m-20 -49.11 -37.31 21.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.181 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -95.46 26.38 20.03 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.377 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -140.77 146.04 37.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.823 0.344 . . . . 0.0 110.787 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -119.53 142.75 48.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.845 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' MET . . . . . 0.435 ' HB3' ' CD1' ' A' ' 2' ' ' ILE . 0.1 OUTLIER -109.09 148.57 30.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.992 -179.988 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.832 179.885 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.432 HG12 ' HG2' ' A' ' 169' ' ' MET . 11.8 tt . . . . . 0 N--CA 1.455 -0.21 0 CA-C-O 120.939 0.399 . . . . 0.0 111.012 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.9 mm -102.27 153.02 5.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.486 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.502 ' CD2' ' CZ ' ' A' ' 14' ' ' PHE . 3.3 m-85 -124.43 101.52 7.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.449 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.36 153.23 34.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.931 0.396 . . . . 0.0 111.398 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.449 ' O ' ' HA ' ' A' ' 10' ' ' HIS . 46.3 t0 -59.34 152.05 22.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.646 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 36.6 tp -81.96 -16.91 48.86 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.551 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.3 mp -91.41 -50.72 12.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 27.8 t -97.35 -18.04 19.37 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.449 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 9.0 m80 64.73 31.39 11.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.832 0.348 . . . . 0.0 110.865 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -97.77 122.1 40.46 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.738 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -58.16 95.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.32 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 5.1 mtt -74.86 -18.55 60.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.662 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.502 ' CZ ' ' CD2' ' A' ' 4' ' ' TYR . 10.7 p90 -178.87 174.02 1.16 Allowed 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.6 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -132.27 -169.97 2.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.729 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.417 ' HB2' HG22 ' A' ' 2' ' ' ILE . 37.6 t0 -96.29 30.75 2.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.192 0.52 . . . . 0.0 110.736 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.407 HG13 ' CD2' ' A' ' 18' ' ' TYR . 45.5 pt -93.31 -10.25 9.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.659 179.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.407 ' CD2' HG13 ' A' ' 17' ' ' ILE . 48.4 m-85 -111.87 -169.16 1.41 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.715 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.72 95.48 8.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.84 0.352 . . . . 0.0 110.901 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.2 mp -92.41 125.74 45.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.097 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.4 mtp85 -117.19 120.45 38.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.055 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -72.14 114.55 10.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.849 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.2 pt -112.86 167.4 6.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.192 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 58.06 30.81 19.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.274 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 63.95 44.08 4.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.347 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.21 -17.36 56.04 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 120.735 -0.745 . . . . 0.0 113.142 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.15 -50.4 61.83 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.831 0.348 . . . . 0.0 111.137 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 55.3 m -130.18 164.33 24.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.744 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.6 135.13 48.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.045 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -96.7 114.82 26.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.126 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 22.2 t -96.37 112.14 27.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.872 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -91.28 115.48 28.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.115 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -98.94 -131.49 7.31 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.458 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -172.39 124.93 0.5 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.804 0.335 . . . . 0.0 110.939 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 24.4 mtp -74.73 123.93 25.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.91 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.2 m . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.236 -179.894 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 N-CA-C 112.353 -0.299 . . . . 0.0 112.353 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.402 ' CG1' HG12 ' A' ' 72' ' ' ILE . 59.0 t -68.02 148.26 11.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.865 0.364 . . . . 0.0 110.851 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -71.56 -59.12 2.93 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.452 -179.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.45 ' HB ' ' CE1' ' A' ' 76' ' ' HIS . 8.9 pt -53.72 -33.94 23.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.437 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.4 ' CG1' ' HB2' ' A' ' 78' ' ' LEU . 61.5 t -72.72 -34.05 46.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.042 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.1 mtm -78.31 -39.15 40.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.576 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.403 ' OD1' ' CD2' ' A' ' 76' ' ' HIS . 19.8 p30 -82.0 -28.46 32.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.559 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.45 ' CE1' ' HB ' ' A' ' 72' ' ' ILE . 26.7 m170 -92.49 -1.17 57.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.841 0.353 . . . . 0.0 110.801 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.41 ' HB2' ' HB3' ' A' ' 138' ' ' GLU . 21.9 m170 58.0 31.41 20.6 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.074 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.4 ' HB2' ' CG1' ' A' ' 73' ' ' VAL . 42.6 mt -60.23 142.41 54.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.489 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -125.24 136.56 53.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.304 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.424 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 1.7 tm-20 -91.86 121.06 33.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.863 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.5 t -113.6 127.07 55.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.881 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 70.6 m -68.96 159.15 33.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.887 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.45 ' HB2' ' CD2' ' A' ' 134' ' ' PHE . 0.3 OUTLIER -166.84 152.44 7.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.818 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.26 166.5 11.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.879 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.0 mtmt -63.56 -52.41 61.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.141 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -61.31 -48.29 82.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.928 0.394 . . . . 0.0 110.811 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.422 ' HB3' ' CE2' ' A' ' 83' ' ' PHE . . . -57.29 -40.84 78.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.074 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.515 ' CZ ' ' CE1' ' A' ' 134' ' ' PHE . 0.4 OUTLIER -59.43 -35.88 74.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.762 179.96 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.421 ' O ' HG22 ' A' ' 92' ' ' ILE . 27.2 mttt -58.31 -47.8 82.55 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.187 0.517 . . . . 0.0 110.527 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.6 tmtm? -76.57 -27.82 56.0 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.704 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -66.73 -46.87 74.09 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.693 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.452 ' O ' ' HG2' ' A' ' 96' ' ' MET . 4.5 tp -59.85 -44.02 93.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.945 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.1 ttmm -59.27 -40.7 86.88 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.205 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.479 ' HA ' ' HG2' ' A' ' 97' ' ' LYS . 47.3 t0 -73.15 -43.21 61.89 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.898 -179.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.45 ' CE2' ' CD1' ' A' ' 92' ' ' ILE . 0.0 OUTLIER -75.35 -39.9 58.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.647 -0.252 . . . . 0.0 111.199 -179.176 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.452 ' HG2' ' O ' ' A' ' 92' ' ' ILE . 15.0 ptm -67.57 -32.22 72.82 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.792 0.33 . . . . 0.0 110.539 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.479 ' HG2' ' HA ' ' A' ' 94' ' ' ASP . 4.6 ptpt -69.91 -34.07 73.01 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.66 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.479 ' N ' ' HG3' ' A' ' 97' ' ' LYS . 2.2 m -61.74 -40.49 95.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.085 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 7.0 mt -79.86 -41.3 21.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.355 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -55.38 -53.91 50.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.521 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -61.5 -45.7 95.84 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.138 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.9 tptt -61.41 -39.49 90.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.883 0.373 . . . . 0.0 110.3 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.435 ' O ' ' N ' ' A' ' 107' ' ' ARG . 3.0 tp -68.69 -32.94 73.12 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.025 179.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.421 ' HA ' ' HA ' ' A' ' 108' ' ' PRO . 83.4 mt-10 -59.99 -30.4 69.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.807 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -88.19 -20.19 25.9 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.605 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 -106.25 -62.82 1.33 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.863 0.363 . . . . 0.0 111.548 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.435 ' N ' ' O ' ' A' ' 103' ' ' LEU . 5.5 mtm180 -126.25 63.43 50.52 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.923 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.421 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 9.9 Cg_endo -50.62 -22.21 9.0 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 123.233 2.622 . . . . 0.0 112.776 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -74.83 -7.06 52.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.372 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.508 ' C ' ' HD2' ' A' ' 113' ' ' PRO . 17.0 mmt180 -113.55 -1.71 14.03 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.681 0.276 . . . . 0.0 111.617 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 34.2 m -67.96 -37.78 78.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.562 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 13.9 mtpt -67.55 -50.48 36.27 Favored Pre-proline 0 CA--C 1.529 0.161 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.617 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.562 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 31.9 Cg_exo -58.06 -33.28 97.13 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.087 1.858 . . . . 0.0 111.521 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.443 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 94.1 t80 -70.48 -40.84 73.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.746 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 15.9 mtm -55.89 -44.77 78.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.761 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 62.9 m -76.51 -44.24 36.05 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.61 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -59.19 -52.04 55.62 Favored Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.768 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.419 ' O ' ' HB ' ' A' ' 122' ' ' ILE . . . -56.89 -51.77 67.77 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.968 0.414 . . . . 0.0 111.117 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.7 -28.09 68.16 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.385 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -74.11 -49.62 23.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.482 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -71.43 -42.48 68.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.437 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.484 ' CG2' ' N ' ' A' ' 123' ' ' LYS . 0.3 OUTLIER -56.06 -49.83 73.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.726 -179.4 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.484 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 10.7 ptmt -63.03 -31.2 72.29 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.046 0.451 . . . . 0.0 110.132 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -67.99 -50.14 57.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.78 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 17.4 pt -65.59 -42.57 93.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.319 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 10.6 mt -53.85 -35.14 61.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.878 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -71.21 -10.84 60.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.289 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -144.98 34.01 1.11 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.042 0.449 . . . . 0.0 110.574 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.503 ' CE1' ' CZ ' ' A' ' 134' ' ' PHE . 13.8 t80 -52.17 -25.19 8.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.2 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -55.14 -27.83 48.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.816 0.341 . . . . 0.0 111.156 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 31.9 m-20 -94.29 -37.5 11.48 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.665 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -100.53 135.01 42.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.912 0.387 . . . . 0.0 111.598 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.6 mm100 -115.89 148.77 39.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.8 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.515 ' CE1' ' CZ ' ' A' ' 88' ' ' TYR . 3.7 m-85 -82.07 128.97 34.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.21 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.424 ' CE2' ' HB2' ' A' ' 80' ' ' GLU . 28.4 m-85 -130.72 156.38 45.04 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.609 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.419 ' HB ' ' HA ' ' A' ' 140' ' ' MET . 0.5 OUTLIER -142.95 162.31 17.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.935 179.885 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -64.0 -163.45 0.61 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.344 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.41 ' HB3' ' HB2' ' A' ' 77' ' ' HIS . 4.7 pt-20 -73.26 -8.85 57.59 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.595 0.236 . . . . 0.0 111.511 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 18.3 m-80 -98.5 -29.1 13.29 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.597 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' MET . . . . . 0.419 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 31.7 mtm 55.44 42.24 30.15 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.905 0.383 . . . . 0.0 111.02 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . 0.401 ' N ' ' OD1' ' A' ' 141' ' ' ASN . 16.3 p-10 -64.93 114.8 16.26 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.014 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -63.89 -28.95 67.31 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.561 2.174 . . . . 0.0 112.219 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -84.61 -14.48 48.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.169 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -73.88 -128.6 0.15 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.463 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 6.6 ptp -126.52 -172.48 2.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.792 0.329 . . . . 0.0 110.859 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 90.5 t -131.54 153.1 38.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.0 0.428 . . . . 0.0 111.355 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.403 ' CB ' ' HE2' ' A' ' 160' ' ' MET . . . -117.4 123.18 45.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.298 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.507 ' HB2' ' HB ' ' A' ' 161' ' ' ILE . 2.5 mt -96.94 106.26 18.56 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.748 -178.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -90.63 119.31 30.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.698 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.489 ' HB3' ' CZ ' ' A' ' 159' ' ' TYR . 12.6 t70 -132.21 164.33 26.61 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.676 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -109.49 150.6 27.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.228 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.82 -176.86 3.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.843 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -56.71 -33.05 66.1 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.929 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -72.21 -15.13 61.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.16 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 65.75 14.64 60.96 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.771 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 94.0 t -112.23 -69.72 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.898 0.38 . . . . 0.0 110.813 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 95.6 m -58.34 109.56 1.92 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.024 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -84.41 130.26 4.53 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.542 2.161 . . . . 0.0 112.244 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.489 ' CZ ' ' HB3' ' A' ' 150' ' ' ASP . 9.7 p90 -124.16 132.86 53.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.868 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' MET . . . . . 0.403 ' HE2' ' CB ' ' A' ' 147' ' ' ALA . 24.4 mtp -104.4 141.09 36.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.133 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.507 ' HB ' ' HB2' ' A' ' 148' ' ' LEU . 82.5 mt -97.07 116.17 38.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.193 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -113.69 156.08 24.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.511 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -99.92 126.54 46.07 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.94 0.4 . . . . 0.0 110.974 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 16.4 ttpp -69.17 -53.48 19.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.312 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.443 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 73.3 m-20 -51.39 -38.87 55.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.046 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -95.8 25.09 26.7 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.33 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -138.96 148.34 43.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.698 0.285 . . . . 0.0 110.83 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -112.0 150.61 30.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.106 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' MET . . . . . 0.432 ' HG2' HG12 ' A' ' 2' ' ' ILE . 2.1 mtm -124.66 122.82 38.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.622 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.12 -179.833 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.477 HG12 ' CG ' ' A' ' 169' ' ' MET . 1.1 tt . . . . . 0 N--CA 1.456 -0.154 0 CA-C-O 120.814 0.34 . . . . 0.0 110.908 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.489 ' O ' ' HA ' ' A' ' 169' ' ' MET . 8.1 mm -107.76 121.04 60.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.341 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.491 ' CG ' ' CE2' ' A' ' 14' ' ' PHE . 11.0 m-85 -91.21 130.3 37.1 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.919 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 17.7 ptt180 -139.22 143.32 37.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.133 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.417 ' O ' ' HA ' ' A' ' 10' ' ' HIS . 36.1 t0 -50.56 151.81 2.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.966 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 66.4 tp -80.69 -25.49 38.14 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.361 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.6 mp -91.3 -43.58 14.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.812 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.3 t -90.62 -30.82 16.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.814 0.34 . . . . 0.0 111.399 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.417 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER 66.49 29.37 9.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.918 -179.78 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -104.92 127.2 52.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.668 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -57.2 97.5 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.156 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 12.5 mtp -83.77 -15.57 47.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.972 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.491 ' CE2' ' CG ' ' A' ' 4' ' ' TYR . 44.8 p90 -178.8 161.36 1.23 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.805 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.2 m -126.37 -169.82 2.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.607 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.406 ' HB2' HG21 ' A' ' 2' ' ' ILE . 38.7 t70 -93.8 30.26 1.86 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.02 0.438 . . . . 0.0 110.952 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 46.2 pt -92.39 -10.52 9.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.573 179.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.442 ' CZ ' HG21 ' A' ' 72' ' ' ILE . 46.6 m-85 -111.54 -167.02 1.13 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.645 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.3 mtpt -97.52 87.57 4.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.797 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.2 mp -88.01 134.1 28.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.042 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -128.22 152.7 47.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.755 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -97.7 121.92 40.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.976 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.8 pt -119.1 166.28 13.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.119 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 57.65 30.31 18.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.217 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 63.18 40.77 8.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.307 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.5 -16.65 60.66 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.652 -0.785 . . . . 0.0 113.068 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.87 -34.22 62.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.823 0.312 . . . . 0.0 111.035 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 12.1 m -146.31 161.19 40.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.938 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -126.61 129.77 49.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.777 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -94.06 119.92 33.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.21 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 17.5 t -102.12 112.16 34.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.699 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -91.58 116.11 28.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.125 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -94.71 -127.38 5.0 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.365 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.3 ptpt -174.38 122.75 0.29 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.79 0.329 . . . . 0.0 110.944 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 86.7 mtp -70.76 123.32 21.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.787 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 m . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.134 -179.927 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.286 -0.325 . . . . 0.0 112.286 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.419 ' CG1' HG12 ' A' ' 72' ' ' ILE . 57.1 t -69.49 144.93 13.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.837 0.351 . . . . 0.0 110.909 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -70.14 -57.03 5.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.479 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.444 ' O ' ' HB2' ' A' ' 76' ' ' HIS . 5.6 pt -53.52 -33.78 22.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.315 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.411 ' CG1' ' HB2' ' A' ' 78' ' ' LEU . 74.4 t -72.39 -34.58 49.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.087 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.7 mtm -78.24 -37.23 45.72 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.925 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 16.9 p30 -82.08 -31.59 30.72 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.451 ' CE1' ' HA ' ' A' ' 14' ' ' PHE . 42.0 m80 -93.58 -2.72 53.84 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.051 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 17.9 m80 61.03 36.57 18.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.164 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.411 ' HB2' ' CG1' ' A' ' 73' ' ' VAL . 28.8 mt -57.59 156.17 8.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.463 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -132.72 135.22 45.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.841 0.353 . . . . 0.0 111.174 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.431 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 5.6 tt0 -101.19 122.5 43.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.822 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.1 t -115.08 153.21 31.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.931 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 29.3 p -88.58 161.5 16.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.914 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.44 ' HB2' ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -165.27 156.21 14.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.874 -179.988 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -99.66 174.05 6.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.904 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -70.3 -52.37 23.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.88 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.98 -43.0 97.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.85 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.15 -42.66 91.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.037 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.517 ' CZ ' ' CE1' ' A' ' 134' ' ' PHE . 0.1 OUTLIER -59.12 -34.94 72.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.862 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 22.8 mttm -59.53 -46.16 89.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.126 0.489 . . . . 0.0 110.413 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt -77.08 -27.83 54.39 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.783 178.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -67.75 -44.1 78.31 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.876 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.419 HD13 ' CE2' ' A' ' 95' ' ' TYR . 6.1 tp -63.74 -42.58 96.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.911 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.401 ' N ' HG23 ' A' ' 92' ' ' ILE . 5.2 ttpm? -63.45 -37.44 87.28 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.781 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.467 ' HA ' ' HG2' ' A' ' 97' ' ' LYS . 12.4 t70 -77.04 -41.5 42.29 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.7 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.457 ' CD1' ' C ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -77.32 -40.08 45.47 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 121.155 -0.218 . . . . 0.0 110.752 -179.591 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.405 ' HG3' ' N ' ' A' ' 97' ' ' LYS . 0.3 OUTLIER -67.58 -32.1 72.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.645 0.26 . . . . 0.0 110.599 179.522 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.467 ' HG2' ' HA ' ' A' ' 94' ' ' ASP . 0.0 OUTLIER -70.2 -34.44 72.94 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.879 0.371 . . . . 0.0 110.491 179.756 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.443 ' N ' ' HG3' ' A' ' 97' ' ' LYS . 2.0 m -61.04 -40.18 92.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.046 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 7.2 mt -79.82 -42.36 22.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.504 179.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.406 ' O ' ' HG3' ' A' ' 104' ' ' GLU . 12.7 tmtt? -54.43 -55.23 30.91 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.523 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -60.86 -44.8 97.63 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.247 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.27 -41.29 96.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.885 0.374 . . . . 0.0 110.492 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.446 ' O ' ' N ' ' A' ' 107' ' ' ARG . 3.3 tp -68.24 -32.82 73.29 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.169 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.406 ' HG3' ' O ' ' A' ' 100' ' ' LYS . 74.6 mt-10 -60.21 -29.66 68.88 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.934 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -88.11 -20.81 25.17 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.569 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -103.74 -57.73 1.99 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.791 0.329 . . . . 0.0 111.665 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.446 ' N ' ' O ' ' A' ' 103' ' ' LEU . 44.7 mtt85 -139.19 68.16 40.35 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.786 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.404 ' O ' ' CG2' ' A' ' 111' ' ' VAL . 9.9 Cg_endo -50.66 -21.39 7.84 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 123.234 2.623 . . . . 0.0 112.968 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -68.95 -9.99 54.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.591 0.234 . . . . 0.0 111.403 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.406 ' C ' ' HD2' ' A' ' 113' ' ' PRO . 0.7 OUTLIER -111.99 -3.01 14.91 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 -179.492 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.404 ' CG2' ' O ' ' A' ' 108' ' ' PRO . 33.9 m -71.26 -26.93 27.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.641 0.258 . . . . 0.0 111.516 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.549 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -69.38 -55.8 9.21 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.517 -179.279 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.549 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 33.4 Cg_exo -56.92 -37.61 97.89 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.084 1.856 . . . . 0.0 111.739 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.446 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 82.5 t80 -66.64 -37.63 85.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.076 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 6.1 mtp -57.03 -54.68 44.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.956 0.407 . . . . 0.0 110.737 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 75.1 m -72.9 -44.73 60.92 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.696 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.97 -38.24 95.15 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.498 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.96 -51.69 68.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.973 0.416 . . . . 0.0 110.926 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.99 -28.2 63.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.251 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -75.6 -41.21 55.11 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.109 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -74.38 -34.85 63.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.901 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.455 ' CG2' ' N ' ' A' ' 123' ' ' LYS . 0.4 OUTLIER -69.95 -45.9 75.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.205 -179.877 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.455 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 5.4 pttp -61.11 -31.83 71.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.993 0.425 . . . . 0.0 110.275 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -67.51 -53.51 28.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.698 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 15.5 pt -62.12 -42.12 93.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.288 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 11.7 mt -53.99 -35.22 61.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.88 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -70.1 -11.29 60.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.296 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -142.49 33.28 1.46 Allowed 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.968 0.413 . . . . 0.0 110.588 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.497 ' CE1' ' CZ ' ' A' ' 134' ' ' PHE . 12.4 t80 -49.71 -26.79 4.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.24 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.91 -29.37 69.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.05 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 28.5 m-20 -94.21 -29.86 14.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.451 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.425 ' CD2' ' OD1' ' A' ' 150' ' ' ASP . 2.5 m-85 -98.47 138.41 35.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.877 0.37 . . . . 0.0 111.295 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -123.07 144.1 49.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.721 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.517 ' CE1' ' CZ ' ' A' ' 88' ' ' TYR . 3.2 m-85 -82.09 123.75 29.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.118 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.431 ' CE2' ' HB2' ' A' ' 80' ' ' GLU . 25.4 m-85 -127.86 140.74 51.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.599 179.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.44 HD11 HG22 ' A' ' 136' ' ' ILE . 0.5 OUTLIER -131.29 160.99 41.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.691 -179.981 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -57.37 -169.58 0.14 Allowed Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.524 -0.846 . . . . 0.0 111.879 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.05 -8.91 57.28 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.582 0.23 . . . . 0.0 111.329 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 26.7 m-80 -94.31 -30.28 14.61 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.41 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' MET . . . . . 0.415 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 70.7 mtm 55.84 44.51 25.85 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.773 0.32 . . . . 0.0 111.256 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.67 117.38 50.16 Favored Pre-proline 0 N--CA 1.453 -0.296 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.625 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -63.2 -23.23 72.82 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.323 2.015 . . . . 0.0 111.854 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -84.72 -15.4 45.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.646 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -77.78 -159.7 12.47 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.276 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 3.6 ptp -98.75 -174.4 2.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.793 0.33 . . . . 0.0 110.796 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 49.1 t -128.83 152.47 37.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.165 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -114.64 119.23 36.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.656 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.493 ' HB2' ' HB ' ' A' ' 161' ' ' ILE . 3.0 mt -93.48 106.29 18.27 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.192 -179.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.0 tp -90.82 119.12 30.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.149 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.451 ' CB ' ' CE1' ' A' ' 159' ' ' TYR . 0.9 OUTLIER -125.99 159.5 32.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.745 179.7 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -109.7 138.13 46.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.887 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.93 -173.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.784 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.3 -41.07 83.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.905 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -67.87 -15.1 63.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.163 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 68.71 20.04 73.75 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.69 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 94.2 t -112.85 -70.04 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.859 0.362 . . . . 0.0 110.751 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 88.7 m -57.59 108.91 1.42 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.891 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -86.71 127.86 2.78 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.723 2.282 . . . . 0.0 112.44 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.451 ' CE1' ' CB ' ' A' ' 150' ' ' ASP . 16.0 p90 -121.67 132.15 54.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.797 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' MET . . . . . 0.463 ' HE2' ' CZ ' ' A' ' 162' ' ' PHE . 0.9 OUTLIER -101.8 140.87 35.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.071 -179.818 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.493 ' HB ' ' HB2' ' A' ' 148' ' ' LEU . 57.4 mt -96.77 121.61 47.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.242 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . 0.463 ' CZ ' ' HE2' ' A' ' 160' ' ' MET . 43.0 m-85 -119.63 156.49 30.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.698 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -102.16 118.63 37.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.858 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 40.9 tttt -61.12 -49.98 75.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.235 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.446 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 32.5 m-20 -55.26 -40.34 70.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.243 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -95.74 25.18 26.22 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.66 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.416 HD11 ' CE1' ' A' ' 14' ' ' PHE . 4.9 tt -150.19 148.71 29.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.88 0.372 . . . . 0.0 110.949 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -133.95 150.61 51.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.395 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' MET . . . . . 0.489 ' HA ' ' O ' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -135.47 160.25 39.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.805 0.336 . . . . 0.0 111.261 -179.796 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.404 ' C ' HG13 ' A' ' 2' ' ' ILE . 1.0 OUTLIER . . . . . 0 N--CA 1.462 0.126 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.547 -179.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.452 ' CG2' ' CE1' ' A' ' 4' ' ' TYR . 1.0 OUTLIER . . . . . 0 N--CA 1.457 -0.082 0 CA-C-O 120.888 0.375 . . . . 0.0 111.082 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.497 ' O ' ' HA ' ' A' ' 169' ' ' MET . 10.1 mm -103.39 119.54 52.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.981 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.452 ' CE1' ' CG2' ' A' ' 2' ' ' ILE . 17.4 m-85 -93.44 128.98 39.75 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.93 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.9 ptt-85 -136.31 144.77 44.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.969 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -52.53 138.01 28.88 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.833 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 59.9 tp -71.34 -23.65 61.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.291 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.3 mp -91.2 -43.64 14.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.805 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.8 m -90.28 -29.4 18.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.391 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 32.3 m80 68.28 30.25 5.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.858 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -111.03 126.21 54.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.655 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -56.0 112.92 1.32 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.266 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 7.2 mtt -96.37 -16.61 21.17 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.908 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.429 ' HA ' ' CE1' ' A' ' 76' ' ' HIS . 37.8 p90 179.9 152.99 0.48 Allowed 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 120.875 0.369 . . . . 0.0 111.0 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -112.86 -169.8 1.55 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.417 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.413 ' HB2' HG23 ' A' ' 2' ' ' ILE . 31.2 t70 -94.98 34.6 1.35 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.948 0.404 . . . . 0.0 110.819 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.425 HG13 ' CD2' ' A' ' 18' ' ' TYR . 41.6 pt -95.43 -7.81 9.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.742 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.432 ' CZ ' HG22 ' A' ' 72' ' ' ILE . 37.2 m-85 -113.63 -167.38 1.19 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.696 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.52 86.95 3.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.855 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.6 mp -89.77 124.01 42.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.086 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -118.16 140.25 50.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.987 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -84.57 116.06 22.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.76 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.6 pt -113.4 166.85 6.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.13 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 59.53 30.57 20.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.086 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 64.83 47.24 2.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.332 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.91 -8.32 73.55 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.718 -0.753 . . . . 0.0 113.358 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.95 -52.36 65.36 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.818 0.342 . . . . 0.0 111.071 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 11.7 m -125.98 163.53 22.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.067 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -126.42 133.45 51.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.735 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -99.83 112.94 25.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.05 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.4 t -92.35 111.94 25.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.697 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -87.78 110.91 20.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.17 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -95.68 -133.55 7.47 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.29 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.4 pttt -174.46 123.99 0.29 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.882 0.373 . . . . 0.0 110.884 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 71.3 mtm -70.91 112.63 7.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.815 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.0 m . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.153 -179.997 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.407 -0.277 . . . . 0.0 112.407 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.469 ' CG1' HG12 ' A' ' 72' ' ' ILE . 46.2 t -72.59 135.4 27.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.808 0.337 . . . . 0.0 110.662 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -64.05 -54.76 29.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.782 -179.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.469 HG12 ' CG1' ' A' ' 70' ' ' VAL . 8.1 pt -53.85 -33.93 24.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.907 0.384 . . . . 0.0 111.267 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 84.2 t -73.59 -35.0 43.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.906 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 5.0 mtm -78.3 -38.83 41.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.788 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.402 ' OD1' ' CD2' ' A' ' 76' ' ' HIS . 22.3 p30 -82.1 -29.44 31.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.655 -179.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.438 ' CE1' ' HB ' ' A' ' 72' ' ' ILE . 26.2 m170 -92.55 -2.58 56.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.775 0.322 . . . . 0.0 110.806 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.482 ' HB2' ' HB3' ' A' ' 138' ' ' GLU . 49.5 m80 59.28 35.12 23.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.043 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 41.5 mt -61.13 141.15 57.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.515 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -120.83 132.33 54.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.011 -179.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.42 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 10.1 tt0 -91.04 124.48 35.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.91 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.4 t -117.23 172.33 7.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.835 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.6 p -107.24 170.69 7.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.006 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.478 ' CE2' ' CE2' ' A' ' 91' ' ' TYR . 0.6 OUTLIER -171.65 152.43 3.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.859 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.8 m -99.87 158.09 16.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.839 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 33.8 mtmt -57.69 -52.5 65.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.917 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.9 tm-20 -65.88 -45.0 83.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.727 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.66 -33.88 72.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.059 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.473 ' CD2' HD12 ' A' ' 122' ' ' ILE . 0.7 OUTLIER -65.03 -37.42 87.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.713 179.902 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 50.4 mttm -58.19 -45.51 87.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.099 0.476 . . . . 0.0 110.333 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.7 mmtp -76.66 -27.8 55.75 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.742 178.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.478 ' CE2' ' CE2' ' A' ' 83' ' ' PHE . 8.4 t80 -67.61 -45.38 75.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.76 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.432 HD13 ' CE2' ' A' ' 95' ' ' TYR . 5.2 tp -61.74 -42.2 93.45 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 CA-C-O 120.888 0.375 . . . . 0.0 110.82 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.494 ' O ' ' CG ' ' A' ' 97' ' ' LYS . 3.6 ttpm? -63.39 -44.9 93.37 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.812 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -70.29 -38.9 75.1 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.866 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.495 ' CD1' ' C ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -78.12 -42.94 30.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.694 -0.23 . . . . 0.0 110.648 -179.513 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.406 ' HG3' ' N ' ' A' ' 97' ' ' LYS . 0.1 OUTLIER -62.72 -31.85 72.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.865 0.364 . . . . 0.0 110.078 179.098 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.494 ' CG ' ' O ' ' A' ' 93' ' ' LYS . 2.5 mmtp -65.73 -43.83 87.84 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.595 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.6 m -54.36 -40.47 68.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.601 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 7.8 mt -79.92 -43.13 22.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.678 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 15.0 tttt -53.19 -55.86 20.98 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.559 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -62.49 -45.07 96.64 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.308 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.78 -37.47 84.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.847 0.355 . . . . 0.0 110.465 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.434 ' O ' ' N ' ' A' ' 107' ' ' ARG . 2.8 tp -70.94 -32.08 68.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.135 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -60.59 -30.25 69.7 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.872 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -89.68 -20.04 24.12 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.543 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -106.01 -62.8 1.33 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.816 0.341 . . . . 0.0 111.413 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.434 ' N ' ' O ' ' A' ' 103' ' ' LEU . 16.7 mtt180 -127.53 63.58 59.85 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.891 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -50.86 -21.92 9.19 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 123.145 2.563 . . . . 0.0 112.82 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -71.35 -11.29 60.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.673 -0.24 . . . . 0.0 111.467 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.52 ' C ' ' HD2' ' A' ' 113' ' ' PRO . 0.0 OUTLIER -112.26 1.06 15.97 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 -179.289 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 34.4 m -68.36 -35.72 71.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.565 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 18.4 mttt -68.69 -50.6 24.12 Favored Pre-proline 0 C--N 1.331 -0.209 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.609 -179.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.565 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 32.3 Cg_exo -57.98 -33.24 96.94 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.11 1.873 . . . . 0.0 111.813 179.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.441 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 86.3 t80 -69.71 -41.72 75.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.15 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -55.45 -49.27 72.91 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.928 0.394 . . . . 0.0 110.871 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 82.4 m -70.98 -44.36 66.12 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.725 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.03 -39.21 97.77 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.644 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.88 -51.54 69.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.94 0.4 . . . . 0.0 111.161 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.1 -28.29 66.36 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.306 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.07 -58.86 3.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.24 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -56.03 -42.66 76.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.218 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.473 HD12 ' CD2' ' A' ' 88' ' ' TYR . 0.3 OUTLIER -61.62 -45.54 98.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.193 -179.828 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.44 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 12.5 mttm -59.98 -31.9 70.34 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.179 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -67.56 -54.52 19.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.806 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 11.9 pt -61.04 -40.77 86.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.218 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.407 ' HG ' ' CD1' ' A' ' 122' ' ' ILE . 11.8 mt -53.95 -37.59 64.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.705 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.6 -15.04 60.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.269 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -138.59 34.6 2.23 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.1 0.476 . . . . 0.0 110.423 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -48.09 -43.34 30.65 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.295 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.3 mmmp? -62.13 -19.88 63.5 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.302 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -93.99 -41.09 9.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.724 0.297 . . . . 0.0 111.317 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.413 ' CD2' ' OD1' ' A' ' 150' ' ' ASP . 3.9 m-85 -89.0 145.31 25.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.126 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.6 mm100 -122.31 145.92 47.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.807 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.456 ' CE2' ' HB2' ' A' ' 83' ' ' PHE . 2.9 m-85 -86.37 129.47 34.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.118 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.42 ' CE2' ' HB2' ' A' ' 80' ' ' GLU . 51.8 m-85 -130.98 132.25 44.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.769 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.44 ' HB ' ' HA ' ' A' ' 140' ' ' MET . 0.4 OUTLIER -121.84 159.31 24.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.681 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -56.67 -171.96 0.16 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.428 -0.891 . . . . 0.0 111.844 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.482 ' HB3' ' HB2' ' A' ' 77' ' ' HIS . 0.0 OUTLIER -70.68 -8.93 55.6 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.571 0.224 . . . . 0.0 111.42 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -93.65 -26.91 16.85 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.673 0.273 . . . . 0.0 111.108 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' MET . . . . . 0.44 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 52.0 mtm 51.62 43.96 29.47 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.442 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -68.77 120.04 73.22 Favored Pre-proline 0 N--CA 1.452 -0.335 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.595 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -60.08 -26.39 82.35 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.279 1.986 . . . . 0.0 111.856 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -84.71 -15.86 43.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.739 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.17 -168.34 10.77 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.404 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 2.0 ptp -93.2 -177.33 4.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.819 0.342 . . . . 0.0 110.811 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 74.8 t -126.64 145.26 34.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.11 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -112.08 112.27 23.78 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.567 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.522 ' HB2' ' HB ' ' A' ' 161' ' ' ILE . 4.9 mt -86.76 108.28 18.63 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.193 -179.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.5 tp -91.03 119.54 31.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.122 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.44 ' HB3' ' CE1' ' A' ' 159' ' ' TYR . 0.5 OUTLIER -133.08 174.52 10.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.642 179.55 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -117.26 143.68 45.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.846 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 11.8 mmm180 -56.78 -175.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.058 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -56.3 -31.46 63.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.9 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -78.48 -15.01 59.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.153 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 70.67 21.74 77.89 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.66 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 89.1 t -112.47 -69.2 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.861 0.362 . . . . 0.0 110.823 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 91.0 m -57.61 109.17 1.58 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.945 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -81.24 127.3 5.89 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.484 2.123 . . . . 0.0 112.331 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.44 ' CE1' ' HB3' ' A' ' 150' ' ' ASP . 13.0 p90 -125.35 148.28 48.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.755 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' MET . . . . . 0.416 ' HE3' ' CG ' ' A' ' 135' ' ' PHE . 0.4 OUTLIER -111.69 142.86 43.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.028 -179.756 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.522 ' HB ' ' HB2' ' A' ' 148' ' ' LEU . 41.9 mt -99.08 120.44 48.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.24 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -125.93 150.17 48.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.643 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -97.45 119.16 35.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.898 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 43.1 tttt -56.27 -53.94 51.28 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.334 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.441 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 44.9 m-20 -53.82 -37.49 63.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.19 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -95.27 24.42 29.07 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.57 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.426 HD13 ' CE1' ' A' ' 14' ' ' PHE . 5.8 tt -150.15 140.11 21.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.842 0.353 . . . . 0.0 110.74 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -120.16 142.96 48.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.58 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' MET . . . . . 0.497 ' HA ' ' O ' ' A' ' 3' ' ' ILE . 0.1 OUTLIER -136.73 160.2 39.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.735 0.302 . . . . 0.0 111.145 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.403 ' O ' HG13 ' A' ' 2' ' ' ILE . 1.5 pt-20 . . . . . 0 N--CA 1.462 0.173 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.366 -179.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.458 HG21 ' HB2' ' A' ' 16' ' ' ASP . 1.8 tt . . . . . 0 N--CA 1.454 -0.249 0 CA-C-O 120.735 0.303 . . . . 0.0 111.055 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.9 mm -102.14 146.5 10.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.877 0.37 . . . . 0.0 111.518 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.518 ' CD2' ' CZ ' ' A' ' 14' ' ' PHE . 4.9 m-85 -115.96 100.15 7.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.422 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 1.1 ptt180 -116.34 147.9 41.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.881 0.372 . . . . 0.0 111.344 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.452 ' O ' ' HA ' ' A' ' 10' ' ' HIS . 44.7 t0 -57.04 152.17 13.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.749 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 59.0 tp -81.32 -21.09 39.46 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.53 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.3 mp -91.29 -47.77 14.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.0 t -96.41 -17.54 20.53 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -179.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.452 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 0.3 OUTLIER 61.98 28.59 17.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.855 0.359 . . . . 0.0 110.774 -179.727 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -98.17 121.71 40.44 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.762 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.17 93.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.282 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 7.7 mtt -71.87 -19.44 61.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.664 179.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.518 ' CZ ' ' CD2' ' A' ' 4' ' ' TYR . 7.4 p90 -177.86 176.86 1.14 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.667 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -133.71 -169.99 2.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.953 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.458 ' HB2' HG21 ' A' ' 2' ' ' ILE . 22.6 t70 -94.42 25.08 4.08 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.98 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.427 HG13 ' CD2' ' A' ' 18' ' ' TYR . 20.8 pt -82.39 -15.49 11.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.525 179.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.437 ' CZ ' HG21 ' A' ' 72' ' ' ILE . 78.4 m-85 -108.84 -174.45 2.52 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.516 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.1 mttp -94.66 88.53 5.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.849 0.357 . . . . 0.0 110.718 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.1 mp -87.94 132.5 32.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.167 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 8.0 mtt180 -124.68 139.68 53.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.807 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.49 122.32 28.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.996 0.427 . . . . 0.0 110.943 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.9 pt -117.37 167.47 10.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.027 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 60.08 27.09 16.5 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.072 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 66.92 55.96 0.7 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.338 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 77.12 0.34 70.07 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 120.853 -0.689 . . . . 0.0 113.422 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.44 -58.23 3.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 117.082 0.441 . . . . 0.0 111.04 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 35.2 m -118.95 164.82 14.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.997 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -126.32 133.18 51.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.862 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -99.06 112.83 24.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.968 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 26.1 t -92.04 111.86 24.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.625 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -80.88 114.08 19.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.252 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -99.19 -141.46 12.27 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.214 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -174.42 126.88 0.33 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.823 0.344 . . . . 0.0 110.978 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 27.7 mtp -68.36 122.58 18.68 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.522 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.1 m . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.465 -179.63 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.496 0 N-CA-C 112.047 -0.421 . . . . 0.0 112.047 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.468 ' CG1' HG12 ' A' ' 72' ' ' ILE . 40.8 t -73.2 130.32 35.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.887 0.375 . . . . 0.0 110.847 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -59.26 -55.3 36.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.64 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.468 HG12 ' CG1' ' A' ' 70' ' ' VAL . 6.9 pt -54.01 -36.72 32.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.544 -179.386 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 97.2 t -70.37 -31.47 46.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.197 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.5 mtm -78.22 -40.47 37.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.786 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.418 ' OD1' ' CD2' ' A' ' 76' ' ' HIS . 0.3 OUTLIER -82.0 -29.33 32.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.546 -179.23 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.442 ' CE1' ' HB ' ' A' ' 72' ' ' ILE . 29.6 m170 -89.95 -5.11 57.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.869 0.366 . . . . 0.0 110.752 179.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.401 ' HB2' ' HB3' ' A' ' 138' ' ' GLU . 28.6 m-70 61.74 28.42 17.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.916 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.403 ' CD1' ' CE ' ' A' ' 160' ' ' MET . 34.2 mt -59.87 152.87 22.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.588 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -138.73 145.84 40.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.799 0.333 . . . . 0.0 111.175 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.418 ' HB2' ' CZ ' ' A' ' 135' ' ' PHE . 0.2 OUTLIER -99.41 133.18 44.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.079 -179.924 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.7 t -117.15 166.9 11.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.755 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 66.8 m -98.38 158.28 15.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.04 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.427 ' HB2' ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -171.78 150.1 2.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.823 179.934 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 54.7 p -99.92 169.61 9.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.821 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -63.17 -52.44 62.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.923 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -60.67 -45.41 94.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.921 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.407 ' HB3' ' CE1' ' A' ' 83' ' ' PHE . . . -59.78 -41.12 90.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.962 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.508 ' CZ ' ' CE1' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -58.03 -36.14 72.29 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.894 179.938 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 36.3 mttm -60.12 -51.11 71.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.069 0.461 . . . . 0.0 110.482 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.1 mttm -72.93 -27.7 62.0 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.591 178.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -64.23 -48.03 77.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.975 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.459 ' CD1' ' CE2' ' A' ' 95' ' ' TYR . 3.1 tp -61.43 -41.91 91.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.733 0.301 . . . . 0.0 111.174 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.445 ' O ' ' CG ' ' A' ' 97' ' ' LYS . 4.6 ttmt -61.17 -46.08 91.98 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.969 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -70.79 -36.86 73.22 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.93 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.532 ' CD1' ' C ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -76.34 -43.11 42.56 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 121.189 -0.205 . . . . 0.0 110.744 -179.544 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.3 ptp -65.07 -32.03 73.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.92 0.391 . . . . 0.0 110.279 179.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.445 ' CG ' ' O ' ' A' ' 93' ' ' LYS . 0.1 OUTLIER -64.01 -44.2 93.33 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.867 179.751 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.4 m -56.47 -43.2 79.38 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.874 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 6.5 mt -79.85 -40.59 20.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.682 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.2 tttt -55.09 -53.47 55.51 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.574 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -62.94 -46.42 93.61 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.334 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.1 tppm? -60.53 -40.85 92.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.858 0.361 . . . . 0.0 110.422 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.429 ' O ' ' N ' ' A' ' 107' ' ' ARG . 3.0 tp -66.52 -35.25 79.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.26 179.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 108' ' ' PRO . 36.2 mt-10 -59.13 -29.38 67.35 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.684 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -88.52 -18.69 27.62 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.617 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -108.56 -61.8 1.55 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.838 0.351 . . . . 0.0 111.586 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.429 ' N ' ' O ' ' A' ' 103' ' ' LEU . 19.9 mtt85 -130.1 65.07 74.6 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.777 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.408 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 9.4 Cg_endo -50.54 -23.33 10.55 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 123.087 2.525 . . . . 0.0 112.652 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -69.1 -13.9 62.7 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.64 0.257 . . . . 0.0 111.15 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.408 ' C ' ' HD2' ' A' ' 113' ' ' PRO . 6.8 mmm-85 -106.21 -1.79 23.19 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -179.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.403 ' CG2' ' O ' ' A' ' 108' ' ' PRO . 24.3 m -71.37 -27.03 27.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.685 0.279 . . . . 0.0 111.521 -179.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.552 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 0.8 OUTLIER -70.37 -55.42 7.78 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.578 -179.291 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.552 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 47.1 Cg_exo -55.37 -40.88 83.2 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.182 1.922 . . . . 0.0 111.975 179.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.436 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 75.6 t80 -65.47 -38.36 89.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.166 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.05 -54.85 40.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.001 0.429 . . . . 0.0 110.926 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 62.7 m -74.37 -44.65 51.28 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.768 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.4 -41.78 98.67 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.644 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.18 -51.57 69.43 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.059 0.457 . . . . 0.0 111.072 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.15 -28.15 65.12 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.325 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -77.93 -43.65 29.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.4 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -71.27 -31.56 67.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.117 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.45 ' CG2' ' N ' ' A' ' 123' ' ' LYS . 0.4 OUTLIER -70.56 -45.93 72.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.36 -179.782 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.45 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 12.1 pttt -60.75 -31.22 70.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.067 0.461 . . . . 0.0 110.365 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -68.36 -54.05 19.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.64 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 15.2 pt -61.67 -42.61 94.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.261 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.402 ' HG ' ' CD1' ' A' ' 122' ' ' ILE . 11.4 mt -54.19 -35.48 62.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.969 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -69.89 -11.29 60.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.343 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 -142.07 32.83 1.55 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.884 0.373 . . . . 0.0 110.599 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.5 ' CE1' ' CZ ' ' A' ' 134' ' ' PHE . 4.5 t80 -52.2 -26.1 10.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.088 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 6.8 mttt -59.17 -30.43 68.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.929 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -94.28 -37.86 11.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.324 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -91.09 135.51 33.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.835 0.35 . . . . 0.0 111.21 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 -121.94 145.8 47.75 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.911 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.508 ' CE1' ' CZ ' ' A' ' 88' ' ' TYR . 1.3 m-85 -78.06 125.95 30.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.85 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.418 ' CZ ' ' HB2' ' A' ' 80' ' ' GLU . 10.7 m-85 -130.77 137.38 49.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.623 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.448 ' HB ' ' HA ' ' A' ' 140' ' ' MET . 0.9 OUTLIER -126.87 161.69 33.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.956 -179.964 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.79 -164.95 0.35 Allowed Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.44 -0.886 . . . . 0.0 111.968 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.401 ' HB3' ' HB2' ' A' ' 77' ' ' HIS . 1.2 pt-20 -72.37 -8.87 57.28 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.594 0.235 . . . . 0.0 111.507 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -96.25 -29.26 14.12 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.594 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' MET . . . . . 0.448 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 75.7 mtp 56.37 46.53 20.77 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.903 0.382 . . . . 0.0 110.997 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . 0.403 ' ND2' ' HA3' ' A' ' 144' ' ' GLY . 13.0 p-10 -69.08 114.48 23.69 Favored Pre-proline 0 N--CA 1.452 -0.338 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.951 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -66.25 -29.39 46.87 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.633 2.222 . . . . 0.0 112.245 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -84.64 -5.25 59.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.47 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.403 ' HA3' ' ND2' ' A' ' 141' ' ' ASN . . . -87.7 -143.38 8.44 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.456 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 2.8 ptp -106.22 -179.17 3.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.824 0.345 . . . . 0.0 110.863 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 53.5 t -128.52 148.2 32.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.225 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -110.67 114.78 28.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.511 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.507 ' HB2' ' HB ' ' A' ' 161' ' ' ILE . 3.8 mt -88.5 106.19 18.12 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.088 -179.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.4 tp -90.37 119.72 30.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.366 -179.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.531 ' HB3' ' CE1' ' A' ' 159' ' ' TYR . 4.7 t70 -138.54 167.41 21.99 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.533 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -105.2 151.71 23.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.865 0.364 . . . . 0.0 111.166 -179.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 12.2 mmt85 -70.31 -175.47 1.0 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.838 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -56.92 -31.05 64.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.063 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -74.43 -15.15 60.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.288 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 74.24 7.29 77.2 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.803 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 72.7 t -110.23 -66.92 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.924 0.393 . . . . 0.0 110.94 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 84.9 m -52.96 107.18 0.78 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.261 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -84.65 129.03 4.09 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.622 2.214 . . . . 0.0 112.245 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.531 ' CE1' ' HB3' ' A' ' 150' ' ' ASP . 8.4 p90 -126.51 147.04 49.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.929 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' MET . . . . . 0.403 ' CE ' ' CD1' ' A' ' 78' ' ' LEU . 0.8 OUTLIER -113.14 145.4 41.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.241 -179.659 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.507 ' HB ' ' HB2' ' A' ' 148' ' ' LEU . 85.0 mt -98.44 112.84 31.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.032 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -118.81 121.0 39.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.679 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -68.98 124.4 23.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.047 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.86 -41.98 74.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.16 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.436 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 2.1 m-20 -55.97 -29.61 60.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.919 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -108.95 29.47 9.73 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.354 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -139.48 148.43 42.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.827 0.346 . . . . 0.0 110.785 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -111.74 155.43 23.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.009 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' MET . . . . . 0.404 ' HB3' ' CD1' ' A' ' 2' ' ' ILE . 0.0 OUTLIER -125.35 137.84 54.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.875 179.998 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.963 -179.967 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.475 HG12 ' CG ' ' A' ' 169' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.456 -0.168 0 CA-C-O 120.863 0.363 . . . . 0.0 110.814 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.505 ' O ' ' HA ' ' A' ' 169' ' ' MET . 4.6 mm -106.11 122.69 60.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.766 -179.347 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.499 ' CG ' ' CE2' ' A' ' 14' ' ' PHE . 3.9 m-85 -90.09 130.22 36.29 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.563 179.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.97 157.5 45.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.966 0.412 . . . . 0.0 111.438 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.433 ' O ' ' HA ' ' A' ' 10' ' ' HIS . 36.8 t0 -63.41 152.18 38.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.721 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 61.3 tp -80.51 -24.83 39.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.312 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.1 mp -91.43 -45.28 14.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.02 -28.49 17.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.486 -179.162 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.433 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 0.2 OUTLIER 66.45 29.55 9.14 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.849 0.356 . . . . 0.0 110.785 -179.782 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -101.16 130.5 47.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.716 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.2 pm0 -61.95 88.49 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.31 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 10.5 mtt -71.42 -17.93 62.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.66 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.499 ' CE2' ' CG ' ' A' ' 4' ' ' TYR . 43.5 p90 -178.62 177.22 0.92 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.676 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.4 m -136.71 -169.8 2.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.943 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.405 ' HB2' ' CG2' ' A' ' 2' ' ' ILE . 40.2 t0 -93.26 23.57 4.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.018 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.421 HG13 ' CD2' ' A' ' 18' ' ' TYR . 45.4 pt -87.55 -9.84 10.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.756 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.424 ' CZ ' HG21 ' A' ' 72' ' ' ILE . 76.1 m-85 -111.14 -170.77 1.7 Allowed 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.765 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.6 mttm -97.07 91.28 5.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.734 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.9 mp -87.93 123.96 40.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.015 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 15.9 mtp180 -120.55 117.62 28.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.811 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -72.1 117.48 13.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.938 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.6 pt -110.95 171.12 3.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.947 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 56.59 33.98 23.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.068 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 64.5 42.84 4.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.183 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.08 -12.95 62.71 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.785 -0.722 . . . . 0.0 113.195 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.93 -33.36 64.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.902 0.351 . . . . 0.0 111.285 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 34.3 m -142.21 164.29 30.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.021 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -128.32 130.85 48.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.994 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 -95.56 112.97 24.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.071 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 159' ' ' TYR . 23.3 t -91.55 111.87 24.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.362 179.39 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -85.5 118.36 24.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.381 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -106.34 -142.91 11.09 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.098 179.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.8 pttt -174.44 123.46 0.29 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.793 0.33 . . . . 0.0 111.187 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 76.5 mtm -65.95 118.62 10.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.538 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 31.1 m . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 120.899 0.38 . . . . 0.0 111.53 -179.578 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.369 0 N-CA-C 112.264 -0.334 . . . . 0.0 112.264 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.428 ' CG1' HG12 ' A' ' 72' ' ' ILE . 46.3 t -70.96 130.5 34.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.878 0.37 . . . . 0.0 110.725 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.4 ' O ' ' ND2' ' A' ' 75' ' ' ASN . 5.3 t0 -58.17 -58.77 6.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.862 -179.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.459 ' HB ' ' CE1' ' A' ' 76' ' ' HIS . 8.5 pt -53.64 -33.81 23.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.678 -179.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 89.9 t -72.77 -34.28 46.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.878 0.37 . . . . 0.0 111.011 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 14.9 mtm -78.24 -39.24 40.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.716 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.403 ' OD1' ' CD2' ' A' ' 76' ' ' HIS . 19.9 p30 -82.15 -29.33 31.65 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -179.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.459 ' CE1' ' HB ' ' A' ' 72' ' ' ILE . 26.0 m170 -92.05 -0.55 57.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.81 0.338 . . . . 0.0 110.787 179.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 30.3 m-70 57.84 31.85 21.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.057 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 58.6 mt -58.63 147.39 32.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.582 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -128.39 133.91 48.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.915 0.388 . . . . 0.0 111.054 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.416 ' HG3' ' CE1' ' A' ' 135' ' ' PHE . 28.9 tt0 -90.24 132.37 35.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.061 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.1 t -121.9 -172.96 2.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.872 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 83.1 p -128.79 168.23 16.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.957 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.499 ' CE2' ' CE2' ' A' ' 91' ' ' TYR . 1.1 m-85 -171.71 157.34 4.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.991 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.34 164.5 11.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.789 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.34 -52.45 65.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.83 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -67.21 -38.94 86.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.725 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.62 -37.13 86.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.992 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.514 ' CZ ' ' CE1' ' A' ' 134' ' ' PHE . 0.1 OUTLIER -63.01 -37.37 86.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.804 -179.999 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.401 ' O ' HG23 ' A' ' 92' ' ' ILE . 58.3 mttt -59.03 -45.43 90.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.084 0.468 . . . . 0.0 110.361 179.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.35 -27.82 52.8 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.643 178.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.499 ' CE2' ' CE2' ' A' ' 83' ' ' PHE . 9.3 t80 -66.88 -44.72 80.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.753 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.429 HD12 ' CE2' ' A' ' 95' ' ' TYR . 5.7 tp -63.36 -43.11 98.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.95 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.1 ttpt -62.28 -40.79 97.41 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.752 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.479 ' HA ' ' HG2' ' A' ' 97' ' ' LYS . 27.6 t0 -72.92 -43.94 61.82 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.762 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.452 ' CD1' ' C ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -75.82 -40.16 55.42 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 121.063 -0.255 . . . . 0.0 110.99 -179.386 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.402 ' HG3' ' N ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -67.57 -32.01 72.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.697 0.284 . . . . 0.0 110.661 179.5 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.479 ' HG2' ' HA ' ' A' ' 94' ' ' ASP . 0.0 OUTLIER -69.19 -34.22 74.56 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.829 0.347 . . . . 0.0 110.272 179.695 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.466 ' N ' ' HG3' ' A' ' 97' ' ' LYS . 1.0 OUTLIER -61.36 -41.03 96.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.969 179.316 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.402 ' CG2' ' HA2' ' A' ' 166' ' ' GLY . 9.3 mt -79.94 -42.86 22.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.564 179.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.91 -49.16 69.22 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.597 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -64.6 -50.44 58.99 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.667 -0.777 . . . . 0.0 112.207 179.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 2.2 tptt -59.84 -40.98 90.35 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.947 0.403 . . . . 0.0 110.426 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.456 ' O ' ' N ' ' A' ' 107' ' ' ARG . 12.3 tp -63.84 -41.1 97.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.043 179.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -55.2 -28.59 54.15 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.809 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -89.71 -16.57 30.08 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.784 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -114.27 -60.81 1.83 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.747 0.308 . . . . 0.0 111.538 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.456 ' N ' ' O ' ' A' ' 103' ' ' LEU . 0.9 OUTLIER -123.96 62.01 26.21 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.821 -179.801 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -50.8 -23.6 11.85 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 123.042 2.495 . . . . 0.0 112.566 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -74.44 -8.03 54.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.295 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.489 ' C ' ' HD2' ' A' ' 113' ' ' PRO . 1.1 mmt180 -111.22 -1.22 16.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.59 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 31.1 m -72.49 -33.17 44.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.55 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 1.9 mtpt -68.39 -49.97 29.79 Favored Pre-proline 0 C--N 1.331 -0.205 0 N-CA-C 111.649 0.24 . . . . 0.0 111.649 -179.2 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.55 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 30.0 Cg_exo -61.77 -33.72 84.68 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.087 1.858 . . . . 0.0 111.938 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.436 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 87.8 t80 -72.07 -36.5 69.56 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.012 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 5.5 mmm -58.02 -53.0 63.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.941 0.4 . . . . 0.0 110.855 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 71.8 m -73.06 -44.41 60.66 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.673 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.98 -37.57 95.17 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.577 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.402 ' O ' ' HB ' ' A' ' 122' ' ' ILE . . . -60.0 -51.65 68.74 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.961 0.41 . . . . 0.0 110.928 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.73 -28.12 62.46 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.425 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -77.92 -42.4 33.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.206 -179.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -72.11 -34.78 68.87 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.035 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.451 HD11 ' CD2' ' A' ' 88' ' ' TYR . 0.4 OUTLIER -68.27 -46.3 81.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.39 -179.81 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.451 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 0.4 OUTLIER -59.76 -32.13 70.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.062 0.458 . . . . 0.0 110.116 179.448 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -66.67 -54.3 24.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.618 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 13.0 pt -61.77 -39.98 85.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.058 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 11.4 mt -53.67 -35.69 61.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.567 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.5 -14.95 62.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.885 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -133.11 32.28 3.75 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.047 0.451 . . . . 0.0 110.243 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -49.08 -35.56 16.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.179 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.4 -20.78 60.66 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.162 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -89.18 -35.53 16.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.41 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.457 ' CD1' ' N ' ' A' ' 132' ' ' TYR . 1.7 m-30 -104.21 151.37 23.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.864 0.364 . . . . 0.0 111.313 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 4.9 mm100 -123.89 150.69 44.35 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.913 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.514 ' CE1' ' CZ ' ' A' ' 88' ' ' TYR . 4.6 m-85 -86.16 132.38 34.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.144 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.424 ' CG ' ' HE2' ' A' ' 160' ' ' MET . 28.8 m-85 -136.93 130.11 31.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.58 179.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.451 ' HB ' ' HA ' ' A' ' 140' ' ' MET . 0.8 OUTLIER -122.09 167.33 15.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.892 -179.81 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.42 -170.84 0.84 Allowed Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.475 -0.869 . . . . 0.0 111.927 179.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -68.92 -11.17 60.36 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.621 0.248 . . . . 0.0 111.389 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -92.39 -33.51 14.53 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.606 0.241 . . . . 0.0 111.242 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' MET . . . . . 0.451 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 75.2 mtm 58.34 41.78 22.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.341 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -70.14 118.18 61.37 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.793 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -64.61 -21.65 65.33 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.331 2.021 . . . . 0.0 111.831 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -84.59 -12.06 54.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.755 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -81.31 -137.12 2.11 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.256 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 3.7 ptp -120.65 178.89 4.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.781 0.324 . . . . 0.0 110.704 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 65.9 t -124.41 147.67 28.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.987 0.422 . . . . 0.0 111.193 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.419 ' HB2' ' CE2' ' A' ' 162' ' ' PHE . . . -113.27 110.2 19.99 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.364 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.512 ' HB2' ' HB ' ' A' ' 161' ' ' ILE . 4.4 mt -83.57 106.17 15.09 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.143 -179.093 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.2 tp -88.71 119.91 29.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.954 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.47 ' HB2' ' CZ ' ' A' ' 159' ' ' TYR . 62.8 m-20 -130.31 161.86 30.3 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.574 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -104.34 151.98 22.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.087 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 3.9 mmt180 -59.36 -176.92 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.0 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -60.9 -40.96 95.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.977 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -79.76 -15.07 58.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.312 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 78.68 33.07 39.16 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.597 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 93.8 t -113.44 -60.96 2.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.841 0.353 . . . . 0.0 111.11 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 51.5 m -80.55 112.56 32.37 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.341 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -82.37 134.28 7.73 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.558 2.172 . . . . 0.0 112.04 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.47 ' CZ ' ' HB2' ' A' ' 150' ' ' ASP . 5.7 p90 -130.51 142.59 50.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.041 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' MET . . . . . 0.424 ' HE2' ' CG ' ' A' ' 135' ' ' PHE . 0.3 OUTLIER -107.14 143.42 35.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.025 -179.899 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.512 ' HB ' ' HB2' ' A' ' 148' ' ' LEU . 73.4 mt -101.81 112.01 33.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.157 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . 0.419 ' CE2' ' HB2' ' A' ' 147' ' ' ALA . 81.0 m-85 -114.23 157.62 22.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.756 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -100.5 122.82 43.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.952 0.406 . . . . 0.0 110.812 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.12 -50.49 63.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.245 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.436 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 1.7 m-20 -52.14 -30.48 26.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.12 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.402 ' HA2' ' CG2' ' A' ' 99' ' ' ILE . . . -108.21 27.75 13.44 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.236 179.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -150.15 142.69 24.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.82 0.343 . . . . 0.0 110.736 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -130.45 156.18 45.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.611 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' MET . . . . . 0.505 ' HA ' ' O ' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -140.16 160.29 40.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.116 179.973 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 . . . . . 0 C--O 1.233 0.186 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.477 -179.161 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.422 HG23 ' HB2' ' A' ' 16' ' ' ASP . 1.9 tt . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.842 0.353 . . . . 0.0 111.002 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.4 ' CG2' ' HB3' ' A' ' 12' ' ' GLU . 16.3 mm -104.25 155.75 5.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.348 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.507 ' CD2' ' CZ ' ' A' ' 14' ' ' PHE . 4.4 m-85 -124.19 106.62 10.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.73 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 27.7 ptt180 -122.66 146.74 47.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.148 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.442 ' O ' ' HA ' ' A' ' 10' ' ' HIS . 49.2 t0 -58.05 143.36 43.72 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.8 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 59.8 tp -73.37 -21.96 60.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.328 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.2 mp -91.32 -45.72 14.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.8 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.94 -20.27 19.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.76 -179.156 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.442 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 14.7 m170 61.24 28.86 18.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.91 0.386 . . . . 0.0 110.717 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -102.08 120.29 40.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.761 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.4 ' HB3' ' CG2' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -56.66 88.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.392 -179.731 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.411 ' O ' ' CG ' ' A' ' 76' ' ' HIS . 7.8 mtt -66.46 -24.22 66.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.721 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.507 ' CZ ' ' CD2' ' A' ' 4' ' ' TYR . 25.6 p90 -173.49 179.65 2.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.696 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -135.24 -169.97 2.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.774 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.422 ' HB2' HG23 ' A' ' 2' ' ' ILE . 26.1 t70 -94.85 23.98 5.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.023 0.439 . . . . 0.0 110.948 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.421 HG13 ' CD2' ' A' ' 18' ' ' TYR . 39.6 pt -82.03 -15.03 12.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.632 179.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.438 ' CZ ' HG22 ' A' ' 72' ' ' ILE . 82.4 m-85 -108.12 -174.27 2.48 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.586 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.4 mmtp -93.19 86.43 5.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.746 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.9 mp -87.83 125.54 41.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.939 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.4 mmm180 -117.77 129.97 56.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.997 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -80.59 116.53 20.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.707 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.9 pt -110.93 173.39 2.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.017 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.413 ' O ' ' HB2' ' A' ' 25' ' ' ASP . . . 56.39 28.42 13.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.166 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.413 ' HB2' ' O ' ' A' ' 24' ' ' ALA . 5.4 m-20 66.06 54.38 1.0 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.238 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 76.61 1.78 72.77 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.894 -0.669 . . . . 0.0 113.415 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.84 -43.47 65.48 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 117.056 0.428 . . . . 0.0 111.083 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 10.1 m -132.17 161.76 32.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.096 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.1 mt -127.1 127.74 45.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.823 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -97.38 112.96 24.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.137 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 24.2 t -92.23 111.97 25.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.567 179.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -82.03 125.17 30.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.228 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -112.07 -141.15 8.26 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.177 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.9 pttp -174.57 126.49 0.31 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.816 0.341 . . . . 0.0 111.132 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 95.1 mtp -67.78 111.28 4.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.631 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 28.9 m . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.453 -179.776 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.369 0 N-CA-C 112.286 -0.326 . . . . 0.0 112.286 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.455 ' CG1' HG12 ' A' ' 72' ' ' ILE . 43.0 t -73.2 129.84 35.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.792 0.33 . . . . 0.0 110.771 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.4 ' N ' ' OD1' ' A' ' 71' ' ' ASP . 20.3 p-10 -59.6 -55.49 33.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.793 -179.144 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.455 HG12 ' CG1' ' A' ' 70' ' ' VAL . 8.7 pt -53.78 -33.94 24.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.833 0.349 . . . . 0.0 111.411 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.4 ' HA ' ' HB2' ' A' ' 78' ' ' LEU . 93.8 t -72.44 -32.1 40.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.919 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.2 mtm -78.21 -40.07 38.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.496 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.41 ' OD1' ' CD2' ' A' ' 76' ' ' HIS . 15.2 p30 -82.12 -28.46 32.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.568 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.439 ' CE1' ' HB ' ' A' ' 72' ' ' ILE . 24.8 m170 -94.29 1.1 55.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.806 0.336 . . . . 0.0 110.963 179.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 56.13 30.16 15.91 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.321 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.4 ' HB2' ' HA ' ' A' ' 73' ' ' VAL . 67.1 mt -60.17 134.46 57.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.604 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -123.91 139.38 54.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.863 0.363 . . . . 0.0 111.196 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.425 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 2.0 tt0 -90.83 130.7 36.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.958 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.9 t -122.14 137.06 54.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.821 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.0 m -77.57 159.16 29.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.028 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.446 ' CB ' ' CE2' ' A' ' 134' ' ' PHE . 0.3 OUTLIER -167.61 149.24 5.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.822 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.88 166.63 13.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.965 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.7 mttp -64.98 -52.55 55.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.764 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -62.67 -41.69 99.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.959 0.409 . . . . 0.0 110.591 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.42 ' HB3' ' CE2' ' A' ' 83' ' ' PHE . . . -59.28 -39.44 82.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.91 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.516 ' CZ ' ' CE1' ' A' ' 134' ' ' PHE . 0.5 OUTLIER -59.78 -37.17 78.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.575 179.807 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 67.6 mttt -56.61 -49.81 73.85 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.112 0.482 . . . . 0.0 110.189 179.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.71 -27.83 60.55 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.521 178.538 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -64.62 -47.63 77.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.814 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.451 ' O ' ' HG2' ' A' ' 96' ' ' MET . 4.8 tp -61.47 -43.97 97.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.98 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.436 ' O ' ' HB3' ' A' ' 97' ' ' LYS . 8.8 ttmm -60.17 -40.66 90.71 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.236 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.427 ' O ' ' HG3' ' A' ' 97' ' ' LYS . 9.4 t0 -73.71 -43.06 60.27 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.984 -179.227 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.492 ' CD1' ' C ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -76.82 -39.59 50.8 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.087 -179.207 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.451 ' HG2' ' O ' ' A' ' 92' ' ' ILE . 6.2 ptt? -67.72 -32.13 72.55 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.929 -0.308 . . . . 0.0 110.69 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.478 ' HG3' ' N ' ' A' ' 98' ' ' SER . 0.0 OUTLIER -70.43 -33.66 71.59 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.517 179.88 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.478 ' N ' ' HG3' ' A' ' 97' ' ' LYS . 1.5 m -62.65 -40.76 98.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.037 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 7.4 mt -79.86 -41.5 21.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.281 179.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.7 tttt -56.21 -57.15 13.42 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.442 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -59.6 -42.84 97.96 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.24 179.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.59 -36.37 83.54 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.885 0.374 . . . . 0.0 110.45 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.449 ' O ' ' N ' ' A' ' 107' ' ' ARG . 3.9 tp -72.6 -32.43 65.97 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.056 0.455 . . . . 0.0 109.9 179.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 108' ' ' PRO . 69.1 mt-10 -60.62 -31.57 70.74 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.674 179.518 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -87.89 -21.58 24.89 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.654 -179.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -105.55 -62.42 1.36 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.78 0.324 . . . . 0.0 111.456 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.449 ' N ' ' O ' ' A' ' 103' ' ' LEU . 0.5 OUTLIER -128.54 63.56 65.04 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.96 -179.761 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.41 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 10.3 Cg_endo -50.97 -22.66 10.67 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 123.114 2.543 . . . . 0.0 112.73 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -68.43 -12.24 60.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.606 0.241 . . . . 0.0 111.335 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.463 ' C ' ' HD2' ' A' ' 113' ' ' PRO . 0.4 OUTLIER -108.03 -1.21 20.72 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -179.562 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.403 ' CG2' ' O ' ' A' ' 108' ' ' PRO . 22.4 m -72.71 -32.33 40.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -179.262 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.544 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 11.9 mtpt -68.99 -50.09 23.0 Favored Pre-proline 0 C--N 1.331 -0.205 0 C-N-CA 120.941 -0.304 . . . . 0.0 111.529 -179.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.544 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 24.2 Cg_exo -63.56 -29.6 70.53 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.138 1.892 . . . . 0.0 111.578 179.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.495 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 54.2 t80 -72.24 -42.31 65.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.016 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -55.48 -47.3 76.36 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.013 0.435 . . . . 0.0 110.757 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 60.1 m -76.08 -44.33 39.39 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.888 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.35 -46.81 93.1 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.774 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.07 -51.82 67.77 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.028 0.442 . . . . 0.0 111.223 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.22 -28.22 67.89 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.39 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -77.72 -43.25 31.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.255 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 -73.17 -37.83 66.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.048 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.457 ' CG2' ' N ' ' A' ' 123' ' ' LYS . 0.3 OUTLIER -66.13 -46.39 87.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.299 -179.888 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.457 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 17.5 pttt -60.64 -31.88 71.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.181 179.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -66.9 -54.05 26.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.774 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 13.6 pt -61.75 -40.77 88.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.155 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 11.7 mt -53.85 -36.43 62.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.828 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -67.4 -13.96 62.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.191 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -141.44 36.28 1.67 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.935 0.397 . . . . 0.0 110.464 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.517 ' CE1' ' CZ ' ' A' ' 134' ' ' PHE . 4.0 t80 -49.66 -29.55 7.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.17 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 5.8 mtmp? -64.98 -21.32 66.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.192 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 32.5 m-20 -94.07 -38.02 11.33 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.287 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.409 ' CD2' ' OD1' ' A' ' 150' ' ' ASP . 4.1 m-85 -99.02 140.77 32.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.15 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.4 mm100 -118.48 145.91 44.91 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.981 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.517 ' CZ ' ' CE1' ' A' ' 129' ' ' PHE . 2.5 m-85 -82.71 122.43 28.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.945 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.425 ' CE2' ' HB2' ' A' ' 80' ' ' GLU . 28.6 m-85 -124.19 146.38 48.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.628 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.447 ' HB ' ' HA ' ' A' ' 140' ' ' MET . 0.8 OUTLIER -134.28 162.85 38.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.972 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -62.64 -164.38 0.43 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.191 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -72.48 -8.94 57.69 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.533 0.206 . . . . 0.0 111.476 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 19.4 m-80 -95.81 -31.49 13.14 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.647 0.26 . . . . 0.0 111.523 -179.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' MET . . . . . 0.447 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 32.7 mtm 56.93 41.41 27.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.885 0.374 . . . . 0.0 111.02 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 15.7 p-10 -66.93 116.03 31.22 Favored Pre-proline 0 N--CA 1.451 -0.42 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.8 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -61.7 -27.84 81.55 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.52 2.147 . . . . 0.0 112.155 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -84.52 -4.85 59.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.018 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -90.1 -175.54 45.17 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.385 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -77.19 177.77 7.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.877 0.37 . . . . 0.0 110.855 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 47.4 t -124.34 152.5 30.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.166 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.429 ' CB ' ' HE3' ' A' ' 160' ' ' MET . . . -116.11 117.42 30.03 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.569 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.544 ' HB2' ' HB ' ' A' ' 161' ' ' ILE . 3.5 mt -91.51 108.22 19.75 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.244 -179.171 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.41 ' CA ' ' HE2' ' A' ' 160' ' ' MET . 1.3 tp -92.51 119.46 32.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.35 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.455 ' CB ' ' CE1' ' A' ' 159' ' ' TYR . 1.0 OUTLIER -129.66 163.6 25.74 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.475 179.332 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -102.91 145.78 29.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.909 0.385 . . . . 0.0 111.052 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.17 -177.01 0.11 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.908 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -57.87 -41.31 82.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.901 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -71.51 -15.08 62.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.171 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 77.36 18.32 78.18 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.738 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 83.7 t -113.41 -73.63 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.794 0.33 . . . . 0.0 110.911 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 83.9 m -53.67 103.13 0.35 Allowed Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.235 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -78.81 130.36 9.58 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.76 2.306 . . . . 0.0 111.952 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.455 ' CE1' ' CB ' ' A' ' 150' ' ' ASP . 11.0 p90 -120.75 137.49 54.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.85 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' MET . . . . . 0.429 ' HE3' ' CB ' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -103.85 134.58 46.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.374 -179.373 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.544 ' HB ' ' HB2' ' A' ' 148' ' ' LEU . 51.0 mt -93.2 123.8 45.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.869 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -129.51 126.73 39.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.182 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.431 ' CE2' ' OH ' ' A' ' 95' ' ' TYR . 4.1 m-30 -72.66 123.8 24.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.577 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 3.0 ttmm -60.56 -56.39 21.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.523 -179.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.495 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 2.4 m-20 -48.63 -36.17 15.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.851 0.358 . . . . 0.0 111.286 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -94.25 28.6 10.42 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.412 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -150.01 142.89 24.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.73 0.3 . . . . 0.0 110.837 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.02 155.74 21.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.799 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -121.32 145.52 47.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.931 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.881 -179.992 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.421 HG21 ' HB2' ' A' ' 16' ' ' ASP . 2.1 tt . . . . . 0 N--CA 1.457 -0.09 0 CA-C-O 120.818 0.342 . . . . 0.0 110.983 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.4 mm -104.79 156.82 5.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.276 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.496 ' CD2' ' CE2' ' A' ' 14' ' ' PHE . 4.9 m-85 -125.75 99.14 5.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.611 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 27.1 ptt180 -113.34 147.32 37.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.136 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.434 ' O ' ' HA ' ' A' ' 10' ' ' HIS . 47.3 t0 -56.95 152.16 13.43 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.8 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 61.1 tp -81.39 -20.27 40.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.377 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.0 mp -91.34 -47.31 14.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -179.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.47 -20.5 19.0 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.167 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.434 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 36.6 m80 63.96 28.93 14.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.9 0.381 . . . . 0.0 110.749 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -102.0 122.57 44.33 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.793 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.5 pm0 -57.96 92.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.251 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 9.7 mtt -72.84 -16.88 61.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.918 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.496 ' CE2' ' CD2' ' A' ' 4' ' ' TYR . 19.1 p90 -177.44 174.16 1.61 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.708 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -133.36 -172.3 2.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.863 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.421 ' HB2' HG21 ' A' ' 2' ' ' ILE . 20.6 t0 -92.52 17.88 9.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.099 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 46.7 pt -79.12 -15.11 13.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.967 0.413 . . . . 0.0 110.649 179.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.459 ' CZ ' HG23 ' A' ' 72' ' ' ILE . 70.7 m-85 -108.07 -174.52 2.54 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.529 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.9 mttp -96.16 93.37 6.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.879 0.371 . . . . 0.0 110.581 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.1 mp -87.81 134.62 27.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.178 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.58 122.87 37.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.838 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -77.82 116.45 18.35 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.876 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.401 HG12 ' HG3' ' A' ' 30' ' ' GLU . 1.4 pt -109.72 168.97 3.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.072 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' ' 25' ' ' ASP . . . 59.59 31.08 20.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.952 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 24' ' ' ALA . 48.1 m-20 65.61 47.39 2.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.179 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.13 -8.23 68.06 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.809 -0.71 . . . . 0.0 113.38 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.94 -39.01 87.86 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.904 0.352 . . . . 0.0 111.239 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 28.2 m -135.47 162.53 32.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.162 -179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.18 132.86 51.71 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.74 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.416 ' OE1' ' CD2' ' A' ' 159' ' ' TYR . 18.9 mt-10 -102.19 116.24 32.23 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.257 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.423 HG22 ' CG ' ' A' ' 14' ' ' PHE . 21.4 t -90.25 112.13 24.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.706 179.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -83.55 115.16 21.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.147 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.57 -143.64 11.91 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.114 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.4 126.84 0.33 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.929 0.395 . . . . 0.0 110.955 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 42.3 mtp -70.83 115.01 9.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.626 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.8 m . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.402 -179.738 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 N-CA-C 112.435 -0.266 . . . . 0.0 112.435 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.405 ' CG1' HG12 ' A' ' 72' ' ' ILE . 60.8 t -68.52 135.89 27.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.916 0.389 . . . . 0.0 110.775 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -59.23 -57.55 12.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.653 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.459 HG23 ' CZ ' ' A' ' 18' ' ' TYR . 5.3 pt -53.95 -33.82 24.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.497 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 92.3 t -75.0 -30.87 24.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.071 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.8 mtm -78.16 -41.51 34.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.902 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.428 ' OD1' ' CD2' ' A' ' 76' ' ' HIS . 15.0 p30 -82.11 -30.35 31.22 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -179.057 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.428 ' CD2' ' OD1' ' A' ' 75' ' ' ASN . 36.3 m80 -91.87 -0.13 57.5 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.856 0.36 . . . . 0.0 110.923 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 9.8 m80 55.8 34.94 24.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.256 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 46.5 mt -58.59 147.32 32.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.553 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -131.82 139.0 48.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.893 0.377 . . . . 0.0 111.148 -179.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.427 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 4.7 tt0 -92.68 131.89 37.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.001 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 7.8 t -122.33 151.81 40.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.768 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 62.3 m -90.47 159.01 16.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.084 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.433 ' CB ' ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -170.02 137.83 1.64 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.76 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -85.39 173.79 10.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.938 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.2 mttp -66.92 -52.31 44.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.949 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -58.46 -46.1 87.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.893 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.431 ' HB2' ' CE2' ' A' ' 83' ' ' PHE . . . -58.67 -40.75 84.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.038 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.519 ' CZ ' ' CE1' ' A' ' 134' ' ' PHE . 0.1 OUTLIER -59.05 -36.93 75.85 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.843 179.851 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.402 ' O ' HG22 ' A' ' 92' ' ' ILE . 73.3 mttt -57.39 -48.52 78.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.159 0.504 . . . . 0.0 110.354 179.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.8 mmtt -76.47 -27.89 56.31 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.441 178.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -64.99 -46.57 80.87 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.615 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.515 ' HA ' ' CD2' ' A' ' 95' ' ' TYR . 4.5 tp -61.43 -46.52 96.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.849 0.357 . . . . 0.0 110.75 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.419 ' O ' ' HB3' ' A' ' 97' ' ' LYS . 18.9 ttpp -59.25 -38.62 80.51 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.952 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -73.89 -44.98 53.56 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.054 -179.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.515 ' CD2' ' HA ' ' A' ' 92' ' ' ILE . 0.1 OUTLIER -76.18 -38.48 56.56 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.292 -179.236 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.423 ' HG2' ' O ' ' A' ' 92' ' ' ILE . 4.0 ptt? -67.39 -32.15 72.85 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.471 179.471 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.504 ' HG3' ' N ' ' A' ' 98' ' ' SER . 0.0 OUTLIER -70.48 -33.45 71.26 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.912 0.387 . . . . 0.0 110.482 179.681 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.504 ' N ' ' HG3' ' A' ' 97' ' ' LYS . 1.7 m -64.17 -40.51 96.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.227 179.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 7.9 mt -79.72 -40.4 21.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.298 179.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -56.1 -54.38 45.73 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.411 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -60.81 -45.74 95.88 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.923 179.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.69 -40.73 96.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.926 0.393 . . . . 0.0 110.207 179.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.448 ' O ' ' N ' ' A' ' 107' ' ' ARG . 3.4 tp -66.5 -36.59 83.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.029 179.224 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.425 ' HA ' ' HA ' ' A' ' 108' ' ' PRO . 63.2 mt-10 -58.39 -29.12 65.8 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.768 179.447 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -87.01 -20.71 26.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.503 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -106.52 -61.33 1.54 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.727 0.298 . . . . 0.0 111.633 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.448 ' N ' ' O ' ' A' ' 103' ' ' LEU . 91.7 mtm-85 -131.64 65.58 76.22 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.859 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.425 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 9.4 Cg_endo -50.5 -23.45 10.66 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 123.105 2.537 . . . . 0.0 112.617 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -70.87 -12.06 61.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.68 0.276 . . . . 0.0 111.038 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.488 ' C ' ' HD2' ' A' ' 113' ' ' PRO . 6.0 mmm180 -106.66 0.57 24.45 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.764 -179.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 22.8 m -73.09 -33.29 41.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.548 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 12.7 mtmm -66.48 -50.02 49.4 Favored Pre-proline 0 C--N 1.332 -0.181 0 C-N-CA 121.022 -0.271 . . . . 0.0 111.583 -179.158 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.548 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 27.1 Cg_exo -62.18 -34.8 77.92 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.254 1.969 . . . . 0.0 111.702 179.543 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -68.31 -38.03 81.21 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.833 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -59.88 -47.17 86.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.021 0.439 . . . . 0.0 110.823 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 63.6 m -76.29 -44.65 36.07 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.69 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.63 -41.01 99.22 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.512 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.0 -47.2 86.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.058 0.456 . . . . 0.0 111.042 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.45 -29.87 66.55 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.188 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -73.65 -52.94 11.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.98 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 3.3 tp-100 -60.74 -45.63 93.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.932 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.448 HD13 ' CD2' ' A' ' 88' ' ' TYR . 0.3 OUTLIER -59.93 -45.4 95.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.936 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.448 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 15.1 mttm -60.49 -30.75 69.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.196 179.315 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -68.88 -54.46 15.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.669 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 11.6 pt -60.68 -40.5 84.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.064 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 11.5 mt -53.95 -38.59 65.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.704 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -68.52 -12.91 61.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.248 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -137.15 33.64 2.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.087 0.47 . . . . 0.0 110.503 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -49.71 -28.49 6.13 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.241 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 5.6 tttp -72.24 -20.32 61.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.341 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -94.1 -35.28 12.62 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.322 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -100.72 146.3 27.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.947 0.403 . . . . 0.0 111.283 -179.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.4 mm100 -125.38 146.22 49.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.787 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.519 ' CE1' ' CZ ' ' A' ' 88' ' ' TYR . 3.2 m-85 -81.5 129.18 34.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.958 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.427 ' CE2' ' HB2' ' A' ' 80' ' ' GLU . 30.6 m-85 -133.93 136.37 44.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.678 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.409 ' HB ' ' HA ' ' A' ' 140' ' ' MET . 1.2 mt -124.65 164.92 22.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.044 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.97 -160.07 0.73 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.165 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -74.48 -8.79 57.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.467 0.175 . . . . 0.0 111.45 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -95.33 -33.31 12.58 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 111.657 0.243 . . . . 0.0 111.657 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' MET . . . . . 0.409 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 73.9 mtm 60.11 34.93 21.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.817 0.342 . . . . 0.0 110.841 -179.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . 0.447 ' ND2' ' HA3' ' A' ' 144' ' ' GLY . 6.4 p-10 -65.94 114.82 18.05 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.043 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -67.12 -24.89 44.17 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.669 2.246 . . . . 0.0 112.386 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -84.44 -6.5 59.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.187 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.447 ' HA3' ' ND2' ' A' ' 141' ' ' ASN . . . -85.85 -124.56 1.53 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.461 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 6.9 ptp -126.57 -177.49 4.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.81 0.338 . . . . 0.0 110.76 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 48.3 t -129.23 149.74 33.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.208 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -113.41 112.17 23.19 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.463 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.49 ' HB2' ' HB ' ' A' ' 161' ' ' ILE . 4.4 mt -86.63 106.05 17.32 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.982 -179.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.5 tp -90.82 120.0 31.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.161 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.481 ' HB3' ' CZ ' ' A' ' 159' ' ' TYR . 29.5 t70 -133.94 165.37 25.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.429 179.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -107.99 147.27 31.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.817 0.341 . . . . 0.0 111.088 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.88 -168.7 0.1 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.863 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.87 -41.26 95.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.963 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -72.98 -15.13 61.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.311 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 65.7 28.64 73.82 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.487 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 73.6 t -112.4 -55.94 4.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.73 0.3 . . . . 0.0 111.177 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 54.5 m -85.78 111.65 39.17 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.4 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -80.5 135.9 10.77 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.526 2.151 . . . . 0.0 111.728 179.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.481 ' CZ ' ' HB3' ' A' ' 150' ' ' ASP . 5.8 p90 -126.02 135.57 51.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.976 0.417 . . . . 0.0 111.085 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' MET . . . . . 0.41 ' HE2' ' CG ' ' A' ' 135' ' ' PHE . 0.8 OUTLIER -104.96 131.62 52.24 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.059 -179.741 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.49 ' HB ' ' HB2' ' A' ' 148' ' ' LEU . 67.2 mt -92.09 118.5 37.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.289 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -117.05 163.42 16.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.703 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.419 ' CZ ' ' OH ' ' A' ' 95' ' ' TYR . 22.6 m-85 -100.44 122.77 43.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.905 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 12.4 tttt -70.06 -51.92 28.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.069 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -51.52 -29.17 15.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.162 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -105.35 24.29 27.99 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.375 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -138.25 146.82 43.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.849 0.357 . . . . 0.0 110.812 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -117.56 151.2 37.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.02 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.42 154.21 24.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.923 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.959 179.977 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.47 HG12 ' CG ' ' A' ' 169' ' ' MET . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.771 0.319 . . . . 0.0 111.037 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.508 ' O ' ' HA ' ' A' ' 169' ' ' MET . 4.3 mm -105.69 120.47 56.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.312 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.497 ' CG ' ' CE2' ' A' ' 14' ' ' PHE . 25.3 m-85 -91.45 125.21 36.12 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.801 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -137.23 143.66 42.39 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.215 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -55.05 144.8 22.39 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.976 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 55.3 tp -73.58 -22.17 60.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.453 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.6 mp -91.24 -43.97 14.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.687 0.28 . . . . 0.0 111.72 -179.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.9 t -92.62 -27.52 17.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.378 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 64.3 m-70 64.53 26.63 13.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.797 0.332 . . . . 0.0 110.773 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -103.15 129.7 50.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.718 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.402 ' HB3' ' CG2' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -57.84 95.9 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.346 -179.673 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 41.8 mtp -78.16 -16.86 57.53 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.7 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.497 ' CE2' ' CG ' ' A' ' 4' ' ' TYR . 37.8 p90 179.98 165.13 1.2 Allowed 'General case' 0 C--O 1.231 0.108 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.806 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.23 -169.93 1.98 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.563 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.426 ' HB2' ' CG2' ' A' ' 2' ' ' ILE . 39.4 t0 -95.67 33.78 1.59 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.02 0.438 . . . . 0.0 110.929 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.432 HG21 HD13 ' A' ' 17' ' ' ILE . 40.3 pt -93.33 -10.77 9.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.618 179.183 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.43 ' CE1' HG22 ' A' ' 72' ' ' ILE . 51.8 m-85 -110.45 -169.32 1.44 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.686 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.0 mmtt -96.88 88.25 4.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.813 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.0 mp -87.99 124.03 40.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.982 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.0 mtt180 -119.47 126.27 50.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.163 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -76.25 116.67 17.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.807 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.0 pt -114.15 170.93 4.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.204 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 56.12 28.48 13.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.286 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 63.43 41.35 7.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.218 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.1 -11.27 70.92 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.581 -0.819 . . . . 0.0 113.172 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.14 -33.87 74.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.916 0.358 . . . . 0.0 111.037 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.5 m -145.53 163.54 34.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.9 0.381 . . . . 0.0 111.158 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -127.68 130.66 49.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.704 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -97.19 112.86 24.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.153 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 22.1 t -98.8 111.84 29.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.633 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -83.56 115.78 22.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.336 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -99.8 -137.91 10.04 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.247 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.4 ptpt -174.45 126.38 0.32 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.845 0.355 . . . . 0.0 110.959 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 23.7 mtm -72.45 121.98 20.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.758 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.7 m . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.391 -179.913 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.365 0 N-CA-C 112.207 -0.357 . . . . 0.0 112.207 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.454 ' CG1' HG12 ' A' ' 72' ' ' ILE . 44.3 t -69.09 135.92 27.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.833 0.349 . . . . 0.0 110.901 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -62.33 -56.94 13.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.639 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.454 HG12 ' CG1' ' A' ' 70' ' ' VAL . 7.6 pt -53.54 -33.79 22.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.36 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.408 ' HA ' ' HB2' ' A' ' 78' ' ' LEU . 91.4 t -73.49 -33.49 39.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.915 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.4 mtm -78.23 -39.2 41.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.614 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 19.1 p30 -82.01 -29.42 32.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.581 -179.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.439 ' CE1' ' HB ' ' A' ' 72' ' ' ILE . 26.1 m170 -91.82 -4.52 54.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.842 0.353 . . . . 0.0 110.825 179.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.45 ' HB2' ' HB3' ' A' ' 138' ' ' GLU . 28.5 m80 60.73 39.57 17.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.95 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.408 ' HB2' ' HA ' ' A' ' 73' ' ' VAL . 38.1 mt -70.79 140.81 51.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.796 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -116.46 132.81 56.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.734 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.429 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 0.1 OUTLIER -91.7 120.86 32.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.94 0.4 . . . . 0.0 111.183 -179.94 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.2 t -108.82 170.01 8.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.792 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.3 p -114.91 170.45 8.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.889 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.465 ' HB2' ' CE2' ' A' ' 134' ' ' PHE . 4.0 m-85 -171.68 152.19 3.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.074 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.44 168.49 9.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.594 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.2 mttm -54.98 -51.94 64.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.125 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.63 -42.82 73.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.238 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.62 -44.83 95.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.858 0.361 . . . . 0.0 111.218 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.442 ' CD2' HD13 ' A' ' 122' ' ' ILE . 0.5 OUTLIER -59.83 -34.82 73.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.89 -179.974 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.453 ' O ' HG23 ' A' ' 92' ' ' ILE . 15.8 mtmt -59.69 -42.22 92.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.067 0.46 . . . . 0.0 110.5 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.6 -29.87 46.31 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.093 178.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -68.07 -46.17 71.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.743 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.475 ' CD1' ' CE2' ' A' ' 95' ' ' TYR . 2.1 tp -64.83 -42.17 94.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.98 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.457 ' O ' ' CG ' ' A' ' 97' ' ' LYS . 3.1 ttpt -62.0 -44.89 95.76 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.792 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -67.79 -40.18 83.95 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.955 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.54 ' CD1' ' C ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -76.5 -45.11 32.34 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 121.023 -0.271 . . . . 0.0 111.022 -179.162 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.402 ' HG2' ' O ' ' A' ' 92' ' ' ILE . 20.3 ptm -59.13 -32.01 69.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.889 0.375 . . . . 0.0 110.117 179.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.457 ' CG ' ' O ' ' A' ' 93' ' ' LYS . 3.7 mmpt? -70.72 -38.71 73.64 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.449 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.3 m -58.86 -40.08 83.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.332 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.2 mt -79.85 -42.56 22.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.416 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.49 -51.71 66.07 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.411 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -63.12 -47.16 90.69 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.044 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 4.0 tppt? -61.12 -39.89 91.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.872 0.367 . . . . 0.0 110.24 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.448 ' O ' ' N ' ' A' ' 107' ' ' ARG . 5.5 tp -66.97 -36.88 83.18 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.071 179.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 108' ' ' PRO . 75.8 mt-10 -57.52 -29.44 64.33 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.658 179.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -86.7 -20.81 27.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.486 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -105.77 -61.17 1.53 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.841 0.353 . . . . 0.0 111.656 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.448 ' N ' ' O ' ' A' ' 103' ' ' LEU . 22.5 mtt85 -134.06 66.81 72.7 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.863 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.4 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 9.6 Cg_endo -50.46 -21.68 7.8 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 123.254 2.636 . . . . 0.0 112.875 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -71.15 -9.86 58.79 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.583 0.23 . . . . 0.0 111.297 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.503 ' C ' ' HD2' ' A' ' 113' ' ' PRO . 8.5 mmt180 -110.34 -0.39 17.65 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.706 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 29.6 m -71.09 -33.93 53.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -179.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.562 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 8.3 mttt -68.27 -50.07 30.6 Favored Pre-proline 0 C--N 1.332 -0.191 0 C-N-CA 121.022 -0.271 . . . . 0.0 111.62 -179.148 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.562 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 31.6 Cg_exo -58.59 -37.76 92.85 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.188 1.925 . . . . 0.0 111.956 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.442 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 69.7 t80 -68.83 -36.9 78.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.937 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.04 -47.95 79.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.803 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 60.4 m -76.41 -44.28 36.67 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.737 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.16 -42.71 99.87 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.538 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.5 -51.59 69.21 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.044 0.449 . . . . 0.0 110.975 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.6 -28.06 67.44 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.183 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -75.87 -49.48 17.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.092 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 3.3 tp-100 -65.82 -39.73 91.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.156 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.442 HD13 ' CD2' ' A' ' 88' ' ' TYR . 0.3 OUTLIER -60.64 -45.54 97.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.984 -179.877 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.435 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 30.8 mttm -60.7 -29.45 69.34 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.317 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -69.25 -53.19 21.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.75 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 12.8 pt -63.0 -41.2 91.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.333 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 11.5 mt -54.79 -37.12 65.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.82 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -71.16 -10.54 59.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.34 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -140.31 33.35 1.89 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.928 0.395 . . . . 0.0 110.66 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.511 ' CE1' ' CZ ' ' A' ' 134' ' ' PHE . 1.5 t80 -51.35 -36.41 42.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.921 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.4 -26.07 66.39 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.977 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 32.0 m-20 -94.1 -43.84 8.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.201 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -91.8 135.52 33.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.227 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.45 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 1.8 mm100 -115.07 144.13 44.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.464 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.511 ' CZ ' ' CE1' ' A' ' 129' ' ' PHE . 0.1 OUTLIER -89.22 130.76 35.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.889 0.376 . . . . 0.0 111.099 -179.638 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.429 ' CE2' ' HB2' ' A' ' 80' ' ' GLU . 17.2 m-85 -123.72 166.29 15.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.681 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -149.23 157.57 6.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.574 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -57.42 -172.77 0.25 Allowed Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.406 -0.902 . . . . 0.0 111.676 179.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.45 ' HB3' ' HB2' ' A' ' 77' ' ' HIS . 1.1 pt-20 -70.08 -8.94 53.54 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.587 0.232 . . . . 0.0 111.292 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -94.93 -23.4 17.44 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.697 -0.229 . . . . 0.0 111.416 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 63.7 mtp 50.95 43.36 28.8 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.824 0.345 . . . . 0.0 111.302 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . 0.412 ' ND2' ' HA3' ' A' ' 144' ' ' GLY . 17.3 p-10 -64.64 117.13 35.01 Favored Pre-proline 0 N--CA 1.451 -0.391 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.816 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -59.35 -30.88 93.91 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.409 2.073 . . . . 0.0 112.26 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -84.61 -4.01 58.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.053 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.412 ' HA3' ' ND2' ' A' ' 141' ' ' ASN . . . -81.53 -153.63 11.0 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.407 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 13.2 ptp -108.59 179.15 4.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.783 0.325 . . . . 0.0 110.815 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.4 ' CG1' ' HB3' ' A' ' 134' ' ' PHE . 0.0 OUTLIER -125.15 128.43 72.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.047 179.846 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -89.91 109.39 20.41 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.257 0.551 . . . . 0.0 110.422 179.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.478 ' HB2' ' HB ' ' A' ' 161' ' ' ILE . 4.7 mt -81.85 106.29 13.66 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.349 -179.103 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.0 tp -91.12 118.63 30.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.158 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.454 ' HB3' ' CZ ' ' A' ' 159' ' ' TYR . 34.6 t70 -130.87 164.99 24.02 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.401 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -110.49 148.81 31.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.908 0.385 . . . . 0.0 110.995 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 5.0 mmm180 -57.42 -177.94 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.071 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -61.19 -41.27 96.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.949 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -87.41 -15.09 38.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.209 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 68.44 44.97 70.95 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.584 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 78.5 t -107.29 -20.8 5.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.743 0.306 . . . . 0.0 111.004 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.4 t -140.89 122.34 9.18 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.985 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -78.4 130.5 10.03 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.408 2.072 . . . . 0.0 112.09 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.454 ' CZ ' ' HB3' ' A' ' 150' ' ' ASP . 8.3 p90 -123.24 138.49 54.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.969 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' MET . . . . . . . . . . . . . 30.4 mtp -105.73 140.72 38.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.042 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.478 ' HB ' ' HB2' ' A' ' 148' ' ' LEU . 59.3 mt -97.92 111.19 27.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.016 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -107.13 154.38 21.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.957 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.408 ' CE2' ' OH ' ' A' ' 95' ' ' TYR . 17.8 m-85 -96.78 118.3 32.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.822 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 19.8 tptt -64.83 -51.54 61.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.082 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.442 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 9.0 m-20 -54.72 -32.1 59.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.151 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -103.84 17.78 48.4 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.748 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 7.0 tt -141.85 144.33 33.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.779 0.323 . . . . 0.0 110.808 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -130.17 150.43 51.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.689 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' MET . . . . . 0.508 ' HA ' ' O ' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -140.11 160.1 40.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.125 179.986 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 . . . . . 0 C--N 1.332 -0.161 0 CA-C-O 120.93 0.395 . . . . 0.0 111.647 -179.243 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.471 HG12 ' CG ' ' A' ' 169' ' ' MET . 0.9 OUTLIER . . . . . 0 N--CA 1.455 -0.177 0 CA-C-O 120.891 0.377 . . . . 0.0 111.026 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.475 ' O ' ' HA ' ' A' ' 169' ' ' MET . 7.7 mm -105.31 118.89 53.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.372 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.495 ' CG ' ' CE2' ' A' ' 14' ' ' PHE . 20.5 m-85 -91.32 129.27 37.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.766 179.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -138.09 148.95 45.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.078 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.415 ' O ' ' HA ' ' A' ' 10' ' ' HIS . 22.7 t0 -55.26 150.86 10.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.844 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 66.6 tp -80.05 -25.07 40.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.295 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.0 mp -91.21 -43.17 14.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.755 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.5 t -91.77 -26.81 18.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.597 -179.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.415 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 0.2 OUTLIER 63.97 28.42 14.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.874 0.369 . . . . 0.0 110.832 -179.774 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -104.79 130.21 52.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.719 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.19 104.69 0.22 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.226 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 17.9 mtt -88.62 -15.67 34.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.917 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.495 ' CE2' ' CG ' ' A' ' 4' ' ' TYR . 38.2 p90 179.63 159.84 0.76 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.719 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -122.15 -169.93 1.98 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.664 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.412 ' HB2' HG21 ' A' ' 2' ' ' ILE . 36.9 t70 -93.49 28.98 2.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.989 0.423 . . . . 0.0 110.967 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.418 HG13 ' CD2' ' A' ' 18' ' ' TYR . 36.1 pt -91.46 -9.04 10.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.826 179.34 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.429 ' CE2' HG21 ' A' ' 72' ' ' ILE . 57.2 m-85 -115.83 -169.74 1.65 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.789 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.0 mttt -95.78 95.06 8.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.006 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.7 mp -91.72 124.02 44.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.939 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.69 137.15 53.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.991 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -83.85 114.7 21.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.818 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.4 pt -111.12 166.35 5.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.237 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 57.35 30.11 17.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.314 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 64.43 40.55 6.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.198 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.55 -18.5 56.96 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.007 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.33 -34.85 49.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.808 0.337 . . . . 0.0 111.041 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 35.8 m -147.9 163.63 36.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.913 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -129.62 132.86 46.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.954 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 73.9 mt-10 -96.26 125.25 40.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.125 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 22.4 t -102.5 111.94 34.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.732 179.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -87.08 112.54 22.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.135 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -94.17 -132.65 6.62 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.355 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.3 ptpt -174.43 123.4 0.29 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.776 0.322 . . . . 0.0 110.836 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 41.1 mtp -68.44 123.41 20.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.931 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.4 m . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.147 -179.975 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.447 0 N-CA-C 112.012 -0.435 . . . . 0.0 112.012 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.437 ' CG1' HG12 ' A' ' 72' ' ' ILE . 46.4 t -78.77 142.45 14.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.829 0.347 . . . . 0.0 110.927 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -69.99 -56.89 5.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.494 -179.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.437 HG12 ' CG1' ' A' ' 70' ' ' VAL . 11.1 pt -53.63 -33.89 23.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.434 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 84.5 t -70.86 -31.43 45.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.783 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.3 mtt -78.26 -41.03 35.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.521 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.401 ' OD1' ' CD2' ' A' ' 76' ' ' HIS . 13.0 p30 -82.13 -28.51 32.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.528 -179.41 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.43 ' CE1' ' HA ' ' A' ' 14' ' ' PHE . 28.4 m170 -93.17 0.11 57.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.852 0.358 . . . . 0.0 110.838 179.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.461 ' HB2' ' HB3' ' A' ' 138' ' ' GLU . 13.2 m-70 56.22 27.96 12.47 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.121 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 43.6 mt -56.79 140.48 47.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.703 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -124.93 135.84 53.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.946 0.403 . . . . 0.0 111.279 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.418 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 0.0 OUTLIER -94.36 117.71 30.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.855 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.3 t -109.68 140.86 43.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.927 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 59.1 m -77.46 159.23 29.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.909 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.452 ' CB ' ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -164.23 156.13 16.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.887 -179.974 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.78 172.87 7.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.911 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.3 mttm -69.48 -52.38 27.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.893 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -62.04 -41.98 98.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.71 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.406 ' HB2' ' CD2' ' A' ' 83' ' ' PHE . . . -59.47 -42.87 93.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.076 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.51 ' CZ ' ' CE1' ' A' ' 134' ' ' PHE . 0.1 OUTLIER -58.27 -34.49 70.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.917 -179.928 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 45.3 mttt -60.31 -48.11 83.14 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.052 0.453 . . . . 0.0 110.451 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.1 mtmt -76.69 -27.85 55.68 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.698 178.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -65.18 -47.49 76.78 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.777 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.443 ' CD1' ' CE2' ' A' ' 95' ' ' TYR . 4.7 tp -62.58 -44.2 99.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.039 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.5 tttp -60.52 -40.08 90.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.139 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.458 ' HA ' ' HG2' ' A' ' 97' ' ' LYS . 26.0 t0 -75.22 -40.07 59.48 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.879 -179.257 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.465 ' CD1' ' C ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -77.95 -40.43 39.47 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 121.053 -0.259 . . . . 0.0 110.944 -179.444 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.423 ' HG2' ' O ' ' A' ' 92' ' ' ILE . 2.4 ptt? -67.64 -32.04 72.46 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.763 0.316 . . . . 0.0 110.59 179.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.458 ' HG2' ' HA ' ' A' ' 94' ' ' ASP . 1.6 ptmm? -70.47 -34.57 72.55 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.524 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.42 ' N ' ' HG3' ' A' ' 97' ' ' LYS . 2.3 m -61.09 -40.24 92.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.046 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 6.9 mt -79.78 -41.07 21.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.433 179.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 5.1 tttp -55.3 -53.73 52.5 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.441 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -60.56 -46.35 94.57 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.017 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 6.4 tptt -62.62 -37.1 84.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.959 0.409 . . . . 0.0 110.336 179.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' A' ' 107' ' ' ARG . 3.1 tp -70.41 -33.96 71.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.059 179.269 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.401 ' HA ' ' HA ' ' A' ' 108' ' ' PRO . 77.3 mt-10 -58.85 -31.63 68.7 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.634 179.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -86.58 -21.09 27.05 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.738 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -105.13 -62.53 1.33 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.74 0.305 . . . . 0.0 111.559 -179.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.441 ' N ' ' O ' ' A' ' 103' ' ' LEU . 19.6 mtt-85 -129.74 64.77 73.08 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.879 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.405 ' HA ' ' CG1' ' A' ' 111' ' ' VAL . 9.5 Cg_endo -50.52 -22.12 8.61 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 123.192 2.595 . . . . 0.0 112.745 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -70.75 -11.88 61.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.609 0.243 . . . . 0.0 111.323 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.528 ' C ' ' HD2' ' A' ' 113' ' ' PRO . 0.0 OUTLIER -110.88 -0.26 16.92 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.342 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.405 ' CG1' ' HA ' ' A' ' 108' ' ' PRO . 34.1 m -66.38 -36.37 77.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -179.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.566 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 1.1 mttp -69.01 -51.2 19.03 Favored Pre-proline 0 C--N 1.332 -0.194 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.457 -179.316 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.566 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 50.1 Cg_exo -52.45 -41.39 67.71 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.04 1.827 . . . . 0.0 111.894 179.367 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.425 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 78.2 t80 -67.28 -39.22 86.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.967 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 1.4 mmm -56.98 -51.22 70.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.971 0.415 . . . . 0.0 110.858 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 62.3 m -76.53 -44.62 34.23 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.758 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.28 -45.93 95.2 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.551 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.07 -51.5 69.44 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.008 0.432 . . . . 0.0 111.068 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.38 -28.11 67.66 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.225 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -71.73 -46.9 57.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.181 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -72.97 -38.43 66.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.07 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.462 ' CG2' ' N ' ' A' ' 123' ' ' LYS . 0.4 OUTLIER -61.54 -46.78 95.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.147 -179.853 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.462 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 3.6 pttp -62.2 -31.74 72.3 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.099 0.476 . . . . 0.0 110.142 179.451 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 3.9 t-160 -67.35 -53.3 30.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.703 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 15.5 pt -61.73 -42.28 93.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.341 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 11.5 mt -53.87 -36.08 62.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.912 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -72.86 -10.16 59.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.173 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -141.64 33.7 1.63 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.017 0.437 . . . . 0.0 110.462 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.5 ' CE1' ' CZ ' ' A' ' 134' ' ' PHE . 11.5 t80 -50.3 -26.41 4.78 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.237 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.2 mmtt -61.76 -27.47 68.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.769 0.319 . . . . 0.0 110.945 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 22.2 m-20 -94.27 -36.75 11.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.488 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.409 ' CG ' ' OD2' ' A' ' 150' ' ' ASP . 10.8 m-85 -98.13 138.75 34.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.918 0.39 . . . . 0.0 111.25 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -122.96 144.69 49.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.951 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.51 ' CE1' ' CZ ' ' A' ' 88' ' ' TYR . 1.3 m-85 -80.52 123.81 28.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.089 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.418 ' CE2' ' HB2' ' A' ' 80' ' ' GLU . 30.3 m-85 -125.57 151.06 46.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.713 179.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.442 ' HB ' ' HA ' ' A' ' 140' ' ' MET . 0.4 OUTLIER -139.38 159.54 28.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.927 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.41 -165.12 0.3 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.403 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.461 ' HB3' ' HB2' ' A' ' 77' ' ' HIS . 5.1 pt-20 -71.52 -9.84 58.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.517 0.199 . . . . 0.0 111.467 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 -96.2 -32.03 12.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.585 0.231 . . . . 0.0 111.594 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' MET . . . . . 0.442 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 58.2 mtm 56.54 41.34 28.76 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.825 0.345 . . . . 0.0 111.137 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -67.02 120.44 71.91 Favored Pre-proline 0 N--CA 1.454 -0.252 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.713 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -61.8 -25.57 78.64 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.248 1.965 . . . . 0.0 111.903 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -84.79 -18.13 35.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.743 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -71.49 -161.74 4.8 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.249 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 3.9 ptp -97.03 177.82 5.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.785 0.326 . . . . 0.0 110.864 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 41.8 t -122.62 148.01 26.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.119 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.421 ' HB3' ' CE1' ' A' ' 162' ' ' PHE . . . -112.07 115.27 28.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.845 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.478 ' HB2' ' HB ' ' A' ' 161' ' ' ILE . 4.0 mt -89.56 105.9 18.1 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.814 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.1 tp -94.55 119.08 32.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.356 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.528 ' HB3' ' CE1' ' A' ' 159' ' ' TYR . 0.5 OUTLIER -134.97 170.16 16.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.561 179.367 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -105.74 150.36 25.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.909 0.385 . . . . 0.0 111.151 -179.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -78.09 -172.62 2.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.814 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -57.54 -41.13 80.32 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.942 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 44.4 p-10 -69.11 -15.07 63.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.238 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 65.3 19.04 65.97 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.589 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 80.4 t -113.44 -65.36 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.904 0.383 . . . . 0.0 111.044 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 98.3 m -64.98 111.87 6.84 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.14 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -82.06 131.61 6.96 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.63 2.22 . . . . 0.0 111.903 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.528 ' CE1' ' HB3' ' A' ' 150' ' ' ASP . 6.7 p90 -125.11 139.14 54.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.96 0.41 . . . . 0.0 111.142 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' MET . . . . . 0.401 ' HA ' ' O ' ' A' ' 148' ' ' LEU . 41.6 mtp -109.89 140.93 43.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.981 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.478 ' HB ' ' HB2' ' A' ' 148' ' ' LEU . 72.3 mt -97.07 116.92 40.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.337 -179.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . 0.421 ' CE1' ' HB3' ' A' ' 147' ' ' ALA . 75.4 m-85 -117.33 151.01 37.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.57 179.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -100.47 124.89 46.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.955 0.407 . . . . 0.0 111.01 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 27.2 tttm -70.02 -45.55 66.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.275 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.425 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 15.8 m-20 -49.28 -35.6 18.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.24 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -109.26 30.71 8.3 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.509 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.411 HD12 ' CE1' ' A' ' 14' ' ' PHE . 1.5 tt -150.06 146.88 27.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.896 0.379 . . . . 0.0 110.918 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -132.06 154.09 49.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.331 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' MET . . . . . 0.475 ' HA ' ' O ' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -139.96 160.27 40.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.829 0.347 . . . . 0.0 111.32 -179.843 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 . . . . . 0 C--O 1.231 0.127 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.355 -179.259 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.433 HG21 ' HB2' ' A' ' 16' ' ' ASP . 1.5 tt . . . . . 0 CA--C 1.528 0.109 0 CA-C-O 120.719 0.295 . . . . 0.0 110.974 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 11.4 mm -100.11 154.18 4.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.433 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.512 ' CD2' ' CZ ' ' A' ' 14' ' ' PHE . 3.5 m-85 -123.85 111.08 15.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.436 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.22 146.65 50.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.919 0.39 . . . . 0.0 111.215 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.451 ' O ' ' HA ' ' A' ' 10' ' ' HIS . 46.1 t0 -54.67 152.16 7.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.897 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 56.2 tp -80.88 -20.36 42.43 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.484 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.1 mp -91.35 -48.28 13.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -93.79 -21.97 18.97 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 -179.157 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.451 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 3.5 m-70 63.52 31.38 14.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.884 0.373 . . . . 0.0 110.8 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -102.66 121.76 43.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.804 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -57.24 98.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.303 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.8 mtt -78.18 -18.07 55.99 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.733 179.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.512 ' CZ ' ' CD2' ' A' ' 4' ' ' TYR . 5.7 p90 -177.37 177.42 1.19 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.778 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -133.84 -171.94 2.86 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.659 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.433 ' HB2' HG21 ' A' ' 2' ' ' ILE . 22.2 t0 -95.0 27.13 3.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.966 0.413 . . . . 0.0 110.876 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.436 HD13 ' CZ ' ' A' ' 18' ' ' TYR . 45.6 pt -86.63 -13.83 10.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.479 179.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.436 ' CZ ' HD13 ' A' ' 17' ' ' ILE . 79.8 m-85 -106.16 -170.34 1.71 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.537 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.39 88.56 4.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.721 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.3 mp -87.97 130.65 37.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.16 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.9 mtt180 -121.73 119.12 30.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.888 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -71.4 116.07 11.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.924 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.6 pt -109.62 172.46 2.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.022 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 58.32 28.1 16.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.194 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 65.11 54.39 1.23 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.451 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.44 -3.51 72.84 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.553 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.48 -56.89 7.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 117.111 0.456 . . . . 0.0 110.815 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 46.9 m -120.08 168.72 10.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.747 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.22 133.43 44.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.853 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -98.42 112.84 24.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.963 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.441 ' CG2' ' CE2' ' A' ' 14' ' ' PHE . 22.8 t -93.63 111.98 25.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.744 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -86.87 124.7 33.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.145 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.59 -135.93 8.38 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.358 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.7 pttm -174.51 124.62 0.3 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.855 0.36 . . . . 0.0 110.881 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 62.9 mtm -69.74 121.83 17.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.75 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.1 m . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.342 -179.784 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.419 0 N-CA-C 112.31 -0.316 . . . . 0.0 112.31 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.41 ' HB ' ' CG2' ' A' ' 73' ' ' VAL . 60.1 t -68.37 141.34 17.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.875 0.369 . . . . 0.0 110.852 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -67.56 -58.77 4.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.48 -179.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.432 HG23 ' CZ ' ' A' ' 18' ' ' TYR . 8.9 pt -53.72 -33.84 23.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.531 -179.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.41 ' CG2' ' HB ' ' A' ' 70' ' ' VAL . 58.7 t -72.26 -33.92 47.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.054 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.5 mtm -78.13 -38.89 42.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.598 -179.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 19.1 p30 -82.07 -28.89 32.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.565 -179.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.424 ' CE1' ' HB ' ' A' ' 72' ' ' ILE . 26.7 m170 -93.43 -1.12 56.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.841 0.353 . . . . 0.0 110.952 179.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 57.87 30.52 19.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.07 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 56.9 mt -57.83 134.88 56.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.535 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -118.48 134.36 55.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.941 0.4 . . . . 0.0 111.161 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.427 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 16.0 tt0 -87.63 129.81 34.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.934 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.1 t -122.81 126.31 47.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.829 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.4 m -68.06 159.02 31.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.999 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -165.42 149.72 8.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.799 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.54 158.18 17.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.798 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.47 -52.5 65.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.896 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -62.35 -44.33 96.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.738 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.64 -37.9 76.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.938 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.481 ' CD2' HD13 ' A' ' 122' ' ' ILE . 2.0 t80 -59.92 -38.64 82.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.736 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.426 ' O ' ' CG2' ' A' ' 92' ' ' ILE . 32.6 mttt -57.46 -49.47 76.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.172 0.51 . . . . 0.0 110.483 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.2 mtmt -72.42 -27.82 62.58 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.829 178.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -66.84 -46.16 75.97 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.957 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.426 ' CG2' ' O ' ' A' ' 89' ' ' LYS . 2.9 tp -60.45 -40.79 85.29 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.172 0 CA-C-O 120.766 0.317 . . . . 0.0 110.866 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.435 ' O ' ' CG ' ' A' ' 97' ' ' LYS . 0.9 OUTLIER -61.31 -46.33 90.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.733 179.935 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -71.2 -38.96 72.04 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.846 -179.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.544 ' CD1' ' C ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -74.5 -41.64 60.33 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.739 -0.21 . . . . 0.0 110.792 -179.542 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.405 ' HG2' ' O ' ' A' ' 92' ' ' ILE . 19.7 ptt? -64.86 -32.06 73.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.825 0.345 . . . . 0.0 110.248 179.271 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.435 ' CG ' ' O ' ' A' ' 93' ' ' LYS . 5.4 mmtp -64.4 -42.91 95.83 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.853 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.7 m -56.96 -43.32 81.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.82 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 6.3 mt -79.72 -40.92 21.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.587 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.83 -51.87 65.98 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.706 179.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -64.33 -45.39 93.55 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.014 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.88 -42.06 92.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.927 0.394 . . . . 0.0 110.447 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.44 ' O ' ' N ' ' A' ' 107' ' ' ARG . 4.1 tp -65.55 -36.49 83.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.181 179.4 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 108' ' ' PRO . 76.9 mt-10 -58.43 -28.55 65.37 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.772 179.358 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -88.73 -19.23 26.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.73 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -110.39 -60.99 1.73 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.77 0.319 . . . . 0.0 111.673 -179.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 103' ' ' LEU . 1.1 mtt85 -125.59 63.17 44.35 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.93 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.408 ' HA ' ' CG1' ' A' ' 111' ' ' VAL . 10.1 Cg_endo -50.77 -22.22 9.44 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 123.064 2.51 . . . . 0.0 112.798 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -73.44 -15.23 61.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.749 0.309 . . . . 0.0 111.253 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.526 ' C ' ' HD2' ' A' ' 113' ' ' PRO . 2.5 mmm180 -106.34 0.73 25.24 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.774 -179.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.408 ' CG1' ' HA ' ' A' ' 108' ' ' PRO . 32.8 m -68.17 -36.66 76.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.573 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 28.4 mttt -66.79 -51.25 40.17 Favored Pre-proline 0 CA--C 1.53 0.186 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.233 -179.286 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.573 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 51.8 Cg_exo -53.31 -41.48 72.35 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.062 1.841 . . . . 0.0 111.821 179.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.448 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 88.2 t80 -68.35 -37.86 80.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.964 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -53.94 -49.81 67.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.004 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.8 m -76.61 -44.29 34.89 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.825 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -59.09 -44.12 96.54 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.691 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.53 -45.95 92.0 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.026 0.441 . . . . 0.0 110.718 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.76 -32.6 65.76 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.67 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -78.28 -43.07 29.09 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.731 0.3 . . . . 0.0 111.242 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -66.26 -39.5 89.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.138 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.481 HD13 ' CD2' ' A' ' 88' ' ' TYR . 0.3 OUTLIER -63.11 -45.0 99.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.053 -179.929 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.443 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 27.0 mttt -59.51 -31.12 69.07 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.215 179.387 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 3.9 t-160 -68.21 -54.12 20.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.622 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 8.7 pt -61.78 -38.51 80.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.118 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.433 ' HG ' ' CD1' ' A' ' 122' ' ' ILE . 12.4 mt -53.6 -40.3 65.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.553 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.02 -19.13 60.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.766 179.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -128.91 28.94 5.28 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.392 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -48.9 -42.28 36.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.273 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 8.4 ttpp -68.67 -15.4 63.51 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.367 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -94.05 -38.54 11.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.382 -179.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.465 ' CD1' ' N ' ' A' ' 132' ' ' TYR . 1.7 m-30 -97.77 153.79 18.04 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.971 0.415 . . . . 0.0 111.365 -179.386 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.424 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 4.8 mm100 -123.35 155.32 37.54 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.538 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.446 ' CE1' ' CE1' ' A' ' 88' ' ' TYR . 3.4 m-85 -93.24 133.86 36.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.876 0.369 . . . . 0.0 111.124 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.427 ' CE2' ' HB2' ' A' ' 80' ' ' GLU . 36.4 m-85 -134.25 151.29 51.21 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.491 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.425 ' HB ' ' HA ' ' A' ' 140' ' ' MET . 0.5 OUTLIER -134.61 161.44 40.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.965 179.897 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -62.19 -164.38 0.37 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.169 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -73.38 -8.93 57.95 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.552 0.215 . . . . 0.0 111.433 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -97.96 -28.7 13.69 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.668 -179.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' MET . . . . . 0.425 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 45.7 mtp 55.72 42.39 29.31 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.897 0.379 . . . . 0.0 111.02 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . 0.417 ' ND2' ' HA3' ' A' ' 144' ' ' GLY . 16.5 p-10 -65.03 114.78 16.34 Favored Pre-proline 0 N--CA 1.452 -0.373 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.993 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -62.19 -29.29 80.37 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.496 2.13 . . . . 0.0 112.142 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -84.64 -7.66 59.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.127 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.417 ' HA3' ' ND2' ' A' ' 141' ' ' ASN . . . -86.41 -167.67 43.9 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.436 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 1.6 ptp -84.99 -174.41 5.26 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.949 0.404 . . . . 0.0 110.794 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 75.6 t -130.27 155.65 41.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.067 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.408 ' HB3' ' CE1' ' A' ' 162' ' ' PHE . . . -116.56 110.84 19.08 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.473 179.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.502 ' HB2' ' HB ' ' A' ' 161' ' ' ILE . 5.0 mt -86.46 106.01 17.18 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.236 -179.174 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.0 tp -89.69 119.77 30.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.928 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.52 ' HB2' ' CZ ' ' A' ' 159' ' ' TYR . 57.6 m-20 -131.91 161.67 32.48 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.68 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -105.3 146.6 29.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.119 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 8.7 mmt180 -59.68 -176.2 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.907 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -56.36 -41.31 75.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.951 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -72.61 -15.13 61.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.164 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 77.83 21.59 71.15 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.626 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 87.5 t -113.41 -73.01 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.772 0.32 . . . . 0.0 110.924 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 98.9 m -53.02 103.23 0.35 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.13 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -77.11 127.88 9.51 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.724 2.283 . . . . 0.0 112.069 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.52 ' CZ ' ' HB2' ' A' ' 150' ' ' ASP . 10.5 p90 -126.54 133.26 51.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.956 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' MET . . . . . 0.42 ' HE1' ' CG ' ' A' ' 135' ' ' PHE . 0.5 OUTLIER -103.46 140.03 38.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.055 -179.659 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.502 ' HB ' ' HB2' ' A' ' 148' ' ' LEU . 90.4 mt -95.59 113.81 30.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.888 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . 0.408 ' CE1' ' HB3' ' A' ' 147' ' ' ALA . 47.9 m-85 -117.45 133.89 55.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.889 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -79.33 128.96 33.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.977 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 12.4 tttm -70.12 -52.83 20.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.101 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.448 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 19.3 m-20 -49.3 -37.83 25.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.155 -179.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -96.56 28.73 12.13 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.341 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -146.74 145.88 30.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.75 0.309 . . . . 0.0 110.843 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -109.84 152.61 25.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.854 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.28 138.66 54.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.935 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.962 179.94 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.1 tt . . . . . 0 N--CA 1.456 -0.136 0 CA-C-O 120.81 0.338 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 19.3 mm -107.56 155.01 8.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.089 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.5 ' CD2' ' CE2' ' A' ' 14' ' ' PHE . 3.4 m-85 -122.2 104.47 9.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.606 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -119.19 152.19 37.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.343 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.441 ' O ' ' HA ' ' A' ' 10' ' ' HIS . 38.9 t0 -58.11 152.2 17.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.802 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 56.6 tp -81.38 -23.89 37.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.306 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.8 mp -91.18 -45.07 14.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.3 t -93.76 -25.34 17.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.781 -179.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.441 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 38.5 m80 66.47 28.84 9.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.883 0.373 . . . . 0.0 110.832 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -102.48 123.57 46.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.749 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.12 99.8 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.259 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 33.3 mtp -80.91 -16.53 53.33 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.795 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.5 ' CE2' ' CD2' ' A' ' 4' ' ' TYR . 12.3 p90 -178.22 175.57 1.2 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.698 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -134.05 -169.85 2.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.071 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.7 p-10 -89.96 19.74 4.68 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.549 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 46.2 pt -86.15 -6.93 10.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.817 0.342 . . . . 0.0 111.266 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.426 ' CE2' HG22 ' A' ' 72' ' ' ILE . 71.1 m-85 -116.5 168.87 9.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.748 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? -79.71 93.34 5.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.681 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.4 mp -87.78 125.66 41.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.066 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -116.97 132.14 56.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.981 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -81.52 116.11 21.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.775 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 7.7 pt -116.45 167.08 9.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.018 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 58.44 34.54 24.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.068 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 64.45 38.62 7.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.214 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.67 -10.49 74.55 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.667 -0.777 . . . . 0.0 113.182 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.18 -37.64 69.86 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.901 0.35 . . . . 0.0 111.143 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 72.0 m -136.98 169.74 17.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.139 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -131.99 119.08 20.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.897 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -83.09 112.94 20.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.107 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 30.6 t -94.74 111.92 26.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.615 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -82.54 118.48 23.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.205 -179.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.4 -139.21 9.67 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.267 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.6 pttm -174.36 129.97 0.36 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.772 0.32 . . . . 0.0 110.958 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 17.4 mtm -76.73 125.0 28.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.896 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.0 m . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.216 -179.963 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.371 0 N-CA-C 112.229 -0.348 . . . . 0.0 112.229 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.413 ' CG1' HG12 ' A' ' 72' ' ' ILE . 59.8 t -69.73 148.28 11.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.911 0.386 . . . . 0.0 110.931 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -72.48 -57.56 4.08 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.338 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.43 ' HB ' ' CE1' ' A' ' 76' ' ' HIS . 10.8 pt -53.53 -34.01 22.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.421 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.418 ' HA ' ' HB2' ' A' ' 78' ' ' LEU . 57.9 t -71.24 -31.88 45.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.882 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.3 mtm -78.01 -40.47 38.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.417 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.406 ' OD1' ' CD2' ' A' ' 76' ' ' HIS . 13.5 p30 -82.12 -28.77 32.06 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.51 -179.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.43 ' CE1' ' HB ' ' A' ' 72' ' ' ILE . 26.9 m170 -93.55 -0.28 56.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.753 0.311 . . . . 0.0 110.88 179.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 55.89 29.62 14.47 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.09 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.418 ' HB2' ' HA ' ' A' ' 73' ' ' VAL . 52.3 mt -57.09 139.84 51.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.652 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -124.44 137.38 54.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.126 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -91.59 131.86 36.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.037 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.2 t -118.5 170.1 9.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.872 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.3 m -107.39 165.19 11.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.955 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.493 ' CE2' ' CE2' ' A' ' 91' ' ' TYR . 2.7 m-85 -171.68 149.84 2.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.95 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.3 m -101.48 166.34 10.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.767 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.7 mtmp? -57.34 -49.86 74.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.873 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.65 -40.25 76.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.831 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.95 -43.73 94.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.101 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.507 ' CZ ' ' CE1' ' A' ' 134' ' ' PHE . 0.6 OUTLIER -61.48 -30.74 70.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.757 179.921 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.447 ' O ' HG22 ' A' ' 92' ' ' ILE . 27.7 mttm -62.98 -44.66 95.43 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.012 0.434 . . . . 0.0 110.566 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 11.3 mttm -78.56 -27.9 45.89 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.771 178.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.493 ' CE2' ' CE2' ' A' ' 83' ' ' PHE . 17.2 t80 -67.03 -47.32 71.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.073 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.457 ' CD1' ' CE2' ' A' ' 95' ' ' TYR . 2.3 tp -65.06 -40.21 88.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.074 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.444 ' O ' ' CG ' ' A' ' 97' ' ' LYS . 4.9 ttpp -62.73 -45.28 93.47 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.923 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -68.76 -39.34 80.32 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.861 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.534 ' CD1' ' C ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -76.03 -43.78 42.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.712 -0.222 . . . . 0.0 110.875 -179.299 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 3.2 ptt? -62.06 -31.99 72.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.914 0.388 . . . . 0.0 110.238 179.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.444 ' CG ' ' O ' ' A' ' 93' ' ' LYS . 3.8 mmtt -66.46 -42.11 88.04 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.717 179.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.4 m -57.22 -41.72 80.0 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.657 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 6.6 mt -79.78 -42.26 22.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.685 179.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.8 tttt -53.64 -54.5 36.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.55 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -62.12 -46.4 94.07 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.126 179.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 26.0 tptt -61.08 -37.01 81.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.945 0.402 . . . . 0.0 110.406 179.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.437 ' O ' ' N ' ' A' ' 107' ' ' ARG . 6.6 tp -70.82 -32.94 70.17 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.051 179.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -60.97 -29.13 69.48 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.806 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -89.97 -19.58 24.32 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.423 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -106.84 -62.68 1.37 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.881 0.372 . . . . 0.0 111.472 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.437 ' N ' ' O ' ' A' ' 103' ' ' LEU . 9.7 mtt-85 -124.91 62.72 37.07 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.902 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -50.82 -24.53 13.63 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 123.091 2.528 . . . . 0.0 112.537 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -73.05 -9.46 58.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.247 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.485 ' C ' ' HD2' ' A' ' 113' ' ' PRO . 58.2 mmt-85 -110.84 0.11 17.11 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.665 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 26.5 m -71.42 -33.8 51.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.545 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 4.9 mttm -67.69 -50.4 35.22 Favored Pre-proline 0 CA--C 1.53 0.197 0 C-N-CA 120.997 -0.281 . . . . 0.0 111.681 -179.12 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.545 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 24.7 Cg_exo -63.16 -29.28 73.99 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.148 1.899 . . . . 0.0 111.67 179.478 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.469 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 89.3 t80 -72.12 -42.4 66.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.861 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 2.7 mmm -58.07 -43.83 87.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.874 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 66.2 m -76.69 -45.15 30.68 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.905 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.15 -45.83 92.69 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.775 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.19 -51.76 68.02 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.045 0.45 . . . . 0.0 111.269 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.405 ' O ' ' HG2' ' A' ' 123' ' ' LYS . . . -71.85 -28.06 63.3 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.502 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -74.13 -50.0 21.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.772 0.32 . . . . 0.0 111.474 -179.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -67.62 -39.2 84.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.512 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.481 ' CG2' ' N ' ' A' ' 123' ' ' LYS . 0.3 OUTLIER -59.5 -49.82 82.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.654 -179.458 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.481 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 9.5 ptpt -60.18 -30.64 69.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.059 0.457 . . . . 0.0 110.276 179.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -68.91 -53.26 21.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.755 179.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 16.7 pt -62.31 -42.33 95.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.309 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 11.3 mt -53.76 -37.18 63.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.946 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -72.89 -9.8 59.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.215 179.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 -142.24 34.44 1.51 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.983 0.42 . . . . 0.0 110.477 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.507 ' CE1' ' CZ ' ' A' ' 134' ' ' PHE . 5.4 t80 -51.95 -24.71 6.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.113 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -55.92 -37.91 69.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.979 0.418 . . . . 0.0 111.0 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 27.0 m-20 -86.25 -42.75 13.51 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.685 -179.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -92.72 129.31 38.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.881 0.372 . . . . 0.0 111.394 -179.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.403 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 2.3 mm100 -114.84 145.13 42.49 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.911 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.507 ' CZ ' ' CE1' ' A' ' 129' ' ' PHE . 1.7 m-85 -79.95 127.52 32.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.174 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.407 ' CE1' ' HB3' ' A' ' 149' ' ' LEU . 48.0 m-85 -132.3 134.18 44.94 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.586 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.459 ' HB ' ' HA ' ' A' ' 140' ' ' MET . 0.7 OUTLIER -120.94 161.86 20.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.939 -179.811 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.47 -165.12 0.14 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.266 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -72.35 -9.18 58.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.566 0.222 . . . . 0.0 111.489 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 -97.59 -33.9 11.17 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 120.652 0.263 . . . . 0.0 111.518 -179.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' MET . . . . . 0.459 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 34.9 mtm 60.47 34.96 20.4 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.683 0.278 . . . . 0.0 111.335 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -64.4 123.6 83.26 Favored Pre-proline 0 N--CA 1.451 -0.392 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.732 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -61.95 -23.35 75.77 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.321 2.014 . . . . 0.0 111.822 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -84.45 -12.14 54.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.734 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -80.96 -175.54 49.96 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.258 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 1.4 ptp -85.37 -177.98 6.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.783 0.325 . . . . 0.0 110.891 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 43.6 t -125.88 149.04 30.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.96 0.41 . . . . 0.0 111.165 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -113.55 112.52 23.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.649 179.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.517 ' HB2' ' HB ' ' A' ' 161' ' ' ILE . 4.7 mt -85.86 106.27 16.95 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.03 -179.361 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.407 ' HB3' ' CE1' ' A' ' 135' ' ' PHE . 3.3 tp -90.75 119.19 30.77 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.381 -179.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.491 ' HB3' ' CE1' ' A' ' 159' ' ' TYR . 13.4 t70 -132.57 164.29 26.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.482 179.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -97.49 146.7 24.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.955 0.407 . . . . 0.0 111.226 -179.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.09 -176.36 0.88 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.882 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -58.96 -41.31 87.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.923 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -67.18 -15.1 63.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.132 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 75.03 11.07 84.17 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.68 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 73.6 t -111.89 -70.15 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.846 0.355 . . . . 0.0 110.872 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 90.5 m -55.6 108.54 1.21 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.163 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -82.65 132.19 6.57 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.579 2.186 . . . . 0.0 112.074 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.491 ' CE1' ' HB3' ' A' ' 150' ' ' ASP . 8.1 p90 -125.28 149.15 48.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.89 0.376 . . . . 0.0 110.983 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -114.52 150.76 34.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.162 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.517 ' HB ' ' HB2' ' A' ' 148' ' ' LEU . 88.5 mt -103.44 111.95 35.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.871 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -114.53 125.84 54.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.907 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.407 ' CE2' ' OH ' ' A' ' 95' ' ' TYR . 2.6 m-85 -71.06 124.68 24.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.744 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 6.3 tttm -66.39 -56.44 11.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.31 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.469 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 0.8 OUTLIER -51.06 -34.4 29.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.238 -179.797 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -95.73 25.28 25.73 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.47 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -137.74 146.99 44.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.867 0.365 . . . . 0.0 110.928 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -119.38 136.85 54.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.79 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 1.6 mpp? -103.98 154.55 19.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.015 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.799 -179.963 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.452 ' CD1' ' HB3' ' A' ' 169' ' ' MET . 10.0 tt . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.854 0.359 . . . . 0.0 111.159 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' A' ' 169' ' ' MET . 19.4 mm -92.88 157.31 2.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.23 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.498 ' CD2' ' CE2' ' A' ' 14' ' ' PHE . 3.0 m-85 -124.54 106.7 10.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.489 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 25.0 ptt180 -121.84 148.28 44.89 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.817 0.341 . . . . 0.0 111.333 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.435 ' O ' ' HA ' ' A' ' 10' ' ' HIS . 23.3 t0 -56.57 152.21 12.27 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.808 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 61.5 tp -80.3 -24.17 40.16 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.373 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.7 mp -91.3 -44.49 14.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.823 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.6 p -93.1 -23.77 18.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.77 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.435 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 5.6 m170 63.44 28.07 15.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.809 0.337 . . . . 0.0 110.817 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -102.73 121.39 42.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.734 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.52 89.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.204 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 6.4 mtt -69.32 -16.07 63.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.881 179.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.498 ' CE2' ' CD2' ' A' ' 4' ' ' TYR . 34.1 p90 -176.87 171.48 2.18 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.93 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.8 m -134.54 -169.94 2.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.005 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.424 ' HB3' HG21 ' A' ' 2' ' ' ILE . 13.5 p-10 -87.24 12.3 12.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.525 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 46.2 pt -81.3 -3.26 6.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.884 0.373 . . . . 0.0 111.062 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.43 ' CE2' HG22 ' A' ' 72' ' ' ILE . 65.2 m-85 -119.89 179.87 4.12 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.705 -179.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.14 88.94 7.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.916 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.4 mp -88.03 123.89 40.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.994 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.79 133.52 55.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.914 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -78.35 121.15 24.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.826 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.8 pt -116.44 174.59 3.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.205 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 57.06 24.82 10.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.393 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 65.72 57.55 0.84 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.37 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 73.56 18.95 79.62 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.756 -0.735 . . . . 0.0 113.354 179.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.53 -45.67 8.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.914 0.357 . . . . 0.0 110.948 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 17.0 m -130.67 171.62 12.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.054 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.48 131.08 46.59 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.941 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -97.25 112.77 24.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.798 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.6 t -92.0 111.78 24.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.726 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -84.19 117.57 23.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.12 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -99.82 -138.37 10.26 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.319 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -174.48 124.82 0.3 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.804 0.335 . . . . 0.0 111.013 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 55.8 mtp -68.61 122.0 17.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.656 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.3 m . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.292 -179.731 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 112.143 -0.383 . . . . 0.0 112.143 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.415 ' CG1' HG12 ' A' ' 72' ' ' ILE . 47.8 t -74.22 142.66 14.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.851 0.357 . . . . 0.0 110.937 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -69.74 -57.53 5.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.399 -179.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.433 ' HB ' ' CE1' ' A' ' 76' ' ' HIS . 9.1 pt -53.72 -33.92 23.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.576 -179.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 71.6 t -72.02 -33.75 48.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.838 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.8 mtm -78.4 -39.87 37.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.714 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.41 ' OD1' ' CD2' ' A' ' 76' ' ' HIS . 18.8 p30 -82.07 -29.13 32.0 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 -179.238 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.433 ' CE1' ' HB ' ' A' ' 72' ' ' ILE . 26.3 m170 -92.98 0.25 57.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.753 0.311 . . . . 0.0 110.858 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.404 ' CD2' ' N ' ' A' ' 77' ' ' HIS . 8.4 m170 55.09 32.79 19.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.913 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 52.4 mt -55.92 141.58 38.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.744 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -119.81 131.25 55.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.035 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.426 ' HG3' ' CE1' ' A' ' 135' ' ' PHE . 6.5 tt0 -95.0 127.26 40.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.93 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.8 t -120.03 165.12 15.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.751 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.0 p -97.03 159.65 14.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.841 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.446 ' HB2' ' CE2' ' A' ' 134' ' ' PHE . 1.6 m-85 -165.6 149.62 8.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.981 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.5 m -101.43 162.94 12.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.867 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 12.7 mttm -58.32 -52.46 65.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.065 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -63.71 -44.13 94.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.82 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.58 -42.22 98.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.02 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.442 ' CD2' HD12 ' A' ' 122' ' ' ILE . 0.7 OUTLIER -61.02 -33.84 73.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.841 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 12.8 mttp -61.19 -43.55 98.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.906 0.384 . . . . 0.0 110.554 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.1 mttp -78.11 -27.82 48.46 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.843 179.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -67.68 -42.27 82.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.878 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.452 HD12 ' CE2' ' A' ' 95' ' ' TYR . 5.0 tp -65.73 -44.24 93.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.898 0.38 . . . . 0.0 110.972 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.472 ' O ' ' CG ' ' A' ' 97' ' ' LYS . 2.0 ttpt -61.26 -45.35 94.88 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.782 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -68.75 -40.37 79.85 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.177 -179.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.538 ' CD1' ' C ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -77.69 -44.08 29.1 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.994 -179.272 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.41 ' HG3' ' N ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -60.17 -31.59 70.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.914 0.388 . . . . 0.0 110.195 179.165 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.472 ' CG ' ' O ' ' A' ' 93' ' ' LYS . 1.6 mmpt? -66.84 -45.14 79.14 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.445 179.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -54.92 -40.65 70.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.813 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.8 mt -79.95 -42.5 22.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.532 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.407 ' O ' ' HG3' ' A' ' 104' ' ' GLU . 0.0 OUTLIER -55.63 -52.05 65.14 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.442 179.62 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -63.19 -46.86 92.18 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.363 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.97 -44.41 94.48 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.877 0.37 . . . . 0.0 110.456 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.435 ' O ' ' N ' ' A' ' 107' ' ' ARG . 3.8 tp -63.26 -37.6 87.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.285 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.415 ' HA ' ' HA ' ' A' ' 108' ' ' PRO . 36.8 mt-10 -57.28 -29.5 63.92 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 120.818 0.342 . . . . 0.0 110.814 179.357 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -86.54 -19.29 29.68 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.617 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -109.52 -60.72 1.74 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.803 0.335 . . . . 0.0 111.774 -179.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.435 ' N ' ' O ' ' A' ' 103' ' ' LEU . 1.7 mtt180 -132.54 66.52 76.98 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.833 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.415 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 10.3 Cg_endo -50.56 -21.02 7.04 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 123.257 2.638 . . . . 0.0 112.879 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -69.76 -7.92 43.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.411 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.47 ' C ' ' HD2' ' A' ' 113' ' ' PRO . 0.0 OUTLIER -113.35 -2.6 13.95 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -179.517 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 33.1 m -73.13 -30.72 32.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -179.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.546 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 2.9 mtpt -69.46 -49.74 21.58 Favored Pre-proline 0 CA--C 1.53 0.197 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.711 -179.104 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.546 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 24.7 Cg_exo -63.13 -34.76 67.98 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.118 1.879 . . . . 0.0 111.987 179.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.447 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 69.6 t80 -72.21 -36.4 69.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.949 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.6 -54.88 41.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.983 0.42 . . . . 0.0 110.713 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 75.3 m -71.58 -44.68 64.05 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.584 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -59.89 -43.06 98.38 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.412 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -55.96 -48.52 75.64 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.022 0.439 . . . . 0.0 111.082 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.74 -33.51 66.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.382 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -74.31 -39.77 62.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.849 0.357 . . . . 0.0 111.256 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -71.75 -35.92 70.25 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.115 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.442 HD12 ' CD2' ' A' ' 88' ' ' TYR . 0.4 OUTLIER -67.06 -45.31 87.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.303 -179.698 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.433 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 10.0 ptpt -61.84 -30.87 71.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.965 0.412 . . . . 0.0 110.23 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -67.88 -53.6 25.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.652 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 14.8 pt -62.05 -41.42 91.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.282 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 13.4 mt -53.8 -37.46 63.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.915 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -65.02 -16.55 63.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.102 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 11.4 m-80 -137.16 33.0 2.59 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.644 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.498 ' CE1' ' CE2' ' A' ' 134' ' ' PHE . 1.1 t80 -52.5 -36.74 55.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.953 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -61.13 -18.76 59.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.286 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 35.2 m-20 -92.29 -43.43 9.29 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.716 0.293 . . . . 0.0 111.306 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.427 ' CD1' ' N ' ' A' ' 132' ' ' TYR . 1.4 m-30 -94.4 163.85 13.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.909 0.385 . . . . 0.0 111.245 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.421 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 2.3 mm100 -136.35 145.67 45.67 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.88 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.498 ' CE2' ' CE1' ' A' ' 129' ' ' PHE . 1.5 m-85 -79.89 125.54 29.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.932 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.426 ' CE1' ' HG3' ' A' ' 80' ' ' GLU . 50.1 m-85 -129.45 132.42 46.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.692 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.426 ' HB ' ' HA ' ' A' ' 140' ' ' MET . 0.3 OUTLIER -120.83 158.15 23.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.576 179.914 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -56.54 -171.76 0.15 Allowed Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.447 -0.883 . . . . 0.0 112.021 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -70.02 -11.18 60.69 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.693 0.282 . . . . 0.0 111.407 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 25.0 m-80 -93.99 -25.24 17.33 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.531 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' MET . . . . . 0.426 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 35.6 mtm 51.33 43.91 29.16 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.806 0.336 . . . . 0.0 111.321 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -66.68 120.72 73.19 Favored Pre-proline 0 N--CA 1.454 -0.267 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.766 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -61.26 -26.18 81.61 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.253 1.968 . . . . 0.0 111.893 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -84.85 -19.67 32.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.701 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -70.17 -172.84 11.16 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.316 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 5.7 ptp -90.4 -173.56 3.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.78 0.324 . . . . 0.0 110.883 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 58.1 t -128.88 150.65 34.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.112 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -115.44 111.53 20.92 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.654 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.509 ' HB2' ' HB ' ' A' ' 161' ' ' ILE . 3.9 mt -85.59 106.23 16.74 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.129 -179.201 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.405 ' HB3' ' CE1' ' A' ' 135' ' ' PHE . 4.2 tp -88.52 120.16 29.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.347 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.461 ' HB3' ' CE1' ' A' ' 159' ' ' TYR . 27.8 t70 -136.75 164.86 27.27 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.39 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -106.46 152.47 23.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.837 0.351 . . . . 0.0 111.13 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.25 -177.1 0.49 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.966 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.99 -37.9 75.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.835 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -76.23 -15.04 60.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.28 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 69.77 26.98 73.79 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.744 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 89.8 t -112.03 -61.89 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.848 0.356 . . . . 0.0 110.929 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 78.2 m -75.78 112.75 21.5 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.202 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -81.08 132.04 8.17 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.562 2.175 . . . . 0.0 112.065 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.461 ' CE1' ' HB3' ' A' ' 150' ' ' ASP . 9.9 p90 -127.13 142.81 51.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.957 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' MET . . . . . 0.416 ' HE3' ' CG ' ' A' ' 135' ' ' PHE . 0.1 OUTLIER -109.6 145.33 36.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.003 -179.848 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.509 ' HB ' ' HB2' ' A' ' 148' ' ' LEU . 74.5 mt -98.47 118.67 45.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.064 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -122.25 154.46 37.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.825 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.418 ' CZ ' ' OH ' ' A' ' 95' ' ' TYR . 11.2 m-85 -102.5 116.06 31.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.984 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.68 -40.72 97.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.104 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.447 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 2.1 m-20 -56.73 -38.4 72.31 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.814 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -98.44 24.38 32.26 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.353 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.431 HD11 ' CE1' ' A' ' 14' ' ' PHE . 0.5 OUTLIER -137.55 146.81 44.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.829 0.347 . . . . 0.0 110.771 179.985 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.406 ' N ' ' HG ' ' A' ' 167' ' ' LEU . 6.7 tt0 -116.45 149.93 38.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.771 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' MET . . . . . 0.452 ' HB3' ' CD1' ' A' ' 2' ' ' ILE . 1.0 OUTLIER -113.79 160.0 19.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.102 -179.829 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.818 179.985 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.404 ' CG2' ' HB2' ' A' ' 16' ' ' ASP . 2.3 tt . . . . . 0 N--CA 1.456 -0.157 0 CA-C-O 120.799 0.333 . . . . 0.0 111.017 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.418 ' O ' ' HA ' ' A' ' 169' ' ' MET . 20.4 mm -111.31 159.36 11.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.378 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.506 ' CD2' ' CE2' ' A' ' 14' ' ' PHE . 5.4 m-85 -122.81 104.56 9.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.306 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 21.9 ptt180 -116.65 145.51 43.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.008 0.432 . . . . 0.0 111.415 -179.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.447 ' O ' ' HA ' ' A' ' 10' ' ' HIS . 50.5 t0 -54.34 152.01 6.86 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.961 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 40.6 tp -82.47 -16.87 47.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.546 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.4 mp -91.27 -51.72 11.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -179.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.9 t -96.74 -16.26 20.97 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -179.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.447 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 1.8 m-70 64.39 30.08 13.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.865 0.364 . . . . 0.0 110.863 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -99.23 122.63 42.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.831 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.43 92.07 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.286 -179.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 35.8 mtp -70.85 -19.07 62.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.714 179.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.506 ' CE2' ' CD2' ' A' ' 4' ' ' TYR . 16.1 p90 -175.25 174.7 2.35 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.525 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.3 m -129.08 -170.53 2.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.822 0.344 . . . . 0.0 111.083 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.404 ' HB2' ' CG2' ' A' ' 2' ' ' ILE . 30.6 t0 -95.43 21.08 8.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.062 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 46.3 pt -87.14 -8.8 11.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.059 179.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.45 ' CZ ' HG23 ' A' ' 72' ' ' ILE . 84.3 m-85 -111.41 -175.99 2.84 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.899 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.1 mmmt -93.32 93.67 8.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.901 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.1 mp -88.06 123.96 40.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.985 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.1 mtp-105 -113.55 126.42 55.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.936 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -77.41 112.74 14.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.879 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.2 pt -109.69 168.46 3.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.063 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 57.72 30.17 18.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.152 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 63.9 40.14 7.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.29 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.7 -12.61 68.48 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.6 -0.81 . . . . 0.0 113.158 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.78 -37.4 76.24 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.824 0.345 . . . . 0.0 111.045 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 13.9 m -141.68 162.94 34.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.141 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -128.76 135.45 49.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.703 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.403 ' OE1' ' CD2' ' A' ' 159' ' ' TYR . 64.6 mt-10 -100.7 118.13 36.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.305 -179.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.415 HG21 ' CD2' ' A' ' 14' ' ' PHE . 24.2 t -94.8 112.02 26.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.729 179.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -84.67 122.96 29.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.205 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -108.98 -138.79 8.42 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.278 179.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.9 ptpt -174.48 128.3 0.34 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.821 0.343 . . . . 0.0 111.024 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 24.4 mtp -74.17 124.9 27.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.567 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.0 m . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.657 -179.556 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.474 0 N-CA-C 112.286 -0.326 . . . . 0.0 112.286 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.442 ' CG1' HG12 ' A' ' 72' ' ' ILE . 48.8 t -67.87 130.34 33.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.805 0.336 . . . . 0.0 110.886 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -59.68 -58.05 10.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.402 -179.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.45 HG23 ' CZ ' ' A' ' 18' ' ' TYR . 6.3 pt -53.85 -33.97 24.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.61 -179.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.407 ' HA ' ' HB2' ' A' ' 78' ' ' LEU . 97.0 t -72.69 -29.98 32.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.137 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 7.3 mtm -78.09 -42.58 31.64 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.664 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.431 ' OD1' ' CD2' ' A' ' 76' ' ' HIS . 22.0 p30 -82.25 -28.89 31.6 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -179.123 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.432 ' CE1' ' HA ' ' A' ' 14' ' ' PHE . 32.7 m170 -88.58 -8.07 55.36 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.904 0.383 . . . . 0.0 110.69 179.307 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 64.65 33.39 10.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.056 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.407 ' HB2' ' HA ' ' A' ' 73' ' ' VAL . 33.4 mt -64.63 142.19 58.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.537 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -129.12 146.99 50.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.909 0.385 . . . . 0.0 111.274 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.426 ' HB2' ' CZ ' ' A' ' 135' ' ' PHE . 1.1 tm-20 -102.05 134.28 45.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.822 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.9 t -124.27 139.81 53.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.908 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 34.5 p -69.4 159.11 33.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.833 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.441 ' HB2' ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -169.48 154.22 5.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.879 -179.941 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 14.3 m -101.52 164.05 11.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.95 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 58.1 mttt -60.74 -52.54 64.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.896 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -64.19 -42.19 96.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.616 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.29 -41.31 88.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.898 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.458 ' CD2' HD13 ' A' ' 122' ' ' ILE . 0.3 OUTLIER -57.71 -38.4 75.2 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.653 179.908 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 21.7 mttt -58.88 -42.3 89.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.521 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 18.0 mtpt -77.27 -27.88 53.27 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.897 179.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.412 ' HB2' ' CE2' ' A' ' 83' ' ' PHE . 28.6 t80 -69.23 -45.68 69.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.565 179.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.451 ' HB ' HG13 ' A' ' 122' ' ' ILE . 6.1 tp -61.28 -39.92 84.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.071 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.501 ' O ' ' CG ' ' A' ' 97' ' ' LYS . 13.8 ttmt -62.05 -46.95 86.86 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.969 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -71.68 -36.13 70.51 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.13 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.473 ' CD1' ' C ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -78.51 -43.4 26.98 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.641 0.257 . . . . 0.0 110.735 -179.268 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.413 ' HG3' ' N ' ' A' ' 97' ' ' LYS . 0.5 OUTLIER -64.71 -31.83 73.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.841 0.353 . . . . 0.0 110.082 179.004 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.501 ' CG ' ' O ' ' A' ' 93' ' ' LYS . 9.5 mmtm -66.94 -41.37 87.08 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.549 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.7 m -55.26 -41.14 71.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.545 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 7.1 mt -79.78 -41.87 22.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.522 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 10.2 tttt -54.75 -52.61 61.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.574 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -61.6 -47.15 92.24 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.141 179.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 19.5 tptt -60.98 -40.3 92.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.841 0.353 . . . . 0.0 110.366 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' A' ' 107' ' ' ARG . 2.4 tp -66.96 -35.53 80.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.14 179.377 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -58.15 -30.15 66.13 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.607 179.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -89.43 -25.1 21.69 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.511 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -100.1 -63.55 1.12 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.858 0.361 . . . . 0.0 111.633 -179.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.441 ' N ' ' O ' ' A' ' 103' ' ' LEU . 16.0 mtm180 -130.43 65.18 75.37 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.882 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.408 ' O ' ' CG2' ' A' ' 111' ' ' VAL . 10.3 Cg_endo -50.86 -22.29 9.79 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 123.17 2.58 . . . . 0.0 112.831 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -66.97 -13.57 61.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.328 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.5 ' C ' ' HD2' ' A' ' 113' ' ' PRO . 0.0 OUTLIER -110.57 0.89 17.8 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.102 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.408 ' CG2' ' O ' ' A' ' 108' ' ' PRO . 33.9 m -70.05 -33.36 54.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.566 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 29.8 mtmt -71.1 -49.95 12.12 Favored Pre-proline 0 CA--C 1.53 0.176 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.574 -179.199 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.566 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 25.8 Cg_exo -63.06 -30.46 75.91 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.16 1.906 . . . . 0.0 111.777 179.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.446 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 88.6 t80 -72.07 -41.05 67.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.987 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 7.6 mtm -56.54 -47.88 78.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.031 0.443 . . . . 0.0 110.817 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 69.0 m -74.32 -44.36 52.83 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.659 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.27 -38.0 95.5 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.483 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.55 -51.62 68.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.921 0.391 . . . . 0.0 110.838 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.96 -28.11 65.28 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.279 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -74.81 -43.04 56.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.856 0.36 . . . . 0.0 110.982 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -73.31 -32.58 64.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.965 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.458 HD13 ' CD2' ' A' ' 88' ' ' TYR . 0.4 OUTLIER -71.56 -46.01 65.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.322 -179.725 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.456 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 9.2 pttt -61.1 -31.54 71.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.036 0.446 . . . . 0.0 110.358 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -68.32 -53.52 23.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.77 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 16.2 pt -62.0 -42.49 95.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.304 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 11.7 mt -53.89 -36.99 63.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.879 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -65.46 -15.95 63.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.21 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -136.35 31.43 2.89 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.77 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.513 ' CE1' ' CZ ' ' A' ' 134' ' ' PHE . 1.8 t80 -49.5 -31.66 10.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.96 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 20.1 tptt -61.3 -21.57 64.08 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.162 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 15.0 m-20 -94.08 -47.22 6.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.429 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.42 ' CD1' ' N ' ' A' ' 132' ' ' TYR . 1.0 OUTLIER -93.01 150.78 20.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.963 0.411 . . . . 0.0 111.48 -179.449 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.466 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 1.0 OUTLIER -126.6 142.95 51.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.317 179.551 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.513 ' CZ ' ' CE1' ' A' ' 129' ' ' PHE . 0.1 OUTLIER -82.49 118.27 23.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.928 0.394 . . . . 0.0 110.979 -179.704 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.426 ' CZ ' ' HB2' ' A' ' 80' ' ' GLU . 20.9 m-85 -119.8 137.17 54.14 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.753 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.452 ' HB ' ' HA ' ' A' ' 140' ' ' MET . 0.8 OUTLIER -120.93 165.43 16.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.842 0.353 . . . . 0.0 110.944 179.933 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -64.59 -166.4 1.19 Allowed Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.539 -0.839 . . . . 0.0 111.981 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -70.98 -9.82 58.64 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.567 0.222 . . . . 0.0 111.38 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 -96.63 -29.83 13.61 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.606 0.241 . . . . 0.0 111.449 -179.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' MET . . . . . 0.452 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 18.7 mtp 55.39 48.57 18.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.879 0.371 . . . . 0.0 111.099 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 15.7 p-10 -71.84 114.8 31.89 Favored Pre-proline 0 N--CA 1.451 -0.409 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.917 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -63.39 -30.65 72.73 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.54 2.16 . . . . 0.0 112.214 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -84.62 -1.44 56.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.354 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -86.87 -115.72 1.0 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.421 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 10.7 ptp -142.27 -178.89 5.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.59 0.233 . . . . 0.0 110.769 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.464 ' CG1' ' HB3' ' A' ' 134' ' ' PHE . 0.0 OUTLIER -129.61 139.79 50.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.077 0.465 . . . . 0.0 111.274 179.961 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.426 ' CB ' ' CE1' ' A' ' 162' ' ' PHE . . . -103.09 110.02 21.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.224 179.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.507 ' HB2' ' HB ' ' A' ' 161' ' ' ILE . 3.8 mt -81.51 106.2 13.28 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.428 -179.051 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.7 tp -90.85 119.6 31.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.074 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.486 ' HB3' ' CE1' ' A' ' 159' ' ' TYR . 31.7 t70 -135.54 164.85 26.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.524 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -102.02 150.8 22.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.915 0.388 . . . . 0.0 111.189 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 16.8 mmm180 -80.59 -175.48 5.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.816 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -54.55 -40.14 68.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.011 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -66.31 -15.17 63.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.205 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 69.66 10.25 63.56 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.745 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 70.1 t -113.47 -68.19 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.843 0.354 . . . . 0.0 110.946 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 96.8 m -54.32 107.8 0.96 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.378 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -83.17 131.52 5.84 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.677 2.251 . . . . 0.0 111.965 179.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.486 ' CE1' ' HB3' ' A' ' 150' ' ' ASP . 9.5 p90 -124.1 135.58 53.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.866 0.365 . . . . 0.0 111.059 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' MET . . . . . 0.421 ' HE2' ' CG ' ' A' ' 135' ' ' PHE . 0.4 OUTLIER -105.09 138.7 40.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.132 -179.706 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.507 ' HB ' ' HB2' ' A' ' 148' ' ' LEU . 68.7 mt -94.96 114.41 31.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.147 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . 0.426 ' CE1' ' CB ' ' A' ' 147' ' ' ALA . 96.6 m-85 -118.1 158.19 25.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.692 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -101.71 129.09 47.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.873 0.368 . . . . 0.0 110.803 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 24.3 tttt -70.09 -51.52 31.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.166 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.446 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 59.6 m-20 -52.2 -38.51 58.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.175 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -95.73 26.87 18.24 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.459 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -144.93 143.84 30.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.778 0.323 . . . . 0.0 110.879 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -116.88 156.61 27.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.822 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' MET . . . . . 0.418 ' HA ' ' O ' ' A' ' 3' ' ' ILE . 3.1 mpp? -115.76 151.02 35.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.052 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.888 -179.964 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.852 0.358 . . . . 0.0 111.121 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.404 ' CD1' ' HB3' ' A' ' 169' ' ' MET . 5.0 tt -105.8 145.96 13.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.912 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.9 mm -106.78 159.06 6.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.523 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.504 ' CD2' ' CE2' ' A' ' 14' ' ' PHE . 4.9 m-85 -121.27 104.73 9.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.427 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 20.9 ptt180 -118.09 146.77 43.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.9 0.381 . . . . 0.0 111.365 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.426 ' O ' ' HA ' ' A' ' 10' ' ' HIS . 47.0 t0 -55.55 152.02 9.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.813 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 49.0 tp -81.6 -18.36 45.03 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.505 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.1 mp -91.36 -48.95 13.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -96.63 -17.75 20.19 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -179.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.426 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 36.1 m170 63.18 29.9 15.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.889 0.376 . . . . 0.0 110.71 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -100.4 121.02 40.85 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.661 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.18 94.84 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.372 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 14.7 mtt -72.13 -20.22 61.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.528 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.504 ' CE2' ' CD2' ' A' ' 4' ' ' TYR . 8.6 p90 -173.07 179.76 2.18 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.325 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -132.74 -170.26 2.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.836 0.35 . . . . 0.0 111.159 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -96.28 24.69 5.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.068 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.422 HG13 ' CD2' ' A' ' 18' ' ' TYR . 41.8 pt -89.03 -9.54 10.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.72 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.426 ' CZ ' HG21 ' A' ' 72' ' ' ILE . 73.6 m-85 -111.34 177.63 4.6 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.765 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -86.76 90.23 8.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.872 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.6 mp -87.93 129.27 39.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.94 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 -123.3 121.04 34.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.979 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -73.32 115.79 13.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.768 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.8 pt -108.86 171.6 2.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.996 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 57.95 31.82 21.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.06 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 65.66 46.95 2.27 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.228 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.35 -11.38 63.52 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.756 -0.735 . . . . 0.0 113.345 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.25 -55.22 37.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.905 0.352 . . . . 0.0 111.141 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 35.0 m -120.17 167.79 11.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.057 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.6 132.46 44.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.785 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -100.43 112.98 25.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.101 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 33.3 t -90.69 111.97 24.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.387 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -84.04 115.9 22.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.284 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -100.63 -138.96 10.51 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.042 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.8 pttp -174.56 125.55 0.3 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.814 0.34 . . . . 0.0 111.08 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 65.3 mtp -70.95 120.43 16.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.529 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.5 m -108.74 116.74 52.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.914 0.387 . . . . 0.0 111.54 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.5 p -85.76 165.7 16.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.613 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.456 ' N ' ' O ' ' A' ' 67' ' ' ILE . 0.0 OUTLIER -148.03 125.0 11.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.99 -179.612 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.6 t 179.86 40.02 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.869 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -131.73 174.96 9.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.946 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 96.07 96.15 1.79 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.485 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -65.93 78.74 0.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.803 0.335 . . . . 0.0 110.844 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 13.1 tt -167.25 112.89 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.131 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -125.59 137.6 53.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.847 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -136.16 -178.92 5.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.947 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.09 -25.05 62.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.995 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 5.4 mt -56.18 -50.54 70.93 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.933 0.397 . . . . 0.0 111.104 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 16.0 mt -81.1 -67.1 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.104 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -151.02 -128.61 1.51 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.485 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 76.24 134.35 0.52 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.495 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -89.75 177.23 6.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.873 0.368 . . . . 0.0 110.911 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -103.67 88.85 3.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.126 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.9 m -68.44 159.16 32.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.863 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -155.61 -46.26 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.044 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -126.07 150.5 48.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.843 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.56 119.36 0.98 Allowed Glycine 0 CA--C 1.52 0.373 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.449 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.19 -45.3 1.96 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.428 2.085 . . . . 0.0 112.363 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.7 104.2 16.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.88 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -163.88 128.61 1.85 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.481 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -124.27 130.39 52.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.88 0.372 . . . . 0.0 110.925 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.23 -22.2 25.47 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.562 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 26.4 m 63.53 113.03 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.787 0.327 . . . . 0.0 110.868 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -83.37 -48.1 10.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.91 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 49.1 m 59.88 68.58 0.77 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.896 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.9 m -119.21 95.94 5.01 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.981 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 39.7 t -120.94 132.09 71.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.896 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.456 ' O ' ' N ' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -122.05 125.32 72.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.099 0.476 . . . . 0.0 111.243 -179.861 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.9 m -139.63 146.1 39.32 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.916 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 169.18 177.65 40.02 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.563 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.434 ' CG1' HG12 ' A' ' 72' ' ' ILE . 47.6 t -71.96 134.14 30.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.847 0.356 . . . . 0.0 110.868 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -61.04 -57.47 12.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.837 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.44 ' HB ' ' CE1' ' A' ' 76' ' ' HIS . 10.1 pt -53.61 -33.8 22.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.642 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.401 ' CG2' ' HB ' ' A' ' 70' ' ' VAL . 90.2 t -71.7 -32.73 46.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.898 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.4 mtm -78.32 -40.29 37.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.554 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.406 ' OD1' ' CD2' ' A' ' 76' ' ' HIS . 16.9 p30 -82.11 -29.92 31.47 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.829 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.44 ' CE1' ' HB ' ' A' ' 72' ' ' ILE . 27.4 m170 -91.94 -2.54 56.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.808 0.337 . . . . 0.0 110.914 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 28.1 m-70 57.29 34.08 24.24 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.808 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 29.7 mt -55.43 148.63 14.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.865 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -128.35 128.02 43.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.922 0.392 . . . . 0.0 110.897 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.412 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 1.4 tt0 -89.9 122.16 32.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.075 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.3 t -108.6 178.88 4.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.817 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 50.5 p -115.85 163.77 15.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.004 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.457 ' CE2' ' CE2' ' A' ' 91' ' ' TYR . 0.6 OUTLIER -171.64 153.87 3.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.806 -179.973 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 13.0 p -101.44 176.34 5.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.969 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.67 -52.55 24.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.944 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -65.36 -41.83 93.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.702 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.29 -38.42 83.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.027 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.473 ' CD2' HD13 ' A' ' 122' ' ' ILE . 0.6 OUTLIER -61.97 -36.76 82.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.673 179.936 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 17.5 mttm -57.68 -46.41 84.33 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.064 0.459 . . . . 0.0 110.225 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.62 -27.95 55.93 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.64 178.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.457 ' CE2' ' CE2' ' A' ' 83' ' ' PHE . 2.8 t80 -66.15 -44.94 82.7 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.745 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.471 ' CD1' ' CE2' ' A' ' 95' ' ' TYR . 3.9 tp -62.08 -45.61 98.34 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.752 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 15.0 ttpt -60.51 -37.95 82.78 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.883 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.478 ' HA ' ' HG2' ' A' ' 97' ' ' LYS . 31.3 t70 -74.67 -42.57 58.22 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.841 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.528 ' CD1' ' C ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -77.05 -40.26 46.95 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.999 -0.281 . . . . 0.0 111.065 -179.35 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.436 ' HG2' ' O ' ' A' ' 92' ' ' ILE . 8.8 ptt? -66.23 -32.11 73.33 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.855 0.36 . . . . 0.0 110.298 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.483 ' HG3' ' N ' ' A' ' 98' ' ' SER . 4.2 ptmt -70.48 -33.74 71.59 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.529 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.483 ' N ' ' HG3' ' A' ' 97' ' ' LYS . 1.8 m -63.92 -40.1 95.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.266 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 8.4 mt -79.76 -41.47 21.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.211 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.9 tmtt? -56.95 -52.1 66.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.266 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -59.21 -48.02 87.97 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.002 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.1 tppm? -62.79 -38.75 91.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.981 0.42 . . . . 0.0 110.122 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.455 ' O ' ' N ' ' A' ' 107' ' ' ARG . 14.3 tp -67.95 -36.87 80.84 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.975 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.405 ' HA ' ' HA ' ' A' ' 108' ' ' PRO . 36.0 mt-10 -55.96 -32.38 63.81 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.752 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -85.61 -19.99 30.18 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.567 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -105.18 -62.95 1.28 Allowed 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.773 0.32 . . . . 0.0 111.517 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.455 ' N ' ' O ' ' A' ' 103' ' ' LEU . 16.5 mmt180 -129.36 64.42 71.2 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.844 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.405 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 9.6 Cg_endo -50.64 -24.02 12.12 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 123.01 2.473 . . . . 0.0 112.596 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -74.13 -9.02 58.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.1 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.408 ' C ' ' HD2' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -108.79 -1.71 19.08 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.5 -179.683 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 27.6 m -72.13 -26.96 25.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.713 0.292 . . . . 0.0 111.299 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.545 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 0.8 OUTLIER -68.47 -56.03 10.92 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.37 -179.398 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.545 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 41.6 Cg_exo -55.67 -40.76 83.4 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 121.921 1.747 . . . . 0.0 111.641 179.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.428 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 56.9 t80 -62.02 -39.9 93.86 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.866 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 4.4 mmm -59.7 -45.3 92.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.829 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 63.1 m -74.82 -44.65 48.14 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.876 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -66.18 -39.44 94.53 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.938 -0.648 . . . . 0.0 112.688 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.63 -51.7 68.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.943 0.401 . . . . 0.0 111.074 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.68 -28.11 68.19 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.37 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -75.39 -57.14 4.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.229 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -58.44 -43.09 88.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.278 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.473 HD13 ' CD2' ' A' ' 88' ' ' TYR . 0.3 OUTLIER -58.79 -46.33 90.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.269 -179.801 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.457 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 25.6 mttt -60.43 -31.52 70.5 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.262 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -67.39 -54.33 21.43 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.715 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 11.8 pt -61.59 -41.05 88.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.149 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.404 ' HG ' ' CD1' ' A' ' 122' ' ' ILE . 11.1 mt -53.88 -35.96 62.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.761 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -68.6 -11.52 60.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.357 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -136.3 32.31 2.85 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.934 0.397 . . . . 0.0 110.522 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -48.23 -32.73 7.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.253 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -69.18 -24.35 64.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.274 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 21.5 m-20 -94.06 -36.43 12.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.419 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.418 ' CE1' ' OD2' ' A' ' 150' ' ' ASP . 3.5 m-85 -92.23 141.39 28.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.175 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.2 mm100 -121.35 145.74 47.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.877 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.427 ' CE2' ' HB2' ' A' ' 83' ' ' PHE . 2.9 m-85 -83.24 125.25 31.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.169 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.412 ' CE2' ' HB2' ' A' ' 80' ' ' GLU . 32.9 m-85 -127.5 150.16 49.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.679 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.438 ' HB ' ' HA ' ' A' ' 140' ' ' MET . 0.7 OUTLIER -140.05 159.97 26.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.719 179.893 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -57.57 -168.81 0.13 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.562 -0.828 . . . . 0.0 111.94 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -71.59 -8.9 56.92 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.622 0.248 . . . . 0.0 111.402 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 -94.09 -31.25 14.27 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.62 -0.263 . . . . 0.0 111.493 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' MET . . . . . 0.438 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 77.7 mtm 58.87 49.95 9.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.821 0.343 . . . . 0.0 111.017 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . 0.417 ' ND2' ' HA3' ' A' ' 144' ' ' GLY . 14.3 p-10 -72.11 114.62 30.8 Favored Pre-proline 0 N--CA 1.452 -0.357 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.987 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -64.98 -29.25 57.55 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.642 2.228 . . . . 0.0 112.288 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -84.59 -3.28 58.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.336 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.417 ' HA3' ' ND2' ' A' ' 141' ' ' ASN . . . -90.61 -155.17 31.07 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.535 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 2.8 ptp -94.75 -176.97 4.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.814 0.34 . . . . 0.0 110.895 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 53.4 t -128.97 151.13 35.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.085 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -111.71 115.85 29.77 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.67 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.517 ' HB2' ' HB ' ' A' ' 161' ' ' ILE . 4.6 mt -92.26 106.24 18.28 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.96 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.8 tp -89.29 119.63 29.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.248 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.427 ' HB3' ' CE1' ' A' ' 159' ' ' TYR . 0.6 OUTLIER -133.12 172.52 12.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.701 179.658 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -116.01 140.84 48.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.763 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 19.2 mmm180 -55.56 -178.66 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.115 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.23 -31.59 53.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.018 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 37.4 p30 -76.69 -15.2 59.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.104 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 71.27 17.47 75.99 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.708 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 93.9 t -111.89 -65.75 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.817 0.342 . . . . 0.0 110.846 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 35.8 m -56.95 109.17 1.53 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.097 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -82.17 122.85 3.83 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.522 2.148 . . . . 0.0 112.406 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.427 ' CE1' ' HB3' ' A' ' 150' ' ' ASP . 12.7 p90 -123.49 146.71 47.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.772 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' MET . . . . . 0.422 ' HE3' ' CZ ' ' A' ' 162' ' ' PHE . 1.1 mtm -112.22 142.53 44.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.949 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.517 ' HB ' ' HB2' ' A' ' 148' ' ' LEU . 46.0 mt -95.45 117.58 39.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.226 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.422 ' CZ ' ' HE3' ' A' ' 160' ' ' MET . 48.4 m-85 -116.34 152.48 33.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.837 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.505 ' CE2' ' CZ ' ' A' ' 95' ' ' TYR . 11.5 m-85 -97.16 120.4 37.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.885 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 9.9 ttpt -65.26 -50.12 66.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.023 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.428 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 52.8 m-20 -57.69 -30.74 65.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.96 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -104.72 26.3 22.94 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.446 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.1 tt -142.69 142.23 31.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.759 0.314 . . . . 0.0 110.911 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -116.66 159.51 22.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.928 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' MET . . . . . 0.404 ' HB3' ' CD1' ' A' ' 2' ' ' ILE . 0.1 OUTLIER -115.48 159.96 20.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.776 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -159.19 120.4 3.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.908 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 5.0 mtpt -85.22 113.81 21.85 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.914 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 69.7 m -139.91 95.3 2.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.902 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 3.8 mp -76.43 -43.69 39.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.931 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.922 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.409 0 CA-C-O 120.828 0.347 . . . . 0.0 111.146 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.519 HG21 ' HB2' ' A' ' 16' ' ' ASP . 3.2 tt -106.65 144.57 15.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.945 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 21.5 mm -99.64 154.02 4.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.292 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.512 ' CD2' ' CZ ' ' A' ' 14' ' ' PHE . 3.3 m-85 -123.67 110.06 14.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.602 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.57 145.78 49.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.906 0.384 . . . . 0.0 111.282 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.453 ' O ' ' HA ' ' A' ' 10' ' ' HIS . 44.3 t0 -55.68 152.17 9.83 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.862 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 57.3 tp -80.2 -23.5 40.91 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.305 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.3 mp -91.3 -45.48 14.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.26 -21.24 19.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.799 -179.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.453 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 14.5 m170 61.78 27.89 17.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.809 0.337 . . . . 0.0 110.731 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -100.77 122.15 42.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.751 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -56.93 89.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.366 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.407 ' O ' ' CD2' ' A' ' 76' ' ' HIS . 25.2 mtt -67.53 -19.24 65.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.644 179.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.512 ' CZ ' ' CD2' ' A' ' 4' ' ' TYR . 12.5 p90 -177.64 175.87 1.32 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.817 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.28 -169.92 2.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.734 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.519 ' HB2' HG21 ' A' ' 2' ' ' ILE . 19.0 t0 -95.76 31.87 1.98 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.148 0.499 . . . . 0.0 110.817 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.433 HD13 ' CE2' ' A' ' 18' ' ' TYR . 35.6 pt -89.66 -13.41 9.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.437 178.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.433 ' CE2' HD13 ' A' ' 17' ' ' ILE . 61.3 m-85 -110.07 178.92 4.25 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.463 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.43 91.55 8.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.75 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.2 mp -88.35 135.61 25.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.178 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 10.7 mtm180 -129.26 117.67 21.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.015 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -71.07 116.33 11.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.71 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.9 pt -109.5 171.07 2.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.162 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 57.91 30.97 19.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.178 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 66.56 42.56 2.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.095 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.89 -17.48 54.97 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.996 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.13 -49.37 60.94 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.852 0.358 . . . . 0.0 111.168 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 6.7 m -128.48 167.07 17.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.727 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.1 mt -129.37 135.08 48.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.878 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -99.62 112.78 24.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.8 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 159' ' ' TYR . 22.0 t -94.24 111.75 25.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.541 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -86.53 110.57 19.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.357 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -92.91 -134.21 6.76 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.212 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 9.3 ptpt -174.49 123.23 0.28 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.802 0.334 . . . . 0.0 111.023 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 15.1 mtt -67.16 121.54 15.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.641 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.4 m -119.11 125.69 74.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.495 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.7 p -101.75 148.36 25.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.521 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.724 ' HB3' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -117.84 127.37 53.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.867 -179.831 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.6 m -143.13 105.43 4.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.867 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -176.97 127.1 0.16 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.883 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 93.59 170.58 39.03 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.517 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 22.2 p-10 -106.64 165.09 11.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.875 0.369 . . . . 0.0 110.899 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.1 mp -128.62 140.34 49.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.046 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.04 -58.55 1.99 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.822 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -124.51 -178.95 4.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.841 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 40.4 p -96.26 -35.17 11.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.9 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 56.9 mt -81.12 -67.09 0.81 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.967 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 52.2 mt 52.28 92.4 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.262 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -156.04 141.93 8.41 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.483 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 71.93 -86.54 0.47 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.473 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 60.34 89.29 0.07 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.859 0.361 . . . . 0.0 110.942 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -97.27 38.16 1.28 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.107 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.6 t -121.85 78.05 1.43 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.839 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -89.6 91.96 8.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.104 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -134.04 -47.25 0.78 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.873 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -123.73 67.4 0.5 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.454 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.64 175.79 7.53 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.637 2.225 . . . . 0.0 112.272 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -160.3 -54.68 0.05 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.965 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -157.68 -141.01 3.06 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.558 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -131.63 177.2 7.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.853 0.359 . . . . 0.0 110.87 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.38 116.37 1.79 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.491 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 76.2 p -71.86 -41.73 67.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.849 0.357 . . . . 0.0 110.972 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -143.31 -60.46 0.42 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.877 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.2 m 59.5 30.21 19.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.95 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 10.8 t -78.57 -168.28 1.33 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.767 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 34.7 t -99.11 124.39 52.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.17 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.724 HG12 ' HB3' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -128.23 128.47 68.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.831 179.679 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 7.3 m -139.29 130.91 27.26 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.962 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -176.71 -169.5 38.12 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.401 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.42 ' HB ' ' CG2' ' A' ' 73' ' ' VAL . 48.4 t -72.34 140.54 17.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.806 0.336 . . . . 0.0 110.967 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.411 ' O ' ' ND2' ' A' ' 75' ' ' ASN . 35.4 t70 -67.75 -59.63 3.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.363 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.434 ' HB ' ' CD2' ' A' ' 76' ' ' HIS . 10.3 pt -53.62 -34.44 24.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.594 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.42 ' CG2' ' HB ' ' A' ' 70' ' ' VAL . 58.7 t -71.18 -33.04 49.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.826 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.6 mtm -78.25 -40.03 38.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.62 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.411 ' ND2' ' O ' ' A' ' 71' ' ' ASP . 15.3 p30 -82.02 -28.44 32.54 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.582 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.434 ' CD2' ' HB ' ' A' ' 72' ' ' ILE . 8.1 m-70 -91.49 -0.77 57.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.928 0.394 . . . . 0.0 110.753 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 10.7 m170 57.61 28.14 15.23 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.131 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 57.1 mt -56.82 137.98 54.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.371 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -122.12 137.01 54.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.973 0.416 . . . . 0.0 111.271 -179.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.424 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 1.5 tt0 -92.09 130.64 37.77 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.961 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.3 t -117.77 165.62 13.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.83 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 40.3 m -96.17 161.39 13.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.963 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.447 ' HB2' ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -171.7 149.94 2.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.013 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -101.54 164.76 11.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.906 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.11 -52.48 65.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.992 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -65.62 -44.9 85.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.785 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.79 -37.61 76.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.07 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.493 ' CZ ' ' CE1' ' A' ' 134' ' ' PHE . 0.5 OUTLIER -62.96 -35.79 81.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.799 179.9 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 52.8 mttt -59.61 -43.65 93.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.475 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.5 tttt -77.72 -27.91 50.72 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.75 178.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.442 ' CG ' ' CZ ' ' A' ' 83' ' ' PHE . 7.8 t80 -67.75 -46.84 70.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.702 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.426 HD11 ' CE2' ' A' ' 95' ' ' TYR . 5.8 tp -60.49 -42.73 92.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 CA-C-O 120.84 0.352 . . . . 0.0 110.668 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.458 ' O ' ' HB3' ' A' ' 97' ' ' LYS . 7.9 ttpp -63.94 -39.73 94.83 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.799 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.43 ' O ' ' HG3' ' A' ' 97' ' ' LYS . 29.1 t70 -75.85 -37.99 58.42 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.769 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.478 ' CD1' ' C ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -78.46 -42.78 28.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.607 0.242 . . . . 0.0 110.619 -179.736 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.419 ' HG3' ' N ' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -67.53 -32.09 72.64 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.035 179.569 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.458 ' HB3' ' O ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -70.91 -34.5 71.6 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.899 0.38 . . . . 0.0 110.656 179.807 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.4 ' N ' ' HG3' ' A' ' 97' ' ' LYS . 1.0 OUTLIER -61.27 -41.03 96.26 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.152 179.446 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.3 mt -79.81 -41.16 21.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.488 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.8 tttt -55.57 -53.16 59.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.462 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -60.64 -46.97 93.4 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.162 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.9 tppt? -62.5 -37.94 87.98 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.878 0.37 . . . . 0.0 110.403 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.44 ' O ' ' N ' ' A' ' 107' ' ' ARG . 3.4 tp -69.55 -34.24 73.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.032 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 108' ' ' PRO . 29.4 mt-10 -59.19 -30.99 68.6 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.691 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -87.38 -20.17 27.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.707 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -107.36 -62.3 1.44 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.833 0.349 . . . . 0.0 111.593 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 103' ' ' LEU . 22.0 mtm180 -128.03 63.52 62.27 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.92 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.414 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 10.0 Cg_endo -50.74 -21.24 7.82 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 123.144 2.562 . . . . 0.0 112.965 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -72.04 -9.22 58.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.584 0.23 . . . . 0.0 111.433 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.515 ' C ' ' HD2' ' A' ' 113' ' ' PRO . 19.0 mmt85 -112.12 -1.27 15.34 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.64 -0.255 . . . . 0.0 111.677 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 33.8 m -71.33 -32.54 47.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.546 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 15.5 mttm -69.81 -49.95 18.98 Favored Pre-proline 0 CA--C 1.53 0.192 0 C-N-CA 121.047 -0.261 . . . . 0.0 111.57 -179.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.546 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 31.4 Cg_exo -58.98 -36.13 97.35 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.183 1.922 . . . . 0.0 111.936 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.442 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 89.9 t80 -71.09 -35.38 71.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.923 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 10.8 mtp -58.61 -52.44 65.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.761 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 63.0 m -73.89 -44.06 56.49 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.552 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.58 -38.71 96.29 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.391 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.99 -51.6 68.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.002 0.429 . . . . 0.0 110.961 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.08 -28.22 65.25 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.129 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -75.88 -44.01 42.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.009 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -71.34 -38.12 71.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.001 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.449 HD12 ' CD2' ' A' ' 88' ' ' TYR . 0.4 OUTLIER -63.89 -46.82 93.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.269 -179.916 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.448 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 6.1 ptmt -60.72 -31.07 70.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.338 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -66.49 -52.37 46.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.996 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.431 HD11 HG23 ' A' ' 125' ' ' ILE . 11.9 pt -65.3 -40.44 88.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.283 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 11.9 mt -53.88 -35.5 61.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.882 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -72.75 -9.9 59.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.3 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -142.93 32.1 1.4 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.985 0.422 . . . . 0.0 110.615 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.495 ' CE1' ' CZ ' ' A' ' 134' ' ' PHE . 5.9 t80 -51.49 -25.32 6.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.22 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 5.7 tttp -62.74 -29.2 70.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.744 0.307 . . . . 0.0 110.915 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 32.8 m-20 -94.09 -39.17 10.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.263 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -89.87 145.59 25.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.086 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 -132.55 145.37 51.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.147 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.495 ' CZ ' ' CE1' ' A' ' 129' ' ' PHE . 1.4 m-85 -78.27 124.78 28.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.858 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.424 ' CE2' ' HB2' ' A' ' 80' ' ' GLU . 38.0 m-85 -129.9 135.96 48.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.767 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.421 ' HB ' ' HA ' ' A' ' 140' ' ' MET . 0.6 OUTLIER -120.99 159.65 22.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.858 179.905 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.68 -165.69 0.38 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.215 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -71.78 -8.93 57.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.573 0.225 . . . . 0.0 111.502 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 -96.97 -28.29 14.24 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' MET . . . . . 0.421 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 62.0 mtm 55.37 37.71 29.28 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.853 0.359 . . . . 0.0 110.93 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -61.87 115.25 14.43 Favored Pre-proline 0 N--CA 1.451 -0.386 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.933 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.21 -30.64 91.71 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.498 2.132 . . . . 0.0 112.183 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -84.59 -3.14 58.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.102 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -87.24 -169.29 45.6 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.472 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 2.3 ptp -86.58 -176.5 5.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.728 0.299 . . . . 0.0 110.91 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 48.9 t -128.17 148.85 32.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.962 0.41 . . . . 0.0 111.164 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -111.64 115.2 28.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.599 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.472 ' HB2' ' HB ' ' A' ' 161' ' ' ILE . 3.2 mt -89.77 106.28 18.36 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.332 -179.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.1 tp -88.83 121.15 30.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.922 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.454 ' HB3' ' CE1' ' A' ' 159' ' ' TYR . 31.2 t70 -134.67 164.01 28.48 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.547 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -110.36 148.52 31.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.051 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.66 -178.01 0.66 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.826 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -61.48 -31.07 71.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.94 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -84.66 -15.03 46.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.289 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 64.59 27.55 72.04 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.468 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 77.9 t -110.06 -42.47 5.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.846 0.355 . . . . 0.0 111.044 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 96.2 m -100.33 106.76 44.25 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.327 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.72 130.74 12.81 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.385 2.057 . . . . 0.0 111.609 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.454 ' CE1' ' HB3' ' A' ' 150' ' ' ASP . 6.1 p90 -127.09 146.43 50.38 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.913 0.387 . . . . 0.0 111.18 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' MET . . . . . 0.412 ' HE3' ' CG ' ' A' ' 135' ' ' PHE . 0.1 OUTLIER -113.12 145.4 40.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.041 -179.827 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.472 ' HB ' ' HB2' ' A' ' 148' ' ' LEU . 59.7 mt -101.78 110.61 29.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.267 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -110.93 154.0 24.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.523 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -102.14 115.14 29.92 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.944 0.402 . . . . 0.0 110.861 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.94 -46.5 87.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.168 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.442 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 56.5 m-20 -51.56 -31.84 25.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.987 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -106.45 25.99 21.42 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.395 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -139.88 146.93 39.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.821 0.343 . . . . 0.0 110.941 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.23 150.79 29.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.843 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.59 142.92 49.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.986 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -148.67 125.02 10.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.948 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 6.1 mttp -91.94 118.64 30.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.901 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 77.5 m -139.72 -48.46 0.47 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.891 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 45.42 40.51 5.6 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.435 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.882 179.982 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 tpp . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.766 0.317 . . . . 0.0 111.162 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.492 HG21 ' HB2' ' A' ' 16' ' ' ASP . 3.5 tt -109.9 146.34 15.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.952 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.3 mm -99.72 155.04 4.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.374 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.501 ' CD2' ' CZ ' ' A' ' 14' ' ' PHE . 4.6 m-85 -124.43 107.29 10.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.669 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -123.8 144.93 49.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.153 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -54.88 140.62 36.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.856 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 43.1 tp -72.31 -20.29 61.52 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.362 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.1 mp -91.39 -46.3 14.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.51 -18.38 19.86 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -179.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.1 m80 62.2 29.28 17.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.864 0.364 . . . . 0.0 110.756 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -101.94 118.36 36.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.762 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -56.79 94.07 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.377 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 9.8 mtt -71.7 -19.24 62.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.695 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.501 ' CZ ' ' CD2' ' A' ' 4' ' ' TYR . 9.4 p90 -177.15 175.84 1.47 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.821 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.86 -171.13 2.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.593 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.492 ' HB2' HG21 ' A' ' 2' ' ' ILE . 21.1 t0 -95.52 36.24 1.28 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.113 0.482 . . . . 0.0 110.785 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.423 HG13 ' CD2' ' A' ' 18' ' ' TYR . 37.4 pt -94.5 -11.77 8.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.571 179.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.423 ' CD2' HG13 ' A' ' 17' ' ' ILE . 43.5 m-85 -109.41 -166.85 1.14 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.573 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.7 mtpp -98.96 89.46 4.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.838 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.8 mp -88.03 124.68 41.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.881 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 11.0 mtp180 -115.78 121.16 41.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.158 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -74.0 116.36 14.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.803 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.1 pt -116.08 171.51 5.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.19 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 56.58 33.45 22.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.167 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 64.57 38.32 7.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.249 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.74 -13.84 66.6 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.737 -0.744 . . . . 0.0 113.113 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -53.57 -48.09 69.48 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.749 0.309 . . . . 0.0 111.368 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 18.8 m -126.0 167.27 15.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.272 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.8 123.83 30.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.76 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -92.0 112.8 24.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.885 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.402 HG22 ' CD2' ' A' ' 14' ' ' PHE . 20.2 t -100.63 111.91 31.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.956 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -87.6 118.77 27.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.029 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -99.9 -128.49 6.3 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.299 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.48 125.89 0.31 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.856 0.36 . . . . 0.0 110.903 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 81.4 mtp -73.21 119.42 17.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.941 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.9 m -111.38 119.29 59.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.152 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 88.4 p -90.14 165.5 13.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.001 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.488 ' HB3' HG12 ' A' ' 67' ' ' ILE . 3.8 ttt85 -155.87 148.54 24.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.697 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 19.8 m -136.65 -56.28 0.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.93 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 62.55 61.83 1.18 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.835 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -77.97 88.03 1.07 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.553 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -133.92 156.15 48.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.866 0.365 . . . . 0.0 110.819 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.0 tp -124.04 121.02 61.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.403 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -175.22 173.95 2.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.896 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.2 t0 71.31 -62.66 0.45 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.174 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -48.71 -28.69 3.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.232 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.3 mt -69.77 -28.98 66.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.884 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -108.73 30.03 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.988 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -81.72 -33.56 27.18 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.58 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 61.3 82.86 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.513 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -120.35 -179.07 3.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.824 0.345 . . . . 0.0 110.916 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -169.5 -43.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.08 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.7 m -79.54 175.34 10.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.958 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -96.25 -36.47 10.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.221 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -161.53 146.87 13.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.893 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 179.16 -89.5 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.41 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.84 174.09 10.09 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.599 2.199 . . . . 0.0 112.33 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.95 153.89 24.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.927 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -141.84 95.89 0.19 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.493 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -99.26 118.6 36.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.863 0.363 . . . . 0.0 110.944 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -158.23 -127.61 0.95 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.424 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.4 m -89.64 115.77 27.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.804 0.335 . . . . 0.0 110.877 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.78 106.35 11.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.903 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.0 t -177.19 -173.58 0.46 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.012 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.6 t -165.79 -43.81 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.744 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 45.5 t -137.9 127.58 34.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.909 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.488 HG12 ' HB3' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -128.32 126.79 66.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.916 179.844 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.3 m -139.33 122.3 16.7 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.923 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -161.82 -177.78 35.18 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.321 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.429 ' CG1' HG12 ' A' ' 72' ' ' ILE . 51.0 t -71.29 148.66 10.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.775 0.322 . . . . 0.0 110.793 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -73.8 -56.35 5.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.453 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.429 HG12 ' CG1' ' A' ' 70' ' ' VAL . 11.2 pt -53.72 -33.97 23.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.349 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.409 ' CG1' ' HB2' ' A' ' 78' ' ' LEU . 59.7 t -71.6 -33.57 49.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.812 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.8 mtt -78.47 -39.6 37.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.693 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.2 p30 -82.04 -28.46 32.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.545 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.416 ' CG ' ' O ' ' A' ' 72' ' ' ILE . 7.2 m-70 -90.28 -2.59 58.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.845 0.355 . . . . 0.0 110.582 179.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.432 ' HB2' ' HB3' ' A' ' 138' ' ' GLU . 8.9 m-70 59.87 28.24 17.7 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.892 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.409 ' HB2' ' CG1' ' A' ' 73' ' ' VAL . 64.2 mt -58.55 144.51 42.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.555 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -128.63 138.06 51.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.891 0.377 . . . . 0.0 111.251 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.413 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 18.4 tt0 -92.84 123.28 36.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.04 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.4 t -108.97 165.05 11.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.76 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.5 m -95.44 160.5 14.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.874 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.503 ' CE2' ' CE2' ' A' ' 91' ' ' TYR . 0.6 OUTLIER -171.66 148.56 2.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.908 -179.884 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.52 167.09 10.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.791 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.66 -52.43 64.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.896 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -63.39 -43.71 96.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.916 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.77 -36.61 79.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.156 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.457 ' CD2' HD11 ' A' ' 122' ' ' ILE . 0.2 OUTLIER -64.16 -33.82 76.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.833 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.496 ' O ' HG21 ' A' ' 92' ' ' ILE . 23.4 mttt -61.62 -45.33 94.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.012 0.434 . . . . 0.0 110.369 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.55 -27.9 45.94 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.834 178.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.503 ' CE2' ' CE2' ' A' ' 83' ' ' PHE . 12.6 t80 -67.77 -47.09 70.18 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.848 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.496 HG21 ' O ' ' A' ' 89' ' ' LYS . 1.6 tp -62.46 -41.61 92.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.828 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.425 ' O ' ' CG ' ' A' ' 97' ' ' LYS . 17.5 ttmt -59.07 -46.36 88.47 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.045 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -66.42 -43.75 84.85 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.149 -179.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.541 ' CD1' ' C ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -73.24 -42.46 62.54 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.943 -179.088 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 23.0 ptm -61.0 -32.16 71.74 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.303 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.425 ' CG ' ' O ' ' A' ' 93' ' ' LYS . 6.4 mmtp -66.91 -43.91 82.13 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.511 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.2 m -56.19 -41.37 75.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.735 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.7 mt -79.79 -41.7 21.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.701 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 13.2 tttt -53.76 -56.29 18.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.532 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -59.97 -45.2 96.3 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.189 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.03 -41.93 97.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.903 0.383 . . . . 0.0 110.378 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.444 ' O ' ' N ' ' A' ' 107' ' ' ARG . 9.2 tp -66.36 -34.2 77.43 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.259 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 108' ' ' PRO . 31.3 mt-10 -60.11 -29.07 68.37 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.617 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -88.19 -18.76 28.01 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.548 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -107.05 -58.49 1.93 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.775 0.322 . . . . 0.0 111.693 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.444 ' N ' ' O ' ' A' ' 103' ' ' LEU . 46.1 mtt180 -134.04 66.4 71.81 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.809 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.4 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 9.1 Cg_endo -50.46 -22.68 9.3 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 123.141 2.561 . . . . 0.0 112.729 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -73.68 -9.3 58.53 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.735 0.302 . . . . 0.0 111.176 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.487 ' C ' ' HD2' ' A' ' 113' ' ' PRO . 3.0 mmt180 -110.91 -0.16 16.91 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.616 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 32.9 m -72.67 -33.43 44.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.575 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 13.9 mttt -66.87 -50.38 43.7 Favored Pre-proline 0 C--N 1.331 -0.21 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.555 -179.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.575 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 32.8 Cg_exo -59.05 -39.36 80.88 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 121.967 1.778 . . . . 0.0 111.724 179.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.426 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 67.3 t80 -64.25 -37.89 89.1 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.887 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 4.1 mmm -58.57 -50.13 74.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.728 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 66.4 m -74.33 -44.34 52.92 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.742 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.47 -40.0 98.31 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.516 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.42 -51.55 69.34 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.006 0.431 . . . . 0.0 110.948 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.6 -31.42 65.17 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.088 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -72.12 -41.33 67.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.106 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -73.53 -36.71 65.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.078 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.457 HD11 ' CD2' ' A' ' 88' ' ' TYR . 0.4 OUTLIER -67.12 -46.08 85.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.247 -179.765 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.451 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 1.2 ptpm? -61.42 -31.41 71.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.083 0.468 . . . . 0.0 110.223 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -67.1 -53.66 28.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.705 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 15.0 pt -62.28 -41.71 92.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.249 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 12.3 mt -53.85 -35.85 61.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.922 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -68.05 -13.82 62.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.14 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -139.98 32.37 1.97 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.011 0.434 . . . . 0.0 110.628 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.514 ' CE1' ' CZ ' ' A' ' 134' ' ' PHE . 2.8 t80 -49.47 -28.87 5.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.096 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.49 -27.04 65.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.986 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -94.22 -35.97 12.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.476 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -94.44 140.52 29.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.923 0.392 . . . . 0.0 111.373 -179.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.2 mm100 -124.13 145.49 49.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.805 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.514 ' CZ ' ' CE1' ' A' ' 129' ' ' PHE . 0.5 OUTLIER -80.47 123.87 28.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.069 -179.787 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.413 ' CE2' ' HB2' ' A' ' 80' ' ' GLU . 36.6 m-85 -126.76 151.94 47.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.499 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -138.7 160.04 30.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.001 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.05 -159.25 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.2 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.432 ' HB3' ' HB2' ' A' ' 77' ' ' HIS . 5.7 pt-20 -76.79 -8.77 57.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.609 0.242 . . . . 0.0 111.436 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 20.4 m-80 -96.58 -29.75 13.68 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 31.1 mtm 57.44 37.73 27.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.907 0.384 . . . . 0.0 110.854 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . 0.407 ' ND2' ' HA3' ' A' ' 144' ' ' GLY . 15.0 p-10 -66.22 115.01 19.45 Favored Pre-proline 0 N--CA 1.452 -0.352 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.164 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -62.73 -28.96 76.75 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.505 2.137 . . . . 0.0 112.17 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -84.55 -3.9 58.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.148 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.407 ' HA3' ' ND2' ' A' ' 141' ' ' ASN . . . -87.05 -146.52 10.5 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.381 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 2.3 ptp -104.9 179.86 4.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.765 0.317 . . . . 0.0 110.768 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 43.7 t -128.98 149.31 33.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.136 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.43 ' HB3' ' CE1' ' A' ' 162' ' ' PHE . . . -111.75 115.86 29.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.663 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.482 ' HB2' ' HB ' ' A' ' 161' ' ' ILE . 4.6 mt -90.57 106.14 18.3 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.86 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 5.2 tp -88.56 120.64 30.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.192 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.463 ' HB3' ' CE1' ' A' ' 159' ' ' TYR . 47.9 t0 -138.06 164.35 29.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.442 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -105.98 146.99 29.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.889 0.376 . . . . 0.0 111.026 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.71 -177.66 0.62 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.863 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -60.46 -41.21 93.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.858 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -79.19 -15.11 58.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.16 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 60.51 33.79 83.0 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.537 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 91.2 t -107.08 -24.08 4.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.78 0.324 . . . . 0.0 111.039 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.4 t -132.22 124.23 19.24 Favored Pre-proline 0 CA--C 1.531 0.241 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.136 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -79.93 135.42 11.21 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.529 2.152 . . . . 0.0 112.079 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.463 ' CE1' ' HB3' ' A' ' 150' ' ' ASP . 8.0 p90 -124.61 136.02 53.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.862 0.363 . . . . 0.0 111.016 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' MET . . . . . . . . . . . . . 24.7 mtp -104.43 140.51 37.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.958 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.482 ' HB ' ' HB2' ' A' ' 148' ' ' LEU . 53.1 mt -99.67 113.67 35.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.16 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.43 ' CE1' ' HB3' ' A' ' 147' ' ' ALA . 92.6 m-85 -110.15 158.14 18.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.705 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.414 ' CZ ' ' OH ' ' A' ' 95' ' ' TYR . 24.2 m-85 -99.18 114.64 27.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.852 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 33.0 tttm -57.98 -51.9 67.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.136 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.426 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 37.8 m-20 -54.55 -35.63 63.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.038 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -96.94 28.51 13.46 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.397 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -147.34 143.6 28.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.878 0.37 . . . . 0.0 110.801 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -105.11 162.58 13.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.803 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.31 138.32 44.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.976 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -144.71 118.16 9.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.845 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 12.8 mtpt -78.71 115.97 18.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.998 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 25.8 p -97.79 -176.05 3.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.786 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -114.76 160.67 19.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.917 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.857 -179.993 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ttt . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.858 0.361 . . . . 0.0 111.215 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.403 HG23 ' HB2' ' A' ' 16' ' ' ASP . 2.4 tt -108.04 147.66 12.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.008 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 21.2 mm -101.77 157.88 4.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.353 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.508 ' CD2' ' CE2' ' A' ' 14' ' ' PHE . 5.5 m-85 -126.58 95.22 4.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.423 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 10.0 ptt180 -110.67 148.59 31.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.955 0.407 . . . . 0.0 111.183 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.441 ' O ' ' HA ' ' A' ' 10' ' ' HIS . 31.8 t0 -56.96 152.2 13.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.741 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 36.1 tp -81.31 -24.05 37.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.225 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.9 mp -91.36 -44.61 14.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.827 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.0 t -94.13 -21.09 19.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.756 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.441 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 25.5 m-70 62.34 26.63 15.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.86 0.362 . . . . 0.0 110.812 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -101.96 124.6 47.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.798 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -58.03 104.06 0.18 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.386 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 19.7 mtt -82.82 -18.68 39.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.62 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.508 ' CE2' ' CD2' ' A' ' 4' ' ' TYR . 16.0 p90 -178.64 176.74 0.96 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.68 179.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.66 -170.73 2.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.824 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.403 ' HB2' HG23 ' A' ' 2' ' ' ILE . 34.5 t70 -95.91 28.53 3.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.114 0.483 . . . . 0.0 110.877 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.418 HD11 ' CZ ' ' A' ' 18' ' ' TYR . 45.9 pt -89.31 -11.34 10.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.731 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.42 ' CZ ' HG22 ' A' ' 72' ' ' ILE . 62.9 m-85 -109.45 -171.09 1.77 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.67 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.1 mttt -94.13 86.97 5.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.702 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.7 mp -88.66 127.06 41.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.203 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -119.87 148.36 43.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.612 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -94.25 117.09 29.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.01 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.1 pt -113.71 166.63 7.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.087 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 57.53 29.99 18.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.203 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 64.56 39.66 6.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.203 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.37 -16.09 61.82 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.593 -0.813 . . . . 0.0 113.071 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.57 -30.14 53.37 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.829 0.347 . . . . 0.0 111.083 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 56.6 m -149.4 164.66 34.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.877 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.32 128.97 44.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.962 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.46 ' HA ' ' O ' ' A' ' 160' ' ' MET . 67.7 mt-10 -91.27 117.25 29.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.306 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 23.0 t -98.79 111.94 29.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.605 179.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -90.74 116.28 28.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.303 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -100.78 -130.52 7.07 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.228 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.2 pttm -174.46 125.98 0.32 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.919 0.39 . . . . 0.0 110.893 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 35.8 mtp -70.37 123.46 21.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.745 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.0 m -114.07 134.39 57.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.229 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 83.3 p -90.16 165.5 13.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.748 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.548 ' HB3' HG12 ' A' ' 67' ' ' ILE . 4.1 ttt180 -144.45 128.25 17.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.016 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 46.0 p -137.98 26.15 2.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.961 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 59.67 160.41 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.933 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.66 -153.17 20.09 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.611 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -99.68 -24.21 14.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.781 0.324 . . . . 0.0 111.102 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.7 mp 69.3 133.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.109 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.31 128.8 50.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.907 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -146.2 -168.18 2.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.782 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 37.8 t -80.1 -34.49 37.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.936 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.69 -35.11 22.78 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.985 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -114.31 170.56 4.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.981 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.32 100.0 1.9 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.463 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -108.66 -29.05 4.29 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.489 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -114.76 162.19 17.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.804 0.335 . . . . 0.0 110.845 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -84.17 -31.12 25.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.076 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.4 151.41 24.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.924 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -98.4 33.1 2.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.132 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.22 164.29 13.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.906 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 160.05 -104.63 0.25 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.564 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -86.07 43.43 1.12 Allowed 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.8 2.333 . . . . 0.0 112.693 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 60.62 113.34 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.878 0.37 . . . . 0.0 110.961 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -142.89 121.11 1.67 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.54 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 28.9 tp10 -130.43 -47.91 1.08 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.859 0.361 . . . . 0.0 110.9 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.63 154.36 30.12 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.477 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.3 m -112.29 -36.42 5.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.864 0.364 . . . . 0.0 110.921 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -137.49 156.58 47.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.877 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.8 m -112.23 90.09 3.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.921 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.0 t -129.18 124.76 35.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.979 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 56.2 t -92.56 133.09 35.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.051 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.548 HG12 ' HB3' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -122.4 130.72 74.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.73 179.792 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.9 m -139.15 127.79 23.21 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.98 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -158.04 -176.22 29.85 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.249 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.436 ' CG1' HG12 ' A' ' 72' ' ' ILE . 47.7 t -72.58 142.73 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-O 120.801 0.334 . . . . 0.0 110.801 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -69.04 -56.61 7.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.551 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.44 ' HB ' ' CE1' ' A' ' 76' ' ' HIS . 9.5 pt -53.66 -33.83 23.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.816 0.341 . . . . 0.0 111.409 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.403 ' CG1' ' HB2' ' A' ' 78' ' ' LEU . 98.6 t -71.2 -33.08 49.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.037 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.0 mtm -78.27 -39.73 39.18 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.634 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.43 ' OD1' ' CD2' ' A' ' 76' ' ' HIS . 15.2 p30 -82.17 -28.24 32.19 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.609 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.44 ' CE1' ' HB ' ' A' ' 72' ' ' ILE . 28.1 m170 -93.07 0.99 57.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.852 0.358 . . . . 0.0 110.801 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.417 ' HB2' ' HB3' ' A' ' 138' ' ' GLU . 7.8 m170 56.58 28.53 14.06 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.314 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.403 ' HB2' ' CG1' ' A' ' 73' ' ' VAL . 71.0 mt -56.99 129.13 40.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.512 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 -112.82 130.58 56.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.254 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.412 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 30.1 tt0 -83.86 129.66 34.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.074 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.6 t -116.57 -179.75 3.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.856 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 69.9 m -121.4 165.67 15.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.96 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.501 ' CE2' ' CE2' ' A' ' 91' ' ' TYR . 3.2 m-85 -171.71 154.01 3.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.043 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.2 m -101.58 166.98 10.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.694 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.0 mtpp -57.73 -52.47 65.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.891 0.377 . . . . 0.0 110.996 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.72 -37.14 76.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.959 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.31 -44.28 88.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.158 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.512 ' CZ ' ' CE1' ' A' ' 134' ' ' PHE . 1.0 OUTLIER -60.98 -32.93 72.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.814 179.876 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 18.2 mttm -61.97 -43.41 98.91 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.549 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.1 mtmt -78.09 -28.02 48.61 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.663 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.501 ' CE2' ' CE2' ' A' ' 83' ' ' PHE . 8.8 t80 -65.48 -47.41 76.15 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.616 179.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.446 ' O ' ' HG2' ' A' ' 96' ' ' MET . 4.7 tp -61.18 -45.91 97.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.956 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 16.6 tttp -58.42 -38.33 77.18 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.252 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.475 ' HA ' ' HG2' ' A' ' 97' ' ' LYS . 19.6 t70 -75.06 -43.64 52.19 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.903 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.46 ' CD1' ' C ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -75.22 -40.07 59.46 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 121.074 -0.25 . . . . 0.0 111.119 -179.368 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.446 ' HG2' ' O ' ' A' ' 92' ' ' ILE . 3.1 ptt? -67.7 -32.27 72.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.734 0.302 . . . . 0.0 110.707 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.475 ' HG2' ' HA ' ' A' ' 94' ' ' ASP . 5.4 ptpt -69.23 -34.32 74.66 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.705 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.469 ' N ' ' HG3' ' A' ' 97' ' ' LYS . 2.1 m -62.71 -41.28 99.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.295 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 5.9 mt -79.89 -39.08 19.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.352 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.97 -57.79 10.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.578 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -59.44 -43.53 97.39 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.625 -0.797 . . . . 0.0 111.914 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.4 tmtt? -61.51 -42.11 98.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.978 0.418 . . . . 0.0 110.276 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.452 ' O ' ' N ' ' A' ' 107' ' ' ARG . 8.7 tp -66.69 -33.35 75.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.1 179.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.406 ' HA ' ' HA ' ' A' ' 108' ' ' PRO . 39.6 mt-10 -60.5 -28.98 68.8 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.611 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -87.24 -20.24 27.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.436 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -104.95 -58.87 1.83 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.779 0.323 . . . . 0.0 111.703 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.452 ' N ' ' O ' ' A' ' 103' ' ' LEU . 23.8 mtt85 -136.43 67.39 60.02 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.027 0.441 . . . . 0.0 110.894 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 9.5 Cg_endo -50.58 -21.71 8.16 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 123.275 2.65 . . . . 0.0 112.733 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -71.07 -9.12 57.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.608 0.242 . . . . 0.0 111.245 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -112.44 -3.4 14.47 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 34.7 m -71.74 -27.19 27.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.659 0.266 . . . . 0.0 111.656 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.551 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 0.9 OUTLIER -68.68 -55.54 11.2 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.574 -179.194 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.551 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 37.1 Cg_exo -59.87 -31.82 94.38 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 121.868 1.712 . . . . 0.0 111.429 179.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.44 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 73.5 t80 -68.15 -42.78 79.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.958 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -56.02 -51.9 66.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.887 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 60.2 m -76.57 -43.82 37.25 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.675 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -55.3 -53.84 38.19 Favored Glycine 0 N--CA 1.452 -0.277 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.761 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.62 -51.78 67.39 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.052 0.453 . . . . 0.0 111.09 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.78 -28.05 69.18 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.182 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -75.49 -57.86 3.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.229 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -60.12 -39.66 87.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.399 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.454 ' CG2' ' N ' ' A' ' 123' ' ' LYS . 0.4 OUTLIER -58.27 -46.5 88.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.897 0.38 . . . . 0.0 111.165 -179.777 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.454 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 20.0 mttm -62.02 -29.98 70.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.229 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -70.88 -54.79 10.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.709 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 15.4 pt -60.41 -43.8 94.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.277 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 11.6 mt -54.36 -37.58 65.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.944 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -72.55 -9.54 58.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.441 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 -142.47 31.68 1.5 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.899 0.381 . . . . 0.0 110.765 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.518 ' CE1' ' CZ ' ' A' ' 134' ' ' PHE . 6.3 t80 -54.11 -24.36 17.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.074 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 40.5 mtmt -57.92 -23.68 54.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.052 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 16.3 m-20 -94.23 -49.22 5.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.447 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.438 ' CD1' ' N ' ' A' ' 132' ' ' TYR . 0.6 OUTLIER -88.21 154.07 20.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.932 0.396 . . . . 0.0 111.212 -179.404 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.427 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 1.7 mm100 -131.29 143.32 50.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.945 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.518 ' CZ ' ' CE1' ' A' ' 129' ' ' PHE . 2.5 m-85 -77.75 121.28 23.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.055 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.412 ' CE2' ' HB2' ' A' ' 80' ' ' GLU . 32.9 m-85 -126.47 134.97 50.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.708 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.454 ' HB ' ' HA ' ' A' ' 140' ' ' MET . 0.7 OUTLIER -120.91 160.99 21.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.785 179.989 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -58.31 -165.5 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.272 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.417 ' HB3' ' HB2' ' A' ' 77' ' ' HIS . 7.1 pm0 -72.54 -9.01 58.04 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.544 0.212 . . . . 0.0 111.371 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 22.5 m-80 -96.92 -35.4 10.9 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.504 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' MET . . . . . 0.454 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 37.0 mtp 60.86 36.91 18.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.701 0.286 . . . . 0.0 111.234 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -66.0 122.21 79.92 Favored Pre-proline 0 N--CA 1.453 -0.297 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.733 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -61.89 -23.46 75.98 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.246 1.964 . . . . 0.0 111.824 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -84.64 -12.24 54.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.672 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -79.27 -160.46 19.01 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.237 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -100.31 -177.38 3.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.766 0.317 . . . . 0.0 110.93 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 46.9 t -126.67 148.92 31.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.135 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.415 ' HB1' ' CE2' ' A' ' 162' ' ' PHE . . . -116.27 110.58 18.94 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.555 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.514 ' HB2' ' HB ' ' A' ' 161' ' ' ILE . 3.9 mt -84.58 115.25 22.52 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.139 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 12.4 tp -88.27 123.62 33.05 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.764 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.474 ' HB2' ' CZ ' ' A' ' 159' ' ' TYR . 24.2 m-20 -127.72 158.69 36.94 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.885 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -117.22 148.84 41.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.907 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -75.48 178.57 5.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.822 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.8 -37.94 80.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.976 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -75.62 -15.11 60.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.302 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 64.05 23.69 68.0 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.492 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 65.3 t -112.0 -38.38 3.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.753 0.311 . . . . 0.0 110.89 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 86.9 m -98.58 103.01 16.34 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.226 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -77.93 127.55 8.65 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.395 2.063 . . . . 0.0 112.057 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.474 ' CZ ' ' HB2' ' A' ' 150' ' ' ASP . 12.1 p90 -124.58 133.17 53.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.668 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' MET . . . . . 0.46 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 0.3 OUTLIER -99.98 169.01 9.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.761 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.514 ' HB ' ' HB2' ' A' ' 148' ' ' LEU . 89.6 mt -123.94 110.7 26.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.175 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.415 ' CE2' ' HB1' ' A' ' 147' ' ' ALA . 87.6 m-85 -114.38 156.71 23.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.729 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -99.21 123.59 43.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.852 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.32 -55.31 29.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.189 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.44 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 0.8 OUTLIER -51.23 -34.92 34.34 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.071 -179.855 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -96.86 27.9 16.03 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.366 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.66 144.05 29.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.777 0.322 . . . . 0.0 110.793 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -112.85 156.82 22.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.811 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.51 149.98 41.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.005 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -157.85 125.55 5.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.926 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 14.4 mmtt -90.68 119.32 30.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.964 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -171.27 140.84 1.51 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.866 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 1.7 mp -93.47 -35.42 12.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.907 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.878 -179.96 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.1 ttt . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.856 0.36 . . . . 0.0 111.205 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.403 ' CD1' ' HB3' ' A' ' 169' ' ' MET . 1.7 tt -104.71 146.69 11.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.036 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 11.7 mm -106.6 155.61 7.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.136 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.502 ' CD2' ' CE2' ' A' ' 14' ' ' PHE . 3.7 m-85 -123.73 104.71 9.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.665 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.73 156.31 32.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.9 0.381 . . . . 0.0 111.277 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.441 ' O ' ' HA ' ' A' ' 10' ' ' HIS . 27.0 t0 -61.64 152.18 31.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.767 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 67.1 tp -80.45 -22.11 41.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.234 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.0 mp -91.23 -46.53 14.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.966 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -93.05 -28.77 16.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.705 -179.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.441 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER 68.72 30.88 4.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.907 0.384 . . . . 0.0 110.747 -179.681 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -102.73 125.06 49.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.806 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.12 96.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.311 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 42.2 mtp -79.71 -16.97 54.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.606 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.502 ' CE2' ' CD2' ' A' ' 4' ' ' TYR . 23.7 p90 -178.98 172.73 1.25 Allowed 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.706 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -133.05 -169.91 2.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.19 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 54.3 p30 -89.3 15.56 8.84 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.521 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 44.6 pt -82.69 -9.31 11.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.816 0.341 . . . . 0.0 111.229 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.432 ' CE2' HG21 ' A' ' 72' ' ' ILE . 74.3 m-85 -111.65 -178.06 3.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.819 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.7 mtmt -94.48 91.45 6.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.683 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.3 mp -87.84 129.94 38.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.11 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.7 mtm180 -120.89 126.0 48.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.892 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -74.36 116.19 14.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.84 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.6 pt -109.6 165.37 5.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.025 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 59.5 32.69 21.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.092 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 64.78 45.01 3.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.301 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.52 -12.4 63.22 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.744 -0.741 . . . . 0.0 113.272 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.89 -39.48 71.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.938 0.369 . . . . 0.0 111.191 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 96.6 m -137.32 170.96 15.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.081 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.74 131.25 40.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.86 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.404 ' OE1' ' CD2' ' A' ' 159' ' ' TYR . 63.3 mt-10 -97.49 113.8 25.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.04 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 23.5 t -90.58 112.08 24.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.904 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -85.53 120.63 27.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.994 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.46 -142.34 11.14 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.457 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.0 ptmm? -165.31 124.73 1.77 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.787 0.327 . . . . 0.0 110.795 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 52.4 mtm -72.04 123.8 23.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.94 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.0 m -119.48 130.23 74.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.133 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 81.0 p -97.99 165.5 11.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.956 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.602 ' HB3' HG12 ' A' ' 67' ' ' ILE . 4.8 ttm180 -131.96 119.06 20.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.748 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 78.3 p -133.72 25.9 4.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.041 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 66.15 -73.86 0.07 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.006 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -164.67 76.53 0.15 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.448 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -77.27 157.91 30.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.869 0.366 . . . . 0.0 110.876 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 22.9 mt 64.25 36.9 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.12 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.17 -44.29 3.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.815 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -70.12 176.24 3.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.874 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.99 -75.82 0.62 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.978 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.1 mt -77.22 -33.38 56.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.023 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 24.0 mt 52.48 83.4 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.212 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 110.64 142.42 9.19 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.569 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 162.7 175.98 34.3 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.483 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 17.1 m-20 -85.7 75.0 10.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.837 0.351 . . . . 0.0 110.874 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -175.75 144.41 0.64 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.079 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 60.66 31.31 20.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.87 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 59.87 168.09 0.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.099 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -113.13 -70.87 0.78 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.896 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -137.1 113.74 1.05 Allowed Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.388 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.39 121.77 8.93 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.479 2.119 . . . . 0.0 112.297 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 60.83 101.76 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.887 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.09 -179.93 51.87 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.512 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.01 88.54 2.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.921 0.391 . . . . 0.0 110.925 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -168.97 145.18 9.26 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.368 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.54 -42.61 42.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.843 0.354 . . . . 0.0 110.877 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 58.78 96.82 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.922 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.3 m -136.6 131.86 34.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.946 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.0 t -59.5 97.36 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.879 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 71.0 t -111.4 133.52 56.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.251 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.602 HG12 ' HB3' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -140.13 131.73 32.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.535 179.349 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.2 m -139.03 127.59 23.12 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.115 0.484 . . . . 0.0 110.984 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -169.24 -173.98 37.33 Favored Glycine 0 N--CA 1.451 -0.33 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.117 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.436 ' CG1' HG12 ' A' ' 72' ' ' ILE . 53.2 t -70.8 147.58 11.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.791 0.329 . . . . 0.0 110.987 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -73.57 -55.56 6.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.306 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.459 ' HB ' ' CE1' ' A' ' 76' ' ' HIS . 8.9 pt -53.62 -33.72 22.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.183 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 84.1 t -71.5 -33.62 50.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.091 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.8 mtm -78.07 -39.2 42.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.585 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.409 ' OD1' ' CD2' ' A' ' 76' ' ' HIS . 15.8 p30 -82.11 -28.38 32.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.508 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.459 ' CE1' ' HB ' ' A' ' 72' ' ' ILE . 24.4 m170 -94.93 1.69 55.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.778 0.323 . . . . 0.0 110.936 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 15.7 m80 54.98 32.22 17.65 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.344 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 54.6 mt -59.13 139.11 57.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.383 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -124.77 137.44 54.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.93 0.395 . . . . 0.0 111.239 -179.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.411 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 2.5 tt0 -92.86 124.14 36.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.926 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.5 t -115.19 127.35 55.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.888 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 89.3 p -68.91 159.67 32.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.941 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -165.32 164.22 19.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.748 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -101.58 167.84 9.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.835 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.5 mtpt -67.02 -52.46 42.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.838 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.7 tp10 -64.89 -42.82 94.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.511 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.88 -39.37 81.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.931 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.51 ' CZ ' ' CE1' ' A' ' 134' ' ' PHE . 1.3 t80 -59.94 -38.66 83.04 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.786 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 70.7 mttt -56.82 -45.72 82.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.112 0.482 . . . . 0.0 110.591 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.79 -27.77 50.28 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.641 178.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -66.77 -44.6 80.95 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.743 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.446 ' HB ' HG13 ' A' ' 122' ' ' ILE . 5.4 tp -63.15 -44.3 99.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.014 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -62.63 -37.15 85.2 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.067 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.449 ' HA ' ' HG2' ' A' ' 97' ' ' LYS . 29.3 t70 -75.76 -42.95 48.97 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.662 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.478 ' CD1' ' C ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -77.8 -40.86 39.26 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 121.013 -0.275 . . . . 0.0 110.863 -179.476 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.444 ' HG3' ' N ' ' A' ' 97' ' ' LYS . 0.1 OUTLIER -65.12 -31.85 73.26 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.249 179.418 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.482 ' HG3' ' N ' ' A' ' 98' ' ' SER . 15.1 pttt -70.64 -34.13 71.74 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 120.945 0.402 . . . . 0.0 110.178 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.482 ' N ' ' HG3' ' A' ' 97' ' ' LYS . 2.0 m -59.47 -37.41 78.12 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.761 179.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.7 mt -79.78 -40.88 21.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.102 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.75 -51.33 70.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.22 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -59.54 -47.69 89.69 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.64 -0.79 . . . . 0.0 111.91 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.6 -41.27 97.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.921 0.391 . . . . 0.0 110.086 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.457 ' O ' ' N ' ' A' ' 107' ' ' ARG . 8.3 tp -65.37 -37.88 88.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.958 179.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 108' ' ' PRO . 76.4 mt-10 -56.62 -29.95 62.75 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.767 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -86.62 -20.19 28.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.531 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -106.84 -60.9 1.61 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.763 0.316 . . . . 0.0 111.602 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.457 ' N ' ' O ' ' A' ' 103' ' ' LEU . 4.0 mtt85 -129.37 65.23 73.92 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.816 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.441 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 9.7 Cg_endo -50.4 -22.5 8.85 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 123.22 2.613 . . . . 0.0 112.745 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -75.69 -6.92 52.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.653 0.263 . . . . 0.0 111.136 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.495 ' C ' ' HD2' ' A' ' 113' ' ' PRO . 13.9 mmt180 -112.38 -1.53 15.02 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.654 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 33.7 m -70.77 -36.24 63.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -179.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.559 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 25.8 mttm -66.65 -50.29 46.37 Favored Pre-proline 0 CA--C 1.529 0.16 0 C-N-CA 121.049 -0.261 . . . . 0.0 111.502 -179.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.559 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 37.0 Cg_exo -59.97 -32.04 94.47 Favored 'Trans proline' 0 C--N 1.347 0.447 0 C-N-CA 121.993 1.796 . . . . 0.0 111.568 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.476 ' CE1' ' HB2' ' A' ' 165' ' ' ASP . 76.0 t80 -69.99 -47.71 61.11 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.852 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -50.97 -42.03 59.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.02 0.438 . . . . 0.0 110.769 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.8 m -76.65 -44.29 34.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.717 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.43 -52.47 52.39 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.679 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.04 -51.74 66.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.937 0.399 . . . . 0.0 111.134 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.58 -28.2 68.97 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.363 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -77.87 -45.69 23.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.9 0.381 . . . . 0.0 111.194 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -70.49 -36.45 73.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.208 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.465 ' CG2' ' N ' ' A' ' 123' ' ' LYS . 0.3 OUTLIER -61.89 -47.37 93.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.326 -179.765 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.465 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 13.4 pttt -61.76 -31.19 71.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.017 0.437 . . . . 0.0 110.072 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -67.9 -53.65 24.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.621 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.419 HG23 ' CD2' ' A' ' 132' ' ' TYR . 15.5 pt -62.01 -42.04 93.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.291 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.404 ' HG ' ' CD1' ' A' ' 122' ' ' ILE . 11.3 mt -53.9 -35.9 62.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.944 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.99 -14.29 62.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.087 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -140.5 33.15 1.85 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.073 0.463 . . . . 0.0 110.398 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.504 ' CE1' ' CZ ' ' A' ' 134' ' ' PHE . 5.5 t80 -49.02 -27.59 3.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.224 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 2.8 ttpp -60.57 -27.78 67.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.791 0.329 . . . . 0.0 110.867 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 30.8 m-20 -94.27 -32.19 13.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.322 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.419 ' CD2' HG23 ' A' ' 125' ' ' ILE . 3.6 m-85 -98.36 131.97 44.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.199 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.7 mm100 -117.33 143.72 45.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.803 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.51 ' CE1' ' CZ ' ' A' ' 88' ' ' TYR . 2.1 m-85 -80.01 124.11 28.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.062 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.411 ' CE2' ' HB2' ' A' ' 80' ' ' GLU . 43.1 m-85 -127.88 145.84 50.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.686 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.411 ' HB ' ' HA ' ' A' ' 140' ' ' MET . 0.7 OUTLIER -131.59 163.64 36.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.042 179.958 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -64.56 -159.55 0.38 Allowed Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.298 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -75.97 -8.89 58.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.597 0.237 . . . . 0.0 111.512 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -97.24 -31.75 12.27 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.583 0.23 . . . . 0.0 111.563 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' MET . . . . . 0.411 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 56.0 mtp 58.26 37.39 26.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.809 0.338 . . . . 0.0 110.945 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 19.6 p-10 -64.35 115.0 16.18 Favored Pre-proline 0 N--CA 1.452 -0.372 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.934 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.92 -29.7 90.04 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.514 2.142 . . . . 0.0 112.287 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -84.55 -6.63 59.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.059 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -79.08 -141.12 2.05 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.413 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 3.2 ptp -113.36 -178.55 3.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.752 0.311 . . . . 0.0 110.919 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.406 ' CG1' ' HB3' ' A' ' 134' ' ' PHE . 42.2 t -128.06 144.95 36.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.283 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -111.67 114.73 27.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.681 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.51 ' HB2' ' HB ' ' A' ' 161' ' ' ILE . 3.3 mt -88.53 106.3 18.2 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.068 -179.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.7 tp -88.93 119.62 29.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.219 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.44 ' HB2' ' CZ ' ' A' ' 159' ' ' TYR . 0.9 OUTLIER -129.08 165.91 20.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.695 179.517 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -111.88 146.15 38.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.96 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 21.9 mmt180 -67.32 -177.46 0.7 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.879 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.41 -31.94 68.17 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.899 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 38.1 p-10 -77.35 -15.05 59.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.23 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 71.83 17.21 76.66 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.72 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 91.1 t -112.93 -70.4 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.841 0.353 . . . . 0.0 110.733 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 86.4 m -55.07 107.86 0.99 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.08 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -84.25 128.22 4.16 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.586 2.19 . . . . 0.0 112.334 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.44 ' CZ ' ' HB2' ' A' ' 150' ' ' ASP . 9.4 p90 -124.22 136.05 53.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.821 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -107.08 136.73 46.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.992 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.51 ' HB ' ' HB2' ' A' ' 148' ' ' LEU . 62.3 mt -91.55 112.65 25.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.103 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -110.24 152.18 26.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.833 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.42 ' CE2' ' OH ' ' A' ' 95' ' ' TYR . 3.1 m-85 -96.28 124.7 40.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.617 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -65.96 -56.36 12.08 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.355 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.476 ' HB2' ' CE1' ' A' ' 114' ' ' PHE . 7.0 m-20 -50.1 -36.29 28.98 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.859 0.362 . . . . 0.0 111.071 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -95.87 24.76 28.3 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.24 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -139.99 145.07 37.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.754 0.311 . . . . 0.0 110.841 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -119.23 143.45 47.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.796 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' MET . . . . . 0.403 ' HB3' ' CD1' ' A' ' 2' ' ' ILE . 0.6 OUTLIER -110.51 146.41 36.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.022 -179.918 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -152.27 135.63 15.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.958 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 12.4 mttm -87.97 128.39 35.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.742 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 3.4 m -45.37 -56.14 5.28 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.423 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 47.4 mt -82.28 81.01 8.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.862 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.927 179.999 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.0 ttp . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.782 0.325 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.417 HG22 ' HB2' ' A' ' 16' ' ' ASP . 0.7 OUTLIER -118.08 144.45 26.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.983 179.969 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 169' ' ' MET . 14.8 mm -100.14 137.75 26.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.723 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.485 ' CD2' ' CZ ' ' A' ' 14' ' ' PHE . 6.1 m-85 -106.36 105.37 15.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.457 179.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -122.44 145.76 47.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.839 0.352 . . . . 0.0 111.231 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.46 ' O ' ' HA ' ' A' ' 10' ' ' HIS . 43.5 t0 -56.21 152.08 11.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.723 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 57.9 tp -78.8 -26.71 44.38 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.2 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.4 mp -91.34 -44.12 14.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -179.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.473 ' O ' ' CG ' ' A' ' 10' ' ' HIS . 30.0 t -95.33 -10.19 30.84 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -178.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.473 ' CG ' ' O ' ' A' ' 9' ' ' SER . 25.5 p80 48.31 27.62 1.4 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.952 0.406 . . . . 0.0 111.267 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -98.21 122.59 41.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.705 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.47 84.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.362 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.413 ' O ' ' CD2' ' A' ' 76' ' ' HIS . 7.0 mtp -64.34 -18.57 64.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.588 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.485 ' CZ ' ' CD2' ' A' ' 4' ' ' TYR . 8.8 p90 -178.94 179.7 0.66 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.634 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -136.99 -169.9 2.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.91 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.417 ' HB2' HG22 ' A' ' 2' ' ' ILE . 37.8 t70 -93.55 26.18 3.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.027 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.424 HG13 ' CD2' ' A' ' 18' ' ' TYR . 46.0 pt -84.77 -13.28 11.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.754 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.428 ' CZ ' HG22 ' A' ' 72' ' ' ILE . 79.0 m-85 -110.72 168.64 9.32 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.618 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.44 94.01 4.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.864 0.364 . . . . 0.0 110.581 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.2 mp -87.79 139.41 17.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.12 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -127.35 119.53 26.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.036 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -71.77 114.7 10.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.859 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.9 pt -111.49 167.1 5.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.203 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 59.29 30.17 19.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.236 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 64.38 36.67 8.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.152 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.12 -15.32 61.64 Favored Glycine 0 CA--C 1.518 0.245 0 C-N-CA 120.556 -0.831 . . . . 0.0 112.986 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.04 -43.39 73.74 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.811 0.338 . . . . 0.0 110.917 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 9.0 m -135.66 165.05 26.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.912 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.02 139.09 52.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.785 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -103.51 113.01 26.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.086 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 23.5 t -91.56 112.05 24.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.721 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -82.12 114.39 20.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.229 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.43 -137.13 8.84 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.288 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -174.51 128.24 0.33 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.885 0.374 . . . . 0.0 110.809 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 8.3 mtt -72.3 124.26 24.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.921 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 28.0 m -129.12 161.39 38.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.208 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 83.5 p -103.13 165.66 10.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.861 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.585 ' HB3' HG12 ' A' ' 67' ' ' ILE . 7.2 ttt85 -125.81 120.32 30.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.918 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.4 p -112.3 -29.8 7.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.853 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 62.93 149.37 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.054 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 178.59 -162.47 29.7 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.439 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 59.99 30.23 19.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.772 0.32 . . . . 0.0 110.969 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 6.3 tt -114.48 67.86 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.964 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 60.86 78.49 0.28 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.863 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.3 p-10 -176.79 -39.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.058 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.44 -65.87 0.58 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.008 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.8 mt -78.8 -35.01 44.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.964 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 27.5 mm -99.03 131.28 46.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.121 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 95.86 -147.9 18.8 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.54 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.63 -28.01 15.8 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.427 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -68.34 -35.09 77.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.846 0.355 . . . . 0.0 110.921 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -145.23 159.46 42.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.11 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.5 t -91.89 -57.14 2.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.843 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -113.08 165.71 12.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.023 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -110.69 -31.39 7.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.912 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -101.24 -74.75 1.1 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.552 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -68.3 -179.0 2.02 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.617 2.212 . . . . 0.0 112.258 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -111.79 100.07 8.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.85 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.09 43.11 97.24 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.461 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -93.97 154.4 17.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.877 0.37 . . . . 0.0 110.859 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -124.79 81.93 0.35 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.525 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.4 p -81.22 -31.84 33.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.858 0.361 . . . . 0.0 110.934 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -115.56 -167.01 1.19 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.841 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.7 t 64.11 52.36 2.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.909 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.13 178.29 0.13 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.805 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 64.3 t -130.06 117.23 40.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.24 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.585 HG12 ' HB3' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -123.13 128.96 75.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.321 179.309 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.7 m -128.49 131.66 48.34 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.225 0.536 . . . . 0.0 111.342 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -166.89 -164.62 22.86 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.891 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.433 ' CG1' HG12 ' A' ' 72' ' ' ILE . 46.8 t -73.25 141.89 15.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.75 0.309 . . . . 0.0 110.754 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -68.59 -56.17 9.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.725 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.439 ' HB ' ' CD2' ' A' ' 76' ' ' HIS . 8.5 pt -53.58 -33.77 22.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.868 0.366 . . . . 0.0 111.32 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.423 ' CG2' ' HB ' ' A' ' 70' ' ' VAL . 92.9 t -70.8 -32.0 47.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.83 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.5 mtm -78.3 -40.64 36.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.539 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -82.07 -28.46 32.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.621 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.439 ' CD2' ' HB ' ' A' ' 72' ' ' ILE . 7.2 m-70 -90.22 -5.68 56.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.857 0.36 . . . . 0.0 110.676 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 9.0 m80 62.45 29.93 17.19 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.103 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.406 ' HB2' ' CG1' ' A' ' 73' ' ' VAL . 34.5 mt -59.53 147.1 38.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.499 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -127.71 137.24 52.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.86 0.362 . . . . 0.0 111.042 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.43 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 2.9 tt0 -99.96 124.11 44.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.056 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.6 t -123.69 135.18 53.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.769 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 9.1 m -68.01 160.58 28.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.092 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.43 ' HB2' ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -156.8 154.54 30.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.866 179.975 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.9 m -99.13 157.08 16.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.786 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.67 -52.39 65.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.904 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -66.51 -43.09 86.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.683 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.6 -37.8 82.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.05 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.461 ' CD2' HD11 ' A' ' 122' ' ' ILE . 1.3 t80 -62.87 -35.13 79.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.745 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 24.4 mttt -59.99 -45.5 92.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.051 0.453 . . . . 0.0 110.443 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.65 -27.93 55.81 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.629 178.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -66.21 -47.47 73.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.638 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.457 ' O ' ' HG2' ' A' ' 96' ' ' MET . 4.7 tp -60.3 -43.93 94.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.968 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 8.6 ttmt -60.08 -43.64 95.36 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.214 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.445 ' HA ' ' HG2' ' A' ' 97' ' ' LYS . 12.0 t70 -72.75 -39.72 66.6 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.819 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.471 ' CD1' ' C ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -76.46 -41.62 46.69 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 121.004 -0.279 . . . . 0.0 110.855 -179.497 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.457 ' HG2' ' O ' ' A' ' 92' ' ' ILE . 2.9 ptt? -67.95 -32.75 73.4 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.73 0.3 . . . . 0.0 110.844 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.445 ' HG2' ' HA ' ' A' ' 94' ' ' ASP . 0.3 OUTLIER -70.68 -35.58 72.89 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.894 0.378 . . . . 0.0 110.577 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.9 m -60.52 -40.49 91.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.144 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 6.6 mt -79.85 -41.63 21.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.445 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.5 tmtt? -54.44 -54.07 45.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.502 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -58.69 -45.93 94.07 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.192 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 10.4 tptp -61.69 -41.28 97.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.806 0.336 . . . . 0.0 110.461 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.446 ' O ' ' N ' ' A' ' 107' ' ' ARG . 5.0 tp -67.4 -34.1 76.57 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.132 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -59.81 -29.83 68.51 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.828 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -87.84 -19.39 27.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.561 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -105.44 -58.17 1.93 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.736 0.303 . . . . 0.0 111.611 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.446 ' N ' ' O ' ' A' ' 103' ' ' LEU . 87.5 mtt180 -138.5 67.91 45.22 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 120.919 0.39 . . . . 0.0 110.858 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.408 ' HA ' HG11 ' A' ' 111' ' ' VAL . 10.3 Cg_endo -50.88 -20.97 7.71 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 123.254 2.636 . . . . 0.0 112.888 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -67.69 -9.72 46.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.592 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.447 ' C ' ' HD2' ' A' ' 113' ' ' PRO . 31.0 mmt-85 -114.23 -4.82 13.02 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.408 HG11 ' HA ' ' A' ' 108' ' ' PRO . 35.6 m -69.52 -27.74 35.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.565 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 4.3 mmtp -71.99 -54.32 6.08 Favored Pre-proline 0 CA--C 1.532 0.257 0 C-N-CA 121.078 -0.249 . . . . 0.0 111.416 -179.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.565 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 37.2 Cg_exo -56.08 -35.89 95.47 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 121.772 1.648 . . . . 0.0 111.547 179.061 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.461 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 87.5 t80 -65.8 -43.18 89.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.904 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.54 -52.36 55.19 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.08 0.467 . . . . 0.0 110.741 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 61.7 m -75.8 -44.19 42.49 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.695 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -56.21 -51.39 56.19 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.687 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.16 -51.67 67.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.994 0.426 . . . . 0.0 110.985 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.55 -28.07 69.07 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.229 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -77.94 -48.54 16.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.859 0.362 . . . . 0.0 111.048 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -67.31 -34.99 78.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.025 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.461 HD11 ' CD2' ' A' ' 88' ' ' TYR . 0.3 OUTLIER -67.03 -45.1 87.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.064 -179.865 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.439 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 26.3 mttt -61.47 -29.94 70.29 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.411 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -70.19 -53.96 14.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.764 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.428 HG22 ' CD2' ' A' ' 132' ' ' TYR . 14.5 pt -60.52 -41.86 89.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.273 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 12.4 mt -55.23 -38.41 68.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.89 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -71.39 -10.82 60.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.317 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -140.59 33.48 1.83 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.859 0.361 . . . . 0.0 110.648 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.511 ' CE1' ' CE2' ' A' ' 134' ' ' PHE . 2.2 t80 -50.13 -29.96 10.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.99 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.6 ttpt -60.1 -29.68 68.75 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.935 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 21.3 m-20 -94.17 -35.73 12.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.436 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.428 ' CD2' HG22 ' A' ' 125' ' ' ILE . 4.7 m-85 -94.84 136.31 35.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.897 0.38 . . . . 0.0 111.211 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.2 mm100 -119.83 145.68 46.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.745 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.511 ' CE2' ' CE1' ' A' ' 129' ' ' PHE . 0.6 OUTLIER -83.35 121.82 27.64 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.989 -179.759 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.459 ' CG ' ' CE ' ' A' ' 160' ' ' MET . 46.5 m-85 -125.46 134.85 51.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.761 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.467 ' HB ' ' HA ' ' A' ' 140' ' ' MET . 0.3 OUTLIER -123.87 164.77 21.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.784 179.989 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.53 -173.05 1.25 Allowed Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.447 -0.882 . . . . 0.0 111.899 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -67.36 -13.68 62.23 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.564 0.221 . . . . 0.0 111.22 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -92.75 -28.66 16.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.723 0.297 . . . . 0.0 111.366 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' MET . . . . . 0.467 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 53.8 mtm 54.69 43.08 30.7 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.811 0.339 . . . . 0.0 111.201 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -67.29 122.28 82.26 Favored Pre-proline 0 N--CA 1.453 -0.279 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.67 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -59.74 -27.23 84.45 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.351 2.034 . . . . 0.0 111.881 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -84.76 -15.99 43.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.814 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.99 -173.45 24.78 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.347 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -88.84 -177.99 5.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.737 0.303 . . . . 0.0 110.881 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 41.6 t -127.6 153.84 37.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.222 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -118.54 115.74 25.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.691 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.533 ' HB2' ' HB ' ' A' ' 161' ' ' ILE . 3.6 mt -90.18 106.7 18.66 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.948 -179.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.6 tp -88.5 119.61 29.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.409 -179.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.445 ' HB3' ' CE1' ' A' ' 159' ' ' TYR . 0.7 OUTLIER -129.49 172.24 11.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.525 179.4 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -117.76 144.41 45.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.847 0.356 . . . . 0.0 111.008 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.41 -177.71 0.05 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.933 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.36 -34.97 71.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.017 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -76.54 -15.14 59.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.218 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 69.17 26.04 74.95 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.711 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 94.5 t -112.83 -69.81 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.932 0.396 . . . . 0.0 110.885 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 73.4 m -63.77 111.23 4.86 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.01 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -81.73 131.17 7.08 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.462 2.108 . . . . 0.0 112.192 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.445 ' CE1' ' HB3' ' A' ' 150' ' ' ASP . 13.9 p90 -125.62 144.59 50.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.92 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' MET . . . . . 0.459 ' CE ' ' CG ' ' A' ' 135' ' ' PHE . 0.2 OUTLIER -110.7 142.65 42.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.137 -179.792 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.533 ' HB ' ' HB2' ' A' ' 148' ' ' LEU . 58.7 mt -97.68 116.34 39.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.974 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -118.6 132.82 56.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.798 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -78.0 123.0 26.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.867 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.46 -54.48 35.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.327 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.461 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 1.6 m-20 -49.54 -36.2 22.75 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.285 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -96.55 27.92 15.49 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.366 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.49 143.96 29.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.814 0.34 . . . . 0.0 110.925 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -113.66 147.76 37.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.725 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' MET . . . . . 0.409 ' HA ' ' O ' ' A' ' 3' ' ' ILE . 0.7 OUTLIER -120.08 140.3 51.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.975 -179.816 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -146.8 133.06 19.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.914 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . 0.412 ' CG ' HD11 ' A' ' 2' ' ' ILE . 31.0 mttp -87.87 119.59 28.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.916 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 27.8 m -141.89 144.45 33.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.928 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 11.2 mt -73.87 -42.68 60.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.913 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.301 -0.857 . . . . 0.0 110.857 -179.968 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.9 ttt . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.727 0.299 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.435 ' CD1' ' HB3' ' A' ' 169' ' ' MET . 4.5 tt -101.37 139.61 22.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.038 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.2 mm -100.98 155.25 4.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.317 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.516 ' CD2' ' CE2' ' A' ' 14' ' ' PHE . 2.8 m-85 -122.8 105.94 10.47 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.424 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 17.5 ptt180 -120.8 150.29 41.25 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.937 0.398 . . . . 0.0 111.469 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.425 ' O ' ' HA ' ' A' ' 10' ' ' HIS . 37.6 t0 -62.38 152.18 34.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.616 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 56.6 tp -81.23 -22.6 38.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.395 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.1 mp -91.27 -45.9 14.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 93.1 p -93.14 -21.39 19.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.616 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.425 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 1.6 m-70 62.23 29.78 17.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.865 0.364 . . . . 0.0 110.805 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -106.1 124.62 49.87 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.804 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -58.44 93.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.207 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 7.3 mtt -70.08 -18.42 63.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.847 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.516 ' CE2' ' CD2' ' A' ' 4' ' ' TYR . 14.3 p90 -177.44 177.33 1.19 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.899 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -136.67 -169.88 2.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.975 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 34.5 p-10 -87.83 13.93 9.75 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.615 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 46.5 pt -78.9 -4.96 7.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.816 0.341 . . . . 0.0 111.13 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.46 ' CE2' HG21 ' A' ' 72' ' ' ILE . 65.3 m-85 -119.56 -179.07 3.77 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.728 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -91.39 88.71 6.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.748 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.0 mp -87.84 123.96 40.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.928 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 8.9 mtt180 -114.85 135.91 53.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.934 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -81.56 114.82 20.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.868 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.3 pt -110.23 162.59 7.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.21 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 60.01 29.77 19.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.251 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 64.42 50.81 2.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.423 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.65 -4.25 74.86 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 120.732 -0.747 . . . . 0.0 113.441 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.65 -29.36 69.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 117.036 0.418 . . . . 0.0 111.0 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 92.4 m -147.59 171.52 15.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.119 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -134.79 129.57 34.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.874 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.414 ' OE1' ' CD2' ' A' ' 159' ' ' TYR . 61.7 mt-10 -97.52 116.36 29.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.166 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.9 t -92.41 111.97 25.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.698 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -83.0 116.77 22.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.172 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -99.98 -144.51 16.22 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.201 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.0 pttm -174.53 126.01 0.31 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.829 0.347 . . . . 0.0 111.02 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 21.7 mtt -70.03 121.93 18.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.778 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.4 m -126.85 144.8 35.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.29 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 57.0 p -95.51 165.59 12.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.844 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.482 ' HB3' HG12 ' A' ' 67' ' ' ILE . 2.7 ttt180 -135.94 141.4 44.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.798 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.2 t -157.71 123.87 4.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.869 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -97.64 -179.81 4.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.895 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -79.53 -22.26 65.01 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.628 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -56.63 -40.24 75.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.87 0.367 . . . . 0.0 111.039 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 14.8 tt -77.69 158.5 5.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.994 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 66.49 -76.02 0.05 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.884 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.11 104.96 11.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.952 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 29.7 m -74.62 -43.71 54.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.843 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 29.0 mt -70.78 -28.81 64.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.004 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 71.8 mt 53.41 79.91 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.173 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 100.3 -54.76 0.88 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.519 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 124.24 -30.77 4.67 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.444 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -97.92 119.74 37.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.779 0.323 . . . . 0.0 110.939 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -128.29 130.81 48.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.076 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.91 31.72 2.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.871 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -154.39 143.02 20.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.085 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -110.66 96.87 6.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.9 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 157.89 158.9 9.23 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.461 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -52.27 139.69 53.61 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.591 2.194 . . . . 0.0 112.29 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.2 pm0 -112.43 -34.7 5.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.855 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -170.46 66.65 0.15 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.468 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -84.24 139.2 32.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.766 0.317 . . . . 0.0 111.006 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 150.08 178.18 24.77 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.461 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 23.3 p -120.44 33.2 5.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.87 0.367 . . . . 0.0 110.905 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -70.27 148.12 48.92 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.892 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 60.5 p -60.86 108.85 0.92 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.852 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 17.5 m -97.76 -22.23 16.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.152 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 22.6 t -93.74 136.89 24.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.108 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.482 HG12 ' HB3' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -129.61 132.98 65.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.984 179.801 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 93.6 m -139.18 142.38 37.94 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.063 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 170.33 -170.38 42.94 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.356 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.452 ' CG1' HG12 ' A' ' 72' ' ' ILE . 47.9 t -69.02 124.27 24.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.913 0.387 . . . . 0.0 110.756 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -54.28 -57.31 11.68 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.833 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.46 HG21 ' CE2' ' A' ' 18' ' ' TYR . 5.4 pt -53.74 -34.13 24.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.842 0.353 . . . . 0.0 111.364 -179.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 97.5 t -73.67 -29.97 27.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.055 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.7 mtt -78.24 -42.25 31.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.82 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.428 ' OD1' ' CD2' ' A' ' 76' ' ' HIS . 19.6 p30 -82.05 -29.68 31.78 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 -179.18 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.428 ' CD2' ' OD1' ' A' ' 75' ' ' ASN . 34.1 m170 -88.99 -5.39 57.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.862 0.363 . . . . 0.0 110.626 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 61.43 30.3 18.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.032 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 60.0 mt -58.57 148.56 28.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.49 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -131.75 136.47 47.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.854 0.359 . . . . 0.0 111.109 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.42 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 2.5 tm-20 -89.81 135.21 33.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.104 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.2 t -120.21 171.85 8.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.725 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 30.2 m -114.56 161.23 18.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.978 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.457 ' HB2' ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -171.62 159.81 5.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.039 -179.898 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 8.6 m -101.54 162.41 12.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.815 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 17.1 mtpt -58.39 -51.95 67.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.104 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -65.64 -46.44 79.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.842 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.46 -36.4 73.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.185 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.444 ' CZ ' ' CE1' ' A' ' 134' ' ' PHE . 1.0 OUTLIER -62.57 -37.9 87.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.809 179.874 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 28.1 mttm -58.58 -44.9 89.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.649 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.1 tttm -77.96 -27.9 49.33 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.652 178.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.4 ' CE2' ' CE2' ' A' ' 83' ' ' PHE . 12.4 t80 -66.9 -46.6 74.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.711 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.451 ' HB ' HG13 ' A' ' 122' ' ' ILE . 6.0 tp -61.9 -42.61 95.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.107 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.475 ' O ' ' CG ' ' A' ' 97' ' ' LYS . 11.3 ttpp -62.0 -45.28 94.32 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.92 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -70.56 -38.14 74.08 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.945 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.447 ' CD1' ' C ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -78.24 -43.51 28.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.742 -0.208 . . . . 0.0 110.839 -179.458 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.42 ' HG3' ' N ' ' A' ' 97' ' ' LYS . 0.3 OUTLIER -62.07 -31.77 72.22 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 178.778 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.475 ' CG ' ' O ' ' A' ' 93' ' ' LYS . 1.4 mmmp? -65.61 -41.87 92.23 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.35 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.7 m -52.85 -40.31 63.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.146 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 8.7 mt -79.76 -42.71 22.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.443 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.69 -49.05 74.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.376 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -60.89 -49.66 76.15 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.013 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.5 -40.53 91.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.86 0.362 . . . . 0.0 110.262 179.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.447 ' O ' ' N ' ' A' ' 107' ' ' ARG . 7.3 tp -65.17 -38.31 90.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.095 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.426 ' HA ' ' HA ' ' A' ' 108' ' ' PRO . 78.7 mt-10 -56.88 -29.54 63.06 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.725 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -87.03 -19.66 28.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.635 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -107.8 -61.77 1.53 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.882 0.372 . . . . 0.0 111.527 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.447 ' N ' ' O ' ' A' ' 103' ' ' LEU . 43.5 mtt-85 -131.11 65.41 76.57 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.715 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.426 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 9.8 Cg_endo -50.49 -22.82 9.58 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 123.19 2.594 . . . . 0.0 112.75 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -70.6 -10.46 59.36 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.217 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.493 ' C ' ' HD2' ' A' ' 113' ' ' PRO . 0.0 OUTLIER -108.89 -1.24 19.28 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -179.482 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 26.5 m -71.81 -34.41 51.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.56 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 23.9 mtmt -68.99 -49.57 24.95 Favored Pre-proline 0 C--N 1.332 -0.178 0 C-N-CA 120.949 -0.301 . . . . 0.0 111.633 -179.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.56 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 37.0 Cg_exo -60.56 -32.07 93.04 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.153 1.902 . . . . 0.0 111.686 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.469 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 36.7 t80 -72.16 -47.09 53.43 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.096 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 15.0 mmm -49.42 -43.25 44.45 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.021 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 69.1 m -76.01 -45.14 36.08 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.842 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.45 -54.78 34.3 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.803 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -52.62 -51.63 59.11 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.897 0.38 . . . . 0.0 111.434 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.424 ' O ' HG22 ' A' ' 122' ' ' ILE . . . -68.58 -29.05 67.51 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.662 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -72.87 -55.87 6.02 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.865 0.364 . . . . 0.0 111.214 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -60.83 -31.51 70.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.487 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.451 HG13 ' HB ' ' A' ' 92' ' ' ILE . 0.4 OUTLIER -63.71 -45.19 98.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.322 -179.532 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.436 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 15.5 mttp -61.45 -30.89 70.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.059 0.457 . . . . 0.0 110.196 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -69.34 -54.78 12.79 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.764 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 15.0 pt -60.26 -42.79 91.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.386 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 12.0 mt -53.98 -38.18 64.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.886 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.58 -15.18 63.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.212 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -137.98 32.32 2.42 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.941 0.401 . . . . 0.0 110.751 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.499 ' CE1' ' CZ ' ' A' ' 134' ' ' PHE . 4.2 t80 -51.93 -27.99 14.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.065 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.59 -18.87 65.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.296 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 15.8 m-80 -94.14 -36.25 12.15 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.325 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.442 ' CD1' ' N ' ' A' ' 132' ' ' TYR . 1.1 m-30 -102.7 162.32 13.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.829 0.347 . . . . 0.0 111.151 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.7 mm100 -138.0 147.57 44.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.889 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.499 ' CZ ' ' CE1' ' A' ' 129' ' ' PHE . 2.8 m-85 -78.62 129.74 35.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.955 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.42 ' CE2' ' HB2' ' A' ' 80' ' ' GLU . 33.2 m-85 -134.71 134.59 41.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.629 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.436 ' HB ' ' HA ' ' A' ' 140' ' ' MET . 0.8 OUTLIER -123.18 161.2 25.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.931 -179.977 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.51 -163.44 0.24 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.207 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -72.49 -8.88 57.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.554 0.216 . . . . 0.0 111.531 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -95.7 -35.34 11.61 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.607 0.241 . . . . 0.0 111.566 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' MET . . . . . 0.436 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 10.3 mtp 58.85 40.77 22.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.695 0.283 . . . . 0.0 111.217 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -69.67 117.64 55.18 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.633 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -62.54 -24.26 75.18 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.345 2.03 . . . . 0.0 111.78 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -84.8 -15.23 45.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.758 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -74.17 -136.11 0.37 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.317 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 5.6 ptp -120.29 -175.87 3.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.86 0.362 . . . . 0.0 110.712 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 57.5 t -129.09 144.78 37.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.338 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -111.39 117.8 34.08 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.378 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.468 ' HB2' ' HB ' ' A' ' 161' ' ' ILE . 5.8 mt -91.53 107.77 19.44 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.323 -179.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.3 tp -88.05 120.67 29.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.552 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.506 ' HB2' ' CZ ' ' A' ' 159' ' ' TYR . 18.3 m-20 -122.0 145.28 48.28 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.056 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.421 ' CE1' ' HB3' ' A' ' 158' ' ' PRO . 64.7 m-85 -100.75 135.44 42.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.933 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 15.2 mmm-85 -60.89 -178.64 0.1 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.943 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -59.88 -41.24 91.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.999 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -77.68 -15.08 59.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.287 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 67.49 25.14 73.86 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.522 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 71.6 t -110.21 -37.05 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.851 0.358 . . . . 0.0 110.964 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 94.3 m -103.41 96.63 8.81 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.225 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.421 ' HB3' ' CE1' ' A' ' 151' ' ' TYR . 71.8 Cg_endo -76.02 128.12 10.47 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.521 2.148 . . . . 0.0 112.169 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.506 ' CZ ' ' HB2' ' A' ' 150' ' ' ASP . 7.7 p90 -120.04 130.56 54.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.73 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' MET . . . . . . . . . . . . . 20.9 mtp -102.2 134.66 45.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.546 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.468 ' HB ' ' HB2' ' A' ' 148' ' ' LEU . 96.4 mt -90.45 113.06 25.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.861 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -109.82 154.54 22.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.921 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.419 ' CD2' ' OH ' ' A' ' 95' ' ' TYR . 3.4 m-30 -95.46 126.26 40.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.717 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.98 -54.91 11.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.306 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.469 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 3.2 m-20 -49.11 -37.31 21.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.181 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -95.46 26.38 20.03 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.377 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -140.77 146.04 37.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.823 0.344 . . . . 0.0 110.787 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -119.53 142.75 48.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.845 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' MET . . . . . 0.435 ' HB3' ' CD1' ' A' ' 2' ' ' ILE . 0.1 OUTLIER -109.09 148.57 30.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.992 -179.988 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -152.38 121.46 6.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.832 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 19.1 mttt -91.56 118.47 30.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.933 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 51.6 t -67.72 99.73 0.83 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.832 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 62.42 148.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.891 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.211 -0.9 . . . . 0.0 110.949 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.9 ttm . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.868 0.366 . . . . 0.0 111.273 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.432 HG12 ' HG2' ' A' ' 169' ' ' MET . 11.8 tt -107.24 151.07 9.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.012 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.9 mm -102.27 153.02 5.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.486 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.502 ' CD2' ' CZ ' ' A' ' 14' ' ' PHE . 3.3 m-85 -124.43 101.52 7.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.449 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.36 153.23 34.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.931 0.396 . . . . 0.0 111.398 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.449 ' O ' ' HA ' ' A' ' 10' ' ' HIS . 46.3 t0 -59.34 152.05 22.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.646 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 36.6 tp -81.96 -16.91 48.86 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.551 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.3 mp -91.41 -50.72 12.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 27.8 t -97.35 -18.04 19.37 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.449 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 9.0 m80 64.73 31.39 11.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.832 0.348 . . . . 0.0 110.865 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -97.77 122.1 40.46 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.738 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -58.16 95.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.32 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 5.1 mtt -74.86 -18.55 60.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.662 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.502 ' CZ ' ' CD2' ' A' ' 4' ' ' TYR . 10.7 p90 -178.87 174.02 1.16 Allowed 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.6 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -132.27 -169.97 2.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.729 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.417 ' HB2' HG22 ' A' ' 2' ' ' ILE . 37.6 t0 -96.29 30.75 2.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.192 0.52 . . . . 0.0 110.736 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.407 HG13 ' CD2' ' A' ' 18' ' ' TYR . 45.5 pt -93.31 -10.25 9.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.659 179.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.407 ' CD2' HG13 ' A' ' 17' ' ' ILE . 48.4 m-85 -111.87 -169.16 1.41 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.715 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.72 95.48 8.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.84 0.352 . . . . 0.0 110.901 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.2 mp -92.41 125.74 45.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.097 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.4 mtp85 -117.19 120.45 38.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.055 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -72.14 114.55 10.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.849 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.2 pt -112.86 167.4 6.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.192 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 58.06 30.81 19.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.274 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 63.95 44.08 4.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.347 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.21 -17.36 56.04 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 120.735 -0.745 . . . . 0.0 113.142 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.15 -50.4 61.83 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.831 0.348 . . . . 0.0 111.137 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 55.3 m -130.18 164.33 24.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.744 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.6 135.13 48.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.045 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -96.7 114.82 26.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.126 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 22.2 t -96.37 112.14 27.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.872 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -91.28 115.48 28.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.115 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -98.94 -131.49 7.31 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.458 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -172.39 124.93 0.5 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.804 0.335 . . . . 0.0 110.939 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 24.4 mtp -74.73 123.93 25.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.91 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.2 m -116.92 135.9 55.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.236 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 7.3 m -96.75 165.61 12.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.902 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.502 ' HB3' HG12 ' A' ' 67' ' ' ILE . 8.7 ttt180 -136.87 119.99 16.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.584 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.4 m -112.0 -28.85 7.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.208 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 62.93 90.61 0.08 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.757 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 167.17 -30.39 0.19 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.513 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -54.76 -25.99 31.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.779 0.324 . . . . 0.0 111.025 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 16.6 tt -56.51 152.5 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.172 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -65.93 179.83 0.83 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.984 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -110.88 179.93 3.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.936 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.1 t -88.24 -18.0 29.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.364 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.9 mt -52.94 -30.39 34.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.818 0.342 . . . . 0.0 111.172 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.2 mt -69.22 124.08 24.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.985 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -79.19 168.59 53.31 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.567 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 114.26 -102.69 1.22 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.463 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -159.88 84.8 0.75 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.819 0.342 . . . . 0.0 110.867 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -171.85 144.32 1.75 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.083 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 19.3 t 62.69 146.93 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.936 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 60.62 156.3 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.144 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 60.07 107.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.913 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.403 ' N ' ' CD ' ' A' ' 57' ' ' PRO . . . 59.47 51.9 56.33 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.473 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.403 ' CD ' ' N ' ' A' ' 56' ' ' GLY . 56.3 Cg_endo -70.43 -179.19 3.03 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.55 2.167 . . . . 0.0 112.371 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -102.15 34.01 2.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.869 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 172.01 -152.59 17.61 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.53 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -175.82 -40.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.862 0.363 . . . . 0.0 110.897 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -105.64 175.65 21.8 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.505 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.8 m -118.51 -48.96 2.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.8 0.333 . . . . 0.0 110.895 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 68.42 -67.31 0.2 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.046 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 6.8 m -115.79 153.0 32.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.868 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 86.7 m -89.78 -72.25 0.57 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.872 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 29.5 t -106.6 133.48 51.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.99 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.502 HG12 ' HB3' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -136.35 131.08 48.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.998 179.829 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 21.6 m -139.33 135.29 33.6 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.994 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -174.6 178.66 46.31 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.353 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.402 ' CG1' HG12 ' A' ' 72' ' ' ILE . 59.0 t -68.02 148.26 11.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.865 0.364 . . . . 0.0 110.851 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -71.56 -59.12 2.93 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.452 -179.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.45 ' HB ' ' CE1' ' A' ' 76' ' ' HIS . 8.9 pt -53.72 -33.94 23.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.437 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.4 ' CG1' ' HB2' ' A' ' 78' ' ' LEU . 61.5 t -72.72 -34.05 46.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.042 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.1 mtm -78.31 -39.15 40.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.576 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.403 ' OD1' ' CD2' ' A' ' 76' ' ' HIS . 19.8 p30 -82.0 -28.46 32.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.559 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.45 ' CE1' ' HB ' ' A' ' 72' ' ' ILE . 26.7 m170 -92.49 -1.17 57.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.841 0.353 . . . . 0.0 110.801 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.41 ' HB2' ' HB3' ' A' ' 138' ' ' GLU . 21.9 m170 58.0 31.41 20.6 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.074 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.4 ' HB2' ' CG1' ' A' ' 73' ' ' VAL . 42.6 mt -60.23 142.41 54.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.489 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -125.24 136.56 53.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.304 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.424 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 1.7 tm-20 -91.86 121.06 33.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.863 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.5 t -113.6 127.07 55.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.881 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 70.6 m -68.96 159.15 33.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.887 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.45 ' HB2' ' CD2' ' A' ' 134' ' ' PHE . 0.3 OUTLIER -166.84 152.44 7.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.818 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.26 166.5 11.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.879 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.0 mtmt -63.56 -52.41 61.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.141 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -61.31 -48.29 82.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.928 0.394 . . . . 0.0 110.811 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.422 ' HB3' ' CE2' ' A' ' 83' ' ' PHE . . . -57.29 -40.84 78.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.074 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.515 ' CZ ' ' CE1' ' A' ' 134' ' ' PHE . 0.4 OUTLIER -59.43 -35.88 74.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.762 179.96 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.421 ' O ' HG22 ' A' ' 92' ' ' ILE . 27.2 mttt -58.31 -47.8 82.55 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.187 0.517 . . . . 0.0 110.527 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.6 tmtm? -76.57 -27.82 56.0 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.704 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -66.73 -46.87 74.09 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.693 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.452 ' O ' ' HG2' ' A' ' 96' ' ' MET . 4.5 tp -59.85 -44.02 93.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.945 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.1 ttmm -59.27 -40.7 86.88 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.205 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.479 ' HA ' ' HG2' ' A' ' 97' ' ' LYS . 47.3 t0 -73.15 -43.21 61.89 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.898 -179.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.45 ' CE2' ' CD1' ' A' ' 92' ' ' ILE . 0.0 OUTLIER -75.35 -39.9 58.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.647 -0.252 . . . . 0.0 111.199 -179.176 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.452 ' HG2' ' O ' ' A' ' 92' ' ' ILE . 15.0 ptm -67.57 -32.22 72.82 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.792 0.33 . . . . 0.0 110.539 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.479 ' HG2' ' HA ' ' A' ' 94' ' ' ASP . 4.6 ptpt -69.91 -34.07 73.01 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.66 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.479 ' N ' ' HG3' ' A' ' 97' ' ' LYS . 2.2 m -61.74 -40.49 95.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.085 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 7.0 mt -79.86 -41.3 21.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.355 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -55.38 -53.91 50.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.521 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -61.5 -45.7 95.84 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.138 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.9 tptt -61.41 -39.49 90.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.883 0.373 . . . . 0.0 110.3 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.435 ' O ' ' N ' ' A' ' 107' ' ' ARG . 3.0 tp -68.69 -32.94 73.12 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.025 179.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.421 ' HA ' ' HA ' ' A' ' 108' ' ' PRO . 83.4 mt-10 -59.99 -30.4 69.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.807 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -88.19 -20.19 25.9 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.605 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 -106.25 -62.82 1.33 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.863 0.363 . . . . 0.0 111.548 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.435 ' N ' ' O ' ' A' ' 103' ' ' LEU . 5.5 mtm180 -126.25 63.43 50.52 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.923 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.421 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 9.9 Cg_endo -50.62 -22.21 9.0 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 123.233 2.622 . . . . 0.0 112.776 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -74.83 -7.06 52.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.372 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.508 ' C ' ' HD2' ' A' ' 113' ' ' PRO . 17.0 mmt180 -113.55 -1.71 14.03 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.681 0.276 . . . . 0.0 111.617 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 34.2 m -67.96 -37.78 78.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.562 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 13.9 mtpt -67.55 -50.48 36.27 Favored Pre-proline 0 CA--C 1.529 0.161 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.617 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.562 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 31.9 Cg_exo -58.06 -33.28 97.13 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.087 1.858 . . . . 0.0 111.521 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.443 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 94.1 t80 -70.48 -40.84 73.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.746 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 15.9 mtm -55.89 -44.77 78.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.761 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 62.9 m -76.51 -44.24 36.05 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.61 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -59.19 -52.04 55.62 Favored Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.768 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.419 ' O ' ' HB ' ' A' ' 122' ' ' ILE . . . -56.89 -51.77 67.77 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.968 0.414 . . . . 0.0 111.117 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.7 -28.09 68.16 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.385 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -74.11 -49.62 23.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.482 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -71.43 -42.48 68.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.437 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.484 ' CG2' ' N ' ' A' ' 123' ' ' LYS . 0.3 OUTLIER -56.06 -49.83 73.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.726 -179.4 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.484 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 10.7 ptmt -63.03 -31.2 72.29 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.046 0.451 . . . . 0.0 110.132 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -67.99 -50.14 57.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.78 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 17.4 pt -65.59 -42.57 93.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.319 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 10.6 mt -53.85 -35.14 61.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.878 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -71.21 -10.84 60.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.289 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -144.98 34.01 1.11 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.042 0.449 . . . . 0.0 110.574 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.503 ' CE1' ' CZ ' ' A' ' 134' ' ' PHE . 13.8 t80 -52.17 -25.19 8.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.2 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -55.14 -27.83 48.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.816 0.341 . . . . 0.0 111.156 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 31.9 m-20 -94.29 -37.5 11.48 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.665 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -100.53 135.01 42.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.912 0.387 . . . . 0.0 111.598 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.6 mm100 -115.89 148.77 39.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.8 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.515 ' CE1' ' CZ ' ' A' ' 88' ' ' TYR . 3.7 m-85 -82.07 128.97 34.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.21 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.424 ' CE2' ' HB2' ' A' ' 80' ' ' GLU . 28.4 m-85 -130.72 156.38 45.04 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.609 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.419 ' HB ' ' HA ' ' A' ' 140' ' ' MET . 0.5 OUTLIER -142.95 162.31 17.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.935 179.885 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -64.0 -163.45 0.61 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.344 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.41 ' HB3' ' HB2' ' A' ' 77' ' ' HIS . 4.7 pt-20 -73.26 -8.85 57.59 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.595 0.236 . . . . 0.0 111.511 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 18.3 m-80 -98.5 -29.1 13.29 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.597 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' MET . . . . . 0.419 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 31.7 mtm 55.44 42.24 30.15 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.905 0.383 . . . . 0.0 111.02 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . 0.401 ' N ' ' OD1' ' A' ' 141' ' ' ASN . 16.3 p-10 -64.93 114.8 16.26 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.014 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -63.89 -28.95 67.31 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.561 2.174 . . . . 0.0 112.219 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -84.61 -14.48 48.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.169 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -73.88 -128.6 0.15 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.463 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 6.6 ptp -126.52 -172.48 2.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.792 0.329 . . . . 0.0 110.859 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 90.5 t -131.54 153.1 38.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.0 0.428 . . . . 0.0 111.355 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.403 ' CB ' ' HE2' ' A' ' 160' ' ' MET . . . -117.4 123.18 45.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.298 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.507 ' HB2' ' HB ' ' A' ' 161' ' ' ILE . 2.5 mt -96.94 106.26 18.56 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.748 -178.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -90.63 119.31 30.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.698 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.489 ' HB3' ' CZ ' ' A' ' 159' ' ' TYR . 12.6 t70 -132.21 164.33 26.61 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.676 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -109.49 150.6 27.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.228 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.82 -176.86 3.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.843 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -56.71 -33.05 66.1 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.929 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -72.21 -15.13 61.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.16 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 65.75 14.64 60.96 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.771 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 94.0 t -112.23 -69.72 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.898 0.38 . . . . 0.0 110.813 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 95.6 m -58.34 109.56 1.92 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.024 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -84.41 130.26 4.53 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.542 2.161 . . . . 0.0 112.244 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.489 ' CZ ' ' HB3' ' A' ' 150' ' ' ASP . 9.7 p90 -124.16 132.86 53.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.868 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' MET . . . . . 0.403 ' HE2' ' CB ' ' A' ' 147' ' ' ALA . 24.4 mtp -104.4 141.09 36.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.133 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.507 ' HB ' ' HB2' ' A' ' 148' ' ' LEU . 82.5 mt -97.07 116.17 38.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.193 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -113.69 156.08 24.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.511 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -99.92 126.54 46.07 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.94 0.4 . . . . 0.0 110.974 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 16.4 ttpp -69.17 -53.48 19.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.312 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.443 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 73.3 m-20 -51.39 -38.87 55.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.046 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -95.8 25.09 26.7 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.33 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -138.96 148.34 43.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.698 0.285 . . . . 0.0 110.83 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -112.0 150.61 30.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.106 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' MET . . . . . 0.432 ' HG2' HG12 ' A' ' 2' ' ' ILE . 2.1 mtm -124.66 122.82 38.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.622 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -140.76 118.38 11.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.12 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 2' ' ' ILE . 0.7 OUTLIER -71.23 112.15 7.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.92 -179.95 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.28 -172.81 3.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.928 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -133.64 33.9 3.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.795 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.28 -0.866 . . . . 0.0 110.878 -179.969 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.814 0.34 . . . . 0.0 111.176 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.477 HG12 ' CG ' ' A' ' 169' ' ' MET . 1.1 tt -106.83 142.55 19.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.908 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.489 ' O ' ' HA ' ' A' ' 169' ' ' MET . 8.1 mm -107.76 121.04 60.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.341 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.491 ' CG ' ' CE2' ' A' ' 14' ' ' PHE . 11.0 m-85 -91.21 130.3 37.1 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.919 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 17.7 ptt180 -139.22 143.32 37.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.133 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.417 ' O ' ' HA ' ' A' ' 10' ' ' HIS . 36.1 t0 -50.56 151.81 2.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.966 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 66.4 tp -80.69 -25.49 38.14 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.361 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.6 mp -91.3 -43.58 14.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.812 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.3 t -90.62 -30.82 16.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.814 0.34 . . . . 0.0 111.399 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.417 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER 66.49 29.37 9.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.918 -179.78 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -104.92 127.2 52.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.668 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -57.2 97.5 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.156 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 12.5 mtp -83.77 -15.57 47.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.972 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.491 ' CE2' ' CG ' ' A' ' 4' ' ' TYR . 44.8 p90 -178.8 161.36 1.23 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.805 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.2 m -126.37 -169.82 2.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.607 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.406 ' HB2' HG21 ' A' ' 2' ' ' ILE . 38.7 t70 -93.8 30.26 1.86 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.02 0.438 . . . . 0.0 110.952 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 46.2 pt -92.39 -10.52 9.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.573 179.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.442 ' CZ ' HG21 ' A' ' 72' ' ' ILE . 46.6 m-85 -111.54 -167.02 1.13 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.645 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.3 mtpt -97.52 87.57 4.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.797 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.2 mp -88.01 134.1 28.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.042 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -128.22 152.7 47.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.755 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -97.7 121.92 40.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.976 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.8 pt -119.1 166.28 13.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.119 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 57.65 30.31 18.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.217 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 63.18 40.77 8.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.307 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.5 -16.65 60.66 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.652 -0.785 . . . . 0.0 113.068 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.87 -34.22 62.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.823 0.312 . . . . 0.0 111.035 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 12.1 m -146.31 161.19 40.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.938 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -126.61 129.77 49.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.777 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -94.06 119.92 33.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.21 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 17.5 t -102.12 112.16 34.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.699 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -91.58 116.11 28.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.125 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -94.71 -127.38 5.0 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.365 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.3 ptpt -174.38 122.75 0.29 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.79 0.329 . . . . 0.0 110.944 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 86.7 mtp -70.76 123.32 21.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.787 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 m -117.89 127.71 75.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.134 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.7 p -97.56 163.12 12.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.932 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.552 ' HB3' HG12 ' A' ' 67' ' ' ILE . 58.3 ttt180 -141.6 116.02 9.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.821 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.6 m -141.26 29.38 1.81 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.865 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -153.94 -66.23 0.14 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.886 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 137.43 -91.62 0.21 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.602 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -178.02 -38.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.823 0.344 . . . . 0.0 110.939 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.7 mt 70.78 69.68 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.107 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -178.05 -39.63 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.743 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 62.66 86.81 0.11 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.049 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.3 t -98.02 -62.47 1.24 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.727 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 5.9 mt -107.08 -61.76 1.5 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.829 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 47.0 mm 60.97 -80.4 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.288 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.68 138.48 9.42 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.504 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -69.57 -161.91 3.1 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.527 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -136.68 99.82 4.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.827 0.346 . . . . 0.0 110.865 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -130.7 31.71 4.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.101 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.1 p -102.08 -47.91 4.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.932 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 60.92 157.55 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.081 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -176.19 142.23 0.47 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.866 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -76.26 -77.87 0.73 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.485 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -66.12 66.83 0.45 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.828 2.352 . . . . 0.0 112.213 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -162.36 30.18 0.11 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.897 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -96.43 55.49 1.46 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.519 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -61.52 -37.8 85.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.798 0.332 . . . . 0.0 110.866 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 79.86 -149.69 31.69 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.514 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 60.61 157.88 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.748 0.308 . . . . 0.0 110.897 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -103.82 -68.22 0.85 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.854 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -59.76 88.21 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.792 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.8 m -102.05 152.25 21.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.03 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 48.0 t -124.35 143.75 36.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.997 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.552 HG12 ' HB3' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -137.85 127.9 36.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.058 -179.987 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.2 m -139.42 125.68 20.14 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.9 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -161.81 -177.01 34.51 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.286 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.419 ' CG1' HG12 ' A' ' 72' ' ' ILE . 57.1 t -69.49 144.93 13.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.837 0.351 . . . . 0.0 110.909 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -70.14 -57.03 5.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.479 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.444 ' O ' ' HB2' ' A' ' 76' ' ' HIS . 5.6 pt -53.52 -33.78 22.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.315 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.411 ' CG1' ' HB2' ' A' ' 78' ' ' LEU . 74.4 t -72.39 -34.58 49.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.087 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.7 mtm -78.24 -37.23 45.72 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.925 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 16.9 p30 -82.08 -31.59 30.72 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.451 ' CE1' ' HA ' ' A' ' 14' ' ' PHE . 42.0 m80 -93.58 -2.72 53.84 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.051 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 17.9 m80 61.03 36.57 18.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.164 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.411 ' HB2' ' CG1' ' A' ' 73' ' ' VAL . 28.8 mt -57.59 156.17 8.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.463 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -132.72 135.22 45.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.841 0.353 . . . . 0.0 111.174 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.431 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 5.6 tt0 -101.19 122.5 43.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.822 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.1 t -115.08 153.21 31.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.931 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 29.3 p -88.58 161.5 16.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.914 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.44 ' HB2' ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -165.27 156.21 14.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.874 -179.988 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -99.66 174.05 6.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.904 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -70.3 -52.37 23.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.88 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.98 -43.0 97.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.85 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.15 -42.66 91.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.037 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.517 ' CZ ' ' CE1' ' A' ' 134' ' ' PHE . 0.1 OUTLIER -59.12 -34.94 72.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.862 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 22.8 mttm -59.53 -46.16 89.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.126 0.489 . . . . 0.0 110.413 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt -77.08 -27.83 54.39 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.783 178.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -67.75 -44.1 78.31 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.876 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.419 HD13 ' CE2' ' A' ' 95' ' ' TYR . 6.1 tp -63.74 -42.58 96.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.911 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.401 ' N ' HG23 ' A' ' 92' ' ' ILE . 5.2 ttpm? -63.45 -37.44 87.28 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.781 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.467 ' HA ' ' HG2' ' A' ' 97' ' ' LYS . 12.4 t70 -77.04 -41.5 42.29 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.7 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.457 ' CD1' ' C ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -77.32 -40.08 45.47 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 121.155 -0.218 . . . . 0.0 110.752 -179.591 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.405 ' HG3' ' N ' ' A' ' 97' ' ' LYS . 0.3 OUTLIER -67.58 -32.1 72.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.645 0.26 . . . . 0.0 110.599 179.522 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.467 ' HG2' ' HA ' ' A' ' 94' ' ' ASP . 0.0 OUTLIER -70.2 -34.44 72.94 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.879 0.371 . . . . 0.0 110.491 179.756 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.443 ' N ' ' HG3' ' A' ' 97' ' ' LYS . 2.0 m -61.04 -40.18 92.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.046 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 7.2 mt -79.82 -42.36 22.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.504 179.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.406 ' O ' ' HG3' ' A' ' 104' ' ' GLU . 12.7 tmtt? -54.43 -55.23 30.91 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.523 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -60.86 -44.8 97.63 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.247 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.27 -41.29 96.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.885 0.374 . . . . 0.0 110.492 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.446 ' O ' ' N ' ' A' ' 107' ' ' ARG . 3.3 tp -68.24 -32.82 73.29 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.169 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.406 ' HG3' ' O ' ' A' ' 100' ' ' LYS . 74.6 mt-10 -60.21 -29.66 68.88 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.934 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -88.11 -20.81 25.17 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.569 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -103.74 -57.73 1.99 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.791 0.329 . . . . 0.0 111.665 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.446 ' N ' ' O ' ' A' ' 103' ' ' LEU . 44.7 mtt85 -139.19 68.16 40.35 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.786 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.404 ' O ' ' CG2' ' A' ' 111' ' ' VAL . 9.9 Cg_endo -50.66 -21.39 7.84 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 123.234 2.623 . . . . 0.0 112.968 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -68.95 -9.99 54.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.591 0.234 . . . . 0.0 111.403 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.406 ' C ' ' HD2' ' A' ' 113' ' ' PRO . 0.7 OUTLIER -111.99 -3.01 14.91 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 -179.492 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.404 ' CG2' ' O ' ' A' ' 108' ' ' PRO . 33.9 m -71.26 -26.93 27.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.641 0.258 . . . . 0.0 111.516 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.549 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -69.38 -55.8 9.21 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.517 -179.279 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.549 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 33.4 Cg_exo -56.92 -37.61 97.89 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.084 1.856 . . . . 0.0 111.739 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.446 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 82.5 t80 -66.64 -37.63 85.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.076 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 6.1 mtp -57.03 -54.68 44.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.956 0.407 . . . . 0.0 110.737 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 75.1 m -72.9 -44.73 60.92 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.696 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.97 -38.24 95.15 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.498 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.96 -51.69 68.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.973 0.416 . . . . 0.0 110.926 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.99 -28.2 63.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.251 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -75.6 -41.21 55.11 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.109 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -74.38 -34.85 63.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.901 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.455 ' CG2' ' N ' ' A' ' 123' ' ' LYS . 0.4 OUTLIER -69.95 -45.9 75.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.205 -179.877 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.455 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 5.4 pttp -61.11 -31.83 71.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.993 0.425 . . . . 0.0 110.275 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -67.51 -53.51 28.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.698 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 15.5 pt -62.12 -42.12 93.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.288 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 11.7 mt -53.99 -35.22 61.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.88 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -70.1 -11.29 60.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.296 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -142.49 33.28 1.46 Allowed 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.968 0.413 . . . . 0.0 110.588 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.497 ' CE1' ' CZ ' ' A' ' 134' ' ' PHE . 12.4 t80 -49.71 -26.79 4.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.24 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.91 -29.37 69.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.05 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 28.5 m-20 -94.21 -29.86 14.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.451 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.425 ' CD2' ' OD1' ' A' ' 150' ' ' ASP . 2.5 m-85 -98.47 138.41 35.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.877 0.37 . . . . 0.0 111.295 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -123.07 144.1 49.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.721 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.517 ' CE1' ' CZ ' ' A' ' 88' ' ' TYR . 3.2 m-85 -82.09 123.75 29.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.118 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.431 ' CE2' ' HB2' ' A' ' 80' ' ' GLU . 25.4 m-85 -127.86 140.74 51.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.599 179.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.44 HD11 HG22 ' A' ' 136' ' ' ILE . 0.5 OUTLIER -131.29 160.99 41.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.691 -179.981 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -57.37 -169.58 0.14 Allowed Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.524 -0.846 . . . . 0.0 111.879 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.05 -8.91 57.28 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.582 0.23 . . . . 0.0 111.329 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 26.7 m-80 -94.31 -30.28 14.61 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.41 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' MET . . . . . 0.415 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 70.7 mtm 55.84 44.51 25.85 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.773 0.32 . . . . 0.0 111.256 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.67 117.38 50.16 Favored Pre-proline 0 N--CA 1.453 -0.296 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.625 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -63.2 -23.23 72.82 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.323 2.015 . . . . 0.0 111.854 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -84.72 -15.4 45.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.646 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -77.78 -159.7 12.47 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.276 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 3.6 ptp -98.75 -174.4 2.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.793 0.33 . . . . 0.0 110.796 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 49.1 t -128.83 152.47 37.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.165 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -114.64 119.23 36.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.656 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.493 ' HB2' ' HB ' ' A' ' 161' ' ' ILE . 3.0 mt -93.48 106.29 18.27 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.192 -179.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.0 tp -90.82 119.12 30.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.149 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.451 ' CB ' ' CE1' ' A' ' 159' ' ' TYR . 0.9 OUTLIER -125.99 159.5 32.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.745 179.7 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -109.7 138.13 46.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.887 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.93 -173.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.784 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.3 -41.07 83.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.905 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -67.87 -15.1 63.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.163 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 68.71 20.04 73.75 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.69 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 94.2 t -112.85 -70.04 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.859 0.362 . . . . 0.0 110.751 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 88.7 m -57.59 108.91 1.42 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.891 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -86.71 127.86 2.78 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.723 2.282 . . . . 0.0 112.44 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.451 ' CE1' ' CB ' ' A' ' 150' ' ' ASP . 16.0 p90 -121.67 132.15 54.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.797 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' MET . . . . . 0.463 ' HE2' ' CZ ' ' A' ' 162' ' ' PHE . 0.9 OUTLIER -101.8 140.87 35.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.071 -179.818 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.493 ' HB ' ' HB2' ' A' ' 148' ' ' LEU . 57.4 mt -96.77 121.61 47.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.242 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.463 ' CZ ' ' HE2' ' A' ' 160' ' ' MET . 43.0 m-85 -119.63 156.49 30.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.698 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -102.16 118.63 37.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.858 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 40.9 tttt -61.12 -49.98 75.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.235 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.446 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 32.5 m-20 -55.26 -40.34 70.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.243 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -95.74 25.18 26.22 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.66 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.416 HD11 ' CE1' ' A' ' 14' ' ' PHE . 4.9 tt -150.19 148.71 29.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.88 0.372 . . . . 0.0 110.949 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -133.95 150.61 51.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.395 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' MET . . . . . 0.489 ' HA ' ' O ' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -135.47 160.25 39.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.805 0.336 . . . . 0.0 111.261 -179.796 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.404 ' C ' HG13 ' A' ' 2' ' ' ILE . 1.0 OUTLIER -146.85 144.61 29.43 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.547 -179.033 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.82 109.06 15.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.095 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 1.5 m 63.35 124.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.005 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 4.1 mt -93.17 165.29 12.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.821 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.976 179.949 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.854 0.359 . . . . 0.0 111.113 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.452 ' CG2' ' CE1' ' A' ' 4' ' ' TYR . 1.0 OUTLIER -113.91 142.11 27.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.082 179.924 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.497 ' O ' ' HA ' ' A' ' 169' ' ' MET . 10.1 mm -103.39 119.54 52.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.981 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.452 ' CE1' ' CG2' ' A' ' 2' ' ' ILE . 17.4 m-85 -93.44 128.98 39.75 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.93 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.9 ptt-85 -136.31 144.77 44.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.969 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -52.53 138.01 28.88 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.833 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 59.9 tp -71.34 -23.65 61.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.291 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.3 mp -91.2 -43.64 14.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.805 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.8 m -90.28 -29.4 18.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.391 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 32.3 m80 68.28 30.25 5.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.858 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -111.03 126.21 54.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.655 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -56.0 112.92 1.32 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.266 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 7.2 mtt -96.37 -16.61 21.17 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.908 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.429 ' HA ' ' CE1' ' A' ' 76' ' ' HIS . 37.8 p90 179.9 152.99 0.48 Allowed 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 120.875 0.369 . . . . 0.0 111.0 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -112.86 -169.8 1.55 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.417 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.413 ' HB2' HG23 ' A' ' 2' ' ' ILE . 31.2 t70 -94.98 34.6 1.35 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.948 0.404 . . . . 0.0 110.819 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.425 HG13 ' CD2' ' A' ' 18' ' ' TYR . 41.6 pt -95.43 -7.81 9.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.742 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.432 ' CZ ' HG22 ' A' ' 72' ' ' ILE . 37.2 m-85 -113.63 -167.38 1.19 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.696 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.52 86.95 3.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.855 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.6 mp -89.77 124.01 42.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.086 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -118.16 140.25 50.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.987 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -84.57 116.06 22.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.76 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.6 pt -113.4 166.85 6.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.13 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 59.53 30.57 20.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.086 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 64.83 47.24 2.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.332 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.91 -8.32 73.55 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.718 -0.753 . . . . 0.0 113.358 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.95 -52.36 65.36 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.818 0.342 . . . . 0.0 111.071 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 11.7 m -125.98 163.53 22.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.067 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -126.42 133.45 51.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.735 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -99.83 112.94 25.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.05 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.4 t -92.35 111.94 25.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.697 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -87.78 110.91 20.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.17 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -95.68 -133.55 7.47 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.29 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.4 pttt -174.46 123.99 0.29 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.882 0.373 . . . . 0.0 110.884 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 71.3 mtm -70.91 112.63 7.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.815 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.0 m -95.65 163.58 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.153 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 79.0 p -125.34 165.63 18.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.697 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.501 ' HB3' HG12 ' A' ' 67' ' ' ILE . 18.0 ttm180 -143.05 116.46 9.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.866 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.9 m -143.59 90.42 2.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.835 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -81.03 -176.35 5.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.915 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -130.83 -142.75 5.16 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.538 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -134.45 165.88 24.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.844 0.354 . . . . 0.0 110.86 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 4.6 mt -92.6 153.58 3.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.075 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 62.01 150.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.93 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 59.83 79.21 0.24 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.947 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.3 m -100.81 -47.44 4.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.89 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.45 -30.93 67.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.982 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 33.2 mm -69.45 123.55 23.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.172 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -100.49 172.55 24.13 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.441 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -84.98 131.88 10.72 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.573 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -83.42 153.9 24.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.802 0.334 . . . . 0.0 110.942 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 60.15 92.03 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.091 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.2 p -118.12 -178.65 3.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.864 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -160.93 -45.45 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.152 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.88 146.28 32.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.865 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.07 -91.91 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.51 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.5 134.4 52.33 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.58 2.187 . . . . 0.0 112.311 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -134.24 125.39 27.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.878 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 177.38 39.64 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.448 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -90.12 97.3 11.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.825 0.345 . . . . 0.0 110.996 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 121.66 -98.29 0.64 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.536 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 18.6 p -137.07 -168.49 2.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.887 0.375 . . . . 0.0 110.854 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 61.36 105.45 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.865 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.66 121.48 1.12 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.904 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.4 t -97.98 27.67 4.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.052 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.5 t -105.82 135.72 42.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.064 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.501 HG12 ' HB3' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -123.09 129.55 74.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.187 -179.921 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 85.2 m -139.57 141.05 37.21 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.024 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 179.71 -179.46 48.83 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.407 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.469 ' CG1' HG12 ' A' ' 72' ' ' ILE . 46.2 t -72.59 135.4 27.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.808 0.337 . . . . 0.0 110.662 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -64.05 -54.76 29.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.782 -179.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.469 HG12 ' CG1' ' A' ' 70' ' ' VAL . 8.1 pt -53.85 -33.93 24.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.907 0.384 . . . . 0.0 111.267 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 84.2 t -73.59 -35.0 43.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.906 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 5.0 mtm -78.3 -38.83 41.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.788 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.402 ' OD1' ' CD2' ' A' ' 76' ' ' HIS . 22.3 p30 -82.1 -29.44 31.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.655 -179.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.438 ' CE1' ' HB ' ' A' ' 72' ' ' ILE . 26.2 m170 -92.55 -2.58 56.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.775 0.322 . . . . 0.0 110.806 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.482 ' HB2' ' HB3' ' A' ' 138' ' ' GLU . 49.5 m80 59.28 35.12 23.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.043 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 41.5 mt -61.13 141.15 57.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.515 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -120.83 132.33 54.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.011 -179.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.42 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 10.1 tt0 -91.04 124.48 35.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.91 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.4 t -117.23 172.33 7.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.835 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.6 p -107.24 170.69 7.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.006 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.478 ' CE2' ' CE2' ' A' ' 91' ' ' TYR . 0.6 OUTLIER -171.65 152.43 3.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.859 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.8 m -99.87 158.09 16.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.839 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 33.8 mtmt -57.69 -52.5 65.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.917 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.9 tm-20 -65.88 -45.0 83.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.727 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.66 -33.88 72.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.059 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.473 ' CD2' HD12 ' A' ' 122' ' ' ILE . 0.7 OUTLIER -65.03 -37.42 87.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.713 179.902 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 50.4 mttm -58.19 -45.51 87.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.099 0.476 . . . . 0.0 110.333 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.7 mmtp -76.66 -27.8 55.75 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.742 178.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.478 ' CE2' ' CE2' ' A' ' 83' ' ' PHE . 8.4 t80 -67.61 -45.38 75.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.76 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.432 HD13 ' CE2' ' A' ' 95' ' ' TYR . 5.2 tp -61.74 -42.2 93.45 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 CA-C-O 120.888 0.375 . . . . 0.0 110.82 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.494 ' O ' ' CG ' ' A' ' 97' ' ' LYS . 3.6 ttpm? -63.39 -44.9 93.37 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.812 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -70.29 -38.9 75.1 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.866 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.495 ' CD1' ' C ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -78.12 -42.94 30.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.694 -0.23 . . . . 0.0 110.648 -179.513 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.406 ' HG3' ' N ' ' A' ' 97' ' ' LYS . 0.1 OUTLIER -62.72 -31.85 72.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.865 0.364 . . . . 0.0 110.078 179.098 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.494 ' CG ' ' O ' ' A' ' 93' ' ' LYS . 2.5 mmtp -65.73 -43.83 87.84 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.595 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.6 m -54.36 -40.47 68.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.601 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 7.8 mt -79.92 -43.13 22.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.678 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 15.0 tttt -53.19 -55.86 20.98 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.559 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -62.49 -45.07 96.64 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.308 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.78 -37.47 84.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.847 0.355 . . . . 0.0 110.465 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.434 ' O ' ' N ' ' A' ' 107' ' ' ARG . 2.8 tp -70.94 -32.08 68.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.135 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -60.59 -30.25 69.7 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.872 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -89.68 -20.04 24.12 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.543 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -106.01 -62.8 1.33 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.816 0.341 . . . . 0.0 111.413 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.434 ' N ' ' O ' ' A' ' 103' ' ' LEU . 16.7 mtt180 -127.53 63.58 59.85 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.891 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -50.86 -21.92 9.19 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 123.145 2.563 . . . . 0.0 112.82 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -71.35 -11.29 60.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.673 -0.24 . . . . 0.0 111.467 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.52 ' C ' ' HD2' ' A' ' 113' ' ' PRO . 0.0 OUTLIER -112.26 1.06 15.97 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 -179.289 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 34.4 m -68.36 -35.72 71.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.565 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 18.4 mttt -68.69 -50.6 24.12 Favored Pre-proline 0 C--N 1.331 -0.209 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.609 -179.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.565 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 32.3 Cg_exo -57.98 -33.24 96.94 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.11 1.873 . . . . 0.0 111.813 179.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.441 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 86.3 t80 -69.71 -41.72 75.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.15 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -55.45 -49.27 72.91 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.928 0.394 . . . . 0.0 110.871 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 82.4 m -70.98 -44.36 66.12 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.725 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.03 -39.21 97.77 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.644 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.88 -51.54 69.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.94 0.4 . . . . 0.0 111.161 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.1 -28.29 66.36 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.306 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.07 -58.86 3.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.24 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -56.03 -42.66 76.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.218 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.473 HD12 ' CD2' ' A' ' 88' ' ' TYR . 0.3 OUTLIER -61.62 -45.54 98.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.193 -179.828 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.44 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 12.5 mttm -59.98 -31.9 70.34 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.179 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -67.56 -54.52 19.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.806 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 11.9 pt -61.04 -40.77 86.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.218 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.407 ' HG ' ' CD1' ' A' ' 122' ' ' ILE . 11.8 mt -53.95 -37.59 64.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.705 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.6 -15.04 60.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.269 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -138.59 34.6 2.23 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.1 0.476 . . . . 0.0 110.423 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -48.09 -43.34 30.65 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.295 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.3 mmmp? -62.13 -19.88 63.5 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.302 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -93.99 -41.09 9.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.724 0.297 . . . . 0.0 111.317 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.413 ' CD2' ' OD1' ' A' ' 150' ' ' ASP . 3.9 m-85 -89.0 145.31 25.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.126 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.6 mm100 -122.31 145.92 47.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.807 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.456 ' CE2' ' HB2' ' A' ' 83' ' ' PHE . 2.9 m-85 -86.37 129.47 34.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.118 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.42 ' CE2' ' HB2' ' A' ' 80' ' ' GLU . 51.8 m-85 -130.98 132.25 44.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.769 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.44 ' HB ' ' HA ' ' A' ' 140' ' ' MET . 0.4 OUTLIER -121.84 159.31 24.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.681 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -56.67 -171.96 0.16 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.428 -0.891 . . . . 0.0 111.844 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.482 ' HB3' ' HB2' ' A' ' 77' ' ' HIS . 0.0 OUTLIER -70.68 -8.93 55.6 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.571 0.224 . . . . 0.0 111.42 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -93.65 -26.91 16.85 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.673 0.273 . . . . 0.0 111.108 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' MET . . . . . 0.44 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 52.0 mtm 51.62 43.96 29.47 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.442 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -68.77 120.04 73.22 Favored Pre-proline 0 N--CA 1.452 -0.335 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.595 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -60.08 -26.39 82.35 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.279 1.986 . . . . 0.0 111.856 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -84.71 -15.86 43.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.739 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.17 -168.34 10.77 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.404 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 2.0 ptp -93.2 -177.33 4.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.819 0.342 . . . . 0.0 110.811 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 74.8 t -126.64 145.26 34.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.11 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -112.08 112.27 23.78 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.567 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.522 ' HB2' ' HB ' ' A' ' 161' ' ' ILE . 4.9 mt -86.76 108.28 18.63 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.193 -179.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.5 tp -91.03 119.54 31.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.122 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.44 ' HB3' ' CE1' ' A' ' 159' ' ' TYR . 0.5 OUTLIER -133.08 174.52 10.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.642 179.55 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -117.26 143.68 45.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.846 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 11.8 mmm180 -56.78 -175.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.058 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -56.3 -31.46 63.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.9 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -78.48 -15.01 59.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.153 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 70.67 21.74 77.89 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.66 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 89.1 t -112.47 -69.2 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.861 0.362 . . . . 0.0 110.823 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 91.0 m -57.61 109.17 1.58 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.945 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -81.24 127.3 5.89 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.484 2.123 . . . . 0.0 112.331 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.44 ' CE1' ' HB3' ' A' ' 150' ' ' ASP . 13.0 p90 -125.35 148.28 48.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.755 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' MET . . . . . 0.416 ' HE3' ' CG ' ' A' ' 135' ' ' PHE . 0.4 OUTLIER -111.69 142.86 43.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.028 -179.756 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.522 ' HB ' ' HB2' ' A' ' 148' ' ' LEU . 41.9 mt -99.08 120.44 48.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.24 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -125.93 150.17 48.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.643 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -97.45 119.16 35.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.898 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 43.1 tttt -56.27 -53.94 51.28 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.334 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.441 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 44.9 m-20 -53.82 -37.49 63.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.19 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -95.27 24.42 29.07 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.57 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.426 HD13 ' CE1' ' A' ' 14' ' ' PHE . 5.8 tt -150.15 140.11 21.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.842 0.353 . . . . 0.0 110.74 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -120.16 142.96 48.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.58 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' MET . . . . . 0.497 ' HA ' ' O ' ' A' ' 3' ' ' ILE . 0.1 OUTLIER -136.73 160.2 39.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.735 0.302 . . . . 0.0 111.145 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.403 ' O ' HG13 ' A' ' 2' ' ' ILE . 1.5 pt-20 -146.97 143.26 28.32 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.366 -179.102 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 2' ' ' ILE . 18.7 mttm -82.41 109.04 16.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.919 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 7.4 t -113.52 108.8 17.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.79 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.21 150.77 20.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.945 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.92 -179.97 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.8 ttt . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.836 0.351 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.458 HG21 ' HB2' ' A' ' 16' ' ' ASP . 1.8 tt -140.51 148.3 22.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.055 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.9 mm -102.14 146.5 10.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.877 0.37 . . . . 0.0 111.518 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.518 ' CD2' ' CZ ' ' A' ' 14' ' ' PHE . 4.9 m-85 -115.96 100.15 7.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.422 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 1.1 ptt180 -116.34 147.9 41.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.881 0.372 . . . . 0.0 111.344 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.452 ' O ' ' HA ' ' A' ' 10' ' ' HIS . 44.7 t0 -57.04 152.17 13.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.749 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 59.0 tp -81.32 -21.09 39.46 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.53 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.3 mp -91.29 -47.77 14.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.0 t -96.41 -17.54 20.53 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -179.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.452 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 0.3 OUTLIER 61.98 28.59 17.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.855 0.359 . . . . 0.0 110.774 -179.727 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -98.17 121.71 40.44 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.762 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.17 93.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.282 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 7.7 mtt -71.87 -19.44 61.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.664 179.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.518 ' CZ ' ' CD2' ' A' ' 4' ' ' TYR . 7.4 p90 -177.86 176.86 1.14 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.667 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -133.71 -169.99 2.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.953 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.458 ' HB2' HG21 ' A' ' 2' ' ' ILE . 22.6 t70 -94.42 25.08 4.08 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.98 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.427 HG13 ' CD2' ' A' ' 18' ' ' TYR . 20.8 pt -82.39 -15.49 11.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.525 179.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.437 ' CZ ' HG21 ' A' ' 72' ' ' ILE . 78.4 m-85 -108.84 -174.45 2.52 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.516 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.1 mttp -94.66 88.53 5.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.849 0.357 . . . . 0.0 110.718 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.1 mp -87.94 132.5 32.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.167 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 8.0 mtt180 -124.68 139.68 53.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.807 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.49 122.32 28.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.996 0.427 . . . . 0.0 110.943 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.9 pt -117.37 167.47 10.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.027 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 60.08 27.09 16.5 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.072 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 66.92 55.96 0.7 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.338 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 77.12 0.34 70.07 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 120.853 -0.689 . . . . 0.0 113.422 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.44 -58.23 3.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 117.082 0.441 . . . . 0.0 111.04 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 35.2 m -118.95 164.82 14.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.997 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -126.32 133.18 51.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.862 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -99.06 112.83 24.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.968 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 26.1 t -92.04 111.86 24.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.625 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -80.88 114.08 19.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.252 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -99.19 -141.46 12.27 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.214 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -174.42 126.88 0.33 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.823 0.344 . . . . 0.0 110.978 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 27.7 mtp -68.36 122.58 18.68 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.522 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.1 m -111.97 116.1 51.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.465 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.4 p -84.07 165.79 18.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.999 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.472 ' N ' ' O ' ' A' ' 67' ' ' ILE . 1.8 mmt-85 -128.12 116.34 19.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.621 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -105.38 33.46 3.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.758 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -93.95 97.71 10.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.876 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -133.71 178.07 18.58 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.483 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -80.53 104.58 11.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.875 0.369 . . . . 0.0 110.897 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 31.9 mt 63.81 143.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.116 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -95.48 -69.51 0.75 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.877 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -155.03 178.82 9.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.959 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 85.8 p -80.93 -33.17 34.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.953 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.1 mt -75.55 -30.61 59.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.894 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -111.58 103.3 15.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.984 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -155.04 90.6 0.12 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.481 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -156.02 81.85 0.16 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.543 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -172.22 -179.78 2.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.869 0.366 . . . . 0.0 110.868 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.87 163.95 23.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.132 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -107.67 169.93 8.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.873 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -156.56 162.59 39.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.093 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -82.92 -31.13 27.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.957 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 79.27 -148.67 31.44 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.483 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -51.39 147.44 22.06 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.583 2.189 . . . . 0.0 112.346 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -110.51 36.39 3.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.945 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -124.66 -129.54 3.41 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.506 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -120.22 -50.36 2.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.859 0.362 . . . . 0.0 110.91 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -149.49 28.24 1.2 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.549 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 68.5 p -87.54 91.53 8.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.824 0.345 . . . . 0.0 110.87 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -115.89 145.15 43.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.914 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.1 m -102.95 -31.78 10.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.765 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 92.3 m 63.39 -79.96 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.075 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 42.0 t -127.07 145.33 34.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.083 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.472 ' O ' ' N ' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -135.62 130.48 49.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.953 179.715 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 86.5 m -139.15 139.9 37.72 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.036 0.446 . . . . 0.0 111.146 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -175.42 179.43 46.65 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.047 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.468 ' CG1' HG12 ' A' ' 72' ' ' ILE . 40.8 t -73.2 130.32 35.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.887 0.375 . . . . 0.0 110.847 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -59.26 -55.3 36.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.64 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.468 HG12 ' CG1' ' A' ' 70' ' ' VAL . 6.9 pt -54.01 -36.72 32.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.544 -179.386 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 97.2 t -70.37 -31.47 46.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.197 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.5 mtm -78.22 -40.47 37.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.786 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.418 ' OD1' ' CD2' ' A' ' 76' ' ' HIS . 0.3 OUTLIER -82.0 -29.33 32.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.546 -179.23 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.442 ' CE1' ' HB ' ' A' ' 72' ' ' ILE . 29.6 m170 -89.95 -5.11 57.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.869 0.366 . . . . 0.0 110.752 179.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.401 ' HB2' ' HB3' ' A' ' 138' ' ' GLU . 28.6 m-70 61.74 28.42 17.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.916 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.403 ' CD1' ' CE ' ' A' ' 160' ' ' MET . 34.2 mt -59.87 152.87 22.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.588 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -138.73 145.84 40.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.799 0.333 . . . . 0.0 111.175 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.418 ' HB2' ' CZ ' ' A' ' 135' ' ' PHE . 0.2 OUTLIER -99.41 133.18 44.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.079 -179.924 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.7 t -117.15 166.9 11.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.755 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 66.8 m -98.38 158.28 15.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.04 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.427 ' HB2' ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -171.78 150.1 2.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.823 179.934 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 54.7 p -99.92 169.61 9.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.821 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -63.17 -52.44 62.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.923 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -60.67 -45.41 94.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.921 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.407 ' HB3' ' CE1' ' A' ' 83' ' ' PHE . . . -59.78 -41.12 90.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.962 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.508 ' CZ ' ' CE1' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -58.03 -36.14 72.29 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.894 179.938 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 36.3 mttm -60.12 -51.11 71.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.069 0.461 . . . . 0.0 110.482 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.1 mttm -72.93 -27.7 62.0 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.591 178.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -64.23 -48.03 77.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.975 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.459 ' CD1' ' CE2' ' A' ' 95' ' ' TYR . 3.1 tp -61.43 -41.91 91.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.733 0.301 . . . . 0.0 111.174 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.445 ' O ' ' CG ' ' A' ' 97' ' ' LYS . 4.6 ttmt -61.17 -46.08 91.98 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.969 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -70.79 -36.86 73.22 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.93 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.532 ' CD1' ' C ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -76.34 -43.11 42.56 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 121.189 -0.205 . . . . 0.0 110.744 -179.544 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.3 ptp -65.07 -32.03 73.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.92 0.391 . . . . 0.0 110.279 179.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.445 ' CG ' ' O ' ' A' ' 93' ' ' LYS . 0.1 OUTLIER -64.01 -44.2 93.33 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.867 179.751 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.4 m -56.47 -43.2 79.38 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.874 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 6.5 mt -79.85 -40.59 20.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.682 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.2 tttt -55.09 -53.47 55.51 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.574 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -62.94 -46.42 93.61 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.334 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.1 tppm? -60.53 -40.85 92.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.858 0.361 . . . . 0.0 110.422 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.429 ' O ' ' N ' ' A' ' 107' ' ' ARG . 3.0 tp -66.52 -35.25 79.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.26 179.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 108' ' ' PRO . 36.2 mt-10 -59.13 -29.38 67.35 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.684 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -88.52 -18.69 27.62 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.617 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -108.56 -61.8 1.55 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.838 0.351 . . . . 0.0 111.586 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.429 ' N ' ' O ' ' A' ' 103' ' ' LEU . 19.9 mtt85 -130.1 65.07 74.6 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.777 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.408 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 9.4 Cg_endo -50.54 -23.33 10.55 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 123.087 2.525 . . . . 0.0 112.652 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -69.1 -13.9 62.7 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.64 0.257 . . . . 0.0 111.15 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.408 ' C ' ' HD2' ' A' ' 113' ' ' PRO . 6.8 mmm-85 -106.21 -1.79 23.19 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -179.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.403 ' CG2' ' O ' ' A' ' 108' ' ' PRO . 24.3 m -71.37 -27.03 27.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.685 0.279 . . . . 0.0 111.521 -179.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.552 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 0.8 OUTLIER -70.37 -55.42 7.78 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.578 -179.291 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.552 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 47.1 Cg_exo -55.37 -40.88 83.2 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.182 1.922 . . . . 0.0 111.975 179.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.436 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 75.6 t80 -65.47 -38.36 89.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.166 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.05 -54.85 40.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.001 0.429 . . . . 0.0 110.926 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 62.7 m -74.37 -44.65 51.28 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.768 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.4 -41.78 98.67 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.644 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.18 -51.57 69.43 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.059 0.457 . . . . 0.0 111.072 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.15 -28.15 65.12 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.325 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -77.93 -43.65 29.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.4 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -71.27 -31.56 67.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.117 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.45 ' CG2' ' N ' ' A' ' 123' ' ' LYS . 0.4 OUTLIER -70.56 -45.93 72.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.36 -179.782 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.45 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 12.1 pttt -60.75 -31.22 70.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.067 0.461 . . . . 0.0 110.365 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -68.36 -54.05 19.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.64 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 15.2 pt -61.67 -42.61 94.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.261 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.402 ' HG ' ' CD1' ' A' ' 122' ' ' ILE . 11.4 mt -54.19 -35.48 62.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.969 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -69.89 -11.29 60.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.343 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 -142.07 32.83 1.55 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.884 0.373 . . . . 0.0 110.599 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.5 ' CE1' ' CZ ' ' A' ' 134' ' ' PHE . 4.5 t80 -52.2 -26.1 10.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.088 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 6.8 mttt -59.17 -30.43 68.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.929 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -94.28 -37.86 11.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.324 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -91.09 135.51 33.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.835 0.35 . . . . 0.0 111.21 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 -121.94 145.8 47.75 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.911 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.508 ' CE1' ' CZ ' ' A' ' 88' ' ' TYR . 1.3 m-85 -78.06 125.95 30.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.85 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.418 ' CZ ' ' HB2' ' A' ' 80' ' ' GLU . 10.7 m-85 -130.77 137.38 49.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.623 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.448 ' HB ' ' HA ' ' A' ' 140' ' ' MET . 0.9 OUTLIER -126.87 161.69 33.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.956 -179.964 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.79 -164.95 0.35 Allowed Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.44 -0.886 . . . . 0.0 111.968 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.401 ' HB3' ' HB2' ' A' ' 77' ' ' HIS . 1.2 pt-20 -72.37 -8.87 57.28 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.594 0.235 . . . . 0.0 111.507 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -96.25 -29.26 14.12 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.594 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' MET . . . . . 0.448 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 75.7 mtp 56.37 46.53 20.77 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.903 0.382 . . . . 0.0 110.997 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . 0.403 ' ND2' ' HA3' ' A' ' 144' ' ' GLY . 13.0 p-10 -69.08 114.48 23.69 Favored Pre-proline 0 N--CA 1.452 -0.338 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.951 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -66.25 -29.39 46.87 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.633 2.222 . . . . 0.0 112.245 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -84.64 -5.25 59.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.47 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.403 ' HA3' ' ND2' ' A' ' 141' ' ' ASN . . . -87.7 -143.38 8.44 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.456 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 2.8 ptp -106.22 -179.17 3.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.824 0.345 . . . . 0.0 110.863 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 53.5 t -128.52 148.2 32.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.225 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -110.67 114.78 28.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.511 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.507 ' HB2' ' HB ' ' A' ' 161' ' ' ILE . 3.8 mt -88.5 106.19 18.12 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.088 -179.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.4 tp -90.37 119.72 30.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.366 -179.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.531 ' HB3' ' CE1' ' A' ' 159' ' ' TYR . 4.7 t70 -138.54 167.41 21.99 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.533 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -105.2 151.71 23.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.865 0.364 . . . . 0.0 111.166 -179.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 12.2 mmt85 -70.31 -175.47 1.0 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.838 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -56.92 -31.05 64.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.063 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -74.43 -15.15 60.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.288 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 74.24 7.29 77.2 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.803 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 72.7 t -110.23 -66.92 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.924 0.393 . . . . 0.0 110.94 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 84.9 m -52.96 107.18 0.78 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.261 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -84.65 129.03 4.09 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.622 2.214 . . . . 0.0 112.245 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.531 ' CE1' ' HB3' ' A' ' 150' ' ' ASP . 8.4 p90 -126.51 147.04 49.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.929 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' MET . . . . . 0.403 ' CE ' ' CD1' ' A' ' 78' ' ' LEU . 0.8 OUTLIER -113.14 145.4 41.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.241 -179.659 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.507 ' HB ' ' HB2' ' A' ' 148' ' ' LEU . 85.0 mt -98.44 112.84 31.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.032 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -118.81 121.0 39.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.679 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -68.98 124.4 23.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.047 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.86 -41.98 74.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.16 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.436 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 2.1 m-20 -55.97 -29.61 60.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.919 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -108.95 29.47 9.73 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.354 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -139.48 148.43 42.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.827 0.346 . . . . 0.0 110.785 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -111.74 155.43 23.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.009 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' MET . . . . . 0.404 ' HB3' ' CD1' ' A' ' 2' ' ' ILE . 0.0 OUTLIER -125.35 137.84 54.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.875 179.998 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -151.42 127.53 10.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.963 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 14.1 mttt -91.55 108.98 20.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.969 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 19.1 m -144.87 18.22 1.62 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.307 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 3.2 mp 50.65 -176.86 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.801 0.334 . . . . 0.0 111.152 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.906 -179.972 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.819 0.343 . . . . 0.0 111.189 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.475 HG12 ' CG ' ' A' ' 169' ' ' MET . 0.8 OUTLIER -98.25 140.83 17.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.814 179.942 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.505 ' O ' ' HA ' ' A' ' 169' ' ' MET . 4.6 mm -106.11 122.69 60.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.766 -179.347 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.499 ' CG ' ' CE2' ' A' ' 14' ' ' PHE . 3.9 m-85 -90.09 130.22 36.29 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.563 179.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.97 157.5 45.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.966 0.412 . . . . 0.0 111.438 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.433 ' O ' ' HA ' ' A' ' 10' ' ' HIS . 36.8 t0 -63.41 152.18 38.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.721 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 61.3 tp -80.51 -24.83 39.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.312 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.1 mp -91.43 -45.28 14.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.02 -28.49 17.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.486 -179.162 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.433 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 0.2 OUTLIER 66.45 29.55 9.14 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.849 0.356 . . . . 0.0 110.785 -179.782 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -101.16 130.5 47.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.716 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.2 pm0 -61.95 88.49 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.31 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 10.5 mtt -71.42 -17.93 62.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.66 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.499 ' CE2' ' CG ' ' A' ' 4' ' ' TYR . 43.5 p90 -178.62 177.22 0.92 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.676 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.4 m -136.71 -169.8 2.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.943 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.405 ' HB2' ' CG2' ' A' ' 2' ' ' ILE . 40.2 t0 -93.26 23.57 4.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.018 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.421 HG13 ' CD2' ' A' ' 18' ' ' TYR . 45.4 pt -87.55 -9.84 10.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.756 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.424 ' CZ ' HG21 ' A' ' 72' ' ' ILE . 76.1 m-85 -111.14 -170.77 1.7 Allowed 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.765 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.6 mttm -97.07 91.28 5.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.734 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.9 mp -87.93 123.96 40.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.015 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 15.9 mtp180 -120.55 117.62 28.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.811 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -72.1 117.48 13.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.938 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.6 pt -110.95 171.12 3.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.947 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 56.59 33.98 23.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.068 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 64.5 42.84 4.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.183 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.08 -12.95 62.71 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.785 -0.722 . . . . 0.0 113.195 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.93 -33.36 64.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.902 0.351 . . . . 0.0 111.285 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 34.3 m -142.21 164.29 30.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.021 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -128.32 130.85 48.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.994 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 -95.56 112.97 24.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.071 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 159' ' ' TYR . 23.3 t -91.55 111.87 24.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.362 179.39 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -85.5 118.36 24.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.381 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -106.34 -142.91 11.09 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.098 179.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.8 pttt -174.44 123.46 0.29 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.793 0.33 . . . . 0.0 111.187 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 76.5 mtm -65.95 118.62 10.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.538 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 31.1 m -104.93 116.19 48.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.899 0.38 . . . . 0.0 111.53 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.43 153.22 20.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.641 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.495 ' HB3' HG12 ' A' ' 67' ' ' ILE . 35.4 ttt180 -138.22 115.94 11.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.827 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 30.4 p -109.06 -33.54 6.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.754 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -139.31 -49.51 0.5 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.915 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 166.57 150.15 6.26 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.521 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -123.79 123.4 40.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.887 0.375 . . . . 0.0 110.878 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.3 mt 60.14 33.01 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.002 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -82.92 -60.3 2.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.902 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.39 142.07 45.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.869 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 38.3 m -102.64 -59.89 1.63 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.946 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 29.8 mt -65.83 -48.37 71.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.935 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 41.3 mt 59.01 158.62 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.144 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 148.87 51.9 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.529 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -148.01 105.09 0.3 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.499 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -166.4 122.19 1.22 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.82 0.343 . . . . 0.0 110.838 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -115.78 -38.62 3.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.075 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 32.0 t -142.92 -51.59 0.37 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.867 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -174.37 -44.27 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.104 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -102.21 167.32 10.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.832 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -89.43 -95.05 1.1 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.535 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.34 -30.27 51.58 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.548 2.165 . . . . 0.0 112.173 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 60.97 31.15 19.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.93 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 161.4 140.89 2.98 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.501 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 60.95 163.34 0.07 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.857 0.36 . . . . 0.0 110.875 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 153.08 168.96 17.69 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.513 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.1 t -86.86 164.44 16.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.775 0.321 . . . . 0.0 110.941 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -100.38 90.91 4.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.949 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 12.2 m -83.53 -22.04 32.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.117 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.7 m 65.31 133.57 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.81 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 57.8 t -74.75 144.26 12.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.044 0.45 . . . . 0.0 111.188 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.495 HG12 ' HB3' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -128.37 127.35 67.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.35 179.338 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.08 118.2 12.61 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.326 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -150.65 175.43 29.67 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.264 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.428 ' CG1' HG12 ' A' ' 72' ' ' ILE . 46.3 t -70.96 130.5 34.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.878 0.37 . . . . 0.0 110.725 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.4 ' O ' ' ND2' ' A' ' 75' ' ' ASN . 5.3 t0 -58.17 -58.77 6.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.862 -179.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.459 ' HB ' ' CE1' ' A' ' 76' ' ' HIS . 8.5 pt -53.64 -33.81 23.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.678 -179.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 89.9 t -72.77 -34.28 46.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.878 0.37 . . . . 0.0 111.011 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 14.9 mtm -78.24 -39.24 40.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.716 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.403 ' OD1' ' CD2' ' A' ' 76' ' ' HIS . 19.9 p30 -82.15 -29.33 31.65 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -179.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.459 ' CE1' ' HB ' ' A' ' 72' ' ' ILE . 26.0 m170 -92.05 -0.55 57.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.81 0.338 . . . . 0.0 110.787 179.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 30.3 m-70 57.84 31.85 21.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.057 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 58.6 mt -58.63 147.39 32.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.582 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -128.39 133.91 48.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.915 0.388 . . . . 0.0 111.054 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.416 ' HG3' ' CE1' ' A' ' 135' ' ' PHE . 28.9 tt0 -90.24 132.37 35.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.061 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.1 t -121.9 -172.96 2.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.872 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 83.1 p -128.79 168.23 16.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.957 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.499 ' CE2' ' CE2' ' A' ' 91' ' ' TYR . 1.1 m-85 -171.71 157.34 4.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.991 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.34 164.5 11.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.789 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.34 -52.45 65.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.83 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -67.21 -38.94 86.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.725 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.62 -37.13 86.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.992 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.514 ' CZ ' ' CE1' ' A' ' 134' ' ' PHE . 0.1 OUTLIER -63.01 -37.37 86.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.804 -179.999 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.401 ' O ' HG23 ' A' ' 92' ' ' ILE . 58.3 mttt -59.03 -45.43 90.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.084 0.468 . . . . 0.0 110.361 179.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.35 -27.82 52.8 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.643 178.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.499 ' CE2' ' CE2' ' A' ' 83' ' ' PHE . 9.3 t80 -66.88 -44.72 80.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.753 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.429 HD12 ' CE2' ' A' ' 95' ' ' TYR . 5.7 tp -63.36 -43.11 98.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.95 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.1 ttpt -62.28 -40.79 97.41 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.752 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.479 ' HA ' ' HG2' ' A' ' 97' ' ' LYS . 27.6 t0 -72.92 -43.94 61.82 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.762 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.452 ' CD1' ' C ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -75.82 -40.16 55.42 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 121.063 -0.255 . . . . 0.0 110.99 -179.386 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.402 ' HG3' ' N ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -67.57 -32.01 72.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.697 0.284 . . . . 0.0 110.661 179.5 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.479 ' HG2' ' HA ' ' A' ' 94' ' ' ASP . 0.0 OUTLIER -69.19 -34.22 74.56 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.829 0.347 . . . . 0.0 110.272 179.695 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.466 ' N ' ' HG3' ' A' ' 97' ' ' LYS . 1.0 OUTLIER -61.36 -41.03 96.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.969 179.316 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.402 ' CG2' ' HA2' ' A' ' 166' ' ' GLY . 9.3 mt -79.94 -42.86 22.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.564 179.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.91 -49.16 69.22 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.597 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -64.6 -50.44 58.99 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.667 -0.777 . . . . 0.0 112.207 179.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 2.2 tptt -59.84 -40.98 90.35 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.947 0.403 . . . . 0.0 110.426 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.456 ' O ' ' N ' ' A' ' 107' ' ' ARG . 12.3 tp -63.84 -41.1 97.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.043 179.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -55.2 -28.59 54.15 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.809 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -89.71 -16.57 30.08 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.784 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -114.27 -60.81 1.83 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.747 0.308 . . . . 0.0 111.538 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.456 ' N ' ' O ' ' A' ' 103' ' ' LEU . 0.9 OUTLIER -123.96 62.01 26.21 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.821 -179.801 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -50.8 -23.6 11.85 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 123.042 2.495 . . . . 0.0 112.566 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -74.44 -8.03 54.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.295 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.489 ' C ' ' HD2' ' A' ' 113' ' ' PRO . 1.1 mmt180 -111.22 -1.22 16.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.59 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 31.1 m -72.49 -33.17 44.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.55 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 1.9 mtpt -68.39 -49.97 29.79 Favored Pre-proline 0 C--N 1.331 -0.205 0 N-CA-C 111.649 0.24 . . . . 0.0 111.649 -179.2 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.55 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 30.0 Cg_exo -61.77 -33.72 84.68 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.087 1.858 . . . . 0.0 111.938 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.436 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 87.8 t80 -72.07 -36.5 69.56 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.012 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 5.5 mmm -58.02 -53.0 63.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.941 0.4 . . . . 0.0 110.855 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 71.8 m -73.06 -44.41 60.66 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.673 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.98 -37.57 95.17 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.577 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.402 ' O ' ' HB ' ' A' ' 122' ' ' ILE . . . -60.0 -51.65 68.74 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.961 0.41 . . . . 0.0 110.928 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.73 -28.12 62.46 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.425 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -77.92 -42.4 33.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.206 -179.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -72.11 -34.78 68.87 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.035 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.451 HD11 ' CD2' ' A' ' 88' ' ' TYR . 0.4 OUTLIER -68.27 -46.3 81.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.39 -179.81 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.451 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 0.4 OUTLIER -59.76 -32.13 70.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.062 0.458 . . . . 0.0 110.116 179.448 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -66.67 -54.3 24.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.618 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 13.0 pt -61.77 -39.98 85.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.058 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 11.4 mt -53.67 -35.69 61.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.567 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.5 -14.95 62.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.885 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -133.11 32.28 3.75 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.047 0.451 . . . . 0.0 110.243 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -49.08 -35.56 16.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.179 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.4 -20.78 60.66 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.162 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -89.18 -35.53 16.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.41 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.457 ' CD1' ' N ' ' A' ' 132' ' ' TYR . 1.7 m-30 -104.21 151.37 23.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.864 0.364 . . . . 0.0 111.313 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 4.9 mm100 -123.89 150.69 44.35 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.913 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.514 ' CE1' ' CZ ' ' A' ' 88' ' ' TYR . 4.6 m-85 -86.16 132.38 34.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.144 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.424 ' CG ' ' HE2' ' A' ' 160' ' ' MET . 28.8 m-85 -136.93 130.11 31.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.58 179.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.451 ' HB ' ' HA ' ' A' ' 140' ' ' MET . 0.8 OUTLIER -122.09 167.33 15.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.892 -179.81 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.42 -170.84 0.84 Allowed Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.475 -0.869 . . . . 0.0 111.927 179.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -68.92 -11.17 60.36 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.621 0.248 . . . . 0.0 111.389 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -92.39 -33.51 14.53 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.606 0.241 . . . . 0.0 111.242 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' MET . . . . . 0.451 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 75.2 mtm 58.34 41.78 22.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.341 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -70.14 118.18 61.37 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.793 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -64.61 -21.65 65.33 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.331 2.021 . . . . 0.0 111.831 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -84.59 -12.06 54.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.755 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -81.31 -137.12 2.11 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.256 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 3.7 ptp -120.65 178.89 4.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.781 0.324 . . . . 0.0 110.704 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 65.9 t -124.41 147.67 28.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.987 0.422 . . . . 0.0 111.193 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.419 ' HB2' ' CE2' ' A' ' 162' ' ' PHE . . . -113.27 110.2 19.99 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.364 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.512 ' HB2' ' HB ' ' A' ' 161' ' ' ILE . 4.4 mt -83.57 106.17 15.09 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.143 -179.093 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.2 tp -88.71 119.91 29.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.954 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.47 ' HB2' ' CZ ' ' A' ' 159' ' ' TYR . 62.8 m-20 -130.31 161.86 30.3 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.574 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -104.34 151.98 22.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.087 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 3.9 mmt180 -59.36 -176.92 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.0 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -60.9 -40.96 95.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.977 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -79.76 -15.07 58.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.312 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 78.68 33.07 39.16 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.597 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 93.8 t -113.44 -60.96 2.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.841 0.353 . . . . 0.0 111.11 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 51.5 m -80.55 112.56 32.37 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.341 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -82.37 134.28 7.73 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.558 2.172 . . . . 0.0 112.04 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.47 ' CZ ' ' HB2' ' A' ' 150' ' ' ASP . 5.7 p90 -130.51 142.59 50.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.041 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' MET . . . . . 0.424 ' HE2' ' CG ' ' A' ' 135' ' ' PHE . 0.3 OUTLIER -107.14 143.42 35.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.025 -179.899 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.512 ' HB ' ' HB2' ' A' ' 148' ' ' LEU . 73.4 mt -101.81 112.01 33.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.157 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.419 ' CE2' ' HB2' ' A' ' 147' ' ' ALA . 81.0 m-85 -114.23 157.62 22.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.756 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -100.5 122.82 43.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.952 0.406 . . . . 0.0 110.812 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.12 -50.49 63.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.245 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.436 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 1.7 m-20 -52.14 -30.48 26.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.12 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.402 ' HA2' ' CG2' ' A' ' 99' ' ' ILE . . . -108.21 27.75 13.44 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.236 179.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -150.15 142.69 24.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.82 0.343 . . . . 0.0 110.736 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -130.45 156.18 45.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.611 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' MET . . . . . 0.505 ' HA ' ' O ' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -140.16 160.29 40.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.116 179.973 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -149.99 149.71 30.76 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.477 -179.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 2' ' ' ILE . 28.7 mttt -87.2 109.04 19.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.822 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 17.7 p -98.81 96.3 7.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.959 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 5.3 mp -81.55 -71.9 0.45 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.83 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.927 179.996 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.5 ttm . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.847 0.356 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.422 HG23 ' HB2' ' A' ' 16' ' ' ASP . 1.9 tt -108.54 148.12 12.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.002 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.4 ' CG2' ' HB3' ' A' ' 12' ' ' GLU . 16.3 mm -104.25 155.75 5.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.348 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.507 ' CD2' ' CZ ' ' A' ' 14' ' ' PHE . 4.4 m-85 -124.19 106.62 10.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.73 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 27.7 ptt180 -122.66 146.74 47.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.148 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.442 ' O ' ' HA ' ' A' ' 10' ' ' HIS . 49.2 t0 -58.05 143.36 43.72 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.8 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 59.8 tp -73.37 -21.96 60.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.328 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.2 mp -91.32 -45.72 14.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.8 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.94 -20.27 19.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.76 -179.156 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.442 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 14.7 m170 61.24 28.86 18.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.91 0.386 . . . . 0.0 110.717 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -102.08 120.29 40.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.761 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.4 ' HB3' ' CG2' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -56.66 88.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.392 -179.731 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.411 ' O ' ' CG ' ' A' ' 76' ' ' HIS . 7.8 mtt -66.46 -24.22 66.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.721 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.507 ' CZ ' ' CD2' ' A' ' 4' ' ' TYR . 25.6 p90 -173.49 179.65 2.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.696 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -135.24 -169.97 2.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.774 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.422 ' HB2' HG23 ' A' ' 2' ' ' ILE . 26.1 t70 -94.85 23.98 5.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.023 0.439 . . . . 0.0 110.948 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.421 HG13 ' CD2' ' A' ' 18' ' ' TYR . 39.6 pt -82.03 -15.03 12.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.632 179.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.438 ' CZ ' HG22 ' A' ' 72' ' ' ILE . 82.4 m-85 -108.12 -174.27 2.48 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.586 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.4 mmtp -93.19 86.43 5.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.746 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.9 mp -87.83 125.54 41.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.939 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.4 mmm180 -117.77 129.97 56.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.997 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -80.59 116.53 20.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.707 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.9 pt -110.93 173.39 2.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.017 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.413 ' O ' ' HB2' ' A' ' 25' ' ' ASP . . . 56.39 28.42 13.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.166 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.413 ' HB2' ' O ' ' A' ' 24' ' ' ALA . 5.4 m-20 66.06 54.38 1.0 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.238 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 76.61 1.78 72.77 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.894 -0.669 . . . . 0.0 113.415 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.84 -43.47 65.48 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 117.056 0.428 . . . . 0.0 111.083 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 10.1 m -132.17 161.76 32.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.096 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.1 mt -127.1 127.74 45.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.823 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -97.38 112.96 24.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.137 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 24.2 t -92.23 111.97 25.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.567 179.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -82.03 125.17 30.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.228 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -112.07 -141.15 8.26 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.177 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.9 pttp -174.57 126.49 0.31 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.816 0.341 . . . . 0.0 111.132 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 95.1 mtp -67.78 111.28 4.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.631 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 28.9 m -110.84 135.56 49.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.453 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.2 p -96.36 165.5 12.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.784 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.513 ' HB3' HG12 ' A' ' 67' ' ' ILE . 0.1 OUTLIER -142.09 141.26 32.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.671 -179.832 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.9 m -164.3 125.73 2.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.829 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -141.74 -74.44 0.31 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.916 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.69 -172.84 21.37 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.478 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -176.68 173.14 2.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.828 0.347 . . . . 0.0 110.8 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.3 mp -94.45 140.74 16.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.025 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -143.22 -169.18 2.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.921 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 59.94 25.24 14.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.929 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -106.12 -47.81 3.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.875 0.369 . . . . 0.0 110.851 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 11.1 mt -92.97 -30.64 15.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.873 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 23.1 mt -75.07 113.2 13.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.071 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 154.12 90.15 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.501 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -140.53 -155.01 6.39 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.615 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 -109.26 -25.64 10.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.796 0.332 . . . . 0.0 111.107 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -54.9 -43.52 73.31 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.271 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 42.4 t -74.12 -66.79 0.68 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.843 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 59.01 34.33 23.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.146 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -175.3 152.01 1.34 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.92 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 144.43 146.66 4.53 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.471 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.24 177.58 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.438 2.092 . . . . 0.0 112.345 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -102.66 -52.0 3.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.891 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -142.79 87.04 0.18 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.461 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -122.15 97.17 5.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.865 0.364 . . . . 0.0 110.796 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -168.76 144.75 8.98 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.521 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.9 t -142.7 -47.9 0.33 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.783 0.325 . . . . 0.0 110.857 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -106.64 87.3 2.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.762 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.2 t -58.08 -61.77 2.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.937 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.2 m -164.1 55.6 0.15 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.943 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 42.5 t -102.93 127.15 56.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.185 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.513 HG12 ' HB3' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -130.16 130.59 65.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.646 179.536 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 10.5 m -139.25 133.02 30.73 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.144 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 176.51 -169.43 41.92 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.286 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.455 ' CG1' HG12 ' A' ' 72' ' ' ILE . 43.0 t -73.2 129.84 35.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.792 0.33 . . . . 0.0 110.771 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.4 ' N ' ' OD1' ' A' ' 71' ' ' ASP . 20.3 p-10 -59.6 -55.49 33.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.793 -179.144 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.455 HG12 ' CG1' ' A' ' 70' ' ' VAL . 8.7 pt -53.78 -33.94 24.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.833 0.349 . . . . 0.0 111.411 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.4 ' HA ' ' HB2' ' A' ' 78' ' ' LEU . 93.8 t -72.44 -32.1 40.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.919 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.2 mtm -78.21 -40.07 38.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.496 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.41 ' OD1' ' CD2' ' A' ' 76' ' ' HIS . 15.2 p30 -82.12 -28.46 32.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.568 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.439 ' CE1' ' HB ' ' A' ' 72' ' ' ILE . 24.8 m170 -94.29 1.1 55.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.806 0.336 . . . . 0.0 110.963 179.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 56.13 30.16 15.91 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.321 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.4 ' HB2' ' HA ' ' A' ' 73' ' ' VAL . 67.1 mt -60.17 134.46 57.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.604 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -123.91 139.38 54.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.863 0.363 . . . . 0.0 111.196 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.425 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 2.0 tt0 -90.83 130.7 36.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.958 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.9 t -122.14 137.06 54.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.821 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.0 m -77.57 159.16 29.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.028 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.446 ' CB ' ' CE2' ' A' ' 134' ' ' PHE . 0.3 OUTLIER -167.61 149.24 5.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.822 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.88 166.63 13.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.965 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.7 mttp -64.98 -52.55 55.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.764 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -62.67 -41.69 99.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.959 0.409 . . . . 0.0 110.591 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.42 ' HB3' ' CE2' ' A' ' 83' ' ' PHE . . . -59.28 -39.44 82.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.91 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.516 ' CZ ' ' CE1' ' A' ' 134' ' ' PHE . 0.5 OUTLIER -59.78 -37.17 78.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.575 179.807 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 67.6 mttt -56.61 -49.81 73.85 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.112 0.482 . . . . 0.0 110.189 179.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.71 -27.83 60.55 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.521 178.538 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -64.62 -47.63 77.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.814 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.451 ' O ' ' HG2' ' A' ' 96' ' ' MET . 4.8 tp -61.47 -43.97 97.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.98 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.436 ' O ' ' HB3' ' A' ' 97' ' ' LYS . 8.8 ttmm -60.17 -40.66 90.71 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.236 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.427 ' O ' ' HG3' ' A' ' 97' ' ' LYS . 9.4 t0 -73.71 -43.06 60.27 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.984 -179.227 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.492 ' CD1' ' C ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -76.82 -39.59 50.8 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.087 -179.207 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.451 ' HG2' ' O ' ' A' ' 92' ' ' ILE . 6.2 ptt? -67.72 -32.13 72.55 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.929 -0.308 . . . . 0.0 110.69 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.478 ' HG3' ' N ' ' A' ' 98' ' ' SER . 0.0 OUTLIER -70.43 -33.66 71.59 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.517 179.88 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.478 ' N ' ' HG3' ' A' ' 97' ' ' LYS . 1.5 m -62.65 -40.76 98.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.037 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 7.4 mt -79.86 -41.5 21.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.281 179.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.7 tttt -56.21 -57.15 13.42 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.442 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -59.6 -42.84 97.96 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.24 179.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.59 -36.37 83.54 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.885 0.374 . . . . 0.0 110.45 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.449 ' O ' ' N ' ' A' ' 107' ' ' ARG . 3.9 tp -72.6 -32.43 65.97 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.056 0.455 . . . . 0.0 109.9 179.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 108' ' ' PRO . 69.1 mt-10 -60.62 -31.57 70.74 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.674 179.518 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -87.89 -21.58 24.89 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.654 -179.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -105.55 -62.42 1.36 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.78 0.324 . . . . 0.0 111.456 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.449 ' N ' ' O ' ' A' ' 103' ' ' LEU . 0.5 OUTLIER -128.54 63.56 65.04 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.96 -179.761 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.41 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 10.3 Cg_endo -50.97 -22.66 10.67 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 123.114 2.543 . . . . 0.0 112.73 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -68.43 -12.24 60.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.606 0.241 . . . . 0.0 111.335 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.463 ' C ' ' HD2' ' A' ' 113' ' ' PRO . 0.4 OUTLIER -108.03 -1.21 20.72 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -179.562 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.403 ' CG2' ' O ' ' A' ' 108' ' ' PRO . 22.4 m -72.71 -32.33 40.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -179.262 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.544 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 11.9 mtpt -68.99 -50.09 23.0 Favored Pre-proline 0 C--N 1.331 -0.205 0 C-N-CA 120.941 -0.304 . . . . 0.0 111.529 -179.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.544 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 24.2 Cg_exo -63.56 -29.6 70.53 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.138 1.892 . . . . 0.0 111.578 179.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.495 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 54.2 t80 -72.24 -42.31 65.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.016 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -55.48 -47.3 76.36 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.013 0.435 . . . . 0.0 110.757 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 60.1 m -76.08 -44.33 39.39 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.888 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.35 -46.81 93.1 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.774 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.07 -51.82 67.77 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.028 0.442 . . . . 0.0 111.223 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.22 -28.22 67.89 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.39 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -77.72 -43.25 31.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.255 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 -73.17 -37.83 66.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.048 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.457 ' CG2' ' N ' ' A' ' 123' ' ' LYS . 0.3 OUTLIER -66.13 -46.39 87.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.299 -179.888 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.457 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 17.5 pttt -60.64 -31.88 71.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.181 179.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -66.9 -54.05 26.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.774 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 13.6 pt -61.75 -40.77 88.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.155 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 11.7 mt -53.85 -36.43 62.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.828 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -67.4 -13.96 62.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.191 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -141.44 36.28 1.67 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.935 0.397 . . . . 0.0 110.464 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.517 ' CE1' ' CZ ' ' A' ' 134' ' ' PHE . 4.0 t80 -49.66 -29.55 7.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.17 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 5.8 mtmp? -64.98 -21.32 66.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.192 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 32.5 m-20 -94.07 -38.02 11.33 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.287 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.409 ' CD2' ' OD1' ' A' ' 150' ' ' ASP . 4.1 m-85 -99.02 140.77 32.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.15 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.4 mm100 -118.48 145.91 44.91 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.981 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.517 ' CZ ' ' CE1' ' A' ' 129' ' ' PHE . 2.5 m-85 -82.71 122.43 28.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.945 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.425 ' CE2' ' HB2' ' A' ' 80' ' ' GLU . 28.6 m-85 -124.19 146.38 48.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.628 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.447 ' HB ' ' HA ' ' A' ' 140' ' ' MET . 0.8 OUTLIER -134.28 162.85 38.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.972 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -62.64 -164.38 0.43 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.191 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -72.48 -8.94 57.69 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.533 0.206 . . . . 0.0 111.476 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 19.4 m-80 -95.81 -31.49 13.14 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.647 0.26 . . . . 0.0 111.523 -179.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' MET . . . . . 0.447 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 32.7 mtm 56.93 41.41 27.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.885 0.374 . . . . 0.0 111.02 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 15.7 p-10 -66.93 116.03 31.22 Favored Pre-proline 0 N--CA 1.451 -0.42 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.8 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -61.7 -27.84 81.55 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.52 2.147 . . . . 0.0 112.155 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -84.52 -4.85 59.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.018 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -90.1 -175.54 45.17 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.385 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -77.19 177.77 7.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.877 0.37 . . . . 0.0 110.855 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 47.4 t -124.34 152.5 30.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.166 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.429 ' CB ' ' HE3' ' A' ' 160' ' ' MET . . . -116.11 117.42 30.03 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.569 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.544 ' HB2' ' HB ' ' A' ' 161' ' ' ILE . 3.5 mt -91.51 108.22 19.75 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.244 -179.171 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.41 ' CA ' ' HE2' ' A' ' 160' ' ' MET . 1.3 tp -92.51 119.46 32.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.35 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.455 ' CB ' ' CE1' ' A' ' 159' ' ' TYR . 1.0 OUTLIER -129.66 163.6 25.74 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.475 179.332 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -102.91 145.78 29.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.909 0.385 . . . . 0.0 111.052 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.17 -177.01 0.11 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.908 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -57.87 -41.31 82.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.901 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -71.51 -15.08 62.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.171 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 77.36 18.32 78.18 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.738 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 83.7 t -113.41 -73.63 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.794 0.33 . . . . 0.0 110.911 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 83.9 m -53.67 103.13 0.35 Allowed Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.235 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -78.81 130.36 9.58 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.76 2.306 . . . . 0.0 111.952 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.455 ' CE1' ' CB ' ' A' ' 150' ' ' ASP . 11.0 p90 -120.75 137.49 54.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.85 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' MET . . . . . 0.429 ' HE3' ' CB ' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -103.85 134.58 46.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.374 -179.373 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.544 ' HB ' ' HB2' ' A' ' 148' ' ' LEU . 51.0 mt -93.2 123.8 45.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.869 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -129.51 126.73 39.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.182 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.431 ' CE2' ' OH ' ' A' ' 95' ' ' TYR . 4.1 m-30 -72.66 123.8 24.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.577 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 3.0 ttmm -60.56 -56.39 21.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.523 -179.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.495 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 2.4 m-20 -48.63 -36.17 15.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.851 0.358 . . . . 0.0 111.286 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -94.25 28.6 10.42 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.412 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -150.01 142.89 24.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.73 0.3 . . . . 0.0 110.837 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.02 155.74 21.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.799 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -121.32 145.52 47.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.931 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -157.03 131.47 8.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.881 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 12.5 mttm -80.1 111.78 16.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.973 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.69 -177.05 4.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.82 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 1.5 tt 59.48 72.04 0.55 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.904 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.175 -0.917 . . . . 0.0 110.924 179.989 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.846 0.355 . . . . 0.0 111.192 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.421 HG21 ' HB2' ' A' ' 16' ' ' ASP . 2.1 tt -110.11 147.82 14.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.983 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.4 mm -104.79 156.82 5.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.276 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.496 ' CD2' ' CE2' ' A' ' 14' ' ' PHE . 4.9 m-85 -125.75 99.14 5.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.611 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 27.1 ptt180 -113.34 147.32 37.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.136 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.434 ' O ' ' HA ' ' A' ' 10' ' ' HIS . 47.3 t0 -56.95 152.16 13.43 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.8 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 61.1 tp -81.39 -20.27 40.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.377 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.0 mp -91.34 -47.31 14.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -179.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.47 -20.5 19.0 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.167 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.434 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 36.6 m80 63.96 28.93 14.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.9 0.381 . . . . 0.0 110.749 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -102.0 122.57 44.33 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.793 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.5 pm0 -57.96 92.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.251 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 9.7 mtt -72.84 -16.88 61.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.918 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.496 ' CE2' ' CD2' ' A' ' 4' ' ' TYR . 19.1 p90 -177.44 174.16 1.61 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.708 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -133.36 -172.3 2.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.863 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.421 ' HB2' HG21 ' A' ' 2' ' ' ILE . 20.6 t0 -92.52 17.88 9.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.099 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 46.7 pt -79.12 -15.11 13.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.967 0.413 . . . . 0.0 110.649 179.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.459 ' CZ ' HG23 ' A' ' 72' ' ' ILE . 70.7 m-85 -108.07 -174.52 2.54 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.529 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.9 mttp -96.16 93.37 6.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.879 0.371 . . . . 0.0 110.581 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.1 mp -87.81 134.62 27.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.178 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.58 122.87 37.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.838 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -77.82 116.45 18.35 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.876 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.401 HG12 ' HG3' ' A' ' 30' ' ' GLU . 1.4 pt -109.72 168.97 3.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.072 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' ' 25' ' ' ASP . . . 59.59 31.08 20.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.952 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 24' ' ' ALA . 48.1 m-20 65.61 47.39 2.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.179 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.13 -8.23 68.06 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.809 -0.71 . . . . 0.0 113.38 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.94 -39.01 87.86 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.904 0.352 . . . . 0.0 111.239 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 28.2 m -135.47 162.53 32.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.162 -179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.18 132.86 51.71 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.74 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.416 ' OE1' ' CD2' ' A' ' 159' ' ' TYR . 18.9 mt-10 -102.19 116.24 32.23 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.257 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.423 HG22 ' CG ' ' A' ' 14' ' ' PHE . 21.4 t -90.25 112.13 24.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.706 179.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -83.55 115.16 21.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.147 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.57 -143.64 11.91 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.114 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.4 126.84 0.33 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.929 0.395 . . . . 0.0 110.955 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 42.3 mtp -70.83 115.01 9.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.626 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.8 m -106.68 122.41 60.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.402 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 68.5 m -89.66 165.49 14.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.791 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.556 ' HB3' HG12 ' A' ' 67' ' ' ILE . 8.4 ttt85 -139.61 134.61 32.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.692 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.3 m 59.34 25.24 13.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.859 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.83 134.28 33.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.89 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.15 28.54 33.61 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.446 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -139.27 93.91 2.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.818 0.342 . . . . 0.0 110.975 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 11.8 tt -100.26 130.72 49.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.118 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -142.62 -176.92 5.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.97 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -60.64 146.72 44.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.945 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 63.0 m -101.34 -60.77 1.47 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.826 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -59.54 -72.59 0.1 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.157 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 80.1 mt 58.15 106.91 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.093 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -127.19 -80.17 0.31 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.465 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -172.18 131.89 2.26 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.461 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 14.1 p30 -169.24 177.25 4.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.825 0.345 . . . . 0.0 110.876 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.74 90.89 0.6 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.08 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.1 p -93.71 -36.82 12.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.89 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 60.0 31.49 20.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.094 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -148.08 133.07 18.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.926 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -103.92 104.12 2.41 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.401 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -67.86 119.5 6.51 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.402 2.068 . . . . 0.0 112.337 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -94.02 -34.45 13.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.917 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -105.97 -119.11 4.5 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.513 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 60.8 174.45 0.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.857 0.36 . . . . 0.0 110.857 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 164.14 -29.7 0.23 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.41 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.5 m -65.87 132.34 48.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.866 0.365 . . . . 0.0 110.842 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -105.06 -75.3 0.63 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.907 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.1 t -177.32 38.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.945 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 10.5 t -106.75 117.79 34.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.987 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 28.6 t -116.76 133.36 63.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.972 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.556 HG12 ' HB3' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -135.14 131.34 52.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.148 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 85.6 m -139.41 140.72 37.47 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.025 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 174.89 172.97 40.34 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.435 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.405 ' CG1' HG12 ' A' ' 72' ' ' ILE . 60.8 t -68.52 135.89 27.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.916 0.389 . . . . 0.0 110.775 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -59.23 -57.55 12.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.653 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.459 HG23 ' CZ ' ' A' ' 18' ' ' TYR . 5.3 pt -53.95 -33.82 24.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.497 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 92.3 t -75.0 -30.87 24.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.071 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.8 mtm -78.16 -41.51 34.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.902 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.428 ' OD1' ' CD2' ' A' ' 76' ' ' HIS . 15.0 p30 -82.11 -30.35 31.22 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -179.057 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.428 ' CD2' ' OD1' ' A' ' 75' ' ' ASN . 36.3 m80 -91.87 -0.13 57.5 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.856 0.36 . . . . 0.0 110.923 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 9.8 m80 55.8 34.94 24.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.256 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 46.5 mt -58.59 147.32 32.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.553 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -131.82 139.0 48.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.893 0.377 . . . . 0.0 111.148 -179.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.427 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 4.7 tt0 -92.68 131.89 37.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.001 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 7.8 t -122.33 151.81 40.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.768 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 62.3 m -90.47 159.01 16.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.084 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.433 ' CB ' ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -170.02 137.83 1.64 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.76 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -85.39 173.79 10.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.938 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.2 mttp -66.92 -52.31 44.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.949 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -58.46 -46.1 87.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.893 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.431 ' HB2' ' CE2' ' A' ' 83' ' ' PHE . . . -58.67 -40.75 84.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.038 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.519 ' CZ ' ' CE1' ' A' ' 134' ' ' PHE . 0.1 OUTLIER -59.05 -36.93 75.85 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.843 179.851 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.402 ' O ' HG22 ' A' ' 92' ' ' ILE . 73.3 mttt -57.39 -48.52 78.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.159 0.504 . . . . 0.0 110.354 179.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.8 mmtt -76.47 -27.89 56.31 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.441 178.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -64.99 -46.57 80.87 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.615 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.515 ' HA ' ' CD2' ' A' ' 95' ' ' TYR . 4.5 tp -61.43 -46.52 96.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.849 0.357 . . . . 0.0 110.75 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.419 ' O ' ' HB3' ' A' ' 97' ' ' LYS . 18.9 ttpp -59.25 -38.62 80.51 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.952 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -73.89 -44.98 53.56 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.054 -179.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.515 ' CD2' ' HA ' ' A' ' 92' ' ' ILE . 0.1 OUTLIER -76.18 -38.48 56.56 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.292 -179.236 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.423 ' HG2' ' O ' ' A' ' 92' ' ' ILE . 4.0 ptt? -67.39 -32.15 72.85 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.471 179.471 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.504 ' HG3' ' N ' ' A' ' 98' ' ' SER . 0.0 OUTLIER -70.48 -33.45 71.26 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.912 0.387 . . . . 0.0 110.482 179.681 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.504 ' N ' ' HG3' ' A' ' 97' ' ' LYS . 1.7 m -64.17 -40.51 96.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.227 179.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 7.9 mt -79.72 -40.4 21.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.298 179.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -56.1 -54.38 45.73 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.411 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -60.81 -45.74 95.88 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.923 179.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.69 -40.73 96.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.926 0.393 . . . . 0.0 110.207 179.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.448 ' O ' ' N ' ' A' ' 107' ' ' ARG . 3.4 tp -66.5 -36.59 83.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.029 179.224 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.425 ' HA ' ' HA ' ' A' ' 108' ' ' PRO . 63.2 mt-10 -58.39 -29.12 65.8 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.768 179.447 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -87.01 -20.71 26.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.503 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -106.52 -61.33 1.54 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.727 0.298 . . . . 0.0 111.633 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.448 ' N ' ' O ' ' A' ' 103' ' ' LEU . 91.7 mtm-85 -131.64 65.58 76.22 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.859 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.425 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 9.4 Cg_endo -50.5 -23.45 10.66 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 123.105 2.537 . . . . 0.0 112.617 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -70.87 -12.06 61.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.68 0.276 . . . . 0.0 111.038 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.488 ' C ' ' HD2' ' A' ' 113' ' ' PRO . 6.0 mmm180 -106.66 0.57 24.45 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.764 -179.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 22.8 m -73.09 -33.29 41.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.548 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 12.7 mtmm -66.48 -50.02 49.4 Favored Pre-proline 0 C--N 1.332 -0.181 0 C-N-CA 121.022 -0.271 . . . . 0.0 111.583 -179.158 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.548 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 27.1 Cg_exo -62.18 -34.8 77.92 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.254 1.969 . . . . 0.0 111.702 179.543 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -68.31 -38.03 81.21 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.833 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -59.88 -47.17 86.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.021 0.439 . . . . 0.0 110.823 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 63.6 m -76.29 -44.65 36.07 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.69 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.63 -41.01 99.22 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.512 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.0 -47.2 86.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.058 0.456 . . . . 0.0 111.042 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.45 -29.87 66.55 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.188 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -73.65 -52.94 11.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.98 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 3.3 tp-100 -60.74 -45.63 93.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.932 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.448 HD13 ' CD2' ' A' ' 88' ' ' TYR . 0.3 OUTLIER -59.93 -45.4 95.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.936 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.448 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 15.1 mttm -60.49 -30.75 69.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.196 179.315 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -68.88 -54.46 15.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.669 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 11.6 pt -60.68 -40.5 84.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.064 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 11.5 mt -53.95 -38.59 65.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.704 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -68.52 -12.91 61.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.248 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -137.15 33.64 2.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.087 0.47 . . . . 0.0 110.503 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -49.71 -28.49 6.13 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.241 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 5.6 tttp -72.24 -20.32 61.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.341 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -94.1 -35.28 12.62 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.322 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -100.72 146.3 27.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.947 0.403 . . . . 0.0 111.283 -179.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.4 mm100 -125.38 146.22 49.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.787 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.519 ' CE1' ' CZ ' ' A' ' 88' ' ' TYR . 3.2 m-85 -81.5 129.18 34.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.958 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.427 ' CE2' ' HB2' ' A' ' 80' ' ' GLU . 30.6 m-85 -133.93 136.37 44.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.678 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.409 ' HB ' ' HA ' ' A' ' 140' ' ' MET . 1.2 mt -124.65 164.92 22.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.044 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.97 -160.07 0.73 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.165 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -74.48 -8.79 57.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.467 0.175 . . . . 0.0 111.45 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -95.33 -33.31 12.58 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 111.657 0.243 . . . . 0.0 111.657 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' MET . . . . . 0.409 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 73.9 mtm 60.11 34.93 21.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.817 0.342 . . . . 0.0 110.841 -179.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . 0.447 ' ND2' ' HA3' ' A' ' 144' ' ' GLY . 6.4 p-10 -65.94 114.82 18.05 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.043 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -67.12 -24.89 44.17 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.669 2.246 . . . . 0.0 112.386 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -84.44 -6.5 59.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.187 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.447 ' HA3' ' ND2' ' A' ' 141' ' ' ASN . . . -85.85 -124.56 1.53 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.461 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 6.9 ptp -126.57 -177.49 4.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.81 0.338 . . . . 0.0 110.76 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 48.3 t -129.23 149.74 33.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.208 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -113.41 112.17 23.19 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.463 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.49 ' HB2' ' HB ' ' A' ' 161' ' ' ILE . 4.4 mt -86.63 106.05 17.32 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.982 -179.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.5 tp -90.82 120.0 31.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.161 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.481 ' HB3' ' CZ ' ' A' ' 159' ' ' TYR . 29.5 t70 -133.94 165.37 25.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.429 179.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -107.99 147.27 31.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.817 0.341 . . . . 0.0 111.088 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.88 -168.7 0.1 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.863 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.87 -41.26 95.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.963 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -72.98 -15.13 61.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.311 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 65.7 28.64 73.82 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.487 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 73.6 t -112.4 -55.94 4.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.73 0.3 . . . . 0.0 111.177 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 54.5 m -85.78 111.65 39.17 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.4 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -80.5 135.9 10.77 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.526 2.151 . . . . 0.0 111.728 179.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.481 ' CZ ' ' HB3' ' A' ' 150' ' ' ASP . 5.8 p90 -126.02 135.57 51.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.976 0.417 . . . . 0.0 111.085 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' MET . . . . . 0.41 ' HE2' ' CG ' ' A' ' 135' ' ' PHE . 0.8 OUTLIER -104.96 131.62 52.24 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.059 -179.741 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.49 ' HB ' ' HB2' ' A' ' 148' ' ' LEU . 67.2 mt -92.09 118.5 37.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.289 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -117.05 163.42 16.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.703 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.419 ' CZ ' ' OH ' ' A' ' 95' ' ' TYR . 22.6 m-85 -100.44 122.77 43.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.905 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 12.4 tttt -70.06 -51.92 28.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.069 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -51.52 -29.17 15.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.162 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -105.35 24.29 27.99 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.375 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -138.25 146.82 43.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.849 0.357 . . . . 0.0 110.812 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -117.56 151.2 37.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.02 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.42 154.21 24.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.923 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -158.58 123.4 4.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.959 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 14.7 mtmm -89.88 119.05 29.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.96 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 32.8 m -111.25 150.72 29.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.933 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.88 142.43 57.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.829 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.278 -0.868 . . . . 0.0 110.855 179.911 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.5 ttt . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.844 0.354 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.47 HG12 ' CG ' ' A' ' 169' ' ' MET . 0.8 OUTLIER -111.33 143.35 21.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.037 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.508 ' O ' ' HA ' ' A' ' 169' ' ' MET . 4.3 mm -105.69 120.47 56.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.312 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.497 ' CG ' ' CE2' ' A' ' 14' ' ' PHE . 25.3 m-85 -91.45 125.21 36.12 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.801 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -137.23 143.66 42.39 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.215 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -55.05 144.8 22.39 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.976 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 55.3 tp -73.58 -22.17 60.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.453 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.6 mp -91.24 -43.97 14.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.687 0.28 . . . . 0.0 111.72 -179.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.9 t -92.62 -27.52 17.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.378 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 64.3 m-70 64.53 26.63 13.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.797 0.332 . . . . 0.0 110.773 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -103.15 129.7 50.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.718 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.402 ' HB3' ' CG2' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -57.84 95.9 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.346 -179.673 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 41.8 mtp -78.16 -16.86 57.53 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.7 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.497 ' CE2' ' CG ' ' A' ' 4' ' ' TYR . 37.8 p90 179.98 165.13 1.2 Allowed 'General case' 0 C--O 1.231 0.108 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.806 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.23 -169.93 1.98 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.563 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.426 ' HB2' ' CG2' ' A' ' 2' ' ' ILE . 39.4 t0 -95.67 33.78 1.59 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.02 0.438 . . . . 0.0 110.929 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.432 HG21 HD13 ' A' ' 17' ' ' ILE . 40.3 pt -93.33 -10.77 9.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.618 179.183 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.43 ' CE1' HG22 ' A' ' 72' ' ' ILE . 51.8 m-85 -110.45 -169.32 1.44 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.686 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.0 mmtt -96.88 88.25 4.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.813 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.0 mp -87.99 124.03 40.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.982 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.0 mtt180 -119.47 126.27 50.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.163 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -76.25 116.67 17.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.807 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.0 pt -114.15 170.93 4.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.204 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 56.12 28.48 13.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.286 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 63.43 41.35 7.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.218 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.1 -11.27 70.92 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.581 -0.819 . . . . 0.0 113.172 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.14 -33.87 74.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.916 0.358 . . . . 0.0 111.037 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.5 m -145.53 163.54 34.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.9 0.381 . . . . 0.0 111.158 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -127.68 130.66 49.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.704 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -97.19 112.86 24.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.153 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 22.1 t -98.8 111.84 29.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.633 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -83.56 115.78 22.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.336 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -99.8 -137.91 10.04 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.247 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.4 ptpt -174.45 126.38 0.32 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.845 0.355 . . . . 0.0 110.959 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 23.7 mtm -72.45 121.98 20.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.758 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.7 m -112.84 125.98 70.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.391 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.1 m -89.45 165.64 14.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.858 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.515 ' HB3' HG12 ' A' ' 67' ' ' ILE . 6.8 ttt180 -133.38 115.97 15.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.753 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.1 t -130.17 83.41 2.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.917 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -67.34 178.38 1.56 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.912 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -160.34 164.42 34.44 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.481 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -157.12 163.88 38.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.8 0.333 . . . . 0.0 110.819 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 15.7 tt -123.39 148.41 27.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.068 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -118.2 174.77 6.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.933 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.34 -179.57 5.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.895 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.4 m -77.89 -48.9 15.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.908 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.0 mp -95.87 -69.7 0.74 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.969 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 18.9 tt -63.43 138.13 23.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.115 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -102.03 48.53 1.07 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.477 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.05 176.42 24.48 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.504 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -160.74 98.09 1.21 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.797 0.332 . . . . 0.0 110.96 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -171.86 75.24 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.163 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -80.32 -65.12 1.05 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.855 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -142.96 156.76 44.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.069 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 59.94 30.97 20.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.877 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -105.72 -139.46 9.69 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.476 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -67.93 139.45 47.33 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.432 2.088 . . . . 0.0 112.298 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -77.73 118.0 19.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.965 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -179.98 114.58 0.44 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.512 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -105.87 142.01 36.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.767 0.318 . . . . 0.0 110.892 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 125.67 -154.17 18.54 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.517 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.37 178.97 7.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.776 0.322 . . . . 0.0 110.91 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -71.01 -64.42 0.91 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.914 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 92.7 p -122.67 128.1 50.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.884 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 58.4 m -135.54 140.51 44.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.857 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 41.2 t -97.06 134.62 34.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.991 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.515 HG12 ' HB3' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -123.96 131.88 72.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.042 -179.937 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 85.6 m -139.26 141.1 37.83 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.109 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -177.58 175.59 47.65 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.207 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.454 ' CG1' HG12 ' A' ' 72' ' ' ILE . 44.3 t -69.09 135.92 27.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.833 0.349 . . . . 0.0 110.901 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -62.33 -56.94 13.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.639 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.454 HG12 ' CG1' ' A' ' 70' ' ' VAL . 7.6 pt -53.54 -33.79 22.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.36 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.408 ' HA ' ' HB2' ' A' ' 78' ' ' LEU . 91.4 t -73.49 -33.49 39.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.915 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.4 mtm -78.23 -39.2 41.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.614 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 19.1 p30 -82.01 -29.42 32.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.581 -179.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.439 ' CE1' ' HB ' ' A' ' 72' ' ' ILE . 26.1 m170 -91.82 -4.52 54.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.842 0.353 . . . . 0.0 110.825 179.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.45 ' HB2' ' HB3' ' A' ' 138' ' ' GLU . 28.5 m80 60.73 39.57 17.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.95 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.408 ' HB2' ' HA ' ' A' ' 73' ' ' VAL . 38.1 mt -70.79 140.81 51.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.796 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -116.46 132.81 56.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.734 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.429 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 0.1 OUTLIER -91.7 120.86 32.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.94 0.4 . . . . 0.0 111.183 -179.94 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.2 t -108.82 170.01 8.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.792 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.3 p -114.91 170.45 8.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.889 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.465 ' HB2' ' CE2' ' A' ' 134' ' ' PHE . 4.0 m-85 -171.68 152.19 3.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.074 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.44 168.49 9.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.594 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.2 mttm -54.98 -51.94 64.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.125 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.63 -42.82 73.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.238 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.62 -44.83 95.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.858 0.361 . . . . 0.0 111.218 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.442 ' CD2' HD13 ' A' ' 122' ' ' ILE . 0.5 OUTLIER -59.83 -34.82 73.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.89 -179.974 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.453 ' O ' HG23 ' A' ' 92' ' ' ILE . 15.8 mtmt -59.69 -42.22 92.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.067 0.46 . . . . 0.0 110.5 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.6 -29.87 46.31 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.093 178.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -68.07 -46.17 71.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.743 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.475 ' CD1' ' CE2' ' A' ' 95' ' ' TYR . 2.1 tp -64.83 -42.17 94.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.98 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.457 ' O ' ' CG ' ' A' ' 97' ' ' LYS . 3.1 ttpt -62.0 -44.89 95.76 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.792 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -67.79 -40.18 83.95 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.955 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.54 ' CD1' ' C ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -76.5 -45.11 32.34 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 121.023 -0.271 . . . . 0.0 111.022 -179.162 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.402 ' HG2' ' O ' ' A' ' 92' ' ' ILE . 20.3 ptm -59.13 -32.01 69.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.889 0.375 . . . . 0.0 110.117 179.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.457 ' CG ' ' O ' ' A' ' 93' ' ' LYS . 3.7 mmpt? -70.72 -38.71 73.64 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.449 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.3 m -58.86 -40.08 83.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.332 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.2 mt -79.85 -42.56 22.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.416 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.49 -51.71 66.07 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.411 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -63.12 -47.16 90.69 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.044 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 4.0 tppt? -61.12 -39.89 91.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.872 0.367 . . . . 0.0 110.24 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.448 ' O ' ' N ' ' A' ' 107' ' ' ARG . 5.5 tp -66.97 -36.88 83.18 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.071 179.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 108' ' ' PRO . 75.8 mt-10 -57.52 -29.44 64.33 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.658 179.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -86.7 -20.81 27.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.486 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -105.77 -61.17 1.53 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.841 0.353 . . . . 0.0 111.656 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.448 ' N ' ' O ' ' A' ' 103' ' ' LEU . 22.5 mtt85 -134.06 66.81 72.7 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.863 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.4 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 9.6 Cg_endo -50.46 -21.68 7.8 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 123.254 2.636 . . . . 0.0 112.875 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -71.15 -9.86 58.79 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.583 0.23 . . . . 0.0 111.297 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.503 ' C ' ' HD2' ' A' ' 113' ' ' PRO . 8.5 mmt180 -110.34 -0.39 17.65 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.706 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 29.6 m -71.09 -33.93 53.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -179.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.562 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 8.3 mttt -68.27 -50.07 30.6 Favored Pre-proline 0 C--N 1.332 -0.191 0 C-N-CA 121.022 -0.271 . . . . 0.0 111.62 -179.148 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.562 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 31.6 Cg_exo -58.59 -37.76 92.85 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.188 1.925 . . . . 0.0 111.956 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.442 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 69.7 t80 -68.83 -36.9 78.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.937 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.04 -47.95 79.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.803 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 60.4 m -76.41 -44.28 36.67 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.737 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.16 -42.71 99.87 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.538 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.5 -51.59 69.21 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.044 0.449 . . . . 0.0 110.975 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.6 -28.06 67.44 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.183 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -75.87 -49.48 17.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.092 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 3.3 tp-100 -65.82 -39.73 91.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.156 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.442 HD13 ' CD2' ' A' ' 88' ' ' TYR . 0.3 OUTLIER -60.64 -45.54 97.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.984 -179.877 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.435 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 30.8 mttm -60.7 -29.45 69.34 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.317 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -69.25 -53.19 21.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.75 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 12.8 pt -63.0 -41.2 91.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.333 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 11.5 mt -54.79 -37.12 65.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.82 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -71.16 -10.54 59.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.34 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -140.31 33.35 1.89 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.928 0.395 . . . . 0.0 110.66 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.511 ' CE1' ' CZ ' ' A' ' 134' ' ' PHE . 1.5 t80 -51.35 -36.41 42.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.921 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.4 -26.07 66.39 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.977 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 32.0 m-20 -94.1 -43.84 8.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.201 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -91.8 135.52 33.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.227 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.45 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 1.8 mm100 -115.07 144.13 44.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.464 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.511 ' CZ ' ' CE1' ' A' ' 129' ' ' PHE . 0.1 OUTLIER -89.22 130.76 35.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.889 0.376 . . . . 0.0 111.099 -179.638 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.429 ' CE2' ' HB2' ' A' ' 80' ' ' GLU . 17.2 m-85 -123.72 166.29 15.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.681 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -149.23 157.57 6.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.574 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -57.42 -172.77 0.25 Allowed Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.406 -0.902 . . . . 0.0 111.676 179.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.45 ' HB3' ' HB2' ' A' ' 77' ' ' HIS . 1.1 pt-20 -70.08 -8.94 53.54 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.587 0.232 . . . . 0.0 111.292 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -94.93 -23.4 17.44 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.697 -0.229 . . . . 0.0 111.416 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 63.7 mtp 50.95 43.36 28.8 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.824 0.345 . . . . 0.0 111.302 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . 0.412 ' ND2' ' HA3' ' A' ' 144' ' ' GLY . 17.3 p-10 -64.64 117.13 35.01 Favored Pre-proline 0 N--CA 1.451 -0.391 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.816 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -59.35 -30.88 93.91 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.409 2.073 . . . . 0.0 112.26 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -84.61 -4.01 58.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.053 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.412 ' HA3' ' ND2' ' A' ' 141' ' ' ASN . . . -81.53 -153.63 11.0 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.407 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 13.2 ptp -108.59 179.15 4.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.783 0.325 . . . . 0.0 110.815 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.4 ' CG1' ' HB3' ' A' ' 134' ' ' PHE . 0.0 OUTLIER -125.15 128.43 72.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.047 179.846 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -89.91 109.39 20.41 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.257 0.551 . . . . 0.0 110.422 179.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.478 ' HB2' ' HB ' ' A' ' 161' ' ' ILE . 4.7 mt -81.85 106.29 13.66 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.349 -179.103 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.0 tp -91.12 118.63 30.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.158 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.454 ' HB3' ' CZ ' ' A' ' 159' ' ' TYR . 34.6 t70 -130.87 164.99 24.02 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.401 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -110.49 148.81 31.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.908 0.385 . . . . 0.0 110.995 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 5.0 mmm180 -57.42 -177.94 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.071 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -61.19 -41.27 96.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.949 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -87.41 -15.09 38.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.209 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 68.44 44.97 70.95 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.584 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 78.5 t -107.29 -20.8 5.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.743 0.306 . . . . 0.0 111.004 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.4 t -140.89 122.34 9.18 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.985 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -78.4 130.5 10.03 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.408 2.072 . . . . 0.0 112.09 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.454 ' CZ ' ' HB3' ' A' ' 150' ' ' ASP . 8.3 p90 -123.24 138.49 54.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.969 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' MET . . . . . . . . . . . . . 30.4 mtp -105.73 140.72 38.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.042 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.478 ' HB ' ' HB2' ' A' ' 148' ' ' LEU . 59.3 mt -97.92 111.19 27.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.016 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -107.13 154.38 21.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.957 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.408 ' CE2' ' OH ' ' A' ' 95' ' ' TYR . 17.8 m-85 -96.78 118.3 32.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.822 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 19.8 tptt -64.83 -51.54 61.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.082 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.442 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 9.0 m-20 -54.72 -32.1 59.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.151 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -103.84 17.78 48.4 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.748 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 7.0 tt -141.85 144.33 33.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.779 0.323 . . . . 0.0 110.808 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -130.17 150.43 51.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.689 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' MET . . . . . 0.508 ' HA ' ' O ' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -140.11 160.1 40.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.125 179.986 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -151.35 152.83 33.68 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.93 0.395 . . . . 0.0 111.647 -179.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . 0.464 ' HG2' ' HB ' ' A' ' 2' ' ' ILE . 30.2 mttp -95.91 115.01 26.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.728 179.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -115.59 162.48 17.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.05 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 60.41 87.78 0.08 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.997 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.136 -0.935 . . . . 0.0 110.922 179.987 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.835 0.35 . . . . 0.0 111.09 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.471 HG12 ' CG ' ' A' ' 169' ' ' MET . 0.9 OUTLIER -104.34 142.47 17.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.026 179.953 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.475 ' O ' ' HA ' ' A' ' 169' ' ' MET . 7.7 mm -105.31 118.89 53.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.372 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.495 ' CG ' ' CE2' ' A' ' 14' ' ' PHE . 20.5 m-85 -91.32 129.27 37.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.766 179.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -138.09 148.95 45.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.078 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.415 ' O ' ' HA ' ' A' ' 10' ' ' HIS . 22.7 t0 -55.26 150.86 10.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.844 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 66.6 tp -80.05 -25.07 40.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.295 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.0 mp -91.21 -43.17 14.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.755 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.5 t -91.77 -26.81 18.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.597 -179.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.415 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 0.2 OUTLIER 63.97 28.42 14.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.874 0.369 . . . . 0.0 110.832 -179.774 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -104.79 130.21 52.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.719 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.19 104.69 0.22 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.226 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 17.9 mtt -88.62 -15.67 34.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.917 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.495 ' CE2' ' CG ' ' A' ' 4' ' ' TYR . 38.2 p90 179.63 159.84 0.76 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.719 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -122.15 -169.93 1.98 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.664 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.412 ' HB2' HG21 ' A' ' 2' ' ' ILE . 36.9 t70 -93.49 28.98 2.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.989 0.423 . . . . 0.0 110.967 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.418 HG13 ' CD2' ' A' ' 18' ' ' TYR . 36.1 pt -91.46 -9.04 10.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.826 179.34 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.429 ' CE2' HG21 ' A' ' 72' ' ' ILE . 57.2 m-85 -115.83 -169.74 1.65 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.789 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.0 mttt -95.78 95.06 8.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.006 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.7 mp -91.72 124.02 44.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.939 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.69 137.15 53.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.991 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -83.85 114.7 21.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.818 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.4 pt -111.12 166.35 5.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.237 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 57.35 30.11 17.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.314 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 64.43 40.55 6.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.198 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.55 -18.5 56.96 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.007 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.33 -34.85 49.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.808 0.337 . . . . 0.0 111.041 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 35.8 m -147.9 163.63 36.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.913 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -129.62 132.86 46.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.954 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 73.9 mt-10 -96.26 125.25 40.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.125 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 22.4 t -102.5 111.94 34.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.732 179.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -87.08 112.54 22.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.135 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -94.17 -132.65 6.62 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.355 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.3 ptpt -174.43 123.4 0.29 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.776 0.322 . . . . 0.0 110.836 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 41.1 mtp -68.44 123.41 20.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.931 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.4 m -117.08 144.73 24.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.147 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.9 p -109.56 165.61 11.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.009 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.508 ' CB ' HG12 ' A' ' 67' ' ' ILE . 2.4 mmt180 -126.54 115.88 20.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.595 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -117.43 27.02 9.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.941 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 62.47 -80.42 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.023 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 119.72 136.63 5.3 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.391 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.0 m120 60.73 101.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.817 0.341 . . . . 0.0 110.874 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 4.3 mt -60.99 -30.79 48.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.092 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -68.81 -47.45 66.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.888 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.3 t70 60.95 59.1 2.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.875 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -105.96 -62.31 1.39 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.919 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.6 mt -59.84 -27.7 66.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.01 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -108.97 86.25 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.016 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 101.64 106.51 2.95 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.453 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -130.11 152.33 19.68 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.505 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 69.65 -65.21 0.31 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.816 0.341 . . . . 0.0 110.977 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.51 137.15 53.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.262 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.4 t 61.29 158.42 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.93 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -156.41 -65.91 0.11 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.166 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -132.29 170.47 15.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.993 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.5 159.59 29.68 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.465 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.48 178.9 4.52 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.56 2.173 . . . . 0.0 112.308 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 60.18 30.63 20.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.908 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.92 -92.23 1.62 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.41 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -82.83 150.26 26.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.841 0.353 . . . . 0.0 110.83 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 176.19 121.59 0.67 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.472 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.9 t -108.33 -26.77 10.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.694 0.283 . . . . 0.0 110.935 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 63.37 138.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.879 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.03 78.83 1.84 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.071 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 22.0 m -77.29 67.8 3.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.822 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 46.2 t -103.66 136.32 37.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.263 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.508 HG12 ' CB ' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -140.05 131.26 31.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.691 179.603 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 16.5 m -139.1 131.52 28.56 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.123 0.487 . . . . 0.0 111.253 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -170.34 -164.87 26.78 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.012 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.437 ' CG1' HG12 ' A' ' 72' ' ' ILE . 46.4 t -78.77 142.45 14.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.829 0.347 . . . . 0.0 110.927 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -69.99 -56.89 5.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.494 -179.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.437 HG12 ' CG1' ' A' ' 70' ' ' VAL . 11.1 pt -53.63 -33.89 23.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.434 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 84.5 t -70.86 -31.43 45.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.783 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.3 mtt -78.26 -41.03 35.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.521 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.401 ' OD1' ' CD2' ' A' ' 76' ' ' HIS . 13.0 p30 -82.13 -28.51 32.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.528 -179.41 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.43 ' CE1' ' HA ' ' A' ' 14' ' ' PHE . 28.4 m170 -93.17 0.11 57.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.852 0.358 . . . . 0.0 110.838 179.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.461 ' HB2' ' HB3' ' A' ' 138' ' ' GLU . 13.2 m-70 56.22 27.96 12.47 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.121 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 43.6 mt -56.79 140.48 47.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.703 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -124.93 135.84 53.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.946 0.403 . . . . 0.0 111.279 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.418 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 0.0 OUTLIER -94.36 117.71 30.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.855 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.3 t -109.68 140.86 43.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.927 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 59.1 m -77.46 159.23 29.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.909 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.452 ' CB ' ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -164.23 156.13 16.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.887 -179.974 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.78 172.87 7.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.911 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.3 mttm -69.48 -52.38 27.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.893 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -62.04 -41.98 98.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.71 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.406 ' HB2' ' CD2' ' A' ' 83' ' ' PHE . . . -59.47 -42.87 93.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.076 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.51 ' CZ ' ' CE1' ' A' ' 134' ' ' PHE . 0.1 OUTLIER -58.27 -34.49 70.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.917 -179.928 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 45.3 mttt -60.31 -48.11 83.14 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.052 0.453 . . . . 0.0 110.451 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.1 mtmt -76.69 -27.85 55.68 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.698 178.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -65.18 -47.49 76.78 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.777 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.443 ' CD1' ' CE2' ' A' ' 95' ' ' TYR . 4.7 tp -62.58 -44.2 99.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.039 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.5 tttp -60.52 -40.08 90.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.139 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.458 ' HA ' ' HG2' ' A' ' 97' ' ' LYS . 26.0 t0 -75.22 -40.07 59.48 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.879 -179.257 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.465 ' CD1' ' C ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -77.95 -40.43 39.47 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 121.053 -0.259 . . . . 0.0 110.944 -179.444 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.423 ' HG2' ' O ' ' A' ' 92' ' ' ILE . 2.4 ptt? -67.64 -32.04 72.46 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.763 0.316 . . . . 0.0 110.59 179.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.458 ' HG2' ' HA ' ' A' ' 94' ' ' ASP . 1.6 ptmm? -70.47 -34.57 72.55 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.524 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.42 ' N ' ' HG3' ' A' ' 97' ' ' LYS . 2.3 m -61.09 -40.24 92.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.046 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 6.9 mt -79.78 -41.07 21.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.433 179.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 5.1 tttp -55.3 -53.73 52.5 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.441 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -60.56 -46.35 94.57 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.017 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 6.4 tptt -62.62 -37.1 84.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.959 0.409 . . . . 0.0 110.336 179.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' A' ' 107' ' ' ARG . 3.1 tp -70.41 -33.96 71.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.059 179.269 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.401 ' HA ' ' HA ' ' A' ' 108' ' ' PRO . 77.3 mt-10 -58.85 -31.63 68.7 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.634 179.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -86.58 -21.09 27.05 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.738 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -105.13 -62.53 1.33 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.74 0.305 . . . . 0.0 111.559 -179.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.441 ' N ' ' O ' ' A' ' 103' ' ' LEU . 19.6 mtt-85 -129.74 64.77 73.08 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.879 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.405 ' HA ' ' CG1' ' A' ' 111' ' ' VAL . 9.5 Cg_endo -50.52 -22.12 8.61 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 123.192 2.595 . . . . 0.0 112.745 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -70.75 -11.88 61.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.609 0.243 . . . . 0.0 111.323 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.528 ' C ' ' HD2' ' A' ' 113' ' ' PRO . 0.0 OUTLIER -110.88 -0.26 16.92 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.342 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.405 ' CG1' ' HA ' ' A' ' 108' ' ' PRO . 34.1 m -66.38 -36.37 77.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -179.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.566 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 1.1 mttp -69.01 -51.2 19.03 Favored Pre-proline 0 C--N 1.332 -0.194 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.457 -179.316 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.566 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 50.1 Cg_exo -52.45 -41.39 67.71 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.04 1.827 . . . . 0.0 111.894 179.367 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.425 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 78.2 t80 -67.28 -39.22 86.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.967 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 1.4 mmm -56.98 -51.22 70.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.971 0.415 . . . . 0.0 110.858 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 62.3 m -76.53 -44.62 34.23 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.758 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.28 -45.93 95.2 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.551 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.07 -51.5 69.44 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.008 0.432 . . . . 0.0 111.068 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.38 -28.11 67.66 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.225 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -71.73 -46.9 57.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.181 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -72.97 -38.43 66.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.07 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.462 ' CG2' ' N ' ' A' ' 123' ' ' LYS . 0.4 OUTLIER -61.54 -46.78 95.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.147 -179.853 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.462 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 3.6 pttp -62.2 -31.74 72.3 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.099 0.476 . . . . 0.0 110.142 179.451 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 3.9 t-160 -67.35 -53.3 30.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.703 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 15.5 pt -61.73 -42.28 93.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.341 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 11.5 mt -53.87 -36.08 62.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.912 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -72.86 -10.16 59.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.173 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -141.64 33.7 1.63 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.017 0.437 . . . . 0.0 110.462 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.5 ' CE1' ' CZ ' ' A' ' 134' ' ' PHE . 11.5 t80 -50.3 -26.41 4.78 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.237 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.2 mmtt -61.76 -27.47 68.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.769 0.319 . . . . 0.0 110.945 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 22.2 m-20 -94.27 -36.75 11.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.488 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.409 ' CG ' ' OD2' ' A' ' 150' ' ' ASP . 10.8 m-85 -98.13 138.75 34.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.918 0.39 . . . . 0.0 111.25 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -122.96 144.69 49.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.951 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.51 ' CE1' ' CZ ' ' A' ' 88' ' ' TYR . 1.3 m-85 -80.52 123.81 28.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.089 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.418 ' CE2' ' HB2' ' A' ' 80' ' ' GLU . 30.3 m-85 -125.57 151.06 46.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.713 179.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.442 ' HB ' ' HA ' ' A' ' 140' ' ' MET . 0.4 OUTLIER -139.38 159.54 28.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.927 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.41 -165.12 0.3 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.403 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.461 ' HB3' ' HB2' ' A' ' 77' ' ' HIS . 5.1 pt-20 -71.52 -9.84 58.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.517 0.199 . . . . 0.0 111.467 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 -96.2 -32.03 12.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.585 0.231 . . . . 0.0 111.594 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' MET . . . . . 0.442 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 58.2 mtm 56.54 41.34 28.76 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.825 0.345 . . . . 0.0 111.137 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -67.02 120.44 71.91 Favored Pre-proline 0 N--CA 1.454 -0.252 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.713 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -61.8 -25.57 78.64 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.248 1.965 . . . . 0.0 111.903 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -84.79 -18.13 35.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.743 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -71.49 -161.74 4.8 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.249 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 3.9 ptp -97.03 177.82 5.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.785 0.326 . . . . 0.0 110.864 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 41.8 t -122.62 148.01 26.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.119 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.421 ' HB3' ' CE1' ' A' ' 162' ' ' PHE . . . -112.07 115.27 28.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.845 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.478 ' HB2' ' HB ' ' A' ' 161' ' ' ILE . 4.0 mt -89.56 105.9 18.1 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.814 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.1 tp -94.55 119.08 32.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.356 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.528 ' HB3' ' CE1' ' A' ' 159' ' ' TYR . 0.5 OUTLIER -134.97 170.16 16.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.561 179.367 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -105.74 150.36 25.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.909 0.385 . . . . 0.0 111.151 -179.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -78.09 -172.62 2.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.814 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -57.54 -41.13 80.32 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.942 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 44.4 p-10 -69.11 -15.07 63.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.238 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 65.3 19.04 65.97 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.589 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 80.4 t -113.44 -65.36 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.904 0.383 . . . . 0.0 111.044 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 98.3 m -64.98 111.87 6.84 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.14 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -82.06 131.61 6.96 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.63 2.22 . . . . 0.0 111.903 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.528 ' CE1' ' HB3' ' A' ' 150' ' ' ASP . 6.7 p90 -125.11 139.14 54.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.96 0.41 . . . . 0.0 111.142 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' MET . . . . . 0.401 ' HA ' ' O ' ' A' ' 148' ' ' LEU . 41.6 mtp -109.89 140.93 43.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.981 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.478 ' HB ' ' HB2' ' A' ' 148' ' ' LEU . 72.3 mt -97.07 116.92 40.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.337 -179.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.421 ' CE1' ' HB3' ' A' ' 147' ' ' ALA . 75.4 m-85 -117.33 151.01 37.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.57 179.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -100.47 124.89 46.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.955 0.407 . . . . 0.0 111.01 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 27.2 tttm -70.02 -45.55 66.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.275 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.425 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 15.8 m-20 -49.28 -35.6 18.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.24 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -109.26 30.71 8.3 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.509 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.411 HD12 ' CE1' ' A' ' 14' ' ' PHE . 1.5 tt -150.06 146.88 27.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.896 0.379 . . . . 0.0 110.918 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -132.06 154.09 49.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.331 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' MET . . . . . 0.475 ' HA ' ' O ' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -139.96 160.27 40.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.829 0.347 . . . . 0.0 111.32 -179.843 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -147.02 144.6 29.27 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.355 -179.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 17.2 mttp -83.56 108.95 17.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.015 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 51.1 t -80.56 -36.42 32.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.848 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 2.0 tt -99.77 144.63 28.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.928 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.207 -0.902 . . . . 0.0 110.944 179.911 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.855 0.36 . . . . 0.0 111.216 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.433 HG21 ' HB2' ' A' ' 16' ' ' ASP . 1.5 tt -121.92 145.77 28.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.974 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 11.4 mm -100.11 154.18 4.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.433 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.512 ' CD2' ' CZ ' ' A' ' 14' ' ' PHE . 3.5 m-85 -123.85 111.08 15.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.436 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.22 146.65 50.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.919 0.39 . . . . 0.0 111.215 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.451 ' O ' ' HA ' ' A' ' 10' ' ' HIS . 46.1 t0 -54.67 152.16 7.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.897 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 56.2 tp -80.88 -20.36 42.43 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.484 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.1 mp -91.35 -48.28 13.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -93.79 -21.97 18.97 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 -179.157 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.451 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 3.5 m-70 63.52 31.38 14.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.884 0.373 . . . . 0.0 110.8 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -102.66 121.76 43.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.804 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -57.24 98.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.303 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.8 mtt -78.18 -18.07 55.99 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.733 179.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.512 ' CZ ' ' CD2' ' A' ' 4' ' ' TYR . 5.7 p90 -177.37 177.42 1.19 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.778 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -133.84 -171.94 2.86 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.659 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.433 ' HB2' HG21 ' A' ' 2' ' ' ILE . 22.2 t0 -95.0 27.13 3.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.966 0.413 . . . . 0.0 110.876 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.436 HD13 ' CZ ' ' A' ' 18' ' ' TYR . 45.6 pt -86.63 -13.83 10.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.479 179.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.436 ' CZ ' HD13 ' A' ' 17' ' ' ILE . 79.8 m-85 -106.16 -170.34 1.71 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.537 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.39 88.56 4.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.721 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.3 mp -87.97 130.65 37.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.16 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.9 mtt180 -121.73 119.12 30.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.888 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -71.4 116.07 11.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.924 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.6 pt -109.62 172.46 2.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.022 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 58.32 28.1 16.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.194 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 65.11 54.39 1.23 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.451 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.44 -3.51 72.84 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.553 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.48 -56.89 7.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 117.111 0.456 . . . . 0.0 110.815 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 46.9 m -120.08 168.72 10.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.747 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.22 133.43 44.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.853 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -98.42 112.84 24.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.963 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.441 ' CG2' ' CE2' ' A' ' 14' ' ' PHE . 22.8 t -93.63 111.98 25.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.744 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -86.87 124.7 33.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.145 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.59 -135.93 8.38 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.358 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.7 pttm -174.51 124.62 0.3 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.855 0.36 . . . . 0.0 110.881 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 62.9 mtm -69.74 121.83 17.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.75 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.1 m -111.66 127.02 69.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.342 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 78.8 p -86.77 165.69 15.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.952 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.469 ' HB3' HG12 ' A' ' 67' ' ' ILE . 0.3 OUTLIER -141.35 152.99 44.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.885 -179.853 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.7 t -177.8 76.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.854 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -162.73 106.7 1.1 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.89 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 126.56 135.74 4.26 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.388 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -95.14 155.33 16.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.777 0.322 . . . . 0.0 110.875 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.3 mp -89.38 111.59 23.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.126 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 60.5 111.07 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.921 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -68.75 159.32 32.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.935 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.34 -66.5 0.92 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.893 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -101.86 -16.23 16.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.285 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 17.9 mt 64.18 -76.9 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.064 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 159.46 -167.72 35.17 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.532 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -85.2 168.31 42.51 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.537 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 60.66 111.25 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.932 0.396 . . . . 0.0 110.867 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -122.61 111.76 17.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.033 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.02 -177.72 4.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.991 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -92.2 -37.9 12.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.051 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -86.98 79.7 8.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.875 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -173.14 103.54 0.19 Allowed Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.459 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -67.56 -175.0 0.62 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.41 2.073 . . . . 0.0 112.282 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -86.93 161.16 18.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.89 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 164.25 104.19 0.18 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.441 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -138.13 129.78 28.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.91 0.386 . . . . 0.0 110.949 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -82.44 84.56 1.51 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.47 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.11 -177.88 4.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.776 0.322 . . . . 0.0 110.853 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -131.17 113.49 13.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.889 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -170.31 153.02 4.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.829 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 63.84 139.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.878 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.8 t -131.33 123.64 53.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.051 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.469 HG12 ' HB3' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -118.02 132.64 67.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.014 -179.986 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 89.0 m -139.05 140.39 38.06 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.966 0.412 . . . . 0.0 111.188 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -175.71 176.94 47.56 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.31 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.41 ' HB ' ' CG2' ' A' ' 73' ' ' VAL . 60.1 t -68.37 141.34 17.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.875 0.369 . . . . 0.0 110.852 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -67.56 -58.77 4.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.48 -179.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.432 HG23 ' CZ ' ' A' ' 18' ' ' TYR . 8.9 pt -53.72 -33.84 23.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.531 -179.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.41 ' CG2' ' HB ' ' A' ' 70' ' ' VAL . 58.7 t -72.26 -33.92 47.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.054 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.5 mtm -78.13 -38.89 42.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.598 -179.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 19.1 p30 -82.07 -28.89 32.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.565 -179.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.424 ' CE1' ' HB ' ' A' ' 72' ' ' ILE . 26.7 m170 -93.43 -1.12 56.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.841 0.353 . . . . 0.0 110.952 179.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 57.87 30.52 19.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.07 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 56.9 mt -57.83 134.88 56.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.535 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -118.48 134.36 55.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.941 0.4 . . . . 0.0 111.161 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.427 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 16.0 tt0 -87.63 129.81 34.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.934 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.1 t -122.81 126.31 47.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.829 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.4 m -68.06 159.02 31.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.999 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -165.42 149.72 8.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.799 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.54 158.18 17.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.798 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.47 -52.5 65.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.896 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -62.35 -44.33 96.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.738 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.64 -37.9 76.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.938 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.481 ' CD2' HD13 ' A' ' 122' ' ' ILE . 2.0 t80 -59.92 -38.64 82.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.736 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.426 ' O ' ' CG2' ' A' ' 92' ' ' ILE . 32.6 mttt -57.46 -49.47 76.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.172 0.51 . . . . 0.0 110.483 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.2 mtmt -72.42 -27.82 62.58 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.829 178.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -66.84 -46.16 75.97 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.957 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.426 ' CG2' ' O ' ' A' ' 89' ' ' LYS . 2.9 tp -60.45 -40.79 85.29 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.172 0 CA-C-O 120.766 0.317 . . . . 0.0 110.866 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.435 ' O ' ' CG ' ' A' ' 97' ' ' LYS . 0.9 OUTLIER -61.31 -46.33 90.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.733 179.935 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -71.2 -38.96 72.04 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.846 -179.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.544 ' CD1' ' C ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -74.5 -41.64 60.33 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.739 -0.21 . . . . 0.0 110.792 -179.542 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.405 ' HG2' ' O ' ' A' ' 92' ' ' ILE . 19.7 ptt? -64.86 -32.06 73.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.825 0.345 . . . . 0.0 110.248 179.271 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.435 ' CG ' ' O ' ' A' ' 93' ' ' LYS . 5.4 mmtp -64.4 -42.91 95.83 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.853 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.7 m -56.96 -43.32 81.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.82 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 6.3 mt -79.72 -40.92 21.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.587 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.83 -51.87 65.98 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.706 179.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -64.33 -45.39 93.55 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.014 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.88 -42.06 92.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.927 0.394 . . . . 0.0 110.447 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.44 ' O ' ' N ' ' A' ' 107' ' ' ARG . 4.1 tp -65.55 -36.49 83.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.181 179.4 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 108' ' ' PRO . 76.9 mt-10 -58.43 -28.55 65.37 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.772 179.358 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -88.73 -19.23 26.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.73 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -110.39 -60.99 1.73 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.77 0.319 . . . . 0.0 111.673 -179.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 103' ' ' LEU . 1.1 mtt85 -125.59 63.17 44.35 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.93 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.408 ' HA ' ' CG1' ' A' ' 111' ' ' VAL . 10.1 Cg_endo -50.77 -22.22 9.44 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 123.064 2.51 . . . . 0.0 112.798 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -73.44 -15.23 61.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.749 0.309 . . . . 0.0 111.253 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.526 ' C ' ' HD2' ' A' ' 113' ' ' PRO . 2.5 mmm180 -106.34 0.73 25.24 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.774 -179.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.408 ' CG1' ' HA ' ' A' ' 108' ' ' PRO . 32.8 m -68.17 -36.66 76.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.573 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 28.4 mttt -66.79 -51.25 40.17 Favored Pre-proline 0 CA--C 1.53 0.186 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.233 -179.286 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.573 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 51.8 Cg_exo -53.31 -41.48 72.35 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.062 1.841 . . . . 0.0 111.821 179.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.448 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 88.2 t80 -68.35 -37.86 80.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.964 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -53.94 -49.81 67.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.004 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.8 m -76.61 -44.29 34.89 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.825 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -59.09 -44.12 96.54 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.691 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.53 -45.95 92.0 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.026 0.441 . . . . 0.0 110.718 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.76 -32.6 65.76 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.67 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -78.28 -43.07 29.09 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.731 0.3 . . . . 0.0 111.242 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -66.26 -39.5 89.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.138 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.481 HD13 ' CD2' ' A' ' 88' ' ' TYR . 0.3 OUTLIER -63.11 -45.0 99.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.053 -179.929 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.443 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 27.0 mttt -59.51 -31.12 69.07 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.215 179.387 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 3.9 t-160 -68.21 -54.12 20.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.622 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 8.7 pt -61.78 -38.51 80.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.118 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.433 ' HG ' ' CD1' ' A' ' 122' ' ' ILE . 12.4 mt -53.6 -40.3 65.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.553 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.02 -19.13 60.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.766 179.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -128.91 28.94 5.28 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.392 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -48.9 -42.28 36.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.273 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 8.4 ttpp -68.67 -15.4 63.51 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.367 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -94.05 -38.54 11.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.382 -179.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.465 ' CD1' ' N ' ' A' ' 132' ' ' TYR . 1.7 m-30 -97.77 153.79 18.04 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.971 0.415 . . . . 0.0 111.365 -179.386 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.424 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 4.8 mm100 -123.35 155.32 37.54 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.538 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.446 ' CE1' ' CE1' ' A' ' 88' ' ' TYR . 3.4 m-85 -93.24 133.86 36.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.876 0.369 . . . . 0.0 111.124 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.427 ' CE2' ' HB2' ' A' ' 80' ' ' GLU . 36.4 m-85 -134.25 151.29 51.21 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.491 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.425 ' HB ' ' HA ' ' A' ' 140' ' ' MET . 0.5 OUTLIER -134.61 161.44 40.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.965 179.897 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -62.19 -164.38 0.37 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.169 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -73.38 -8.93 57.95 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.552 0.215 . . . . 0.0 111.433 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -97.96 -28.7 13.69 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.668 -179.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' MET . . . . . 0.425 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 45.7 mtp 55.72 42.39 29.31 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.897 0.379 . . . . 0.0 111.02 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . 0.417 ' ND2' ' HA3' ' A' ' 144' ' ' GLY . 16.5 p-10 -65.03 114.78 16.34 Favored Pre-proline 0 N--CA 1.452 -0.373 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.993 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -62.19 -29.29 80.37 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.496 2.13 . . . . 0.0 112.142 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -84.64 -7.66 59.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.127 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.417 ' HA3' ' ND2' ' A' ' 141' ' ' ASN . . . -86.41 -167.67 43.9 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.436 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 1.6 ptp -84.99 -174.41 5.26 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.949 0.404 . . . . 0.0 110.794 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 75.6 t -130.27 155.65 41.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.067 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.408 ' HB3' ' CE1' ' A' ' 162' ' ' PHE . . . -116.56 110.84 19.08 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.473 179.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.502 ' HB2' ' HB ' ' A' ' 161' ' ' ILE . 5.0 mt -86.46 106.01 17.18 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.236 -179.174 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.0 tp -89.69 119.77 30.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.928 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.52 ' HB2' ' CZ ' ' A' ' 159' ' ' TYR . 57.6 m-20 -131.91 161.67 32.48 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.68 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -105.3 146.6 29.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.119 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 8.7 mmt180 -59.68 -176.2 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.907 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -56.36 -41.31 75.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.951 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -72.61 -15.13 61.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.164 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 77.83 21.59 71.15 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.626 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 87.5 t -113.41 -73.01 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.772 0.32 . . . . 0.0 110.924 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 98.9 m -53.02 103.23 0.35 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.13 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -77.11 127.88 9.51 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.724 2.283 . . . . 0.0 112.069 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.52 ' CZ ' ' HB2' ' A' ' 150' ' ' ASP . 10.5 p90 -126.54 133.26 51.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.956 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' MET . . . . . 0.42 ' HE1' ' CG ' ' A' ' 135' ' ' PHE . 0.5 OUTLIER -103.46 140.03 38.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.055 -179.659 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.502 ' HB ' ' HB2' ' A' ' 148' ' ' LEU . 90.4 mt -95.59 113.81 30.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.888 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.408 ' CE1' ' HB3' ' A' ' 147' ' ' ALA . 47.9 m-85 -117.45 133.89 55.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.889 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -79.33 128.96 33.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.977 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 12.4 tttm -70.12 -52.83 20.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.101 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.448 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 19.3 m-20 -49.3 -37.83 25.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.155 -179.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -96.56 28.73 12.13 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.341 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -146.74 145.88 30.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.75 0.309 . . . . 0.0 110.843 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -109.84 152.61 25.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.854 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.28 138.66 54.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.935 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -149.88 130.73 14.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.962 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 17.3 mttm -83.76 116.57 22.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.899 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 1.8 t -93.2 165.3 12.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.888 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -112.6 -33.58 6.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.964 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.185 -0.912 . . . . 0.0 110.861 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.0 ttt . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.837 0.351 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.1 tt -110.08 147.81 14.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.14 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 19.3 mm -107.56 155.01 8.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.089 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.5 ' CD2' ' CE2' ' A' ' 14' ' ' PHE . 3.4 m-85 -122.2 104.47 9.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.606 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -119.19 152.19 37.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.343 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.441 ' O ' ' HA ' ' A' ' 10' ' ' HIS . 38.9 t0 -58.11 152.2 17.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.802 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 56.6 tp -81.38 -23.89 37.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.306 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.8 mp -91.18 -45.07 14.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.3 t -93.76 -25.34 17.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.781 -179.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.441 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 38.5 m80 66.47 28.84 9.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.883 0.373 . . . . 0.0 110.832 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -102.48 123.57 46.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.749 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.12 99.8 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.259 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 33.3 mtp -80.91 -16.53 53.33 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.795 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.5 ' CE2' ' CD2' ' A' ' 4' ' ' TYR . 12.3 p90 -178.22 175.57 1.2 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.698 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -134.05 -169.85 2.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.071 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.7 p-10 -89.96 19.74 4.68 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.549 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 46.2 pt -86.15 -6.93 10.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.817 0.342 . . . . 0.0 111.266 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.426 ' CE2' HG22 ' A' ' 72' ' ' ILE . 71.1 m-85 -116.5 168.87 9.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.748 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? -79.71 93.34 5.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.681 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.4 mp -87.78 125.66 41.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.066 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -116.97 132.14 56.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.981 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -81.52 116.11 21.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.775 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 7.7 pt -116.45 167.08 9.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.018 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 58.44 34.54 24.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.068 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 64.45 38.62 7.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.214 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.67 -10.49 74.55 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.667 -0.777 . . . . 0.0 113.182 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.18 -37.64 69.86 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.901 0.35 . . . . 0.0 111.143 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 72.0 m -136.98 169.74 17.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.139 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -131.99 119.08 20.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.897 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -83.09 112.94 20.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.107 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 30.6 t -94.74 111.92 26.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.615 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -82.54 118.48 23.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.205 -179.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.4 -139.21 9.67 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.267 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.6 pttm -174.36 129.97 0.36 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.772 0.32 . . . . 0.0 110.958 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 17.4 mtm -76.73 125.0 28.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.896 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.0 m -118.2 134.39 61.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.216 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.22 165.54 12.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.957 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.42 ' HB3' HG12 ' A' ' 67' ' ' ILE . 1.1 ttt180 -158.58 124.02 4.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.796 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.8 p -109.46 49.68 0.82 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.877 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -96.57 153.03 18.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.862 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 161.82 150.41 5.95 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.505 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -111.77 144.45 41.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.806 0.336 . . . . 0.0 110.878 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 6.4 tp -65.17 131.46 30.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.267 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -129.51 118.08 21.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.994 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -138.83 -178.06 5.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.89 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.5 -32.5 16.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.872 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 42.8 mt -80.05 -35.77 36.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.861 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 46.0 mm 62.76 -78.07 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.124 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 66.72 -95.17 0.26 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.574 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -59.99 114.51 6.45 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.584 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -97.67 57.23 1.34 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.876 0.369 . . . . 0.0 110.868 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -98.09 35.19 1.78 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.149 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.07 78.59 2.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.9 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -77.52 -36.66 52.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.025 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -89.67 89.15 7.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.901 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 134.9 114.33 1.41 Allowed Glycine 0 CA--C 1.521 0.417 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.627 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -60.27 -15.96 37.97 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.565 2.177 . . . . 0.0 112.454 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 77.36 99.74 0.07 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.972 0.415 . . . . 0.0 110.899 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -156.81 -45.34 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.495 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -96.76 -176.85 3.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.736 0.303 . . . . 0.0 110.925 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -87.53 -73.04 1.28 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.519 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 12.9 p 55.12 101.74 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.829 0.347 . . . . 0.0 111.004 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.05 -179.81 7.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.852 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.4 m -97.42 38.03 1.3 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.912 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 22.0 m -86.8 147.43 25.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.008 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 88.1 t -73.32 143.19 14.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.134 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.42 HG12 ' HB3' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -122.25 126.25 74.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.696 179.67 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.49 114.69 10.24 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.893 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -147.24 -176.66 21.13 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.229 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.413 ' CG1' HG12 ' A' ' 72' ' ' ILE . 59.8 t -69.73 148.28 11.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.911 0.386 . . . . 0.0 110.931 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -72.48 -57.56 4.08 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.338 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.43 ' HB ' ' CE1' ' A' ' 76' ' ' HIS . 10.8 pt -53.53 -34.01 22.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.421 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.418 ' HA ' ' HB2' ' A' ' 78' ' ' LEU . 57.9 t -71.24 -31.88 45.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.882 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.3 mtm -78.01 -40.47 38.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.417 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.406 ' OD1' ' CD2' ' A' ' 76' ' ' HIS . 13.5 p30 -82.12 -28.77 32.06 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.51 -179.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.43 ' CE1' ' HB ' ' A' ' 72' ' ' ILE . 26.9 m170 -93.55 -0.28 56.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.753 0.311 . . . . 0.0 110.88 179.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 55.89 29.62 14.47 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.09 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.418 ' HB2' ' HA ' ' A' ' 73' ' ' VAL . 52.3 mt -57.09 139.84 51.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.652 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -124.44 137.38 54.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.126 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -91.59 131.86 36.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.037 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.2 t -118.5 170.1 9.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.872 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.3 m -107.39 165.19 11.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.955 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.493 ' CE2' ' CE2' ' A' ' 91' ' ' TYR . 2.7 m-85 -171.68 149.84 2.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.95 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.3 m -101.48 166.34 10.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.767 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.7 mtmp? -57.34 -49.86 74.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.873 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.65 -40.25 76.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.831 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.95 -43.73 94.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.101 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.507 ' CZ ' ' CE1' ' A' ' 134' ' ' PHE . 0.6 OUTLIER -61.48 -30.74 70.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.757 179.921 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.447 ' O ' HG22 ' A' ' 92' ' ' ILE . 27.7 mttm -62.98 -44.66 95.43 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.012 0.434 . . . . 0.0 110.566 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 11.3 mttm -78.56 -27.9 45.89 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.771 178.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.493 ' CE2' ' CE2' ' A' ' 83' ' ' PHE . 17.2 t80 -67.03 -47.32 71.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.073 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.457 ' CD1' ' CE2' ' A' ' 95' ' ' TYR . 2.3 tp -65.06 -40.21 88.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.074 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.444 ' O ' ' CG ' ' A' ' 97' ' ' LYS . 4.9 ttpp -62.73 -45.28 93.47 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.923 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -68.76 -39.34 80.32 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.861 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.534 ' CD1' ' C ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -76.03 -43.78 42.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.712 -0.222 . . . . 0.0 110.875 -179.299 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 3.2 ptt? -62.06 -31.99 72.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.914 0.388 . . . . 0.0 110.238 179.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.444 ' CG ' ' O ' ' A' ' 93' ' ' LYS . 3.8 mmtt -66.46 -42.11 88.04 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.717 179.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.4 m -57.22 -41.72 80.0 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.657 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 6.6 mt -79.78 -42.26 22.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.685 179.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.8 tttt -53.64 -54.5 36.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.55 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -62.12 -46.4 94.07 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.126 179.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 26.0 tptt -61.08 -37.01 81.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.945 0.402 . . . . 0.0 110.406 179.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.437 ' O ' ' N ' ' A' ' 107' ' ' ARG . 6.6 tp -70.82 -32.94 70.17 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.051 179.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -60.97 -29.13 69.48 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.806 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -89.97 -19.58 24.32 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.423 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -106.84 -62.68 1.37 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.881 0.372 . . . . 0.0 111.472 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.437 ' N ' ' O ' ' A' ' 103' ' ' LEU . 9.7 mtt-85 -124.91 62.72 37.07 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.902 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -50.82 -24.53 13.63 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 123.091 2.528 . . . . 0.0 112.537 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -73.05 -9.46 58.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.247 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.485 ' C ' ' HD2' ' A' ' 113' ' ' PRO . 58.2 mmt-85 -110.84 0.11 17.11 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.665 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 26.5 m -71.42 -33.8 51.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.545 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 4.9 mttm -67.69 -50.4 35.22 Favored Pre-proline 0 CA--C 1.53 0.197 0 C-N-CA 120.997 -0.281 . . . . 0.0 111.681 -179.12 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.545 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 24.7 Cg_exo -63.16 -29.28 73.99 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.148 1.899 . . . . 0.0 111.67 179.478 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.469 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 89.3 t80 -72.12 -42.4 66.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.861 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 2.7 mmm -58.07 -43.83 87.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.874 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 66.2 m -76.69 -45.15 30.68 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.905 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.15 -45.83 92.69 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.775 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.19 -51.76 68.02 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.045 0.45 . . . . 0.0 111.269 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.405 ' O ' ' HG2' ' A' ' 123' ' ' LYS . . . -71.85 -28.06 63.3 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.502 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -74.13 -50.0 21.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.772 0.32 . . . . 0.0 111.474 -179.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -67.62 -39.2 84.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.512 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.481 ' CG2' ' N ' ' A' ' 123' ' ' LYS . 0.3 OUTLIER -59.5 -49.82 82.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.654 -179.458 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.481 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 9.5 ptpt -60.18 -30.64 69.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.059 0.457 . . . . 0.0 110.276 179.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -68.91 -53.26 21.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.755 179.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 16.7 pt -62.31 -42.33 95.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.309 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 11.3 mt -53.76 -37.18 63.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.946 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -72.89 -9.8 59.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.215 179.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 -142.24 34.44 1.51 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.983 0.42 . . . . 0.0 110.477 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.507 ' CE1' ' CZ ' ' A' ' 134' ' ' PHE . 5.4 t80 -51.95 -24.71 6.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.113 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -55.92 -37.91 69.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.979 0.418 . . . . 0.0 111.0 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 27.0 m-20 -86.25 -42.75 13.51 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.685 -179.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -92.72 129.31 38.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.881 0.372 . . . . 0.0 111.394 -179.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.403 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 2.3 mm100 -114.84 145.13 42.49 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.911 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.507 ' CZ ' ' CE1' ' A' ' 129' ' ' PHE . 1.7 m-85 -79.95 127.52 32.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.174 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.407 ' CE1' ' HB3' ' A' ' 149' ' ' LEU . 48.0 m-85 -132.3 134.18 44.94 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.586 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.459 ' HB ' ' HA ' ' A' ' 140' ' ' MET . 0.7 OUTLIER -120.94 161.86 20.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.939 -179.811 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.47 -165.12 0.14 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.266 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -72.35 -9.18 58.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.566 0.222 . . . . 0.0 111.489 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 -97.59 -33.9 11.17 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 120.652 0.263 . . . . 0.0 111.518 -179.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' MET . . . . . 0.459 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 34.9 mtm 60.47 34.96 20.4 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.683 0.278 . . . . 0.0 111.335 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -64.4 123.6 83.26 Favored Pre-proline 0 N--CA 1.451 -0.392 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.732 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -61.95 -23.35 75.77 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.321 2.014 . . . . 0.0 111.822 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -84.45 -12.14 54.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.734 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -80.96 -175.54 49.96 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.258 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 1.4 ptp -85.37 -177.98 6.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.783 0.325 . . . . 0.0 110.891 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 43.6 t -125.88 149.04 30.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.96 0.41 . . . . 0.0 111.165 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -113.55 112.52 23.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.649 179.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.517 ' HB2' ' HB ' ' A' ' 161' ' ' ILE . 4.7 mt -85.86 106.27 16.95 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.03 -179.361 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.407 ' HB3' ' CE1' ' A' ' 135' ' ' PHE . 3.3 tp -90.75 119.19 30.77 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.381 -179.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.491 ' HB3' ' CE1' ' A' ' 159' ' ' TYR . 13.4 t70 -132.57 164.29 26.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.482 179.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -97.49 146.7 24.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.955 0.407 . . . . 0.0 111.226 -179.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.09 -176.36 0.88 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.882 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -58.96 -41.31 87.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.923 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -67.18 -15.1 63.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.132 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 75.03 11.07 84.17 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.68 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 73.6 t -111.89 -70.15 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.846 0.355 . . . . 0.0 110.872 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 90.5 m -55.6 108.54 1.21 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.163 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -82.65 132.19 6.57 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.579 2.186 . . . . 0.0 112.074 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.491 ' CE1' ' HB3' ' A' ' 150' ' ' ASP . 8.1 p90 -125.28 149.15 48.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.89 0.376 . . . . 0.0 110.983 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -114.52 150.76 34.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.162 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.517 ' HB ' ' HB2' ' A' ' 148' ' ' LEU . 88.5 mt -103.44 111.95 35.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.871 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -114.53 125.84 54.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.907 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.407 ' CE2' ' OH ' ' A' ' 95' ' ' TYR . 2.6 m-85 -71.06 124.68 24.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.744 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 6.3 tttm -66.39 -56.44 11.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.31 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.469 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 0.8 OUTLIER -51.06 -34.4 29.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.238 -179.797 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -95.73 25.28 25.73 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.47 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -137.74 146.99 44.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.867 0.365 . . . . 0.0 110.928 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -119.38 136.85 54.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.79 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 1.6 mpp? -103.98 154.55 19.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.015 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -157.48 125.19 5.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.799 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 3.3 mtpp -88.22 117.81 27.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.867 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER 67.0 -74.85 0.06 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.813 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 3.3 pp -151.93 32.07 0.55 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.89 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.922 179.986 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.1 ttp . . . . . 0 N--CA 1.486 1.375 0 CA-C-O 120.848 0.356 . . . . 0.0 111.116 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.452 ' CD1' ' HB3' ' A' ' 169' ' ' MET . 10.0 tt -88.84 128.93 40.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.159 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' A' ' 169' ' ' MET . 19.4 mm -92.88 157.31 2.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.23 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.498 ' CD2' ' CE2' ' A' ' 14' ' ' PHE . 3.0 m-85 -124.54 106.7 10.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.489 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 25.0 ptt180 -121.84 148.28 44.89 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.817 0.341 . . . . 0.0 111.333 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.435 ' O ' ' HA ' ' A' ' 10' ' ' HIS . 23.3 t0 -56.57 152.21 12.27 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.808 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 61.5 tp -80.3 -24.17 40.16 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.373 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.7 mp -91.3 -44.49 14.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.823 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.6 p -93.1 -23.77 18.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.77 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.435 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 5.6 m170 63.44 28.07 15.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.809 0.337 . . . . 0.0 110.817 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -102.73 121.39 42.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.734 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.52 89.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.204 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 6.4 mtt -69.32 -16.07 63.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.881 179.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.498 ' CE2' ' CD2' ' A' ' 4' ' ' TYR . 34.1 p90 -176.87 171.48 2.18 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.93 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.8 m -134.54 -169.94 2.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.005 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.424 ' HB3' HG21 ' A' ' 2' ' ' ILE . 13.5 p-10 -87.24 12.3 12.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.525 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 46.2 pt -81.3 -3.26 6.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.884 0.373 . . . . 0.0 111.062 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.43 ' CE2' HG22 ' A' ' 72' ' ' ILE . 65.2 m-85 -119.89 179.87 4.12 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.705 -179.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.14 88.94 7.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.916 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.4 mp -88.03 123.89 40.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.994 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.79 133.52 55.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.914 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -78.35 121.15 24.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.826 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.8 pt -116.44 174.59 3.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.205 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 57.06 24.82 10.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.393 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 65.72 57.55 0.84 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.37 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 73.56 18.95 79.62 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.756 -0.735 . . . . 0.0 113.354 179.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.53 -45.67 8.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.914 0.357 . . . . 0.0 110.948 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 17.0 m -130.67 171.62 12.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.054 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.48 131.08 46.59 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.941 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -97.25 112.77 24.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.798 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.6 t -92.0 111.78 24.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.726 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -84.19 117.57 23.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.12 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -99.82 -138.37 10.26 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.319 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -174.48 124.82 0.3 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.804 0.335 . . . . 0.0 111.013 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 55.8 mtp -68.61 122.0 17.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.656 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.3 m -119.08 133.81 64.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.292 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.405 ' HA ' ' HA ' ' A' ' 68' ' ' THR . 0.9 OUTLIER -83.27 149.35 26.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.785 179.865 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.436 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 0.0 OUTLIER -132.0 115.9 16.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.858 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.3 m -74.19 -60.59 2.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.845 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -66.68 -172.51 0.17 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.872 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.99 -147.68 16.3 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.464 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -116.83 -176.24 2.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.8 0.333 . . . . 0.0 110.88 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.8 mt -79.59 131.88 33.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.096 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -78.11 -48.84 15.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.861 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -138.79 -179.09 5.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.955 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 17.3 p -90.17 -32.55 16.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.85 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 21.8 mt -85.81 -18.89 31.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.152 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 38.9 mm 55.82 92.69 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.884 0.373 . . . . 0.0 111.092 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -79.66 74.9 2.19 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.506 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -97.71 -174.21 33.63 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.455 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -165.88 -48.11 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.76 0.314 . . . . 0.0 110.834 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.89 119.09 4.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.105 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.4 m -148.6 100.21 3.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.901 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -127.93 136.82 51.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.142 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -137.42 -74.26 0.42 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.843 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 148.28 -75.15 0.27 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.488 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.51 159.6 52.31 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.559 2.173 . . . . 0.0 112.343 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 60.7 157.64 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.917 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -81.69 115.32 4.0 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.517 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -105.21 138.91 40.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.756 0.312 . . . . 0.0 110.985 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 135.72 -27.6 3.06 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.503 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.93 -167.72 2.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.836 0.35 . . . . 0.0 110.809 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 67.48 -73.33 0.08 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.964 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 79.4 p -117.77 154.0 32.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.983 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.7 m -118.91 168.58 10.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.83 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' A' ' 38' ' ' ARG . 60.8 t -86.63 137.16 21.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.201 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.405 HG13 ' HB3' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -128.19 99.88 5.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.383 179.35 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 37' ' ' SER . 0.3 OUTLIER -100.84 108.87 20.77 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.035 -179.777 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -134.76 -173.63 13.17 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.143 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.415 ' CG1' HG12 ' A' ' 72' ' ' ILE . 47.8 t -74.22 142.66 14.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.851 0.357 . . . . 0.0 110.937 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -69.74 -57.53 5.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.399 -179.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.433 ' HB ' ' CE1' ' A' ' 76' ' ' HIS . 9.1 pt -53.72 -33.92 23.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.576 -179.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 71.6 t -72.02 -33.75 48.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.838 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.8 mtm -78.4 -39.87 37.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.714 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.41 ' OD1' ' CD2' ' A' ' 76' ' ' HIS . 18.8 p30 -82.07 -29.13 32.0 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 -179.238 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.433 ' CE1' ' HB ' ' A' ' 72' ' ' ILE . 26.3 m170 -92.98 0.25 57.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.753 0.311 . . . . 0.0 110.858 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.404 ' CD2' ' N ' ' A' ' 77' ' ' HIS . 8.4 m170 55.09 32.79 19.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.913 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 52.4 mt -55.92 141.58 38.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.744 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -119.81 131.25 55.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.035 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.426 ' HG3' ' CE1' ' A' ' 135' ' ' PHE . 6.5 tt0 -95.0 127.26 40.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.93 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.8 t -120.03 165.12 15.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.751 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.0 p -97.03 159.65 14.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.841 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.446 ' HB2' ' CE2' ' A' ' 134' ' ' PHE . 1.6 m-85 -165.6 149.62 8.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.981 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.5 m -101.43 162.94 12.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.867 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 12.7 mttm -58.32 -52.46 65.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.065 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -63.71 -44.13 94.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.82 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.58 -42.22 98.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.02 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.442 ' CD2' HD12 ' A' ' 122' ' ' ILE . 0.7 OUTLIER -61.02 -33.84 73.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.841 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 12.8 mttp -61.19 -43.55 98.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.906 0.384 . . . . 0.0 110.554 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.1 mttp -78.11 -27.82 48.46 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.843 179.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -67.68 -42.27 82.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.878 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.452 HD12 ' CE2' ' A' ' 95' ' ' TYR . 5.0 tp -65.73 -44.24 93.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.898 0.38 . . . . 0.0 110.972 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.472 ' O ' ' CG ' ' A' ' 97' ' ' LYS . 2.0 ttpt -61.26 -45.35 94.88 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.782 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -68.75 -40.37 79.85 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.177 -179.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.538 ' CD1' ' C ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -77.69 -44.08 29.1 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.994 -179.272 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.41 ' HG3' ' N ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -60.17 -31.59 70.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.914 0.388 . . . . 0.0 110.195 179.165 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.472 ' CG ' ' O ' ' A' ' 93' ' ' LYS . 1.6 mmpt? -66.84 -45.14 79.14 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.445 179.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -54.92 -40.65 70.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.813 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.8 mt -79.95 -42.5 22.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.532 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.407 ' O ' ' HG3' ' A' ' 104' ' ' GLU . 0.0 OUTLIER -55.63 -52.05 65.14 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.442 179.62 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -63.19 -46.86 92.18 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.363 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.97 -44.41 94.48 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.877 0.37 . . . . 0.0 110.456 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.435 ' O ' ' N ' ' A' ' 107' ' ' ARG . 3.8 tp -63.26 -37.6 87.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.285 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.415 ' HA ' ' HA ' ' A' ' 108' ' ' PRO . 36.8 mt-10 -57.28 -29.5 63.92 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 120.818 0.342 . . . . 0.0 110.814 179.357 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -86.54 -19.29 29.68 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.617 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -109.52 -60.72 1.74 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.803 0.335 . . . . 0.0 111.774 -179.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.435 ' N ' ' O ' ' A' ' 103' ' ' LEU . 1.7 mtt180 -132.54 66.52 76.98 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.833 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.415 ' HA ' ' HA ' ' A' ' 104' ' ' GLU . 10.3 Cg_endo -50.56 -21.02 7.04 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 123.257 2.638 . . . . 0.0 112.879 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -69.76 -7.92 43.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.411 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.47 ' C ' ' HD2' ' A' ' 113' ' ' PRO . 0.0 OUTLIER -113.35 -2.6 13.95 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -179.517 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 33.1 m -73.13 -30.72 32.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -179.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.546 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 2.9 mtpt -69.46 -49.74 21.58 Favored Pre-proline 0 CA--C 1.53 0.197 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.711 -179.104 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.546 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 24.7 Cg_exo -63.13 -34.76 67.98 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.118 1.879 . . . . 0.0 111.987 179.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.447 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 69.6 t80 -72.21 -36.4 69.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.949 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.6 -54.88 41.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.983 0.42 . . . . 0.0 110.713 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 75.3 m -71.58 -44.68 64.05 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.584 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -59.89 -43.06 98.38 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.412 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -55.96 -48.52 75.64 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.022 0.439 . . . . 0.0 111.082 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.74 -33.51 66.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.382 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -74.31 -39.77 62.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.849 0.357 . . . . 0.0 111.256 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -71.75 -35.92 70.25 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.115 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.442 HD12 ' CD2' ' A' ' 88' ' ' TYR . 0.4 OUTLIER -67.06 -45.31 87.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.303 -179.698 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.433 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 10.0 ptpt -61.84 -30.87 71.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.965 0.412 . . . . 0.0 110.23 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -67.88 -53.6 25.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.652 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 14.8 pt -62.05 -41.42 91.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.282 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 13.4 mt -53.8 -37.46 63.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.915 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -65.02 -16.55 63.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.102 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 11.4 m-80 -137.16 33.0 2.59 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.644 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.498 ' CE1' ' CE2' ' A' ' 134' ' ' PHE . 1.1 t80 -52.5 -36.74 55.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.953 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -61.13 -18.76 59.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.286 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 35.2 m-20 -92.29 -43.43 9.29 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.716 0.293 . . . . 0.0 111.306 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.427 ' CD1' ' N ' ' A' ' 132' ' ' TYR . 1.4 m-30 -94.4 163.85 13.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.909 0.385 . . . . 0.0 111.245 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.421 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 2.3 mm100 -136.35 145.67 45.67 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.88 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.498 ' CE2' ' CE1' ' A' ' 129' ' ' PHE . 1.5 m-85 -79.89 125.54 29.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.932 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.426 ' CE1' ' HG3' ' A' ' 80' ' ' GLU . 50.1 m-85 -129.45 132.42 46.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.692 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.426 ' HB ' ' HA ' ' A' ' 140' ' ' MET . 0.3 OUTLIER -120.83 158.15 23.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.576 179.914 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -56.54 -171.76 0.15 Allowed Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.447 -0.883 . . . . 0.0 112.021 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -70.02 -11.18 60.69 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.693 0.282 . . . . 0.0 111.407 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 25.0 m-80 -93.99 -25.24 17.33 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.531 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' MET . . . . . 0.426 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 35.6 mtm 51.33 43.91 29.16 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.806 0.336 . . . . 0.0 111.321 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -66.68 120.72 73.19 Favored Pre-proline 0 N--CA 1.454 -0.267 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.766 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -61.26 -26.18 81.61 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.253 1.968 . . . . 0.0 111.893 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -84.85 -19.67 32.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.701 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -70.17 -172.84 11.16 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.316 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 5.7 ptp -90.4 -173.56 3.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.78 0.324 . . . . 0.0 110.883 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 58.1 t -128.88 150.65 34.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.112 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -115.44 111.53 20.92 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.654 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.509 ' HB2' ' HB ' ' A' ' 161' ' ' ILE . 3.9 mt -85.59 106.23 16.74 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.129 -179.201 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.405 ' HB3' ' CE1' ' A' ' 135' ' ' PHE . 4.2 tp -88.52 120.16 29.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.347 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.461 ' HB3' ' CE1' ' A' ' 159' ' ' TYR . 27.8 t70 -136.75 164.86 27.27 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.39 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -106.46 152.47 23.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.837 0.351 . . . . 0.0 111.13 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.25 -177.1 0.49 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.966 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.99 -37.9 75.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.835 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -76.23 -15.04 60.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.28 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 69.77 26.98 73.79 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.744 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 89.8 t -112.03 -61.89 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.848 0.356 . . . . 0.0 110.929 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 78.2 m -75.78 112.75 21.5 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.202 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -81.08 132.04 8.17 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.562 2.175 . . . . 0.0 112.065 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.461 ' CE1' ' HB3' ' A' ' 150' ' ' ASP . 9.9 p90 -127.13 142.81 51.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.957 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' MET . . . . . 0.416 ' HE3' ' CG ' ' A' ' 135' ' ' PHE . 0.1 OUTLIER -109.6 145.33 36.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.003 -179.848 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.509 ' HB ' ' HB2' ' A' ' 148' ' ' LEU . 74.5 mt -98.47 118.67 45.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.064 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -122.25 154.46 37.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.825 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.418 ' CZ ' ' OH ' ' A' ' 95' ' ' TYR . 11.2 m-85 -102.5 116.06 31.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.984 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.68 -40.72 97.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.104 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.447 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 2.1 m-20 -56.73 -38.4 72.31 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.814 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -98.44 24.38 32.26 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.353 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.431 HD11 ' CE1' ' A' ' 14' ' ' PHE . 0.5 OUTLIER -137.55 146.81 44.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.829 0.347 . . . . 0.0 110.771 179.985 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.406 ' N ' ' HG ' ' A' ' 167' ' ' LEU . 6.7 tt0 -116.45 149.93 38.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.771 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' MET . . . . . 0.452 ' HB3' ' CD1' ' A' ' 2' ' ' ILE . 1.0 OUTLIER -113.79 160.0 19.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.102 -179.829 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -161.83 122.09 2.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.818 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.36 117.47 30.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.986 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 3.9 t -150.82 162.49 40.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.909 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 45.49 40.63 5.9 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.383 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.13 -0.938 . . . . 0.0 110.843 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 tpt . . . . . 0 N--CA 1.487 1.412 0 CA-C-O 120.846 0.355 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.404 ' CG2' ' HB2' ' A' ' 16' ' ' ASP . 2.3 tt -108.48 149.57 11.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.017 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.418 ' O ' ' HA ' ' A' ' 169' ' ' MET . 20.4 mm -111.31 159.36 11.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.378 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.506 ' CD2' ' CE2' ' A' ' 14' ' ' PHE . 5.4 m-85 -122.81 104.56 9.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.306 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 21.9 ptt180 -116.65 145.51 43.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.008 0.432 . . . . 0.0 111.415 -179.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.447 ' O ' ' HA ' ' A' ' 10' ' ' HIS . 50.5 t0 -54.34 152.01 6.86 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.961 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 40.6 tp -82.47 -16.87 47.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.546 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.4 mp -91.27 -51.72 11.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -179.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.9 t -96.74 -16.26 20.97 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -179.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.447 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 1.8 m-70 64.39 30.08 13.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.865 0.364 . . . . 0.0 110.863 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -99.23 122.63 42.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.831 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.43 92.07 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.286 -179.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 35.8 mtp -70.85 -19.07 62.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.714 179.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.506 ' CE2' ' CD2' ' A' ' 4' ' ' TYR . 16.1 p90 -175.25 174.7 2.35 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.525 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.3 m -129.08 -170.53 2.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.822 0.344 . . . . 0.0 111.083 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.404 ' HB2' ' CG2' ' A' ' 2' ' ' ILE . 30.6 t0 -95.43 21.08 8.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.062 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 46.3 pt -87.14 -8.8 11.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.059 179.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.45 ' CZ ' HG23 ' A' ' 72' ' ' ILE . 84.3 m-85 -111.41 -175.99 2.84 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.899 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.1 mmmt -93.32 93.67 8.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.901 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.1 mp -88.06 123.96 40.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.985 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.1 mtp-105 -113.55 126.42 55.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.936 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -77.41 112.74 14.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.879 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.2 pt -109.69 168.46 3.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.063 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 57.72 30.17 18.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.152 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 63.9 40.14 7.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.29 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.7 -12.61 68.48 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.6 -0.81 . . . . 0.0 113.158 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.78 -37.4 76.24 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.824 0.345 . . . . 0.0 111.045 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 13.9 m -141.68 162.94 34.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.141 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -128.76 135.45 49.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.703 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.403 ' OE1' ' CD2' ' A' ' 159' ' ' TYR . 64.6 mt-10 -100.7 118.13 36.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.305 -179.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.415 HG21 ' CD2' ' A' ' 14' ' ' PHE . 24.2 t -94.8 112.02 26.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.729 179.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -84.67 122.96 29.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.205 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -108.98 -138.79 8.42 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.278 179.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.9 ptpt -174.48 128.3 0.34 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.821 0.343 . . . . 0.0 111.024 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 24.4 mtp -74.17 124.9 27.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.567 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.0 m -125.28 140.12 49.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.657 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 16.9 p -91.33 165.64 13.32 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.696 179.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.471 ' N ' ' O ' ' A' ' 67' ' ' ILE . 8.0 tpp180 -134.61 115.77 14.23 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.052 -179.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.65 108.97 19.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.795 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -141.04 48.5 1.69 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.003 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 122.31 172.99 14.2 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.597 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 31.8 p-10 -179.15 -39.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.827 0.346 . . . . 0.0 110.837 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 15.2 tt -90.09 159.65 2.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.01 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 64.07 44.8 4.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.867 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -155.95 26.83 0.37 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.919 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.11 -42.09 5.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.894 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.03 -30.84 68.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.933 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 34.1 mm -67.42 -63.97 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.105 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 154.01 -134.28 4.27 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.542 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 164.3 -139.44 5.85 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.5 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -115.83 56.16 0.77 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.901 0.381 . . . . 0.0 110.953 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -139.73 31.51 2.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.113 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.1 t -86.24 -31.68 21.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.796 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -138.31 80.69 1.81 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.079 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -164.48 -58.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.87 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 97.17 157.2 30.77 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.51 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -52.41 104.56 0.1 OUTLIER 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.581 2.187 . . . . 0.0 112.252 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -115.26 146.36 41.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.91 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -92.8 58.84 2.5 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.505 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -89.97 179.02 6.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.856 0.36 . . . . 0.0 110.881 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -59.93 157.09 27.33 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.482 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.7 t -64.49 119.52 10.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.852 0.358 . . . . 0.0 110.868 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.5 tt0 -175.95 126.6 0.22 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.944 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 63.1 m -132.23 -76.82 0.5 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.823 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 59.5 m -103.23 -35.02 8.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.842 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.5 p -74.82 136.52 24.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.932 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.471 ' O ' ' N ' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -103.37 131.62 51.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.812 0.339 . . . . 0.0 110.674 179.731 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 86.4 m -137.89 140.18 40.25 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.047 0.451 . . . . 0.0 111.243 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 179.64 -176.48 47.63 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.286 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.442 ' CG1' HG12 ' A' ' 72' ' ' ILE . 48.8 t -67.87 130.34 33.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.805 0.336 . . . . 0.0 110.886 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -59.68 -58.05 10.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.402 -179.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.45 HG23 ' CZ ' ' A' ' 18' ' ' TYR . 6.3 pt -53.85 -33.97 24.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.61 -179.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.407 ' HA ' ' HB2' ' A' ' 78' ' ' LEU . 97.0 t -72.69 -29.98 32.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.137 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 7.3 mtm -78.09 -42.58 31.64 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.664 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.431 ' OD1' ' CD2' ' A' ' 76' ' ' HIS . 22.0 p30 -82.25 -28.89 31.6 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -179.123 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.432 ' CE1' ' HA ' ' A' ' 14' ' ' PHE . 32.7 m170 -88.58 -8.07 55.36 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.904 0.383 . . . . 0.0 110.69 179.307 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 64.65 33.39 10.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.056 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.407 ' HB2' ' HA ' ' A' ' 73' ' ' VAL . 33.4 mt -64.63 142.19 58.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.537 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -129.12 146.99 50.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.909 0.385 . . . . 0.0 111.274 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.426 ' HB2' ' CZ ' ' A' ' 135' ' ' PHE . 1.1 tm-20 -102.05 134.28 45.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.822 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.9 t -124.27 139.81 53.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.908 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 34.5 p -69.4 159.11 33.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.833 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.441 ' HB2' ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -169.48 154.22 5.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.879 -179.941 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 14.3 m -101.52 164.05 11.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.95 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 58.1 mttt -60.74 -52.54 64.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.896 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -64.19 -42.19 96.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.616 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.29 -41.31 88.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.898 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.458 ' CD2' HD13 ' A' ' 122' ' ' ILE . 0.3 OUTLIER -57.71 -38.4 75.2 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.653 179.908 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 21.7 mttt -58.88 -42.3 89.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.521 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 18.0 mtpt -77.27 -27.88 53.27 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.897 179.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.412 ' HB2' ' CE2' ' A' ' 83' ' ' PHE . 28.6 t80 -69.23 -45.68 69.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.565 179.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.451 ' HB ' HG13 ' A' ' 122' ' ' ILE . 6.1 tp -61.28 -39.92 84.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.071 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.501 ' O ' ' CG ' ' A' ' 97' ' ' LYS . 13.8 ttmt -62.05 -46.95 86.86 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.969 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -71.68 -36.13 70.51 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.13 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.473 ' CD1' ' C ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -78.51 -43.4 26.98 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.641 0.257 . . . . 0.0 110.735 -179.268 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.413 ' HG3' ' N ' ' A' ' 97' ' ' LYS . 0.5 OUTLIER -64.71 -31.83 73.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.841 0.353 . . . . 0.0 110.082 179.004 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.501 ' CG ' ' O ' ' A' ' 93' ' ' LYS . 9.5 mmtm -66.94 -41.37 87.08 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.549 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.7 m -55.26 -41.14 71.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.545 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 7.1 mt -79.78 -41.87 22.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.522 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 10.2 tttt -54.75 -52.61 61.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.574 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -61.6 -47.15 92.24 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.141 179.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 19.5 tptt -60.98 -40.3 92.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.841 0.353 . . . . 0.0 110.366 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' A' ' 107' ' ' ARG . 2.4 tp -66.96 -35.53 80.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.14 179.377 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -58.15 -30.15 66.13 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.607 179.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -89.43 -25.1 21.69 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.511 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -100.1 -63.55 1.12 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.858 0.361 . . . . 0.0 111.633 -179.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.441 ' N ' ' O ' ' A' ' 103' ' ' LEU . 16.0 mtm180 -130.43 65.18 75.37 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.882 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.408 ' O ' ' CG2' ' A' ' 111' ' ' VAL . 10.3 Cg_endo -50.86 -22.29 9.79 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 123.17 2.58 . . . . 0.0 112.831 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -66.97 -13.57 61.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.328 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.5 ' C ' ' HD2' ' A' ' 113' ' ' PRO . 0.0 OUTLIER -110.57 0.89 17.8 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.102 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.408 ' CG2' ' O ' ' A' ' 108' ' ' PRO . 33.9 m -70.05 -33.36 54.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.566 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 29.8 mtmt -71.1 -49.95 12.12 Favored Pre-proline 0 CA--C 1.53 0.176 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.574 -179.199 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.566 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 25.8 Cg_exo -63.06 -30.46 75.91 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.16 1.906 . . . . 0.0 111.777 179.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.446 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 88.6 t80 -72.07 -41.05 67.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.987 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 7.6 mtm -56.54 -47.88 78.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.031 0.443 . . . . 0.0 110.817 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 69.0 m -74.32 -44.36 52.83 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.659 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.27 -38.0 95.5 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.483 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.55 -51.62 68.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.921 0.391 . . . . 0.0 110.838 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.96 -28.11 65.28 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.279 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -74.81 -43.04 56.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.856 0.36 . . . . 0.0 110.982 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -73.31 -32.58 64.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.965 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.458 HD13 ' CD2' ' A' ' 88' ' ' TYR . 0.4 OUTLIER -71.56 -46.01 65.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.322 -179.725 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.456 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 9.2 pttt -61.1 -31.54 71.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.036 0.446 . . . . 0.0 110.358 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -68.32 -53.52 23.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.77 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 16.2 pt -62.0 -42.49 95.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.304 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 11.7 mt -53.89 -36.99 63.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.879 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -65.46 -15.95 63.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.21 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -136.35 31.43 2.89 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.77 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.513 ' CE1' ' CZ ' ' A' ' 134' ' ' PHE . 1.8 t80 -49.5 -31.66 10.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.96 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 20.1 tptt -61.3 -21.57 64.08 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.162 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 15.0 m-20 -94.08 -47.22 6.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.429 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.42 ' CD1' ' N ' ' A' ' 132' ' ' TYR . 1.0 OUTLIER -93.01 150.78 20.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.963 0.411 . . . . 0.0 111.48 -179.449 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.466 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 1.0 OUTLIER -126.6 142.95 51.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.317 179.551 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.513 ' CZ ' ' CE1' ' A' ' 129' ' ' PHE . 0.1 OUTLIER -82.49 118.27 23.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.928 0.394 . . . . 0.0 110.979 -179.704 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.426 ' CZ ' ' HB2' ' A' ' 80' ' ' GLU . 20.9 m-85 -119.8 137.17 54.14 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.753 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.452 ' HB ' ' HA ' ' A' ' 140' ' ' MET . 0.8 OUTLIER -120.93 165.43 16.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.842 0.353 . . . . 0.0 110.944 179.933 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -64.59 -166.4 1.19 Allowed Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.539 -0.839 . . . . 0.0 111.981 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -70.98 -9.82 58.64 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.567 0.222 . . . . 0.0 111.38 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 -96.63 -29.83 13.61 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.606 0.241 . . . . 0.0 111.449 -179.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' MET . . . . . 0.452 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 18.7 mtp 55.39 48.57 18.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.879 0.371 . . . . 0.0 111.099 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 15.7 p-10 -71.84 114.8 31.89 Favored Pre-proline 0 N--CA 1.451 -0.409 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.917 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -63.39 -30.65 72.73 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.54 2.16 . . . . 0.0 112.214 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -84.62 -1.44 56.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.354 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -86.87 -115.72 1.0 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.421 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 10.7 ptp -142.27 -178.89 5.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.59 0.233 . . . . 0.0 110.769 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.464 ' CG1' ' HB3' ' A' ' 134' ' ' PHE . 0.0 OUTLIER -129.61 139.79 50.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.077 0.465 . . . . 0.0 111.274 179.961 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.426 ' CB ' ' CE1' ' A' ' 162' ' ' PHE . . . -103.09 110.02 21.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.224 179.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.507 ' HB2' ' HB ' ' A' ' 161' ' ' ILE . 3.8 mt -81.51 106.2 13.28 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.428 -179.051 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.7 tp -90.85 119.6 31.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.074 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.486 ' HB3' ' CE1' ' A' ' 159' ' ' TYR . 31.7 t70 -135.54 164.85 26.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.524 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -102.02 150.8 22.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.915 0.388 . . . . 0.0 111.189 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 16.8 mmm180 -80.59 -175.48 5.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.816 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -54.55 -40.14 68.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.011 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -66.31 -15.17 63.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.205 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 69.66 10.25 63.56 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.745 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 70.1 t -113.47 -68.19 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.843 0.354 . . . . 0.0 110.946 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 96.8 m -54.32 107.8 0.96 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.378 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -83.17 131.52 5.84 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.677 2.251 . . . . 0.0 111.965 179.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.486 ' CE1' ' HB3' ' A' ' 150' ' ' ASP . 9.5 p90 -124.1 135.58 53.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.866 0.365 . . . . 0.0 111.059 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' MET . . . . . 0.421 ' HE2' ' CG ' ' A' ' 135' ' ' PHE . 0.4 OUTLIER -105.09 138.7 40.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.132 -179.706 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.507 ' HB ' ' HB2' ' A' ' 148' ' ' LEU . 68.7 mt -94.96 114.41 31.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.147 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.426 ' CE1' ' CB ' ' A' ' 147' ' ' ALA . 96.6 m-85 -118.1 158.19 25.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.692 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -101.71 129.09 47.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.873 0.368 . . . . 0.0 110.803 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 24.3 tttt -70.09 -51.52 31.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.166 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.446 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 59.6 m-20 -52.2 -38.51 58.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.175 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -95.73 26.87 18.24 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.459 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -144.93 143.84 30.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.778 0.323 . . . . 0.0 110.879 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -116.88 156.61 27.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.822 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' MET . . . . . 0.418 ' HA ' ' O ' ' A' ' 3' ' ' ILE . 3.1 mpp? -115.76 151.02 35.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.052 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -149.29 127.06 11.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.888 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 5.6 mttp -89.18 118.4 28.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.025 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 1.8 m 60.7 157.61 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.037 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 3.2 tt -132.68 16.63 4.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.142 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.314 -0.851 . . . . 0.0 111.037 179.902 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.766 HD11 ' HB3' ' A' ' 169' ' ' MET . 5.0 tt . . . . . 0 N--CA 1.456 -0.151 0 CA-C-O 120.755 0.312 . . . . 0.0 110.912 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.526 HG21 ' HB3' ' A' ' 12' ' ' GLU . 13.9 mm -106.78 159.06 6.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.523 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.504 ' CD2' ' CE2' ' A' ' 14' ' ' PHE . 4.9 m-85 -121.27 104.73 9.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.427 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 20.9 ptt180 -118.09 146.77 43.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.9 0.381 . . . . 0.0 111.365 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.553 ' OD1' HD12 ' A' ' 8' ' ' ILE . 47.0 t0 -55.55 152.02 9.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.813 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.454 HD13 ' HG3' ' A' ' 168' ' ' GLU . 49.0 tp -81.6 -18.36 45.03 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.505 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.553 HD12 ' OD1' ' A' ' 6' ' ' ASP . 4.1 mp -91.36 -48.95 13.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -96.63 -17.75 20.19 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -179.117 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.431 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 36.1 m170 63.18 29.9 15.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.889 0.376 . . . . 0.0 110.71 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -100.4 121.02 40.85 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.661 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.526 ' HB3' HG21 ' A' ' 3' ' ' ILE . 0.2 OUTLIER -58.18 94.84 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.372 -179.726 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 14.7 mtt -72.13 -20.22 61.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.528 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.54 ' CD2' HG21 ' A' ' 31' ' ' VAL . 8.6 p90 -173.07 179.76 2.18 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.325 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -132.74 -170.26 2.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.836 0.35 . . . . 0.0 111.159 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.419 ' HB2' ' CG2' ' A' ' 2' ' ' ILE . 32.2 t70 -96.28 24.69 5.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.068 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.437 HG13 ' CD2' ' A' ' 18' ' ' TYR . 41.8 pt -89.03 -9.54 10.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.72 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.946 ' CZ ' HG22 ' A' ' 72' ' ' ILE . 73.6 m-85 -111.34 177.63 4.6 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.765 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -86.76 90.23 8.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.872 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.411 HD12 ' O ' ' A' ' 18' ' ' TYR . 3.6 mp -87.93 129.27 39.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.94 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 -123.3 121.04 34.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.979 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -73.32 115.79 13.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.768 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.469 HD12 ' NE2' ' A' ' 121' ' ' GLN . 2.8 pt -108.86 171.6 2.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.996 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.657 ' HB2' ' NE2' ' A' ' 121' ' ' GLN . . . 57.95 31.82 21.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.06 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 65.66 46.95 2.27 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.228 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.35 -11.38 63.52 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.756 -0.735 . . . . 0.0 113.345 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.5 ' HB3' ' HB3' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -57.25 -55.22 37.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.905 0.352 . . . . 0.0 111.141 -179.866 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 35.0 m -120.17 167.79 11.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.057 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.6 132.46 44.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.785 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -100.43 112.98 25.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.101 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.54 HG21 ' CD2' ' A' ' 14' ' ' PHE . 33.3 t -90.69 111.97 24.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.387 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -84.04 115.9 22.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.284 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -100.63 -138.96 10.51 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.042 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.8 pttp -174.56 125.55 0.3 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.814 0.34 . . . . 0.0 111.08 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 65.3 mtp -70.95 120.43 16.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.529 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.5 m . . . . . 0 C--N 1.33 -0.278 0 CA-C-O 120.914 0.387 . . . . 0.0 111.54 -179.572 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.375 0 N-CA-C 112.563 -0.215 . . . . 0.0 112.563 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.551 HG12 HG12 ' A' ' 72' ' ' ILE . 47.6 t -71.96 134.14 30.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.847 0.356 . . . . 0.0 110.868 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -61.04 -57.47 12.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.837 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.946 HG22 ' CZ ' ' A' ' 18' ' ' TYR . 10.1 pt -53.61 -33.8 22.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.642 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.799 HG13 ' HB2' ' A' ' 78' ' ' LEU . 90.2 t -71.7 -32.73 46.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.898 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.4 mtm -78.32 -40.29 37.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.554 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 16.9 p30 -82.11 -29.92 31.47 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.829 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.532 ' CD2' ' HB ' ' A' ' 72' ' ' ILE . 19.4 m-70 -91.94 -2.54 56.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.808 0.337 . . . . 0.0 110.914 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 28.1 m-70 57.29 34.08 24.24 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.808 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.799 ' HB2' HG13 ' A' ' 73' ' ' VAL . 29.7 mt -55.43 148.63 14.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.865 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -128.35 128.02 43.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.922 0.392 . . . . 0.0 110.897 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.411 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 1.4 tt0 -89.9 122.16 32.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.075 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.3 t -108.6 178.88 4.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.817 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 50.5 p -115.85 163.77 15.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.004 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.457 ' CE2' ' CE2' ' A' ' 91' ' ' TYR . 0.6 OUTLIER -171.64 153.87 3.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.806 -179.973 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 13.0 p -101.44 176.34 5.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.969 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.67 -52.55 24.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.944 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -65.36 -41.83 93.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.702 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.29 -38.42 83.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.027 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.865 ' CD2' HD11 ' A' ' 122' ' ' ILE . 0.6 OUTLIER -61.97 -36.76 82.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.673 179.936 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.405 ' O ' HG22 ' A' ' 92' ' ' ILE . 17.5 mttm -57.68 -46.41 84.33 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.064 0.459 . . . . 0.0 110.225 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.62 -27.95 55.93 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.64 178.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.57 ' HE2' HG21 ' A' ' 146' ' ' VAL . 2.8 t80 -66.15 -44.94 82.7 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.745 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.54 HD12 ' CE2' ' A' ' 95' ' ' TYR . 3.9 tp -62.08 -45.61 98.34 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.752 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.417 ' HA ' ' HG2' ' A' ' 96' ' ' MET . 15.0 ttpt -60.51 -37.95 82.78 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.883 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.513 ' HA ' ' HG2' ' A' ' 97' ' ' LYS . 31.3 t70 -74.67 -42.57 58.22 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.841 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.54 ' CE2' HD12 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -77.05 -40.26 46.95 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.999 -0.281 . . . . 0.0 111.065 -179.35 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.432 ' HG2' ' O ' ' A' ' 92' ' ' ILE . 8.8 ptt? -66.23 -32.11 73.33 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.855 0.36 . . . . 0.0 110.298 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.513 ' HG2' ' HA ' ' A' ' 94' ' ' ASP . 4.2 ptmt -70.48 -33.74 71.59 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.529 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.493 ' N ' ' HG3' ' A' ' 97' ' ' LYS . 1.8 m -63.92 -40.1 95.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.266 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.41 HG23 ' HA2' ' A' ' 166' ' ' GLY . 8.4 mt -79.76 -41.47 21.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.211 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.9 tmtt? -56.95 -52.1 66.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.266 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -59.21 -48.02 87.97 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.002 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.1 tppm? -62.79 -38.75 91.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.981 0.42 . . . . 0.0 110.122 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.548 ' HB3' HG12 ' A' ' 111' ' ' VAL . 14.3 tp -67.95 -36.87 80.84 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.975 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.482 ' CG ' HG11 ' A' ' 111' ' ' VAL . 36.0 mt-10 -55.96 -32.38 63.81 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.752 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -85.61 -19.99 30.18 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.567 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -105.18 -62.95 1.28 Allowed 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.773 0.32 . . . . 0.0 111.517 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.455 ' N ' ' O ' ' A' ' 103' ' ' LEU . 16.5 mmt180 -129.36 64.42 71.2 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.844 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.895 ' O ' HG22 ' A' ' 111' ' ' VAL . 9.6 Cg_endo -50.64 -24.02 12.12 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 123.01 2.473 . . . . 0.0 112.596 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -74.13 -9.02 58.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.1 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.425 ' C ' ' HD2' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -108.79 -1.71 19.08 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.5 -179.683 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.895 HG22 ' O ' ' A' ' 108' ' ' PRO . 27.6 m -72.13 -26.96 25.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.713 0.292 . . . . 0.0 111.299 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.601 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 0.8 OUTLIER -68.47 -56.03 10.92 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.37 -179.398 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.601 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 41.6 Cg_exo -55.67 -40.76 83.4 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 121.921 1.747 . . . . 0.0 111.641 179.237 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.434 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 56.9 t80 -62.02 -39.9 93.86 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.866 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 4.4 mmm -59.7 -45.3 92.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.829 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 63.1 m -74.82 -44.65 48.14 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.876 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -66.18 -39.44 94.53 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.938 -0.648 . . . . 0.0 112.688 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.63 -51.7 68.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.943 0.401 . . . . 0.0 111.074 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.51 ' HB1' ' HE3' ' A' ' 123' ' ' LYS . . . -66.68 -28.11 68.19 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.37 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -75.39 -57.14 4.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.229 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.657 ' NE2' ' HB2' ' A' ' 24' ' ' ALA . 2.0 tp-100 -58.44 -43.09 88.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.278 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.865 HD11 ' CD2' ' A' ' 88' ' ' TYR . 0.3 OUTLIER -58.79 -46.33 90.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.269 -179.801 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.51 ' HE3' ' HB1' ' A' ' 119' ' ' ALA . 25.6 mttt -60.43 -31.52 70.5 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.262 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 -67.39 -54.33 21.43 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.715 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.926 HG21 HD13 ' A' ' 148' ' ' LEU . 11.8 pt -61.59 -41.05 88.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.149 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 126' ' ' LEU . 11.1 mt -53.88 -35.96 62.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.761 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -68.6 -11.52 60.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.357 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -136.3 32.31 2.85 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.934 0.397 . . . . 0.0 110.522 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -48.23 -32.73 7.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.253 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -69.18 -24.35 64.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.274 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 21.5 m-20 -94.06 -36.43 12.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.419 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.418 ' CE1' ' OD2' ' A' ' 150' ' ' ASP . 3.5 m-85 -92.23 141.39 28.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.175 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -121.35 145.74 47.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.877 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.453 ' CE2' ' HB2' ' A' ' 83' ' ' PHE . 2.9 m-85 -83.24 125.25 31.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.169 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.46 ' HB2' ' HB3' ' A' ' 147' ' ' ALA . 32.9 m-85 -127.5 150.16 49.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.679 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.446 ' HB ' ' HA ' ' A' ' 140' ' ' MET . 0.7 OUTLIER -140.05 159.97 26.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.719 179.893 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -57.57 -168.81 0.13 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.562 -0.828 . . . . 0.0 111.94 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -71.59 -8.9 56.92 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.622 0.248 . . . . 0.0 111.402 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 -94.09 -31.25 14.27 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.62 -0.263 . . . . 0.0 111.493 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' MET . . . . . 0.446 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 77.7 mtm 58.87 49.95 9.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.821 0.343 . . . . 0.0 111.017 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ASN . . . . . 0.43 ' ND2' ' HA3' ' A' ' 144' ' ' GLY . 14.3 p-10 -72.11 114.62 30.8 Favored Pre-proline 0 N--CA 1.452 -0.357 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.987 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -64.98 -29.25 57.55 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.642 2.228 . . . . 0.0 112.288 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -84.59 -3.28 58.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.336 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.43 ' HA3' ' ND2' ' A' ' 141' ' ' ASN . . . -90.61 -155.17 31.07 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.535 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 2.8 ptp -94.75 -176.97 4.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.814 0.34 . . . . 0.0 110.895 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.57 HG21 ' HE2' ' A' ' 91' ' ' TYR . 53.4 t -128.97 151.13 35.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.085 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.691 ' HB1' ' HE3' ' A' ' 160' ' ' MET . . . -111.71 115.85 29.77 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.67 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.926 HD13 HG21 ' A' ' 125' ' ' ILE . 4.6 mt -92.26 106.24 18.28 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.96 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.502 HD12 ' HG2' ' A' ' 160' ' ' MET . 1.8 tp -89.29 119.63 29.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.248 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.449 ' HB3' ' CE1' ' A' ' 159' ' ' TYR . 0.6 OUTLIER -133.12 172.52 12.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.701 179.658 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -116.01 140.84 48.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.763 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 19.2 mmm180 -55.56 -178.66 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.115 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.23 -31.59 53.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.018 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 37.4 p30 -76.69 -15.2 59.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.104 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 71.27 17.47 75.99 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.708 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 93.9 t -111.89 -65.75 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.817 0.342 . . . . 0.0 110.846 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 35.8 m -56.95 109.17 1.53 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.097 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -82.17 122.85 3.83 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.522 2.148 . . . . 0.0 112.406 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.449 ' CE1' ' HB3' ' A' ' 150' ' ' ASP . 12.7 p90 -123.49 146.71 47.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.772 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' MET . . . . . 0.691 ' HE3' ' HB1' ' A' ' 147' ' ' ALA . 1.1 mtm -112.22 142.53 44.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.949 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.527 ' HB ' ' HB2' ' A' ' 148' ' ' LEU . 46.0 mt -95.45 117.58 39.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.226 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.443 ' CZ ' ' HE3' ' A' ' 160' ' ' MET . 48.4 m-85 -116.34 152.48 33.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.837 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.505 ' CE2' ' CZ ' ' A' ' 95' ' ' TYR . 11.5 m-85 -97.16 120.4 37.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.885 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 9.9 ttpt -65.26 -50.12 66.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.023 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.434 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 52.8 m-20 -57.69 -30.74 65.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.96 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.41 ' HA2' HG23 ' A' ' 99' ' ' ILE . . . -104.72 26.3 22.94 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.446 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.453 HD21 ' HB3' ' A' ' 4' ' ' TYR . 1.1 tt -142.69 142.23 31.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.759 0.314 . . . . 0.0 110.911 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.454 ' HG3' HD13 ' A' ' 7' ' ' LEU . 1.1 mt-10 -116.66 159.51 22.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.928 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' MET . . . . . 0.766 ' HB3' HD11 ' A' ' 2' ' ' ILE . 0.1 OUTLIER -115.48 159.96 20.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.776 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.908 -179.974 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.788 HD11 ' HB3' ' A' ' 169' ' ' MET . 3.2 tt . . . . . 0 N--CA 1.456 -0.138 0 CA-C-O 120.848 0.356 . . . . 0.0 110.945 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 21.5 mm -99.64 154.02 4.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.292 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.609 ' HE1' HG23 ' A' ' 2' ' ' ILE . 3.3 m-85 -123.67 110.06 14.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.602 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.57 145.78 49.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.906 0.384 . . . . 0.0 111.282 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.457 ' O ' ' HA ' ' A' ' 10' ' ' HIS . 44.3 t0 -55.68 152.17 9.83 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.862 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.547 HD23 HG23 ' A' ' 99' ' ' ILE . 57.3 tp -80.2 -23.5 40.91 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.305 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.758 HD11 ' CG1' ' A' ' 99' ' ' ILE . 4.3 mp -91.3 -45.48 14.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.26 -21.24 19.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.799 -179.085 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.457 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 14.5 m170 61.78 27.89 17.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.809 0.337 . . . . 0.0 110.731 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -100.77 122.15 42.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.751 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -56.93 89.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.366 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.407 ' O ' ' CD2' ' A' ' 76' ' ' HIS . 25.2 mtt -67.53 -19.24 65.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.644 179.337 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.512 ' CZ ' ' CD2' ' A' ' 4' ' ' TYR . 12.5 p90 -177.64 175.87 1.32 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.817 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.28 -169.92 2.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.734 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.411 ' HA ' ' CD1' ' A' ' 20' ' ' ILE . 19.0 t0 -95.76 31.87 1.98 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.148 0.499 . . . . 0.0 110.817 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.413 HG13 ' CD2' ' A' ' 18' ' ' TYR . 35.6 pt -89.66 -13.41 9.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.437 178.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.748 ' CZ ' HG22 ' A' ' 72' ' ' ILE . 61.3 m-85 -110.07 178.92 4.25 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.463 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.408 ' HB2' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -86.43 91.55 8.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.75 179.828 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.51 HD12 ' O ' ' A' ' 18' ' ' TYR . 4.2 mp -88.35 135.61 25.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.178 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 10.7 mtm180 -129.26 117.67 21.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.015 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -71.07 116.33 11.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.71 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.558 HD11 HG23 ' A' ' 161' ' ' ILE . 2.9 pt -109.5 171.07 2.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.162 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.491 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . . . 57.91 30.97 19.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.178 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 66.56 42.56 2.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.095 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.89 -17.48 54.97 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.996 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.491 ' HB3' ' HB3' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -51.13 -49.37 60.94 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.852 0.358 . . . . 0.0 111.168 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 6.7 m -128.48 167.07 17.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.727 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.629 HD11 ' CD ' ' A' ' 164' ' ' LYS . 1.1 mt -129.37 135.08 48.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.878 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -99.62 112.78 24.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.8 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 159' ' ' TYR . 22.0 t -94.24 111.75 25.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.541 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.408 ' HB2' ' HB2' ' A' ' 19' ' ' LYS . 9.2 mt-10 -86.53 110.57 19.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.357 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -92.91 -134.21 6.76 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.212 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 9.3 ptpt -174.49 123.23 0.28 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.802 0.334 . . . . 0.0 111.023 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 15.1 mtt -67.16 121.54 15.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.641 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.4 m . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.495 -179.696 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 N-CA-C 112.401 -0.28 . . . . 0.0 112.401 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.462 HG21 HD11 ' A' ' 149' ' ' LEU . 48.4 t -72.34 140.54 17.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.806 0.336 . . . . 0.0 110.967 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.411 ' O ' ' ND2' ' A' ' 75' ' ' ASN . 35.4 t70 -67.75 -59.63 3.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.363 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.748 HG22 ' CZ ' ' A' ' 18' ' ' TYR . 10.3 pt -53.62 -34.44 24.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.594 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.781 HG13 ' HB2' ' A' ' 78' ' ' LEU . 58.7 t -71.18 -33.04 49.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.826 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.6 mtm -78.25 -40.03 38.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.62 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.411 ' ND2' ' O ' ' A' ' 71' ' ' ASP . 15.3 p30 -82.02 -28.44 32.54 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.582 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.438 ' CD2' ' HB ' ' A' ' 72' ' ' ILE . 8.1 m-70 -91.49 -0.77 57.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.928 0.394 . . . . 0.0 110.753 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 10.7 m170 57.61 28.14 15.23 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.131 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.781 ' HB2' HG13 ' A' ' 73' ' ' VAL . 57.1 mt -56.82 137.98 54.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.371 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -122.12 137.01 54.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.973 0.416 . . . . 0.0 111.271 -179.28 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.423 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 1.5 tt0 -92.09 130.64 37.77 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.961 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.58 HG21 HD11 ' A' ' 136' ' ' ILE . 1.3 t -117.77 165.62 13.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.83 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 40.3 m -96.17 161.39 13.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.963 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.477 ' HB2' ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -171.7 149.94 2.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.013 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -101.54 164.76 11.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.906 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.11 -52.48 65.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.992 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -65.62 -44.9 85.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.785 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.79 -37.61 76.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.07 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.868 ' CD2' HD11 ' A' ' 122' ' ' ILE . 0.5 OUTLIER -62.96 -35.79 81.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.799 179.9 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.405 ' O ' HG22 ' A' ' 92' ' ' ILE . 52.8 mttt -59.61 -43.65 93.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.475 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.5 tttt -77.72 -27.91 50.72 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.75 178.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.56 ' HE2' HG21 ' A' ' 146' ' ' VAL . 7.8 t80 -67.75 -46.84 70.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.702 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.625 HD12 ' CE2' ' A' ' 95' ' ' TYR . 5.8 tp -60.49 -42.73 92.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 CA-C-O 120.84 0.352 . . . . 0.0 110.668 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.453 ' O ' ' HB3' ' A' ' 97' ' ' LYS . 7.9 ttpp -63.94 -39.73 94.83 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.799 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.453 ' O ' ' HG3' ' A' ' 97' ' ' LYS . 29.1 t70 -75.85 -37.99 58.42 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.769 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.625 ' CE2' HD12 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -78.46 -42.78 28.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.607 0.242 . . . . 0.0 110.619 -179.736 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.412 ' HG3' ' N ' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -67.53 -32.09 72.64 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.035 179.569 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.453 ' HB3' ' O ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -70.91 -34.5 71.6 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.899 0.38 . . . . 0.0 110.656 179.807 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.27 -41.03 96.26 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.152 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.758 ' CG1' HD11 ' A' ' 8' ' ' ILE . 9.3 mt -79.81 -41.16 21.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.488 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.8 tttt -55.57 -53.16 59.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.462 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -60.64 -46.97 93.4 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.162 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.9 tppt? -62.5 -37.94 87.98 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.878 0.37 . . . . 0.0 110.403 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.73 HD21 ' CB ' ' A' ' 110' ' ' ARG . 3.4 tp -69.55 -34.24 73.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.032 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.672 ' HG3' HG11 ' A' ' 111' ' ' VAL . 29.4 mt-10 -59.19 -30.99 68.6 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.691 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.424 ' HG3' ' HG3' ' A' ' 106' ' ' GLN . 0.8 OUTLIER -87.38 -20.17 27.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.707 -179.646 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.424 ' HG3' ' HG3' ' A' ' 105' ' ' GLU . 50.9 mt-30 -107.36 -62.3 1.44 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.833 0.349 . . . . 0.0 111.593 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 103' ' ' LEU . 22.0 mtm180 -128.03 63.52 62.27 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.92 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.912 ' O ' HG22 ' A' ' 111' ' ' VAL . 10.0 Cg_endo -50.74 -21.24 7.82 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 123.144 2.562 . . . . 0.0 112.965 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -72.04 -9.22 58.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.584 0.23 . . . . 0.0 111.433 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.73 ' CB ' HD21 ' A' ' 103' ' ' LEU . 19.0 mmt85 -112.12 -1.27 15.34 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.64 -0.255 . . . . 0.0 111.677 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.912 HG22 ' O ' ' A' ' 108' ' ' PRO . 33.8 m -71.33 -32.54 47.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.547 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 15.5 mttm -69.81 -49.95 18.98 Favored Pre-proline 0 CA--C 1.53 0.192 0 C-N-CA 121.047 -0.261 . . . . 0.0 111.57 -179.215 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.547 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 31.4 Cg_exo -58.98 -36.13 97.35 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.183 1.922 . . . . 0.0 111.936 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.455 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 89.9 t80 -71.09 -35.38 71.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.923 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 10.8 mtp -58.61 -52.44 65.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.761 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 63.0 m -73.89 -44.06 56.49 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.552 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.58 -38.71 96.29 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.391 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.99 -51.6 68.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.002 0.429 . . . . 0.0 110.961 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.08 -28.22 65.25 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.129 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -75.88 -44.01 42.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.009 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -71.34 -38.12 71.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.001 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.868 HD11 ' CD2' ' A' ' 88' ' ' TYR . 0.4 OUTLIER -63.89 -46.82 93.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.269 -179.916 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.448 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 6.1 ptmt -60.72 -31.07 70.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.338 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 8.8 t-80 -66.49 -52.37 46.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.996 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.67 HG21 HD13 ' A' ' 148' ' ' LEU . 11.9 pt -65.3 -40.44 88.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.283 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 11.9 mt -53.88 -35.5 61.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.882 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -72.75 -9.9 59.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.3 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -142.93 32.1 1.4 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.985 0.422 . . . . 0.0 110.615 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.495 ' CE1' ' CZ ' ' A' ' 134' ' ' PHE . 5.9 t80 -51.49 -25.32 6.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.22 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 5.7 tttp -62.74 -29.2 70.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.744 0.307 . . . . 0.0 110.915 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 32.8 m-20 -94.09 -39.17 10.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.263 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -89.87 145.59 25.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.086 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -132.55 145.37 51.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.147 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.495 ' CZ ' ' CE1' ' A' ' 129' ' ' PHE . 1.4 m-85 -78.27 124.78 28.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.858 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.423 ' CE2' ' HB2' ' A' ' 80' ' ' GLU . 38.0 m-85 -129.9 135.96 48.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.767 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.58 HD11 HG21 ' A' ' 81' ' ' THR . 0.6 OUTLIER -120.99 159.65 22.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.858 179.905 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.68 -165.69 0.38 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.215 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -71.78 -8.93 57.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.573 0.225 . . . . 0.0 111.502 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 -96.97 -28.29 14.24 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' MET . . . . . 0.435 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 62.0 mtm 55.37 37.71 29.28 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.853 0.359 . . . . 0.0 110.93 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ASN . . . . . 0.41 ' ND2' ' HA3' ' A' ' 144' ' ' GLY . 16.7 p-10 -61.87 115.25 14.43 Favored Pre-proline 0 N--CA 1.451 -0.386 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.933 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.21 -30.64 91.71 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.498 2.132 . . . . 0.0 112.183 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -84.59 -3.14 58.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.102 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.41 ' HA3' ' ND2' ' A' ' 141' ' ' ASN . . . -87.24 -169.29 45.6 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.472 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 2.3 ptp -86.58 -176.5 5.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.728 0.299 . . . . 0.0 110.91 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.56 HG21 ' HE2' ' A' ' 91' ' ' TYR . 48.9 t -128.17 148.85 32.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.962 0.41 . . . . 0.0 111.164 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.569 ' HB1' ' SD ' ' A' ' 160' ' ' MET . . . -111.64 115.2 28.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.599 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.67 HD13 HG21 ' A' ' 125' ' ' ILE . 3.2 mt -89.77 106.28 18.36 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.332 -179.174 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.462 HD11 HG21 ' A' ' 70' ' ' VAL . 4.1 tp -88.83 121.15 30.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.922 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.453 ' HB3' ' CZ ' ' A' ' 159' ' ' TYR . 31.2 t70 -134.67 164.01 28.48 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.547 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -110.36 148.52 31.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.051 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.66 -178.01 0.66 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.826 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -61.48 -31.07 71.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.94 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -84.66 -15.03 46.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.289 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 64.59 27.55 72.04 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.468 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 77.9 t -110.06 -42.47 5.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.846 0.355 . . . . 0.0 111.044 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 96.2 m -100.33 106.76 44.25 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.327 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.72 130.74 12.81 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.385 2.057 . . . . 0.0 111.609 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.453 ' CZ ' ' HB3' ' A' ' 150' ' ' ASP . 6.1 p90 -127.09 146.43 50.38 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.913 0.387 . . . . 0.0 111.18 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' MET . . . . . 0.713 ' CE ' HD13 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -113.12 145.4 40.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.041 -179.827 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.558 HG23 HD11 ' A' ' 23' ' ' ILE . 59.7 mt -101.78 110.61 29.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.267 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.515 ' CE1' ' HB2' ' A' ' 147' ' ' ALA . 52.2 m-85 -110.93 154.0 24.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.523 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -102.14 115.14 29.92 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.944 0.402 . . . . 0.0 110.861 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.629 ' CD ' HD11 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -58.94 -46.5 87.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.168 -179.655 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.455 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 56.5 m-20 -51.56 -31.84 25.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.987 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -106.45 25.99 21.42 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.395 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.525 HD21 ' HB3' ' A' ' 4' ' ' TYR . 0.6 OUTLIER -139.88 146.93 39.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.821 0.343 . . . . 0.0 110.941 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.23 150.79 29.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.843 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' MET . . . . . 0.788 ' HB3' HD11 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -121.59 142.92 49.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.986 -179.976 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.948 179.955 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.738 HD11 ' HB3' ' A' ' 169' ' ' MET . 3.5 tt . . . . . 0 N--CA 1.457 -0.097 0 CA-C-O 120.806 0.336 . . . . 0.0 110.952 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.419 HG22 ' N ' ' A' ' 4' ' ' TYR . 29.3 mm -99.72 155.04 4.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.374 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.58 ' CE1' HG23 ' A' ' 2' ' ' ILE . 4.6 m-85 -124.43 107.29 10.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.669 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -123.8 144.93 49.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.153 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.58 ' OD1' HD12 ' A' ' 8' ' ' ILE . 42.5 t0 -54.88 140.62 36.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.856 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 43.1 tp -72.31 -20.29 61.52 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.362 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.58 HD12 ' OD1' ' A' ' 6' ' ' ASP . 4.1 mp -91.39 -46.3 14.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.51 -18.38 19.86 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -179.133 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.402 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 4.1 m80 62.2 29.28 17.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.864 0.364 . . . . 0.0 110.756 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -101.94 118.36 36.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.762 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -56.79 94.07 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.377 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 9.8 mtt -71.7 -19.24 62.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.695 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.501 ' CZ ' ' CD2' ' A' ' 4' ' ' TYR . 9.4 p90 -177.15 175.84 1.47 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.821 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.86 -171.13 2.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.593 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.409 ' HA ' ' CD1' ' A' ' 20' ' ' ILE . 21.1 t0 -95.52 36.24 1.28 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.113 0.482 . . . . 0.0 110.785 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.44 HG13 ' CD2' ' A' ' 18' ' ' TYR . 37.4 pt -94.5 -11.77 8.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.571 179.065 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.89 ' CZ ' HG22 ' A' ' 72' ' ' ILE . 43.5 m-85 -109.41 -166.85 1.14 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.573 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.7 mtpp -98.96 89.46 4.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.838 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.409 ' CD1' ' HA ' ' A' ' 16' ' ' ASP . 3.8 mp -88.03 124.68 41.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.881 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 11.0 mtp180 -115.78 121.16 41.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.158 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.515 ' HG3' HD23 ' A' ' 29' ' ' LEU . 5.1 mt-10 -74.0 116.36 14.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.803 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.457 HD11 HG23 ' A' ' 161' ' ' ILE . 5.1 pt -116.08 171.51 5.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.19 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 56.58 33.45 22.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.167 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 64.57 38.32 7.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.249 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.74 -13.84 66.6 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.737 -0.744 . . . . 0.0 113.113 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.806 HD21 ' HA ' ' A' ' 114' ' ' PHE . 0.1 OUTLIER -53.57 -48.09 69.48 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.749 0.309 . . . . 0.0 111.368 -179.885 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 18.8 m -126.0 167.27 15.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.272 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.831 HD21 ' HD2' ' A' ' 164' ' ' LYS . 0.3 OUTLIER -130.8 123.83 30.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.76 179.932 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -92.0 112.8 24.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.885 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.2 t -100.63 111.91 31.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.956 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -87.6 118.77 27.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.029 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -99.9 -128.49 6.3 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.299 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.48 125.89 0.31 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.856 0.36 . . . . 0.0 110.903 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 81.4 mtp -73.21 119.42 17.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.941 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.9 m . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.152 179.944 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.45 0 N-CA-C 112.321 -0.312 . . . . 0.0 112.321 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.728 HG22 ' HG3' ' A' ' 158' ' ' PRO . 51.0 t -71.29 148.66 10.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.775 0.322 . . . . 0.0 110.793 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -73.8 -56.35 5.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.453 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.89 HG22 ' CZ ' ' A' ' 18' ' ' TYR . 11.2 pt -53.72 -33.97 23.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.349 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.789 HG13 ' HB2' ' A' ' 78' ' ' LEU . 59.7 t -71.6 -33.57 49.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.812 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.8 mtt -78.47 -39.6 37.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.693 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.2 p30 -82.04 -28.46 32.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.545 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.416 ' CG ' ' O ' ' A' ' 72' ' ' ILE . 7.2 m-70 -90.28 -2.59 58.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.845 0.355 . . . . 0.0 110.582 179.188 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.455 ' HB2' ' HB3' ' A' ' 138' ' ' GLU . 7.4 m80 59.87 28.24 17.7 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.892 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.789 ' HB2' HG13 ' A' ' 73' ' ' VAL . 64.2 mt -58.55 144.51 42.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.555 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -128.63 138.06 51.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.891 0.377 . . . . 0.0 111.251 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.412 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 18.4 tt0 -92.84 123.28 36.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.04 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.411 HG21 HD11 ' A' ' 136' ' ' ILE . 10.4 t -108.97 165.05 11.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.76 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.5 m -95.44 160.5 14.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.874 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.503 ' CE2' ' CE2' ' A' ' 91' ' ' TYR . 0.6 OUTLIER -171.66 148.56 2.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.908 -179.884 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.52 167.09 10.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.791 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.66 -52.43 64.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.896 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -63.39 -43.71 96.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.916 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.77 -36.61 79.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.156 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.952 ' CD2' HD11 ' A' ' 122' ' ' ILE . 0.2 OUTLIER -64.16 -33.82 76.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.833 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 23.4 mttt -61.62 -45.33 94.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.012 0.434 . . . . 0.0 110.369 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.55 -27.9 45.94 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.834 178.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.576 ' HE2' HG21 ' A' ' 146' ' ' VAL . 12.6 t80 -67.77 -47.09 70.18 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.848 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.861 HG22 ' O ' ' A' ' 88' ' ' TYR . 1.6 tp -62.46 -41.61 92.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.828 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.425 ' O ' ' CG ' ' A' ' 97' ' ' LYS . 17.5 ttmt -59.07 -46.36 88.47 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.045 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -66.42 -43.75 84.85 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.149 -179.298 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.541 ' CD1' ' C ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -73.24 -42.46 62.54 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.943 -179.088 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 23.0 ptm -61.0 -32.16 71.74 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.303 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.425 ' CG ' ' O ' ' A' ' 93' ' ' LYS . 6.4 mmtp -66.91 -43.91 82.13 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.511 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.2 m -56.19 -41.37 75.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.735 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.7 mt -79.79 -41.7 21.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.701 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 13.2 tttt -53.76 -56.29 18.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.532 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -59.97 -45.2 96.3 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.189 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.03 -41.93 97.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.903 0.383 . . . . 0.0 110.378 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.599 ' HB3' HG12 ' A' ' 111' ' ' VAL . 9.2 tp -66.36 -34.2 77.43 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.259 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.665 ' CG ' HG11 ' A' ' 111' ' ' VAL . 31.3 mt-10 -60.11 -29.07 68.37 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.617 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -88.19 -18.76 28.01 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.548 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -107.05 -58.49 1.93 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.775 0.322 . . . . 0.0 111.693 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.444 ' N ' ' O ' ' A' ' 103' ' ' LEU . 46.1 mtt180 -134.04 66.4 71.81 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.809 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.888 ' O ' HG22 ' A' ' 111' ' ' VAL . 9.1 Cg_endo -50.46 -22.68 9.3 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 123.141 2.561 . . . . 0.0 112.729 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -73.68 -9.3 58.53 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.735 0.302 . . . . 0.0 111.176 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.503 ' C ' ' HD2' ' A' ' 113' ' ' PRO . 3.0 mmt180 -110.91 -0.16 16.91 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.616 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.888 HG22 ' O ' ' A' ' 108' ' ' PRO . 32.9 m -72.67 -33.43 44.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.603 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 13.9 mttt -66.87 -50.38 43.7 Favored Pre-proline 0 C--N 1.331 -0.21 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.555 -179.257 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.603 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 32.8 Cg_exo -59.05 -39.36 80.88 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 121.967 1.778 . . . . 0.0 111.724 179.325 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.806 ' HA ' HD21 ' A' ' 27' ' ' LEU . 67.3 t80 -64.25 -37.89 89.1 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.887 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 4.1 mmm -58.57 -50.13 74.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.728 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 66.4 m -74.33 -44.34 52.92 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.742 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.47 -40.0 98.31 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.516 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.42 -51.55 69.34 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.006 0.431 . . . . 0.0 110.948 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.6 -31.42 65.17 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.088 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -72.12 -41.33 67.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.106 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 50.3 tp60 -73.53 -36.71 65.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.078 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.952 HD11 ' CD2' ' A' ' 88' ' ' TYR . 0.4 OUTLIER -67.12 -46.08 85.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.247 -179.765 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.451 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 1.2 ptpm? -61.42 -31.41 71.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.083 0.468 . . . . 0.0 110.223 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 7.0 t-80 -67.1 -53.66 28.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.705 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.59 HG21 HD13 ' A' ' 148' ' ' LEU . 15.0 pt -62.28 -41.71 92.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.249 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.466 ' HA ' HD23 ' A' ' 126' ' ' LEU . 12.3 mt -53.85 -35.85 61.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.922 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -68.05 -13.82 62.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.14 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -139.98 32.37 1.97 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.011 0.434 . . . . 0.0 110.628 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.514 ' CE1' ' CZ ' ' A' ' 134' ' ' PHE . 2.8 t80 -49.47 -28.87 5.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.096 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.49 -27.04 65.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.986 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -94.22 -35.97 12.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.476 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -94.44 140.52 29.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.923 0.392 . . . . 0.0 111.373 -179.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.406 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 4.9 mm-40 -124.13 145.49 49.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.805 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.514 ' CZ ' ' CE1' ' A' ' 129' ' ' PHE . 0.5 OUTLIER -80.47 123.87 28.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.069 -179.787 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.54 ' HB2' ' HB3' ' A' ' 147' ' ' ALA . 36.6 m-85 -126.76 151.94 47.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.499 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.412 ' CG2' ' HA ' ' A' ' 140' ' ' MET . 1.0 OUTLIER -138.7 160.04 30.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.001 179.863 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.05 -159.25 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.2 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.455 ' HB3' ' HB2' ' A' ' 77' ' ' HIS . 5.7 pt-20 -76.79 -8.77 57.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.609 0.242 . . . . 0.0 111.436 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 20.4 m-80 -96.58 -29.75 13.68 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' MET . . . . . 0.412 ' HA ' ' CG2' ' A' ' 136' ' ' ILE . 31.1 mtm 57.44 37.73 27.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.907 0.384 . . . . 0.0 110.854 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ASN . . . . . 0.423 ' ND2' ' HA3' ' A' ' 144' ' ' GLY . 15.0 p-10 -66.22 115.01 19.45 Favored Pre-proline 0 N--CA 1.452 -0.352 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.164 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 141' ' ' ASN . 23.3 Cg_exo -62.73 -28.96 76.75 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.505 2.137 . . . . 0.0 112.17 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -84.55 -3.9 58.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.148 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.423 ' HA3' ' ND2' ' A' ' 141' ' ' ASN . . . -87.05 -146.52 10.5 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.381 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.425 ' HE3' ' O ' ' A' ' 166' ' ' GLY . 2.3 ptp -104.9 179.86 4.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.765 0.317 . . . . 0.0 110.768 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.576 HG21 ' HE2' ' A' ' 91' ' ' TYR . 43.7 t -128.98 149.31 33.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.136 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.54 ' HB3' ' HB2' ' A' ' 135' ' ' PHE . . . -111.75 115.86 29.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.663 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.59 HD13 HG21 ' A' ' 125' ' ' ILE . 4.6 mt -90.57 106.14 18.3 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.86 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.49 HD11 HG21 ' A' ' 70' ' ' VAL . 5.2 tp -88.56 120.64 30.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.192 -179.526 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.456 ' HB3' ' CE1' ' A' ' 159' ' ' TYR . 47.9 t0 -138.06 164.35 29.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.442 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -105.98 146.99 29.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.889 0.376 . . . . 0.0 111.026 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.71 -177.66 0.62 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.863 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -60.46 -41.21 93.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.858 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -79.19 -15.11 58.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.16 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 60.51 33.79 83.0 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.537 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 91.2 t -107.08 -24.08 4.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.78 0.324 . . . . 0.0 111.039 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.4 t -132.22 124.23 19.24 Favored Pre-proline 0 CA--C 1.531 0.241 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.136 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.728 ' HG3' HG22 ' A' ' 70' ' ' VAL . 93.7 Cg_endo -79.93 135.42 11.21 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.529 2.152 . . . . 0.0 112.079 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.456 ' CE1' ' HB3' ' A' ' 150' ' ' ASP . 8.0 p90 -124.61 136.02 53.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.862 0.363 . . . . 0.0 111.016 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' MET . . . . . 0.642 ' HG3' HD11 ' A' ' 72' ' ' ILE . 24.7 mtp -104.43 140.51 37.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.958 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.495 ' HB ' ' HB2' ' A' ' 148' ' ' LEU . 53.1 mt -99.67 113.67 35.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.16 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -110.15 158.14 18.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.705 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.413 ' CZ ' ' OH ' ' A' ' 95' ' ' TYR . 24.2 m-85 -99.18 114.64 27.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.852 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.831 ' HD2' HD21 ' A' ' 29' ' ' LEU . 33.0 tttm -57.98 -51.9 67.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.136 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.43 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 37.8 m-20 -54.55 -35.63 63.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.038 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.425 ' O ' ' HE3' ' A' ' 145' ' ' MET . . . -96.94 28.51 13.46 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.397 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.429 HD11 ' HB3' ' A' ' 4' ' ' TYR . 1.0 OUTLIER -147.34 143.6 28.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.878 0.37 . . . . 0.0 110.801 -179.911 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -105.11 162.58 13.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.803 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' MET . . . . . 0.738 ' HB3' HD11 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -134.31 138.32 44.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.976 179.934 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.845 -179.953 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.765 HD11 ' HB3' ' A' ' 169' ' ' MET . 2.4 tt . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.837 0.351 . . . . 0.0 111.008 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.477 HG21 ' HB3' ' A' ' 12' ' ' GLU . 21.2 mm -101.77 157.88 4.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.353 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.566 ' HE1' HG23 ' A' ' 2' ' ' ILE . 5.5 m-85 -126.58 95.22 4.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.423 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 10.0 ptt180 -110.67 148.59 31.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.955 0.407 . . . . 0.0 111.183 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.443 ' O ' ' HA ' ' A' ' 10' ' ' HIS . 31.8 t0 -56.96 152.2 13.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.741 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 36.1 tp -81.31 -24.05 37.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.225 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.684 HD11 HG13 ' A' ' 99' ' ' ILE . 3.9 mp -91.36 -44.61 14.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.827 -179.556 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.0 t -94.13 -21.09 19.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.756 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.443 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 25.5 m-70 62.34 26.63 15.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.86 0.362 . . . . 0.0 110.812 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -101.96 124.6 47.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.798 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.477 ' HB3' HG21 ' A' ' 3' ' ' ILE . 1.3 pm0 -58.03 104.06 0.18 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.386 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 19.7 mtt -82.82 -18.68 39.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.62 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.508 ' CE2' ' CD2' ' A' ' 4' ' ' TYR . 16.0 p90 -178.64 176.74 0.96 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.68 179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.66 -170.73 2.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.824 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -95.91 28.53 3.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.114 0.483 . . . . 0.0 110.877 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 45.9 pt -89.31 -11.34 10.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.731 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.806 ' CZ ' HG22 ' A' ' 72' ' ' ILE . 62.9 m-85 -109.45 -171.09 1.77 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.67 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.1 mttt -94.13 86.97 5.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.702 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.7 mp -88.66 127.06 41.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.203 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -119.87 148.36 43.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.612 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.53 ' HG3' HD23 ' A' ' 29' ' ' LEU . 3.1 mt-10 -94.25 117.09 29.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.01 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.42 HD11 HG23 ' A' ' 161' ' ' ILE . 6.1 pt -113.71 166.63 7.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.087 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 57.53 29.99 18.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.203 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 64.56 39.66 6.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.203 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.37 -16.09 61.82 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.593 -0.813 . . . . 0.0 113.071 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.57 -30.14 53.37 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.829 0.347 . . . . 0.0 111.083 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 56.6 m -149.4 164.66 34.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.877 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.53 HD23 ' HG3' ' A' ' 22' ' ' GLU . 0.5 OUTLIER -129.32 128.97 44.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.962 -179.961 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.471 ' HA ' ' O ' ' A' ' 160' ' ' MET . 67.7 mt-10 -91.27 117.25 29.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.306 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' ' 159' ' ' TYR . 23.0 t -98.79 111.94 29.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.605 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -90.74 116.28 28.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.303 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -100.78 -130.52 7.07 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.228 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.2 pttm -174.46 125.98 0.32 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.919 0.39 . . . . 0.0 110.893 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 35.8 mtp -70.37 123.46 21.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.745 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.0 m . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.229 -179.879 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.249 -0.34 . . . . 0.0 112.249 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.496 HG12 HG12 ' A' ' 72' ' ' ILE . 47.7 t -72.58 142.73 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-O 120.801 0.334 . . . . 0.0 110.801 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -69.04 -56.61 7.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.551 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.806 HG22 ' CZ ' ' A' ' 18' ' ' TYR . 9.5 pt -53.66 -33.83 23.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.816 0.341 . . . . 0.0 111.409 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.782 HG13 ' HB2' ' A' ' 78' ' ' LEU . 98.6 t -71.2 -33.08 49.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.037 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.0 mtm -78.27 -39.73 39.18 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.634 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.43 ' OD1' ' CD2' ' A' ' 76' ' ' HIS . 15.2 p30 -82.17 -28.24 32.19 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.609 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.441 ' CE1' ' HB ' ' A' ' 72' ' ' ILE . 28.1 m170 -93.07 0.99 57.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.852 0.358 . . . . 0.0 110.801 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.438 ' HB2' ' HB3' ' A' ' 138' ' ' GLU . 7.8 m170 56.58 28.53 14.06 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.314 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.782 ' HB2' HG13 ' A' ' 73' ' ' VAL . 71.0 mt -56.99 129.13 40.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.512 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 -112.82 130.58 56.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.254 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.412 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 30.1 tt0 -83.86 129.66 34.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.074 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.6 t -116.57 -179.75 3.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.856 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 69.9 m -121.4 165.67 15.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.96 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.501 ' CE2' ' CE2' ' A' ' 91' ' ' TYR . 3.2 m-85 -171.71 154.01 3.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.043 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.4 ' H ' ' HB3' ' A' ' 87' ' ' ALA . 3.2 m -101.58 166.98 10.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.694 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.0 mtpp -57.73 -52.47 65.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.891 0.377 . . . . 0.0 110.996 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.72 -37.14 76.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.959 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.4 ' HB3' ' H ' ' A' ' 84' ' ' THR . . . -65.31 -44.28 88.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.158 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.826 ' CD2' HD11 ' A' ' 122' ' ' ILE . 1.0 OUTLIER -60.98 -32.93 72.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.814 179.876 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 18.2 mttm -61.97 -43.41 98.91 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.549 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.1 mtmt -78.09 -28.02 48.61 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.663 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.554 ' HE2' HG21 ' A' ' 146' ' ' VAL . 8.8 t80 -65.48 -47.41 76.15 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.616 179.544 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.444 ' O ' ' HG2' ' A' ' 96' ' ' MET . 4.7 tp -61.18 -45.91 97.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.956 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.405 ' N ' HG23 ' A' ' 92' ' ' ILE . 16.6 tttp -58.42 -38.33 77.18 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.252 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.514 ' HA ' ' HG2' ' A' ' 97' ' ' LYS . 19.6 t70 -75.06 -43.64 52.19 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.903 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.46 ' CD1' ' C ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -75.22 -40.07 59.46 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 121.074 -0.25 . . . . 0.0 111.119 -179.368 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.444 ' HG2' ' O ' ' A' ' 92' ' ' ILE . 3.1 ptt? -67.7 -32.27 72.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.734 0.302 . . . . 0.0 110.707 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.514 ' HG2' ' HA ' ' A' ' 94' ' ' ASP . 5.4 ptpt -69.23 -34.32 74.66 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.705 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.478 ' N ' ' HG3' ' A' ' 97' ' ' LYS . 2.1 m -62.71 -41.28 99.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.295 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.684 HG13 HD11 ' A' ' 8' ' ' ILE . 5.9 mt -79.89 -39.08 19.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.352 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.97 -57.79 10.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.578 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -59.44 -43.53 97.39 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.625 -0.797 . . . . 0.0 111.914 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.4 tmtt? -61.51 -42.11 98.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.978 0.418 . . . . 0.0 110.276 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.715 ' HB3' HG12 ' A' ' 111' ' ' VAL . 8.7 tp -66.69 -33.35 75.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.1 179.327 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.706 ' CG ' HG11 ' A' ' 111' ' ' VAL . 39.6 mt-10 -60.5 -28.98 68.8 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.611 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -87.24 -20.24 27.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.436 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -104.95 -58.87 1.83 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.779 0.323 . . . . 0.0 111.703 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.452 ' N ' ' O ' ' A' ' 103' ' ' LEU . 23.8 mtt85 -136.43 67.39 60.02 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.027 0.441 . . . . 0.0 110.894 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.919 ' O ' HG22 ' A' ' 111' ' ' VAL . 9.5 Cg_endo -50.58 -21.71 8.16 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 123.275 2.65 . . . . 0.0 112.733 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -71.07 -9.12 57.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.608 0.242 . . . . 0.0 111.245 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.481 ' CB ' HD21 ' A' ' 103' ' ' LEU . 0.1 OUTLIER -112.44 -3.4 14.47 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 -179.472 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.919 HG22 ' O ' ' A' ' 108' ' ' PRO . 34.7 m -71.74 -27.19 27.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.659 0.266 . . . . 0.0 111.656 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.604 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 0.9 OUTLIER -68.68 -55.54 11.2 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.574 -179.194 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.604 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 37.1 Cg_exo -59.87 -31.82 94.38 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 121.868 1.712 . . . . 0.0 111.429 179.141 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.443 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 73.5 t80 -68.15 -42.78 79.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.958 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -56.02 -51.9 66.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.887 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 60.2 m -76.57 -43.82 37.25 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.675 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -55.3 -53.84 38.19 Favored Glycine 0 N--CA 1.452 -0.277 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.761 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.403 ' O ' ' HB ' ' A' ' 122' ' ' ILE . . . -56.62 -51.78 67.39 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.052 0.453 . . . . 0.0 111.09 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.78 -28.05 69.18 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.182 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -75.49 -57.86 3.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.229 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -60.12 -39.66 87.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.399 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.826 HD11 ' CD2' ' A' ' 88' ' ' TYR . 0.4 OUTLIER -58.27 -46.5 88.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.897 0.38 . . . . 0.0 111.165 -179.777 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.454 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 20.0 mttm -62.02 -29.98 70.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.229 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -70.88 -54.79 10.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.709 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.635 HG22 ' CD2' ' A' ' 132' ' ' TYR . 15.4 pt -60.41 -43.8 94.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.277 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.52 HD21 ' CD2' ' A' ' 88' ' ' TYR . 11.6 mt -54.36 -37.58 65.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.944 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -72.55 -9.54 58.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.441 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 -142.47 31.68 1.5 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.899 0.381 . . . . 0.0 110.765 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.518 ' CE1' ' CZ ' ' A' ' 134' ' ' PHE . 6.3 t80 -54.11 -24.36 17.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.074 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 40.5 mtmt -57.92 -23.68 54.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.052 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 16.3 m-20 -94.23 -49.22 5.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.447 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.635 ' CD2' HG22 ' A' ' 125' ' ' ILE . 0.6 OUTLIER -88.21 154.07 20.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.932 0.396 . . . . 0.0 111.212 -179.404 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.446 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 4.0 mm-40 -131.29 143.32 50.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.945 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.518 ' CZ ' ' CE1' ' A' ' 129' ' ' PHE . 2.5 m-85 -77.75 121.28 23.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.055 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.412 ' CE2' ' HB2' ' A' ' 80' ' ' GLU . 32.9 m-85 -126.47 134.97 50.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.708 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.464 ' HB ' ' HA ' ' A' ' 140' ' ' MET . 0.7 OUTLIER -120.91 160.99 21.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.785 179.989 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -58.31 -165.5 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.272 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.438 ' HB3' ' HB2' ' A' ' 77' ' ' HIS . 7.1 pm0 -72.54 -9.01 58.04 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.544 0.212 . . . . 0.0 111.371 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ASN . . . . . 0.519 ' HB3' ' ND2' ' A' ' 141' ' ' ASN . 22.5 m-80 -96.92 -35.4 10.9 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.504 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' MET . . . . . 0.464 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 37.0 mtp 60.86 36.91 18.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.701 0.286 . . . . 0.0 111.234 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ASN . . . . . 0.519 ' ND2' ' HB3' ' A' ' 139' ' ' ASN . 7.4 m120 -66.0 122.21 79.92 Favored Pre-proline 0 N--CA 1.453 -0.297 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.733 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -61.89 -23.46 75.98 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.246 1.964 . . . . 0.0 111.824 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -84.64 -12.24 54.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.672 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -79.27 -160.46 19.01 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.237 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.481 ' HE2' ' HB2' ' A' ' 163' ' ' PHE . 0.7 OUTLIER -100.31 -177.38 3.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.766 0.317 . . . . 0.0 110.93 179.827 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.554 HG21 ' HE2' ' A' ' 91' ' ' TYR . 46.9 t -126.67 148.92 31.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.135 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.504 ' HB2' ' CE2' ' A' ' 162' ' ' PHE . . . -116.27 110.58 18.94 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.555 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.582 HD13 HG21 ' A' ' 125' ' ' ILE . 3.9 mt -84.58 115.25 22.52 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.139 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.425 HD12 ' HG2' ' A' ' 160' ' ' MET . 12.4 tp -88.27 123.62 33.05 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.764 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.501 ' HB2' ' CZ ' ' A' ' 159' ' ' TYR . 24.2 m-20 -127.72 158.69 36.94 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.885 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -117.22 148.84 41.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.907 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -75.48 178.57 5.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.822 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.8 -37.94 80.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.976 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -75.62 -15.11 60.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.302 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 64.05 23.69 68.0 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.492 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 65.3 t -112.0 -38.38 3.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.753 0.311 . . . . 0.0 110.89 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 86.9 m -98.58 103.01 16.34 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.226 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -77.93 127.55 8.65 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.395 2.063 . . . . 0.0 112.057 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.501 ' CZ ' ' HB2' ' A' ' 150' ' ' ASP . 12.1 p90 -124.58 133.17 53.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.668 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' MET . . . . . 0.587 ' HE3' HD13 ' A' ' 78' ' ' LEU . 0.3 OUTLIER -99.98 169.01 9.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.761 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.529 ' HB ' ' HB2' ' A' ' 148' ' ' LEU . 89.6 mt -123.94 110.7 26.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.175 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.504 ' CE2' ' HB2' ' A' ' 147' ' ' ALA . 87.6 m-85 -114.38 156.71 23.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.729 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.481 ' HB2' ' HE2' ' A' ' 145' ' ' MET . 4.4 m-85 -99.21 123.59 43.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.852 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.492 ' CG ' HD11 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -62.32 -55.31 29.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.189 -179.789 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.443 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 0.8 OUTLIER -51.23 -34.92 34.34 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.071 -179.855 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -96.86 27.9 16.03 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.366 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.466 HD21 ' HB3' ' A' ' 4' ' ' TYR . 0.7 OUTLIER -146.66 144.05 29.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.777 0.322 . . . . 0.0 110.793 -179.848 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -112.85 156.82 22.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.811 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' MET . . . . . 0.765 ' HB3' HD11 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -120.51 149.98 41.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.005 -179.974 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.926 179.945 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.693 HD11 ' HB3' ' A' ' 169' ' ' MET . 1.7 tt . . . . . 0 N--CA 1.456 -0.158 0 CA-C-O 120.854 0.359 . . . . 0.0 111.036 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.501 HG21 ' HB3' ' A' ' 12' ' ' GLU . 11.7 mm -106.6 155.61 7.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.136 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.603 ' HE1' HG23 ' A' ' 2' ' ' ILE . 3.7 m-85 -123.73 104.71 9.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.665 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.73 156.31 32.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.9 0.381 . . . . 0.0 111.277 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.445 ' O ' ' HA ' ' A' ' 10' ' ' HIS . 27.0 t0 -61.64 152.18 31.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.767 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 67.1 tp -80.45 -22.11 41.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.234 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.417 ' H ' HD12 ' A' ' 8' ' ' ILE . 4.0 mp -91.23 -46.53 14.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.966 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -93.05 -28.77 16.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.705 -179.249 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.445 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER 68.72 30.88 4.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.907 0.384 . . . . 0.0 110.747 -179.681 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -102.73 125.06 49.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.806 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.501 ' HB3' HG21 ' A' ' 3' ' ' ILE . 0.9 OUTLIER -57.12 96.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.311 -179.764 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 42.2 mtp -79.71 -16.97 54.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.606 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.502 ' CE2' ' CD2' ' A' ' 4' ' ' TYR . 23.7 p90 -178.98 172.73 1.25 Allowed 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.706 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -133.05 -169.91 2.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.19 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 54.3 p30 -89.3 15.56 8.84 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.521 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 44.6 pt -82.69 -9.31 11.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.816 0.341 . . . . 0.0 111.229 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.875 ' CZ ' HG22 ' A' ' 72' ' ' ILE . 74.3 m-85 -111.65 -178.06 3.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.819 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.7 mtmt -94.48 91.45 6.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.683 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.539 ' N ' HD12 ' A' ' 20' ' ' ILE . 4.3 mp -87.84 129.94 38.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.11 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.7 mtm180 -120.89 126.0 48.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.892 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -74.36 116.19 14.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.84 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.85 HD11 HG23 ' A' ' 161' ' ' ILE . 3.6 pt -109.6 165.37 5.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.025 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.431 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . . . 59.5 32.69 21.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.092 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 64.78 45.01 3.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.301 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.52 -12.4 63.22 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.744 -0.741 . . . . 0.0 113.272 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.431 ' HB3' ' HB3' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -55.89 -39.48 71.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.938 0.369 . . . . 0.0 111.191 -179.885 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.427 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 96.6 m -137.32 170.96 15.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.081 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.74 131.25 40.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.86 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.404 ' OE1' ' CD2' ' A' ' 159' ' ' TYR . 63.3 mt-10 -97.49 113.8 25.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.04 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.462 HG23 ' HD2' ' A' ' 162' ' ' PHE . 23.5 t -90.58 112.08 24.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.904 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -85.53 120.63 27.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.994 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.46 -142.34 11.14 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.457 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.408 ' HG3' ' HB2' ' A' ' 71' ' ' ASP . 4.0 ptmm? -165.31 124.73 1.77 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.787 0.327 . . . . 0.0 110.795 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 52.4 mtm -72.04 123.8 23.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.94 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.0 m . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.133 -179.953 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 112.117 -0.393 . . . . 0.0 112.117 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.448 ' CG1' HG12 ' A' ' 72' ' ' ILE . 53.2 t -70.8 147.58 11.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.791 0.329 . . . . 0.0 110.987 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.408 ' HB2' ' HG3' ' A' ' 34' ' ' LYS . 26.4 t70 -73.57 -55.56 6.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.306 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.875 HG22 ' CZ ' ' A' ' 18' ' ' TYR . 8.9 pt -53.62 -33.72 22.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.183 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.81 HG13 ' HB2' ' A' ' 78' ' ' LEU . 84.1 t -71.5 -33.62 50.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.091 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.8 mtm -78.07 -39.2 42.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.585 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.409 ' OD1' ' CD2' ' A' ' 76' ' ' HIS . 15.8 p30 -82.11 -28.38 32.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.508 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.461 ' CE1' ' HB ' ' A' ' 72' ' ' ILE . 24.4 m170 -94.93 1.69 55.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.778 0.323 . . . . 0.0 110.936 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.423 ' HB2' ' HB3' ' A' ' 138' ' ' GLU . 15.7 m80 54.98 32.22 17.65 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.344 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.81 ' HB2' HG13 ' A' ' 73' ' ' VAL . 54.6 mt -59.13 139.11 57.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.383 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -124.77 137.44 54.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.93 0.395 . . . . 0.0 111.239 -179.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.409 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 2.5 tt0 -92.86 124.14 36.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.926 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.85 HG21 HD11 ' A' ' 136' ' ' ILE . 3.5 t -115.19 127.35 55.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.888 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 89.3 p -68.91 159.67 32.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.941 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -165.32 164.22 19.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.748 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -101.58 167.84 9.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.835 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.5 mtpt -67.02 -52.46 42.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.838 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.7 tp10 -64.89 -42.82 94.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.511 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.88 -39.37 81.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.931 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.82 ' CD2' HD11 ' A' ' 122' ' ' ILE . 1.3 t80 -59.94 -38.66 83.04 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.786 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.432 ' O ' HG22 ' A' ' 92' ' ' ILE . 70.7 mttt -56.82 -45.72 82.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.112 0.482 . . . . 0.0 110.591 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.79 -27.77 50.28 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.641 178.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.532 ' HE2' HG21 ' A' ' 146' ' ' VAL . 13.4 t80 -66.77 -44.6 80.95 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.743 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.563 HD12 ' CE2' ' A' ' 95' ' ' TYR . 5.4 tp -63.15 -44.3 99.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.014 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -62.63 -37.15 85.2 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.067 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.483 ' HA ' ' HG2' ' A' ' 97' ' ' LYS . 29.3 t70 -75.76 -42.95 48.97 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.662 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.563 ' CE2' HD12 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -77.8 -40.86 39.26 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 121.013 -0.275 . . . . 0.0 110.863 -179.476 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.439 ' HG3' ' N ' ' A' ' 97' ' ' LYS . 0.1 OUTLIER -65.12 -31.85 73.26 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.249 179.418 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.488 ' HG3' ' N ' ' A' ' 98' ' ' SER . 15.1 pttt -70.64 -34.13 71.74 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 120.945 0.402 . . . . 0.0 110.178 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.488 ' N ' ' HG3' ' A' ' 97' ' ' LYS . 2.0 m -59.47 -37.41 78.12 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.761 179.122 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.7 mt -79.78 -40.88 21.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.102 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.75 -51.33 70.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.22 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -59.54 -47.69 89.69 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.64 -0.79 . . . . 0.0 111.91 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.6 -41.27 97.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.921 0.391 . . . . 0.0 110.086 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.641 ' HB3' HG12 ' A' ' 111' ' ' VAL . 8.3 tp -65.37 -37.88 88.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.958 179.192 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.681 ' CG ' HG11 ' A' ' 111' ' ' VAL . 76.4 mt-10 -56.62 -29.95 62.75 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.767 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -86.62 -20.19 28.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.531 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -106.84 -60.9 1.61 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.763 0.316 . . . . 0.0 111.602 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.457 ' N ' ' O ' ' A' ' 103' ' ' LEU . 4.0 mtt85 -129.37 65.23 73.92 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.816 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.876 ' O ' HG22 ' A' ' 111' ' ' VAL . 9.7 Cg_endo -50.4 -22.5 8.85 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 123.22 2.613 . . . . 0.0 112.745 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -75.69 -6.92 52.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.653 0.263 . . . . 0.0 111.136 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.515 ' C ' ' HD2' ' A' ' 113' ' ' PRO . 13.9 mmt180 -112.38 -1.53 15.02 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.654 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.876 HG22 ' O ' ' A' ' 108' ' ' PRO . 33.7 m -70.77 -36.24 63.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.574 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 25.8 mttm -66.65 -50.29 46.37 Favored Pre-proline 0 CA--C 1.529 0.16 0 C-N-CA 121.049 -0.261 . . . . 0.0 111.502 -179.194 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.574 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 37.0 Cg_exo -59.97 -32.04 94.47 Favored 'Trans proline' 0 C--N 1.347 0.447 0 C-N-CA 121.993 1.796 . . . . 0.0 111.568 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.485 ' CE1' ' HB2' ' A' ' 165' ' ' ASP . 76.0 t80 -69.99 -47.71 61.11 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.852 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -50.97 -42.03 59.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.02 0.438 . . . . 0.0 110.769 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.8 m -76.65 -44.29 34.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.717 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.43 -52.47 52.39 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.679 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.04 -51.74 66.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.937 0.399 . . . . 0.0 111.134 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.58 -28.2 68.97 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.363 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -77.87 -45.69 23.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.9 0.381 . . . . 0.0 111.194 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.427 ' NE2' ' SG ' ' A' ' 28' ' ' CYS . 26.3 tt0 -70.49 -36.45 73.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.208 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.82 HD11 ' CD2' ' A' ' 88' ' ' TYR . 0.3 OUTLIER -61.89 -47.37 93.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.326 -179.765 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.465 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 13.4 pttt -61.76 -31.19 71.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.017 0.437 . . . . 0.0 110.072 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 10.2 t-80 -67.9 -53.65 24.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.621 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.605 HG21 HD13 ' A' ' 148' ' ' LEU . 15.5 pt -62.01 -42.04 93.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.291 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.474 ' HA ' HD23 ' A' ' 126' ' ' LEU . 11.3 mt -53.9 -35.9 62.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.944 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.99 -14.29 62.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.087 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -140.5 33.15 1.85 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.073 0.463 . . . . 0.0 110.398 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.504 ' CE1' ' CZ ' ' A' ' 134' ' ' PHE . 5.5 t80 -49.02 -27.59 3.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.224 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 2.8 ttpp -60.57 -27.78 67.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.791 0.329 . . . . 0.0 110.867 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 30.8 m-20 -94.27 -32.19 13.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.322 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.412 ' CZ ' ' OD2' ' A' ' 150' ' ' ASP . 3.6 m-85 -98.36 131.97 44.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.199 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -117.33 143.72 45.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.803 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.51 ' CE1' ' CZ ' ' A' ' 88' ' ' TYR . 2.1 m-85 -80.01 124.11 28.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.062 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.409 ' CE2' ' HB2' ' A' ' 80' ' ' GLU . 43.1 m-85 -127.88 145.84 50.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.686 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.85 HD11 HG21 ' A' ' 81' ' ' THR . 0.7 OUTLIER -131.59 163.64 36.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.042 179.958 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -64.56 -159.55 0.38 Allowed Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.298 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.423 ' HB3' ' HB2' ' A' ' 77' ' ' HIS . 1.2 pt-20 -75.97 -8.89 58.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.597 0.237 . . . . 0.0 111.512 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -97.24 -31.75 12.27 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.583 0.23 . . . . 0.0 111.563 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' MET . . . . . 0.422 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 56.0 mtp 58.26 37.39 26.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.809 0.338 . . . . 0.0 110.945 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ASN . . . . . 0.41 ' ND2' ' HA3' ' A' ' 144' ' ' GLY . 19.6 p-10 -64.35 115.0 16.18 Favored Pre-proline 0 N--CA 1.452 -0.372 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.934 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.92 -29.7 90.04 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.514 2.142 . . . . 0.0 112.287 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -84.55 -6.63 59.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.059 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.41 ' HA3' ' ND2' ' A' ' 141' ' ' ASN . . . -79.08 -141.12 2.05 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.413 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 3.2 ptp -113.36 -178.55 3.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.752 0.311 . . . . 0.0 110.919 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.532 HG21 ' HE2' ' A' ' 91' ' ' TYR . 42.2 t -128.06 144.95 36.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.283 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -111.67 114.73 27.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.681 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.605 HD13 HG21 ' A' ' 125' ' ' ILE . 3.3 mt -88.53 106.3 18.2 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.068 -179.374 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.483 HD12 ' HG2' ' A' ' 160' ' ' MET . 2.7 tp -88.93 119.62 29.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.219 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.462 ' HB2' ' CZ ' ' A' ' 159' ' ' TYR . 0.9 OUTLIER -129.08 165.91 20.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.695 179.517 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -111.88 146.15 38.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.96 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 21.9 mmt180 -67.32 -177.46 0.7 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.879 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.41 -31.94 68.17 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.899 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 38.1 p-10 -77.35 -15.05 59.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.23 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 71.83 17.21 76.66 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.72 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 91.1 t -112.93 -70.4 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.841 0.353 . . . . 0.0 110.733 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 86.4 m -55.07 107.86 0.99 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.08 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -84.25 128.22 4.16 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.586 2.19 . . . . 0.0 112.334 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.462 ' CZ ' ' HB2' ' A' ' 150' ' ' ASP . 9.4 p90 -124.22 136.05 53.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.821 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' MET . . . . . 0.492 ' CE ' HD13 ' A' ' 78' ' ' LEU . 0.5 OUTLIER -107.08 136.73 46.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.992 -179.765 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.85 HG23 HD11 ' A' ' 23' ' ' ILE . 62.3 mt -91.55 112.65 25.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.103 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.462 ' HD2' HG23 ' A' ' 31' ' ' VAL . 89.6 m-85 -110.24 152.18 26.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.833 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.42 ' CE2' ' OH ' ' A' ' 95' ' ' TYR . 3.1 m-85 -96.28 124.7 40.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.617 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -65.96 -56.36 12.08 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.355 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.485 ' HB2' ' CE1' ' A' ' 114' ' ' PHE . 7.0 m-20 -50.1 -36.29 28.98 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.859 0.362 . . . . 0.0 111.071 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -95.87 24.76 28.3 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.24 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.467 HD21 ' HB3' ' A' ' 4' ' ' TYR . 0.6 OUTLIER -139.99 145.07 37.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.754 0.311 . . . . 0.0 110.841 -179.885 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -119.23 143.45 47.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.796 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' MET . . . . . 0.693 ' HB3' HD11 ' A' ' 2' ' ' ILE . 0.6 OUTLIER -110.51 146.41 36.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.022 -179.918 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.958 -179.944 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.52 HG23 ' HE1' ' A' ' 4' ' ' TYR . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.741 0.305 . . . . 0.0 110.983 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' A' ' 169' ' ' MET . 14.8 mm -100.14 137.75 26.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.723 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.52 ' HE1' HG23 ' A' ' 2' ' ' ILE . 6.1 m-85 -106.36 105.37 15.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.457 179.276 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -122.44 145.76 47.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.839 0.352 . . . . 0.0 111.231 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.465 ' O ' ' HA ' ' A' ' 10' ' ' HIS . 43.5 t0 -56.21 152.08 11.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.723 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 57.9 tp -78.8 -26.71 44.38 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.2 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.866 HD11 ' CG1' ' A' ' 99' ' ' ILE . 4.4 mp -91.34 -44.12 14.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.473 ' O ' ' CG ' ' A' ' 10' ' ' HIS . 30.0 t -95.33 -10.19 30.84 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -178.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.473 ' CG ' ' O ' ' A' ' 9' ' ' SER . 25.5 p80 48.31 27.62 1.4 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.952 0.406 . . . . 0.0 111.267 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -98.21 122.59 41.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.705 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.408 ' HB3' ' CG2' ' A' ' 3' ' ' ILE . 0.1 OUTLIER -60.47 84.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.362 -179.816 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.413 ' O ' ' CD2' ' A' ' 76' ' ' HIS . 7.0 mtp -64.34 -18.57 64.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.588 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.485 ' CZ ' ' CD2' ' A' ' 4' ' ' TYR . 8.8 p90 -178.94 179.7 0.66 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.634 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -136.99 -169.9 2.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.91 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.401 ' HA ' HD11 ' A' ' 20' ' ' ILE . 37.8 t70 -93.55 26.18 3.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.027 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.436 HG13 ' CD2' ' A' ' 18' ' ' TYR . 46.0 pt -84.77 -13.28 11.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.754 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.801 ' CE2' HG22 ' A' ' 72' ' ' ILE . 79.0 m-85 -110.72 168.64 9.32 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.618 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.44 94.01 4.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.864 0.364 . . . . 0.0 110.581 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.703 HD12 ' O ' ' A' ' 18' ' ' TYR . 4.2 mp -87.79 139.41 17.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.12 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -127.35 119.53 26.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.036 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.612 ' HG3' HD23 ' A' ' 29' ' ' LEU . 1.9 mt-10 -71.77 114.7 10.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.859 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.567 HD11 HG23 ' A' ' 161' ' ' ILE . 3.9 pt -111.49 167.1 5.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.203 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 59.29 30.17 19.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.236 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 64.38 36.67 8.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.152 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.12 -15.32 61.64 Favored Glycine 0 CA--C 1.518 0.245 0 C-N-CA 120.556 -0.831 . . . . 0.0 112.986 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.419 HD22 ' HA ' ' A' ' 27' ' ' LEU . 0.2 OUTLIER -55.04 -43.39 73.74 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.811 0.338 . . . . 0.0 110.917 -179.912 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 9.0 m -135.66 165.05 26.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.912 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.612 HD23 ' HG3' ' A' ' 22' ' ' GLU . 0.4 OUTLIER -128.02 139.09 52.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.785 -179.947 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -103.51 113.01 26.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.086 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 23.5 t -91.56 112.05 24.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.721 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -82.12 114.39 20.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.229 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.43 -137.13 8.84 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.288 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -174.51 128.24 0.33 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.885 0.374 . . . . 0.0 110.809 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 8.3 mtt -72.3 124.26 24.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.921 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 28.0 m . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.208 -179.899 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.466 0 N-CA-C 111.891 -0.484 . . . . 0.0 111.891 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.51 HG12 HG12 ' A' ' 72' ' ' ILE . 46.8 t -73.25 141.89 15.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.75 0.309 . . . . 0.0 110.754 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -68.59 -56.17 9.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.725 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.801 HG22 ' CE2' ' A' ' 18' ' ' TYR . 8.5 pt -53.58 -33.77 22.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.868 0.366 . . . . 0.0 111.32 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.789 HG13 ' HB2' ' A' ' 78' ' ' LEU . 92.9 t -70.8 -32.0 47.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.83 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.5 mtm -78.3 -40.64 36.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.539 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -82.07 -28.46 32.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.621 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.447 ' CD2' ' HB ' ' A' ' 72' ' ' ILE . 7.2 m-70 -90.22 -5.68 56.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.857 0.36 . . . . 0.0 110.676 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 9.0 m80 62.45 29.93 17.19 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.103 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.789 ' HB2' HG13 ' A' ' 73' ' ' VAL . 34.5 mt -59.53 147.1 38.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.499 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -127.71 137.24 52.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.86 0.362 . . . . 0.0 111.042 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.429 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 2.9 tt0 -99.96 124.11 44.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.056 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.742 HG21 HD11 ' A' ' 136' ' ' ILE . 6.6 t -123.69 135.18 53.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.769 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 9.1 m -68.01 160.58 28.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.092 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.457 ' HB2' ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -156.8 154.54 30.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.866 179.975 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.9 m -99.13 157.08 16.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.786 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.67 -52.39 65.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.904 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -66.51 -43.09 86.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.683 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.6 -37.8 82.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.05 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.847 ' CD2' HD11 ' A' ' 122' ' ' ILE . 1.3 t80 -62.87 -35.13 79.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.745 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.411 ' O ' HG22 ' A' ' 92' ' ' ILE . 24.4 mttt -59.99 -45.5 92.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.051 0.453 . . . . 0.0 110.443 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.65 -27.93 55.81 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.629 178.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.563 ' HE2' HG21 ' A' ' 146' ' ' VAL . 13.3 t80 -66.21 -47.47 73.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.638 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.454 ' O ' ' HG2' ' A' ' 96' ' ' MET . 4.7 tp -60.3 -43.93 94.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.968 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 8.6 ttmt -60.08 -43.64 95.36 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.214 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.473 ' HA ' ' HG2' ' A' ' 97' ' ' LYS . 12.0 t70 -72.75 -39.72 66.6 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.819 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.471 ' CD1' ' C ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -76.46 -41.62 46.69 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 121.004 -0.279 . . . . 0.0 110.855 -179.497 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.454 ' HG2' ' O ' ' A' ' 92' ' ' ILE . 2.9 ptt? -67.95 -32.75 73.4 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.73 0.3 . . . . 0.0 110.844 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.473 ' HG2' ' HA ' ' A' ' 94' ' ' ASP . 0.3 OUTLIER -70.68 -35.58 72.89 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.894 0.378 . . . . 0.0 110.577 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.406 ' N ' ' HG3' ' A' ' 97' ' ' LYS . 1.9 m -60.52 -40.49 91.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.144 179.354 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.866 ' CG1' HD11 ' A' ' 8' ' ' ILE . 6.6 mt -79.85 -41.63 21.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.445 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.5 tmtt? -54.44 -54.07 45.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.502 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -58.69 -45.93 94.07 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.192 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 10.4 tptp -61.69 -41.28 97.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.806 0.336 . . . . 0.0 110.461 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.73 ' HB3' HG12 ' A' ' 111' ' ' VAL . 5.0 tp -67.4 -34.1 76.57 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.132 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.707 ' CG ' HG11 ' A' ' 111' ' ' VAL . 40.5 mt-10 -59.81 -29.83 68.51 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.828 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.413 ' HG3' ' HG3' ' A' ' 106' ' ' GLN . 0.6 OUTLIER -87.84 -19.39 27.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.561 -179.782 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.413 ' HG3' ' HG3' ' A' ' 105' ' ' GLU . 56.8 mt-30 -105.44 -58.17 1.93 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.736 0.303 . . . . 0.0 111.611 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.446 ' N ' ' O ' ' A' ' 103' ' ' LEU . 87.5 mtt180 -138.5 67.91 45.22 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 120.919 0.39 . . . . 0.0 110.858 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.944 ' O ' HG22 ' A' ' 111' ' ' VAL . 10.3 Cg_endo -50.88 -20.97 7.71 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 123.254 2.636 . . . . 0.0 112.888 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -67.69 -9.72 46.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.592 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.637 ' CB ' HD21 ' A' ' 103' ' ' LEU . 31.0 mmt-85 -114.23 -4.82 13.02 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.944 HG22 ' O ' ' A' ' 108' ' ' PRO . 35.6 m -69.52 -27.74 35.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.609 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 4.3 mmtp -71.99 -54.32 6.08 Favored Pre-proline 0 CA--C 1.532 0.257 0 C-N-CA 121.078 -0.249 . . . . 0.0 111.416 -179.393 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.609 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 37.2 Cg_exo -56.08 -35.89 95.47 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 121.772 1.648 . . . . 0.0 111.547 179.061 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.469 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 87.5 t80 -65.8 -43.18 89.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.904 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.54 -52.36 55.19 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.08 0.467 . . . . 0.0 110.741 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 61.7 m -75.8 -44.19 42.49 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.695 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -56.21 -51.39 56.19 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.687 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.16 -51.67 67.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.994 0.426 . . . . 0.0 110.985 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.526 ' HB1' ' HE3' ' A' ' 123' ' ' LYS . . . -61.55 -28.07 69.07 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.229 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -77.94 -48.54 16.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.859 0.362 . . . . 0.0 111.048 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 14.2 tp60 -67.31 -34.99 78.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.025 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.847 HD11 ' CD2' ' A' ' 88' ' ' TYR . 0.3 OUTLIER -67.03 -45.1 87.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.064 -179.865 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.526 ' HE3' ' HB1' ' A' ' 119' ' ' ALA . 26.3 mttt -61.47 -29.94 70.29 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.411 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 9.7 t-80 -70.19 -53.96 14.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.764 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.869 HG21 HD13 ' A' ' 148' ' ' LEU . 14.5 pt -60.52 -41.86 89.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.273 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.401 ' HA ' HD23 ' A' ' 126' ' ' LEU . 12.4 mt -55.23 -38.41 68.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.89 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -71.39 -10.82 60.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.317 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -140.59 33.48 1.83 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.859 0.361 . . . . 0.0 110.648 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.511 ' CE1' ' CE2' ' A' ' 134' ' ' PHE . 2.2 t80 -50.13 -29.96 10.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.99 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.6 ttpt -60.1 -29.68 68.75 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.935 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 21.3 m-20 -94.17 -35.73 12.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.436 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.598 ' CD2' HG22 ' A' ' 125' ' ' ILE . 4.7 m-85 -94.84 136.31 35.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.897 0.38 . . . . 0.0 111.211 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.406 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 4.8 mm-40 -119.83 145.68 46.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.745 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.511 ' CE2' ' CE1' ' A' ' 129' ' ' PHE . 0.6 OUTLIER -83.35 121.82 27.64 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.989 -179.759 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.459 ' CG ' ' CE ' ' A' ' 160' ' ' MET . 46.5 m-85 -125.46 134.85 51.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.761 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.742 HD11 HG21 ' A' ' 81' ' ' THR . 0.3 OUTLIER -123.87 164.77 21.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.784 179.989 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.53 -173.05 1.25 Allowed Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.447 -0.882 . . . . 0.0 111.899 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -67.36 -13.68 62.23 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.564 0.221 . . . . 0.0 111.22 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ASN . . . . . 0.501 ' HB3' ' ND2' ' A' ' 141' ' ' ASN . 22.4 m-80 -92.75 -28.66 16.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.723 0.297 . . . . 0.0 111.366 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' MET . . . . . 0.472 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 53.8 mtm 54.69 43.08 30.7 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.811 0.339 . . . . 0.0 111.201 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ASN . . . . . 0.501 ' ND2' ' HB3' ' A' ' 139' ' ' ASN . 2.4 m120 -67.29 122.28 82.26 Favored Pre-proline 0 N--CA 1.453 -0.279 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.67 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -59.74 -27.23 84.45 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.351 2.034 . . . . 0.0 111.881 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -84.76 -15.99 43.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.814 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.99 -173.45 24.78 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.347 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -88.84 -177.99 5.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.737 0.303 . . . . 0.0 110.881 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.563 HG21 ' HE2' ' A' ' 91' ' ' TYR . 41.6 t -127.6 153.84 37.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.222 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.417 ' N ' HG12 ' A' ' 146' ' ' VAL . . . -118.54 115.74 25.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.691 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.869 HD13 HG21 ' A' ' 125' ' ' ILE . 3.6 mt -90.18 106.7 18.66 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.948 -179.351 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.514 HD12 ' HG2' ' A' ' 160' ' ' MET . 1.6 tp -88.5 119.61 29.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.409 -179.304 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.47 ' HB3' ' CE1' ' A' ' 159' ' ' TYR . 0.7 OUTLIER -129.49 172.24 11.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.525 179.4 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -117.76 144.41 45.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.847 0.356 . . . . 0.0 111.008 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.41 -177.71 0.05 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.933 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.36 -34.97 71.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.017 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.573 ' OD1' HG23 ' A' ' 156' ' ' VAL . 9.2 t70 -76.54 -15.14 59.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.218 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 69.17 26.04 74.95 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.711 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.573 HG23 ' OD1' ' A' ' 154' ' ' ASP . 94.5 t -112.83 -69.81 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.932 0.396 . . . . 0.0 110.885 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 73.4 m -63.77 111.23 4.86 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.01 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -81.73 131.17 7.08 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.462 2.108 . . . . 0.0 112.192 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.47 ' CE1' ' HB3' ' A' ' 150' ' ' ASP . 13.9 p90 -125.62 144.59 50.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.92 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' MET . . . . . 0.514 ' HG2' HD12 ' A' ' 149' ' ' LEU . 0.2 OUTLIER -110.7 142.65 42.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.137 -179.792 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.567 HG23 HD11 ' A' ' 23' ' ' ILE . 58.7 mt -97.68 116.34 39.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.974 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -118.6 132.82 56.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.798 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -78.0 123.0 26.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.867 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.46 -54.48 35.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.327 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.469 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 1.6 m-20 -49.54 -36.2 22.75 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.285 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -96.55 27.92 15.49 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.366 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.49 143.96 29.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.814 0.34 . . . . 0.0 110.925 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -113.66 147.76 37.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.725 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' MET . . . . . 0.422 ' HA ' ' O ' ' A' ' 3' ' ' ILE . 0.7 OUTLIER -120.08 140.3 51.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.975 -179.816 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.914 179.955 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.809 HD11 ' HB3' ' A' ' 169' ' ' MET . 4.5 tt . . . . . 0 N--CA 1.456 -0.139 0 CA-C-O 120.892 0.377 . . . . 0.0 111.038 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.408 HG21 ' HB3' ' A' ' 12' ' ' GLU . 20.2 mm -100.98 155.25 4.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.317 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.602 ' HB3' HD21 ' A' ' 167' ' ' LEU . 2.8 m-85 -122.8 105.94 10.47 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.424 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 17.5 ptt180 -120.8 150.29 41.25 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.937 0.398 . . . . 0.0 111.469 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.428 ' O ' ' HA ' ' A' ' 10' ' ' HIS . 37.6 t0 -62.38 152.18 34.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.616 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.508 HD23 HG23 ' A' ' 99' ' ' ILE . 56.6 tp -81.23 -22.6 38.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.395 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.911 HD11 ' CG1' ' A' ' 99' ' ' ILE . 4.1 mp -91.27 -45.9 14.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 93.1 p -93.14 -21.39 19.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.616 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.428 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 1.6 m-70 62.23 29.78 17.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.865 0.364 . . . . 0.0 110.805 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -106.1 124.62 49.87 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.804 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.408 ' HB3' HG21 ' A' ' 3' ' ' ILE . 2.6 pm0 -58.44 93.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.207 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 7.3 mtt -70.08 -18.42 63.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.847 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.516 ' CE2' ' CD2' ' A' ' 4' ' ' TYR . 14.3 p90 -177.44 177.33 1.19 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.899 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.473 ' O ' HD11 ' A' ' 20' ' ' ILE . 0.9 OUTLIER -136.67 -169.88 2.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.975 -179.827 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 34.5 p-10 -87.83 13.93 9.75 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.615 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 46.5 pt -78.9 -4.96 7.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.816 0.341 . . . . 0.0 111.13 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.864 ' CZ ' HG22 ' A' ' 72' ' ' ILE . 65.3 m-85 -119.56 -179.07 3.77 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.728 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -91.39 88.71 6.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.748 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.473 HD11 ' O ' ' A' ' 15' ' ' SER . 4.0 mp -87.84 123.96 40.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.928 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 8.9 mtt180 -114.85 135.91 53.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.934 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.702 ' HG3' HD23 ' A' ' 29' ' ' LEU . 2.3 mp0 -81.56 114.82 20.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.868 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.714 HD11 HG23 ' A' ' 161' ' ' ILE . 3.3 pt -110.23 162.59 7.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.21 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.428 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . . . 60.01 29.77 19.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.251 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 64.42 50.81 2.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.423 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.65 -4.25 74.86 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 120.732 -0.747 . . . . 0.0 113.441 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.531 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -66.65 -29.36 69.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 117.036 0.418 . . . . 0.0 111.0 -179.903 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.424 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 92.4 m -147.59 171.52 15.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.119 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.702 HD23 ' HG3' ' A' ' 22' ' ' GLU . 0.7 OUTLIER -134.79 129.57 34.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.874 -179.954 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.414 ' OE1' ' CD2' ' A' ' 159' ' ' TYR . 61.7 mt-10 -97.52 116.36 29.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.166 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.41 HG23 ' HD2' ' A' ' 162' ' ' PHE . 21.9 t -92.41 111.97 25.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.698 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -83.0 116.77 22.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.172 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -99.98 -144.51 16.22 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.201 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.0 pttm -174.53 126.01 0.31 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.829 0.347 . . . . 0.0 111.02 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 21.7 mtt -70.03 121.93 18.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.778 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.4 m . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.29 -179.775 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 N-CA-C 112.356 -0.298 . . . . 0.0 112.356 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.636 HG12 HG12 ' A' ' 72' ' ' ILE . 47.9 t -69.02 124.27 24.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.913 0.387 . . . . 0.0 110.756 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -54.28 -57.31 11.68 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.833 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.864 HG22 ' CZ ' ' A' ' 18' ' ' TYR . 5.4 pt -53.74 -34.13 24.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.842 0.353 . . . . 0.0 111.364 -179.334 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.783 HG13 ' HB2' ' A' ' 78' ' ' LEU . 97.5 t -73.67 -29.97 27.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.055 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.7 mtt -78.24 -42.25 31.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.82 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.428 ' OD1' ' CD2' ' A' ' 76' ' ' HIS . 19.6 p30 -82.05 -29.68 31.78 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 -179.18 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.428 ' CD2' ' OD1' ' A' ' 75' ' ' ASN . 34.1 m170 -88.99 -5.39 57.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.862 0.363 . . . . 0.0 110.626 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.417 ' HB2' ' HB3' ' A' ' 138' ' ' GLU . 78.0 m-70 61.43 30.3 18.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.032 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.783 ' HB2' HG13 ' A' ' 73' ' ' VAL . 60.0 mt -58.57 148.56 28.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.49 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -131.75 136.47 47.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.854 0.359 . . . . 0.0 111.109 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.419 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 2.5 tm-20 -89.81 135.21 33.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.104 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.495 HG23 ' HB2' ' A' ' 134' ' ' PHE . 5.2 t -120.21 171.85 8.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.725 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 30.2 m -114.56 161.23 18.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.978 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.482 ' HB2' ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -171.62 159.81 5.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.039 -179.898 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 8.6 m -101.54 162.41 12.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.815 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 17.1 mtpt -58.39 -51.95 67.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.104 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -65.64 -46.44 79.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.842 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.46 -36.4 73.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.185 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.91 ' CD2' HD11 ' A' ' 122' ' ' ILE . 1.0 OUTLIER -62.57 -37.9 87.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.809 179.874 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.523 ' NZ ' HD13 ' A' ' 126' ' ' LEU . 28.1 mttm -58.58 -44.9 89.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.649 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.1 tttm -77.96 -27.9 49.33 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.652 178.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.562 ' HE2' HG21 ' A' ' 146' ' ' VAL . 12.4 t80 -66.9 -46.6 74.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.711 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.538 HD12 ' CE2' ' A' ' 95' ' ' TYR . 6.0 tp -61.9 -42.61 95.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.107 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.475 ' O ' ' CG ' ' A' ' 97' ' ' LYS . 11.3 ttpp -62.0 -45.28 94.32 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.92 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -70.56 -38.14 74.08 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.945 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.538 ' CE2' HD12 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -78.24 -43.51 28.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.742 -0.208 . . . . 0.0 110.839 -179.458 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.413 ' HG3' ' N ' ' A' ' 97' ' ' LYS . 0.3 OUTLIER -62.07 -31.77 72.22 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 178.778 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.475 ' CG ' ' O ' ' A' ' 93' ' ' LYS . 1.4 mmmp? -65.61 -41.87 92.23 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.35 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.7 m -52.85 -40.31 63.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.146 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.911 ' CG1' HD11 ' A' ' 8' ' ' ILE . 8.7 mt -79.76 -42.71 22.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.443 179.314 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.69 -49.05 74.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.376 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -60.89 -49.66 76.15 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.013 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.5 -40.53 91.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.86 0.362 . . . . 0.0 110.262 179.531 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.612 ' HB3' HG12 ' A' ' 111' ' ' VAL . 7.3 tp -65.17 -38.31 90.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.095 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.693 ' HG3' HG11 ' A' ' 111' ' ' VAL . 78.7 mt-10 -56.88 -29.54 63.06 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.725 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -87.03 -19.66 28.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.635 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -107.8 -61.77 1.53 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.882 0.372 . . . . 0.0 111.527 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.447 ' N ' ' O ' ' A' ' 103' ' ' LEU . 43.5 mtt-85 -131.11 65.41 76.57 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.715 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.881 ' O ' HG22 ' A' ' 111' ' ' VAL . 9.8 Cg_endo -50.49 -22.82 9.58 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 123.19 2.594 . . . . 0.0 112.75 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -70.6 -10.46 59.36 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.217 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.546 ' CB ' HD21 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -108.89 -1.24 19.28 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -179.482 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.881 HG22 ' O ' ' A' ' 108' ' ' PRO . 26.5 m -71.81 -34.41 51.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -179.434 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.568 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 23.9 mtmt -68.99 -49.57 24.95 Favored Pre-proline 0 C--N 1.332 -0.178 0 C-N-CA 120.949 -0.301 . . . . 0.0 111.633 -179.239 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.568 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 37.0 Cg_exo -60.56 -32.07 93.04 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.153 1.902 . . . . 0.0 111.686 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.472 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 36.7 t80 -72.16 -47.09 53.43 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.096 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 15.0 mmm -49.42 -43.25 44.45 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.021 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 69.1 m -76.01 -45.14 36.08 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.842 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.45 -54.78 34.3 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.803 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -52.62 -51.63 59.11 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.897 0.38 . . . . 0.0 111.434 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.47 ' O ' HG22 ' A' ' 122' ' ' ILE . . . -68.58 -29.05 67.51 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.662 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -72.87 -55.87 6.02 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.865 0.364 . . . . 0.0 111.214 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.424 ' NE2' ' SG ' ' A' ' 28' ' ' CYS . 7.9 tt0 -60.83 -31.51 70.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.487 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.91 HD11 ' CD2' ' A' ' 88' ' ' TYR . 0.4 OUTLIER -63.71 -45.19 98.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.322 -179.532 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.436 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 15.5 mttp -61.45 -30.89 70.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.059 0.457 . . . . 0.0 110.196 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 9.0 t-80 -69.34 -54.78 12.79 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.764 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.661 HG21 HD13 ' A' ' 148' ' ' LEU . 15.0 pt -60.26 -42.79 91.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.386 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.523 HD13 ' NZ ' ' A' ' 89' ' ' LYS . 12.0 mt -53.98 -38.18 64.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.886 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.58 -15.18 63.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.212 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -137.98 32.32 2.42 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.941 0.401 . . . . 0.0 110.751 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.499 ' CE1' ' CZ ' ' A' ' 134' ' ' PHE . 4.2 t80 -51.93 -27.99 14.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.065 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.59 -18.87 65.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.296 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 15.8 m-80 -94.14 -36.25 12.15 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.325 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.458 ' CD2' HG22 ' A' ' 125' ' ' ILE . 1.1 m-30 -102.7 162.32 13.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.829 0.347 . . . . 0.0 111.151 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 5.8 mm-40 -138.0 147.57 44.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.889 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.499 ' CZ ' ' CE1' ' A' ' 129' ' ' PHE . 2.8 m-85 -78.62 129.74 35.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.955 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.44 ' O ' ' HB3' ' A' ' 147' ' ' ALA . 33.2 m-85 -134.71 134.59 41.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.629 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.45 ' HB ' ' HA ' ' A' ' 140' ' ' MET . 0.8 OUTLIER -123.18 161.2 25.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.931 -179.977 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.51 -163.44 0.24 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.207 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.417 ' HB3' ' HB2' ' A' ' 77' ' ' HIS . 5.2 pt-20 -72.49 -8.88 57.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.554 0.216 . . . . 0.0 111.531 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ASN . . . . . 0.525 ' HB3' ' ND2' ' A' ' 141' ' ' ASN . 19.2 m-80 -95.7 -35.34 11.61 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.607 0.241 . . . . 0.0 111.566 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' MET . . . . . 0.45 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 10.3 mtp 58.85 40.77 22.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.695 0.283 . . . . 0.0 111.217 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ASN . . . . . 0.525 ' ND2' ' HB3' ' A' ' 139' ' ' ASN . 1.3 m120 -69.67 117.64 55.18 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.633 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -62.54 -24.26 75.18 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.345 2.03 . . . . 0.0 111.78 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -84.8 -15.23 45.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.758 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -74.17 -136.11 0.37 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.317 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.4 ' HE3' ' O ' ' A' ' 166' ' ' GLY . 5.6 ptp -120.29 -175.87 3.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.86 0.362 . . . . 0.0 110.712 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.562 HG21 ' HE2' ' A' ' 91' ' ' TYR . 57.5 t -129.09 144.78 37.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.338 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' A' ' 135' ' ' PHE . . . -111.39 117.8 34.08 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.378 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.661 HD13 HG21 ' A' ' 125' ' ' ILE . 5.8 mt -91.53 107.77 19.44 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.323 -179.042 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.567 HD12 ' HG2' ' A' ' 160' ' ' MET . 2.3 tp -88.05 120.67 29.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.552 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.536 ' HB2' ' CZ ' ' A' ' 159' ' ' TYR . 18.3 m-20 -122.0 145.28 48.28 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.056 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.433 ' CE1' ' HB3' ' A' ' 158' ' ' PRO . 64.7 m-85 -100.75 135.44 42.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.933 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 15.2 mmm-85 -60.89 -178.64 0.1 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.943 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -59.88 -41.24 91.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.999 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -77.68 -15.08 59.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.287 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 67.49 25.14 73.86 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.522 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 71.6 t -110.21 -37.05 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.851 0.358 . . . . 0.0 110.964 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 94.3 m -103.41 96.63 8.81 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.225 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.523 ' HB2' HD11 ' A' ' 149' ' ' LEU . 71.8 Cg_endo -76.02 128.12 10.47 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.521 2.148 . . . . 0.0 112.169 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.536 ' CZ ' ' HB2' ' A' ' 150' ' ' ASP . 7.7 p90 -120.04 130.56 54.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.73 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' MET . . . . . 0.765 ' HG3' HD11 ' A' ' 72' ' ' ILE . 20.9 mtp -102.2 134.66 45.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.546 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.714 HG23 HD11 ' A' ' 23' ' ' ILE . 96.4 mt -90.45 113.06 25.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.861 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.41 ' HD2' HG23 ' A' ' 31' ' ' VAL . 59.1 m-85 -109.82 154.54 22.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.921 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.419 ' CD2' ' OH ' ' A' ' 95' ' ' TYR . 3.4 m-30 -95.46 126.26 40.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.717 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.446 ' HG3' HD11 ' A' ' 29' ' ' LEU . 0.6 OUTLIER -69.98 -54.91 11.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.306 -179.662 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.472 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 3.2 m-20 -49.11 -37.31 21.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.181 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.4 ' O ' ' HE3' ' A' ' 145' ' ' MET . . . -95.46 26.38 20.03 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.377 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.602 HD21 ' HB3' ' A' ' 4' ' ' TYR . 0.8 OUTLIER -140.77 146.04 37.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.823 0.344 . . . . 0.0 110.787 -179.867 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -119.53 142.75 48.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.845 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' MET . . . . . 0.809 ' HB3' HD11 ' A' ' 2' ' ' ILE . 0.1 OUTLIER -109.09 148.57 30.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.992 -179.988 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.832 179.885 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.638 HG23 ' CE1' ' A' ' 4' ' ' TYR . 11.8 tt . . . . . 0 N--CA 1.455 -0.21 0 CA-C-O 120.939 0.399 . . . . 0.0 111.012 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.9 mm -102.27 153.02 5.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.486 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.638 ' CE1' HG23 ' A' ' 2' ' ' ILE . 3.3 m-85 -124.43 101.52 7.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.449 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.36 153.23 34.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.931 0.396 . . . . 0.0 111.398 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.536 ' OD1' HD12 ' A' ' 8' ' ' ILE . 46.3 t0 -59.34 152.05 22.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.646 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 36.6 tp -81.96 -16.91 48.86 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.551 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.536 HD12 ' OD1' ' A' ' 6' ' ' ASP . 4.3 mp -91.41 -50.72 12.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 27.8 t -97.35 -18.04 19.37 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.455 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 9.0 m80 64.73 31.39 11.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.832 0.348 . . . . 0.0 110.865 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -97.77 122.1 40.46 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.738 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -58.16 95.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.32 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 5.1 mtt -74.86 -18.55 60.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.662 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.502 ' CZ ' ' CD2' ' A' ' 4' ' ' TYR . 10.7 p90 -178.87 174.02 1.16 Allowed 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.6 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -132.27 -169.97 2.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.729 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.424 ' HA ' HD11 ' A' ' 20' ' ' ILE . 37.6 t0 -96.29 30.75 2.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.192 0.52 . . . . 0.0 110.736 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.42 HG13 ' CD2' ' A' ' 18' ' ' TYR . 45.5 pt -93.31 -10.25 9.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.659 179.269 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.796 ' CZ ' HG22 ' A' ' 72' ' ' ILE . 48.4 m-85 -111.87 -169.16 1.41 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.715 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.72 95.48 8.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.84 0.352 . . . . 0.0 110.901 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.424 HD11 ' HA ' ' A' ' 16' ' ' ASP . 4.2 mp -92.41 125.74 45.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.097 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.4 mtp85 -117.19 120.45 38.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.055 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.702 ' HG3' HD23 ' A' ' 29' ' ' LEU . 3.5 mp0 -72.14 114.55 10.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.849 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.597 HD11 HG23 ' A' ' 161' ' ' ILE . 4.2 pt -112.86 167.4 6.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.192 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.436 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . . . 58.06 30.81 19.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.274 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 63.95 44.08 4.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.347 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.21 -17.36 56.04 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 120.735 -0.745 . . . . 0.0 113.142 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.436 ' HB3' ' HB3' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -52.15 -50.4 61.83 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.831 0.348 . . . . 0.0 111.137 -179.872 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 55.3 m -130.18 164.33 24.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.744 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.702 HD23 ' HG3' ' A' ' 22' ' ' GLU . 0.7 OUTLIER -128.6 135.13 48.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.045 -179.724 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -96.7 114.82 26.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.126 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.441 HG21 ' CD2' ' A' ' 14' ' ' PHE . 22.2 t -96.37 112.14 27.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.872 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -91.28 115.48 28.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.115 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -98.94 -131.49 7.31 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.458 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -172.39 124.93 0.5 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.804 0.335 . . . . 0.0 110.939 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 24.4 mtp -74.73 123.93 25.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.91 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.2 m . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.236 -179.894 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 N-CA-C 112.353 -0.299 . . . . 0.0 112.353 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.564 HG22 ' HG3' ' A' ' 158' ' ' PRO . 59.0 t -68.02 148.26 11.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.865 0.364 . . . . 0.0 110.851 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -71.56 -59.12 2.93 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.452 -179.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.796 HG22 ' CZ ' ' A' ' 18' ' ' TYR . 8.9 pt -53.72 -33.94 23.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.437 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.782 HG13 ' HB2' ' A' ' 78' ' ' LEU . 61.5 t -72.72 -34.05 46.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.042 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.1 mtm -78.31 -39.15 40.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.576 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.403 ' OD1' ' CD2' ' A' ' 76' ' ' HIS . 19.8 p30 -82.0 -28.46 32.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.559 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.448 ' CE1' ' HB ' ' A' ' 72' ' ' ILE . 26.7 m170 -92.49 -1.17 57.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.841 0.353 . . . . 0.0 110.801 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.435 ' HB2' ' HB3' ' A' ' 138' ' ' GLU . 21.9 m170 58.0 31.41 20.6 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.074 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.782 ' HB2' HG13 ' A' ' 73' ' ' VAL . 42.6 mt -60.23 142.41 54.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.489 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -125.24 136.56 53.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.304 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.429 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 1.7 tm-20 -91.86 121.06 33.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.863 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.896 HG21 HD11 ' A' ' 136' ' ' ILE . 3.5 t -113.6 127.07 55.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.881 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 70.6 m -68.96 159.15 33.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.887 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.476 ' HB2' ' CD2' ' A' ' 134' ' ' PHE . 0.3 OUTLIER -166.84 152.44 7.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.818 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.26 166.5 11.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.879 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.0 mtmt -63.56 -52.41 61.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.141 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -61.31 -48.29 82.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.928 0.394 . . . . 0.0 110.811 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.29 -40.84 78.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.074 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.902 ' CD2' HD11 ' A' ' 122' ' ' ILE . 0.4 OUTLIER -59.43 -35.88 74.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.762 179.96 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.46 ' O ' HG22 ' A' ' 92' ' ' ILE . 27.2 mttt -58.31 -47.8 82.55 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.187 0.517 . . . . 0.0 110.527 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.6 tmtm? -76.57 -27.82 56.0 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.704 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.54 ' HE2' HG21 ' A' ' 146' ' ' VAL . 11.0 t80 -66.73 -46.87 74.09 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.693 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.46 HG22 ' O ' ' A' ' 89' ' ' LYS . 4.5 tp -59.85 -44.02 93.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.945 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.1 ttmm -59.27 -40.7 86.88 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.205 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.513 ' HA ' ' HG2' ' A' ' 97' ' ' LYS . 47.3 t0 -73.15 -43.21 61.89 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.898 -179.205 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.45 ' CE2' ' CD1' ' A' ' 92' ' ' ILE . 0.0 OUTLIER -75.35 -39.9 58.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.647 -0.252 . . . . 0.0 111.199 -179.176 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.448 ' HG2' ' O ' ' A' ' 92' ' ' ILE . 15.0 ptm -67.57 -32.22 72.82 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.792 0.33 . . . . 0.0 110.539 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.513 ' HG2' ' HA ' ' A' ' 94' ' ' ASP . 4.6 ptpt -69.91 -34.07 73.01 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.66 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.489 ' N ' ' HG3' ' A' ' 97' ' ' LYS . 2.2 m -61.74 -40.49 95.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.085 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 7.0 mt -79.86 -41.3 21.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.355 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -55.38 -53.91 50.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.521 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' A' ' 104' ' ' GLU . . . -61.5 -45.7 95.84 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.138 179.387 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.9 tptt -61.41 -39.49 90.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.883 0.373 . . . . 0.0 110.3 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.654 HD21 ' CB ' ' A' ' 110' ' ' ARG . 3.0 tp -68.69 -32.94 73.12 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.025 179.329 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.66 ' CG ' HG11 ' A' ' 111' ' ' VAL . 83.4 mt-10 -59.99 -30.4 69.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.807 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -88.19 -20.19 25.9 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.605 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 -106.25 -62.82 1.33 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.863 0.363 . . . . 0.0 111.548 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.435 ' N ' ' O ' ' A' ' 103' ' ' LEU . 5.5 mtm180 -126.25 63.43 50.52 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.923 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.86 ' O ' HG22 ' A' ' 111' ' ' VAL . 9.9 Cg_endo -50.62 -22.21 9.0 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 123.233 2.622 . . . . 0.0 112.776 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -74.83 -7.06 52.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.372 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.654 ' CB ' HD21 ' A' ' 103' ' ' LEU . 17.0 mmt180 -113.55 -1.71 14.03 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.681 0.276 . . . . 0.0 111.617 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.86 HG22 ' O ' ' A' ' 108' ' ' PRO . 34.2 m -67.96 -37.78 78.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -179.248 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.577 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 13.9 mtpt -67.55 -50.48 36.27 Favored Pre-proline 0 CA--C 1.529 0.161 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.617 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.577 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 31.9 Cg_exo -58.06 -33.28 97.13 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.087 1.858 . . . . 0.0 111.521 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.457 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 94.1 t80 -70.48 -40.84 73.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.746 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 15.9 mtm -55.89 -44.77 78.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.761 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 62.9 m -76.51 -44.24 36.05 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.61 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -59.19 -52.04 55.62 Favored Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.768 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.442 ' O ' ' HB ' ' A' ' 122' ' ' ILE . . . -56.89 -51.77 67.77 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.968 0.414 . . . . 0.0 111.117 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.7 -28.09 68.16 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.385 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -74.11 -49.62 23.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.482 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -71.43 -42.48 68.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.437 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.902 HD11 ' CD2' ' A' ' 88' ' ' TYR . 0.3 OUTLIER -56.06 -49.83 73.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.726 -179.4 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.484 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 10.7 ptmt -63.03 -31.2 72.29 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.046 0.451 . . . . 0.0 110.132 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 10.6 t-80 -67.99 -50.14 57.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.78 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.414 HD11 ' HA ' ' A' ' 122' ' ' ILE . 17.4 pt -65.59 -42.57 93.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.319 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.472 HD21 ' CD2' ' A' ' 88' ' ' TYR . 10.6 mt -53.85 -35.14 61.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.878 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -71.21 -10.84 60.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.289 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -144.98 34.01 1.11 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.042 0.449 . . . . 0.0 110.574 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.503 ' CE1' ' CZ ' ' A' ' 134' ' ' PHE . 13.8 t80 -52.17 -25.19 8.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.2 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -55.14 -27.83 48.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.816 0.341 . . . . 0.0 111.156 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 31.9 m-20 -94.29 -37.5 11.48 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.665 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.42 ' HE2' HD11 ' A' ' 161' ' ' ILE . 4.1 m-85 -100.53 135.01 42.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.912 0.387 . . . . 0.0 111.598 -179.293 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.444 ' NE2' ' CZ ' ' A' ' 129' ' ' PHE . 5.8 mm-40 -115.89 148.77 39.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.8 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.515 ' CE1' ' CZ ' ' A' ' 88' ' ' TYR . 3.7 m-85 -82.07 128.97 34.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.21 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.429 ' CE2' ' HB2' ' A' ' 80' ' ' GLU . 28.4 m-85 -130.72 156.38 45.04 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.609 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.896 HD11 HG21 ' A' ' 81' ' ' THR . 0.5 OUTLIER -142.95 162.31 17.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.935 179.885 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -64.0 -163.45 0.61 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.344 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.435 ' HB3' ' HB2' ' A' ' 77' ' ' HIS . 4.7 pt-20 -73.26 -8.85 57.59 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.595 0.236 . . . . 0.0 111.511 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 18.3 m-80 -98.5 -29.1 13.29 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.597 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' MET . . . . . 0.429 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 31.7 mtm 55.44 42.24 30.15 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.905 0.383 . . . . 0.0 111.02 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ASN . . . . . 0.406 ' ND2' ' HA3' ' A' ' 144' ' ' GLY . 16.3 p-10 -64.93 114.8 16.26 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.014 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -63.89 -28.95 67.31 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.561 2.174 . . . . 0.0 112.219 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -84.61 -14.48 48.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.169 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.406 ' HA3' ' ND2' ' A' ' 141' ' ' ASN . . . -73.88 -128.6 0.15 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.463 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.42 ' HE3' ' O ' ' A' ' 166' ' ' GLY . 6.6 ptp -126.52 -172.48 2.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.792 0.329 . . . . 0.0 110.859 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.54 HG21 ' HE2' ' A' ' 91' ' ' TYR . 90.5 t -131.54 153.1 38.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.0 0.428 . . . . 0.0 111.355 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.401 ' N ' HG12 ' A' ' 146' ' ' VAL . . . -117.4 123.18 45.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.298 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.523 ' HB2' ' HB ' ' A' ' 161' ' ' ILE . 2.5 mt -96.94 106.26 18.56 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.748 -178.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.504 HD12 ' HG2' ' A' ' 160' ' ' MET . 1.0 OUTLIER -90.63 119.31 30.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.698 179.805 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.495 ' HB3' ' CZ ' ' A' ' 159' ' ' TYR . 12.6 t70 -132.21 164.33 26.61 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.676 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -109.49 150.6 27.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.228 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.82 -176.86 3.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.843 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -56.71 -33.05 66.1 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.929 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -72.21 -15.13 61.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.16 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 65.75 14.64 60.96 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.771 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 94.0 t -112.23 -69.72 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.898 0.38 . . . . 0.0 110.813 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 95.6 m -58.34 109.56 1.92 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.024 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.564 ' HG3' HG22 ' A' ' 70' ' ' VAL . 92.1 Cg_endo -84.41 130.26 4.53 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.542 2.161 . . . . 0.0 112.244 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.495 ' CZ ' ' HB3' ' A' ' 150' ' ' ASP . 9.7 p90 -124.16 132.86 53.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.868 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' MET . . . . . 0.601 ' SD ' HD13 ' A' ' 78' ' ' LEU . 24.4 mtp -104.4 141.09 36.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.133 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.597 HG23 HD11 ' A' ' 23' ' ' ILE . 82.5 mt -97.07 116.17 38.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.193 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -113.69 156.08 24.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.511 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -99.92 126.54 46.07 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.94 0.4 . . . . 0.0 110.974 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 16.4 ttpp -69.17 -53.48 19.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.312 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.457 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 73.3 m-20 -51.39 -38.87 55.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.046 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.42 ' O ' ' HE3' ' A' ' 145' ' ' MET . . . -95.8 25.09 26.7 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.33 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.527 HD21 ' HB3' ' A' ' 4' ' ' TYR . 0.6 OUTLIER -138.96 148.34 43.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.698 0.285 . . . . 0.0 110.83 -179.876 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -112.0 150.61 30.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.106 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' MET . . . . . 0.6 ' HB3' HD11 ' A' ' 2' ' ' ILE . 2.1 mtm -124.66 122.82 38.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.622 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.12 -179.833 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.639 HG23 ' CE1' ' A' ' 4' ' ' TYR . 1.1 tt . . . . . 0 N--CA 1.456 -0.154 0 CA-C-O 120.814 0.34 . . . . 0.0 110.908 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.509 ' O ' ' HA ' ' A' ' 169' ' ' MET . 8.1 mm -107.76 121.04 60.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.341 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.639 ' CE1' HG23 ' A' ' 2' ' ' ILE . 11.0 m-85 -91.21 130.3 37.1 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.919 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 17.7 ptt180 -139.22 143.32 37.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.133 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.42 ' O ' ' HA ' ' A' ' 10' ' ' HIS . 36.1 t0 -50.56 151.81 2.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.966 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 66.4 tp -80.69 -25.49 38.14 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.361 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.696 HD11 ' CG1' ' A' ' 99' ' ' ILE . 4.6 mp -91.3 -43.58 14.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.812 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.3 t -90.62 -30.82 16.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.814 0.34 . . . . 0.0 111.399 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.42 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER 66.49 29.37 9.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.918 -179.78 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -104.92 127.2 52.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.668 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -57.2 97.5 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.156 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 12.5 mtp -83.77 -15.57 47.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.972 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.491 ' CE2' ' CG ' ' A' ' 4' ' ' TYR . 44.8 p90 -178.8 161.36 1.23 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.805 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.2 m -126.37 -169.82 2.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.607 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.583 ' HB2' HG22 ' A' ' 2' ' ' ILE . 38.7 t70 -93.8 30.26 1.86 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.02 0.438 . . . . 0.0 110.952 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.4 HD11 ' CZ ' ' A' ' 18' ' ' TYR . 46.2 pt -92.39 -10.52 9.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.573 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.865 ' CZ ' HG22 ' A' ' 72' ' ' ILE . 46.6 m-85 -111.54 -167.02 1.13 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.645 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.3 mtpt -97.52 87.57 4.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.797 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.543 ' N ' HD12 ' A' ' 20' ' ' ILE . 4.2 mp -88.01 134.1 28.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.042 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -128.22 152.7 47.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.755 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.72 ' HG3' HD23 ' A' ' 29' ' ' LEU . 2.3 mp0 -97.7 121.92 40.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.976 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.687 HD11 HG23 ' A' ' 161' ' ' ILE . 4.8 pt -119.1 166.28 13.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.119 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 57.65 30.31 18.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.217 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 63.18 40.77 8.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.307 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.5 -16.65 60.66 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.652 -0.785 . . . . 0.0 113.068 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.87 -34.22 62.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.823 0.312 . . . . 0.0 111.035 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 12.1 m -146.31 161.19 40.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.938 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.72 HD23 ' HG3' ' A' ' 22' ' ' GLU . 0.3 OUTLIER -126.61 129.77 49.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.777 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -94.06 119.92 33.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.21 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 17.5 t -102.12 112.16 34.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.699 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -91.58 116.11 28.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.125 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -94.71 -127.38 5.0 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.365 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.3 ptpt -174.38 122.75 0.29 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.79 0.329 . . . . 0.0 110.944 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 86.7 mtp -70.76 123.32 21.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.787 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.459 HG23 ' CE ' ' A' ' 74' ' ' MET . 5.5 m . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.134 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.286 -0.325 . . . . 0.0 112.286 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.501 HG22 ' HG3' ' A' ' 158' ' ' PRO . 57.1 t -69.49 144.93 13.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.837 0.351 . . . . 0.0 110.909 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -70.14 -57.03 5.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.479 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.865 HG22 ' CZ ' ' A' ' 18' ' ' TYR . 5.6 pt -53.52 -33.78 22.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.315 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.803 HG13 ' HB2' ' A' ' 78' ' ' LEU . 74.4 t -72.39 -34.58 49.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.087 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.459 ' CE ' HG23 ' A' ' 36' ' ' VAL . 2.7 mtm -78.24 -37.23 45.72 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.925 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.415 HD21 ' HA ' ' A' ' 72' ' ' ILE . 16.9 p30 -82.08 -31.59 30.72 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -178.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.462 ' CE1' ' HA ' ' A' ' 14' ' ' PHE . 42.0 m80 -93.58 -2.72 53.84 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.051 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 17.9 m80 61.03 36.57 18.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.164 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.803 ' HB2' HG13 ' A' ' 73' ' ' VAL . 28.8 mt -57.59 156.17 8.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.463 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.414 ' HG3' ' HG3' ' A' ' 140' ' ' MET . 3.9 mm-40 -132.72 135.22 45.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.841 0.353 . . . . 0.0 111.174 -179.396 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.438 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 5.6 tt0 -101.19 122.5 43.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.822 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.416 HG21 HD11 ' A' ' 136' ' ' ILE . 10.1 t -115.08 153.21 31.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.931 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 29.3 p -88.58 161.5 16.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.914 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.47 ' HB2' ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -165.27 156.21 14.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.874 -179.988 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -99.66 174.05 6.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.904 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -70.3 -52.37 23.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.88 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.98 -43.0 97.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.85 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.15 -42.66 91.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.037 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.912 ' CD2' HD11 ' A' ' 122' ' ' ILE . 0.1 OUTLIER -59.12 -34.94 72.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.862 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.441 ' O ' HG22 ' A' ' 92' ' ' ILE . 22.8 mttm -59.53 -46.16 89.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.126 0.489 . . . . 0.0 110.413 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt -77.08 -27.83 54.39 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.783 178.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.559 ' HE2' HG21 ' A' ' 146' ' ' VAL . 9.5 t80 -67.75 -44.1 78.31 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.876 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.607 HD12 ' CE2' ' A' ' 95' ' ' TYR . 6.1 tp -63.74 -42.58 96.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.911 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -63.45 -37.44 87.28 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.781 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.498 ' HA ' ' HG2' ' A' ' 97' ' ' LYS . 12.4 t70 -77.04 -41.5 42.29 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.7 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.607 ' CE2' HD12 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -77.32 -40.08 45.47 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 121.155 -0.218 . . . . 0.0 110.752 -179.591 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -67.58 -32.1 72.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.645 0.26 . . . . 0.0 110.599 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.498 ' HG2' ' HA ' ' A' ' 94' ' ' ASP . 0.0 OUTLIER -70.2 -34.44 72.94 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.879 0.371 . . . . 0.0 110.491 179.756 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.456 ' N ' ' HG3' ' A' ' 97' ' ' LYS . 2.0 m -61.04 -40.18 92.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.046 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.696 ' CG1' HD11 ' A' ' 8' ' ' ILE . 7.2 mt -79.82 -42.36 22.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.504 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.403 ' O ' ' HG3' ' A' ' 104' ' ' GLU . 12.7 tmtt? -54.43 -55.23 30.91 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.523 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -60.86 -44.8 97.63 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.247 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.27 -41.29 96.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.885 0.374 . . . . 0.0 110.492 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.765 HD21 ' CB ' ' A' ' 110' ' ' ARG . 3.3 tp -68.24 -32.82 73.29 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.169 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.705 ' HG3' HG11 ' A' ' 111' ' ' VAL . 74.6 mt-10 -60.21 -29.66 68.88 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.934 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -88.11 -20.81 25.17 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.569 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -103.74 -57.73 1.99 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.791 0.329 . . . . 0.0 111.665 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.446 ' N ' ' O ' ' A' ' 103' ' ' LEU . 44.7 mtt85 -139.19 68.16 40.35 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.786 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.93 ' O ' HG22 ' A' ' 111' ' ' VAL . 9.9 Cg_endo -50.66 -21.39 7.84 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 123.234 2.623 . . . . 0.0 112.968 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -68.95 -9.99 54.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.591 0.234 . . . . 0.0 111.403 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.765 ' CB ' HD21 ' A' ' 103' ' ' LEU . 0.7 OUTLIER -111.99 -3.01 14.91 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 -179.492 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.93 HG22 ' O ' ' A' ' 108' ' ' PRO . 33.9 m -71.26 -26.93 27.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.641 0.258 . . . . 0.0 111.516 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.601 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -69.38 -55.8 9.21 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.517 -179.279 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.601 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 33.4 Cg_exo -56.92 -37.61 97.89 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.084 1.856 . . . . 0.0 111.739 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.461 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 82.5 t80 -66.64 -37.63 85.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.076 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 6.1 mtp -57.03 -54.68 44.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.956 0.407 . . . . 0.0 110.737 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 75.1 m -72.9 -44.73 60.92 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.696 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.97 -38.24 95.15 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.498 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.96 -51.69 68.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.973 0.416 . . . . 0.0 110.926 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.99 -28.2 63.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.251 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -75.6 -41.21 55.11 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.109 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -74.38 -34.85 63.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.901 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.912 HD11 ' CD2' ' A' ' 88' ' ' TYR . 0.4 OUTLIER -69.95 -45.9 75.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.205 -179.877 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.455 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 5.4 pttp -61.11 -31.83 71.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.993 0.425 . . . . 0.0 110.275 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 7.0 t-80 -67.51 -53.51 28.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.698 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.613 HG21 HD13 ' A' ' 148' ' ' LEU . 15.5 pt -62.12 -42.12 93.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.288 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.475 ' HA ' HD23 ' A' ' 126' ' ' LEU . 11.7 mt -53.99 -35.22 61.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.88 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -70.1 -11.29 60.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.296 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -142.49 33.28 1.46 Allowed 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.968 0.413 . . . . 0.0 110.588 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.497 ' CE1' ' CZ ' ' A' ' 134' ' ' PHE . 12.4 t80 -49.71 -26.79 4.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.24 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.91 -29.37 69.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.05 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 28.5 m-20 -94.21 -29.86 14.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.451 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.448 ' CD2' HG22 ' A' ' 125' ' ' ILE . 2.5 m-85 -98.47 138.41 35.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.877 0.37 . . . . 0.0 111.295 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.4 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 4.4 mm-40 -123.07 144.1 49.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.721 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.517 ' CE1' ' CZ ' ' A' ' 88' ' ' TYR . 3.2 m-85 -82.09 123.75 29.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.118 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.438 ' CE2' ' HB2' ' A' ' 80' ' ' GLU . 25.4 m-85 -127.86 140.74 51.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.599 179.466 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.419 ' HB ' ' HA ' ' A' ' 140' ' ' MET . 0.5 OUTLIER -131.29 160.99 41.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.691 -179.981 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -57.37 -169.58 0.14 Allowed Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.524 -0.846 . . . . 0.0 111.879 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.05 -8.91 57.28 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.582 0.23 . . . . 0.0 111.329 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ASN . . . . . 0.506 ' HB3' ' ND2' ' A' ' 141' ' ' ASN . 26.7 m-80 -94.31 -30.28 14.61 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.41 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' MET . . . . . 0.419 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 70.7 mtm 55.84 44.51 25.85 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.773 0.32 . . . . 0.0 111.256 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ASN . . . . . 0.506 ' ND2' ' HB3' ' A' ' 139' ' ' ASN . 1.2 m120 -68.67 117.38 50.16 Favored Pre-proline 0 N--CA 1.453 -0.296 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.625 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -63.2 -23.23 72.82 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.323 2.015 . . . . 0.0 111.854 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -84.72 -15.4 45.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.646 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -77.78 -159.7 12.47 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.276 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.457 ' HE3' ' O ' ' A' ' 166' ' ' GLY . 3.6 ptp -98.75 -174.4 2.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.793 0.33 . . . . 0.0 110.796 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.559 HG21 ' HE2' ' A' ' 91' ' ' TYR . 49.1 t -128.83 152.47 37.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.165 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.488 ' HB1' ' HE3' ' A' ' 160' ' ' MET . . . -114.64 119.23 36.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.656 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.613 HD13 HG21 ' A' ' 125' ' ' ILE . 3.0 mt -93.48 106.29 18.27 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.192 -179.322 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.591 HD12 ' HG2' ' A' ' 160' ' ' MET . 2.0 tp -90.82 119.12 30.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.149 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.469 ' HB2' ' CZ ' ' A' ' 159' ' ' TYR . 0.9 OUTLIER -125.99 159.5 32.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.745 179.7 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -109.7 138.13 46.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.887 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.93 -173.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.784 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.3 -41.07 83.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.905 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -67.87 -15.1 63.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.163 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 68.71 20.04 73.75 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.69 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 94.2 t -112.85 -70.04 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.859 0.362 . . . . 0.0 110.751 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 88.7 m -57.59 108.91 1.42 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.891 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.548 ' HB2' HD11 ' A' ' 149' ' ' LEU . 90.8 Cg_endo -86.71 127.86 2.78 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.723 2.282 . . . . 0.0 112.44 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.469 ' CZ ' ' HB2' ' A' ' 150' ' ' ASP . 16.0 p90 -121.67 132.15 54.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.797 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' MET . . . . . 0.591 ' HG2' HD12 ' A' ' 149' ' ' LEU . 0.9 OUTLIER -101.8 140.87 35.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.071 -179.818 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.687 HG23 HD11 ' A' ' 23' ' ' ILE . 57.4 mt -96.77 121.61 47.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.242 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.47 ' CZ ' ' HE3' ' A' ' 160' ' ' MET . 43.0 m-85 -119.63 156.49 30.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.698 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -102.16 118.63 37.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.858 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 40.9 tttt -61.12 -49.98 75.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.235 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.461 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 32.5 m-20 -55.26 -40.34 70.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.243 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.457 ' O ' ' HE3' ' A' ' 145' ' ' MET . . . -95.74 25.18 26.22 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.66 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.561 HD21 ' HB3' ' A' ' 4' ' ' TYR . 4.9 tt -150.19 148.71 29.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.88 0.372 . . . . 0.0 110.949 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -133.95 150.61 51.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.395 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' MET . . . . . 0.509 ' HA ' ' O ' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -135.47 160.25 39.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.805 0.336 . . . . 0.0 111.261 -179.796 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.462 0.126 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.547 -179.033 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.795 HG23 ' CE1' ' A' ' 4' ' ' TYR . 1.0 OUTLIER . . . . . 0 N--CA 1.457 -0.082 0 CA-C-O 120.888 0.375 . . . . 0.0 111.082 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.518 ' O ' ' HA ' ' A' ' 169' ' ' MET . 10.1 mm -103.39 119.54 52.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.981 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.795 ' CE1' HG23 ' A' ' 2' ' ' ILE . 17.4 m-85 -93.44 128.98 39.75 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.93 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.9 ptt-85 -136.31 144.77 44.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.969 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -52.53 138.01 28.88 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.833 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 59.9 tp -71.34 -23.65 61.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.291 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.499 ' N ' HD12 ' A' ' 8' ' ' ILE . 4.3 mp -91.2 -43.64 14.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.805 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.8 m -90.28 -29.4 18.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.391 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 32.3 m80 68.28 30.25 5.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.858 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -111.03 126.21 54.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.655 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -56.0 112.92 1.32 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.266 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 7.2 mtt -96.37 -16.61 21.17 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.908 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.436 ' HA ' ' CE1' ' A' ' 76' ' ' HIS . 37.8 p90 179.9 152.99 0.48 Allowed 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 120.875 0.369 . . . . 0.0 111.0 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.417 ' HB3' HD13 ' A' ' 3' ' ' ILE . 0.9 OUTLIER -112.86 -169.8 1.55 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.417 179.629 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.712 ' HB2' HG22 ' A' ' 2' ' ' ILE . 31.2 t70 -94.98 34.6 1.35 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.948 0.404 . . . . 0.0 110.819 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.518 HD11 ' CZ ' ' A' ' 18' ' ' TYR . 41.6 pt -95.43 -7.81 9.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.742 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.776 ' CZ ' HG22 ' A' ' 72' ' ' ILE . 37.2 m-85 -113.63 -167.38 1.19 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.696 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.52 86.95 3.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.855 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.462 ' H ' HD12 ' A' ' 20' ' ' ILE . 4.6 mp -89.77 124.01 42.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.086 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -118.16 140.25 50.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.987 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.706 ' HG3' HD23 ' A' ' 29' ' ' LEU . 1.1 mp0 -84.57 116.06 22.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.76 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.442 HD11 HG23 ' A' ' 161' ' ' ILE . 4.6 pt -113.4 166.85 6.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.13 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.522 ' HB2' ' NE2' ' A' ' 121' ' ' GLN . . . 59.53 30.57 20.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.086 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 64.83 47.24 2.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.332 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.91 -8.32 73.55 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.718 -0.753 . . . . 0.0 113.358 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.479 ' HB3' ' HB3' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -60.95 -52.36 65.36 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.818 0.342 . . . . 0.0 111.071 -179.915 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 11.7 m -125.98 163.53 22.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.067 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.706 HD23 ' HG3' ' A' ' 22' ' ' GLU . 0.3 OUTLIER -126.42 133.45 51.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.735 179.909 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -99.83 112.94 25.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.05 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 159' ' ' TYR . 20.4 t -92.35 111.94 25.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.697 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -87.78 110.91 20.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.17 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -95.68 -133.55 7.47 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.29 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.4 pttt -174.46 123.99 0.29 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.882 0.373 . . . . 0.0 110.884 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 71.3 mtm -70.91 112.63 7.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.815 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.0 m . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.153 -179.997 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.407 -0.277 . . . . 0.0 112.407 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.578 HG12 HG12 ' A' ' 72' ' ' ILE . 46.2 t -72.59 135.4 27.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.808 0.337 . . . . 0.0 110.662 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -64.05 -54.76 29.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.782 -179.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.776 HG22 ' CZ ' ' A' ' 18' ' ' TYR . 8.1 pt -53.85 -33.93 24.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.907 0.384 . . . . 0.0 111.267 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.756 HG13 ' HB2' ' A' ' 78' ' ' LEU . 84.2 t -73.59 -35.0 43.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.906 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 5.0 mtm -78.3 -38.83 41.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.788 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.402 ' OD1' ' CD2' ' A' ' 76' ' ' HIS . 22.3 p30 -82.1 -29.44 31.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.655 -179.135 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.436 ' CE1' ' HA ' ' A' ' 14' ' ' PHE . 26.2 m170 -92.55 -2.58 56.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.775 0.322 . . . . 0.0 110.806 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.512 ' HB2' ' HB3' ' A' ' 138' ' ' GLU . 49.5 m80 59.28 35.12 23.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.043 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.756 ' HB2' HG13 ' A' ' 73' ' ' VAL . 41.5 mt -61.13 141.15 57.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.515 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -120.83 132.33 54.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.011 -179.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.417 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 10.1 tt0 -91.04 124.48 35.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.91 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.901 HG21 HD11 ' A' ' 136' ' ' ILE . 1.4 t -117.23 172.33 7.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.835 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.6 p -107.24 170.69 7.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.006 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.481 ' HB2' ' CE2' ' A' ' 134' ' ' PHE . 0.6 OUTLIER -171.65 152.43 3.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.859 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.8 m -99.87 158.09 16.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.839 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 33.8 mtmt -57.69 -52.5 65.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.917 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.9 tm-20 -65.88 -45.0 83.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.727 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.66 -33.88 72.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.059 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.88 ' CD2' HD11 ' A' ' 122' ' ' ILE . 0.7 OUTLIER -65.03 -37.42 87.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.713 179.902 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.436 ' O ' HG22 ' A' ' 92' ' ' ILE . 50.4 mttm -58.19 -45.51 87.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.099 0.476 . . . . 0.0 110.333 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.7 mmtp -76.66 -27.8 55.75 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.742 178.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.537 ' HE2' HG21 ' A' ' 146' ' ' VAL . 8.4 t80 -67.61 -45.38 75.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.76 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.676 HD12 ' CE2' ' A' ' 95' ' ' TYR . 5.2 tp -61.74 -42.2 93.45 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 CA-C-O 120.888 0.375 . . . . 0.0 110.82 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.494 ' O ' ' CG ' ' A' ' 97' ' ' LYS . 3.6 ttpm? -63.39 -44.9 93.37 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.812 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -70.29 -38.9 75.1 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.866 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.676 ' CE2' HD12 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -78.12 -42.94 30.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.694 -0.23 . . . . 0.0 110.648 -179.513 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -62.72 -31.85 72.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.865 0.364 . . . . 0.0 110.078 179.098 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.494 ' CG ' ' O ' ' A' ' 93' ' ' LYS . 2.5 mmtp -65.73 -43.83 87.84 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.595 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.6 m -54.36 -40.47 68.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.601 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.483 ' CG1' HD11 ' A' ' 8' ' ' ILE . 7.8 mt -79.92 -43.13 22.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.678 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 15.0 tttt -53.19 -55.86 20.98 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.559 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -62.49 -45.07 96.64 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.308 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.78 -37.47 84.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.847 0.355 . . . . 0.0 110.465 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.671 HD21 ' CB ' ' A' ' 110' ' ' ARG . 2.8 tp -70.94 -32.08 68.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.135 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.627 ' CG ' HG11 ' A' ' 111' ' ' VAL . 30.0 mt-10 -60.59 -30.25 69.7 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.872 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -89.68 -20.04 24.12 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.543 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -106.01 -62.8 1.33 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.816 0.341 . . . . 0.0 111.413 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.434 ' N ' ' O ' ' A' ' 103' ' ' LEU . 16.7 mtt180 -127.53 63.58 59.85 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.891 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.883 ' O ' HG22 ' A' ' 111' ' ' VAL . 10.2 Cg_endo -50.86 -21.92 9.19 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 123.145 2.563 . . . . 0.0 112.82 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -71.35 -11.29 60.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.673 -0.24 . . . . 0.0 111.467 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.671 ' CB ' HD21 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -112.26 1.06 15.97 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 -179.289 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.883 HG22 ' O ' ' A' ' 108' ' ' PRO . 34.4 m -68.36 -35.72 71.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -179.42 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.573 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 18.4 mttt -68.69 -50.6 24.12 Favored Pre-proline 0 C--N 1.331 -0.209 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.609 -179.2 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.573 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 32.3 Cg_exo -57.98 -33.24 96.94 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.11 1.873 . . . . 0.0 111.813 179.399 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.452 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 86.3 t80 -69.71 -41.72 75.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.15 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -55.45 -49.27 72.91 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.928 0.394 . . . . 0.0 110.871 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 82.4 m -70.98 -44.36 66.12 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.725 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.03 -39.21 97.77 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.644 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.4 ' O ' ' HB ' ' A' ' 122' ' ' ILE . . . -57.88 -51.54 69.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.94 0.4 . . . . 0.0 111.161 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.1 -28.29 66.36 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.306 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.07 -58.86 3.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.24 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.522 ' NE2' ' HB2' ' A' ' 24' ' ' ALA . 3.5 tp-100 -56.03 -42.66 76.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.218 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.88 HD11 ' CD2' ' A' ' 88' ' ' TYR . 0.3 OUTLIER -61.62 -45.54 98.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.193 -179.828 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.44 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 12.5 mttm -59.98 -31.9 70.34 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.179 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 5.7 t-80 -67.56 -54.52 19.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.806 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.972 HG21 HD13 ' A' ' 148' ' ' LEU . 11.9 pt -61.04 -40.77 86.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.218 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 126' ' ' LEU . 11.8 mt -53.95 -37.59 64.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.705 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.6 -15.04 60.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.269 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -138.59 34.6 2.23 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.1 0.476 . . . . 0.0 110.423 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -48.09 -43.34 30.65 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.295 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.3 mmmp? -62.13 -19.88 63.5 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.302 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -93.99 -41.09 9.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.724 0.297 . . . . 0.0 111.317 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.413 ' CD2' ' OD1' ' A' ' 150' ' ' ASP . 3.9 m-85 -89.0 145.31 25.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.126 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.412 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 5.6 mm-40 -122.31 145.92 47.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.807 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.481 ' CE2' ' HB2' ' A' ' 83' ' ' PHE . 2.9 m-85 -86.37 129.47 34.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.118 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.417 ' CE2' ' HB2' ' A' ' 80' ' ' GLU . 51.8 m-85 -130.98 132.25 44.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.769 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.901 HD11 HG21 ' A' ' 81' ' ' THR . 0.4 OUTLIER -121.84 159.31 24.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.681 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -56.67 -171.96 0.16 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.428 -0.891 . . . . 0.0 111.844 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.512 ' HB3' ' HB2' ' A' ' 77' ' ' HIS . 0.0 OUTLIER -70.68 -8.93 55.6 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.571 0.224 . . . . 0.0 111.42 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ASN . . . . . 0.514 ' HB3' ' ND2' ' A' ' 141' ' ' ASN . 19.8 m-80 -93.65 -26.91 16.85 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.673 0.273 . . . . 0.0 111.108 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' MET . . . . . 0.445 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 52.0 mtm 51.62 43.96 29.47 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.442 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ASN . . . . . 0.514 ' ND2' ' HB3' ' A' ' 139' ' ' ASN . 1.7 m120 -68.77 120.04 73.22 Favored Pre-proline 0 N--CA 1.452 -0.335 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.595 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -60.08 -26.39 82.35 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.279 1.986 . . . . 0.0 111.856 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -84.71 -15.86 43.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.739 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.17 -168.34 10.77 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.404 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 2.0 ptp -93.2 -177.33 4.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.819 0.342 . . . . 0.0 110.811 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.537 HG21 ' HE2' ' A' ' 91' ' ' TYR . 74.8 t -126.64 145.26 34.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.11 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.621 ' HB2' ' CE1' ' A' ' 162' ' ' PHE . . . -112.08 112.27 23.78 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.567 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.972 HD13 HG21 ' A' ' 125' ' ' ILE . 4.9 mt -86.76 108.28 18.63 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.193 -179.182 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.45 ' HB2' ' HE2' ' A' ' 160' ' ' MET . 1.5 tp -91.03 119.54 31.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.122 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.465 ' HB3' ' CE1' ' A' ' 159' ' ' TYR . 0.5 OUTLIER -133.08 174.52 10.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.642 179.55 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -117.26 143.68 45.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.846 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 11.8 mmm180 -56.78 -175.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.058 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -56.3 -31.46 63.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.9 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -78.48 -15.01 59.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.153 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 70.67 21.74 77.89 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.66 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 89.1 t -112.47 -69.2 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.861 0.362 . . . . 0.0 110.823 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 91.0 m -57.61 109.17 1.58 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.945 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -81.24 127.3 5.89 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.484 2.123 . . . . 0.0 112.331 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.465 ' CE1' ' HB3' ' A' ' 150' ' ' ASP . 13.0 p90 -125.35 148.28 48.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.755 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' MET . . . . . 0.627 ' HE1' HD13 ' A' ' 78' ' ' LEU . 0.4 OUTLIER -111.69 142.86 43.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.028 -179.756 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.532 ' HB ' ' HB2' ' A' ' 148' ' ' LEU . 41.9 mt -99.08 120.44 48.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.24 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.621 ' CE1' ' HB2' ' A' ' 147' ' ' ALA . 99.1 m-85 -125.93 150.17 48.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.643 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -97.45 119.16 35.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.898 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 43.1 tttt -56.27 -53.94 51.28 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.334 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.452 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 44.9 m-20 -53.82 -37.49 63.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.19 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.476 ' HA2' HG23 ' A' ' 99' ' ' ILE . . . -95.27 24.42 29.07 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.57 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.723 HD21 ' HB3' ' A' ' 4' ' ' TYR . 5.8 tt -150.15 140.11 21.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.842 0.353 . . . . 0.0 110.74 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -120.16 142.96 48.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.58 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' MET . . . . . 0.518 ' HA ' ' O ' ' A' ' 3' ' ' ILE . 0.1 OUTLIER -136.73 160.2 39.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.735 0.302 . . . . 0.0 111.145 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.404 ' O ' HG13 ' A' ' 2' ' ' ILE . 1.5 pt-20 . . . . . 0 N--CA 1.462 0.173 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.366 -179.102 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.716 HD11 ' HB3' ' A' ' 169' ' ' MET . 1.8 tt . . . . . 0 N--CA 1.454 -0.249 0 CA-C-O 120.735 0.303 . . . . 0.0 111.055 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.408 ' CG2' ' HB3' ' A' ' 12' ' ' GLU . 16.9 mm -102.14 146.5 10.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.877 0.37 . . . . 0.0 111.518 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.552 ' HE1' HG23 ' A' ' 2' ' ' ILE . 4.9 m-85 -115.96 100.15 7.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.422 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 1.1 ptt180 -116.34 147.9 41.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.881 0.372 . . . . 0.0 111.344 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.458 ' O ' ' HA ' ' A' ' 10' ' ' HIS . 44.7 t0 -57.04 152.17 13.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.749 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.558 HD23 HG23 ' A' ' 99' ' ' ILE . 59.0 tp -81.32 -21.09 39.46 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.53 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.658 HD11 ' CG1' ' A' ' 99' ' ' ILE . 4.3 mp -91.29 -47.77 14.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -179.416 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.414 ' HB2' ' ND2' ' A' ' 141' ' ' ASN . 3.0 t -96.41 -17.54 20.53 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -179.077 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.458 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 0.3 OUTLIER 61.98 28.59 17.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.855 0.359 . . . . 0.0 110.774 -179.727 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -98.17 121.71 40.44 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.762 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.408 ' HB3' ' CG2' ' A' ' 3' ' ' ILE . 0.3 OUTLIER -58.17 93.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.282 -179.756 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 7.7 mtt -71.87 -19.44 61.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.664 179.442 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.608 ' HA ' ' CE1' ' A' ' 76' ' ' HIS . 7.4 p90 -177.86 176.86 1.14 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.667 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.422 ' O ' HD11 ' A' ' 20' ' ' ILE . 0.9 OUTLIER -133.71 -169.99 2.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.953 -179.886 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.406 ' HB2' HG22 ' A' ' 2' ' ' ILE . 22.6 t70 -94.42 25.08 4.08 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.98 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.43 HG13 ' CD2' ' A' ' 18' ' ' TYR . 20.8 pt -82.39 -15.49 11.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.525 179.091 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.839 ' CE2' HG22 ' A' ' 72' ' ' ILE . 78.4 m-85 -108.84 -174.45 2.52 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.516 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.1 mttp -94.66 88.53 5.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.849 0.357 . . . . 0.0 110.718 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.422 HD11 ' O ' ' A' ' 15' ' ' SER . 4.1 mp -87.94 132.5 32.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.167 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 8.0 mtt180 -124.68 139.68 53.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.807 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.49 122.32 28.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.996 0.427 . . . . 0.0 110.943 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.9 pt -117.37 167.47 10.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.027 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.472 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . . . 60.08 27.09 16.5 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.072 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 66.92 55.96 0.7 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.338 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 77.12 0.34 70.07 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 120.853 -0.689 . . . . 0.0 113.422 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.472 ' HB3' ' HB3' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -70.44 -58.23 3.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 117.082 0.441 . . . . 0.0 111.04 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 35.2 m -118.95 164.82 14.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.997 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.698 HD11 ' CG ' ' A' ' 164' ' ' LYS . 0.4 OUTLIER -126.32 133.18 51.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.862 -179.931 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -99.06 112.83 24.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.968 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.481 HG21 ' CD2' ' A' ' 14' ' ' PHE . 26.1 t -92.04 111.86 24.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.625 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -80.88 114.08 19.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.252 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -99.19 -141.46 12.27 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.214 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -174.42 126.88 0.33 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.823 0.344 . . . . 0.0 110.978 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 27.7 mtp -68.36 122.58 18.68 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.522 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.1 m . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.465 -179.63 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.496 0 N-CA-C 112.047 -0.421 . . . . 0.0 112.047 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.579 HG12 HG12 ' A' ' 72' ' ' ILE . 40.8 t -73.2 130.32 35.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.887 0.375 . . . . 0.0 110.847 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -59.26 -55.3 36.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.64 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.839 HG22 ' CE2' ' A' ' 18' ' ' TYR . 6.9 pt -54.01 -36.72 32.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.544 -179.386 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.796 HG13 ' HB2' ' A' ' 78' ' ' LEU . 97.2 t -70.37 -31.47 46.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.197 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.5 mtm -78.22 -40.47 37.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.786 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.433 HD22 ' CE1' ' A' ' 76' ' ' HIS . 0.0 OUTLIER -82.0 -29.33 32.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.546 -179.23 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.608 ' CE1' ' HA ' ' A' ' 14' ' ' PHE . 30.2 m-70 -89.95 -5.11 57.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.869 0.366 . . . . 0.0 110.752 179.657 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.433 ' HB2' ' HB3' ' A' ' 138' ' ' GLU . 28.6 m-70 61.74 28.42 17.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.916 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.842 HD13 ' CE ' ' A' ' 160' ' ' MET . 34.2 mt -59.87 152.87 22.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.588 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -138.73 145.84 40.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.799 0.333 . . . . 0.0 111.175 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.421 ' HB2' ' CZ ' ' A' ' 135' ' ' PHE . 0.2 OUTLIER -99.41 133.18 44.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.079 -179.924 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.445 HG21 HD11 ' A' ' 136' ' ' ILE . 9.7 t -117.15 166.9 11.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.755 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 66.8 m -98.38 158.28 15.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.04 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.456 ' HB2' ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -171.78 150.1 2.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.823 179.934 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 54.7 p -99.92 169.61 9.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.821 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -63.17 -52.44 62.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.923 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -60.67 -45.41 94.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.921 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.434 ' HB1' ' CE1' ' A' ' 83' ' ' PHE . . . -59.78 -41.12 90.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.962 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.793 ' CD2' HD11 ' A' ' 122' ' ' ILE . 0.2 OUTLIER -58.03 -36.14 72.29 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.894 179.938 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.442 ' O ' HG22 ' A' ' 92' ' ' ILE . 36.3 mttm -60.12 -51.11 71.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.069 0.461 . . . . 0.0 110.482 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.1 mttm -72.93 -27.7 62.0 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.591 178.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.566 ' HE2' HG21 ' A' ' 146' ' ' VAL . 7.5 t80 -64.23 -48.03 77.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.975 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.459 ' CD1' ' CE2' ' A' ' 95' ' ' TYR . 3.1 tp -61.43 -41.91 91.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.733 0.301 . . . . 0.0 111.174 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.445 ' O ' ' CG ' ' A' ' 97' ' ' LYS . 4.6 ttmt -61.17 -46.08 91.98 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.969 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -70.79 -36.86 73.22 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.93 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.532 ' CD1' ' C ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -76.34 -43.11 42.56 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 121.189 -0.205 . . . . 0.0 110.744 -179.544 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.3 ptp -65.07 -32.03 73.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.92 0.391 . . . . 0.0 110.279 179.174 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.445 ' CG ' ' O ' ' A' ' 93' ' ' LYS . 0.1 OUTLIER -64.01 -44.2 93.33 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.867 179.751 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.4 m -56.47 -43.2 79.38 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.874 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.658 ' CG1' HD11 ' A' ' 8' ' ' ILE . 6.5 mt -79.85 -40.59 20.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.682 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.2 tttt -55.09 -53.47 55.51 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.574 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -62.94 -46.42 93.61 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.334 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.1 tppm? -60.53 -40.85 92.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.858 0.361 . . . . 0.0 110.422 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.727 HD21 ' CB ' ' A' ' 110' ' ' ARG . 3.0 tp -66.52 -35.25 79.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.26 179.329 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.645 ' CG ' HG11 ' A' ' 111' ' ' VAL . 36.2 mt-10 -59.13 -29.38 67.35 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.684 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -88.52 -18.69 27.62 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.617 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -108.56 -61.8 1.55 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.838 0.351 . . . . 0.0 111.586 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.429 ' N ' ' O ' ' A' ' 103' ' ' LEU . 19.9 mtt85 -130.1 65.07 74.6 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.777 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.919 ' O ' HG22 ' A' ' 111' ' ' VAL . 9.4 Cg_endo -50.54 -23.33 10.55 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 123.087 2.525 . . . . 0.0 112.652 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -69.1 -13.9 62.7 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.64 0.257 . . . . 0.0 111.15 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.727 ' CB ' HD21 ' A' ' 103' ' ' LEU . 6.8 mmm-85 -106.21 -1.79 23.19 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -179.399 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.919 HG22 ' O ' ' A' ' 108' ' ' PRO . 24.3 m -71.37 -27.03 27.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.685 0.279 . . . . 0.0 111.521 -179.561 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.6 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 0.8 OUTLIER -70.37 -55.42 7.78 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.578 -179.291 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.6 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 47.1 Cg_exo -55.37 -40.88 83.2 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.182 1.922 . . . . 0.0 111.975 179.384 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.45 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 75.6 t80 -65.47 -38.36 89.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.166 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.05 -54.85 40.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.001 0.429 . . . . 0.0 110.926 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.446 HG22 ' OE1' ' A' ' 120' ' ' GLU . 62.7 m -74.37 -44.65 51.28 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.768 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.4 -41.78 98.67 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.644 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.18 -51.57 69.43 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.059 0.457 . . . . 0.0 111.072 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.15 -28.15 65.12 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.325 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.446 ' OE1' HG22 ' A' ' 116' ' ' THR . 11.4 mt-10 -77.93 -43.65 29.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.4 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 9.2 tp60 -71.27 -31.56 67.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.117 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.793 HD11 ' CD2' ' A' ' 88' ' ' TYR . 0.4 OUTLIER -70.56 -45.93 72.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.36 -179.782 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.45 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 12.1 pttt -60.75 -31.22 70.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.067 0.461 . . . . 0.0 110.365 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 10.0 t-80 -68.36 -54.05 19.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.64 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.797 HG21 HD13 ' A' ' 148' ' ' LEU . 15.2 pt -61.67 -42.61 94.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.261 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.435 ' HA ' HD23 ' A' ' 126' ' ' LEU . 11.4 mt -54.19 -35.48 62.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.969 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -69.89 -11.29 60.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.343 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 -142.07 32.83 1.55 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.884 0.373 . . . . 0.0 110.599 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.5 ' CE1' ' CZ ' ' A' ' 134' ' ' PHE . 4.5 t80 -52.2 -26.1 10.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.088 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 6.8 mttt -59.17 -30.43 68.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.929 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -94.28 -37.86 11.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.324 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.412 ' HE2' HD11 ' A' ' 161' ' ' ILE . 15.1 m-85 -91.09 135.51 33.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.835 0.35 . . . . 0.0 111.21 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 -121.94 145.8 47.75 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.911 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.508 ' CE1' ' CZ ' ' A' ' 88' ' ' TYR . 1.3 m-85 -78.06 125.95 30.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.85 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.423 ' O ' ' HB3' ' A' ' 147' ' ' ALA . 10.7 m-85 -130.77 137.38 49.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.623 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.465 ' HB ' ' HA ' ' A' ' 140' ' ' MET . 0.9 OUTLIER -126.87 161.69 33.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.956 -179.964 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.79 -164.95 0.35 Allowed Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.44 -0.886 . . . . 0.0 111.968 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.433 ' HB3' ' HB2' ' A' ' 77' ' ' HIS . 1.2 pt-20 -72.37 -8.87 57.28 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.594 0.235 . . . . 0.0 111.507 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -96.25 -29.26 14.12 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.594 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' MET . . . . . 0.465 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 75.7 mtp 56.37 46.53 20.77 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.903 0.382 . . . . 0.0 110.997 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ASN . . . . . 0.419 ' ND2' ' HA3' ' A' ' 144' ' ' GLY . 13.0 p-10 -69.08 114.48 23.69 Favored Pre-proline 0 N--CA 1.452 -0.338 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.951 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 141' ' ' ASN . 16.3 Cg_exo -66.25 -29.39 46.87 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.633 2.222 . . . . 0.0 112.245 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -84.64 -5.25 59.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.47 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.419 ' HA3' ' ND2' ' A' ' 141' ' ' ASN . . . -87.7 -143.38 8.44 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.456 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 2.8 ptp -106.22 -179.17 3.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.824 0.345 . . . . 0.0 110.863 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.566 HG21 ' HE2' ' A' ' 91' ' ' TYR . 53.5 t -128.52 148.2 32.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.225 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.57 ' HB1' ' SD ' ' A' ' 160' ' ' MET . . . -110.67 114.78 28.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.511 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.797 HD13 HG21 ' A' ' 125' ' ' ILE . 3.8 mt -88.5 106.19 18.12 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.088 -179.342 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.481 HD12 ' HG2' ' A' ' 160' ' ' MET . 4.4 tp -90.37 119.72 30.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.366 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.538 ' HB3' ' CE1' ' A' ' 159' ' ' TYR . 4.7 t70 -138.54 167.41 21.99 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.533 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -105.2 151.71 23.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.865 0.364 . . . . 0.0 111.166 -179.545 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 12.2 mmt85 -70.31 -175.47 1.0 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.838 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -56.92 -31.05 64.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.063 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -74.43 -15.15 60.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.288 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 74.24 7.29 77.2 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.803 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 72.7 t -110.23 -66.92 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.924 0.393 . . . . 0.0 110.94 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 84.9 m -52.96 107.18 0.78 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.261 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -84.65 129.03 4.09 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.622 2.214 . . . . 0.0 112.245 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.538 ' CE1' ' HB3' ' A' ' 150' ' ' ASP . 8.4 p90 -126.51 147.04 49.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.929 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' MET . . . . . 0.842 ' CE ' HD13 ' A' ' 78' ' ' LEU . 0.8 OUTLIER -113.14 145.4 41.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.241 -179.659 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.516 ' HB ' ' HB2' ' A' ' 148' ' ' LEU . 85.0 mt -98.44 112.84 31.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.032 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.526 ' CE1' ' HB2' ' A' ' 147' ' ' ALA . 62.2 m-85 -118.81 121.0 39.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.679 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -68.98 124.4 23.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.047 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.698 ' CG ' HD11 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -69.86 -41.98 74.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.16 -179.738 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.45 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 2.1 m-20 -55.97 -29.61 60.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.919 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -108.95 29.47 9.73 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.354 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.411 HD21 ' HB3' ' A' ' 4' ' ' TYR . 0.6 OUTLIER -139.48 148.43 42.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.827 0.346 . . . . 0.0 110.785 -179.9 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -111.74 155.43 23.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.009 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' MET . . . . . 0.716 ' HB3' HD11 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -125.35 137.84 54.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.875 179.998 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.963 -179.967 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.52 HG23 ' HE1' ' A' ' 4' ' ' TYR . 0.8 OUTLIER . . . . . 0 N--CA 1.456 -0.168 0 CA-C-O 120.863 0.363 . . . . 0.0 110.814 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.526 ' O ' ' HA ' ' A' ' 169' ' ' MET . 4.6 mm -106.11 122.69 60.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.766 -179.347 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.521 ' HD2' HD21 ' A' ' 167' ' ' LEU . 3.9 m-85 -90.09 130.22 36.29 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.563 179.382 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.97 157.5 45.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.966 0.412 . . . . 0.0 111.438 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.437 ' O ' ' HA ' ' A' ' 10' ' ' HIS . 36.8 t0 -63.41 152.18 38.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.721 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.653 HD23 HG23 ' A' ' 99' ' ' ILE . 61.3 tp -80.51 -24.83 39.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.312 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.906 HD11 ' CG1' ' A' ' 99' ' ' ILE . 4.1 mp -91.43 -45.28 14.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.02 -28.49 17.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.486 -179.162 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.437 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 0.2 OUTLIER 66.45 29.55 9.14 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.849 0.356 . . . . 0.0 110.785 -179.782 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -101.16 130.5 47.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.716 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.2 pm0 -61.95 88.49 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.31 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 10.5 mtt -71.42 -17.93 62.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.66 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.499 ' CE2' ' CG ' ' A' ' 4' ' ' TYR . 43.5 p90 -178.62 177.22 0.92 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.676 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.4 m -136.71 -169.8 2.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.943 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.434 ' HB2' ' CG2' ' A' ' 2' ' ' ILE . 40.2 t0 -93.26 23.57 4.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.018 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.435 HG13 ' CD2' ' A' ' 18' ' ' TYR . 45.4 pt -87.55 -9.84 10.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.756 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.887 ' CZ ' HG22 ' A' ' 72' ' ' ILE . 76.1 m-85 -111.14 -170.77 1.7 Allowed 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.765 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.6 mttm -97.07 91.28 5.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.734 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.44 ' N ' HD12 ' A' ' 20' ' ' ILE . 4.9 mp -87.93 123.96 40.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.015 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 15.9 mtp180 -120.55 117.62 28.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.811 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -72.1 117.48 13.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.938 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.403 HG12 ' HG3' ' A' ' 30' ' ' GLU . 1.6 pt -110.95 171.12 3.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.947 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 56.59 33.98 23.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.068 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 64.5 42.84 4.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.183 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.08 -12.95 62.71 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.785 -0.722 . . . . 0.0 113.195 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.532 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -55.93 -33.36 64.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.902 0.351 . . . . 0.0 111.285 -179.859 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 34.3 m -142.21 164.29 30.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.021 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.838 HD11 ' CG ' ' A' ' 164' ' ' LYS . 1.0 OUTLIER -128.32 130.85 48.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.994 -179.915 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.403 ' HG3' HG12 ' A' ' 23' ' ' ILE . 59.3 mt-10 -95.56 112.97 24.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.071 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 159' ' ' TYR . 23.3 t -91.55 111.87 24.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.362 179.39 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -85.5 118.36 24.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.381 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -106.34 -142.91 11.09 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.098 179.579 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.8 pttt -174.44 123.46 0.29 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.793 0.33 . . . . 0.0 111.187 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 76.5 mtm -65.95 118.62 10.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.538 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 36' ' ' VAL . 31.1 m . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 120.899 0.38 . . . . 0.0 111.53 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.369 0 N-CA-C 112.264 -0.334 . . . . 0.0 112.264 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.596 HG12 HG12 ' A' ' 72' ' ' ILE . 46.3 t -70.96 130.5 34.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.878 0.37 . . . . 0.0 110.725 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.4 ' O ' ' ND2' ' A' ' 75' ' ' ASN . 5.3 t0 -58.17 -58.77 6.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.862 -179.221 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.887 HG22 ' CZ ' ' A' ' 18' ' ' TYR . 8.5 pt -53.64 -33.81 23.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.678 -179.205 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.762 HG13 ' HB2' ' A' ' 78' ' ' LEU . 89.9 t -72.77 -34.28 46.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.878 0.37 . . . . 0.0 111.011 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 14.9 mtm -78.24 -39.24 40.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.716 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.403 ' OD1' ' CD2' ' A' ' 76' ' ' HIS . 19.9 p30 -82.15 -29.33 31.65 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -179.262 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.457 ' CE1' ' HB ' ' A' ' 72' ' ' ILE . 26.0 m170 -92.05 -0.55 57.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.81 0.338 . . . . 0.0 110.787 179.519 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.406 ' HB2' ' HB3' ' A' ' 138' ' ' GLU . 30.3 m-70 57.84 31.85 21.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.057 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.762 ' HB2' HG13 ' A' ' 73' ' ' VAL . 58.6 mt -58.63 147.39 32.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.582 179.739 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -128.39 133.91 48.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.915 0.388 . . . . 0.0 111.054 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.414 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 28.9 tt0 -90.24 132.37 35.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.061 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.1 t -121.9 -172.96 2.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.872 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 83.1 p -128.79 168.23 16.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.957 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.499 ' CE2' ' CE2' ' A' ' 91' ' ' TYR . 1.1 m-85 -171.71 157.34 4.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.991 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.34 164.5 11.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.789 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.34 -52.45 65.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.83 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -67.21 -38.94 86.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.725 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.62 -37.13 86.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.992 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.929 ' CD2' HD11 ' A' ' 122' ' ' ILE . 0.1 OUTLIER -63.01 -37.37 86.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.804 -179.999 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.439 ' O ' HG22 ' A' ' 92' ' ' ILE . 58.3 mttt -59.03 -45.43 90.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.084 0.468 . . . . 0.0 110.361 179.478 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.35 -27.82 52.8 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.643 178.778 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.539 ' HE2' HG21 ' A' ' 146' ' ' VAL . 9.3 t80 -66.88 -44.72 80.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.753 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.65 HD12 ' CE2' ' A' ' 95' ' ' TYR . 5.7 tp -63.36 -43.11 98.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.95 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.1 ttpt -62.28 -40.79 97.41 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.752 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.514 ' HA ' ' HG2' ' A' ' 97' ' ' LYS . 27.6 t0 -72.92 -43.94 61.82 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.762 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.65 ' CE2' HD12 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -75.82 -40.16 55.42 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 121.063 -0.255 . . . . 0.0 110.99 -179.386 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.57 -32.01 72.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.697 0.284 . . . . 0.0 110.661 179.5 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.514 ' HG2' ' HA ' ' A' ' 94' ' ' ASP . 0.0 OUTLIER -69.19 -34.22 74.56 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.829 0.347 . . . . 0.0 110.272 179.695 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.472 ' N ' ' HG3' ' A' ' 97' ' ' LYS . 1.0 OUTLIER -61.36 -41.03 96.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.969 179.316 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.906 ' CG1' HD11 ' A' ' 8' ' ' ILE . 9.3 mt -79.94 -42.86 22.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.564 179.379 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.91 -49.16 69.22 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.597 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -64.6 -50.44 58.99 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.667 -0.777 . . . . 0.0 112.207 179.495 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 2.2 tptt -59.84 -40.98 90.35 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.947 0.403 . . . . 0.0 110.426 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.59 ' HB3' HG12 ' A' ' 111' ' ' VAL . 12.3 tp -63.84 -41.1 97.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.043 179.364 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.667 ' HG3' HG11 ' A' ' 111' ' ' VAL . 32.2 mt-10 -55.2 -28.59 54.15 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.809 179.373 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -89.71 -16.57 30.08 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.784 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -114.27 -60.81 1.83 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.747 0.308 . . . . 0.0 111.538 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.456 ' N ' ' O ' ' A' ' 103' ' ' LEU . 0.9 OUTLIER -123.96 62.01 26.21 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.821 -179.801 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.877 ' O ' HG22 ' A' ' 111' ' ' VAL . 10.0 Cg_endo -50.8 -23.6 11.85 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 123.042 2.495 . . . . 0.0 112.566 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -74.44 -8.03 54.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.295 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.512 ' C ' ' HD2' ' A' ' 113' ' ' PRO . 1.1 mmt180 -111.22 -1.22 16.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.59 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.877 HG22 ' O ' ' A' ' 108' ' ' PRO . 31.1 m -72.49 -33.17 44.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.564 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 1.9 mtpt -68.39 -49.97 29.79 Favored Pre-proline 0 C--N 1.331 -0.205 0 N-CA-C 111.649 0.24 . . . . 0.0 111.649 -179.2 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.564 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 30.0 Cg_exo -61.77 -33.72 84.68 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.087 1.858 . . . . 0.0 111.938 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.45 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 87.8 t80 -72.07 -36.5 69.56 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.012 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 5.5 mmm -58.02 -53.0 63.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.941 0.4 . . . . 0.0 110.855 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 71.8 m -73.06 -44.41 60.66 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.673 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.98 -37.57 95.17 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.577 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.42 ' O ' ' HB ' ' A' ' 122' ' ' ILE . . . -60.0 -51.65 68.74 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.961 0.41 . . . . 0.0 110.928 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.73 -28.12 62.46 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.425 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.404 ' O ' ' HG2' ' A' ' 123' ' ' LYS . 0.6 OUTLIER -77.92 -42.4 33.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.206 -179.711 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 30.5 tp60 -72.11 -34.78 68.87 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.035 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.929 HD11 ' CD2' ' A' ' 88' ' ' TYR . 0.4 OUTLIER -68.27 -46.3 81.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.39 -179.81 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.451 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 0.4 OUTLIER -59.76 -32.13 70.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.062 0.458 . . . . 0.0 110.116 179.448 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 7.1 t-80 -66.67 -54.3 24.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.618 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.862 HG21 HD13 ' A' ' 148' ' ' LEU . 13.0 pt -61.77 -39.98 85.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.058 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 11.4 mt -53.67 -35.69 61.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.567 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.5 -14.95 62.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.885 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -133.11 32.28 3.75 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.047 0.451 . . . . 0.0 110.243 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -49.08 -35.56 16.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.179 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.4 -20.78 60.66 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.162 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -89.18 -35.53 16.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.41 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.457 ' CD1' ' N ' ' A' ' 132' ' ' TYR . 1.7 m-30 -104.21 151.37 23.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.864 0.364 . . . . 0.0 111.313 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.416 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 9.9 mm-40 -123.89 150.69 44.35 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.913 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.514 ' CE1' ' CZ ' ' A' ' 88' ' ' TYR . 4.6 m-85 -86.16 132.38 34.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.144 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.515 ' O ' ' HB3' ' A' ' 147' ' ' ALA . 28.8 m-85 -136.93 130.11 31.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.58 179.466 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.458 ' HB ' ' HA ' ' A' ' 140' ' ' MET . 0.8 OUTLIER -122.09 167.33 15.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.892 -179.81 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.42 -170.84 0.84 Allowed Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.475 -0.869 . . . . 0.0 111.927 179.475 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.406 ' HB3' ' HB2' ' A' ' 77' ' ' HIS . 1.9 pt-20 -68.92 -11.17 60.36 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.621 0.248 . . . . 0.0 111.389 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -92.39 -33.51 14.53 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.606 0.241 . . . . 0.0 111.242 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' MET . . . . . 0.458 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 75.2 mtm 58.34 41.78 22.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.341 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -70.14 118.18 61.37 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.793 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -64.61 -21.65 65.33 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.331 2.021 . . . . 0.0 111.831 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -84.59 -12.06 54.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.755 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -81.31 -137.12 2.11 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.256 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.557 ' HE3' ' O ' ' A' ' 166' ' ' GLY . 3.7 ptp -120.65 178.89 4.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.781 0.324 . . . . 0.0 110.704 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.539 HG21 ' HE2' ' A' ' 91' ' ' TYR . 65.9 t -124.41 147.67 28.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.987 0.422 . . . . 0.0 111.193 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.604 ' HB2' ' CE2' ' A' ' 162' ' ' PHE . . . -113.27 110.2 19.99 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.364 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.862 HD13 HG21 ' A' ' 125' ' ' ILE . 4.4 mt -83.57 106.17 15.09 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.143 -179.093 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.486 HD12 ' HG2' ' A' ' 160' ' ' MET . 2.2 tp -88.71 119.91 29.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.954 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.497 ' HB2' ' CZ ' ' A' ' 159' ' ' TYR . 62.8 m-20 -130.31 161.86 30.3 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.574 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.406 ' HB3' ' HA2' ' A' ' 155' ' ' GLY . 80.1 m-85 -104.34 151.98 22.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.087 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 3.9 mmt180 -59.36 -176.92 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.0 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -60.9 -40.96 95.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.977 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -79.76 -15.07 58.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.312 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.406 ' HA2' ' HB3' ' A' ' 151' ' ' TYR . . . 78.68 33.07 39.16 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.597 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 93.8 t -113.44 -60.96 2.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.841 0.353 . . . . 0.0 111.11 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 51.5 m -80.55 112.56 32.37 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.341 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -82.37 134.28 7.73 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.558 2.172 . . . . 0.0 112.04 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.497 ' CZ ' ' HB2' ' A' ' 150' ' ' ASP . 5.7 p90 -130.51 142.59 50.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.041 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' MET . . . . . 0.563 ' CE ' HD13 ' A' ' 78' ' ' LEU . 0.3 OUTLIER -107.14 143.42 35.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.025 -179.899 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.528 ' HB ' ' HB2' ' A' ' 148' ' ' LEU . 73.4 mt -101.81 112.01 33.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.157 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.604 ' CE2' ' HB2' ' A' ' 147' ' ' ALA . 81.0 m-85 -114.23 157.62 22.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.756 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -100.5 122.82 43.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.952 0.406 . . . . 0.0 110.812 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.838 ' CG ' HD11 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -66.12 -50.49 63.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.245 -179.672 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.45 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 1.7 m-20 -52.14 -30.48 26.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.12 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.557 ' O ' ' HE3' ' A' ' 145' ' ' MET . . . -108.21 27.75 13.44 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.236 179.758 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.521 HD21 ' HD2' ' A' ' 4' ' ' TYR . 0.7 OUTLIER -150.15 142.69 24.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.82 0.343 . . . . 0.0 110.736 -179.861 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -130.45 156.18 45.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.611 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' MET . . . . . 0.526 ' HA ' ' O ' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -140.16 160.29 40.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.116 179.973 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 . . . . . 0 C--O 1.233 0.186 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.477 -179.161 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.723 HD11 ' HB3' ' A' ' 169' ' ' MET . 1.9 tt . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.842 0.353 . . . . 0.0 111.002 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.419 ' CG2' ' HB3' ' A' ' 12' ' ' GLU . 16.3 mm -104.25 155.75 5.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.348 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.592 ' HE1' HG23 ' A' ' 2' ' ' ILE . 4.4 m-85 -124.19 106.62 10.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.73 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 27.7 ptt180 -122.66 146.74 47.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.148 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.563 ' OD1' HD12 ' A' ' 8' ' ' ILE . 49.2 t0 -58.05 143.36 43.72 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.8 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 59.8 tp -73.37 -21.96 60.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.328 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.69 HD11 ' CG1' ' A' ' 99' ' ' ILE . 4.2 mp -91.32 -45.72 14.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.8 -179.544 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.94 -20.27 19.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.76 -179.156 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.445 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 14.7 m170 61.24 28.86 18.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.91 0.386 . . . . 0.0 110.717 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -102.08 120.29 40.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.761 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.419 ' HB3' ' CG2' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -56.66 88.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.392 -179.731 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.411 ' O ' ' CG ' ' A' ' 76' ' ' HIS . 7.8 mtt -66.46 -24.22 66.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.721 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.507 ' CZ ' ' CD2' ' A' ' 4' ' ' TYR . 25.6 p90 -173.49 179.65 2.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.696 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -135.24 -169.97 2.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.774 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -94.85 23.98 5.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.023 0.439 . . . . 0.0 110.948 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.429 HG13 ' CD2' ' A' ' 18' ' ' TYR . 39.6 pt -82.03 -15.03 12.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.632 179.223 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.837 ' CE2' HG22 ' A' ' 72' ' ' ILE . 82.4 m-85 -108.12 -174.27 2.48 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.586 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.4 mmtp -93.19 86.43 5.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.746 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.574 ' N ' HD12 ' A' ' 20' ' ' ILE . 3.9 mp -87.83 125.54 41.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.939 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.4 mmm180 -117.77 129.97 56.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.997 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -80.59 116.53 20.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.707 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.402 HG12 ' HG3' ' A' ' 30' ' ' GLU . 2.9 pt -110.93 173.39 2.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.017 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.492 ' HB2' ' NE2' ' A' ' 121' ' ' GLN . . . 56.39 28.42 13.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.166 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.414 ' HB2' ' O ' ' A' ' 24' ' ' ALA . 5.4 m-20 66.06 54.38 1.0 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.238 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 76.61 1.78 72.77 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.894 -0.669 . . . . 0.0 113.415 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.477 ' HB3' ' HB3' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -71.84 -43.47 65.48 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 117.056 0.428 . . . . 0.0 111.083 -179.962 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 10.1 m -132.17 161.76 32.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.096 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.625 HD11 ' HG3' ' A' ' 164' ' ' LYS . 1.1 mt -127.1 127.74 45.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.823 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.402 ' HG3' HG12 ' A' ' 23' ' ' ILE . 56.4 mt-10 -97.38 112.96 24.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.137 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.402 HG21 ' CD2' ' A' ' 14' ' ' PHE . 24.2 t -92.23 111.97 25.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.567 179.494 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -82.03 125.17 30.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.228 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -112.07 -141.15 8.26 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.177 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.9 pttp -174.57 126.49 0.31 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.816 0.341 . . . . 0.0 111.132 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 95.1 mtp -67.78 111.28 4.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.631 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 28.9 m . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.453 -179.776 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.369 0 N-CA-C 112.286 -0.326 . . . . 0.0 112.286 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.798 HG22 ' HG2' ' A' ' 158' ' ' PRO . 43.0 t -73.2 129.84 35.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.792 0.33 . . . . 0.0 110.771 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.4 ' N ' ' OD1' ' A' ' 71' ' ' ASP . 20.3 p-10 -59.6 -55.49 33.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.793 -179.144 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.837 HG22 ' CE2' ' A' ' 18' ' ' TYR . 8.7 pt -53.78 -33.94 24.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.833 0.349 . . . . 0.0 111.411 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.782 HG13 ' HB2' ' A' ' 78' ' ' LEU . 93.8 t -72.44 -32.1 40.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.919 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.2 mtm -78.21 -40.07 38.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.496 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.41 ' OD1' ' CD2' ' A' ' 76' ' ' HIS . 15.2 p30 -82.12 -28.46 32.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.568 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.44 ' CE1' ' HB ' ' A' ' 72' ' ' ILE . 24.8 m170 -94.29 1.1 55.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.806 0.336 . . . . 0.0 110.963 179.523 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.409 ' HB2' ' HB3' ' A' ' 138' ' ' GLU . 89.9 m-70 56.13 30.16 15.91 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.321 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.782 ' HB2' HG13 ' A' ' 73' ' ' VAL . 67.1 mt -60.17 134.46 57.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.604 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -123.91 139.38 54.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.863 0.363 . . . . 0.0 111.196 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.43 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 2.0 tt0 -90.83 130.7 36.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.958 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.837 HG21 HD11 ' A' ' 136' ' ' ILE . 9.9 t -122.14 137.06 54.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.821 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.0 m -77.57 159.16 29.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.028 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.473 ' CE2' ' HB1' ' A' ' 87' ' ' ALA . 0.3 OUTLIER -167.61 149.24 5.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.822 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.88 166.63 13.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.965 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.7 mttp -64.98 -52.55 55.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.764 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -62.67 -41.69 99.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.959 0.409 . . . . 0.0 110.591 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.473 ' HB1' ' CE2' ' A' ' 83' ' ' PHE . . . -59.28 -39.44 82.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.91 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.84 ' CD2' HD11 ' A' ' 122' ' ' ILE . 0.5 OUTLIER -59.78 -37.17 78.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.575 179.807 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.415 ' O ' HG22 ' A' ' 92' ' ' ILE . 67.6 mttt -56.61 -49.81 73.85 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.112 0.482 . . . . 0.0 110.189 179.482 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.71 -27.83 60.55 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.521 178.538 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.537 ' HE2' HG21 ' A' ' 146' ' ' VAL . 6.3 t80 -64.62 -47.63 77.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.814 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.57 HD12 ' CE2' ' A' ' 95' ' ' TYR . 4.8 tp -61.47 -43.97 97.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.98 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.431 ' O ' ' HB3' ' A' ' 97' ' ' LYS . 8.8 ttmm -60.17 -40.66 90.71 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.236 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.453 ' O ' ' HG3' ' A' ' 97' ' ' LYS . 9.4 t0 -73.71 -43.06 60.27 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.984 -179.227 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.57 ' CE2' HD12 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -76.82 -39.59 50.8 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.087 -179.207 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.449 ' HG2' ' O ' ' A' ' 92' ' ' ILE . 6.2 ptt? -67.72 -32.13 72.55 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.929 -0.308 . . . . 0.0 110.69 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.471 ' HG3' ' N ' ' A' ' 98' ' ' SER . 0.0 OUTLIER -70.43 -33.66 71.59 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.517 179.88 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.471 ' N ' ' HG3' ' A' ' 97' ' ' LYS . 1.5 m -62.65 -40.76 98.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.037 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.69 ' CG1' HD11 ' A' ' 8' ' ' ILE . 7.4 mt -79.86 -41.5 21.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.281 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.7 tttt -56.21 -57.15 13.42 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.442 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -59.6 -42.84 97.96 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.24 179.485 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.59 -36.37 83.54 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.885 0.374 . . . . 0.0 110.45 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.841 HD21 ' CB ' ' A' ' 110' ' ' ARG . 3.9 tp -72.6 -32.43 65.97 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.056 0.455 . . . . 0.0 109.9 179.188 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.611 ' CG ' HG11 ' A' ' 111' ' ' VAL . 69.1 mt-10 -60.62 -31.57 70.74 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.674 179.518 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -87.89 -21.58 24.89 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.654 -179.622 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -105.55 -62.42 1.36 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.78 0.324 . . . . 0.0 111.456 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.449 ' N ' ' O ' ' A' ' 103' ' ' LEU . 0.5 OUTLIER -128.54 63.56 65.04 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.96 -179.761 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.927 ' O ' HG22 ' A' ' 111' ' ' VAL . 10.3 Cg_endo -50.97 -22.66 10.67 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 123.114 2.543 . . . . 0.0 112.73 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -68.43 -12.24 60.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.606 0.241 . . . . 0.0 111.335 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.841 ' CB ' HD21 ' A' ' 103' ' ' LEU . 0.4 OUTLIER -108.03 -1.21 20.72 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -179.562 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.927 HG22 ' O ' ' A' ' 108' ' ' PRO . 22.4 m -72.71 -32.33 40.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -179.262 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.554 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 11.9 mtpt -68.99 -50.09 23.0 Favored Pre-proline 0 C--N 1.331 -0.205 0 C-N-CA 120.941 -0.304 . . . . 0.0 111.529 -179.221 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.554 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 24.2 Cg_exo -63.56 -29.6 70.53 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.138 1.892 . . . . 0.0 111.578 179.384 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.499 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 54.2 t80 -72.24 -42.31 65.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.016 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -55.48 -47.3 76.36 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.013 0.435 . . . . 0.0 110.757 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 60.1 m -76.08 -44.33 39.39 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.888 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.35 -46.81 93.1 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.774 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.4 ' O ' ' HB ' ' A' ' 122' ' ' ILE . . . -57.07 -51.82 67.77 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.028 0.442 . . . . 0.0 111.223 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.22 -28.22 67.89 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.39 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -77.72 -43.25 31.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.255 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.492 ' NE2' ' HB2' ' A' ' 24' ' ' ALA . 3.1 tp-100 -73.17 -37.83 66.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.048 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.84 HD11 ' CD2' ' A' ' 88' ' ' TYR . 0.3 OUTLIER -66.13 -46.39 87.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.299 -179.888 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.457 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 17.5 pttt -60.64 -31.88 71.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.181 179.567 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 9.3 t-80 -66.9 -54.05 26.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.774 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.562 HG21 HD13 ' A' ' 148' ' ' LEU . 13.6 pt -61.75 -40.77 88.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.155 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.42 ' HA ' HD23 ' A' ' 126' ' ' LEU . 11.7 mt -53.85 -36.43 62.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.828 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -67.4 -13.96 62.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.191 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -141.44 36.28 1.67 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.935 0.397 . . . . 0.0 110.464 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.517 ' CE1' ' CZ ' ' A' ' 134' ' ' PHE . 4.0 t80 -49.66 -29.55 7.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.17 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 5.8 mtmp? -64.98 -21.32 66.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.192 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 32.5 m-20 -94.07 -38.02 11.33 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.287 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.409 ' CD2' ' OD1' ' A' ' 150' ' ' ASP . 4.1 m-85 -99.02 140.77 32.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.15 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 5.3 mm-40 -118.48 145.91 44.91 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.981 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.517 ' CZ ' ' CE1' ' A' ' 129' ' ' PHE . 2.5 m-85 -82.71 122.43 28.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.945 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.43 ' CE2' ' HB2' ' A' ' 80' ' ' GLU . 28.6 m-85 -124.19 146.38 48.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.628 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.837 HD11 HG21 ' A' ' 81' ' ' THR . 0.8 OUTLIER -134.28 162.85 38.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.972 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -62.64 -164.38 0.43 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.191 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.409 ' HB3' ' HB2' ' A' ' 77' ' ' HIS . 7.5 pt-20 -72.48 -8.94 57.69 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.533 0.206 . . . . 0.0 111.476 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 19.4 m-80 -95.81 -31.49 13.14 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.647 0.26 . . . . 0.0 111.523 -179.626 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' MET . . . . . 0.454 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 32.7 mtm 56.93 41.41 27.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.885 0.374 . . . . 0.0 111.02 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ASN . . . . . 0.404 ' ND2' ' HA3' ' A' ' 144' ' ' GLY . 15.7 p-10 -66.93 116.03 31.22 Favored Pre-proline 0 N--CA 1.451 -0.42 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.8 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 141' ' ' ASN . 24.2 Cg_exo -61.7 -27.84 81.55 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.52 2.147 . . . . 0.0 112.155 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -84.52 -4.85 59.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.018 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.404 ' HA3' ' ND2' ' A' ' 141' ' ' ASN . . . -90.1 -175.54 45.17 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.385 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -77.19 177.77 7.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.877 0.37 . . . . 0.0 110.855 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.537 HG21 ' HE2' ' A' ' 91' ' ' TYR . 47.4 t -124.34 152.5 30.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.166 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.764 ' HB1' ' HE2' ' A' ' 160' ' ' MET . . . -116.11 117.42 30.03 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.569 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.562 HD13 HG21 ' A' ' 125' ' ' ILE . 3.5 mt -91.51 108.22 19.75 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.244 -179.171 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.461 HD12 ' HG2' ' A' ' 160' ' ' MET . 1.3 tp -92.51 119.46 32.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.35 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.474 ' HB2' ' CZ ' ' A' ' 159' ' ' TYR . 1.0 OUTLIER -129.66 163.6 25.74 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.475 179.332 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -102.91 145.78 29.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.909 0.385 . . . . 0.0 111.052 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.17 -177.01 0.11 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.908 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -57.87 -41.31 82.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.901 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -71.51 -15.08 62.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.171 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 77.36 18.32 78.18 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.738 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 83.7 t -113.41 -73.63 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.794 0.33 . . . . 0.0 110.911 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 83.9 m -53.67 103.13 0.35 Allowed Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.235 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.798 ' HG2' HG22 ' A' ' 70' ' ' VAL . 6.0 Cg_exo -78.81 130.36 9.58 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.76 2.306 . . . . 0.0 111.952 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.474 ' CZ ' ' HB2' ' A' ' 150' ' ' ASP . 11.0 p90 -120.75 137.49 54.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.85 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' MET . . . . . 0.764 ' HE2' ' HB1' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -103.85 134.58 46.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.374 -179.373 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.558 ' HB ' ' HB2' ' A' ' 148' ' ' LEU . 51.0 mt -93.2 123.8 45.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.869 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.53 ' CE1' ' HB2' ' A' ' 147' ' ' ALA . 71.2 m-85 -129.51 126.73 39.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.182 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.431 ' CE2' ' OH ' ' A' ' 95' ' ' TYR . 4.1 m-30 -72.66 123.8 24.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.577 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.625 ' HG3' HD11 ' A' ' 29' ' ' LEU . 3.0 ttmm -60.56 -56.39 21.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.523 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.499 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 2.4 m-20 -48.63 -36.17 15.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.851 0.358 . . . . 0.0 111.286 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -94.25 28.6 10.42 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.412 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.464 HD11 ' HB3' ' A' ' 4' ' ' TYR . 1.0 OUTLIER -150.01 142.89 24.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.73 0.3 . . . . 0.0 110.837 -179.858 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.02 155.74 21.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.799 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' MET . . . . . 0.723 ' HB3' HD11 ' A' ' 2' ' ' ILE . 0.1 OUTLIER -121.32 145.52 47.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.931 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.881 -179.992 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.723 HD11 ' HB3' ' A' ' 169' ' ' MET . 2.1 tt . . . . . 0 N--CA 1.457 -0.09 0 CA-C-O 120.818 0.342 . . . . 0.0 110.983 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.467 HG21 ' HB3' ' A' ' 12' ' ' GLU . 16.4 mm -104.79 156.82 5.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.276 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.605 ' HE1' HG23 ' A' ' 2' ' ' ILE . 4.9 m-85 -125.75 99.14 5.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.611 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 27.1 ptt180 -113.34 147.32 37.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.136 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.542 ' OD1' HD12 ' A' ' 8' ' ' ILE . 47.3 t0 -56.95 152.16 13.43 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.8 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 61.1 tp -81.39 -20.27 40.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.377 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.542 HD12 ' OD1' ' A' ' 6' ' ' ASP . 4.0 mp -91.34 -47.31 14.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -179.508 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.47 -20.5 19.0 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.167 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.44 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 36.6 m80 63.96 28.93 14.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.9 0.381 . . . . 0.0 110.749 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -102.0 122.57 44.33 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.793 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.467 ' HB3' HG21 ' A' ' 3' ' ' ILE . 5.5 pm0 -57.96 92.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.251 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 9.7 mtt -72.84 -16.88 61.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.918 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.496 ' CE2' ' CD2' ' A' ' 4' ' ' TYR . 19.1 p90 -177.44 174.16 1.61 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.708 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -133.36 -172.3 2.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.863 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -92.52 17.88 9.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.099 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 46.7 pt -79.12 -15.11 13.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.967 0.413 . . . . 0.0 110.649 179.252 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.939 ' CE2' HG22 ' A' ' 72' ' ' ILE . 70.7 m-85 -108.07 -174.52 2.54 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.529 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.406 ' HB2' ' HB2' ' A' ' 32' ' ' GLU . 4.9 mttp -96.16 93.37 6.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.879 0.371 . . . . 0.0 110.581 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.568 ' N ' HD12 ' A' ' 20' ' ' ILE . 4.1 mp -87.81 134.62 27.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.178 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.58 122.87 37.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.838 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -77.82 116.45 18.35 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.876 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.634 HD11 HG23 ' A' ' 161' ' ' ILE . 1.4 pt -109.72 168.97 3.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.072 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.441 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . . . 59.59 31.08 20.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.952 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 65.61 47.39 2.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.179 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.13 -8.23 68.06 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.809 -0.71 . . . . 0.0 113.38 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.441 ' HB3' ' HB3' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -60.94 -39.01 87.86 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.904 0.352 . . . . 0.0 111.239 -179.838 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 28.2 m -135.47 162.53 32.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.162 -179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.772 HD11 ' HG3' ' A' ' 164' ' ' LYS . 0.5 OUTLIER -126.18 132.86 51.71 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.74 179.886 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.429 ' HG3' HG12 ' A' ' 23' ' ' ILE . 18.9 mt-10 -102.19 116.24 32.23 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.257 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.4 t -90.25 112.13 24.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.706 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.406 ' HB2' ' HB2' ' A' ' 19' ' ' LYS . 18.1 mt-10 -83.55 115.16 21.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.147 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.57 -143.64 11.91 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.114 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.4 126.84 0.33 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.929 0.395 . . . . 0.0 110.955 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 42.3 mtp -70.83 115.01 9.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.626 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.491 HG23 ' CE ' ' A' ' 74' ' ' MET . 4.8 m . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.402 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 N-CA-C 112.435 -0.266 . . . . 0.0 112.435 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.703 HG22 ' HG3' ' A' ' 158' ' ' PRO . 60.8 t -68.52 135.89 27.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.916 0.389 . . . . 0.0 110.775 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -59.23 -57.55 12.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.653 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.939 HG22 ' CE2' ' A' ' 18' ' ' TYR . 5.3 pt -53.95 -33.82 24.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.497 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.805 HG13 ' HB2' ' A' ' 78' ' ' LEU . 92.3 t -75.0 -30.87 24.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.071 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.491 ' CE ' HG23 ' A' ' 36' ' ' VAL . 1.8 mtm -78.16 -41.51 34.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.902 -179.426 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.428 ' OD1' ' CD2' ' A' ' 76' ' ' HIS . 15.0 p30 -82.11 -30.35 31.22 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -179.057 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.432 ' CE1' ' HA ' ' A' ' 14' ' ' PHE . 36.3 m80 -91.87 -0.13 57.5 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.856 0.36 . . . . 0.0 110.923 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 9.8 m80 55.8 34.94 24.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.256 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.805 ' HB2' HG13 ' A' ' 73' ' ' VAL . 46.5 mt -58.59 147.32 32.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.553 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -131.82 139.0 48.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.893 0.377 . . . . 0.0 111.148 -179.432 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.428 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 4.7 tt0 -92.68 131.89 37.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.001 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.494 HG21 HD11 ' A' ' 136' ' ' ILE . 7.8 t -122.33 151.81 40.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.768 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 62.3 m -90.47 159.01 16.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.084 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.537 ' CE2' ' HB1' ' A' ' 87' ' ' ALA . 0.2 OUTLIER -170.02 137.83 1.64 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.76 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -85.39 173.79 10.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.938 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.2 mttp -66.92 -52.31 44.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.949 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -58.46 -46.1 87.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.893 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.537 ' HB1' ' CE2' ' A' ' 83' ' ' PHE . . . -58.67 -40.75 84.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.038 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.859 ' CD2' HD11 ' A' ' 122' ' ' ILE . 0.1 OUTLIER -59.05 -36.93 75.85 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.843 179.851 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -57.39 -48.52 78.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.159 0.504 . . . . 0.0 110.354 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.8 mmtt -76.47 -27.89 56.31 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.441 178.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.583 ' HE2' HG21 ' A' ' 146' ' ' VAL . 4.6 t80 -64.99 -46.57 80.87 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.615 179.571 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.626 HD12 ' CE2' ' A' ' 95' ' ' TYR . 4.5 tp -61.43 -46.52 96.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.849 0.357 . . . . 0.0 110.75 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.414 ' O ' ' HB3' ' A' ' 97' ' ' LYS . 18.9 ttpp -59.25 -38.62 80.51 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.952 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.433 ' HA ' ' HG2' ' A' ' 97' ' ' LYS . 31.5 t70 -73.89 -44.98 53.56 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.054 -179.198 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.626 ' CE2' HD12 ' A' ' 92' ' ' ILE . 0.1 OUTLIER -76.18 -38.48 56.56 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.292 -179.236 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.42 ' HG2' ' O ' ' A' ' 92' ' ' ILE . 4.0 ptt? -67.39 -32.15 72.85 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.471 179.471 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.504 ' HG3' ' N ' ' A' ' 98' ' ' SER . 0.0 OUTLIER -70.48 -33.45 71.26 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.912 0.387 . . . . 0.0 110.482 179.681 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.504 ' N ' ' HG3' ' A' ' 97' ' ' LYS . 1.7 m -64.17 -40.51 96.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.227 179.486 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.523 HG23 ' HA2' ' A' ' 166' ' ' GLY . 7.9 mt -79.72 -40.4 21.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.298 179.296 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -56.1 -54.38 45.73 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.411 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -60.81 -45.74 95.88 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.923 179.417 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.69 -40.73 96.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.926 0.393 . . . . 0.0 110.207 179.433 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.607 HD21 ' CB ' ' A' ' 110' ' ' ARG . 3.4 tp -66.5 -36.59 83.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.029 179.224 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.619 ' CG ' HG11 ' A' ' 111' ' ' VAL . 63.2 mt-10 -58.39 -29.12 65.8 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.768 179.447 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -87.01 -20.71 26.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.503 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -106.52 -61.33 1.54 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.727 0.298 . . . . 0.0 111.633 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.439 ' N ' ' O ' ' A' ' 103' ' ' LEU . 91.7 mtm-85 -131.64 65.58 76.22 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.859 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.888 ' O ' HG22 ' A' ' 111' ' ' VAL . 9.4 Cg_endo -50.5 -23.45 10.66 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 123.105 2.537 . . . . 0.0 112.617 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -70.87 -12.06 61.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.68 0.276 . . . . 0.0 111.038 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.607 ' CB ' HD21 ' A' ' 103' ' ' LEU . 6.0 mmm180 -106.66 0.57 24.45 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.764 -179.576 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.888 HG22 ' O ' ' A' ' 108' ' ' PRO . 22.8 m -73.09 -33.29 41.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.547 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 12.7 mtmm -66.48 -50.02 49.4 Favored Pre-proline 0 C--N 1.332 -0.181 0 C-N-CA 121.022 -0.271 . . . . 0.0 111.583 -179.158 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.547 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 27.1 Cg_exo -62.18 -34.8 77.92 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.254 1.969 . . . . 0.0 111.702 179.543 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -68.31 -38.03 81.21 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.833 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -59.88 -47.17 86.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.021 0.439 . . . . 0.0 110.823 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 63.6 m -76.29 -44.65 36.07 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.69 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.63 -41.01 99.22 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.512 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.0 -47.2 86.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.058 0.456 . . . . 0.0 111.042 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.492 ' HB1' ' CE ' ' A' ' 123' ' ' LYS . . . -70.45 -29.87 66.55 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.188 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -73.65 -52.94 11.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.98 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.479 ' HA ' ' NE2' ' A' ' 121' ' ' GLN . 3.9 tp60 -60.74 -45.63 93.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.932 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.859 HD11 ' CD2' ' A' ' 88' ' ' TYR . 0.3 OUTLIER -59.93 -45.4 95.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.936 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.492 ' CE ' ' HB1' ' A' ' 119' ' ' ALA . 15.1 mttm -60.49 -30.75 69.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.196 179.315 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -68.88 -54.46 15.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.669 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.746 HG21 HD13 ' A' ' 148' ' ' LEU . 11.6 pt -60.68 -40.5 84.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.064 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 11.5 mt -53.95 -38.59 65.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.704 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -68.52 -12.91 61.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.248 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -137.15 33.64 2.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.087 0.47 . . . . 0.0 110.503 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -49.71 -28.49 6.13 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.241 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 5.6 tttp -72.24 -20.32 61.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.341 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -94.1 -35.28 12.62 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.322 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -100.72 146.3 27.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.947 0.403 . . . . 0.0 111.283 -179.58 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -125.38 146.22 49.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.787 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.519 ' CE1' ' CZ ' ' A' ' 88' ' ' TYR . 3.2 m-85 -81.5 129.18 34.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.958 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.449 ' O ' ' HB3' ' A' ' 147' ' ' ALA . 30.6 m-85 -133.93 136.37 44.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.678 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.494 HD11 HG21 ' A' ' 81' ' ' THR . 1.2 mt -124.65 164.92 22.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.044 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.97 -160.07 0.73 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.165 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -74.48 -8.79 57.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.467 0.175 . . . . 0.0 111.45 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -95.33 -33.31 12.58 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 111.657 0.243 . . . . 0.0 111.657 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' MET . . . . . 0.424 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 73.9 mtm 60.11 34.93 21.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.817 0.342 . . . . 0.0 110.841 -179.692 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ASN . . . . . 0.46 ' ND2' ' HA3' ' A' ' 144' ' ' GLY . 6.4 p-10 -65.94 114.82 18.05 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.043 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -67.12 -24.89 44.17 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.669 2.246 . . . . 0.0 112.386 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -84.44 -6.5 59.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.187 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.46 ' HA3' ' ND2' ' A' ' 141' ' ' ASN . . . -85.85 -124.56 1.53 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.461 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.512 ' HE2' ' HB2' ' A' ' 163' ' ' PHE . 6.9 ptp -126.57 -177.49 4.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.81 0.338 . . . . 0.0 110.76 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.583 HG21 ' HE2' ' A' ' 91' ' ' TYR . 48.3 t -129.23 149.74 33.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.208 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.524 ' HB2' ' CE2' ' A' ' 162' ' ' PHE . . . -113.41 112.17 23.19 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.463 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.746 HD13 HG21 ' A' ' 125' ' ' ILE . 4.4 mt -86.63 106.05 17.32 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.982 -179.278 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.419 ' HB2' ' HE2' ' A' ' 160' ' ' MET . 1.5 tp -90.82 120.0 31.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.161 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.481 ' HB3' ' CZ ' ' A' ' 159' ' ' TYR . 29.5 t70 -133.94 165.37 25.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.429 179.617 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -107.99 147.27 31.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.817 0.341 . . . . 0.0 111.088 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.88 -168.7 0.1 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.863 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.87 -41.26 95.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.963 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -72.98 -15.13 61.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.311 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 65.7 28.64 73.82 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.487 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 73.6 t -112.4 -55.94 4.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.73 0.3 . . . . 0.0 111.177 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 54.5 m -85.78 111.65 39.17 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.4 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.703 ' HG3' HG22 ' A' ' 70' ' ' VAL . 88.2 Cg_endo -80.5 135.9 10.77 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.526 2.151 . . . . 0.0 111.728 179.256 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.481 ' CZ ' ' HB3' ' A' ' 150' ' ' ASP . 5.8 p90 -126.02 135.57 51.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.976 0.417 . . . . 0.0 111.085 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' MET . . . . . 0.448 ' CE ' HD13 ' A' ' 78' ' ' LEU . 0.8 OUTLIER -104.96 131.62 52.24 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.059 -179.741 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.634 HG23 HD11 ' A' ' 23' ' ' ILE . 67.2 mt -92.09 118.5 37.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.289 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.524 ' CE2' ' HB2' ' A' ' 147' ' ' ALA . 78.6 m-85 -117.05 163.42 16.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.703 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.512 ' HB2' ' HE2' ' A' ' 145' ' ' MET . 22.6 m-85 -100.44 122.77 43.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.905 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.772 ' HG3' HD11 ' A' ' 29' ' ' LEU . 12.4 tttt -70.06 -51.92 28.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.069 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -51.52 -29.17 15.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.162 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.523 ' HA2' HG23 ' A' ' 99' ' ' ILE . . . -105.35 24.29 27.99 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.375 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.557 HD21 ' HB3' ' A' ' 4' ' ' TYR . 0.5 OUTLIER -138.25 146.82 43.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.849 0.357 . . . . 0.0 110.812 -179.903 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -117.56 151.2 37.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.02 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' MET . . . . . 0.723 ' HB3' HD11 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -111.42 154.21 24.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.923 179.972 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.959 179.977 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.616 HG22 ' HB2' ' A' ' 16' ' ' ASP . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.771 0.319 . . . . 0.0 111.037 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.527 ' O ' ' HA ' ' A' ' 169' ' ' MET . 4.3 mm -105.69 120.47 56.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.312 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.597 ' CE1' HG23 ' A' ' 2' ' ' ILE . 25.3 m-85 -91.45 125.21 36.12 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.801 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -137.23 143.66 42.39 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.215 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -55.05 144.8 22.39 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.976 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 55.3 tp -73.58 -22.17 60.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.453 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.465 HD11 ' CG1' ' A' ' 99' ' ' ILE . 4.6 mp -91.24 -43.97 14.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.687 0.28 . . . . 0.0 111.72 -179.636 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.422 ' HB2' ' ND2' ' A' ' 141' ' ' ASN . 1.9 t -92.62 -27.52 17.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.378 -179.453 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 64.3 m-70 64.53 26.63 13.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.797 0.332 . . . . 0.0 110.773 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -103.15 129.7 50.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.718 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.422 ' HB3' ' CG2' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -57.84 95.9 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.346 -179.673 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 41.8 mtp -78.16 -16.86 57.53 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.7 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.497 ' CE2' ' CG ' ' A' ' 4' ' ' TYR . 37.8 p90 179.98 165.13 1.2 Allowed 'General case' 0 C--O 1.231 0.108 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.806 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.23 -169.93 1.98 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.563 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.616 ' HB2' HG22 ' A' ' 2' ' ' ILE . 39.4 t0 -95.67 33.78 1.59 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.02 0.438 . . . . 0.0 110.929 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.435 HG13 ' CD2' ' A' ' 18' ' ' TYR . 40.3 pt -93.33 -10.77 9.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.618 179.183 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.969 ' CZ ' HG22 ' A' ' 72' ' ' ILE . 51.8 m-85 -110.45 -169.32 1.44 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.686 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.0 mmtt -96.88 88.25 4.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.813 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.0 mp -87.99 124.03 40.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.982 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.0 mtt180 -119.47 126.27 50.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.163 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.799 ' HG3' HD23 ' A' ' 29' ' ' LEU . 1.0 OUTLIER -76.25 116.67 17.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.807 179.989 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.51 HD11 HG23 ' A' ' 161' ' ' ILE . 6.0 pt -114.15 170.93 4.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.204 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 56.12 28.48 13.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.286 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 63.43 41.35 7.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.218 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.1 -11.27 70.92 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.581 -0.819 . . . . 0.0 113.172 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.14 -33.87 74.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.916 0.358 . . . . 0.0 111.037 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.5 m -145.53 163.54 34.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.9 0.381 . . . . 0.0 111.158 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.799 HD23 ' HG3' ' A' ' 22' ' ' GLU . 0.4 OUTLIER -127.68 130.66 49.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.704 179.876 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -97.19 112.86 24.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.153 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' ' 159' ' ' TYR . 22.1 t -98.8 111.84 29.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.633 179.551 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -83.56 115.78 22.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.336 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -99.8 -137.91 10.04 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.247 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.4 ptpt -174.45 126.38 0.32 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.845 0.355 . . . . 0.0 110.959 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 23.7 mtm -72.45 121.98 20.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.758 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.446 HG23 ' CE ' ' A' ' 74' ' ' MET . 5.7 m . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.391 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.365 0 N-CA-C 112.207 -0.357 . . . . 0.0 112.207 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.578 HG12 HG12 ' A' ' 72' ' ' ILE . 44.3 t -69.09 135.92 27.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.833 0.349 . . . . 0.0 110.901 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -62.33 -56.94 13.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.639 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.969 HG22 ' CZ ' ' A' ' 18' ' ' TYR . 7.6 pt -53.54 -33.79 22.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.36 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.785 HG13 ' HB2' ' A' ' 78' ' ' LEU . 91.4 t -73.49 -33.49 39.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.915 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.446 ' CE ' HG23 ' A' ' 36' ' ' VAL . 2.4 mtm -78.23 -39.2 41.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.614 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 19.1 p30 -82.01 -29.42 32.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.581 -179.201 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.436 ' CE1' ' HB ' ' A' ' 72' ' ' ILE . 26.1 m170 -91.82 -4.52 54.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.842 0.353 . . . . 0.0 110.825 179.497 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.476 ' HB2' ' HB3' ' A' ' 138' ' ' GLU . 28.5 m80 60.73 39.57 17.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.95 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.785 ' HB2' HG13 ' A' ' 73' ' ' VAL . 38.1 mt -70.79 140.81 51.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.796 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -116.46 132.81 56.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.734 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.435 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 0.1 OUTLIER -91.7 120.86 32.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.94 0.4 . . . . 0.0 111.183 -179.94 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.454 HG21 HD11 ' A' ' 136' ' ' ILE . 9.2 t -108.82 170.01 8.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.792 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.3 p -114.91 170.45 8.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.889 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.48 ' HB2' ' CE2' ' A' ' 134' ' ' PHE . 4.0 m-85 -171.68 152.19 3.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.074 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.405 ' H ' ' HB3' ' A' ' 87' ' ' ALA . 0.2 OUTLIER -101.44 168.49 9.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.594 179.638 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.2 mttm -54.98 -51.94 64.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.125 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.63 -42.82 73.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.238 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.405 ' HB3' ' H ' ' A' ' 84' ' ' THR . . . -60.62 -44.83 95.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.858 0.361 . . . . 0.0 111.218 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.836 ' CD2' HD11 ' A' ' 122' ' ' ILE . 0.5 OUTLIER -59.83 -34.82 73.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.89 -179.974 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 15.8 mtmt -59.69 -42.22 92.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.067 0.46 . . . . 0.0 110.5 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.6 -29.87 46.31 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.093 178.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -68.07 -46.17 71.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.743 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.818 HG22 ' O ' ' A' ' 88' ' ' TYR . 2.1 tp -64.83 -42.17 94.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.98 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.457 ' O ' ' CG ' ' A' ' 97' ' ' LYS . 3.1 ttpt -62.0 -44.89 95.76 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.792 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -67.79 -40.18 83.95 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.955 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.54 ' CD1' ' C ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -76.5 -45.11 32.34 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 121.023 -0.271 . . . . 0.0 111.022 -179.162 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.501 ' HB2' ' HE3' ' A' ' 96' ' ' MET . 20.3 ptm -59.13 -32.01 69.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.889 0.375 . . . . 0.0 110.117 179.287 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.457 ' CG ' ' O ' ' A' ' 93' ' ' LYS . 3.7 mmpt? -70.72 -38.71 73.64 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.449 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.3 m -58.86 -40.08 83.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.332 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.465 ' CG1' HD11 ' A' ' 8' ' ' ILE . 10.2 mt -79.85 -42.56 22.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.416 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.49 -51.71 66.07 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.411 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -63.12 -47.16 90.69 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.044 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 4.0 tppt? -61.12 -39.89 91.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.872 0.367 . . . . 0.0 110.24 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.63 ' HB3' HG12 ' A' ' 111' ' ' VAL . 5.5 tp -66.97 -36.88 83.18 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.071 179.281 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.685 ' HG3' HG11 ' A' ' 111' ' ' VAL . 75.8 mt-10 -57.52 -29.44 64.33 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.658 179.367 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -86.7 -20.81 27.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.486 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -105.77 -61.17 1.53 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.841 0.353 . . . . 0.0 111.656 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.448 ' N ' ' O ' ' A' ' 103' ' ' LEU . 22.5 mtt85 -134.06 66.81 72.7 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.863 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.88 ' O ' HG22 ' A' ' 111' ' ' VAL . 9.6 Cg_endo -50.46 -21.68 7.8 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 123.254 2.636 . . . . 0.0 112.875 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -71.15 -9.86 58.79 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.583 0.23 . . . . 0.0 111.297 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.601 ' CB ' HD21 ' A' ' 103' ' ' LEU . 8.5 mmt180 -110.34 -0.39 17.65 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.706 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.88 HG22 ' O ' ' A' ' 108' ' ' PRO . 29.6 m -71.09 -33.93 53.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -179.335 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.57 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 8.3 mttt -68.27 -50.07 30.6 Favored Pre-proline 0 C--N 1.332 -0.191 0 C-N-CA 121.022 -0.271 . . . . 0.0 111.62 -179.148 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.57 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 31.6 Cg_exo -58.59 -37.76 92.85 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.188 1.925 . . . . 0.0 111.956 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.449 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 69.7 t80 -68.83 -36.9 78.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.937 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.04 -47.95 79.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.803 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 60.4 m -76.41 -44.28 36.67 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.737 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.16 -42.71 99.87 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.538 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.5 -51.59 69.21 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.044 0.449 . . . . 0.0 110.975 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.6 -28.06 67.44 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.183 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -75.87 -49.48 17.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.092 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 3.3 tp-100 -65.82 -39.73 91.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.156 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.836 HD11 ' CD2' ' A' ' 88' ' ' TYR . 0.3 OUTLIER -60.64 -45.54 97.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.984 -179.877 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.435 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 30.8 mttm -60.7 -29.45 69.34 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.317 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 11.8 t-80 -69.25 -53.19 21.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.75 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.763 HG21 HD13 ' A' ' 148' ' ' LEU . 12.8 pt -63.0 -41.2 91.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.333 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 11.5 mt -54.79 -37.12 65.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.82 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -71.16 -10.54 59.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.34 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -140.31 33.35 1.89 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.928 0.395 . . . . 0.0 110.66 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.511 ' CE1' ' CZ ' ' A' ' 134' ' ' PHE . 1.5 t80 -51.35 -36.41 42.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.921 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.4 -26.07 66.39 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.977 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 32.0 m-20 -94.1 -43.84 8.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.201 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -91.8 135.52 33.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.227 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.47 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 3.9 mm-40 -115.07 144.13 44.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.464 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.511 ' CZ ' ' CE1' ' A' ' 129' ' ' PHE . 0.1 OUTLIER -89.22 130.76 35.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.889 0.376 . . . . 0.0 111.099 -179.638 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.536 ' HB2' ' HB3' ' A' ' 147' ' ' ALA . 17.2 m-85 -123.72 166.29 15.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.681 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.454 HD11 HG21 ' A' ' 81' ' ' THR . 0.4 OUTLIER -149.23 157.57 6.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.574 179.737 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -57.42 -172.77 0.25 Allowed Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.406 -0.902 . . . . 0.0 111.676 179.338 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.476 ' HB3' ' HB2' ' A' ' 77' ' ' HIS . 1.1 pt-20 -70.08 -8.94 53.54 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.587 0.232 . . . . 0.0 111.292 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -94.93 -23.4 17.44 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.697 -0.229 . . . . 0.0 111.416 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' MET . . . . . 0.405 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 63.7 mtp 50.95 43.36 28.8 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.824 0.345 . . . . 0.0 111.302 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ASN . . . . . 0.426 ' ND2' ' HA3' ' A' ' 144' ' ' GLY . 17.3 p-10 -64.64 117.13 35.01 Favored Pre-proline 0 N--CA 1.451 -0.391 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.816 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -59.35 -30.88 93.91 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.409 2.073 . . . . 0.0 112.26 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -84.61 -4.01 58.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.053 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.426 ' HA3' ' ND2' ' A' ' 141' ' ' ASN . . . -81.53 -153.63 11.0 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.407 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.507 ' HE3' ' O ' ' A' ' 166' ' ' GLY . 13.2 ptp -108.59 179.15 4.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.783 0.325 . . . . 0.0 110.815 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.426 ' CG1' ' HB3' ' A' ' 134' ' ' PHE . 0.0 OUTLIER -125.15 128.43 72.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.047 179.846 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.536 ' HB3' ' HB2' ' A' ' 135' ' ' PHE . . . -89.91 109.39 20.41 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.257 0.551 . . . . 0.0 110.422 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.763 HD13 HG21 ' A' ' 125' ' ' ILE . 4.7 mt -81.85 106.29 13.66 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.349 -179.103 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.561 HD12 ' HG2' ' A' ' 160' ' ' MET . 2.0 tp -91.12 118.63 30.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.158 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.453 ' HB3' ' CZ ' ' A' ' 159' ' ' TYR . 34.6 t70 -130.87 164.99 24.02 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.401 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -110.49 148.81 31.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.908 0.385 . . . . 0.0 110.995 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.487 ' HG3' HG22 ' A' ' 157' ' ' THR . 5.0 mmm180 -57.42 -177.94 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.071 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -61.19 -41.27 96.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.949 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -87.41 -15.09 38.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.209 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 68.44 44.97 70.95 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.584 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 78.5 t -107.29 -20.8 5.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.743 0.306 . . . . 0.0 111.004 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.487 HG22 ' HG3' ' A' ' 152' ' ' ARG . 1.4 t -140.89 122.34 9.18 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.985 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.442 ' HB2' HD11 ' A' ' 149' ' ' LEU . 84.4 Cg_endo -78.4 130.5 10.03 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.408 2.072 . . . . 0.0 112.09 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.453 ' CZ ' ' HB3' ' A' ' 150' ' ' ASP . 8.3 p90 -123.24 138.49 54.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.969 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' MET . . . . . 0.626 ' HG3' HD11 ' A' ' 72' ' ' ILE . 30.4 mtp -105.73 140.72 38.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.042 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.51 HG23 HD11 ' A' ' 23' ' ' ILE . 59.3 mt -97.92 111.19 27.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.016 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -107.13 154.38 21.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.957 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -96.78 118.3 32.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.822 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.475 ' HD3' HD11 ' A' ' 29' ' ' LEU . 19.8 tptt -64.83 -51.54 61.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.082 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.449 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 9.0 m-20 -54.72 -32.1 59.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.151 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.507 ' O ' ' HE3' ' A' ' 145' ' ' MET . . . -103.84 17.78 48.4 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.748 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.439 HD21 ' HB3' ' A' ' 4' ' ' TYR . 7.0 tt -141.85 144.33 33.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.779 0.323 . . . . 0.0 110.808 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -130.17 150.43 51.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.689 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' MET . . . . . 0.527 ' HA ' ' O ' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -140.11 160.1 40.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.125 179.986 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 . . . . . 0 C--N 1.332 -0.161 0 CA-C-O 120.93 0.395 . . . . 0.0 111.647 -179.243 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.683 HG23 ' CE1' ' A' ' 4' ' ' TYR . 0.9 OUTLIER . . . . . 0 N--CA 1.455 -0.177 0 CA-C-O 120.891 0.377 . . . . 0.0 111.026 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.493 ' O ' ' HA ' ' A' ' 169' ' ' MET . 7.7 mm -105.31 118.89 53.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.372 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.683 ' CE1' HG23 ' A' ' 2' ' ' ILE . 20.5 m-85 -91.32 129.27 37.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.766 179.572 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -138.09 148.95 45.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.078 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.418 ' O ' ' HA ' ' A' ' 10' ' ' HIS . 22.7 t0 -55.26 150.86 10.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.844 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 66.6 tp -80.05 -25.07 40.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.295 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.684 HD11 ' CG1' ' A' ' 99' ' ' ILE . 4.0 mp -91.21 -43.17 14.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.755 -179.61 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.5 t -91.77 -26.81 18.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.597 -179.267 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.418 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 0.2 OUTLIER 63.97 28.42 14.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.874 0.369 . . . . 0.0 110.832 -179.774 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -104.79 130.21 52.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.719 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.19 104.69 0.22 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.226 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 17.9 mtt -88.62 -15.67 34.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.917 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.495 ' CE2' ' CG ' ' A' ' 4' ' ' TYR . 38.2 p90 179.63 159.84 0.76 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.719 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -122.15 -169.93 1.98 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.664 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.662 ' HB2' HG22 ' A' ' 2' ' ' ILE . 36.9 t70 -93.49 28.98 2.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.989 0.423 . . . . 0.0 110.967 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.434 HG13 ' CD2' ' A' ' 18' ' ' TYR . 36.1 pt -91.46 -9.04 10.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.826 179.34 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.876 ' CZ ' HG22 ' A' ' 72' ' ' ILE . 57.2 m-85 -115.83 -169.74 1.65 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.789 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.0 mttt -95.78 95.06 8.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.006 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.7 mp -91.72 124.02 44.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.939 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.69 137.15 53.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.991 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.81 ' HG3' HD23 ' A' ' 29' ' ' LEU . 1.2 mp0 -83.85 114.7 21.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.818 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.622 HD11 HG23 ' A' ' 161' ' ' ILE . 5.4 pt -111.12 166.35 5.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.237 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 57.35 30.11 17.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.314 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 64.43 40.55 6.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.198 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.55 -18.5 56.96 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.007 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.33 -34.85 49.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.808 0.337 . . . . 0.0 111.041 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.426 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 35.8 m -147.9 163.63 36.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.913 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.81 HD23 ' HG3' ' A' ' 22' ' ' GLU . 0.4 OUTLIER -129.62 132.86 46.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.954 -179.832 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 73.9 mt-10 -96.26 125.25 40.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.125 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 22.4 t -102.5 111.94 34.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.732 179.453 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -87.08 112.54 22.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.135 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -94.17 -132.65 6.62 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.355 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.3 ptpt -174.43 123.4 0.29 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.776 0.322 . . . . 0.0 110.836 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 41.1 mtp -68.44 123.41 20.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.931 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.4 m . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.147 -179.975 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.447 0 N-CA-C 112.012 -0.435 . . . . 0.0 112.012 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.488 HG12 HG12 ' A' ' 72' ' ' ILE . 46.4 t -78.77 142.45 14.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.829 0.347 . . . . 0.0 110.927 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -69.99 -56.89 5.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.494 -179.416 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.876 HG22 ' CZ ' ' A' ' 18' ' ' TYR . 11.1 pt -53.63 -33.89 23.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.434 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.807 HG13 ' HB2' ' A' ' 78' ' ' LEU . 84.5 t -70.86 -31.43 45.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.783 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.3 mtt -78.26 -41.03 35.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.521 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.401 ' OD1' ' CD2' ' A' ' 76' ' ' HIS . 13.0 p30 -82.13 -28.51 32.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.528 -179.41 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.441 ' CE1' ' HA ' ' A' ' 14' ' ' PHE . 28.4 m170 -93.17 0.11 57.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.852 0.358 . . . . 0.0 110.838 179.445 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.487 ' HB2' ' HB3' ' A' ' 138' ' ' GLU . 13.2 m-70 56.22 27.96 12.47 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.121 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.807 ' HB2' HG13 ' A' ' 73' ' ' VAL . 43.6 mt -56.79 140.48 47.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.703 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -124.93 135.84 53.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.946 0.403 . . . . 0.0 111.279 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.421 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 0.0 OUTLIER -94.36 117.71 30.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.855 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.758 HG21 HD11 ' A' ' 136' ' ' ILE . 8.3 t -109.68 140.86 43.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.927 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 59.1 m -77.46 159.23 29.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.909 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.472 ' CE2' ' HB1' ' A' ' 87' ' ' ALA . 0.2 OUTLIER -164.23 156.13 16.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.887 -179.974 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.78 172.87 7.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.911 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.3 mttm -69.48 -52.38 27.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.893 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -62.04 -41.98 98.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.71 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.472 ' HB1' ' CE2' ' A' ' 83' ' ' PHE . . . -59.47 -42.87 93.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.076 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.893 ' CD2' HD11 ' A' ' 122' ' ' ILE . 0.1 OUTLIER -58.27 -34.49 70.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.917 -179.928 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 45.3 mttt -60.31 -48.11 83.14 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.052 0.453 . . . . 0.0 110.451 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.1 mtmt -76.69 -27.85 55.68 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.698 178.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.546 ' HE2' HG21 ' A' ' 146' ' ' VAL . 8.2 t80 -65.18 -47.49 76.78 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.777 179.585 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.443 ' CD1' ' CE2' ' A' ' 95' ' ' TYR . 4.7 tp -62.58 -44.2 99.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.039 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.406 ' N ' HG23 ' A' ' 92' ' ' ILE . 4.5 tttp -60.52 -40.08 90.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.139 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.492 ' HA ' ' HG2' ' A' ' 97' ' ' LYS . 26.0 t0 -75.22 -40.07 59.48 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.879 -179.257 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.465 ' CD1' ' C ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -77.95 -40.43 39.47 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 121.053 -0.259 . . . . 0.0 110.944 -179.444 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.422 ' HG2' ' O ' ' A' ' 92' ' ' ILE . 2.4 ptt? -67.64 -32.04 72.46 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.763 0.316 . . . . 0.0 110.59 179.388 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.492 ' HG2' ' HA ' ' A' ' 94' ' ' ASP . 1.6 ptmm? -70.47 -34.57 72.55 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.524 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.433 ' N ' ' HG3' ' A' ' 97' ' ' LYS . 2.3 m -61.09 -40.24 92.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.046 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.684 ' CG1' HD11 ' A' ' 8' ' ' ILE . 6.9 mt -79.78 -41.07 21.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.433 179.367 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 5.1 tttp -55.3 -53.73 52.5 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.441 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -60.56 -46.35 94.57 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.017 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 6.4 tptt -62.62 -37.1 84.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.959 0.409 . . . . 0.0 110.336 179.508 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.633 HD21 ' CB ' ' A' ' 110' ' ' ARG . 3.1 tp -70.41 -33.96 71.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.059 179.269 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.626 ' CG ' HG11 ' A' ' 111' ' ' VAL . 77.3 mt-10 -58.85 -31.63 68.7 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.634 179.418 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.414 ' HG3' ' HG3' ' A' ' 106' ' ' GLN . 2.2 pt-20 -86.58 -21.09 27.05 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.738 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.414 ' HG3' ' HG3' ' A' ' 105' ' ' GLU . 21.0 mt-30 -105.13 -62.53 1.33 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.74 0.305 . . . . 0.0 111.559 -179.64 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.441 ' N ' ' O ' ' A' ' 103' ' ' LEU . 19.6 mtt-85 -129.74 64.77 73.08 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.879 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.867 ' O ' HG22 ' A' ' 111' ' ' VAL . 9.5 Cg_endo -50.52 -22.12 8.61 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 123.192 2.595 . . . . 0.0 112.745 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -70.75 -11.88 61.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.609 0.243 . . . . 0.0 111.323 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.633 ' CB ' HD21 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -110.88 -0.26 16.92 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.342 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.867 HG22 ' O ' ' A' ' 108' ' ' PRO . 34.1 m -66.38 -36.37 77.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -179.437 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.591 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 1.1 mttp -69.01 -51.2 19.03 Favored Pre-proline 0 C--N 1.332 -0.194 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.457 -179.316 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.591 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 50.1 Cg_exo -52.45 -41.39 67.71 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.04 1.827 . . . . 0.0 111.894 179.367 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.435 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 78.2 t80 -67.28 -39.22 86.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.967 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 1.4 mmm -56.98 -51.22 70.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.971 0.415 . . . . 0.0 110.858 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 62.3 m -76.53 -44.62 34.23 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.758 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.28 -45.93 95.2 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.551 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.07 -51.5 69.44 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.008 0.432 . . . . 0.0 111.068 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.38 -28.11 67.66 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.225 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.423 ' O ' ' HG2' ' A' ' 123' ' ' LYS . 45.4 tt0 -71.73 -46.9 57.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.181 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.426 ' NE2' ' SG ' ' A' ' 28' ' ' CYS . 4.2 tt0 -72.97 -38.43 66.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.07 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.893 HD11 ' CD2' ' A' ' 88' ' ' TYR . 0.4 OUTLIER -61.54 -46.78 95.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.147 -179.853 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.462 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 3.6 pttp -62.2 -31.74 72.3 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.099 0.476 . . . . 0.0 110.142 179.451 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 -67.35 -53.3 30.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.703 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.535 HG21 HD13 ' A' ' 148' ' ' LEU . 15.5 pt -61.73 -42.28 93.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.341 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.475 ' HA ' HD23 ' A' ' 126' ' ' LEU . 11.5 mt -53.87 -36.08 62.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.912 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -72.86 -10.16 59.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.173 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -141.64 33.7 1.63 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.017 0.437 . . . . 0.0 110.462 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.5 ' CE1' ' CZ ' ' A' ' 134' ' ' PHE . 11.5 t80 -50.3 -26.41 4.78 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.237 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.2 mmtt -61.76 -27.47 68.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.769 0.319 . . . . 0.0 110.945 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 22.2 m-20 -94.27 -36.75 11.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.488 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.409 ' CG ' ' OD2' ' A' ' 150' ' ' ASP . 10.8 m-85 -98.13 138.75 34.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.918 0.39 . . . . 0.0 111.25 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -122.96 144.69 49.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.951 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.51 ' CE1' ' CZ ' ' A' ' 88' ' ' TYR . 1.3 m-85 -80.52 123.81 28.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.089 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.461 ' HB2' ' HB3' ' A' ' 147' ' ' ALA . 30.3 m-85 -125.57 151.06 46.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.713 179.505 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.758 HD11 HG21 ' A' ' 81' ' ' THR . 0.4 OUTLIER -139.38 159.54 28.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.927 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.41 -165.12 0.3 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.403 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.487 ' HB3' ' HB2' ' A' ' 77' ' ' HIS . 5.1 pt-20 -71.52 -9.84 58.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.517 0.199 . . . . 0.0 111.467 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ASN . . . . . 0.516 ' HB3' ' ND2' ' A' ' 141' ' ' ASN . 21.6 m-80 -96.2 -32.03 12.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.585 0.231 . . . . 0.0 111.594 -179.547 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' MET . . . . . 0.452 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 58.2 mtm 56.54 41.34 28.76 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.825 0.345 . . . . 0.0 111.137 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ASN . . . . . 0.516 ' ND2' ' HB3' ' A' ' 139' ' ' ASN . 1.7 m120 -67.02 120.44 71.91 Favored Pre-proline 0 N--CA 1.454 -0.252 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.713 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -61.8 -25.57 78.64 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.248 1.965 . . . . 0.0 111.903 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -84.79 -18.13 35.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.743 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -71.49 -161.74 4.8 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.249 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.417 ' HE1' ' O ' ' A' ' 163' ' ' PHE . 3.9 ptp -97.03 177.82 5.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.785 0.326 . . . . 0.0 110.864 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.546 HG21 ' HE2' ' A' ' 91' ' ' TYR . 41.8 t -122.62 148.01 26.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.119 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.461 ' HB3' ' HB2' ' A' ' 135' ' ' PHE . . . -112.07 115.27 28.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.845 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.535 HD13 HG21 ' A' ' 125' ' ' ILE . 4.0 mt -89.56 105.9 18.1 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.814 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.513 HD12 ' HG2' ' A' ' 160' ' ' MET . 1.1 tp -94.55 119.08 32.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.356 -179.428 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.545 ' HB3' ' CE1' ' A' ' 159' ' ' TYR . 0.5 OUTLIER -134.97 170.16 16.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.561 179.367 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -105.74 150.36 25.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.909 0.385 . . . . 0.0 111.151 -179.449 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -78.09 -172.62 2.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.814 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -57.54 -41.13 80.32 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.942 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 44.4 p-10 -69.11 -15.07 63.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.238 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 65.3 19.04 65.97 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.589 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 80.4 t -113.44 -65.36 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.904 0.383 . . . . 0.0 111.044 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 98.3 m -64.98 111.87 6.84 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.14 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -82.06 131.61 6.96 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.63 2.22 . . . . 0.0 111.903 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.545 ' CE1' ' HB3' ' A' ' 150' ' ' ASP . 6.7 p90 -125.11 139.14 54.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.96 0.41 . . . . 0.0 111.142 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' MET . . . . . 0.66 ' SD ' HD13 ' A' ' 78' ' ' LEU . 41.6 mtp -109.89 140.93 43.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.981 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.622 HG23 HD11 ' A' ' 23' ' ' ILE . 72.3 mt -97.07 116.92 40.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.337 -179.685 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -117.33 151.01 37.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.57 179.606 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.417 ' O ' ' HE1' ' A' ' 145' ' ' MET . 5.5 m-85 -100.47 124.89 46.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.955 0.407 . . . . 0.0 111.01 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.633 ' HB2' HD11 ' A' ' 29' ' ' LEU . 27.2 tttm -70.02 -45.55 66.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.275 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.435 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 15.8 m-20 -49.28 -35.6 18.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.24 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.44 ' HA2' HG23 ' A' ' 99' ' ' ILE . . . -109.26 30.71 8.3 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.509 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.502 HD21 ' HD2' ' A' ' 4' ' ' TYR . 1.5 tt -150.06 146.88 27.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.896 0.379 . . . . 0.0 110.918 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -132.06 154.09 49.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.331 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' MET . . . . . 0.493 ' HA ' ' O ' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -139.96 160.27 40.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.829 0.347 . . . . 0.0 111.32 -179.843 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 . . . . . 0 C--O 1.231 0.127 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.355 -179.259 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.653 HD11 ' HB3' ' A' ' 169' ' ' MET . 1.5 tt . . . . . 0 CA--C 1.528 0.109 0 CA-C-O 120.719 0.295 . . . . 0.0 110.974 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 11.4 mm -100.11 154.18 4.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.433 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.633 ' HE1' HG23 ' A' ' 2' ' ' ILE . 3.5 m-85 -123.85 111.08 15.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.436 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.22 146.65 50.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.919 0.39 . . . . 0.0 111.215 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.496 ' OD1' HD12 ' A' ' 8' ' ' ILE . 46.1 t0 -54.67 152.16 7.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.897 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.549 HD23 HG23 ' A' ' 99' ' ' ILE . 56.2 tp -80.88 -20.36 42.43 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.484 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.592 HD11 ' CG1' ' A' ' 99' ' ' ILE . 4.1 mp -91.35 -48.28 13.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.463 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -93.79 -21.97 18.97 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 -179.157 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.454 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 3.5 m-70 63.52 31.38 14.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.884 0.373 . . . . 0.0 110.8 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -102.66 121.76 43.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.804 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -57.24 98.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.303 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.8 mtt -78.18 -18.07 55.99 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.733 179.443 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.643 ' CD2' HG21 ' A' ' 31' ' ' VAL . 5.7 p90 -177.37 177.42 1.19 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.778 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -133.84 -171.94 2.86 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.659 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -95.0 27.13 3.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.966 0.413 . . . . 0.0 110.876 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.418 HG13 ' CD2' ' A' ' 18' ' ' TYR . 45.6 pt -86.63 -13.83 10.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.479 179.263 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.914 ' CZ ' HG22 ' A' ' 72' ' ' ILE . 79.8 m-85 -106.16 -170.34 1.71 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.537 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.39 88.56 4.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.721 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.3 mp -87.97 130.65 37.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.16 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.9 mtt180 -121.73 119.12 30.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.888 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -71.4 116.07 11.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.924 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.538 HD11 HG23 ' A' ' 161' ' ' ILE . 3.6 pt -109.62 172.46 2.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.022 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.462 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . . . 58.32 28.1 16.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.194 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 65.11 54.39 1.23 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.451 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.44 -3.51 72.84 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.553 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.462 ' HB3' ' HB3' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -67.48 -56.89 7.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 117.111 0.456 . . . . 0.0 110.815 179.993 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 46.9 m -120.08 168.72 10.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.747 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.523 HD21 ' HD2' ' A' ' 164' ' ' LYS . 0.5 OUTLIER -132.22 133.43 44.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.853 -179.849 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -98.42 112.84 24.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.963 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.643 HG21 ' CD2' ' A' ' 14' ' ' PHE . 22.8 t -93.63 111.98 25.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.744 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -86.87 124.7 33.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.145 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.59 -135.93 8.38 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.358 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.7 pttm -174.51 124.62 0.3 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.855 0.36 . . . . 0.0 110.881 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 62.9 mtm -69.74 121.83 17.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.75 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.1 m . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.342 -179.784 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.419 0 N-CA-C 112.31 -0.316 . . . . 0.0 112.31 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.451 HG12 HG12 ' A' ' 72' ' ' ILE . 60.1 t -68.37 141.34 17.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.875 0.369 . . . . 0.0 110.852 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -67.56 -58.77 4.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.48 -179.463 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.914 HG22 ' CZ ' ' A' ' 18' ' ' TYR . 8.9 pt -53.72 -33.84 23.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.531 -179.594 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.78 HG13 ' HB2' ' A' ' 78' ' ' LEU . 58.7 t -72.26 -33.92 47.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.054 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.5 mtm -78.13 -38.89 42.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.598 -179.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.4 HD21 ' HA ' ' A' ' 72' ' ' ILE . 19.1 p30 -82.07 -28.89 32.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.565 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.423 ' CE1' ' HB ' ' A' ' 72' ' ' ILE . 26.7 m170 -93.43 -1.12 56.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.841 0.353 . . . . 0.0 110.952 179.531 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 57.87 30.52 19.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.07 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.78 ' HB2' HG13 ' A' ' 73' ' ' VAL . 56.9 mt -57.83 134.88 56.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.535 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -118.48 134.36 55.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.941 0.4 . . . . 0.0 111.161 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.426 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 16.0 tt0 -87.63 129.81 34.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.934 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.871 HG21 HD11 ' A' ' 136' ' ' ILE . 3.1 t -122.81 126.31 47.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.829 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.4 m -68.06 159.02 31.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.999 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -165.42 149.72 8.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.799 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.54 158.18 17.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.798 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.47 -52.5 65.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.896 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -62.35 -44.33 96.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.738 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.64 -37.9 76.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.938 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.843 ' CD2' HD11 ' A' ' 122' ' ' ILE . 2.0 t80 -59.92 -38.64 82.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.736 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.444 ' O ' HG22 ' A' ' 92' ' ' ILE . 32.6 mttt -57.46 -49.47 76.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.172 0.51 . . . . 0.0 110.483 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.2 mtmt -72.42 -27.82 62.58 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.829 178.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.476 ' HE2' HG21 ' A' ' 146' ' ' VAL . 5.0 t80 -66.84 -46.16 75.97 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.957 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.444 HG22 ' O ' ' A' ' 89' ' ' LYS . 2.9 tp -60.45 -40.79 85.29 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.172 0 CA-C-O 120.766 0.317 . . . . 0.0 110.866 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.435 ' O ' ' CG ' ' A' ' 97' ' ' LYS . 0.9 OUTLIER -61.31 -46.33 90.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.733 179.935 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -71.2 -38.96 72.04 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.846 -179.448 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.544 ' CD1' ' C ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -74.5 -41.64 60.33 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.739 -0.21 . . . . 0.0 110.792 -179.542 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 19.7 ptt? -64.86 -32.06 73.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.825 0.345 . . . . 0.0 110.248 179.271 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.435 ' CG ' ' O ' ' A' ' 93' ' ' LYS . 5.4 mmtp -64.4 -42.91 95.83 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.853 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.7 m -56.96 -43.32 81.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.82 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.592 ' CG1' HD11 ' A' ' 8' ' ' ILE . 6.3 mt -79.72 -40.92 21.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.587 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.83 -51.87 65.98 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.706 179.631 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -64.33 -45.39 93.55 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.014 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.88 -42.06 92.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.927 0.394 . . . . 0.0 110.447 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.528 ' HB3' HG12 ' A' ' 111' ' ' VAL . 4.1 tp -65.55 -36.49 83.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.181 179.4 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.613 ' CG ' HG11 ' A' ' 111' ' ' VAL . 76.9 mt-10 -58.43 -28.55 65.37 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.772 179.358 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -88.73 -19.23 26.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.73 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -110.39 -60.99 1.73 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.77 0.319 . . . . 0.0 111.673 -179.505 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 103' ' ' LEU . 1.1 mtt85 -125.59 63.17 44.35 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.93 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.86 ' O ' HG22 ' A' ' 111' ' ' VAL . 10.1 Cg_endo -50.77 -22.22 9.44 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 123.064 2.51 . . . . 0.0 112.798 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -73.44 -15.23 61.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.749 0.309 . . . . 0.0 111.253 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.543 ' C ' ' HD2' ' A' ' 113' ' ' PRO . 2.5 mmm180 -106.34 0.73 25.24 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.774 -179.36 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.86 HG22 ' O ' ' A' ' 108' ' ' PRO . 32.8 m -68.17 -36.66 76.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.591 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 28.4 mttt -66.79 -51.25 40.17 Favored Pre-proline 0 CA--C 1.53 0.186 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.233 -179.286 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.591 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 51.8 Cg_exo -53.31 -41.48 72.35 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.062 1.841 . . . . 0.0 111.821 179.304 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.461 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 88.2 t80 -68.35 -37.86 80.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.964 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' MET . . . . . 0.435 ' HE3' ' HA ' ' A' ' 115' ' ' MET . 0.6 OUTLIER -53.94 -49.81 67.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.004 -179.942 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.8 m -76.61 -44.29 34.89 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.825 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.4 ' O ' ' HG2' ' A' ' 120' ' ' GLU . . . -59.09 -44.12 96.54 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.691 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.53 -45.95 92.0 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.026 0.441 . . . . 0.0 110.718 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.76 -32.6 65.76 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.67 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.4 ' HG2' ' O ' ' A' ' 117' ' ' GLY . 6.7 pt-20 -78.28 -43.07 29.09 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.731 0.3 . . . . 0.0 111.242 -179.59 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 51.9 tp60 -66.26 -39.5 89.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.138 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.843 HD11 ' CD2' ' A' ' 88' ' ' TYR . 0.3 OUTLIER -63.11 -45.0 99.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.053 -179.929 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.443 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 27.0 mttt -59.51 -31.12 69.07 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.215 179.387 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 -68.21 -54.12 20.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.622 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.814 HG21 HD13 ' A' ' 148' ' ' LEU . 8.7 pt -61.78 -38.51 80.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.118 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.434 ' HG ' ' CD1' ' A' ' 122' ' ' ILE . 12.4 mt -53.6 -40.3 65.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.553 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.02 -19.13 60.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.766 179.167 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -128.91 28.94 5.28 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.392 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -48.9 -42.28 36.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.273 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 8.4 ttpp -68.67 -15.4 63.51 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.367 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -94.05 -38.54 11.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.382 -179.683 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.47 ' CD2' HG22 ' A' ' 125' ' ' ILE . 1.7 m-30 -97.77 153.79 18.04 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.971 0.415 . . . . 0.0 111.365 -179.386 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.447 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 9.5 mm-40 -123.35 155.32 37.54 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.538 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.446 ' CE1' ' CE1' ' A' ' 88' ' ' TYR . 3.4 m-85 -93.24 133.86 36.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.876 0.369 . . . . 0.0 111.124 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.426 ' CE2' ' HB2' ' A' ' 80' ' ' GLU . 36.4 m-85 -134.25 151.29 51.21 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.491 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.871 HD11 HG21 ' A' ' 81' ' ' THR . 0.5 OUTLIER -134.61 161.44 40.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.965 179.897 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -62.19 -164.38 0.37 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.169 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -73.38 -8.93 57.95 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.552 0.215 . . . . 0.0 111.433 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -97.96 -28.7 13.69 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.668 -179.438 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' MET . . . . . 0.436 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 45.7 mtp 55.72 42.39 29.31 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.897 0.379 . . . . 0.0 111.02 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ASN . . . . . 0.432 ' ND2' ' HA3' ' A' ' 144' ' ' GLY . 16.5 p-10 -65.03 114.78 16.34 Favored Pre-proline 0 N--CA 1.452 -0.373 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.993 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -62.19 -29.29 80.37 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.496 2.13 . . . . 0.0 112.142 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -84.64 -7.66 59.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.127 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.432 ' HA3' ' ND2' ' A' ' 141' ' ' ASN . . . -86.41 -167.67 43.9 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.436 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 1.6 ptp -84.99 -174.41 5.26 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.949 0.404 . . . . 0.0 110.794 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.476 HG21 ' HE2' ' A' ' 91' ' ' TYR . 75.6 t -130.27 155.65 41.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.067 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.573 ' HB2' ' CE1' ' A' ' 162' ' ' PHE . . . -116.56 110.84 19.08 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.473 179.488 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.814 HD13 HG21 ' A' ' 125' ' ' ILE . 5.0 mt -86.46 106.01 17.18 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.236 -179.174 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.537 ' HB2' ' HE2' ' A' ' 160' ' ' MET . 2.0 tp -89.69 119.77 30.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.928 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.549 ' HB2' ' CZ ' ' A' ' 159' ' ' TYR . 57.6 m-20 -131.91 161.67 32.48 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.68 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -105.3 146.6 29.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.119 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 8.7 mmt180 -59.68 -176.2 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.907 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -56.36 -41.31 75.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.951 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.488 ' OD1' HG23 ' A' ' 156' ' ' VAL . 11.1 t70 -72.61 -15.13 61.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.164 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 77.83 21.59 71.15 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.626 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.488 HG23 ' OD1' ' A' ' 154' ' ' ASP . 87.5 t -113.41 -73.01 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.772 0.32 . . . . 0.0 110.924 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 98.9 m -53.02 103.23 0.35 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.13 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -77.11 127.88 9.51 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.724 2.283 . . . . 0.0 112.069 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.549 ' CZ ' ' HB2' ' A' ' 150' ' ' ASP . 10.5 p90 -126.54 133.26 51.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.956 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' MET . . . . . 0.568 ' CE ' HD13 ' A' ' 78' ' ' LEU . 0.5 OUTLIER -103.46 140.03 38.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.055 -179.659 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.538 HG23 HD11 ' A' ' 23' ' ' ILE . 90.4 mt -95.59 113.81 30.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.888 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.573 ' CE1' ' HB2' ' A' ' 147' ' ' ALA . 47.9 m-85 -117.45 133.89 55.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.889 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -79.33 128.96 33.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.977 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.523 ' HD2' HD21 ' A' ' 29' ' ' LEU . 12.4 tttm -70.12 -52.83 20.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.101 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.461 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 19.3 m-20 -49.3 -37.83 25.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.155 -179.763 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -96.56 28.73 12.13 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.341 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.445 HD21 ' HB3' ' A' ' 4' ' ' TYR . 0.5 OUTLIER -146.74 145.88 30.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.75 0.309 . . . . 0.0 110.843 -179.91 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -109.84 152.61 25.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.854 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' MET . . . . . 0.653 ' HB3' HD11 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -124.28 138.66 54.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.935 179.982 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.962 179.94 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.732 HD11 ' HB3' ' A' ' 169' ' ' MET . 2.1 tt . . . . . 0 N--CA 1.456 -0.136 0 CA-C-O 120.81 0.338 . . . . 0.0 111.14 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.445 HG21 ' HB3' ' A' ' 12' ' ' GLU . 19.3 mm -107.56 155.01 8.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.089 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.571 ' HE1' HG23 ' A' ' 2' ' ' ILE . 3.4 m-85 -122.2 104.47 9.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.606 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -119.19 152.19 37.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.343 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.447 ' O ' ' HA ' ' A' ' 10' ' ' HIS . 38.9 t0 -58.11 152.2 17.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.802 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.472 HD23 HG23 ' A' ' 99' ' ' ILE . 56.6 tp -81.38 -23.89 37.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.306 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.765 HD11 ' CG1' ' A' ' 99' ' ' ILE . 3.8 mp -91.18 -45.07 14.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.631 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.3 t -93.76 -25.34 17.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.781 -179.029 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.447 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 38.5 m80 66.47 28.84 9.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.883 0.373 . . . . 0.0 110.832 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -102.48 123.57 46.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.749 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.445 ' HB3' HG21 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -57.12 99.8 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.259 -179.746 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 33.3 mtp -80.91 -16.53 53.33 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.795 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.5 ' CE2' ' CD2' ' A' ' 4' ' ' TYR . 12.3 p90 -178.22 175.57 1.2 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.698 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -134.05 -169.85 2.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.071 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.7 p-10 -89.96 19.74 4.68 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.549 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 46.2 pt -86.15 -6.93 10.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.817 0.342 . . . . 0.0 111.266 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.861 ' CZ ' HG22 ' A' ' 72' ' ' ILE . 71.1 m-85 -116.5 168.87 9.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.748 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.403 ' HB2' ' HB2' ' A' ' 32' ' ' GLU . 2.6 mmpt? -79.71 93.34 5.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.681 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.726 HD12 ' O ' ' A' ' 18' ' ' TYR . 4.4 mp -87.78 125.66 41.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.066 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -116.97 132.14 56.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.981 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.452 ' HG3' HD23 ' A' ' 29' ' ' LEU . 5.7 mt-10 -81.52 116.11 21.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.775 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 7.7 pt -116.45 167.08 9.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.018 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 58.44 34.54 24.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.068 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 64.45 38.62 7.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.214 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.67 -10.49 74.55 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.667 -0.777 . . . . 0.0 113.182 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.417 HD21 ' HA ' ' A' ' 114' ' ' PHE . 0.1 OUTLIER -56.18 -37.64 69.86 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.901 0.35 . . . . 0.0 111.143 -179.879 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 72.0 m -136.98 169.74 17.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.139 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.496 HD21 ' HD2' ' A' ' 164' ' ' LYS . 0.3 OUTLIER -131.99 119.08 20.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.897 -179.74 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -83.09 112.94 20.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.107 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.4 HG23 ' HD2' ' A' ' 162' ' ' PHE . 30.6 t -94.74 111.92 26.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.615 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.403 ' HB2' ' HB2' ' A' ' 19' ' ' LYS . 2.0 mt-10 -82.54 118.48 23.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.205 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.4 -139.21 9.67 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.267 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.6 pttm -174.36 129.97 0.36 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.772 0.32 . . . . 0.0 110.958 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.409 ' HE2' ' O ' ' A' ' 156' ' ' VAL . 17.4 mtm -76.73 125.0 28.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.896 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.452 HG23 ' CE ' ' A' ' 74' ' ' MET . 5.0 m . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.216 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.371 0 N-CA-C 112.229 -0.348 . . . . 0.0 112.229 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.44 HG22 ' HG3' ' A' ' 158' ' ' PRO . 59.8 t -69.73 148.28 11.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.911 0.386 . . . . 0.0 110.931 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -72.48 -57.56 4.08 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.338 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.861 HG22 ' CZ ' ' A' ' 18' ' ' TYR . 10.8 pt -53.53 -34.01 22.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.421 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.792 HG13 ' HB2' ' A' ' 78' ' ' LEU . 57.9 t -71.24 -31.88 45.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.882 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.452 ' CE ' HG23 ' A' ' 36' ' ' VAL . 2.3 mtm -78.01 -40.47 38.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.417 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.406 ' OD1' ' CD2' ' A' ' 76' ' ' HIS . 13.5 p30 -82.12 -28.77 32.06 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.51 -179.539 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.431 ' CE1' ' HB ' ' A' ' 72' ' ' ILE . 26.9 m170 -93.55 -0.28 56.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.753 0.311 . . . . 0.0 110.88 179.47 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.415 ' HB2' ' HB3' ' A' ' 138' ' ' GLU . 13.0 m80 55.89 29.62 14.47 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.09 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.792 ' HB2' HG13 ' A' ' 73' ' ' VAL . 52.3 mt -57.09 139.84 51.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.652 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -124.44 137.38 54.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.126 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -91.59 131.86 36.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.037 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.525 HG21 HD11 ' A' ' 136' ' ' ILE . 6.2 t -118.5 170.1 9.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.872 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.3 m -107.39 165.19 11.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.955 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.493 ' CE2' ' CE2' ' A' ' 91' ' ' TYR . 2.7 m-85 -171.68 149.84 2.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.95 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.3 m -101.48 166.34 10.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.767 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.7 mtmp? -57.34 -49.86 74.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.873 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.65 -40.25 76.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.831 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.95 -43.73 94.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.101 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.851 ' CD2' HD11 ' A' ' 122' ' ' ILE . 0.6 OUTLIER -61.48 -30.74 70.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.757 179.921 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 27.7 mttm -62.98 -44.66 95.43 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.012 0.434 . . . . 0.0 110.566 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 11.3 mttm -78.56 -27.9 45.89 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.771 178.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.567 ' HE2' HG21 ' A' ' 146' ' ' VAL . 17.2 t80 -67.03 -47.32 71.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.073 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.778 HG22 ' O ' ' A' ' 88' ' ' TYR . 2.3 tp -65.06 -40.21 88.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.074 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.444 ' O ' ' CG ' ' A' ' 97' ' ' LYS . 4.9 ttpp -62.73 -45.28 93.47 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.923 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -68.76 -39.34 80.32 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.861 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.534 ' CD1' ' C ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -76.03 -43.78 42.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.712 -0.222 . . . . 0.0 110.875 -179.299 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 3.2 ptt? -62.06 -31.99 72.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.914 0.388 . . . . 0.0 110.238 179.186 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.444 ' CG ' ' O ' ' A' ' 93' ' ' LYS . 3.8 mmtt -66.46 -42.11 88.04 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.717 179.657 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.4 m -57.22 -41.72 80.0 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.657 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.765 ' CG1' HD11 ' A' ' 8' ' ' ILE . 6.6 mt -79.78 -42.26 22.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.685 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.8 tttt -53.64 -54.5 36.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.55 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -62.12 -46.4 94.07 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.126 179.404 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 26.0 tptt -61.08 -37.01 81.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.945 0.402 . . . . 0.0 110.406 179.618 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.527 HD21 ' CB ' ' A' ' 110' ' ' ARG . 6.6 tp -70.82 -32.94 70.17 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.051 179.298 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.605 ' CG ' HG11 ' A' ' 111' ' ' VAL . 84.0 mt-10 -60.97 -29.13 69.48 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.806 179.628 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -89.97 -19.58 24.32 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.423 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -106.84 -62.68 1.37 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.881 0.372 . . . . 0.0 111.472 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.428 ' N ' ' O ' ' A' ' 103' ' ' LEU . 9.7 mtt-85 -124.91 62.72 37.07 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.902 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.864 ' O ' HG22 ' A' ' 111' ' ' VAL . 10.3 Cg_endo -50.82 -24.53 13.63 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 123.091 2.528 . . . . 0.0 112.537 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -73.05 -9.46 58.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.247 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.527 ' CB ' HD21 ' A' ' 103' ' ' LEU . 58.2 mmt-85 -110.84 0.11 17.11 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.665 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.864 HG22 ' O ' ' A' ' 108' ' ' PRO . 26.5 m -71.42 -33.8 51.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.407 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.545 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 4.9 mttm -67.69 -50.4 35.22 Favored Pre-proline 0 CA--C 1.53 0.197 0 C-N-CA 120.997 -0.281 . . . . 0.0 111.681 -179.12 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.545 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 24.7 Cg_exo -63.16 -29.28 73.99 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.148 1.899 . . . . 0.0 111.67 179.478 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.481 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 89.3 t80 -72.12 -42.4 66.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.861 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 2.7 mmm -58.07 -43.83 87.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.874 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 66.2 m -76.69 -45.15 30.68 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.905 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.15 -45.83 92.69 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.775 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.402 ' O ' ' HB ' ' A' ' 122' ' ' ILE . . . -57.19 -51.76 68.02 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.045 0.45 . . . . 0.0 111.269 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.85 -28.06 63.3 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.502 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.401 ' O ' ' HG2' ' A' ' 123' ' ' LYS . 5.8 tt0 -74.13 -50.0 21.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.772 0.32 . . . . 0.0 111.474 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -67.62 -39.2 84.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.512 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.851 HD11 ' CD2' ' A' ' 88' ' ' TYR . 0.3 OUTLIER -59.5 -49.82 82.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.654 -179.458 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.481 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 9.5 ptpt -60.18 -30.64 69.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.059 0.457 . . . . 0.0 110.276 179.643 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 -68.91 -53.26 21.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.755 179.518 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.503 HG21 HD13 ' A' ' 148' ' ' LEU . 16.7 pt -62.31 -42.33 95.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.309 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.498 HD21 ' CD2' ' A' ' 88' ' ' TYR . 11.3 mt -53.76 -37.18 63.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.946 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -72.89 -9.8 59.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.215 179.677 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 -142.24 34.44 1.51 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.983 0.42 . . . . 0.0 110.477 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.507 ' CE1' ' CZ ' ' A' ' 134' ' ' PHE . 5.4 t80 -51.95 -24.71 6.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.113 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -55.92 -37.91 69.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.979 0.418 . . . . 0.0 111.0 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 27.0 m-20 -86.25 -42.75 13.51 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.685 -179.509 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.443 ' HE2' HD11 ' A' ' 161' ' ' ILE . 14.1 m-85 -92.72 129.31 38.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.881 0.372 . . . . 0.0 111.394 -179.552 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.424 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 5.0 mm-40 -114.84 145.13 42.49 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.911 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.507 ' CE1' ' CZ ' ' A' ' 88' ' ' TYR . 1.7 m-85 -79.95 127.52 32.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.174 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.422 ' CE1' ' HB3' ' A' ' 149' ' ' LEU . 48.0 m-85 -132.3 134.18 44.94 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.586 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.525 HD11 HG21 ' A' ' 81' ' ' THR . 0.7 OUTLIER -120.94 161.86 20.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.939 -179.811 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.47 -165.12 0.14 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.266 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.415 ' HB3' ' HB2' ' A' ' 77' ' ' HIS . 4.1 pt-20 -72.35 -9.18 58.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.566 0.222 . . . . 0.0 111.489 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ASN . . . . . 0.511 ' HB3' ' ND2' ' A' ' 141' ' ' ASN . 25.5 m-80 -97.59 -33.9 11.17 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 120.652 0.263 . . . . 0.0 111.518 -179.453 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' MET . . . . . 0.468 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 34.9 mtm 60.47 34.96 20.4 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.683 0.278 . . . . 0.0 111.335 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ASN . . . . . 0.511 ' ND2' ' HB3' ' A' ' 139' ' ' ASN . 10.2 m120 -64.4 123.6 83.26 Favored Pre-proline 0 N--CA 1.451 -0.392 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.732 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -61.95 -23.35 75.77 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.321 2.014 . . . . 0.0 111.822 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -84.45 -12.14 54.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.734 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -80.96 -175.54 49.96 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.258 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 1.4 ptp -85.37 -177.98 6.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.783 0.325 . . . . 0.0 110.891 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.567 HG21 ' HE2' ' A' ' 91' ' ' TYR . 43.6 t -125.88 149.04 30.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.96 0.41 . . . . 0.0 111.165 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.424 ' HB1' ' SD ' ' A' ' 160' ' ' MET . . . -113.55 112.52 23.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.649 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.532 ' HB2' ' HB ' ' A' ' 161' ' ' ILE . 4.7 mt -85.86 106.27 16.95 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.03 -179.361 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.573 HD12 ' HG2' ' A' ' 160' ' ' MET . 3.3 tp -90.75 119.19 30.77 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.381 -179.293 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.49 ' HB3' ' CE1' ' A' ' 159' ' ' TYR . 13.4 t70 -132.57 164.29 26.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.482 179.318 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -97.49 146.7 24.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.955 0.407 . . . . 0.0 111.226 -179.436 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.09 -176.36 0.88 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.882 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -58.96 -41.31 87.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.923 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -67.18 -15.1 63.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.132 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 75.03 11.07 84.17 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.68 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.409 ' O ' ' HE2' ' A' ' 35' ' ' MET . 73.6 t -111.89 -70.15 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.846 0.355 . . . . 0.0 110.872 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 90.5 m -55.6 108.54 1.21 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.163 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.44 ' HG3' HG22 ' A' ' 70' ' ' VAL . 88.4 Cg_endo -82.65 132.19 6.57 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.579 2.186 . . . . 0.0 112.074 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.49 ' CE1' ' HB3' ' A' ' 150' ' ' ASP . 8.1 p90 -125.28 149.15 48.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.89 0.376 . . . . 0.0 110.983 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' MET . . . . . 0.79 ' CE ' HD13 ' A' ' 78' ' ' LEU . 0.6 OUTLIER -114.52 150.76 34.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.162 -179.75 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.532 ' HB ' ' HB2' ' A' ' 148' ' ' LEU . 88.5 mt -103.44 111.95 35.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.871 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.4 ' HD2' HG23 ' A' ' 31' ' ' VAL . 90.3 m-85 -114.53 125.84 54.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.907 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.407 ' CE2' ' OH ' ' A' ' 95' ' ' TYR . 2.6 m-85 -71.06 124.68 24.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.744 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.496 ' HD2' HD21 ' A' ' 29' ' ' LEU . 6.3 tttm -66.39 -56.44 11.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.31 -179.61 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.481 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 0.8 OUTLIER -51.06 -34.4 29.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.238 -179.797 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.409 ' HA2' ' CG2' ' A' ' 99' ' ' ILE . . . -95.73 25.28 25.73 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.47 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.438 HD21 ' HB3' ' A' ' 4' ' ' TYR . 0.6 OUTLIER -137.74 146.99 44.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.867 0.365 . . . . 0.0 110.928 -179.91 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -119.38 136.85 54.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.79 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' MET . . . . . 0.732 ' HB3' HD11 ' A' ' 2' ' ' ILE . 1.6 mpp? -103.98 154.55 19.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.015 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.799 -179.963 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.82 HD11 ' HB3' ' A' ' 169' ' ' MET . 10.0 tt . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.854 0.359 . . . . 0.0 111.159 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.453 HG21 ' HB3' ' A' ' 12' ' ' GLU . 19.4 mm -92.88 157.31 2.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.23 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.624 ' HB3' HD21 ' A' ' 167' ' ' LEU . 3.0 m-85 -124.54 106.7 10.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.489 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 25.0 ptt180 -121.84 148.28 44.89 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.817 0.341 . . . . 0.0 111.333 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.441 ' O ' ' HA ' ' A' ' 10' ' ' HIS . 23.3 t0 -56.57 152.21 12.27 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.808 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 61.5 tp -80.3 -24.17 40.16 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.373 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.797 HD11 ' CG1' ' A' ' 99' ' ' ILE . 4.7 mp -91.3 -44.49 14.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.823 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.6 p -93.1 -23.77 18.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.77 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.441 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 5.6 m170 63.44 28.07 15.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.809 0.337 . . . . 0.0 110.817 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -102.73 121.39 42.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.734 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.453 ' HB3' HG21 ' A' ' 3' ' ' ILE . 1.0 OUTLIER -58.52 89.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.204 -179.81 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 6.4 mtt -69.32 -16.07 63.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.881 179.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.498 ' CE2' ' CD2' ' A' ' 4' ' ' TYR . 34.1 p90 -176.87 171.48 2.18 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.93 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.8 m -134.54 -169.94 2.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.005 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -87.24 12.3 12.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.525 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 46.2 pt -81.3 -3.26 6.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.884 0.373 . . . . 0.0 111.062 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.843 ' CZ ' HG22 ' A' ' 72' ' ' ILE . 65.2 m-85 -119.89 179.87 4.12 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.705 -179.679 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.403 ' HB2' ' HB2' ' A' ' 32' ' ' GLU . 0.1 OUTLIER -90.14 88.94 7.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.916 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.566 HD12 ' O ' ' A' ' 18' ' ' TYR . 4.4 mp -88.03 123.89 40.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.994 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.79 133.52 55.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.914 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -78.35 121.15 24.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.826 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.477 HD11 HG23 ' A' ' 161' ' ' ILE . 3.8 pt -116.44 174.59 3.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.205 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 57.06 24.82 10.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.393 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 65.72 57.55 0.84 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.37 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 73.56 18.95 79.62 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.756 -0.735 . . . . 0.0 113.354 179.464 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.522 HD21 ' O ' ' A' ' 113' ' ' PRO . 0.2 OUTLIER -92.53 -45.67 8.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.914 0.357 . . . . 0.0 110.948 179.853 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 17.0 m -130.67 171.62 12.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.054 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.75 HD11 ' HB3' ' A' ' 164' ' ' LYS . 0.5 OUTLIER -129.48 131.08 46.59 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.941 -179.926 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -97.25 112.77 24.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.798 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.6 t -92.0 111.78 24.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.726 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.403 ' HB2' ' HB2' ' A' ' 19' ' ' LYS . 8.6 mt-10 -84.19 117.57 23.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.12 -179.725 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -99.82 -138.37 10.26 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.319 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -174.48 124.82 0.3 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.804 0.335 . . . . 0.0 111.013 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 55.8 mtp -68.61 122.0 17.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.656 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.409 HG23 ' CE ' ' A' ' 74' ' ' MET . 17.3 m . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.292 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 112.143 -0.383 . . . . 0.0 112.143 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.447 HG12 HG12 ' A' ' 72' ' ' ILE . 47.8 t -74.22 142.66 14.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.851 0.357 . . . . 0.0 110.937 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -69.74 -57.53 5.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.399 -179.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.843 HG22 ' CZ ' ' A' ' 18' ' ' TYR . 9.1 pt -53.72 -33.92 23.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.576 -179.552 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.755 HG13 ' HB2' ' A' ' 78' ' ' LEU . 71.6 t -72.02 -33.75 48.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.838 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.409 ' CE ' HG23 ' A' ' 36' ' ' VAL . 3.8 mtm -78.4 -39.87 37.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.714 -179.576 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.41 ' OD1' ' CD2' ' A' ' 76' ' ' HIS . 18.8 p30 -82.07 -29.13 32.0 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 -179.238 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.432 ' CE1' ' HB ' ' A' ' 72' ' ' ILE . 26.3 m170 -92.98 0.25 57.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.753 0.311 . . . . 0.0 110.858 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 55.09 32.79 19.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.913 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.755 ' HB2' HG13 ' A' ' 73' ' ' VAL . 52.4 mt -55.92 141.58 38.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.744 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -119.81 131.25 55.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.035 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.427 ' HG3' ' CE1' ' A' ' 135' ' ' PHE . 6.5 tt0 -95.0 127.26 40.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.93 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.709 HG21 HD11 ' A' ' 136' ' ' ILE . 1.8 t -120.03 165.12 15.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.751 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.0 p -97.03 159.65 14.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.841 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.468 ' HB2' ' CE2' ' A' ' 134' ' ' PHE . 1.6 m-85 -165.6 149.62 8.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.981 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.5 m -101.43 162.94 12.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.867 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 12.7 mttm -58.32 -52.46 65.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.065 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -63.71 -44.13 94.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.82 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.58 -42.22 98.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.02 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.92 ' CD2' HD11 ' A' ' 122' ' ' ILE . 0.7 OUTLIER -61.02 -33.84 73.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.841 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 12.8 mttp -61.19 -43.55 98.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.906 0.384 . . . . 0.0 110.554 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.1 mttp -78.11 -27.82 48.46 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.843 179.079 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.556 ' HE2' HG21 ' A' ' 146' ' ' VAL . 7.2 t80 -67.68 -42.27 82.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.878 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.729 HD12 ' CE2' ' A' ' 95' ' ' TYR . 5.0 tp -65.73 -44.24 93.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.898 0.38 . . . . 0.0 110.972 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.472 ' O ' ' CG ' ' A' ' 97' ' ' LYS . 2.0 ttpt -61.26 -45.35 94.88 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.782 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -68.75 -40.37 79.85 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.177 -179.425 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.729 ' CE2' HD12 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -77.69 -44.08 29.1 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.994 -179.272 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.403 ' HG3' ' N ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -60.17 -31.59 70.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.914 0.388 . . . . 0.0 110.195 179.165 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.472 ' CG ' ' O ' ' A' ' 93' ' ' LYS . 1.6 mmpt? -66.84 -45.14 79.14 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.445 179.457 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -54.92 -40.65 70.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.813 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.797 ' CG1' HD11 ' A' ' 8' ' ' ILE . 11.8 mt -79.95 -42.5 22.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.532 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.63 -52.05 65.14 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.442 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -63.19 -46.86 92.18 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.363 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.97 -44.41 94.48 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.877 0.37 . . . . 0.0 110.456 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.812 HD21 ' CB ' ' A' ' 110' ' ' ARG . 3.8 tp -63.26 -37.6 87.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.285 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.773 ' HG3' HG11 ' A' ' 111' ' ' VAL . 36.8 mt-10 -57.28 -29.5 63.92 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 120.818 0.342 . . . . 0.0 110.814 179.357 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -86.54 -19.29 29.68 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.617 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -109.52 -60.72 1.74 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.803 0.335 . . . . 0.0 111.774 -179.481 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.435 ' N ' ' O ' ' A' ' 103' ' ' LEU . 1.7 mtt180 -132.54 66.52 76.98 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.833 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.915 ' O ' HG22 ' A' ' 111' ' ' VAL . 10.3 Cg_endo -50.56 -21.02 7.04 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 123.257 2.638 . . . . 0.0 112.879 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -69.76 -7.92 43.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.411 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.812 ' CB ' HD21 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -113.35 -2.6 13.95 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -179.517 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.915 HG22 ' O ' ' A' ' 108' ' ' PRO . 33.1 m -73.13 -30.72 32.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.557 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 2.9 mtpt -69.46 -49.74 21.58 Favored Pre-proline 0 CA--C 1.53 0.197 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.711 -179.104 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.557 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 24.7 Cg_exo -63.13 -34.76 67.98 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.118 1.879 . . . . 0.0 111.987 179.647 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.453 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 69.6 t80 -72.21 -36.4 69.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.949 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.6 -54.88 41.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.983 0.42 . . . . 0.0 110.713 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 75.3 m -71.58 -44.68 64.05 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.584 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -59.89 -43.06 98.38 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.412 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -55.96 -48.52 75.64 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.022 0.439 . . . . 0.0 111.082 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.74 -33.51 66.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.382 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -74.31 -39.77 62.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.849 0.357 . . . . 0.0 111.256 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 50.7 tp60 -71.75 -35.92 70.25 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.115 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.92 HD11 ' CD2' ' A' ' 88' ' ' TYR . 0.4 OUTLIER -67.06 -45.31 87.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.303 -179.698 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.433 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 10.0 ptpt -61.84 -30.87 71.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.965 0.412 . . . . 0.0 110.23 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 -67.88 -53.6 25.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.652 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.887 HG21 HD13 ' A' ' 148' ' ' LEU . 14.8 pt -62.05 -41.42 91.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.282 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 13.4 mt -53.8 -37.46 63.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.915 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -65.02 -16.55 63.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.102 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 11.4 m-80 -137.16 33.0 2.59 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.644 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.498 ' CE1' ' CE2' ' A' ' 134' ' ' PHE . 1.1 t80 -52.5 -36.74 55.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.953 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -61.13 -18.76 59.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.286 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 35.2 m-20 -92.29 -43.43 9.29 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.716 0.293 . . . . 0.0 111.306 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.427 ' CD1' ' N ' ' A' ' 132' ' ' TYR . 1.4 m-30 -94.4 163.85 13.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.909 0.385 . . . . 0.0 111.245 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.441 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 4.9 mm-40 -136.35 145.67 45.67 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.88 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.498 ' CE2' ' CE1' ' A' ' 129' ' ' PHE . 1.5 m-85 -79.89 125.54 29.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.932 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.427 ' CE1' ' HG3' ' A' ' 80' ' ' GLU . 50.1 m-85 -129.45 132.42 46.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.692 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.709 HD11 HG21 ' A' ' 81' ' ' THR . 0.3 OUTLIER -120.83 158.15 23.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.576 179.914 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -56.54 -171.76 0.15 Allowed Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.447 -0.883 . . . . 0.0 112.021 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -70.02 -11.18 60.69 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.693 0.282 . . . . 0.0 111.407 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ASN . . . . . 0.507 ' HB3' ' ND2' ' A' ' 141' ' ' ASN . 25.0 m-80 -93.99 -25.24 17.33 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.531 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' MET . . . . . 0.428 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 35.6 mtm 51.33 43.91 29.16 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.806 0.336 . . . . 0.0 111.321 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ASN . . . . . 0.507 ' ND2' ' HB3' ' A' ' 139' ' ' ASN . 1.6 m120 -66.68 120.72 73.19 Favored Pre-proline 0 N--CA 1.454 -0.267 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.766 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -61.26 -26.18 81.61 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.253 1.968 . . . . 0.0 111.893 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -84.85 -19.67 32.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.701 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -70.17 -172.84 11.16 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.316 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 5.7 ptp -90.4 -173.56 3.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.78 0.324 . . . . 0.0 110.883 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.556 HG21 ' HE2' ' A' ' 91' ' ' TYR . 58.1 t -128.88 150.65 34.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.112 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.521 ' HB1' ' SD ' ' A' ' 160' ' ' MET . . . -115.44 111.53 20.92 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.654 179.584 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.887 HD13 HG21 ' A' ' 125' ' ' ILE . 3.9 mt -85.59 106.23 16.74 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.129 -179.201 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.44 HD12 ' HG2' ' A' ' 160' ' ' MET . 4.2 tp -88.52 120.16 29.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.347 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.453 ' HB3' ' CE1' ' A' ' 159' ' ' TYR . 27.8 t70 -136.75 164.86 27.27 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.39 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -106.46 152.47 23.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.837 0.351 . . . . 0.0 111.13 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.25 -177.1 0.49 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.966 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.99 -37.9 75.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.835 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -76.23 -15.04 60.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.28 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 69.77 26.98 73.79 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.744 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 89.8 t -112.03 -61.89 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.848 0.356 . . . . 0.0 110.929 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 78.2 m -75.78 112.75 21.5 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.202 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -81.08 132.04 8.17 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.562 2.175 . . . . 0.0 112.065 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.453 ' CE1' ' HB3' ' A' ' 150' ' ' ASP . 9.9 p90 -127.13 142.81 51.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.957 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' MET . . . . . 0.708 ' CE ' HD13 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -109.6 145.33 36.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.003 -179.848 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.525 ' HB ' ' HB2' ' A' ' 148' ' ' LEU . 74.5 mt -98.47 118.67 45.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.064 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.464 ' CE1' ' HB2' ' A' ' 147' ' ' ALA . 96.7 m-85 -122.25 154.46 37.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.825 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -102.5 116.06 31.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.984 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.75 ' HB3' HD11 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -62.68 -40.72 97.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.104 -179.751 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.453 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 2.1 m-20 -56.73 -38.4 72.31 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.814 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -98.44 24.38 32.26 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.353 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.624 HD21 ' HB3' ' A' ' 4' ' ' TYR . 0.5 OUTLIER -137.55 146.81 44.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.829 0.347 . . . . 0.0 110.771 179.985 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.423 ' N ' ' HG ' ' A' ' 167' ' ' LEU . 6.7 tt0 -116.45 149.93 38.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.771 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 169' ' ' MET . . . . . 0.82 ' HB3' HD11 ' A' ' 2' ' ' ILE . 1.0 OUTLIER -113.79 160.0 19.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.102 -179.829 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.818 179.985 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.655 HD11 ' HB3' ' A' ' 169' ' ' MET . 2.3 tt . . . . . 0 N--CA 1.456 -0.157 0 CA-C-O 120.799 0.333 . . . . 0.0 111.017 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.486 HG21 ' HB3' ' A' ' 12' ' ' GLU . 20.4 mm -111.31 159.36 11.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.378 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.506 ' CD2' ' CE2' ' A' ' 14' ' ' PHE . 5.4 m-85 -122.81 104.56 9.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.306 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 21.9 ptt180 -116.65 145.51 43.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.008 0.432 . . . . 0.0 111.415 -179.541 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.54 ' OD1' HD12 ' A' ' 8' ' ' ILE . 50.5 t0 -54.34 152.01 6.86 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.961 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 40.6 tp -82.47 -16.87 47.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.546 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.54 HD12 ' OD1' ' A' ' 6' ' ' ASP . 4.4 mp -91.27 -51.72 11.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -179.366 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.41 ' HB2' ' ND2' ' A' ' 141' ' ' ASN . 5.9 t -96.74 -16.26 20.97 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -179.113 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.454 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 1.8 m-70 64.39 30.08 13.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.865 0.364 . . . . 0.0 110.863 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -99.23 122.63 42.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.831 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.486 ' HB3' HG21 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -58.43 92.07 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.286 -179.739 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 35.8 mtp -70.85 -19.07 62.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.714 179.389 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.506 ' CE2' ' CD2' ' A' ' 4' ' ' TYR . 16.1 p90 -175.25 174.7 2.35 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.525 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.3 m -129.08 -170.53 2.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.822 0.344 . . . . 0.0 111.083 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.427 ' HB2' ' CG2' ' A' ' 2' ' ' ILE . 30.6 t0 -95.43 21.08 8.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.062 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.4 HG13 ' CD2' ' A' ' 18' ' ' TYR . 46.3 pt -87.14 -8.8 11.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.059 179.41 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.966 ' CZ ' HG22 ' A' ' 72' ' ' ILE . 84.3 m-85 -111.41 -175.99 2.84 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.899 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.1 mmmt -93.32 93.67 8.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.901 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.1 mp -88.06 123.96 40.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.985 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.405 ' HB3' ' NH1' ' A' ' 21' ' ' ARG . 9.1 mtp-105 -113.55 126.42 55.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.936 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.739 ' HG3' HD23 ' A' ' 29' ' ' LEU . 3.8 mt-10 -77.41 112.74 14.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.879 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.613 HD11 HG23 ' A' ' 161' ' ' ILE . 4.2 pt -109.69 168.46 3.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.063 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.417 ' HB2' ' NE2' ' A' ' 121' ' ' GLN . . . 57.72 30.17 18.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.152 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 63.9 40.14 7.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.29 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.7 -12.61 68.48 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.6 -0.81 . . . . 0.0 113.158 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.78 -37.4 76.24 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.824 0.345 . . . . 0.0 111.045 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 13.9 m -141.68 162.94 34.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.141 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.739 HD23 ' HG3' ' A' ' 22' ' ' GLU . 0.5 OUTLIER -128.76 135.45 49.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.703 179.894 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.403 ' OE1' ' CD2' ' A' ' 159' ' ' TYR . 64.6 mt-10 -100.7 118.13 36.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.305 -179.68 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.496 HG21 ' CD2' ' A' ' 14' ' ' PHE . 24.2 t -94.8 112.02 26.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.729 179.47 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -84.67 122.96 29.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.205 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -108.98 -138.79 8.42 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.278 179.613 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.9 ptpt -174.48 128.3 0.34 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.821 0.343 . . . . 0.0 111.024 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 24.4 mtp -74.17 124.9 27.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.567 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.0 m . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.657 -179.556 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.474 0 N-CA-C 112.286 -0.326 . . . . 0.0 112.286 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.541 HG12 HG12 ' A' ' 72' ' ' ILE . 48.8 t -67.87 130.34 33.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.805 0.336 . . . . 0.0 110.886 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -59.68 -58.05 10.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.402 -179.455 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.966 HG22 ' CZ ' ' A' ' 18' ' ' TYR . 6.3 pt -53.85 -33.97 24.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.61 -179.569 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.768 HG13 ' HB2' ' A' ' 78' ' ' LEU . 97.0 t -72.69 -29.98 32.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.137 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 7.3 mtm -78.09 -42.58 31.64 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.664 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.44 HD21 ' HA ' ' A' ' 72' ' ' ILE . 22.0 p30 -82.25 -28.89 31.6 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -179.123 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.447 ' CE1' ' HA ' ' A' ' 14' ' ' PHE . 32.7 m170 -88.58 -8.07 55.36 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.904 0.383 . . . . 0.0 110.69 179.307 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.407 ' HB2' ' HB3' ' A' ' 138' ' ' GLU . 72.4 m-70 64.65 33.39 10.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.056 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.768 ' HB2' HG13 ' A' ' 73' ' ' VAL . 33.4 mt -64.63 142.19 58.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.537 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -129.12 146.99 50.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.909 0.385 . . . . 0.0 111.274 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.437 ' HG3' ' CE1' ' A' ' 135' ' ' PHE . 1.1 tm-20 -102.05 134.28 45.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.822 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.578 HG21 HD11 ' A' ' 136' ' ' ILE . 8.9 t -124.27 139.81 53.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.908 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 34.5 p -69.4 159.11 33.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.833 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.471 ' HB2' ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -169.48 154.22 5.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.879 -179.941 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.421 HG22 ' N ' ' A' ' 85' ' ' LYS . 14.3 m -101.52 164.05 11.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.95 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.421 ' N ' HG22 ' A' ' 84' ' ' THR . 58.1 mttt -60.74 -52.54 64.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.896 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -64.19 -42.19 96.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.616 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.29 -41.31 88.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.898 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.818 ' CD2' HD11 ' A' ' 122' ' ' ILE . 0.3 OUTLIER -57.71 -38.4 75.2 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.653 179.908 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.436 ' O ' HG22 ' A' ' 92' ' ' ILE . 21.7 mttt -58.88 -42.3 89.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.521 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 18.0 mtpt -77.27 -27.88 53.27 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.897 179.15 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.416 ' HB2' ' CE2' ' A' ' 83' ' ' PHE . 28.6 t80 -69.23 -45.68 69.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.565 179.544 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.586 HD12 ' CE2' ' A' ' 95' ' ' TYR . 6.1 tp -61.28 -39.92 84.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.071 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.501 ' O ' ' CG ' ' A' ' 97' ' ' LYS . 13.8 ttmt -62.05 -46.95 86.86 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.969 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -71.68 -36.13 70.51 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.13 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.586 ' CE2' HD12 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -78.51 -43.4 26.98 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.641 0.257 . . . . 0.0 110.735 -179.268 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.403 ' HG3' ' N ' ' A' ' 97' ' ' LYS . 0.5 OUTLIER -64.71 -31.83 73.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.841 0.353 . . . . 0.0 110.082 179.004 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.501 ' CG ' ' O ' ' A' ' 93' ' ' LYS . 9.5 mmtm -66.94 -41.37 87.08 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.549 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.7 m -55.26 -41.14 71.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.545 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.519 ' CG1' HD11 ' A' ' 8' ' ' ILE . 7.1 mt -79.78 -41.87 22.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.522 179.497 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 10.2 tttt -54.75 -52.61 61.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.574 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -61.6 -47.15 92.24 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.141 179.519 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 19.5 tptt -60.98 -40.3 92.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.841 0.353 . . . . 0.0 110.366 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.732 HD21 ' CB ' ' A' ' 110' ' ' ARG . 2.4 tp -66.96 -35.53 80.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.14 179.377 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.64 ' CG ' HG11 ' A' ' 111' ' ' VAL . 30.6 mt-10 -58.15 -30.15 66.13 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.607 179.361 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -89.43 -25.1 21.69 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.511 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -100.1 -63.55 1.12 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.858 0.361 . . . . 0.0 111.633 -179.607 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.441 ' N ' ' O ' ' A' ' 103' ' ' LEU . 16.0 mtm180 -130.43 65.18 75.37 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.882 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.93 ' O ' HG22 ' A' ' 111' ' ' VAL . 10.3 Cg_endo -50.86 -22.29 9.79 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 123.17 2.58 . . . . 0.0 112.831 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -66.97 -13.57 61.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.328 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.732 ' CB ' HD21 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -110.57 0.89 17.8 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.102 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.93 HG22 ' O ' ' A' ' 108' ' ' PRO . 33.9 m -70.05 -33.36 54.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.43 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.579 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 29.8 mtmt -71.1 -49.95 12.12 Favored Pre-proline 0 CA--C 1.53 0.176 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.574 -179.199 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.579 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 25.8 Cg_exo -63.06 -30.46 75.91 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.16 1.906 . . . . 0.0 111.777 179.479 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.459 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 88.6 t80 -72.07 -41.05 67.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.987 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 7.6 mtm -56.54 -47.88 78.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.031 0.443 . . . . 0.0 110.817 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 69.0 m -74.32 -44.36 52.83 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.659 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.27 -38.0 95.5 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.483 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.55 -51.62 68.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.921 0.391 . . . . 0.0 110.838 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.96 -28.11 65.28 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.279 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -74.81 -43.04 56.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.856 0.36 . . . . 0.0 110.982 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.417 ' NE2' ' HB2' ' A' ' 24' ' ' ALA . 3.8 tp-100 -73.31 -32.58 64.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.965 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.818 HD11 ' CD2' ' A' ' 88' ' ' TYR . 0.4 OUTLIER -71.56 -46.01 65.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.322 -179.725 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.456 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 9.2 pttt -61.1 -31.54 71.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.036 0.446 . . . . 0.0 110.358 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 6.5 t-80 -68.32 -53.52 23.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.77 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.822 HG21 HD13 ' A' ' 148' ' ' LEU . 16.2 pt -62.0 -42.49 95.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.304 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.46 ' HA ' HD23 ' A' ' 126' ' ' LEU . 11.7 mt -53.89 -36.99 63.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.879 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -65.46 -15.95 63.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.21 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -136.35 31.43 2.89 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.77 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.513 ' CE1' ' CZ ' ' A' ' 134' ' ' PHE . 1.8 t80 -49.5 -31.66 10.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.96 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 20.1 tptt -61.3 -21.57 64.08 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.162 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 15.0 m-20 -94.08 -47.22 6.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.429 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.479 ' CD2' HG22 ' A' ' 125' ' ' ILE . 1.0 OUTLIER -93.01 150.78 20.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.963 0.411 . . . . 0.0 111.48 -179.449 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.489 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 2.7 mm-40 -126.6 142.95 51.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.317 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.513 ' CZ ' ' CE1' ' A' ' 129' ' ' PHE . 0.1 OUTLIER -82.49 118.27 23.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.928 0.394 . . . . 0.0 110.979 -179.704 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.437 ' CE1' ' HG3' ' A' ' 80' ' ' GLU . 20.9 m-85 -119.8 137.17 54.14 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.753 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.578 HD11 HG21 ' A' ' 81' ' ' THR . 0.8 OUTLIER -120.93 165.43 16.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.842 0.353 . . . . 0.0 110.944 179.933 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -64.59 -166.4 1.19 Allowed Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.539 -0.839 . . . . 0.0 111.981 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.407 ' HB3' ' HB2' ' A' ' 77' ' ' HIS . 12.5 pt-20 -70.98 -9.82 58.64 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.567 0.222 . . . . 0.0 111.38 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 -96.63 -29.83 13.61 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.606 0.241 . . . . 0.0 111.449 -179.571 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' MET . . . . . 0.489 ' HE2' ' HB ' ' A' ' 81' ' ' THR . 18.7 mtp 55.39 48.57 18.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.879 0.371 . . . . 0.0 111.099 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ASN . . . . . 0.413 ' ND2' ' HA3' ' A' ' 144' ' ' GLY . 15.7 p-10 -71.84 114.8 31.89 Favored Pre-proline 0 N--CA 1.451 -0.409 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.917 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 141' ' ' ASN . 22.6 Cg_exo -63.39 -30.65 72.73 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.54 2.16 . . . . 0.0 112.214 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -84.62 -1.44 56.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.354 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.413 ' HA3' ' ND2' ' A' ' 141' ' ' ASN . . . -86.87 -115.72 1.0 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.421 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 10.7 ptp -142.27 -178.89 5.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.59 0.233 . . . . 0.0 110.769 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.504 HG11 ' HB3' ' A' ' 134' ' ' PHE . 0.0 OUTLIER -129.61 139.79 50.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.077 0.465 . . . . 0.0 111.274 179.961 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.671 ' HB2' ' CE1' ' A' ' 162' ' ' PHE . . . -103.09 110.02 21.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.224 179.248 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.822 HD13 HG21 ' A' ' 125' ' ' ILE . 3.8 mt -81.51 106.2 13.28 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.428 -179.051 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.526 HD11 HG21 ' A' ' 70' ' ' VAL . 1.7 tp -90.85 119.6 31.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.074 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.482 ' HB3' ' CE1' ' A' ' 159' ' ' TYR . 31.7 t70 -135.54 164.85 26.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.524 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -102.02 150.8 22.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.915 0.388 . . . . 0.0 111.189 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 16.8 mmm180 -80.59 -175.48 5.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.816 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -54.55 -40.14 68.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.011 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -66.31 -15.17 63.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.205 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 69.66 10.25 63.56 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.745 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 70.1 t -113.47 -68.19 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.843 0.354 . . . . 0.0 110.946 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 96.8 m -54.32 107.8 0.96 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.378 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -83.17 131.52 5.84 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.677 2.251 . . . . 0.0 111.965 179.519 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.482 ' CE1' ' HB3' ' A' ' 150' ' ' ASP . 9.5 p90 -124.1 135.58 53.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.866 0.365 . . . . 0.0 111.059 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' MET . . . . . 0.652 ' HE1' HD13 ' A' ' 78' ' ' LEU . 0.4 OUTLIER -105.09 138.7 40.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.132 -179.706 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.613 HG23 HD11 ' A' ' 23' ' ' ILE . 68.7 mt -94.96 114.41 31.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.147 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.671 ' CE1' ' HB2' ' A' ' 147' ' ' ALA . 96.6 m-85 -118.1 158.19 25.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.692 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -101.71 129.09 47.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.873 0.368 . . . . 0.0 110.803 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.519 ' HB2' HD11 ' A' ' 29' ' ' LEU . 24.3 tttt -70.09 -51.52 31.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.166 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.459 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 59.6 m-20 -52.2 -38.51 58.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.175 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.454 ' HA2' HG23 ' A' ' 99' ' ' ILE . . . -95.73 26.87 18.24 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.459 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.477 HD21 ' HB3' ' A' ' 4' ' ' TYR . 0.6 OUTLIER -144.93 143.84 30.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.778 0.323 . . . . 0.0 110.879 -179.871 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -116.88 156.61 27.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.822 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' MET . . . . . 0.655 ' HB3' HD11 ' A' ' 2' ' ' ILE . 3.1 mpp? -115.76 151.02 35.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.052 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.888 -179.964 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.852 0.358 . . . . 0.0 111.121 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.766 HD11 ' HB3' ' A' ' 169' ' ' MET . 5.0 tt -105.8 145.96 13.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.912 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.526 HG21 ' HB3' ' A' ' 12' ' ' GLU . 13.9 mm -106.78 159.06 6.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.523 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.504 ' CD2' ' CE2' ' A' ' 14' ' ' PHE . 4.9 m-85 -121.27 104.73 9.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.427 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 20.9 ptt180 -118.09 146.77 43.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.9 0.381 . . . . 0.0 111.365 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.553 ' OD1' HD12 ' A' ' 8' ' ' ILE . 47.0 t0 -55.55 152.02 9.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.813 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.454 HD13 ' HG3' ' A' ' 168' ' ' GLU . 49.0 tp -81.6 -18.36 45.03 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.505 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.553 HD12 ' OD1' ' A' ' 6' ' ' ASP . 4.1 mp -91.36 -48.95 13.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -96.63 -17.75 20.19 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -179.117 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.431 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 36.1 m170 63.18 29.9 15.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.889 0.376 . . . . 0.0 110.71 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -100.4 121.02 40.85 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.661 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.526 ' HB3' HG21 ' A' ' 3' ' ' ILE . 0.2 OUTLIER -58.18 94.84 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.372 -179.726 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 14.7 mtt -72.13 -20.22 61.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.528 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.54 ' CD2' HG21 ' A' ' 31' ' ' VAL . 8.6 p90 -173.07 179.76 2.18 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.325 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -132.74 -170.26 2.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.836 0.35 . . . . 0.0 111.159 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.419 ' HB2' ' CG2' ' A' ' 2' ' ' ILE . 32.2 t70 -96.28 24.69 5.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.068 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.437 HG13 ' CD2' ' A' ' 18' ' ' TYR . 41.8 pt -89.03 -9.54 10.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.72 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.946 ' CZ ' HG22 ' A' ' 72' ' ' ILE . 73.6 m-85 -111.34 177.63 4.6 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.765 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -86.76 90.23 8.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.872 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.411 HD12 ' O ' ' A' ' 18' ' ' TYR . 3.6 mp -87.93 129.27 39.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.94 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 -123.3 121.04 34.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.979 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -73.32 115.79 13.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.768 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.469 HD12 ' NE2' ' A' ' 121' ' ' GLN . 2.8 pt -108.86 171.6 2.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.996 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.657 ' HB2' ' NE2' ' A' ' 121' ' ' GLN . . . 57.95 31.82 21.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.06 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 65.66 46.95 2.27 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.228 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.35 -11.38 63.52 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.756 -0.735 . . . . 0.0 113.345 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.5 ' HB3' ' HB3' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -57.25 -55.22 37.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.905 0.352 . . . . 0.0 111.141 -179.866 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 35.0 m -120.17 167.79 11.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.057 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.6 132.46 44.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.785 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -100.43 112.98 25.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.101 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.54 HG21 ' CD2' ' A' ' 14' ' ' PHE . 33.3 t -90.69 111.97 24.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.387 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -84.04 115.9 22.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.284 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -100.63 -138.96 10.51 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.042 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.8 pttp -174.56 125.55 0.3 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.814 0.34 . . . . 0.0 111.08 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 65.3 mtp -70.95 120.43 16.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.529 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.5 m -108.74 116.74 52.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.914 0.387 . . . . 0.0 111.54 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.5 p -85.76 165.7 16.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.613 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.588 ' O ' HG13 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -148.03 125.0 11.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.99 -179.612 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.6 t 179.86 40.02 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.869 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -131.73 174.96 9.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.946 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 96.07 96.15 1.79 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.485 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -65.93 78.74 0.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.803 0.335 . . . . 0.0 110.844 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.561 ' O ' HG23 ' A' ' 43' ' ' ILE . 13.1 tt -167.25 112.89 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.131 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -125.59 137.6 53.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.847 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -136.16 -178.92 5.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.947 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.09 -25.05 62.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.995 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 5.4 mt -56.18 -50.54 70.93 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.933 0.397 . . . . 0.0 111.104 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.702 ' CG2' HG21 ' A' ' 65' ' ' THR . 16.0 mt -81.1 -67.1 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.104 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -151.02 -128.61 1.51 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.485 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 76.24 134.35 0.52 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.495 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -89.75 177.23 6.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.873 0.368 . . . . 0.0 110.911 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -103.67 88.85 3.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.126 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.9 m -68.44 159.16 32.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.863 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -155.61 -46.26 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.044 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -126.07 150.5 48.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.843 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.56 119.36 0.98 Allowed Glycine 0 CA--C 1.52 0.373 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.449 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.19 -45.3 1.96 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.428 2.085 . . . . 0.0 112.363 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.7 104.2 16.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.88 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -163.88 128.61 1.85 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.481 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -124.27 130.39 52.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.88 0.372 . . . . 0.0 110.925 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.23 -22.2 25.47 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.562 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 26.4 m 63.53 113.03 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.787 0.327 . . . . 0.0 110.868 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -83.37 -48.1 10.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.91 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 49.1 m 59.88 68.58 0.77 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.896 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.702 HG21 ' CG2' ' A' ' 48' ' ' ILE . 1.9 m -119.21 95.94 5.01 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.981 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.656 ' C ' HD13 ' A' ' 67' ' ' ILE . 39.7 t -120.94 132.09 71.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.896 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.656 HD13 ' C ' ' A' ' 66' ' ' VAL . 0.0 OUTLIER -122.05 125.32 72.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.099 0.476 . . . . 0.0 111.243 -179.861 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.9 m -139.63 146.1 39.32 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.916 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 169.18 177.65 40.02 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.563 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.551 HG12 HG12 ' A' ' 72' ' ' ILE . 47.6 t -71.96 134.14 30.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.847 0.356 . . . . 0.0 110.868 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -61.04 -57.47 12.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.837 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.946 HG22 ' CZ ' ' A' ' 18' ' ' TYR . 10.1 pt -53.61 -33.8 22.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.642 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.799 HG13 ' HB2' ' A' ' 78' ' ' LEU . 90.2 t -71.7 -32.73 46.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.898 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.4 mtm -78.32 -40.29 37.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.554 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 16.9 p30 -82.11 -29.92 31.47 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.829 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.532 ' CD2' ' HB ' ' A' ' 72' ' ' ILE . 19.4 m-70 -91.94 -2.54 56.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.808 0.337 . . . . 0.0 110.914 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 28.1 m-70 57.29 34.08 24.24 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.808 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.799 ' HB2' HG13 ' A' ' 73' ' ' VAL . 29.7 mt -55.43 148.63 14.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.865 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -128.35 128.02 43.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.922 0.392 . . . . 0.0 110.897 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.411 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 1.4 tt0 -89.9 122.16 32.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.075 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.3 t -108.6 178.88 4.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.817 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 50.5 p -115.85 163.77 15.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.004 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.457 ' CE2' ' CE2' ' A' ' 91' ' ' TYR . 0.6 OUTLIER -171.64 153.87 3.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.806 -179.973 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 13.0 p -101.44 176.34 5.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.969 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.67 -52.55 24.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.944 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -65.36 -41.83 93.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.702 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.29 -38.42 83.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.027 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.865 ' CD2' HD11 ' A' ' 122' ' ' ILE . 0.6 OUTLIER -61.97 -36.76 82.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.673 179.936 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.405 ' O ' HG22 ' A' ' 92' ' ' ILE . 17.5 mttm -57.68 -46.41 84.33 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.064 0.459 . . . . 0.0 110.225 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.62 -27.95 55.93 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.64 178.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.57 ' HE2' HG21 ' A' ' 146' ' ' VAL . 2.8 t80 -66.15 -44.94 82.7 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.745 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.54 HD12 ' CE2' ' A' ' 95' ' ' TYR . 3.9 tp -62.08 -45.61 98.34 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.752 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.417 ' HA ' ' HG2' ' A' ' 96' ' ' MET . 15.0 ttpt -60.51 -37.95 82.78 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.883 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.513 ' HA ' ' HG2' ' A' ' 97' ' ' LYS . 31.3 t70 -74.67 -42.57 58.22 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.841 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.54 ' CE2' HD12 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -77.05 -40.26 46.95 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.999 -0.281 . . . . 0.0 111.065 -179.35 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.432 ' HG2' ' O ' ' A' ' 92' ' ' ILE . 8.8 ptt? -66.23 -32.11 73.33 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.855 0.36 . . . . 0.0 110.298 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.513 ' HG2' ' HA ' ' A' ' 94' ' ' ASP . 4.2 ptmt -70.48 -33.74 71.59 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.529 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.493 ' N ' ' HG3' ' A' ' 97' ' ' LYS . 1.8 m -63.92 -40.1 95.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.266 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.41 HG23 ' HA2' ' A' ' 166' ' ' GLY . 8.4 mt -79.76 -41.47 21.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.211 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.9 tmtt? -56.95 -52.1 66.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.266 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -59.21 -48.02 87.97 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.002 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.1 tppm? -62.79 -38.75 91.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.981 0.42 . . . . 0.0 110.122 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.548 ' HB3' HG12 ' A' ' 111' ' ' VAL . 14.3 tp -67.95 -36.87 80.84 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.975 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.482 ' CG ' HG11 ' A' ' 111' ' ' VAL . 36.0 mt-10 -55.96 -32.38 63.81 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.752 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -85.61 -19.99 30.18 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.567 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -105.18 -62.95 1.28 Allowed 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.773 0.32 . . . . 0.0 111.517 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.455 ' N ' ' O ' ' A' ' 103' ' ' LEU . 16.5 mmt180 -129.36 64.42 71.2 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.844 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.895 ' O ' HG22 ' A' ' 111' ' ' VAL . 9.6 Cg_endo -50.64 -24.02 12.12 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 123.01 2.473 . . . . 0.0 112.596 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -74.13 -9.02 58.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.1 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.425 ' C ' ' HD2' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -108.79 -1.71 19.08 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.5 -179.683 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.895 HG22 ' O ' ' A' ' 108' ' ' PRO . 27.6 m -72.13 -26.96 25.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.713 0.292 . . . . 0.0 111.299 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.601 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 0.8 OUTLIER -68.47 -56.03 10.92 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.37 -179.398 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.601 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 41.6 Cg_exo -55.67 -40.76 83.4 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 121.921 1.747 . . . . 0.0 111.641 179.237 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.434 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 56.9 t80 -62.02 -39.9 93.86 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.866 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 4.4 mmm -59.7 -45.3 92.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.829 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 63.1 m -74.82 -44.65 48.14 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.876 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -66.18 -39.44 94.53 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.938 -0.648 . . . . 0.0 112.688 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.63 -51.7 68.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.943 0.401 . . . . 0.0 111.074 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.51 ' HB1' ' HE3' ' A' ' 123' ' ' LYS . . . -66.68 -28.11 68.19 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.37 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -75.39 -57.14 4.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.229 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.657 ' NE2' ' HB2' ' A' ' 24' ' ' ALA . 2.0 tp-100 -58.44 -43.09 88.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.278 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.865 HD11 ' CD2' ' A' ' 88' ' ' TYR . 0.3 OUTLIER -58.79 -46.33 90.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.269 -179.801 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.51 ' HE3' ' HB1' ' A' ' 119' ' ' ALA . 25.6 mttt -60.43 -31.52 70.5 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.262 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 -67.39 -54.33 21.43 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.715 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.926 HG21 HD13 ' A' ' 148' ' ' LEU . 11.8 pt -61.59 -41.05 88.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.149 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 126' ' ' LEU . 11.1 mt -53.88 -35.96 62.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.761 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -68.6 -11.52 60.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.357 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -136.3 32.31 2.85 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.934 0.397 . . . . 0.0 110.522 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -48.23 -32.73 7.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.253 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -69.18 -24.35 64.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.274 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 21.5 m-20 -94.06 -36.43 12.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.419 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.418 ' CE1' ' OD2' ' A' ' 150' ' ' ASP . 3.5 m-85 -92.23 141.39 28.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.175 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -121.35 145.74 47.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.877 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.453 ' CE2' ' HB2' ' A' ' 83' ' ' PHE . 2.9 m-85 -83.24 125.25 31.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.169 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.46 ' HB2' ' HB3' ' A' ' 147' ' ' ALA . 32.9 m-85 -127.5 150.16 49.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.679 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.446 ' HB ' ' HA ' ' A' ' 140' ' ' MET . 0.7 OUTLIER -140.05 159.97 26.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.719 179.893 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -57.57 -168.81 0.13 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.562 -0.828 . . . . 0.0 111.94 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -71.59 -8.9 56.92 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.622 0.248 . . . . 0.0 111.402 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 -94.09 -31.25 14.27 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.62 -0.263 . . . . 0.0 111.493 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.446 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 77.7 mtm 58.87 49.95 9.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.821 0.343 . . . . 0.0 111.017 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ASN . . . . . 0.43 ' ND2' ' HA3' ' A' ' 144' ' ' GLY . 14.3 p-10 -72.11 114.62 30.8 Favored Pre-proline 0 N--CA 1.452 -0.357 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.987 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -64.98 -29.25 57.55 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.642 2.228 . . . . 0.0 112.288 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -84.59 -3.28 58.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.336 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.43 ' HA3' ' ND2' ' A' ' 141' ' ' ASN . . . -90.61 -155.17 31.07 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.535 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 2.8 ptp -94.75 -176.97 4.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.814 0.34 . . . . 0.0 110.895 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.57 HG21 ' HE2' ' A' ' 91' ' ' TYR . 53.4 t -128.97 151.13 35.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.085 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.691 ' HB1' ' HE3' ' A' ' 160' ' ' MET . . . -111.71 115.85 29.77 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.67 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.926 HD13 HG21 ' A' ' 125' ' ' ILE . 4.6 mt -92.26 106.24 18.28 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.96 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.502 HD12 ' HG2' ' A' ' 160' ' ' MET . 1.8 tp -89.29 119.63 29.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.248 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.449 ' HB3' ' CE1' ' A' ' 159' ' ' TYR . 0.6 OUTLIER -133.12 172.52 12.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.701 179.658 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -116.01 140.84 48.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.763 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 19.2 mmm180 -55.56 -178.66 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.115 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.23 -31.59 53.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.018 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 37.4 p30 -76.69 -15.2 59.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.104 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 71.27 17.47 75.99 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.708 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 93.9 t -111.89 -65.75 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.817 0.342 . . . . 0.0 110.846 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 35.8 m -56.95 109.17 1.53 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.097 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -82.17 122.85 3.83 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.522 2.148 . . . . 0.0 112.406 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.449 ' CE1' ' HB3' ' A' ' 150' ' ' ASP . 12.7 p90 -123.49 146.71 47.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.772 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' MET . . . . . 0.691 ' HE3' ' HB1' ' A' ' 147' ' ' ALA . 1.1 mtm -112.22 142.53 44.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.949 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.527 ' HB ' ' HB2' ' A' ' 148' ' ' LEU . 46.0 mt -95.45 117.58 39.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.226 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.443 ' CZ ' ' HE3' ' A' ' 160' ' ' MET . 48.4 m-85 -116.34 152.48 33.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.837 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.505 ' CE2' ' CZ ' ' A' ' 95' ' ' TYR . 11.5 m-85 -97.16 120.4 37.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.885 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 9.9 ttpt -65.26 -50.12 66.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.023 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.434 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 52.8 m-20 -57.69 -30.74 65.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.96 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.41 ' HA2' HG23 ' A' ' 99' ' ' ILE . . . -104.72 26.3 22.94 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.446 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.453 HD21 ' HB3' ' A' ' 4' ' ' TYR . 1.1 tt -142.69 142.23 31.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.759 0.314 . . . . 0.0 110.911 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.454 ' HG3' HD13 ' A' ' 7' ' ' LEU . 1.1 mt-10 -116.66 159.51 22.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.928 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.766 ' HB3' HD11 ' A' ' 2' ' ' ILE . 0.1 OUTLIER -115.48 159.96 20.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.776 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -159.19 120.4 3.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.908 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.422 ' CG ' HD12 ' A' ' 2' ' ' ILE . 5.0 mtpt -85.22 113.81 21.85 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.914 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 69.7 m -139.91 95.3 2.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.902 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.582 ' H ' HD12 ' A' ' 173' ' ' LEU . 3.8 mp -76.43 -43.69 39.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.931 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.922 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.409 0 CA-C-O 120.828 0.347 . . . . 0.0 111.146 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.788 HD11 ' HB3' ' A' ' 169' ' ' MET . 3.2 tt -106.65 144.57 15.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.945 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 21.5 mm -99.64 154.02 4.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.292 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.609 ' HE1' HG23 ' A' ' 2' ' ' ILE . 3.3 m-85 -123.67 110.06 14.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.602 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.57 145.78 49.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.906 0.384 . . . . 0.0 111.282 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.457 ' O ' ' HA ' ' A' ' 10' ' ' HIS . 44.3 t0 -55.68 152.17 9.83 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.862 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.547 HD23 HG23 ' A' ' 99' ' ' ILE . 57.3 tp -80.2 -23.5 40.91 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.305 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.758 HD11 ' CG1' ' A' ' 99' ' ' ILE . 4.3 mp -91.3 -45.48 14.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.26 -21.24 19.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.799 -179.085 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.457 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 14.5 m170 61.78 27.89 17.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.809 0.337 . . . . 0.0 110.731 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -100.77 122.15 42.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.751 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -56.93 89.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.366 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.407 ' O ' ' CD2' ' A' ' 76' ' ' HIS . 25.2 mtt -67.53 -19.24 65.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.644 179.337 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.512 ' CZ ' ' CD2' ' A' ' 4' ' ' TYR . 12.5 p90 -177.64 175.87 1.32 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.817 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.28 -169.92 2.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.734 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.411 ' HA ' ' CD1' ' A' ' 20' ' ' ILE . 19.0 t0 -95.76 31.87 1.98 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.148 0.499 . . . . 0.0 110.817 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.413 HG13 ' CD2' ' A' ' 18' ' ' TYR . 35.6 pt -89.66 -13.41 9.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.437 178.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.748 ' CZ ' HG22 ' A' ' 72' ' ' ILE . 61.3 m-85 -110.07 178.92 4.25 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.463 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.408 ' HB2' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -86.43 91.55 8.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.75 179.828 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.51 HD12 ' O ' ' A' ' 18' ' ' TYR . 4.2 mp -88.35 135.61 25.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.178 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 10.7 mtm180 -129.26 117.67 21.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.015 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -71.07 116.33 11.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.71 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.558 HD11 HG23 ' A' ' 161' ' ' ILE . 2.9 pt -109.5 171.07 2.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.162 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.491 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . . . 57.91 30.97 19.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.178 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 66.56 42.56 2.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.095 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.89 -17.48 54.97 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.996 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.491 ' HB3' ' HB3' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -51.13 -49.37 60.94 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.852 0.358 . . . . 0.0 111.168 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 6.7 m -128.48 167.07 17.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.727 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.629 HD11 ' CD ' ' A' ' 164' ' ' LYS . 1.1 mt -129.37 135.08 48.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.878 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -99.62 112.78 24.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.8 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 159' ' ' TYR . 22.0 t -94.24 111.75 25.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.541 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.408 ' HB2' ' HB2' ' A' ' 19' ' ' LYS . 9.2 mt-10 -86.53 110.57 19.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.357 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -92.91 -134.21 6.76 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.212 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 9.3 ptpt -174.49 123.23 0.28 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.802 0.334 . . . . 0.0 111.023 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 15.1 mtt -67.16 121.54 15.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.641 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.4 m -119.11 125.69 74.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.495 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.404 ' HB3' HG23 ' A' ' 68' ' ' THR . 1.7 p -101.75 148.36 25.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.521 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.757 ' HB3' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -117.84 127.37 53.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.867 -179.831 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.6 m -143.13 105.43 4.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.867 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -176.97 127.1 0.16 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.883 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 93.59 170.58 39.03 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.517 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 22.2 p-10 -106.64 165.09 11.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.875 0.369 . . . . 0.0 110.899 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.1 mp -128.62 140.34 49.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.046 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.04 -58.55 1.99 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.822 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -124.51 -178.95 4.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.841 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 40.4 p -96.26 -35.17 11.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.9 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 56.9 mt -81.12 -67.09 0.81 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.967 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 52.2 mt 52.28 92.4 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.262 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -156.04 141.93 8.41 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.483 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 71.93 -86.54 0.47 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.473 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 60.34 89.29 0.07 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.859 0.361 . . . . 0.0 110.942 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -97.27 38.16 1.28 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.107 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.6 t -121.85 78.05 1.43 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.839 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -89.6 91.96 8.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.104 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -134.04 -47.25 0.78 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.873 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -123.73 67.4 0.5 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.454 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.64 175.79 7.53 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.637 2.225 . . . . 0.0 112.272 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -160.3 -54.68 0.05 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.965 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -157.68 -141.01 3.06 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.558 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -131.63 177.2 7.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.853 0.359 . . . . 0.0 110.87 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.38 116.37 1.79 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.491 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 76.2 p -71.86 -41.73 67.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.849 0.357 . . . . 0.0 110.972 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -143.31 -60.46 0.42 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.877 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.2 m 59.5 30.21 19.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.95 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.426 HG23 ' CD1' ' A' ' 67' ' ' ILE . 10.8 t -78.57 -168.28 1.33 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.767 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.52 ' C ' HD13 ' A' ' 67' ' ' ILE . 34.7 t -99.11 124.39 52.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.17 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.757 HG12 ' HB3' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -128.23 128.47 68.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.831 179.679 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.404 HG23 ' HB3' ' A' ' 37' ' ' SER . 7.3 m -139.29 130.91 27.26 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.962 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -176.71 -169.5 38.12 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.401 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.462 HG21 HD11 ' A' ' 149' ' ' LEU . 48.4 t -72.34 140.54 17.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.806 0.336 . . . . 0.0 110.967 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.411 ' O ' ' ND2' ' A' ' 75' ' ' ASN . 35.4 t70 -67.75 -59.63 3.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.363 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.748 HG22 ' CZ ' ' A' ' 18' ' ' TYR . 10.3 pt -53.62 -34.44 24.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.594 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.781 HG13 ' HB2' ' A' ' 78' ' ' LEU . 58.7 t -71.18 -33.04 49.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.826 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.6 mtm -78.25 -40.03 38.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.62 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.411 ' ND2' ' O ' ' A' ' 71' ' ' ASP . 15.3 p30 -82.02 -28.44 32.54 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.582 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.438 ' CD2' ' HB ' ' A' ' 72' ' ' ILE . 8.1 m-70 -91.49 -0.77 57.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.928 0.394 . . . . 0.0 110.753 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 10.7 m170 57.61 28.14 15.23 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.131 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.781 ' HB2' HG13 ' A' ' 73' ' ' VAL . 57.1 mt -56.82 137.98 54.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.371 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -122.12 137.01 54.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.973 0.416 . . . . 0.0 111.271 -179.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.423 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 1.5 tt0 -92.09 130.64 37.77 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.961 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.58 HG21 HD11 ' A' ' 136' ' ' ILE . 1.3 t -117.77 165.62 13.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.83 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 40.3 m -96.17 161.39 13.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.963 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.477 ' HB2' ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -171.7 149.94 2.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.013 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -101.54 164.76 11.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.906 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.11 -52.48 65.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.992 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -65.62 -44.9 85.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.785 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.79 -37.61 76.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.07 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.868 ' CD2' HD11 ' A' ' 122' ' ' ILE . 0.5 OUTLIER -62.96 -35.79 81.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.799 179.9 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.405 ' O ' HG22 ' A' ' 92' ' ' ILE . 52.8 mttt -59.61 -43.65 93.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.475 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.5 tttt -77.72 -27.91 50.72 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.75 178.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.56 ' HE2' HG21 ' A' ' 146' ' ' VAL . 7.8 t80 -67.75 -46.84 70.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.702 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.625 HD12 ' CE2' ' A' ' 95' ' ' TYR . 5.8 tp -60.49 -42.73 92.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 CA-C-O 120.84 0.352 . . . . 0.0 110.668 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.453 ' O ' ' HB3' ' A' ' 97' ' ' LYS . 7.9 ttpp -63.94 -39.73 94.83 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.799 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.453 ' O ' ' HG3' ' A' ' 97' ' ' LYS . 29.1 t70 -75.85 -37.99 58.42 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.769 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.625 ' CE2' HD12 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -78.46 -42.78 28.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.607 0.242 . . . . 0.0 110.619 -179.736 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.412 ' HG3' ' N ' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -67.53 -32.09 72.64 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.035 179.569 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.453 ' HB3' ' O ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -70.91 -34.5 71.6 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.899 0.38 . . . . 0.0 110.656 179.807 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.27 -41.03 96.26 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.152 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.758 ' CG1' HD11 ' A' ' 8' ' ' ILE . 9.3 mt -79.81 -41.16 21.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.488 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.8 tttt -55.57 -53.16 59.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.462 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -60.64 -46.97 93.4 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.162 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.9 tppt? -62.5 -37.94 87.98 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.878 0.37 . . . . 0.0 110.403 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.73 HD21 ' CB ' ' A' ' 110' ' ' ARG . 3.4 tp -69.55 -34.24 73.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.032 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.672 ' HG3' HG11 ' A' ' 111' ' ' VAL . 29.4 mt-10 -59.19 -30.99 68.6 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.691 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.424 ' HG3' ' HG3' ' A' ' 106' ' ' GLN . 0.8 OUTLIER -87.38 -20.17 27.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.707 -179.646 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.424 ' HG3' ' HG3' ' A' ' 105' ' ' GLU . 50.9 mt-30 -107.36 -62.3 1.44 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.833 0.349 . . . . 0.0 111.593 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 103' ' ' LEU . 22.0 mtm180 -128.03 63.52 62.27 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.92 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.912 ' O ' HG22 ' A' ' 111' ' ' VAL . 10.0 Cg_endo -50.74 -21.24 7.82 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 123.144 2.562 . . . . 0.0 112.965 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -72.04 -9.22 58.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.584 0.23 . . . . 0.0 111.433 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.73 ' CB ' HD21 ' A' ' 103' ' ' LEU . 19.0 mmt85 -112.12 -1.27 15.34 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.64 -0.255 . . . . 0.0 111.677 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.912 HG22 ' O ' ' A' ' 108' ' ' PRO . 33.8 m -71.33 -32.54 47.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.547 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 15.5 mttm -69.81 -49.95 18.98 Favored Pre-proline 0 CA--C 1.53 0.192 0 C-N-CA 121.047 -0.261 . . . . 0.0 111.57 -179.215 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.547 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 31.4 Cg_exo -58.98 -36.13 97.35 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.183 1.922 . . . . 0.0 111.936 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.455 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 89.9 t80 -71.09 -35.38 71.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.923 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 10.8 mtp -58.61 -52.44 65.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.761 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 63.0 m -73.89 -44.06 56.49 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.552 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.58 -38.71 96.29 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.391 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.99 -51.6 68.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.002 0.429 . . . . 0.0 110.961 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.08 -28.22 65.25 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.129 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -75.88 -44.01 42.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.009 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -71.34 -38.12 71.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.001 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.868 HD11 ' CD2' ' A' ' 88' ' ' TYR . 0.4 OUTLIER -63.89 -46.82 93.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.269 -179.916 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.448 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 6.1 ptmt -60.72 -31.07 70.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.338 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 8.8 t-80 -66.49 -52.37 46.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.996 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.67 HG21 HD13 ' A' ' 148' ' ' LEU . 11.9 pt -65.3 -40.44 88.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.283 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 11.9 mt -53.88 -35.5 61.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.882 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -72.75 -9.9 59.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.3 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -142.93 32.1 1.4 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.985 0.422 . . . . 0.0 110.615 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.495 ' CE1' ' CZ ' ' A' ' 134' ' ' PHE . 5.9 t80 -51.49 -25.32 6.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.22 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 5.7 tttp -62.74 -29.2 70.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.744 0.307 . . . . 0.0 110.915 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 32.8 m-20 -94.09 -39.17 10.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.263 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -89.87 145.59 25.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.086 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -132.55 145.37 51.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.147 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.495 ' CZ ' ' CE1' ' A' ' 129' ' ' PHE . 1.4 m-85 -78.27 124.78 28.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.858 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.423 ' CE2' ' HB2' ' A' ' 80' ' ' GLU . 38.0 m-85 -129.9 135.96 48.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.767 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.58 HD11 HG21 ' A' ' 81' ' ' THR . 0.6 OUTLIER -120.99 159.65 22.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.858 179.905 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.68 -165.69 0.38 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.215 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -71.78 -8.93 57.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.573 0.225 . . . . 0.0 111.502 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 -96.97 -28.29 14.24 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.435 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 62.0 mtm 55.37 37.71 29.28 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.853 0.359 . . . . 0.0 110.93 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ASN . . . . . 0.41 ' ND2' ' HA3' ' A' ' 144' ' ' GLY . 16.7 p-10 -61.87 115.25 14.43 Favored Pre-proline 0 N--CA 1.451 -0.386 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.933 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.21 -30.64 91.71 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.498 2.132 . . . . 0.0 112.183 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -84.59 -3.14 58.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.102 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.41 ' HA3' ' ND2' ' A' ' 141' ' ' ASN . . . -87.24 -169.29 45.6 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.472 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 2.3 ptp -86.58 -176.5 5.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.728 0.299 . . . . 0.0 110.91 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.56 HG21 ' HE2' ' A' ' 91' ' ' TYR . 48.9 t -128.17 148.85 32.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.962 0.41 . . . . 0.0 111.164 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.569 ' HB1' ' SD ' ' A' ' 160' ' ' MET . . . -111.64 115.2 28.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.599 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.67 HD13 HG21 ' A' ' 125' ' ' ILE . 3.2 mt -89.77 106.28 18.36 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.332 -179.174 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.462 HD11 HG21 ' A' ' 70' ' ' VAL . 4.1 tp -88.83 121.15 30.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.922 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.453 ' HB3' ' CZ ' ' A' ' 159' ' ' TYR . 31.2 t70 -134.67 164.01 28.48 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.547 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -110.36 148.52 31.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.051 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.66 -178.01 0.66 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.826 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -61.48 -31.07 71.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.94 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -84.66 -15.03 46.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.289 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 64.59 27.55 72.04 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.468 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 77.9 t -110.06 -42.47 5.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.846 0.355 . . . . 0.0 111.044 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 96.2 m -100.33 106.76 44.25 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.327 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.72 130.74 12.81 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.385 2.057 . . . . 0.0 111.609 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.453 ' CZ ' ' HB3' ' A' ' 150' ' ' ASP . 6.1 p90 -127.09 146.43 50.38 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.913 0.387 . . . . 0.0 111.18 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' MET . . . . . 0.713 ' CE ' HD13 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -113.12 145.4 40.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.041 -179.827 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.558 HG23 HD11 ' A' ' 23' ' ' ILE . 59.7 mt -101.78 110.61 29.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.267 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.515 ' CE1' ' HB2' ' A' ' 147' ' ' ALA . 52.2 m-85 -110.93 154.0 24.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.523 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -102.14 115.14 29.92 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.944 0.402 . . . . 0.0 110.861 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.629 ' CD ' HD11 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -58.94 -46.5 87.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.168 -179.655 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.455 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 56.5 m-20 -51.56 -31.84 25.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.987 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -106.45 25.99 21.42 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.395 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.525 HD21 ' HB3' ' A' ' 4' ' ' TYR . 0.6 OUTLIER -139.88 146.93 39.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.821 0.343 . . . . 0.0 110.941 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.23 150.79 29.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.843 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.788 ' HB3' HD11 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -121.59 142.92 49.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.986 -179.976 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -148.67 125.02 10.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.948 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.634 ' HG2' HD12 ' A' ' 2' ' ' ILE . 6.1 mttp -91.94 118.64 30.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.901 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' CYS . . . . . 0.687 ' C ' HD23 ' A' ' 173' ' ' LEU . 77.5 m -139.72 -48.46 0.47 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.891 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.687 HD23 ' C ' ' A' ' 172' ' ' CYS . 0.9 OUTLIER 45.42 40.51 5.6 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.435 179.979 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.882 179.982 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 tpp . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.766 0.317 . . . . 0.0 111.162 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.738 HD11 ' HB3' ' A' ' 169' ' ' MET . 3.5 tt -109.9 146.34 15.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.952 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.419 HG22 ' N ' ' A' ' 4' ' ' TYR . 29.3 mm -99.72 155.04 4.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.374 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.58 ' CE1' HG23 ' A' ' 2' ' ' ILE . 4.6 m-85 -124.43 107.29 10.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.669 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -123.8 144.93 49.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.153 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.58 ' OD1' HD12 ' A' ' 8' ' ' ILE . 42.5 t0 -54.88 140.62 36.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.856 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 43.1 tp -72.31 -20.29 61.52 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.362 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.58 HD12 ' OD1' ' A' ' 6' ' ' ASP . 4.1 mp -91.39 -46.3 14.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.51 -18.38 19.86 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -179.133 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.402 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 4.1 m80 62.2 29.28 17.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.864 0.364 . . . . 0.0 110.756 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -101.94 118.36 36.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.762 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -56.79 94.07 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.377 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 9.8 mtt -71.7 -19.24 62.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.695 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.501 ' CZ ' ' CD2' ' A' ' 4' ' ' TYR . 9.4 p90 -177.15 175.84 1.47 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.821 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.86 -171.13 2.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.593 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.409 ' HA ' ' CD1' ' A' ' 20' ' ' ILE . 21.1 t0 -95.52 36.24 1.28 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.113 0.482 . . . . 0.0 110.785 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.44 HG13 ' CD2' ' A' ' 18' ' ' TYR . 37.4 pt -94.5 -11.77 8.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.571 179.065 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.89 ' CZ ' HG22 ' A' ' 72' ' ' ILE . 43.5 m-85 -109.41 -166.85 1.14 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.573 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.7 mtpp -98.96 89.46 4.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.838 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.409 ' CD1' ' HA ' ' A' ' 16' ' ' ASP . 3.8 mp -88.03 124.68 41.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.881 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 11.0 mtp180 -115.78 121.16 41.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.158 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.515 ' HG3' HD23 ' A' ' 29' ' ' LEU . 5.1 mt-10 -74.0 116.36 14.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.803 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.457 HD11 HG23 ' A' ' 161' ' ' ILE . 5.1 pt -116.08 171.51 5.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.19 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 56.58 33.45 22.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.167 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 64.57 38.32 7.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.249 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.74 -13.84 66.6 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.737 -0.744 . . . . 0.0 113.113 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.806 HD21 ' HA ' ' A' ' 114' ' ' PHE . 0.1 OUTLIER -53.57 -48.09 69.48 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.749 0.309 . . . . 0.0 111.368 -179.885 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 18.8 m -126.0 167.27 15.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.272 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.831 HD21 ' HD2' ' A' ' 164' ' ' LYS . 0.3 OUTLIER -130.8 123.83 30.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.76 179.932 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -92.0 112.8 24.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.885 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.2 t -100.63 111.91 31.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.956 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -87.6 118.77 27.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.029 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -99.9 -128.49 6.3 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.299 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.48 125.89 0.31 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.856 0.36 . . . . 0.0 110.903 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 81.4 mtp -73.21 119.42 17.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.941 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.9 m -111.38 119.29 59.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.152 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.597 ' HB3' HG23 ' A' ' 68' ' ' THR . 88.4 p -90.14 165.5 13.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.001 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.515 ' HB3' HG12 ' A' ' 67' ' ' ILE . 3.8 ttt85 -155.87 148.54 24.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.697 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 19.8 m -136.65 -56.28 0.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.93 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 62.55 61.83 1.18 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.835 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -77.97 88.03 1.07 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.553 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -133.92 156.15 48.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.866 0.365 . . . . 0.0 110.819 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.506 ' O ' HG23 ' A' ' 43' ' ' ILE . 3.0 tp -124.04 121.02 61.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.403 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -175.22 173.95 2.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.896 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.2 t0 71.31 -62.66 0.45 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.174 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -48.71 -28.69 3.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.232 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.3 mt -69.77 -28.98 66.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.884 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -108.73 30.03 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.988 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -81.72 -33.56 27.18 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.58 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 61.3 82.86 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.513 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -120.35 -179.07 3.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.824 0.345 . . . . 0.0 110.916 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -169.5 -43.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.08 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.7 m -79.54 175.34 10.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.958 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -96.25 -36.47 10.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.221 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -161.53 146.87 13.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.893 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 179.16 -89.5 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.41 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.84 174.09 10.09 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.599 2.199 . . . . 0.0 112.33 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.95 153.89 24.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.927 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -141.84 95.89 0.19 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.493 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -99.26 118.6 36.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.863 0.363 . . . . 0.0 110.944 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -158.23 -127.61 0.95 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.424 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.4 m -89.64 115.77 27.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.804 0.335 . . . . 0.0 110.877 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.78 106.35 11.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.903 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.0 t -177.19 -173.58 0.46 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.012 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.6 t -165.79 -43.81 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.744 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 45.5 t -137.9 127.58 34.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.909 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.515 HG12 ' HB3' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -128.32 126.79 66.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.916 179.844 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.597 HG23 ' HB3' ' A' ' 37' ' ' SER . 1.3 m -139.33 122.3 16.7 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.923 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -161.82 -177.78 35.18 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.321 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.728 HG22 ' HG3' ' A' ' 158' ' ' PRO . 51.0 t -71.29 148.66 10.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.775 0.322 . . . . 0.0 110.793 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -73.8 -56.35 5.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.453 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.89 HG22 ' CZ ' ' A' ' 18' ' ' TYR . 11.2 pt -53.72 -33.97 23.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.349 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.789 HG13 ' HB2' ' A' ' 78' ' ' LEU . 59.7 t -71.6 -33.57 49.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.812 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.8 mtt -78.47 -39.6 37.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.693 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.2 p30 -82.04 -28.46 32.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.545 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.416 ' CG ' ' O ' ' A' ' 72' ' ' ILE . 7.2 m-70 -90.28 -2.59 58.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.845 0.355 . . . . 0.0 110.582 179.188 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.455 ' HB2' ' HB3' ' A' ' 138' ' ' GLU . 7.4 m80 59.87 28.24 17.7 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.892 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.789 ' HB2' HG13 ' A' ' 73' ' ' VAL . 64.2 mt -58.55 144.51 42.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.555 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -128.63 138.06 51.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.891 0.377 . . . . 0.0 111.251 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.412 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 18.4 tt0 -92.84 123.28 36.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.04 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.411 HG21 HD11 ' A' ' 136' ' ' ILE . 10.4 t -108.97 165.05 11.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.76 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.5 m -95.44 160.5 14.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.874 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.503 ' CE2' ' CE2' ' A' ' 91' ' ' TYR . 0.6 OUTLIER -171.66 148.56 2.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.908 -179.884 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.52 167.09 10.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.791 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.66 -52.43 64.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.896 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -63.39 -43.71 96.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.916 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.77 -36.61 79.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.156 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.952 ' CD2' HD11 ' A' ' 122' ' ' ILE . 0.2 OUTLIER -64.16 -33.82 76.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.833 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 23.4 mttt -61.62 -45.33 94.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.012 0.434 . . . . 0.0 110.369 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.55 -27.9 45.94 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.834 178.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.576 ' HE2' HG21 ' A' ' 146' ' ' VAL . 12.6 t80 -67.77 -47.09 70.18 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.848 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.861 HG22 ' O ' ' A' ' 88' ' ' TYR . 1.6 tp -62.46 -41.61 92.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.828 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.425 ' O ' ' CG ' ' A' ' 97' ' ' LYS . 17.5 ttmt -59.07 -46.36 88.47 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.045 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -66.42 -43.75 84.85 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.149 -179.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.541 ' CD1' ' C ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -73.24 -42.46 62.54 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.943 -179.088 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 23.0 ptm -61.0 -32.16 71.74 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.303 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.425 ' CG ' ' O ' ' A' ' 93' ' ' LYS . 6.4 mmtp -66.91 -43.91 82.13 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.511 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.2 m -56.19 -41.37 75.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.735 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.7 mt -79.79 -41.7 21.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.701 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 13.2 tttt -53.76 -56.29 18.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.532 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -59.97 -45.2 96.3 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.189 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.03 -41.93 97.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.903 0.383 . . . . 0.0 110.378 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.599 ' HB3' HG12 ' A' ' 111' ' ' VAL . 9.2 tp -66.36 -34.2 77.43 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.259 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.665 ' CG ' HG11 ' A' ' 111' ' ' VAL . 31.3 mt-10 -60.11 -29.07 68.37 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.617 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -88.19 -18.76 28.01 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.548 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -107.05 -58.49 1.93 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.775 0.322 . . . . 0.0 111.693 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.444 ' N ' ' O ' ' A' ' 103' ' ' LEU . 46.1 mtt180 -134.04 66.4 71.81 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.809 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.888 ' O ' HG22 ' A' ' 111' ' ' VAL . 9.1 Cg_endo -50.46 -22.68 9.3 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 123.141 2.561 . . . . 0.0 112.729 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -73.68 -9.3 58.53 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.735 0.302 . . . . 0.0 111.176 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.503 ' C ' ' HD2' ' A' ' 113' ' ' PRO . 3.0 mmt180 -110.91 -0.16 16.91 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.616 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.888 HG22 ' O ' ' A' ' 108' ' ' PRO . 32.9 m -72.67 -33.43 44.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.603 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 13.9 mttt -66.87 -50.38 43.7 Favored Pre-proline 0 C--N 1.331 -0.21 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.555 -179.257 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.603 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 32.8 Cg_exo -59.05 -39.36 80.88 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 121.967 1.778 . . . . 0.0 111.724 179.325 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.806 ' HA ' HD21 ' A' ' 27' ' ' LEU . 67.3 t80 -64.25 -37.89 89.1 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.887 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 4.1 mmm -58.57 -50.13 74.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.728 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 66.4 m -74.33 -44.34 52.92 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.742 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.47 -40.0 98.31 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.516 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.42 -51.55 69.34 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.006 0.431 . . . . 0.0 110.948 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.6 -31.42 65.17 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.088 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -72.12 -41.33 67.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.106 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 50.3 tp60 -73.53 -36.71 65.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.078 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.952 HD11 ' CD2' ' A' ' 88' ' ' TYR . 0.4 OUTLIER -67.12 -46.08 85.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.247 -179.765 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.451 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 1.2 ptpm? -61.42 -31.41 71.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.083 0.468 . . . . 0.0 110.223 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 7.0 t-80 -67.1 -53.66 28.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.705 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.59 HG21 HD13 ' A' ' 148' ' ' LEU . 15.0 pt -62.28 -41.71 92.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.249 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.466 ' HA ' HD23 ' A' ' 126' ' ' LEU . 12.3 mt -53.85 -35.85 61.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.922 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -68.05 -13.82 62.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.14 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -139.98 32.37 1.97 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.011 0.434 . . . . 0.0 110.628 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.514 ' CE1' ' CZ ' ' A' ' 134' ' ' PHE . 2.8 t80 -49.47 -28.87 5.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.096 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.49 -27.04 65.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.986 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -94.22 -35.97 12.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.476 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -94.44 140.52 29.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.923 0.392 . . . . 0.0 111.373 -179.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.406 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 4.9 mm-40 -124.13 145.49 49.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.805 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.514 ' CZ ' ' CE1' ' A' ' 129' ' ' PHE . 0.5 OUTLIER -80.47 123.87 28.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.069 -179.787 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.54 ' HB2' ' HB3' ' A' ' 147' ' ' ALA . 36.6 m-85 -126.76 151.94 47.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.499 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.412 ' CG2' ' HA ' ' A' ' 140' ' ' MET . 1.0 OUTLIER -138.7 160.04 30.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.001 179.863 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.05 -159.25 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.2 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.455 ' HB3' ' HB2' ' A' ' 77' ' ' HIS . 5.7 pt-20 -76.79 -8.77 57.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.609 0.242 . . . . 0.0 111.436 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 20.4 m-80 -96.58 -29.75 13.68 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.412 ' HA ' ' CG2' ' A' ' 136' ' ' ILE . 31.1 mtm 57.44 37.73 27.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.907 0.384 . . . . 0.0 110.854 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ASN . . . . . 0.423 ' ND2' ' HA3' ' A' ' 144' ' ' GLY . 15.0 p-10 -66.22 115.01 19.45 Favored Pre-proline 0 N--CA 1.452 -0.352 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.164 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 141' ' ' ASN . 23.3 Cg_exo -62.73 -28.96 76.75 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.505 2.137 . . . . 0.0 112.17 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -84.55 -3.9 58.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.148 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.423 ' HA3' ' ND2' ' A' ' 141' ' ' ASN . . . -87.05 -146.52 10.5 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.381 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.425 ' HE3' ' O ' ' A' ' 166' ' ' GLY . 2.3 ptp -104.9 179.86 4.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.765 0.317 . . . . 0.0 110.768 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.576 HG21 ' HE2' ' A' ' 91' ' ' TYR . 43.7 t -128.98 149.31 33.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.136 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.54 ' HB3' ' HB2' ' A' ' 135' ' ' PHE . . . -111.75 115.86 29.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.663 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.59 HD13 HG21 ' A' ' 125' ' ' ILE . 4.6 mt -90.57 106.14 18.3 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.86 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.49 HD11 HG21 ' A' ' 70' ' ' VAL . 5.2 tp -88.56 120.64 30.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.192 -179.526 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.456 ' HB3' ' CE1' ' A' ' 159' ' ' TYR . 47.9 t0 -138.06 164.35 29.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.442 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -105.98 146.99 29.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.889 0.376 . . . . 0.0 111.026 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.71 -177.66 0.62 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.863 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -60.46 -41.21 93.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.858 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -79.19 -15.11 58.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.16 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 60.51 33.79 83.0 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.537 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 91.2 t -107.08 -24.08 4.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.78 0.324 . . . . 0.0 111.039 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.4 t -132.22 124.23 19.24 Favored Pre-proline 0 CA--C 1.531 0.241 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.136 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.728 ' HG3' HG22 ' A' ' 70' ' ' VAL . 93.7 Cg_endo -79.93 135.42 11.21 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.529 2.152 . . . . 0.0 112.079 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.456 ' CE1' ' HB3' ' A' ' 150' ' ' ASP . 8.0 p90 -124.61 136.02 53.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.862 0.363 . . . . 0.0 111.016 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' MET . . . . . 0.642 ' HG3' HD11 ' A' ' 72' ' ' ILE . 24.7 mtp -104.43 140.51 37.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.958 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.495 ' HB ' ' HB2' ' A' ' 148' ' ' LEU . 53.1 mt -99.67 113.67 35.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.16 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -110.15 158.14 18.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.705 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.413 ' CZ ' ' OH ' ' A' ' 95' ' ' TYR . 24.2 m-85 -99.18 114.64 27.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.852 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.831 ' HD2' HD21 ' A' ' 29' ' ' LEU . 33.0 tttm -57.98 -51.9 67.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.136 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.43 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 37.8 m-20 -54.55 -35.63 63.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.038 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.425 ' O ' ' HE3' ' A' ' 145' ' ' MET . . . -96.94 28.51 13.46 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.397 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.429 HD11 ' HB3' ' A' ' 4' ' ' TYR . 1.0 OUTLIER -147.34 143.6 28.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.878 0.37 . . . . 0.0 110.801 -179.911 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -105.11 162.58 13.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.803 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.738 ' HB3' HD11 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -134.31 138.32 44.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.976 179.934 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -144.71 118.16 9.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.845 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.497 ' HG2' HD12 ' A' ' 2' ' ' ILE . 12.8 mtpt -78.71 115.97 18.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.998 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 25.8 p -97.79 -176.05 3.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.786 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -114.76 160.67 19.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.917 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.857 -179.993 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ttt . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.858 0.361 . . . . 0.0 111.215 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.765 HD11 ' HB3' ' A' ' 169' ' ' MET . 2.4 tt -108.04 147.66 12.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.008 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.477 HG21 ' HB3' ' A' ' 12' ' ' GLU . 21.2 mm -101.77 157.88 4.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.353 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.566 ' HE1' HG23 ' A' ' 2' ' ' ILE . 5.5 m-85 -126.58 95.22 4.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.423 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 10.0 ptt180 -110.67 148.59 31.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.955 0.407 . . . . 0.0 111.183 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.443 ' O ' ' HA ' ' A' ' 10' ' ' HIS . 31.8 t0 -56.96 152.2 13.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.741 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 36.1 tp -81.31 -24.05 37.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.225 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.684 HD11 HG13 ' A' ' 99' ' ' ILE . 3.9 mp -91.36 -44.61 14.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.827 -179.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.0 t -94.13 -21.09 19.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.756 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.443 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 25.5 m-70 62.34 26.63 15.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.86 0.362 . . . . 0.0 110.812 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -101.96 124.6 47.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.798 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.477 ' HB3' HG21 ' A' ' 3' ' ' ILE . 1.3 pm0 -58.03 104.06 0.18 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.386 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 19.7 mtt -82.82 -18.68 39.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.62 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.508 ' CE2' ' CD2' ' A' ' 4' ' ' TYR . 16.0 p90 -178.64 176.74 0.96 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.68 179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.66 -170.73 2.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.824 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -95.91 28.53 3.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.114 0.483 . . . . 0.0 110.877 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 45.9 pt -89.31 -11.34 10.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.731 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.806 ' CZ ' HG22 ' A' ' 72' ' ' ILE . 62.9 m-85 -109.45 -171.09 1.77 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.67 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.1 mttt -94.13 86.97 5.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.702 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.7 mp -88.66 127.06 41.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.203 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -119.87 148.36 43.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.612 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.53 ' HG3' HD23 ' A' ' 29' ' ' LEU . 3.1 mt-10 -94.25 117.09 29.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.01 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.42 HD11 HG23 ' A' ' 161' ' ' ILE . 6.1 pt -113.71 166.63 7.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.087 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 57.53 29.99 18.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.203 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 64.56 39.66 6.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.203 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.37 -16.09 61.82 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.593 -0.813 . . . . 0.0 113.071 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.57 -30.14 53.37 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.829 0.347 . . . . 0.0 111.083 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 56.6 m -149.4 164.66 34.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.877 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.53 HD23 ' HG3' ' A' ' 22' ' ' GLU . 0.5 OUTLIER -129.32 128.97 44.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.962 -179.961 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.471 ' HA ' ' O ' ' A' ' 160' ' ' MET . 67.7 mt-10 -91.27 117.25 29.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.306 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' ' 159' ' ' TYR . 23.0 t -98.79 111.94 29.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.605 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -90.74 116.28 28.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.303 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -100.78 -130.52 7.07 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.228 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.2 pttm -174.46 125.98 0.32 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.919 0.39 . . . . 0.0 110.893 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 35.8 mtp -70.37 123.46 21.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.745 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.0 m -114.07 134.39 57.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.229 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.424 ' HA ' HG23 ' A' ' 68' ' ' THR . 83.3 p -90.16 165.5 13.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.748 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.573 ' HB3' HG12 ' A' ' 67' ' ' ILE . 4.1 ttt180 -144.45 128.25 17.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.016 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 46.0 p -137.98 26.15 2.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.961 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 59.67 160.41 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.933 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.66 -153.17 20.09 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.611 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -99.68 -24.21 14.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.781 0.324 . . . . 0.0 111.102 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.7 mp 69.3 133.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.109 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.31 128.8 50.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.907 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -146.2 -168.18 2.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.782 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 37.8 t -80.1 -34.49 37.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.936 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.69 -35.11 22.78 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.985 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -114.31 170.56 4.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.981 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.32 100.0 1.9 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.463 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -108.66 -29.05 4.29 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.489 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -114.76 162.19 17.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.804 0.335 . . . . 0.0 110.845 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -84.17 -31.12 25.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.076 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.4 151.41 24.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.924 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -98.4 33.1 2.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.132 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.22 164.29 13.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.906 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 160.05 -104.63 0.25 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.564 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -86.07 43.43 1.12 Allowed 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.8 2.333 . . . . 0.0 112.693 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 60.62 113.34 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.878 0.37 . . . . 0.0 110.961 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -142.89 121.11 1.67 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.54 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 28.9 tp10 -130.43 -47.91 1.08 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.859 0.361 . . . . 0.0 110.9 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.63 154.36 30.12 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.477 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.3 m -112.29 -36.42 5.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.864 0.364 . . . . 0.0 110.921 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -137.49 156.58 47.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.877 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.8 m -112.23 90.09 3.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.921 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.0 t -129.18 124.76 35.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.979 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.419 ' C ' HD13 ' A' ' 67' ' ' ILE . 56.2 t -92.56 133.09 35.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.051 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.573 HG12 ' HB3' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -122.4 130.72 74.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.73 179.792 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.424 HG23 ' HA ' ' A' ' 37' ' ' SER . 2.9 m -139.15 127.79 23.21 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.98 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -158.04 -176.22 29.85 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.249 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.496 HG12 HG12 ' A' ' 72' ' ' ILE . 47.7 t -72.58 142.73 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-O 120.801 0.334 . . . . 0.0 110.801 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -69.04 -56.61 7.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.551 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.806 HG22 ' CZ ' ' A' ' 18' ' ' TYR . 9.5 pt -53.66 -33.83 23.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.816 0.341 . . . . 0.0 111.409 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.782 HG13 ' HB2' ' A' ' 78' ' ' LEU . 98.6 t -71.2 -33.08 49.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.037 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.0 mtm -78.27 -39.73 39.18 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.634 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.43 ' OD1' ' CD2' ' A' ' 76' ' ' HIS . 15.2 p30 -82.17 -28.24 32.19 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.609 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.441 ' CE1' ' HB ' ' A' ' 72' ' ' ILE . 28.1 m170 -93.07 0.99 57.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.852 0.358 . . . . 0.0 110.801 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.438 ' HB2' ' HB3' ' A' ' 138' ' ' GLU . 7.8 m170 56.58 28.53 14.06 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.314 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.782 ' HB2' HG13 ' A' ' 73' ' ' VAL . 71.0 mt -56.99 129.13 40.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.512 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 -112.82 130.58 56.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.254 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.412 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 30.1 tt0 -83.86 129.66 34.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.074 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.6 t -116.57 -179.75 3.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.856 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 69.9 m -121.4 165.67 15.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.96 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.501 ' CE2' ' CE2' ' A' ' 91' ' ' TYR . 3.2 m-85 -171.71 154.01 3.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.043 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.4 ' H ' ' HB3' ' A' ' 87' ' ' ALA . 3.2 m -101.58 166.98 10.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.694 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.0 mtpp -57.73 -52.47 65.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.891 0.377 . . . . 0.0 110.996 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.72 -37.14 76.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.959 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.4 ' HB3' ' H ' ' A' ' 84' ' ' THR . . . -65.31 -44.28 88.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.158 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.826 ' CD2' HD11 ' A' ' 122' ' ' ILE . 1.0 OUTLIER -60.98 -32.93 72.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.814 179.876 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 18.2 mttm -61.97 -43.41 98.91 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.549 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.1 mtmt -78.09 -28.02 48.61 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.663 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.554 ' HE2' HG21 ' A' ' 146' ' ' VAL . 8.8 t80 -65.48 -47.41 76.15 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.616 179.544 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.444 ' O ' ' HG2' ' A' ' 96' ' ' MET . 4.7 tp -61.18 -45.91 97.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.956 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.405 ' N ' HG23 ' A' ' 92' ' ' ILE . 16.6 tttp -58.42 -38.33 77.18 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.252 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.514 ' HA ' ' HG2' ' A' ' 97' ' ' LYS . 19.6 t70 -75.06 -43.64 52.19 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.903 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.46 ' CD1' ' C ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -75.22 -40.07 59.46 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 121.074 -0.25 . . . . 0.0 111.119 -179.368 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.444 ' HG2' ' O ' ' A' ' 92' ' ' ILE . 3.1 ptt? -67.7 -32.27 72.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.734 0.302 . . . . 0.0 110.707 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.514 ' HG2' ' HA ' ' A' ' 94' ' ' ASP . 5.4 ptpt -69.23 -34.32 74.66 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.705 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.478 ' N ' ' HG3' ' A' ' 97' ' ' LYS . 2.1 m -62.71 -41.28 99.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.295 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.684 HG13 HD11 ' A' ' 8' ' ' ILE . 5.9 mt -79.89 -39.08 19.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.352 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.97 -57.79 10.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.578 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -59.44 -43.53 97.39 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.625 -0.797 . . . . 0.0 111.914 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.4 tmtt? -61.51 -42.11 98.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.978 0.418 . . . . 0.0 110.276 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.715 ' HB3' HG12 ' A' ' 111' ' ' VAL . 8.7 tp -66.69 -33.35 75.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.1 179.327 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.706 ' CG ' HG11 ' A' ' 111' ' ' VAL . 39.6 mt-10 -60.5 -28.98 68.8 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.611 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -87.24 -20.24 27.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.436 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -104.95 -58.87 1.83 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.779 0.323 . . . . 0.0 111.703 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.452 ' N ' ' O ' ' A' ' 103' ' ' LEU . 23.8 mtt85 -136.43 67.39 60.02 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.027 0.441 . . . . 0.0 110.894 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.919 ' O ' HG22 ' A' ' 111' ' ' VAL . 9.5 Cg_endo -50.58 -21.71 8.16 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 123.275 2.65 . . . . 0.0 112.733 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -71.07 -9.12 57.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.608 0.242 . . . . 0.0 111.245 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.481 ' CB ' HD21 ' A' ' 103' ' ' LEU . 0.1 OUTLIER -112.44 -3.4 14.47 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 -179.472 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.919 HG22 ' O ' ' A' ' 108' ' ' PRO . 34.7 m -71.74 -27.19 27.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.659 0.266 . . . . 0.0 111.656 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.604 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 0.9 OUTLIER -68.68 -55.54 11.2 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.574 -179.194 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.604 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 37.1 Cg_exo -59.87 -31.82 94.38 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 121.868 1.712 . . . . 0.0 111.429 179.141 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.443 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 73.5 t80 -68.15 -42.78 79.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.958 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -56.02 -51.9 66.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.887 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 60.2 m -76.57 -43.82 37.25 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.675 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -55.3 -53.84 38.19 Favored Glycine 0 N--CA 1.452 -0.277 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.761 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.403 ' O ' ' HB ' ' A' ' 122' ' ' ILE . . . -56.62 -51.78 67.39 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.052 0.453 . . . . 0.0 111.09 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.78 -28.05 69.18 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.182 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -75.49 -57.86 3.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.229 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -60.12 -39.66 87.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.399 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.826 HD11 ' CD2' ' A' ' 88' ' ' TYR . 0.4 OUTLIER -58.27 -46.5 88.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.897 0.38 . . . . 0.0 111.165 -179.777 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.454 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 20.0 mttm -62.02 -29.98 70.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.229 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -70.88 -54.79 10.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.709 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.635 HG22 ' CD2' ' A' ' 132' ' ' TYR . 15.4 pt -60.41 -43.8 94.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.277 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.52 HD21 ' CD2' ' A' ' 88' ' ' TYR . 11.6 mt -54.36 -37.58 65.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.944 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -72.55 -9.54 58.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.441 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 -142.47 31.68 1.5 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.899 0.381 . . . . 0.0 110.765 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.518 ' CE1' ' CZ ' ' A' ' 134' ' ' PHE . 6.3 t80 -54.11 -24.36 17.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.074 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 40.5 mtmt -57.92 -23.68 54.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.052 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 16.3 m-20 -94.23 -49.22 5.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.447 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.635 ' CD2' HG22 ' A' ' 125' ' ' ILE . 0.6 OUTLIER -88.21 154.07 20.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.932 0.396 . . . . 0.0 111.212 -179.404 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.446 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 4.0 mm-40 -131.29 143.32 50.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.945 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.518 ' CZ ' ' CE1' ' A' ' 129' ' ' PHE . 2.5 m-85 -77.75 121.28 23.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.055 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.412 ' CE2' ' HB2' ' A' ' 80' ' ' GLU . 32.9 m-85 -126.47 134.97 50.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.708 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.464 ' HB ' ' HA ' ' A' ' 140' ' ' MET . 0.7 OUTLIER -120.91 160.99 21.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.785 179.989 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -58.31 -165.5 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.272 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.438 ' HB3' ' HB2' ' A' ' 77' ' ' HIS . 7.1 pm0 -72.54 -9.01 58.04 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.544 0.212 . . . . 0.0 111.371 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.519 ' HB3' ' ND2' ' A' ' 141' ' ' ASN . 22.5 m-80 -96.92 -35.4 10.9 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.504 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.464 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 37.0 mtp 60.86 36.91 18.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.701 0.286 . . . . 0.0 111.234 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ASN . . . . . 0.519 ' ND2' ' HB3' ' A' ' 139' ' ' ASN . 7.4 m120 -66.0 122.21 79.92 Favored Pre-proline 0 N--CA 1.453 -0.297 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.733 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -61.89 -23.46 75.98 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.246 1.964 . . . . 0.0 111.824 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -84.64 -12.24 54.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.672 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -79.27 -160.46 19.01 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.237 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.481 ' HE2' ' HB2' ' A' ' 163' ' ' PHE . 0.7 OUTLIER -100.31 -177.38 3.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.766 0.317 . . . . 0.0 110.93 179.827 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.554 HG21 ' HE2' ' A' ' 91' ' ' TYR . 46.9 t -126.67 148.92 31.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.135 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.504 ' HB2' ' CE2' ' A' ' 162' ' ' PHE . . . -116.27 110.58 18.94 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.555 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.582 HD13 HG21 ' A' ' 125' ' ' ILE . 3.9 mt -84.58 115.25 22.52 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.139 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.425 HD12 ' HG2' ' A' ' 160' ' ' MET . 12.4 tp -88.27 123.62 33.05 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.764 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.501 ' HB2' ' CZ ' ' A' ' 159' ' ' TYR . 24.2 m-20 -127.72 158.69 36.94 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.885 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -117.22 148.84 41.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.907 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -75.48 178.57 5.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.822 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.8 -37.94 80.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.976 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -75.62 -15.11 60.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.302 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 64.05 23.69 68.0 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.492 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 65.3 t -112.0 -38.38 3.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.753 0.311 . . . . 0.0 110.89 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 86.9 m -98.58 103.01 16.34 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.226 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -77.93 127.55 8.65 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.395 2.063 . . . . 0.0 112.057 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.501 ' CZ ' ' HB2' ' A' ' 150' ' ' ASP . 12.1 p90 -124.58 133.17 53.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.668 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' MET . . . . . 0.587 ' HE3' HD13 ' A' ' 78' ' ' LEU . 0.3 OUTLIER -99.98 169.01 9.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.761 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.529 ' HB ' ' HB2' ' A' ' 148' ' ' LEU . 89.6 mt -123.94 110.7 26.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.175 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.504 ' CE2' ' HB2' ' A' ' 147' ' ' ALA . 87.6 m-85 -114.38 156.71 23.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.729 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.481 ' HB2' ' HE2' ' A' ' 145' ' ' MET . 4.4 m-85 -99.21 123.59 43.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.852 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.492 ' CG ' HD11 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -62.32 -55.31 29.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.189 -179.789 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.443 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 0.8 OUTLIER -51.23 -34.92 34.34 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.071 -179.855 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -96.86 27.9 16.03 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.366 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.466 HD21 ' HB3' ' A' ' 4' ' ' TYR . 0.7 OUTLIER -146.66 144.05 29.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.777 0.322 . . . . 0.0 110.793 -179.848 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -112.85 156.82 22.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.811 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.765 ' HB3' HD11 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -120.51 149.98 41.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.005 -179.974 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -157.85 125.55 5.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.926 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.696 ' HG2' HD12 ' A' ' 2' ' ' ILE . 14.4 mmtt -90.68 119.32 30.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.964 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -171.27 140.84 1.51 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.866 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 1.7 mp -93.47 -35.42 12.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.907 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.878 -179.96 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.1 ttt . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.856 0.36 . . . . 0.0 111.205 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.693 HD11 ' HB3' ' A' ' 169' ' ' MET . 1.7 tt -104.71 146.69 11.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.036 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.501 HG21 ' HB3' ' A' ' 12' ' ' GLU . 11.7 mm -106.6 155.61 7.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.136 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.603 ' HE1' HG23 ' A' ' 2' ' ' ILE . 3.7 m-85 -123.73 104.71 9.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.665 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.73 156.31 32.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.9 0.381 . . . . 0.0 111.277 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.445 ' O ' ' HA ' ' A' ' 10' ' ' HIS . 27.0 t0 -61.64 152.18 31.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.767 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 67.1 tp -80.45 -22.11 41.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.234 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.417 ' H ' HD12 ' A' ' 8' ' ' ILE . 4.0 mp -91.23 -46.53 14.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.966 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -93.05 -28.77 16.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.705 -179.249 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.445 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER 68.72 30.88 4.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.907 0.384 . . . . 0.0 110.747 -179.681 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -102.73 125.06 49.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.806 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.501 ' HB3' HG21 ' A' ' 3' ' ' ILE . 0.9 OUTLIER -57.12 96.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.311 -179.764 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 42.2 mtp -79.71 -16.97 54.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.606 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.502 ' CE2' ' CD2' ' A' ' 4' ' ' TYR . 23.7 p90 -178.98 172.73 1.25 Allowed 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.706 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -133.05 -169.91 2.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.19 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 54.3 p30 -89.3 15.56 8.84 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.521 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 44.6 pt -82.69 -9.31 11.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.816 0.341 . . . . 0.0 111.229 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.875 ' CZ ' HG22 ' A' ' 72' ' ' ILE . 74.3 m-85 -111.65 -178.06 3.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.819 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.7 mtmt -94.48 91.45 6.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.683 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.539 ' N ' HD12 ' A' ' 20' ' ' ILE . 4.3 mp -87.84 129.94 38.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.11 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.7 mtm180 -120.89 126.0 48.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.892 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -74.36 116.19 14.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.84 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.85 HD11 HG23 ' A' ' 161' ' ' ILE . 3.6 pt -109.6 165.37 5.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.025 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.431 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . . . 59.5 32.69 21.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.092 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 64.78 45.01 3.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.301 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.52 -12.4 63.22 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.744 -0.741 . . . . 0.0 113.272 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.431 ' HB3' ' HB3' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -55.89 -39.48 71.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.938 0.369 . . . . 0.0 111.191 -179.885 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.427 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 96.6 m -137.32 170.96 15.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.081 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.74 131.25 40.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.86 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.404 ' OE1' ' CD2' ' A' ' 159' ' ' TYR . 63.3 mt-10 -97.49 113.8 25.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.04 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.462 HG23 ' HD2' ' A' ' 162' ' ' PHE . 23.5 t -90.58 112.08 24.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.904 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -85.53 120.63 27.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.994 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.46 -142.34 11.14 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.457 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.408 ' HG3' ' HB2' ' A' ' 71' ' ' ASP . 4.0 ptmm? -165.31 124.73 1.77 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.787 0.327 . . . . 0.0 110.795 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 52.4 mtm -72.04 123.8 23.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.94 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.0 m -119.48 130.23 74.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.133 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 81.0 p -97.99 165.5 11.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.956 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.624 ' HB3' HG12 ' A' ' 67' ' ' ILE . 4.8 ttm180 -131.96 119.06 20.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.748 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 78.3 p -133.72 25.9 4.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.041 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 66.15 -73.86 0.07 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.006 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -164.67 76.53 0.15 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.448 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -77.27 157.91 30.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.869 0.366 . . . . 0.0 110.876 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.581 HG22 ' O ' ' A' ' 43' ' ' ILE . 22.9 mt 64.25 36.9 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.12 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.17 -44.29 3.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.815 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -70.12 176.24 3.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.874 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.99 -75.82 0.62 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.978 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.1 mt -77.22 -33.38 56.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.023 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 24.0 mt 52.48 83.4 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.212 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 110.64 142.42 9.19 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.569 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 162.7 175.98 34.3 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.483 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 17.1 m-20 -85.7 75.0 10.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.837 0.351 . . . . 0.0 110.874 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -175.75 144.41 0.64 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.079 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 60.66 31.31 20.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.87 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 59.87 168.09 0.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.099 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -113.13 -70.87 0.78 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.896 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -137.1 113.74 1.05 Allowed Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.388 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.39 121.77 8.93 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.479 2.119 . . . . 0.0 112.297 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 60.83 101.76 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.887 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.09 -179.93 51.87 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.512 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.01 88.54 2.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.921 0.391 . . . . 0.0 110.925 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -168.97 145.18 9.26 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.368 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.54 -42.61 42.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.843 0.354 . . . . 0.0 110.877 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 58.78 96.82 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.922 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.516 ' O ' HG23 ' A' ' 66' ' ' VAL . 9.3 m -136.6 131.86 34.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.946 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.418 ' O ' HG23 ' A' ' 65' ' ' THR . 3.0 t -59.5 97.36 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.879 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.762 ' C ' HD13 ' A' ' 67' ' ' ILE . 71.0 t -111.4 133.52 56.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.251 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.762 HD13 ' C ' ' A' ' 66' ' ' VAL . 0.0 OUTLIER -140.13 131.73 32.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.535 179.349 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.2 m -139.03 127.59 23.12 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.115 0.484 . . . . 0.0 110.984 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -169.24 -173.98 37.33 Favored Glycine 0 N--CA 1.451 -0.33 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.117 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.448 ' CG1' HG12 ' A' ' 72' ' ' ILE . 53.2 t -70.8 147.58 11.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.791 0.329 . . . . 0.0 110.987 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.408 ' HB2' ' HG3' ' A' ' 34' ' ' LYS . 26.4 t70 -73.57 -55.56 6.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.306 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.875 HG22 ' CZ ' ' A' ' 18' ' ' TYR . 8.9 pt -53.62 -33.72 22.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.183 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.81 HG13 ' HB2' ' A' ' 78' ' ' LEU . 84.1 t -71.5 -33.62 50.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.091 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.8 mtm -78.07 -39.2 42.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.585 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.409 ' OD1' ' CD2' ' A' ' 76' ' ' HIS . 15.8 p30 -82.11 -28.38 32.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.508 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.461 ' CE1' ' HB ' ' A' ' 72' ' ' ILE . 24.4 m170 -94.93 1.69 55.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.778 0.323 . . . . 0.0 110.936 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.423 ' HB2' ' HB3' ' A' ' 138' ' ' GLU . 15.7 m80 54.98 32.22 17.65 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.344 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.81 ' HB2' HG13 ' A' ' 73' ' ' VAL . 54.6 mt -59.13 139.11 57.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.383 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -124.77 137.44 54.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.93 0.395 . . . . 0.0 111.239 -179.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.409 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 2.5 tt0 -92.86 124.14 36.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.926 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.85 HG21 HD11 ' A' ' 136' ' ' ILE . 3.5 t -115.19 127.35 55.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.888 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 89.3 p -68.91 159.67 32.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.941 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -165.32 164.22 19.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.748 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -101.58 167.84 9.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.835 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.5 mtpt -67.02 -52.46 42.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.838 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.7 tp10 -64.89 -42.82 94.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.511 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.88 -39.37 81.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.931 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.82 ' CD2' HD11 ' A' ' 122' ' ' ILE . 1.3 t80 -59.94 -38.66 83.04 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.786 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.432 ' O ' HG22 ' A' ' 92' ' ' ILE . 70.7 mttt -56.82 -45.72 82.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.112 0.482 . . . . 0.0 110.591 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.79 -27.77 50.28 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.641 178.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.532 ' HE2' HG21 ' A' ' 146' ' ' VAL . 13.4 t80 -66.77 -44.6 80.95 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.743 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.563 HD12 ' CE2' ' A' ' 95' ' ' TYR . 5.4 tp -63.15 -44.3 99.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.014 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -62.63 -37.15 85.2 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.067 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.483 ' HA ' ' HG2' ' A' ' 97' ' ' LYS . 29.3 t70 -75.76 -42.95 48.97 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.662 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.563 ' CE2' HD12 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -77.8 -40.86 39.26 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 121.013 -0.275 . . . . 0.0 110.863 -179.476 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.439 ' HG3' ' N ' ' A' ' 97' ' ' LYS . 0.1 OUTLIER -65.12 -31.85 73.26 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.249 179.418 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.488 ' HG3' ' N ' ' A' ' 98' ' ' SER . 15.1 pttt -70.64 -34.13 71.74 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 120.945 0.402 . . . . 0.0 110.178 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.488 ' N ' ' HG3' ' A' ' 97' ' ' LYS . 2.0 m -59.47 -37.41 78.12 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.761 179.122 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.7 mt -79.78 -40.88 21.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.102 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.75 -51.33 70.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.22 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -59.54 -47.69 89.69 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.64 -0.79 . . . . 0.0 111.91 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.6 -41.27 97.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.921 0.391 . . . . 0.0 110.086 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.641 ' HB3' HG12 ' A' ' 111' ' ' VAL . 8.3 tp -65.37 -37.88 88.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.958 179.192 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.681 ' CG ' HG11 ' A' ' 111' ' ' VAL . 76.4 mt-10 -56.62 -29.95 62.75 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.767 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -86.62 -20.19 28.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.531 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -106.84 -60.9 1.61 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.763 0.316 . . . . 0.0 111.602 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.457 ' N ' ' O ' ' A' ' 103' ' ' LEU . 4.0 mtt85 -129.37 65.23 73.92 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.816 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.876 ' O ' HG22 ' A' ' 111' ' ' VAL . 9.7 Cg_endo -50.4 -22.5 8.85 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 123.22 2.613 . . . . 0.0 112.745 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -75.69 -6.92 52.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.653 0.263 . . . . 0.0 111.136 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.515 ' C ' ' HD2' ' A' ' 113' ' ' PRO . 13.9 mmt180 -112.38 -1.53 15.02 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.654 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.876 HG22 ' O ' ' A' ' 108' ' ' PRO . 33.7 m -70.77 -36.24 63.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.574 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 25.8 mttm -66.65 -50.29 46.37 Favored Pre-proline 0 CA--C 1.529 0.16 0 C-N-CA 121.049 -0.261 . . . . 0.0 111.502 -179.194 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.574 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 37.0 Cg_exo -59.97 -32.04 94.47 Favored 'Trans proline' 0 C--N 1.347 0.447 0 C-N-CA 121.993 1.796 . . . . 0.0 111.568 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.485 ' CE1' ' HB2' ' A' ' 165' ' ' ASP . 76.0 t80 -69.99 -47.71 61.11 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.852 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -50.97 -42.03 59.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.02 0.438 . . . . 0.0 110.769 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.8 m -76.65 -44.29 34.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.717 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.43 -52.47 52.39 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.679 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.04 -51.74 66.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.937 0.399 . . . . 0.0 111.134 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.58 -28.2 68.97 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.363 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -77.87 -45.69 23.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.9 0.381 . . . . 0.0 111.194 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.427 ' NE2' ' SG ' ' A' ' 28' ' ' CYS . 26.3 tt0 -70.49 -36.45 73.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.208 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.82 HD11 ' CD2' ' A' ' 88' ' ' TYR . 0.3 OUTLIER -61.89 -47.37 93.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.326 -179.765 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.465 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 13.4 pttt -61.76 -31.19 71.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.017 0.437 . . . . 0.0 110.072 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 10.2 t-80 -67.9 -53.65 24.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.621 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.605 HG21 HD13 ' A' ' 148' ' ' LEU . 15.5 pt -62.01 -42.04 93.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.291 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.474 ' HA ' HD23 ' A' ' 126' ' ' LEU . 11.3 mt -53.9 -35.9 62.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.944 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.99 -14.29 62.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.087 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -140.5 33.15 1.85 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.073 0.463 . . . . 0.0 110.398 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.504 ' CE1' ' CZ ' ' A' ' 134' ' ' PHE . 5.5 t80 -49.02 -27.59 3.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.224 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 2.8 ttpp -60.57 -27.78 67.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.791 0.329 . . . . 0.0 110.867 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 30.8 m-20 -94.27 -32.19 13.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.322 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.412 ' CZ ' ' OD2' ' A' ' 150' ' ' ASP . 3.6 m-85 -98.36 131.97 44.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.199 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -117.33 143.72 45.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.803 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.51 ' CE1' ' CZ ' ' A' ' 88' ' ' TYR . 2.1 m-85 -80.01 124.11 28.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.062 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.409 ' CE2' ' HB2' ' A' ' 80' ' ' GLU . 43.1 m-85 -127.88 145.84 50.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.686 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.85 HD11 HG21 ' A' ' 81' ' ' THR . 0.7 OUTLIER -131.59 163.64 36.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.042 179.958 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -64.56 -159.55 0.38 Allowed Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.298 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.423 ' HB3' ' HB2' ' A' ' 77' ' ' HIS . 1.2 pt-20 -75.97 -8.89 58.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.597 0.237 . . . . 0.0 111.512 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -97.24 -31.75 12.27 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.583 0.23 . . . . 0.0 111.563 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.422 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 56.0 mtp 58.26 37.39 26.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.809 0.338 . . . . 0.0 110.945 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ASN . . . . . 0.41 ' ND2' ' HA3' ' A' ' 144' ' ' GLY . 19.6 p-10 -64.35 115.0 16.18 Favored Pre-proline 0 N--CA 1.452 -0.372 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.934 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.92 -29.7 90.04 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.514 2.142 . . . . 0.0 112.287 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -84.55 -6.63 59.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.059 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.41 ' HA3' ' ND2' ' A' ' 141' ' ' ASN . . . -79.08 -141.12 2.05 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.413 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 3.2 ptp -113.36 -178.55 3.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.752 0.311 . . . . 0.0 110.919 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.532 HG21 ' HE2' ' A' ' 91' ' ' TYR . 42.2 t -128.06 144.95 36.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.283 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -111.67 114.73 27.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.681 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.605 HD13 HG21 ' A' ' 125' ' ' ILE . 3.3 mt -88.53 106.3 18.2 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.068 -179.374 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.483 HD12 ' HG2' ' A' ' 160' ' ' MET . 2.7 tp -88.93 119.62 29.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.219 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.462 ' HB2' ' CZ ' ' A' ' 159' ' ' TYR . 0.9 OUTLIER -129.08 165.91 20.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.695 179.517 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -111.88 146.15 38.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.96 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 21.9 mmt180 -67.32 -177.46 0.7 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.879 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.41 -31.94 68.17 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.899 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 38.1 p-10 -77.35 -15.05 59.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.23 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 71.83 17.21 76.66 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.72 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 91.1 t -112.93 -70.4 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.841 0.353 . . . . 0.0 110.733 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 86.4 m -55.07 107.86 0.99 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.08 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -84.25 128.22 4.16 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.586 2.19 . . . . 0.0 112.334 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.462 ' CZ ' ' HB2' ' A' ' 150' ' ' ASP . 9.4 p90 -124.22 136.05 53.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.821 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' MET . . . . . 0.492 ' CE ' HD13 ' A' ' 78' ' ' LEU . 0.5 OUTLIER -107.08 136.73 46.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.992 -179.765 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.85 HG23 HD11 ' A' ' 23' ' ' ILE . 62.3 mt -91.55 112.65 25.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.103 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.462 ' HD2' HG23 ' A' ' 31' ' ' VAL . 89.6 m-85 -110.24 152.18 26.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.833 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.42 ' CE2' ' OH ' ' A' ' 95' ' ' TYR . 3.1 m-85 -96.28 124.7 40.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.617 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -65.96 -56.36 12.08 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.355 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.485 ' HB2' ' CE1' ' A' ' 114' ' ' PHE . 7.0 m-20 -50.1 -36.29 28.98 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.859 0.362 . . . . 0.0 111.071 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -95.87 24.76 28.3 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.24 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.467 HD21 ' HB3' ' A' ' 4' ' ' TYR . 0.6 OUTLIER -139.99 145.07 37.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.754 0.311 . . . . 0.0 110.841 -179.885 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -119.23 143.45 47.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.796 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.693 ' HB3' HD11 ' A' ' 2' ' ' ILE . 0.6 OUTLIER -110.51 146.41 36.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.022 -179.918 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -152.27 135.63 15.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.958 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 12.4 mttm -87.97 128.39 35.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.742 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 3.4 m -45.37 -56.14 5.28 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.423 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 47.4 mt -82.28 81.01 8.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.862 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.927 179.999 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.0 ttp . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.782 0.325 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.52 HG23 ' HE1' ' A' ' 4' ' ' TYR . 0.7 OUTLIER -118.08 144.45 26.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.983 179.969 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' A' ' 169' ' ' MET . 14.8 mm -100.14 137.75 26.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.723 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.52 ' HE1' HG23 ' A' ' 2' ' ' ILE . 6.1 m-85 -106.36 105.37 15.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.457 179.276 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -122.44 145.76 47.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.839 0.352 . . . . 0.0 111.231 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.465 ' O ' ' HA ' ' A' ' 10' ' ' HIS . 43.5 t0 -56.21 152.08 11.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.723 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 57.9 tp -78.8 -26.71 44.38 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.2 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.866 HD11 ' CG1' ' A' ' 99' ' ' ILE . 4.4 mp -91.34 -44.12 14.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.473 ' O ' ' CG ' ' A' ' 10' ' ' HIS . 30.0 t -95.33 -10.19 30.84 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -178.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.473 ' CG ' ' O ' ' A' ' 9' ' ' SER . 25.5 p80 48.31 27.62 1.4 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.952 0.406 . . . . 0.0 111.267 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -98.21 122.59 41.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.705 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.408 ' HB3' ' CG2' ' A' ' 3' ' ' ILE . 0.1 OUTLIER -60.47 84.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.362 -179.816 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.413 ' O ' ' CD2' ' A' ' 76' ' ' HIS . 7.0 mtp -64.34 -18.57 64.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.588 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.485 ' CZ ' ' CD2' ' A' ' 4' ' ' TYR . 8.8 p90 -178.94 179.7 0.66 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.634 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -136.99 -169.9 2.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.91 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.401 ' HA ' HD11 ' A' ' 20' ' ' ILE . 37.8 t70 -93.55 26.18 3.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.027 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.436 HG13 ' CD2' ' A' ' 18' ' ' TYR . 46.0 pt -84.77 -13.28 11.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.754 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.801 ' CE2' HG22 ' A' ' 72' ' ' ILE . 79.0 m-85 -110.72 168.64 9.32 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.618 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.44 94.01 4.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.864 0.364 . . . . 0.0 110.581 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.703 HD12 ' O ' ' A' ' 18' ' ' TYR . 4.2 mp -87.79 139.41 17.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.12 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -127.35 119.53 26.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.036 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.612 ' HG3' HD23 ' A' ' 29' ' ' LEU . 1.9 mt-10 -71.77 114.7 10.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.859 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.567 HD11 HG23 ' A' ' 161' ' ' ILE . 3.9 pt -111.49 167.1 5.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.203 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 59.29 30.17 19.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.236 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 64.38 36.67 8.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.152 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.12 -15.32 61.64 Favored Glycine 0 CA--C 1.518 0.245 0 C-N-CA 120.556 -0.831 . . . . 0.0 112.986 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.419 HD22 ' HA ' ' A' ' 27' ' ' LEU . 0.2 OUTLIER -55.04 -43.39 73.74 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.811 0.338 . . . . 0.0 110.917 -179.912 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 9.0 m -135.66 165.05 26.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.912 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.612 HD23 ' HG3' ' A' ' 22' ' ' GLU . 0.4 OUTLIER -128.02 139.09 52.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.785 -179.947 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -103.51 113.01 26.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.086 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 23.5 t -91.56 112.05 24.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.721 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -82.12 114.39 20.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.229 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.43 -137.13 8.84 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.288 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -174.51 128.24 0.33 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.885 0.374 . . . . 0.0 110.809 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 8.3 mtt -72.3 124.26 24.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.921 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 28.0 m -129.12 161.39 38.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.208 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 83.5 p -103.13 165.66 10.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.861 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.605 ' HB3' HG12 ' A' ' 67' ' ' ILE . 7.2 ttt85 -125.81 120.32 30.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.918 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.4 p -112.3 -29.8 7.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.853 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 62.93 149.37 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.054 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 178.59 -162.47 29.7 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.439 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 59.99 30.23 19.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.772 0.32 . . . . 0.0 110.969 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.573 ' O ' HG23 ' A' ' 43' ' ' ILE . 6.3 tt -114.48 67.86 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.964 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 60.86 78.49 0.28 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.863 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.3 p-10 -176.79 -39.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.058 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.44 -65.87 0.58 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.008 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.8 mt -78.8 -35.01 44.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.964 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 27.5 mm -99.03 131.28 46.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.121 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 95.86 -147.9 18.8 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.54 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.63 -28.01 15.8 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.427 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -68.34 -35.09 77.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.846 0.355 . . . . 0.0 110.921 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -145.23 159.46 42.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.11 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.5 t -91.89 -57.14 2.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.843 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -113.08 165.71 12.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.023 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -110.69 -31.39 7.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.912 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -101.24 -74.75 1.1 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.552 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -68.3 -179.0 2.02 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.617 2.212 . . . . 0.0 112.258 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -111.79 100.07 8.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.85 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.09 43.11 97.24 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.461 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -93.97 154.4 17.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.877 0.37 . . . . 0.0 110.859 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -124.79 81.93 0.35 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.525 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.4 p -81.22 -31.84 33.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.858 0.361 . . . . 0.0 110.934 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -115.56 -167.01 1.19 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.841 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.7 t 64.11 52.36 2.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.909 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.466 HG22 ' H ' ' A' ' 66' ' ' VAL . 0.2 OUTLIER -59.13 178.29 0.13 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.805 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.572 ' C ' HD13 ' A' ' 67' ' ' ILE . 64.3 t -130.06 117.23 40.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.24 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.605 HG12 ' HB3' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -123.13 128.96 75.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.321 179.309 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.7 m -128.49 131.66 48.34 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.225 0.536 . . . . 0.0 111.342 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -166.89 -164.62 22.86 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.891 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.51 HG12 HG12 ' A' ' 72' ' ' ILE . 46.8 t -73.25 141.89 15.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.75 0.309 . . . . 0.0 110.754 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -68.59 -56.17 9.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.725 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.801 HG22 ' CE2' ' A' ' 18' ' ' TYR . 8.5 pt -53.58 -33.77 22.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.868 0.366 . . . . 0.0 111.32 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.789 HG13 ' HB2' ' A' ' 78' ' ' LEU . 92.9 t -70.8 -32.0 47.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.83 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.5 mtm -78.3 -40.64 36.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.539 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -82.07 -28.46 32.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.621 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.447 ' CD2' ' HB ' ' A' ' 72' ' ' ILE . 7.2 m-70 -90.22 -5.68 56.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.857 0.36 . . . . 0.0 110.676 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 9.0 m80 62.45 29.93 17.19 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.103 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.789 ' HB2' HG13 ' A' ' 73' ' ' VAL . 34.5 mt -59.53 147.1 38.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.499 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -127.71 137.24 52.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.86 0.362 . . . . 0.0 111.042 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.429 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 2.9 tt0 -99.96 124.11 44.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.056 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.742 HG21 HD11 ' A' ' 136' ' ' ILE . 6.6 t -123.69 135.18 53.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.769 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 9.1 m -68.01 160.58 28.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.092 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.457 ' HB2' ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -156.8 154.54 30.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.866 179.975 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.9 m -99.13 157.08 16.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.786 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.67 -52.39 65.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.904 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -66.51 -43.09 86.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.683 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.6 -37.8 82.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.05 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.847 ' CD2' HD11 ' A' ' 122' ' ' ILE . 1.3 t80 -62.87 -35.13 79.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.745 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.411 ' O ' HG22 ' A' ' 92' ' ' ILE . 24.4 mttt -59.99 -45.5 92.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.051 0.453 . . . . 0.0 110.443 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.65 -27.93 55.81 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.629 178.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.563 ' HE2' HG21 ' A' ' 146' ' ' VAL . 13.3 t80 -66.21 -47.47 73.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.638 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.454 ' O ' ' HG2' ' A' ' 96' ' ' MET . 4.7 tp -60.3 -43.93 94.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.968 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 8.6 ttmt -60.08 -43.64 95.36 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.214 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.473 ' HA ' ' HG2' ' A' ' 97' ' ' LYS . 12.0 t70 -72.75 -39.72 66.6 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.819 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.471 ' CD1' ' C ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -76.46 -41.62 46.69 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 121.004 -0.279 . . . . 0.0 110.855 -179.497 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.454 ' HG2' ' O ' ' A' ' 92' ' ' ILE . 2.9 ptt? -67.95 -32.75 73.4 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.73 0.3 . . . . 0.0 110.844 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.473 ' HG2' ' HA ' ' A' ' 94' ' ' ASP . 0.3 OUTLIER -70.68 -35.58 72.89 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.894 0.378 . . . . 0.0 110.577 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.406 ' N ' ' HG3' ' A' ' 97' ' ' LYS . 1.9 m -60.52 -40.49 91.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.144 179.354 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.866 ' CG1' HD11 ' A' ' 8' ' ' ILE . 6.6 mt -79.85 -41.63 21.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.445 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.5 tmtt? -54.44 -54.07 45.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.502 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -58.69 -45.93 94.07 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.192 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 10.4 tptp -61.69 -41.28 97.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.806 0.336 . . . . 0.0 110.461 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.73 ' HB3' HG12 ' A' ' 111' ' ' VAL . 5.0 tp -67.4 -34.1 76.57 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.132 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.707 ' CG ' HG11 ' A' ' 111' ' ' VAL . 40.5 mt-10 -59.81 -29.83 68.51 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.828 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.413 ' HG3' ' HG3' ' A' ' 106' ' ' GLN . 0.6 OUTLIER -87.84 -19.39 27.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.561 -179.782 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.413 ' HG3' ' HG3' ' A' ' 105' ' ' GLU . 56.8 mt-30 -105.44 -58.17 1.93 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.736 0.303 . . . . 0.0 111.611 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.446 ' N ' ' O ' ' A' ' 103' ' ' LEU . 87.5 mtt180 -138.5 67.91 45.22 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 120.919 0.39 . . . . 0.0 110.858 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.944 ' O ' HG22 ' A' ' 111' ' ' VAL . 10.3 Cg_endo -50.88 -20.97 7.71 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 123.254 2.636 . . . . 0.0 112.888 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -67.69 -9.72 46.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.592 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.637 ' CB ' HD21 ' A' ' 103' ' ' LEU . 31.0 mmt-85 -114.23 -4.82 13.02 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.944 HG22 ' O ' ' A' ' 108' ' ' PRO . 35.6 m -69.52 -27.74 35.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.609 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 4.3 mmtp -71.99 -54.32 6.08 Favored Pre-proline 0 CA--C 1.532 0.257 0 C-N-CA 121.078 -0.249 . . . . 0.0 111.416 -179.393 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.609 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 37.2 Cg_exo -56.08 -35.89 95.47 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 121.772 1.648 . . . . 0.0 111.547 179.061 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.469 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 87.5 t80 -65.8 -43.18 89.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.904 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.54 -52.36 55.19 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.08 0.467 . . . . 0.0 110.741 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 61.7 m -75.8 -44.19 42.49 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.695 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -56.21 -51.39 56.19 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.687 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.16 -51.67 67.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.994 0.426 . . . . 0.0 110.985 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.526 ' HB1' ' HE3' ' A' ' 123' ' ' LYS . . . -61.55 -28.07 69.07 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.229 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -77.94 -48.54 16.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.859 0.362 . . . . 0.0 111.048 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 14.2 tp60 -67.31 -34.99 78.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.025 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.847 HD11 ' CD2' ' A' ' 88' ' ' TYR . 0.3 OUTLIER -67.03 -45.1 87.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.064 -179.865 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.526 ' HE3' ' HB1' ' A' ' 119' ' ' ALA . 26.3 mttt -61.47 -29.94 70.29 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.411 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 9.7 t-80 -70.19 -53.96 14.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.764 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.869 HG21 HD13 ' A' ' 148' ' ' LEU . 14.5 pt -60.52 -41.86 89.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.273 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.401 ' HA ' HD23 ' A' ' 126' ' ' LEU . 12.4 mt -55.23 -38.41 68.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.89 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -71.39 -10.82 60.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.317 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -140.59 33.48 1.83 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.859 0.361 . . . . 0.0 110.648 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.511 ' CE1' ' CE2' ' A' ' 134' ' ' PHE . 2.2 t80 -50.13 -29.96 10.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.99 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.6 ttpt -60.1 -29.68 68.75 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.935 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 21.3 m-20 -94.17 -35.73 12.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.436 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.598 ' CD2' HG22 ' A' ' 125' ' ' ILE . 4.7 m-85 -94.84 136.31 35.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.897 0.38 . . . . 0.0 111.211 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.406 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 4.8 mm-40 -119.83 145.68 46.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.745 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.511 ' CE2' ' CE1' ' A' ' 129' ' ' PHE . 0.6 OUTLIER -83.35 121.82 27.64 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.989 -179.759 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.459 ' CG ' ' CE ' ' A' ' 160' ' ' MET . 46.5 m-85 -125.46 134.85 51.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.761 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.742 HD11 HG21 ' A' ' 81' ' ' THR . 0.3 OUTLIER -123.87 164.77 21.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.784 179.989 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.53 -173.05 1.25 Allowed Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.447 -0.882 . . . . 0.0 111.899 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -67.36 -13.68 62.23 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.564 0.221 . . . . 0.0 111.22 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.501 ' HB3' ' ND2' ' A' ' 141' ' ' ASN . 22.4 m-80 -92.75 -28.66 16.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.723 0.297 . . . . 0.0 111.366 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.472 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 53.8 mtm 54.69 43.08 30.7 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.811 0.339 . . . . 0.0 111.201 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ASN . . . . . 0.501 ' ND2' ' HB3' ' A' ' 139' ' ' ASN . 2.4 m120 -67.29 122.28 82.26 Favored Pre-proline 0 N--CA 1.453 -0.279 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.67 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -59.74 -27.23 84.45 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.351 2.034 . . . . 0.0 111.881 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -84.76 -15.99 43.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.814 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.99 -173.45 24.78 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.347 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -88.84 -177.99 5.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.737 0.303 . . . . 0.0 110.881 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.563 HG21 ' HE2' ' A' ' 91' ' ' TYR . 41.6 t -127.6 153.84 37.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.222 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.417 ' N ' HG12 ' A' ' 146' ' ' VAL . . . -118.54 115.74 25.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.691 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.869 HD13 HG21 ' A' ' 125' ' ' ILE . 3.6 mt -90.18 106.7 18.66 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.948 -179.351 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.514 HD12 ' HG2' ' A' ' 160' ' ' MET . 1.6 tp -88.5 119.61 29.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.409 -179.304 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.47 ' HB3' ' CE1' ' A' ' 159' ' ' TYR . 0.7 OUTLIER -129.49 172.24 11.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.525 179.4 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -117.76 144.41 45.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.847 0.356 . . . . 0.0 111.008 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.41 -177.71 0.05 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.933 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.36 -34.97 71.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.017 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.573 ' OD1' HG23 ' A' ' 156' ' ' VAL . 9.2 t70 -76.54 -15.14 59.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.218 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 69.17 26.04 74.95 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.711 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.573 HG23 ' OD1' ' A' ' 154' ' ' ASP . 94.5 t -112.83 -69.81 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.932 0.396 . . . . 0.0 110.885 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 73.4 m -63.77 111.23 4.86 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.01 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -81.73 131.17 7.08 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.462 2.108 . . . . 0.0 112.192 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.47 ' CE1' ' HB3' ' A' ' 150' ' ' ASP . 13.9 p90 -125.62 144.59 50.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.92 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' MET . . . . . 0.514 ' HG2' HD12 ' A' ' 149' ' ' LEU . 0.2 OUTLIER -110.7 142.65 42.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.137 -179.792 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.567 HG23 HD11 ' A' ' 23' ' ' ILE . 58.7 mt -97.68 116.34 39.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.974 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -118.6 132.82 56.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.798 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -78.0 123.0 26.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.867 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.46 -54.48 35.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.327 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.469 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 1.6 m-20 -49.54 -36.2 22.75 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.285 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -96.55 27.92 15.49 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.366 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.49 143.96 29.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.814 0.34 . . . . 0.0 110.925 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -113.66 147.76 37.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.725 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.422 ' HA ' ' O ' ' A' ' 3' ' ' ILE . 0.7 OUTLIER -120.08 140.3 51.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.975 -179.816 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -146.8 133.06 19.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.914 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.421 ' CG ' HD12 ' A' ' 2' ' ' ILE . 31.0 mttp -87.87 119.59 28.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.916 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 27.8 m -141.89 144.45 33.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.928 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 11.2 mt -73.87 -42.68 60.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.913 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.301 -0.857 . . . . 0.0 110.857 -179.968 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.9 ttt . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.727 0.299 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.809 HD11 ' HB3' ' A' ' 169' ' ' MET . 4.5 tt -101.37 139.61 22.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.038 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.408 HG21 ' HB3' ' A' ' 12' ' ' GLU . 20.2 mm -100.98 155.25 4.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.317 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.602 ' HB3' HD21 ' A' ' 167' ' ' LEU . 2.8 m-85 -122.8 105.94 10.47 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.424 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 17.5 ptt180 -120.8 150.29 41.25 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.937 0.398 . . . . 0.0 111.469 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.428 ' O ' ' HA ' ' A' ' 10' ' ' HIS . 37.6 t0 -62.38 152.18 34.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.616 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.508 HD23 HG23 ' A' ' 99' ' ' ILE . 56.6 tp -81.23 -22.6 38.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.395 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.911 HD11 ' CG1' ' A' ' 99' ' ' ILE . 4.1 mp -91.27 -45.9 14.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 93.1 p -93.14 -21.39 19.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.616 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.428 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 1.6 m-70 62.23 29.78 17.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.865 0.364 . . . . 0.0 110.805 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -106.1 124.62 49.87 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.804 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.408 ' HB3' HG21 ' A' ' 3' ' ' ILE . 2.6 pm0 -58.44 93.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.207 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 7.3 mtt -70.08 -18.42 63.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.847 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.516 ' CE2' ' CD2' ' A' ' 4' ' ' TYR . 14.3 p90 -177.44 177.33 1.19 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.899 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.473 ' O ' HD11 ' A' ' 20' ' ' ILE . 0.9 OUTLIER -136.67 -169.88 2.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.975 -179.827 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 34.5 p-10 -87.83 13.93 9.75 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.615 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 46.5 pt -78.9 -4.96 7.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.816 0.341 . . . . 0.0 111.13 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.864 ' CZ ' HG22 ' A' ' 72' ' ' ILE . 65.3 m-85 -119.56 -179.07 3.77 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.728 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -91.39 88.71 6.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.748 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.473 HD11 ' O ' ' A' ' 15' ' ' SER . 4.0 mp -87.84 123.96 40.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.928 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 8.9 mtt180 -114.85 135.91 53.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.934 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.702 ' HG3' HD23 ' A' ' 29' ' ' LEU . 2.3 mp0 -81.56 114.82 20.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.868 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.714 HD11 HG23 ' A' ' 161' ' ' ILE . 3.3 pt -110.23 162.59 7.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.21 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.428 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . . . 60.01 29.77 19.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.251 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 64.42 50.81 2.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.423 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.65 -4.25 74.86 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 120.732 -0.747 . . . . 0.0 113.441 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.531 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -66.65 -29.36 69.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 117.036 0.418 . . . . 0.0 111.0 -179.903 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.424 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 92.4 m -147.59 171.52 15.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.119 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.702 HD23 ' HG3' ' A' ' 22' ' ' GLU . 0.7 OUTLIER -134.79 129.57 34.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.874 -179.954 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.414 ' OE1' ' CD2' ' A' ' 159' ' ' TYR . 61.7 mt-10 -97.52 116.36 29.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.166 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.41 HG23 ' HD2' ' A' ' 162' ' ' PHE . 21.9 t -92.41 111.97 25.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.698 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -83.0 116.77 22.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.172 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -99.98 -144.51 16.22 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.201 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.0 pttm -174.53 126.01 0.31 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.829 0.347 . . . . 0.0 111.02 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 21.7 mtt -70.03 121.93 18.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.778 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.4 m -126.85 144.8 35.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.29 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 57.0 p -95.51 165.59 12.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.844 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.753 ' O ' HG13 ' A' ' 66' ' ' VAL . 2.7 ttt180 -135.94 141.4 44.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.798 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.2 t -157.71 123.87 4.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.869 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -97.64 -179.81 4.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.895 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -79.53 -22.26 65.01 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.628 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.427 ' HA ' HD11 ' A' ' 48' ' ' ILE . 39.0 m-80 -56.63 -40.24 75.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.87 0.367 . . . . 0.0 111.039 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 14.8 tt -77.69 158.5 5.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.994 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 66.49 -76.02 0.05 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.884 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.11 104.96 11.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.952 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 29.7 m -74.62 -43.71 54.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.843 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 29.0 mt -70.78 -28.81 64.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.004 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.427 HD11 ' HA ' ' A' ' 42' ' ' ASN . 71.8 mt 53.41 79.91 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.173 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 100.3 -54.76 0.88 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.519 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 124.24 -30.77 4.67 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.444 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -97.92 119.74 37.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.779 0.323 . . . . 0.0 110.939 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -128.29 130.81 48.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.076 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.91 31.72 2.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.871 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -154.39 143.02 20.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.085 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -110.66 96.87 6.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.9 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 157.89 158.9 9.23 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.461 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -52.27 139.69 53.61 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.591 2.194 . . . . 0.0 112.29 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.2 pm0 -112.43 -34.7 5.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.855 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -170.46 66.65 0.15 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.468 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -84.24 139.2 32.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.766 0.317 . . . . 0.0 111.006 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 150.08 178.18 24.77 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.461 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 23.3 p -120.44 33.2 5.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.87 0.367 . . . . 0.0 110.905 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -70.27 148.12 48.92 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.892 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 60.5 p -60.86 108.85 0.92 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.852 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 17.5 m -97.76 -22.23 16.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.152 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.753 HG13 ' O ' ' A' ' 38' ' ' ARG . 22.6 t -93.74 136.89 24.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.108 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.723 HD13 ' C ' ' A' ' 66' ' ' VAL . 0.0 OUTLIER -129.61 132.98 65.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.984 179.801 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 93.6 m -139.18 142.38 37.94 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.063 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 170.33 -170.38 42.94 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.356 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.636 HG12 HG12 ' A' ' 72' ' ' ILE . 47.9 t -69.02 124.27 24.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.913 0.387 . . . . 0.0 110.756 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -54.28 -57.31 11.68 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.833 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.864 HG22 ' CZ ' ' A' ' 18' ' ' TYR . 5.4 pt -53.74 -34.13 24.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.842 0.353 . . . . 0.0 111.364 -179.334 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.783 HG13 ' HB2' ' A' ' 78' ' ' LEU . 97.5 t -73.67 -29.97 27.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.055 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.7 mtt -78.24 -42.25 31.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.82 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.428 ' OD1' ' CD2' ' A' ' 76' ' ' HIS . 19.6 p30 -82.05 -29.68 31.78 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 -179.18 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.428 ' CD2' ' OD1' ' A' ' 75' ' ' ASN . 34.1 m170 -88.99 -5.39 57.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.862 0.363 . . . . 0.0 110.626 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.417 ' HB2' ' HB3' ' A' ' 138' ' ' GLU . 78.0 m-70 61.43 30.3 18.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.032 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.783 ' HB2' HG13 ' A' ' 73' ' ' VAL . 60.0 mt -58.57 148.56 28.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.49 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -131.75 136.47 47.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.854 0.359 . . . . 0.0 111.109 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.419 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 2.5 tm-20 -89.81 135.21 33.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.104 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.495 HG23 ' HB2' ' A' ' 134' ' ' PHE . 5.2 t -120.21 171.85 8.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.725 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 30.2 m -114.56 161.23 18.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.978 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.482 ' HB2' ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -171.62 159.81 5.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.039 -179.898 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 8.6 m -101.54 162.41 12.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.815 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 17.1 mtpt -58.39 -51.95 67.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.104 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -65.64 -46.44 79.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.842 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.46 -36.4 73.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.185 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.91 ' CD2' HD11 ' A' ' 122' ' ' ILE . 1.0 OUTLIER -62.57 -37.9 87.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.809 179.874 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.523 ' NZ ' HD13 ' A' ' 126' ' ' LEU . 28.1 mttm -58.58 -44.9 89.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.649 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.1 tttm -77.96 -27.9 49.33 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.652 178.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.562 ' HE2' HG21 ' A' ' 146' ' ' VAL . 12.4 t80 -66.9 -46.6 74.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.711 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.538 HD12 ' CE2' ' A' ' 95' ' ' TYR . 6.0 tp -61.9 -42.61 95.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.107 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.475 ' O ' ' CG ' ' A' ' 97' ' ' LYS . 11.3 ttpp -62.0 -45.28 94.32 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.92 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -70.56 -38.14 74.08 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.945 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.538 ' CE2' HD12 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -78.24 -43.51 28.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.742 -0.208 . . . . 0.0 110.839 -179.458 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.413 ' HG3' ' N ' ' A' ' 97' ' ' LYS . 0.3 OUTLIER -62.07 -31.77 72.22 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 178.778 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.475 ' CG ' ' O ' ' A' ' 93' ' ' LYS . 1.4 mmmp? -65.61 -41.87 92.23 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.35 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.7 m -52.85 -40.31 63.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.146 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.911 ' CG1' HD11 ' A' ' 8' ' ' ILE . 8.7 mt -79.76 -42.71 22.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.443 179.314 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.69 -49.05 74.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.376 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -60.89 -49.66 76.15 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.013 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.5 -40.53 91.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.86 0.362 . . . . 0.0 110.262 179.531 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.612 ' HB3' HG12 ' A' ' 111' ' ' VAL . 7.3 tp -65.17 -38.31 90.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.095 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.693 ' HG3' HG11 ' A' ' 111' ' ' VAL . 78.7 mt-10 -56.88 -29.54 63.06 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.725 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -87.03 -19.66 28.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.635 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -107.8 -61.77 1.53 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.882 0.372 . . . . 0.0 111.527 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.447 ' N ' ' O ' ' A' ' 103' ' ' LEU . 43.5 mtt-85 -131.11 65.41 76.57 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.715 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.881 ' O ' HG22 ' A' ' 111' ' ' VAL . 9.8 Cg_endo -50.49 -22.82 9.58 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 123.19 2.594 . . . . 0.0 112.75 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -70.6 -10.46 59.36 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.217 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.546 ' CB ' HD21 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -108.89 -1.24 19.28 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -179.482 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.881 HG22 ' O ' ' A' ' 108' ' ' PRO . 26.5 m -71.81 -34.41 51.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -179.434 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.568 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 23.9 mtmt -68.99 -49.57 24.95 Favored Pre-proline 0 C--N 1.332 -0.178 0 C-N-CA 120.949 -0.301 . . . . 0.0 111.633 -179.239 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.568 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 37.0 Cg_exo -60.56 -32.07 93.04 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.153 1.902 . . . . 0.0 111.686 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.472 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 36.7 t80 -72.16 -47.09 53.43 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.096 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 15.0 mmm -49.42 -43.25 44.45 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.021 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 69.1 m -76.01 -45.14 36.08 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.842 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.45 -54.78 34.3 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.803 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -52.62 -51.63 59.11 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.897 0.38 . . . . 0.0 111.434 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.47 ' O ' HG22 ' A' ' 122' ' ' ILE . . . -68.58 -29.05 67.51 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.662 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -72.87 -55.87 6.02 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.865 0.364 . . . . 0.0 111.214 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.424 ' NE2' ' SG ' ' A' ' 28' ' ' CYS . 7.9 tt0 -60.83 -31.51 70.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.487 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.91 HD11 ' CD2' ' A' ' 88' ' ' TYR . 0.4 OUTLIER -63.71 -45.19 98.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.322 -179.532 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.436 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 15.5 mttp -61.45 -30.89 70.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.059 0.457 . . . . 0.0 110.196 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 9.0 t-80 -69.34 -54.78 12.79 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.764 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.661 HG21 HD13 ' A' ' 148' ' ' LEU . 15.0 pt -60.26 -42.79 91.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.386 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.523 HD13 ' NZ ' ' A' ' 89' ' ' LYS . 12.0 mt -53.98 -38.18 64.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.886 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.58 -15.18 63.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.212 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -137.98 32.32 2.42 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.941 0.401 . . . . 0.0 110.751 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.499 ' CE1' ' CZ ' ' A' ' 134' ' ' PHE . 4.2 t80 -51.93 -27.99 14.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.065 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.59 -18.87 65.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.296 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 15.8 m-80 -94.14 -36.25 12.15 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.325 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.458 ' CD2' HG22 ' A' ' 125' ' ' ILE . 1.1 m-30 -102.7 162.32 13.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.829 0.347 . . . . 0.0 111.151 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 5.8 mm-40 -138.0 147.57 44.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.889 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.499 ' CZ ' ' CE1' ' A' ' 129' ' ' PHE . 2.8 m-85 -78.62 129.74 35.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.955 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.44 ' O ' ' HB3' ' A' ' 147' ' ' ALA . 33.2 m-85 -134.71 134.59 41.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.629 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.45 ' HB ' ' HA ' ' A' ' 140' ' ' MET . 0.8 OUTLIER -123.18 161.2 25.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.931 -179.977 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.51 -163.44 0.24 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.207 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.417 ' HB3' ' HB2' ' A' ' 77' ' ' HIS . 5.2 pt-20 -72.49 -8.88 57.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.554 0.216 . . . . 0.0 111.531 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.525 ' HB3' ' ND2' ' A' ' 141' ' ' ASN . 19.2 m-80 -95.7 -35.34 11.61 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.607 0.241 . . . . 0.0 111.566 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.45 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 10.3 mtp 58.85 40.77 22.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.695 0.283 . . . . 0.0 111.217 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ASN . . . . . 0.525 ' ND2' ' HB3' ' A' ' 139' ' ' ASN . 1.3 m120 -69.67 117.64 55.18 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.633 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -62.54 -24.26 75.18 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.345 2.03 . . . . 0.0 111.78 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -84.8 -15.23 45.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.758 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -74.17 -136.11 0.37 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.317 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.4 ' HE3' ' O ' ' A' ' 166' ' ' GLY . 5.6 ptp -120.29 -175.87 3.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.86 0.362 . . . . 0.0 110.712 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.562 HG21 ' HE2' ' A' ' 91' ' ' TYR . 57.5 t -129.09 144.78 37.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.338 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' A' ' 135' ' ' PHE . . . -111.39 117.8 34.08 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.378 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.661 HD13 HG21 ' A' ' 125' ' ' ILE . 5.8 mt -91.53 107.77 19.44 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.323 -179.042 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.567 HD12 ' HG2' ' A' ' 160' ' ' MET . 2.3 tp -88.05 120.67 29.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.552 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.536 ' HB2' ' CZ ' ' A' ' 159' ' ' TYR . 18.3 m-20 -122.0 145.28 48.28 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.056 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.433 ' CE1' ' HB3' ' A' ' 158' ' ' PRO . 64.7 m-85 -100.75 135.44 42.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.933 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 15.2 mmm-85 -60.89 -178.64 0.1 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.943 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -59.88 -41.24 91.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.999 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -77.68 -15.08 59.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.287 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 67.49 25.14 73.86 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.522 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 71.6 t -110.21 -37.05 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.851 0.358 . . . . 0.0 110.964 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 94.3 m -103.41 96.63 8.81 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.225 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.523 ' HB2' HD11 ' A' ' 149' ' ' LEU . 71.8 Cg_endo -76.02 128.12 10.47 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.521 2.148 . . . . 0.0 112.169 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.536 ' CZ ' ' HB2' ' A' ' 150' ' ' ASP . 7.7 p90 -120.04 130.56 54.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.73 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' MET . . . . . 0.765 ' HG3' HD11 ' A' ' 72' ' ' ILE . 20.9 mtp -102.2 134.66 45.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.546 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.714 HG23 HD11 ' A' ' 23' ' ' ILE . 96.4 mt -90.45 113.06 25.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.861 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.41 ' HD2' HG23 ' A' ' 31' ' ' VAL . 59.1 m-85 -109.82 154.54 22.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.921 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.419 ' CD2' ' OH ' ' A' ' 95' ' ' TYR . 3.4 m-30 -95.46 126.26 40.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.717 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.446 ' HG3' HD11 ' A' ' 29' ' ' LEU . 0.6 OUTLIER -69.98 -54.91 11.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.306 -179.662 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.472 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 3.2 m-20 -49.11 -37.31 21.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.181 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.4 ' O ' ' HE3' ' A' ' 145' ' ' MET . . . -95.46 26.38 20.03 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.377 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.602 HD21 ' HB3' ' A' ' 4' ' ' TYR . 0.8 OUTLIER -140.77 146.04 37.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.823 0.344 . . . . 0.0 110.787 -179.867 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -119.53 142.75 48.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.845 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.809 ' HB3' HD11 ' A' ' 2' ' ' ILE . 0.1 OUTLIER -109.09 148.57 30.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.992 -179.988 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -152.38 121.46 6.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.832 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.672 ' HG2' HD12 ' A' ' 2' ' ' ILE . 19.1 mttt -91.56 118.47 30.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.933 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 51.6 t -67.72 99.73 0.83 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.832 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 62.42 148.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.891 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.211 -0.9 . . . . 0.0 110.949 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.9 ttm . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.868 0.366 . . . . 0.0 111.273 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.638 HG23 ' CE1' ' A' ' 4' ' ' TYR . 11.8 tt -107.24 151.07 9.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.012 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.9 mm -102.27 153.02 5.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.486 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.638 ' CE1' HG23 ' A' ' 2' ' ' ILE . 3.3 m-85 -124.43 101.52 7.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.449 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.36 153.23 34.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.931 0.396 . . . . 0.0 111.398 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.536 ' OD1' HD12 ' A' ' 8' ' ' ILE . 46.3 t0 -59.34 152.05 22.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.646 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 36.6 tp -81.96 -16.91 48.86 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.551 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.536 HD12 ' OD1' ' A' ' 6' ' ' ASP . 4.3 mp -91.41 -50.72 12.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 27.8 t -97.35 -18.04 19.37 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.455 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 9.0 m80 64.73 31.39 11.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.832 0.348 . . . . 0.0 110.865 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -97.77 122.1 40.46 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.738 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -58.16 95.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.32 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 5.1 mtt -74.86 -18.55 60.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.662 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.502 ' CZ ' ' CD2' ' A' ' 4' ' ' TYR . 10.7 p90 -178.87 174.02 1.16 Allowed 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.6 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -132.27 -169.97 2.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.729 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.424 ' HA ' HD11 ' A' ' 20' ' ' ILE . 37.6 t0 -96.29 30.75 2.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.192 0.52 . . . . 0.0 110.736 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.42 HG13 ' CD2' ' A' ' 18' ' ' TYR . 45.5 pt -93.31 -10.25 9.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.659 179.269 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.796 ' CZ ' HG22 ' A' ' 72' ' ' ILE . 48.4 m-85 -111.87 -169.16 1.41 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.715 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.72 95.48 8.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.84 0.352 . . . . 0.0 110.901 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.424 HD11 ' HA ' ' A' ' 16' ' ' ASP . 4.2 mp -92.41 125.74 45.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.097 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.4 mtp85 -117.19 120.45 38.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.055 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.702 ' HG3' HD23 ' A' ' 29' ' ' LEU . 3.5 mp0 -72.14 114.55 10.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.849 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.597 HD11 HG23 ' A' ' 161' ' ' ILE . 4.2 pt -112.86 167.4 6.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.192 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.436 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . . . 58.06 30.81 19.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.274 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 63.95 44.08 4.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.347 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.21 -17.36 56.04 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 120.735 -0.745 . . . . 0.0 113.142 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.436 ' HB3' ' HB3' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -52.15 -50.4 61.83 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.831 0.348 . . . . 0.0 111.137 -179.872 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 55.3 m -130.18 164.33 24.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.744 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.702 HD23 ' HG3' ' A' ' 22' ' ' GLU . 0.7 OUTLIER -128.6 135.13 48.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.045 -179.724 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -96.7 114.82 26.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.126 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.441 HG21 ' CD2' ' A' ' 14' ' ' PHE . 22.2 t -96.37 112.14 27.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.872 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -91.28 115.48 28.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.115 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -98.94 -131.49 7.31 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.458 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -172.39 124.93 0.5 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.804 0.335 . . . . 0.0 110.939 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 24.4 mtp -74.73 123.93 25.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.91 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.2 m -116.92 135.9 55.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.236 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 7.3 m -96.75 165.61 12.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.902 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.521 ' HB3' HG12 ' A' ' 67' ' ' ILE . 8.7 ttt180 -136.87 119.99 16.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.584 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.4 m -112.0 -28.85 7.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.208 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.454 ' OE2' HG23 ' A' ' 62' ' ' THR . 1.7 mt-10 62.93 90.61 0.08 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.757 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 167.17 -30.39 0.19 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.513 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -54.76 -25.99 31.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.779 0.324 . . . . 0.0 111.025 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 16.6 tt -56.51 152.5 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.172 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -65.93 179.83 0.83 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.984 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -110.88 179.93 3.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.936 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.1 t -88.24 -18.0 29.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.364 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.9 mt -52.94 -30.39 34.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.818 0.342 . . . . 0.0 111.172 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.2 mt -69.22 124.08 24.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.985 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -79.19 168.59 53.31 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.567 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 114.26 -102.69 1.22 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.463 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -159.88 84.8 0.75 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.819 0.342 . . . . 0.0 110.867 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -171.85 144.32 1.75 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.083 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 19.3 t 62.69 146.93 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.936 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 60.62 156.3 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.144 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 60.07 107.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.913 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.403 ' N ' ' CD ' ' A' ' 57' ' ' PRO . . . 59.47 51.9 56.33 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.473 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.403 ' CD ' ' N ' ' A' ' 56' ' ' GLY . 56.3 Cg_endo -70.43 -179.19 3.03 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.55 2.167 . . . . 0.0 112.371 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -102.15 34.01 2.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.869 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 172.01 -152.59 17.61 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.53 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -175.82 -40.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.862 0.363 . . . . 0.0 110.897 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -105.64 175.65 21.8 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.505 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.454 HG23 ' OE2' ' A' ' 40' ' ' GLU . 1.8 m -118.51 -48.96 2.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.8 0.333 . . . . 0.0 110.895 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 68.42 -67.31 0.2 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.046 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 6.8 m -115.79 153.0 32.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.868 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 86.7 m -89.78 -72.25 0.57 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.872 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.756 ' C ' HD13 ' A' ' 67' ' ' ILE . 29.5 t -106.6 133.48 51.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.99 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.756 HD13 ' C ' ' A' ' 66' ' ' VAL . 0.0 OUTLIER -136.35 131.08 48.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.998 179.829 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 21.6 m -139.33 135.29 33.6 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.994 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -174.6 178.66 46.31 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.353 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.564 HG22 ' HG3' ' A' ' 158' ' ' PRO . 59.0 t -68.02 148.26 11.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.865 0.364 . . . . 0.0 110.851 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -71.56 -59.12 2.93 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.452 -179.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.796 HG22 ' CZ ' ' A' ' 18' ' ' TYR . 8.9 pt -53.72 -33.94 23.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.437 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.782 HG13 ' HB2' ' A' ' 78' ' ' LEU . 61.5 t -72.72 -34.05 46.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.042 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.1 mtm -78.31 -39.15 40.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.576 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.403 ' OD1' ' CD2' ' A' ' 76' ' ' HIS . 19.8 p30 -82.0 -28.46 32.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.559 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.448 ' CE1' ' HB ' ' A' ' 72' ' ' ILE . 26.7 m170 -92.49 -1.17 57.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.841 0.353 . . . . 0.0 110.801 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.435 ' HB2' ' HB3' ' A' ' 138' ' ' GLU . 21.9 m170 58.0 31.41 20.6 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.074 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.782 ' HB2' HG13 ' A' ' 73' ' ' VAL . 42.6 mt -60.23 142.41 54.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.489 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -125.24 136.56 53.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.304 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.429 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 1.7 tm-20 -91.86 121.06 33.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.863 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.896 HG21 HD11 ' A' ' 136' ' ' ILE . 3.5 t -113.6 127.07 55.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.881 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 70.6 m -68.96 159.15 33.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.887 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.476 ' HB2' ' CD2' ' A' ' 134' ' ' PHE . 0.3 OUTLIER -166.84 152.44 7.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.818 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.26 166.5 11.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.879 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.0 mtmt -63.56 -52.41 61.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.141 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -61.31 -48.29 82.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.928 0.394 . . . . 0.0 110.811 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.29 -40.84 78.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.074 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.902 ' CD2' HD11 ' A' ' 122' ' ' ILE . 0.4 OUTLIER -59.43 -35.88 74.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.762 179.96 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.46 ' O ' HG22 ' A' ' 92' ' ' ILE . 27.2 mttt -58.31 -47.8 82.55 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.187 0.517 . . . . 0.0 110.527 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.6 tmtm? -76.57 -27.82 56.0 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.704 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.54 ' HE2' HG21 ' A' ' 146' ' ' VAL . 11.0 t80 -66.73 -46.87 74.09 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.693 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.46 HG22 ' O ' ' A' ' 89' ' ' LYS . 4.5 tp -59.85 -44.02 93.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.945 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.1 ttmm -59.27 -40.7 86.88 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.205 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.513 ' HA ' ' HG2' ' A' ' 97' ' ' LYS . 47.3 t0 -73.15 -43.21 61.89 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.898 -179.205 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.45 ' CE2' ' CD1' ' A' ' 92' ' ' ILE . 0.0 OUTLIER -75.35 -39.9 58.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.647 -0.252 . . . . 0.0 111.199 -179.176 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.448 ' HG2' ' O ' ' A' ' 92' ' ' ILE . 15.0 ptm -67.57 -32.22 72.82 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.792 0.33 . . . . 0.0 110.539 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.513 ' HG2' ' HA ' ' A' ' 94' ' ' ASP . 4.6 ptpt -69.91 -34.07 73.01 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.66 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.489 ' N ' ' HG3' ' A' ' 97' ' ' LYS . 2.2 m -61.74 -40.49 95.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.085 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 7.0 mt -79.86 -41.3 21.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.355 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -55.38 -53.91 50.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.521 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' A' ' 104' ' ' GLU . . . -61.5 -45.7 95.84 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.138 179.387 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.9 tptt -61.41 -39.49 90.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.883 0.373 . . . . 0.0 110.3 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.654 HD21 ' CB ' ' A' ' 110' ' ' ARG . 3.0 tp -68.69 -32.94 73.12 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.025 179.329 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.66 ' CG ' HG11 ' A' ' 111' ' ' VAL . 83.4 mt-10 -59.99 -30.4 69.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.807 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -88.19 -20.19 25.9 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.605 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 -106.25 -62.82 1.33 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.863 0.363 . . . . 0.0 111.548 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.435 ' N ' ' O ' ' A' ' 103' ' ' LEU . 5.5 mtm180 -126.25 63.43 50.52 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.923 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.86 ' O ' HG22 ' A' ' 111' ' ' VAL . 9.9 Cg_endo -50.62 -22.21 9.0 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 123.233 2.622 . . . . 0.0 112.776 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -74.83 -7.06 52.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.372 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.654 ' CB ' HD21 ' A' ' 103' ' ' LEU . 17.0 mmt180 -113.55 -1.71 14.03 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.681 0.276 . . . . 0.0 111.617 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.86 HG22 ' O ' ' A' ' 108' ' ' PRO . 34.2 m -67.96 -37.78 78.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -179.248 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.577 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 13.9 mtpt -67.55 -50.48 36.27 Favored Pre-proline 0 CA--C 1.529 0.161 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.617 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.577 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 31.9 Cg_exo -58.06 -33.28 97.13 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.087 1.858 . . . . 0.0 111.521 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.457 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 94.1 t80 -70.48 -40.84 73.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.746 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 15.9 mtm -55.89 -44.77 78.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.761 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 62.9 m -76.51 -44.24 36.05 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.61 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -59.19 -52.04 55.62 Favored Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.768 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.442 ' O ' ' HB ' ' A' ' 122' ' ' ILE . . . -56.89 -51.77 67.77 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.968 0.414 . . . . 0.0 111.117 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.7 -28.09 68.16 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.385 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -74.11 -49.62 23.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.482 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -71.43 -42.48 68.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.437 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.902 HD11 ' CD2' ' A' ' 88' ' ' TYR . 0.3 OUTLIER -56.06 -49.83 73.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.726 -179.4 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.484 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 10.7 ptmt -63.03 -31.2 72.29 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.046 0.451 . . . . 0.0 110.132 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 10.6 t-80 -67.99 -50.14 57.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.78 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.414 HD11 ' HA ' ' A' ' 122' ' ' ILE . 17.4 pt -65.59 -42.57 93.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.319 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.472 HD21 ' CD2' ' A' ' 88' ' ' TYR . 10.6 mt -53.85 -35.14 61.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.878 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -71.21 -10.84 60.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.289 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -144.98 34.01 1.11 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.042 0.449 . . . . 0.0 110.574 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.503 ' CE1' ' CZ ' ' A' ' 134' ' ' PHE . 13.8 t80 -52.17 -25.19 8.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.2 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -55.14 -27.83 48.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.816 0.341 . . . . 0.0 111.156 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 31.9 m-20 -94.29 -37.5 11.48 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.665 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.42 ' HE2' HD11 ' A' ' 161' ' ' ILE . 4.1 m-85 -100.53 135.01 42.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.912 0.387 . . . . 0.0 111.598 -179.293 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.444 ' NE2' ' CZ ' ' A' ' 129' ' ' PHE . 5.8 mm-40 -115.89 148.77 39.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.8 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.515 ' CE1' ' CZ ' ' A' ' 88' ' ' TYR . 3.7 m-85 -82.07 128.97 34.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.21 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.429 ' CE2' ' HB2' ' A' ' 80' ' ' GLU . 28.4 m-85 -130.72 156.38 45.04 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.609 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.896 HD11 HG21 ' A' ' 81' ' ' THR . 0.5 OUTLIER -142.95 162.31 17.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.935 179.885 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -64.0 -163.45 0.61 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.344 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.435 ' HB3' ' HB2' ' A' ' 77' ' ' HIS . 4.7 pt-20 -73.26 -8.85 57.59 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.595 0.236 . . . . 0.0 111.511 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 18.3 m-80 -98.5 -29.1 13.29 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.597 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.429 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 31.7 mtm 55.44 42.24 30.15 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.905 0.383 . . . . 0.0 111.02 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ASN . . . . . 0.406 ' ND2' ' HA3' ' A' ' 144' ' ' GLY . 16.3 p-10 -64.93 114.8 16.26 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.014 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -63.89 -28.95 67.31 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.561 2.174 . . . . 0.0 112.219 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -84.61 -14.48 48.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.169 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.406 ' HA3' ' ND2' ' A' ' 141' ' ' ASN . . . -73.88 -128.6 0.15 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.463 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.42 ' HE3' ' O ' ' A' ' 166' ' ' GLY . 6.6 ptp -126.52 -172.48 2.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.792 0.329 . . . . 0.0 110.859 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.54 HG21 ' HE2' ' A' ' 91' ' ' TYR . 90.5 t -131.54 153.1 38.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.0 0.428 . . . . 0.0 111.355 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.401 ' N ' HG12 ' A' ' 146' ' ' VAL . . . -117.4 123.18 45.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.298 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.523 ' HB2' ' HB ' ' A' ' 161' ' ' ILE . 2.5 mt -96.94 106.26 18.56 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.748 -178.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.504 HD12 ' HG2' ' A' ' 160' ' ' MET . 1.0 OUTLIER -90.63 119.31 30.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.698 179.805 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.495 ' HB3' ' CZ ' ' A' ' 159' ' ' TYR . 12.6 t70 -132.21 164.33 26.61 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.676 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -109.49 150.6 27.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.228 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.82 -176.86 3.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.843 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -56.71 -33.05 66.1 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.929 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -72.21 -15.13 61.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.16 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 65.75 14.64 60.96 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.771 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 94.0 t -112.23 -69.72 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.898 0.38 . . . . 0.0 110.813 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 95.6 m -58.34 109.56 1.92 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.024 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.564 ' HG3' HG22 ' A' ' 70' ' ' VAL . 92.1 Cg_endo -84.41 130.26 4.53 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.542 2.161 . . . . 0.0 112.244 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.495 ' CZ ' ' HB3' ' A' ' 150' ' ' ASP . 9.7 p90 -124.16 132.86 53.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.868 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' MET . . . . . 0.601 ' SD ' HD13 ' A' ' 78' ' ' LEU . 24.4 mtp -104.4 141.09 36.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.133 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.597 HG23 HD11 ' A' ' 23' ' ' ILE . 82.5 mt -97.07 116.17 38.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.193 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -113.69 156.08 24.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.511 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -99.92 126.54 46.07 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.94 0.4 . . . . 0.0 110.974 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 16.4 ttpp -69.17 -53.48 19.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.312 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.457 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 73.3 m-20 -51.39 -38.87 55.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.046 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.42 ' O ' ' HE3' ' A' ' 145' ' ' MET . . . -95.8 25.09 26.7 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.33 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.527 HD21 ' HB3' ' A' ' 4' ' ' TYR . 0.6 OUTLIER -138.96 148.34 43.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.698 0.285 . . . . 0.0 110.83 -179.876 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -112.0 150.61 30.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.106 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.6 ' HB3' HD11 ' A' ' 2' ' ' ILE . 2.1 mtm -124.66 122.82 38.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.622 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -140.76 118.38 11.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.12 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 2' ' ' ILE . 0.7 OUTLIER -71.23 112.15 7.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.92 -179.95 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.28 -172.81 3.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.928 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -133.64 33.9 3.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.795 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.28 -0.866 . . . . 0.0 110.878 -179.969 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.814 0.34 . . . . 0.0 111.176 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.639 HG23 ' CE1' ' A' ' 4' ' ' TYR . 1.1 tt -106.83 142.55 19.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.908 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.509 ' O ' ' HA ' ' A' ' 169' ' ' MET . 8.1 mm -107.76 121.04 60.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.341 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.639 ' CE1' HG23 ' A' ' 2' ' ' ILE . 11.0 m-85 -91.21 130.3 37.1 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.919 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 17.7 ptt180 -139.22 143.32 37.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.133 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.42 ' O ' ' HA ' ' A' ' 10' ' ' HIS . 36.1 t0 -50.56 151.81 2.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.966 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 66.4 tp -80.69 -25.49 38.14 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.361 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.696 HD11 ' CG1' ' A' ' 99' ' ' ILE . 4.6 mp -91.3 -43.58 14.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.812 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.3 t -90.62 -30.82 16.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.814 0.34 . . . . 0.0 111.399 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.42 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER 66.49 29.37 9.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.918 -179.78 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -104.92 127.2 52.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.668 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -57.2 97.5 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.156 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 12.5 mtp -83.77 -15.57 47.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.972 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.491 ' CE2' ' CG ' ' A' ' 4' ' ' TYR . 44.8 p90 -178.8 161.36 1.23 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.805 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.2 m -126.37 -169.82 2.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.607 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.583 ' HB2' HG22 ' A' ' 2' ' ' ILE . 38.7 t70 -93.8 30.26 1.86 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.02 0.438 . . . . 0.0 110.952 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.4 HD11 ' CZ ' ' A' ' 18' ' ' TYR . 46.2 pt -92.39 -10.52 9.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.573 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.865 ' CZ ' HG22 ' A' ' 72' ' ' ILE . 46.6 m-85 -111.54 -167.02 1.13 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.645 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.3 mtpt -97.52 87.57 4.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.797 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.543 ' N ' HD12 ' A' ' 20' ' ' ILE . 4.2 mp -88.01 134.1 28.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.042 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -128.22 152.7 47.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.755 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.72 ' HG3' HD23 ' A' ' 29' ' ' LEU . 2.3 mp0 -97.7 121.92 40.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.976 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.687 HD11 HG23 ' A' ' 161' ' ' ILE . 4.8 pt -119.1 166.28 13.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.119 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 57.65 30.31 18.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.217 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 63.18 40.77 8.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.307 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.5 -16.65 60.66 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.652 -0.785 . . . . 0.0 113.068 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.87 -34.22 62.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.823 0.312 . . . . 0.0 111.035 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 12.1 m -146.31 161.19 40.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.938 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.72 HD23 ' HG3' ' A' ' 22' ' ' GLU . 0.3 OUTLIER -126.61 129.77 49.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.777 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -94.06 119.92 33.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.21 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 17.5 t -102.12 112.16 34.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.699 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -91.58 116.11 28.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.125 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -94.71 -127.38 5.0 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.365 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.3 ptpt -174.38 122.75 0.29 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.79 0.329 . . . . 0.0 110.944 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 86.7 mtp -70.76 123.32 21.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.787 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.459 HG23 ' CE ' ' A' ' 74' ' ' MET . 5.5 m -117.89 127.71 75.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.134 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.507 ' HB3' HG23 ' A' ' 68' ' ' THR . 13.7 p -97.56 163.12 12.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.932 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.577 ' HB3' HG12 ' A' ' 67' ' ' ILE . 58.3 ttt180 -141.6 116.02 9.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.821 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.743 HG23 HG22 ' A' ' 66' ' ' VAL . 1.6 m -141.26 29.38 1.81 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.865 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -153.94 -66.23 0.14 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.886 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 137.43 -91.62 0.21 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.602 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -178.02 -38.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.823 0.344 . . . . 0.0 110.939 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.7 mt 70.78 69.68 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.107 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -178.05 -39.63 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.743 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 62.66 86.81 0.11 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.049 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.3 t -98.02 -62.47 1.24 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.727 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 5.9 mt -107.08 -61.76 1.5 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.829 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 47.0 mm 60.97 -80.4 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.288 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.68 138.48 9.42 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.504 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -69.57 -161.91 3.1 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.527 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -136.68 99.82 4.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.827 0.346 . . . . 0.0 110.865 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -130.7 31.71 4.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.101 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.1 p -102.08 -47.91 4.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.932 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 60.92 157.55 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.081 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -176.19 142.23 0.47 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.866 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -76.26 -77.87 0.73 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.485 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -66.12 66.83 0.45 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.828 2.352 . . . . 0.0 112.213 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -162.36 30.18 0.11 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.897 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -96.43 55.49 1.46 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.519 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -61.52 -37.8 85.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.798 0.332 . . . . 0.0 110.866 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 79.86 -149.69 31.69 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.514 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 60.61 157.88 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.748 0.308 . . . . 0.0 110.897 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -103.82 -68.22 0.85 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.854 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -59.76 88.21 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.792 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.8 m -102.05 152.25 21.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.03 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.743 HG22 HG23 ' A' ' 39' ' ' THR . 48.0 t -124.35 143.75 36.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.997 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.665 HD13 ' C ' ' A' ' 66' ' ' VAL . 0.0 OUTLIER -137.85 127.9 36.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.058 -179.987 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.507 HG23 ' HB3' ' A' ' 37' ' ' SER . 2.2 m -139.42 125.68 20.14 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.9 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -161.81 -177.01 34.51 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.286 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.501 HG22 ' HG3' ' A' ' 158' ' ' PRO . 57.1 t -69.49 144.93 13.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.837 0.351 . . . . 0.0 110.909 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -70.14 -57.03 5.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.479 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.865 HG22 ' CZ ' ' A' ' 18' ' ' TYR . 5.6 pt -53.52 -33.78 22.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.315 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.803 HG13 ' HB2' ' A' ' 78' ' ' LEU . 74.4 t -72.39 -34.58 49.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.087 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.459 ' CE ' HG23 ' A' ' 36' ' ' VAL . 2.7 mtm -78.24 -37.23 45.72 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.925 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.415 HD21 ' HA ' ' A' ' 72' ' ' ILE . 16.9 p30 -82.08 -31.59 30.72 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -178.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.462 ' CE1' ' HA ' ' A' ' 14' ' ' PHE . 42.0 m80 -93.58 -2.72 53.84 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.051 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 17.9 m80 61.03 36.57 18.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.164 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.803 ' HB2' HG13 ' A' ' 73' ' ' VAL . 28.8 mt -57.59 156.17 8.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.463 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.414 ' HG3' ' HG3' ' A' ' 140' ' ' MET . 3.9 mm-40 -132.72 135.22 45.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.841 0.353 . . . . 0.0 111.174 -179.396 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.438 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 5.6 tt0 -101.19 122.5 43.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.822 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.416 HG21 HD11 ' A' ' 136' ' ' ILE . 10.1 t -115.08 153.21 31.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.931 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 29.3 p -88.58 161.5 16.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.914 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.47 ' HB2' ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -165.27 156.21 14.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.874 -179.988 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -99.66 174.05 6.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.904 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -70.3 -52.37 23.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.88 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.98 -43.0 97.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.85 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.15 -42.66 91.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.037 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.912 ' CD2' HD11 ' A' ' 122' ' ' ILE . 0.1 OUTLIER -59.12 -34.94 72.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.862 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.441 ' O ' HG22 ' A' ' 92' ' ' ILE . 22.8 mttm -59.53 -46.16 89.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.126 0.489 . . . . 0.0 110.413 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt -77.08 -27.83 54.39 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.783 178.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.559 ' HE2' HG21 ' A' ' 146' ' ' VAL . 9.5 t80 -67.75 -44.1 78.31 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.876 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.607 HD12 ' CE2' ' A' ' 95' ' ' TYR . 6.1 tp -63.74 -42.58 96.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.911 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -63.45 -37.44 87.28 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.781 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.498 ' HA ' ' HG2' ' A' ' 97' ' ' LYS . 12.4 t70 -77.04 -41.5 42.29 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.7 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.607 ' CE2' HD12 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -77.32 -40.08 45.47 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 121.155 -0.218 . . . . 0.0 110.752 -179.591 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -67.58 -32.1 72.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.645 0.26 . . . . 0.0 110.599 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.498 ' HG2' ' HA ' ' A' ' 94' ' ' ASP . 0.0 OUTLIER -70.2 -34.44 72.94 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.879 0.371 . . . . 0.0 110.491 179.756 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.456 ' N ' ' HG3' ' A' ' 97' ' ' LYS . 2.0 m -61.04 -40.18 92.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.046 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.696 ' CG1' HD11 ' A' ' 8' ' ' ILE . 7.2 mt -79.82 -42.36 22.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.504 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.403 ' O ' ' HG3' ' A' ' 104' ' ' GLU . 12.7 tmtt? -54.43 -55.23 30.91 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.523 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -60.86 -44.8 97.63 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.247 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.27 -41.29 96.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.885 0.374 . . . . 0.0 110.492 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.765 HD21 ' CB ' ' A' ' 110' ' ' ARG . 3.3 tp -68.24 -32.82 73.29 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.169 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.705 ' HG3' HG11 ' A' ' 111' ' ' VAL . 74.6 mt-10 -60.21 -29.66 68.88 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.934 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -88.11 -20.81 25.17 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.569 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -103.74 -57.73 1.99 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.791 0.329 . . . . 0.0 111.665 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.446 ' N ' ' O ' ' A' ' 103' ' ' LEU . 44.7 mtt85 -139.19 68.16 40.35 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.786 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.93 ' O ' HG22 ' A' ' 111' ' ' VAL . 9.9 Cg_endo -50.66 -21.39 7.84 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 123.234 2.623 . . . . 0.0 112.968 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -68.95 -9.99 54.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.591 0.234 . . . . 0.0 111.403 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.765 ' CB ' HD21 ' A' ' 103' ' ' LEU . 0.7 OUTLIER -111.99 -3.01 14.91 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 -179.492 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.93 HG22 ' O ' ' A' ' 108' ' ' PRO . 33.9 m -71.26 -26.93 27.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.641 0.258 . . . . 0.0 111.516 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.601 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -69.38 -55.8 9.21 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.517 -179.279 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.601 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 33.4 Cg_exo -56.92 -37.61 97.89 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.084 1.856 . . . . 0.0 111.739 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.461 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 82.5 t80 -66.64 -37.63 85.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.076 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 6.1 mtp -57.03 -54.68 44.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.956 0.407 . . . . 0.0 110.737 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 75.1 m -72.9 -44.73 60.92 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.696 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.97 -38.24 95.15 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.498 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.96 -51.69 68.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.973 0.416 . . . . 0.0 110.926 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.99 -28.2 63.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.251 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -75.6 -41.21 55.11 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.109 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -74.38 -34.85 63.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.901 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.912 HD11 ' CD2' ' A' ' 88' ' ' TYR . 0.4 OUTLIER -69.95 -45.9 75.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.205 -179.877 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.455 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 5.4 pttp -61.11 -31.83 71.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.993 0.425 . . . . 0.0 110.275 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 7.0 t-80 -67.51 -53.51 28.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.698 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.613 HG21 HD13 ' A' ' 148' ' ' LEU . 15.5 pt -62.12 -42.12 93.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.288 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.475 ' HA ' HD23 ' A' ' 126' ' ' LEU . 11.7 mt -53.99 -35.22 61.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.88 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -70.1 -11.29 60.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.296 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -142.49 33.28 1.46 Allowed 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.968 0.413 . . . . 0.0 110.588 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.497 ' CE1' ' CZ ' ' A' ' 134' ' ' PHE . 12.4 t80 -49.71 -26.79 4.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.24 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.91 -29.37 69.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.05 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 28.5 m-20 -94.21 -29.86 14.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.451 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.448 ' CD2' HG22 ' A' ' 125' ' ' ILE . 2.5 m-85 -98.47 138.41 35.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.877 0.37 . . . . 0.0 111.295 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.4 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 4.4 mm-40 -123.07 144.1 49.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.721 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.517 ' CE1' ' CZ ' ' A' ' 88' ' ' TYR . 3.2 m-85 -82.09 123.75 29.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.118 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.438 ' CE2' ' HB2' ' A' ' 80' ' ' GLU . 25.4 m-85 -127.86 140.74 51.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.599 179.466 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.419 ' HB ' ' HA ' ' A' ' 140' ' ' MET . 0.5 OUTLIER -131.29 160.99 41.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.691 -179.981 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -57.37 -169.58 0.14 Allowed Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.524 -0.846 . . . . 0.0 111.879 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.05 -8.91 57.28 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.582 0.23 . . . . 0.0 111.329 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.506 ' HB3' ' ND2' ' A' ' 141' ' ' ASN . 26.7 m-80 -94.31 -30.28 14.61 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.41 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.419 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 70.7 mtm 55.84 44.51 25.85 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.773 0.32 . . . . 0.0 111.256 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ASN . . . . . 0.506 ' ND2' ' HB3' ' A' ' 139' ' ' ASN . 1.2 m120 -68.67 117.38 50.16 Favored Pre-proline 0 N--CA 1.453 -0.296 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.625 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -63.2 -23.23 72.82 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.323 2.015 . . . . 0.0 111.854 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -84.72 -15.4 45.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.646 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -77.78 -159.7 12.47 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.276 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.457 ' HE3' ' O ' ' A' ' 166' ' ' GLY . 3.6 ptp -98.75 -174.4 2.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.793 0.33 . . . . 0.0 110.796 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.559 HG21 ' HE2' ' A' ' 91' ' ' TYR . 49.1 t -128.83 152.47 37.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.165 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.488 ' HB1' ' HE3' ' A' ' 160' ' ' MET . . . -114.64 119.23 36.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.656 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.613 HD13 HG21 ' A' ' 125' ' ' ILE . 3.0 mt -93.48 106.29 18.27 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.192 -179.322 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.591 HD12 ' HG2' ' A' ' 160' ' ' MET . 2.0 tp -90.82 119.12 30.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.149 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.469 ' HB2' ' CZ ' ' A' ' 159' ' ' TYR . 0.9 OUTLIER -125.99 159.5 32.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.745 179.7 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -109.7 138.13 46.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.887 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.93 -173.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.784 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.3 -41.07 83.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.905 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -67.87 -15.1 63.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.163 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 68.71 20.04 73.75 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.69 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 94.2 t -112.85 -70.04 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.859 0.362 . . . . 0.0 110.751 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 88.7 m -57.59 108.91 1.42 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.891 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.548 ' HB2' HD11 ' A' ' 149' ' ' LEU . 90.8 Cg_endo -86.71 127.86 2.78 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.723 2.282 . . . . 0.0 112.44 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.469 ' CZ ' ' HB2' ' A' ' 150' ' ' ASP . 16.0 p90 -121.67 132.15 54.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.797 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' MET . . . . . 0.591 ' HG2' HD12 ' A' ' 149' ' ' LEU . 0.9 OUTLIER -101.8 140.87 35.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.071 -179.818 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.687 HG23 HD11 ' A' ' 23' ' ' ILE . 57.4 mt -96.77 121.61 47.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.242 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.47 ' CZ ' ' HE3' ' A' ' 160' ' ' MET . 43.0 m-85 -119.63 156.49 30.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.698 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -102.16 118.63 37.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.858 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 40.9 tttt -61.12 -49.98 75.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.235 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.461 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 32.5 m-20 -55.26 -40.34 70.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.243 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.457 ' O ' ' HE3' ' A' ' 145' ' ' MET . . . -95.74 25.18 26.22 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.66 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.561 HD21 ' HB3' ' A' ' 4' ' ' TYR . 4.9 tt -150.19 148.71 29.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.88 0.372 . . . . 0.0 110.949 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -133.95 150.61 51.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.395 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.509 ' HA ' ' O ' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -135.47 160.25 39.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.805 0.336 . . . . 0.0 111.261 -179.796 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -146.85 144.61 29.43 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.547 -179.033 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 2' ' ' ILE . 0.1 OUTLIER -81.82 109.06 15.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.095 179.812 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 1.5 m 63.35 124.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.005 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 4.1 mt -93.17 165.29 12.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.821 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.976 179.949 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.854 0.359 . . . . 0.0 111.113 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.795 HG23 ' CE1' ' A' ' 4' ' ' TYR . 1.0 OUTLIER -113.91 142.11 27.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.082 179.924 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.518 ' O ' ' HA ' ' A' ' 169' ' ' MET . 10.1 mm -103.39 119.54 52.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.981 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.795 ' CE1' HG23 ' A' ' 2' ' ' ILE . 17.4 m-85 -93.44 128.98 39.75 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.93 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.9 ptt-85 -136.31 144.77 44.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.969 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -52.53 138.01 28.88 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.833 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 59.9 tp -71.34 -23.65 61.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.291 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.499 ' N ' HD12 ' A' ' 8' ' ' ILE . 4.3 mp -91.2 -43.64 14.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.805 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.8 m -90.28 -29.4 18.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.391 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 32.3 m80 68.28 30.25 5.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.858 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -111.03 126.21 54.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.655 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -56.0 112.92 1.32 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.266 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 7.2 mtt -96.37 -16.61 21.17 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.908 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.436 ' HA ' ' CE1' ' A' ' 76' ' ' HIS . 37.8 p90 179.9 152.99 0.48 Allowed 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 120.875 0.369 . . . . 0.0 111.0 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.417 ' HB3' HD13 ' A' ' 3' ' ' ILE . 0.9 OUTLIER -112.86 -169.8 1.55 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.417 179.629 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.712 ' HB2' HG22 ' A' ' 2' ' ' ILE . 31.2 t70 -94.98 34.6 1.35 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.948 0.404 . . . . 0.0 110.819 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.518 HD11 ' CZ ' ' A' ' 18' ' ' TYR . 41.6 pt -95.43 -7.81 9.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.742 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.776 ' CZ ' HG22 ' A' ' 72' ' ' ILE . 37.2 m-85 -113.63 -167.38 1.19 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.696 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.52 86.95 3.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.855 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.462 ' H ' HD12 ' A' ' 20' ' ' ILE . 4.6 mp -89.77 124.01 42.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.086 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -118.16 140.25 50.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.987 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.706 ' HG3' HD23 ' A' ' 29' ' ' LEU . 1.1 mp0 -84.57 116.06 22.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.76 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.442 HD11 HG23 ' A' ' 161' ' ' ILE . 4.6 pt -113.4 166.85 6.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.13 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.522 ' HB2' ' NE2' ' A' ' 121' ' ' GLN . . . 59.53 30.57 20.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.086 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 64.83 47.24 2.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.332 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.91 -8.32 73.55 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.718 -0.753 . . . . 0.0 113.358 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.479 ' HB3' ' HB3' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -60.95 -52.36 65.36 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.818 0.342 . . . . 0.0 111.071 -179.915 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 11.7 m -125.98 163.53 22.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.067 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.706 HD23 ' HG3' ' A' ' 22' ' ' GLU . 0.3 OUTLIER -126.42 133.45 51.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.735 179.909 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -99.83 112.94 25.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.05 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 159' ' ' TYR . 20.4 t -92.35 111.94 25.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.697 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -87.78 110.91 20.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.17 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -95.68 -133.55 7.47 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.29 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.4 pttt -174.46 123.99 0.29 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.882 0.373 . . . . 0.0 110.884 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 71.3 mtm -70.91 112.63 7.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.815 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.719 ' O ' HG23 ' A' ' 68' ' ' THR . 24.0 m -95.65 163.58 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.153 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 79.0 p -125.34 165.63 18.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.697 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.742 ' O ' HG13 ' A' ' 66' ' ' VAL . 18.0 ttm180 -143.05 116.46 9.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.866 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.9 m -143.59 90.42 2.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.835 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -81.03 -176.35 5.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.915 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -130.83 -142.75 5.16 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.538 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -134.45 165.88 24.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.844 0.354 . . . . 0.0 110.86 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.41 HG22 ' N ' ' A' ' 44' ' ' ASP . 4.6 mt -92.6 153.58 3.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.075 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.41 ' N ' HG22 ' A' ' 43' ' ' ILE . 2.4 m-20 62.01 150.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.93 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 59.83 79.21 0.24 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.947 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.3 m -100.81 -47.44 4.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.89 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.465 HD12 HD13 ' A' ' 48' ' ' ILE . 0.6 OUTLIER -70.45 -30.93 67.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.982 -179.977 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.465 HD13 HD12 ' A' ' 47' ' ' LEU . 33.2 mm -69.45 123.55 23.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.172 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -100.49 172.55 24.13 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.441 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -84.98 131.88 10.72 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.573 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -83.42 153.9 24.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.802 0.334 . . . . 0.0 110.942 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 60.15 92.03 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.091 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.2 p -118.12 -178.65 3.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.864 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -160.93 -45.45 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.152 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.88 146.28 32.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.865 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.07 -91.91 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.51 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.5 134.4 52.33 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.58 2.187 . . . . 0.0 112.311 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -134.24 125.39 27.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.878 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 177.38 39.64 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.448 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -90.12 97.3 11.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.825 0.345 . . . . 0.0 110.996 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 121.66 -98.29 0.64 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.536 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 18.6 p -137.07 -168.49 2.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.887 0.375 . . . . 0.0 110.854 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 61.36 105.45 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.865 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.66 121.48 1.12 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.904 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.4 t -97.98 27.67 4.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.052 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.742 HG13 ' O ' ' A' ' 38' ' ' ARG . 27.5 t -105.82 135.72 42.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.064 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.586 HD13 ' C ' ' A' ' 66' ' ' VAL . 0.0 OUTLIER -123.09 129.55 74.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.187 -179.921 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.719 HG23 ' O ' ' A' ' 36' ' ' VAL . 85.2 m -139.57 141.05 37.21 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.024 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 179.71 -179.46 48.83 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.407 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.578 HG12 HG12 ' A' ' 72' ' ' ILE . 46.2 t -72.59 135.4 27.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.808 0.337 . . . . 0.0 110.662 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -64.05 -54.76 29.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.782 -179.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.776 HG22 ' CZ ' ' A' ' 18' ' ' TYR . 8.1 pt -53.85 -33.93 24.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.907 0.384 . . . . 0.0 111.267 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.756 HG13 ' HB2' ' A' ' 78' ' ' LEU . 84.2 t -73.59 -35.0 43.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.906 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 5.0 mtm -78.3 -38.83 41.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.788 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.402 ' OD1' ' CD2' ' A' ' 76' ' ' HIS . 22.3 p30 -82.1 -29.44 31.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.655 -179.135 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.436 ' CE1' ' HA ' ' A' ' 14' ' ' PHE . 26.2 m170 -92.55 -2.58 56.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.775 0.322 . . . . 0.0 110.806 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.512 ' HB2' ' HB3' ' A' ' 138' ' ' GLU . 49.5 m80 59.28 35.12 23.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.043 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.756 ' HB2' HG13 ' A' ' 73' ' ' VAL . 41.5 mt -61.13 141.15 57.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.515 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -120.83 132.33 54.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.011 -179.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.417 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 10.1 tt0 -91.04 124.48 35.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.91 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.901 HG21 HD11 ' A' ' 136' ' ' ILE . 1.4 t -117.23 172.33 7.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.835 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.6 p -107.24 170.69 7.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.006 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.481 ' HB2' ' CE2' ' A' ' 134' ' ' PHE . 0.6 OUTLIER -171.65 152.43 3.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.859 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.8 m -99.87 158.09 16.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.839 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 33.8 mtmt -57.69 -52.5 65.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.917 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.9 tm-20 -65.88 -45.0 83.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.727 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.66 -33.88 72.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.059 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.88 ' CD2' HD11 ' A' ' 122' ' ' ILE . 0.7 OUTLIER -65.03 -37.42 87.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.713 179.902 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.436 ' O ' HG22 ' A' ' 92' ' ' ILE . 50.4 mttm -58.19 -45.51 87.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.099 0.476 . . . . 0.0 110.333 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.7 mmtp -76.66 -27.8 55.75 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.742 178.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.537 ' HE2' HG21 ' A' ' 146' ' ' VAL . 8.4 t80 -67.61 -45.38 75.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.76 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.676 HD12 ' CE2' ' A' ' 95' ' ' TYR . 5.2 tp -61.74 -42.2 93.45 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 CA-C-O 120.888 0.375 . . . . 0.0 110.82 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.494 ' O ' ' CG ' ' A' ' 97' ' ' LYS . 3.6 ttpm? -63.39 -44.9 93.37 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.812 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -70.29 -38.9 75.1 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.866 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.676 ' CE2' HD12 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -78.12 -42.94 30.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.694 -0.23 . . . . 0.0 110.648 -179.513 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -62.72 -31.85 72.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.865 0.364 . . . . 0.0 110.078 179.098 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.494 ' CG ' ' O ' ' A' ' 93' ' ' LYS . 2.5 mmtp -65.73 -43.83 87.84 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.595 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.6 m -54.36 -40.47 68.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.601 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.483 ' CG1' HD11 ' A' ' 8' ' ' ILE . 7.8 mt -79.92 -43.13 22.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.678 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 15.0 tttt -53.19 -55.86 20.98 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.559 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -62.49 -45.07 96.64 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.308 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.78 -37.47 84.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.847 0.355 . . . . 0.0 110.465 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.671 HD21 ' CB ' ' A' ' 110' ' ' ARG . 2.8 tp -70.94 -32.08 68.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.135 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.627 ' CG ' HG11 ' A' ' 111' ' ' VAL . 30.0 mt-10 -60.59 -30.25 69.7 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.872 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -89.68 -20.04 24.12 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.543 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -106.01 -62.8 1.33 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.816 0.341 . . . . 0.0 111.413 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.434 ' N ' ' O ' ' A' ' 103' ' ' LEU . 16.7 mtt180 -127.53 63.58 59.85 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.891 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.883 ' O ' HG22 ' A' ' 111' ' ' VAL . 10.2 Cg_endo -50.86 -21.92 9.19 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 123.145 2.563 . . . . 0.0 112.82 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -71.35 -11.29 60.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.673 -0.24 . . . . 0.0 111.467 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.671 ' CB ' HD21 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -112.26 1.06 15.97 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 -179.289 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.883 HG22 ' O ' ' A' ' 108' ' ' PRO . 34.4 m -68.36 -35.72 71.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -179.42 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.573 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 18.4 mttt -68.69 -50.6 24.12 Favored Pre-proline 0 C--N 1.331 -0.209 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.609 -179.2 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.573 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 32.3 Cg_exo -57.98 -33.24 96.94 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.11 1.873 . . . . 0.0 111.813 179.399 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.452 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 86.3 t80 -69.71 -41.72 75.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.15 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -55.45 -49.27 72.91 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.928 0.394 . . . . 0.0 110.871 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 82.4 m -70.98 -44.36 66.12 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.725 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.03 -39.21 97.77 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.644 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.4 ' O ' ' HB ' ' A' ' 122' ' ' ILE . . . -57.88 -51.54 69.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.94 0.4 . . . . 0.0 111.161 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.1 -28.29 66.36 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.306 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.07 -58.86 3.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.24 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.522 ' NE2' ' HB2' ' A' ' 24' ' ' ALA . 3.5 tp-100 -56.03 -42.66 76.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.218 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.88 HD11 ' CD2' ' A' ' 88' ' ' TYR . 0.3 OUTLIER -61.62 -45.54 98.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.193 -179.828 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.44 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 12.5 mttm -59.98 -31.9 70.34 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.179 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 5.7 t-80 -67.56 -54.52 19.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.806 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.972 HG21 HD13 ' A' ' 148' ' ' LEU . 11.9 pt -61.04 -40.77 86.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.218 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 126' ' ' LEU . 11.8 mt -53.95 -37.59 64.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.705 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.6 -15.04 60.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.269 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -138.59 34.6 2.23 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.1 0.476 . . . . 0.0 110.423 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -48.09 -43.34 30.65 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.295 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.3 mmmp? -62.13 -19.88 63.5 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.302 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -93.99 -41.09 9.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.724 0.297 . . . . 0.0 111.317 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.413 ' CD2' ' OD1' ' A' ' 150' ' ' ASP . 3.9 m-85 -89.0 145.31 25.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.126 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.412 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 5.6 mm-40 -122.31 145.92 47.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.807 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.481 ' CE2' ' HB2' ' A' ' 83' ' ' PHE . 2.9 m-85 -86.37 129.47 34.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.118 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.417 ' CE2' ' HB2' ' A' ' 80' ' ' GLU . 51.8 m-85 -130.98 132.25 44.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.769 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.901 HD11 HG21 ' A' ' 81' ' ' THR . 0.4 OUTLIER -121.84 159.31 24.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.681 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -56.67 -171.96 0.16 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.428 -0.891 . . . . 0.0 111.844 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.512 ' HB3' ' HB2' ' A' ' 77' ' ' HIS . 0.0 OUTLIER -70.68 -8.93 55.6 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.571 0.224 . . . . 0.0 111.42 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.514 ' HB3' ' ND2' ' A' ' 141' ' ' ASN . 19.8 m-80 -93.65 -26.91 16.85 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.673 0.273 . . . . 0.0 111.108 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.445 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 52.0 mtm 51.62 43.96 29.47 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.442 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ASN . . . . . 0.514 ' ND2' ' HB3' ' A' ' 139' ' ' ASN . 1.7 m120 -68.77 120.04 73.22 Favored Pre-proline 0 N--CA 1.452 -0.335 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.595 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -60.08 -26.39 82.35 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.279 1.986 . . . . 0.0 111.856 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -84.71 -15.86 43.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.739 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.17 -168.34 10.77 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.404 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 2.0 ptp -93.2 -177.33 4.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.819 0.342 . . . . 0.0 110.811 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.537 HG21 ' HE2' ' A' ' 91' ' ' TYR . 74.8 t -126.64 145.26 34.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.11 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.621 ' HB2' ' CE1' ' A' ' 162' ' ' PHE . . . -112.08 112.27 23.78 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.567 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.972 HD13 HG21 ' A' ' 125' ' ' ILE . 4.9 mt -86.76 108.28 18.63 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.193 -179.182 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.45 ' HB2' ' HE2' ' A' ' 160' ' ' MET . 1.5 tp -91.03 119.54 31.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.122 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.465 ' HB3' ' CE1' ' A' ' 159' ' ' TYR . 0.5 OUTLIER -133.08 174.52 10.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.642 179.55 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -117.26 143.68 45.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.846 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 11.8 mmm180 -56.78 -175.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.058 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -56.3 -31.46 63.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.9 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -78.48 -15.01 59.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.153 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 70.67 21.74 77.89 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.66 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 89.1 t -112.47 -69.2 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.861 0.362 . . . . 0.0 110.823 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 91.0 m -57.61 109.17 1.58 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.945 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -81.24 127.3 5.89 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.484 2.123 . . . . 0.0 112.331 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.465 ' CE1' ' HB3' ' A' ' 150' ' ' ASP . 13.0 p90 -125.35 148.28 48.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.755 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' MET . . . . . 0.627 ' HE1' HD13 ' A' ' 78' ' ' LEU . 0.4 OUTLIER -111.69 142.86 43.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.028 -179.756 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.532 ' HB ' ' HB2' ' A' ' 148' ' ' LEU . 41.9 mt -99.08 120.44 48.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.24 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.621 ' CE1' ' HB2' ' A' ' 147' ' ' ALA . 99.1 m-85 -125.93 150.17 48.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.643 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -97.45 119.16 35.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.898 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 43.1 tttt -56.27 -53.94 51.28 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.334 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.452 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 44.9 m-20 -53.82 -37.49 63.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.19 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.476 ' HA2' HG23 ' A' ' 99' ' ' ILE . . . -95.27 24.42 29.07 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.57 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.723 HD21 ' HB3' ' A' ' 4' ' ' TYR . 5.8 tt -150.15 140.11 21.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.842 0.353 . . . . 0.0 110.74 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -120.16 142.96 48.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.58 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.518 ' HA ' ' O ' ' A' ' 3' ' ' ILE . 0.1 OUTLIER -136.73 160.2 39.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.735 0.302 . . . . 0.0 111.145 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.404 ' O ' HG13 ' A' ' 2' ' ' ILE . 1.5 pt-20 -146.97 143.26 28.32 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.366 -179.102 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.487 ' N ' HD12 ' A' ' 2' ' ' ILE . 18.7 mttm -82.41 109.04 16.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.919 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 7.4 t -113.52 108.8 17.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.79 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.21 150.77 20.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.945 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.92 -179.97 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.479 ' HE2' ' HB3' ' A' ' 174' ' ' GLU . 11.8 ttt . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.836 0.351 . . . . 0.0 111.183 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.716 HD11 ' HB3' ' A' ' 169' ' ' MET . 1.8 tt -140.51 148.3 22.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.055 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.408 ' CG2' ' HB3' ' A' ' 12' ' ' GLU . 16.9 mm -102.14 146.5 10.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.877 0.37 . . . . 0.0 111.518 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.552 ' HE1' HG23 ' A' ' 2' ' ' ILE . 4.9 m-85 -115.96 100.15 7.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.422 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 1.1 ptt180 -116.34 147.9 41.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.881 0.372 . . . . 0.0 111.344 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.458 ' O ' ' HA ' ' A' ' 10' ' ' HIS . 44.7 t0 -57.04 152.17 13.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.749 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.558 HD23 HG23 ' A' ' 99' ' ' ILE . 59.0 tp -81.32 -21.09 39.46 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.53 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.658 HD11 ' CG1' ' A' ' 99' ' ' ILE . 4.3 mp -91.29 -47.77 14.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -179.416 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.414 ' HB2' ' ND2' ' A' ' 141' ' ' ASN . 3.0 t -96.41 -17.54 20.53 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -179.077 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.458 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 0.3 OUTLIER 61.98 28.59 17.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.855 0.359 . . . . 0.0 110.774 -179.727 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -98.17 121.71 40.44 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.762 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.408 ' HB3' ' CG2' ' A' ' 3' ' ' ILE . 0.3 OUTLIER -58.17 93.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.282 -179.756 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 7.7 mtt -71.87 -19.44 61.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.664 179.442 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.608 ' HA ' ' CE1' ' A' ' 76' ' ' HIS . 7.4 p90 -177.86 176.86 1.14 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.667 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.422 ' O ' HD11 ' A' ' 20' ' ' ILE . 0.9 OUTLIER -133.71 -169.99 2.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.953 -179.886 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.406 ' HB2' HG22 ' A' ' 2' ' ' ILE . 22.6 t70 -94.42 25.08 4.08 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.98 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.43 HG13 ' CD2' ' A' ' 18' ' ' TYR . 20.8 pt -82.39 -15.49 11.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.525 179.091 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.839 ' CE2' HG22 ' A' ' 72' ' ' ILE . 78.4 m-85 -108.84 -174.45 2.52 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.516 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.1 mttp -94.66 88.53 5.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.849 0.357 . . . . 0.0 110.718 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.422 HD11 ' O ' ' A' ' 15' ' ' SER . 4.1 mp -87.94 132.5 32.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.167 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 8.0 mtt180 -124.68 139.68 53.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.807 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.49 122.32 28.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.996 0.427 . . . . 0.0 110.943 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.9 pt -117.37 167.47 10.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.027 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.472 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . . . 60.08 27.09 16.5 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.072 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 66.92 55.96 0.7 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.338 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 77.12 0.34 70.07 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 120.853 -0.689 . . . . 0.0 113.422 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.472 ' HB3' ' HB3' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -70.44 -58.23 3.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 117.082 0.441 . . . . 0.0 111.04 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 35.2 m -118.95 164.82 14.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.997 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.698 HD11 ' CG ' ' A' ' 164' ' ' LYS . 0.4 OUTLIER -126.32 133.18 51.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.862 -179.931 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -99.06 112.83 24.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.968 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.481 HG21 ' CD2' ' A' ' 14' ' ' PHE . 26.1 t -92.04 111.86 24.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.625 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -80.88 114.08 19.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.252 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -99.19 -141.46 12.27 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.214 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -174.42 126.88 0.33 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.823 0.344 . . . . 0.0 110.978 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 27.7 mtp -68.36 122.58 18.68 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.522 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.1 m -111.97 116.1 51.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.465 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.4 p -84.07 165.79 18.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.999 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.478 ' CB ' HG12 ' A' ' 67' ' ' ILE . 1.8 mmt-85 -128.12 116.34 19.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.621 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -105.38 33.46 3.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.758 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -93.95 97.71 10.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.876 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -133.71 178.07 18.58 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.483 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -80.53 104.58 11.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.875 0.369 . . . . 0.0 110.897 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 31.9 mt 63.81 143.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.116 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -95.48 -69.51 0.75 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.877 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -155.03 178.82 9.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.959 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 85.8 p -80.93 -33.17 34.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.953 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.1 mt -75.55 -30.61 59.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.894 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -111.58 103.3 15.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.984 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -155.04 90.6 0.12 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.481 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -156.02 81.85 0.16 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.543 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -172.22 -179.78 2.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.869 0.366 . . . . 0.0 110.868 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.87 163.95 23.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.132 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -107.67 169.93 8.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.873 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -156.56 162.59 39.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.093 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -82.92 -31.13 27.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.957 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 79.27 -148.67 31.44 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.483 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -51.39 147.44 22.06 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.583 2.189 . . . . 0.0 112.346 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -110.51 36.39 3.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.945 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -124.66 -129.54 3.41 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.506 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -120.22 -50.36 2.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.859 0.362 . . . . 0.0 110.91 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -149.49 28.24 1.2 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.549 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 68.5 p -87.54 91.53 8.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.824 0.345 . . . . 0.0 110.87 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -115.89 145.15 43.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.914 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.1 m -102.95 -31.78 10.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.765 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.969 HG22 HG23 ' A' ' 66' ' ' VAL . 92.3 m 63.39 -79.96 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.075 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.969 HG23 HG22 ' A' ' 65' ' ' THR . 42.0 t -127.07 145.33 34.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.083 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.478 HG12 ' CB ' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -135.62 130.48 49.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.953 179.715 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 86.5 m -139.15 139.9 37.72 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.036 0.446 . . . . 0.0 111.146 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -175.42 179.43 46.65 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.047 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.579 HG12 HG12 ' A' ' 72' ' ' ILE . 40.8 t -73.2 130.32 35.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.887 0.375 . . . . 0.0 110.847 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -59.26 -55.3 36.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.64 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.839 HG22 ' CE2' ' A' ' 18' ' ' TYR . 6.9 pt -54.01 -36.72 32.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.544 -179.386 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.796 HG13 ' HB2' ' A' ' 78' ' ' LEU . 97.2 t -70.37 -31.47 46.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.197 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.5 mtm -78.22 -40.47 37.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.786 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.433 HD22 ' CE1' ' A' ' 76' ' ' HIS . 0.0 OUTLIER -82.0 -29.33 32.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.546 -179.23 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.608 ' CE1' ' HA ' ' A' ' 14' ' ' PHE . 30.2 m-70 -89.95 -5.11 57.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.869 0.366 . . . . 0.0 110.752 179.657 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.433 ' HB2' ' HB3' ' A' ' 138' ' ' GLU . 28.6 m-70 61.74 28.42 17.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.916 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.842 HD13 ' CE ' ' A' ' 160' ' ' MET . 34.2 mt -59.87 152.87 22.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.588 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -138.73 145.84 40.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.799 0.333 . . . . 0.0 111.175 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.421 ' HB2' ' CZ ' ' A' ' 135' ' ' PHE . 0.2 OUTLIER -99.41 133.18 44.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.079 -179.924 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.445 HG21 HD11 ' A' ' 136' ' ' ILE . 9.7 t -117.15 166.9 11.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.755 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 66.8 m -98.38 158.28 15.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.04 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.456 ' HB2' ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -171.78 150.1 2.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.823 179.934 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 54.7 p -99.92 169.61 9.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.821 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -63.17 -52.44 62.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.923 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -60.67 -45.41 94.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.921 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.434 ' HB1' ' CE1' ' A' ' 83' ' ' PHE . . . -59.78 -41.12 90.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.962 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.793 ' CD2' HD11 ' A' ' 122' ' ' ILE . 0.2 OUTLIER -58.03 -36.14 72.29 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.894 179.938 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.442 ' O ' HG22 ' A' ' 92' ' ' ILE . 36.3 mttm -60.12 -51.11 71.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.069 0.461 . . . . 0.0 110.482 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.1 mttm -72.93 -27.7 62.0 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.591 178.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.566 ' HE2' HG21 ' A' ' 146' ' ' VAL . 7.5 t80 -64.23 -48.03 77.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.975 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.459 ' CD1' ' CE2' ' A' ' 95' ' ' TYR . 3.1 tp -61.43 -41.91 91.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.733 0.301 . . . . 0.0 111.174 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.445 ' O ' ' CG ' ' A' ' 97' ' ' LYS . 4.6 ttmt -61.17 -46.08 91.98 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.969 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -70.79 -36.86 73.22 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.93 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.532 ' CD1' ' C ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -76.34 -43.11 42.56 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 121.189 -0.205 . . . . 0.0 110.744 -179.544 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.3 ptp -65.07 -32.03 73.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.92 0.391 . . . . 0.0 110.279 179.174 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.445 ' CG ' ' O ' ' A' ' 93' ' ' LYS . 0.1 OUTLIER -64.01 -44.2 93.33 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.867 179.751 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.4 m -56.47 -43.2 79.38 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.874 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.658 ' CG1' HD11 ' A' ' 8' ' ' ILE . 6.5 mt -79.85 -40.59 20.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.682 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.2 tttt -55.09 -53.47 55.51 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.574 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -62.94 -46.42 93.61 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.334 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.1 tppm? -60.53 -40.85 92.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.858 0.361 . . . . 0.0 110.422 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.727 HD21 ' CB ' ' A' ' 110' ' ' ARG . 3.0 tp -66.52 -35.25 79.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.26 179.329 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.645 ' CG ' HG11 ' A' ' 111' ' ' VAL . 36.2 mt-10 -59.13 -29.38 67.35 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.684 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -88.52 -18.69 27.62 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.617 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -108.56 -61.8 1.55 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.838 0.351 . . . . 0.0 111.586 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.429 ' N ' ' O ' ' A' ' 103' ' ' LEU . 19.9 mtt85 -130.1 65.07 74.6 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.777 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.919 ' O ' HG22 ' A' ' 111' ' ' VAL . 9.4 Cg_endo -50.54 -23.33 10.55 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 123.087 2.525 . . . . 0.0 112.652 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -69.1 -13.9 62.7 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.64 0.257 . . . . 0.0 111.15 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.727 ' CB ' HD21 ' A' ' 103' ' ' LEU . 6.8 mmm-85 -106.21 -1.79 23.19 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -179.399 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.919 HG22 ' O ' ' A' ' 108' ' ' PRO . 24.3 m -71.37 -27.03 27.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.685 0.279 . . . . 0.0 111.521 -179.561 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.6 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 0.8 OUTLIER -70.37 -55.42 7.78 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.578 -179.291 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.6 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 47.1 Cg_exo -55.37 -40.88 83.2 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.182 1.922 . . . . 0.0 111.975 179.384 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.45 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 75.6 t80 -65.47 -38.36 89.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.166 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.05 -54.85 40.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.001 0.429 . . . . 0.0 110.926 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.446 HG22 ' OE1' ' A' ' 120' ' ' GLU . 62.7 m -74.37 -44.65 51.28 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.768 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.4 -41.78 98.67 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.644 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.18 -51.57 69.43 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.059 0.457 . . . . 0.0 111.072 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.15 -28.15 65.12 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.325 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.446 ' OE1' HG22 ' A' ' 116' ' ' THR . 11.4 mt-10 -77.93 -43.65 29.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.4 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 9.2 tp60 -71.27 -31.56 67.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.117 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.793 HD11 ' CD2' ' A' ' 88' ' ' TYR . 0.4 OUTLIER -70.56 -45.93 72.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.36 -179.782 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.45 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 12.1 pttt -60.75 -31.22 70.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.067 0.461 . . . . 0.0 110.365 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 10.0 t-80 -68.36 -54.05 19.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.64 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.797 HG21 HD13 ' A' ' 148' ' ' LEU . 15.2 pt -61.67 -42.61 94.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.261 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.435 ' HA ' HD23 ' A' ' 126' ' ' LEU . 11.4 mt -54.19 -35.48 62.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.969 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -69.89 -11.29 60.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.343 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 -142.07 32.83 1.55 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.884 0.373 . . . . 0.0 110.599 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.5 ' CE1' ' CZ ' ' A' ' 134' ' ' PHE . 4.5 t80 -52.2 -26.1 10.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.088 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 6.8 mttt -59.17 -30.43 68.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.929 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -94.28 -37.86 11.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.324 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.412 ' HE2' HD11 ' A' ' 161' ' ' ILE . 15.1 m-85 -91.09 135.51 33.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.835 0.35 . . . . 0.0 111.21 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 -121.94 145.8 47.75 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.911 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.508 ' CE1' ' CZ ' ' A' ' 88' ' ' TYR . 1.3 m-85 -78.06 125.95 30.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.85 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.423 ' O ' ' HB3' ' A' ' 147' ' ' ALA . 10.7 m-85 -130.77 137.38 49.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.623 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.465 ' HB ' ' HA ' ' A' ' 140' ' ' MET . 0.9 OUTLIER -126.87 161.69 33.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.956 -179.964 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.79 -164.95 0.35 Allowed Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.44 -0.886 . . . . 0.0 111.968 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.433 ' HB3' ' HB2' ' A' ' 77' ' ' HIS . 1.2 pt-20 -72.37 -8.87 57.28 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.594 0.235 . . . . 0.0 111.507 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -96.25 -29.26 14.12 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.594 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.465 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 75.7 mtp 56.37 46.53 20.77 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.903 0.382 . . . . 0.0 110.997 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ASN . . . . . 0.419 ' ND2' ' HA3' ' A' ' 144' ' ' GLY . 13.0 p-10 -69.08 114.48 23.69 Favored Pre-proline 0 N--CA 1.452 -0.338 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.951 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 141' ' ' ASN . 16.3 Cg_exo -66.25 -29.39 46.87 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.633 2.222 . . . . 0.0 112.245 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -84.64 -5.25 59.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.47 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.419 ' HA3' ' ND2' ' A' ' 141' ' ' ASN . . . -87.7 -143.38 8.44 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.456 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 2.8 ptp -106.22 -179.17 3.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.824 0.345 . . . . 0.0 110.863 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.566 HG21 ' HE2' ' A' ' 91' ' ' TYR . 53.5 t -128.52 148.2 32.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.225 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.57 ' HB1' ' SD ' ' A' ' 160' ' ' MET . . . -110.67 114.78 28.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.511 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.797 HD13 HG21 ' A' ' 125' ' ' ILE . 3.8 mt -88.5 106.19 18.12 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.088 -179.342 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.481 HD12 ' HG2' ' A' ' 160' ' ' MET . 4.4 tp -90.37 119.72 30.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.366 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.538 ' HB3' ' CE1' ' A' ' 159' ' ' TYR . 4.7 t70 -138.54 167.41 21.99 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.533 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -105.2 151.71 23.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.865 0.364 . . . . 0.0 111.166 -179.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 12.2 mmt85 -70.31 -175.47 1.0 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.838 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -56.92 -31.05 64.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.063 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -74.43 -15.15 60.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.288 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 74.24 7.29 77.2 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.803 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 72.7 t -110.23 -66.92 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.924 0.393 . . . . 0.0 110.94 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 84.9 m -52.96 107.18 0.78 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.261 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -84.65 129.03 4.09 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.622 2.214 . . . . 0.0 112.245 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.538 ' CE1' ' HB3' ' A' ' 150' ' ' ASP . 8.4 p90 -126.51 147.04 49.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.929 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' MET . . . . . 0.842 ' CE ' HD13 ' A' ' 78' ' ' LEU . 0.8 OUTLIER -113.14 145.4 41.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.241 -179.659 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.516 ' HB ' ' HB2' ' A' ' 148' ' ' LEU . 85.0 mt -98.44 112.84 31.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.032 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.526 ' CE1' ' HB2' ' A' ' 147' ' ' ALA . 62.2 m-85 -118.81 121.0 39.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.679 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -68.98 124.4 23.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.047 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.698 ' CG ' HD11 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -69.86 -41.98 74.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.16 -179.738 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.45 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 2.1 m-20 -55.97 -29.61 60.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.919 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -108.95 29.47 9.73 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.354 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.411 HD21 ' HB3' ' A' ' 4' ' ' TYR . 0.6 OUTLIER -139.48 148.43 42.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.827 0.346 . . . . 0.0 110.785 -179.9 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -111.74 155.43 23.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.009 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.716 ' HB3' HD11 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -125.35 137.84 54.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.875 179.998 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -151.42 127.53 10.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.963 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.464 ' HG2' HD12 ' A' ' 2' ' ' ILE . 14.1 mttt -91.55 108.98 20.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.969 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 19.1 m -144.87 18.22 1.62 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.307 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 3.2 mp 50.65 -176.86 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.801 0.334 . . . . 0.0 111.152 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.479 ' HB3' ' HE2' ' A' ' 1' ' ' MET . 1.9 pt-20 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.906 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.819 0.343 . . . . 0.0 111.189 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.52 HG23 ' HE1' ' A' ' 4' ' ' TYR . 0.8 OUTLIER -98.25 140.83 17.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.814 179.942 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.526 ' O ' ' HA ' ' A' ' 169' ' ' MET . 4.6 mm -106.11 122.69 60.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.766 -179.347 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.521 ' HD2' HD21 ' A' ' 167' ' ' LEU . 3.9 m-85 -90.09 130.22 36.29 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.563 179.382 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.97 157.5 45.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.966 0.412 . . . . 0.0 111.438 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.437 ' O ' ' HA ' ' A' ' 10' ' ' HIS . 36.8 t0 -63.41 152.18 38.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.721 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.653 HD23 HG23 ' A' ' 99' ' ' ILE . 61.3 tp -80.51 -24.83 39.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.312 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.906 HD11 ' CG1' ' A' ' 99' ' ' ILE . 4.1 mp -91.43 -45.28 14.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.02 -28.49 17.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.486 -179.162 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.437 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 0.2 OUTLIER 66.45 29.55 9.14 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.849 0.356 . . . . 0.0 110.785 -179.782 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -101.16 130.5 47.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.716 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.2 pm0 -61.95 88.49 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.31 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 10.5 mtt -71.42 -17.93 62.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.66 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.499 ' CE2' ' CG ' ' A' ' 4' ' ' TYR . 43.5 p90 -178.62 177.22 0.92 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.676 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.4 m -136.71 -169.8 2.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.943 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.434 ' HB2' ' CG2' ' A' ' 2' ' ' ILE . 40.2 t0 -93.26 23.57 4.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.018 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.435 HG13 ' CD2' ' A' ' 18' ' ' TYR . 45.4 pt -87.55 -9.84 10.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.756 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.887 ' CZ ' HG22 ' A' ' 72' ' ' ILE . 76.1 m-85 -111.14 -170.77 1.7 Allowed 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.765 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.6 mttm -97.07 91.28 5.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.734 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.44 ' N ' HD12 ' A' ' 20' ' ' ILE . 4.9 mp -87.93 123.96 40.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.015 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 15.9 mtp180 -120.55 117.62 28.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.811 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -72.1 117.48 13.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.938 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.403 HG12 ' HG3' ' A' ' 30' ' ' GLU . 1.6 pt -110.95 171.12 3.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.947 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 56.59 33.98 23.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.068 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 64.5 42.84 4.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.183 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.08 -12.95 62.71 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.785 -0.722 . . . . 0.0 113.195 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.532 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -55.93 -33.36 64.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.902 0.351 . . . . 0.0 111.285 -179.859 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 34.3 m -142.21 164.29 30.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.021 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.838 HD11 ' CG ' ' A' ' 164' ' ' LYS . 1.0 OUTLIER -128.32 130.85 48.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.994 -179.915 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.403 ' HG3' HG12 ' A' ' 23' ' ' ILE . 59.3 mt-10 -95.56 112.97 24.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.071 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 159' ' ' TYR . 23.3 t -91.55 111.87 24.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.362 179.39 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -85.5 118.36 24.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.381 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -106.34 -142.91 11.09 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.098 179.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.8 pttt -174.44 123.46 0.29 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.793 0.33 . . . . 0.0 111.187 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 76.5 mtm -65.95 118.62 10.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.538 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 36' ' ' VAL . 31.1 m -104.93 116.19 48.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.899 0.38 . . . . 0.0 111.53 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.735 ' CA ' HG23 ' A' ' 68' ' ' THR . 0.3 OUTLIER -91.43 153.22 20.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.641 179.721 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.529 ' HB3' HG12 ' A' ' 67' ' ' ILE . 35.4 ttt180 -138.22 115.94 11.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.827 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.436 HG22 HG22 ' A' ' 66' ' ' VAL . 30.4 p -109.06 -33.54 6.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.754 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -139.31 -49.51 0.5 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.915 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 166.57 150.15 6.26 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.521 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -123.79 123.4 40.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.887 0.375 . . . . 0.0 110.878 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.604 HG22 ' O ' ' A' ' 43' ' ' ILE . 3.3 mt 60.14 33.01 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.002 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -82.92 -60.3 2.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.902 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.39 142.07 45.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.869 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 38.3 m -102.64 -59.89 1.63 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.946 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 29.8 mt -65.83 -48.37 71.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.935 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.491 HG22 ' N ' ' A' ' 49' ' ' GLY . 41.3 mt 59.01 158.62 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.144 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.491 ' N ' HG22 ' A' ' 48' ' ' ILE . . . 148.87 51.9 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.529 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -148.01 105.09 0.3 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.499 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -166.4 122.19 1.22 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.82 0.343 . . . . 0.0 110.838 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -115.78 -38.62 3.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.075 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 32.0 t -142.92 -51.59 0.37 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.867 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -174.37 -44.27 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.104 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -102.21 167.32 10.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.832 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -89.43 -95.05 1.1 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.535 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.34 -30.27 51.58 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.548 2.165 . . . . 0.0 112.173 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 60.97 31.15 19.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.93 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 161.4 140.89 2.98 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.501 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 60.95 163.34 0.07 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.857 0.36 . . . . 0.0 110.875 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 153.08 168.96 17.69 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.513 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.1 t -86.86 164.44 16.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.775 0.321 . . . . 0.0 110.941 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -100.38 90.91 4.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.949 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 12.2 m -83.53 -22.04 32.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.117 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.523 ' O ' HD13 ' A' ' 67' ' ' ILE . 3.7 m 65.31 133.57 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.81 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.436 HG22 HG22 ' A' ' 39' ' ' THR . 57.8 t -74.75 144.26 12.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.044 0.45 . . . . 0.0 111.188 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.529 HG12 ' HB3' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -128.37 127.35 67.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.35 179.338 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.735 HG23 ' CA ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -139.08 118.2 12.61 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.326 -179.671 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -150.65 175.43 29.67 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.264 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.596 HG12 HG12 ' A' ' 72' ' ' ILE . 46.3 t -70.96 130.5 34.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.878 0.37 . . . . 0.0 110.725 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.4 ' O ' ' ND2' ' A' ' 75' ' ' ASN . 5.3 t0 -58.17 -58.77 6.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.862 -179.221 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.887 HG22 ' CZ ' ' A' ' 18' ' ' TYR . 8.5 pt -53.64 -33.81 23.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.678 -179.205 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.762 HG13 ' HB2' ' A' ' 78' ' ' LEU . 89.9 t -72.77 -34.28 46.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.878 0.37 . . . . 0.0 111.011 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 14.9 mtm -78.24 -39.24 40.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.716 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.403 ' OD1' ' CD2' ' A' ' 76' ' ' HIS . 19.9 p30 -82.15 -29.33 31.65 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -179.262 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.457 ' CE1' ' HB ' ' A' ' 72' ' ' ILE . 26.0 m170 -92.05 -0.55 57.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.81 0.338 . . . . 0.0 110.787 179.519 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.406 ' HB2' ' HB3' ' A' ' 138' ' ' GLU . 30.3 m-70 57.84 31.85 21.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.057 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.762 ' HB2' HG13 ' A' ' 73' ' ' VAL . 58.6 mt -58.63 147.39 32.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.582 179.739 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -128.39 133.91 48.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.915 0.388 . . . . 0.0 111.054 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.414 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 28.9 tt0 -90.24 132.37 35.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.061 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.1 t -121.9 -172.96 2.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.872 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 83.1 p -128.79 168.23 16.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.957 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.499 ' CE2' ' CE2' ' A' ' 91' ' ' TYR . 1.1 m-85 -171.71 157.34 4.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.991 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.34 164.5 11.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.789 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.34 -52.45 65.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.83 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -67.21 -38.94 86.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.725 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.62 -37.13 86.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.992 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.929 ' CD2' HD11 ' A' ' 122' ' ' ILE . 0.1 OUTLIER -63.01 -37.37 86.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.804 -179.999 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.439 ' O ' HG22 ' A' ' 92' ' ' ILE . 58.3 mttt -59.03 -45.43 90.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.084 0.468 . . . . 0.0 110.361 179.478 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.35 -27.82 52.8 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.643 178.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.539 ' HE2' HG21 ' A' ' 146' ' ' VAL . 9.3 t80 -66.88 -44.72 80.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.753 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.65 HD12 ' CE2' ' A' ' 95' ' ' TYR . 5.7 tp -63.36 -43.11 98.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.95 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.1 ttpt -62.28 -40.79 97.41 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.752 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.514 ' HA ' ' HG2' ' A' ' 97' ' ' LYS . 27.6 t0 -72.92 -43.94 61.82 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.762 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.65 ' CE2' HD12 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -75.82 -40.16 55.42 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 121.063 -0.255 . . . . 0.0 110.99 -179.386 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.57 -32.01 72.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.697 0.284 . . . . 0.0 110.661 179.5 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.514 ' HG2' ' HA ' ' A' ' 94' ' ' ASP . 0.0 OUTLIER -69.19 -34.22 74.56 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.829 0.347 . . . . 0.0 110.272 179.695 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.472 ' N ' ' HG3' ' A' ' 97' ' ' LYS . 1.0 OUTLIER -61.36 -41.03 96.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.969 179.316 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.906 ' CG1' HD11 ' A' ' 8' ' ' ILE . 9.3 mt -79.94 -42.86 22.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.564 179.379 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.91 -49.16 69.22 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.597 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -64.6 -50.44 58.99 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.667 -0.777 . . . . 0.0 112.207 179.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 2.2 tptt -59.84 -40.98 90.35 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.947 0.403 . . . . 0.0 110.426 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.59 ' HB3' HG12 ' A' ' 111' ' ' VAL . 12.3 tp -63.84 -41.1 97.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.043 179.364 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.667 ' HG3' HG11 ' A' ' 111' ' ' VAL . 32.2 mt-10 -55.2 -28.59 54.15 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.809 179.373 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -89.71 -16.57 30.08 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.784 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -114.27 -60.81 1.83 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.747 0.308 . . . . 0.0 111.538 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.456 ' N ' ' O ' ' A' ' 103' ' ' LEU . 0.9 OUTLIER -123.96 62.01 26.21 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.821 -179.801 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.877 ' O ' HG22 ' A' ' 111' ' ' VAL . 10.0 Cg_endo -50.8 -23.6 11.85 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 123.042 2.495 . . . . 0.0 112.566 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -74.44 -8.03 54.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.295 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.512 ' C ' ' HD2' ' A' ' 113' ' ' PRO . 1.1 mmt180 -111.22 -1.22 16.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.59 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.877 HG22 ' O ' ' A' ' 108' ' ' PRO . 31.1 m -72.49 -33.17 44.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.564 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 1.9 mtpt -68.39 -49.97 29.79 Favored Pre-proline 0 C--N 1.331 -0.205 0 N-CA-C 111.649 0.24 . . . . 0.0 111.649 -179.2 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.564 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 30.0 Cg_exo -61.77 -33.72 84.68 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.087 1.858 . . . . 0.0 111.938 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.45 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 87.8 t80 -72.07 -36.5 69.56 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.012 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 5.5 mmm -58.02 -53.0 63.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.941 0.4 . . . . 0.0 110.855 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 71.8 m -73.06 -44.41 60.66 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.673 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.98 -37.57 95.17 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.577 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.42 ' O ' ' HB ' ' A' ' 122' ' ' ILE . . . -60.0 -51.65 68.74 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.961 0.41 . . . . 0.0 110.928 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.73 -28.12 62.46 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.425 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.404 ' O ' ' HG2' ' A' ' 123' ' ' LYS . 0.6 OUTLIER -77.92 -42.4 33.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.206 -179.711 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 30.5 tp60 -72.11 -34.78 68.87 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.035 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.929 HD11 ' CD2' ' A' ' 88' ' ' TYR . 0.4 OUTLIER -68.27 -46.3 81.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.39 -179.81 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.451 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 0.4 OUTLIER -59.76 -32.13 70.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.062 0.458 . . . . 0.0 110.116 179.448 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 7.1 t-80 -66.67 -54.3 24.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.618 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.862 HG21 HD13 ' A' ' 148' ' ' LEU . 13.0 pt -61.77 -39.98 85.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.058 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 11.4 mt -53.67 -35.69 61.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.567 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.5 -14.95 62.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.885 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -133.11 32.28 3.75 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.047 0.451 . . . . 0.0 110.243 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -49.08 -35.56 16.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.179 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.4 -20.78 60.66 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.162 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -89.18 -35.53 16.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.41 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.457 ' CD1' ' N ' ' A' ' 132' ' ' TYR . 1.7 m-30 -104.21 151.37 23.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.864 0.364 . . . . 0.0 111.313 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.416 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 9.9 mm-40 -123.89 150.69 44.35 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.913 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.514 ' CE1' ' CZ ' ' A' ' 88' ' ' TYR . 4.6 m-85 -86.16 132.38 34.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.144 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.515 ' O ' ' HB3' ' A' ' 147' ' ' ALA . 28.8 m-85 -136.93 130.11 31.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.58 179.466 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.458 ' HB ' ' HA ' ' A' ' 140' ' ' MET . 0.8 OUTLIER -122.09 167.33 15.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.892 -179.81 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.42 -170.84 0.84 Allowed Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.475 -0.869 . . . . 0.0 111.927 179.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.406 ' HB3' ' HB2' ' A' ' 77' ' ' HIS . 1.9 pt-20 -68.92 -11.17 60.36 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.621 0.248 . . . . 0.0 111.389 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -92.39 -33.51 14.53 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.606 0.241 . . . . 0.0 111.242 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.458 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 75.2 mtm 58.34 41.78 22.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.341 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -70.14 118.18 61.37 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.793 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -64.61 -21.65 65.33 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.331 2.021 . . . . 0.0 111.831 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -84.59 -12.06 54.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.755 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -81.31 -137.12 2.11 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.256 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.557 ' HE3' ' O ' ' A' ' 166' ' ' GLY . 3.7 ptp -120.65 178.89 4.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.781 0.324 . . . . 0.0 110.704 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.539 HG21 ' HE2' ' A' ' 91' ' ' TYR . 65.9 t -124.41 147.67 28.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.987 0.422 . . . . 0.0 111.193 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.604 ' HB2' ' CE2' ' A' ' 162' ' ' PHE . . . -113.27 110.2 19.99 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.364 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.862 HD13 HG21 ' A' ' 125' ' ' ILE . 4.4 mt -83.57 106.17 15.09 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.143 -179.093 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.486 HD12 ' HG2' ' A' ' 160' ' ' MET . 2.2 tp -88.71 119.91 29.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.954 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.497 ' HB2' ' CZ ' ' A' ' 159' ' ' TYR . 62.8 m-20 -130.31 161.86 30.3 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.574 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.406 ' HB3' ' HA2' ' A' ' 155' ' ' GLY . 80.1 m-85 -104.34 151.98 22.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.087 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 3.9 mmt180 -59.36 -176.92 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.0 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -60.9 -40.96 95.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.977 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -79.76 -15.07 58.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.312 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.406 ' HA2' ' HB3' ' A' ' 151' ' ' TYR . . . 78.68 33.07 39.16 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.597 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 93.8 t -113.44 -60.96 2.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.841 0.353 . . . . 0.0 111.11 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 51.5 m -80.55 112.56 32.37 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.341 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -82.37 134.28 7.73 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.558 2.172 . . . . 0.0 112.04 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.497 ' CZ ' ' HB2' ' A' ' 150' ' ' ASP . 5.7 p90 -130.51 142.59 50.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.041 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' MET . . . . . 0.563 ' CE ' HD13 ' A' ' 78' ' ' LEU . 0.3 OUTLIER -107.14 143.42 35.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.025 -179.899 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.528 ' HB ' ' HB2' ' A' ' 148' ' ' LEU . 73.4 mt -101.81 112.01 33.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.157 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.604 ' CE2' ' HB2' ' A' ' 147' ' ' ALA . 81.0 m-85 -114.23 157.62 22.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.756 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -100.5 122.82 43.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.952 0.406 . . . . 0.0 110.812 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.838 ' CG ' HD11 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -66.12 -50.49 63.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.245 -179.672 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.45 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 1.7 m-20 -52.14 -30.48 26.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.12 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.557 ' O ' ' HE3' ' A' ' 145' ' ' MET . . . -108.21 27.75 13.44 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.236 179.758 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.521 HD21 ' HD2' ' A' ' 4' ' ' TYR . 0.7 OUTLIER -150.15 142.69 24.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.82 0.343 . . . . 0.0 110.736 -179.861 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -130.45 156.18 45.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.611 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.526 ' HA ' ' O ' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -140.16 160.29 40.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.116 179.973 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -149.99 149.71 30.76 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.477 -179.161 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.432 ' N ' HD12 ' A' ' 2' ' ' ILE . 28.7 mttt -87.2 109.04 19.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.822 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 17.7 p -98.81 96.3 7.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.959 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 5.3 mp -81.55 -71.9 0.45 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.83 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.927 179.996 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.5 ttm . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.847 0.356 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.723 HD11 ' HB3' ' A' ' 169' ' ' MET . 1.9 tt -108.54 148.12 12.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.002 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.419 ' CG2' ' HB3' ' A' ' 12' ' ' GLU . 16.3 mm -104.25 155.75 5.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.348 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.592 ' HE1' HG23 ' A' ' 2' ' ' ILE . 4.4 m-85 -124.19 106.62 10.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.73 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 27.7 ptt180 -122.66 146.74 47.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.148 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.563 ' OD1' HD12 ' A' ' 8' ' ' ILE . 49.2 t0 -58.05 143.36 43.72 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.8 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 59.8 tp -73.37 -21.96 60.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.328 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.69 HD11 ' CG1' ' A' ' 99' ' ' ILE . 4.2 mp -91.32 -45.72 14.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.8 -179.544 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.94 -20.27 19.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.76 -179.156 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.445 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 14.7 m170 61.24 28.86 18.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.91 0.386 . . . . 0.0 110.717 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -102.08 120.29 40.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.761 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.419 ' HB3' ' CG2' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -56.66 88.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.392 -179.731 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.411 ' O ' ' CG ' ' A' ' 76' ' ' HIS . 7.8 mtt -66.46 -24.22 66.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.721 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.507 ' CZ ' ' CD2' ' A' ' 4' ' ' TYR . 25.6 p90 -173.49 179.65 2.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.696 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -135.24 -169.97 2.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.774 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -94.85 23.98 5.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.023 0.439 . . . . 0.0 110.948 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.429 HG13 ' CD2' ' A' ' 18' ' ' TYR . 39.6 pt -82.03 -15.03 12.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.632 179.223 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.837 ' CE2' HG22 ' A' ' 72' ' ' ILE . 82.4 m-85 -108.12 -174.27 2.48 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.586 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.4 mmtp -93.19 86.43 5.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.746 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.574 ' N ' HD12 ' A' ' 20' ' ' ILE . 3.9 mp -87.83 125.54 41.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.939 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.4 mmm180 -117.77 129.97 56.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.997 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -80.59 116.53 20.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.707 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.402 HG12 ' HG3' ' A' ' 30' ' ' GLU . 2.9 pt -110.93 173.39 2.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.017 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.492 ' HB2' ' NE2' ' A' ' 121' ' ' GLN . . . 56.39 28.42 13.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.166 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.414 ' HB2' ' O ' ' A' ' 24' ' ' ALA . 5.4 m-20 66.06 54.38 1.0 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.238 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 76.61 1.78 72.77 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.894 -0.669 . . . . 0.0 113.415 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.477 ' HB3' ' HB3' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -71.84 -43.47 65.48 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 117.056 0.428 . . . . 0.0 111.083 -179.962 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 10.1 m -132.17 161.76 32.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.096 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.625 HD11 ' HG3' ' A' ' 164' ' ' LYS . 1.1 mt -127.1 127.74 45.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.823 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.402 ' HG3' HG12 ' A' ' 23' ' ' ILE . 56.4 mt-10 -97.38 112.96 24.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.137 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.402 HG21 ' CD2' ' A' ' 14' ' ' PHE . 24.2 t -92.23 111.97 25.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.567 179.494 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -82.03 125.17 30.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.228 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -112.07 -141.15 8.26 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.177 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.9 pttp -174.57 126.49 0.31 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.816 0.341 . . . . 0.0 111.132 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 95.1 mtp -67.78 111.28 4.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.631 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 28.9 m -110.84 135.56 49.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.453 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.2 p -96.36 165.5 12.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.784 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.623 ' O ' HG13 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -142.09 141.26 32.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.671 -179.832 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.411 HG23 HG22 ' A' ' 66' ' ' VAL . 4.9 m -164.3 125.73 2.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.829 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -141.74 -74.44 0.31 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.916 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.69 -172.84 21.37 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.478 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -176.68 173.14 2.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.828 0.347 . . . . 0.0 110.8 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.3 mp -94.45 140.74 16.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.025 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -143.22 -169.18 2.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.921 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 59.94 25.24 14.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.929 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -106.12 -47.81 3.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.875 0.369 . . . . 0.0 110.851 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 11.1 mt -92.97 -30.64 15.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.873 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 23.1 mt -75.07 113.2 13.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.071 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 154.12 90.15 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.501 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -140.53 -155.01 6.39 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.615 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 -109.26 -25.64 10.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.796 0.332 . . . . 0.0 111.107 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -54.9 -43.52 73.31 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.271 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 42.4 t -74.12 -66.79 0.68 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.843 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 59.01 34.33 23.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.146 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -175.3 152.01 1.34 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.92 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 144.43 146.66 4.53 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.471 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.24 177.58 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.438 2.092 . . . . 0.0 112.345 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -102.66 -52.0 3.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.891 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -142.79 87.04 0.18 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.461 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -122.15 97.17 5.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.865 0.364 . . . . 0.0 110.796 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -168.76 144.75 8.98 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.521 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.413 HG23 ' N ' ' A' ' 63' ' ' GLU . 4.9 t -142.7 -47.9 0.33 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.783 0.325 . . . . 0.0 110.857 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.413 ' N ' HG23 ' A' ' 62' ' ' THR . 1.6 tp10 -106.64 87.3 2.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.762 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.2 t -58.08 -61.77 2.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.937 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.2 m -164.1 55.6 0.15 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.943 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.623 HG13 ' O ' ' A' ' 38' ' ' ARG . 42.5 t -102.93 127.15 56.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.185 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.607 HD13 ' C ' ' A' ' 66' ' ' VAL . 0.0 OUTLIER -130.16 130.59 65.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.646 179.536 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 10.5 m -139.25 133.02 30.73 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.144 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 176.51 -169.43 41.92 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.286 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.798 HG22 ' HG2' ' A' ' 158' ' ' PRO . 43.0 t -73.2 129.84 35.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.792 0.33 . . . . 0.0 110.771 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.4 ' N ' ' OD1' ' A' ' 71' ' ' ASP . 20.3 p-10 -59.6 -55.49 33.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.793 -179.144 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.837 HG22 ' CE2' ' A' ' 18' ' ' TYR . 8.7 pt -53.78 -33.94 24.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.833 0.349 . . . . 0.0 111.411 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.782 HG13 ' HB2' ' A' ' 78' ' ' LEU . 93.8 t -72.44 -32.1 40.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.919 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.2 mtm -78.21 -40.07 38.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.496 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.41 ' OD1' ' CD2' ' A' ' 76' ' ' HIS . 15.2 p30 -82.12 -28.46 32.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.568 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.44 ' CE1' ' HB ' ' A' ' 72' ' ' ILE . 24.8 m170 -94.29 1.1 55.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.806 0.336 . . . . 0.0 110.963 179.523 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.409 ' HB2' ' HB3' ' A' ' 138' ' ' GLU . 89.9 m-70 56.13 30.16 15.91 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.321 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.782 ' HB2' HG13 ' A' ' 73' ' ' VAL . 67.1 mt -60.17 134.46 57.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.604 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -123.91 139.38 54.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.863 0.363 . . . . 0.0 111.196 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.43 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 2.0 tt0 -90.83 130.7 36.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.958 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.837 HG21 HD11 ' A' ' 136' ' ' ILE . 9.9 t -122.14 137.06 54.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.821 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.0 m -77.57 159.16 29.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.028 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.473 ' CE2' ' HB1' ' A' ' 87' ' ' ALA . 0.3 OUTLIER -167.61 149.24 5.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.822 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.88 166.63 13.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.965 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.7 mttp -64.98 -52.55 55.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.764 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -62.67 -41.69 99.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.959 0.409 . . . . 0.0 110.591 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.473 ' HB1' ' CE2' ' A' ' 83' ' ' PHE . . . -59.28 -39.44 82.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.91 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.84 ' CD2' HD11 ' A' ' 122' ' ' ILE . 0.5 OUTLIER -59.78 -37.17 78.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.575 179.807 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.415 ' O ' HG22 ' A' ' 92' ' ' ILE . 67.6 mttt -56.61 -49.81 73.85 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.112 0.482 . . . . 0.0 110.189 179.482 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.71 -27.83 60.55 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.521 178.538 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.537 ' HE2' HG21 ' A' ' 146' ' ' VAL . 6.3 t80 -64.62 -47.63 77.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.814 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.57 HD12 ' CE2' ' A' ' 95' ' ' TYR . 4.8 tp -61.47 -43.97 97.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.98 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.431 ' O ' ' HB3' ' A' ' 97' ' ' LYS . 8.8 ttmm -60.17 -40.66 90.71 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.236 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.453 ' O ' ' HG3' ' A' ' 97' ' ' LYS . 9.4 t0 -73.71 -43.06 60.27 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.984 -179.227 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.57 ' CE2' HD12 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -76.82 -39.59 50.8 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.087 -179.207 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.449 ' HG2' ' O ' ' A' ' 92' ' ' ILE . 6.2 ptt? -67.72 -32.13 72.55 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.929 -0.308 . . . . 0.0 110.69 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.471 ' HG3' ' N ' ' A' ' 98' ' ' SER . 0.0 OUTLIER -70.43 -33.66 71.59 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.517 179.88 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.471 ' N ' ' HG3' ' A' ' 97' ' ' LYS . 1.5 m -62.65 -40.76 98.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.037 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.69 ' CG1' HD11 ' A' ' 8' ' ' ILE . 7.4 mt -79.86 -41.5 21.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.281 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.7 tttt -56.21 -57.15 13.42 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.442 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -59.6 -42.84 97.96 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.24 179.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.59 -36.37 83.54 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.885 0.374 . . . . 0.0 110.45 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.841 HD21 ' CB ' ' A' ' 110' ' ' ARG . 3.9 tp -72.6 -32.43 65.97 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.056 0.455 . . . . 0.0 109.9 179.188 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.611 ' CG ' HG11 ' A' ' 111' ' ' VAL . 69.1 mt-10 -60.62 -31.57 70.74 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.674 179.518 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -87.89 -21.58 24.89 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.654 -179.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -105.55 -62.42 1.36 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.78 0.324 . . . . 0.0 111.456 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.449 ' N ' ' O ' ' A' ' 103' ' ' LEU . 0.5 OUTLIER -128.54 63.56 65.04 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.96 -179.761 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.927 ' O ' HG22 ' A' ' 111' ' ' VAL . 10.3 Cg_endo -50.97 -22.66 10.67 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 123.114 2.543 . . . . 0.0 112.73 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -68.43 -12.24 60.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.606 0.241 . . . . 0.0 111.335 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.841 ' CB ' HD21 ' A' ' 103' ' ' LEU . 0.4 OUTLIER -108.03 -1.21 20.72 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -179.562 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.927 HG22 ' O ' ' A' ' 108' ' ' PRO . 22.4 m -72.71 -32.33 40.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -179.262 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.554 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 11.9 mtpt -68.99 -50.09 23.0 Favored Pre-proline 0 C--N 1.331 -0.205 0 C-N-CA 120.941 -0.304 . . . . 0.0 111.529 -179.221 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.554 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 24.2 Cg_exo -63.56 -29.6 70.53 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.138 1.892 . . . . 0.0 111.578 179.384 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.499 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 54.2 t80 -72.24 -42.31 65.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.016 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -55.48 -47.3 76.36 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.013 0.435 . . . . 0.0 110.757 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 60.1 m -76.08 -44.33 39.39 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.888 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.35 -46.81 93.1 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.774 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.4 ' O ' ' HB ' ' A' ' 122' ' ' ILE . . . -57.07 -51.82 67.77 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.028 0.442 . . . . 0.0 111.223 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.22 -28.22 67.89 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.39 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -77.72 -43.25 31.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.255 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.492 ' NE2' ' HB2' ' A' ' 24' ' ' ALA . 3.1 tp-100 -73.17 -37.83 66.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.048 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.84 HD11 ' CD2' ' A' ' 88' ' ' TYR . 0.3 OUTLIER -66.13 -46.39 87.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.299 -179.888 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.457 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 17.5 pttt -60.64 -31.88 71.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.181 179.567 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 9.3 t-80 -66.9 -54.05 26.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.774 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.562 HG21 HD13 ' A' ' 148' ' ' LEU . 13.6 pt -61.75 -40.77 88.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.155 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.42 ' HA ' HD23 ' A' ' 126' ' ' LEU . 11.7 mt -53.85 -36.43 62.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.828 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -67.4 -13.96 62.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.191 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -141.44 36.28 1.67 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.935 0.397 . . . . 0.0 110.464 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.517 ' CE1' ' CZ ' ' A' ' 134' ' ' PHE . 4.0 t80 -49.66 -29.55 7.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.17 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 5.8 mtmp? -64.98 -21.32 66.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.192 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 32.5 m-20 -94.07 -38.02 11.33 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.287 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.409 ' CD2' ' OD1' ' A' ' 150' ' ' ASP . 4.1 m-85 -99.02 140.77 32.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.15 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 5.3 mm-40 -118.48 145.91 44.91 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.981 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.517 ' CZ ' ' CE1' ' A' ' 129' ' ' PHE . 2.5 m-85 -82.71 122.43 28.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.945 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.43 ' CE2' ' HB2' ' A' ' 80' ' ' GLU . 28.6 m-85 -124.19 146.38 48.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.628 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.837 HD11 HG21 ' A' ' 81' ' ' THR . 0.8 OUTLIER -134.28 162.85 38.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.972 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -62.64 -164.38 0.43 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.191 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.409 ' HB3' ' HB2' ' A' ' 77' ' ' HIS . 7.5 pt-20 -72.48 -8.94 57.69 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.533 0.206 . . . . 0.0 111.476 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 19.4 m-80 -95.81 -31.49 13.14 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.647 0.26 . . . . 0.0 111.523 -179.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.454 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 32.7 mtm 56.93 41.41 27.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.885 0.374 . . . . 0.0 111.02 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ASN . . . . . 0.404 ' ND2' ' HA3' ' A' ' 144' ' ' GLY . 15.7 p-10 -66.93 116.03 31.22 Favored Pre-proline 0 N--CA 1.451 -0.42 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.8 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 141' ' ' ASN . 24.2 Cg_exo -61.7 -27.84 81.55 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.52 2.147 . . . . 0.0 112.155 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -84.52 -4.85 59.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.018 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.404 ' HA3' ' ND2' ' A' ' 141' ' ' ASN . . . -90.1 -175.54 45.17 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.385 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -77.19 177.77 7.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.877 0.37 . . . . 0.0 110.855 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.537 HG21 ' HE2' ' A' ' 91' ' ' TYR . 47.4 t -124.34 152.5 30.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.166 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.764 ' HB1' ' HE2' ' A' ' 160' ' ' MET . . . -116.11 117.42 30.03 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.569 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.562 HD13 HG21 ' A' ' 125' ' ' ILE . 3.5 mt -91.51 108.22 19.75 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.244 -179.171 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.461 HD12 ' HG2' ' A' ' 160' ' ' MET . 1.3 tp -92.51 119.46 32.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.35 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.474 ' HB2' ' CZ ' ' A' ' 159' ' ' TYR . 1.0 OUTLIER -129.66 163.6 25.74 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.475 179.332 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -102.91 145.78 29.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.909 0.385 . . . . 0.0 111.052 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.17 -177.01 0.11 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.908 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -57.87 -41.31 82.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.901 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -71.51 -15.08 62.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.171 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 77.36 18.32 78.18 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.738 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 83.7 t -113.41 -73.63 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.794 0.33 . . . . 0.0 110.911 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 83.9 m -53.67 103.13 0.35 Allowed Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.235 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.798 ' HG2' HG22 ' A' ' 70' ' ' VAL . 6.0 Cg_exo -78.81 130.36 9.58 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.76 2.306 . . . . 0.0 111.952 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.474 ' CZ ' ' HB2' ' A' ' 150' ' ' ASP . 11.0 p90 -120.75 137.49 54.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.85 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' MET . . . . . 0.764 ' HE2' ' HB1' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -103.85 134.58 46.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.374 -179.373 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.558 ' HB ' ' HB2' ' A' ' 148' ' ' LEU . 51.0 mt -93.2 123.8 45.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.869 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.53 ' CE1' ' HB2' ' A' ' 147' ' ' ALA . 71.2 m-85 -129.51 126.73 39.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.182 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.431 ' CE2' ' OH ' ' A' ' 95' ' ' TYR . 4.1 m-30 -72.66 123.8 24.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.577 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.625 ' HG3' HD11 ' A' ' 29' ' ' LEU . 3.0 ttmm -60.56 -56.39 21.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.523 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.499 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 2.4 m-20 -48.63 -36.17 15.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.851 0.358 . . . . 0.0 111.286 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -94.25 28.6 10.42 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.412 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.464 HD11 ' HB3' ' A' ' 4' ' ' TYR . 1.0 OUTLIER -150.01 142.89 24.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.73 0.3 . . . . 0.0 110.837 -179.858 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.02 155.74 21.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.799 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.723 ' HB3' HD11 ' A' ' 2' ' ' ILE . 0.1 OUTLIER -121.32 145.52 47.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.931 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -157.03 131.47 8.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.881 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 2' ' ' ILE . 12.5 mttm -80.1 111.78 16.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.973 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.69 -177.05 4.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.82 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 1.5 tt 59.48 72.04 0.55 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.904 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.175 -0.917 . . . . 0.0 110.924 179.989 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.846 0.355 . . . . 0.0 111.192 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.723 HD11 ' HB3' ' A' ' 169' ' ' MET . 2.1 tt -110.11 147.82 14.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.983 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.467 HG21 ' HB3' ' A' ' 12' ' ' GLU . 16.4 mm -104.79 156.82 5.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.276 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.605 ' HE1' HG23 ' A' ' 2' ' ' ILE . 4.9 m-85 -125.75 99.14 5.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.611 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 27.1 ptt180 -113.34 147.32 37.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.136 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.542 ' OD1' HD12 ' A' ' 8' ' ' ILE . 47.3 t0 -56.95 152.16 13.43 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.8 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 61.1 tp -81.39 -20.27 40.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.377 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.542 HD12 ' OD1' ' A' ' 6' ' ' ASP . 4.0 mp -91.34 -47.31 14.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -179.508 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.47 -20.5 19.0 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.167 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.44 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 36.6 m80 63.96 28.93 14.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.9 0.381 . . . . 0.0 110.749 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -102.0 122.57 44.33 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.793 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.467 ' HB3' HG21 ' A' ' 3' ' ' ILE . 5.5 pm0 -57.96 92.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.251 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 9.7 mtt -72.84 -16.88 61.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.918 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.496 ' CE2' ' CD2' ' A' ' 4' ' ' TYR . 19.1 p90 -177.44 174.16 1.61 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.708 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -133.36 -172.3 2.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.863 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -92.52 17.88 9.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.099 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 46.7 pt -79.12 -15.11 13.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.967 0.413 . . . . 0.0 110.649 179.252 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.939 ' CE2' HG22 ' A' ' 72' ' ' ILE . 70.7 m-85 -108.07 -174.52 2.54 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.529 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.406 ' HB2' ' HB2' ' A' ' 32' ' ' GLU . 4.9 mttp -96.16 93.37 6.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.879 0.371 . . . . 0.0 110.581 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.568 ' N ' HD12 ' A' ' 20' ' ' ILE . 4.1 mp -87.81 134.62 27.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.178 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.58 122.87 37.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.838 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -77.82 116.45 18.35 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.876 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.634 HD11 HG23 ' A' ' 161' ' ' ILE . 1.4 pt -109.72 168.97 3.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.072 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.441 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . . . 59.59 31.08 20.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.952 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 65.61 47.39 2.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.179 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.13 -8.23 68.06 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.809 -0.71 . . . . 0.0 113.38 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.441 ' HB3' ' HB3' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -60.94 -39.01 87.86 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.904 0.352 . . . . 0.0 111.239 -179.838 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 28.2 m -135.47 162.53 32.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.162 -179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.772 HD11 ' HG3' ' A' ' 164' ' ' LYS . 0.5 OUTLIER -126.18 132.86 51.71 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.74 179.886 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.429 ' HG3' HG12 ' A' ' 23' ' ' ILE . 18.9 mt-10 -102.19 116.24 32.23 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.257 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.4 t -90.25 112.13 24.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.706 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.406 ' HB2' ' HB2' ' A' ' 19' ' ' LYS . 18.1 mt-10 -83.55 115.16 21.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.147 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.57 -143.64 11.91 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.114 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.4 126.84 0.33 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.929 0.395 . . . . 0.0 110.955 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 42.3 mtp -70.83 115.01 9.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.626 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.491 HG23 ' CE ' ' A' ' 74' ' ' MET . 4.8 m -106.68 122.41 60.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.402 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 68.5 m -89.66 165.49 14.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.791 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.573 ' HB3' HG12 ' A' ' 67' ' ' ILE . 8.4 ttt85 -139.61 134.61 32.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.692 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.474 HG23 ' CG2' ' A' ' 62' ' ' THR . 6.3 m 59.34 25.24 13.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.859 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.83 134.28 33.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.89 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.15 28.54 33.61 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.446 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -139.27 93.91 2.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.818 0.342 . . . . 0.0 110.975 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 11.8 tt -100.26 130.72 49.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.118 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -142.62 -176.92 5.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.97 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.429 ' HB2' HD11 ' A' ' 48' ' ' ILE . 76.7 m-20 -60.64 146.72 44.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.945 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 63.0 m -101.34 -60.77 1.47 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.826 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.407 HD13 ' HA ' ' A' ' 47' ' ' LEU . 2.8 mm? -59.54 -72.59 0.1 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.157 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.429 HD11 ' HB2' ' A' ' 45' ' ' ASP . 80.1 mt 58.15 106.91 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.093 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -127.19 -80.17 0.31 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.465 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -172.18 131.89 2.26 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.461 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 14.1 p30 -169.24 177.25 4.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.825 0.345 . . . . 0.0 110.876 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.74 90.89 0.6 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.08 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.1 p -93.71 -36.82 12.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.89 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 60.0 31.49 20.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.094 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -148.08 133.07 18.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.926 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -103.92 104.12 2.41 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.401 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -67.86 119.5 6.51 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.402 2.068 . . . . 0.0 112.337 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -94.02 -34.45 13.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.917 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -105.97 -119.11 4.5 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.513 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 60.8 174.45 0.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.857 0.36 . . . . 0.0 110.857 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 164.14 -29.7 0.23 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.41 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.474 ' CG2' HG23 ' A' ' 39' ' ' THR . 2.5 m -65.87 132.34 48.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.866 0.365 . . . . 0.0 110.842 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -105.06 -75.3 0.63 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.907 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.1 t -177.32 38.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.945 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.46 ' O ' HG23 ' A' ' 65' ' ' THR . 10.5 t -106.75 117.79 34.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.987 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.764 ' C ' HD13 ' A' ' 67' ' ' ILE . 28.6 t -116.76 133.36 63.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.972 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.764 HD13 ' C ' ' A' ' 66' ' ' VAL . 0.0 OUTLIER -135.14 131.34 52.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.148 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 85.6 m -139.41 140.72 37.47 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.025 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 174.89 172.97 40.34 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.435 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.703 HG22 ' HG3' ' A' ' 158' ' ' PRO . 60.8 t -68.52 135.89 27.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.916 0.389 . . . . 0.0 110.775 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -59.23 -57.55 12.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.653 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.939 HG22 ' CE2' ' A' ' 18' ' ' TYR . 5.3 pt -53.95 -33.82 24.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.497 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.805 HG13 ' HB2' ' A' ' 78' ' ' LEU . 92.3 t -75.0 -30.87 24.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.071 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.491 ' CE ' HG23 ' A' ' 36' ' ' VAL . 1.8 mtm -78.16 -41.51 34.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.902 -179.426 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.428 ' OD1' ' CD2' ' A' ' 76' ' ' HIS . 15.0 p30 -82.11 -30.35 31.22 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -179.057 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.432 ' CE1' ' HA ' ' A' ' 14' ' ' PHE . 36.3 m80 -91.87 -0.13 57.5 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.856 0.36 . . . . 0.0 110.923 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 9.8 m80 55.8 34.94 24.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.256 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.805 ' HB2' HG13 ' A' ' 73' ' ' VAL . 46.5 mt -58.59 147.32 32.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.553 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -131.82 139.0 48.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.893 0.377 . . . . 0.0 111.148 -179.432 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.428 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 4.7 tt0 -92.68 131.89 37.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.001 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.494 HG21 HD11 ' A' ' 136' ' ' ILE . 7.8 t -122.33 151.81 40.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.768 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 62.3 m -90.47 159.01 16.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.084 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.537 ' CE2' ' HB1' ' A' ' 87' ' ' ALA . 0.2 OUTLIER -170.02 137.83 1.64 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.76 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -85.39 173.79 10.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.938 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.2 mttp -66.92 -52.31 44.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.949 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -58.46 -46.1 87.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.893 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.537 ' HB1' ' CE2' ' A' ' 83' ' ' PHE . . . -58.67 -40.75 84.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.038 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.859 ' CD2' HD11 ' A' ' 122' ' ' ILE . 0.1 OUTLIER -59.05 -36.93 75.85 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.843 179.851 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -57.39 -48.52 78.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.159 0.504 . . . . 0.0 110.354 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.8 mmtt -76.47 -27.89 56.31 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.441 178.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.583 ' HE2' HG21 ' A' ' 146' ' ' VAL . 4.6 t80 -64.99 -46.57 80.87 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.615 179.571 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.626 HD12 ' CE2' ' A' ' 95' ' ' TYR . 4.5 tp -61.43 -46.52 96.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.849 0.357 . . . . 0.0 110.75 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.414 ' O ' ' HB3' ' A' ' 97' ' ' LYS . 18.9 ttpp -59.25 -38.62 80.51 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.952 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.433 ' HA ' ' HG2' ' A' ' 97' ' ' LYS . 31.5 t70 -73.89 -44.98 53.56 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.054 -179.198 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.626 ' CE2' HD12 ' A' ' 92' ' ' ILE . 0.1 OUTLIER -76.18 -38.48 56.56 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.292 -179.236 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.42 ' HG2' ' O ' ' A' ' 92' ' ' ILE . 4.0 ptt? -67.39 -32.15 72.85 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.471 179.471 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.504 ' HG3' ' N ' ' A' ' 98' ' ' SER . 0.0 OUTLIER -70.48 -33.45 71.26 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.912 0.387 . . . . 0.0 110.482 179.681 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.504 ' N ' ' HG3' ' A' ' 97' ' ' LYS . 1.7 m -64.17 -40.51 96.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.227 179.486 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.523 HG23 ' HA2' ' A' ' 166' ' ' GLY . 7.9 mt -79.72 -40.4 21.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.298 179.296 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -56.1 -54.38 45.73 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.411 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -60.81 -45.74 95.88 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.923 179.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.69 -40.73 96.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.926 0.393 . . . . 0.0 110.207 179.433 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.607 HD21 ' CB ' ' A' ' 110' ' ' ARG . 3.4 tp -66.5 -36.59 83.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.029 179.224 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.619 ' CG ' HG11 ' A' ' 111' ' ' VAL . 63.2 mt-10 -58.39 -29.12 65.8 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.768 179.447 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -87.01 -20.71 26.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.503 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -106.52 -61.33 1.54 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.727 0.298 . . . . 0.0 111.633 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.439 ' N ' ' O ' ' A' ' 103' ' ' LEU . 91.7 mtm-85 -131.64 65.58 76.22 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.859 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.888 ' O ' HG22 ' A' ' 111' ' ' VAL . 9.4 Cg_endo -50.5 -23.45 10.66 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 123.105 2.537 . . . . 0.0 112.617 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -70.87 -12.06 61.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.68 0.276 . . . . 0.0 111.038 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.607 ' CB ' HD21 ' A' ' 103' ' ' LEU . 6.0 mmm180 -106.66 0.57 24.45 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.764 -179.576 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.888 HG22 ' O ' ' A' ' 108' ' ' PRO . 22.8 m -73.09 -33.29 41.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.547 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 12.7 mtmm -66.48 -50.02 49.4 Favored Pre-proline 0 C--N 1.332 -0.181 0 C-N-CA 121.022 -0.271 . . . . 0.0 111.583 -179.158 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.547 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 27.1 Cg_exo -62.18 -34.8 77.92 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.254 1.969 . . . . 0.0 111.702 179.543 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -68.31 -38.03 81.21 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.833 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -59.88 -47.17 86.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.021 0.439 . . . . 0.0 110.823 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 63.6 m -76.29 -44.65 36.07 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.69 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.63 -41.01 99.22 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.512 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.0 -47.2 86.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.058 0.456 . . . . 0.0 111.042 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.492 ' HB1' ' CE ' ' A' ' 123' ' ' LYS . . . -70.45 -29.87 66.55 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.188 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -73.65 -52.94 11.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.98 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.479 ' HA ' ' NE2' ' A' ' 121' ' ' GLN . 3.9 tp60 -60.74 -45.63 93.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.932 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.859 HD11 ' CD2' ' A' ' 88' ' ' TYR . 0.3 OUTLIER -59.93 -45.4 95.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.936 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.492 ' CE ' ' HB1' ' A' ' 119' ' ' ALA . 15.1 mttm -60.49 -30.75 69.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.196 179.315 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -68.88 -54.46 15.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.669 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.746 HG21 HD13 ' A' ' 148' ' ' LEU . 11.6 pt -60.68 -40.5 84.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.064 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 11.5 mt -53.95 -38.59 65.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.704 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -68.52 -12.91 61.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.248 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -137.15 33.64 2.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.087 0.47 . . . . 0.0 110.503 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -49.71 -28.49 6.13 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.241 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 5.6 tttp -72.24 -20.32 61.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.341 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -94.1 -35.28 12.62 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.322 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -100.72 146.3 27.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.947 0.403 . . . . 0.0 111.283 -179.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -125.38 146.22 49.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.787 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.519 ' CE1' ' CZ ' ' A' ' 88' ' ' TYR . 3.2 m-85 -81.5 129.18 34.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.958 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.449 ' O ' ' HB3' ' A' ' 147' ' ' ALA . 30.6 m-85 -133.93 136.37 44.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.678 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.494 HD11 HG21 ' A' ' 81' ' ' THR . 1.2 mt -124.65 164.92 22.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.044 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.97 -160.07 0.73 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.165 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -74.48 -8.79 57.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.467 0.175 . . . . 0.0 111.45 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -95.33 -33.31 12.58 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 111.657 0.243 . . . . 0.0 111.657 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.424 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 73.9 mtm 60.11 34.93 21.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.817 0.342 . . . . 0.0 110.841 -179.692 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ASN . . . . . 0.46 ' ND2' ' HA3' ' A' ' 144' ' ' GLY . 6.4 p-10 -65.94 114.82 18.05 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.043 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -67.12 -24.89 44.17 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.669 2.246 . . . . 0.0 112.386 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -84.44 -6.5 59.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.187 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.46 ' HA3' ' ND2' ' A' ' 141' ' ' ASN . . . -85.85 -124.56 1.53 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.461 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.512 ' HE2' ' HB2' ' A' ' 163' ' ' PHE . 6.9 ptp -126.57 -177.49 4.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.81 0.338 . . . . 0.0 110.76 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.583 HG21 ' HE2' ' A' ' 91' ' ' TYR . 48.3 t -129.23 149.74 33.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.208 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.524 ' HB2' ' CE2' ' A' ' 162' ' ' PHE . . . -113.41 112.17 23.19 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.463 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.746 HD13 HG21 ' A' ' 125' ' ' ILE . 4.4 mt -86.63 106.05 17.32 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.982 -179.278 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.419 ' HB2' ' HE2' ' A' ' 160' ' ' MET . 1.5 tp -90.82 120.0 31.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.161 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.481 ' HB3' ' CZ ' ' A' ' 159' ' ' TYR . 29.5 t70 -133.94 165.37 25.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.429 179.617 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -107.99 147.27 31.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.817 0.341 . . . . 0.0 111.088 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.88 -168.7 0.1 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.863 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.87 -41.26 95.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.963 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -72.98 -15.13 61.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.311 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 65.7 28.64 73.82 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.487 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 73.6 t -112.4 -55.94 4.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.73 0.3 . . . . 0.0 111.177 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 54.5 m -85.78 111.65 39.17 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.4 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.703 ' HG3' HG22 ' A' ' 70' ' ' VAL . 88.2 Cg_endo -80.5 135.9 10.77 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.526 2.151 . . . . 0.0 111.728 179.256 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.481 ' CZ ' ' HB3' ' A' ' 150' ' ' ASP . 5.8 p90 -126.02 135.57 51.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.976 0.417 . . . . 0.0 111.085 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' MET . . . . . 0.448 ' CE ' HD13 ' A' ' 78' ' ' LEU . 0.8 OUTLIER -104.96 131.62 52.24 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.059 -179.741 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.634 HG23 HD11 ' A' ' 23' ' ' ILE . 67.2 mt -92.09 118.5 37.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.289 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.524 ' CE2' ' HB2' ' A' ' 147' ' ' ALA . 78.6 m-85 -117.05 163.42 16.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.703 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.512 ' HB2' ' HE2' ' A' ' 145' ' ' MET . 22.6 m-85 -100.44 122.77 43.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.905 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.772 ' HG3' HD11 ' A' ' 29' ' ' LEU . 12.4 tttt -70.06 -51.92 28.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.069 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -51.52 -29.17 15.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.162 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.523 ' HA2' HG23 ' A' ' 99' ' ' ILE . . . -105.35 24.29 27.99 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.375 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.557 HD21 ' HB3' ' A' ' 4' ' ' TYR . 0.5 OUTLIER -138.25 146.82 43.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.849 0.357 . . . . 0.0 110.812 -179.903 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -117.56 151.2 37.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.02 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.723 ' HB3' HD11 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -111.42 154.21 24.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.923 179.972 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -158.58 123.4 4.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.959 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.61 ' CG ' HD12 ' A' ' 2' ' ' ILE . 14.7 mtmm -89.88 119.05 29.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.96 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 32.8 m -111.25 150.72 29.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.933 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.88 142.43 57.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.829 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.278 -0.868 . . . . 0.0 110.855 179.911 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.5 ttt . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.844 0.354 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.616 HG22 ' HB2' ' A' ' 16' ' ' ASP . 0.8 OUTLIER -111.33 143.35 21.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.037 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.527 ' O ' ' HA ' ' A' ' 169' ' ' MET . 4.3 mm -105.69 120.47 56.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.312 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.597 ' CE1' HG23 ' A' ' 2' ' ' ILE . 25.3 m-85 -91.45 125.21 36.12 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.801 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -137.23 143.66 42.39 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.215 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -55.05 144.8 22.39 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.976 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 55.3 tp -73.58 -22.17 60.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.453 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.465 HD11 ' CG1' ' A' ' 99' ' ' ILE . 4.6 mp -91.24 -43.97 14.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.687 0.28 . . . . 0.0 111.72 -179.636 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.422 ' HB2' ' ND2' ' A' ' 141' ' ' ASN . 1.9 t -92.62 -27.52 17.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.378 -179.453 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 64.3 m-70 64.53 26.63 13.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.797 0.332 . . . . 0.0 110.773 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -103.15 129.7 50.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.718 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.422 ' HB3' ' CG2' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -57.84 95.9 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.346 -179.673 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 41.8 mtp -78.16 -16.86 57.53 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.7 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.497 ' CE2' ' CG ' ' A' ' 4' ' ' TYR . 37.8 p90 179.98 165.13 1.2 Allowed 'General case' 0 C--O 1.231 0.108 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.806 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.23 -169.93 1.98 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.563 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.616 ' HB2' HG22 ' A' ' 2' ' ' ILE . 39.4 t0 -95.67 33.78 1.59 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.02 0.438 . . . . 0.0 110.929 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.435 HG13 ' CD2' ' A' ' 18' ' ' TYR . 40.3 pt -93.33 -10.77 9.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.618 179.183 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.969 ' CZ ' HG22 ' A' ' 72' ' ' ILE . 51.8 m-85 -110.45 -169.32 1.44 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.686 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.0 mmtt -96.88 88.25 4.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.813 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.0 mp -87.99 124.03 40.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.982 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.0 mtt180 -119.47 126.27 50.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.163 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.799 ' HG3' HD23 ' A' ' 29' ' ' LEU . 1.0 OUTLIER -76.25 116.67 17.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.807 179.989 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.51 HD11 HG23 ' A' ' 161' ' ' ILE . 6.0 pt -114.15 170.93 4.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.204 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 56.12 28.48 13.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.286 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 63.43 41.35 7.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.218 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.1 -11.27 70.92 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.581 -0.819 . . . . 0.0 113.172 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.14 -33.87 74.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.916 0.358 . . . . 0.0 111.037 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.5 m -145.53 163.54 34.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.9 0.381 . . . . 0.0 111.158 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.799 HD23 ' HG3' ' A' ' 22' ' ' GLU . 0.4 OUTLIER -127.68 130.66 49.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.704 179.876 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -97.19 112.86 24.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.153 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' ' 159' ' ' TYR . 22.1 t -98.8 111.84 29.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.633 179.551 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -83.56 115.78 22.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.336 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -99.8 -137.91 10.04 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.247 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.4 ptpt -174.45 126.38 0.32 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.845 0.355 . . . . 0.0 110.959 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 23.7 mtm -72.45 121.98 20.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.758 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.446 HG23 ' CE ' ' A' ' 74' ' ' MET . 5.7 m -112.84 125.98 70.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.391 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.1 m -89.45 165.64 14.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.858 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.528 ' HB3' HG12 ' A' ' 67' ' ' ILE . 6.8 ttt180 -133.38 115.97 15.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.753 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 39' ' ' THR . 4.1 t -130.17 83.41 2.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.917 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -67.34 178.38 1.56 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.912 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -160.34 164.42 34.44 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.481 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -157.12 163.88 38.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.8 0.333 . . . . 0.0 110.819 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 15.7 tt -123.39 148.41 27.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.068 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -118.2 174.77 6.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.933 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.429 ' HB2' HG23 ' A' ' 48' ' ' ILE . 0.7 OUTLIER -89.34 -179.57 5.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.895 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.4 m -77.89 -48.9 15.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.908 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.0 mp -95.87 -69.7 0.74 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.969 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.429 HG23 ' HB2' ' A' ' 45' ' ' ASP . 18.9 tt -63.43 138.13 23.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.115 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -102.03 48.53 1.07 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.477 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.05 176.42 24.48 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.504 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -160.74 98.09 1.21 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.797 0.332 . . . . 0.0 110.96 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -171.86 75.24 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.163 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -80.32 -65.12 1.05 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.855 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -142.96 156.76 44.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.069 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 59.94 30.97 20.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.877 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -105.72 -139.46 9.69 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.476 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -67.93 139.45 47.33 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.432 2.088 . . . . 0.0 112.298 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -77.73 118.0 19.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.965 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -179.98 114.58 0.44 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.512 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -105.87 142.01 36.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.767 0.318 . . . . 0.0 110.892 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 125.67 -154.17 18.54 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.517 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.37 178.97 7.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.776 0.322 . . . . 0.0 110.91 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -71.01 -64.42 0.91 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.914 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 92.7 p -122.67 128.1 50.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.884 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 58.4 m -135.54 140.51 44.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.857 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.695 ' C ' HD13 ' A' ' 67' ' ' ILE . 41.2 t -97.06 134.62 34.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.991 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.695 HD13 ' C ' ' A' ' 66' ' ' VAL . 0.0 OUTLIER -123.96 131.88 72.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.042 -179.937 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 85.6 m -139.26 141.1 37.83 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.109 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -177.58 175.59 47.65 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.207 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.578 HG12 HG12 ' A' ' 72' ' ' ILE . 44.3 t -69.09 135.92 27.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.833 0.349 . . . . 0.0 110.901 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -62.33 -56.94 13.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.639 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.969 HG22 ' CZ ' ' A' ' 18' ' ' TYR . 7.6 pt -53.54 -33.79 22.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.36 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.785 HG13 ' HB2' ' A' ' 78' ' ' LEU . 91.4 t -73.49 -33.49 39.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.915 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.446 ' CE ' HG23 ' A' ' 36' ' ' VAL . 2.4 mtm -78.23 -39.2 41.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.614 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 19.1 p30 -82.01 -29.42 32.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.581 -179.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.436 ' CE1' ' HB ' ' A' ' 72' ' ' ILE . 26.1 m170 -91.82 -4.52 54.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.842 0.353 . . . . 0.0 110.825 179.497 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.476 ' HB2' ' HB3' ' A' ' 138' ' ' GLU . 28.5 m80 60.73 39.57 17.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.95 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.785 ' HB2' HG13 ' A' ' 73' ' ' VAL . 38.1 mt -70.79 140.81 51.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.796 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -116.46 132.81 56.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.734 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.435 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 0.1 OUTLIER -91.7 120.86 32.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.94 0.4 . . . . 0.0 111.183 -179.94 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.454 HG21 HD11 ' A' ' 136' ' ' ILE . 9.2 t -108.82 170.01 8.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.792 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.3 p -114.91 170.45 8.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.889 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.48 ' HB2' ' CE2' ' A' ' 134' ' ' PHE . 4.0 m-85 -171.68 152.19 3.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.074 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.405 ' H ' ' HB3' ' A' ' 87' ' ' ALA . 0.2 OUTLIER -101.44 168.49 9.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.594 179.638 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.2 mttm -54.98 -51.94 64.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.125 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.63 -42.82 73.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.238 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.405 ' HB3' ' H ' ' A' ' 84' ' ' THR . . . -60.62 -44.83 95.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.858 0.361 . . . . 0.0 111.218 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.836 ' CD2' HD11 ' A' ' 122' ' ' ILE . 0.5 OUTLIER -59.83 -34.82 73.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.89 -179.974 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 15.8 mtmt -59.69 -42.22 92.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.067 0.46 . . . . 0.0 110.5 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.6 -29.87 46.31 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.093 178.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -68.07 -46.17 71.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.743 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.818 HG22 ' O ' ' A' ' 88' ' ' TYR . 2.1 tp -64.83 -42.17 94.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.98 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.457 ' O ' ' CG ' ' A' ' 97' ' ' LYS . 3.1 ttpt -62.0 -44.89 95.76 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.792 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -67.79 -40.18 83.95 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.955 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.54 ' CD1' ' C ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -76.5 -45.11 32.34 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 121.023 -0.271 . . . . 0.0 111.022 -179.162 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.501 ' HB2' ' HE3' ' A' ' 96' ' ' MET . 20.3 ptm -59.13 -32.01 69.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.889 0.375 . . . . 0.0 110.117 179.287 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.457 ' CG ' ' O ' ' A' ' 93' ' ' LYS . 3.7 mmpt? -70.72 -38.71 73.64 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.449 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.3 m -58.86 -40.08 83.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.332 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.465 ' CG1' HD11 ' A' ' 8' ' ' ILE . 10.2 mt -79.85 -42.56 22.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.416 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.49 -51.71 66.07 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.411 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -63.12 -47.16 90.69 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.044 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 4.0 tppt? -61.12 -39.89 91.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.872 0.367 . . . . 0.0 110.24 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.63 ' HB3' HG12 ' A' ' 111' ' ' VAL . 5.5 tp -66.97 -36.88 83.18 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.071 179.281 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.685 ' HG3' HG11 ' A' ' 111' ' ' VAL . 75.8 mt-10 -57.52 -29.44 64.33 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.658 179.367 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -86.7 -20.81 27.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.486 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -105.77 -61.17 1.53 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.841 0.353 . . . . 0.0 111.656 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.448 ' N ' ' O ' ' A' ' 103' ' ' LEU . 22.5 mtt85 -134.06 66.81 72.7 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.863 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.88 ' O ' HG22 ' A' ' 111' ' ' VAL . 9.6 Cg_endo -50.46 -21.68 7.8 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 123.254 2.636 . . . . 0.0 112.875 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -71.15 -9.86 58.79 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.583 0.23 . . . . 0.0 111.297 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.601 ' CB ' HD21 ' A' ' 103' ' ' LEU . 8.5 mmt180 -110.34 -0.39 17.65 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.706 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.88 HG22 ' O ' ' A' ' 108' ' ' PRO . 29.6 m -71.09 -33.93 53.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -179.335 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.57 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 8.3 mttt -68.27 -50.07 30.6 Favored Pre-proline 0 C--N 1.332 -0.191 0 C-N-CA 121.022 -0.271 . . . . 0.0 111.62 -179.148 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.57 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 31.6 Cg_exo -58.59 -37.76 92.85 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.188 1.925 . . . . 0.0 111.956 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.449 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 69.7 t80 -68.83 -36.9 78.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.937 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.04 -47.95 79.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.803 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 60.4 m -76.41 -44.28 36.67 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.737 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.16 -42.71 99.87 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.538 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.5 -51.59 69.21 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.044 0.449 . . . . 0.0 110.975 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.6 -28.06 67.44 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.183 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -75.87 -49.48 17.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.092 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 3.3 tp-100 -65.82 -39.73 91.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.156 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.836 HD11 ' CD2' ' A' ' 88' ' ' TYR . 0.3 OUTLIER -60.64 -45.54 97.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.984 -179.877 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.435 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 30.8 mttm -60.7 -29.45 69.34 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.317 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 11.8 t-80 -69.25 -53.19 21.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.75 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.763 HG21 HD13 ' A' ' 148' ' ' LEU . 12.8 pt -63.0 -41.2 91.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.333 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 11.5 mt -54.79 -37.12 65.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.82 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -71.16 -10.54 59.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.34 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -140.31 33.35 1.89 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.928 0.395 . . . . 0.0 110.66 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.511 ' CE1' ' CZ ' ' A' ' 134' ' ' PHE . 1.5 t80 -51.35 -36.41 42.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.921 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.4 -26.07 66.39 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.977 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 32.0 m-20 -94.1 -43.84 8.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.201 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -91.8 135.52 33.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.227 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.47 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 3.9 mm-40 -115.07 144.13 44.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.464 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.511 ' CZ ' ' CE1' ' A' ' 129' ' ' PHE . 0.1 OUTLIER -89.22 130.76 35.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.889 0.376 . . . . 0.0 111.099 -179.638 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.536 ' HB2' ' HB3' ' A' ' 147' ' ' ALA . 17.2 m-85 -123.72 166.29 15.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.681 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.454 HD11 HG21 ' A' ' 81' ' ' THR . 0.4 OUTLIER -149.23 157.57 6.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.574 179.737 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -57.42 -172.77 0.25 Allowed Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.406 -0.902 . . . . 0.0 111.676 179.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.476 ' HB3' ' HB2' ' A' ' 77' ' ' HIS . 1.1 pt-20 -70.08 -8.94 53.54 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.587 0.232 . . . . 0.0 111.292 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -94.93 -23.4 17.44 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.697 -0.229 . . . . 0.0 111.416 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.405 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 63.7 mtp 50.95 43.36 28.8 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.824 0.345 . . . . 0.0 111.302 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ASN . . . . . 0.426 ' ND2' ' HA3' ' A' ' 144' ' ' GLY . 17.3 p-10 -64.64 117.13 35.01 Favored Pre-proline 0 N--CA 1.451 -0.391 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.816 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -59.35 -30.88 93.91 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.409 2.073 . . . . 0.0 112.26 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -84.61 -4.01 58.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.053 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.426 ' HA3' ' ND2' ' A' ' 141' ' ' ASN . . . -81.53 -153.63 11.0 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.407 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.507 ' HE3' ' O ' ' A' ' 166' ' ' GLY . 13.2 ptp -108.59 179.15 4.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.783 0.325 . . . . 0.0 110.815 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.426 ' CG1' ' HB3' ' A' ' 134' ' ' PHE . 0.0 OUTLIER -125.15 128.43 72.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.047 179.846 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.536 ' HB3' ' HB2' ' A' ' 135' ' ' PHE . . . -89.91 109.39 20.41 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.257 0.551 . . . . 0.0 110.422 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.763 HD13 HG21 ' A' ' 125' ' ' ILE . 4.7 mt -81.85 106.29 13.66 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.349 -179.103 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.561 HD12 ' HG2' ' A' ' 160' ' ' MET . 2.0 tp -91.12 118.63 30.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.158 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.453 ' HB3' ' CZ ' ' A' ' 159' ' ' TYR . 34.6 t70 -130.87 164.99 24.02 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.401 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -110.49 148.81 31.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.908 0.385 . . . . 0.0 110.995 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.487 ' HG3' HG22 ' A' ' 157' ' ' THR . 5.0 mmm180 -57.42 -177.94 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.071 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -61.19 -41.27 96.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.949 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -87.41 -15.09 38.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.209 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 68.44 44.97 70.95 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.584 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 78.5 t -107.29 -20.8 5.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.743 0.306 . . . . 0.0 111.004 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.487 HG22 ' HG3' ' A' ' 152' ' ' ARG . 1.4 t -140.89 122.34 9.18 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.985 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.442 ' HB2' HD11 ' A' ' 149' ' ' LEU . 84.4 Cg_endo -78.4 130.5 10.03 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.408 2.072 . . . . 0.0 112.09 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.453 ' CZ ' ' HB3' ' A' ' 150' ' ' ASP . 8.3 p90 -123.24 138.49 54.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.969 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' MET . . . . . 0.626 ' HG3' HD11 ' A' ' 72' ' ' ILE . 30.4 mtp -105.73 140.72 38.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.042 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.51 HG23 HD11 ' A' ' 23' ' ' ILE . 59.3 mt -97.92 111.19 27.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.016 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -107.13 154.38 21.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.957 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -96.78 118.3 32.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.822 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.475 ' HD3' HD11 ' A' ' 29' ' ' LEU . 19.8 tptt -64.83 -51.54 61.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.082 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.449 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 9.0 m-20 -54.72 -32.1 59.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.151 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.507 ' O ' ' HE3' ' A' ' 145' ' ' MET . . . -103.84 17.78 48.4 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.748 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.439 HD21 ' HB3' ' A' ' 4' ' ' TYR . 7.0 tt -141.85 144.33 33.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.779 0.323 . . . . 0.0 110.808 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -130.17 150.43 51.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.689 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.527 ' HA ' ' O ' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -140.11 160.1 40.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.125 179.986 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -151.35 152.83 33.68 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.93 0.395 . . . . 0.0 111.647 -179.243 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.5 ' HG2' ' HB ' ' A' ' 2' ' ' ILE . 30.2 mttp -95.91 115.01 26.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.728 179.382 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -115.59 162.48 17.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.05 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.51 HD22 ' N ' ' A' ' 173' ' ' LEU . 3.3 mm? 60.41 87.78 0.08 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.997 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.136 -0.935 . . . . 0.0 110.922 179.987 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.835 0.35 . . . . 0.0 111.09 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.683 HG23 ' CE1' ' A' ' 4' ' ' TYR . 0.9 OUTLIER -104.34 142.47 17.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.026 179.953 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.493 ' O ' ' HA ' ' A' ' 169' ' ' MET . 7.7 mm -105.31 118.89 53.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.372 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.683 ' CE1' HG23 ' A' ' 2' ' ' ILE . 20.5 m-85 -91.32 129.27 37.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.766 179.572 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -138.09 148.95 45.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.078 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.418 ' O ' ' HA ' ' A' ' 10' ' ' HIS . 22.7 t0 -55.26 150.86 10.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.844 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 66.6 tp -80.05 -25.07 40.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.295 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.684 HD11 ' CG1' ' A' ' 99' ' ' ILE . 4.0 mp -91.21 -43.17 14.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.755 -179.61 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.5 t -91.77 -26.81 18.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.597 -179.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.418 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 0.2 OUTLIER 63.97 28.42 14.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.874 0.369 . . . . 0.0 110.832 -179.774 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -104.79 130.21 52.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.719 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.19 104.69 0.22 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.226 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 17.9 mtt -88.62 -15.67 34.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.917 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.495 ' CE2' ' CG ' ' A' ' 4' ' ' TYR . 38.2 p90 179.63 159.84 0.76 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.719 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -122.15 -169.93 1.98 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.664 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.662 ' HB2' HG22 ' A' ' 2' ' ' ILE . 36.9 t70 -93.49 28.98 2.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.989 0.423 . . . . 0.0 110.967 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.434 HG13 ' CD2' ' A' ' 18' ' ' TYR . 36.1 pt -91.46 -9.04 10.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.826 179.34 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.876 ' CZ ' HG22 ' A' ' 72' ' ' ILE . 57.2 m-85 -115.83 -169.74 1.65 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.789 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.0 mttt -95.78 95.06 8.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.006 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.7 mp -91.72 124.02 44.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.939 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.69 137.15 53.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.991 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.81 ' HG3' HD23 ' A' ' 29' ' ' LEU . 1.2 mp0 -83.85 114.7 21.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.818 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.622 HD11 HG23 ' A' ' 161' ' ' ILE . 5.4 pt -111.12 166.35 5.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.237 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 57.35 30.11 17.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.314 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 64.43 40.55 6.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.198 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.55 -18.5 56.96 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.007 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.33 -34.85 49.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.808 0.337 . . . . 0.0 111.041 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.426 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 35.8 m -147.9 163.63 36.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.913 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.81 HD23 ' HG3' ' A' ' 22' ' ' GLU . 0.4 OUTLIER -129.62 132.86 46.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.954 -179.832 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 73.9 mt-10 -96.26 125.25 40.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.125 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 22.4 t -102.5 111.94 34.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.732 179.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -87.08 112.54 22.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.135 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -94.17 -132.65 6.62 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.355 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.3 ptpt -174.43 123.4 0.29 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.776 0.322 . . . . 0.0 110.836 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 41.1 mtp -68.44 123.41 20.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.931 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.4 m -117.08 144.73 24.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.147 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.9 p -109.56 165.61 11.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.009 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.536 ' CB ' HG12 ' A' ' 67' ' ' ILE . 2.4 mmt180 -126.54 115.88 20.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.595 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -117.43 27.02 9.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.941 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 62.47 -80.42 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.023 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 119.72 136.63 5.3 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.391 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.0 m120 60.73 101.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.817 0.341 . . . . 0.0 110.874 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 4.3 mt -60.99 -30.79 48.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.092 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -68.81 -47.45 66.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.888 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.3 t70 60.95 59.1 2.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.875 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -105.96 -62.31 1.39 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.919 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.6 mt -59.84 -27.7 66.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.01 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -108.97 86.25 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.016 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 101.64 106.51 2.95 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.453 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -130.11 152.33 19.68 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.505 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 69.65 -65.21 0.31 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.816 0.341 . . . . 0.0 110.977 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.51 137.15 53.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.262 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.4 t 61.29 158.42 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.93 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -156.41 -65.91 0.11 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.166 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -132.29 170.47 15.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.993 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.5 159.59 29.68 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.465 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.48 178.9 4.52 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.56 2.173 . . . . 0.0 112.308 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 60.18 30.63 20.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.908 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.92 -92.23 1.62 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.41 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -82.83 150.26 26.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.841 0.353 . . . . 0.0 110.83 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 176.19 121.59 0.67 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.472 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.9 t -108.33 -26.77 10.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.694 0.283 . . . . 0.0 110.935 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 63.37 138.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.879 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.03 78.83 1.84 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.071 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 22.0 m -77.29 67.8 3.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.822 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 46.2 t -103.66 136.32 37.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.263 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.536 HG12 ' CB ' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -140.05 131.26 31.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.691 179.603 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 16.5 m -139.1 131.52 28.56 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.123 0.487 . . . . 0.0 111.253 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -170.34 -164.87 26.78 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.012 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.488 HG12 HG12 ' A' ' 72' ' ' ILE . 46.4 t -78.77 142.45 14.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.829 0.347 . . . . 0.0 110.927 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -69.99 -56.89 5.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.494 -179.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.876 HG22 ' CZ ' ' A' ' 18' ' ' TYR . 11.1 pt -53.63 -33.89 23.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.434 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.807 HG13 ' HB2' ' A' ' 78' ' ' LEU . 84.5 t -70.86 -31.43 45.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.783 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.3 mtt -78.26 -41.03 35.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.521 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.401 ' OD1' ' CD2' ' A' ' 76' ' ' HIS . 13.0 p30 -82.13 -28.51 32.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.528 -179.41 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.441 ' CE1' ' HA ' ' A' ' 14' ' ' PHE . 28.4 m170 -93.17 0.11 57.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.852 0.358 . . . . 0.0 110.838 179.445 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.487 ' HB2' ' HB3' ' A' ' 138' ' ' GLU . 13.2 m-70 56.22 27.96 12.47 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.121 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.807 ' HB2' HG13 ' A' ' 73' ' ' VAL . 43.6 mt -56.79 140.48 47.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.703 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -124.93 135.84 53.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.946 0.403 . . . . 0.0 111.279 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.421 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 0.0 OUTLIER -94.36 117.71 30.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.855 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.758 HG21 HD11 ' A' ' 136' ' ' ILE . 8.3 t -109.68 140.86 43.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.927 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 59.1 m -77.46 159.23 29.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.909 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.472 ' CE2' ' HB1' ' A' ' 87' ' ' ALA . 0.2 OUTLIER -164.23 156.13 16.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.887 -179.974 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.78 172.87 7.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.911 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.3 mttm -69.48 -52.38 27.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.893 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -62.04 -41.98 98.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.71 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.472 ' HB1' ' CE2' ' A' ' 83' ' ' PHE . . . -59.47 -42.87 93.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.076 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.893 ' CD2' HD11 ' A' ' 122' ' ' ILE . 0.1 OUTLIER -58.27 -34.49 70.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.917 -179.928 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 45.3 mttt -60.31 -48.11 83.14 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.052 0.453 . . . . 0.0 110.451 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.1 mtmt -76.69 -27.85 55.68 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.698 178.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.546 ' HE2' HG21 ' A' ' 146' ' ' VAL . 8.2 t80 -65.18 -47.49 76.78 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.777 179.585 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.443 ' CD1' ' CE2' ' A' ' 95' ' ' TYR . 4.7 tp -62.58 -44.2 99.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.039 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.406 ' N ' HG23 ' A' ' 92' ' ' ILE . 4.5 tttp -60.52 -40.08 90.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.139 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.492 ' HA ' ' HG2' ' A' ' 97' ' ' LYS . 26.0 t0 -75.22 -40.07 59.48 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.879 -179.257 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.465 ' CD1' ' C ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -77.95 -40.43 39.47 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 121.053 -0.259 . . . . 0.0 110.944 -179.444 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.422 ' HG2' ' O ' ' A' ' 92' ' ' ILE . 2.4 ptt? -67.64 -32.04 72.46 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.763 0.316 . . . . 0.0 110.59 179.388 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.492 ' HG2' ' HA ' ' A' ' 94' ' ' ASP . 1.6 ptmm? -70.47 -34.57 72.55 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.524 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.433 ' N ' ' HG3' ' A' ' 97' ' ' LYS . 2.3 m -61.09 -40.24 92.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.046 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.684 ' CG1' HD11 ' A' ' 8' ' ' ILE . 6.9 mt -79.78 -41.07 21.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.433 179.367 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 5.1 tttp -55.3 -53.73 52.5 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.441 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -60.56 -46.35 94.57 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.017 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 6.4 tptt -62.62 -37.1 84.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.959 0.409 . . . . 0.0 110.336 179.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.633 HD21 ' CB ' ' A' ' 110' ' ' ARG . 3.1 tp -70.41 -33.96 71.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.059 179.269 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.626 ' CG ' HG11 ' A' ' 111' ' ' VAL . 77.3 mt-10 -58.85 -31.63 68.7 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.634 179.418 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.414 ' HG3' ' HG3' ' A' ' 106' ' ' GLN . 2.2 pt-20 -86.58 -21.09 27.05 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.738 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.414 ' HG3' ' HG3' ' A' ' 105' ' ' GLU . 21.0 mt-30 -105.13 -62.53 1.33 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.74 0.305 . . . . 0.0 111.559 -179.64 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.441 ' N ' ' O ' ' A' ' 103' ' ' LEU . 19.6 mtt-85 -129.74 64.77 73.08 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.879 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.867 ' O ' HG22 ' A' ' 111' ' ' VAL . 9.5 Cg_endo -50.52 -22.12 8.61 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 123.192 2.595 . . . . 0.0 112.745 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -70.75 -11.88 61.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.609 0.243 . . . . 0.0 111.323 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.633 ' CB ' HD21 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -110.88 -0.26 16.92 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.342 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.867 HG22 ' O ' ' A' ' 108' ' ' PRO . 34.1 m -66.38 -36.37 77.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -179.437 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.591 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 1.1 mttp -69.01 -51.2 19.03 Favored Pre-proline 0 C--N 1.332 -0.194 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.457 -179.316 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.591 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 50.1 Cg_exo -52.45 -41.39 67.71 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.04 1.827 . . . . 0.0 111.894 179.367 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.435 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 78.2 t80 -67.28 -39.22 86.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.967 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 1.4 mmm -56.98 -51.22 70.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.971 0.415 . . . . 0.0 110.858 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 62.3 m -76.53 -44.62 34.23 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.758 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.28 -45.93 95.2 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.551 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.07 -51.5 69.44 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.008 0.432 . . . . 0.0 111.068 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.38 -28.11 67.66 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.225 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.423 ' O ' ' HG2' ' A' ' 123' ' ' LYS . 45.4 tt0 -71.73 -46.9 57.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.181 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.426 ' NE2' ' SG ' ' A' ' 28' ' ' CYS . 4.2 tt0 -72.97 -38.43 66.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.07 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.893 HD11 ' CD2' ' A' ' 88' ' ' TYR . 0.4 OUTLIER -61.54 -46.78 95.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.147 -179.853 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.462 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 3.6 pttp -62.2 -31.74 72.3 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.099 0.476 . . . . 0.0 110.142 179.451 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 -67.35 -53.3 30.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.703 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.535 HG21 HD13 ' A' ' 148' ' ' LEU . 15.5 pt -61.73 -42.28 93.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.341 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.475 ' HA ' HD23 ' A' ' 126' ' ' LEU . 11.5 mt -53.87 -36.08 62.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.912 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -72.86 -10.16 59.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.173 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -141.64 33.7 1.63 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.017 0.437 . . . . 0.0 110.462 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.5 ' CE1' ' CZ ' ' A' ' 134' ' ' PHE . 11.5 t80 -50.3 -26.41 4.78 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.237 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.2 mmtt -61.76 -27.47 68.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.769 0.319 . . . . 0.0 110.945 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 22.2 m-20 -94.27 -36.75 11.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.488 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.409 ' CG ' ' OD2' ' A' ' 150' ' ' ASP . 10.8 m-85 -98.13 138.75 34.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.918 0.39 . . . . 0.0 111.25 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -122.96 144.69 49.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.951 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.51 ' CE1' ' CZ ' ' A' ' 88' ' ' TYR . 1.3 m-85 -80.52 123.81 28.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.089 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.461 ' HB2' ' HB3' ' A' ' 147' ' ' ALA . 30.3 m-85 -125.57 151.06 46.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.713 179.505 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.758 HD11 HG21 ' A' ' 81' ' ' THR . 0.4 OUTLIER -139.38 159.54 28.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.927 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.41 -165.12 0.3 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.403 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.487 ' HB3' ' HB2' ' A' ' 77' ' ' HIS . 5.1 pt-20 -71.52 -9.84 58.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.517 0.199 . . . . 0.0 111.467 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.516 ' HB3' ' ND2' ' A' ' 141' ' ' ASN . 21.6 m-80 -96.2 -32.03 12.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.585 0.231 . . . . 0.0 111.594 -179.547 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.452 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 58.2 mtm 56.54 41.34 28.76 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.825 0.345 . . . . 0.0 111.137 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ASN . . . . . 0.516 ' ND2' ' HB3' ' A' ' 139' ' ' ASN . 1.7 m120 -67.02 120.44 71.91 Favored Pre-proline 0 N--CA 1.454 -0.252 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.713 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -61.8 -25.57 78.64 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.248 1.965 . . . . 0.0 111.903 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -84.79 -18.13 35.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.743 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -71.49 -161.74 4.8 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.249 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.417 ' HE1' ' O ' ' A' ' 163' ' ' PHE . 3.9 ptp -97.03 177.82 5.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.785 0.326 . . . . 0.0 110.864 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.546 HG21 ' HE2' ' A' ' 91' ' ' TYR . 41.8 t -122.62 148.01 26.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.119 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.461 ' HB3' ' HB2' ' A' ' 135' ' ' PHE . . . -112.07 115.27 28.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.845 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.535 HD13 HG21 ' A' ' 125' ' ' ILE . 4.0 mt -89.56 105.9 18.1 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.814 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.513 HD12 ' HG2' ' A' ' 160' ' ' MET . 1.1 tp -94.55 119.08 32.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.356 -179.428 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.545 ' HB3' ' CE1' ' A' ' 159' ' ' TYR . 0.5 OUTLIER -134.97 170.16 16.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.561 179.367 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -105.74 150.36 25.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.909 0.385 . . . . 0.0 111.151 -179.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -78.09 -172.62 2.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.814 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -57.54 -41.13 80.32 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.942 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 44.4 p-10 -69.11 -15.07 63.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.238 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 65.3 19.04 65.97 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.589 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 80.4 t -113.44 -65.36 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.904 0.383 . . . . 0.0 111.044 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 98.3 m -64.98 111.87 6.84 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.14 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -82.06 131.61 6.96 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.63 2.22 . . . . 0.0 111.903 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.545 ' CE1' ' HB3' ' A' ' 150' ' ' ASP . 6.7 p90 -125.11 139.14 54.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.96 0.41 . . . . 0.0 111.142 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' MET . . . . . 0.66 ' SD ' HD13 ' A' ' 78' ' ' LEU . 41.6 mtp -109.89 140.93 43.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.981 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.622 HG23 HD11 ' A' ' 23' ' ' ILE . 72.3 mt -97.07 116.92 40.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.337 -179.685 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -117.33 151.01 37.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.57 179.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.417 ' O ' ' HE1' ' A' ' 145' ' ' MET . 5.5 m-85 -100.47 124.89 46.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.955 0.407 . . . . 0.0 111.01 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.633 ' HB2' HD11 ' A' ' 29' ' ' LEU . 27.2 tttm -70.02 -45.55 66.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.275 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.435 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 15.8 m-20 -49.28 -35.6 18.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.24 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.44 ' HA2' HG23 ' A' ' 99' ' ' ILE . . . -109.26 30.71 8.3 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.509 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.502 HD21 ' HD2' ' A' ' 4' ' ' TYR . 1.5 tt -150.06 146.88 27.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.896 0.379 . . . . 0.0 110.918 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -132.06 154.09 49.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.331 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.493 ' HA ' ' O ' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -139.96 160.27 40.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.829 0.347 . . . . 0.0 111.32 -179.843 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -147.02 144.6 29.27 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.355 -179.259 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.485 ' N ' HD12 ' A' ' 2' ' ' ILE . 17.2 mttp -83.56 108.95 17.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.015 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 51.1 t -80.56 -36.42 32.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.848 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.419 HD23 ' N ' ' A' ' 174' ' ' GLU . 2.0 tt -99.77 144.63 28.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.928 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.419 ' N ' HD23 ' A' ' 173' ' ' LEU . 1.1 tm-20 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.207 -0.902 . . . . 0.0 110.944 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.855 0.36 . . . . 0.0 111.216 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.653 HD11 ' HB3' ' A' ' 169' ' ' MET . 1.5 tt -121.92 145.77 28.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.974 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 11.4 mm -100.11 154.18 4.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.433 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.633 ' HE1' HG23 ' A' ' 2' ' ' ILE . 3.5 m-85 -123.85 111.08 15.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.436 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.22 146.65 50.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.919 0.39 . . . . 0.0 111.215 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.496 ' OD1' HD12 ' A' ' 8' ' ' ILE . 46.1 t0 -54.67 152.16 7.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.897 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.549 HD23 HG23 ' A' ' 99' ' ' ILE . 56.2 tp -80.88 -20.36 42.43 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.484 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.592 HD11 ' CG1' ' A' ' 99' ' ' ILE . 4.1 mp -91.35 -48.28 13.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.463 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -93.79 -21.97 18.97 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 -179.157 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.454 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 3.5 m-70 63.52 31.38 14.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.884 0.373 . . . . 0.0 110.8 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -102.66 121.76 43.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.804 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -57.24 98.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.303 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.8 mtt -78.18 -18.07 55.99 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.733 179.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.643 ' CD2' HG21 ' A' ' 31' ' ' VAL . 5.7 p90 -177.37 177.42 1.19 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.778 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -133.84 -171.94 2.86 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.659 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -95.0 27.13 3.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.966 0.413 . . . . 0.0 110.876 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.418 HG13 ' CD2' ' A' ' 18' ' ' TYR . 45.6 pt -86.63 -13.83 10.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.479 179.263 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.914 ' CZ ' HG22 ' A' ' 72' ' ' ILE . 79.8 m-85 -106.16 -170.34 1.71 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.537 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.39 88.56 4.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.721 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.3 mp -87.97 130.65 37.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.16 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.9 mtt180 -121.73 119.12 30.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.888 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -71.4 116.07 11.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.924 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.538 HD11 HG23 ' A' ' 161' ' ' ILE . 3.6 pt -109.62 172.46 2.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.022 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.462 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . . . 58.32 28.1 16.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.194 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 65.11 54.39 1.23 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.451 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.44 -3.51 72.84 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.553 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.462 ' HB3' ' HB3' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -67.48 -56.89 7.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 117.111 0.456 . . . . 0.0 110.815 179.993 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 46.9 m -120.08 168.72 10.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.747 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.523 HD21 ' HD2' ' A' ' 164' ' ' LYS . 0.5 OUTLIER -132.22 133.43 44.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.853 -179.849 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -98.42 112.84 24.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.963 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.643 HG21 ' CD2' ' A' ' 14' ' ' PHE . 22.8 t -93.63 111.98 25.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.744 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -86.87 124.7 33.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.145 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.59 -135.93 8.38 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.358 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.7 pttm -174.51 124.62 0.3 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.855 0.36 . . . . 0.0 110.881 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 62.9 mtm -69.74 121.83 17.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.75 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.1 m -111.66 127.02 69.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.342 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 78.8 p -86.77 165.69 15.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.952 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.6 ' O ' HG13 ' A' ' 66' ' ' VAL . 0.3 OUTLIER -141.35 152.99 44.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.885 -179.853 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.553 HG23 ' O ' ' A' ' 39' ' ' THR . 8.7 t -177.8 76.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.854 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -162.73 106.7 1.1 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.89 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 126.56 135.74 4.26 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.388 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.504 HD22 HG21 ' A' ' 62' ' ' THR . 1.3 t-20 -95.14 155.33 16.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.777 0.322 . . . . 0.0 110.875 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.696 HD11 ' OG1' ' A' ' 65' ' ' THR . 3.3 mp -89.38 111.59 23.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.126 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 60.5 111.07 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.921 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -68.75 159.32 32.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.935 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.34 -66.5 0.92 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.893 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -101.86 -16.23 16.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.285 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 17.9 mt 64.18 -76.9 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.064 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 159.46 -167.72 35.17 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.532 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -85.2 168.31 42.51 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.537 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 60.66 111.25 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.932 0.396 . . . . 0.0 110.867 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -122.61 111.76 17.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.033 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.02 -177.72 4.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.991 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -92.2 -37.9 12.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.051 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -86.98 79.7 8.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.875 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -173.14 103.54 0.19 Allowed Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.459 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -67.56 -175.0 0.62 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.41 2.073 . . . . 0.0 112.282 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -86.93 161.16 18.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.89 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 164.25 104.19 0.18 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.441 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -138.13 129.78 28.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.91 0.386 . . . . 0.0 110.949 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -82.44 84.56 1.51 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.47 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.504 HG21 HD22 ' A' ' 42' ' ' ASN . 0.2 OUTLIER -130.11 -177.88 4.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.776 0.322 . . . . 0.0 110.853 -179.904 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.446 ' H ' HG22 ' A' ' 62' ' ' THR . 8.7 mt-10 -131.17 113.49 13.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.889 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -170.31 153.02 4.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.829 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.696 ' OG1' HD11 ' A' ' 43' ' ' ILE . 0.2 OUTLIER 63.84 139.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.878 -179.988 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.603 ' C ' HD13 ' A' ' 67' ' ' ILE . 21.8 t -131.33 123.64 53.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.051 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.603 HD13 ' C ' ' A' ' 66' ' ' VAL . 0.0 OUTLIER -118.02 132.64 67.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.014 -179.986 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 89.0 m -139.05 140.39 38.06 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.966 0.412 . . . . 0.0 111.188 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -175.71 176.94 47.56 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.31 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.451 HG12 HG12 ' A' ' 72' ' ' ILE . 60.1 t -68.37 141.34 17.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.875 0.369 . . . . 0.0 110.852 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -67.56 -58.77 4.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.48 -179.463 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.914 HG22 ' CZ ' ' A' ' 18' ' ' TYR . 8.9 pt -53.72 -33.84 23.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.531 -179.594 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.78 HG13 ' HB2' ' A' ' 78' ' ' LEU . 58.7 t -72.26 -33.92 47.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.054 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.5 mtm -78.13 -38.89 42.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.598 -179.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.4 HD21 ' HA ' ' A' ' 72' ' ' ILE . 19.1 p30 -82.07 -28.89 32.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.565 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.423 ' CE1' ' HB ' ' A' ' 72' ' ' ILE . 26.7 m170 -93.43 -1.12 56.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.841 0.353 . . . . 0.0 110.952 179.531 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 57.87 30.52 19.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.07 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.78 ' HB2' HG13 ' A' ' 73' ' ' VAL . 56.9 mt -57.83 134.88 56.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.535 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -118.48 134.36 55.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.941 0.4 . . . . 0.0 111.161 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.426 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 16.0 tt0 -87.63 129.81 34.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.934 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.871 HG21 HD11 ' A' ' 136' ' ' ILE . 3.1 t -122.81 126.31 47.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.829 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.4 m -68.06 159.02 31.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.999 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -165.42 149.72 8.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.799 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.54 158.18 17.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.798 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.47 -52.5 65.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.896 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -62.35 -44.33 96.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.738 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.64 -37.9 76.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.938 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.843 ' CD2' HD11 ' A' ' 122' ' ' ILE . 2.0 t80 -59.92 -38.64 82.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.736 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.444 ' O ' HG22 ' A' ' 92' ' ' ILE . 32.6 mttt -57.46 -49.47 76.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.172 0.51 . . . . 0.0 110.483 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.2 mtmt -72.42 -27.82 62.58 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.829 178.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.476 ' HE2' HG21 ' A' ' 146' ' ' VAL . 5.0 t80 -66.84 -46.16 75.97 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.957 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.444 HG22 ' O ' ' A' ' 89' ' ' LYS . 2.9 tp -60.45 -40.79 85.29 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.172 0 CA-C-O 120.766 0.317 . . . . 0.0 110.866 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.435 ' O ' ' CG ' ' A' ' 97' ' ' LYS . 0.9 OUTLIER -61.31 -46.33 90.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.733 179.935 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -71.2 -38.96 72.04 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.846 -179.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.544 ' CD1' ' C ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -74.5 -41.64 60.33 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.739 -0.21 . . . . 0.0 110.792 -179.542 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 19.7 ptt? -64.86 -32.06 73.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.825 0.345 . . . . 0.0 110.248 179.271 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.435 ' CG ' ' O ' ' A' ' 93' ' ' LYS . 5.4 mmtp -64.4 -42.91 95.83 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.853 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.7 m -56.96 -43.32 81.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.82 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.592 ' CG1' HD11 ' A' ' 8' ' ' ILE . 6.3 mt -79.72 -40.92 21.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.587 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.83 -51.87 65.98 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.706 179.631 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -64.33 -45.39 93.55 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.014 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.88 -42.06 92.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.927 0.394 . . . . 0.0 110.447 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.528 ' HB3' HG12 ' A' ' 111' ' ' VAL . 4.1 tp -65.55 -36.49 83.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.181 179.4 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.613 ' CG ' HG11 ' A' ' 111' ' ' VAL . 76.9 mt-10 -58.43 -28.55 65.37 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.772 179.358 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -88.73 -19.23 26.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.73 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -110.39 -60.99 1.73 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.77 0.319 . . . . 0.0 111.673 -179.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 103' ' ' LEU . 1.1 mtt85 -125.59 63.17 44.35 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.93 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.86 ' O ' HG22 ' A' ' 111' ' ' VAL . 10.1 Cg_endo -50.77 -22.22 9.44 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 123.064 2.51 . . . . 0.0 112.798 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -73.44 -15.23 61.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.749 0.309 . . . . 0.0 111.253 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.543 ' C ' ' HD2' ' A' ' 113' ' ' PRO . 2.5 mmm180 -106.34 0.73 25.24 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.774 -179.36 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.86 HG22 ' O ' ' A' ' 108' ' ' PRO . 32.8 m -68.17 -36.66 76.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.591 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 28.4 mttt -66.79 -51.25 40.17 Favored Pre-proline 0 CA--C 1.53 0.186 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.233 -179.286 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.591 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 51.8 Cg_exo -53.31 -41.48 72.35 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.062 1.841 . . . . 0.0 111.821 179.304 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.461 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 88.2 t80 -68.35 -37.86 80.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.964 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' MET . . . . . 0.435 ' HE3' ' HA ' ' A' ' 115' ' ' MET . 0.6 OUTLIER -53.94 -49.81 67.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.004 -179.942 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.8 m -76.61 -44.29 34.89 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.825 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.4 ' O ' ' HG2' ' A' ' 120' ' ' GLU . . . -59.09 -44.12 96.54 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.691 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.53 -45.95 92.0 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.026 0.441 . . . . 0.0 110.718 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.76 -32.6 65.76 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.67 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.4 ' HG2' ' O ' ' A' ' 117' ' ' GLY . 6.7 pt-20 -78.28 -43.07 29.09 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.731 0.3 . . . . 0.0 111.242 -179.59 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 51.9 tp60 -66.26 -39.5 89.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.138 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.843 HD11 ' CD2' ' A' ' 88' ' ' TYR . 0.3 OUTLIER -63.11 -45.0 99.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.053 -179.929 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.443 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 27.0 mttt -59.51 -31.12 69.07 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.215 179.387 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 -68.21 -54.12 20.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.622 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.814 HG21 HD13 ' A' ' 148' ' ' LEU . 8.7 pt -61.78 -38.51 80.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.118 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.434 ' HG ' ' CD1' ' A' ' 122' ' ' ILE . 12.4 mt -53.6 -40.3 65.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.553 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.02 -19.13 60.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.766 179.167 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -128.91 28.94 5.28 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.392 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -48.9 -42.28 36.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.273 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 8.4 ttpp -68.67 -15.4 63.51 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.367 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -94.05 -38.54 11.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.382 -179.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.47 ' CD2' HG22 ' A' ' 125' ' ' ILE . 1.7 m-30 -97.77 153.79 18.04 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.971 0.415 . . . . 0.0 111.365 -179.386 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.447 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 9.5 mm-40 -123.35 155.32 37.54 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.538 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.446 ' CE1' ' CE1' ' A' ' 88' ' ' TYR . 3.4 m-85 -93.24 133.86 36.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.876 0.369 . . . . 0.0 111.124 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.426 ' CE2' ' HB2' ' A' ' 80' ' ' GLU . 36.4 m-85 -134.25 151.29 51.21 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.491 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.871 HD11 HG21 ' A' ' 81' ' ' THR . 0.5 OUTLIER -134.61 161.44 40.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.965 179.897 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -62.19 -164.38 0.37 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.169 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -73.38 -8.93 57.95 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.552 0.215 . . . . 0.0 111.433 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -97.96 -28.7 13.69 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.668 -179.438 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.436 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 45.7 mtp 55.72 42.39 29.31 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.897 0.379 . . . . 0.0 111.02 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ASN . . . . . 0.432 ' ND2' ' HA3' ' A' ' 144' ' ' GLY . 16.5 p-10 -65.03 114.78 16.34 Favored Pre-proline 0 N--CA 1.452 -0.373 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.993 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -62.19 -29.29 80.37 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.496 2.13 . . . . 0.0 112.142 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -84.64 -7.66 59.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.127 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.432 ' HA3' ' ND2' ' A' ' 141' ' ' ASN . . . -86.41 -167.67 43.9 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.436 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 1.6 ptp -84.99 -174.41 5.26 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.949 0.404 . . . . 0.0 110.794 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.476 HG21 ' HE2' ' A' ' 91' ' ' TYR . 75.6 t -130.27 155.65 41.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.067 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.573 ' HB2' ' CE1' ' A' ' 162' ' ' PHE . . . -116.56 110.84 19.08 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.473 179.488 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.814 HD13 HG21 ' A' ' 125' ' ' ILE . 5.0 mt -86.46 106.01 17.18 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.236 -179.174 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.537 ' HB2' ' HE2' ' A' ' 160' ' ' MET . 2.0 tp -89.69 119.77 30.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.928 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.549 ' HB2' ' CZ ' ' A' ' 159' ' ' TYR . 57.6 m-20 -131.91 161.67 32.48 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.68 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -105.3 146.6 29.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.119 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 8.7 mmt180 -59.68 -176.2 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.907 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -56.36 -41.31 75.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.951 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.488 ' OD1' HG23 ' A' ' 156' ' ' VAL . 11.1 t70 -72.61 -15.13 61.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.164 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 77.83 21.59 71.15 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.626 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.488 HG23 ' OD1' ' A' ' 154' ' ' ASP . 87.5 t -113.41 -73.01 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.772 0.32 . . . . 0.0 110.924 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 98.9 m -53.02 103.23 0.35 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.13 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -77.11 127.88 9.51 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.724 2.283 . . . . 0.0 112.069 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.549 ' CZ ' ' HB2' ' A' ' 150' ' ' ASP . 10.5 p90 -126.54 133.26 51.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.956 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' MET . . . . . 0.568 ' CE ' HD13 ' A' ' 78' ' ' LEU . 0.5 OUTLIER -103.46 140.03 38.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.055 -179.659 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.538 HG23 HD11 ' A' ' 23' ' ' ILE . 90.4 mt -95.59 113.81 30.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.888 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.573 ' CE1' ' HB2' ' A' ' 147' ' ' ALA . 47.9 m-85 -117.45 133.89 55.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.889 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -79.33 128.96 33.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.977 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.523 ' HD2' HD21 ' A' ' 29' ' ' LEU . 12.4 tttm -70.12 -52.83 20.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.101 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.461 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 19.3 m-20 -49.3 -37.83 25.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.155 -179.763 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -96.56 28.73 12.13 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.341 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.445 HD21 ' HB3' ' A' ' 4' ' ' TYR . 0.5 OUTLIER -146.74 145.88 30.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.75 0.309 . . . . 0.0 110.843 -179.91 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -109.84 152.61 25.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.854 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.653 ' HB3' HD11 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -124.28 138.66 54.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.935 179.982 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -149.88 130.73 14.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.962 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 17.3 mttm -83.76 116.57 22.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.899 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 1.8 t -93.2 165.3 12.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.888 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.627 ' H ' HD23 ' A' ' 173' ' ' LEU . 1.4 pt? -112.6 -33.58 6.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.964 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.185 -0.912 . . . . 0.0 110.861 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.0 ttt . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.837 0.351 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.732 HD11 ' HB3' ' A' ' 169' ' ' MET . 2.1 tt -110.08 147.81 14.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.14 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.445 HG21 ' HB3' ' A' ' 12' ' ' GLU . 19.3 mm -107.56 155.01 8.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.089 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.571 ' HE1' HG23 ' A' ' 2' ' ' ILE . 3.4 m-85 -122.2 104.47 9.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.606 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -119.19 152.19 37.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.343 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.447 ' O ' ' HA ' ' A' ' 10' ' ' HIS . 38.9 t0 -58.11 152.2 17.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.802 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.472 HD23 HG23 ' A' ' 99' ' ' ILE . 56.6 tp -81.38 -23.89 37.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.306 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.765 HD11 ' CG1' ' A' ' 99' ' ' ILE . 3.8 mp -91.18 -45.07 14.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.631 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.3 t -93.76 -25.34 17.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.781 -179.029 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.447 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 38.5 m80 66.47 28.84 9.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.883 0.373 . . . . 0.0 110.832 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -102.48 123.57 46.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.749 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.445 ' HB3' HG21 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -57.12 99.8 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.259 -179.746 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 33.3 mtp -80.91 -16.53 53.33 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.795 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.5 ' CE2' ' CD2' ' A' ' 4' ' ' TYR . 12.3 p90 -178.22 175.57 1.2 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.698 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -134.05 -169.85 2.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.071 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.7 p-10 -89.96 19.74 4.68 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.549 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 46.2 pt -86.15 -6.93 10.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.817 0.342 . . . . 0.0 111.266 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.861 ' CZ ' HG22 ' A' ' 72' ' ' ILE . 71.1 m-85 -116.5 168.87 9.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.748 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.403 ' HB2' ' HB2' ' A' ' 32' ' ' GLU . 2.6 mmpt? -79.71 93.34 5.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.681 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.726 HD12 ' O ' ' A' ' 18' ' ' TYR . 4.4 mp -87.78 125.66 41.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.066 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -116.97 132.14 56.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.981 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.452 ' HG3' HD23 ' A' ' 29' ' ' LEU . 5.7 mt-10 -81.52 116.11 21.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.775 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 7.7 pt -116.45 167.08 9.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.018 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 58.44 34.54 24.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.068 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 64.45 38.62 7.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.214 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.67 -10.49 74.55 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.667 -0.777 . . . . 0.0 113.182 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.417 HD21 ' HA ' ' A' ' 114' ' ' PHE . 0.1 OUTLIER -56.18 -37.64 69.86 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.901 0.35 . . . . 0.0 111.143 -179.879 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 72.0 m -136.98 169.74 17.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.139 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.496 HD21 ' HD2' ' A' ' 164' ' ' LYS . 0.3 OUTLIER -131.99 119.08 20.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.897 -179.74 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -83.09 112.94 20.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.107 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.4 HG23 ' HD2' ' A' ' 162' ' ' PHE . 30.6 t -94.74 111.92 26.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.615 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.403 ' HB2' ' HB2' ' A' ' 19' ' ' LYS . 2.0 mt-10 -82.54 118.48 23.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.205 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.4 -139.21 9.67 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.267 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.6 pttm -174.36 129.97 0.36 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.772 0.32 . . . . 0.0 110.958 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.409 ' HE2' ' O ' ' A' ' 156' ' ' VAL . 17.4 mtm -76.73 125.0 28.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.896 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.452 HG23 ' CE ' ' A' ' 74' ' ' MET . 5.0 m -118.2 134.39 61.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.216 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.695 ' CA ' HG23 ' A' ' 68' ' ' THR . 0.8 OUTLIER -93.22 165.54 12.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.957 -179.986 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.45 ' HB3' HG12 ' A' ' 67' ' ' ILE . 1.1 ttt180 -158.58 124.02 4.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.796 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.905 HG22 HG22 ' A' ' 66' ' ' VAL . 5.8 p -109.46 49.68 0.82 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.877 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -96.57 153.03 18.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.862 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 161.82 150.41 5.95 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.505 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -111.77 144.45 41.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.806 0.336 . . . . 0.0 110.878 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 6.4 tp -65.17 131.46 30.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.267 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -129.51 118.08 21.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.994 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -138.83 -178.06 5.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.89 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.5 -32.5 16.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.872 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 42.8 mt -80.05 -35.77 36.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.861 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 46.0 mm 62.76 -78.07 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.124 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 66.72 -95.17 0.26 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.574 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -59.99 114.51 6.45 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.584 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -97.67 57.23 1.34 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.876 0.369 . . . . 0.0 110.868 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -98.09 35.19 1.78 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.149 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.07 78.59 2.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.9 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -77.52 -36.66 52.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.025 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -89.67 89.15 7.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.901 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 134.9 114.33 1.41 Allowed Glycine 0 CA--C 1.521 0.417 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.627 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -60.27 -15.96 37.97 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.565 2.177 . . . . 0.0 112.454 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 77.36 99.74 0.07 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.972 0.415 . . . . 0.0 110.899 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -156.81 -45.34 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.495 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -96.76 -176.85 3.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.736 0.303 . . . . 0.0 110.925 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -87.53 -73.04 1.28 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.519 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 12.9 p 55.12 101.74 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.829 0.347 . . . . 0.0 111.004 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.05 -179.81 7.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.852 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.4 m -97.42 38.03 1.3 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.912 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.482 ' O ' HD13 ' A' ' 67' ' ' ILE . 22.0 m -86.8 147.43 25.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.008 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.905 HG22 HG22 ' A' ' 39' ' ' THR . 88.1 t -73.32 143.19 14.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.134 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.482 HD13 ' O ' ' A' ' 65' ' ' THR . 0.0 OUTLIER -122.25 126.25 74.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.696 179.67 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.695 HG23 ' CA ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -138.49 114.69 10.24 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.893 179.865 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -147.24 -176.66 21.13 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.229 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.44 HG22 ' HG3' ' A' ' 158' ' ' PRO . 59.8 t -69.73 148.28 11.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.911 0.386 . . . . 0.0 110.931 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -72.48 -57.56 4.08 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.338 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.861 HG22 ' CZ ' ' A' ' 18' ' ' TYR . 10.8 pt -53.53 -34.01 22.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.421 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.792 HG13 ' HB2' ' A' ' 78' ' ' LEU . 57.9 t -71.24 -31.88 45.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.882 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.452 ' CE ' HG23 ' A' ' 36' ' ' VAL . 2.3 mtm -78.01 -40.47 38.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.417 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.406 ' OD1' ' CD2' ' A' ' 76' ' ' HIS . 13.5 p30 -82.12 -28.77 32.06 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.51 -179.539 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.431 ' CE1' ' HB ' ' A' ' 72' ' ' ILE . 26.9 m170 -93.55 -0.28 56.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.753 0.311 . . . . 0.0 110.88 179.47 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.415 ' HB2' ' HB3' ' A' ' 138' ' ' GLU . 13.0 m80 55.89 29.62 14.47 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.09 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.792 ' HB2' HG13 ' A' ' 73' ' ' VAL . 52.3 mt -57.09 139.84 51.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.652 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -124.44 137.38 54.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.126 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -91.59 131.86 36.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.037 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.525 HG21 HD11 ' A' ' 136' ' ' ILE . 6.2 t -118.5 170.1 9.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.872 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.3 m -107.39 165.19 11.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.955 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.493 ' CE2' ' CE2' ' A' ' 91' ' ' TYR . 2.7 m-85 -171.68 149.84 2.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.95 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.3 m -101.48 166.34 10.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.767 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.7 mtmp? -57.34 -49.86 74.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.873 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.65 -40.25 76.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.831 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.95 -43.73 94.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.101 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.851 ' CD2' HD11 ' A' ' 122' ' ' ILE . 0.6 OUTLIER -61.48 -30.74 70.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.757 179.921 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 27.7 mttm -62.98 -44.66 95.43 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.012 0.434 . . . . 0.0 110.566 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 11.3 mttm -78.56 -27.9 45.89 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.771 178.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.567 ' HE2' HG21 ' A' ' 146' ' ' VAL . 17.2 t80 -67.03 -47.32 71.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.073 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.778 HG22 ' O ' ' A' ' 88' ' ' TYR . 2.3 tp -65.06 -40.21 88.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.074 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.444 ' O ' ' CG ' ' A' ' 97' ' ' LYS . 4.9 ttpp -62.73 -45.28 93.47 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.923 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -68.76 -39.34 80.32 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.861 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.534 ' CD1' ' C ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -76.03 -43.78 42.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.712 -0.222 . . . . 0.0 110.875 -179.299 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 3.2 ptt? -62.06 -31.99 72.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.914 0.388 . . . . 0.0 110.238 179.186 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.444 ' CG ' ' O ' ' A' ' 93' ' ' LYS . 3.8 mmtt -66.46 -42.11 88.04 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.717 179.657 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.4 m -57.22 -41.72 80.0 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.657 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.765 ' CG1' HD11 ' A' ' 8' ' ' ILE . 6.6 mt -79.78 -42.26 22.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.685 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.8 tttt -53.64 -54.5 36.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.55 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -62.12 -46.4 94.07 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.126 179.404 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 26.0 tptt -61.08 -37.01 81.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.945 0.402 . . . . 0.0 110.406 179.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.527 HD21 ' CB ' ' A' ' 110' ' ' ARG . 6.6 tp -70.82 -32.94 70.17 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.051 179.298 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.605 ' CG ' HG11 ' A' ' 111' ' ' VAL . 84.0 mt-10 -60.97 -29.13 69.48 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.806 179.628 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -89.97 -19.58 24.32 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.423 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -106.84 -62.68 1.37 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.881 0.372 . . . . 0.0 111.472 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.428 ' N ' ' O ' ' A' ' 103' ' ' LEU . 9.7 mtt-85 -124.91 62.72 37.07 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.902 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.864 ' O ' HG22 ' A' ' 111' ' ' VAL . 10.3 Cg_endo -50.82 -24.53 13.63 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 123.091 2.528 . . . . 0.0 112.537 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -73.05 -9.46 58.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.247 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.527 ' CB ' HD21 ' A' ' 103' ' ' LEU . 58.2 mmt-85 -110.84 0.11 17.11 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.665 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.864 HG22 ' O ' ' A' ' 108' ' ' PRO . 26.5 m -71.42 -33.8 51.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.407 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.545 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 4.9 mttm -67.69 -50.4 35.22 Favored Pre-proline 0 CA--C 1.53 0.197 0 C-N-CA 120.997 -0.281 . . . . 0.0 111.681 -179.12 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.545 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 24.7 Cg_exo -63.16 -29.28 73.99 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.148 1.899 . . . . 0.0 111.67 179.478 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.481 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 89.3 t80 -72.12 -42.4 66.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.861 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 2.7 mmm -58.07 -43.83 87.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.874 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 66.2 m -76.69 -45.15 30.68 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.905 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.15 -45.83 92.69 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.775 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.402 ' O ' ' HB ' ' A' ' 122' ' ' ILE . . . -57.19 -51.76 68.02 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.045 0.45 . . . . 0.0 111.269 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.85 -28.06 63.3 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.502 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.401 ' O ' ' HG2' ' A' ' 123' ' ' LYS . 5.8 tt0 -74.13 -50.0 21.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.772 0.32 . . . . 0.0 111.474 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -67.62 -39.2 84.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.512 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.851 HD11 ' CD2' ' A' ' 88' ' ' TYR . 0.3 OUTLIER -59.5 -49.82 82.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.654 -179.458 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.481 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 9.5 ptpt -60.18 -30.64 69.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.059 0.457 . . . . 0.0 110.276 179.643 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 -68.91 -53.26 21.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.755 179.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.503 HG21 HD13 ' A' ' 148' ' ' LEU . 16.7 pt -62.31 -42.33 95.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.309 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.498 HD21 ' CD2' ' A' ' 88' ' ' TYR . 11.3 mt -53.76 -37.18 63.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.946 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -72.89 -9.8 59.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.215 179.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 -142.24 34.44 1.51 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.983 0.42 . . . . 0.0 110.477 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.507 ' CE1' ' CZ ' ' A' ' 134' ' ' PHE . 5.4 t80 -51.95 -24.71 6.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.113 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -55.92 -37.91 69.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.979 0.418 . . . . 0.0 111.0 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 27.0 m-20 -86.25 -42.75 13.51 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.685 -179.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.443 ' HE2' HD11 ' A' ' 161' ' ' ILE . 14.1 m-85 -92.72 129.31 38.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.881 0.372 . . . . 0.0 111.394 -179.552 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.424 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 5.0 mm-40 -114.84 145.13 42.49 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.911 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.507 ' CE1' ' CZ ' ' A' ' 88' ' ' TYR . 1.7 m-85 -79.95 127.52 32.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.174 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.422 ' CE1' ' HB3' ' A' ' 149' ' ' LEU . 48.0 m-85 -132.3 134.18 44.94 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.586 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.525 HD11 HG21 ' A' ' 81' ' ' THR . 0.7 OUTLIER -120.94 161.86 20.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.939 -179.811 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.47 -165.12 0.14 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.266 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.415 ' HB3' ' HB2' ' A' ' 77' ' ' HIS . 4.1 pt-20 -72.35 -9.18 58.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.566 0.222 . . . . 0.0 111.489 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.511 ' HB3' ' ND2' ' A' ' 141' ' ' ASN . 25.5 m-80 -97.59 -33.9 11.17 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 120.652 0.263 . . . . 0.0 111.518 -179.453 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.468 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 34.9 mtm 60.47 34.96 20.4 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.683 0.278 . . . . 0.0 111.335 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ASN . . . . . 0.511 ' ND2' ' HB3' ' A' ' 139' ' ' ASN . 10.2 m120 -64.4 123.6 83.26 Favored Pre-proline 0 N--CA 1.451 -0.392 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.732 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -61.95 -23.35 75.77 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.321 2.014 . . . . 0.0 111.822 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -84.45 -12.14 54.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.734 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -80.96 -175.54 49.96 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.258 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 1.4 ptp -85.37 -177.98 6.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.783 0.325 . . . . 0.0 110.891 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.567 HG21 ' HE2' ' A' ' 91' ' ' TYR . 43.6 t -125.88 149.04 30.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.96 0.41 . . . . 0.0 111.165 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.424 ' HB1' ' SD ' ' A' ' 160' ' ' MET . . . -113.55 112.52 23.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.649 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.532 ' HB2' ' HB ' ' A' ' 161' ' ' ILE . 4.7 mt -85.86 106.27 16.95 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.03 -179.361 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.573 HD12 ' HG2' ' A' ' 160' ' ' MET . 3.3 tp -90.75 119.19 30.77 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.381 -179.293 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.49 ' HB3' ' CE1' ' A' ' 159' ' ' TYR . 13.4 t70 -132.57 164.29 26.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.482 179.318 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -97.49 146.7 24.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.955 0.407 . . . . 0.0 111.226 -179.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.09 -176.36 0.88 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.882 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -58.96 -41.31 87.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.923 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -67.18 -15.1 63.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.132 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 75.03 11.07 84.17 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.68 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.409 ' O ' ' HE2' ' A' ' 35' ' ' MET . 73.6 t -111.89 -70.15 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.846 0.355 . . . . 0.0 110.872 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 90.5 m -55.6 108.54 1.21 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.163 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.44 ' HG3' HG22 ' A' ' 70' ' ' VAL . 88.4 Cg_endo -82.65 132.19 6.57 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.579 2.186 . . . . 0.0 112.074 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.49 ' CE1' ' HB3' ' A' ' 150' ' ' ASP . 8.1 p90 -125.28 149.15 48.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.89 0.376 . . . . 0.0 110.983 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' MET . . . . . 0.79 ' CE ' HD13 ' A' ' 78' ' ' LEU . 0.6 OUTLIER -114.52 150.76 34.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.162 -179.75 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.532 ' HB ' ' HB2' ' A' ' 148' ' ' LEU . 88.5 mt -103.44 111.95 35.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.871 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.4 ' HD2' HG23 ' A' ' 31' ' ' VAL . 90.3 m-85 -114.53 125.84 54.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.907 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.407 ' CE2' ' OH ' ' A' ' 95' ' ' TYR . 2.6 m-85 -71.06 124.68 24.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.744 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.496 ' HD2' HD21 ' A' ' 29' ' ' LEU . 6.3 tttm -66.39 -56.44 11.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.31 -179.61 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.481 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 0.8 OUTLIER -51.06 -34.4 29.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.238 -179.797 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.409 ' HA2' ' CG2' ' A' ' 99' ' ' ILE . . . -95.73 25.28 25.73 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.47 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.438 HD21 ' HB3' ' A' ' 4' ' ' TYR . 0.6 OUTLIER -137.74 146.99 44.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.867 0.365 . . . . 0.0 110.928 -179.91 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -119.38 136.85 54.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.79 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.732 ' HB3' HD11 ' A' ' 2' ' ' ILE . 1.6 mpp? -103.98 154.55 19.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.015 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -157.48 125.19 5.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.799 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.689 ' HG2' HD12 ' A' ' 2' ' ' ILE . 3.3 mtpp -88.22 117.81 27.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.867 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER 67.0 -74.85 0.06 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.813 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.408 HD12 ' C ' ' A' ' 173' ' ' LEU . 3.3 pp -151.93 32.07 0.55 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.89 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.922 179.986 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.1 ttp . . . . . 0 N--CA 1.486 1.375 0 CA-C-O 120.848 0.356 . . . . 0.0 111.116 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.82 HD11 ' HB3' ' A' ' 169' ' ' MET . 10.0 tt -88.84 128.93 40.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.159 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.453 HG21 ' HB3' ' A' ' 12' ' ' GLU . 19.4 mm -92.88 157.31 2.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.23 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.624 ' HB3' HD21 ' A' ' 167' ' ' LEU . 3.0 m-85 -124.54 106.7 10.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.489 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 25.0 ptt180 -121.84 148.28 44.89 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.817 0.341 . . . . 0.0 111.333 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.441 ' O ' ' HA ' ' A' ' 10' ' ' HIS . 23.3 t0 -56.57 152.21 12.27 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.808 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 61.5 tp -80.3 -24.17 40.16 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.373 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.797 HD11 ' CG1' ' A' ' 99' ' ' ILE . 4.7 mp -91.3 -44.49 14.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.823 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.6 p -93.1 -23.77 18.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.77 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.441 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 5.6 m170 63.44 28.07 15.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.809 0.337 . . . . 0.0 110.817 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -102.73 121.39 42.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.734 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.453 ' HB3' HG21 ' A' ' 3' ' ' ILE . 1.0 OUTLIER -58.52 89.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.204 -179.81 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 6.4 mtt -69.32 -16.07 63.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.881 179.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.498 ' CE2' ' CD2' ' A' ' 4' ' ' TYR . 34.1 p90 -176.87 171.48 2.18 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.93 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.8 m -134.54 -169.94 2.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.005 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -87.24 12.3 12.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.525 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 46.2 pt -81.3 -3.26 6.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.884 0.373 . . . . 0.0 111.062 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.843 ' CZ ' HG22 ' A' ' 72' ' ' ILE . 65.2 m-85 -119.89 179.87 4.12 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.705 -179.679 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.403 ' HB2' ' HB2' ' A' ' 32' ' ' GLU . 0.1 OUTLIER -90.14 88.94 7.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.916 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.566 HD12 ' O ' ' A' ' 18' ' ' TYR . 4.4 mp -88.03 123.89 40.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.994 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.79 133.52 55.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.914 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -78.35 121.15 24.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.826 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.477 HD11 HG23 ' A' ' 161' ' ' ILE . 3.8 pt -116.44 174.59 3.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.205 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 57.06 24.82 10.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.393 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 65.72 57.55 0.84 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.37 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 73.56 18.95 79.62 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.756 -0.735 . . . . 0.0 113.354 179.464 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.522 HD21 ' O ' ' A' ' 113' ' ' PRO . 0.2 OUTLIER -92.53 -45.67 8.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.914 0.357 . . . . 0.0 110.948 179.853 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 17.0 m -130.67 171.62 12.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.054 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.75 HD11 ' HB3' ' A' ' 164' ' ' LYS . 0.5 OUTLIER -129.48 131.08 46.59 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.941 -179.926 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -97.25 112.77 24.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.798 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.6 t -92.0 111.78 24.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.726 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.403 ' HB2' ' HB2' ' A' ' 19' ' ' LYS . 8.6 mt-10 -84.19 117.57 23.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.12 -179.725 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -99.82 -138.37 10.26 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.319 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -174.48 124.82 0.3 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.804 0.335 . . . . 0.0 111.013 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 55.8 mtp -68.61 122.0 17.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.656 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.409 HG23 ' CE ' ' A' ' 74' ' ' MET . 17.3 m -119.08 133.81 64.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.292 -179.731 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.665 ' CA ' HG23 ' A' ' 68' ' ' THR . 0.9 OUTLIER -83.27 149.35 26.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.785 179.865 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.436 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 0.0 OUTLIER -132.0 115.9 16.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.858 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.3 m -74.19 -60.59 2.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.845 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -66.68 -172.51 0.17 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.872 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.99 -147.68 16.3 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.464 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -116.83 -176.24 2.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.8 0.333 . . . . 0.0 110.88 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.545 HG23 HD11 ' A' ' 48' ' ' ILE . 1.8 mt -79.59 131.88 33.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.096 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -78.11 -48.84 15.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.861 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.45 ' O ' HG22 ' A' ' 43' ' ' ILE . 1.4 m-20 -138.79 -179.09 5.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.955 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 17.3 p -90.17 -32.55 16.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.85 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 21.8 mt -85.81 -18.89 31.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.152 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.62 HD12 HG21 ' A' ' 65' ' ' THR . 38.9 mm 55.82 92.69 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.884 0.373 . . . . 0.0 111.092 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -79.66 74.9 2.19 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.506 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -97.71 -174.21 33.63 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.455 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -165.88 -48.11 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.76 0.314 . . . . 0.0 110.834 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.89 119.09 4.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.105 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.4 m -148.6 100.21 3.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.901 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -127.93 136.82 51.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.142 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -137.42 -74.26 0.42 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.843 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 148.28 -75.15 0.27 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.488 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.51 159.6 52.31 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.559 2.173 . . . . 0.0 112.343 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 60.7 157.64 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.917 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -81.69 115.32 4.0 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.517 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -105.21 138.91 40.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.756 0.312 . . . . 0.0 110.985 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 135.72 -27.6 3.06 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.503 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.414 HG22 ' H ' ' A' ' 63' ' ' GLU . 0.2 OUTLIER -141.93 -167.72 2.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.836 0.35 . . . . 0.0 110.809 -179.974 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.414 ' H ' HG22 ' A' ' 62' ' ' THR . 0.0 OUTLIER 67.48 -73.33 0.08 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.964 -179.993 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 79.4 p -117.77 154.0 32.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.983 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.62 HG21 HD12 ' A' ' 48' ' ' ILE . 2.7 m -118.91 168.58 10.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.83 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' A' ' 38' ' ' ARG . 60.8 t -86.63 137.16 21.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.201 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.433 HG13 ' HB3' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -128.19 99.88 5.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.383 179.35 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.665 HG23 ' CA ' ' A' ' 37' ' ' SER . 0.3 OUTLIER -100.84 108.87 20.77 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.035 -179.777 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -134.76 -173.63 13.17 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.143 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.447 HG12 HG12 ' A' ' 72' ' ' ILE . 47.8 t -74.22 142.66 14.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.851 0.357 . . . . 0.0 110.937 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -69.74 -57.53 5.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.399 -179.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.843 HG22 ' CZ ' ' A' ' 18' ' ' TYR . 9.1 pt -53.72 -33.92 23.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.576 -179.552 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.755 HG13 ' HB2' ' A' ' 78' ' ' LEU . 71.6 t -72.02 -33.75 48.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.838 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.409 ' CE ' HG23 ' A' ' 36' ' ' VAL . 3.8 mtm -78.4 -39.87 37.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.714 -179.576 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.41 ' OD1' ' CD2' ' A' ' 76' ' ' HIS . 18.8 p30 -82.07 -29.13 32.0 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 -179.238 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.432 ' CE1' ' HB ' ' A' ' 72' ' ' ILE . 26.3 m170 -92.98 0.25 57.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.753 0.311 . . . . 0.0 110.858 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 55.09 32.79 19.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.913 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.755 ' HB2' HG13 ' A' ' 73' ' ' VAL . 52.4 mt -55.92 141.58 38.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.744 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -119.81 131.25 55.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.035 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.427 ' HG3' ' CE1' ' A' ' 135' ' ' PHE . 6.5 tt0 -95.0 127.26 40.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.93 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.709 HG21 HD11 ' A' ' 136' ' ' ILE . 1.8 t -120.03 165.12 15.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.751 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.0 p -97.03 159.65 14.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.841 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.468 ' HB2' ' CE2' ' A' ' 134' ' ' PHE . 1.6 m-85 -165.6 149.62 8.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.981 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.5 m -101.43 162.94 12.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.867 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 12.7 mttm -58.32 -52.46 65.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.065 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -63.71 -44.13 94.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.82 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.58 -42.22 98.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.02 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.92 ' CD2' HD11 ' A' ' 122' ' ' ILE . 0.7 OUTLIER -61.02 -33.84 73.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.841 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 12.8 mttp -61.19 -43.55 98.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.906 0.384 . . . . 0.0 110.554 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.1 mttp -78.11 -27.82 48.46 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.843 179.079 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.556 ' HE2' HG21 ' A' ' 146' ' ' VAL . 7.2 t80 -67.68 -42.27 82.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.878 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.729 HD12 ' CE2' ' A' ' 95' ' ' TYR . 5.0 tp -65.73 -44.24 93.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.898 0.38 . . . . 0.0 110.972 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.472 ' O ' ' CG ' ' A' ' 97' ' ' LYS . 2.0 ttpt -61.26 -45.35 94.88 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.782 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -68.75 -40.37 79.85 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.177 -179.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.729 ' CE2' HD12 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -77.69 -44.08 29.1 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.994 -179.272 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.403 ' HG3' ' N ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -60.17 -31.59 70.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.914 0.388 . . . . 0.0 110.195 179.165 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.472 ' CG ' ' O ' ' A' ' 93' ' ' LYS . 1.6 mmpt? -66.84 -45.14 79.14 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.445 179.457 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -54.92 -40.65 70.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.813 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.797 ' CG1' HD11 ' A' ' 8' ' ' ILE . 11.8 mt -79.95 -42.5 22.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.532 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.63 -52.05 65.14 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.442 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -63.19 -46.86 92.18 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.363 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.97 -44.41 94.48 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.877 0.37 . . . . 0.0 110.456 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.812 HD21 ' CB ' ' A' ' 110' ' ' ARG . 3.8 tp -63.26 -37.6 87.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.285 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.773 ' HG3' HG11 ' A' ' 111' ' ' VAL . 36.8 mt-10 -57.28 -29.5 63.92 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 120.818 0.342 . . . . 0.0 110.814 179.357 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -86.54 -19.29 29.68 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.617 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -109.52 -60.72 1.74 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.803 0.335 . . . . 0.0 111.774 -179.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.435 ' N ' ' O ' ' A' ' 103' ' ' LEU . 1.7 mtt180 -132.54 66.52 76.98 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.833 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.915 ' O ' HG22 ' A' ' 111' ' ' VAL . 10.3 Cg_endo -50.56 -21.02 7.04 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 123.257 2.638 . . . . 0.0 112.879 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -69.76 -7.92 43.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.411 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.812 ' CB ' HD21 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -113.35 -2.6 13.95 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -179.517 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.915 HG22 ' O ' ' A' ' 108' ' ' PRO . 33.1 m -73.13 -30.72 32.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.557 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 2.9 mtpt -69.46 -49.74 21.58 Favored Pre-proline 0 CA--C 1.53 0.197 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.711 -179.104 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.557 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 24.7 Cg_exo -63.13 -34.76 67.98 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.118 1.879 . . . . 0.0 111.987 179.647 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.453 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 69.6 t80 -72.21 -36.4 69.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.949 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.6 -54.88 41.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.983 0.42 . . . . 0.0 110.713 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 75.3 m -71.58 -44.68 64.05 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.584 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -59.89 -43.06 98.38 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.412 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -55.96 -48.52 75.64 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.022 0.439 . . . . 0.0 111.082 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.74 -33.51 66.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.382 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -74.31 -39.77 62.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.849 0.357 . . . . 0.0 111.256 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 50.7 tp60 -71.75 -35.92 70.25 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.115 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.92 HD11 ' CD2' ' A' ' 88' ' ' TYR . 0.4 OUTLIER -67.06 -45.31 87.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.303 -179.698 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.433 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 10.0 ptpt -61.84 -30.87 71.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.965 0.412 . . . . 0.0 110.23 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 -67.88 -53.6 25.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.652 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.887 HG21 HD13 ' A' ' 148' ' ' LEU . 14.8 pt -62.05 -41.42 91.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.282 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 13.4 mt -53.8 -37.46 63.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.915 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -65.02 -16.55 63.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.102 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 11.4 m-80 -137.16 33.0 2.59 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.644 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.498 ' CE1' ' CE2' ' A' ' 134' ' ' PHE . 1.1 t80 -52.5 -36.74 55.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.953 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -61.13 -18.76 59.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.286 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 35.2 m-20 -92.29 -43.43 9.29 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.716 0.293 . . . . 0.0 111.306 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.427 ' CD1' ' N ' ' A' ' 132' ' ' TYR . 1.4 m-30 -94.4 163.85 13.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.909 0.385 . . . . 0.0 111.245 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.441 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 4.9 mm-40 -136.35 145.67 45.67 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.88 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.498 ' CE2' ' CE1' ' A' ' 129' ' ' PHE . 1.5 m-85 -79.89 125.54 29.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.932 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.427 ' CE1' ' HG3' ' A' ' 80' ' ' GLU . 50.1 m-85 -129.45 132.42 46.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.692 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.709 HD11 HG21 ' A' ' 81' ' ' THR . 0.3 OUTLIER -120.83 158.15 23.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.576 179.914 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -56.54 -171.76 0.15 Allowed Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.447 -0.883 . . . . 0.0 112.021 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -70.02 -11.18 60.69 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.693 0.282 . . . . 0.0 111.407 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.507 ' HB3' ' ND2' ' A' ' 141' ' ' ASN . 25.0 m-80 -93.99 -25.24 17.33 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.531 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.428 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 35.6 mtm 51.33 43.91 29.16 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.806 0.336 . . . . 0.0 111.321 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ASN . . . . . 0.507 ' ND2' ' HB3' ' A' ' 139' ' ' ASN . 1.6 m120 -66.68 120.72 73.19 Favored Pre-proline 0 N--CA 1.454 -0.267 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.766 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -61.26 -26.18 81.61 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.253 1.968 . . . . 0.0 111.893 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -84.85 -19.67 32.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.701 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -70.17 -172.84 11.16 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.316 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 5.7 ptp -90.4 -173.56 3.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.78 0.324 . . . . 0.0 110.883 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.556 HG21 ' HE2' ' A' ' 91' ' ' TYR . 58.1 t -128.88 150.65 34.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.112 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.521 ' HB1' ' SD ' ' A' ' 160' ' ' MET . . . -115.44 111.53 20.92 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.654 179.584 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.887 HD13 HG21 ' A' ' 125' ' ' ILE . 3.9 mt -85.59 106.23 16.74 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.129 -179.201 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.44 HD12 ' HG2' ' A' ' 160' ' ' MET . 4.2 tp -88.52 120.16 29.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.347 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.453 ' HB3' ' CE1' ' A' ' 159' ' ' TYR . 27.8 t70 -136.75 164.86 27.27 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.39 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -106.46 152.47 23.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.837 0.351 . . . . 0.0 111.13 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.25 -177.1 0.49 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.966 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.99 -37.9 75.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.835 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -76.23 -15.04 60.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.28 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 69.77 26.98 73.79 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.744 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 89.8 t -112.03 -61.89 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.848 0.356 . . . . 0.0 110.929 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 78.2 m -75.78 112.75 21.5 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.202 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -81.08 132.04 8.17 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.562 2.175 . . . . 0.0 112.065 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.453 ' CE1' ' HB3' ' A' ' 150' ' ' ASP . 9.9 p90 -127.13 142.81 51.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.957 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' MET . . . . . 0.708 ' CE ' HD13 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -109.6 145.33 36.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.003 -179.848 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.525 ' HB ' ' HB2' ' A' ' 148' ' ' LEU . 74.5 mt -98.47 118.67 45.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.064 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.464 ' CE1' ' HB2' ' A' ' 147' ' ' ALA . 96.7 m-85 -122.25 154.46 37.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.825 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -102.5 116.06 31.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.984 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.75 ' HB3' HD11 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -62.68 -40.72 97.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.104 -179.751 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.453 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 2.1 m-20 -56.73 -38.4 72.31 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.814 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -98.44 24.38 32.26 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.353 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.624 HD21 ' HB3' ' A' ' 4' ' ' TYR . 0.5 OUTLIER -137.55 146.81 44.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.829 0.347 . . . . 0.0 110.771 179.985 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.423 ' N ' ' HG ' ' A' ' 167' ' ' LEU . 6.7 tt0 -116.45 149.93 38.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.771 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.82 ' HB3' HD11 ' A' ' 2' ' ' ILE . 1.0 OUTLIER -113.79 160.0 19.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.102 -179.829 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -161.83 122.09 2.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.818 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.577 ' HG2' HD12 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -95.36 117.47 30.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.986 179.98 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 172' ' ' CYS . . . . . 0.675 ' C ' HD23 ' A' ' 173' ' ' LEU . 3.9 t -150.82 162.49 40.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.909 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.675 HD23 ' C ' ' A' ' 172' ' ' CYS . 0.9 OUTLIER 45.49 40.63 5.9 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.383 179.962 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.13 -0.938 . . . . 0.0 110.843 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 tpt . . . . . 0 N--CA 1.487 1.412 0 CA-C-O 120.846 0.355 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.707 HD12 ' HG2' ' A' ' 171' ' ' LYS . 2.3 tt -108.48 149.57 11.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.017 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.486 HG21 ' HB3' ' A' ' 12' ' ' GLU . 20.4 mm -111.31 159.36 11.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.378 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.506 ' CD2' ' CE2' ' A' ' 14' ' ' PHE . 5.4 m-85 -122.81 104.56 9.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.306 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 21.9 ptt180 -116.65 145.51 43.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.008 0.432 . . . . 0.0 111.415 -179.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.54 ' OD1' HD12 ' A' ' 8' ' ' ILE . 50.5 t0 -54.34 152.01 6.86 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.961 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 40.6 tp -82.47 -16.87 47.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.546 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.54 HD12 ' OD1' ' A' ' 6' ' ' ASP . 4.4 mp -91.27 -51.72 11.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -179.366 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.41 ' HB2' ' ND2' ' A' ' 141' ' ' ASN . 5.9 t -96.74 -16.26 20.97 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -179.113 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.454 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 1.8 m-70 64.39 30.08 13.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.865 0.364 . . . . 0.0 110.863 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -99.23 122.63 42.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.831 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.486 ' HB3' HG21 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -58.43 92.07 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.286 -179.739 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 35.8 mtp -70.85 -19.07 62.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.714 179.389 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.506 ' CE2' ' CD2' ' A' ' 4' ' ' TYR . 16.1 p90 -175.25 174.7 2.35 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.525 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.3 m -129.08 -170.53 2.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.822 0.344 . . . . 0.0 111.083 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.427 ' HB2' ' CG2' ' A' ' 2' ' ' ILE . 30.6 t0 -95.43 21.08 8.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.062 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.4 HG13 ' CD2' ' A' ' 18' ' ' TYR . 46.3 pt -87.14 -8.8 11.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.059 179.41 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.966 ' CZ ' HG22 ' A' ' 72' ' ' ILE . 84.3 m-85 -111.41 -175.99 2.84 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.899 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.1 mmmt -93.32 93.67 8.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.901 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.1 mp -88.06 123.96 40.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.985 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.405 ' HB3' ' NH1' ' A' ' 21' ' ' ARG . 9.1 mtp-105 -113.55 126.42 55.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.936 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.739 ' HG3' HD23 ' A' ' 29' ' ' LEU . 3.8 mt-10 -77.41 112.74 14.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.879 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.613 HD11 HG23 ' A' ' 161' ' ' ILE . 4.2 pt -109.69 168.46 3.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.063 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.417 ' HB2' ' NE2' ' A' ' 121' ' ' GLN . . . 57.72 30.17 18.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.152 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 63.9 40.14 7.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.29 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.7 -12.61 68.48 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.6 -0.81 . . . . 0.0 113.158 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.78 -37.4 76.24 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.824 0.345 . . . . 0.0 111.045 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 13.9 m -141.68 162.94 34.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.141 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.739 HD23 ' HG3' ' A' ' 22' ' ' GLU . 0.5 OUTLIER -128.76 135.45 49.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.703 179.894 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.403 ' OE1' ' CD2' ' A' ' 159' ' ' TYR . 64.6 mt-10 -100.7 118.13 36.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.305 -179.68 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.496 HG21 ' CD2' ' A' ' 14' ' ' PHE . 24.2 t -94.8 112.02 26.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.729 179.47 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -84.67 122.96 29.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.205 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -108.98 -138.79 8.42 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.278 179.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.9 ptpt -174.48 128.3 0.34 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.821 0.343 . . . . 0.0 111.024 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 24.4 mtp -74.17 124.9 27.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.567 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.0 m -125.28 140.12 49.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.657 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 16.9 p -91.33 165.64 13.32 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.696 179.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.769 ' O ' HG23 ' A' ' 66' ' ' VAL . 8.0 tpp180 -134.61 115.77 14.23 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.052 -179.571 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.65 108.97 19.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.795 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -141.04 48.5 1.69 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.003 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 122.31 172.99 14.2 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.597 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 31.8 p-10 -179.15 -39.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.827 0.346 . . . . 0.0 110.837 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 15.2 tt -90.09 159.65 2.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.01 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 64.07 44.8 4.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.867 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -155.95 26.83 0.37 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.919 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.11 -42.09 5.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.894 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.03 -30.84 68.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.933 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 34.1 mm -67.42 -63.97 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.105 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 154.01 -134.28 4.27 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.542 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 164.3 -139.44 5.85 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.5 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -115.83 56.16 0.77 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.901 0.381 . . . . 0.0 110.953 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -139.73 31.51 2.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.113 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.1 t -86.24 -31.68 21.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.796 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -138.31 80.69 1.81 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.079 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -164.48 -58.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.87 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 97.17 157.2 30.77 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.51 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -52.41 104.56 0.1 OUTLIER 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.581 2.187 . . . . 0.0 112.252 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -115.26 146.36 41.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.91 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -92.8 58.84 2.5 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.505 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -89.97 179.02 6.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.856 0.36 . . . . 0.0 110.881 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -59.93 157.09 27.33 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.482 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.7 t -64.49 119.52 10.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.852 0.358 . . . . 0.0 110.868 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.5 tt0 -175.95 126.6 0.22 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.944 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 63.1 m -132.23 -76.82 0.5 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.823 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 59.5 m -103.23 -35.02 8.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.842 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.769 HG23 ' O ' ' A' ' 38' ' ' ARG . 14.5 p -74.82 136.52 24.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.932 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.528 ' N ' HD13 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -103.37 131.62 51.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.812 0.339 . . . . 0.0 110.674 179.731 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 86.4 m -137.89 140.18 40.25 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.047 0.451 . . . . 0.0 111.243 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 179.64 -176.48 47.63 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.286 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.541 HG12 HG12 ' A' ' 72' ' ' ILE . 48.8 t -67.87 130.34 33.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.805 0.336 . . . . 0.0 110.886 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -59.68 -58.05 10.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.402 -179.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.966 HG22 ' CZ ' ' A' ' 18' ' ' TYR . 6.3 pt -53.85 -33.97 24.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.61 -179.569 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.768 HG13 ' HB2' ' A' ' 78' ' ' LEU . 97.0 t -72.69 -29.98 32.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.137 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 7.3 mtm -78.09 -42.58 31.64 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.664 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.44 HD21 ' HA ' ' A' ' 72' ' ' ILE . 22.0 p30 -82.25 -28.89 31.6 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -179.123 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.447 ' CE1' ' HA ' ' A' ' 14' ' ' PHE . 32.7 m170 -88.58 -8.07 55.36 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.904 0.383 . . . . 0.0 110.69 179.307 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.407 ' HB2' ' HB3' ' A' ' 138' ' ' GLU . 72.4 m-70 64.65 33.39 10.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.056 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.768 ' HB2' HG13 ' A' ' 73' ' ' VAL . 33.4 mt -64.63 142.19 58.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.537 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -129.12 146.99 50.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.909 0.385 . . . . 0.0 111.274 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.437 ' HG3' ' CE1' ' A' ' 135' ' ' PHE . 1.1 tm-20 -102.05 134.28 45.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.822 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.578 HG21 HD11 ' A' ' 136' ' ' ILE . 8.9 t -124.27 139.81 53.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.908 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 34.5 p -69.4 159.11 33.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.833 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.471 ' HB2' ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -169.48 154.22 5.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.879 -179.941 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.421 HG22 ' N ' ' A' ' 85' ' ' LYS . 14.3 m -101.52 164.05 11.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.95 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.421 ' N ' HG22 ' A' ' 84' ' ' THR . 58.1 mttt -60.74 -52.54 64.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.896 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -64.19 -42.19 96.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.616 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.29 -41.31 88.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.898 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.818 ' CD2' HD11 ' A' ' 122' ' ' ILE . 0.3 OUTLIER -57.71 -38.4 75.2 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.653 179.908 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.436 ' O ' HG22 ' A' ' 92' ' ' ILE . 21.7 mttt -58.88 -42.3 89.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.521 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 18.0 mtpt -77.27 -27.88 53.27 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.897 179.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.416 ' HB2' ' CE2' ' A' ' 83' ' ' PHE . 28.6 t80 -69.23 -45.68 69.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.565 179.544 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.586 HD12 ' CE2' ' A' ' 95' ' ' TYR . 6.1 tp -61.28 -39.92 84.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.071 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.501 ' O ' ' CG ' ' A' ' 97' ' ' LYS . 13.8 ttmt -62.05 -46.95 86.86 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.969 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -71.68 -36.13 70.51 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.13 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.586 ' CE2' HD12 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -78.51 -43.4 26.98 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.641 0.257 . . . . 0.0 110.735 -179.268 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.403 ' HG3' ' N ' ' A' ' 97' ' ' LYS . 0.5 OUTLIER -64.71 -31.83 73.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.841 0.353 . . . . 0.0 110.082 179.004 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.501 ' CG ' ' O ' ' A' ' 93' ' ' LYS . 9.5 mmtm -66.94 -41.37 87.08 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.549 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.7 m -55.26 -41.14 71.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.545 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.519 ' CG1' HD11 ' A' ' 8' ' ' ILE . 7.1 mt -79.78 -41.87 22.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.522 179.497 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 10.2 tttt -54.75 -52.61 61.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.574 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -61.6 -47.15 92.24 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.141 179.519 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 19.5 tptt -60.98 -40.3 92.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.841 0.353 . . . . 0.0 110.366 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.732 HD21 ' CB ' ' A' ' 110' ' ' ARG . 2.4 tp -66.96 -35.53 80.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.14 179.377 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.64 ' CG ' HG11 ' A' ' 111' ' ' VAL . 30.6 mt-10 -58.15 -30.15 66.13 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.607 179.361 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -89.43 -25.1 21.69 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.511 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -100.1 -63.55 1.12 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.858 0.361 . . . . 0.0 111.633 -179.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.441 ' N ' ' O ' ' A' ' 103' ' ' LEU . 16.0 mtm180 -130.43 65.18 75.37 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.882 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.93 ' O ' HG22 ' A' ' 111' ' ' VAL . 10.3 Cg_endo -50.86 -22.29 9.79 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 123.17 2.58 . . . . 0.0 112.831 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -66.97 -13.57 61.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.328 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.732 ' CB ' HD21 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -110.57 0.89 17.8 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.102 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.93 HG22 ' O ' ' A' ' 108' ' ' PRO . 33.9 m -70.05 -33.36 54.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.43 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.579 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 29.8 mtmt -71.1 -49.95 12.12 Favored Pre-proline 0 CA--C 1.53 0.176 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.574 -179.199 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.579 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 25.8 Cg_exo -63.06 -30.46 75.91 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.16 1.906 . . . . 0.0 111.777 179.479 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.459 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 88.6 t80 -72.07 -41.05 67.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.987 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 7.6 mtm -56.54 -47.88 78.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.031 0.443 . . . . 0.0 110.817 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 69.0 m -74.32 -44.36 52.83 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.659 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.27 -38.0 95.5 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.483 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.55 -51.62 68.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.921 0.391 . . . . 0.0 110.838 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.96 -28.11 65.28 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.279 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -74.81 -43.04 56.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.856 0.36 . . . . 0.0 110.982 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.417 ' NE2' ' HB2' ' A' ' 24' ' ' ALA . 3.8 tp-100 -73.31 -32.58 64.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.965 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.818 HD11 ' CD2' ' A' ' 88' ' ' TYR . 0.4 OUTLIER -71.56 -46.01 65.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.322 -179.725 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.456 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 9.2 pttt -61.1 -31.54 71.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.036 0.446 . . . . 0.0 110.358 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 6.5 t-80 -68.32 -53.52 23.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.77 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.822 HG21 HD13 ' A' ' 148' ' ' LEU . 16.2 pt -62.0 -42.49 95.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.304 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.46 ' HA ' HD23 ' A' ' 126' ' ' LEU . 11.7 mt -53.89 -36.99 63.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.879 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -65.46 -15.95 63.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.21 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -136.35 31.43 2.89 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.77 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.513 ' CE1' ' CZ ' ' A' ' 134' ' ' PHE . 1.8 t80 -49.5 -31.66 10.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.96 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 20.1 tptt -61.3 -21.57 64.08 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.162 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 15.0 m-20 -94.08 -47.22 6.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.429 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.479 ' CD2' HG22 ' A' ' 125' ' ' ILE . 1.0 OUTLIER -93.01 150.78 20.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.963 0.411 . . . . 0.0 111.48 -179.449 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.489 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 2.7 mm-40 -126.6 142.95 51.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.317 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.513 ' CZ ' ' CE1' ' A' ' 129' ' ' PHE . 0.1 OUTLIER -82.49 118.27 23.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.928 0.394 . . . . 0.0 110.979 -179.704 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.437 ' CE1' ' HG3' ' A' ' 80' ' ' GLU . 20.9 m-85 -119.8 137.17 54.14 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.753 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.578 HD11 HG21 ' A' ' 81' ' ' THR . 0.8 OUTLIER -120.93 165.43 16.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.842 0.353 . . . . 0.0 110.944 179.933 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -64.59 -166.4 1.19 Allowed Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.539 -0.839 . . . . 0.0 111.981 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.407 ' HB3' ' HB2' ' A' ' 77' ' ' HIS . 12.5 pt-20 -70.98 -9.82 58.64 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.567 0.222 . . . . 0.0 111.38 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 -96.63 -29.83 13.61 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.606 0.241 . . . . 0.0 111.449 -179.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.489 ' HE2' ' HB ' ' A' ' 81' ' ' THR . 18.7 mtp 55.39 48.57 18.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.879 0.371 . . . . 0.0 111.099 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ASN . . . . . 0.413 ' ND2' ' HA3' ' A' ' 144' ' ' GLY . 15.7 p-10 -71.84 114.8 31.89 Favored Pre-proline 0 N--CA 1.451 -0.409 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.917 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 141' ' ' ASN . 22.6 Cg_exo -63.39 -30.65 72.73 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.54 2.16 . . . . 0.0 112.214 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -84.62 -1.44 56.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.354 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.413 ' HA3' ' ND2' ' A' ' 141' ' ' ASN . . . -86.87 -115.72 1.0 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.421 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 10.7 ptp -142.27 -178.89 5.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.59 0.233 . . . . 0.0 110.769 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.504 HG11 ' HB3' ' A' ' 134' ' ' PHE . 0.0 OUTLIER -129.61 139.79 50.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.077 0.465 . . . . 0.0 111.274 179.961 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.671 ' HB2' ' CE1' ' A' ' 162' ' ' PHE . . . -103.09 110.02 21.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.224 179.248 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.822 HD13 HG21 ' A' ' 125' ' ' ILE . 3.8 mt -81.51 106.2 13.28 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.428 -179.051 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.526 HD11 HG21 ' A' ' 70' ' ' VAL . 1.7 tp -90.85 119.6 31.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.074 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.482 ' HB3' ' CE1' ' A' ' 159' ' ' TYR . 31.7 t70 -135.54 164.85 26.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.524 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -102.02 150.8 22.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.915 0.388 . . . . 0.0 111.189 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 16.8 mmm180 -80.59 -175.48 5.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.816 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -54.55 -40.14 68.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.011 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -66.31 -15.17 63.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.205 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 69.66 10.25 63.56 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.745 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 70.1 t -113.47 -68.19 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.843 0.354 . . . . 0.0 110.946 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 96.8 m -54.32 107.8 0.96 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.378 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -83.17 131.52 5.84 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.677 2.251 . . . . 0.0 111.965 179.519 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.482 ' CE1' ' HB3' ' A' ' 150' ' ' ASP . 9.5 p90 -124.1 135.58 53.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.866 0.365 . . . . 0.0 111.059 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' MET . . . . . 0.652 ' HE1' HD13 ' A' ' 78' ' ' LEU . 0.4 OUTLIER -105.09 138.7 40.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.132 -179.706 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.613 HG23 HD11 ' A' ' 23' ' ' ILE . 68.7 mt -94.96 114.41 31.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.147 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.671 ' CE1' ' HB2' ' A' ' 147' ' ' ALA . 96.6 m-85 -118.1 158.19 25.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.692 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -101.71 129.09 47.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.873 0.368 . . . . 0.0 110.803 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.519 ' HB2' HD11 ' A' ' 29' ' ' LEU . 24.3 tttt -70.09 -51.52 31.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.166 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.459 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 59.6 m-20 -52.2 -38.51 58.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.175 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.454 ' HA2' HG23 ' A' ' 99' ' ' ILE . . . -95.73 26.87 18.24 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.459 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.477 HD21 ' HB3' ' A' ' 4' ' ' TYR . 0.6 OUTLIER -144.93 143.84 30.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.778 0.323 . . . . 0.0 110.879 -179.871 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -116.88 156.61 27.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.822 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.655 ' HB3' HD11 ' A' ' 2' ' ' ILE . 3.1 mpp? -115.76 151.02 35.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.052 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -149.29 127.06 11.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.888 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.707 ' HG2' HD12 ' A' ' 2' ' ' ILE . 5.6 mttp -89.18 118.4 28.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.025 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 1.8 m 60.7 157.61 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.037 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.588 ' O ' HD23 ' A' ' 173' ' ' LEU . 3.2 tt -132.68 16.63 4.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.142 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.314 -0.851 . . . . 0.0 111.037 179.902 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.766 HD11 ' HB3' ' A' ' 169' ' ' MET . 5.0 tt . . . . . 0 N--CA 1.456 -0.151 0 CA-C-O 120.755 0.312 . . . . 0.0 110.912 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.526 HG21 ' HB3' ' A' ' 12' ' ' GLU . 13.9 mm -106.78 159.06 6.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.523 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.504 ' CD2' ' CE2' ' A' ' 14' ' ' PHE . 4.9 m-85 -121.27 104.73 9.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.427 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 20.9 ptt180 -118.09 146.77 43.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.9 0.381 . . . . 0.0 111.365 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.553 ' OD1' HD12 ' A' ' 8' ' ' ILE . 47.0 t0 -55.55 152.02 9.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.813 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.454 HD13 ' HG3' ' A' ' 168' ' ' GLU . 49.0 tp -81.6 -18.36 45.03 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.505 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.553 HD12 ' OD1' ' A' ' 6' ' ' ASP . 4.1 mp -91.36 -48.95 13.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -96.63 -17.75 20.19 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -179.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.431 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 36.1 m170 63.18 29.9 15.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.889 0.376 . . . . 0.0 110.71 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -100.4 121.02 40.85 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.661 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.526 ' HB3' HG21 ' A' ' 3' ' ' ILE . 0.2 OUTLIER -58.18 94.84 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.372 -179.726 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 14.7 mtt -72.13 -20.22 61.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.528 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.54 ' CD2' HG21 ' A' ' 31' ' ' VAL . 8.6 p90 -173.07 179.76 2.18 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.325 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -132.74 -170.26 2.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.836 0.35 . . . . 0.0 111.159 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.419 ' HB2' ' CG2' ' A' ' 2' ' ' ILE . 32.2 t70 -96.28 24.69 5.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.068 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.437 HG13 ' CD2' ' A' ' 18' ' ' TYR . 41.8 pt -89.03 -9.54 10.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.72 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.946 ' CZ ' HG22 ' A' ' 72' ' ' ILE . 73.6 m-85 -111.34 177.63 4.6 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.765 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -86.76 90.23 8.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.872 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.411 HD12 ' O ' ' A' ' 18' ' ' TYR . 3.6 mp -87.93 129.27 39.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.94 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 -123.3 121.04 34.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.979 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -73.32 115.79 13.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.768 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.469 HD12 ' NE2' ' A' ' 121' ' ' GLN . 2.8 pt -108.86 171.6 2.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.996 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.657 ' HB2' ' NE2' ' A' ' 121' ' ' GLN . . . 57.95 31.82 21.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.06 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 65.66 46.95 2.27 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.228 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.35 -11.38 63.52 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.756 -0.735 . . . . 0.0 113.345 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.5 ' HB3' ' HB3' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -57.25 -55.22 37.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.905 0.352 . . . . 0.0 111.141 -179.866 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 35.0 m -120.17 167.79 11.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.057 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.6 132.46 44.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.785 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -100.43 112.98 25.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.101 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.54 HG21 ' CD2' ' A' ' 14' ' ' PHE . 33.3 t -90.69 111.97 24.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.387 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -84.04 115.9 22.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.284 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -100.63 -138.96 10.51 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.042 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.8 pttp -174.56 125.55 0.3 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.814 0.34 . . . . 0.0 111.08 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 65.3 mtp -70.95 120.43 16.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.529 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.5 m . . . . . 0 C--N 1.33 -0.278 0 CA-C-O 120.914 0.387 . . . . 0.0 111.54 -179.572 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.375 0 N-CA-C 112.563 -0.215 . . . . 0.0 112.563 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.551 HG12 HG12 ' A' ' 72' ' ' ILE . 47.6 t -71.96 134.14 30.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.847 0.356 . . . . 0.0 110.868 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -61.04 -57.47 12.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.837 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.946 HG22 ' CZ ' ' A' ' 18' ' ' TYR . 10.1 pt -53.61 -33.8 22.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.642 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.799 HG13 ' HB2' ' A' ' 78' ' ' LEU . 90.2 t -71.7 -32.73 46.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.898 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.4 mtm -78.32 -40.29 37.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.554 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.406 ' OD1' ' CD2' ' A' ' 76' ' ' HIS . 16.9 p30 -82.11 -29.92 31.47 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.829 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.44 ' CE1' ' HB ' ' A' ' 72' ' ' ILE . 27.4 m170 -91.94 -2.54 56.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.808 0.337 . . . . 0.0 110.914 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 28.1 m-70 57.29 34.08 24.24 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.808 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.799 ' HB2' HG13 ' A' ' 73' ' ' VAL . 29.7 mt -55.43 148.63 14.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.865 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -128.35 128.02 43.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.922 0.392 . . . . 0.0 110.897 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.411 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 1.4 tt0 -89.9 122.16 32.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.075 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.3 t -108.6 178.88 4.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.817 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 50.5 p -115.85 163.77 15.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.004 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.457 ' CE2' ' CE2' ' A' ' 91' ' ' TYR . 0.6 OUTLIER -171.64 153.87 3.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.806 -179.973 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 13.0 p -101.44 176.34 5.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.969 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.67 -52.55 24.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.944 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -65.36 -41.83 93.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.702 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.29 -38.42 83.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.027 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.865 ' CD2' HD11 ' A' ' 122' ' ' ILE . 0.6 OUTLIER -61.97 -36.76 82.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.673 179.936 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.405 ' O ' HG22 ' A' ' 92' ' ' ILE . 17.5 mttm -57.68 -46.41 84.33 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.064 0.459 . . . . 0.0 110.225 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.62 -27.95 55.93 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.64 178.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.57 ' HE2' HG21 ' A' ' 146' ' ' VAL . 2.8 t80 -66.15 -44.94 82.7 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.745 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.54 HD12 ' CE2' ' A' ' 95' ' ' TYR . 3.9 tp -62.08 -45.61 98.34 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.752 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.417 ' HA ' ' HG2' ' A' ' 96' ' ' MET . 15.0 ttpt -60.51 -37.95 82.78 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.883 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.513 ' HA ' ' HG2' ' A' ' 97' ' ' LYS . 31.3 t70 -74.67 -42.57 58.22 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.841 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.54 ' CE2' HD12 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -77.05 -40.26 46.95 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.999 -0.281 . . . . 0.0 111.065 -179.35 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.432 ' HG2' ' O ' ' A' ' 92' ' ' ILE . 8.8 ptt? -66.23 -32.11 73.33 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.855 0.36 . . . . 0.0 110.298 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.513 ' HG2' ' HA ' ' A' ' 94' ' ' ASP . 4.2 ptmt -70.48 -33.74 71.59 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.529 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.493 ' N ' ' HG3' ' A' ' 97' ' ' LYS . 1.8 m -63.92 -40.1 95.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.266 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.41 HG23 ' HA2' ' A' ' 166' ' ' GLY . 8.4 mt -79.76 -41.47 21.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.211 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.9 tmtt? -56.95 -52.1 66.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.266 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -59.21 -48.02 87.97 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.002 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.1 tppm? -62.79 -38.75 91.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.981 0.42 . . . . 0.0 110.122 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.548 ' HB3' HG12 ' A' ' 111' ' ' VAL . 14.3 tp -67.95 -36.87 80.84 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.975 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.482 ' CG ' HG11 ' A' ' 111' ' ' VAL . 36.0 mt-10 -55.96 -32.38 63.81 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.752 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -85.61 -19.99 30.18 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.567 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -105.18 -62.95 1.28 Allowed 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.773 0.32 . . . . 0.0 111.517 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.455 ' N ' ' O ' ' A' ' 103' ' ' LEU . 16.5 mmt180 -129.36 64.42 71.2 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.844 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.895 ' O ' HG22 ' A' ' 111' ' ' VAL . 9.6 Cg_endo -50.64 -24.02 12.12 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 123.01 2.473 . . . . 0.0 112.596 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -74.13 -9.02 58.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.1 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.425 ' C ' ' HD2' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -108.79 -1.71 19.08 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.5 -179.683 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.895 HG22 ' O ' ' A' ' 108' ' ' PRO . 27.6 m -72.13 -26.96 25.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.713 0.292 . . . . 0.0 111.299 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.601 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 0.8 OUTLIER -68.47 -56.03 10.92 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.37 -179.398 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.601 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 41.6 Cg_exo -55.67 -40.76 83.4 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 121.921 1.747 . . . . 0.0 111.641 179.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.434 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 56.9 t80 -62.02 -39.9 93.86 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.866 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 4.4 mmm -59.7 -45.3 92.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.829 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 63.1 m -74.82 -44.65 48.14 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.876 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -66.18 -39.44 94.53 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.938 -0.648 . . . . 0.0 112.688 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.63 -51.7 68.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.943 0.401 . . . . 0.0 111.074 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.51 ' HB1' ' HE3' ' A' ' 123' ' ' LYS . . . -66.68 -28.11 68.19 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.37 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -75.39 -57.14 4.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.229 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.657 ' NE2' ' HB2' ' A' ' 24' ' ' ALA . 2.0 tp-100 -58.44 -43.09 88.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.278 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.865 HD11 ' CD2' ' A' ' 88' ' ' TYR . 0.3 OUTLIER -58.79 -46.33 90.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.269 -179.801 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.51 ' HE3' ' HB1' ' A' ' 119' ' ' ALA . 25.6 mttt -60.43 -31.52 70.5 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.262 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -67.39 -54.33 21.43 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.715 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.926 HG21 HD13 ' A' ' 148' ' ' LEU . 11.8 pt -61.59 -41.05 88.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.149 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 126' ' ' LEU . 11.1 mt -53.88 -35.96 62.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.761 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -68.6 -11.52 60.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.357 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -136.3 32.31 2.85 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.934 0.397 . . . . 0.0 110.522 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -48.23 -32.73 7.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.253 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -69.18 -24.35 64.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.274 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 21.5 m-20 -94.06 -36.43 12.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.419 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.418 ' CE1' ' OD2' ' A' ' 150' ' ' ASP . 3.5 m-85 -92.23 141.39 28.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.175 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.2 mm100 -121.35 145.74 47.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.877 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.453 ' CE2' ' HB2' ' A' ' 83' ' ' PHE . 2.9 m-85 -83.24 125.25 31.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.169 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.46 ' HB2' ' HB3' ' A' ' 147' ' ' ALA . 32.9 m-85 -127.5 150.16 49.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.679 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.446 ' HB ' ' HA ' ' A' ' 140' ' ' MET . 0.7 OUTLIER -140.05 159.97 26.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.719 179.893 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -57.57 -168.81 0.13 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.562 -0.828 . . . . 0.0 111.94 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -71.59 -8.9 56.92 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.622 0.248 . . . . 0.0 111.402 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 -94.09 -31.25 14.27 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.62 -0.263 . . . . 0.0 111.493 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . 0.446 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 77.7 mtm 58.87 49.95 9.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.821 0.343 . . . . 0.0 111.017 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . 0.43 ' ND2' ' HA3' ' A' ' 144' ' ' GLY . 14.3 p-10 -72.11 114.62 30.8 Favored Pre-proline 0 N--CA 1.452 -0.357 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.987 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -64.98 -29.25 57.55 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.642 2.228 . . . . 0.0 112.288 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -84.59 -3.28 58.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.336 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.43 ' HA3' ' ND2' ' A' ' 141' ' ' ASN . . . -90.61 -155.17 31.07 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.535 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 2.8 ptp -94.75 -176.97 4.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.814 0.34 . . . . 0.0 110.895 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.57 HG21 ' HE2' ' A' ' 91' ' ' TYR . 53.4 t -128.97 151.13 35.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.085 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.691 ' HB1' ' HE3' ' A' ' 160' ' ' MET . . . -111.71 115.85 29.77 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.67 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.926 HD13 HG21 ' A' ' 125' ' ' ILE . 4.6 mt -92.26 106.24 18.28 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.96 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.502 HD12 ' HG2' ' A' ' 160' ' ' MET . 1.8 tp -89.29 119.63 29.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.248 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.449 ' HB3' ' CE1' ' A' ' 159' ' ' TYR . 0.6 OUTLIER -133.12 172.52 12.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.701 179.658 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -116.01 140.84 48.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.763 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 19.2 mmm180 -55.56 -178.66 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.115 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.23 -31.59 53.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.018 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 37.4 p30 -76.69 -15.2 59.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.104 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 71.27 17.47 75.99 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.708 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 93.9 t -111.89 -65.75 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.817 0.342 . . . . 0.0 110.846 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 35.8 m -56.95 109.17 1.53 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.097 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -82.17 122.85 3.83 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.522 2.148 . . . . 0.0 112.406 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.449 ' CE1' ' HB3' ' A' ' 150' ' ' ASP . 12.7 p90 -123.49 146.71 47.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.772 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' MET . . . . . 0.691 ' HE3' ' HB1' ' A' ' 147' ' ' ALA . 1.1 mtm -112.22 142.53 44.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.949 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.527 ' HB ' ' HB2' ' A' ' 148' ' ' LEU . 46.0 mt -95.45 117.58 39.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.226 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.443 ' CZ ' ' HE3' ' A' ' 160' ' ' MET . 48.4 m-85 -116.34 152.48 33.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.837 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.505 ' CE2' ' CZ ' ' A' ' 95' ' ' TYR . 11.5 m-85 -97.16 120.4 37.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.885 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 9.9 ttpt -65.26 -50.12 66.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.023 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.434 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 52.8 m-20 -57.69 -30.74 65.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.96 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.41 ' HA2' HG23 ' A' ' 99' ' ' ILE . . . -104.72 26.3 22.94 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.446 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.453 HD21 ' HB3' ' A' ' 4' ' ' TYR . 1.1 tt -142.69 142.23 31.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.759 0.314 . . . . 0.0 110.911 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.454 ' HG3' HD13 ' A' ' 7' ' ' LEU . 1.1 mt-10 -116.66 159.51 22.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.928 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . 0.766 ' HB3' HD11 ' A' ' 2' ' ' ILE . 0.1 OUTLIER -115.48 159.96 20.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.776 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.908 -179.974 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.788 HD11 ' HB3' ' A' ' 169' ' ' MET . 3.2 tt . . . . . 0 N--CA 1.456 -0.138 0 CA-C-O 120.848 0.356 . . . . 0.0 110.945 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 21.5 mm -99.64 154.02 4.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.292 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.609 ' HE1' HG23 ' A' ' 2' ' ' ILE . 3.3 m-85 -123.67 110.06 14.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.602 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.57 145.78 49.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.906 0.384 . . . . 0.0 111.282 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.457 ' O ' ' HA ' ' A' ' 10' ' ' HIS . 44.3 t0 -55.68 152.17 9.83 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.862 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.547 HD23 HG23 ' A' ' 99' ' ' ILE . 57.3 tp -80.2 -23.5 40.91 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.305 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.758 HD11 ' CG1' ' A' ' 99' ' ' ILE . 4.3 mp -91.3 -45.48 14.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.26 -21.24 19.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.799 -179.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.457 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 14.5 m170 61.78 27.89 17.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.809 0.337 . . . . 0.0 110.731 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -100.77 122.15 42.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.751 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -56.93 89.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.366 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.407 ' O ' ' CD2' ' A' ' 76' ' ' HIS . 25.2 mtt -67.53 -19.24 65.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.644 179.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.512 ' CZ ' ' CD2' ' A' ' 4' ' ' TYR . 12.5 p90 -177.64 175.87 1.32 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.817 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.28 -169.92 2.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.734 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.411 ' HA ' ' CD1' ' A' ' 20' ' ' ILE . 19.0 t0 -95.76 31.87 1.98 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.148 0.499 . . . . 0.0 110.817 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.413 HG13 ' CD2' ' A' ' 18' ' ' TYR . 35.6 pt -89.66 -13.41 9.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.437 178.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.748 ' CZ ' HG22 ' A' ' 72' ' ' ILE . 61.3 m-85 -110.07 178.92 4.25 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.463 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.408 ' HB2' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -86.43 91.55 8.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.75 179.828 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.51 HD12 ' O ' ' A' ' 18' ' ' TYR . 4.2 mp -88.35 135.61 25.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.178 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 10.7 mtm180 -129.26 117.67 21.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.015 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -71.07 116.33 11.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.71 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.558 HD11 HG23 ' A' ' 161' ' ' ILE . 2.9 pt -109.5 171.07 2.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.162 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.491 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . . . 57.91 30.97 19.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.178 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 66.56 42.56 2.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.095 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.89 -17.48 54.97 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.996 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.491 ' HB3' ' HB3' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -51.13 -49.37 60.94 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.852 0.358 . . . . 0.0 111.168 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 6.7 m -128.48 167.07 17.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.727 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.629 HD11 ' CD ' ' A' ' 164' ' ' LYS . 1.1 mt -129.37 135.08 48.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.878 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -99.62 112.78 24.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.8 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 159' ' ' TYR . 22.0 t -94.24 111.75 25.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.541 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.408 ' HB2' ' HB2' ' A' ' 19' ' ' LYS . 9.2 mt-10 -86.53 110.57 19.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.357 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -92.91 -134.21 6.76 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.212 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 9.3 ptpt -174.49 123.23 0.28 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.802 0.334 . . . . 0.0 111.023 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 15.1 mtt -67.16 121.54 15.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.641 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.4 m . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.495 -179.696 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 N-CA-C 112.401 -0.28 . . . . 0.0 112.401 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.462 HG21 HD11 ' A' ' 149' ' ' LEU . 48.4 t -72.34 140.54 17.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.806 0.336 . . . . 0.0 110.967 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.411 ' O ' ' ND2' ' A' ' 75' ' ' ASN . 35.4 t70 -67.75 -59.63 3.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.363 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.748 HG22 ' CZ ' ' A' ' 18' ' ' TYR . 10.3 pt -53.62 -34.44 24.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.594 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.781 HG13 ' HB2' ' A' ' 78' ' ' LEU . 58.7 t -71.18 -33.04 49.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.826 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.6 mtm -78.25 -40.03 38.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.62 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.411 ' ND2' ' O ' ' A' ' 71' ' ' ASP . 15.3 p30 -82.02 -28.44 32.54 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.582 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.438 ' CD2' ' HB ' ' A' ' 72' ' ' ILE . 8.1 m-70 -91.49 -0.77 57.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.928 0.394 . . . . 0.0 110.753 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 10.7 m170 57.61 28.14 15.23 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.131 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.781 ' HB2' HG13 ' A' ' 73' ' ' VAL . 57.1 mt -56.82 137.98 54.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.371 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -122.12 137.01 54.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.973 0.416 . . . . 0.0 111.271 -179.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.423 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 1.5 tt0 -92.09 130.64 37.77 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.961 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.58 HG21 HD11 ' A' ' 136' ' ' ILE . 1.3 t -117.77 165.62 13.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.83 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 40.3 m -96.17 161.39 13.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.963 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.477 ' HB2' ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -171.7 149.94 2.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.013 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -101.54 164.76 11.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.906 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.11 -52.48 65.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.992 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -65.62 -44.9 85.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.785 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.79 -37.61 76.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.07 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.868 ' CD2' HD11 ' A' ' 122' ' ' ILE . 0.5 OUTLIER -62.96 -35.79 81.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.799 179.9 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.405 ' O ' HG22 ' A' ' 92' ' ' ILE . 52.8 mttt -59.61 -43.65 93.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.475 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.5 tttt -77.72 -27.91 50.72 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.75 178.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.56 ' HE2' HG21 ' A' ' 146' ' ' VAL . 7.8 t80 -67.75 -46.84 70.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.702 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.625 HD12 ' CE2' ' A' ' 95' ' ' TYR . 5.8 tp -60.49 -42.73 92.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 CA-C-O 120.84 0.352 . . . . 0.0 110.668 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.453 ' O ' ' HB3' ' A' ' 97' ' ' LYS . 7.9 ttpp -63.94 -39.73 94.83 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.799 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.453 ' O ' ' HG3' ' A' ' 97' ' ' LYS . 29.1 t70 -75.85 -37.99 58.42 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.769 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.625 ' CE2' HD12 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -78.46 -42.78 28.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.607 0.242 . . . . 0.0 110.619 -179.736 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.412 ' HG3' ' N ' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -67.53 -32.09 72.64 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.035 179.569 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.453 ' HB3' ' O ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -70.91 -34.5 71.6 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.899 0.38 . . . . 0.0 110.656 179.807 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.27 -41.03 96.26 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.152 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.758 ' CG1' HD11 ' A' ' 8' ' ' ILE . 9.3 mt -79.81 -41.16 21.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.488 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.8 tttt -55.57 -53.16 59.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.462 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -60.64 -46.97 93.4 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.162 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.9 tppt? -62.5 -37.94 87.98 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.878 0.37 . . . . 0.0 110.403 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.73 HD21 ' CB ' ' A' ' 110' ' ' ARG . 3.4 tp -69.55 -34.24 73.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.032 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.672 ' HG3' HG11 ' A' ' 111' ' ' VAL . 29.4 mt-10 -59.19 -30.99 68.6 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.691 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.424 ' HG3' ' HG3' ' A' ' 106' ' ' GLN . 0.8 OUTLIER -87.38 -20.17 27.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.707 -179.646 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.537 HE22 HD11 ' A' ' 7' ' ' LEU . 21.4 mt-30 -107.36 -62.3 1.44 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.833 0.349 . . . . 0.0 111.593 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 103' ' ' LEU . 22.0 mtm180 -128.03 63.52 62.27 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.92 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.912 ' O ' HG22 ' A' ' 111' ' ' VAL . 10.0 Cg_endo -50.74 -21.24 7.82 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 123.144 2.562 . . . . 0.0 112.965 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -72.04 -9.22 58.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.584 0.23 . . . . 0.0 111.433 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.73 ' CB ' HD21 ' A' ' 103' ' ' LEU . 19.0 mmt85 -112.12 -1.27 15.34 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.64 -0.255 . . . . 0.0 111.677 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.912 HG22 ' O ' ' A' ' 108' ' ' PRO . 33.8 m -71.33 -32.54 47.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.547 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 15.5 mttm -69.81 -49.95 18.98 Favored Pre-proline 0 CA--C 1.53 0.192 0 C-N-CA 121.047 -0.261 . . . . 0.0 111.57 -179.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.547 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 31.4 Cg_exo -58.98 -36.13 97.35 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.183 1.922 . . . . 0.0 111.936 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.455 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 89.9 t80 -71.09 -35.38 71.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.923 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 10.8 mtp -58.61 -52.44 65.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.761 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 63.0 m -73.89 -44.06 56.49 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.552 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.58 -38.71 96.29 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.391 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.99 -51.6 68.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.002 0.429 . . . . 0.0 110.961 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.08 -28.22 65.25 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.129 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -75.88 -44.01 42.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.009 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -71.34 -38.12 71.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.001 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.868 HD11 ' CD2' ' A' ' 88' ' ' TYR . 0.4 OUTLIER -63.89 -46.82 93.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.269 -179.916 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.448 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 6.1 ptmt -60.72 -31.07 70.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.338 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -66.49 -52.37 46.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.996 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.67 HG21 HD13 ' A' ' 148' ' ' LEU . 11.9 pt -65.3 -40.44 88.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.283 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 11.9 mt -53.88 -35.5 61.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.882 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -72.75 -9.9 59.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.3 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -142.93 32.1 1.4 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.985 0.422 . . . . 0.0 110.615 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.495 ' CE1' ' CZ ' ' A' ' 134' ' ' PHE . 5.9 t80 -51.49 -25.32 6.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.22 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 5.7 tttp -62.74 -29.2 70.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.744 0.307 . . . . 0.0 110.915 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 32.8 m-20 -94.09 -39.17 10.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.263 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -89.87 145.59 25.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.086 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 -132.55 145.37 51.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.147 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.495 ' CZ ' ' CE1' ' A' ' 129' ' ' PHE . 1.4 m-85 -78.27 124.78 28.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.858 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.423 ' CE2' ' HB2' ' A' ' 80' ' ' GLU . 38.0 m-85 -129.9 135.96 48.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.767 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.58 HD11 HG21 ' A' ' 81' ' ' THR . 0.6 OUTLIER -120.99 159.65 22.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.858 179.905 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.68 -165.69 0.38 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.215 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -71.78 -8.93 57.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.573 0.225 . . . . 0.0 111.502 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 -96.97 -28.29 14.24 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . 0.435 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 62.0 mtm 55.37 37.71 29.28 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.853 0.359 . . . . 0.0 110.93 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . 0.41 ' ND2' ' HA3' ' A' ' 144' ' ' GLY . 16.7 p-10 -61.87 115.25 14.43 Favored Pre-proline 0 N--CA 1.451 -0.386 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.933 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.21 -30.64 91.71 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.498 2.132 . . . . 0.0 112.183 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -84.59 -3.14 58.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.102 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.41 ' HA3' ' ND2' ' A' ' 141' ' ' ASN . . . -87.24 -169.29 45.6 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.472 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 2.3 ptp -86.58 -176.5 5.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.728 0.299 . . . . 0.0 110.91 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.56 HG21 ' HE2' ' A' ' 91' ' ' TYR . 48.9 t -128.17 148.85 32.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.962 0.41 . . . . 0.0 111.164 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.569 ' HB1' ' SD ' ' A' ' 160' ' ' MET . . . -111.64 115.2 28.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.599 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.67 HD13 HG21 ' A' ' 125' ' ' ILE . 3.2 mt -89.77 106.28 18.36 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.332 -179.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.462 HD11 HG21 ' A' ' 70' ' ' VAL . 4.1 tp -88.83 121.15 30.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.922 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.453 ' HB3' ' CZ ' ' A' ' 159' ' ' TYR . 31.2 t70 -134.67 164.01 28.48 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.547 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -110.36 148.52 31.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.051 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.66 -178.01 0.66 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.826 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -61.48 -31.07 71.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.94 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -84.66 -15.03 46.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.289 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 64.59 27.55 72.04 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.468 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 77.9 t -110.06 -42.47 5.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.846 0.355 . . . . 0.0 111.044 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 96.2 m -100.33 106.76 44.25 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.327 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.72 130.74 12.81 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.385 2.057 . . . . 0.0 111.609 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.453 ' CZ ' ' HB3' ' A' ' 150' ' ' ASP . 6.1 p90 -127.09 146.43 50.38 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.913 0.387 . . . . 0.0 111.18 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' MET . . . . . 0.713 ' CE ' HD13 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -113.12 145.4 40.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.041 -179.827 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.558 HG23 HD11 ' A' ' 23' ' ' ILE . 59.7 mt -101.78 110.61 29.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.267 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.515 ' CE1' ' HB2' ' A' ' 147' ' ' ALA . 52.2 m-85 -110.93 154.0 24.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.523 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -102.14 115.14 29.92 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.944 0.402 . . . . 0.0 110.861 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.629 ' CD ' HD11 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -58.94 -46.5 87.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.168 -179.655 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.455 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 56.5 m-20 -51.56 -31.84 25.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.987 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -106.45 25.99 21.42 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.395 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.525 HD21 ' HB3' ' A' ' 4' ' ' TYR . 0.6 OUTLIER -139.88 146.93 39.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.821 0.343 . . . . 0.0 110.941 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.23 150.79 29.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.843 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . 0.788 ' HB3' HD11 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -121.59 142.92 49.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.986 -179.976 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.948 179.955 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.738 HD11 ' HB3' ' A' ' 169' ' ' MET . 3.5 tt . . . . . 0 N--CA 1.457 -0.097 0 CA-C-O 120.806 0.336 . . . . 0.0 110.952 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.419 HG22 ' N ' ' A' ' 4' ' ' TYR . 29.3 mm -99.72 155.04 4.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.374 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.58 ' CE1' HG23 ' A' ' 2' ' ' ILE . 4.6 m-85 -124.43 107.29 10.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.669 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -123.8 144.93 49.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.153 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.58 ' OD1' HD12 ' A' ' 8' ' ' ILE . 42.5 t0 -54.88 140.62 36.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.856 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 43.1 tp -72.31 -20.29 61.52 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.362 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.58 HD12 ' OD1' ' A' ' 6' ' ' ASP . 4.1 mp -91.39 -46.3 14.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.51 -18.38 19.86 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -179.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.402 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 4.1 m80 62.2 29.28 17.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.864 0.364 . . . . 0.0 110.756 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -101.94 118.36 36.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.762 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -56.79 94.07 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.377 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 9.8 mtt -71.7 -19.24 62.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.695 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.501 ' CZ ' ' CD2' ' A' ' 4' ' ' TYR . 9.4 p90 -177.15 175.84 1.47 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.821 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.86 -171.13 2.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.593 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.409 ' HA ' ' CD1' ' A' ' 20' ' ' ILE . 21.1 t0 -95.52 36.24 1.28 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.113 0.482 . . . . 0.0 110.785 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.44 HG13 ' CD2' ' A' ' 18' ' ' TYR . 37.4 pt -94.5 -11.77 8.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.571 179.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.89 ' CZ ' HG22 ' A' ' 72' ' ' ILE . 43.5 m-85 -109.41 -166.85 1.14 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.573 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.7 mtpp -98.96 89.46 4.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.838 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.409 ' CD1' ' HA ' ' A' ' 16' ' ' ASP . 3.8 mp -88.03 124.68 41.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.881 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 11.0 mtp180 -115.78 121.16 41.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.158 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.515 ' HG3' HD23 ' A' ' 29' ' ' LEU . 5.1 mt-10 -74.0 116.36 14.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.803 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.457 HD11 HG23 ' A' ' 161' ' ' ILE . 5.1 pt -116.08 171.51 5.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.19 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.512 ' HB2' ' NE2' ' A' ' 121' ' ' GLN . . . 56.58 33.45 22.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.167 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 64.57 38.32 7.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.249 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.74 -13.84 66.6 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.737 -0.744 . . . . 0.0 113.113 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.806 HD21 ' HA ' ' A' ' 114' ' ' PHE . 0.1 OUTLIER -53.57 -48.09 69.48 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.749 0.309 . . . . 0.0 111.368 -179.885 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 18.8 m -126.0 167.27 15.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.272 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.831 HD21 ' HD2' ' A' ' 164' ' ' LYS . 0.3 OUTLIER -130.8 123.83 30.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.76 179.932 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -92.0 112.8 24.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.885 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.2 t -100.63 111.91 31.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.956 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -87.6 118.77 27.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.029 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -99.9 -128.49 6.3 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.299 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.48 125.89 0.31 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.856 0.36 . . . . 0.0 110.903 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 81.4 mtp -73.21 119.42 17.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.941 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.9 m . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.152 179.944 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.45 0 N-CA-C 112.321 -0.312 . . . . 0.0 112.321 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.728 HG22 ' HG3' ' A' ' 158' ' ' PRO . 51.0 t -71.29 148.66 10.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.775 0.322 . . . . 0.0 110.793 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -73.8 -56.35 5.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.453 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.89 HG22 ' CZ ' ' A' ' 18' ' ' TYR . 11.2 pt -53.72 -33.97 23.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.349 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.789 HG13 ' HB2' ' A' ' 78' ' ' LEU . 59.7 t -71.6 -33.57 49.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.812 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.8 mtt -78.47 -39.6 37.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.693 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.2 p30 -82.04 -28.46 32.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.545 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.416 ' CG ' ' O ' ' A' ' 72' ' ' ILE . 7.2 m-70 -90.28 -2.59 58.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.845 0.355 . . . . 0.0 110.582 179.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.455 ' HB2' ' HB3' ' A' ' 138' ' ' GLU . 8.9 m-70 59.87 28.24 17.7 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.892 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.789 ' HB2' HG13 ' A' ' 73' ' ' VAL . 64.2 mt -58.55 144.51 42.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.555 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -128.63 138.06 51.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.891 0.377 . . . . 0.0 111.251 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.412 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 18.4 tt0 -92.84 123.28 36.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.04 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.411 HG21 HD11 ' A' ' 136' ' ' ILE . 10.4 t -108.97 165.05 11.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.76 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.5 m -95.44 160.5 14.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.874 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.503 ' CE2' ' CE2' ' A' ' 91' ' ' TYR . 0.6 OUTLIER -171.66 148.56 2.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.908 -179.884 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.52 167.09 10.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.791 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.66 -52.43 64.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.896 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -63.39 -43.71 96.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.916 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.77 -36.61 79.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.156 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.952 ' CD2' HD11 ' A' ' 122' ' ' ILE . 0.2 OUTLIER -64.16 -33.82 76.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.833 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 23.4 mttt -61.62 -45.33 94.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.012 0.434 . . . . 0.0 110.369 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.55 -27.9 45.94 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.834 178.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.576 ' HE2' HG21 ' A' ' 146' ' ' VAL . 12.6 t80 -67.77 -47.09 70.18 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.848 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.861 HG22 ' O ' ' A' ' 88' ' ' TYR . 1.6 tp -62.46 -41.61 92.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.828 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.425 ' O ' ' CG ' ' A' ' 97' ' ' LYS . 17.5 ttmt -59.07 -46.36 88.47 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.045 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -66.42 -43.75 84.85 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.149 -179.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.541 ' CD1' ' C ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -73.24 -42.46 62.54 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.943 -179.088 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 23.0 ptm -61.0 -32.16 71.74 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.303 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.425 ' CG ' ' O ' ' A' ' 93' ' ' LYS . 6.4 mmtp -66.91 -43.91 82.13 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.511 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.2 m -56.19 -41.37 75.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.735 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.7 mt -79.79 -41.7 21.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.701 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 13.2 tttt -53.76 -56.29 18.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.532 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -59.97 -45.2 96.3 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.189 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.03 -41.93 97.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.903 0.383 . . . . 0.0 110.378 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.599 ' HB3' HG12 ' A' ' 111' ' ' VAL . 9.2 tp -66.36 -34.2 77.43 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.259 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.665 ' CG ' HG11 ' A' ' 111' ' ' VAL . 31.3 mt-10 -60.11 -29.07 68.37 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.617 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -88.19 -18.76 28.01 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.548 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -107.05 -58.49 1.93 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.775 0.322 . . . . 0.0 111.693 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.444 ' N ' ' O ' ' A' ' 103' ' ' LEU . 46.1 mtt180 -134.04 66.4 71.81 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.809 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.888 ' O ' HG22 ' A' ' 111' ' ' VAL . 9.1 Cg_endo -50.46 -22.68 9.3 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 123.141 2.561 . . . . 0.0 112.729 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -73.68 -9.3 58.53 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.735 0.302 . . . . 0.0 111.176 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.503 ' C ' ' HD2' ' A' ' 113' ' ' PRO . 3.0 mmt180 -110.91 -0.16 16.91 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.616 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.888 HG22 ' O ' ' A' ' 108' ' ' PRO . 32.9 m -72.67 -33.43 44.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.603 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 13.9 mttt -66.87 -50.38 43.7 Favored Pre-proline 0 C--N 1.331 -0.21 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.555 -179.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.603 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 32.8 Cg_exo -59.05 -39.36 80.88 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 121.967 1.778 . . . . 0.0 111.724 179.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.806 ' HA ' HD21 ' A' ' 27' ' ' LEU . 67.3 t80 -64.25 -37.89 89.1 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.887 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 4.1 mmm -58.57 -50.13 74.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.728 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 66.4 m -74.33 -44.34 52.92 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.742 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.47 -40.0 98.31 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.516 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.42 -51.55 69.34 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.006 0.431 . . . . 0.0 110.948 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.6 -31.42 65.17 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.088 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -72.12 -41.33 67.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.106 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.512 ' NE2' ' HB2' ' A' ' 24' ' ' ALA . 7.7 tp-100 -73.53 -36.71 65.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.078 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.952 HD11 ' CD2' ' A' ' 88' ' ' TYR . 0.4 OUTLIER -67.12 -46.08 85.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.247 -179.765 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.451 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 1.2 ptpm? -61.42 -31.41 71.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.083 0.468 . . . . 0.0 110.223 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -67.1 -53.66 28.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.705 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.59 HG21 HD13 ' A' ' 148' ' ' LEU . 15.0 pt -62.28 -41.71 92.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.249 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.466 HD23 ' HA ' ' A' ' 126' ' ' LEU . 12.3 mt -53.85 -35.85 61.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.922 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -68.05 -13.82 62.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.14 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -139.98 32.37 1.97 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.011 0.434 . . . . 0.0 110.628 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.514 ' CE1' ' CZ ' ' A' ' 134' ' ' PHE . 2.8 t80 -49.47 -28.87 5.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.096 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.49 -27.04 65.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.986 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -94.22 -35.97 12.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.476 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -94.44 140.52 29.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.923 0.392 . . . . 0.0 111.373 -179.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.406 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 2.2 mm100 -124.13 145.49 49.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.805 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.514 ' CZ ' ' CE1' ' A' ' 129' ' ' PHE . 0.5 OUTLIER -80.47 123.87 28.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.069 -179.787 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.54 ' HB2' ' HB3' ' A' ' 147' ' ' ALA . 36.6 m-85 -126.76 151.94 47.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.499 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.412 ' CG2' ' HA ' ' A' ' 140' ' ' MET . 1.0 OUTLIER -138.7 160.04 30.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.001 179.863 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.05 -159.25 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.2 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.455 ' HB3' ' HB2' ' A' ' 77' ' ' HIS . 5.7 pt-20 -76.79 -8.77 57.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.609 0.242 . . . . 0.0 111.436 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 20.4 m-80 -96.58 -29.75 13.68 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . 0.412 ' HA ' ' CG2' ' A' ' 136' ' ' ILE . 31.1 mtm 57.44 37.73 27.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.907 0.384 . . . . 0.0 110.854 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . 0.423 ' ND2' ' HA3' ' A' ' 144' ' ' GLY . 15.0 p-10 -66.22 115.01 19.45 Favored Pre-proline 0 N--CA 1.452 -0.352 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.164 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 141' ' ' ASN . 23.3 Cg_exo -62.73 -28.96 76.75 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.505 2.137 . . . . 0.0 112.17 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -84.55 -3.9 58.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.148 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.423 ' HA3' ' ND2' ' A' ' 141' ' ' ASN . . . -87.05 -146.52 10.5 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.381 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.425 ' HE3' ' O ' ' A' ' 166' ' ' GLY . 2.3 ptp -104.9 179.86 4.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.765 0.317 . . . . 0.0 110.768 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.576 HG21 ' HE2' ' A' ' 91' ' ' TYR . 43.7 t -128.98 149.31 33.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.136 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.54 ' HB3' ' HB2' ' A' ' 135' ' ' PHE . . . -111.75 115.86 29.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.663 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.59 HD13 HG21 ' A' ' 125' ' ' ILE . 4.6 mt -90.57 106.14 18.3 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.86 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.49 HD11 HG21 ' A' ' 70' ' ' VAL . 5.2 tp -88.56 120.64 30.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.192 -179.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.456 ' HB3' ' CE1' ' A' ' 159' ' ' TYR . 47.9 t0 -138.06 164.35 29.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.442 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -105.98 146.99 29.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.889 0.376 . . . . 0.0 111.026 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.71 -177.66 0.62 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.863 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -60.46 -41.21 93.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.858 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -79.19 -15.11 58.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.16 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 60.51 33.79 83.0 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.537 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 91.2 t -107.08 -24.08 4.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.78 0.324 . . . . 0.0 111.039 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.4 t -132.22 124.23 19.24 Favored Pre-proline 0 CA--C 1.531 0.241 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.136 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.728 ' HG3' HG22 ' A' ' 70' ' ' VAL . 93.7 Cg_endo -79.93 135.42 11.21 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.529 2.152 . . . . 0.0 112.079 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.456 ' CE1' ' HB3' ' A' ' 150' ' ' ASP . 8.0 p90 -124.61 136.02 53.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.862 0.363 . . . . 0.0 111.016 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' MET . . . . . 0.642 ' HG3' HD11 ' A' ' 72' ' ' ILE . 24.7 mtp -104.43 140.51 37.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.958 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.495 ' HB ' ' HB2' ' A' ' 148' ' ' LEU . 53.1 mt -99.67 113.67 35.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.16 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -110.15 158.14 18.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.705 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.413 ' CZ ' ' OH ' ' A' ' 95' ' ' TYR . 24.2 m-85 -99.18 114.64 27.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.852 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.831 ' HD2' HD21 ' A' ' 29' ' ' LEU . 33.0 tttm -57.98 -51.9 67.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.136 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.43 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 37.8 m-20 -54.55 -35.63 63.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.038 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.425 ' O ' ' HE3' ' A' ' 145' ' ' MET . . . -96.94 28.51 13.46 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.397 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.429 HD11 ' HB3' ' A' ' 4' ' ' TYR . 1.0 OUTLIER -147.34 143.6 28.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.878 0.37 . . . . 0.0 110.801 -179.911 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -105.11 162.58 13.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.803 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . 0.738 ' HB3' HD11 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -134.31 138.32 44.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.976 179.934 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.845 -179.953 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.765 HD11 ' HB3' ' A' ' 169' ' ' MET . 2.4 tt . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.837 0.351 . . . . 0.0 111.008 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.477 HG21 ' HB3' ' A' ' 12' ' ' GLU . 21.2 mm -101.77 157.88 4.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.353 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.566 ' HE1' HG23 ' A' ' 2' ' ' ILE . 5.5 m-85 -126.58 95.22 4.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.423 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 10.0 ptt180 -110.67 148.59 31.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.955 0.407 . . . . 0.0 111.183 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.443 ' O ' ' HA ' ' A' ' 10' ' ' HIS . 31.8 t0 -56.96 152.2 13.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.741 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 36.1 tp -81.31 -24.05 37.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.225 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.684 HD11 HG13 ' A' ' 99' ' ' ILE . 3.9 mp -91.36 -44.61 14.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.827 -179.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.0 t -94.13 -21.09 19.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.756 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.443 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 25.5 m-70 62.34 26.63 15.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.86 0.362 . . . . 0.0 110.812 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -101.96 124.6 47.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.798 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.477 ' HB3' HG21 ' A' ' 3' ' ' ILE . 1.3 pm0 -58.03 104.06 0.18 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.386 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 19.7 mtt -82.82 -18.68 39.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.62 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.508 ' CE2' ' CD2' ' A' ' 4' ' ' TYR . 16.0 p90 -178.64 176.74 0.96 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.68 179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.66 -170.73 2.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.824 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -95.91 28.53 3.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.114 0.483 . . . . 0.0 110.877 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 45.9 pt -89.31 -11.34 10.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.731 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.806 ' CZ ' HG22 ' A' ' 72' ' ' ILE . 62.9 m-85 -109.45 -171.09 1.77 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.67 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.1 mttt -94.13 86.97 5.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.702 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.7 mp -88.66 127.06 41.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.203 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -119.87 148.36 43.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.612 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.53 ' HG3' HD23 ' A' ' 29' ' ' LEU . 3.1 mt-10 -94.25 117.09 29.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.01 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.42 HD11 HG23 ' A' ' 161' ' ' ILE . 6.1 pt -113.71 166.63 7.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.087 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 57.53 29.99 18.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.203 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 64.56 39.66 6.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.203 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.37 -16.09 61.82 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.593 -0.813 . . . . 0.0 113.071 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.57 -30.14 53.37 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.829 0.347 . . . . 0.0 111.083 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 56.6 m -149.4 164.66 34.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.877 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.53 HD23 ' HG3' ' A' ' 22' ' ' GLU . 0.5 OUTLIER -129.32 128.97 44.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.962 -179.961 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.471 ' HA ' ' O ' ' A' ' 160' ' ' MET . 67.7 mt-10 -91.27 117.25 29.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.306 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' ' 159' ' ' TYR . 23.0 t -98.79 111.94 29.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.605 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -90.74 116.28 28.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.303 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -100.78 -130.52 7.07 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.228 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.2 pttm -174.46 125.98 0.32 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.919 0.39 . . . . 0.0 110.893 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 35.8 mtp -70.37 123.46 21.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.745 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.0 m . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.229 -179.879 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.249 -0.34 . . . . 0.0 112.249 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.496 HG12 HG12 ' A' ' 72' ' ' ILE . 47.7 t -72.58 142.73 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-O 120.801 0.334 . . . . 0.0 110.801 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -69.04 -56.61 7.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.551 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.806 HG22 ' CZ ' ' A' ' 18' ' ' TYR . 9.5 pt -53.66 -33.83 23.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.816 0.341 . . . . 0.0 111.409 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.782 HG13 ' HB2' ' A' ' 78' ' ' LEU . 98.6 t -71.2 -33.08 49.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.037 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.0 mtm -78.27 -39.73 39.18 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.634 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.43 ' OD1' ' CD2' ' A' ' 76' ' ' HIS . 15.2 p30 -82.17 -28.24 32.19 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.609 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.441 ' CE1' ' HB ' ' A' ' 72' ' ' ILE . 28.1 m170 -93.07 0.99 57.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.852 0.358 . . . . 0.0 110.801 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.438 ' HB2' ' HB3' ' A' ' 138' ' ' GLU . 7.8 m170 56.58 28.53 14.06 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.314 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.782 ' HB2' HG13 ' A' ' 73' ' ' VAL . 71.0 mt -56.99 129.13 40.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.512 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 -112.82 130.58 56.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.254 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.412 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 30.1 tt0 -83.86 129.66 34.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.074 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.6 t -116.57 -179.75 3.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.856 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 69.9 m -121.4 165.67 15.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.96 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.501 ' CE2' ' CE2' ' A' ' 91' ' ' TYR . 3.2 m-85 -171.71 154.01 3.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.043 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.4 ' H ' ' HB3' ' A' ' 87' ' ' ALA . 3.2 m -101.58 166.98 10.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.694 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.0 mtpp -57.73 -52.47 65.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.891 0.377 . . . . 0.0 110.996 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.72 -37.14 76.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.959 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.4 ' HB3' ' H ' ' A' ' 84' ' ' THR . . . -65.31 -44.28 88.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.158 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.826 ' CD2' HD11 ' A' ' 122' ' ' ILE . 1.0 OUTLIER -60.98 -32.93 72.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.814 179.876 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 18.2 mttm -61.97 -43.41 98.91 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.549 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.1 mtmt -78.09 -28.02 48.61 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.663 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.554 ' HE2' HG21 ' A' ' 146' ' ' VAL . 8.8 t80 -65.48 -47.41 76.15 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.616 179.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.444 ' O ' ' HG2' ' A' ' 96' ' ' MET . 4.7 tp -61.18 -45.91 97.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.956 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.405 ' N ' HG23 ' A' ' 92' ' ' ILE . 16.6 tttp -58.42 -38.33 77.18 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.252 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.514 ' HA ' ' HG2' ' A' ' 97' ' ' LYS . 19.6 t70 -75.06 -43.64 52.19 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.903 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.46 ' CD1' ' C ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -75.22 -40.07 59.46 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 121.074 -0.25 . . . . 0.0 111.119 -179.368 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.444 ' HG2' ' O ' ' A' ' 92' ' ' ILE . 3.1 ptt? -67.7 -32.27 72.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.734 0.302 . . . . 0.0 110.707 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.514 ' HG2' ' HA ' ' A' ' 94' ' ' ASP . 5.4 ptpt -69.23 -34.32 74.66 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.705 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.478 ' N ' ' HG3' ' A' ' 97' ' ' LYS . 2.1 m -62.71 -41.28 99.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.295 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.684 HG13 HD11 ' A' ' 8' ' ' ILE . 5.9 mt -79.89 -39.08 19.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.352 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.97 -57.79 10.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.578 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -59.44 -43.53 97.39 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.625 -0.797 . . . . 0.0 111.914 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.4 tmtt? -61.51 -42.11 98.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.978 0.418 . . . . 0.0 110.276 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.715 ' HB3' HG12 ' A' ' 111' ' ' VAL . 8.7 tp -66.69 -33.35 75.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.1 179.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.706 ' CG ' HG11 ' A' ' 111' ' ' VAL . 39.6 mt-10 -60.5 -28.98 68.8 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.611 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -87.24 -20.24 27.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.436 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -104.95 -58.87 1.83 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.779 0.323 . . . . 0.0 111.703 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.452 ' N ' ' O ' ' A' ' 103' ' ' LEU . 23.8 mtt85 -136.43 67.39 60.02 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.027 0.441 . . . . 0.0 110.894 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.919 ' O ' HG22 ' A' ' 111' ' ' VAL . 9.5 Cg_endo -50.58 -21.71 8.16 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 123.275 2.65 . . . . 0.0 112.733 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -71.07 -9.12 57.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.608 0.242 . . . . 0.0 111.245 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.481 ' CB ' HD21 ' A' ' 103' ' ' LEU . 0.1 OUTLIER -112.44 -3.4 14.47 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 -179.472 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.919 HG22 ' O ' ' A' ' 108' ' ' PRO . 34.7 m -71.74 -27.19 27.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.659 0.266 . . . . 0.0 111.656 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.604 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 0.9 OUTLIER -68.68 -55.54 11.2 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.574 -179.194 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.604 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 37.1 Cg_exo -59.87 -31.82 94.38 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 121.868 1.712 . . . . 0.0 111.429 179.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.443 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 73.5 t80 -68.15 -42.78 79.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.958 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -56.02 -51.9 66.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.887 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 60.2 m -76.57 -43.82 37.25 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.675 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -55.3 -53.84 38.19 Favored Glycine 0 N--CA 1.452 -0.277 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.761 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.403 ' O ' ' HB ' ' A' ' 122' ' ' ILE . . . -56.62 -51.78 67.39 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.052 0.453 . . . . 0.0 111.09 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.78 -28.05 69.18 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.182 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -75.49 -57.86 3.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.229 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -60.12 -39.66 87.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.399 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.826 HD11 ' CD2' ' A' ' 88' ' ' TYR . 0.4 OUTLIER -58.27 -46.5 88.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.897 0.38 . . . . 0.0 111.165 -179.777 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.454 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 20.0 mttm -62.02 -29.98 70.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.229 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -70.88 -54.79 10.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.709 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.635 HG22 ' CD2' ' A' ' 132' ' ' TYR . 15.4 pt -60.41 -43.8 94.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.277 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.52 HD21 ' CD2' ' A' ' 88' ' ' TYR . 11.6 mt -54.36 -37.58 65.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.944 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -72.55 -9.54 58.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.441 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 -142.47 31.68 1.5 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.899 0.381 . . . . 0.0 110.765 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.518 ' CE1' ' CZ ' ' A' ' 134' ' ' PHE . 6.3 t80 -54.11 -24.36 17.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.074 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 40.5 mtmt -57.92 -23.68 54.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.052 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 16.3 m-20 -94.23 -49.22 5.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.447 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.635 ' CD2' HG22 ' A' ' 125' ' ' ILE . 0.6 OUTLIER -88.21 154.07 20.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.932 0.396 . . . . 0.0 111.212 -179.404 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.446 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 1.7 mm100 -131.29 143.32 50.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.945 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.518 ' CZ ' ' CE1' ' A' ' 129' ' ' PHE . 2.5 m-85 -77.75 121.28 23.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.055 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.412 ' CE2' ' HB2' ' A' ' 80' ' ' GLU . 32.9 m-85 -126.47 134.97 50.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.708 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.464 ' HB ' ' HA ' ' A' ' 140' ' ' MET . 0.7 OUTLIER -120.91 160.99 21.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.785 179.989 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -58.31 -165.5 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.272 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.438 ' HB3' ' HB2' ' A' ' 77' ' ' HIS . 7.1 pm0 -72.54 -9.01 58.04 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.544 0.212 . . . . 0.0 111.371 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 22.5 m-80 -96.92 -35.4 10.9 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.504 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . 0.464 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 37.0 mtp 60.86 36.91 18.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.701 0.286 . . . . 0.0 111.234 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -66.0 122.21 79.92 Favored Pre-proline 0 N--CA 1.453 -0.297 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.733 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -61.89 -23.46 75.98 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.246 1.964 . . . . 0.0 111.824 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -84.64 -12.24 54.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.672 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -79.27 -160.46 19.01 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.237 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.481 ' HE2' ' HB2' ' A' ' 163' ' ' PHE . 0.7 OUTLIER -100.31 -177.38 3.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.766 0.317 . . . . 0.0 110.93 179.827 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.554 HG21 ' HE2' ' A' ' 91' ' ' TYR . 46.9 t -126.67 148.92 31.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.135 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.504 ' HB2' ' CE2' ' A' ' 162' ' ' PHE . . . -116.27 110.58 18.94 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.555 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.582 HD13 HG21 ' A' ' 125' ' ' ILE . 3.9 mt -84.58 115.25 22.52 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.139 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.425 HD12 ' HG2' ' A' ' 160' ' ' MET . 12.4 tp -88.27 123.62 33.05 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.764 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.501 ' HB2' ' CZ ' ' A' ' 159' ' ' TYR . 24.2 m-20 -127.72 158.69 36.94 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.885 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -117.22 148.84 41.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.907 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -75.48 178.57 5.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.822 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.8 -37.94 80.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.976 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -75.62 -15.11 60.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.302 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 64.05 23.69 68.0 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.492 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 65.3 t -112.0 -38.38 3.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.753 0.311 . . . . 0.0 110.89 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 86.9 m -98.58 103.01 16.34 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.226 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -77.93 127.55 8.65 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.395 2.063 . . . . 0.0 112.057 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.501 ' CZ ' ' HB2' ' A' ' 150' ' ' ASP . 12.1 p90 -124.58 133.17 53.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.668 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' MET . . . . . 0.587 ' HE3' HD13 ' A' ' 78' ' ' LEU . 0.3 OUTLIER -99.98 169.01 9.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.761 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.529 ' HB ' ' HB2' ' A' ' 148' ' ' LEU . 89.6 mt -123.94 110.7 26.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.175 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.504 ' CE2' ' HB2' ' A' ' 147' ' ' ALA . 87.6 m-85 -114.38 156.71 23.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.729 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.481 ' HB2' ' HE2' ' A' ' 145' ' ' MET . 4.4 m-85 -99.21 123.59 43.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.852 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.492 ' CG ' HD11 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -62.32 -55.31 29.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.189 -179.789 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.443 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 0.8 OUTLIER -51.23 -34.92 34.34 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.071 -179.855 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -96.86 27.9 16.03 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.366 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.466 HD21 ' HB3' ' A' ' 4' ' ' TYR . 0.7 OUTLIER -146.66 144.05 29.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.777 0.322 . . . . 0.0 110.793 -179.848 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -112.85 156.82 22.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.811 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . 0.765 ' HB3' HD11 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -120.51 149.98 41.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.005 -179.974 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.926 179.945 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.693 HD11 ' HB3' ' A' ' 169' ' ' MET . 1.7 tt . . . . . 0 N--CA 1.456 -0.158 0 CA-C-O 120.854 0.359 . . . . 0.0 111.036 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.501 HG21 ' HB3' ' A' ' 12' ' ' GLU . 11.7 mm -106.6 155.61 7.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.136 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.603 ' HE1' HG23 ' A' ' 2' ' ' ILE . 3.7 m-85 -123.73 104.71 9.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.665 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.73 156.31 32.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.9 0.381 . . . . 0.0 111.277 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.445 ' O ' ' HA ' ' A' ' 10' ' ' HIS . 27.0 t0 -61.64 152.18 31.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.767 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 67.1 tp -80.45 -22.11 41.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.234 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.417 ' H ' HD12 ' A' ' 8' ' ' ILE . 4.0 mp -91.23 -46.53 14.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.966 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -93.05 -28.77 16.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.705 -179.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.445 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER 68.72 30.88 4.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.907 0.384 . . . . 0.0 110.747 -179.681 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -102.73 125.06 49.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.806 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.501 ' HB3' HG21 ' A' ' 3' ' ' ILE . 0.9 OUTLIER -57.12 96.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.311 -179.764 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 42.2 mtp -79.71 -16.97 54.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.606 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.502 ' CE2' ' CD2' ' A' ' 4' ' ' TYR . 23.7 p90 -178.98 172.73 1.25 Allowed 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.706 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -133.05 -169.91 2.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.19 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 54.3 p30 -89.3 15.56 8.84 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.521 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 44.6 pt -82.69 -9.31 11.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.816 0.341 . . . . 0.0 111.229 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.875 ' CZ ' HG22 ' A' ' 72' ' ' ILE . 74.3 m-85 -111.65 -178.06 3.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.819 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.7 mtmt -94.48 91.45 6.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.683 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.539 HD12 ' N ' ' A' ' 20' ' ' ILE . 4.3 mp -87.84 129.94 38.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.11 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.7 mtm180 -120.89 126.0 48.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.892 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -74.36 116.19 14.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.84 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.85 HD11 HG23 ' A' ' 161' ' ' ILE . 3.6 pt -109.6 165.37 5.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.025 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.431 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . . . 59.5 32.69 21.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.092 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 64.78 45.01 3.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.301 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.52 -12.4 63.22 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.744 -0.741 . . . . 0.0 113.272 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.431 ' HB3' ' HB3' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -55.89 -39.48 71.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.938 0.369 . . . . 0.0 111.191 -179.885 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 96.6 m -137.32 170.96 15.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.081 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.74 131.25 40.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.86 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.404 ' OE1' ' CD2' ' A' ' 159' ' ' TYR . 63.3 mt-10 -97.49 113.8 25.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.04 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.462 HG23 ' HD2' ' A' ' 162' ' ' PHE . 23.5 t -90.58 112.08 24.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.904 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -85.53 120.63 27.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.994 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.46 -142.34 11.14 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.457 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.408 ' HG3' ' HB2' ' A' ' 71' ' ' ASP . 4.0 ptmm? -165.31 124.73 1.77 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.787 0.327 . . . . 0.0 110.795 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 52.4 mtm -72.04 123.8 23.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.94 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.0 m . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.133 -179.953 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 112.117 -0.393 . . . . 0.0 112.117 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.448 ' CG1' HG12 ' A' ' 72' ' ' ILE . 53.2 t -70.8 147.58 11.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.791 0.329 . . . . 0.0 110.987 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.408 ' HB2' ' HG3' ' A' ' 34' ' ' LYS . 26.4 t70 -73.57 -55.56 6.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.306 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.875 HG22 ' CZ ' ' A' ' 18' ' ' TYR . 8.9 pt -53.62 -33.72 22.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.183 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.81 HG13 ' HB2' ' A' ' 78' ' ' LEU . 84.1 t -71.5 -33.62 50.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.091 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.8 mtm -78.07 -39.2 42.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.585 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.409 ' OD1' ' CD2' ' A' ' 76' ' ' HIS . 15.8 p30 -82.11 -28.38 32.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.508 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.461 ' CE1' ' HB ' ' A' ' 72' ' ' ILE . 24.4 m170 -94.93 1.69 55.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.778 0.323 . . . . 0.0 110.936 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.423 ' HB2' ' HB3' ' A' ' 138' ' ' GLU . 15.7 m80 54.98 32.22 17.65 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.344 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.81 ' HB2' HG13 ' A' ' 73' ' ' VAL . 54.6 mt -59.13 139.11 57.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.383 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -124.77 137.44 54.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.93 0.395 . . . . 0.0 111.239 -179.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.409 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 2.5 tt0 -92.86 124.14 36.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.926 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.85 HG21 HD11 ' A' ' 136' ' ' ILE . 3.5 t -115.19 127.35 55.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.888 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 89.3 p -68.91 159.67 32.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.941 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -165.32 164.22 19.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.748 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -101.58 167.84 9.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.835 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.5 mtpt -67.02 -52.46 42.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.838 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.7 tp10 -64.89 -42.82 94.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.511 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.88 -39.37 81.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.931 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.82 ' CD2' HD11 ' A' ' 122' ' ' ILE . 1.3 t80 -59.94 -38.66 83.04 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.786 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.432 ' O ' HG22 ' A' ' 92' ' ' ILE . 70.7 mttt -56.82 -45.72 82.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.112 0.482 . . . . 0.0 110.591 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.79 -27.77 50.28 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.641 178.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.532 ' HE2' HG21 ' A' ' 146' ' ' VAL . 13.4 t80 -66.77 -44.6 80.95 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.743 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.563 HD12 ' CE2' ' A' ' 95' ' ' TYR . 5.4 tp -63.15 -44.3 99.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.014 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -62.63 -37.15 85.2 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.067 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.483 ' HA ' ' HG2' ' A' ' 97' ' ' LYS . 29.3 t70 -75.76 -42.95 48.97 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.662 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.563 ' CE2' HD12 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -77.8 -40.86 39.26 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 121.013 -0.275 . . . . 0.0 110.863 -179.476 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.439 ' HG3' ' N ' ' A' ' 97' ' ' LYS . 0.1 OUTLIER -65.12 -31.85 73.26 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.249 179.418 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.488 ' HG3' ' N ' ' A' ' 98' ' ' SER . 15.1 pttt -70.64 -34.13 71.74 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 120.945 0.402 . . . . 0.0 110.178 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.488 ' N ' ' HG3' ' A' ' 97' ' ' LYS . 2.0 m -59.47 -37.41 78.12 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.761 179.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.7 mt -79.78 -40.88 21.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.102 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.75 -51.33 70.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.22 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -59.54 -47.69 89.69 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.64 -0.79 . . . . 0.0 111.91 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.6 -41.27 97.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.921 0.391 . . . . 0.0 110.086 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.641 ' HB3' HG12 ' A' ' 111' ' ' VAL . 8.3 tp -65.37 -37.88 88.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.958 179.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.681 ' CG ' HG11 ' A' ' 111' ' ' VAL . 76.4 mt-10 -56.62 -29.95 62.75 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.767 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -86.62 -20.19 28.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.531 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -106.84 -60.9 1.61 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.763 0.316 . . . . 0.0 111.602 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.457 ' N ' ' O ' ' A' ' 103' ' ' LEU . 4.0 mtt85 -129.37 65.23 73.92 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.816 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.876 ' O ' HG22 ' A' ' 111' ' ' VAL . 9.7 Cg_endo -50.4 -22.5 8.85 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 123.22 2.613 . . . . 0.0 112.745 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -75.69 -6.92 52.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.653 0.263 . . . . 0.0 111.136 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.515 ' C ' ' HD2' ' A' ' 113' ' ' PRO . 13.9 mmt180 -112.38 -1.53 15.02 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.654 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.876 HG22 ' O ' ' A' ' 108' ' ' PRO . 33.7 m -70.77 -36.24 63.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.574 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 25.8 mttm -66.65 -50.29 46.37 Favored Pre-proline 0 CA--C 1.529 0.16 0 C-N-CA 121.049 -0.261 . . . . 0.0 111.502 -179.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.574 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 37.0 Cg_exo -59.97 -32.04 94.47 Favored 'Trans proline' 0 C--N 1.347 0.447 0 C-N-CA 121.993 1.796 . . . . 0.0 111.568 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.485 ' CE1' ' HB2' ' A' ' 165' ' ' ASP . 76.0 t80 -69.99 -47.71 61.11 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.852 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -50.97 -42.03 59.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.02 0.438 . . . . 0.0 110.769 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.8 m -76.65 -44.29 34.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.717 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.43 -52.47 52.39 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.679 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.04 -51.74 66.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.937 0.399 . . . . 0.0 111.134 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.58 -28.2 68.97 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.363 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -77.87 -45.69 23.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.9 0.381 . . . . 0.0 111.194 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.401 HE21 ' HB2' ' A' ' 24' ' ' ALA . 23.6 tt0 -70.49 -36.45 73.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.208 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.82 HD11 ' CD2' ' A' ' 88' ' ' TYR . 0.3 OUTLIER -61.89 -47.37 93.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.326 -179.765 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.465 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 13.4 pttt -61.76 -31.19 71.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.017 0.437 . . . . 0.0 110.072 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -67.9 -53.65 24.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.621 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.605 HG21 HD13 ' A' ' 148' ' ' LEU . 15.5 pt -62.01 -42.04 93.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.291 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.474 HD23 ' HA ' ' A' ' 126' ' ' LEU . 11.3 mt -53.9 -35.9 62.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.944 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.99 -14.29 62.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.087 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -140.5 33.15 1.85 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.073 0.463 . . . . 0.0 110.398 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.504 ' CE1' ' CZ ' ' A' ' 134' ' ' PHE . 5.5 t80 -49.02 -27.59 3.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.224 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 2.8 ttpp -60.57 -27.78 67.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.791 0.329 . . . . 0.0 110.867 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 30.8 m-20 -94.27 -32.19 13.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.322 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.412 ' CZ ' ' OD2' ' A' ' 150' ' ' ASP . 3.6 m-85 -98.36 131.97 44.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.199 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.7 mm100 -117.33 143.72 45.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.803 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.51 ' CE1' ' CZ ' ' A' ' 88' ' ' TYR . 2.1 m-85 -80.01 124.11 28.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.062 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.409 ' CE2' ' HB2' ' A' ' 80' ' ' GLU . 43.1 m-85 -127.88 145.84 50.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.686 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.85 HD11 HG21 ' A' ' 81' ' ' THR . 0.7 OUTLIER -131.59 163.64 36.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.042 179.958 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -64.56 -159.55 0.38 Allowed Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.298 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.423 ' HB3' ' HB2' ' A' ' 77' ' ' HIS . 1.2 pt-20 -75.97 -8.89 58.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.597 0.237 . . . . 0.0 111.512 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -97.24 -31.75 12.27 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.583 0.23 . . . . 0.0 111.563 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . 0.422 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 56.0 mtp 58.26 37.39 26.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.809 0.338 . . . . 0.0 110.945 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . 0.41 ' ND2' ' HA3' ' A' ' 144' ' ' GLY . 19.6 p-10 -64.35 115.0 16.18 Favored Pre-proline 0 N--CA 1.452 -0.372 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.934 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.92 -29.7 90.04 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.514 2.142 . . . . 0.0 112.287 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -84.55 -6.63 59.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.059 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.41 ' HA3' ' ND2' ' A' ' 141' ' ' ASN . . . -79.08 -141.12 2.05 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.413 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 3.2 ptp -113.36 -178.55 3.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.752 0.311 . . . . 0.0 110.919 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.532 HG21 ' HE2' ' A' ' 91' ' ' TYR . 42.2 t -128.06 144.95 36.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.283 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -111.67 114.73 27.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.681 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.605 HD13 HG21 ' A' ' 125' ' ' ILE . 3.3 mt -88.53 106.3 18.2 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.068 -179.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.483 HD12 ' HG2' ' A' ' 160' ' ' MET . 2.7 tp -88.93 119.62 29.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.219 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.462 ' HB2' ' CZ ' ' A' ' 159' ' ' TYR . 0.9 OUTLIER -129.08 165.91 20.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.695 179.517 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -111.88 146.15 38.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.96 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 21.9 mmt180 -67.32 -177.46 0.7 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.879 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.41 -31.94 68.17 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.899 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 38.1 p-10 -77.35 -15.05 59.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.23 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 71.83 17.21 76.66 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.72 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 91.1 t -112.93 -70.4 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.841 0.353 . . . . 0.0 110.733 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 86.4 m -55.07 107.86 0.99 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.08 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -84.25 128.22 4.16 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.586 2.19 . . . . 0.0 112.334 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.462 ' CZ ' ' HB2' ' A' ' 150' ' ' ASP . 9.4 p90 -124.22 136.05 53.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.821 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' MET . . . . . 0.492 ' CE ' HD13 ' A' ' 78' ' ' LEU . 0.5 OUTLIER -107.08 136.73 46.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.992 -179.765 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.85 HG23 HD11 ' A' ' 23' ' ' ILE . 62.3 mt -91.55 112.65 25.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.103 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.462 ' HD2' HG23 ' A' ' 31' ' ' VAL . 89.6 m-85 -110.24 152.18 26.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.833 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.42 ' CE2' ' OH ' ' A' ' 95' ' ' TYR . 3.1 m-85 -96.28 124.7 40.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.617 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -65.96 -56.36 12.08 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.355 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.485 ' HB2' ' CE1' ' A' ' 114' ' ' PHE . 7.0 m-20 -50.1 -36.29 28.98 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.859 0.362 . . . . 0.0 111.071 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -95.87 24.76 28.3 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.24 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.467 HD21 ' HB3' ' A' ' 4' ' ' TYR . 0.6 OUTLIER -139.99 145.07 37.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.754 0.311 . . . . 0.0 110.841 -179.885 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -119.23 143.45 47.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.796 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . 0.693 ' HB3' HD11 ' A' ' 2' ' ' ILE . 0.6 OUTLIER -110.51 146.41 36.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.022 -179.918 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.958 -179.944 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.52 HG23 ' HE1' ' A' ' 4' ' ' TYR . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.741 0.305 . . . . 0.0 110.983 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' A' ' 169' ' ' MET . 14.8 mm -100.14 137.75 26.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.723 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.52 ' HE1' HG23 ' A' ' 2' ' ' ILE . 6.1 m-85 -106.36 105.37 15.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.457 179.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -122.44 145.76 47.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.839 0.352 . . . . 0.0 111.231 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.465 ' O ' ' HA ' ' A' ' 10' ' ' HIS . 43.5 t0 -56.21 152.08 11.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.723 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 57.9 tp -78.8 -26.71 44.38 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.2 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.866 HD11 ' CG1' ' A' ' 99' ' ' ILE . 4.4 mp -91.34 -44.12 14.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.473 ' O ' ' CG ' ' A' ' 10' ' ' HIS . 30.0 t -95.33 -10.19 30.84 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -178.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.473 ' CG ' ' O ' ' A' ' 9' ' ' SER . 25.5 p80 48.31 27.62 1.4 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.952 0.406 . . . . 0.0 111.267 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -98.21 122.59 41.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.705 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.408 ' HB3' ' CG2' ' A' ' 3' ' ' ILE . 0.1 OUTLIER -60.47 84.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.362 -179.816 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.413 ' O ' ' CD2' ' A' ' 76' ' ' HIS . 7.0 mtp -64.34 -18.57 64.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.588 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.485 ' CZ ' ' CD2' ' A' ' 4' ' ' TYR . 8.8 p90 -178.94 179.7 0.66 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.634 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -136.99 -169.9 2.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.91 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.401 ' HA ' HD11 ' A' ' 20' ' ' ILE . 37.8 t70 -93.55 26.18 3.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.027 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.436 HG13 ' CD2' ' A' ' 18' ' ' TYR . 46.0 pt -84.77 -13.28 11.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.754 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.801 ' CE2' HG22 ' A' ' 72' ' ' ILE . 79.0 m-85 -110.72 168.64 9.32 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.618 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.44 94.01 4.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.864 0.364 . . . . 0.0 110.581 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.703 HD12 ' O ' ' A' ' 18' ' ' TYR . 4.2 mp -87.79 139.41 17.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.12 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -127.35 119.53 26.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.036 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.612 ' HG3' HD23 ' A' ' 29' ' ' LEU . 1.9 mt-10 -71.77 114.7 10.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.859 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.567 HD11 HG23 ' A' ' 161' ' ' ILE . 3.9 pt -111.49 167.1 5.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.203 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.418 ' HB2' ' NE2' ' A' ' 121' ' ' GLN . . . 59.29 30.17 19.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.236 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 64.38 36.67 8.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.152 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.12 -15.32 61.64 Favored Glycine 0 CA--C 1.518 0.245 0 C-N-CA 120.556 -0.831 . . . . 0.0 112.986 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.419 ' HA ' HD22 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -55.04 -43.39 73.74 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.811 0.338 . . . . 0.0 110.917 -179.912 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 9.0 m -135.66 165.05 26.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.912 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.612 HD23 ' HG3' ' A' ' 22' ' ' GLU . 0.4 OUTLIER -128.02 139.09 52.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.785 -179.947 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -103.51 113.01 26.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.086 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 23.5 t -91.56 112.05 24.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.721 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -82.12 114.39 20.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.229 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.43 -137.13 8.84 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.288 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -174.51 128.24 0.33 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.885 0.374 . . . . 0.0 110.809 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 8.3 mtt -72.3 124.26 24.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.921 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 28.0 m . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.208 -179.899 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.466 0 N-CA-C 111.891 -0.484 . . . . 0.0 111.891 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.51 HG12 HG12 ' A' ' 72' ' ' ILE . 46.8 t -73.25 141.89 15.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.75 0.309 . . . . 0.0 110.754 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -68.59 -56.17 9.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.725 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.801 HG22 ' CE2' ' A' ' 18' ' ' TYR . 8.5 pt -53.58 -33.77 22.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.868 0.366 . . . . 0.0 111.32 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.789 HG13 ' HB2' ' A' ' 78' ' ' LEU . 92.9 t -70.8 -32.0 47.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.83 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.5 mtm -78.3 -40.64 36.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.539 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -82.07 -28.46 32.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.621 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.447 ' CD2' ' HB ' ' A' ' 72' ' ' ILE . 7.2 m-70 -90.22 -5.68 56.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.857 0.36 . . . . 0.0 110.676 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 9.0 m80 62.45 29.93 17.19 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.103 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.789 ' HB2' HG13 ' A' ' 73' ' ' VAL . 34.5 mt -59.53 147.1 38.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.499 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -127.71 137.24 52.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.86 0.362 . . . . 0.0 111.042 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.429 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 2.9 tt0 -99.96 124.11 44.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.056 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.742 HG21 HD11 ' A' ' 136' ' ' ILE . 6.6 t -123.69 135.18 53.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.769 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 9.1 m -68.01 160.58 28.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.092 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.457 ' HB2' ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -156.8 154.54 30.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.866 179.975 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.9 m -99.13 157.08 16.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.786 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.67 -52.39 65.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.904 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -66.51 -43.09 86.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.683 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.6 -37.8 82.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.05 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.847 ' CD2' HD11 ' A' ' 122' ' ' ILE . 1.3 t80 -62.87 -35.13 79.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.745 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.411 ' O ' HG22 ' A' ' 92' ' ' ILE . 24.4 mttt -59.99 -45.5 92.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.051 0.453 . . . . 0.0 110.443 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.65 -27.93 55.81 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.629 178.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.563 ' HE2' HG21 ' A' ' 146' ' ' VAL . 13.3 t80 -66.21 -47.47 73.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.638 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.454 ' O ' ' HG2' ' A' ' 96' ' ' MET . 4.7 tp -60.3 -43.93 94.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.968 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 8.6 ttmt -60.08 -43.64 95.36 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.214 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.473 ' HA ' ' HG2' ' A' ' 97' ' ' LYS . 12.0 t70 -72.75 -39.72 66.6 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.819 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.471 ' CD1' ' C ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -76.46 -41.62 46.69 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 121.004 -0.279 . . . . 0.0 110.855 -179.497 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.454 ' HG2' ' O ' ' A' ' 92' ' ' ILE . 2.9 ptt? -67.95 -32.75 73.4 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.73 0.3 . . . . 0.0 110.844 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.473 ' HG2' ' HA ' ' A' ' 94' ' ' ASP . 0.3 OUTLIER -70.68 -35.58 72.89 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.894 0.378 . . . . 0.0 110.577 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.406 ' N ' ' HG3' ' A' ' 97' ' ' LYS . 1.9 m -60.52 -40.49 91.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.144 179.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.866 ' CG1' HD11 ' A' ' 8' ' ' ILE . 6.6 mt -79.85 -41.63 21.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.445 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.5 tmtt? -54.44 -54.07 45.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.502 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -58.69 -45.93 94.07 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.192 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 10.4 tptp -61.69 -41.28 97.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.806 0.336 . . . . 0.0 110.461 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.73 ' HB3' HG12 ' A' ' 111' ' ' VAL . 5.0 tp -67.4 -34.1 76.57 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.132 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.707 ' CG ' HG11 ' A' ' 111' ' ' VAL . 40.5 mt-10 -59.81 -29.83 68.51 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.828 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.413 ' HG3' ' HG3' ' A' ' 106' ' ' GLN . 0.6 OUTLIER -87.84 -19.39 27.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.561 -179.782 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.413 ' HG3' ' HG3' ' A' ' 105' ' ' GLU . 20.3 mt-30 -105.44 -58.17 1.93 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.736 0.303 . . . . 0.0 111.611 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.446 ' N ' ' O ' ' A' ' 103' ' ' LEU . 87.5 mtt180 -138.5 67.91 45.22 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 120.919 0.39 . . . . 0.0 110.858 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.944 ' O ' HG22 ' A' ' 111' ' ' VAL . 10.3 Cg_endo -50.88 -20.97 7.71 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 123.254 2.636 . . . . 0.0 112.888 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -67.69 -9.72 46.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.592 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.637 ' CB ' HD21 ' A' ' 103' ' ' LEU . 31.0 mmt-85 -114.23 -4.82 13.02 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.944 HG22 ' O ' ' A' ' 108' ' ' PRO . 35.6 m -69.52 -27.74 35.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.609 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 4.3 mmtp -71.99 -54.32 6.08 Favored Pre-proline 0 CA--C 1.532 0.257 0 C-N-CA 121.078 -0.249 . . . . 0.0 111.416 -179.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.609 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 37.2 Cg_exo -56.08 -35.89 95.47 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 121.772 1.648 . . . . 0.0 111.547 179.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.469 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 87.5 t80 -65.8 -43.18 89.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.904 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.54 -52.36 55.19 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.08 0.467 . . . . 0.0 110.741 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 61.7 m -75.8 -44.19 42.49 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.695 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -56.21 -51.39 56.19 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.687 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.16 -51.67 67.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.994 0.426 . . . . 0.0 110.985 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.526 ' HB1' ' HE3' ' A' ' 123' ' ' LYS . . . -61.55 -28.07 69.07 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.229 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -77.94 -48.54 16.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.859 0.362 . . . . 0.0 111.048 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.418 ' NE2' ' HB2' ' A' ' 24' ' ' ALA . 4.6 tp-100 -67.31 -34.99 78.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.025 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.847 HD11 ' CD2' ' A' ' 88' ' ' TYR . 0.3 OUTLIER -67.03 -45.1 87.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.064 -179.865 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.526 ' HE3' ' HB1' ' A' ' 119' ' ' ALA . 26.3 mttt -61.47 -29.94 70.29 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.411 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -70.19 -53.96 14.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.764 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.869 HG21 HD13 ' A' ' 148' ' ' LEU . 14.5 pt -60.52 -41.86 89.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.273 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.401 ' HA ' HD23 ' A' ' 126' ' ' LEU . 12.4 mt -55.23 -38.41 68.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.89 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -71.39 -10.82 60.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.317 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -140.59 33.48 1.83 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.859 0.361 . . . . 0.0 110.648 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.511 ' CE1' ' CE2' ' A' ' 134' ' ' PHE . 2.2 t80 -50.13 -29.96 10.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.99 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.6 ttpt -60.1 -29.68 68.75 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.935 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 21.3 m-20 -94.17 -35.73 12.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.436 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.598 ' CD2' HG22 ' A' ' 125' ' ' ILE . 4.7 m-85 -94.84 136.31 35.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.897 0.38 . . . . 0.0 111.211 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.406 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 2.2 mm100 -119.83 145.68 46.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.745 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.511 ' CE2' ' CE1' ' A' ' 129' ' ' PHE . 0.6 OUTLIER -83.35 121.82 27.64 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.989 -179.759 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.459 ' CG ' ' CE ' ' A' ' 160' ' ' MET . 46.5 m-85 -125.46 134.85 51.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.761 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.742 HD11 HG21 ' A' ' 81' ' ' THR . 0.3 OUTLIER -123.87 164.77 21.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.784 179.989 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.53 -173.05 1.25 Allowed Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.447 -0.882 . . . . 0.0 111.899 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -67.36 -13.68 62.23 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.564 0.221 . . . . 0.0 111.22 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -92.75 -28.66 16.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.723 0.297 . . . . 0.0 111.366 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . 0.472 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 53.8 mtm 54.69 43.08 30.7 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.811 0.339 . . . . 0.0 111.201 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -67.29 122.28 82.26 Favored Pre-proline 0 N--CA 1.453 -0.279 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.67 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -59.74 -27.23 84.45 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.351 2.034 . . . . 0.0 111.881 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -84.76 -15.99 43.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.814 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.99 -173.45 24.78 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.347 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -88.84 -177.99 5.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.737 0.303 . . . . 0.0 110.881 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.563 HG21 ' HE2' ' A' ' 91' ' ' TYR . 41.6 t -127.6 153.84 37.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.222 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.417 ' N ' HG12 ' A' ' 146' ' ' VAL . . . -118.54 115.74 25.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.691 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.869 HD13 HG21 ' A' ' 125' ' ' ILE . 3.6 mt -90.18 106.7 18.66 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.948 -179.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.514 HD12 ' HG2' ' A' ' 160' ' ' MET . 1.6 tp -88.5 119.61 29.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.409 -179.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.47 ' HB3' ' CE1' ' A' ' 159' ' ' TYR . 0.7 OUTLIER -129.49 172.24 11.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.525 179.4 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -117.76 144.41 45.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.847 0.356 . . . . 0.0 111.008 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.41 -177.71 0.05 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.933 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.36 -34.97 71.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.017 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.573 ' OD1' HG23 ' A' ' 156' ' ' VAL . 9.2 t70 -76.54 -15.14 59.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.218 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 69.17 26.04 74.95 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.711 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.573 HG23 ' OD1' ' A' ' 154' ' ' ASP . 94.5 t -112.83 -69.81 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.932 0.396 . . . . 0.0 110.885 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 73.4 m -63.77 111.23 4.86 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.01 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -81.73 131.17 7.08 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.462 2.108 . . . . 0.0 112.192 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.47 ' CE1' ' HB3' ' A' ' 150' ' ' ASP . 13.9 p90 -125.62 144.59 50.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.92 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' MET . . . . . 0.514 ' HG2' HD12 ' A' ' 149' ' ' LEU . 0.2 OUTLIER -110.7 142.65 42.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.137 -179.792 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.567 HG23 HD11 ' A' ' 23' ' ' ILE . 58.7 mt -97.68 116.34 39.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.974 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -118.6 132.82 56.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.798 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -78.0 123.0 26.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.867 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.46 -54.48 35.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.327 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.469 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 1.6 m-20 -49.54 -36.2 22.75 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.285 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -96.55 27.92 15.49 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.366 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.49 143.96 29.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.814 0.34 . . . . 0.0 110.925 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -113.66 147.76 37.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.725 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . 0.422 ' HA ' ' O ' ' A' ' 3' ' ' ILE . 0.7 OUTLIER -120.08 140.3 51.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.975 -179.816 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.914 179.955 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.809 HD11 ' HB3' ' A' ' 169' ' ' MET . 4.5 tt . . . . . 0 N--CA 1.456 -0.139 0 CA-C-O 120.892 0.377 . . . . 0.0 111.038 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.408 HG21 ' HB3' ' A' ' 12' ' ' GLU . 20.2 mm -100.98 155.25 4.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.317 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.602 ' HB3' HD21 ' A' ' 167' ' ' LEU . 2.8 m-85 -122.8 105.94 10.47 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.424 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 17.5 ptt180 -120.8 150.29 41.25 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.937 0.398 . . . . 0.0 111.469 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.428 ' O ' ' HA ' ' A' ' 10' ' ' HIS . 37.6 t0 -62.38 152.18 34.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.616 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.508 HD23 HG23 ' A' ' 99' ' ' ILE . 56.6 tp -81.23 -22.6 38.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.395 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.911 HD11 ' CG1' ' A' ' 99' ' ' ILE . 4.1 mp -91.27 -45.9 14.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 93.1 p -93.14 -21.39 19.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.616 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.428 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 1.6 m-70 62.23 29.78 17.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.865 0.364 . . . . 0.0 110.805 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -106.1 124.62 49.87 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.804 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.408 ' HB3' HG21 ' A' ' 3' ' ' ILE . 2.6 pm0 -58.44 93.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.207 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 7.3 mtt -70.08 -18.42 63.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.847 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.516 ' CE2' ' CD2' ' A' ' 4' ' ' TYR . 14.3 p90 -177.44 177.33 1.19 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.899 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.473 ' O ' HD11 ' A' ' 20' ' ' ILE . 0.9 OUTLIER -136.67 -169.88 2.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.975 -179.827 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 34.5 p-10 -87.83 13.93 9.75 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.615 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 46.5 pt -78.9 -4.96 7.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.816 0.341 . . . . 0.0 111.13 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.864 ' CZ ' HG22 ' A' ' 72' ' ' ILE . 65.3 m-85 -119.56 -179.07 3.77 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.728 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -91.39 88.71 6.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.748 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.473 HD11 ' O ' ' A' ' 15' ' ' SER . 4.0 mp -87.84 123.96 40.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.928 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 8.9 mtt180 -114.85 135.91 53.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.934 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.702 ' HG3' HD23 ' A' ' 29' ' ' LEU . 2.3 mp0 -81.56 114.82 20.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.868 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.714 HD11 HG23 ' A' ' 161' ' ' ILE . 3.3 pt -110.23 162.59 7.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.21 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.428 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . . . 60.01 29.77 19.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.251 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 64.42 50.81 2.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.423 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.65 -4.25 74.86 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 120.732 -0.747 . . . . 0.0 113.441 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.531 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -66.65 -29.36 69.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 117.036 0.418 . . . . 0.0 111.0 -179.903 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 92.4 m -147.59 171.52 15.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.119 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.702 HD23 ' HG3' ' A' ' 22' ' ' GLU . 0.7 OUTLIER -134.79 129.57 34.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.874 -179.954 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.414 ' OE1' ' CD2' ' A' ' 159' ' ' TYR . 61.7 mt-10 -97.52 116.36 29.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.166 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.41 HG23 ' HD2' ' A' ' 162' ' ' PHE . 21.9 t -92.41 111.97 25.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.698 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -83.0 116.77 22.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.172 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -99.98 -144.51 16.22 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.201 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.0 pttm -174.53 126.01 0.31 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.829 0.347 . . . . 0.0 111.02 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 21.7 mtt -70.03 121.93 18.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.778 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.4 m . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.29 -179.775 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 N-CA-C 112.356 -0.298 . . . . 0.0 112.356 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.636 HG12 HG12 ' A' ' 72' ' ' ILE . 47.9 t -69.02 124.27 24.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.913 0.387 . . . . 0.0 110.756 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -54.28 -57.31 11.68 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.833 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.864 HG22 ' CZ ' ' A' ' 18' ' ' TYR . 5.4 pt -53.74 -34.13 24.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.842 0.353 . . . . 0.0 111.364 -179.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.783 HG13 ' HB2' ' A' ' 78' ' ' LEU . 97.5 t -73.67 -29.97 27.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.055 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.7 mtt -78.24 -42.25 31.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.82 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.428 ' OD1' ' CD2' ' A' ' 76' ' ' HIS . 19.6 p30 -82.05 -29.68 31.78 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 -179.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.428 ' CD2' ' OD1' ' A' ' 75' ' ' ASN . 34.1 m170 -88.99 -5.39 57.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.862 0.363 . . . . 0.0 110.626 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.417 ' HB2' ' HB3' ' A' ' 138' ' ' GLU . 78.0 m-70 61.43 30.3 18.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.032 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.783 ' HB2' HG13 ' A' ' 73' ' ' VAL . 60.0 mt -58.57 148.56 28.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.49 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -131.75 136.47 47.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.854 0.359 . . . . 0.0 111.109 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.419 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 2.5 tm-20 -89.81 135.21 33.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.104 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.495 HG23 ' HB2' ' A' ' 134' ' ' PHE . 5.2 t -120.21 171.85 8.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.725 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 30.2 m -114.56 161.23 18.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.978 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.482 ' HB2' ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -171.62 159.81 5.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.039 -179.898 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 8.6 m -101.54 162.41 12.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.815 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 17.1 mtpt -58.39 -51.95 67.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.104 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -65.64 -46.44 79.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.842 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.46 -36.4 73.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.185 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.91 ' CD2' HD11 ' A' ' 122' ' ' ILE . 1.0 OUTLIER -62.57 -37.9 87.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.809 179.874 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.523 ' NZ ' HD13 ' A' ' 126' ' ' LEU . 28.1 mttm -58.58 -44.9 89.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.649 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.1 tttm -77.96 -27.9 49.33 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.652 178.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.562 ' HE2' HG21 ' A' ' 146' ' ' VAL . 12.4 t80 -66.9 -46.6 74.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.711 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.538 HD12 ' CE2' ' A' ' 95' ' ' TYR . 6.0 tp -61.9 -42.61 95.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.107 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.475 ' O ' ' CG ' ' A' ' 97' ' ' LYS . 11.3 ttpp -62.0 -45.28 94.32 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.92 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -70.56 -38.14 74.08 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.945 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.538 ' CE2' HD12 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -78.24 -43.51 28.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.742 -0.208 . . . . 0.0 110.839 -179.458 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.413 ' HG3' ' N ' ' A' ' 97' ' ' LYS . 0.3 OUTLIER -62.07 -31.77 72.22 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 178.778 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.475 ' CG ' ' O ' ' A' ' 93' ' ' LYS . 1.4 mmmp? -65.61 -41.87 92.23 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.35 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.7 m -52.85 -40.31 63.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.146 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.911 ' CG1' HD11 ' A' ' 8' ' ' ILE . 8.7 mt -79.76 -42.71 22.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.443 179.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.69 -49.05 74.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.376 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -60.89 -49.66 76.15 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.013 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.5 -40.53 91.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.86 0.362 . . . . 0.0 110.262 179.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.612 ' HB3' HG12 ' A' ' 111' ' ' VAL . 7.3 tp -65.17 -38.31 90.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.095 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.693 ' HG3' HG11 ' A' ' 111' ' ' VAL . 78.7 mt-10 -56.88 -29.54 63.06 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.725 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -87.03 -19.66 28.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.635 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -107.8 -61.77 1.53 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.882 0.372 . . . . 0.0 111.527 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.447 ' N ' ' O ' ' A' ' 103' ' ' LEU . 43.5 mtt-85 -131.11 65.41 76.57 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.715 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.881 ' O ' HG22 ' A' ' 111' ' ' VAL . 9.8 Cg_endo -50.49 -22.82 9.58 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 123.19 2.594 . . . . 0.0 112.75 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -70.6 -10.46 59.36 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.217 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.546 ' CB ' HD21 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -108.89 -1.24 19.28 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -179.482 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.881 HG22 ' O ' ' A' ' 108' ' ' PRO . 26.5 m -71.81 -34.41 51.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -179.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.568 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 23.9 mtmt -68.99 -49.57 24.95 Favored Pre-proline 0 C--N 1.332 -0.178 0 C-N-CA 120.949 -0.301 . . . . 0.0 111.633 -179.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.568 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 37.0 Cg_exo -60.56 -32.07 93.04 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.153 1.902 . . . . 0.0 111.686 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.472 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 36.7 t80 -72.16 -47.09 53.43 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.096 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 15.0 mmm -49.42 -43.25 44.45 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.021 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 69.1 m -76.01 -45.14 36.08 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.842 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.45 -54.78 34.3 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.803 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -52.62 -51.63 59.11 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.897 0.38 . . . . 0.0 111.434 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.47 ' O ' HG22 ' A' ' 122' ' ' ILE . . . -68.58 -29.05 67.51 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.662 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -72.87 -55.87 6.02 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.865 0.364 . . . . 0.0 111.214 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -60.83 -31.51 70.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.487 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.91 HD11 ' CD2' ' A' ' 88' ' ' TYR . 0.4 OUTLIER -63.71 -45.19 98.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.322 -179.532 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.436 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 15.5 mttp -61.45 -30.89 70.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.059 0.457 . . . . 0.0 110.196 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -69.34 -54.78 12.79 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.764 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.661 HG21 HD13 ' A' ' 148' ' ' LEU . 15.0 pt -60.26 -42.79 91.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.386 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.523 HD13 ' NZ ' ' A' ' 89' ' ' LYS . 12.0 mt -53.98 -38.18 64.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.886 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.58 -15.18 63.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.212 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -137.98 32.32 2.42 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.941 0.401 . . . . 0.0 110.751 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.499 ' CE1' ' CZ ' ' A' ' 134' ' ' PHE . 4.2 t80 -51.93 -27.99 14.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.065 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.59 -18.87 65.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.296 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 15.8 m-80 -94.14 -36.25 12.15 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.325 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.458 ' CD2' HG22 ' A' ' 125' ' ' ILE . 1.1 m-30 -102.7 162.32 13.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.829 0.347 . . . . 0.0 111.151 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.7 mm100 -138.0 147.57 44.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.889 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.499 ' CZ ' ' CE1' ' A' ' 129' ' ' PHE . 2.8 m-85 -78.62 129.74 35.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.955 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.44 ' O ' ' HB3' ' A' ' 147' ' ' ALA . 33.2 m-85 -134.71 134.59 41.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.629 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.45 ' HB ' ' HA ' ' A' ' 140' ' ' MET . 0.8 OUTLIER -123.18 161.2 25.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.931 -179.977 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.51 -163.44 0.24 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.207 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.417 ' HB3' ' HB2' ' A' ' 77' ' ' HIS . 5.2 pt-20 -72.49 -8.88 57.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.554 0.216 . . . . 0.0 111.531 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -95.7 -35.34 11.61 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.607 0.241 . . . . 0.0 111.566 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . 0.45 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 10.3 mtp 58.85 40.77 22.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.695 0.283 . . . . 0.0 111.217 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -69.67 117.64 55.18 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.633 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -62.54 -24.26 75.18 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.345 2.03 . . . . 0.0 111.78 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -84.8 -15.23 45.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.758 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -74.17 -136.11 0.37 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.317 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.4 ' HE3' ' O ' ' A' ' 166' ' ' GLY . 5.6 ptp -120.29 -175.87 3.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.86 0.362 . . . . 0.0 110.712 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.562 HG21 ' HE2' ' A' ' 91' ' ' TYR . 57.5 t -129.09 144.78 37.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.338 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' A' ' 135' ' ' PHE . . . -111.39 117.8 34.08 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.378 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.661 HD13 HG21 ' A' ' 125' ' ' ILE . 5.8 mt -91.53 107.77 19.44 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.323 -179.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.567 HD12 ' HG2' ' A' ' 160' ' ' MET . 2.3 tp -88.05 120.67 29.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.552 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.536 ' HB2' ' CZ ' ' A' ' 159' ' ' TYR . 18.3 m-20 -122.0 145.28 48.28 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.056 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.433 ' CE1' ' HB3' ' A' ' 158' ' ' PRO . 64.7 m-85 -100.75 135.44 42.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.933 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 15.2 mmm-85 -60.89 -178.64 0.1 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.943 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -59.88 -41.24 91.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.999 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -77.68 -15.08 59.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.287 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 67.49 25.14 73.86 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.522 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 71.6 t -110.21 -37.05 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.851 0.358 . . . . 0.0 110.964 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 94.3 m -103.41 96.63 8.81 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.225 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.523 ' HB2' HD11 ' A' ' 149' ' ' LEU . 71.8 Cg_endo -76.02 128.12 10.47 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.521 2.148 . . . . 0.0 112.169 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.536 ' CZ ' ' HB2' ' A' ' 150' ' ' ASP . 7.7 p90 -120.04 130.56 54.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.73 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' MET . . . . . 0.765 ' HG3' HD11 ' A' ' 72' ' ' ILE . 20.9 mtp -102.2 134.66 45.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.546 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.714 HG23 HD11 ' A' ' 23' ' ' ILE . 96.4 mt -90.45 113.06 25.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.861 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.41 ' HD2' HG23 ' A' ' 31' ' ' VAL . 59.1 m-85 -109.82 154.54 22.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.921 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.419 ' CD2' ' OH ' ' A' ' 95' ' ' TYR . 3.4 m-30 -95.46 126.26 40.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.717 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.446 ' HG3' HD11 ' A' ' 29' ' ' LEU . 0.6 OUTLIER -69.98 -54.91 11.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.306 -179.662 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.472 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 3.2 m-20 -49.11 -37.31 21.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.181 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.4 ' O ' ' HE3' ' A' ' 145' ' ' MET . . . -95.46 26.38 20.03 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.377 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.602 HD21 ' HB3' ' A' ' 4' ' ' TYR . 0.8 OUTLIER -140.77 146.04 37.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.823 0.344 . . . . 0.0 110.787 -179.867 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -119.53 142.75 48.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.845 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . 0.809 ' HB3' HD11 ' A' ' 2' ' ' ILE . 0.1 OUTLIER -109.09 148.57 30.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.992 -179.988 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.832 179.885 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.638 HG23 ' CE1' ' A' ' 4' ' ' TYR . 11.8 tt . . . . . 0 N--CA 1.455 -0.21 0 CA-C-O 120.939 0.399 . . . . 0.0 111.012 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.9 mm -102.27 153.02 5.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.486 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.638 ' CE1' HG23 ' A' ' 2' ' ' ILE . 3.3 m-85 -124.43 101.52 7.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.449 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.36 153.23 34.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.931 0.396 . . . . 0.0 111.398 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.536 ' OD1' HD12 ' A' ' 8' ' ' ILE . 46.3 t0 -59.34 152.05 22.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.646 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 36.6 tp -81.96 -16.91 48.86 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.551 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.536 HD12 ' OD1' ' A' ' 6' ' ' ASP . 4.3 mp -91.41 -50.72 12.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 27.8 t -97.35 -18.04 19.37 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.455 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 9.0 m80 64.73 31.39 11.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.832 0.348 . . . . 0.0 110.865 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -97.77 122.1 40.46 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.738 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -58.16 95.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.32 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 5.1 mtt -74.86 -18.55 60.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.662 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.502 ' CZ ' ' CD2' ' A' ' 4' ' ' TYR . 10.7 p90 -178.87 174.02 1.16 Allowed 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.6 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -132.27 -169.97 2.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.729 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.424 ' HA ' HD11 ' A' ' 20' ' ' ILE . 37.6 t0 -96.29 30.75 2.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.192 0.52 . . . . 0.0 110.736 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.42 HG13 ' CD2' ' A' ' 18' ' ' TYR . 45.5 pt -93.31 -10.25 9.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.659 179.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.796 ' CZ ' HG22 ' A' ' 72' ' ' ILE . 48.4 m-85 -111.87 -169.16 1.41 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.715 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.72 95.48 8.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.84 0.352 . . . . 0.0 110.901 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.424 HD11 ' HA ' ' A' ' 16' ' ' ASP . 4.2 mp -92.41 125.74 45.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.097 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.4 mtp85 -117.19 120.45 38.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.055 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.702 ' HG3' HD23 ' A' ' 29' ' ' LEU . 3.5 mp0 -72.14 114.55 10.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.849 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.597 HD11 HG23 ' A' ' 161' ' ' ILE . 4.2 pt -112.86 167.4 6.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.192 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.436 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . . . 58.06 30.81 19.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.274 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 63.95 44.08 4.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.347 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.21 -17.36 56.04 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 120.735 -0.745 . . . . 0.0 113.142 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.436 ' HB3' ' HB3' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -52.15 -50.4 61.83 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.831 0.348 . . . . 0.0 111.137 -179.872 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 55.3 m -130.18 164.33 24.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.744 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.702 HD23 ' HG3' ' A' ' 22' ' ' GLU . 0.7 OUTLIER -128.6 135.13 48.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.045 -179.724 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -96.7 114.82 26.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.126 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.441 HG21 ' CD2' ' A' ' 14' ' ' PHE . 22.2 t -96.37 112.14 27.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.872 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -91.28 115.48 28.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.115 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -98.94 -131.49 7.31 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.458 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -172.39 124.93 0.5 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.804 0.335 . . . . 0.0 110.939 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 24.4 mtp -74.73 123.93 25.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.91 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.2 m . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.236 -179.894 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 N-CA-C 112.353 -0.299 . . . . 0.0 112.353 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.564 HG22 ' HG3' ' A' ' 158' ' ' PRO . 59.0 t -68.02 148.26 11.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.865 0.364 . . . . 0.0 110.851 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -71.56 -59.12 2.93 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.452 -179.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.796 HG22 ' CZ ' ' A' ' 18' ' ' TYR . 8.9 pt -53.72 -33.94 23.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.437 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.782 HG13 ' HB2' ' A' ' 78' ' ' LEU . 61.5 t -72.72 -34.05 46.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.042 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.1 mtm -78.31 -39.15 40.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.576 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.403 ' OD1' ' CD2' ' A' ' 76' ' ' HIS . 19.8 p30 -82.0 -28.46 32.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.559 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.448 ' CE1' ' HB ' ' A' ' 72' ' ' ILE . 26.7 m170 -92.49 -1.17 57.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.841 0.353 . . . . 0.0 110.801 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.435 ' HB2' ' HB3' ' A' ' 138' ' ' GLU . 21.9 m170 58.0 31.41 20.6 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.074 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.782 ' HB2' HG13 ' A' ' 73' ' ' VAL . 42.6 mt -60.23 142.41 54.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.489 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -125.24 136.56 53.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.304 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.429 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 1.7 tm-20 -91.86 121.06 33.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.863 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.896 HG21 HD11 ' A' ' 136' ' ' ILE . 3.5 t -113.6 127.07 55.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.881 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 70.6 m -68.96 159.15 33.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.887 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.476 ' HB2' ' CD2' ' A' ' 134' ' ' PHE . 0.3 OUTLIER -166.84 152.44 7.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.818 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.26 166.5 11.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.879 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.0 mtmt -63.56 -52.41 61.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.141 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -61.31 -48.29 82.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.928 0.394 . . . . 0.0 110.811 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.29 -40.84 78.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.074 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.902 ' CD2' HD11 ' A' ' 122' ' ' ILE . 0.4 OUTLIER -59.43 -35.88 74.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.762 179.96 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.46 ' O ' HG22 ' A' ' 92' ' ' ILE . 27.2 mttt -58.31 -47.8 82.55 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.187 0.517 . . . . 0.0 110.527 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.6 tmtm? -76.57 -27.82 56.0 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.704 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.54 ' HE2' HG21 ' A' ' 146' ' ' VAL . 11.0 t80 -66.73 -46.87 74.09 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.693 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.46 HG22 ' O ' ' A' ' 89' ' ' LYS . 4.5 tp -59.85 -44.02 93.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.945 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.1 ttmm -59.27 -40.7 86.88 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.205 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.513 ' HA ' ' HG2' ' A' ' 97' ' ' LYS . 47.3 t0 -73.15 -43.21 61.89 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.898 -179.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.45 ' CE2' ' CD1' ' A' ' 92' ' ' ILE . 0.0 OUTLIER -75.35 -39.9 58.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.647 -0.252 . . . . 0.0 111.199 -179.176 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.448 ' HG2' ' O ' ' A' ' 92' ' ' ILE . 15.0 ptm -67.57 -32.22 72.82 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.792 0.33 . . . . 0.0 110.539 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.513 ' HG2' ' HA ' ' A' ' 94' ' ' ASP . 4.6 ptpt -69.91 -34.07 73.01 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.66 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.489 ' N ' ' HG3' ' A' ' 97' ' ' LYS . 2.2 m -61.74 -40.49 95.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.085 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 7.0 mt -79.86 -41.3 21.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.355 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -55.38 -53.91 50.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.521 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' A' ' 104' ' ' GLU . . . -61.5 -45.7 95.84 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.138 179.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.9 tptt -61.41 -39.49 90.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.883 0.373 . . . . 0.0 110.3 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.654 HD21 ' CB ' ' A' ' 110' ' ' ARG . 3.0 tp -68.69 -32.94 73.12 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.025 179.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.66 ' CG ' HG11 ' A' ' 111' ' ' VAL . 83.4 mt-10 -59.99 -30.4 69.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.807 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -88.19 -20.19 25.9 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.605 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 -106.25 -62.82 1.33 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.863 0.363 . . . . 0.0 111.548 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.435 ' N ' ' O ' ' A' ' 103' ' ' LEU . 5.5 mtm180 -126.25 63.43 50.52 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.923 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.86 ' O ' HG22 ' A' ' 111' ' ' VAL . 9.9 Cg_endo -50.62 -22.21 9.0 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 123.233 2.622 . . . . 0.0 112.776 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -74.83 -7.06 52.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.372 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.654 ' CB ' HD21 ' A' ' 103' ' ' LEU . 17.0 mmt180 -113.55 -1.71 14.03 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.681 0.276 . . . . 0.0 111.617 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.86 HG22 ' O ' ' A' ' 108' ' ' PRO . 34.2 m -67.96 -37.78 78.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -179.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.577 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 13.9 mtpt -67.55 -50.48 36.27 Favored Pre-proline 0 CA--C 1.529 0.161 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.617 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.577 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 31.9 Cg_exo -58.06 -33.28 97.13 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.087 1.858 . . . . 0.0 111.521 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.457 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 94.1 t80 -70.48 -40.84 73.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.746 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 15.9 mtm -55.89 -44.77 78.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.761 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 62.9 m -76.51 -44.24 36.05 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.61 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -59.19 -52.04 55.62 Favored Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.768 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.442 ' O ' ' HB ' ' A' ' 122' ' ' ILE . . . -56.89 -51.77 67.77 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.968 0.414 . . . . 0.0 111.117 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.7 -28.09 68.16 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.385 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -74.11 -49.62 23.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.482 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -71.43 -42.48 68.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.437 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.902 HD11 ' CD2' ' A' ' 88' ' ' TYR . 0.3 OUTLIER -56.06 -49.83 73.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.726 -179.4 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.484 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 10.7 ptmt -63.03 -31.2 72.29 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.046 0.451 . . . . 0.0 110.132 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -67.99 -50.14 57.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.78 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.414 HD11 ' HA ' ' A' ' 122' ' ' ILE . 17.4 pt -65.59 -42.57 93.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.319 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.472 HD21 ' CD2' ' A' ' 88' ' ' TYR . 10.6 mt -53.85 -35.14 61.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.878 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -71.21 -10.84 60.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.289 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -144.98 34.01 1.11 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.042 0.449 . . . . 0.0 110.574 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.503 ' CE1' ' CZ ' ' A' ' 134' ' ' PHE . 13.8 t80 -52.17 -25.19 8.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.2 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -55.14 -27.83 48.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.816 0.341 . . . . 0.0 111.156 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 31.9 m-20 -94.29 -37.5 11.48 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.665 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.42 ' HE2' HD11 ' A' ' 161' ' ' ILE . 4.1 m-85 -100.53 135.01 42.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.912 0.387 . . . . 0.0 111.598 -179.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.418 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 2.6 mm100 -115.89 148.77 39.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.8 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.515 ' CE1' ' CZ ' ' A' ' 88' ' ' TYR . 3.7 m-85 -82.07 128.97 34.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.21 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.429 ' CE2' ' HB2' ' A' ' 80' ' ' GLU . 28.4 m-85 -130.72 156.38 45.04 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.609 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.896 HD11 HG21 ' A' ' 81' ' ' THR . 0.5 OUTLIER -142.95 162.31 17.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.935 179.885 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -64.0 -163.45 0.61 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.344 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.435 ' HB3' ' HB2' ' A' ' 77' ' ' HIS . 4.7 pt-20 -73.26 -8.85 57.59 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.595 0.236 . . . . 0.0 111.511 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 18.3 m-80 -98.5 -29.1 13.29 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.597 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . 0.429 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 31.7 mtm 55.44 42.24 30.15 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.905 0.383 . . . . 0.0 111.02 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . 0.406 ' ND2' ' HA3' ' A' ' 144' ' ' GLY . 16.3 p-10 -64.93 114.8 16.26 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.014 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -63.89 -28.95 67.31 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.561 2.174 . . . . 0.0 112.219 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -84.61 -14.48 48.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.169 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.406 ' HA3' ' ND2' ' A' ' 141' ' ' ASN . . . -73.88 -128.6 0.15 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.463 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.42 ' HE3' ' O ' ' A' ' 166' ' ' GLY . 6.6 ptp -126.52 -172.48 2.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.792 0.329 . . . . 0.0 110.859 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.54 HG21 ' HE2' ' A' ' 91' ' ' TYR . 90.5 t -131.54 153.1 38.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.0 0.428 . . . . 0.0 111.355 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.401 ' N ' HG12 ' A' ' 146' ' ' VAL . . . -117.4 123.18 45.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.298 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.523 ' HB2' ' HB ' ' A' ' 161' ' ' ILE . 2.5 mt -96.94 106.26 18.56 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.748 -178.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.504 HD12 ' HG2' ' A' ' 160' ' ' MET . 1.0 OUTLIER -90.63 119.31 30.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.698 179.805 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.495 ' HB3' ' CZ ' ' A' ' 159' ' ' TYR . 12.6 t70 -132.21 164.33 26.61 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.676 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -109.49 150.6 27.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.228 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.82 -176.86 3.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.843 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -56.71 -33.05 66.1 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.929 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -72.21 -15.13 61.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.16 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 65.75 14.64 60.96 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.771 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 94.0 t -112.23 -69.72 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.898 0.38 . . . . 0.0 110.813 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 95.6 m -58.34 109.56 1.92 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.024 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.564 ' HG3' HG22 ' A' ' 70' ' ' VAL . 92.1 Cg_endo -84.41 130.26 4.53 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.542 2.161 . . . . 0.0 112.244 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.495 ' CZ ' ' HB3' ' A' ' 150' ' ' ASP . 9.7 p90 -124.16 132.86 53.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.868 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' MET . . . . . 0.601 ' SD ' HD13 ' A' ' 78' ' ' LEU . 24.4 mtp -104.4 141.09 36.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.133 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.597 HG23 HD11 ' A' ' 23' ' ' ILE . 82.5 mt -97.07 116.17 38.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.193 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -113.69 156.08 24.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.511 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -99.92 126.54 46.07 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.94 0.4 . . . . 0.0 110.974 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 16.4 ttpp -69.17 -53.48 19.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.312 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.457 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 73.3 m-20 -51.39 -38.87 55.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.046 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.42 ' O ' ' HE3' ' A' ' 145' ' ' MET . . . -95.8 25.09 26.7 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.33 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.527 HD21 ' HB3' ' A' ' 4' ' ' TYR . 0.6 OUTLIER -138.96 148.34 43.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.698 0.285 . . . . 0.0 110.83 -179.876 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -112.0 150.61 30.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.106 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . 0.6 ' HB3' HD11 ' A' ' 2' ' ' ILE . 2.1 mtm -124.66 122.82 38.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.622 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.12 -179.833 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.639 HG23 ' CE1' ' A' ' 4' ' ' TYR . 1.1 tt . . . . . 0 N--CA 1.456 -0.154 0 CA-C-O 120.814 0.34 . . . . 0.0 110.908 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.509 ' O ' ' HA ' ' A' ' 169' ' ' MET . 8.1 mm -107.76 121.04 60.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.341 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.639 ' CE1' HG23 ' A' ' 2' ' ' ILE . 11.0 m-85 -91.21 130.3 37.1 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.919 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 17.7 ptt180 -139.22 143.32 37.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.133 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.42 ' O ' ' HA ' ' A' ' 10' ' ' HIS . 36.1 t0 -50.56 151.81 2.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.966 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 66.4 tp -80.69 -25.49 38.14 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.361 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.696 HD11 ' CG1' ' A' ' 99' ' ' ILE . 4.6 mp -91.3 -43.58 14.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.812 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.3 t -90.62 -30.82 16.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.814 0.34 . . . . 0.0 111.399 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.42 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER 66.49 29.37 9.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.918 -179.78 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -104.92 127.2 52.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.668 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -57.2 97.5 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.156 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 12.5 mtp -83.77 -15.57 47.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.972 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.491 ' CE2' ' CG ' ' A' ' 4' ' ' TYR . 44.8 p90 -178.8 161.36 1.23 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.805 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.2 m -126.37 -169.82 2.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.607 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.583 ' HB2' HG22 ' A' ' 2' ' ' ILE . 38.7 t70 -93.8 30.26 1.86 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.02 0.438 . . . . 0.0 110.952 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.4 HD11 ' CZ ' ' A' ' 18' ' ' TYR . 46.2 pt -92.39 -10.52 9.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.573 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.865 ' CZ ' HG22 ' A' ' 72' ' ' ILE . 46.6 m-85 -111.54 -167.02 1.13 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.645 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.3 mtpt -97.52 87.57 4.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.797 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.543 HD12 ' N ' ' A' ' 20' ' ' ILE . 4.2 mp -88.01 134.1 28.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.042 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -128.22 152.7 47.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.755 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.72 ' HG3' HD23 ' A' ' 29' ' ' LEU . 2.3 mp0 -97.7 121.92 40.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.976 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.687 HD11 HG23 ' A' ' 161' ' ' ILE . 4.8 pt -119.1 166.28 13.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.119 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 57.65 30.31 18.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.217 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 63.18 40.77 8.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.307 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.5 -16.65 60.66 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.652 -0.785 . . . . 0.0 113.068 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.87 -34.22 62.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.823 0.312 . . . . 0.0 111.035 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 12.1 m -146.31 161.19 40.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.938 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.72 HD23 ' HG3' ' A' ' 22' ' ' GLU . 0.3 OUTLIER -126.61 129.77 49.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.777 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -94.06 119.92 33.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.21 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 17.5 t -102.12 112.16 34.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.699 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -91.58 116.11 28.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.125 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -94.71 -127.38 5.0 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.365 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.3 ptpt -174.38 122.75 0.29 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.79 0.329 . . . . 0.0 110.944 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 86.7 mtp -70.76 123.32 21.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.787 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.459 HG23 ' CE ' ' A' ' 74' ' ' MET . 5.5 m . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.134 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.286 -0.325 . . . . 0.0 112.286 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.501 HG22 ' HG3' ' A' ' 158' ' ' PRO . 57.1 t -69.49 144.93 13.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.837 0.351 . . . . 0.0 110.909 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -70.14 -57.03 5.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.479 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.865 HG22 ' CZ ' ' A' ' 18' ' ' TYR . 5.6 pt -53.52 -33.78 22.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.315 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.803 HG13 ' HB2' ' A' ' 78' ' ' LEU . 74.4 t -72.39 -34.58 49.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.087 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.459 ' CE ' HG23 ' A' ' 36' ' ' VAL . 2.7 mtm -78.24 -37.23 45.72 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.925 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.415 HD21 ' HA ' ' A' ' 72' ' ' ILE . 16.9 p30 -82.08 -31.59 30.72 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -178.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.462 ' CE1' ' HA ' ' A' ' 14' ' ' PHE . 42.0 m80 -93.58 -2.72 53.84 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.051 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 17.9 m80 61.03 36.57 18.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.164 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.803 ' HB2' HG13 ' A' ' 73' ' ' VAL . 28.8 mt -57.59 156.17 8.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.463 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.414 ' HG3' ' HG3' ' A' ' 140' ' ' MET . 3.9 mm-40 -132.72 135.22 45.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.841 0.353 . . . . 0.0 111.174 -179.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.438 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 5.6 tt0 -101.19 122.5 43.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.822 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.416 HG21 HD11 ' A' ' 136' ' ' ILE . 10.1 t -115.08 153.21 31.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.931 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 29.3 p -88.58 161.5 16.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.914 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.47 ' HB2' ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -165.27 156.21 14.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.874 -179.988 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -99.66 174.05 6.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.904 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -70.3 -52.37 23.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.88 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.98 -43.0 97.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.85 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.15 -42.66 91.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.037 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.912 ' CD2' HD11 ' A' ' 122' ' ' ILE . 0.1 OUTLIER -59.12 -34.94 72.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.862 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.441 ' O ' HG22 ' A' ' 92' ' ' ILE . 22.8 mttm -59.53 -46.16 89.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.126 0.489 . . . . 0.0 110.413 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt -77.08 -27.83 54.39 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.783 178.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.559 ' HE2' HG21 ' A' ' 146' ' ' VAL . 9.5 t80 -67.75 -44.1 78.31 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.876 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.607 HD12 ' CE2' ' A' ' 95' ' ' TYR . 6.1 tp -63.74 -42.58 96.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.911 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -63.45 -37.44 87.28 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.781 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.498 ' HA ' ' HG2' ' A' ' 97' ' ' LYS . 12.4 t70 -77.04 -41.5 42.29 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.7 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.607 ' CE2' HD12 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -77.32 -40.08 45.47 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 121.155 -0.218 . . . . 0.0 110.752 -179.591 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -67.58 -32.1 72.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.645 0.26 . . . . 0.0 110.599 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.498 ' HG2' ' HA ' ' A' ' 94' ' ' ASP . 0.0 OUTLIER -70.2 -34.44 72.94 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.879 0.371 . . . . 0.0 110.491 179.756 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.456 ' N ' ' HG3' ' A' ' 97' ' ' LYS . 2.0 m -61.04 -40.18 92.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.046 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.696 ' CG1' HD11 ' A' ' 8' ' ' ILE . 7.2 mt -79.82 -42.36 22.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.504 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.403 ' O ' ' HG3' ' A' ' 104' ' ' GLU . 12.7 tmtt? -54.43 -55.23 30.91 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.523 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -60.86 -44.8 97.63 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.247 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.27 -41.29 96.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.885 0.374 . . . . 0.0 110.492 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.765 HD21 ' CB ' ' A' ' 110' ' ' ARG . 3.3 tp -68.24 -32.82 73.29 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.169 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.705 ' HG3' HG11 ' A' ' 111' ' ' VAL . 74.6 mt-10 -60.21 -29.66 68.88 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.934 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -88.11 -20.81 25.17 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.569 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -103.74 -57.73 1.99 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.791 0.329 . . . . 0.0 111.665 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.446 ' N ' ' O ' ' A' ' 103' ' ' LEU . 44.7 mtt85 -139.19 68.16 40.35 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.786 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.93 ' O ' HG22 ' A' ' 111' ' ' VAL . 9.9 Cg_endo -50.66 -21.39 7.84 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 123.234 2.623 . . . . 0.0 112.968 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -68.95 -9.99 54.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.591 0.234 . . . . 0.0 111.403 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.765 ' CB ' HD21 ' A' ' 103' ' ' LEU . 0.7 OUTLIER -111.99 -3.01 14.91 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 -179.492 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.93 HG22 ' O ' ' A' ' 108' ' ' PRO . 33.9 m -71.26 -26.93 27.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.641 0.258 . . . . 0.0 111.516 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.601 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -69.38 -55.8 9.21 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.517 -179.279 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.601 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 33.4 Cg_exo -56.92 -37.61 97.89 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.084 1.856 . . . . 0.0 111.739 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.461 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 82.5 t80 -66.64 -37.63 85.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.076 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 6.1 mtp -57.03 -54.68 44.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.956 0.407 . . . . 0.0 110.737 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 75.1 m -72.9 -44.73 60.92 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.696 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.97 -38.24 95.15 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.498 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.96 -51.69 68.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.973 0.416 . . . . 0.0 110.926 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.99 -28.2 63.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.251 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -75.6 -41.21 55.11 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.109 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -74.38 -34.85 63.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.901 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.912 HD11 ' CD2' ' A' ' 88' ' ' TYR . 0.4 OUTLIER -69.95 -45.9 75.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.205 -179.877 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.455 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 5.4 pttp -61.11 -31.83 71.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.993 0.425 . . . . 0.0 110.275 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -67.51 -53.51 28.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.698 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.613 HG21 HD13 ' A' ' 148' ' ' LEU . 15.5 pt -62.12 -42.12 93.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.288 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.475 HD23 ' HA ' ' A' ' 126' ' ' LEU . 11.7 mt -53.99 -35.22 61.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.88 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -70.1 -11.29 60.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.296 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -142.49 33.28 1.46 Allowed 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.968 0.413 . . . . 0.0 110.588 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.497 ' CE1' ' CZ ' ' A' ' 134' ' ' PHE . 12.4 t80 -49.71 -26.79 4.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.24 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.91 -29.37 69.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.05 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 28.5 m-20 -94.21 -29.86 14.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.451 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.448 ' CD2' HG22 ' A' ' 125' ' ' ILE . 2.5 m-85 -98.47 138.41 35.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.877 0.37 . . . . 0.0 111.295 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.4 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 2.0 mm100 -123.07 144.1 49.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.721 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.517 ' CE1' ' CZ ' ' A' ' 88' ' ' TYR . 3.2 m-85 -82.09 123.75 29.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.118 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.438 ' CE2' ' HB2' ' A' ' 80' ' ' GLU . 25.4 m-85 -127.86 140.74 51.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.599 179.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.419 ' HB ' ' HA ' ' A' ' 140' ' ' MET . 0.5 OUTLIER -131.29 160.99 41.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.691 -179.981 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -57.37 -169.58 0.14 Allowed Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.524 -0.846 . . . . 0.0 111.879 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.05 -8.91 57.28 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.582 0.23 . . . . 0.0 111.329 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 26.7 m-80 -94.31 -30.28 14.61 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.41 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . 0.419 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 70.7 mtm 55.84 44.51 25.85 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.773 0.32 . . . . 0.0 111.256 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.67 117.38 50.16 Favored Pre-proline 0 N--CA 1.453 -0.296 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.625 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -63.2 -23.23 72.82 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.323 2.015 . . . . 0.0 111.854 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -84.72 -15.4 45.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.646 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -77.78 -159.7 12.47 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.276 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.457 ' HE3' ' O ' ' A' ' 166' ' ' GLY . 3.6 ptp -98.75 -174.4 2.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.793 0.33 . . . . 0.0 110.796 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.559 HG21 ' HE2' ' A' ' 91' ' ' TYR . 49.1 t -128.83 152.47 37.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.165 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.488 ' HB1' ' HE3' ' A' ' 160' ' ' MET . . . -114.64 119.23 36.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.656 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.613 HD13 HG21 ' A' ' 125' ' ' ILE . 3.0 mt -93.48 106.29 18.27 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.192 -179.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.591 HD12 ' HG2' ' A' ' 160' ' ' MET . 2.0 tp -90.82 119.12 30.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.149 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.469 ' HB2' ' CZ ' ' A' ' 159' ' ' TYR . 0.9 OUTLIER -125.99 159.5 32.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.745 179.7 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -109.7 138.13 46.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.887 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.93 -173.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.784 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.3 -41.07 83.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.905 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -67.87 -15.1 63.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.163 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 68.71 20.04 73.75 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.69 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 94.2 t -112.85 -70.04 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.859 0.362 . . . . 0.0 110.751 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 88.7 m -57.59 108.91 1.42 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.891 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.548 ' HB2' HD11 ' A' ' 149' ' ' LEU . 90.8 Cg_endo -86.71 127.86 2.78 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.723 2.282 . . . . 0.0 112.44 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.469 ' CZ ' ' HB2' ' A' ' 150' ' ' ASP . 16.0 p90 -121.67 132.15 54.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.797 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' MET . . . . . 0.591 ' HG2' HD12 ' A' ' 149' ' ' LEU . 0.9 OUTLIER -101.8 140.87 35.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.071 -179.818 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.687 HG23 HD11 ' A' ' 23' ' ' ILE . 57.4 mt -96.77 121.61 47.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.242 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.47 ' CZ ' ' HE3' ' A' ' 160' ' ' MET . 43.0 m-85 -119.63 156.49 30.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.698 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -102.16 118.63 37.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.858 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 40.9 tttt -61.12 -49.98 75.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.235 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.461 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 32.5 m-20 -55.26 -40.34 70.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.243 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.457 ' O ' ' HE3' ' A' ' 145' ' ' MET . . . -95.74 25.18 26.22 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.66 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.561 HD21 ' HB3' ' A' ' 4' ' ' TYR . 4.9 tt -150.19 148.71 29.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.88 0.372 . . . . 0.0 110.949 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -133.95 150.61 51.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.395 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . 0.509 ' HA ' ' O ' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -135.47 160.25 39.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.805 0.336 . . . . 0.0 111.261 -179.796 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.462 0.126 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.547 -179.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.795 HG23 ' CE1' ' A' ' 4' ' ' TYR . 1.0 OUTLIER . . . . . 0 N--CA 1.457 -0.082 0 CA-C-O 120.888 0.375 . . . . 0.0 111.082 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.518 ' O ' ' HA ' ' A' ' 169' ' ' MET . 10.1 mm -103.39 119.54 52.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.981 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.795 ' CE1' HG23 ' A' ' 2' ' ' ILE . 17.4 m-85 -93.44 128.98 39.75 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.93 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.9 ptt-85 -136.31 144.77 44.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.969 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -52.53 138.01 28.88 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.833 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.419 HD11 HE22 ' A' ' 106' ' ' GLN . 59.9 tp -71.34 -23.65 61.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.291 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.499 ' N ' HD12 ' A' ' 8' ' ' ILE . 4.3 mp -91.2 -43.64 14.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.805 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.8 m -90.28 -29.4 18.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.391 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 32.3 m80 68.28 30.25 5.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.858 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -111.03 126.21 54.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.655 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -56.0 112.92 1.32 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.266 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 7.2 mtt -96.37 -16.61 21.17 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.908 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.436 ' HA ' ' CE1' ' A' ' 76' ' ' HIS . 37.8 p90 179.9 152.99 0.48 Allowed 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 120.875 0.369 . . . . 0.0 111.0 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.417 ' HB3' HD13 ' A' ' 3' ' ' ILE . 0.9 OUTLIER -112.86 -169.8 1.55 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.417 179.629 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.712 ' HB2' HG22 ' A' ' 2' ' ' ILE . 31.2 t70 -94.98 34.6 1.35 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.948 0.404 . . . . 0.0 110.819 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.518 HD11 ' CZ ' ' A' ' 18' ' ' TYR . 41.6 pt -95.43 -7.81 9.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.742 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.776 ' CZ ' HG22 ' A' ' 72' ' ' ILE . 37.2 m-85 -113.63 -167.38 1.19 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.696 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.52 86.95 3.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.855 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.462 ' H ' HD12 ' A' ' 20' ' ' ILE . 4.6 mp -89.77 124.01 42.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.086 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -118.16 140.25 50.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.987 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.706 ' HG3' HD23 ' A' ' 29' ' ' LEU . 1.1 mp0 -84.57 116.06 22.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.76 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.442 HD11 HG23 ' A' ' 161' ' ' ILE . 4.6 pt -113.4 166.85 6.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.13 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.522 ' HB2' ' NE2' ' A' ' 121' ' ' GLN . . . 59.53 30.57 20.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.086 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 64.83 47.24 2.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.332 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.91 -8.32 73.55 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.718 -0.753 . . . . 0.0 113.358 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.479 ' HB3' ' HB3' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -60.95 -52.36 65.36 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.818 0.342 . . . . 0.0 111.071 -179.915 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 11.7 m -125.98 163.53 22.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.067 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.706 HD23 ' HG3' ' A' ' 22' ' ' GLU . 0.3 OUTLIER -126.42 133.45 51.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.735 179.909 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -99.83 112.94 25.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.05 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 159' ' ' TYR . 20.4 t -92.35 111.94 25.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.697 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -87.78 110.91 20.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.17 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -95.68 -133.55 7.47 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.29 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.4 pttt -174.46 123.99 0.29 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.882 0.373 . . . . 0.0 110.884 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 71.3 mtm -70.91 112.63 7.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.815 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.0 m . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.153 -179.997 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.407 -0.277 . . . . 0.0 112.407 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.578 HG12 HG12 ' A' ' 72' ' ' ILE . 46.2 t -72.59 135.4 27.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.808 0.337 . . . . 0.0 110.662 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -64.05 -54.76 29.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.782 -179.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.776 HG22 ' CZ ' ' A' ' 18' ' ' TYR . 8.1 pt -53.85 -33.93 24.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.907 0.384 . . . . 0.0 111.267 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.756 HG13 ' HB2' ' A' ' 78' ' ' LEU . 84.2 t -73.59 -35.0 43.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.906 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 5.0 mtm -78.3 -38.83 41.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.788 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.402 ' OD1' ' CD2' ' A' ' 76' ' ' HIS . 22.3 p30 -82.1 -29.44 31.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.655 -179.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.436 ' CE1' ' HA ' ' A' ' 14' ' ' PHE . 26.2 m170 -92.55 -2.58 56.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.775 0.322 . . . . 0.0 110.806 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.512 ' HB2' ' HB3' ' A' ' 138' ' ' GLU . 49.5 m80 59.28 35.12 23.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.043 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.756 ' HB2' HG13 ' A' ' 73' ' ' VAL . 41.5 mt -61.13 141.15 57.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.515 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -120.83 132.33 54.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.011 -179.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.417 ' HG3' ' CE1' ' A' ' 135' ' ' PHE . 10.1 tt0 -91.04 124.48 35.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.91 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.901 HG21 HD11 ' A' ' 136' ' ' ILE . 1.4 t -117.23 172.33 7.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.835 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.6 p -107.24 170.69 7.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.006 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.481 ' HB2' ' CE2' ' A' ' 134' ' ' PHE . 0.6 OUTLIER -171.65 152.43 3.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.859 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.8 m -99.87 158.09 16.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.839 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 33.8 mtmt -57.69 -52.5 65.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.917 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.9 tm-20 -65.88 -45.0 83.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.727 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.66 -33.88 72.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.059 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.88 ' CD2' HD11 ' A' ' 122' ' ' ILE . 0.7 OUTLIER -65.03 -37.42 87.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.713 179.902 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.436 ' O ' HG22 ' A' ' 92' ' ' ILE . 50.4 mttm -58.19 -45.51 87.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.099 0.476 . . . . 0.0 110.333 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.7 mmtp -76.66 -27.8 55.75 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.742 178.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.537 ' HE2' HG21 ' A' ' 146' ' ' VAL . 8.4 t80 -67.61 -45.38 75.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.76 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.676 HD12 ' CE2' ' A' ' 95' ' ' TYR . 5.2 tp -61.74 -42.2 93.45 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 CA-C-O 120.888 0.375 . . . . 0.0 110.82 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.494 ' O ' ' CG ' ' A' ' 97' ' ' LYS . 3.6 ttpm? -63.39 -44.9 93.37 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.812 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -70.29 -38.9 75.1 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.866 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.676 ' CE2' HD12 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -78.12 -42.94 30.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.694 -0.23 . . . . 0.0 110.648 -179.513 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -62.72 -31.85 72.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.865 0.364 . . . . 0.0 110.078 179.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.494 ' CG ' ' O ' ' A' ' 93' ' ' LYS . 2.5 mmtp -65.73 -43.83 87.84 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.595 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.6 m -54.36 -40.47 68.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.601 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.483 ' CG1' HD11 ' A' ' 8' ' ' ILE . 7.8 mt -79.92 -43.13 22.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.678 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 15.0 tttt -53.19 -55.86 20.98 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.559 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -62.49 -45.07 96.64 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.308 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.78 -37.47 84.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.847 0.355 . . . . 0.0 110.465 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.671 HD21 ' CB ' ' A' ' 110' ' ' ARG . 2.8 tp -70.94 -32.08 68.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.135 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.627 ' CG ' HG11 ' A' ' 111' ' ' VAL . 30.0 mt-10 -60.59 -30.25 69.7 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.872 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -89.68 -20.04 24.12 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.543 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.419 HE22 HD11 ' A' ' 7' ' ' LEU . 21.7 mt-30 -106.01 -62.8 1.33 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.816 0.341 . . . . 0.0 111.413 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.434 ' N ' ' O ' ' A' ' 103' ' ' LEU . 16.7 mtt180 -127.53 63.58 59.85 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.891 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.883 ' O ' HG22 ' A' ' 111' ' ' VAL . 10.2 Cg_endo -50.86 -21.92 9.19 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 123.145 2.563 . . . . 0.0 112.82 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -71.35 -11.29 60.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.673 -0.24 . . . . 0.0 111.467 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.671 ' CB ' HD21 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -112.26 1.06 15.97 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 -179.289 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.883 HG22 ' O ' ' A' ' 108' ' ' PRO . 34.4 m -68.36 -35.72 71.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -179.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.573 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 18.4 mttt -68.69 -50.6 24.12 Favored Pre-proline 0 C--N 1.331 -0.209 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.609 -179.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.573 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 32.3 Cg_exo -57.98 -33.24 96.94 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.11 1.873 . . . . 0.0 111.813 179.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.452 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 86.3 t80 -69.71 -41.72 75.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.15 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -55.45 -49.27 72.91 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.928 0.394 . . . . 0.0 110.871 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 82.4 m -70.98 -44.36 66.12 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.725 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.03 -39.21 97.77 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.644 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.4 ' O ' ' HB ' ' A' ' 122' ' ' ILE . . . -57.88 -51.54 69.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.94 0.4 . . . . 0.0 111.161 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.1 -28.29 66.36 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.306 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.07 -58.86 3.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.24 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.522 ' NE2' ' HB2' ' A' ' 24' ' ' ALA . 3.5 tp-100 -56.03 -42.66 76.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.218 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.88 HD11 ' CD2' ' A' ' 88' ' ' TYR . 0.3 OUTLIER -61.62 -45.54 98.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.193 -179.828 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.44 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 12.5 mttm -59.98 -31.9 70.34 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.179 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -67.56 -54.52 19.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.806 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.972 HG21 HD13 ' A' ' 148' ' ' LEU . 11.9 pt -61.04 -40.77 86.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.218 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 126' ' ' LEU . 11.8 mt -53.95 -37.59 64.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.705 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.6 -15.04 60.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.269 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -138.59 34.6 2.23 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.1 0.476 . . . . 0.0 110.423 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -48.09 -43.34 30.65 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.295 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.3 mmmp? -62.13 -19.88 63.5 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.302 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -93.99 -41.09 9.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.724 0.297 . . . . 0.0 111.317 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.413 ' CD2' ' OD1' ' A' ' 150' ' ' ASP . 3.9 m-85 -89.0 145.31 25.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.126 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.412 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 2.6 mm100 -122.31 145.92 47.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.807 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.481 ' CE2' ' HB2' ' A' ' 83' ' ' PHE . 2.9 m-85 -86.37 129.47 34.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.118 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.417 ' CE1' ' HG3' ' A' ' 80' ' ' GLU . 51.8 m-85 -130.98 132.25 44.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.769 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.901 HD11 HG21 ' A' ' 81' ' ' THR . 0.4 OUTLIER -121.84 159.31 24.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.681 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -56.67 -171.96 0.16 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.428 -0.891 . . . . 0.0 111.844 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.512 ' HB3' ' HB2' ' A' ' 77' ' ' HIS . 0.0 OUTLIER -70.68 -8.93 55.6 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.571 0.224 . . . . 0.0 111.42 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -93.65 -26.91 16.85 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.673 0.273 . . . . 0.0 111.108 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . 0.445 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 52.0 mtm 51.62 43.96 29.47 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.442 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -68.77 120.04 73.22 Favored Pre-proline 0 N--CA 1.452 -0.335 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.595 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -60.08 -26.39 82.35 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.279 1.986 . . . . 0.0 111.856 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -84.71 -15.86 43.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.739 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.17 -168.34 10.77 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.404 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 2.0 ptp -93.2 -177.33 4.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.819 0.342 . . . . 0.0 110.811 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.537 HG21 ' HE2' ' A' ' 91' ' ' TYR . 74.8 t -126.64 145.26 34.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.11 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.621 ' HB2' ' CE1' ' A' ' 162' ' ' PHE . . . -112.08 112.27 23.78 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.567 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.972 HD13 HG21 ' A' ' 125' ' ' ILE . 4.9 mt -86.76 108.28 18.63 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.193 -179.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.45 ' HB2' ' HE2' ' A' ' 160' ' ' MET . 1.5 tp -91.03 119.54 31.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.122 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.465 ' HB3' ' CE1' ' A' ' 159' ' ' TYR . 0.5 OUTLIER -133.08 174.52 10.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.642 179.55 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -117.26 143.68 45.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.846 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 11.8 mmm180 -56.78 -175.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.058 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -56.3 -31.46 63.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.9 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -78.48 -15.01 59.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.153 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 70.67 21.74 77.89 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.66 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 89.1 t -112.47 -69.2 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.861 0.362 . . . . 0.0 110.823 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 91.0 m -57.61 109.17 1.58 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.945 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -81.24 127.3 5.89 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.484 2.123 . . . . 0.0 112.331 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.465 ' CE1' ' HB3' ' A' ' 150' ' ' ASP . 13.0 p90 -125.35 148.28 48.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.755 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' MET . . . . . 0.627 ' HE1' HD13 ' A' ' 78' ' ' LEU . 0.4 OUTLIER -111.69 142.86 43.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.028 -179.756 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.532 ' HB ' ' HB2' ' A' ' 148' ' ' LEU . 41.9 mt -99.08 120.44 48.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.24 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.621 ' CE1' ' HB2' ' A' ' 147' ' ' ALA . 99.1 m-85 -125.93 150.17 48.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.643 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -97.45 119.16 35.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.898 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 43.1 tttt -56.27 -53.94 51.28 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.334 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.452 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 44.9 m-20 -53.82 -37.49 63.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.19 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.476 ' HA2' HG23 ' A' ' 99' ' ' ILE . . . -95.27 24.42 29.07 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.57 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.723 HD21 ' HB3' ' A' ' 4' ' ' TYR . 5.8 tt -150.15 140.11 21.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.842 0.353 . . . . 0.0 110.74 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -120.16 142.96 48.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.58 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . 0.518 ' HA ' ' O ' ' A' ' 3' ' ' ILE . 0.1 OUTLIER -136.73 160.2 39.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.735 0.302 . . . . 0.0 111.145 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.404 ' O ' HG13 ' A' ' 2' ' ' ILE . 1.5 pt-20 . . . . . 0 N--CA 1.462 0.173 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.366 -179.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.716 HD11 ' HB3' ' A' ' 169' ' ' MET . 1.8 tt . . . . . 0 N--CA 1.454 -0.249 0 CA-C-O 120.735 0.303 . . . . 0.0 111.055 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.408 ' CG2' ' HB3' ' A' ' 12' ' ' GLU . 16.9 mm -102.14 146.5 10.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.877 0.37 . . . . 0.0 111.518 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.552 ' HE1' HG23 ' A' ' 2' ' ' ILE . 4.9 m-85 -115.96 100.15 7.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.422 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 1.1 ptt180 -116.34 147.9 41.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.881 0.372 . . . . 0.0 111.344 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.458 ' O ' ' HA ' ' A' ' 10' ' ' HIS . 44.7 t0 -57.04 152.17 13.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.749 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.558 HD23 HG23 ' A' ' 99' ' ' ILE . 59.0 tp -81.32 -21.09 39.46 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.53 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.658 HD11 ' CG1' ' A' ' 99' ' ' ILE . 4.3 mp -91.29 -47.77 14.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -179.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.414 ' HB2' ' ND2' ' A' ' 141' ' ' ASN . 3.0 t -96.41 -17.54 20.53 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -179.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.458 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 0.3 OUTLIER 61.98 28.59 17.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.855 0.359 . . . . 0.0 110.774 -179.727 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -98.17 121.71 40.44 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.762 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.408 ' HB3' ' CG2' ' A' ' 3' ' ' ILE . 0.3 OUTLIER -58.17 93.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.282 -179.756 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 7.7 mtt -71.87 -19.44 61.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.664 179.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.518 ' CZ ' ' CD2' ' A' ' 4' ' ' TYR . 7.4 p90 -177.86 176.86 1.14 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.667 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.422 ' O ' HD11 ' A' ' 20' ' ' ILE . 0.9 OUTLIER -133.71 -169.99 2.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.953 -179.886 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.406 ' HB2' HG22 ' A' ' 2' ' ' ILE . 22.6 t70 -94.42 25.08 4.08 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.98 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.43 HG13 ' CD2' ' A' ' 18' ' ' TYR . 20.8 pt -82.39 -15.49 11.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.525 179.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.839 ' CE2' HG22 ' A' ' 72' ' ' ILE . 78.4 m-85 -108.84 -174.45 2.52 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.516 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.1 mttp -94.66 88.53 5.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.849 0.357 . . . . 0.0 110.718 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.422 HD11 ' O ' ' A' ' 15' ' ' SER . 4.1 mp -87.94 132.5 32.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.167 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 8.0 mtt180 -124.68 139.68 53.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.807 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.49 122.32 28.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.996 0.427 . . . . 0.0 110.943 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.9 pt -117.37 167.47 10.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.027 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.472 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . . . 60.08 27.09 16.5 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.072 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 66.92 55.96 0.7 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.338 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 77.12 0.34 70.07 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 120.853 -0.689 . . . . 0.0 113.422 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.472 ' HB3' ' HB3' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -70.44 -58.23 3.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 117.082 0.441 . . . . 0.0 111.04 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 35.2 m -118.95 164.82 14.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.997 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.698 HD11 ' CG ' ' A' ' 164' ' ' LYS . 0.4 OUTLIER -126.32 133.18 51.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.862 -179.931 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -99.06 112.83 24.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.968 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.481 HG21 ' CD2' ' A' ' 14' ' ' PHE . 26.1 t -92.04 111.86 24.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.625 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -80.88 114.08 19.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.252 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -99.19 -141.46 12.27 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.214 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -174.42 126.88 0.33 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.823 0.344 . . . . 0.0 110.978 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 27.7 mtp -68.36 122.58 18.68 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.522 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.1 m . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.465 -179.63 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.496 0 N-CA-C 112.047 -0.421 . . . . 0.0 112.047 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.579 HG12 HG12 ' A' ' 72' ' ' ILE . 40.8 t -73.2 130.32 35.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.887 0.375 . . . . 0.0 110.847 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -59.26 -55.3 36.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.64 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.839 HG22 ' CE2' ' A' ' 18' ' ' TYR . 6.9 pt -54.01 -36.72 32.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.544 -179.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.796 HG13 ' HB2' ' A' ' 78' ' ' LEU . 97.2 t -70.37 -31.47 46.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.197 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.5 mtm -78.22 -40.47 37.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.786 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.426 ' ND2' ' HA ' ' A' ' 72' ' ' ILE . 0.3 OUTLIER -82.0 -29.33 32.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.546 -179.23 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.446 ' CE1' ' HB ' ' A' ' 72' ' ' ILE . 29.6 m170 -89.95 -5.11 57.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.869 0.366 . . . . 0.0 110.752 179.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.433 ' HB2' ' HB3' ' A' ' 138' ' ' GLU . 28.6 m-70 61.74 28.42 17.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.916 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.842 HD13 ' CE ' ' A' ' 160' ' ' MET . 34.2 mt -59.87 152.87 22.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.588 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -138.73 145.84 40.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.799 0.333 . . . . 0.0 111.175 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.421 ' HB2' ' CZ ' ' A' ' 135' ' ' PHE . 0.2 OUTLIER -99.41 133.18 44.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.079 -179.924 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.445 HG21 HD11 ' A' ' 136' ' ' ILE . 9.7 t -117.15 166.9 11.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.755 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 66.8 m -98.38 158.28 15.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.04 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.456 ' HB2' ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -171.78 150.1 2.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.823 179.934 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 54.7 p -99.92 169.61 9.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.821 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -63.17 -52.44 62.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.923 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -60.67 -45.41 94.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.921 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.434 ' HB1' ' CE1' ' A' ' 83' ' ' PHE . . . -59.78 -41.12 90.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.962 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.793 ' CD2' HD11 ' A' ' 122' ' ' ILE . 0.2 OUTLIER -58.03 -36.14 72.29 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.894 179.938 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.442 ' O ' HG22 ' A' ' 92' ' ' ILE . 36.3 mttm -60.12 -51.11 71.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.069 0.461 . . . . 0.0 110.482 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.1 mttm -72.93 -27.7 62.0 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.591 178.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.566 ' HE2' HG21 ' A' ' 146' ' ' VAL . 7.5 t80 -64.23 -48.03 77.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.975 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.459 ' CD1' ' CE2' ' A' ' 95' ' ' TYR . 3.1 tp -61.43 -41.91 91.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.733 0.301 . . . . 0.0 111.174 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.445 ' O ' ' CG ' ' A' ' 97' ' ' LYS . 4.6 ttmt -61.17 -46.08 91.98 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.969 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -70.79 -36.86 73.22 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.93 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.532 ' CD1' ' C ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -76.34 -43.11 42.56 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 121.189 -0.205 . . . . 0.0 110.744 -179.544 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.3 ptp -65.07 -32.03 73.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.92 0.391 . . . . 0.0 110.279 179.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.445 ' CG ' ' O ' ' A' ' 93' ' ' LYS . 0.1 OUTLIER -64.01 -44.2 93.33 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.867 179.751 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.4 m -56.47 -43.2 79.38 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.874 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.658 ' CG1' HD11 ' A' ' 8' ' ' ILE . 6.5 mt -79.85 -40.59 20.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.682 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.2 tttt -55.09 -53.47 55.51 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.574 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -62.94 -46.42 93.61 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.334 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.1 tppm? -60.53 -40.85 92.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.858 0.361 . . . . 0.0 110.422 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.727 HD21 ' CB ' ' A' ' 110' ' ' ARG . 3.0 tp -66.52 -35.25 79.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.26 179.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.645 ' CG ' HG11 ' A' ' 111' ' ' VAL . 36.2 mt-10 -59.13 -29.38 67.35 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.684 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -88.52 -18.69 27.62 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.617 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -108.56 -61.8 1.55 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.838 0.351 . . . . 0.0 111.586 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.429 ' N ' ' O ' ' A' ' 103' ' ' LEU . 19.9 mtt85 -130.1 65.07 74.6 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.777 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.919 ' O ' HG22 ' A' ' 111' ' ' VAL . 9.4 Cg_endo -50.54 -23.33 10.55 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 123.087 2.525 . . . . 0.0 112.652 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -69.1 -13.9 62.7 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.64 0.257 . . . . 0.0 111.15 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.727 ' CB ' HD21 ' A' ' 103' ' ' LEU . 6.8 mmm-85 -106.21 -1.79 23.19 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -179.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.919 HG22 ' O ' ' A' ' 108' ' ' PRO . 24.3 m -71.37 -27.03 27.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.685 0.279 . . . . 0.0 111.521 -179.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.6 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 0.8 OUTLIER -70.37 -55.42 7.78 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.578 -179.291 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.6 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 47.1 Cg_exo -55.37 -40.88 83.2 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.182 1.922 . . . . 0.0 111.975 179.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.45 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 75.6 t80 -65.47 -38.36 89.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.166 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.05 -54.85 40.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.001 0.429 . . . . 0.0 110.926 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.446 HG22 ' OE1' ' A' ' 120' ' ' GLU . 62.7 m -74.37 -44.65 51.28 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.768 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.4 -41.78 98.67 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.644 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.18 -51.57 69.43 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.059 0.457 . . . . 0.0 111.072 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.15 -28.15 65.12 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.325 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.446 ' OE1' HG22 ' A' ' 116' ' ' THR . 11.4 mt-10 -77.93 -43.65 29.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.4 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.447 ' NE2' ' HB2' ' A' ' 24' ' ' ALA . 4.9 tp-100 -71.27 -31.56 67.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.117 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.793 HD11 ' CD2' ' A' ' 88' ' ' TYR . 0.4 OUTLIER -70.56 -45.93 72.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.36 -179.782 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.45 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 12.1 pttt -60.75 -31.22 70.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.067 0.461 . . . . 0.0 110.365 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -68.36 -54.05 19.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.64 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.797 HG21 HD13 ' A' ' 148' ' ' LEU . 15.2 pt -61.67 -42.61 94.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.261 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' A' ' 126' ' ' LEU . 11.4 mt -54.19 -35.48 62.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.969 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -69.89 -11.29 60.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.343 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 -142.07 32.83 1.55 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.884 0.373 . . . . 0.0 110.599 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.5 ' CE1' ' CZ ' ' A' ' 134' ' ' PHE . 4.5 t80 -52.2 -26.1 10.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.088 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 6.8 mttt -59.17 -30.43 68.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.929 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -94.28 -37.86 11.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.324 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.412 ' HE2' HD11 ' A' ' 161' ' ' ILE . 15.1 m-85 -91.09 135.51 33.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.835 0.35 . . . . 0.0 111.21 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 -121.94 145.8 47.75 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.911 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.508 ' CE1' ' CZ ' ' A' ' 88' ' ' TYR . 1.3 m-85 -78.06 125.95 30.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.85 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.423 ' O ' ' HB3' ' A' ' 147' ' ' ALA . 10.7 m-85 -130.77 137.38 49.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.623 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.465 ' HB ' ' HA ' ' A' ' 140' ' ' MET . 0.9 OUTLIER -126.87 161.69 33.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.956 -179.964 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.79 -164.95 0.35 Allowed Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.44 -0.886 . . . . 0.0 111.968 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.433 ' HB3' ' HB2' ' A' ' 77' ' ' HIS . 1.2 pt-20 -72.37 -8.87 57.28 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.594 0.235 . . . . 0.0 111.507 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -96.25 -29.26 14.12 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.594 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . 0.465 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 75.7 mtp 56.37 46.53 20.77 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.903 0.382 . . . . 0.0 110.997 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . 0.419 ' ND2' ' HA3' ' A' ' 144' ' ' GLY . 13.0 p-10 -69.08 114.48 23.69 Favored Pre-proline 0 N--CA 1.452 -0.338 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.951 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 141' ' ' ASN . 16.3 Cg_exo -66.25 -29.39 46.87 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.633 2.222 . . . . 0.0 112.245 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -84.64 -5.25 59.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.47 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.419 ' HA3' ' ND2' ' A' ' 141' ' ' ASN . . . -87.7 -143.38 8.44 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.456 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 2.8 ptp -106.22 -179.17 3.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.824 0.345 . . . . 0.0 110.863 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.566 HG21 ' HE2' ' A' ' 91' ' ' TYR . 53.5 t -128.52 148.2 32.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.225 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.57 ' HB1' ' SD ' ' A' ' 160' ' ' MET . . . -110.67 114.78 28.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.511 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.797 HD13 HG21 ' A' ' 125' ' ' ILE . 3.8 mt -88.5 106.19 18.12 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.088 -179.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.481 HD12 ' HG2' ' A' ' 160' ' ' MET . 4.4 tp -90.37 119.72 30.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.366 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.538 ' HB3' ' CE1' ' A' ' 159' ' ' TYR . 4.7 t70 -138.54 167.41 21.99 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.533 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -105.2 151.71 23.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.865 0.364 . . . . 0.0 111.166 -179.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 12.2 mmt85 -70.31 -175.47 1.0 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.838 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -56.92 -31.05 64.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.063 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -74.43 -15.15 60.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.288 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 74.24 7.29 77.2 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.803 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 72.7 t -110.23 -66.92 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.924 0.393 . . . . 0.0 110.94 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 84.9 m -52.96 107.18 0.78 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.261 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -84.65 129.03 4.09 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.622 2.214 . . . . 0.0 112.245 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.538 ' CE1' ' HB3' ' A' ' 150' ' ' ASP . 8.4 p90 -126.51 147.04 49.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.929 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' MET . . . . . 0.842 ' CE ' HD13 ' A' ' 78' ' ' LEU . 0.8 OUTLIER -113.14 145.4 41.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.241 -179.659 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.516 ' HB ' ' HB2' ' A' ' 148' ' ' LEU . 85.0 mt -98.44 112.84 31.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.032 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.526 ' CE1' ' HB2' ' A' ' 147' ' ' ALA . 62.2 m-85 -118.81 121.0 39.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.679 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -68.98 124.4 23.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.047 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.698 ' CG ' HD11 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -69.86 -41.98 74.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.16 -179.738 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.45 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 2.1 m-20 -55.97 -29.61 60.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.919 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -108.95 29.47 9.73 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.354 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.411 HD21 ' HB3' ' A' ' 4' ' ' TYR . 0.6 OUTLIER -139.48 148.43 42.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.827 0.346 . . . . 0.0 110.785 -179.9 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -111.74 155.43 23.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.009 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . 0.716 ' HB3' HD11 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -125.35 137.84 54.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.875 179.998 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.963 -179.967 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.52 HG23 ' HE1' ' A' ' 4' ' ' TYR . 0.8 OUTLIER . . . . . 0 N--CA 1.456 -0.168 0 CA-C-O 120.863 0.363 . . . . 0.0 110.814 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.526 ' O ' ' HA ' ' A' ' 169' ' ' MET . 4.6 mm -106.11 122.69 60.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.766 -179.347 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.521 ' HD2' HD21 ' A' ' 167' ' ' LEU . 3.9 m-85 -90.09 130.22 36.29 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.563 179.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.97 157.5 45.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.966 0.412 . . . . 0.0 111.438 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.437 ' O ' ' HA ' ' A' ' 10' ' ' HIS . 36.8 t0 -63.41 152.18 38.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.721 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.653 HD23 HG23 ' A' ' 99' ' ' ILE . 61.3 tp -80.51 -24.83 39.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.312 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.906 HD11 ' CG1' ' A' ' 99' ' ' ILE . 4.1 mp -91.43 -45.28 14.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.02 -28.49 17.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.486 -179.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.437 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 0.2 OUTLIER 66.45 29.55 9.14 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.849 0.356 . . . . 0.0 110.785 -179.782 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -101.16 130.5 47.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.716 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.2 pm0 -61.95 88.49 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.31 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 10.5 mtt -71.42 -17.93 62.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.66 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.499 ' CE2' ' CG ' ' A' ' 4' ' ' TYR . 43.5 p90 -178.62 177.22 0.92 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.676 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.4 m -136.71 -169.8 2.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.943 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.434 ' HB2' ' CG2' ' A' ' 2' ' ' ILE . 40.2 t0 -93.26 23.57 4.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.018 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.435 HG13 ' CD2' ' A' ' 18' ' ' TYR . 45.4 pt -87.55 -9.84 10.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.756 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.887 ' CZ ' HG22 ' A' ' 72' ' ' ILE . 76.1 m-85 -111.14 -170.77 1.7 Allowed 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.765 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.6 mttm -97.07 91.28 5.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.734 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.44 HD12 ' N ' ' A' ' 20' ' ' ILE . 4.9 mp -87.93 123.96 40.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.015 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 15.9 mtp180 -120.55 117.62 28.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.811 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -72.1 117.48 13.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.938 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.403 HG12 ' HG3' ' A' ' 30' ' ' GLU . 1.6 pt -110.95 171.12 3.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.947 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.414 ' HB2' ' NE2' ' A' ' 121' ' ' GLN . . . 56.59 33.98 23.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.068 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 64.5 42.84 4.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.183 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.08 -12.95 62.71 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.785 -0.722 . . . . 0.0 113.195 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.532 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -55.93 -33.36 64.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.902 0.351 . . . . 0.0 111.285 -179.859 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 34.3 m -142.21 164.29 30.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.021 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.838 HD11 ' CG ' ' A' ' 164' ' ' LYS . 1.0 OUTLIER -128.32 130.85 48.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.994 -179.915 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.403 ' HG3' HG12 ' A' ' 23' ' ' ILE . 59.3 mt-10 -95.56 112.97 24.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.071 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 159' ' ' TYR . 23.3 t -91.55 111.87 24.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.362 179.39 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -85.5 118.36 24.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.381 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -106.34 -142.91 11.09 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.098 179.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.8 pttt -174.44 123.46 0.29 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.793 0.33 . . . . 0.0 111.187 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 76.5 mtm -65.95 118.62 10.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.538 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.486 ' O ' HG23 ' A' ' 36' ' ' VAL . 31.1 m . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 120.899 0.38 . . . . 0.0 111.53 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.369 0 N-CA-C 112.264 -0.334 . . . . 0.0 112.264 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.596 HG12 HG12 ' A' ' 72' ' ' ILE . 46.3 t -70.96 130.5 34.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.878 0.37 . . . . 0.0 110.725 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.4 ' O ' ' ND2' ' A' ' 75' ' ' ASN . 5.3 t0 -58.17 -58.77 6.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.862 -179.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.887 HG22 ' CZ ' ' A' ' 18' ' ' TYR . 8.5 pt -53.64 -33.81 23.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.678 -179.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.762 HG13 ' HB2' ' A' ' 78' ' ' LEU . 89.9 t -72.77 -34.28 46.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.878 0.37 . . . . 0.0 111.011 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 14.9 mtm -78.24 -39.24 40.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.716 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.403 ' OD1' ' CD2' ' A' ' 76' ' ' HIS . 19.9 p30 -82.15 -29.33 31.65 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -179.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.457 ' CE1' ' HB ' ' A' ' 72' ' ' ILE . 26.0 m170 -92.05 -0.55 57.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.81 0.338 . . . . 0.0 110.787 179.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.406 ' HB2' ' HB3' ' A' ' 138' ' ' GLU . 30.3 m-70 57.84 31.85 21.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.057 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.762 ' HB2' HG13 ' A' ' 73' ' ' VAL . 58.6 mt -58.63 147.39 32.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.582 179.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -128.39 133.91 48.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.915 0.388 . . . . 0.0 111.054 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.414 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 28.9 tt0 -90.24 132.37 35.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.061 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.1 t -121.9 -172.96 2.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.872 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 83.1 p -128.79 168.23 16.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.957 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.499 ' CE2' ' CE2' ' A' ' 91' ' ' TYR . 1.1 m-85 -171.71 157.34 4.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.991 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.34 164.5 11.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.789 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.34 -52.45 65.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.83 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -67.21 -38.94 86.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.725 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.62 -37.13 86.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.992 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.929 ' CD2' HD11 ' A' ' 122' ' ' ILE . 0.1 OUTLIER -63.01 -37.37 86.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.804 -179.999 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.439 ' O ' HG22 ' A' ' 92' ' ' ILE . 58.3 mttt -59.03 -45.43 90.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.084 0.468 . . . . 0.0 110.361 179.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.35 -27.82 52.8 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.643 178.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.539 ' HE2' HG21 ' A' ' 146' ' ' VAL . 9.3 t80 -66.88 -44.72 80.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.753 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.65 HD12 ' CE2' ' A' ' 95' ' ' TYR . 5.7 tp -63.36 -43.11 98.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.95 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.1 ttpt -62.28 -40.79 97.41 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.752 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.514 ' HA ' ' HG2' ' A' ' 97' ' ' LYS . 27.6 t0 -72.92 -43.94 61.82 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.762 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.65 ' CE2' HD12 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -75.82 -40.16 55.42 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 121.063 -0.255 . . . . 0.0 110.99 -179.386 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.57 -32.01 72.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.697 0.284 . . . . 0.0 110.661 179.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.514 ' HG2' ' HA ' ' A' ' 94' ' ' ASP . 0.0 OUTLIER -69.19 -34.22 74.56 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.829 0.347 . . . . 0.0 110.272 179.695 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.472 ' N ' ' HG3' ' A' ' 97' ' ' LYS . 1.0 OUTLIER -61.36 -41.03 96.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.969 179.316 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.906 ' CG1' HD11 ' A' ' 8' ' ' ILE . 9.3 mt -79.94 -42.86 22.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.564 179.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.91 -49.16 69.22 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.597 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -64.6 -50.44 58.99 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.667 -0.777 . . . . 0.0 112.207 179.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 2.2 tptt -59.84 -40.98 90.35 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.947 0.403 . . . . 0.0 110.426 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.59 ' HB3' HG12 ' A' ' 111' ' ' VAL . 12.3 tp -63.84 -41.1 97.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.043 179.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.667 ' HG3' HG11 ' A' ' 111' ' ' VAL . 32.2 mt-10 -55.2 -28.59 54.15 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.809 179.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -89.71 -16.57 30.08 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.784 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.461 ' NE2' HD11 ' A' ' 7' ' ' LEU . 15.0 mt-30 -114.27 -60.81 1.83 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.747 0.308 . . . . 0.0 111.538 -179.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.456 ' N ' ' O ' ' A' ' 103' ' ' LEU . 0.9 OUTLIER -123.96 62.01 26.21 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.821 -179.801 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.877 ' O ' HG22 ' A' ' 111' ' ' VAL . 10.0 Cg_endo -50.8 -23.6 11.85 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 123.042 2.495 . . . . 0.0 112.566 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -74.44 -8.03 54.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.295 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.512 ' C ' ' HD2' ' A' ' 113' ' ' PRO . 1.1 mmt180 -111.22 -1.22 16.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.59 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.877 HG22 ' O ' ' A' ' 108' ' ' PRO . 31.1 m -72.49 -33.17 44.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.564 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 1.9 mtpt -68.39 -49.97 29.79 Favored Pre-proline 0 C--N 1.331 -0.205 0 N-CA-C 111.649 0.24 . . . . 0.0 111.649 -179.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.564 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 30.0 Cg_exo -61.77 -33.72 84.68 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.087 1.858 . . . . 0.0 111.938 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.45 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 87.8 t80 -72.07 -36.5 69.56 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.012 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 5.5 mmm -58.02 -53.0 63.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.941 0.4 . . . . 0.0 110.855 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 71.8 m -73.06 -44.41 60.66 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.673 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.98 -37.57 95.17 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.577 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.42 ' O ' ' HB ' ' A' ' 122' ' ' ILE . . . -60.0 -51.65 68.74 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.961 0.41 . . . . 0.0 110.928 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.73 -28.12 62.46 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.425 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.404 ' O ' ' HG2' ' A' ' 123' ' ' LYS . 0.6 OUTLIER -77.92 -42.4 33.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.206 -179.711 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.414 ' NE2' ' HB2' ' A' ' 24' ' ' ALA . 6.7 tp-100 -72.11 -34.78 68.87 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.035 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.929 HD11 ' CD2' ' A' ' 88' ' ' TYR . 0.4 OUTLIER -68.27 -46.3 81.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.39 -179.81 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.451 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 0.4 OUTLIER -59.76 -32.13 70.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.062 0.458 . . . . 0.0 110.116 179.448 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -66.67 -54.3 24.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.618 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.862 HG21 HD13 ' A' ' 148' ' ' LEU . 13.0 pt -61.77 -39.98 85.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.058 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 11.4 mt -53.67 -35.69 61.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.567 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.5 -14.95 62.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.885 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -133.11 32.28 3.75 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.047 0.451 . . . . 0.0 110.243 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -49.08 -35.56 16.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.179 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.4 -20.78 60.66 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.162 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -89.18 -35.53 16.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.41 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.457 ' CD1' ' N ' ' A' ' 132' ' ' TYR . 1.7 m-30 -104.21 151.37 23.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.864 0.364 . . . . 0.0 111.313 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.416 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 4.9 mm100 -123.89 150.69 44.35 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.913 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.514 ' CE1' ' CZ ' ' A' ' 88' ' ' TYR . 4.6 m-85 -86.16 132.38 34.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.144 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.515 ' O ' ' HB3' ' A' ' 147' ' ' ALA . 28.8 m-85 -136.93 130.11 31.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.58 179.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.458 ' HB ' ' HA ' ' A' ' 140' ' ' MET . 0.8 OUTLIER -122.09 167.33 15.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.892 -179.81 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.42 -170.84 0.84 Allowed Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.475 -0.869 . . . . 0.0 111.927 179.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.406 ' HB3' ' HB2' ' A' ' 77' ' ' HIS . 1.9 pt-20 -68.92 -11.17 60.36 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.621 0.248 . . . . 0.0 111.389 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -92.39 -33.51 14.53 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.606 0.241 . . . . 0.0 111.242 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . 0.458 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 75.2 mtm 58.34 41.78 22.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.341 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -70.14 118.18 61.37 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.793 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -64.61 -21.65 65.33 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.331 2.021 . . . . 0.0 111.831 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -84.59 -12.06 54.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.755 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -81.31 -137.12 2.11 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.256 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.557 ' HE3' ' O ' ' A' ' 166' ' ' GLY . 3.7 ptp -120.65 178.89 4.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.781 0.324 . . . . 0.0 110.704 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.539 HG21 ' HE2' ' A' ' 91' ' ' TYR . 65.9 t -124.41 147.67 28.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.987 0.422 . . . . 0.0 111.193 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.604 ' HB2' ' CE2' ' A' ' 162' ' ' PHE . . . -113.27 110.2 19.99 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.364 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.862 HD13 HG21 ' A' ' 125' ' ' ILE . 4.4 mt -83.57 106.17 15.09 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.143 -179.093 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.486 HD12 ' HG2' ' A' ' 160' ' ' MET . 2.2 tp -88.71 119.91 29.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.954 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.497 ' HB2' ' CZ ' ' A' ' 159' ' ' TYR . 62.8 m-20 -130.31 161.86 30.3 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.574 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.406 ' HB3' ' HA2' ' A' ' 155' ' ' GLY . 80.1 m-85 -104.34 151.98 22.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.087 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 3.9 mmt180 -59.36 -176.92 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.0 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -60.9 -40.96 95.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.977 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -79.76 -15.07 58.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.312 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.406 ' HA2' ' HB3' ' A' ' 151' ' ' TYR . . . 78.68 33.07 39.16 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.597 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 93.8 t -113.44 -60.96 2.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.841 0.353 . . . . 0.0 111.11 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 51.5 m -80.55 112.56 32.37 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.341 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -82.37 134.28 7.73 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.558 2.172 . . . . 0.0 112.04 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.497 ' CZ ' ' HB2' ' A' ' 150' ' ' ASP . 5.7 p90 -130.51 142.59 50.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.041 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' MET . . . . . 0.563 ' CE ' HD13 ' A' ' 78' ' ' LEU . 0.3 OUTLIER -107.14 143.42 35.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.025 -179.899 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.528 ' HB ' ' HB2' ' A' ' 148' ' ' LEU . 73.4 mt -101.81 112.01 33.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.157 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.604 ' CE2' ' HB2' ' A' ' 147' ' ' ALA . 81.0 m-85 -114.23 157.62 22.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.756 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -100.5 122.82 43.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.952 0.406 . . . . 0.0 110.812 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.838 ' CG ' HD11 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -66.12 -50.49 63.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.245 -179.672 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.45 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 1.7 m-20 -52.14 -30.48 26.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.12 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.557 ' O ' ' HE3' ' A' ' 145' ' ' MET . . . -108.21 27.75 13.44 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.236 179.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.521 HD21 ' HD2' ' A' ' 4' ' ' TYR . 0.7 OUTLIER -150.15 142.69 24.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.82 0.343 . . . . 0.0 110.736 -179.861 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -130.45 156.18 45.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.611 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . 0.526 ' HA ' ' O ' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -140.16 160.29 40.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.116 179.973 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 . . . . . 0 C--O 1.233 0.186 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.477 -179.161 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.723 HD11 ' HB3' ' A' ' 169' ' ' MET . 1.9 tt . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.842 0.353 . . . . 0.0 111.002 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.419 ' CG2' ' HB3' ' A' ' 12' ' ' GLU . 16.3 mm -104.25 155.75 5.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.348 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.592 ' HE1' HG23 ' A' ' 2' ' ' ILE . 4.4 m-85 -124.19 106.62 10.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.73 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 27.7 ptt180 -122.66 146.74 47.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.148 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.563 ' OD1' HD12 ' A' ' 8' ' ' ILE . 49.2 t0 -58.05 143.36 43.72 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.8 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 59.8 tp -73.37 -21.96 60.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.328 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.69 HD11 ' CG1' ' A' ' 99' ' ' ILE . 4.2 mp -91.32 -45.72 14.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.8 -179.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.94 -20.27 19.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.76 -179.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.445 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 14.7 m170 61.24 28.86 18.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.91 0.386 . . . . 0.0 110.717 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -102.08 120.29 40.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.761 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.419 ' HB3' ' CG2' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -56.66 88.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.392 -179.731 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.411 ' O ' ' CG ' ' A' ' 76' ' ' HIS . 7.8 mtt -66.46 -24.22 66.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.721 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.507 ' CZ ' ' CD2' ' A' ' 4' ' ' TYR . 25.6 p90 -173.49 179.65 2.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.696 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -135.24 -169.97 2.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.774 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -94.85 23.98 5.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.023 0.439 . . . . 0.0 110.948 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.429 HG13 ' CD2' ' A' ' 18' ' ' TYR . 39.6 pt -82.03 -15.03 12.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.632 179.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.837 ' CE2' HG22 ' A' ' 72' ' ' ILE . 82.4 m-85 -108.12 -174.27 2.48 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.586 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.4 mmtp -93.19 86.43 5.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.746 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.574 HD12 ' N ' ' A' ' 20' ' ' ILE . 3.9 mp -87.83 125.54 41.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.939 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.4 mmm180 -117.77 129.97 56.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.997 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -80.59 116.53 20.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.707 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.402 HG12 ' HG3' ' A' ' 30' ' ' GLU . 2.9 pt -110.93 173.39 2.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.017 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.492 ' HB2' ' NE2' ' A' ' 121' ' ' GLN . . . 56.39 28.42 13.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.166 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.414 ' HB2' ' O ' ' A' ' 24' ' ' ALA . 5.4 m-20 66.06 54.38 1.0 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.238 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 76.61 1.78 72.77 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.894 -0.669 . . . . 0.0 113.415 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.477 ' HB3' ' HB3' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -71.84 -43.47 65.48 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 117.056 0.428 . . . . 0.0 111.083 -179.962 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 10.1 m -132.17 161.76 32.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.096 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.625 HD11 ' HG3' ' A' ' 164' ' ' LYS . 1.1 mt -127.1 127.74 45.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.823 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.402 ' HG3' HG12 ' A' ' 23' ' ' ILE . 56.4 mt-10 -97.38 112.96 24.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.137 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.402 HG21 ' CD2' ' A' ' 14' ' ' PHE . 24.2 t -92.23 111.97 25.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.567 179.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -82.03 125.17 30.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.228 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -112.07 -141.15 8.26 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.177 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.9 pttp -174.57 126.49 0.31 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.816 0.341 . . . . 0.0 111.132 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 95.1 mtp -67.78 111.28 4.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.631 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 28.9 m . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.453 -179.776 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.369 0 N-CA-C 112.286 -0.326 . . . . 0.0 112.286 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.798 HG22 ' HG2' ' A' ' 158' ' ' PRO . 43.0 t -73.2 129.84 35.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.792 0.33 . . . . 0.0 110.771 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.4 ' N ' ' OD1' ' A' ' 71' ' ' ASP . 20.3 p-10 -59.6 -55.49 33.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.793 -179.144 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.837 HG22 ' CE2' ' A' ' 18' ' ' TYR . 8.7 pt -53.78 -33.94 24.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.833 0.349 . . . . 0.0 111.411 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.782 HG13 ' HB2' ' A' ' 78' ' ' LEU . 93.8 t -72.44 -32.1 40.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.919 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.2 mtm -78.21 -40.07 38.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.496 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.41 ' OD1' ' CD2' ' A' ' 76' ' ' HIS . 15.2 p30 -82.12 -28.46 32.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.568 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.44 ' CE1' ' HB ' ' A' ' 72' ' ' ILE . 24.8 m170 -94.29 1.1 55.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.806 0.336 . . . . 0.0 110.963 179.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.409 ' HB2' ' HB3' ' A' ' 138' ' ' GLU . 89.9 m-70 56.13 30.16 15.91 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.321 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.782 ' HB2' HG13 ' A' ' 73' ' ' VAL . 67.1 mt -60.17 134.46 57.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.604 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -123.91 139.38 54.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.863 0.363 . . . . 0.0 111.196 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.43 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 2.0 tt0 -90.83 130.7 36.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.958 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.837 HG21 HD11 ' A' ' 136' ' ' ILE . 9.9 t -122.14 137.06 54.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.821 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.0 m -77.57 159.16 29.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.028 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.473 ' CE2' ' HB1' ' A' ' 87' ' ' ALA . 0.3 OUTLIER -167.61 149.24 5.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.822 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.88 166.63 13.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.965 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.7 mttp -64.98 -52.55 55.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.764 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -62.67 -41.69 99.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.959 0.409 . . . . 0.0 110.591 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.473 ' HB1' ' CE2' ' A' ' 83' ' ' PHE . . . -59.28 -39.44 82.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.91 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.84 ' CD2' HD11 ' A' ' 122' ' ' ILE . 0.5 OUTLIER -59.78 -37.17 78.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.575 179.807 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.415 ' O ' HG22 ' A' ' 92' ' ' ILE . 67.6 mttt -56.61 -49.81 73.85 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.112 0.482 . . . . 0.0 110.189 179.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.71 -27.83 60.55 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.521 178.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.537 ' HE2' HG21 ' A' ' 146' ' ' VAL . 6.3 t80 -64.62 -47.63 77.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.814 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.57 HD12 ' CE2' ' A' ' 95' ' ' TYR . 4.8 tp -61.47 -43.97 97.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.98 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.431 ' O ' ' HB3' ' A' ' 97' ' ' LYS . 8.8 ttmm -60.17 -40.66 90.71 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.236 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.453 ' O ' ' HG3' ' A' ' 97' ' ' LYS . 9.4 t0 -73.71 -43.06 60.27 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.984 -179.227 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.57 ' CE2' HD12 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -76.82 -39.59 50.8 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.087 -179.207 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.449 ' HG2' ' O ' ' A' ' 92' ' ' ILE . 6.2 ptt? -67.72 -32.13 72.55 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.929 -0.308 . . . . 0.0 110.69 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.471 ' HG3' ' N ' ' A' ' 98' ' ' SER . 0.0 OUTLIER -70.43 -33.66 71.59 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.517 179.88 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.471 ' N ' ' HG3' ' A' ' 97' ' ' LYS . 1.5 m -62.65 -40.76 98.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.037 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.69 ' CG1' HD11 ' A' ' 8' ' ' ILE . 7.4 mt -79.86 -41.5 21.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.281 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.7 tttt -56.21 -57.15 13.42 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.442 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -59.6 -42.84 97.96 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.24 179.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.59 -36.37 83.54 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.885 0.374 . . . . 0.0 110.45 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.841 HD21 ' CB ' ' A' ' 110' ' ' ARG . 3.9 tp -72.6 -32.43 65.97 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.056 0.455 . . . . 0.0 109.9 179.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.611 ' CG ' HG11 ' A' ' 111' ' ' VAL . 69.1 mt-10 -60.62 -31.57 70.74 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.674 179.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -87.89 -21.58 24.89 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.654 -179.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -105.55 -62.42 1.36 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.78 0.324 . . . . 0.0 111.456 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.449 ' N ' ' O ' ' A' ' 103' ' ' LEU . 0.5 OUTLIER -128.54 63.56 65.04 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.96 -179.761 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.927 ' O ' HG22 ' A' ' 111' ' ' VAL . 10.3 Cg_endo -50.97 -22.66 10.67 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 123.114 2.543 . . . . 0.0 112.73 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -68.43 -12.24 60.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.606 0.241 . . . . 0.0 111.335 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.841 ' CB ' HD21 ' A' ' 103' ' ' LEU . 0.4 OUTLIER -108.03 -1.21 20.72 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -179.562 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.927 HG22 ' O ' ' A' ' 108' ' ' PRO . 22.4 m -72.71 -32.33 40.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -179.262 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.554 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 11.9 mtpt -68.99 -50.09 23.0 Favored Pre-proline 0 C--N 1.331 -0.205 0 C-N-CA 120.941 -0.304 . . . . 0.0 111.529 -179.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.554 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 24.2 Cg_exo -63.56 -29.6 70.53 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.138 1.892 . . . . 0.0 111.578 179.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.499 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 54.2 t80 -72.24 -42.31 65.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.016 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -55.48 -47.3 76.36 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.013 0.435 . . . . 0.0 110.757 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 60.1 m -76.08 -44.33 39.39 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.888 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.35 -46.81 93.1 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.774 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.4 ' O ' ' HB ' ' A' ' 122' ' ' ILE . . . -57.07 -51.82 67.77 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.028 0.442 . . . . 0.0 111.223 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.22 -28.22 67.89 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.39 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -77.72 -43.25 31.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.255 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.492 ' NE2' ' HB2' ' A' ' 24' ' ' ALA . 3.1 tp-100 -73.17 -37.83 66.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.048 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.84 HD11 ' CD2' ' A' ' 88' ' ' TYR . 0.3 OUTLIER -66.13 -46.39 87.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.299 -179.888 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.457 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 17.5 pttt -60.64 -31.88 71.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.181 179.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -66.9 -54.05 26.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.774 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.562 HG21 HD13 ' A' ' 148' ' ' LEU . 13.6 pt -61.75 -40.77 88.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.155 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.42 ' HA ' HD23 ' A' ' 126' ' ' LEU . 11.7 mt -53.85 -36.43 62.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.828 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -67.4 -13.96 62.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.191 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -141.44 36.28 1.67 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.935 0.397 . . . . 0.0 110.464 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.517 ' CE1' ' CZ ' ' A' ' 134' ' ' PHE . 4.0 t80 -49.66 -29.55 7.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.17 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 5.8 mtmp? -64.98 -21.32 66.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.192 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 32.5 m-20 -94.07 -38.02 11.33 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.287 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.409 ' CD2' ' OD1' ' A' ' 150' ' ' ASP . 4.1 m-85 -99.02 140.77 32.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.15 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.4 mm100 -118.48 145.91 44.91 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.981 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.517 ' CZ ' ' CE1' ' A' ' 129' ' ' PHE . 2.5 m-85 -82.71 122.43 28.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.945 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.43 ' CE2' ' HB2' ' A' ' 80' ' ' GLU . 28.6 m-85 -124.19 146.38 48.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.628 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.837 HD11 HG21 ' A' ' 81' ' ' THR . 0.8 OUTLIER -134.28 162.85 38.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.972 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -62.64 -164.38 0.43 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.191 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.409 ' HB3' ' HB2' ' A' ' 77' ' ' HIS . 7.5 pt-20 -72.48 -8.94 57.69 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.533 0.206 . . . . 0.0 111.476 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 19.4 m-80 -95.81 -31.49 13.14 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.647 0.26 . . . . 0.0 111.523 -179.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . 0.454 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 32.7 mtm 56.93 41.41 27.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.885 0.374 . . . . 0.0 111.02 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . 0.404 ' ND2' ' HA3' ' A' ' 144' ' ' GLY . 15.7 p-10 -66.93 116.03 31.22 Favored Pre-proline 0 N--CA 1.451 -0.42 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.8 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 141' ' ' ASN . 24.2 Cg_exo -61.7 -27.84 81.55 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.52 2.147 . . . . 0.0 112.155 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -84.52 -4.85 59.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.018 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.404 ' HA3' ' ND2' ' A' ' 141' ' ' ASN . . . -90.1 -175.54 45.17 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.385 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -77.19 177.77 7.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.877 0.37 . . . . 0.0 110.855 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.537 HG21 ' HE2' ' A' ' 91' ' ' TYR . 47.4 t -124.34 152.5 30.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.166 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.764 ' HB1' ' HE2' ' A' ' 160' ' ' MET . . . -116.11 117.42 30.03 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.569 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.562 HD13 HG21 ' A' ' 125' ' ' ILE . 3.5 mt -91.51 108.22 19.75 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.244 -179.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.461 HD12 ' HG2' ' A' ' 160' ' ' MET . 1.3 tp -92.51 119.46 32.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.35 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.474 ' HB2' ' CZ ' ' A' ' 159' ' ' TYR . 1.0 OUTLIER -129.66 163.6 25.74 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.475 179.332 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -102.91 145.78 29.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.909 0.385 . . . . 0.0 111.052 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.17 -177.01 0.11 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.908 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -57.87 -41.31 82.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.901 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -71.51 -15.08 62.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.171 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 77.36 18.32 78.18 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.738 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 83.7 t -113.41 -73.63 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.794 0.33 . . . . 0.0 110.911 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 83.9 m -53.67 103.13 0.35 Allowed Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.235 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.798 ' HG2' HG22 ' A' ' 70' ' ' VAL . 6.0 Cg_exo -78.81 130.36 9.58 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.76 2.306 . . . . 0.0 111.952 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.474 ' CZ ' ' HB2' ' A' ' 150' ' ' ASP . 11.0 p90 -120.75 137.49 54.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.85 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' MET . . . . . 0.764 ' HE2' ' HB1' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -103.85 134.58 46.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.374 -179.373 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.558 ' HB ' ' HB2' ' A' ' 148' ' ' LEU . 51.0 mt -93.2 123.8 45.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.869 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.53 ' CE1' ' HB2' ' A' ' 147' ' ' ALA . 71.2 m-85 -129.51 126.73 39.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.182 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.431 ' CE2' ' OH ' ' A' ' 95' ' ' TYR . 4.1 m-30 -72.66 123.8 24.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.577 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.625 ' HG3' HD11 ' A' ' 29' ' ' LEU . 3.0 ttmm -60.56 -56.39 21.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.523 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.499 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 2.4 m-20 -48.63 -36.17 15.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.851 0.358 . . . . 0.0 111.286 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -94.25 28.6 10.42 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.412 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.464 HD11 ' HB3' ' A' ' 4' ' ' TYR . 1.0 OUTLIER -150.01 142.89 24.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.73 0.3 . . . . 0.0 110.837 -179.858 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.02 155.74 21.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.799 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . 0.723 ' HB3' HD11 ' A' ' 2' ' ' ILE . 0.1 OUTLIER -121.32 145.52 47.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.931 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.881 -179.992 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.723 HD11 ' HB3' ' A' ' 169' ' ' MET . 2.1 tt . . . . . 0 N--CA 1.457 -0.09 0 CA-C-O 120.818 0.342 . . . . 0.0 110.983 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.467 HG21 ' HB3' ' A' ' 12' ' ' GLU . 16.4 mm -104.79 156.82 5.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.276 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.605 ' HE1' HG23 ' A' ' 2' ' ' ILE . 4.9 m-85 -125.75 99.14 5.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.611 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 27.1 ptt180 -113.34 147.32 37.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.136 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.542 ' OD1' HD12 ' A' ' 8' ' ' ILE . 47.3 t0 -56.95 152.16 13.43 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.8 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 61.1 tp -81.39 -20.27 40.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.377 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.542 HD12 ' OD1' ' A' ' 6' ' ' ASP . 4.0 mp -91.34 -47.31 14.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -179.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.47 -20.5 19.0 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.44 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 36.6 m80 63.96 28.93 14.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.9 0.381 . . . . 0.0 110.749 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -102.0 122.57 44.33 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.793 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.467 ' HB3' HG21 ' A' ' 3' ' ' ILE . 5.5 pm0 -57.96 92.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.251 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 9.7 mtt -72.84 -16.88 61.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.918 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.496 ' CE2' ' CD2' ' A' ' 4' ' ' TYR . 19.1 p90 -177.44 174.16 1.61 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.708 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -133.36 -172.3 2.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.863 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -92.52 17.88 9.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.099 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 46.7 pt -79.12 -15.11 13.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.967 0.413 . . . . 0.0 110.649 179.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.939 ' CE2' HG22 ' A' ' 72' ' ' ILE . 70.7 m-85 -108.07 -174.52 2.54 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.529 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.406 ' HB2' ' HB2' ' A' ' 32' ' ' GLU . 4.9 mttp -96.16 93.37 6.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.879 0.371 . . . . 0.0 110.581 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.568 HD12 ' N ' ' A' ' 20' ' ' ILE . 4.1 mp -87.81 134.62 27.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.178 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.58 122.87 37.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.838 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -77.82 116.45 18.35 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.876 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.634 HD11 HG23 ' A' ' 161' ' ' ILE . 1.4 pt -109.72 168.97 3.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.072 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.579 ' HB2' ' NE2' ' A' ' 121' ' ' GLN . . . 59.59 31.08 20.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.952 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 65.61 47.39 2.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.179 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.13 -8.23 68.06 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.809 -0.71 . . . . 0.0 113.38 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.441 ' HB3' ' HB3' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -60.94 -39.01 87.86 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.904 0.352 . . . . 0.0 111.239 -179.838 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 28.2 m -135.47 162.53 32.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.162 -179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.772 HD11 ' HG3' ' A' ' 164' ' ' LYS . 0.5 OUTLIER -126.18 132.86 51.71 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.74 179.886 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.429 ' HG3' HG12 ' A' ' 23' ' ' ILE . 18.9 mt-10 -102.19 116.24 32.23 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.257 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.4 t -90.25 112.13 24.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.706 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.406 ' HB2' ' HB2' ' A' ' 19' ' ' LYS . 18.1 mt-10 -83.55 115.16 21.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.147 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.57 -143.64 11.91 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.114 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.4 126.84 0.33 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.929 0.395 . . . . 0.0 110.955 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 42.3 mtp -70.83 115.01 9.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.626 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.491 HG23 ' CE ' ' A' ' 74' ' ' MET . 4.8 m . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.402 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 N-CA-C 112.435 -0.266 . . . . 0.0 112.435 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.703 HG22 ' HG3' ' A' ' 158' ' ' PRO . 60.8 t -68.52 135.89 27.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.916 0.389 . . . . 0.0 110.775 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -59.23 -57.55 12.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.653 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.939 HG22 ' CE2' ' A' ' 18' ' ' TYR . 5.3 pt -53.95 -33.82 24.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.497 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.805 HG13 ' HB2' ' A' ' 78' ' ' LEU . 92.3 t -75.0 -30.87 24.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.071 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.491 ' CE ' HG23 ' A' ' 36' ' ' VAL . 1.8 mtm -78.16 -41.51 34.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.902 -179.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.428 ' OD1' ' CD2' ' A' ' 76' ' ' HIS . 15.0 p30 -82.11 -30.35 31.22 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -179.057 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.432 ' CE1' ' HA ' ' A' ' 14' ' ' PHE . 36.3 m80 -91.87 -0.13 57.5 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.856 0.36 . . . . 0.0 110.923 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 9.8 m80 55.8 34.94 24.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.256 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.805 ' HB2' HG13 ' A' ' 73' ' ' VAL . 46.5 mt -58.59 147.32 32.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.553 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -131.82 139.0 48.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.893 0.377 . . . . 0.0 111.148 -179.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.428 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 4.7 tt0 -92.68 131.89 37.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.001 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.494 HG21 HD11 ' A' ' 136' ' ' ILE . 7.8 t -122.33 151.81 40.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.768 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 62.3 m -90.47 159.01 16.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.084 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.537 ' CE2' ' HB1' ' A' ' 87' ' ' ALA . 0.2 OUTLIER -170.02 137.83 1.64 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.76 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -85.39 173.79 10.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.938 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.2 mttp -66.92 -52.31 44.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.949 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -58.46 -46.1 87.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.893 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.537 ' HB1' ' CE2' ' A' ' 83' ' ' PHE . . . -58.67 -40.75 84.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.038 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.859 ' CD2' HD11 ' A' ' 122' ' ' ILE . 0.1 OUTLIER -59.05 -36.93 75.85 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.843 179.851 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -57.39 -48.52 78.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.159 0.504 . . . . 0.0 110.354 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.8 mmtt -76.47 -27.89 56.31 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.441 178.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.583 ' HE2' HG21 ' A' ' 146' ' ' VAL . 4.6 t80 -64.99 -46.57 80.87 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.615 179.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.626 HD12 ' CE2' ' A' ' 95' ' ' TYR . 4.5 tp -61.43 -46.52 96.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.849 0.357 . . . . 0.0 110.75 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.414 ' O ' ' HB3' ' A' ' 97' ' ' LYS . 18.9 ttpp -59.25 -38.62 80.51 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.952 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.433 ' HA ' ' HG2' ' A' ' 97' ' ' LYS . 31.5 t70 -73.89 -44.98 53.56 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.054 -179.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.626 ' CE2' HD12 ' A' ' 92' ' ' ILE . 0.1 OUTLIER -76.18 -38.48 56.56 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.292 -179.236 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.42 ' HG2' ' O ' ' A' ' 92' ' ' ILE . 4.0 ptt? -67.39 -32.15 72.85 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.471 179.471 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.504 ' HG3' ' N ' ' A' ' 98' ' ' SER . 0.0 OUTLIER -70.48 -33.45 71.26 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.912 0.387 . . . . 0.0 110.482 179.681 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.504 ' N ' ' HG3' ' A' ' 97' ' ' LYS . 1.7 m -64.17 -40.51 96.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.227 179.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.523 HG23 ' HA2' ' A' ' 166' ' ' GLY . 7.9 mt -79.72 -40.4 21.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.298 179.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -56.1 -54.38 45.73 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.411 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -60.81 -45.74 95.88 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.923 179.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.69 -40.73 96.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.926 0.393 . . . . 0.0 110.207 179.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.607 HD21 ' CB ' ' A' ' 110' ' ' ARG . 3.4 tp -66.5 -36.59 83.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.029 179.224 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.619 ' CG ' HG11 ' A' ' 111' ' ' VAL . 63.2 mt-10 -58.39 -29.12 65.8 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.768 179.447 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -87.01 -20.71 26.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.503 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -106.52 -61.33 1.54 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.727 0.298 . . . . 0.0 111.633 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.439 ' N ' ' O ' ' A' ' 103' ' ' LEU . 91.7 mtm-85 -131.64 65.58 76.22 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.859 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.888 ' O ' HG22 ' A' ' 111' ' ' VAL . 9.4 Cg_endo -50.5 -23.45 10.66 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 123.105 2.537 . . . . 0.0 112.617 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -70.87 -12.06 61.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.68 0.276 . . . . 0.0 111.038 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.607 ' CB ' HD21 ' A' ' 103' ' ' LEU . 6.0 mmm180 -106.66 0.57 24.45 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.764 -179.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.888 HG22 ' O ' ' A' ' 108' ' ' PRO . 22.8 m -73.09 -33.29 41.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.547 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 12.7 mtmm -66.48 -50.02 49.4 Favored Pre-proline 0 C--N 1.332 -0.181 0 C-N-CA 121.022 -0.271 . . . . 0.0 111.583 -179.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.547 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 27.1 Cg_exo -62.18 -34.8 77.92 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.254 1.969 . . . . 0.0 111.702 179.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -68.31 -38.03 81.21 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.833 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -59.88 -47.17 86.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.021 0.439 . . . . 0.0 110.823 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 63.6 m -76.29 -44.65 36.07 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.69 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.63 -41.01 99.22 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.512 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.0 -47.2 86.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.058 0.456 . . . . 0.0 111.042 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.492 ' HB1' ' CE ' ' A' ' 123' ' ' LYS . . . -70.45 -29.87 66.55 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.188 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -73.65 -52.94 11.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.98 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.579 ' NE2' ' HB2' ' A' ' 24' ' ' ALA . 3.3 tp-100 -60.74 -45.63 93.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.932 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.859 HD11 ' CD2' ' A' ' 88' ' ' TYR . 0.3 OUTLIER -59.93 -45.4 95.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.936 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.492 ' CE ' ' HB1' ' A' ' 119' ' ' ALA . 15.1 mttm -60.49 -30.75 69.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.196 179.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -68.88 -54.46 15.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.669 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.746 HG21 HD13 ' A' ' 148' ' ' LEU . 11.6 pt -60.68 -40.5 84.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.064 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 11.5 mt -53.95 -38.59 65.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.704 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -68.52 -12.91 61.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.248 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -137.15 33.64 2.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.087 0.47 . . . . 0.0 110.503 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -49.71 -28.49 6.13 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.241 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 5.6 tttp -72.24 -20.32 61.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.341 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -94.1 -35.28 12.62 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.322 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -100.72 146.3 27.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.947 0.403 . . . . 0.0 111.283 -179.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.4 mm100 -125.38 146.22 49.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.787 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.519 ' CE1' ' CZ ' ' A' ' 88' ' ' TYR . 3.2 m-85 -81.5 129.18 34.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.958 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.449 ' O ' ' HB3' ' A' ' 147' ' ' ALA . 30.6 m-85 -133.93 136.37 44.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.678 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.494 HD11 HG21 ' A' ' 81' ' ' THR . 1.2 mt -124.65 164.92 22.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.044 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.97 -160.07 0.73 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.165 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -74.48 -8.79 57.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.467 0.175 . . . . 0.0 111.45 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -95.33 -33.31 12.58 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 111.657 0.243 . . . . 0.0 111.657 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . 0.424 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 73.9 mtm 60.11 34.93 21.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.817 0.342 . . . . 0.0 110.841 -179.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . 0.46 ' ND2' ' HA3' ' A' ' 144' ' ' GLY . 6.4 p-10 -65.94 114.82 18.05 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.043 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -67.12 -24.89 44.17 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.669 2.246 . . . . 0.0 112.386 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -84.44 -6.5 59.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.187 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.46 ' HA3' ' ND2' ' A' ' 141' ' ' ASN . . . -85.85 -124.56 1.53 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.461 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.512 ' HE2' ' HB2' ' A' ' 163' ' ' PHE . 6.9 ptp -126.57 -177.49 4.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.81 0.338 . . . . 0.0 110.76 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.583 HG21 ' HE2' ' A' ' 91' ' ' TYR . 48.3 t -129.23 149.74 33.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.208 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.524 ' HB2' ' CE2' ' A' ' 162' ' ' PHE . . . -113.41 112.17 23.19 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.463 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.746 HD13 HG21 ' A' ' 125' ' ' ILE . 4.4 mt -86.63 106.05 17.32 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.982 -179.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.419 ' HB2' ' HE2' ' A' ' 160' ' ' MET . 1.5 tp -90.82 120.0 31.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.161 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.481 ' HB3' ' CZ ' ' A' ' 159' ' ' TYR . 29.5 t70 -133.94 165.37 25.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.429 179.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -107.99 147.27 31.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.817 0.341 . . . . 0.0 111.088 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.88 -168.7 0.1 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.863 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.87 -41.26 95.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.963 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -72.98 -15.13 61.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.311 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 65.7 28.64 73.82 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.487 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 73.6 t -112.4 -55.94 4.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.73 0.3 . . . . 0.0 111.177 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 54.5 m -85.78 111.65 39.17 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.4 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.703 ' HG3' HG22 ' A' ' 70' ' ' VAL . 88.2 Cg_endo -80.5 135.9 10.77 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.526 2.151 . . . . 0.0 111.728 179.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.481 ' CZ ' ' HB3' ' A' ' 150' ' ' ASP . 5.8 p90 -126.02 135.57 51.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.976 0.417 . . . . 0.0 111.085 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' MET . . . . . 0.448 ' CE ' HD13 ' A' ' 78' ' ' LEU . 0.8 OUTLIER -104.96 131.62 52.24 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.059 -179.741 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.634 HG23 HD11 ' A' ' 23' ' ' ILE . 67.2 mt -92.09 118.5 37.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.289 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.524 ' CE2' ' HB2' ' A' ' 147' ' ' ALA . 78.6 m-85 -117.05 163.42 16.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.703 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.512 ' HB2' ' HE2' ' A' ' 145' ' ' MET . 22.6 m-85 -100.44 122.77 43.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.905 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.772 ' HG3' HD11 ' A' ' 29' ' ' LEU . 12.4 tttt -70.06 -51.92 28.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.069 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -51.52 -29.17 15.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.162 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.523 ' HA2' HG23 ' A' ' 99' ' ' ILE . . . -105.35 24.29 27.99 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.375 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.557 HD21 ' HB3' ' A' ' 4' ' ' TYR . 0.5 OUTLIER -138.25 146.82 43.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.849 0.357 . . . . 0.0 110.812 -179.903 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -117.56 151.2 37.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.02 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . 0.723 ' HB3' HD11 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -111.42 154.21 24.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.923 179.972 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.959 179.977 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.616 HG22 ' HB2' ' A' ' 16' ' ' ASP . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.771 0.319 . . . . 0.0 111.037 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.527 ' O ' ' HA ' ' A' ' 169' ' ' MET . 4.3 mm -105.69 120.47 56.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.312 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.597 ' CE1' HG23 ' A' ' 2' ' ' ILE . 25.3 m-85 -91.45 125.21 36.12 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.801 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -137.23 143.66 42.39 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.215 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -55.05 144.8 22.39 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.976 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 55.3 tp -73.58 -22.17 60.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.453 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.465 HD11 ' CG1' ' A' ' 99' ' ' ILE . 4.6 mp -91.24 -43.97 14.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.687 0.28 . . . . 0.0 111.72 -179.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.422 ' HB2' ' ND2' ' A' ' 141' ' ' ASN . 1.9 t -92.62 -27.52 17.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.378 -179.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 64.3 m-70 64.53 26.63 13.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.797 0.332 . . . . 0.0 110.773 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -103.15 129.7 50.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.718 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.422 ' HB3' ' CG2' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -57.84 95.9 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.346 -179.673 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 41.8 mtp -78.16 -16.86 57.53 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.7 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.497 ' CE2' ' CG ' ' A' ' 4' ' ' TYR . 37.8 p90 179.98 165.13 1.2 Allowed 'General case' 0 C--O 1.231 0.108 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.806 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.23 -169.93 1.98 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.563 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.616 ' HB2' HG22 ' A' ' 2' ' ' ILE . 39.4 t0 -95.67 33.78 1.59 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.02 0.438 . . . . 0.0 110.929 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.435 HG13 ' CD2' ' A' ' 18' ' ' TYR . 40.3 pt -93.33 -10.77 9.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.618 179.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.969 ' CZ ' HG22 ' A' ' 72' ' ' ILE . 51.8 m-85 -110.45 -169.32 1.44 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.686 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.0 mmtt -96.88 88.25 4.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.813 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.0 mp -87.99 124.03 40.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.982 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.0 mtt180 -119.47 126.27 50.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.163 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.799 ' HG3' HD23 ' A' ' 29' ' ' LEU . 1.0 OUTLIER -76.25 116.67 17.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.807 179.989 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.51 HD11 HG23 ' A' ' 161' ' ' ILE . 6.0 pt -114.15 170.93 4.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.204 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 56.12 28.48 13.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.286 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 63.43 41.35 7.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.218 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.1 -11.27 70.92 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.581 -0.819 . . . . 0.0 113.172 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.14 -33.87 74.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.916 0.358 . . . . 0.0 111.037 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.5 m -145.53 163.54 34.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.9 0.381 . . . . 0.0 111.158 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.799 HD23 ' HG3' ' A' ' 22' ' ' GLU . 0.4 OUTLIER -127.68 130.66 49.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.704 179.876 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -97.19 112.86 24.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.153 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' ' 159' ' ' TYR . 22.1 t -98.8 111.84 29.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.633 179.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -83.56 115.78 22.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.336 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -99.8 -137.91 10.04 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.247 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.4 ptpt -174.45 126.38 0.32 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.845 0.355 . . . . 0.0 110.959 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 23.7 mtm -72.45 121.98 20.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.758 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.446 HG23 ' CE ' ' A' ' 74' ' ' MET . 5.7 m . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.391 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.365 0 N-CA-C 112.207 -0.357 . . . . 0.0 112.207 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.578 HG12 HG12 ' A' ' 72' ' ' ILE . 44.3 t -69.09 135.92 27.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.833 0.349 . . . . 0.0 110.901 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -62.33 -56.94 13.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.639 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.969 HG22 ' CZ ' ' A' ' 18' ' ' TYR . 7.6 pt -53.54 -33.79 22.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.36 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.785 HG13 ' HB2' ' A' ' 78' ' ' LEU . 91.4 t -73.49 -33.49 39.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.915 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.446 ' CE ' HG23 ' A' ' 36' ' ' VAL . 2.4 mtm -78.23 -39.2 41.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.614 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 19.1 p30 -82.01 -29.42 32.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.581 -179.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.436 ' CE1' ' HB ' ' A' ' 72' ' ' ILE . 26.1 m170 -91.82 -4.52 54.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.842 0.353 . . . . 0.0 110.825 179.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.476 ' HB2' ' HB3' ' A' ' 138' ' ' GLU . 28.5 m80 60.73 39.57 17.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.95 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.785 ' HB2' HG13 ' A' ' 73' ' ' VAL . 38.1 mt -70.79 140.81 51.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.796 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -116.46 132.81 56.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.734 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.435 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 0.1 OUTLIER -91.7 120.86 32.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.94 0.4 . . . . 0.0 111.183 -179.94 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.454 HG21 HD11 ' A' ' 136' ' ' ILE . 9.2 t -108.82 170.01 8.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.792 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.3 p -114.91 170.45 8.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.889 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.48 ' HB2' ' CE2' ' A' ' 134' ' ' PHE . 4.0 m-85 -171.68 152.19 3.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.074 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.405 ' H ' ' HB3' ' A' ' 87' ' ' ALA . 0.2 OUTLIER -101.44 168.49 9.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.594 179.638 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.2 mttm -54.98 -51.94 64.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.125 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.63 -42.82 73.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.238 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.405 ' HB3' ' H ' ' A' ' 84' ' ' THR . . . -60.62 -44.83 95.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.858 0.361 . . . . 0.0 111.218 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.836 ' CD2' HD11 ' A' ' 122' ' ' ILE . 0.5 OUTLIER -59.83 -34.82 73.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.89 -179.974 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 15.8 mtmt -59.69 -42.22 92.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.067 0.46 . . . . 0.0 110.5 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.6 -29.87 46.31 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.093 178.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -68.07 -46.17 71.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.743 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.818 HG22 ' O ' ' A' ' 88' ' ' TYR . 2.1 tp -64.83 -42.17 94.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.98 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.457 ' O ' ' CG ' ' A' ' 97' ' ' LYS . 3.1 ttpt -62.0 -44.89 95.76 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.792 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -67.79 -40.18 83.95 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.955 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.54 ' CD1' ' C ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -76.5 -45.11 32.34 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 121.023 -0.271 . . . . 0.0 111.022 -179.162 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.501 ' HE3' ' HB2' ' A' ' 96' ' ' MET . 20.3 ptm -59.13 -32.01 69.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.889 0.375 . . . . 0.0 110.117 179.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.457 ' CG ' ' O ' ' A' ' 93' ' ' LYS . 3.7 mmpt? -70.72 -38.71 73.64 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.449 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.3 m -58.86 -40.08 83.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.332 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.465 ' CG1' HD11 ' A' ' 8' ' ' ILE . 10.2 mt -79.85 -42.56 22.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.416 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.49 -51.71 66.07 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.411 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -63.12 -47.16 90.69 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.044 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 4.0 tppt? -61.12 -39.89 91.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.872 0.367 . . . . 0.0 110.24 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.63 ' HB3' HG12 ' A' ' 111' ' ' VAL . 5.5 tp -66.97 -36.88 83.18 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.071 179.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.685 ' HG3' HG11 ' A' ' 111' ' ' VAL . 75.8 mt-10 -57.52 -29.44 64.33 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.658 179.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -86.7 -20.81 27.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.486 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -105.77 -61.17 1.53 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.841 0.353 . . . . 0.0 111.656 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.448 ' N ' ' O ' ' A' ' 103' ' ' LEU . 22.5 mtt85 -134.06 66.81 72.7 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.863 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.88 ' O ' HG22 ' A' ' 111' ' ' VAL . 9.6 Cg_endo -50.46 -21.68 7.8 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 123.254 2.636 . . . . 0.0 112.875 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -71.15 -9.86 58.79 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.583 0.23 . . . . 0.0 111.297 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.601 ' CB ' HD21 ' A' ' 103' ' ' LEU . 8.5 mmt180 -110.34 -0.39 17.65 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.706 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.88 HG22 ' O ' ' A' ' 108' ' ' PRO . 29.6 m -71.09 -33.93 53.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -179.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.57 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 8.3 mttt -68.27 -50.07 30.6 Favored Pre-proline 0 C--N 1.332 -0.191 0 C-N-CA 121.022 -0.271 . . . . 0.0 111.62 -179.148 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.57 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 31.6 Cg_exo -58.59 -37.76 92.85 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.188 1.925 . . . . 0.0 111.956 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.449 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 69.7 t80 -68.83 -36.9 78.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.937 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.04 -47.95 79.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.803 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 60.4 m -76.41 -44.28 36.67 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.737 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.16 -42.71 99.87 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.538 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.5 -51.59 69.21 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.044 0.449 . . . . 0.0 110.975 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.6 -28.06 67.44 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.183 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -75.87 -49.48 17.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.092 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 3.3 tp-100 -65.82 -39.73 91.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.156 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.836 HD11 ' CD2' ' A' ' 88' ' ' TYR . 0.3 OUTLIER -60.64 -45.54 97.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.984 -179.877 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.435 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 30.8 mttm -60.7 -29.45 69.34 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.317 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -69.25 -53.19 21.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.75 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.763 HG21 HD13 ' A' ' 148' ' ' LEU . 12.8 pt -63.0 -41.2 91.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.333 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 11.5 mt -54.79 -37.12 65.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.82 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -71.16 -10.54 59.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.34 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -140.31 33.35 1.89 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.928 0.395 . . . . 0.0 110.66 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.511 ' CE1' ' CZ ' ' A' ' 134' ' ' PHE . 1.5 t80 -51.35 -36.41 42.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.921 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.4 -26.07 66.39 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.977 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 32.0 m-20 -94.1 -43.84 8.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.201 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -91.8 135.52 33.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.227 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.47 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 1.8 mm100 -115.07 144.13 44.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.464 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.511 ' CZ ' ' CE1' ' A' ' 129' ' ' PHE . 0.1 OUTLIER -89.22 130.76 35.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.889 0.376 . . . . 0.0 111.099 -179.638 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.536 ' HB2' ' HB3' ' A' ' 147' ' ' ALA . 17.2 m-85 -123.72 166.29 15.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.681 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.454 HD11 HG21 ' A' ' 81' ' ' THR . 0.4 OUTLIER -149.23 157.57 6.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.574 179.737 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -57.42 -172.77 0.25 Allowed Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.406 -0.902 . . . . 0.0 111.676 179.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.476 ' HB3' ' HB2' ' A' ' 77' ' ' HIS . 1.1 pt-20 -70.08 -8.94 53.54 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.587 0.232 . . . . 0.0 111.292 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -94.93 -23.4 17.44 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.697 -0.229 . . . . 0.0 111.416 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . 0.405 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 63.7 mtp 50.95 43.36 28.8 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.824 0.345 . . . . 0.0 111.302 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . 0.426 ' ND2' ' HA3' ' A' ' 144' ' ' GLY . 17.3 p-10 -64.64 117.13 35.01 Favored Pre-proline 0 N--CA 1.451 -0.391 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.816 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -59.35 -30.88 93.91 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.409 2.073 . . . . 0.0 112.26 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -84.61 -4.01 58.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.053 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.426 ' HA3' ' ND2' ' A' ' 141' ' ' ASN . . . -81.53 -153.63 11.0 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.407 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.507 ' HE3' ' O ' ' A' ' 166' ' ' GLY . 13.2 ptp -108.59 179.15 4.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.783 0.325 . . . . 0.0 110.815 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.426 ' CG1' ' HB3' ' A' ' 134' ' ' PHE . 0.0 OUTLIER -125.15 128.43 72.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.047 179.846 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.536 ' HB3' ' HB2' ' A' ' 135' ' ' PHE . . . -89.91 109.39 20.41 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.257 0.551 . . . . 0.0 110.422 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.763 HD13 HG21 ' A' ' 125' ' ' ILE . 4.7 mt -81.85 106.29 13.66 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.349 -179.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.561 HD12 ' HG2' ' A' ' 160' ' ' MET . 2.0 tp -91.12 118.63 30.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.158 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.453 ' HB3' ' CZ ' ' A' ' 159' ' ' TYR . 34.6 t70 -130.87 164.99 24.02 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.401 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -110.49 148.81 31.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.908 0.385 . . . . 0.0 110.995 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.487 ' HG3' HG22 ' A' ' 157' ' ' THR . 5.0 mmm180 -57.42 -177.94 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.071 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -61.19 -41.27 96.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.949 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -87.41 -15.09 38.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.209 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 68.44 44.97 70.95 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.584 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 78.5 t -107.29 -20.8 5.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.743 0.306 . . . . 0.0 111.004 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.487 HG22 ' HG3' ' A' ' 152' ' ' ARG . 1.4 t -140.89 122.34 9.18 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.985 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.442 ' HB2' HD11 ' A' ' 149' ' ' LEU . 84.4 Cg_endo -78.4 130.5 10.03 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.408 2.072 . . . . 0.0 112.09 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.453 ' CZ ' ' HB3' ' A' ' 150' ' ' ASP . 8.3 p90 -123.24 138.49 54.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.969 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' MET . . . . . 0.626 ' HG3' HD11 ' A' ' 72' ' ' ILE . 30.4 mtp -105.73 140.72 38.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.042 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.51 HG23 HD11 ' A' ' 23' ' ' ILE . 59.3 mt -97.92 111.19 27.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.016 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -107.13 154.38 21.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.957 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -96.78 118.3 32.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.822 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.475 ' HD3' HD11 ' A' ' 29' ' ' LEU . 19.8 tptt -64.83 -51.54 61.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.082 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.449 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 9.0 m-20 -54.72 -32.1 59.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.151 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.507 ' O ' ' HE3' ' A' ' 145' ' ' MET . . . -103.84 17.78 48.4 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.748 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.439 HD21 ' HB3' ' A' ' 4' ' ' TYR . 7.0 tt -141.85 144.33 33.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.779 0.323 . . . . 0.0 110.808 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -130.17 150.43 51.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.689 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . 0.527 ' HA ' ' O ' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -140.11 160.1 40.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.125 179.986 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 . . . . . 0 C--N 1.332 -0.161 0 CA-C-O 120.93 0.395 . . . . 0.0 111.647 -179.243 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.683 HG23 ' CE1' ' A' ' 4' ' ' TYR . 0.9 OUTLIER . . . . . 0 N--CA 1.455 -0.177 0 CA-C-O 120.891 0.377 . . . . 0.0 111.026 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.493 ' O ' ' HA ' ' A' ' 169' ' ' MET . 7.7 mm -105.31 118.89 53.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.372 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.683 ' CE1' HG23 ' A' ' 2' ' ' ILE . 20.5 m-85 -91.32 129.27 37.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.766 179.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -138.09 148.95 45.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.078 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.418 ' O ' ' HA ' ' A' ' 10' ' ' HIS . 22.7 t0 -55.26 150.86 10.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.844 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 66.6 tp -80.05 -25.07 40.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.295 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.684 HD11 ' CG1' ' A' ' 99' ' ' ILE . 4.0 mp -91.21 -43.17 14.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.755 -179.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.5 t -91.77 -26.81 18.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.597 -179.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.418 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 0.2 OUTLIER 63.97 28.42 14.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.874 0.369 . . . . 0.0 110.832 -179.774 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -104.79 130.21 52.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.719 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.19 104.69 0.22 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.226 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 17.9 mtt -88.62 -15.67 34.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.917 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.495 ' CE2' ' CG ' ' A' ' 4' ' ' TYR . 38.2 p90 179.63 159.84 0.76 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.719 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -122.15 -169.93 1.98 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.664 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.662 ' HB2' HG22 ' A' ' 2' ' ' ILE . 36.9 t70 -93.49 28.98 2.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.989 0.423 . . . . 0.0 110.967 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.434 HG13 ' CD2' ' A' ' 18' ' ' TYR . 36.1 pt -91.46 -9.04 10.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.826 179.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.876 ' CZ ' HG22 ' A' ' 72' ' ' ILE . 57.2 m-85 -115.83 -169.74 1.65 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.789 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.0 mttt -95.78 95.06 8.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.006 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.7 mp -91.72 124.02 44.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.939 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.69 137.15 53.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.991 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.81 ' HG3' HD23 ' A' ' 29' ' ' LEU . 1.2 mp0 -83.85 114.7 21.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.818 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.622 HD11 HG23 ' A' ' 161' ' ' ILE . 5.4 pt -111.12 166.35 5.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.237 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 57.35 30.11 17.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.314 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 64.43 40.55 6.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.198 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.55 -18.5 56.96 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.007 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.33 -34.85 49.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.808 0.337 . . . . 0.0 111.041 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 35.8 m -147.9 163.63 36.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.913 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.81 HD23 ' HG3' ' A' ' 22' ' ' GLU . 0.4 OUTLIER -129.62 132.86 46.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.954 -179.832 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 73.9 mt-10 -96.26 125.25 40.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.125 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 22.4 t -102.5 111.94 34.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.732 179.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -87.08 112.54 22.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.135 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -94.17 -132.65 6.62 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.355 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.3 ptpt -174.43 123.4 0.29 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.776 0.322 . . . . 0.0 110.836 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 41.1 mtp -68.44 123.41 20.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.931 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.4 m . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.147 -179.975 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.447 0 N-CA-C 112.012 -0.435 . . . . 0.0 112.012 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.488 HG12 HG12 ' A' ' 72' ' ' ILE . 46.4 t -78.77 142.45 14.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.829 0.347 . . . . 0.0 110.927 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -69.99 -56.89 5.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.494 -179.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.876 HG22 ' CZ ' ' A' ' 18' ' ' TYR . 11.1 pt -53.63 -33.89 23.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.434 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.807 HG13 ' HB2' ' A' ' 78' ' ' LEU . 84.5 t -70.86 -31.43 45.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.783 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.3 mtt -78.26 -41.03 35.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.521 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.401 ' OD1' ' CD2' ' A' ' 76' ' ' HIS . 13.0 p30 -82.13 -28.51 32.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.528 -179.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.441 ' CE1' ' HA ' ' A' ' 14' ' ' PHE . 28.4 m170 -93.17 0.11 57.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.852 0.358 . . . . 0.0 110.838 179.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.487 ' HB2' ' HB3' ' A' ' 138' ' ' GLU . 13.2 m-70 56.22 27.96 12.47 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.121 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.807 ' HB2' HG13 ' A' ' 73' ' ' VAL . 43.6 mt -56.79 140.48 47.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.703 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -124.93 135.84 53.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.946 0.403 . . . . 0.0 111.279 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.421 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 0.0 OUTLIER -94.36 117.71 30.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.855 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.758 HG21 HD11 ' A' ' 136' ' ' ILE . 8.3 t -109.68 140.86 43.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.927 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 59.1 m -77.46 159.23 29.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.909 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.472 ' CE2' ' HB1' ' A' ' 87' ' ' ALA . 0.2 OUTLIER -164.23 156.13 16.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.887 -179.974 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.78 172.87 7.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.911 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.3 mttm -69.48 -52.38 27.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.893 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -62.04 -41.98 98.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.71 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.472 ' HB1' ' CE2' ' A' ' 83' ' ' PHE . . . -59.47 -42.87 93.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.076 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.893 ' CD2' HD11 ' A' ' 122' ' ' ILE . 0.1 OUTLIER -58.27 -34.49 70.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.917 -179.928 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 45.3 mttt -60.31 -48.11 83.14 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.052 0.453 . . . . 0.0 110.451 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.1 mtmt -76.69 -27.85 55.68 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.698 178.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.546 ' HE2' HG21 ' A' ' 146' ' ' VAL . 8.2 t80 -65.18 -47.49 76.78 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.777 179.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.443 ' CD1' ' CE2' ' A' ' 95' ' ' TYR . 4.7 tp -62.58 -44.2 99.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.039 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.406 ' N ' HG23 ' A' ' 92' ' ' ILE . 4.5 tttp -60.52 -40.08 90.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.139 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.492 ' HA ' ' HG2' ' A' ' 97' ' ' LYS . 26.0 t0 -75.22 -40.07 59.48 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.879 -179.257 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.465 ' CD1' ' C ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -77.95 -40.43 39.47 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 121.053 -0.259 . . . . 0.0 110.944 -179.444 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.422 ' HG2' ' O ' ' A' ' 92' ' ' ILE . 2.4 ptt? -67.64 -32.04 72.46 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.763 0.316 . . . . 0.0 110.59 179.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.492 ' HG2' ' HA ' ' A' ' 94' ' ' ASP . 1.6 ptmm? -70.47 -34.57 72.55 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.524 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.433 ' N ' ' HG3' ' A' ' 97' ' ' LYS . 2.3 m -61.09 -40.24 92.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.046 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.684 ' CG1' HD11 ' A' ' 8' ' ' ILE . 6.9 mt -79.78 -41.07 21.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.433 179.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 5.1 tttp -55.3 -53.73 52.5 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.441 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -60.56 -46.35 94.57 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.017 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 6.4 tptt -62.62 -37.1 84.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.959 0.409 . . . . 0.0 110.336 179.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.633 HD21 ' CB ' ' A' ' 110' ' ' ARG . 3.1 tp -70.41 -33.96 71.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.059 179.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.626 ' CG ' HG11 ' A' ' 111' ' ' VAL . 77.3 mt-10 -58.85 -31.63 68.7 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.634 179.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.414 ' HG3' ' HG3' ' A' ' 106' ' ' GLN . 2.2 pt-20 -86.58 -21.09 27.05 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.738 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.414 ' HG3' ' HG3' ' A' ' 105' ' ' GLU . 21.0 mt-30 -105.13 -62.53 1.33 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.74 0.305 . . . . 0.0 111.559 -179.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.441 ' N ' ' O ' ' A' ' 103' ' ' LEU . 19.6 mtt-85 -129.74 64.77 73.08 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.879 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.867 ' O ' HG22 ' A' ' 111' ' ' VAL . 9.5 Cg_endo -50.52 -22.12 8.61 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 123.192 2.595 . . . . 0.0 112.745 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -70.75 -11.88 61.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.609 0.243 . . . . 0.0 111.323 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.633 ' CB ' HD21 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -110.88 -0.26 16.92 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.342 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.867 HG22 ' O ' ' A' ' 108' ' ' PRO . 34.1 m -66.38 -36.37 77.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -179.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.591 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 1.1 mttp -69.01 -51.2 19.03 Favored Pre-proline 0 C--N 1.332 -0.194 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.457 -179.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.591 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 50.1 Cg_exo -52.45 -41.39 67.71 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.04 1.827 . . . . 0.0 111.894 179.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.435 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 78.2 t80 -67.28 -39.22 86.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.967 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 1.4 mmm -56.98 -51.22 70.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.971 0.415 . . . . 0.0 110.858 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 62.3 m -76.53 -44.62 34.23 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.758 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.28 -45.93 95.2 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.551 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.07 -51.5 69.44 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.008 0.432 . . . . 0.0 111.068 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.38 -28.11 67.66 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.225 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.423 ' O ' ' HG2' ' A' ' 123' ' ' LYS . 45.4 tt0 -71.73 -46.9 57.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.181 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -72.97 -38.43 66.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.07 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.893 HD11 ' CD2' ' A' ' 88' ' ' TYR . 0.4 OUTLIER -61.54 -46.78 95.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.147 -179.853 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.462 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 3.6 pttp -62.2 -31.74 72.3 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.099 0.476 . . . . 0.0 110.142 179.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 3.9 t-160 -67.35 -53.3 30.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.703 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.535 HG21 HD13 ' A' ' 148' ' ' LEU . 15.5 pt -61.73 -42.28 93.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.341 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.475 HD23 ' HA ' ' A' ' 126' ' ' LEU . 11.5 mt -53.87 -36.08 62.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.912 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -72.86 -10.16 59.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.173 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -141.64 33.7 1.63 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.017 0.437 . . . . 0.0 110.462 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.5 ' CE1' ' CZ ' ' A' ' 134' ' ' PHE . 11.5 t80 -50.3 -26.41 4.78 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.237 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.2 mmtt -61.76 -27.47 68.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.769 0.319 . . . . 0.0 110.945 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 22.2 m-20 -94.27 -36.75 11.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.488 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.409 ' CG ' ' OD2' ' A' ' 150' ' ' ASP . 10.8 m-85 -98.13 138.75 34.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.918 0.39 . . . . 0.0 111.25 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -122.96 144.69 49.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.951 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.51 ' CE1' ' CZ ' ' A' ' 88' ' ' TYR . 1.3 m-85 -80.52 123.81 28.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.089 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.461 ' HB2' ' HB3' ' A' ' 147' ' ' ALA . 30.3 m-85 -125.57 151.06 46.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.713 179.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.758 HD11 HG21 ' A' ' 81' ' ' THR . 0.4 OUTLIER -139.38 159.54 28.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.927 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.41 -165.12 0.3 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.403 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.487 ' HB3' ' HB2' ' A' ' 77' ' ' HIS . 5.1 pt-20 -71.52 -9.84 58.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.517 0.199 . . . . 0.0 111.467 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 -96.2 -32.03 12.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.585 0.231 . . . . 0.0 111.594 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . 0.452 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 58.2 mtm 56.54 41.34 28.76 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.825 0.345 . . . . 0.0 111.137 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -67.02 120.44 71.91 Favored Pre-proline 0 N--CA 1.454 -0.252 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.713 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -61.8 -25.57 78.64 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.248 1.965 . . . . 0.0 111.903 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -84.79 -18.13 35.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.743 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -71.49 -161.74 4.8 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.249 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.417 ' HE1' ' O ' ' A' ' 163' ' ' PHE . 3.9 ptp -97.03 177.82 5.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.785 0.326 . . . . 0.0 110.864 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.546 HG21 ' HE2' ' A' ' 91' ' ' TYR . 41.8 t -122.62 148.01 26.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.119 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.461 ' HB3' ' HB2' ' A' ' 135' ' ' PHE . . . -112.07 115.27 28.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.845 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.535 HD13 HG21 ' A' ' 125' ' ' ILE . 4.0 mt -89.56 105.9 18.1 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.814 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.513 HD12 ' HG2' ' A' ' 160' ' ' MET . 1.1 tp -94.55 119.08 32.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.356 -179.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.545 ' HB3' ' CE1' ' A' ' 159' ' ' TYR . 0.5 OUTLIER -134.97 170.16 16.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.561 179.367 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -105.74 150.36 25.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.909 0.385 . . . . 0.0 111.151 -179.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -78.09 -172.62 2.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.814 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -57.54 -41.13 80.32 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.942 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 44.4 p-10 -69.11 -15.07 63.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.238 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 65.3 19.04 65.97 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.589 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 80.4 t -113.44 -65.36 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.904 0.383 . . . . 0.0 111.044 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 98.3 m -64.98 111.87 6.84 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.14 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -82.06 131.61 6.96 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.63 2.22 . . . . 0.0 111.903 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.545 ' CE1' ' HB3' ' A' ' 150' ' ' ASP . 6.7 p90 -125.11 139.14 54.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.96 0.41 . . . . 0.0 111.142 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' MET . . . . . 0.66 ' SD ' HD13 ' A' ' 78' ' ' LEU . 41.6 mtp -109.89 140.93 43.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.981 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.622 HG23 HD11 ' A' ' 23' ' ' ILE . 72.3 mt -97.07 116.92 40.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.337 -179.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -117.33 151.01 37.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.57 179.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.417 ' O ' ' HE1' ' A' ' 145' ' ' MET . 5.5 m-85 -100.47 124.89 46.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.955 0.407 . . . . 0.0 111.01 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.633 ' HB2' HD11 ' A' ' 29' ' ' LEU . 27.2 tttm -70.02 -45.55 66.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.275 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.435 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 15.8 m-20 -49.28 -35.6 18.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.24 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.44 ' HA2' HG23 ' A' ' 99' ' ' ILE . . . -109.26 30.71 8.3 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.509 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.502 HD21 ' HD2' ' A' ' 4' ' ' TYR . 1.5 tt -150.06 146.88 27.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.896 0.379 . . . . 0.0 110.918 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -132.06 154.09 49.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.331 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . 0.493 ' HA ' ' O ' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -139.96 160.27 40.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.829 0.347 . . . . 0.0 111.32 -179.843 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 . . . . . 0 C--O 1.231 0.127 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.355 -179.259 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.653 HD11 ' HB3' ' A' ' 169' ' ' MET . 1.5 tt . . . . . 0 CA--C 1.528 0.109 0 CA-C-O 120.719 0.295 . . . . 0.0 110.974 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 11.4 mm -100.11 154.18 4.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.433 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.633 ' HE1' HG23 ' A' ' 2' ' ' ILE . 3.5 m-85 -123.85 111.08 15.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.436 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.22 146.65 50.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.919 0.39 . . . . 0.0 111.215 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.496 ' OD1' HD12 ' A' ' 8' ' ' ILE . 46.1 t0 -54.67 152.16 7.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.897 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.549 HD23 HG23 ' A' ' 99' ' ' ILE . 56.2 tp -80.88 -20.36 42.43 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.484 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.592 HD11 ' CG1' ' A' ' 99' ' ' ILE . 4.1 mp -91.35 -48.28 13.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -93.79 -21.97 18.97 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 -179.157 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.454 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 3.5 m-70 63.52 31.38 14.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.884 0.373 . . . . 0.0 110.8 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -102.66 121.76 43.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.804 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -57.24 98.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.303 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.8 mtt -78.18 -18.07 55.99 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.733 179.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.643 ' CD2' HG21 ' A' ' 31' ' ' VAL . 5.7 p90 -177.37 177.42 1.19 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.778 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -133.84 -171.94 2.86 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.659 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -95.0 27.13 3.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.966 0.413 . . . . 0.0 110.876 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.418 HG13 ' CD2' ' A' ' 18' ' ' TYR . 45.6 pt -86.63 -13.83 10.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.479 179.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.914 ' CZ ' HG22 ' A' ' 72' ' ' ILE . 79.8 m-85 -106.16 -170.34 1.71 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.537 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.39 88.56 4.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.721 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.3 mp -87.97 130.65 37.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.16 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.9 mtt180 -121.73 119.12 30.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.888 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -71.4 116.07 11.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.924 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.538 HD11 HG23 ' A' ' 161' ' ' ILE . 3.6 pt -109.62 172.46 2.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.022 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.482 ' HB2' ' NE2' ' A' ' 121' ' ' GLN . . . 58.32 28.1 16.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.194 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 65.11 54.39 1.23 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.451 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.44 -3.51 72.84 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.553 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.462 ' HB3' ' HB3' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -67.48 -56.89 7.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 117.111 0.456 . . . . 0.0 110.815 179.993 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 46.9 m -120.08 168.72 10.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.747 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.523 HD21 ' HD2' ' A' ' 164' ' ' LYS . 0.5 OUTLIER -132.22 133.43 44.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.853 -179.849 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -98.42 112.84 24.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.963 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.643 HG21 ' CD2' ' A' ' 14' ' ' PHE . 22.8 t -93.63 111.98 25.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.744 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -86.87 124.7 33.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.145 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.59 -135.93 8.38 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.358 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.7 pttm -174.51 124.62 0.3 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.855 0.36 . . . . 0.0 110.881 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 62.9 mtm -69.74 121.83 17.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.75 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.1 m . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.342 -179.784 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.419 0 N-CA-C 112.31 -0.316 . . . . 0.0 112.31 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.451 HG12 HG12 ' A' ' 72' ' ' ILE . 60.1 t -68.37 141.34 17.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.875 0.369 . . . . 0.0 110.852 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -67.56 -58.77 4.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.48 -179.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.914 HG22 ' CZ ' ' A' ' 18' ' ' TYR . 8.9 pt -53.72 -33.84 23.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.531 -179.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.78 HG13 ' HB2' ' A' ' 78' ' ' LEU . 58.7 t -72.26 -33.92 47.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.054 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.5 mtm -78.13 -38.89 42.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.598 -179.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.4 HD21 ' HA ' ' A' ' 72' ' ' ILE . 19.1 p30 -82.07 -28.89 32.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.565 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.423 ' CE1' ' HB ' ' A' ' 72' ' ' ILE . 26.7 m170 -93.43 -1.12 56.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.841 0.353 . . . . 0.0 110.952 179.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 57.87 30.52 19.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.07 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.78 ' HB2' HG13 ' A' ' 73' ' ' VAL . 56.9 mt -57.83 134.88 56.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.535 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -118.48 134.36 55.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.941 0.4 . . . . 0.0 111.161 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.426 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 16.0 tt0 -87.63 129.81 34.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.934 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.871 HG21 HD11 ' A' ' 136' ' ' ILE . 3.1 t -122.81 126.31 47.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.829 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.4 m -68.06 159.02 31.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.999 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -165.42 149.72 8.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.799 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.54 158.18 17.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.798 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.47 -52.5 65.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.896 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -62.35 -44.33 96.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.738 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.64 -37.9 76.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.938 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.843 ' CD2' HD11 ' A' ' 122' ' ' ILE . 2.0 t80 -59.92 -38.64 82.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.736 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.444 ' O ' HG22 ' A' ' 92' ' ' ILE . 32.6 mttt -57.46 -49.47 76.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.172 0.51 . . . . 0.0 110.483 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.2 mtmt -72.42 -27.82 62.58 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.829 178.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.476 ' HE2' HG21 ' A' ' 146' ' ' VAL . 5.0 t80 -66.84 -46.16 75.97 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.957 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.444 HG22 ' O ' ' A' ' 89' ' ' LYS . 2.9 tp -60.45 -40.79 85.29 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.172 0 CA-C-O 120.766 0.317 . . . . 0.0 110.866 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.435 ' O ' ' CG ' ' A' ' 97' ' ' LYS . 0.9 OUTLIER -61.31 -46.33 90.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.733 179.935 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -71.2 -38.96 72.04 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.846 -179.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.544 ' CD1' ' C ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -74.5 -41.64 60.33 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.739 -0.21 . . . . 0.0 110.792 -179.542 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 19.7 ptt? -64.86 -32.06 73.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.825 0.345 . . . . 0.0 110.248 179.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.435 ' CG ' ' O ' ' A' ' 93' ' ' LYS . 5.4 mmtp -64.4 -42.91 95.83 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.853 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.7 m -56.96 -43.32 81.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.82 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.592 ' CG1' HD11 ' A' ' 8' ' ' ILE . 6.3 mt -79.72 -40.92 21.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.587 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.83 -51.87 65.98 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.706 179.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -64.33 -45.39 93.55 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.014 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.88 -42.06 92.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.927 0.394 . . . . 0.0 110.447 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.528 ' HB3' HG12 ' A' ' 111' ' ' VAL . 4.1 tp -65.55 -36.49 83.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.181 179.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.613 ' CG ' HG11 ' A' ' 111' ' ' VAL . 76.9 mt-10 -58.43 -28.55 65.37 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.772 179.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -88.73 -19.23 26.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.73 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -110.39 -60.99 1.73 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.77 0.319 . . . . 0.0 111.673 -179.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 103' ' ' LEU . 1.1 mtt85 -125.59 63.17 44.35 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.93 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.86 ' O ' HG22 ' A' ' 111' ' ' VAL . 10.1 Cg_endo -50.77 -22.22 9.44 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 123.064 2.51 . . . . 0.0 112.798 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -73.44 -15.23 61.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.749 0.309 . . . . 0.0 111.253 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.543 ' C ' ' HD2' ' A' ' 113' ' ' PRO . 2.5 mmm180 -106.34 0.73 25.24 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.774 -179.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.86 HG22 ' O ' ' A' ' 108' ' ' PRO . 32.8 m -68.17 -36.66 76.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.591 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 28.4 mttt -66.79 -51.25 40.17 Favored Pre-proline 0 CA--C 1.53 0.186 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.233 -179.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.591 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 51.8 Cg_exo -53.31 -41.48 72.35 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.062 1.841 . . . . 0.0 111.821 179.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.461 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 88.2 t80 -68.35 -37.86 80.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.964 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . 0.435 ' HA ' ' HE3' ' A' ' 115' ' ' MET . 0.6 OUTLIER -53.94 -49.81 67.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.004 -179.942 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.8 m -76.61 -44.29 34.89 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.825 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.4 ' O ' ' HG2' ' A' ' 120' ' ' GLU . . . -59.09 -44.12 96.54 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.691 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.53 -45.95 92.0 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.026 0.441 . . . . 0.0 110.718 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.76 -32.6 65.76 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.67 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.4 ' HG2' ' O ' ' A' ' 117' ' ' GLY . 6.7 pt-20 -78.28 -43.07 29.09 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.731 0.3 . . . . 0.0 111.242 -179.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.482 ' NE2' ' HB2' ' A' ' 24' ' ' ALA . 9.7 tp-100 -66.26 -39.5 89.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.138 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.843 HD11 ' CD2' ' A' ' 88' ' ' TYR . 0.3 OUTLIER -63.11 -45.0 99.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.053 -179.929 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.443 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 27.0 mttt -59.51 -31.12 69.07 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.215 179.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 3.9 t-160 -68.21 -54.12 20.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.622 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.814 HG21 HD13 ' A' ' 148' ' ' LEU . 8.7 pt -61.78 -38.51 80.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.118 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.434 ' HG ' ' CD1' ' A' ' 122' ' ' ILE . 12.4 mt -53.6 -40.3 65.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.553 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.02 -19.13 60.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.766 179.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -128.91 28.94 5.28 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.392 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -48.9 -42.28 36.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.273 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 8.4 ttpp -68.67 -15.4 63.51 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.367 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -94.05 -38.54 11.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.382 -179.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.47 ' CD2' HG22 ' A' ' 125' ' ' ILE . 1.7 m-30 -97.77 153.79 18.04 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.971 0.415 . . . . 0.0 111.365 -179.386 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.447 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 4.8 mm100 -123.35 155.32 37.54 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.538 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.446 ' CE1' ' CE1' ' A' ' 88' ' ' TYR . 3.4 m-85 -93.24 133.86 36.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.876 0.369 . . . . 0.0 111.124 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.426 ' CE2' ' HB2' ' A' ' 80' ' ' GLU . 36.4 m-85 -134.25 151.29 51.21 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.491 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.871 HD11 HG21 ' A' ' 81' ' ' THR . 0.5 OUTLIER -134.61 161.44 40.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.965 179.897 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -62.19 -164.38 0.37 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.169 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -73.38 -8.93 57.95 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.552 0.215 . . . . 0.0 111.433 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -97.96 -28.7 13.69 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.668 -179.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . 0.436 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 45.7 mtp 55.72 42.39 29.31 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.897 0.379 . . . . 0.0 111.02 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . 0.432 ' ND2' ' HA3' ' A' ' 144' ' ' GLY . 16.5 p-10 -65.03 114.78 16.34 Favored Pre-proline 0 N--CA 1.452 -0.373 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.993 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -62.19 -29.29 80.37 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.496 2.13 . . . . 0.0 112.142 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -84.64 -7.66 59.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.127 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.432 ' HA3' ' ND2' ' A' ' 141' ' ' ASN . . . -86.41 -167.67 43.9 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.436 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 1.6 ptp -84.99 -174.41 5.26 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.949 0.404 . . . . 0.0 110.794 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.476 HG21 ' HE2' ' A' ' 91' ' ' TYR . 75.6 t -130.27 155.65 41.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.067 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.573 ' HB2' ' CE1' ' A' ' 162' ' ' PHE . . . -116.56 110.84 19.08 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.473 179.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.814 HD13 HG21 ' A' ' 125' ' ' ILE . 5.0 mt -86.46 106.01 17.18 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.236 -179.174 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.537 ' HB2' ' HE2' ' A' ' 160' ' ' MET . 2.0 tp -89.69 119.77 30.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.928 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.549 ' HB2' ' CZ ' ' A' ' 159' ' ' TYR . 57.6 m-20 -131.91 161.67 32.48 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.68 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -105.3 146.6 29.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.119 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 8.7 mmt180 -59.68 -176.2 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.907 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -56.36 -41.31 75.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.951 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.488 ' OD1' HG23 ' A' ' 156' ' ' VAL . 11.1 t70 -72.61 -15.13 61.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.164 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 77.83 21.59 71.15 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.626 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.488 HG23 ' OD1' ' A' ' 154' ' ' ASP . 87.5 t -113.41 -73.01 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.772 0.32 . . . . 0.0 110.924 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 98.9 m -53.02 103.23 0.35 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.13 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -77.11 127.88 9.51 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.724 2.283 . . . . 0.0 112.069 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.549 ' CZ ' ' HB2' ' A' ' 150' ' ' ASP . 10.5 p90 -126.54 133.26 51.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.956 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' MET . . . . . 0.568 ' CE ' HD13 ' A' ' 78' ' ' LEU . 0.5 OUTLIER -103.46 140.03 38.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.055 -179.659 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.538 HG23 HD11 ' A' ' 23' ' ' ILE . 90.4 mt -95.59 113.81 30.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.888 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.573 ' CE1' ' HB2' ' A' ' 147' ' ' ALA . 47.9 m-85 -117.45 133.89 55.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.889 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -79.33 128.96 33.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.977 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.523 ' HD2' HD21 ' A' ' 29' ' ' LEU . 12.4 tttm -70.12 -52.83 20.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.101 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.461 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 19.3 m-20 -49.3 -37.83 25.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.155 -179.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -96.56 28.73 12.13 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.341 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.445 HD21 ' HB3' ' A' ' 4' ' ' TYR . 0.5 OUTLIER -146.74 145.88 30.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.75 0.309 . . . . 0.0 110.843 -179.91 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -109.84 152.61 25.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.854 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . 0.653 ' HB3' HD11 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -124.28 138.66 54.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.935 179.982 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.962 179.94 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.732 HD11 ' HB3' ' A' ' 169' ' ' MET . 2.1 tt . . . . . 0 N--CA 1.456 -0.136 0 CA-C-O 120.81 0.338 . . . . 0.0 111.14 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.445 HG21 ' HB3' ' A' ' 12' ' ' GLU . 19.3 mm -107.56 155.01 8.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.089 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.571 ' HE1' HG23 ' A' ' 2' ' ' ILE . 3.4 m-85 -122.2 104.47 9.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.606 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -119.19 152.19 37.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.343 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.447 ' O ' ' HA ' ' A' ' 10' ' ' HIS . 38.9 t0 -58.11 152.2 17.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.802 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.472 HD23 HG23 ' A' ' 99' ' ' ILE . 56.6 tp -81.38 -23.89 37.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.306 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.765 HD11 ' CG1' ' A' ' 99' ' ' ILE . 3.8 mp -91.18 -45.07 14.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.3 t -93.76 -25.34 17.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.781 -179.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.447 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 38.5 m80 66.47 28.84 9.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.883 0.373 . . . . 0.0 110.832 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -102.48 123.57 46.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.749 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.445 ' HB3' HG21 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -57.12 99.8 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.259 -179.746 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 33.3 mtp -80.91 -16.53 53.33 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.795 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.5 ' CE2' ' CD2' ' A' ' 4' ' ' TYR . 12.3 p90 -178.22 175.57 1.2 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.698 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -134.05 -169.85 2.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.071 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.7 p-10 -89.96 19.74 4.68 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.549 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 46.2 pt -86.15 -6.93 10.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.817 0.342 . . . . 0.0 111.266 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.861 ' CZ ' HG22 ' A' ' 72' ' ' ILE . 71.1 m-85 -116.5 168.87 9.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.748 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.403 ' HB2' ' HB2' ' A' ' 32' ' ' GLU . 2.6 mmpt? -79.71 93.34 5.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.681 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.726 HD12 ' O ' ' A' ' 18' ' ' TYR . 4.4 mp -87.78 125.66 41.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.066 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -116.97 132.14 56.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.981 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.452 ' HG3' HD23 ' A' ' 29' ' ' LEU . 5.7 mt-10 -81.52 116.11 21.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.775 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 7.7 pt -116.45 167.08 9.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.018 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 58.44 34.54 24.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.068 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 64.45 38.62 7.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.214 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.67 -10.49 74.55 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.667 -0.777 . . . . 0.0 113.182 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.417 HD21 ' HA ' ' A' ' 114' ' ' PHE . 0.1 OUTLIER -56.18 -37.64 69.86 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.901 0.35 . . . . 0.0 111.143 -179.879 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 72.0 m -136.98 169.74 17.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.139 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.496 HD21 ' HD2' ' A' ' 164' ' ' LYS . 0.3 OUTLIER -131.99 119.08 20.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.897 -179.74 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -83.09 112.94 20.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.107 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.4 HG23 ' HD2' ' A' ' 162' ' ' PHE . 30.6 t -94.74 111.92 26.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.615 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.403 ' HB2' ' HB2' ' A' ' 19' ' ' LYS . 2.0 mt-10 -82.54 118.48 23.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.205 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.4 -139.21 9.67 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.267 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.6 pttm -174.36 129.97 0.36 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.772 0.32 . . . . 0.0 110.958 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.409 ' HE2' ' O ' ' A' ' 156' ' ' VAL . 17.4 mtm -76.73 125.0 28.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.896 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.452 HG23 ' CE ' ' A' ' 74' ' ' MET . 5.0 m . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.216 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.371 0 N-CA-C 112.229 -0.348 . . . . 0.0 112.229 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.44 HG22 ' HG3' ' A' ' 158' ' ' PRO . 59.8 t -69.73 148.28 11.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.911 0.386 . . . . 0.0 110.931 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -72.48 -57.56 4.08 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.338 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.861 HG22 ' CZ ' ' A' ' 18' ' ' TYR . 10.8 pt -53.53 -34.01 22.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.421 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.792 HG13 ' HB2' ' A' ' 78' ' ' LEU . 57.9 t -71.24 -31.88 45.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.882 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.452 ' CE ' HG23 ' A' ' 36' ' ' VAL . 2.3 mtm -78.01 -40.47 38.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.417 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.406 ' OD1' ' CD2' ' A' ' 76' ' ' HIS . 13.5 p30 -82.12 -28.77 32.06 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.51 -179.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.431 ' CE1' ' HB ' ' A' ' 72' ' ' ILE . 26.9 m170 -93.55 -0.28 56.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.753 0.311 . . . . 0.0 110.88 179.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.415 ' HB2' ' HB3' ' A' ' 138' ' ' GLU . 13.8 m-70 55.89 29.62 14.47 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.09 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.792 ' HB2' HG13 ' A' ' 73' ' ' VAL . 52.3 mt -57.09 139.84 51.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.652 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -124.44 137.38 54.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.126 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -91.59 131.86 36.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.037 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.525 HG21 HD11 ' A' ' 136' ' ' ILE . 6.2 t -118.5 170.1 9.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.872 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.3 m -107.39 165.19 11.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.955 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.493 ' CE2' ' CE2' ' A' ' 91' ' ' TYR . 2.7 m-85 -171.68 149.84 2.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.95 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.3 m -101.48 166.34 10.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.767 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.7 mtmp? -57.34 -49.86 74.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.873 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.65 -40.25 76.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.831 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.95 -43.73 94.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.101 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.851 ' CD2' HD11 ' A' ' 122' ' ' ILE . 0.6 OUTLIER -61.48 -30.74 70.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.757 179.921 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 27.7 mttm -62.98 -44.66 95.43 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.012 0.434 . . . . 0.0 110.566 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 11.3 mttm -78.56 -27.9 45.89 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.771 178.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.567 ' HE2' HG21 ' A' ' 146' ' ' VAL . 17.2 t80 -67.03 -47.32 71.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.073 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.778 HG22 ' O ' ' A' ' 88' ' ' TYR . 2.3 tp -65.06 -40.21 88.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.074 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.444 ' O ' ' CG ' ' A' ' 97' ' ' LYS . 4.9 ttpp -62.73 -45.28 93.47 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.923 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -68.76 -39.34 80.32 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.861 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.534 ' CD1' ' C ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -76.03 -43.78 42.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.712 -0.222 . . . . 0.0 110.875 -179.299 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 3.2 ptt? -62.06 -31.99 72.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.914 0.388 . . . . 0.0 110.238 179.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.444 ' CG ' ' O ' ' A' ' 93' ' ' LYS . 3.8 mmtt -66.46 -42.11 88.04 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.717 179.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.4 m -57.22 -41.72 80.0 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.657 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.765 ' CG1' HD11 ' A' ' 8' ' ' ILE . 6.6 mt -79.78 -42.26 22.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.685 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.8 tttt -53.64 -54.5 36.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.55 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -62.12 -46.4 94.07 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.126 179.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 26.0 tptt -61.08 -37.01 81.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.945 0.402 . . . . 0.0 110.406 179.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.527 HD21 ' CB ' ' A' ' 110' ' ' ARG . 6.6 tp -70.82 -32.94 70.17 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.051 179.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.605 ' CG ' HG11 ' A' ' 111' ' ' VAL . 84.0 mt-10 -60.97 -29.13 69.48 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.806 179.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -89.97 -19.58 24.32 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.423 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -106.84 -62.68 1.37 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.881 0.372 . . . . 0.0 111.472 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.428 ' N ' ' O ' ' A' ' 103' ' ' LEU . 9.7 mtt-85 -124.91 62.72 37.07 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.902 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.864 ' O ' HG22 ' A' ' 111' ' ' VAL . 10.3 Cg_endo -50.82 -24.53 13.63 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 123.091 2.528 . . . . 0.0 112.537 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -73.05 -9.46 58.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.247 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.527 ' CB ' HD21 ' A' ' 103' ' ' LEU . 58.2 mmt-85 -110.84 0.11 17.11 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.665 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.864 HG22 ' O ' ' A' ' 108' ' ' PRO . 26.5 m -71.42 -33.8 51.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.545 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 4.9 mttm -67.69 -50.4 35.22 Favored Pre-proline 0 CA--C 1.53 0.197 0 C-N-CA 120.997 -0.281 . . . . 0.0 111.681 -179.12 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.545 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 24.7 Cg_exo -63.16 -29.28 73.99 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.148 1.899 . . . . 0.0 111.67 179.478 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.481 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 89.3 t80 -72.12 -42.4 66.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.861 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 2.7 mmm -58.07 -43.83 87.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.874 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 66.2 m -76.69 -45.15 30.68 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.905 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.15 -45.83 92.69 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.775 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.402 ' O ' ' HB ' ' A' ' 122' ' ' ILE . . . -57.19 -51.76 68.02 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.045 0.45 . . . . 0.0 111.269 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.85 -28.06 63.3 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.502 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.401 ' O ' ' HG2' ' A' ' 123' ' ' LYS . 5.8 tt0 -74.13 -50.0 21.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.772 0.32 . . . . 0.0 111.474 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -67.62 -39.2 84.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.512 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.851 HD11 ' CD2' ' A' ' 88' ' ' TYR . 0.3 OUTLIER -59.5 -49.82 82.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.654 -179.458 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.481 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 9.5 ptpt -60.18 -30.64 69.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.059 0.457 . . . . 0.0 110.276 179.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -68.91 -53.26 21.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.755 179.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.503 HG21 HD13 ' A' ' 148' ' ' LEU . 16.7 pt -62.31 -42.33 95.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.309 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.498 HD21 ' CD2' ' A' ' 88' ' ' TYR . 11.3 mt -53.76 -37.18 63.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.946 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -72.89 -9.8 59.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.215 179.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 -142.24 34.44 1.51 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.983 0.42 . . . . 0.0 110.477 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.507 ' CE1' ' CZ ' ' A' ' 134' ' ' PHE . 5.4 t80 -51.95 -24.71 6.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.113 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -55.92 -37.91 69.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.979 0.418 . . . . 0.0 111.0 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 27.0 m-20 -86.25 -42.75 13.51 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.685 -179.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.443 ' HE2' HD11 ' A' ' 161' ' ' ILE . 14.1 m-85 -92.72 129.31 38.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.881 0.372 . . . . 0.0 111.394 -179.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.424 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 2.3 mm100 -114.84 145.13 42.49 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.911 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.507 ' CZ ' ' CE1' ' A' ' 129' ' ' PHE . 1.7 m-85 -79.95 127.52 32.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.174 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.422 ' CE1' ' HB3' ' A' ' 149' ' ' LEU . 48.0 m-85 -132.3 134.18 44.94 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.586 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.525 HD11 HG21 ' A' ' 81' ' ' THR . 0.7 OUTLIER -120.94 161.86 20.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.939 -179.811 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.47 -165.12 0.14 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.266 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.415 ' HB3' ' HB2' ' A' ' 77' ' ' HIS . 4.1 pt-20 -72.35 -9.18 58.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.566 0.222 . . . . 0.0 111.489 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 -97.59 -33.9 11.17 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 120.652 0.263 . . . . 0.0 111.518 -179.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . 0.468 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 34.9 mtm 60.47 34.96 20.4 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.683 0.278 . . . . 0.0 111.335 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -64.4 123.6 83.26 Favored Pre-proline 0 N--CA 1.451 -0.392 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.732 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -61.95 -23.35 75.77 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.321 2.014 . . . . 0.0 111.822 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -84.45 -12.14 54.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.734 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -80.96 -175.54 49.96 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.258 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 1.4 ptp -85.37 -177.98 6.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.783 0.325 . . . . 0.0 110.891 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.567 HG21 ' HE2' ' A' ' 91' ' ' TYR . 43.6 t -125.88 149.04 30.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.96 0.41 . . . . 0.0 111.165 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.424 ' HB1' ' SD ' ' A' ' 160' ' ' MET . . . -113.55 112.52 23.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.649 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.532 ' HB2' ' HB ' ' A' ' 161' ' ' ILE . 4.7 mt -85.86 106.27 16.95 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.03 -179.361 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.573 HD12 ' HG2' ' A' ' 160' ' ' MET . 3.3 tp -90.75 119.19 30.77 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.381 -179.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.49 ' HB3' ' CE1' ' A' ' 159' ' ' TYR . 13.4 t70 -132.57 164.29 26.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.482 179.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -97.49 146.7 24.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.955 0.407 . . . . 0.0 111.226 -179.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.09 -176.36 0.88 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.882 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -58.96 -41.31 87.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.923 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -67.18 -15.1 63.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.132 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 75.03 11.07 84.17 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.68 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.409 ' O ' ' HE2' ' A' ' 35' ' ' MET . 73.6 t -111.89 -70.15 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.846 0.355 . . . . 0.0 110.872 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 90.5 m -55.6 108.54 1.21 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.163 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.44 ' HG3' HG22 ' A' ' 70' ' ' VAL . 88.4 Cg_endo -82.65 132.19 6.57 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.579 2.186 . . . . 0.0 112.074 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.49 ' CE1' ' HB3' ' A' ' 150' ' ' ASP . 8.1 p90 -125.28 149.15 48.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.89 0.376 . . . . 0.0 110.983 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' MET . . . . . 0.79 ' CE ' HD13 ' A' ' 78' ' ' LEU . 0.6 OUTLIER -114.52 150.76 34.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.162 -179.75 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.532 ' HB ' ' HB2' ' A' ' 148' ' ' LEU . 88.5 mt -103.44 111.95 35.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.871 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.4 ' HD2' HG23 ' A' ' 31' ' ' VAL . 90.3 m-85 -114.53 125.84 54.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.907 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.407 ' CE2' ' OH ' ' A' ' 95' ' ' TYR . 2.6 m-85 -71.06 124.68 24.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.744 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.496 ' HD2' HD21 ' A' ' 29' ' ' LEU . 6.3 tttm -66.39 -56.44 11.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.31 -179.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.481 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 0.8 OUTLIER -51.06 -34.4 29.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.238 -179.797 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.409 ' HA2' ' CG2' ' A' ' 99' ' ' ILE . . . -95.73 25.28 25.73 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.47 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.438 HD21 ' HB3' ' A' ' 4' ' ' TYR . 0.6 OUTLIER -137.74 146.99 44.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.867 0.365 . . . . 0.0 110.928 -179.91 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -119.38 136.85 54.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.79 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . 0.732 ' HB3' HD11 ' A' ' 2' ' ' ILE . 1.6 mpp? -103.98 154.55 19.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.015 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.799 -179.963 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.82 HD11 ' HB3' ' A' ' 169' ' ' MET . 10.0 tt . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.854 0.359 . . . . 0.0 111.159 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.453 HG21 ' HB3' ' A' ' 12' ' ' GLU . 19.4 mm -92.88 157.31 2.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.23 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.624 ' HB3' HD21 ' A' ' 167' ' ' LEU . 3.0 m-85 -124.54 106.7 10.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.489 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 25.0 ptt180 -121.84 148.28 44.89 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.817 0.341 . . . . 0.0 111.333 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.441 ' O ' ' HA ' ' A' ' 10' ' ' HIS . 23.3 t0 -56.57 152.21 12.27 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.808 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.634 HD11 HE22 ' A' ' 106' ' ' GLN . 61.5 tp -80.3 -24.17 40.16 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.373 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.797 HD11 ' CG1' ' A' ' 99' ' ' ILE . 4.7 mp -91.3 -44.49 14.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.823 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.402 ' HB2' ' ND2' ' A' ' 141' ' ' ASN . 28.6 p -93.1 -23.77 18.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.77 -179.185 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.441 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 5.6 m170 63.44 28.07 15.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.809 0.337 . . . . 0.0 110.817 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -102.73 121.39 42.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.734 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.453 ' HB3' HG21 ' A' ' 3' ' ' ILE . 1.0 OUTLIER -58.52 89.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.204 -179.81 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 6.4 mtt -69.32 -16.07 63.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.881 179.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.498 ' CE2' ' CD2' ' A' ' 4' ' ' TYR . 34.1 p90 -176.87 171.48 2.18 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.93 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.8 m -134.54 -169.94 2.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.005 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -87.24 12.3 12.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.525 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 46.2 pt -81.3 -3.26 6.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.884 0.373 . . . . 0.0 111.062 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.843 ' CZ ' HG22 ' A' ' 72' ' ' ILE . 65.2 m-85 -119.89 179.87 4.12 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.705 -179.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.403 ' HB2' ' HB2' ' A' ' 32' ' ' GLU . 0.1 OUTLIER -90.14 88.94 7.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.916 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.566 HD12 ' O ' ' A' ' 18' ' ' TYR . 4.4 mp -88.03 123.89 40.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.994 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.79 133.52 55.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.914 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -78.35 121.15 24.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.826 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.477 HD11 HG23 ' A' ' 161' ' ' ILE . 3.8 pt -116.44 174.59 3.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.205 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.464 ' HB2' ' NE2' ' A' ' 121' ' ' GLN . . . 57.06 24.82 10.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.393 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 65.72 57.55 0.84 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.37 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 73.56 18.95 79.62 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.756 -0.735 . . . . 0.0 113.354 179.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.522 HD21 ' O ' ' A' ' 113' ' ' PRO . 0.2 OUTLIER -92.53 -45.67 8.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.914 0.357 . . . . 0.0 110.948 179.853 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 17.0 m -130.67 171.62 12.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.054 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.75 HD11 ' HB3' ' A' ' 164' ' ' LYS . 0.5 OUTLIER -129.48 131.08 46.59 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.941 -179.926 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -97.25 112.77 24.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.798 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.6 t -92.0 111.78 24.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.726 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.403 ' HB2' ' HB2' ' A' ' 19' ' ' LYS . 8.6 mt-10 -84.19 117.57 23.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.12 -179.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -99.82 -138.37 10.26 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.319 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -174.48 124.82 0.3 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.804 0.335 . . . . 0.0 111.013 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 55.8 mtp -68.61 122.0 17.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.656 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.409 HG23 ' CE ' ' A' ' 74' ' ' MET . 17.3 m . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.292 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 112.143 -0.383 . . . . 0.0 112.143 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.447 HG12 HG12 ' A' ' 72' ' ' ILE . 47.8 t -74.22 142.66 14.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.851 0.357 . . . . 0.0 110.937 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -69.74 -57.53 5.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.399 -179.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.843 HG22 ' CZ ' ' A' ' 18' ' ' TYR . 9.1 pt -53.72 -33.92 23.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.576 -179.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.755 HG13 ' HB2' ' A' ' 78' ' ' LEU . 71.6 t -72.02 -33.75 48.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.838 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.409 ' CE ' HG23 ' A' ' 36' ' ' VAL . 3.8 mtm -78.4 -39.87 37.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.714 -179.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.41 ' OD1' ' CD2' ' A' ' 76' ' ' HIS . 18.8 p30 -82.07 -29.13 32.0 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 -179.238 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.432 ' CE1' ' HB ' ' A' ' 72' ' ' ILE . 26.3 m170 -92.98 0.25 57.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.753 0.311 . . . . 0.0 110.858 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.404 ' CD2' ' N ' ' A' ' 77' ' ' HIS . 8.4 m170 55.09 32.79 19.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.913 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.755 ' HB2' HG13 ' A' ' 73' ' ' VAL . 52.4 mt -55.92 141.58 38.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.744 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -119.81 131.25 55.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.035 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.427 ' HG3' ' CE1' ' A' ' 135' ' ' PHE . 6.5 tt0 -95.0 127.26 40.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.93 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.709 HG21 HD11 ' A' ' 136' ' ' ILE . 1.8 t -120.03 165.12 15.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.751 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.0 p -97.03 159.65 14.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.841 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.468 ' HB2' ' CE2' ' A' ' 134' ' ' PHE . 1.6 m-85 -165.6 149.62 8.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.981 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.5 m -101.43 162.94 12.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.867 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 12.7 mttm -58.32 -52.46 65.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.065 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -63.71 -44.13 94.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.82 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.58 -42.22 98.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.02 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.92 ' CD2' HD11 ' A' ' 122' ' ' ILE . 0.7 OUTLIER -61.02 -33.84 73.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.841 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 12.8 mttp -61.19 -43.55 98.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.906 0.384 . . . . 0.0 110.554 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.1 mttp -78.11 -27.82 48.46 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.843 179.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.556 ' HE2' HG21 ' A' ' 146' ' ' VAL . 7.2 t80 -67.68 -42.27 82.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.878 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.729 HD12 ' CE2' ' A' ' 95' ' ' TYR . 5.0 tp -65.73 -44.24 93.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.898 0.38 . . . . 0.0 110.972 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.472 ' O ' ' CG ' ' A' ' 97' ' ' LYS . 2.0 ttpt -61.26 -45.35 94.88 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.782 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -68.75 -40.37 79.85 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.177 -179.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.729 ' CE2' HD12 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -77.69 -44.08 29.1 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.994 -179.272 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.403 ' HG3' ' N ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -60.17 -31.59 70.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.914 0.388 . . . . 0.0 110.195 179.165 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.472 ' CG ' ' O ' ' A' ' 93' ' ' LYS . 1.6 mmpt? -66.84 -45.14 79.14 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.445 179.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -54.92 -40.65 70.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.813 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.797 ' CG1' HD11 ' A' ' 8' ' ' ILE . 11.8 mt -79.95 -42.5 22.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.532 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.63 -52.05 65.14 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.442 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -63.19 -46.86 92.18 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.363 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.97 -44.41 94.48 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.877 0.37 . . . . 0.0 110.456 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.812 HD21 ' CB ' ' A' ' 110' ' ' ARG . 3.8 tp -63.26 -37.6 87.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.285 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.773 ' HG3' HG11 ' A' ' 111' ' ' VAL . 36.8 mt-10 -57.28 -29.5 63.92 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 120.818 0.342 . . . . 0.0 110.814 179.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -86.54 -19.29 29.68 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.617 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.634 HE22 HD11 ' A' ' 7' ' ' LEU . 30.4 mt-30 -109.52 -60.72 1.74 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.803 0.335 . . . . 0.0 111.774 -179.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.435 ' N ' ' O ' ' A' ' 103' ' ' LEU . 1.7 mtt180 -132.54 66.52 76.98 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.833 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.915 ' O ' HG22 ' A' ' 111' ' ' VAL . 10.3 Cg_endo -50.56 -21.02 7.04 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 123.257 2.638 . . . . 0.0 112.879 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -69.76 -7.92 43.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.411 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.812 ' CB ' HD21 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -113.35 -2.6 13.95 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -179.517 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.915 HG22 ' O ' ' A' ' 108' ' ' PRO . 33.1 m -73.13 -30.72 32.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.557 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 2.9 mtpt -69.46 -49.74 21.58 Favored Pre-proline 0 CA--C 1.53 0.197 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.711 -179.104 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.557 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 24.7 Cg_exo -63.13 -34.76 67.98 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.118 1.879 . . . . 0.0 111.987 179.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.453 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 69.6 t80 -72.21 -36.4 69.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.949 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.6 -54.88 41.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.983 0.42 . . . . 0.0 110.713 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 75.3 m -71.58 -44.68 64.05 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.584 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -59.89 -43.06 98.38 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.412 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -55.96 -48.52 75.64 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.022 0.439 . . . . 0.0 111.082 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.74 -33.51 66.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.382 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -74.31 -39.77 62.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.849 0.357 . . . . 0.0 111.256 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.464 ' NE2' ' HB2' ' A' ' 24' ' ' ALA . 8.9 tp-100 -71.75 -35.92 70.25 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.115 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.92 HD11 ' CD2' ' A' ' 88' ' ' TYR . 0.4 OUTLIER -67.06 -45.31 87.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.303 -179.698 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.433 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 10.0 ptpt -61.84 -30.87 71.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.965 0.412 . . . . 0.0 110.23 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -67.88 -53.6 25.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.652 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.887 HG21 HD13 ' A' ' 148' ' ' LEU . 14.8 pt -62.05 -41.42 91.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.282 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 13.4 mt -53.8 -37.46 63.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.915 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -65.02 -16.55 63.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.102 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 11.4 m-80 -137.16 33.0 2.59 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.644 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.498 ' CE1' ' CE2' ' A' ' 134' ' ' PHE . 1.1 t80 -52.5 -36.74 55.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.953 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -61.13 -18.76 59.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.286 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 35.2 m-20 -92.29 -43.43 9.29 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.716 0.293 . . . . 0.0 111.306 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.427 ' CD1' ' N ' ' A' ' 132' ' ' TYR . 1.4 m-30 -94.4 163.85 13.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.909 0.385 . . . . 0.0 111.245 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.441 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 2.3 mm100 -136.35 145.67 45.67 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.88 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.498 ' CE2' ' CE1' ' A' ' 129' ' ' PHE . 1.5 m-85 -79.89 125.54 29.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.932 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.427 ' CE1' ' HG3' ' A' ' 80' ' ' GLU . 50.1 m-85 -129.45 132.42 46.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.692 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.709 HD11 HG21 ' A' ' 81' ' ' THR . 0.3 OUTLIER -120.83 158.15 23.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.576 179.914 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -56.54 -171.76 0.15 Allowed Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.447 -0.883 . . . . 0.0 112.021 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -70.02 -11.18 60.69 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.693 0.282 . . . . 0.0 111.407 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 25.0 m-80 -93.99 -25.24 17.33 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.531 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . 0.428 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 35.6 mtm 51.33 43.91 29.16 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.806 0.336 . . . . 0.0 111.321 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . 0.402 ' ND2' ' HB2' ' A' ' 9' ' ' SER . 1.4 m-80 -66.68 120.72 73.19 Favored Pre-proline 0 N--CA 1.454 -0.267 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.766 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -61.26 -26.18 81.61 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.253 1.968 . . . . 0.0 111.893 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -84.85 -19.67 32.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.701 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -70.17 -172.84 11.16 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.316 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 5.7 ptp -90.4 -173.56 3.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.78 0.324 . . . . 0.0 110.883 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.556 HG21 ' HE2' ' A' ' 91' ' ' TYR . 58.1 t -128.88 150.65 34.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.112 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.521 ' HB1' ' SD ' ' A' ' 160' ' ' MET . . . -115.44 111.53 20.92 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.654 179.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.887 HD13 HG21 ' A' ' 125' ' ' ILE . 3.9 mt -85.59 106.23 16.74 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.129 -179.201 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.44 HD12 ' HG2' ' A' ' 160' ' ' MET . 4.2 tp -88.52 120.16 29.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.347 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.453 ' HB3' ' CE1' ' A' ' 159' ' ' TYR . 27.8 t70 -136.75 164.86 27.27 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.39 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -106.46 152.47 23.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.837 0.351 . . . . 0.0 111.13 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.25 -177.1 0.49 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.966 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.99 -37.9 75.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.835 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -76.23 -15.04 60.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.28 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 69.77 26.98 73.79 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.744 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 89.8 t -112.03 -61.89 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.848 0.356 . . . . 0.0 110.929 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 78.2 m -75.78 112.75 21.5 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.202 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -81.08 132.04 8.17 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.562 2.175 . . . . 0.0 112.065 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.453 ' CE1' ' HB3' ' A' ' 150' ' ' ASP . 9.9 p90 -127.13 142.81 51.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.957 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' MET . . . . . 0.708 ' CE ' HD13 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -109.6 145.33 36.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.003 -179.848 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.525 ' HB ' ' HB2' ' A' ' 148' ' ' LEU . 74.5 mt -98.47 118.67 45.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.064 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.464 ' CE1' ' HB2' ' A' ' 147' ' ' ALA . 96.7 m-85 -122.25 154.46 37.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.825 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -102.5 116.06 31.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.984 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.75 ' HB3' HD11 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -62.68 -40.72 97.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.104 -179.751 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.453 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 2.1 m-20 -56.73 -38.4 72.31 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.814 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -98.44 24.38 32.26 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.353 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.624 HD21 ' HB3' ' A' ' 4' ' ' TYR . 0.5 OUTLIER -137.55 146.81 44.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.829 0.347 . . . . 0.0 110.771 179.985 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.423 ' N ' ' HG ' ' A' ' 167' ' ' LEU . 6.7 tt0 -116.45 149.93 38.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.771 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . 0.82 ' HB3' HD11 ' A' ' 2' ' ' ILE . 1.0 OUTLIER -113.79 160.0 19.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.102 -179.829 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.818 179.985 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.655 HD11 ' HB3' ' A' ' 169' ' ' MET . 2.3 tt . . . . . 0 N--CA 1.456 -0.157 0 CA-C-O 120.799 0.333 . . . . 0.0 111.017 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.486 HG21 ' HB3' ' A' ' 12' ' ' GLU . 20.4 mm -111.31 159.36 11.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.378 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.506 ' CD2' ' CE2' ' A' ' 14' ' ' PHE . 5.4 m-85 -122.81 104.56 9.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.306 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 21.9 ptt180 -116.65 145.51 43.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.008 0.432 . . . . 0.0 111.415 -179.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.54 ' OD1' HD12 ' A' ' 8' ' ' ILE . 50.5 t0 -54.34 152.01 6.86 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.961 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 40.6 tp -82.47 -16.87 47.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.546 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.54 HD12 ' OD1' ' A' ' 6' ' ' ASP . 4.4 mp -91.27 -51.72 11.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -179.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.41 ' HB2' ' ND2' ' A' ' 141' ' ' ASN . 5.9 t -96.74 -16.26 20.97 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -179.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.454 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 1.8 m-70 64.39 30.08 13.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.865 0.364 . . . . 0.0 110.863 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -99.23 122.63 42.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.831 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.486 ' HB3' HG21 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -58.43 92.07 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.286 -179.739 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 35.8 mtp -70.85 -19.07 62.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.714 179.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.506 ' CE2' ' CD2' ' A' ' 4' ' ' TYR . 16.1 p90 -175.25 174.7 2.35 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.525 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.3 m -129.08 -170.53 2.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.822 0.344 . . . . 0.0 111.083 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.427 ' HB2' ' CG2' ' A' ' 2' ' ' ILE . 30.6 t0 -95.43 21.08 8.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.062 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.4 HG13 ' CD2' ' A' ' 18' ' ' TYR . 46.3 pt -87.14 -8.8 11.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.059 179.41 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.966 ' CZ ' HG22 ' A' ' 72' ' ' ILE . 84.3 m-85 -111.41 -175.99 2.84 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.899 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.1 mmmt -93.32 93.67 8.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.901 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.1 mp -88.06 123.96 40.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.985 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.405 ' NH1' ' HB3' ' A' ' 21' ' ' ARG . 9.1 mtp-105 -113.55 126.42 55.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.936 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.739 ' HG3' HD23 ' A' ' 29' ' ' LEU . 3.8 mt-10 -77.41 112.74 14.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.879 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.613 HD11 HG23 ' A' ' 161' ' ' ILE . 4.2 pt -109.69 168.46 3.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.063 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.417 ' HB2' ' NE2' ' A' ' 121' ' ' GLN . . . 57.72 30.17 18.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.152 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 63.9 40.14 7.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.29 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.7 -12.61 68.48 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.6 -0.81 . . . . 0.0 113.158 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.78 -37.4 76.24 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.824 0.345 . . . . 0.0 111.045 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 13.9 m -141.68 162.94 34.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.141 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.739 HD23 ' HG3' ' A' ' 22' ' ' GLU . 0.5 OUTLIER -128.76 135.45 49.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.703 179.894 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.403 ' OE1' ' CD2' ' A' ' 159' ' ' TYR . 64.6 mt-10 -100.7 118.13 36.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.305 -179.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.496 HG21 ' CD2' ' A' ' 14' ' ' PHE . 24.2 t -94.8 112.02 26.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.729 179.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -84.67 122.96 29.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.205 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -108.98 -138.79 8.42 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.278 179.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.9 ptpt -174.48 128.3 0.34 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.821 0.343 . . . . 0.0 111.024 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 24.4 mtp -74.17 124.9 27.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.567 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.0 m . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.657 -179.556 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.474 0 N-CA-C 112.286 -0.326 . . . . 0.0 112.286 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.541 HG12 HG12 ' A' ' 72' ' ' ILE . 48.8 t -67.87 130.34 33.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.805 0.336 . . . . 0.0 110.886 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -59.68 -58.05 10.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.402 -179.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.966 HG22 ' CZ ' ' A' ' 18' ' ' TYR . 6.3 pt -53.85 -33.97 24.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.61 -179.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.768 HG13 ' HB2' ' A' ' 78' ' ' LEU . 97.0 t -72.69 -29.98 32.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.137 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 7.3 mtm -78.09 -42.58 31.64 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.664 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.44 HD21 ' HA ' ' A' ' 72' ' ' ILE . 22.0 p30 -82.25 -28.89 31.6 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -179.123 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.447 ' CE1' ' HA ' ' A' ' 14' ' ' PHE . 32.7 m170 -88.58 -8.07 55.36 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.904 0.383 . . . . 0.0 110.69 179.307 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.407 ' HB2' ' HB3' ' A' ' 138' ' ' GLU . 72.4 m-70 64.65 33.39 10.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.056 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.768 ' HB2' HG13 ' A' ' 73' ' ' VAL . 33.4 mt -64.63 142.19 58.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.537 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -129.12 146.99 50.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.909 0.385 . . . . 0.0 111.274 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.437 ' HG3' ' CE1' ' A' ' 135' ' ' PHE . 1.1 tm-20 -102.05 134.28 45.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.822 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.578 HG21 HD11 ' A' ' 136' ' ' ILE . 8.9 t -124.27 139.81 53.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.908 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 34.5 p -69.4 159.11 33.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.833 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.471 ' HB2' ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -169.48 154.22 5.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.879 -179.941 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.421 HG22 ' N ' ' A' ' 85' ' ' LYS . 14.3 m -101.52 164.05 11.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.95 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.421 ' N ' HG22 ' A' ' 84' ' ' THR . 58.1 mttt -60.74 -52.54 64.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.896 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -64.19 -42.19 96.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.616 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.29 -41.31 88.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.898 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.818 ' CD2' HD11 ' A' ' 122' ' ' ILE . 0.3 OUTLIER -57.71 -38.4 75.2 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.653 179.908 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.436 ' O ' HG22 ' A' ' 92' ' ' ILE . 21.7 mttt -58.88 -42.3 89.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.521 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 18.0 mtpt -77.27 -27.88 53.27 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.897 179.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.416 ' HB2' ' CE2' ' A' ' 83' ' ' PHE . 28.6 t80 -69.23 -45.68 69.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.565 179.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.586 HD12 ' CE2' ' A' ' 95' ' ' TYR . 6.1 tp -61.28 -39.92 84.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.071 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.501 ' O ' ' CG ' ' A' ' 97' ' ' LYS . 13.8 ttmt -62.05 -46.95 86.86 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.969 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -71.68 -36.13 70.51 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.13 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.586 ' CE2' HD12 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -78.51 -43.4 26.98 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.641 0.257 . . . . 0.0 110.735 -179.268 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.403 ' HG3' ' N ' ' A' ' 97' ' ' LYS . 0.5 OUTLIER -64.71 -31.83 73.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.841 0.353 . . . . 0.0 110.082 179.004 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.501 ' CG ' ' O ' ' A' ' 93' ' ' LYS . 9.5 mmtm -66.94 -41.37 87.08 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.549 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.7 m -55.26 -41.14 71.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.545 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.519 ' CG1' HD11 ' A' ' 8' ' ' ILE . 7.1 mt -79.78 -41.87 22.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.522 179.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 10.2 tttt -54.75 -52.61 61.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.574 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -61.6 -47.15 92.24 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.141 179.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 19.5 tptt -60.98 -40.3 92.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.841 0.353 . . . . 0.0 110.366 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.732 HD21 ' CB ' ' A' ' 110' ' ' ARG . 2.4 tp -66.96 -35.53 80.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.14 179.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.64 ' CG ' HG11 ' A' ' 111' ' ' VAL . 30.6 mt-10 -58.15 -30.15 66.13 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.607 179.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -89.43 -25.1 21.69 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.511 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -100.1 -63.55 1.12 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.858 0.361 . . . . 0.0 111.633 -179.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.441 ' N ' ' O ' ' A' ' 103' ' ' LEU . 16.0 mtm180 -130.43 65.18 75.37 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.882 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.93 ' O ' HG22 ' A' ' 111' ' ' VAL . 10.3 Cg_endo -50.86 -22.29 9.79 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 123.17 2.58 . . . . 0.0 112.831 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -66.97 -13.57 61.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.328 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.732 ' CB ' HD21 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -110.57 0.89 17.8 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.102 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.93 HG22 ' O ' ' A' ' 108' ' ' PRO . 33.9 m -70.05 -33.36 54.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.579 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 29.8 mtmt -71.1 -49.95 12.12 Favored Pre-proline 0 CA--C 1.53 0.176 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.574 -179.199 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.579 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 25.8 Cg_exo -63.06 -30.46 75.91 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.16 1.906 . . . . 0.0 111.777 179.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.459 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 88.6 t80 -72.07 -41.05 67.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.987 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 7.6 mtm -56.54 -47.88 78.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.031 0.443 . . . . 0.0 110.817 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 69.0 m -74.32 -44.36 52.83 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.659 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.27 -38.0 95.5 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.483 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.55 -51.62 68.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.921 0.391 . . . . 0.0 110.838 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.96 -28.11 65.28 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.279 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -74.81 -43.04 56.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.856 0.36 . . . . 0.0 110.982 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.417 ' NE2' ' HB2' ' A' ' 24' ' ' ALA . 3.8 tp-100 -73.31 -32.58 64.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.965 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.818 HD11 ' CD2' ' A' ' 88' ' ' TYR . 0.4 OUTLIER -71.56 -46.01 65.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.322 -179.725 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.456 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 9.2 pttt -61.1 -31.54 71.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.036 0.446 . . . . 0.0 110.358 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -68.32 -53.52 23.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.77 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.822 HG21 HD13 ' A' ' 148' ' ' LEU . 16.2 pt -62.0 -42.49 95.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.304 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.46 HD23 ' HA ' ' A' ' 126' ' ' LEU . 11.7 mt -53.89 -36.99 63.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.879 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -65.46 -15.95 63.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.21 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -136.35 31.43 2.89 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.77 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.513 ' CE1' ' CZ ' ' A' ' 134' ' ' PHE . 1.8 t80 -49.5 -31.66 10.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.96 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 20.1 tptt -61.3 -21.57 64.08 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.162 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 15.0 m-20 -94.08 -47.22 6.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.429 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.479 ' CD2' HG22 ' A' ' 125' ' ' ILE . 1.0 OUTLIER -93.01 150.78 20.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.963 0.411 . . . . 0.0 111.48 -179.449 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.489 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 1.0 OUTLIER -126.6 142.95 51.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.317 179.551 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.513 ' CZ ' ' CE1' ' A' ' 129' ' ' PHE . 0.1 OUTLIER -82.49 118.27 23.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.928 0.394 . . . . 0.0 110.979 -179.704 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.437 ' CE1' ' HG3' ' A' ' 80' ' ' GLU . 20.9 m-85 -119.8 137.17 54.14 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.753 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.578 HD11 HG21 ' A' ' 81' ' ' THR . 0.8 OUTLIER -120.93 165.43 16.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.842 0.353 . . . . 0.0 110.944 179.933 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -64.59 -166.4 1.19 Allowed Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.539 -0.839 . . . . 0.0 111.981 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.407 ' HB3' ' HB2' ' A' ' 77' ' ' HIS . 12.5 pt-20 -70.98 -9.82 58.64 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.567 0.222 . . . . 0.0 111.38 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 -96.63 -29.83 13.61 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.606 0.241 . . . . 0.0 111.449 -179.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . 0.489 ' HE2' ' HB ' ' A' ' 81' ' ' THR . 18.7 mtp 55.39 48.57 18.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.879 0.371 . . . . 0.0 111.099 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . 0.413 ' ND2' ' HA3' ' A' ' 144' ' ' GLY . 15.7 p-10 -71.84 114.8 31.89 Favored Pre-proline 0 N--CA 1.451 -0.409 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.917 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 141' ' ' ASN . 22.6 Cg_exo -63.39 -30.65 72.73 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.54 2.16 . . . . 0.0 112.214 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -84.62 -1.44 56.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.354 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.413 ' HA3' ' ND2' ' A' ' 141' ' ' ASN . . . -86.87 -115.72 1.0 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.421 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 10.7 ptp -142.27 -178.89 5.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.59 0.233 . . . . 0.0 110.769 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.504 HG11 ' HB3' ' A' ' 134' ' ' PHE . 0.0 OUTLIER -129.61 139.79 50.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.077 0.465 . . . . 0.0 111.274 179.961 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.671 ' HB2' ' CE1' ' A' ' 162' ' ' PHE . . . -103.09 110.02 21.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.224 179.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.822 HD13 HG21 ' A' ' 125' ' ' ILE . 3.8 mt -81.51 106.2 13.28 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.428 -179.051 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.526 HD11 HG21 ' A' ' 70' ' ' VAL . 1.7 tp -90.85 119.6 31.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.074 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.482 ' HB3' ' CE1' ' A' ' 159' ' ' TYR . 31.7 t70 -135.54 164.85 26.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.524 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -102.02 150.8 22.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.915 0.388 . . . . 0.0 111.189 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 16.8 mmm180 -80.59 -175.48 5.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.816 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -54.55 -40.14 68.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.011 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -66.31 -15.17 63.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.205 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 69.66 10.25 63.56 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.745 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 70.1 t -113.47 -68.19 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.843 0.354 . . . . 0.0 110.946 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 96.8 m -54.32 107.8 0.96 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.378 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -83.17 131.52 5.84 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.677 2.251 . . . . 0.0 111.965 179.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.482 ' CE1' ' HB3' ' A' ' 150' ' ' ASP . 9.5 p90 -124.1 135.58 53.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.866 0.365 . . . . 0.0 111.059 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' MET . . . . . 0.652 ' HE1' HD13 ' A' ' 78' ' ' LEU . 0.4 OUTLIER -105.09 138.7 40.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.132 -179.706 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.613 HG23 HD11 ' A' ' 23' ' ' ILE . 68.7 mt -94.96 114.41 31.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.147 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.671 ' CE1' ' HB2' ' A' ' 147' ' ' ALA . 96.6 m-85 -118.1 158.19 25.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.692 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -101.71 129.09 47.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.873 0.368 . . . . 0.0 110.803 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.519 ' HB2' HD11 ' A' ' 29' ' ' LEU . 24.3 tttt -70.09 -51.52 31.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.166 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.459 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 59.6 m-20 -52.2 -38.51 58.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.175 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.454 ' HA2' HG23 ' A' ' 99' ' ' ILE . . . -95.73 26.87 18.24 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.459 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.477 HD21 ' HB3' ' A' ' 4' ' ' TYR . 0.6 OUTLIER -144.93 143.84 30.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.778 0.323 . . . . 0.0 110.879 -179.871 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -116.88 156.61 27.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.822 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . 0.655 ' HB3' HD11 ' A' ' 2' ' ' ILE . 3.1 mpp? -115.76 151.02 35.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.052 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.888 -179.964 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.852 0.358 . . . . 0.0 111.121 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.766 HD11 ' HB3' ' A' ' 169' ' ' MET . 5.0 tt -105.8 145.96 13.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.912 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.526 HG21 ' HB3' ' A' ' 12' ' ' GLU . 13.9 mm -106.78 159.06 6.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.523 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.504 ' CD2' ' CE2' ' A' ' 14' ' ' PHE . 4.9 m-85 -121.27 104.73 9.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.427 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 20.9 ptt180 -118.09 146.77 43.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.9 0.381 . . . . 0.0 111.365 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.553 ' OD1' HD12 ' A' ' 8' ' ' ILE . 47.0 t0 -55.55 152.02 9.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.813 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.454 HD13 ' HG3' ' A' ' 168' ' ' GLU . 49.0 tp -81.6 -18.36 45.03 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.505 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.553 HD12 ' OD1' ' A' ' 6' ' ' ASP . 4.1 mp -91.36 -48.95 13.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -96.63 -17.75 20.19 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -179.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.431 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 36.1 m170 63.18 29.9 15.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.889 0.376 . . . . 0.0 110.71 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -100.4 121.02 40.85 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.661 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.526 ' HB3' HG21 ' A' ' 3' ' ' ILE . 0.2 OUTLIER -58.18 94.84 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.372 -179.726 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 14.7 mtt -72.13 -20.22 61.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.528 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.54 ' CD2' HG21 ' A' ' 31' ' ' VAL . 8.6 p90 -173.07 179.76 2.18 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.325 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -132.74 -170.26 2.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.836 0.35 . . . . 0.0 111.159 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.419 ' HB2' ' CG2' ' A' ' 2' ' ' ILE . 32.2 t70 -96.28 24.69 5.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.068 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.437 HG13 ' CD2' ' A' ' 18' ' ' TYR . 41.8 pt -89.03 -9.54 10.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.72 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.946 ' CZ ' HG22 ' A' ' 72' ' ' ILE . 73.6 m-85 -111.34 177.63 4.6 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.765 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -86.76 90.23 8.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.872 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.411 HD12 ' O ' ' A' ' 18' ' ' TYR . 3.6 mp -87.93 129.27 39.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.94 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 -123.3 121.04 34.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.979 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -73.32 115.79 13.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.768 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.469 HD12 ' NE2' ' A' ' 121' ' ' GLN . 2.8 pt -108.86 171.6 2.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.996 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.657 ' HB2' ' NE2' ' A' ' 121' ' ' GLN . . . 57.95 31.82 21.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.06 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 65.66 46.95 2.27 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.228 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.35 -11.38 63.52 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.756 -0.735 . . . . 0.0 113.345 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.5 ' HB3' ' HB3' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -57.25 -55.22 37.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.905 0.352 . . . . 0.0 111.141 -179.866 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 35.0 m -120.17 167.79 11.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.057 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.6 132.46 44.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.785 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -100.43 112.98 25.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.101 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.54 HG21 ' CD2' ' A' ' 14' ' ' PHE . 33.3 t -90.69 111.97 24.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.387 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -84.04 115.9 22.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.284 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -100.63 -138.96 10.51 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.042 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.8 pttp -174.56 125.55 0.3 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.814 0.34 . . . . 0.0 111.08 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 65.3 mtp -70.95 120.43 16.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.529 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.5 m -108.74 116.74 52.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.914 0.387 . . . . 0.0 111.54 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.5 p -85.76 165.7 16.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.613 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.588 ' O ' HG13 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -148.03 125.0 11.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.99 -179.612 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.6 t 179.86 40.02 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.869 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -131.73 174.96 9.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.946 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 96.07 96.15 1.79 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.485 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -65.93 78.74 0.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.803 0.335 . . . . 0.0 110.844 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.561 HG23 ' O ' ' A' ' 43' ' ' ILE . 13.1 tt -167.25 112.89 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.131 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -125.59 137.6 53.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.847 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -136.16 -178.92 5.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.947 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.09 -25.05 62.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.995 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 5.4 mt -56.18 -50.54 70.93 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.933 0.397 . . . . 0.0 111.104 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.702 ' CG2' HG21 ' A' ' 65' ' ' THR . 16.0 mt -81.1 -67.1 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.104 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -151.02 -128.61 1.51 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.485 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 76.24 134.35 0.52 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.495 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -89.75 177.23 6.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.873 0.368 . . . . 0.0 110.911 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -103.67 88.85 3.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.126 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.9 m -68.44 159.16 32.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.863 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -155.61 -46.26 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.044 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -126.07 150.5 48.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.843 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.56 119.36 0.98 Allowed Glycine 0 CA--C 1.52 0.373 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.449 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.19 -45.3 1.96 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.428 2.085 . . . . 0.0 112.363 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.7 104.2 16.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.88 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -163.88 128.61 1.85 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.481 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -124.27 130.39 52.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.88 0.372 . . . . 0.0 110.925 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.23 -22.2 25.47 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.562 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 26.4 m 63.53 113.03 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.787 0.327 . . . . 0.0 110.868 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -83.37 -48.1 10.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.91 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 49.1 m 59.88 68.58 0.77 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.896 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.702 HG21 ' CG2' ' A' ' 48' ' ' ILE . 1.9 m -119.21 95.94 5.01 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.981 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.656 ' C ' HD13 ' A' ' 67' ' ' ILE . 39.7 t -120.94 132.09 71.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.896 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.656 HD13 ' C ' ' A' ' 66' ' ' VAL . 0.0 OUTLIER -122.05 125.32 72.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.099 0.476 . . . . 0.0 111.243 -179.861 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.9 m -139.63 146.1 39.32 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.916 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 169.18 177.65 40.02 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.563 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.551 HG12 HG12 ' A' ' 72' ' ' ILE . 47.6 t -71.96 134.14 30.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.847 0.356 . . . . 0.0 110.868 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -61.04 -57.47 12.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.837 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.946 HG22 ' CZ ' ' A' ' 18' ' ' TYR . 10.1 pt -53.61 -33.8 22.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.642 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.799 HG13 ' HB2' ' A' ' 78' ' ' LEU . 90.2 t -71.7 -32.73 46.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.898 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.4 mtm -78.32 -40.29 37.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.554 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.406 ' OD1' ' CD2' ' A' ' 76' ' ' HIS . 16.9 p30 -82.11 -29.92 31.47 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.829 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.44 ' CE1' ' HB ' ' A' ' 72' ' ' ILE . 27.4 m170 -91.94 -2.54 56.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.808 0.337 . . . . 0.0 110.914 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 28.1 m-70 57.29 34.08 24.24 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.808 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.799 ' HB2' HG13 ' A' ' 73' ' ' VAL . 29.7 mt -55.43 148.63 14.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.865 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -128.35 128.02 43.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.922 0.392 . . . . 0.0 110.897 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.411 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 1.4 tt0 -89.9 122.16 32.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.075 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.3 t -108.6 178.88 4.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.817 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 50.5 p -115.85 163.77 15.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.004 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.457 ' CE2' ' CE2' ' A' ' 91' ' ' TYR . 0.6 OUTLIER -171.64 153.87 3.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.806 -179.973 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 13.0 p -101.44 176.34 5.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.969 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.67 -52.55 24.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.944 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -65.36 -41.83 93.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.702 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.29 -38.42 83.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.027 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.865 ' CD2' HD11 ' A' ' 122' ' ' ILE . 0.6 OUTLIER -61.97 -36.76 82.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.673 179.936 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.405 ' O ' HG22 ' A' ' 92' ' ' ILE . 17.5 mttm -57.68 -46.41 84.33 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.064 0.459 . . . . 0.0 110.225 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.62 -27.95 55.93 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.64 178.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.57 ' HE2' HG21 ' A' ' 146' ' ' VAL . 2.8 t80 -66.15 -44.94 82.7 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.745 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.54 HD12 ' CE2' ' A' ' 95' ' ' TYR . 3.9 tp -62.08 -45.61 98.34 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.752 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.417 ' HA ' ' HG2' ' A' ' 96' ' ' MET . 15.0 ttpt -60.51 -37.95 82.78 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.883 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.513 ' HA ' ' HG2' ' A' ' 97' ' ' LYS . 31.3 t70 -74.67 -42.57 58.22 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.841 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.54 ' CE2' HD12 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -77.05 -40.26 46.95 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.999 -0.281 . . . . 0.0 111.065 -179.35 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.432 ' HG2' ' O ' ' A' ' 92' ' ' ILE . 8.8 ptt? -66.23 -32.11 73.33 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.855 0.36 . . . . 0.0 110.298 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.513 ' HG2' ' HA ' ' A' ' 94' ' ' ASP . 4.2 ptmt -70.48 -33.74 71.59 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.529 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.493 ' N ' ' HG3' ' A' ' 97' ' ' LYS . 1.8 m -63.92 -40.1 95.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.266 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.41 HG23 ' HA2' ' A' ' 166' ' ' GLY . 8.4 mt -79.76 -41.47 21.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.211 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.9 tmtt? -56.95 -52.1 66.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.266 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -59.21 -48.02 87.97 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.002 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.1 tppm? -62.79 -38.75 91.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.981 0.42 . . . . 0.0 110.122 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.548 ' HB3' HG12 ' A' ' 111' ' ' VAL . 14.3 tp -67.95 -36.87 80.84 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.975 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.482 ' CG ' HG11 ' A' ' 111' ' ' VAL . 36.0 mt-10 -55.96 -32.38 63.81 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.752 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -85.61 -19.99 30.18 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.567 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -105.18 -62.95 1.28 Allowed 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.773 0.32 . . . . 0.0 111.517 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.455 ' N ' ' O ' ' A' ' 103' ' ' LEU . 16.5 mmt180 -129.36 64.42 71.2 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.844 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.895 ' O ' HG22 ' A' ' 111' ' ' VAL . 9.6 Cg_endo -50.64 -24.02 12.12 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 123.01 2.473 . . . . 0.0 112.596 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -74.13 -9.02 58.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.1 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.425 ' C ' ' HD2' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -108.79 -1.71 19.08 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.5 -179.683 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.895 HG22 ' O ' ' A' ' 108' ' ' PRO . 27.6 m -72.13 -26.96 25.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.713 0.292 . . . . 0.0 111.299 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.601 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 0.8 OUTLIER -68.47 -56.03 10.92 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.37 -179.398 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.601 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 41.6 Cg_exo -55.67 -40.76 83.4 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 121.921 1.747 . . . . 0.0 111.641 179.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.434 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 56.9 t80 -62.02 -39.9 93.86 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.866 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 4.4 mmm -59.7 -45.3 92.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.829 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 63.1 m -74.82 -44.65 48.14 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.876 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -66.18 -39.44 94.53 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.938 -0.648 . . . . 0.0 112.688 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.63 -51.7 68.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.943 0.401 . . . . 0.0 111.074 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.51 ' HB1' ' HE3' ' A' ' 123' ' ' LYS . . . -66.68 -28.11 68.19 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.37 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -75.39 -57.14 4.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.229 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.657 ' NE2' ' HB2' ' A' ' 24' ' ' ALA . 2.0 tp-100 -58.44 -43.09 88.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.278 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.865 HD11 ' CD2' ' A' ' 88' ' ' TYR . 0.3 OUTLIER -58.79 -46.33 90.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.269 -179.801 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.51 ' HE3' ' HB1' ' A' ' 119' ' ' ALA . 25.6 mttt -60.43 -31.52 70.5 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.262 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -67.39 -54.33 21.43 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.715 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.926 HG21 HD13 ' A' ' 148' ' ' LEU . 11.8 pt -61.59 -41.05 88.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.149 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 126' ' ' LEU . 11.1 mt -53.88 -35.96 62.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.761 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -68.6 -11.52 60.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.357 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -136.3 32.31 2.85 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.934 0.397 . . . . 0.0 110.522 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -48.23 -32.73 7.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.253 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -69.18 -24.35 64.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.274 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 21.5 m-20 -94.06 -36.43 12.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.419 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.418 ' CE1' ' OD2' ' A' ' 150' ' ' ASP . 3.5 m-85 -92.23 141.39 28.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.175 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.2 mm100 -121.35 145.74 47.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.877 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.453 ' CE2' ' HB2' ' A' ' 83' ' ' PHE . 2.9 m-85 -83.24 125.25 31.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.169 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.46 ' HB2' ' HB3' ' A' ' 147' ' ' ALA . 32.9 m-85 -127.5 150.16 49.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.679 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.446 ' HB ' ' HA ' ' A' ' 140' ' ' MET . 0.7 OUTLIER -140.05 159.97 26.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.719 179.893 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -57.57 -168.81 0.13 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.562 -0.828 . . . . 0.0 111.94 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -71.59 -8.9 56.92 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.622 0.248 . . . . 0.0 111.402 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 -94.09 -31.25 14.27 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.62 -0.263 . . . . 0.0 111.493 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.446 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 77.7 mtm 58.87 49.95 9.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.821 0.343 . . . . 0.0 111.017 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . 0.43 ' ND2' ' HA3' ' A' ' 144' ' ' GLY . 14.3 p-10 -72.11 114.62 30.8 Favored Pre-proline 0 N--CA 1.452 -0.357 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.987 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -64.98 -29.25 57.55 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.642 2.228 . . . . 0.0 112.288 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -84.59 -3.28 58.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.336 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.43 ' HA3' ' ND2' ' A' ' 141' ' ' ASN . . . -90.61 -155.17 31.07 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.535 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 2.8 ptp -94.75 -176.97 4.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.814 0.34 . . . . 0.0 110.895 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.57 HG21 ' HE2' ' A' ' 91' ' ' TYR . 53.4 t -128.97 151.13 35.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.085 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.691 ' HB1' ' HE3' ' A' ' 160' ' ' MET . . . -111.71 115.85 29.77 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.67 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.926 HD13 HG21 ' A' ' 125' ' ' ILE . 4.6 mt -92.26 106.24 18.28 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.96 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.502 HD12 ' HG2' ' A' ' 160' ' ' MET . 1.8 tp -89.29 119.63 29.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.248 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.449 ' HB3' ' CE1' ' A' ' 159' ' ' TYR . 0.6 OUTLIER -133.12 172.52 12.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.701 179.658 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -116.01 140.84 48.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.763 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 19.2 mmm180 -55.56 -178.66 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.115 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.23 -31.59 53.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.018 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 37.4 p30 -76.69 -15.2 59.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.104 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 71.27 17.47 75.99 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.708 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 93.9 t -111.89 -65.75 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.817 0.342 . . . . 0.0 110.846 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 35.8 m -56.95 109.17 1.53 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.097 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -82.17 122.85 3.83 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.522 2.148 . . . . 0.0 112.406 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.449 ' CE1' ' HB3' ' A' ' 150' ' ' ASP . 12.7 p90 -123.49 146.71 47.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.772 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' MET . . . . . 0.691 ' HE3' ' HB1' ' A' ' 147' ' ' ALA . 1.1 mtm -112.22 142.53 44.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.949 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.527 ' HB ' ' HB2' ' A' ' 148' ' ' LEU . 46.0 mt -95.45 117.58 39.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.226 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.443 ' CZ ' ' HE3' ' A' ' 160' ' ' MET . 48.4 m-85 -116.34 152.48 33.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.837 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.505 ' CE2' ' CZ ' ' A' ' 95' ' ' TYR . 11.5 m-85 -97.16 120.4 37.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.885 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 9.9 ttpt -65.26 -50.12 66.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.023 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.434 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 52.8 m-20 -57.69 -30.74 65.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.96 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.41 ' HA2' HG23 ' A' ' 99' ' ' ILE . . . -104.72 26.3 22.94 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.446 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.453 HD21 ' HB3' ' A' ' 4' ' ' TYR . 1.1 tt -142.69 142.23 31.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.759 0.314 . . . . 0.0 110.911 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.454 ' HG3' HD13 ' A' ' 7' ' ' LEU . 1.1 mt-10 -116.66 159.51 22.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.928 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.766 ' HB3' HD11 ' A' ' 2' ' ' ILE . 0.1 OUTLIER -115.48 159.96 20.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.776 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -159.19 120.4 3.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.908 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.422 ' CG ' HD12 ' A' ' 2' ' ' ILE . 5.0 mtpt -85.22 113.81 21.85 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.914 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 69.7 m -139.91 95.3 2.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.902 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.582 ' H ' HD12 ' A' ' 173' ' ' LEU . 3.8 mp -76.43 -43.69 39.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.931 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.922 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.409 0 CA-C-O 120.828 0.347 . . . . 0.0 111.146 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.788 HD11 ' HB3' ' A' ' 169' ' ' MET . 3.2 tt -106.65 144.57 15.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.945 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 21.5 mm -99.64 154.02 4.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.292 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.609 ' HE1' HG23 ' A' ' 2' ' ' ILE . 3.3 m-85 -123.67 110.06 14.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.602 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.57 145.78 49.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.906 0.384 . . . . 0.0 111.282 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.457 ' O ' ' HA ' ' A' ' 10' ' ' HIS . 44.3 t0 -55.68 152.17 9.83 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.862 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.547 HD23 HG23 ' A' ' 99' ' ' ILE . 57.3 tp -80.2 -23.5 40.91 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.305 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.758 HD11 ' CG1' ' A' ' 99' ' ' ILE . 4.3 mp -91.3 -45.48 14.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.26 -21.24 19.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.799 -179.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.457 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 14.5 m170 61.78 27.89 17.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.809 0.337 . . . . 0.0 110.731 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -100.77 122.15 42.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.751 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -56.93 89.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.366 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.407 ' O ' ' CD2' ' A' ' 76' ' ' HIS . 25.2 mtt -67.53 -19.24 65.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.644 179.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.512 ' CZ ' ' CD2' ' A' ' 4' ' ' TYR . 12.5 p90 -177.64 175.87 1.32 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.817 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.28 -169.92 2.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.734 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.411 ' HA ' ' CD1' ' A' ' 20' ' ' ILE . 19.0 t0 -95.76 31.87 1.98 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.148 0.499 . . . . 0.0 110.817 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.413 HG13 ' CD2' ' A' ' 18' ' ' TYR . 35.6 pt -89.66 -13.41 9.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.437 178.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.748 ' CZ ' HG22 ' A' ' 72' ' ' ILE . 61.3 m-85 -110.07 178.92 4.25 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.463 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.408 ' HB2' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -86.43 91.55 8.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.75 179.828 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.51 HD12 ' O ' ' A' ' 18' ' ' TYR . 4.2 mp -88.35 135.61 25.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.178 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 10.7 mtm180 -129.26 117.67 21.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.015 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -71.07 116.33 11.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.71 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.558 HD11 HG23 ' A' ' 161' ' ' ILE . 2.9 pt -109.5 171.07 2.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.162 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.491 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . . . 57.91 30.97 19.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.178 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 66.56 42.56 2.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.095 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.89 -17.48 54.97 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.996 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.491 ' HB3' ' HB3' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -51.13 -49.37 60.94 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.852 0.358 . . . . 0.0 111.168 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 6.7 m -128.48 167.07 17.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.727 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.629 HD11 ' CD ' ' A' ' 164' ' ' LYS . 1.1 mt -129.37 135.08 48.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.878 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -99.62 112.78 24.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.8 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 159' ' ' TYR . 22.0 t -94.24 111.75 25.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.541 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.408 ' HB2' ' HB2' ' A' ' 19' ' ' LYS . 9.2 mt-10 -86.53 110.57 19.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.357 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -92.91 -134.21 6.76 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.212 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 9.3 ptpt -174.49 123.23 0.28 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.802 0.334 . . . . 0.0 111.023 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 15.1 mtt -67.16 121.54 15.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.641 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.4 m -119.11 125.69 74.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.495 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.404 ' HB3' HG23 ' A' ' 68' ' ' THR . 1.7 p -101.75 148.36 25.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.521 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.757 ' HB3' HG12 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -117.84 127.37 53.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.867 -179.831 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.6 m -143.13 105.43 4.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.867 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -176.97 127.1 0.16 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.883 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 93.59 170.58 39.03 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.517 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 22.2 p-10 -106.64 165.09 11.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.875 0.369 . . . . 0.0 110.899 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.1 mp -128.62 140.34 49.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.046 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.04 -58.55 1.99 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.822 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -124.51 -178.95 4.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.841 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 40.4 p -96.26 -35.17 11.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.9 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 56.9 mt -81.12 -67.09 0.81 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.967 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 52.2 mt 52.28 92.4 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.262 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -156.04 141.93 8.41 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.483 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 71.93 -86.54 0.47 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.473 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 60.34 89.29 0.07 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.859 0.361 . . . . 0.0 110.942 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -97.27 38.16 1.28 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.107 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.6 t -121.85 78.05 1.43 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.839 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -89.6 91.96 8.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.104 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -134.04 -47.25 0.78 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.873 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -123.73 67.4 0.5 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.454 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.64 175.79 7.53 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.637 2.225 . . . . 0.0 112.272 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -160.3 -54.68 0.05 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.965 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -157.68 -141.01 3.06 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.558 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -131.63 177.2 7.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.853 0.359 . . . . 0.0 110.87 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.38 116.37 1.79 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.491 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 76.2 p -71.86 -41.73 67.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.849 0.357 . . . . 0.0 110.972 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -143.31 -60.46 0.42 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.877 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.2 m 59.5 30.21 19.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.95 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.426 HG23 ' CD1' ' A' ' 67' ' ' ILE . 10.8 t -78.57 -168.28 1.33 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.767 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.52 ' C ' HD13 ' A' ' 67' ' ' ILE . 34.7 t -99.11 124.39 52.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.17 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.757 HG12 ' HB3' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -128.23 128.47 68.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.831 179.679 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.404 HG23 ' HB3' ' A' ' 37' ' ' SER . 7.3 m -139.29 130.91 27.26 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.962 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -176.71 -169.5 38.12 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.401 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.462 HG21 HD11 ' A' ' 149' ' ' LEU . 48.4 t -72.34 140.54 17.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.806 0.336 . . . . 0.0 110.967 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.411 ' O ' ' ND2' ' A' ' 75' ' ' ASN . 35.4 t70 -67.75 -59.63 3.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.363 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.748 HG22 ' CZ ' ' A' ' 18' ' ' TYR . 10.3 pt -53.62 -34.44 24.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.594 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.781 HG13 ' HB2' ' A' ' 78' ' ' LEU . 58.7 t -71.18 -33.04 49.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.826 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.6 mtm -78.25 -40.03 38.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.62 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.411 ' ND2' ' O ' ' A' ' 71' ' ' ASP . 15.3 p30 -82.02 -28.44 32.54 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.582 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.438 ' CD2' ' HB ' ' A' ' 72' ' ' ILE . 8.1 m-70 -91.49 -0.77 57.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.928 0.394 . . . . 0.0 110.753 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 10.7 m170 57.61 28.14 15.23 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.131 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.781 ' HB2' HG13 ' A' ' 73' ' ' VAL . 57.1 mt -56.82 137.98 54.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.371 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -122.12 137.01 54.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.973 0.416 . . . . 0.0 111.271 -179.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.423 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 1.5 tt0 -92.09 130.64 37.77 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.961 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.58 HG21 HD11 ' A' ' 136' ' ' ILE . 1.3 t -117.77 165.62 13.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.83 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 40.3 m -96.17 161.39 13.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.963 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.477 ' HB2' ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -171.7 149.94 2.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.013 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -101.54 164.76 11.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.906 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.11 -52.48 65.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.992 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -65.62 -44.9 85.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.785 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.79 -37.61 76.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.07 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.868 ' CD2' HD11 ' A' ' 122' ' ' ILE . 0.5 OUTLIER -62.96 -35.79 81.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.799 179.9 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.405 ' O ' HG22 ' A' ' 92' ' ' ILE . 52.8 mttt -59.61 -43.65 93.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.475 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.5 tttt -77.72 -27.91 50.72 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.75 178.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.56 ' HE2' HG21 ' A' ' 146' ' ' VAL . 7.8 t80 -67.75 -46.84 70.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.702 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.625 HD12 ' CE2' ' A' ' 95' ' ' TYR . 5.8 tp -60.49 -42.73 92.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 CA-C-O 120.84 0.352 . . . . 0.0 110.668 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.453 ' O ' ' HB3' ' A' ' 97' ' ' LYS . 7.9 ttpp -63.94 -39.73 94.83 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.799 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.453 ' O ' ' HG3' ' A' ' 97' ' ' LYS . 29.1 t70 -75.85 -37.99 58.42 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.769 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.625 ' CE2' HD12 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -78.46 -42.78 28.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.607 0.242 . . . . 0.0 110.619 -179.736 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.412 ' HG3' ' N ' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -67.53 -32.09 72.64 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.035 179.569 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.453 ' HB3' ' O ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -70.91 -34.5 71.6 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.899 0.38 . . . . 0.0 110.656 179.807 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.27 -41.03 96.26 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.152 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.758 ' CG1' HD11 ' A' ' 8' ' ' ILE . 9.3 mt -79.81 -41.16 21.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.488 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.8 tttt -55.57 -53.16 59.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.462 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -60.64 -46.97 93.4 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.162 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.9 tppt? -62.5 -37.94 87.98 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.878 0.37 . . . . 0.0 110.403 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.73 HD21 ' CB ' ' A' ' 110' ' ' ARG . 3.4 tp -69.55 -34.24 73.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.032 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.672 ' HG3' HG11 ' A' ' 111' ' ' VAL . 29.4 mt-10 -59.19 -30.99 68.6 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.691 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.424 ' HG3' ' HG3' ' A' ' 106' ' ' GLN . 0.8 OUTLIER -87.38 -20.17 27.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.707 -179.646 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.537 HE22 HD11 ' A' ' 7' ' ' LEU . 21.4 mt-30 -107.36 -62.3 1.44 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.833 0.349 . . . . 0.0 111.593 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 103' ' ' LEU . 22.0 mtm180 -128.03 63.52 62.27 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.92 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.912 ' O ' HG22 ' A' ' 111' ' ' VAL . 10.0 Cg_endo -50.74 -21.24 7.82 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 123.144 2.562 . . . . 0.0 112.965 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -72.04 -9.22 58.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.584 0.23 . . . . 0.0 111.433 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.73 ' CB ' HD21 ' A' ' 103' ' ' LEU . 19.0 mmt85 -112.12 -1.27 15.34 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.64 -0.255 . . . . 0.0 111.677 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.912 HG22 ' O ' ' A' ' 108' ' ' PRO . 33.8 m -71.33 -32.54 47.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.547 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 15.5 mttm -69.81 -49.95 18.98 Favored Pre-proline 0 CA--C 1.53 0.192 0 C-N-CA 121.047 -0.261 . . . . 0.0 111.57 -179.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.547 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 31.4 Cg_exo -58.98 -36.13 97.35 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.183 1.922 . . . . 0.0 111.936 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.455 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 89.9 t80 -71.09 -35.38 71.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.923 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 10.8 mtp -58.61 -52.44 65.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.761 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 63.0 m -73.89 -44.06 56.49 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.552 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.58 -38.71 96.29 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.391 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.99 -51.6 68.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.002 0.429 . . . . 0.0 110.961 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.08 -28.22 65.25 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.129 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -75.88 -44.01 42.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.009 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -71.34 -38.12 71.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.001 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.868 HD11 ' CD2' ' A' ' 88' ' ' TYR . 0.4 OUTLIER -63.89 -46.82 93.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.269 -179.916 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.448 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 6.1 ptmt -60.72 -31.07 70.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.338 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -66.49 -52.37 46.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.996 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.67 HG21 HD13 ' A' ' 148' ' ' LEU . 11.9 pt -65.3 -40.44 88.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.283 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 11.9 mt -53.88 -35.5 61.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.882 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -72.75 -9.9 59.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.3 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -142.93 32.1 1.4 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.985 0.422 . . . . 0.0 110.615 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.495 ' CE1' ' CZ ' ' A' ' 134' ' ' PHE . 5.9 t80 -51.49 -25.32 6.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.22 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 5.7 tttp -62.74 -29.2 70.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.744 0.307 . . . . 0.0 110.915 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 32.8 m-20 -94.09 -39.17 10.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.263 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -89.87 145.59 25.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.086 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 -132.55 145.37 51.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.147 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.495 ' CZ ' ' CE1' ' A' ' 129' ' ' PHE . 1.4 m-85 -78.27 124.78 28.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.858 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.423 ' CE2' ' HB2' ' A' ' 80' ' ' GLU . 38.0 m-85 -129.9 135.96 48.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.767 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.58 HD11 HG21 ' A' ' 81' ' ' THR . 0.6 OUTLIER -120.99 159.65 22.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.858 179.905 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.68 -165.69 0.38 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.215 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -71.78 -8.93 57.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.573 0.225 . . . . 0.0 111.502 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 -96.97 -28.29 14.24 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.435 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 62.0 mtm 55.37 37.71 29.28 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.853 0.359 . . . . 0.0 110.93 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . 0.41 ' ND2' ' HA3' ' A' ' 144' ' ' GLY . 16.7 p-10 -61.87 115.25 14.43 Favored Pre-proline 0 N--CA 1.451 -0.386 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.933 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.21 -30.64 91.71 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.498 2.132 . . . . 0.0 112.183 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -84.59 -3.14 58.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.102 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.41 ' HA3' ' ND2' ' A' ' 141' ' ' ASN . . . -87.24 -169.29 45.6 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.472 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 2.3 ptp -86.58 -176.5 5.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.728 0.299 . . . . 0.0 110.91 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.56 HG21 ' HE2' ' A' ' 91' ' ' TYR . 48.9 t -128.17 148.85 32.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.962 0.41 . . . . 0.0 111.164 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.569 ' HB1' ' SD ' ' A' ' 160' ' ' MET . . . -111.64 115.2 28.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.599 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.67 HD13 HG21 ' A' ' 125' ' ' ILE . 3.2 mt -89.77 106.28 18.36 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.332 -179.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.462 HD11 HG21 ' A' ' 70' ' ' VAL . 4.1 tp -88.83 121.15 30.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.922 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.453 ' HB3' ' CZ ' ' A' ' 159' ' ' TYR . 31.2 t70 -134.67 164.01 28.48 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.547 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -110.36 148.52 31.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.051 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.66 -178.01 0.66 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.826 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -61.48 -31.07 71.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.94 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -84.66 -15.03 46.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.289 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 64.59 27.55 72.04 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.468 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 77.9 t -110.06 -42.47 5.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.846 0.355 . . . . 0.0 111.044 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 96.2 m -100.33 106.76 44.25 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.327 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.72 130.74 12.81 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.385 2.057 . . . . 0.0 111.609 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.453 ' CZ ' ' HB3' ' A' ' 150' ' ' ASP . 6.1 p90 -127.09 146.43 50.38 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.913 0.387 . . . . 0.0 111.18 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' MET . . . . . 0.713 ' CE ' HD13 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -113.12 145.4 40.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.041 -179.827 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.558 HG23 HD11 ' A' ' 23' ' ' ILE . 59.7 mt -101.78 110.61 29.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.267 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.515 ' CE1' ' HB2' ' A' ' 147' ' ' ALA . 52.2 m-85 -110.93 154.0 24.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.523 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -102.14 115.14 29.92 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.944 0.402 . . . . 0.0 110.861 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.629 ' CD ' HD11 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -58.94 -46.5 87.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.168 -179.655 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.455 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 56.5 m-20 -51.56 -31.84 25.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.987 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -106.45 25.99 21.42 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.395 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.525 HD21 ' HB3' ' A' ' 4' ' ' TYR . 0.6 OUTLIER -139.88 146.93 39.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.821 0.343 . . . . 0.0 110.941 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.23 150.79 29.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.843 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.788 ' HB3' HD11 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -121.59 142.92 49.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.986 -179.976 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -148.67 125.02 10.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.948 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.634 ' HG2' HD12 ' A' ' 2' ' ' ILE . 6.1 mttp -91.94 118.64 30.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.901 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' CYS . . . . . 0.687 ' C ' HD23 ' A' ' 173' ' ' LEU . 77.5 m -139.72 -48.46 0.47 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.891 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.687 HD23 ' C ' ' A' ' 172' ' ' CYS . 0.9 OUTLIER 45.42 40.51 5.6 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.435 179.979 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.882 179.982 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 tpp . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.766 0.317 . . . . 0.0 111.162 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.738 HD11 ' HB3' ' A' ' 169' ' ' MET . 3.5 tt -109.9 146.34 15.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.952 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.419 HG22 ' N ' ' A' ' 4' ' ' TYR . 29.3 mm -99.72 155.04 4.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.374 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.58 ' CE1' HG23 ' A' ' 2' ' ' ILE . 4.6 m-85 -124.43 107.29 10.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.669 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -123.8 144.93 49.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.153 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.58 ' OD1' HD12 ' A' ' 8' ' ' ILE . 42.5 t0 -54.88 140.62 36.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.856 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 43.1 tp -72.31 -20.29 61.52 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.362 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.58 HD12 ' OD1' ' A' ' 6' ' ' ASP . 4.1 mp -91.39 -46.3 14.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.51 -18.38 19.86 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -179.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.402 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 4.1 m80 62.2 29.28 17.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.864 0.364 . . . . 0.0 110.756 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -101.94 118.36 36.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.762 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -56.79 94.07 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.377 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 9.8 mtt -71.7 -19.24 62.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.695 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.501 ' CZ ' ' CD2' ' A' ' 4' ' ' TYR . 9.4 p90 -177.15 175.84 1.47 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.821 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.86 -171.13 2.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.593 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.409 ' HA ' ' CD1' ' A' ' 20' ' ' ILE . 21.1 t0 -95.52 36.24 1.28 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.113 0.482 . . . . 0.0 110.785 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.44 HG13 ' CD2' ' A' ' 18' ' ' TYR . 37.4 pt -94.5 -11.77 8.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.571 179.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.89 ' CZ ' HG22 ' A' ' 72' ' ' ILE . 43.5 m-85 -109.41 -166.85 1.14 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.573 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.7 mtpp -98.96 89.46 4.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.838 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.409 ' CD1' ' HA ' ' A' ' 16' ' ' ASP . 3.8 mp -88.03 124.68 41.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.881 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 11.0 mtp180 -115.78 121.16 41.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.158 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.515 ' HG3' HD23 ' A' ' 29' ' ' LEU . 5.1 mt-10 -74.0 116.36 14.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.803 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.457 HD11 HG23 ' A' ' 161' ' ' ILE . 5.1 pt -116.08 171.51 5.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.19 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.512 ' HB2' ' NE2' ' A' ' 121' ' ' GLN . . . 56.58 33.45 22.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.167 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 64.57 38.32 7.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.249 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.74 -13.84 66.6 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.737 -0.744 . . . . 0.0 113.113 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.806 HD21 ' HA ' ' A' ' 114' ' ' PHE . 0.1 OUTLIER -53.57 -48.09 69.48 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.749 0.309 . . . . 0.0 111.368 -179.885 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 18.8 m -126.0 167.27 15.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.272 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.831 HD21 ' HD2' ' A' ' 164' ' ' LYS . 0.3 OUTLIER -130.8 123.83 30.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.76 179.932 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -92.0 112.8 24.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.885 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.2 t -100.63 111.91 31.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.956 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -87.6 118.77 27.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.029 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -99.9 -128.49 6.3 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.299 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.48 125.89 0.31 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.856 0.36 . . . . 0.0 110.903 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 81.4 mtp -73.21 119.42 17.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.941 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.9 m -111.38 119.29 59.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.152 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.597 ' HB3' HG23 ' A' ' 68' ' ' THR . 88.4 p -90.14 165.5 13.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.001 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.515 ' HB3' HG12 ' A' ' 67' ' ' ILE . 3.8 ttt85 -155.87 148.54 24.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.697 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 19.8 m -136.65 -56.28 0.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.93 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 62.55 61.83 1.18 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.835 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -77.97 88.03 1.07 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.553 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -133.92 156.15 48.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.866 0.365 . . . . 0.0 110.819 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.506 HG23 ' O ' ' A' ' 43' ' ' ILE . 3.0 tp -124.04 121.02 61.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.403 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -175.22 173.95 2.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.896 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.2 t0 71.31 -62.66 0.45 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.174 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -48.71 -28.69 3.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.232 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.3 mt -69.77 -28.98 66.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.884 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -108.73 30.03 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.988 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -81.72 -33.56 27.18 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.58 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 61.3 82.86 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.513 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -120.35 -179.07 3.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.824 0.345 . . . . 0.0 110.916 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -169.5 -43.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.08 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.7 m -79.54 175.34 10.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.958 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -96.25 -36.47 10.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.221 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -161.53 146.87 13.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.893 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 179.16 -89.5 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.41 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.84 174.09 10.09 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.599 2.199 . . . . 0.0 112.33 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.95 153.89 24.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.927 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -141.84 95.89 0.19 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.493 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -99.26 118.6 36.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.863 0.363 . . . . 0.0 110.944 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -158.23 -127.61 0.95 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.424 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.4 m -89.64 115.77 27.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.804 0.335 . . . . 0.0 110.877 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.78 106.35 11.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.903 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.0 t -177.19 -173.58 0.46 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.012 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.6 t -165.79 -43.81 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.744 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 45.5 t -137.9 127.58 34.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.909 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.515 HG12 ' HB3' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -128.32 126.79 66.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.916 179.844 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.597 HG23 ' HB3' ' A' ' 37' ' ' SER . 1.3 m -139.33 122.3 16.7 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.923 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -161.82 -177.78 35.18 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.321 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.728 HG22 ' HG3' ' A' ' 158' ' ' PRO . 51.0 t -71.29 148.66 10.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.775 0.322 . . . . 0.0 110.793 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -73.8 -56.35 5.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.453 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.89 HG22 ' CZ ' ' A' ' 18' ' ' TYR . 11.2 pt -53.72 -33.97 23.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.349 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.789 HG13 ' HB2' ' A' ' 78' ' ' LEU . 59.7 t -71.6 -33.57 49.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.812 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.8 mtt -78.47 -39.6 37.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.693 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.2 p30 -82.04 -28.46 32.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.545 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.416 ' CG ' ' O ' ' A' ' 72' ' ' ILE . 7.2 m-70 -90.28 -2.59 58.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.845 0.355 . . . . 0.0 110.582 179.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.455 ' HB2' ' HB3' ' A' ' 138' ' ' GLU . 8.9 m-70 59.87 28.24 17.7 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.892 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.789 ' HB2' HG13 ' A' ' 73' ' ' VAL . 64.2 mt -58.55 144.51 42.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.555 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -128.63 138.06 51.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.891 0.377 . . . . 0.0 111.251 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.412 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 18.4 tt0 -92.84 123.28 36.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.04 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.411 HG21 HD11 ' A' ' 136' ' ' ILE . 10.4 t -108.97 165.05 11.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.76 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.5 m -95.44 160.5 14.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.874 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.503 ' CE2' ' CE2' ' A' ' 91' ' ' TYR . 0.6 OUTLIER -171.66 148.56 2.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.908 -179.884 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.52 167.09 10.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.791 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.66 -52.43 64.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.896 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -63.39 -43.71 96.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.916 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.77 -36.61 79.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.156 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.952 ' CD2' HD11 ' A' ' 122' ' ' ILE . 0.2 OUTLIER -64.16 -33.82 76.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.833 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 23.4 mttt -61.62 -45.33 94.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.012 0.434 . . . . 0.0 110.369 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.55 -27.9 45.94 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.834 178.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.576 ' HE2' HG21 ' A' ' 146' ' ' VAL . 12.6 t80 -67.77 -47.09 70.18 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.848 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.861 HG22 ' O ' ' A' ' 88' ' ' TYR . 1.6 tp -62.46 -41.61 92.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.828 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.425 ' O ' ' CG ' ' A' ' 97' ' ' LYS . 17.5 ttmt -59.07 -46.36 88.47 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.045 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -66.42 -43.75 84.85 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.149 -179.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.541 ' CD1' ' C ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -73.24 -42.46 62.54 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.943 -179.088 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 23.0 ptm -61.0 -32.16 71.74 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.303 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.425 ' CG ' ' O ' ' A' ' 93' ' ' LYS . 6.4 mmtp -66.91 -43.91 82.13 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.511 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.2 m -56.19 -41.37 75.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.735 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.7 mt -79.79 -41.7 21.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.701 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 13.2 tttt -53.76 -56.29 18.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.532 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -59.97 -45.2 96.3 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.189 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.03 -41.93 97.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.903 0.383 . . . . 0.0 110.378 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.599 ' HB3' HG12 ' A' ' 111' ' ' VAL . 9.2 tp -66.36 -34.2 77.43 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.259 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.665 ' CG ' HG11 ' A' ' 111' ' ' VAL . 31.3 mt-10 -60.11 -29.07 68.37 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.617 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -88.19 -18.76 28.01 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.548 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -107.05 -58.49 1.93 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.775 0.322 . . . . 0.0 111.693 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.444 ' N ' ' O ' ' A' ' 103' ' ' LEU . 46.1 mtt180 -134.04 66.4 71.81 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.809 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.888 ' O ' HG22 ' A' ' 111' ' ' VAL . 9.1 Cg_endo -50.46 -22.68 9.3 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 123.141 2.561 . . . . 0.0 112.729 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -73.68 -9.3 58.53 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.735 0.302 . . . . 0.0 111.176 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.503 ' C ' ' HD2' ' A' ' 113' ' ' PRO . 3.0 mmt180 -110.91 -0.16 16.91 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.616 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.888 HG22 ' O ' ' A' ' 108' ' ' PRO . 32.9 m -72.67 -33.43 44.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.603 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 13.9 mttt -66.87 -50.38 43.7 Favored Pre-proline 0 C--N 1.331 -0.21 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.555 -179.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.603 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 32.8 Cg_exo -59.05 -39.36 80.88 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 121.967 1.778 . . . . 0.0 111.724 179.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.806 ' HA ' HD21 ' A' ' 27' ' ' LEU . 67.3 t80 -64.25 -37.89 89.1 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.887 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 4.1 mmm -58.57 -50.13 74.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.728 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 66.4 m -74.33 -44.34 52.92 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.742 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.47 -40.0 98.31 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.516 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.42 -51.55 69.34 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.006 0.431 . . . . 0.0 110.948 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.6 -31.42 65.17 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.088 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -72.12 -41.33 67.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.106 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.512 ' NE2' ' HB2' ' A' ' 24' ' ' ALA . 7.7 tp-100 -73.53 -36.71 65.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.078 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.952 HD11 ' CD2' ' A' ' 88' ' ' TYR . 0.4 OUTLIER -67.12 -46.08 85.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.247 -179.765 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.451 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 1.2 ptpm? -61.42 -31.41 71.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.083 0.468 . . . . 0.0 110.223 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -67.1 -53.66 28.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.705 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.59 HG21 HD13 ' A' ' 148' ' ' LEU . 15.0 pt -62.28 -41.71 92.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.249 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.466 HD23 ' HA ' ' A' ' 126' ' ' LEU . 12.3 mt -53.85 -35.85 61.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.922 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -68.05 -13.82 62.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.14 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -139.98 32.37 1.97 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.011 0.434 . . . . 0.0 110.628 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.514 ' CE1' ' CZ ' ' A' ' 134' ' ' PHE . 2.8 t80 -49.47 -28.87 5.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.096 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.49 -27.04 65.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.986 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -94.22 -35.97 12.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.476 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -94.44 140.52 29.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.923 0.392 . . . . 0.0 111.373 -179.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.406 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 2.2 mm100 -124.13 145.49 49.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.805 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.514 ' CZ ' ' CE1' ' A' ' 129' ' ' PHE . 0.5 OUTLIER -80.47 123.87 28.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.069 -179.787 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.54 ' HB2' ' HB3' ' A' ' 147' ' ' ALA . 36.6 m-85 -126.76 151.94 47.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.499 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.412 ' CG2' ' HA ' ' A' ' 140' ' ' MET . 1.0 OUTLIER -138.7 160.04 30.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.001 179.863 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.05 -159.25 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.2 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.455 ' HB3' ' HB2' ' A' ' 77' ' ' HIS . 5.7 pt-20 -76.79 -8.77 57.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.609 0.242 . . . . 0.0 111.436 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 20.4 m-80 -96.58 -29.75 13.68 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.412 ' HA ' ' CG2' ' A' ' 136' ' ' ILE . 31.1 mtm 57.44 37.73 27.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.907 0.384 . . . . 0.0 110.854 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . 0.423 ' ND2' ' HA3' ' A' ' 144' ' ' GLY . 15.0 p-10 -66.22 115.01 19.45 Favored Pre-proline 0 N--CA 1.452 -0.352 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.164 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 141' ' ' ASN . 23.3 Cg_exo -62.73 -28.96 76.75 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.505 2.137 . . . . 0.0 112.17 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -84.55 -3.9 58.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.148 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.423 ' HA3' ' ND2' ' A' ' 141' ' ' ASN . . . -87.05 -146.52 10.5 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.381 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.425 ' HE3' ' O ' ' A' ' 166' ' ' GLY . 2.3 ptp -104.9 179.86 4.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.765 0.317 . . . . 0.0 110.768 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.576 HG21 ' HE2' ' A' ' 91' ' ' TYR . 43.7 t -128.98 149.31 33.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.136 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.54 ' HB3' ' HB2' ' A' ' 135' ' ' PHE . . . -111.75 115.86 29.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.663 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.59 HD13 HG21 ' A' ' 125' ' ' ILE . 4.6 mt -90.57 106.14 18.3 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.86 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.49 HD11 HG21 ' A' ' 70' ' ' VAL . 5.2 tp -88.56 120.64 30.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.192 -179.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.456 ' HB3' ' CE1' ' A' ' 159' ' ' TYR . 47.9 t0 -138.06 164.35 29.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.442 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -105.98 146.99 29.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.889 0.376 . . . . 0.0 111.026 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.71 -177.66 0.62 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.863 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -60.46 -41.21 93.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.858 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -79.19 -15.11 58.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.16 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 60.51 33.79 83.0 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.537 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 91.2 t -107.08 -24.08 4.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.78 0.324 . . . . 0.0 111.039 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.4 t -132.22 124.23 19.24 Favored Pre-proline 0 CA--C 1.531 0.241 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.136 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.728 ' HG3' HG22 ' A' ' 70' ' ' VAL . 93.7 Cg_endo -79.93 135.42 11.21 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.529 2.152 . . . . 0.0 112.079 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.456 ' CE1' ' HB3' ' A' ' 150' ' ' ASP . 8.0 p90 -124.61 136.02 53.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.862 0.363 . . . . 0.0 111.016 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' MET . . . . . 0.642 ' HG3' HD11 ' A' ' 72' ' ' ILE . 24.7 mtp -104.43 140.51 37.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.958 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.495 ' HB ' ' HB2' ' A' ' 148' ' ' LEU . 53.1 mt -99.67 113.67 35.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.16 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -110.15 158.14 18.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.705 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.413 ' CZ ' ' OH ' ' A' ' 95' ' ' TYR . 24.2 m-85 -99.18 114.64 27.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.852 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.831 ' HD2' HD21 ' A' ' 29' ' ' LEU . 33.0 tttm -57.98 -51.9 67.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.136 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.43 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 37.8 m-20 -54.55 -35.63 63.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.038 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.425 ' O ' ' HE3' ' A' ' 145' ' ' MET . . . -96.94 28.51 13.46 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.397 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.429 HD11 ' HB3' ' A' ' 4' ' ' TYR . 1.0 OUTLIER -147.34 143.6 28.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.878 0.37 . . . . 0.0 110.801 -179.911 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -105.11 162.58 13.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.803 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.738 ' HB3' HD11 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -134.31 138.32 44.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.976 179.934 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -144.71 118.16 9.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.845 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.497 ' HG2' HD12 ' A' ' 2' ' ' ILE . 12.8 mtpt -78.71 115.97 18.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.998 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 25.8 p -97.79 -176.05 3.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.786 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -114.76 160.67 19.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.917 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.857 -179.993 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ttt . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.858 0.361 . . . . 0.0 111.215 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.765 HD11 ' HB3' ' A' ' 169' ' ' MET . 2.4 tt -108.04 147.66 12.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.008 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.477 HG21 ' HB3' ' A' ' 12' ' ' GLU . 21.2 mm -101.77 157.88 4.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.353 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.566 ' HE1' HG23 ' A' ' 2' ' ' ILE . 5.5 m-85 -126.58 95.22 4.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.423 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 10.0 ptt180 -110.67 148.59 31.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.955 0.407 . . . . 0.0 111.183 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.443 ' O ' ' HA ' ' A' ' 10' ' ' HIS . 31.8 t0 -56.96 152.2 13.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.741 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 36.1 tp -81.31 -24.05 37.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.225 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.684 HD11 HG13 ' A' ' 99' ' ' ILE . 3.9 mp -91.36 -44.61 14.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.827 -179.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.0 t -94.13 -21.09 19.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.756 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.443 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 25.5 m-70 62.34 26.63 15.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.86 0.362 . . . . 0.0 110.812 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -101.96 124.6 47.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.798 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.477 ' HB3' HG21 ' A' ' 3' ' ' ILE . 1.3 pm0 -58.03 104.06 0.18 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.386 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 19.7 mtt -82.82 -18.68 39.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.62 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.508 ' CE2' ' CD2' ' A' ' 4' ' ' TYR . 16.0 p90 -178.64 176.74 0.96 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.68 179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.66 -170.73 2.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.824 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -95.91 28.53 3.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.114 0.483 . . . . 0.0 110.877 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 45.9 pt -89.31 -11.34 10.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.731 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.806 ' CZ ' HG22 ' A' ' 72' ' ' ILE . 62.9 m-85 -109.45 -171.09 1.77 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.67 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.1 mttt -94.13 86.97 5.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.702 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.7 mp -88.66 127.06 41.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.203 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -119.87 148.36 43.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.612 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.53 ' HG3' HD23 ' A' ' 29' ' ' LEU . 3.1 mt-10 -94.25 117.09 29.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.01 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.42 HD11 HG23 ' A' ' 161' ' ' ILE . 6.1 pt -113.71 166.63 7.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.087 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 57.53 29.99 18.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.203 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 64.56 39.66 6.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.203 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.37 -16.09 61.82 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.593 -0.813 . . . . 0.0 113.071 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.57 -30.14 53.37 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.829 0.347 . . . . 0.0 111.083 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 56.6 m -149.4 164.66 34.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.877 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.53 HD23 ' HG3' ' A' ' 22' ' ' GLU . 0.5 OUTLIER -129.32 128.97 44.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.962 -179.961 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.471 ' HA ' ' O ' ' A' ' 160' ' ' MET . 67.7 mt-10 -91.27 117.25 29.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.306 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' ' 159' ' ' TYR . 23.0 t -98.79 111.94 29.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.605 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -90.74 116.28 28.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.303 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -100.78 -130.52 7.07 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.228 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.2 pttm -174.46 125.98 0.32 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.919 0.39 . . . . 0.0 110.893 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 35.8 mtp -70.37 123.46 21.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.745 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.0 m -114.07 134.39 57.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.229 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.424 ' HA ' HG23 ' A' ' 68' ' ' THR . 83.3 p -90.16 165.5 13.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.748 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.573 ' HB3' HG12 ' A' ' 67' ' ' ILE . 4.1 ttt180 -144.45 128.25 17.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.016 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 46.0 p -137.98 26.15 2.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.961 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 59.67 160.41 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.933 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.66 -153.17 20.09 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.611 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -99.68 -24.21 14.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.781 0.324 . . . . 0.0 111.102 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.7 mp 69.3 133.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.109 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.31 128.8 50.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.907 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -146.2 -168.18 2.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.782 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 37.8 t -80.1 -34.49 37.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.936 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.69 -35.11 22.78 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.985 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -114.31 170.56 4.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.981 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.32 100.0 1.9 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.463 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -108.66 -29.05 4.29 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.489 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -114.76 162.19 17.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.804 0.335 . . . . 0.0 110.845 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -84.17 -31.12 25.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.076 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.4 151.41 24.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.924 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -98.4 33.1 2.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.132 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.22 164.29 13.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.906 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 160.05 -104.63 0.25 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.564 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -86.07 43.43 1.12 Allowed 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.8 2.333 . . . . 0.0 112.693 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 60.62 113.34 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.878 0.37 . . . . 0.0 110.961 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -142.89 121.11 1.67 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.54 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 28.9 tp10 -130.43 -47.91 1.08 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.859 0.361 . . . . 0.0 110.9 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.63 154.36 30.12 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.477 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.3 m -112.29 -36.42 5.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.864 0.364 . . . . 0.0 110.921 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -137.49 156.58 47.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.877 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.8 m -112.23 90.09 3.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.921 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.0 t -129.18 124.76 35.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.979 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.419 ' C ' HD13 ' A' ' 67' ' ' ILE . 56.2 t -92.56 133.09 35.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.051 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.573 HG12 ' HB3' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -122.4 130.72 74.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.73 179.792 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.424 HG23 ' HA ' ' A' ' 37' ' ' SER . 2.9 m -139.15 127.79 23.21 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.98 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -158.04 -176.22 29.85 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.249 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.496 HG12 HG12 ' A' ' 72' ' ' ILE . 47.7 t -72.58 142.73 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-O 120.801 0.334 . . . . 0.0 110.801 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -69.04 -56.61 7.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.551 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.806 HG22 ' CZ ' ' A' ' 18' ' ' TYR . 9.5 pt -53.66 -33.83 23.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.816 0.341 . . . . 0.0 111.409 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.782 HG13 ' HB2' ' A' ' 78' ' ' LEU . 98.6 t -71.2 -33.08 49.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.037 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.0 mtm -78.27 -39.73 39.18 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.634 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.43 ' OD1' ' CD2' ' A' ' 76' ' ' HIS . 15.2 p30 -82.17 -28.24 32.19 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.609 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.441 ' CE1' ' HB ' ' A' ' 72' ' ' ILE . 28.1 m170 -93.07 0.99 57.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.852 0.358 . . . . 0.0 110.801 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.438 ' HB2' ' HB3' ' A' ' 138' ' ' GLU . 7.8 m170 56.58 28.53 14.06 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.314 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.782 ' HB2' HG13 ' A' ' 73' ' ' VAL . 71.0 mt -56.99 129.13 40.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.512 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 -112.82 130.58 56.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.254 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.412 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 30.1 tt0 -83.86 129.66 34.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.074 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.6 t -116.57 -179.75 3.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.856 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 69.9 m -121.4 165.67 15.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.96 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.501 ' CE2' ' CE2' ' A' ' 91' ' ' TYR . 3.2 m-85 -171.71 154.01 3.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.043 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.4 ' H ' ' HB3' ' A' ' 87' ' ' ALA . 3.2 m -101.58 166.98 10.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.694 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.0 mtpp -57.73 -52.47 65.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.891 0.377 . . . . 0.0 110.996 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.72 -37.14 76.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.959 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.4 ' HB3' ' H ' ' A' ' 84' ' ' THR . . . -65.31 -44.28 88.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.158 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.826 ' CD2' HD11 ' A' ' 122' ' ' ILE . 1.0 OUTLIER -60.98 -32.93 72.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.814 179.876 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 18.2 mttm -61.97 -43.41 98.91 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.549 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.1 mtmt -78.09 -28.02 48.61 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.663 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.554 ' HE2' HG21 ' A' ' 146' ' ' VAL . 8.8 t80 -65.48 -47.41 76.15 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.616 179.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.444 ' O ' ' HG2' ' A' ' 96' ' ' MET . 4.7 tp -61.18 -45.91 97.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.956 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.405 ' N ' HG23 ' A' ' 92' ' ' ILE . 16.6 tttp -58.42 -38.33 77.18 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.252 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.514 ' HA ' ' HG2' ' A' ' 97' ' ' LYS . 19.6 t70 -75.06 -43.64 52.19 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.903 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.46 ' CD1' ' C ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -75.22 -40.07 59.46 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 121.074 -0.25 . . . . 0.0 111.119 -179.368 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.444 ' HG2' ' O ' ' A' ' 92' ' ' ILE . 3.1 ptt? -67.7 -32.27 72.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.734 0.302 . . . . 0.0 110.707 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.514 ' HG2' ' HA ' ' A' ' 94' ' ' ASP . 5.4 ptpt -69.23 -34.32 74.66 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.705 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.478 ' N ' ' HG3' ' A' ' 97' ' ' LYS . 2.1 m -62.71 -41.28 99.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.295 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.684 HG13 HD11 ' A' ' 8' ' ' ILE . 5.9 mt -79.89 -39.08 19.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.352 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.97 -57.79 10.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.578 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -59.44 -43.53 97.39 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.625 -0.797 . . . . 0.0 111.914 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.4 tmtt? -61.51 -42.11 98.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.978 0.418 . . . . 0.0 110.276 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.715 ' HB3' HG12 ' A' ' 111' ' ' VAL . 8.7 tp -66.69 -33.35 75.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.1 179.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.706 ' CG ' HG11 ' A' ' 111' ' ' VAL . 39.6 mt-10 -60.5 -28.98 68.8 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.611 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -87.24 -20.24 27.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.436 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -104.95 -58.87 1.83 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.779 0.323 . . . . 0.0 111.703 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.452 ' N ' ' O ' ' A' ' 103' ' ' LEU . 23.8 mtt85 -136.43 67.39 60.02 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.027 0.441 . . . . 0.0 110.894 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.919 ' O ' HG22 ' A' ' 111' ' ' VAL . 9.5 Cg_endo -50.58 -21.71 8.16 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 123.275 2.65 . . . . 0.0 112.733 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -71.07 -9.12 57.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.608 0.242 . . . . 0.0 111.245 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.481 ' CB ' HD21 ' A' ' 103' ' ' LEU . 0.1 OUTLIER -112.44 -3.4 14.47 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 -179.472 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.919 HG22 ' O ' ' A' ' 108' ' ' PRO . 34.7 m -71.74 -27.19 27.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.659 0.266 . . . . 0.0 111.656 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.604 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 0.9 OUTLIER -68.68 -55.54 11.2 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.574 -179.194 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.604 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 37.1 Cg_exo -59.87 -31.82 94.38 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 121.868 1.712 . . . . 0.0 111.429 179.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.443 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 73.5 t80 -68.15 -42.78 79.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.958 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -56.02 -51.9 66.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.887 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 60.2 m -76.57 -43.82 37.25 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.675 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -55.3 -53.84 38.19 Favored Glycine 0 N--CA 1.452 -0.277 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.761 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.403 ' O ' ' HB ' ' A' ' 122' ' ' ILE . . . -56.62 -51.78 67.39 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.052 0.453 . . . . 0.0 111.09 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.78 -28.05 69.18 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.182 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -75.49 -57.86 3.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.229 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -60.12 -39.66 87.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.399 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.826 HD11 ' CD2' ' A' ' 88' ' ' TYR . 0.4 OUTLIER -58.27 -46.5 88.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.897 0.38 . . . . 0.0 111.165 -179.777 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.454 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 20.0 mttm -62.02 -29.98 70.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.229 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -70.88 -54.79 10.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.709 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.635 HG22 ' CD2' ' A' ' 132' ' ' TYR . 15.4 pt -60.41 -43.8 94.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.277 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.52 HD21 ' CD2' ' A' ' 88' ' ' TYR . 11.6 mt -54.36 -37.58 65.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.944 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -72.55 -9.54 58.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.441 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 -142.47 31.68 1.5 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.899 0.381 . . . . 0.0 110.765 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.518 ' CE1' ' CZ ' ' A' ' 134' ' ' PHE . 6.3 t80 -54.11 -24.36 17.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.074 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 40.5 mtmt -57.92 -23.68 54.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.052 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 16.3 m-20 -94.23 -49.22 5.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.447 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.635 ' CD2' HG22 ' A' ' 125' ' ' ILE . 0.6 OUTLIER -88.21 154.07 20.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.932 0.396 . . . . 0.0 111.212 -179.404 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.446 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 1.7 mm100 -131.29 143.32 50.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.945 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.518 ' CZ ' ' CE1' ' A' ' 129' ' ' PHE . 2.5 m-85 -77.75 121.28 23.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.055 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.412 ' CE2' ' HB2' ' A' ' 80' ' ' GLU . 32.9 m-85 -126.47 134.97 50.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.708 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.464 ' HB ' ' HA ' ' A' ' 140' ' ' MET . 0.7 OUTLIER -120.91 160.99 21.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.785 179.989 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -58.31 -165.5 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.272 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.438 ' HB3' ' HB2' ' A' ' 77' ' ' HIS . 7.1 pm0 -72.54 -9.01 58.04 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.544 0.212 . . . . 0.0 111.371 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 22.5 m-80 -96.92 -35.4 10.9 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.504 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.464 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 37.0 mtp 60.86 36.91 18.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.701 0.286 . . . . 0.0 111.234 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -66.0 122.21 79.92 Favored Pre-proline 0 N--CA 1.453 -0.297 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.733 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -61.89 -23.46 75.98 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.246 1.964 . . . . 0.0 111.824 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -84.64 -12.24 54.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.672 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -79.27 -160.46 19.01 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.237 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.481 ' HE2' ' HB2' ' A' ' 163' ' ' PHE . 0.7 OUTLIER -100.31 -177.38 3.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.766 0.317 . . . . 0.0 110.93 179.827 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.554 HG21 ' HE2' ' A' ' 91' ' ' TYR . 46.9 t -126.67 148.92 31.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.135 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.504 ' HB2' ' CE2' ' A' ' 162' ' ' PHE . . . -116.27 110.58 18.94 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.555 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.582 HD13 HG21 ' A' ' 125' ' ' ILE . 3.9 mt -84.58 115.25 22.52 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.139 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.425 HD12 ' HG2' ' A' ' 160' ' ' MET . 12.4 tp -88.27 123.62 33.05 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.764 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.501 ' HB2' ' CZ ' ' A' ' 159' ' ' TYR . 24.2 m-20 -127.72 158.69 36.94 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.885 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -117.22 148.84 41.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.907 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -75.48 178.57 5.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.822 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.8 -37.94 80.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.976 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -75.62 -15.11 60.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.302 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 64.05 23.69 68.0 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.492 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 65.3 t -112.0 -38.38 3.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.753 0.311 . . . . 0.0 110.89 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 86.9 m -98.58 103.01 16.34 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.226 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -77.93 127.55 8.65 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.395 2.063 . . . . 0.0 112.057 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.501 ' CZ ' ' HB2' ' A' ' 150' ' ' ASP . 12.1 p90 -124.58 133.17 53.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.668 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' MET . . . . . 0.587 ' HE3' HD13 ' A' ' 78' ' ' LEU . 0.3 OUTLIER -99.98 169.01 9.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.761 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.529 ' HB ' ' HB2' ' A' ' 148' ' ' LEU . 89.6 mt -123.94 110.7 26.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.175 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.504 ' CE2' ' HB2' ' A' ' 147' ' ' ALA . 87.6 m-85 -114.38 156.71 23.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.729 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.481 ' HB2' ' HE2' ' A' ' 145' ' ' MET . 4.4 m-85 -99.21 123.59 43.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.852 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.492 ' CG ' HD11 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -62.32 -55.31 29.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.189 -179.789 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.443 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 0.8 OUTLIER -51.23 -34.92 34.34 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.071 -179.855 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -96.86 27.9 16.03 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.366 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.466 HD21 ' HB3' ' A' ' 4' ' ' TYR . 0.7 OUTLIER -146.66 144.05 29.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.777 0.322 . . . . 0.0 110.793 -179.848 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -112.85 156.82 22.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.811 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.765 ' HB3' HD11 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -120.51 149.98 41.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.005 -179.974 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -157.85 125.55 5.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.926 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.696 ' HG2' HD12 ' A' ' 2' ' ' ILE . 14.4 mmtt -90.68 119.32 30.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.964 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -171.27 140.84 1.51 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.866 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 1.7 mp -93.47 -35.42 12.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.907 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.878 -179.96 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.1 ttt . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.856 0.36 . . . . 0.0 111.205 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.693 HD11 ' HB3' ' A' ' 169' ' ' MET . 1.7 tt -104.71 146.69 11.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.036 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.501 HG21 ' HB3' ' A' ' 12' ' ' GLU . 11.7 mm -106.6 155.61 7.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.136 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.603 ' HE1' HG23 ' A' ' 2' ' ' ILE . 3.7 m-85 -123.73 104.71 9.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.665 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.73 156.31 32.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.9 0.381 . . . . 0.0 111.277 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.445 ' O ' ' HA ' ' A' ' 10' ' ' HIS . 27.0 t0 -61.64 152.18 31.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.767 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 67.1 tp -80.45 -22.11 41.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.234 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.417 ' H ' HD12 ' A' ' 8' ' ' ILE . 4.0 mp -91.23 -46.53 14.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.966 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -93.05 -28.77 16.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.705 -179.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.445 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER 68.72 30.88 4.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.907 0.384 . . . . 0.0 110.747 -179.681 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -102.73 125.06 49.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.806 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.501 ' HB3' HG21 ' A' ' 3' ' ' ILE . 0.9 OUTLIER -57.12 96.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.311 -179.764 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 42.2 mtp -79.71 -16.97 54.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.606 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.502 ' CE2' ' CD2' ' A' ' 4' ' ' TYR . 23.7 p90 -178.98 172.73 1.25 Allowed 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.706 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -133.05 -169.91 2.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.19 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 54.3 p30 -89.3 15.56 8.84 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.521 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 44.6 pt -82.69 -9.31 11.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.816 0.341 . . . . 0.0 111.229 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.875 ' CZ ' HG22 ' A' ' 72' ' ' ILE . 74.3 m-85 -111.65 -178.06 3.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.819 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.7 mtmt -94.48 91.45 6.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.683 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.539 HD12 ' N ' ' A' ' 20' ' ' ILE . 4.3 mp -87.84 129.94 38.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.11 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.7 mtm180 -120.89 126.0 48.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.892 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -74.36 116.19 14.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.84 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.85 HD11 HG23 ' A' ' 161' ' ' ILE . 3.6 pt -109.6 165.37 5.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.025 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.431 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . . . 59.5 32.69 21.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.092 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 64.78 45.01 3.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.301 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.52 -12.4 63.22 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.744 -0.741 . . . . 0.0 113.272 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.431 ' HB3' ' HB3' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -55.89 -39.48 71.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.938 0.369 . . . . 0.0 111.191 -179.885 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 96.6 m -137.32 170.96 15.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.081 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.74 131.25 40.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.86 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.404 ' OE1' ' CD2' ' A' ' 159' ' ' TYR . 63.3 mt-10 -97.49 113.8 25.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.04 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.462 HG23 ' HD2' ' A' ' 162' ' ' PHE . 23.5 t -90.58 112.08 24.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.904 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -85.53 120.63 27.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.994 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.46 -142.34 11.14 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.457 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.408 ' HG3' ' HB2' ' A' ' 71' ' ' ASP . 4.0 ptmm? -165.31 124.73 1.77 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.787 0.327 . . . . 0.0 110.795 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 52.4 mtm -72.04 123.8 23.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.94 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.0 m -119.48 130.23 74.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.133 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 81.0 p -97.99 165.5 11.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.956 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.624 ' HB3' HG12 ' A' ' 67' ' ' ILE . 4.8 ttm180 -131.96 119.06 20.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.748 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 78.3 p -133.72 25.9 4.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.041 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 66.15 -73.86 0.07 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.006 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -164.67 76.53 0.15 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.448 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -77.27 157.91 30.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.869 0.366 . . . . 0.0 110.876 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.581 HG22 ' O ' ' A' ' 43' ' ' ILE . 22.9 mt 64.25 36.9 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.12 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.17 -44.29 3.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.815 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -70.12 176.24 3.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.874 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.99 -75.82 0.62 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.978 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.1 mt -77.22 -33.38 56.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.023 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 24.0 mt 52.48 83.4 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.212 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 110.64 142.42 9.19 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.569 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 162.7 175.98 34.3 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.483 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 17.1 m-20 -85.7 75.0 10.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.837 0.351 . . . . 0.0 110.874 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -175.75 144.41 0.64 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.079 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 60.66 31.31 20.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.87 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 59.87 168.09 0.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.099 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -113.13 -70.87 0.78 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.896 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -137.1 113.74 1.05 Allowed Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.388 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.39 121.77 8.93 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.479 2.119 . . . . 0.0 112.297 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 60.83 101.76 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.887 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.09 -179.93 51.87 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.512 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.01 88.54 2.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.921 0.391 . . . . 0.0 110.925 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -168.97 145.18 9.26 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.368 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.54 -42.61 42.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.843 0.354 . . . . 0.0 110.877 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 58.78 96.82 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.922 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.516 ' O ' HG23 ' A' ' 66' ' ' VAL . 9.3 m -136.6 131.86 34.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.946 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.418 HG23 ' O ' ' A' ' 65' ' ' THR . 3.0 t -59.5 97.36 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.879 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.762 ' C ' HD13 ' A' ' 67' ' ' ILE . 71.0 t -111.4 133.52 56.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.251 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.762 HD13 ' C ' ' A' ' 66' ' ' VAL . 0.0 OUTLIER -140.13 131.73 32.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.535 179.349 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.2 m -139.03 127.59 23.12 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.115 0.484 . . . . 0.0 110.984 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -169.24 -173.98 37.33 Favored Glycine 0 N--CA 1.451 -0.33 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.117 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.448 ' CG1' HG12 ' A' ' 72' ' ' ILE . 53.2 t -70.8 147.58 11.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.791 0.329 . . . . 0.0 110.987 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.408 ' HB2' ' HG3' ' A' ' 34' ' ' LYS . 26.4 t70 -73.57 -55.56 6.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.306 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.875 HG22 ' CZ ' ' A' ' 18' ' ' TYR . 8.9 pt -53.62 -33.72 22.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.183 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.81 HG13 ' HB2' ' A' ' 78' ' ' LEU . 84.1 t -71.5 -33.62 50.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.091 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.8 mtm -78.07 -39.2 42.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.585 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.409 ' OD1' ' CD2' ' A' ' 76' ' ' HIS . 15.8 p30 -82.11 -28.38 32.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.508 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.461 ' CE1' ' HB ' ' A' ' 72' ' ' ILE . 24.4 m170 -94.93 1.69 55.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.778 0.323 . . . . 0.0 110.936 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.423 ' HB2' ' HB3' ' A' ' 138' ' ' GLU . 15.7 m80 54.98 32.22 17.65 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.344 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.81 ' HB2' HG13 ' A' ' 73' ' ' VAL . 54.6 mt -59.13 139.11 57.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.383 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -124.77 137.44 54.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.93 0.395 . . . . 0.0 111.239 -179.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.409 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 2.5 tt0 -92.86 124.14 36.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.926 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.85 HG21 HD11 ' A' ' 136' ' ' ILE . 3.5 t -115.19 127.35 55.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.888 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 89.3 p -68.91 159.67 32.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.941 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -165.32 164.22 19.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.748 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -101.58 167.84 9.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.835 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.5 mtpt -67.02 -52.46 42.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.838 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.7 tp10 -64.89 -42.82 94.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.511 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.88 -39.37 81.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.931 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.82 ' CD2' HD11 ' A' ' 122' ' ' ILE . 1.3 t80 -59.94 -38.66 83.04 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.786 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.432 ' O ' HG22 ' A' ' 92' ' ' ILE . 70.7 mttt -56.82 -45.72 82.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.112 0.482 . . . . 0.0 110.591 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.79 -27.77 50.28 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.641 178.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.532 ' HE2' HG21 ' A' ' 146' ' ' VAL . 13.4 t80 -66.77 -44.6 80.95 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.743 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.563 HD12 ' CE2' ' A' ' 95' ' ' TYR . 5.4 tp -63.15 -44.3 99.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.014 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -62.63 -37.15 85.2 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.067 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.483 ' HA ' ' HG2' ' A' ' 97' ' ' LYS . 29.3 t70 -75.76 -42.95 48.97 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.662 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.563 ' CE2' HD12 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -77.8 -40.86 39.26 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 121.013 -0.275 . . . . 0.0 110.863 -179.476 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.439 ' HG3' ' N ' ' A' ' 97' ' ' LYS . 0.1 OUTLIER -65.12 -31.85 73.26 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.249 179.418 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.488 ' HG3' ' N ' ' A' ' 98' ' ' SER . 15.1 pttt -70.64 -34.13 71.74 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 120.945 0.402 . . . . 0.0 110.178 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.488 ' N ' ' HG3' ' A' ' 97' ' ' LYS . 2.0 m -59.47 -37.41 78.12 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.761 179.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.7 mt -79.78 -40.88 21.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.102 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.75 -51.33 70.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.22 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -59.54 -47.69 89.69 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.64 -0.79 . . . . 0.0 111.91 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.6 -41.27 97.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.921 0.391 . . . . 0.0 110.086 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.641 ' HB3' HG12 ' A' ' 111' ' ' VAL . 8.3 tp -65.37 -37.88 88.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.958 179.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.681 ' CG ' HG11 ' A' ' 111' ' ' VAL . 76.4 mt-10 -56.62 -29.95 62.75 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.767 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -86.62 -20.19 28.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.531 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -106.84 -60.9 1.61 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.763 0.316 . . . . 0.0 111.602 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.457 ' N ' ' O ' ' A' ' 103' ' ' LEU . 4.0 mtt85 -129.37 65.23 73.92 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.816 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.876 ' O ' HG22 ' A' ' 111' ' ' VAL . 9.7 Cg_endo -50.4 -22.5 8.85 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 123.22 2.613 . . . . 0.0 112.745 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -75.69 -6.92 52.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.653 0.263 . . . . 0.0 111.136 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.515 ' C ' ' HD2' ' A' ' 113' ' ' PRO . 13.9 mmt180 -112.38 -1.53 15.02 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.654 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.876 HG22 ' O ' ' A' ' 108' ' ' PRO . 33.7 m -70.77 -36.24 63.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.574 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 25.8 mttm -66.65 -50.29 46.37 Favored Pre-proline 0 CA--C 1.529 0.16 0 C-N-CA 121.049 -0.261 . . . . 0.0 111.502 -179.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.574 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 37.0 Cg_exo -59.97 -32.04 94.47 Favored 'Trans proline' 0 C--N 1.347 0.447 0 C-N-CA 121.993 1.796 . . . . 0.0 111.568 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.485 ' CE1' ' HB2' ' A' ' 165' ' ' ASP . 76.0 t80 -69.99 -47.71 61.11 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.852 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -50.97 -42.03 59.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.02 0.438 . . . . 0.0 110.769 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.8 m -76.65 -44.29 34.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.717 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.43 -52.47 52.39 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.679 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.04 -51.74 66.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.937 0.399 . . . . 0.0 111.134 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.58 -28.2 68.97 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.363 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -77.87 -45.69 23.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.9 0.381 . . . . 0.0 111.194 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.401 HE21 ' HB2' ' A' ' 24' ' ' ALA . 23.6 tt0 -70.49 -36.45 73.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.208 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.82 HD11 ' CD2' ' A' ' 88' ' ' TYR . 0.3 OUTLIER -61.89 -47.37 93.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.326 -179.765 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.465 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 13.4 pttt -61.76 -31.19 71.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.017 0.437 . . . . 0.0 110.072 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -67.9 -53.65 24.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.621 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.605 HG21 HD13 ' A' ' 148' ' ' LEU . 15.5 pt -62.01 -42.04 93.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.291 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.474 HD23 ' HA ' ' A' ' 126' ' ' LEU . 11.3 mt -53.9 -35.9 62.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.944 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.99 -14.29 62.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.087 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -140.5 33.15 1.85 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.073 0.463 . . . . 0.0 110.398 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.504 ' CE1' ' CZ ' ' A' ' 134' ' ' PHE . 5.5 t80 -49.02 -27.59 3.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.224 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 2.8 ttpp -60.57 -27.78 67.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.791 0.329 . . . . 0.0 110.867 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 30.8 m-20 -94.27 -32.19 13.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.322 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.412 ' CZ ' ' OD2' ' A' ' 150' ' ' ASP . 3.6 m-85 -98.36 131.97 44.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.199 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.7 mm100 -117.33 143.72 45.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.803 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.51 ' CE1' ' CZ ' ' A' ' 88' ' ' TYR . 2.1 m-85 -80.01 124.11 28.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.062 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.409 ' CE2' ' HB2' ' A' ' 80' ' ' GLU . 43.1 m-85 -127.88 145.84 50.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.686 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.85 HD11 HG21 ' A' ' 81' ' ' THR . 0.7 OUTLIER -131.59 163.64 36.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.042 179.958 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -64.56 -159.55 0.38 Allowed Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.298 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.423 ' HB3' ' HB2' ' A' ' 77' ' ' HIS . 1.2 pt-20 -75.97 -8.89 58.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.597 0.237 . . . . 0.0 111.512 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -97.24 -31.75 12.27 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.583 0.23 . . . . 0.0 111.563 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.422 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 56.0 mtp 58.26 37.39 26.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.809 0.338 . . . . 0.0 110.945 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . 0.41 ' ND2' ' HA3' ' A' ' 144' ' ' GLY . 19.6 p-10 -64.35 115.0 16.18 Favored Pre-proline 0 N--CA 1.452 -0.372 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.934 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.92 -29.7 90.04 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.514 2.142 . . . . 0.0 112.287 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -84.55 -6.63 59.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.059 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.41 ' HA3' ' ND2' ' A' ' 141' ' ' ASN . . . -79.08 -141.12 2.05 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.413 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 3.2 ptp -113.36 -178.55 3.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.752 0.311 . . . . 0.0 110.919 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.532 HG21 ' HE2' ' A' ' 91' ' ' TYR . 42.2 t -128.06 144.95 36.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.283 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -111.67 114.73 27.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.681 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.605 HD13 HG21 ' A' ' 125' ' ' ILE . 3.3 mt -88.53 106.3 18.2 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.068 -179.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.483 HD12 ' HG2' ' A' ' 160' ' ' MET . 2.7 tp -88.93 119.62 29.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.219 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.462 ' HB2' ' CZ ' ' A' ' 159' ' ' TYR . 0.9 OUTLIER -129.08 165.91 20.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.695 179.517 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -111.88 146.15 38.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.96 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 21.9 mmt180 -67.32 -177.46 0.7 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.879 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.41 -31.94 68.17 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.899 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 38.1 p-10 -77.35 -15.05 59.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.23 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 71.83 17.21 76.66 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.72 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 91.1 t -112.93 -70.4 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.841 0.353 . . . . 0.0 110.733 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 86.4 m -55.07 107.86 0.99 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.08 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -84.25 128.22 4.16 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.586 2.19 . . . . 0.0 112.334 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.462 ' CZ ' ' HB2' ' A' ' 150' ' ' ASP . 9.4 p90 -124.22 136.05 53.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.821 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' MET . . . . . 0.492 ' CE ' HD13 ' A' ' 78' ' ' LEU . 0.5 OUTLIER -107.08 136.73 46.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.992 -179.765 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.85 HG23 HD11 ' A' ' 23' ' ' ILE . 62.3 mt -91.55 112.65 25.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.103 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.462 ' HD2' HG23 ' A' ' 31' ' ' VAL . 89.6 m-85 -110.24 152.18 26.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.833 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.42 ' CE2' ' OH ' ' A' ' 95' ' ' TYR . 3.1 m-85 -96.28 124.7 40.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.617 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -65.96 -56.36 12.08 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.355 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.485 ' HB2' ' CE1' ' A' ' 114' ' ' PHE . 7.0 m-20 -50.1 -36.29 28.98 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.859 0.362 . . . . 0.0 111.071 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -95.87 24.76 28.3 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.24 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.467 HD21 ' HB3' ' A' ' 4' ' ' TYR . 0.6 OUTLIER -139.99 145.07 37.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.754 0.311 . . . . 0.0 110.841 -179.885 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -119.23 143.45 47.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.796 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.693 ' HB3' HD11 ' A' ' 2' ' ' ILE . 0.6 OUTLIER -110.51 146.41 36.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.022 -179.918 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -152.27 135.63 15.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.958 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 12.4 mttm -87.97 128.39 35.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.742 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 3.4 m -45.37 -56.14 5.28 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.423 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 47.4 mt -82.28 81.01 8.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.862 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.927 179.999 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.0 ttp . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.782 0.325 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.52 HG23 ' HE1' ' A' ' 4' ' ' TYR . 0.7 OUTLIER -118.08 144.45 26.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.983 179.969 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' A' ' 169' ' ' MET . 14.8 mm -100.14 137.75 26.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.723 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.52 ' HE1' HG23 ' A' ' 2' ' ' ILE . 6.1 m-85 -106.36 105.37 15.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.457 179.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -122.44 145.76 47.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.839 0.352 . . . . 0.0 111.231 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.465 ' O ' ' HA ' ' A' ' 10' ' ' HIS . 43.5 t0 -56.21 152.08 11.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.723 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 57.9 tp -78.8 -26.71 44.38 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.2 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.866 HD11 ' CG1' ' A' ' 99' ' ' ILE . 4.4 mp -91.34 -44.12 14.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.473 ' O ' ' CG ' ' A' ' 10' ' ' HIS . 30.0 t -95.33 -10.19 30.84 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -178.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.473 ' CG ' ' O ' ' A' ' 9' ' ' SER . 25.5 p80 48.31 27.62 1.4 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.952 0.406 . . . . 0.0 111.267 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -98.21 122.59 41.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.705 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.408 ' HB3' ' CG2' ' A' ' 3' ' ' ILE . 0.1 OUTLIER -60.47 84.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.362 -179.816 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.413 ' O ' ' CD2' ' A' ' 76' ' ' HIS . 7.0 mtp -64.34 -18.57 64.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.588 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.485 ' CZ ' ' CD2' ' A' ' 4' ' ' TYR . 8.8 p90 -178.94 179.7 0.66 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.634 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -136.99 -169.9 2.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.91 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.401 ' HA ' HD11 ' A' ' 20' ' ' ILE . 37.8 t70 -93.55 26.18 3.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.027 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.436 HG13 ' CD2' ' A' ' 18' ' ' TYR . 46.0 pt -84.77 -13.28 11.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.754 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.801 ' CE2' HG22 ' A' ' 72' ' ' ILE . 79.0 m-85 -110.72 168.64 9.32 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.618 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.44 94.01 4.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.864 0.364 . . . . 0.0 110.581 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.703 HD12 ' O ' ' A' ' 18' ' ' TYR . 4.2 mp -87.79 139.41 17.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.12 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -127.35 119.53 26.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.036 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.612 ' HG3' HD23 ' A' ' 29' ' ' LEU . 1.9 mt-10 -71.77 114.7 10.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.859 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.567 HD11 HG23 ' A' ' 161' ' ' ILE . 3.9 pt -111.49 167.1 5.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.203 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.418 ' HB2' ' NE2' ' A' ' 121' ' ' GLN . . . 59.29 30.17 19.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.236 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 64.38 36.67 8.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.152 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.12 -15.32 61.64 Favored Glycine 0 CA--C 1.518 0.245 0 C-N-CA 120.556 -0.831 . . . . 0.0 112.986 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.419 ' HA ' HD22 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -55.04 -43.39 73.74 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.811 0.338 . . . . 0.0 110.917 -179.912 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 9.0 m -135.66 165.05 26.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.912 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.612 HD23 ' HG3' ' A' ' 22' ' ' GLU . 0.4 OUTLIER -128.02 139.09 52.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.785 -179.947 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -103.51 113.01 26.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.086 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 23.5 t -91.56 112.05 24.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.721 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -82.12 114.39 20.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.229 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.43 -137.13 8.84 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.288 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -174.51 128.24 0.33 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.885 0.374 . . . . 0.0 110.809 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 8.3 mtt -72.3 124.26 24.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.921 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 28.0 m -129.12 161.39 38.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.208 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 83.5 p -103.13 165.66 10.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.861 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.605 ' HB3' HG12 ' A' ' 67' ' ' ILE . 7.2 ttt85 -125.81 120.32 30.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.918 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.4 p -112.3 -29.8 7.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.853 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 62.93 149.37 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.054 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 178.59 -162.47 29.7 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.439 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 59.99 30.23 19.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.772 0.32 . . . . 0.0 110.969 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.573 HG23 ' O ' ' A' ' 43' ' ' ILE . 6.3 tt -114.48 67.86 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.964 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 60.86 78.49 0.28 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.863 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.3 p-10 -176.79 -39.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.058 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.44 -65.87 0.58 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.008 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.8 mt -78.8 -35.01 44.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.964 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 27.5 mm -99.03 131.28 46.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.121 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 95.86 -147.9 18.8 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.54 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.63 -28.01 15.8 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.427 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -68.34 -35.09 77.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.846 0.355 . . . . 0.0 110.921 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -145.23 159.46 42.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.11 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.5 t -91.89 -57.14 2.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.843 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -113.08 165.71 12.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.023 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -110.69 -31.39 7.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.912 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -101.24 -74.75 1.1 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.552 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -68.3 -179.0 2.02 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.617 2.212 . . . . 0.0 112.258 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -111.79 100.07 8.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.85 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.09 43.11 97.24 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.461 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -93.97 154.4 17.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.877 0.37 . . . . 0.0 110.859 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -124.79 81.93 0.35 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.525 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.4 p -81.22 -31.84 33.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.858 0.361 . . . . 0.0 110.934 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -115.56 -167.01 1.19 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.841 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.7 t 64.11 52.36 2.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.909 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.466 HG22 ' H ' ' A' ' 66' ' ' VAL . 0.2 OUTLIER -59.13 178.29 0.13 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.805 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.572 ' C ' HD13 ' A' ' 67' ' ' ILE . 64.3 t -130.06 117.23 40.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.24 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.605 HG12 ' HB3' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -123.13 128.96 75.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.321 179.309 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.7 m -128.49 131.66 48.34 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.225 0.536 . . . . 0.0 111.342 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -166.89 -164.62 22.86 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.891 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.51 HG12 HG12 ' A' ' 72' ' ' ILE . 46.8 t -73.25 141.89 15.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.75 0.309 . . . . 0.0 110.754 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -68.59 -56.17 9.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.725 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.801 HG22 ' CE2' ' A' ' 18' ' ' TYR . 8.5 pt -53.58 -33.77 22.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.868 0.366 . . . . 0.0 111.32 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.789 HG13 ' HB2' ' A' ' 78' ' ' LEU . 92.9 t -70.8 -32.0 47.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.83 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.5 mtm -78.3 -40.64 36.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.539 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -82.07 -28.46 32.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.621 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.447 ' CD2' ' HB ' ' A' ' 72' ' ' ILE . 7.2 m-70 -90.22 -5.68 56.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.857 0.36 . . . . 0.0 110.676 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 9.0 m80 62.45 29.93 17.19 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.103 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.789 ' HB2' HG13 ' A' ' 73' ' ' VAL . 34.5 mt -59.53 147.1 38.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.499 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -127.71 137.24 52.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.86 0.362 . . . . 0.0 111.042 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.429 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 2.9 tt0 -99.96 124.11 44.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.056 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.742 HG21 HD11 ' A' ' 136' ' ' ILE . 6.6 t -123.69 135.18 53.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.769 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 9.1 m -68.01 160.58 28.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.092 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.457 ' HB2' ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -156.8 154.54 30.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.866 179.975 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.9 m -99.13 157.08 16.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.786 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.67 -52.39 65.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.904 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -66.51 -43.09 86.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.683 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.6 -37.8 82.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.05 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.847 ' CD2' HD11 ' A' ' 122' ' ' ILE . 1.3 t80 -62.87 -35.13 79.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.745 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.411 ' O ' HG22 ' A' ' 92' ' ' ILE . 24.4 mttt -59.99 -45.5 92.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.051 0.453 . . . . 0.0 110.443 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.65 -27.93 55.81 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.629 178.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.563 ' HE2' HG21 ' A' ' 146' ' ' VAL . 13.3 t80 -66.21 -47.47 73.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.638 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.454 ' O ' ' HG2' ' A' ' 96' ' ' MET . 4.7 tp -60.3 -43.93 94.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.968 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 8.6 ttmt -60.08 -43.64 95.36 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.214 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.473 ' HA ' ' HG2' ' A' ' 97' ' ' LYS . 12.0 t70 -72.75 -39.72 66.6 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.819 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.471 ' CD1' ' C ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -76.46 -41.62 46.69 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 121.004 -0.279 . . . . 0.0 110.855 -179.497 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.454 ' HG2' ' O ' ' A' ' 92' ' ' ILE . 2.9 ptt? -67.95 -32.75 73.4 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.73 0.3 . . . . 0.0 110.844 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.473 ' HG2' ' HA ' ' A' ' 94' ' ' ASP . 0.3 OUTLIER -70.68 -35.58 72.89 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.894 0.378 . . . . 0.0 110.577 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.406 ' N ' ' HG3' ' A' ' 97' ' ' LYS . 1.9 m -60.52 -40.49 91.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.144 179.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.866 ' CG1' HD11 ' A' ' 8' ' ' ILE . 6.6 mt -79.85 -41.63 21.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.445 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.5 tmtt? -54.44 -54.07 45.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.502 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -58.69 -45.93 94.07 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.192 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 10.4 tptp -61.69 -41.28 97.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.806 0.336 . . . . 0.0 110.461 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.73 ' HB3' HG12 ' A' ' 111' ' ' VAL . 5.0 tp -67.4 -34.1 76.57 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.132 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.707 ' CG ' HG11 ' A' ' 111' ' ' VAL . 40.5 mt-10 -59.81 -29.83 68.51 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.828 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.413 ' HG3' ' HG3' ' A' ' 106' ' ' GLN . 0.6 OUTLIER -87.84 -19.39 27.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.561 -179.782 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.413 ' HG3' ' HG3' ' A' ' 105' ' ' GLU . 20.3 mt-30 -105.44 -58.17 1.93 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.736 0.303 . . . . 0.0 111.611 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.446 ' N ' ' O ' ' A' ' 103' ' ' LEU . 87.5 mtt180 -138.5 67.91 45.22 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 120.919 0.39 . . . . 0.0 110.858 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.944 ' O ' HG22 ' A' ' 111' ' ' VAL . 10.3 Cg_endo -50.88 -20.97 7.71 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 123.254 2.636 . . . . 0.0 112.888 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -67.69 -9.72 46.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.592 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.637 ' CB ' HD21 ' A' ' 103' ' ' LEU . 31.0 mmt-85 -114.23 -4.82 13.02 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.944 HG22 ' O ' ' A' ' 108' ' ' PRO . 35.6 m -69.52 -27.74 35.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.609 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 4.3 mmtp -71.99 -54.32 6.08 Favored Pre-proline 0 CA--C 1.532 0.257 0 C-N-CA 121.078 -0.249 . . . . 0.0 111.416 -179.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.609 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 37.2 Cg_exo -56.08 -35.89 95.47 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 121.772 1.648 . . . . 0.0 111.547 179.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.469 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 87.5 t80 -65.8 -43.18 89.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.904 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.54 -52.36 55.19 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.08 0.467 . . . . 0.0 110.741 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 61.7 m -75.8 -44.19 42.49 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.695 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -56.21 -51.39 56.19 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.687 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.16 -51.67 67.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.994 0.426 . . . . 0.0 110.985 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.526 ' HB1' ' HE3' ' A' ' 123' ' ' LYS . . . -61.55 -28.07 69.07 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.229 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -77.94 -48.54 16.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.859 0.362 . . . . 0.0 111.048 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.418 ' NE2' ' HB2' ' A' ' 24' ' ' ALA . 4.6 tp-100 -67.31 -34.99 78.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.025 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.847 HD11 ' CD2' ' A' ' 88' ' ' TYR . 0.3 OUTLIER -67.03 -45.1 87.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.064 -179.865 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.526 ' HE3' ' HB1' ' A' ' 119' ' ' ALA . 26.3 mttt -61.47 -29.94 70.29 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.411 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -70.19 -53.96 14.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.764 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.869 HG21 HD13 ' A' ' 148' ' ' LEU . 14.5 pt -60.52 -41.86 89.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.273 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.401 ' HA ' HD23 ' A' ' 126' ' ' LEU . 12.4 mt -55.23 -38.41 68.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.89 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -71.39 -10.82 60.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.317 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -140.59 33.48 1.83 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.859 0.361 . . . . 0.0 110.648 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.511 ' CE1' ' CE2' ' A' ' 134' ' ' PHE . 2.2 t80 -50.13 -29.96 10.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.99 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.6 ttpt -60.1 -29.68 68.75 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.935 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 21.3 m-20 -94.17 -35.73 12.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.436 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.598 ' CD2' HG22 ' A' ' 125' ' ' ILE . 4.7 m-85 -94.84 136.31 35.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.897 0.38 . . . . 0.0 111.211 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.406 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 2.2 mm100 -119.83 145.68 46.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.745 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.511 ' CE2' ' CE1' ' A' ' 129' ' ' PHE . 0.6 OUTLIER -83.35 121.82 27.64 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.989 -179.759 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.459 ' CG ' ' CE ' ' A' ' 160' ' ' MET . 46.5 m-85 -125.46 134.85 51.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.761 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.742 HD11 HG21 ' A' ' 81' ' ' THR . 0.3 OUTLIER -123.87 164.77 21.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.784 179.989 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.53 -173.05 1.25 Allowed Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.447 -0.882 . . . . 0.0 111.899 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -67.36 -13.68 62.23 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.564 0.221 . . . . 0.0 111.22 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -92.75 -28.66 16.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.723 0.297 . . . . 0.0 111.366 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.472 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 53.8 mtm 54.69 43.08 30.7 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.811 0.339 . . . . 0.0 111.201 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -67.29 122.28 82.26 Favored Pre-proline 0 N--CA 1.453 -0.279 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.67 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -59.74 -27.23 84.45 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.351 2.034 . . . . 0.0 111.881 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -84.76 -15.99 43.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.814 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.99 -173.45 24.78 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.347 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -88.84 -177.99 5.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.737 0.303 . . . . 0.0 110.881 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.563 HG21 ' HE2' ' A' ' 91' ' ' TYR . 41.6 t -127.6 153.84 37.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.222 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.417 ' N ' HG12 ' A' ' 146' ' ' VAL . . . -118.54 115.74 25.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.691 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.869 HD13 HG21 ' A' ' 125' ' ' ILE . 3.6 mt -90.18 106.7 18.66 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.948 -179.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.514 HD12 ' HG2' ' A' ' 160' ' ' MET . 1.6 tp -88.5 119.61 29.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.409 -179.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.47 ' HB3' ' CE1' ' A' ' 159' ' ' TYR . 0.7 OUTLIER -129.49 172.24 11.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.525 179.4 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -117.76 144.41 45.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.847 0.356 . . . . 0.0 111.008 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.41 -177.71 0.05 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.933 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.36 -34.97 71.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.017 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.573 ' OD1' HG23 ' A' ' 156' ' ' VAL . 9.2 t70 -76.54 -15.14 59.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.218 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 69.17 26.04 74.95 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.711 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.573 HG23 ' OD1' ' A' ' 154' ' ' ASP . 94.5 t -112.83 -69.81 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.932 0.396 . . . . 0.0 110.885 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 73.4 m -63.77 111.23 4.86 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.01 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -81.73 131.17 7.08 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.462 2.108 . . . . 0.0 112.192 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.47 ' CE1' ' HB3' ' A' ' 150' ' ' ASP . 13.9 p90 -125.62 144.59 50.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.92 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' MET . . . . . 0.514 ' HG2' HD12 ' A' ' 149' ' ' LEU . 0.2 OUTLIER -110.7 142.65 42.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.137 -179.792 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.567 HG23 HD11 ' A' ' 23' ' ' ILE . 58.7 mt -97.68 116.34 39.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.974 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -118.6 132.82 56.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.798 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -78.0 123.0 26.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.867 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.46 -54.48 35.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.327 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.469 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 1.6 m-20 -49.54 -36.2 22.75 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.285 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -96.55 27.92 15.49 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.366 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.49 143.96 29.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.814 0.34 . . . . 0.0 110.925 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -113.66 147.76 37.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.725 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.422 ' HA ' ' O ' ' A' ' 3' ' ' ILE . 0.7 OUTLIER -120.08 140.3 51.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.975 -179.816 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -146.8 133.06 19.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.914 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.421 ' CG ' HD12 ' A' ' 2' ' ' ILE . 31.0 mttp -87.87 119.59 28.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.916 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 27.8 m -141.89 144.45 33.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.928 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 11.2 mt -73.87 -42.68 60.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.913 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.301 -0.857 . . . . 0.0 110.857 -179.968 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.9 ttt . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.727 0.299 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.809 HD11 ' HB3' ' A' ' 169' ' ' MET . 4.5 tt -101.37 139.61 22.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.038 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.408 HG21 ' HB3' ' A' ' 12' ' ' GLU . 20.2 mm -100.98 155.25 4.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.317 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.602 ' HB3' HD21 ' A' ' 167' ' ' LEU . 2.8 m-85 -122.8 105.94 10.47 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.424 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 17.5 ptt180 -120.8 150.29 41.25 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.937 0.398 . . . . 0.0 111.469 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.428 ' O ' ' HA ' ' A' ' 10' ' ' HIS . 37.6 t0 -62.38 152.18 34.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.616 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.508 HD23 HG23 ' A' ' 99' ' ' ILE . 56.6 tp -81.23 -22.6 38.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.395 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.911 HD11 ' CG1' ' A' ' 99' ' ' ILE . 4.1 mp -91.27 -45.9 14.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 93.1 p -93.14 -21.39 19.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.616 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.428 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 1.6 m-70 62.23 29.78 17.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.865 0.364 . . . . 0.0 110.805 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -106.1 124.62 49.87 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.804 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.408 ' HB3' HG21 ' A' ' 3' ' ' ILE . 2.6 pm0 -58.44 93.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.207 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 7.3 mtt -70.08 -18.42 63.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.847 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.516 ' CE2' ' CD2' ' A' ' 4' ' ' TYR . 14.3 p90 -177.44 177.33 1.19 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.899 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.473 ' O ' HD11 ' A' ' 20' ' ' ILE . 0.9 OUTLIER -136.67 -169.88 2.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.975 -179.827 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 34.5 p-10 -87.83 13.93 9.75 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.615 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 46.5 pt -78.9 -4.96 7.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.816 0.341 . . . . 0.0 111.13 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.864 ' CZ ' HG22 ' A' ' 72' ' ' ILE . 65.3 m-85 -119.56 -179.07 3.77 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.728 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -91.39 88.71 6.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.748 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.473 HD11 ' O ' ' A' ' 15' ' ' SER . 4.0 mp -87.84 123.96 40.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.928 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 8.9 mtt180 -114.85 135.91 53.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.934 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.702 ' HG3' HD23 ' A' ' 29' ' ' LEU . 2.3 mp0 -81.56 114.82 20.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.868 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.714 HD11 HG23 ' A' ' 161' ' ' ILE . 3.3 pt -110.23 162.59 7.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.21 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.428 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . . . 60.01 29.77 19.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.251 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 64.42 50.81 2.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.423 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.65 -4.25 74.86 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 120.732 -0.747 . . . . 0.0 113.441 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.531 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -66.65 -29.36 69.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 117.036 0.418 . . . . 0.0 111.0 -179.903 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 92.4 m -147.59 171.52 15.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.119 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.702 HD23 ' HG3' ' A' ' 22' ' ' GLU . 0.7 OUTLIER -134.79 129.57 34.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.874 -179.954 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.414 ' OE1' ' CD2' ' A' ' 159' ' ' TYR . 61.7 mt-10 -97.52 116.36 29.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.166 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.41 HG23 ' HD2' ' A' ' 162' ' ' PHE . 21.9 t -92.41 111.97 25.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.698 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -83.0 116.77 22.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.172 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -99.98 -144.51 16.22 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.201 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.0 pttm -174.53 126.01 0.31 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.829 0.347 . . . . 0.0 111.02 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 21.7 mtt -70.03 121.93 18.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.778 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.4 m -126.85 144.8 35.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.29 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 57.0 p -95.51 165.59 12.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.844 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.753 ' O ' HG13 ' A' ' 66' ' ' VAL . 2.7 ttt180 -135.94 141.4 44.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.798 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.2 t -157.71 123.87 4.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.869 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -97.64 -179.81 4.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.895 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -79.53 -22.26 65.01 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.628 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.427 ' HA ' HD11 ' A' ' 48' ' ' ILE . 39.0 m-80 -56.63 -40.24 75.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.87 0.367 . . . . 0.0 111.039 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 14.8 tt -77.69 158.5 5.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.994 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 66.49 -76.02 0.05 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.884 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.11 104.96 11.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.952 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 29.7 m -74.62 -43.71 54.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.843 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 29.0 mt -70.78 -28.81 64.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.004 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.427 HD11 ' HA ' ' A' ' 42' ' ' ASN . 71.8 mt 53.41 79.91 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.173 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 100.3 -54.76 0.88 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.519 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 124.24 -30.77 4.67 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.444 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -97.92 119.74 37.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.779 0.323 . . . . 0.0 110.939 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -128.29 130.81 48.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.076 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.91 31.72 2.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.871 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -154.39 143.02 20.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.085 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -110.66 96.87 6.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.9 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 157.89 158.9 9.23 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.461 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -52.27 139.69 53.61 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.591 2.194 . . . . 0.0 112.29 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.2 pm0 -112.43 -34.7 5.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.855 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -170.46 66.65 0.15 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.468 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -84.24 139.2 32.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.766 0.317 . . . . 0.0 111.006 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 150.08 178.18 24.77 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.461 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 23.3 p -120.44 33.2 5.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.87 0.367 . . . . 0.0 110.905 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -70.27 148.12 48.92 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.892 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 60.5 p -60.86 108.85 0.92 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.852 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 17.5 m -97.76 -22.23 16.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.152 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.753 HG13 ' O ' ' A' ' 38' ' ' ARG . 22.6 t -93.74 136.89 24.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.108 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.723 HD13 ' C ' ' A' ' 66' ' ' VAL . 0.0 OUTLIER -129.61 132.98 65.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.984 179.801 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 93.6 m -139.18 142.38 37.94 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.063 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 170.33 -170.38 42.94 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.356 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.636 HG12 HG12 ' A' ' 72' ' ' ILE . 47.9 t -69.02 124.27 24.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.913 0.387 . . . . 0.0 110.756 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -54.28 -57.31 11.68 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.833 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.864 HG22 ' CZ ' ' A' ' 18' ' ' TYR . 5.4 pt -53.74 -34.13 24.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.842 0.353 . . . . 0.0 111.364 -179.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.783 HG13 ' HB2' ' A' ' 78' ' ' LEU . 97.5 t -73.67 -29.97 27.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.055 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.7 mtt -78.24 -42.25 31.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.82 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.428 ' OD1' ' CD2' ' A' ' 76' ' ' HIS . 19.6 p30 -82.05 -29.68 31.78 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 -179.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.428 ' CD2' ' OD1' ' A' ' 75' ' ' ASN . 34.1 m170 -88.99 -5.39 57.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.862 0.363 . . . . 0.0 110.626 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.417 ' HB2' ' HB3' ' A' ' 138' ' ' GLU . 78.0 m-70 61.43 30.3 18.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.032 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.783 ' HB2' HG13 ' A' ' 73' ' ' VAL . 60.0 mt -58.57 148.56 28.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.49 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -131.75 136.47 47.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.854 0.359 . . . . 0.0 111.109 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.419 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 2.5 tm-20 -89.81 135.21 33.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.104 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.495 HG23 ' HB2' ' A' ' 134' ' ' PHE . 5.2 t -120.21 171.85 8.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.725 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 30.2 m -114.56 161.23 18.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.978 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.482 ' HB2' ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -171.62 159.81 5.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.039 -179.898 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 8.6 m -101.54 162.41 12.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.815 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 17.1 mtpt -58.39 -51.95 67.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.104 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -65.64 -46.44 79.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.842 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.46 -36.4 73.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.185 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.91 ' CD2' HD11 ' A' ' 122' ' ' ILE . 1.0 OUTLIER -62.57 -37.9 87.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.809 179.874 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.523 ' NZ ' HD13 ' A' ' 126' ' ' LEU . 28.1 mttm -58.58 -44.9 89.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.649 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.1 tttm -77.96 -27.9 49.33 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.652 178.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.562 ' HE2' HG21 ' A' ' 146' ' ' VAL . 12.4 t80 -66.9 -46.6 74.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.711 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.538 HD12 ' CE2' ' A' ' 95' ' ' TYR . 6.0 tp -61.9 -42.61 95.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.107 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.475 ' O ' ' CG ' ' A' ' 97' ' ' LYS . 11.3 ttpp -62.0 -45.28 94.32 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.92 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -70.56 -38.14 74.08 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.945 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.538 ' CE2' HD12 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -78.24 -43.51 28.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.742 -0.208 . . . . 0.0 110.839 -179.458 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.413 ' HG3' ' N ' ' A' ' 97' ' ' LYS . 0.3 OUTLIER -62.07 -31.77 72.22 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 178.778 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.475 ' CG ' ' O ' ' A' ' 93' ' ' LYS . 1.4 mmmp? -65.61 -41.87 92.23 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.35 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.7 m -52.85 -40.31 63.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.146 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.911 ' CG1' HD11 ' A' ' 8' ' ' ILE . 8.7 mt -79.76 -42.71 22.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.443 179.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.69 -49.05 74.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.376 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -60.89 -49.66 76.15 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.013 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.5 -40.53 91.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.86 0.362 . . . . 0.0 110.262 179.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.612 ' HB3' HG12 ' A' ' 111' ' ' VAL . 7.3 tp -65.17 -38.31 90.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.095 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.693 ' HG3' HG11 ' A' ' 111' ' ' VAL . 78.7 mt-10 -56.88 -29.54 63.06 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.725 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -87.03 -19.66 28.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.635 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -107.8 -61.77 1.53 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.882 0.372 . . . . 0.0 111.527 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.447 ' N ' ' O ' ' A' ' 103' ' ' LEU . 43.5 mtt-85 -131.11 65.41 76.57 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.715 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.881 ' O ' HG22 ' A' ' 111' ' ' VAL . 9.8 Cg_endo -50.49 -22.82 9.58 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 123.19 2.594 . . . . 0.0 112.75 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -70.6 -10.46 59.36 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.217 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.546 ' CB ' HD21 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -108.89 -1.24 19.28 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -179.482 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.881 HG22 ' O ' ' A' ' 108' ' ' PRO . 26.5 m -71.81 -34.41 51.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -179.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.568 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 23.9 mtmt -68.99 -49.57 24.95 Favored Pre-proline 0 C--N 1.332 -0.178 0 C-N-CA 120.949 -0.301 . . . . 0.0 111.633 -179.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.568 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 37.0 Cg_exo -60.56 -32.07 93.04 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.153 1.902 . . . . 0.0 111.686 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.472 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 36.7 t80 -72.16 -47.09 53.43 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.096 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 15.0 mmm -49.42 -43.25 44.45 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.021 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 69.1 m -76.01 -45.14 36.08 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.842 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.45 -54.78 34.3 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.803 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -52.62 -51.63 59.11 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.897 0.38 . . . . 0.0 111.434 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.47 ' O ' HG22 ' A' ' 122' ' ' ILE . . . -68.58 -29.05 67.51 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.662 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -72.87 -55.87 6.02 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.865 0.364 . . . . 0.0 111.214 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -60.83 -31.51 70.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.487 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.91 HD11 ' CD2' ' A' ' 88' ' ' TYR . 0.4 OUTLIER -63.71 -45.19 98.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.322 -179.532 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.436 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 15.5 mttp -61.45 -30.89 70.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.059 0.457 . . . . 0.0 110.196 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -69.34 -54.78 12.79 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.764 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.661 HG21 HD13 ' A' ' 148' ' ' LEU . 15.0 pt -60.26 -42.79 91.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.386 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.523 HD13 ' NZ ' ' A' ' 89' ' ' LYS . 12.0 mt -53.98 -38.18 64.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.886 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.58 -15.18 63.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.212 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -137.98 32.32 2.42 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.941 0.401 . . . . 0.0 110.751 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.499 ' CE1' ' CZ ' ' A' ' 134' ' ' PHE . 4.2 t80 -51.93 -27.99 14.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.065 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.59 -18.87 65.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.296 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 15.8 m-80 -94.14 -36.25 12.15 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.325 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.458 ' CD2' HG22 ' A' ' 125' ' ' ILE . 1.1 m-30 -102.7 162.32 13.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.829 0.347 . . . . 0.0 111.151 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.7 mm100 -138.0 147.57 44.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.889 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.499 ' CZ ' ' CE1' ' A' ' 129' ' ' PHE . 2.8 m-85 -78.62 129.74 35.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.955 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.44 ' O ' ' HB3' ' A' ' 147' ' ' ALA . 33.2 m-85 -134.71 134.59 41.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.629 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.45 ' HB ' ' HA ' ' A' ' 140' ' ' MET . 0.8 OUTLIER -123.18 161.2 25.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.931 -179.977 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.51 -163.44 0.24 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.207 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.417 ' HB3' ' HB2' ' A' ' 77' ' ' HIS . 5.2 pt-20 -72.49 -8.88 57.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.554 0.216 . . . . 0.0 111.531 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -95.7 -35.34 11.61 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.607 0.241 . . . . 0.0 111.566 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.45 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 10.3 mtp 58.85 40.77 22.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.695 0.283 . . . . 0.0 111.217 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -69.67 117.64 55.18 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.633 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -62.54 -24.26 75.18 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.345 2.03 . . . . 0.0 111.78 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -84.8 -15.23 45.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.758 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -74.17 -136.11 0.37 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.317 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.4 ' HE3' ' O ' ' A' ' 166' ' ' GLY . 5.6 ptp -120.29 -175.87 3.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.86 0.362 . . . . 0.0 110.712 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.562 HG21 ' HE2' ' A' ' 91' ' ' TYR . 57.5 t -129.09 144.78 37.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.338 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' A' ' 135' ' ' PHE . . . -111.39 117.8 34.08 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.378 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.661 HD13 HG21 ' A' ' 125' ' ' ILE . 5.8 mt -91.53 107.77 19.44 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.323 -179.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.567 HD12 ' HG2' ' A' ' 160' ' ' MET . 2.3 tp -88.05 120.67 29.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.552 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.536 ' HB2' ' CZ ' ' A' ' 159' ' ' TYR . 18.3 m-20 -122.0 145.28 48.28 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.056 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.433 ' CE1' ' HB3' ' A' ' 158' ' ' PRO . 64.7 m-85 -100.75 135.44 42.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.933 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 15.2 mmm-85 -60.89 -178.64 0.1 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.943 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -59.88 -41.24 91.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.999 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -77.68 -15.08 59.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.287 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 67.49 25.14 73.86 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.522 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 71.6 t -110.21 -37.05 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.851 0.358 . . . . 0.0 110.964 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 94.3 m -103.41 96.63 8.81 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.225 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.523 ' HB2' HD11 ' A' ' 149' ' ' LEU . 71.8 Cg_endo -76.02 128.12 10.47 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.521 2.148 . . . . 0.0 112.169 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.536 ' CZ ' ' HB2' ' A' ' 150' ' ' ASP . 7.7 p90 -120.04 130.56 54.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.73 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' MET . . . . . 0.765 ' HG3' HD11 ' A' ' 72' ' ' ILE . 20.9 mtp -102.2 134.66 45.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.546 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.714 HG23 HD11 ' A' ' 23' ' ' ILE . 96.4 mt -90.45 113.06 25.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.861 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.41 ' HD2' HG23 ' A' ' 31' ' ' VAL . 59.1 m-85 -109.82 154.54 22.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.921 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.419 ' CD2' ' OH ' ' A' ' 95' ' ' TYR . 3.4 m-30 -95.46 126.26 40.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.717 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.446 ' HG3' HD11 ' A' ' 29' ' ' LEU . 0.6 OUTLIER -69.98 -54.91 11.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.306 -179.662 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.472 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 3.2 m-20 -49.11 -37.31 21.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.181 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.4 ' O ' ' HE3' ' A' ' 145' ' ' MET . . . -95.46 26.38 20.03 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.377 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.602 HD21 ' HB3' ' A' ' 4' ' ' TYR . 0.8 OUTLIER -140.77 146.04 37.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.823 0.344 . . . . 0.0 110.787 -179.867 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -119.53 142.75 48.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.845 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.809 ' HB3' HD11 ' A' ' 2' ' ' ILE . 0.1 OUTLIER -109.09 148.57 30.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.992 -179.988 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -152.38 121.46 6.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.832 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.672 ' HG2' HD12 ' A' ' 2' ' ' ILE . 19.1 mttt -91.56 118.47 30.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.933 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 51.6 t -67.72 99.73 0.83 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.832 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 62.42 148.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.891 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.211 -0.9 . . . . 0.0 110.949 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.9 ttm . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.868 0.366 . . . . 0.0 111.273 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.638 HG23 ' CE1' ' A' ' 4' ' ' TYR . 11.8 tt -107.24 151.07 9.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.012 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.9 mm -102.27 153.02 5.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.486 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.638 ' CE1' HG23 ' A' ' 2' ' ' ILE . 3.3 m-85 -124.43 101.52 7.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.449 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.36 153.23 34.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.931 0.396 . . . . 0.0 111.398 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.536 ' OD1' HD12 ' A' ' 8' ' ' ILE . 46.3 t0 -59.34 152.05 22.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.646 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 36.6 tp -81.96 -16.91 48.86 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.551 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.536 HD12 ' OD1' ' A' ' 6' ' ' ASP . 4.3 mp -91.41 -50.72 12.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 27.8 t -97.35 -18.04 19.37 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.455 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 9.0 m80 64.73 31.39 11.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.832 0.348 . . . . 0.0 110.865 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -97.77 122.1 40.46 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.738 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -58.16 95.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.32 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 5.1 mtt -74.86 -18.55 60.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.662 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.502 ' CZ ' ' CD2' ' A' ' 4' ' ' TYR . 10.7 p90 -178.87 174.02 1.16 Allowed 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.6 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -132.27 -169.97 2.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.729 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.424 ' HA ' HD11 ' A' ' 20' ' ' ILE . 37.6 t0 -96.29 30.75 2.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.192 0.52 . . . . 0.0 110.736 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.42 HG13 ' CD2' ' A' ' 18' ' ' TYR . 45.5 pt -93.31 -10.25 9.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.659 179.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.796 ' CZ ' HG22 ' A' ' 72' ' ' ILE . 48.4 m-85 -111.87 -169.16 1.41 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.715 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.72 95.48 8.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.84 0.352 . . . . 0.0 110.901 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.424 HD11 ' HA ' ' A' ' 16' ' ' ASP . 4.2 mp -92.41 125.74 45.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.097 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.4 mtp85 -117.19 120.45 38.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.055 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.702 ' HG3' HD23 ' A' ' 29' ' ' LEU . 3.5 mp0 -72.14 114.55 10.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.849 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.597 HD11 HG23 ' A' ' 161' ' ' ILE . 4.2 pt -112.86 167.4 6.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.192 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.436 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . . . 58.06 30.81 19.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.274 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 63.95 44.08 4.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.347 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.21 -17.36 56.04 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 120.735 -0.745 . . . . 0.0 113.142 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.436 ' HB3' ' HB3' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -52.15 -50.4 61.83 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.831 0.348 . . . . 0.0 111.137 -179.872 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 55.3 m -130.18 164.33 24.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.744 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.702 HD23 ' HG3' ' A' ' 22' ' ' GLU . 0.7 OUTLIER -128.6 135.13 48.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.045 -179.724 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -96.7 114.82 26.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.126 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.441 HG21 ' CD2' ' A' ' 14' ' ' PHE . 22.2 t -96.37 112.14 27.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.872 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -91.28 115.48 28.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.115 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -98.94 -131.49 7.31 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.458 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -172.39 124.93 0.5 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.804 0.335 . . . . 0.0 110.939 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 24.4 mtp -74.73 123.93 25.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.91 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.2 m -116.92 135.9 55.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.236 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 7.3 m -96.75 165.61 12.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.902 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.521 ' HB3' HG12 ' A' ' 67' ' ' ILE . 8.7 ttt180 -136.87 119.99 16.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.584 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.4 m -112.0 -28.85 7.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.208 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.454 ' OE2' HG23 ' A' ' 62' ' ' THR . 1.7 mt-10 62.93 90.61 0.08 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.757 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 167.17 -30.39 0.19 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.513 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -54.76 -25.99 31.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.779 0.324 . . . . 0.0 111.025 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 16.6 tt -56.51 152.5 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.172 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -65.93 179.83 0.83 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.984 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -110.88 179.93 3.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.936 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.1 t -88.24 -18.0 29.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.364 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.9 mt -52.94 -30.39 34.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.818 0.342 . . . . 0.0 111.172 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.2 mt -69.22 124.08 24.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.985 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -79.19 168.59 53.31 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.567 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 114.26 -102.69 1.22 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.463 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -159.88 84.8 0.75 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.819 0.342 . . . . 0.0 110.867 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -171.85 144.32 1.75 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.083 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 19.3 t 62.69 146.93 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.936 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 60.62 156.3 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.144 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 60.07 107.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.913 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.403 ' N ' ' CD ' ' A' ' 57' ' ' PRO . . . 59.47 51.9 56.33 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.473 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.403 ' CD ' ' N ' ' A' ' 56' ' ' GLY . 56.3 Cg_endo -70.43 -179.19 3.03 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.55 2.167 . . . . 0.0 112.371 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -102.15 34.01 2.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.869 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 172.01 -152.59 17.61 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.53 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -175.82 -40.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.862 0.363 . . . . 0.0 110.897 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -105.64 175.65 21.8 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.505 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.454 HG23 ' OE2' ' A' ' 40' ' ' GLU . 1.8 m -118.51 -48.96 2.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.8 0.333 . . . . 0.0 110.895 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 68.42 -67.31 0.2 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.046 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 6.8 m -115.79 153.0 32.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.868 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 86.7 m -89.78 -72.25 0.57 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.872 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.756 ' C ' HD13 ' A' ' 67' ' ' ILE . 29.5 t -106.6 133.48 51.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.99 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.756 HD13 ' C ' ' A' ' 66' ' ' VAL . 0.0 OUTLIER -136.35 131.08 48.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.998 179.829 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 21.6 m -139.33 135.29 33.6 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.994 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -174.6 178.66 46.31 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.353 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.564 HG22 ' HG3' ' A' ' 158' ' ' PRO . 59.0 t -68.02 148.26 11.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.865 0.364 . . . . 0.0 110.851 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -71.56 -59.12 2.93 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.452 -179.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.796 HG22 ' CZ ' ' A' ' 18' ' ' TYR . 8.9 pt -53.72 -33.94 23.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.437 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.782 HG13 ' HB2' ' A' ' 78' ' ' LEU . 61.5 t -72.72 -34.05 46.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.042 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.1 mtm -78.31 -39.15 40.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.576 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.403 ' OD1' ' CD2' ' A' ' 76' ' ' HIS . 19.8 p30 -82.0 -28.46 32.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.559 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.448 ' CE1' ' HB ' ' A' ' 72' ' ' ILE . 26.7 m170 -92.49 -1.17 57.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.841 0.353 . . . . 0.0 110.801 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.435 ' HB2' ' HB3' ' A' ' 138' ' ' GLU . 21.9 m170 58.0 31.41 20.6 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.074 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.782 ' HB2' HG13 ' A' ' 73' ' ' VAL . 42.6 mt -60.23 142.41 54.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.489 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -125.24 136.56 53.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.304 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.429 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 1.7 tm-20 -91.86 121.06 33.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.863 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.896 HG21 HD11 ' A' ' 136' ' ' ILE . 3.5 t -113.6 127.07 55.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.881 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 70.6 m -68.96 159.15 33.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.887 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.476 ' HB2' ' CD2' ' A' ' 134' ' ' PHE . 0.3 OUTLIER -166.84 152.44 7.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.818 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.26 166.5 11.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.879 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.0 mtmt -63.56 -52.41 61.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.141 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -61.31 -48.29 82.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.928 0.394 . . . . 0.0 110.811 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.29 -40.84 78.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.074 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.902 ' CD2' HD11 ' A' ' 122' ' ' ILE . 0.4 OUTLIER -59.43 -35.88 74.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.762 179.96 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.46 ' O ' HG22 ' A' ' 92' ' ' ILE . 27.2 mttt -58.31 -47.8 82.55 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.187 0.517 . . . . 0.0 110.527 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.6 tmtm? -76.57 -27.82 56.0 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.704 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.54 ' HE2' HG21 ' A' ' 146' ' ' VAL . 11.0 t80 -66.73 -46.87 74.09 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.693 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.46 HG22 ' O ' ' A' ' 89' ' ' LYS . 4.5 tp -59.85 -44.02 93.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.945 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.1 ttmm -59.27 -40.7 86.88 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.205 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.513 ' HA ' ' HG2' ' A' ' 97' ' ' LYS . 47.3 t0 -73.15 -43.21 61.89 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.898 -179.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.45 ' CE2' ' CD1' ' A' ' 92' ' ' ILE . 0.0 OUTLIER -75.35 -39.9 58.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.647 -0.252 . . . . 0.0 111.199 -179.176 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.448 ' HG2' ' O ' ' A' ' 92' ' ' ILE . 15.0 ptm -67.57 -32.22 72.82 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.792 0.33 . . . . 0.0 110.539 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.513 ' HG2' ' HA ' ' A' ' 94' ' ' ASP . 4.6 ptpt -69.91 -34.07 73.01 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.66 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.489 ' N ' ' HG3' ' A' ' 97' ' ' LYS . 2.2 m -61.74 -40.49 95.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.085 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 7.0 mt -79.86 -41.3 21.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.355 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -55.38 -53.91 50.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.521 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' A' ' 104' ' ' GLU . . . -61.5 -45.7 95.84 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.138 179.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.9 tptt -61.41 -39.49 90.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.883 0.373 . . . . 0.0 110.3 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.654 HD21 ' CB ' ' A' ' 110' ' ' ARG . 3.0 tp -68.69 -32.94 73.12 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.025 179.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.66 ' CG ' HG11 ' A' ' 111' ' ' VAL . 83.4 mt-10 -59.99 -30.4 69.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.807 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -88.19 -20.19 25.9 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.605 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 -106.25 -62.82 1.33 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.863 0.363 . . . . 0.0 111.548 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.435 ' N ' ' O ' ' A' ' 103' ' ' LEU . 5.5 mtm180 -126.25 63.43 50.52 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.923 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.86 ' O ' HG22 ' A' ' 111' ' ' VAL . 9.9 Cg_endo -50.62 -22.21 9.0 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 123.233 2.622 . . . . 0.0 112.776 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -74.83 -7.06 52.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.372 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.654 ' CB ' HD21 ' A' ' 103' ' ' LEU . 17.0 mmt180 -113.55 -1.71 14.03 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.681 0.276 . . . . 0.0 111.617 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.86 HG22 ' O ' ' A' ' 108' ' ' PRO . 34.2 m -67.96 -37.78 78.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -179.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.577 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 13.9 mtpt -67.55 -50.48 36.27 Favored Pre-proline 0 CA--C 1.529 0.161 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.617 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.577 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 31.9 Cg_exo -58.06 -33.28 97.13 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.087 1.858 . . . . 0.0 111.521 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.457 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 94.1 t80 -70.48 -40.84 73.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.746 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 15.9 mtm -55.89 -44.77 78.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.761 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 62.9 m -76.51 -44.24 36.05 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.61 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -59.19 -52.04 55.62 Favored Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.768 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.442 ' O ' ' HB ' ' A' ' 122' ' ' ILE . . . -56.89 -51.77 67.77 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.968 0.414 . . . . 0.0 111.117 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.7 -28.09 68.16 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.385 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -74.11 -49.62 23.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.482 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -71.43 -42.48 68.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.437 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.902 HD11 ' CD2' ' A' ' 88' ' ' TYR . 0.3 OUTLIER -56.06 -49.83 73.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.726 -179.4 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.484 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 10.7 ptmt -63.03 -31.2 72.29 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.046 0.451 . . . . 0.0 110.132 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -67.99 -50.14 57.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.78 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.414 HD11 ' HA ' ' A' ' 122' ' ' ILE . 17.4 pt -65.59 -42.57 93.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.319 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.472 HD21 ' CD2' ' A' ' 88' ' ' TYR . 10.6 mt -53.85 -35.14 61.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.878 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -71.21 -10.84 60.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.289 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -144.98 34.01 1.11 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.042 0.449 . . . . 0.0 110.574 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.503 ' CE1' ' CZ ' ' A' ' 134' ' ' PHE . 13.8 t80 -52.17 -25.19 8.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.2 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -55.14 -27.83 48.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.816 0.341 . . . . 0.0 111.156 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 31.9 m-20 -94.29 -37.5 11.48 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.665 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.42 ' HE2' HD11 ' A' ' 161' ' ' ILE . 4.1 m-85 -100.53 135.01 42.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.912 0.387 . . . . 0.0 111.598 -179.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.418 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 2.6 mm100 -115.89 148.77 39.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.8 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.515 ' CE1' ' CZ ' ' A' ' 88' ' ' TYR . 3.7 m-85 -82.07 128.97 34.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.21 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.429 ' CE2' ' HB2' ' A' ' 80' ' ' GLU . 28.4 m-85 -130.72 156.38 45.04 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.609 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.896 HD11 HG21 ' A' ' 81' ' ' THR . 0.5 OUTLIER -142.95 162.31 17.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.935 179.885 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -64.0 -163.45 0.61 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.344 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.435 ' HB3' ' HB2' ' A' ' 77' ' ' HIS . 4.7 pt-20 -73.26 -8.85 57.59 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.595 0.236 . . . . 0.0 111.511 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 18.3 m-80 -98.5 -29.1 13.29 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.597 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.429 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 31.7 mtm 55.44 42.24 30.15 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.905 0.383 . . . . 0.0 111.02 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . 0.406 ' ND2' ' HA3' ' A' ' 144' ' ' GLY . 16.3 p-10 -64.93 114.8 16.26 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.014 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -63.89 -28.95 67.31 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.561 2.174 . . . . 0.0 112.219 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -84.61 -14.48 48.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.169 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.406 ' HA3' ' ND2' ' A' ' 141' ' ' ASN . . . -73.88 -128.6 0.15 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.463 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.42 ' HE3' ' O ' ' A' ' 166' ' ' GLY . 6.6 ptp -126.52 -172.48 2.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.792 0.329 . . . . 0.0 110.859 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.54 HG21 ' HE2' ' A' ' 91' ' ' TYR . 90.5 t -131.54 153.1 38.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.0 0.428 . . . . 0.0 111.355 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.401 ' N ' HG12 ' A' ' 146' ' ' VAL . . . -117.4 123.18 45.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.298 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.523 ' HB2' ' HB ' ' A' ' 161' ' ' ILE . 2.5 mt -96.94 106.26 18.56 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.748 -178.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.504 HD12 ' HG2' ' A' ' 160' ' ' MET . 1.0 OUTLIER -90.63 119.31 30.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.698 179.805 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.495 ' HB3' ' CZ ' ' A' ' 159' ' ' TYR . 12.6 t70 -132.21 164.33 26.61 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.676 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -109.49 150.6 27.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.228 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.82 -176.86 3.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.843 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -56.71 -33.05 66.1 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.929 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -72.21 -15.13 61.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.16 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 65.75 14.64 60.96 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.771 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 94.0 t -112.23 -69.72 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.898 0.38 . . . . 0.0 110.813 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 95.6 m -58.34 109.56 1.92 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.024 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.564 ' HG3' HG22 ' A' ' 70' ' ' VAL . 92.1 Cg_endo -84.41 130.26 4.53 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.542 2.161 . . . . 0.0 112.244 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.495 ' CZ ' ' HB3' ' A' ' 150' ' ' ASP . 9.7 p90 -124.16 132.86 53.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.868 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' MET . . . . . 0.601 ' SD ' HD13 ' A' ' 78' ' ' LEU . 24.4 mtp -104.4 141.09 36.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.133 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.597 HG23 HD11 ' A' ' 23' ' ' ILE . 82.5 mt -97.07 116.17 38.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.193 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -113.69 156.08 24.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.511 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -99.92 126.54 46.07 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.94 0.4 . . . . 0.0 110.974 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 16.4 ttpp -69.17 -53.48 19.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.312 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.457 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 73.3 m-20 -51.39 -38.87 55.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.046 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.42 ' O ' ' HE3' ' A' ' 145' ' ' MET . . . -95.8 25.09 26.7 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.33 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.527 HD21 ' HB3' ' A' ' 4' ' ' TYR . 0.6 OUTLIER -138.96 148.34 43.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.698 0.285 . . . . 0.0 110.83 -179.876 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -112.0 150.61 30.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.106 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.6 ' HB3' HD11 ' A' ' 2' ' ' ILE . 2.1 mtm -124.66 122.82 38.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.622 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -140.76 118.38 11.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.12 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 2' ' ' ILE . 0.7 OUTLIER -71.23 112.15 7.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.92 -179.95 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.28 -172.81 3.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.928 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -133.64 33.9 3.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.795 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.28 -0.866 . . . . 0.0 110.878 -179.969 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.814 0.34 . . . . 0.0 111.176 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.639 HG23 ' CE1' ' A' ' 4' ' ' TYR . 1.1 tt -106.83 142.55 19.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.908 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.509 ' O ' ' HA ' ' A' ' 169' ' ' MET . 8.1 mm -107.76 121.04 60.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.341 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.639 ' CE1' HG23 ' A' ' 2' ' ' ILE . 11.0 m-85 -91.21 130.3 37.1 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.919 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 17.7 ptt180 -139.22 143.32 37.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.133 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.42 ' O ' ' HA ' ' A' ' 10' ' ' HIS . 36.1 t0 -50.56 151.81 2.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.966 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 66.4 tp -80.69 -25.49 38.14 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.361 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.696 HD11 ' CG1' ' A' ' 99' ' ' ILE . 4.6 mp -91.3 -43.58 14.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.812 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.3 t -90.62 -30.82 16.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.814 0.34 . . . . 0.0 111.399 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.42 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER 66.49 29.37 9.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.918 -179.78 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -104.92 127.2 52.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.668 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -57.2 97.5 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.156 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 12.5 mtp -83.77 -15.57 47.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.972 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.491 ' CE2' ' CG ' ' A' ' 4' ' ' TYR . 44.8 p90 -178.8 161.36 1.23 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.805 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.2 m -126.37 -169.82 2.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.607 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.583 ' HB2' HG22 ' A' ' 2' ' ' ILE . 38.7 t70 -93.8 30.26 1.86 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.02 0.438 . . . . 0.0 110.952 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.4 HD11 ' CZ ' ' A' ' 18' ' ' TYR . 46.2 pt -92.39 -10.52 9.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.573 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.865 ' CZ ' HG22 ' A' ' 72' ' ' ILE . 46.6 m-85 -111.54 -167.02 1.13 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.645 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.3 mtpt -97.52 87.57 4.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.797 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.543 HD12 ' N ' ' A' ' 20' ' ' ILE . 4.2 mp -88.01 134.1 28.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.042 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -128.22 152.7 47.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.755 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.72 ' HG3' HD23 ' A' ' 29' ' ' LEU . 2.3 mp0 -97.7 121.92 40.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.976 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.687 HD11 HG23 ' A' ' 161' ' ' ILE . 4.8 pt -119.1 166.28 13.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.119 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 57.65 30.31 18.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.217 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 63.18 40.77 8.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.307 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.5 -16.65 60.66 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.652 -0.785 . . . . 0.0 113.068 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.87 -34.22 62.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.823 0.312 . . . . 0.0 111.035 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 12.1 m -146.31 161.19 40.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.938 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.72 HD23 ' HG3' ' A' ' 22' ' ' GLU . 0.3 OUTLIER -126.61 129.77 49.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.777 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -94.06 119.92 33.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.21 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 17.5 t -102.12 112.16 34.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.699 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -91.58 116.11 28.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.125 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -94.71 -127.38 5.0 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.365 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.3 ptpt -174.38 122.75 0.29 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.79 0.329 . . . . 0.0 110.944 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 86.7 mtp -70.76 123.32 21.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.787 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.459 HG23 ' CE ' ' A' ' 74' ' ' MET . 5.5 m -117.89 127.71 75.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.134 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.507 ' HB3' HG23 ' A' ' 68' ' ' THR . 13.7 p -97.56 163.12 12.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.932 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.577 ' HB3' HG12 ' A' ' 67' ' ' ILE . 58.3 ttt180 -141.6 116.02 9.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.821 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.743 HG23 HG22 ' A' ' 66' ' ' VAL . 1.6 m -141.26 29.38 1.81 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.865 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -153.94 -66.23 0.14 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.886 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 137.43 -91.62 0.21 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.602 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -178.02 -38.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.823 0.344 . . . . 0.0 110.939 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.7 mt 70.78 69.68 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.107 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -178.05 -39.63 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.743 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 62.66 86.81 0.11 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.049 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.3 t -98.02 -62.47 1.24 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.727 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 5.9 mt -107.08 -61.76 1.5 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.829 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 47.0 mm 60.97 -80.4 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.288 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.68 138.48 9.42 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.504 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -69.57 -161.91 3.1 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.527 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -136.68 99.82 4.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.827 0.346 . . . . 0.0 110.865 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -130.7 31.71 4.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.101 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.1 p -102.08 -47.91 4.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.932 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 60.92 157.55 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.081 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -176.19 142.23 0.47 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.866 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -76.26 -77.87 0.73 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.485 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -66.12 66.83 0.45 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.828 2.352 . . . . 0.0 112.213 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -162.36 30.18 0.11 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.897 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -96.43 55.49 1.46 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.519 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -61.52 -37.8 85.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.798 0.332 . . . . 0.0 110.866 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 79.86 -149.69 31.69 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.514 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 60.61 157.88 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.748 0.308 . . . . 0.0 110.897 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -103.82 -68.22 0.85 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.854 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -59.76 88.21 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.792 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.8 m -102.05 152.25 21.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.03 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.743 HG22 HG23 ' A' ' 39' ' ' THR . 48.0 t -124.35 143.75 36.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.997 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.665 HD13 ' C ' ' A' ' 66' ' ' VAL . 0.0 OUTLIER -137.85 127.9 36.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.058 -179.987 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.507 HG23 ' HB3' ' A' ' 37' ' ' SER . 2.2 m -139.42 125.68 20.14 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.9 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -161.81 -177.01 34.51 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.286 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.501 HG22 ' HG3' ' A' ' 158' ' ' PRO . 57.1 t -69.49 144.93 13.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.837 0.351 . . . . 0.0 110.909 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -70.14 -57.03 5.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.479 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.865 HG22 ' CZ ' ' A' ' 18' ' ' TYR . 5.6 pt -53.52 -33.78 22.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.315 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.803 HG13 ' HB2' ' A' ' 78' ' ' LEU . 74.4 t -72.39 -34.58 49.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.087 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.459 ' CE ' HG23 ' A' ' 36' ' ' VAL . 2.7 mtm -78.24 -37.23 45.72 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.925 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.415 HD21 ' HA ' ' A' ' 72' ' ' ILE . 16.9 p30 -82.08 -31.59 30.72 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -178.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.462 ' CE1' ' HA ' ' A' ' 14' ' ' PHE . 42.0 m80 -93.58 -2.72 53.84 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.051 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 17.9 m80 61.03 36.57 18.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.164 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.803 ' HB2' HG13 ' A' ' 73' ' ' VAL . 28.8 mt -57.59 156.17 8.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.463 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.414 ' HG3' ' HG3' ' A' ' 140' ' ' MET . 3.9 mm-40 -132.72 135.22 45.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.841 0.353 . . . . 0.0 111.174 -179.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.438 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 5.6 tt0 -101.19 122.5 43.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.822 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.416 HG21 HD11 ' A' ' 136' ' ' ILE . 10.1 t -115.08 153.21 31.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.931 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 29.3 p -88.58 161.5 16.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.914 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.47 ' HB2' ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -165.27 156.21 14.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.874 -179.988 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -99.66 174.05 6.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.904 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -70.3 -52.37 23.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.88 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.98 -43.0 97.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.85 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.15 -42.66 91.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.037 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.912 ' CD2' HD11 ' A' ' 122' ' ' ILE . 0.1 OUTLIER -59.12 -34.94 72.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.862 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.441 ' O ' HG22 ' A' ' 92' ' ' ILE . 22.8 mttm -59.53 -46.16 89.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.126 0.489 . . . . 0.0 110.413 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt -77.08 -27.83 54.39 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.783 178.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.559 ' HE2' HG21 ' A' ' 146' ' ' VAL . 9.5 t80 -67.75 -44.1 78.31 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.876 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.607 HD12 ' CE2' ' A' ' 95' ' ' TYR . 6.1 tp -63.74 -42.58 96.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.911 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? -63.45 -37.44 87.28 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.781 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.498 ' HA ' ' HG2' ' A' ' 97' ' ' LYS . 12.4 t70 -77.04 -41.5 42.29 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.7 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.607 ' CE2' HD12 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -77.32 -40.08 45.47 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 121.155 -0.218 . . . . 0.0 110.752 -179.591 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -67.58 -32.1 72.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.645 0.26 . . . . 0.0 110.599 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.498 ' HG2' ' HA ' ' A' ' 94' ' ' ASP . 0.0 OUTLIER -70.2 -34.44 72.94 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.879 0.371 . . . . 0.0 110.491 179.756 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.456 ' N ' ' HG3' ' A' ' 97' ' ' LYS . 2.0 m -61.04 -40.18 92.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.046 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.696 ' CG1' HD11 ' A' ' 8' ' ' ILE . 7.2 mt -79.82 -42.36 22.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.504 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.403 ' O ' ' HG3' ' A' ' 104' ' ' GLU . 12.7 tmtt? -54.43 -55.23 30.91 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.523 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -60.86 -44.8 97.63 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.247 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.27 -41.29 96.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.885 0.374 . . . . 0.0 110.492 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.765 HD21 ' CB ' ' A' ' 110' ' ' ARG . 3.3 tp -68.24 -32.82 73.29 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.169 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.705 ' HG3' HG11 ' A' ' 111' ' ' VAL . 74.6 mt-10 -60.21 -29.66 68.88 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.934 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -88.11 -20.81 25.17 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.569 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -103.74 -57.73 1.99 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.791 0.329 . . . . 0.0 111.665 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.446 ' N ' ' O ' ' A' ' 103' ' ' LEU . 44.7 mtt85 -139.19 68.16 40.35 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.786 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.93 ' O ' HG22 ' A' ' 111' ' ' VAL . 9.9 Cg_endo -50.66 -21.39 7.84 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 123.234 2.623 . . . . 0.0 112.968 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -68.95 -9.99 54.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.591 0.234 . . . . 0.0 111.403 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.765 ' CB ' HD21 ' A' ' 103' ' ' LEU . 0.7 OUTLIER -111.99 -3.01 14.91 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 -179.492 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.93 HG22 ' O ' ' A' ' 108' ' ' PRO . 33.9 m -71.26 -26.93 27.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.641 0.258 . . . . 0.0 111.516 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.601 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -69.38 -55.8 9.21 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.517 -179.279 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.601 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 33.4 Cg_exo -56.92 -37.61 97.89 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.084 1.856 . . . . 0.0 111.739 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.461 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 82.5 t80 -66.64 -37.63 85.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.076 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 6.1 mtp -57.03 -54.68 44.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.956 0.407 . . . . 0.0 110.737 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 75.1 m -72.9 -44.73 60.92 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.696 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.97 -38.24 95.15 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.498 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.96 -51.69 68.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.973 0.416 . . . . 0.0 110.926 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.99 -28.2 63.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.251 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -75.6 -41.21 55.11 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.109 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -74.38 -34.85 63.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.901 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.912 HD11 ' CD2' ' A' ' 88' ' ' TYR . 0.4 OUTLIER -69.95 -45.9 75.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.205 -179.877 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.455 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 5.4 pttp -61.11 -31.83 71.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.993 0.425 . . . . 0.0 110.275 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -67.51 -53.51 28.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.698 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.613 HG21 HD13 ' A' ' 148' ' ' LEU . 15.5 pt -62.12 -42.12 93.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.288 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.475 HD23 ' HA ' ' A' ' 126' ' ' LEU . 11.7 mt -53.99 -35.22 61.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.88 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -70.1 -11.29 60.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.296 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -142.49 33.28 1.46 Allowed 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.968 0.413 . . . . 0.0 110.588 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.497 ' CE1' ' CZ ' ' A' ' 134' ' ' PHE . 12.4 t80 -49.71 -26.79 4.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.24 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.91 -29.37 69.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.05 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 28.5 m-20 -94.21 -29.86 14.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.451 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.448 ' CD2' HG22 ' A' ' 125' ' ' ILE . 2.5 m-85 -98.47 138.41 35.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.877 0.37 . . . . 0.0 111.295 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.4 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 2.0 mm100 -123.07 144.1 49.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.721 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.517 ' CE1' ' CZ ' ' A' ' 88' ' ' TYR . 3.2 m-85 -82.09 123.75 29.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.118 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.438 ' CE2' ' HB2' ' A' ' 80' ' ' GLU . 25.4 m-85 -127.86 140.74 51.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.599 179.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.419 ' HB ' ' HA ' ' A' ' 140' ' ' MET . 0.5 OUTLIER -131.29 160.99 41.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.691 -179.981 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -57.37 -169.58 0.14 Allowed Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.524 -0.846 . . . . 0.0 111.879 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.05 -8.91 57.28 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.582 0.23 . . . . 0.0 111.329 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 26.7 m-80 -94.31 -30.28 14.61 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.41 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.419 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 70.7 mtm 55.84 44.51 25.85 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.773 0.32 . . . . 0.0 111.256 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.67 117.38 50.16 Favored Pre-proline 0 N--CA 1.453 -0.296 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.625 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -63.2 -23.23 72.82 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.323 2.015 . . . . 0.0 111.854 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -84.72 -15.4 45.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.646 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -77.78 -159.7 12.47 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.276 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.457 ' HE3' ' O ' ' A' ' 166' ' ' GLY . 3.6 ptp -98.75 -174.4 2.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.793 0.33 . . . . 0.0 110.796 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.559 HG21 ' HE2' ' A' ' 91' ' ' TYR . 49.1 t -128.83 152.47 37.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.165 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.488 ' HB1' ' HE3' ' A' ' 160' ' ' MET . . . -114.64 119.23 36.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.656 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.613 HD13 HG21 ' A' ' 125' ' ' ILE . 3.0 mt -93.48 106.29 18.27 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.192 -179.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.591 HD12 ' HG2' ' A' ' 160' ' ' MET . 2.0 tp -90.82 119.12 30.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.149 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.469 ' HB2' ' CZ ' ' A' ' 159' ' ' TYR . 0.9 OUTLIER -125.99 159.5 32.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.745 179.7 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -109.7 138.13 46.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.887 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.93 -173.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.784 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.3 -41.07 83.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.905 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -67.87 -15.1 63.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.163 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 68.71 20.04 73.75 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.69 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 94.2 t -112.85 -70.04 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.859 0.362 . . . . 0.0 110.751 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 88.7 m -57.59 108.91 1.42 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.891 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.548 ' HB2' HD11 ' A' ' 149' ' ' LEU . 90.8 Cg_endo -86.71 127.86 2.78 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.723 2.282 . . . . 0.0 112.44 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.469 ' CZ ' ' HB2' ' A' ' 150' ' ' ASP . 16.0 p90 -121.67 132.15 54.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.797 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' MET . . . . . 0.591 ' HG2' HD12 ' A' ' 149' ' ' LEU . 0.9 OUTLIER -101.8 140.87 35.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.071 -179.818 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.687 HG23 HD11 ' A' ' 23' ' ' ILE . 57.4 mt -96.77 121.61 47.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.242 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.47 ' CZ ' ' HE3' ' A' ' 160' ' ' MET . 43.0 m-85 -119.63 156.49 30.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.698 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -102.16 118.63 37.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.858 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 40.9 tttt -61.12 -49.98 75.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.235 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.461 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 32.5 m-20 -55.26 -40.34 70.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.243 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.457 ' O ' ' HE3' ' A' ' 145' ' ' MET . . . -95.74 25.18 26.22 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.66 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.561 HD21 ' HB3' ' A' ' 4' ' ' TYR . 4.9 tt -150.19 148.71 29.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.88 0.372 . . . . 0.0 110.949 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -133.95 150.61 51.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.395 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.509 ' HA ' ' O ' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -135.47 160.25 39.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.805 0.336 . . . . 0.0 111.261 -179.796 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -146.85 144.61 29.43 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.547 -179.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 2' ' ' ILE . 0.1 OUTLIER -81.82 109.06 15.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.095 179.812 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 1.5 m 63.35 124.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.005 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 4.1 mt -93.17 165.29 12.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.821 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.976 179.949 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.854 0.359 . . . . 0.0 111.113 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.795 HG23 ' CE1' ' A' ' 4' ' ' TYR . 1.0 OUTLIER -113.91 142.11 27.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.082 179.924 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.518 ' O ' ' HA ' ' A' ' 169' ' ' MET . 10.1 mm -103.39 119.54 52.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.981 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.795 ' CE1' HG23 ' A' ' 2' ' ' ILE . 17.4 m-85 -93.44 128.98 39.75 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.93 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.9 ptt-85 -136.31 144.77 44.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.969 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -52.53 138.01 28.88 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.833 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.419 HD11 HE22 ' A' ' 106' ' ' GLN . 59.9 tp -71.34 -23.65 61.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.291 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.499 ' N ' HD12 ' A' ' 8' ' ' ILE . 4.3 mp -91.2 -43.64 14.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.805 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.8 m -90.28 -29.4 18.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.391 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 32.3 m80 68.28 30.25 5.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.858 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -111.03 126.21 54.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.655 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -56.0 112.92 1.32 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.266 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 7.2 mtt -96.37 -16.61 21.17 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.908 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.436 ' HA ' ' CE1' ' A' ' 76' ' ' HIS . 37.8 p90 179.9 152.99 0.48 Allowed 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 120.875 0.369 . . . . 0.0 111.0 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.417 ' HB3' HD13 ' A' ' 3' ' ' ILE . 0.9 OUTLIER -112.86 -169.8 1.55 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.417 179.629 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.712 ' HB2' HG22 ' A' ' 2' ' ' ILE . 31.2 t70 -94.98 34.6 1.35 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.948 0.404 . . . . 0.0 110.819 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.518 HD11 ' CZ ' ' A' ' 18' ' ' TYR . 41.6 pt -95.43 -7.81 9.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.742 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.776 ' CZ ' HG22 ' A' ' 72' ' ' ILE . 37.2 m-85 -113.63 -167.38 1.19 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.696 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.52 86.95 3.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.855 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.462 ' H ' HD12 ' A' ' 20' ' ' ILE . 4.6 mp -89.77 124.01 42.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.086 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -118.16 140.25 50.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.987 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.706 ' HG3' HD23 ' A' ' 29' ' ' LEU . 1.1 mp0 -84.57 116.06 22.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.76 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.442 HD11 HG23 ' A' ' 161' ' ' ILE . 4.6 pt -113.4 166.85 6.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.13 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.522 ' HB2' ' NE2' ' A' ' 121' ' ' GLN . . . 59.53 30.57 20.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.086 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 64.83 47.24 2.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.332 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.91 -8.32 73.55 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.718 -0.753 . . . . 0.0 113.358 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.479 ' HB3' ' HB3' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -60.95 -52.36 65.36 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.818 0.342 . . . . 0.0 111.071 -179.915 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 11.7 m -125.98 163.53 22.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.067 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.706 HD23 ' HG3' ' A' ' 22' ' ' GLU . 0.3 OUTLIER -126.42 133.45 51.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.735 179.909 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -99.83 112.94 25.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.05 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 159' ' ' TYR . 20.4 t -92.35 111.94 25.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.697 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -87.78 110.91 20.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.17 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -95.68 -133.55 7.47 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.29 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.4 pttt -174.46 123.99 0.29 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.882 0.373 . . . . 0.0 110.884 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 71.3 mtm -70.91 112.63 7.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.815 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.719 ' O ' HG23 ' A' ' 68' ' ' THR . 24.0 m -95.65 163.58 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.153 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 79.0 p -125.34 165.63 18.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.697 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.742 ' O ' HG13 ' A' ' 66' ' ' VAL . 18.0 ttm180 -143.05 116.46 9.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.866 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.9 m -143.59 90.42 2.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.835 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -81.03 -176.35 5.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.915 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -130.83 -142.75 5.16 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.538 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -134.45 165.88 24.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.844 0.354 . . . . 0.0 110.86 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.41 HG22 ' N ' ' A' ' 44' ' ' ASP . 4.6 mt -92.6 153.58 3.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.075 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.41 ' N ' HG22 ' A' ' 43' ' ' ILE . 2.4 m-20 62.01 150.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.93 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 59.83 79.21 0.24 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.947 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.3 m -100.81 -47.44 4.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.89 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.465 HD12 HD13 ' A' ' 48' ' ' ILE . 0.6 OUTLIER -70.45 -30.93 67.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.982 -179.977 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.465 HD13 HD12 ' A' ' 47' ' ' LEU . 33.2 mm -69.45 123.55 23.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.172 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -100.49 172.55 24.13 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.441 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -84.98 131.88 10.72 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.573 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -83.42 153.9 24.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.802 0.334 . . . . 0.0 110.942 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 60.15 92.03 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.091 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.2 p -118.12 -178.65 3.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.864 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -160.93 -45.45 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.152 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.88 146.28 32.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.865 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.07 -91.91 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.51 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.5 134.4 52.33 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.58 2.187 . . . . 0.0 112.311 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -134.24 125.39 27.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.878 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 177.38 39.64 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.448 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -90.12 97.3 11.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.825 0.345 . . . . 0.0 110.996 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 121.66 -98.29 0.64 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.536 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 18.6 p -137.07 -168.49 2.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.887 0.375 . . . . 0.0 110.854 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 61.36 105.45 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.865 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.66 121.48 1.12 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.904 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.4 t -97.98 27.67 4.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.052 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.742 HG13 ' O ' ' A' ' 38' ' ' ARG . 27.5 t -105.82 135.72 42.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.064 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.586 HD13 ' C ' ' A' ' 66' ' ' VAL . 0.0 OUTLIER -123.09 129.55 74.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.187 -179.921 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.719 HG23 ' O ' ' A' ' 36' ' ' VAL . 85.2 m -139.57 141.05 37.21 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.024 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 179.71 -179.46 48.83 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.407 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.578 HG12 HG12 ' A' ' 72' ' ' ILE . 46.2 t -72.59 135.4 27.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.808 0.337 . . . . 0.0 110.662 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -64.05 -54.76 29.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.782 -179.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.776 HG22 ' CZ ' ' A' ' 18' ' ' TYR . 8.1 pt -53.85 -33.93 24.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.907 0.384 . . . . 0.0 111.267 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.756 HG13 ' HB2' ' A' ' 78' ' ' LEU . 84.2 t -73.59 -35.0 43.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.906 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 5.0 mtm -78.3 -38.83 41.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.788 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.402 ' OD1' ' CD2' ' A' ' 76' ' ' HIS . 22.3 p30 -82.1 -29.44 31.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.655 -179.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.436 ' CE1' ' HA ' ' A' ' 14' ' ' PHE . 26.2 m170 -92.55 -2.58 56.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.775 0.322 . . . . 0.0 110.806 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.512 ' HB2' ' HB3' ' A' ' 138' ' ' GLU . 49.5 m80 59.28 35.12 23.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.043 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.756 ' HB2' HG13 ' A' ' 73' ' ' VAL . 41.5 mt -61.13 141.15 57.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.515 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -120.83 132.33 54.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.011 -179.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.417 ' HG3' ' CE1' ' A' ' 135' ' ' PHE . 10.1 tt0 -91.04 124.48 35.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.91 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.901 HG21 HD11 ' A' ' 136' ' ' ILE . 1.4 t -117.23 172.33 7.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.835 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.6 p -107.24 170.69 7.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.006 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.481 ' HB2' ' CE2' ' A' ' 134' ' ' PHE . 0.6 OUTLIER -171.65 152.43 3.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.859 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.8 m -99.87 158.09 16.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.839 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 33.8 mtmt -57.69 -52.5 65.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.917 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.9 tm-20 -65.88 -45.0 83.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.727 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.66 -33.88 72.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.059 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.88 ' CD2' HD11 ' A' ' 122' ' ' ILE . 0.7 OUTLIER -65.03 -37.42 87.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.713 179.902 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.436 ' O ' HG22 ' A' ' 92' ' ' ILE . 50.4 mttm -58.19 -45.51 87.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.099 0.476 . . . . 0.0 110.333 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.7 mmtp -76.66 -27.8 55.75 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.742 178.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.537 ' HE2' HG21 ' A' ' 146' ' ' VAL . 8.4 t80 -67.61 -45.38 75.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.76 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.676 HD12 ' CE2' ' A' ' 95' ' ' TYR . 5.2 tp -61.74 -42.2 93.45 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 CA-C-O 120.888 0.375 . . . . 0.0 110.82 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.494 ' O ' ' CG ' ' A' ' 97' ' ' LYS . 3.6 ttpm? -63.39 -44.9 93.37 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.812 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -70.29 -38.9 75.1 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.866 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.676 ' CE2' HD12 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -78.12 -42.94 30.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.694 -0.23 . . . . 0.0 110.648 -179.513 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -62.72 -31.85 72.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.865 0.364 . . . . 0.0 110.078 179.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.494 ' CG ' ' O ' ' A' ' 93' ' ' LYS . 2.5 mmtp -65.73 -43.83 87.84 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.595 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.6 m -54.36 -40.47 68.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.601 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.483 ' CG1' HD11 ' A' ' 8' ' ' ILE . 7.8 mt -79.92 -43.13 22.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.678 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 15.0 tttt -53.19 -55.86 20.98 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.559 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -62.49 -45.07 96.64 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.308 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.78 -37.47 84.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.847 0.355 . . . . 0.0 110.465 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.671 HD21 ' CB ' ' A' ' 110' ' ' ARG . 2.8 tp -70.94 -32.08 68.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.135 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.627 ' CG ' HG11 ' A' ' 111' ' ' VAL . 30.0 mt-10 -60.59 -30.25 69.7 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.872 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -89.68 -20.04 24.12 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.543 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.419 HE22 HD11 ' A' ' 7' ' ' LEU . 21.7 mt-30 -106.01 -62.8 1.33 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.816 0.341 . . . . 0.0 111.413 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.434 ' N ' ' O ' ' A' ' 103' ' ' LEU . 16.7 mtt180 -127.53 63.58 59.85 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.891 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.883 ' O ' HG22 ' A' ' 111' ' ' VAL . 10.2 Cg_endo -50.86 -21.92 9.19 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 123.145 2.563 . . . . 0.0 112.82 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -71.35 -11.29 60.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.673 -0.24 . . . . 0.0 111.467 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.671 ' CB ' HD21 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -112.26 1.06 15.97 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 -179.289 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.883 HG22 ' O ' ' A' ' 108' ' ' PRO . 34.4 m -68.36 -35.72 71.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -179.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.573 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 18.4 mttt -68.69 -50.6 24.12 Favored Pre-proline 0 C--N 1.331 -0.209 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.609 -179.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.573 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 32.3 Cg_exo -57.98 -33.24 96.94 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.11 1.873 . . . . 0.0 111.813 179.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.452 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 86.3 t80 -69.71 -41.72 75.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.15 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -55.45 -49.27 72.91 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.928 0.394 . . . . 0.0 110.871 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 82.4 m -70.98 -44.36 66.12 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.725 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.03 -39.21 97.77 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.644 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.4 ' O ' ' HB ' ' A' ' 122' ' ' ILE . . . -57.88 -51.54 69.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.94 0.4 . . . . 0.0 111.161 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.1 -28.29 66.36 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.306 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.07 -58.86 3.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.24 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.522 ' NE2' ' HB2' ' A' ' 24' ' ' ALA . 3.5 tp-100 -56.03 -42.66 76.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.218 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.88 HD11 ' CD2' ' A' ' 88' ' ' TYR . 0.3 OUTLIER -61.62 -45.54 98.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.193 -179.828 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.44 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 12.5 mttm -59.98 -31.9 70.34 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.179 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -67.56 -54.52 19.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.806 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.972 HG21 HD13 ' A' ' 148' ' ' LEU . 11.9 pt -61.04 -40.77 86.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.218 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 126' ' ' LEU . 11.8 mt -53.95 -37.59 64.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.705 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.6 -15.04 60.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.269 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -138.59 34.6 2.23 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.1 0.476 . . . . 0.0 110.423 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -48.09 -43.34 30.65 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.295 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.3 mmmp? -62.13 -19.88 63.5 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.302 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -93.99 -41.09 9.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.724 0.297 . . . . 0.0 111.317 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.413 ' CD2' ' OD1' ' A' ' 150' ' ' ASP . 3.9 m-85 -89.0 145.31 25.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.126 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.412 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 2.6 mm100 -122.31 145.92 47.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.807 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.481 ' CE2' ' HB2' ' A' ' 83' ' ' PHE . 2.9 m-85 -86.37 129.47 34.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.118 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.417 ' CE1' ' HG3' ' A' ' 80' ' ' GLU . 51.8 m-85 -130.98 132.25 44.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.769 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.901 HD11 HG21 ' A' ' 81' ' ' THR . 0.4 OUTLIER -121.84 159.31 24.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.681 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -56.67 -171.96 0.16 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.428 -0.891 . . . . 0.0 111.844 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.512 ' HB3' ' HB2' ' A' ' 77' ' ' HIS . 0.0 OUTLIER -70.68 -8.93 55.6 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.571 0.224 . . . . 0.0 111.42 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -93.65 -26.91 16.85 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.673 0.273 . . . . 0.0 111.108 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.445 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 52.0 mtm 51.62 43.96 29.47 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.442 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -68.77 120.04 73.22 Favored Pre-proline 0 N--CA 1.452 -0.335 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.595 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -60.08 -26.39 82.35 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.279 1.986 . . . . 0.0 111.856 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -84.71 -15.86 43.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.739 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.17 -168.34 10.77 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.404 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 2.0 ptp -93.2 -177.33 4.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.819 0.342 . . . . 0.0 110.811 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.537 HG21 ' HE2' ' A' ' 91' ' ' TYR . 74.8 t -126.64 145.26 34.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.11 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.621 ' HB2' ' CE1' ' A' ' 162' ' ' PHE . . . -112.08 112.27 23.78 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.567 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.972 HD13 HG21 ' A' ' 125' ' ' ILE . 4.9 mt -86.76 108.28 18.63 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.193 -179.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.45 ' HB2' ' HE2' ' A' ' 160' ' ' MET . 1.5 tp -91.03 119.54 31.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.122 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.465 ' HB3' ' CE1' ' A' ' 159' ' ' TYR . 0.5 OUTLIER -133.08 174.52 10.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.642 179.55 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -117.26 143.68 45.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.846 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 11.8 mmm180 -56.78 -175.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.058 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -56.3 -31.46 63.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.9 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -78.48 -15.01 59.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.153 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 70.67 21.74 77.89 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.66 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 89.1 t -112.47 -69.2 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.861 0.362 . . . . 0.0 110.823 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 91.0 m -57.61 109.17 1.58 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.945 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -81.24 127.3 5.89 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.484 2.123 . . . . 0.0 112.331 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.465 ' CE1' ' HB3' ' A' ' 150' ' ' ASP . 13.0 p90 -125.35 148.28 48.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.755 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' MET . . . . . 0.627 ' HE1' HD13 ' A' ' 78' ' ' LEU . 0.4 OUTLIER -111.69 142.86 43.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.028 -179.756 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.532 ' HB ' ' HB2' ' A' ' 148' ' ' LEU . 41.9 mt -99.08 120.44 48.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.24 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.621 ' CE1' ' HB2' ' A' ' 147' ' ' ALA . 99.1 m-85 -125.93 150.17 48.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.643 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -97.45 119.16 35.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.898 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 43.1 tttt -56.27 -53.94 51.28 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.334 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.452 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 44.9 m-20 -53.82 -37.49 63.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.19 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.476 ' HA2' HG23 ' A' ' 99' ' ' ILE . . . -95.27 24.42 29.07 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.57 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.723 HD21 ' HB3' ' A' ' 4' ' ' TYR . 5.8 tt -150.15 140.11 21.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.842 0.353 . . . . 0.0 110.74 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -120.16 142.96 48.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.58 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.518 ' HA ' ' O ' ' A' ' 3' ' ' ILE . 0.1 OUTLIER -136.73 160.2 39.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.735 0.302 . . . . 0.0 111.145 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.404 ' O ' HG13 ' A' ' 2' ' ' ILE . 1.5 pt-20 -146.97 143.26 28.32 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.366 -179.102 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.487 ' N ' HD12 ' A' ' 2' ' ' ILE . 18.7 mttm -82.41 109.04 16.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.919 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 7.4 t -113.52 108.8 17.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.79 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.21 150.77 20.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.945 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.92 -179.97 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.479 ' HE2' ' HB3' ' A' ' 174' ' ' GLU . 11.8 ttt . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.836 0.351 . . . . 0.0 111.183 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.716 HD11 ' HB3' ' A' ' 169' ' ' MET . 1.8 tt -140.51 148.3 22.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.055 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.408 ' CG2' ' HB3' ' A' ' 12' ' ' GLU . 16.9 mm -102.14 146.5 10.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.877 0.37 . . . . 0.0 111.518 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.552 ' HE1' HG23 ' A' ' 2' ' ' ILE . 4.9 m-85 -115.96 100.15 7.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.422 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 1.1 ptt180 -116.34 147.9 41.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.881 0.372 . . . . 0.0 111.344 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.458 ' O ' ' HA ' ' A' ' 10' ' ' HIS . 44.7 t0 -57.04 152.17 13.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.749 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.558 HD23 HG23 ' A' ' 99' ' ' ILE . 59.0 tp -81.32 -21.09 39.46 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.53 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.658 HD11 ' CG1' ' A' ' 99' ' ' ILE . 4.3 mp -91.29 -47.77 14.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -179.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.414 ' HB2' ' ND2' ' A' ' 141' ' ' ASN . 3.0 t -96.41 -17.54 20.53 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -179.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.458 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 0.3 OUTLIER 61.98 28.59 17.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.855 0.359 . . . . 0.0 110.774 -179.727 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -98.17 121.71 40.44 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.762 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.408 ' HB3' ' CG2' ' A' ' 3' ' ' ILE . 0.3 OUTLIER -58.17 93.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.282 -179.756 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 7.7 mtt -71.87 -19.44 61.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.664 179.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.518 ' CZ ' ' CD2' ' A' ' 4' ' ' TYR . 7.4 p90 -177.86 176.86 1.14 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.667 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.422 ' O ' HD11 ' A' ' 20' ' ' ILE . 0.9 OUTLIER -133.71 -169.99 2.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.953 -179.886 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.406 ' HB2' HG22 ' A' ' 2' ' ' ILE . 22.6 t70 -94.42 25.08 4.08 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.98 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.43 HG13 ' CD2' ' A' ' 18' ' ' TYR . 20.8 pt -82.39 -15.49 11.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.525 179.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.839 ' CE2' HG22 ' A' ' 72' ' ' ILE . 78.4 m-85 -108.84 -174.45 2.52 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.516 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.1 mttp -94.66 88.53 5.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.849 0.357 . . . . 0.0 110.718 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.422 HD11 ' O ' ' A' ' 15' ' ' SER . 4.1 mp -87.94 132.5 32.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.167 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 8.0 mtt180 -124.68 139.68 53.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.807 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.49 122.32 28.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.996 0.427 . . . . 0.0 110.943 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.9 pt -117.37 167.47 10.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.027 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.472 ' HB3' ' HB3' ' A' ' 27' ' ' LEU . . . 60.08 27.09 16.5 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.072 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 66.92 55.96 0.7 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.338 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 77.12 0.34 70.07 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 120.853 -0.689 . . . . 0.0 113.422 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.472 ' HB3' ' HB3' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -70.44 -58.23 3.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 117.082 0.441 . . . . 0.0 111.04 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 35.2 m -118.95 164.82 14.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.997 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.698 HD11 ' CG ' ' A' ' 164' ' ' LYS . 0.4 OUTLIER -126.32 133.18 51.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.862 -179.931 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -99.06 112.83 24.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.968 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.481 HG21 ' CD2' ' A' ' 14' ' ' PHE . 26.1 t -92.04 111.86 24.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.625 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -80.88 114.08 19.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.252 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -99.19 -141.46 12.27 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.214 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -174.42 126.88 0.33 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.823 0.344 . . . . 0.0 110.978 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 27.7 mtp -68.36 122.58 18.68 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.522 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.1 m -111.97 116.1 51.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.465 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.4 p -84.07 165.79 18.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.999 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.478 ' CB ' HG12 ' A' ' 67' ' ' ILE . 1.8 mmt-85 -128.12 116.34 19.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.621 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -105.38 33.46 3.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.758 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -93.95 97.71 10.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.876 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -133.71 178.07 18.58 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.483 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -80.53 104.58 11.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.875 0.369 . . . . 0.0 110.897 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 31.9 mt 63.81 143.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.116 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -95.48 -69.51 0.75 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.877 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -155.03 178.82 9.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.959 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 85.8 p -80.93 -33.17 34.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.953 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.1 mt -75.55 -30.61 59.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.894 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -111.58 103.3 15.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.984 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -155.04 90.6 0.12 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.481 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -156.02 81.85 0.16 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.543 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -172.22 -179.78 2.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.869 0.366 . . . . 0.0 110.868 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.87 163.95 23.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.132 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -107.67 169.93 8.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.873 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -156.56 162.59 39.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.093 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -82.92 -31.13 27.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.957 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 79.27 -148.67 31.44 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.483 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -51.39 147.44 22.06 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.583 2.189 . . . . 0.0 112.346 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -110.51 36.39 3.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.945 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -124.66 -129.54 3.41 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.506 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -120.22 -50.36 2.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.859 0.362 . . . . 0.0 110.91 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -149.49 28.24 1.2 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.549 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 68.5 p -87.54 91.53 8.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.824 0.345 . . . . 0.0 110.87 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -115.89 145.15 43.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.914 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.1 m -102.95 -31.78 10.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.765 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.969 HG22 HG23 ' A' ' 66' ' ' VAL . 92.3 m 63.39 -79.96 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.075 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.969 HG23 HG22 ' A' ' 65' ' ' THR . 42.0 t -127.07 145.33 34.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.083 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.478 HG12 ' CB ' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -135.62 130.48 49.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.953 179.715 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 86.5 m -139.15 139.9 37.72 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.036 0.446 . . . . 0.0 111.146 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -175.42 179.43 46.65 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.047 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.579 HG12 HG12 ' A' ' 72' ' ' ILE . 40.8 t -73.2 130.32 35.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.887 0.375 . . . . 0.0 110.847 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -59.26 -55.3 36.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.64 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.839 HG22 ' CE2' ' A' ' 18' ' ' TYR . 6.9 pt -54.01 -36.72 32.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.544 -179.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.796 HG13 ' HB2' ' A' ' 78' ' ' LEU . 97.2 t -70.37 -31.47 46.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.197 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.5 mtm -78.22 -40.47 37.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.786 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.426 ' ND2' ' HA ' ' A' ' 72' ' ' ILE . 0.3 OUTLIER -82.0 -29.33 32.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.546 -179.23 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.446 ' CE1' ' HB ' ' A' ' 72' ' ' ILE . 29.6 m170 -89.95 -5.11 57.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.869 0.366 . . . . 0.0 110.752 179.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.433 ' HB2' ' HB3' ' A' ' 138' ' ' GLU . 28.6 m-70 61.74 28.42 17.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.916 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.842 HD13 ' CE ' ' A' ' 160' ' ' MET . 34.2 mt -59.87 152.87 22.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.588 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -138.73 145.84 40.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.799 0.333 . . . . 0.0 111.175 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.421 ' HB2' ' CZ ' ' A' ' 135' ' ' PHE . 0.2 OUTLIER -99.41 133.18 44.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.079 -179.924 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.445 HG21 HD11 ' A' ' 136' ' ' ILE . 9.7 t -117.15 166.9 11.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.755 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 66.8 m -98.38 158.28 15.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.04 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.456 ' HB2' ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -171.78 150.1 2.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.823 179.934 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 54.7 p -99.92 169.61 9.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.821 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -63.17 -52.44 62.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.923 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -60.67 -45.41 94.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.921 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.434 ' HB1' ' CE1' ' A' ' 83' ' ' PHE . . . -59.78 -41.12 90.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.962 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.793 ' CD2' HD11 ' A' ' 122' ' ' ILE . 0.2 OUTLIER -58.03 -36.14 72.29 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.894 179.938 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.442 ' O ' HG22 ' A' ' 92' ' ' ILE . 36.3 mttm -60.12 -51.11 71.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.069 0.461 . . . . 0.0 110.482 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.1 mttm -72.93 -27.7 62.0 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.591 178.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.566 ' HE2' HG21 ' A' ' 146' ' ' VAL . 7.5 t80 -64.23 -48.03 77.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.975 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.459 ' CD1' ' CE2' ' A' ' 95' ' ' TYR . 3.1 tp -61.43 -41.91 91.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.733 0.301 . . . . 0.0 111.174 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.445 ' O ' ' CG ' ' A' ' 97' ' ' LYS . 4.6 ttmt -61.17 -46.08 91.98 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.969 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -70.79 -36.86 73.22 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.93 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.532 ' CD1' ' C ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -76.34 -43.11 42.56 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 121.189 -0.205 . . . . 0.0 110.744 -179.544 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.3 ptp -65.07 -32.03 73.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.92 0.391 . . . . 0.0 110.279 179.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.445 ' CG ' ' O ' ' A' ' 93' ' ' LYS . 0.1 OUTLIER -64.01 -44.2 93.33 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.867 179.751 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.4 m -56.47 -43.2 79.38 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.874 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.658 ' CG1' HD11 ' A' ' 8' ' ' ILE . 6.5 mt -79.85 -40.59 20.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.682 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.2 tttt -55.09 -53.47 55.51 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.574 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -62.94 -46.42 93.61 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.334 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.1 tppm? -60.53 -40.85 92.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.858 0.361 . . . . 0.0 110.422 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.727 HD21 ' CB ' ' A' ' 110' ' ' ARG . 3.0 tp -66.52 -35.25 79.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.26 179.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.645 ' CG ' HG11 ' A' ' 111' ' ' VAL . 36.2 mt-10 -59.13 -29.38 67.35 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.684 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -88.52 -18.69 27.62 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.617 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -108.56 -61.8 1.55 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.838 0.351 . . . . 0.0 111.586 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.429 ' N ' ' O ' ' A' ' 103' ' ' LEU . 19.9 mtt85 -130.1 65.07 74.6 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.777 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.919 ' O ' HG22 ' A' ' 111' ' ' VAL . 9.4 Cg_endo -50.54 -23.33 10.55 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 123.087 2.525 . . . . 0.0 112.652 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -69.1 -13.9 62.7 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.64 0.257 . . . . 0.0 111.15 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.727 ' CB ' HD21 ' A' ' 103' ' ' LEU . 6.8 mmm-85 -106.21 -1.79 23.19 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -179.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.919 HG22 ' O ' ' A' ' 108' ' ' PRO . 24.3 m -71.37 -27.03 27.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.685 0.279 . . . . 0.0 111.521 -179.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.6 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 0.8 OUTLIER -70.37 -55.42 7.78 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.578 -179.291 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.6 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 47.1 Cg_exo -55.37 -40.88 83.2 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.182 1.922 . . . . 0.0 111.975 179.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.45 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 75.6 t80 -65.47 -38.36 89.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.166 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.05 -54.85 40.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.001 0.429 . . . . 0.0 110.926 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.446 HG22 ' OE1' ' A' ' 120' ' ' GLU . 62.7 m -74.37 -44.65 51.28 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.768 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.4 -41.78 98.67 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.644 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.18 -51.57 69.43 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.059 0.457 . . . . 0.0 111.072 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.15 -28.15 65.12 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.325 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.446 ' OE1' HG22 ' A' ' 116' ' ' THR . 11.4 mt-10 -77.93 -43.65 29.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.4 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.447 ' NE2' ' HB2' ' A' ' 24' ' ' ALA . 4.9 tp-100 -71.27 -31.56 67.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.117 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.793 HD11 ' CD2' ' A' ' 88' ' ' TYR . 0.4 OUTLIER -70.56 -45.93 72.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.36 -179.782 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.45 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 12.1 pttt -60.75 -31.22 70.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.067 0.461 . . . . 0.0 110.365 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -68.36 -54.05 19.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.64 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.797 HG21 HD13 ' A' ' 148' ' ' LEU . 15.2 pt -61.67 -42.61 94.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.261 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' A' ' 126' ' ' LEU . 11.4 mt -54.19 -35.48 62.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.969 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -69.89 -11.29 60.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.343 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 -142.07 32.83 1.55 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.884 0.373 . . . . 0.0 110.599 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.5 ' CE1' ' CZ ' ' A' ' 134' ' ' PHE . 4.5 t80 -52.2 -26.1 10.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.088 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 6.8 mttt -59.17 -30.43 68.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.929 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -94.28 -37.86 11.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.324 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.412 ' HE2' HD11 ' A' ' 161' ' ' ILE . 15.1 m-85 -91.09 135.51 33.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.835 0.35 . . . . 0.0 111.21 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 -121.94 145.8 47.75 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.911 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.508 ' CE1' ' CZ ' ' A' ' 88' ' ' TYR . 1.3 m-85 -78.06 125.95 30.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.85 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.423 ' O ' ' HB3' ' A' ' 147' ' ' ALA . 10.7 m-85 -130.77 137.38 49.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.623 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.465 ' HB ' ' HA ' ' A' ' 140' ' ' MET . 0.9 OUTLIER -126.87 161.69 33.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.956 -179.964 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.79 -164.95 0.35 Allowed Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.44 -0.886 . . . . 0.0 111.968 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.433 ' HB3' ' HB2' ' A' ' 77' ' ' HIS . 1.2 pt-20 -72.37 -8.87 57.28 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.594 0.235 . . . . 0.0 111.507 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -96.25 -29.26 14.12 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.594 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.465 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 75.7 mtp 56.37 46.53 20.77 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.903 0.382 . . . . 0.0 110.997 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . 0.419 ' ND2' ' HA3' ' A' ' 144' ' ' GLY . 13.0 p-10 -69.08 114.48 23.69 Favored Pre-proline 0 N--CA 1.452 -0.338 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.951 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 141' ' ' ASN . 16.3 Cg_exo -66.25 -29.39 46.87 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.633 2.222 . . . . 0.0 112.245 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -84.64 -5.25 59.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.47 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.419 ' HA3' ' ND2' ' A' ' 141' ' ' ASN . . . -87.7 -143.38 8.44 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.456 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 2.8 ptp -106.22 -179.17 3.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.824 0.345 . . . . 0.0 110.863 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.566 HG21 ' HE2' ' A' ' 91' ' ' TYR . 53.5 t -128.52 148.2 32.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.225 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.57 ' HB1' ' SD ' ' A' ' 160' ' ' MET . . . -110.67 114.78 28.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.511 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.797 HD13 HG21 ' A' ' 125' ' ' ILE . 3.8 mt -88.5 106.19 18.12 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.088 -179.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.481 HD12 ' HG2' ' A' ' 160' ' ' MET . 4.4 tp -90.37 119.72 30.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.366 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.538 ' HB3' ' CE1' ' A' ' 159' ' ' TYR . 4.7 t70 -138.54 167.41 21.99 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.533 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -105.2 151.71 23.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.865 0.364 . . . . 0.0 111.166 -179.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 12.2 mmt85 -70.31 -175.47 1.0 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.838 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -56.92 -31.05 64.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.063 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -74.43 -15.15 60.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.288 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 74.24 7.29 77.2 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.803 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 72.7 t -110.23 -66.92 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.924 0.393 . . . . 0.0 110.94 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 84.9 m -52.96 107.18 0.78 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.261 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -84.65 129.03 4.09 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.622 2.214 . . . . 0.0 112.245 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.538 ' CE1' ' HB3' ' A' ' 150' ' ' ASP . 8.4 p90 -126.51 147.04 49.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.929 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' MET . . . . . 0.842 ' CE ' HD13 ' A' ' 78' ' ' LEU . 0.8 OUTLIER -113.14 145.4 41.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.241 -179.659 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.516 ' HB ' ' HB2' ' A' ' 148' ' ' LEU . 85.0 mt -98.44 112.84 31.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.032 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.526 ' CE1' ' HB2' ' A' ' 147' ' ' ALA . 62.2 m-85 -118.81 121.0 39.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.679 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -68.98 124.4 23.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.047 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.698 ' CG ' HD11 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -69.86 -41.98 74.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.16 -179.738 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.45 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 2.1 m-20 -55.97 -29.61 60.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.919 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -108.95 29.47 9.73 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.354 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.411 HD21 ' HB3' ' A' ' 4' ' ' TYR . 0.6 OUTLIER -139.48 148.43 42.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.827 0.346 . . . . 0.0 110.785 -179.9 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -111.74 155.43 23.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.009 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.716 ' HB3' HD11 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -125.35 137.84 54.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.875 179.998 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -151.42 127.53 10.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.963 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.464 ' HG2' HD12 ' A' ' 2' ' ' ILE . 14.1 mttt -91.55 108.98 20.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.969 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 19.1 m -144.87 18.22 1.62 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.307 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 3.2 mp 50.65 -176.86 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.801 0.334 . . . . 0.0 111.152 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.479 ' HB3' ' HE2' ' A' ' 1' ' ' MET . 1.9 pt-20 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.906 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.819 0.343 . . . . 0.0 111.189 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.52 HG23 ' HE1' ' A' ' 4' ' ' TYR . 0.8 OUTLIER -98.25 140.83 17.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.814 179.942 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.526 ' O ' ' HA ' ' A' ' 169' ' ' MET . 4.6 mm -106.11 122.69 60.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.766 -179.347 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.521 ' HD2' HD21 ' A' ' 167' ' ' LEU . 3.9 m-85 -90.09 130.22 36.29 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.563 179.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.97 157.5 45.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.966 0.412 . . . . 0.0 111.438 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.437 ' O ' ' HA ' ' A' ' 10' ' ' HIS . 36.8 t0 -63.41 152.18 38.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.721 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.653 HD23 HG23 ' A' ' 99' ' ' ILE . 61.3 tp -80.51 -24.83 39.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.312 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.906 HD11 ' CG1' ' A' ' 99' ' ' ILE . 4.1 mp -91.43 -45.28 14.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.02 -28.49 17.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.486 -179.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.437 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 0.2 OUTLIER 66.45 29.55 9.14 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.849 0.356 . . . . 0.0 110.785 -179.782 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -101.16 130.5 47.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.716 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.2 pm0 -61.95 88.49 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.31 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 10.5 mtt -71.42 -17.93 62.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.66 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.499 ' CE2' ' CG ' ' A' ' 4' ' ' TYR . 43.5 p90 -178.62 177.22 0.92 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.676 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.4 m -136.71 -169.8 2.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.943 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.434 ' HB2' ' CG2' ' A' ' 2' ' ' ILE . 40.2 t0 -93.26 23.57 4.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.018 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.435 HG13 ' CD2' ' A' ' 18' ' ' TYR . 45.4 pt -87.55 -9.84 10.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.756 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.887 ' CZ ' HG22 ' A' ' 72' ' ' ILE . 76.1 m-85 -111.14 -170.77 1.7 Allowed 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.765 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.6 mttm -97.07 91.28 5.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.734 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.44 HD12 ' N ' ' A' ' 20' ' ' ILE . 4.9 mp -87.93 123.96 40.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.015 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 15.9 mtp180 -120.55 117.62 28.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.811 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -72.1 117.48 13.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.938 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.403 HG12 ' HG3' ' A' ' 30' ' ' GLU . 1.6 pt -110.95 171.12 3.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.947 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.414 ' HB2' ' NE2' ' A' ' 121' ' ' GLN . . . 56.59 33.98 23.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.068 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 64.5 42.84 4.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.183 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.08 -12.95 62.71 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.785 -0.722 . . . . 0.0 113.195 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.532 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -55.93 -33.36 64.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.902 0.351 . . . . 0.0 111.285 -179.859 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 34.3 m -142.21 164.29 30.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.021 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.838 HD11 ' CG ' ' A' ' 164' ' ' LYS . 1.0 OUTLIER -128.32 130.85 48.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.994 -179.915 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.403 ' HG3' HG12 ' A' ' 23' ' ' ILE . 59.3 mt-10 -95.56 112.97 24.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.071 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 159' ' ' TYR . 23.3 t -91.55 111.87 24.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.362 179.39 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -85.5 118.36 24.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.381 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -106.34 -142.91 11.09 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.098 179.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.8 pttt -174.44 123.46 0.29 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.793 0.33 . . . . 0.0 111.187 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 76.5 mtm -65.95 118.62 10.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.538 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.486 ' O ' HG23 ' A' ' 36' ' ' VAL . 31.1 m -104.93 116.19 48.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.899 0.38 . . . . 0.0 111.53 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.735 ' CA ' HG23 ' A' ' 68' ' ' THR . 0.3 OUTLIER -91.43 153.22 20.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.641 179.721 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.529 ' HB3' HG12 ' A' ' 67' ' ' ILE . 35.4 ttt180 -138.22 115.94 11.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.827 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.436 HG22 HG22 ' A' ' 66' ' ' VAL . 30.4 p -109.06 -33.54 6.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.754 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -139.31 -49.51 0.5 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.915 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 166.57 150.15 6.26 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.521 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -123.79 123.4 40.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.887 0.375 . . . . 0.0 110.878 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.604 HG22 ' O ' ' A' ' 43' ' ' ILE . 3.3 mt 60.14 33.01 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.002 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -82.92 -60.3 2.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.902 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.39 142.07 45.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.869 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 38.3 m -102.64 -59.89 1.63 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.946 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 29.8 mt -65.83 -48.37 71.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.935 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.491 HG22 ' N ' ' A' ' 49' ' ' GLY . 41.3 mt 59.01 158.62 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.144 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.491 ' N ' HG22 ' A' ' 48' ' ' ILE . . . 148.87 51.9 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.529 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -148.01 105.09 0.3 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.499 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -166.4 122.19 1.22 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.82 0.343 . . . . 0.0 110.838 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -115.78 -38.62 3.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.075 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 32.0 t -142.92 -51.59 0.37 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.867 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -174.37 -44.27 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.104 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -102.21 167.32 10.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.832 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -89.43 -95.05 1.1 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.535 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.34 -30.27 51.58 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.548 2.165 . . . . 0.0 112.173 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 60.97 31.15 19.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.93 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 161.4 140.89 2.98 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.501 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 60.95 163.34 0.07 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.857 0.36 . . . . 0.0 110.875 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 153.08 168.96 17.69 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.513 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.1 t -86.86 164.44 16.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.775 0.321 . . . . 0.0 110.941 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -100.38 90.91 4.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.949 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 12.2 m -83.53 -22.04 32.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.117 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.523 ' O ' HD13 ' A' ' 67' ' ' ILE . 3.7 m 65.31 133.57 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.81 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.436 HG22 HG22 ' A' ' 39' ' ' THR . 57.8 t -74.75 144.26 12.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.044 0.45 . . . . 0.0 111.188 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.529 HG12 ' HB3' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -128.37 127.35 67.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.35 179.338 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.735 HG23 ' CA ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -139.08 118.2 12.61 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.326 -179.671 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -150.65 175.43 29.67 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.264 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.596 HG12 HG12 ' A' ' 72' ' ' ILE . 46.3 t -70.96 130.5 34.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.878 0.37 . . . . 0.0 110.725 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.4 ' O ' ' ND2' ' A' ' 75' ' ' ASN . 5.3 t0 -58.17 -58.77 6.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.862 -179.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.887 HG22 ' CZ ' ' A' ' 18' ' ' TYR . 8.5 pt -53.64 -33.81 23.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.678 -179.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.762 HG13 ' HB2' ' A' ' 78' ' ' LEU . 89.9 t -72.77 -34.28 46.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.878 0.37 . . . . 0.0 111.011 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 14.9 mtm -78.24 -39.24 40.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.716 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.403 ' OD1' ' CD2' ' A' ' 76' ' ' HIS . 19.9 p30 -82.15 -29.33 31.65 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -179.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.457 ' CE1' ' HB ' ' A' ' 72' ' ' ILE . 26.0 m170 -92.05 -0.55 57.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.81 0.338 . . . . 0.0 110.787 179.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.406 ' HB2' ' HB3' ' A' ' 138' ' ' GLU . 30.3 m-70 57.84 31.85 21.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.057 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.762 ' HB2' HG13 ' A' ' 73' ' ' VAL . 58.6 mt -58.63 147.39 32.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.582 179.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -128.39 133.91 48.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.915 0.388 . . . . 0.0 111.054 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.414 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 28.9 tt0 -90.24 132.37 35.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.061 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.1 t -121.9 -172.96 2.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.872 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 83.1 p -128.79 168.23 16.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.957 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.499 ' CE2' ' CE2' ' A' ' 91' ' ' TYR . 1.1 m-85 -171.71 157.34 4.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.991 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.34 164.5 11.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.789 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.34 -52.45 65.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.83 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -67.21 -38.94 86.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.725 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.62 -37.13 86.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.992 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.929 ' CD2' HD11 ' A' ' 122' ' ' ILE . 0.1 OUTLIER -63.01 -37.37 86.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.804 -179.999 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.439 ' O ' HG22 ' A' ' 92' ' ' ILE . 58.3 mttt -59.03 -45.43 90.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.084 0.468 . . . . 0.0 110.361 179.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.35 -27.82 52.8 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.643 178.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.539 ' HE2' HG21 ' A' ' 146' ' ' VAL . 9.3 t80 -66.88 -44.72 80.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.753 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.65 HD12 ' CE2' ' A' ' 95' ' ' TYR . 5.7 tp -63.36 -43.11 98.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.95 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.1 ttpt -62.28 -40.79 97.41 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.752 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.514 ' HA ' ' HG2' ' A' ' 97' ' ' LYS . 27.6 t0 -72.92 -43.94 61.82 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.762 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.65 ' CE2' HD12 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -75.82 -40.16 55.42 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 121.063 -0.255 . . . . 0.0 110.99 -179.386 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.57 -32.01 72.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.697 0.284 . . . . 0.0 110.661 179.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.514 ' HG2' ' HA ' ' A' ' 94' ' ' ASP . 0.0 OUTLIER -69.19 -34.22 74.56 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.829 0.347 . . . . 0.0 110.272 179.695 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.472 ' N ' ' HG3' ' A' ' 97' ' ' LYS . 1.0 OUTLIER -61.36 -41.03 96.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.969 179.316 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.906 ' CG1' HD11 ' A' ' 8' ' ' ILE . 9.3 mt -79.94 -42.86 22.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.564 179.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.91 -49.16 69.22 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.597 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -64.6 -50.44 58.99 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.667 -0.777 . . . . 0.0 112.207 179.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 2.2 tptt -59.84 -40.98 90.35 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.947 0.403 . . . . 0.0 110.426 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.59 ' HB3' HG12 ' A' ' 111' ' ' VAL . 12.3 tp -63.84 -41.1 97.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.043 179.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.667 ' HG3' HG11 ' A' ' 111' ' ' VAL . 32.2 mt-10 -55.2 -28.59 54.15 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.809 179.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -89.71 -16.57 30.08 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.784 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.461 ' NE2' HD11 ' A' ' 7' ' ' LEU . 15.0 mt-30 -114.27 -60.81 1.83 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.747 0.308 . . . . 0.0 111.538 -179.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.456 ' N ' ' O ' ' A' ' 103' ' ' LEU . 0.9 OUTLIER -123.96 62.01 26.21 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.821 -179.801 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.877 ' O ' HG22 ' A' ' 111' ' ' VAL . 10.0 Cg_endo -50.8 -23.6 11.85 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 123.042 2.495 . . . . 0.0 112.566 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -74.44 -8.03 54.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.295 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.512 ' C ' ' HD2' ' A' ' 113' ' ' PRO . 1.1 mmt180 -111.22 -1.22 16.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.59 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.877 HG22 ' O ' ' A' ' 108' ' ' PRO . 31.1 m -72.49 -33.17 44.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.564 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 1.9 mtpt -68.39 -49.97 29.79 Favored Pre-proline 0 C--N 1.331 -0.205 0 N-CA-C 111.649 0.24 . . . . 0.0 111.649 -179.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.564 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 30.0 Cg_exo -61.77 -33.72 84.68 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.087 1.858 . . . . 0.0 111.938 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.45 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 87.8 t80 -72.07 -36.5 69.56 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.012 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 5.5 mmm -58.02 -53.0 63.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.941 0.4 . . . . 0.0 110.855 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 71.8 m -73.06 -44.41 60.66 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.673 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.98 -37.57 95.17 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.577 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.42 ' O ' ' HB ' ' A' ' 122' ' ' ILE . . . -60.0 -51.65 68.74 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.961 0.41 . . . . 0.0 110.928 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.73 -28.12 62.46 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.425 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.404 ' O ' ' HG2' ' A' ' 123' ' ' LYS . 0.6 OUTLIER -77.92 -42.4 33.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.206 -179.711 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.414 ' NE2' ' HB2' ' A' ' 24' ' ' ALA . 6.7 tp-100 -72.11 -34.78 68.87 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.035 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.929 HD11 ' CD2' ' A' ' 88' ' ' TYR . 0.4 OUTLIER -68.27 -46.3 81.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.39 -179.81 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.451 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 0.4 OUTLIER -59.76 -32.13 70.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.062 0.458 . . . . 0.0 110.116 179.448 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -66.67 -54.3 24.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.618 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.862 HG21 HD13 ' A' ' 148' ' ' LEU . 13.0 pt -61.77 -39.98 85.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.058 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 11.4 mt -53.67 -35.69 61.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.567 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.5 -14.95 62.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.885 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -133.11 32.28 3.75 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.047 0.451 . . . . 0.0 110.243 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -49.08 -35.56 16.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.179 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.4 -20.78 60.66 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.162 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -89.18 -35.53 16.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.41 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.457 ' CD1' ' N ' ' A' ' 132' ' ' TYR . 1.7 m-30 -104.21 151.37 23.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.864 0.364 . . . . 0.0 111.313 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.416 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 4.9 mm100 -123.89 150.69 44.35 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.913 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.514 ' CE1' ' CZ ' ' A' ' 88' ' ' TYR . 4.6 m-85 -86.16 132.38 34.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.144 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.515 ' O ' ' HB3' ' A' ' 147' ' ' ALA . 28.8 m-85 -136.93 130.11 31.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.58 179.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.458 ' HB ' ' HA ' ' A' ' 140' ' ' MET . 0.8 OUTLIER -122.09 167.33 15.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.892 -179.81 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.42 -170.84 0.84 Allowed Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.475 -0.869 . . . . 0.0 111.927 179.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.406 ' HB3' ' HB2' ' A' ' 77' ' ' HIS . 1.9 pt-20 -68.92 -11.17 60.36 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.621 0.248 . . . . 0.0 111.389 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -92.39 -33.51 14.53 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.606 0.241 . . . . 0.0 111.242 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.458 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 75.2 mtm 58.34 41.78 22.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.341 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -70.14 118.18 61.37 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.793 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -64.61 -21.65 65.33 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.331 2.021 . . . . 0.0 111.831 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -84.59 -12.06 54.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.755 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -81.31 -137.12 2.11 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.256 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.557 ' HE3' ' O ' ' A' ' 166' ' ' GLY . 3.7 ptp -120.65 178.89 4.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.781 0.324 . . . . 0.0 110.704 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.539 HG21 ' HE2' ' A' ' 91' ' ' TYR . 65.9 t -124.41 147.67 28.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.987 0.422 . . . . 0.0 111.193 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.604 ' HB2' ' CE2' ' A' ' 162' ' ' PHE . . . -113.27 110.2 19.99 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.364 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.862 HD13 HG21 ' A' ' 125' ' ' ILE . 4.4 mt -83.57 106.17 15.09 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.143 -179.093 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.486 HD12 ' HG2' ' A' ' 160' ' ' MET . 2.2 tp -88.71 119.91 29.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.954 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.497 ' HB2' ' CZ ' ' A' ' 159' ' ' TYR . 62.8 m-20 -130.31 161.86 30.3 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.574 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.406 ' HB3' ' HA2' ' A' ' 155' ' ' GLY . 80.1 m-85 -104.34 151.98 22.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.087 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 3.9 mmt180 -59.36 -176.92 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.0 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -60.9 -40.96 95.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.977 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -79.76 -15.07 58.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.312 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.406 ' HA2' ' HB3' ' A' ' 151' ' ' TYR . . . 78.68 33.07 39.16 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.597 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 93.8 t -113.44 -60.96 2.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.841 0.353 . . . . 0.0 111.11 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 51.5 m -80.55 112.56 32.37 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.341 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -82.37 134.28 7.73 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.558 2.172 . . . . 0.0 112.04 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.497 ' CZ ' ' HB2' ' A' ' 150' ' ' ASP . 5.7 p90 -130.51 142.59 50.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.041 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' MET . . . . . 0.563 ' CE ' HD13 ' A' ' 78' ' ' LEU . 0.3 OUTLIER -107.14 143.42 35.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.025 -179.899 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.528 ' HB ' ' HB2' ' A' ' 148' ' ' LEU . 73.4 mt -101.81 112.01 33.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.157 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.604 ' CE2' ' HB2' ' A' ' 147' ' ' ALA . 81.0 m-85 -114.23 157.62 22.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.756 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -100.5 122.82 43.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.952 0.406 . . . . 0.0 110.812 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.838 ' CG ' HD11 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -66.12 -50.49 63.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.245 -179.672 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.45 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 1.7 m-20 -52.14 -30.48 26.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.12 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.557 ' O ' ' HE3' ' A' ' 145' ' ' MET . . . -108.21 27.75 13.44 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.236 179.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.521 HD21 ' HD2' ' A' ' 4' ' ' TYR . 0.7 OUTLIER -150.15 142.69 24.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.82 0.343 . . . . 0.0 110.736 -179.861 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -130.45 156.18 45.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.611 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.526 ' HA ' ' O ' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -140.16 160.29 40.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.116 179.973 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -149.99 149.71 30.76 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.477 -179.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.432 ' N ' HD12 ' A' ' 2' ' ' ILE . 28.7 mttt -87.2 109.04 19.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.822 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 17.7 p -98.81 96.3 7.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.959 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 5.3 mp -81.55 -71.9 0.45 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.83 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.927 179.996 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.5 ttm . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.847 0.356 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.723 HD11 ' HB3' ' A' ' 169' ' ' MET . 1.9 tt -108.54 148.12 12.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.002 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.419 ' CG2' ' HB3' ' A' ' 12' ' ' GLU . 16.3 mm -104.25 155.75 5.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.348 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.592 ' HE1' HG23 ' A' ' 2' ' ' ILE . 4.4 m-85 -124.19 106.62 10.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.73 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 27.7 ptt180 -122.66 146.74 47.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.148 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.563 ' OD1' HD12 ' A' ' 8' ' ' ILE . 49.2 t0 -58.05 143.36 43.72 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.8 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 59.8 tp -73.37 -21.96 60.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.328 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.69 HD11 ' CG1' ' A' ' 99' ' ' ILE . 4.2 mp -91.32 -45.72 14.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.8 -179.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.94 -20.27 19.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.76 -179.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.445 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 14.7 m170 61.24 28.86 18.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.91 0.386 . . . . 0.0 110.717 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -102.08 120.29 40.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.761 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.419 ' HB3' ' CG2' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -56.66 88.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.392 -179.731 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.411 ' O ' ' CG ' ' A' ' 76' ' ' HIS . 7.8 mtt -66.46 -24.22 66.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.721 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.507 ' CZ ' ' CD2' ' A' ' 4' ' ' TYR . 25.6 p90 -173.49 179.65 2.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.696 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -135.24 -169.97 2.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.774 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -94.85 23.98 5.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.023 0.439 . . . . 0.0 110.948 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.429 HG13 ' CD2' ' A' ' 18' ' ' TYR . 39.6 pt -82.03 -15.03 12.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.632 179.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.837 ' CE2' HG22 ' A' ' 72' ' ' ILE . 82.4 m-85 -108.12 -174.27 2.48 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.586 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.4 mmtp -93.19 86.43 5.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.746 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.574 HD12 ' N ' ' A' ' 20' ' ' ILE . 3.9 mp -87.83 125.54 41.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.939 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.4 mmm180 -117.77 129.97 56.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.997 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -80.59 116.53 20.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.707 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.402 HG12 ' HG3' ' A' ' 30' ' ' GLU . 2.9 pt -110.93 173.39 2.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.017 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.492 ' HB2' ' NE2' ' A' ' 121' ' ' GLN . . . 56.39 28.42 13.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.166 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.414 ' HB2' ' O ' ' A' ' 24' ' ' ALA . 5.4 m-20 66.06 54.38 1.0 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.238 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 76.61 1.78 72.77 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.894 -0.669 . . . . 0.0 113.415 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.477 ' HB3' ' HB3' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -71.84 -43.47 65.48 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 117.056 0.428 . . . . 0.0 111.083 -179.962 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 10.1 m -132.17 161.76 32.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.096 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.625 HD11 ' HG3' ' A' ' 164' ' ' LYS . 1.1 mt -127.1 127.74 45.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.823 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.402 ' HG3' HG12 ' A' ' 23' ' ' ILE . 56.4 mt-10 -97.38 112.96 24.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.137 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.402 HG21 ' CD2' ' A' ' 14' ' ' PHE . 24.2 t -92.23 111.97 25.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.567 179.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -82.03 125.17 30.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.228 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -112.07 -141.15 8.26 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.177 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.9 pttp -174.57 126.49 0.31 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.816 0.341 . . . . 0.0 111.132 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 95.1 mtp -67.78 111.28 4.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.631 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 28.9 m -110.84 135.56 49.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.453 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.2 p -96.36 165.5 12.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.784 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.623 ' O ' HG13 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -142.09 141.26 32.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.671 -179.832 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.411 HG23 HG22 ' A' ' 66' ' ' VAL . 4.9 m -164.3 125.73 2.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.829 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -141.74 -74.44 0.31 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.916 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.69 -172.84 21.37 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.478 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -176.68 173.14 2.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.828 0.347 . . . . 0.0 110.8 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.3 mp -94.45 140.74 16.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.025 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -143.22 -169.18 2.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.921 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 59.94 25.24 14.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.929 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -106.12 -47.81 3.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.875 0.369 . . . . 0.0 110.851 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 11.1 mt -92.97 -30.64 15.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.873 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 23.1 mt -75.07 113.2 13.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.071 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 154.12 90.15 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.501 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -140.53 -155.01 6.39 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.615 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 -109.26 -25.64 10.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.796 0.332 . . . . 0.0 111.107 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -54.9 -43.52 73.31 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.271 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 42.4 t -74.12 -66.79 0.68 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.843 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 59.01 34.33 23.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.146 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -175.3 152.01 1.34 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.92 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 144.43 146.66 4.53 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.471 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.24 177.58 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.438 2.092 . . . . 0.0 112.345 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -102.66 -52.0 3.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.891 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -142.79 87.04 0.18 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.461 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -122.15 97.17 5.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.865 0.364 . . . . 0.0 110.796 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -168.76 144.75 8.98 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.521 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.413 HG23 ' N ' ' A' ' 63' ' ' GLU . 4.9 t -142.7 -47.9 0.33 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.783 0.325 . . . . 0.0 110.857 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.413 ' N ' HG23 ' A' ' 62' ' ' THR . 1.6 tp10 -106.64 87.3 2.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.762 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.2 t -58.08 -61.77 2.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.937 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.2 m -164.1 55.6 0.15 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.943 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.623 HG13 ' O ' ' A' ' 38' ' ' ARG . 42.5 t -102.93 127.15 56.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.185 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.607 HD13 ' C ' ' A' ' 66' ' ' VAL . 0.0 OUTLIER -130.16 130.59 65.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.646 179.536 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 10.5 m -139.25 133.02 30.73 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.144 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 176.51 -169.43 41.92 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.286 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.798 HG22 ' HG2' ' A' ' 158' ' ' PRO . 43.0 t -73.2 129.84 35.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.792 0.33 . . . . 0.0 110.771 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.4 ' N ' ' OD1' ' A' ' 71' ' ' ASP . 20.3 p-10 -59.6 -55.49 33.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.793 -179.144 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.837 HG22 ' CE2' ' A' ' 18' ' ' TYR . 8.7 pt -53.78 -33.94 24.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.833 0.349 . . . . 0.0 111.411 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.782 HG13 ' HB2' ' A' ' 78' ' ' LEU . 93.8 t -72.44 -32.1 40.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.919 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.2 mtm -78.21 -40.07 38.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.496 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.41 ' OD1' ' CD2' ' A' ' 76' ' ' HIS . 15.2 p30 -82.12 -28.46 32.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.568 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.44 ' CE1' ' HB ' ' A' ' 72' ' ' ILE . 24.8 m170 -94.29 1.1 55.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.806 0.336 . . . . 0.0 110.963 179.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.409 ' HB2' ' HB3' ' A' ' 138' ' ' GLU . 89.9 m-70 56.13 30.16 15.91 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.321 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.782 ' HB2' HG13 ' A' ' 73' ' ' VAL . 67.1 mt -60.17 134.46 57.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.604 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -123.91 139.38 54.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.863 0.363 . . . . 0.0 111.196 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.43 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 2.0 tt0 -90.83 130.7 36.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.958 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.837 HG21 HD11 ' A' ' 136' ' ' ILE . 9.9 t -122.14 137.06 54.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.821 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.0 m -77.57 159.16 29.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.028 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.473 ' CE2' ' HB1' ' A' ' 87' ' ' ALA . 0.3 OUTLIER -167.61 149.24 5.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.822 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.88 166.63 13.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.965 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.7 mttp -64.98 -52.55 55.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.764 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -62.67 -41.69 99.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.959 0.409 . . . . 0.0 110.591 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.473 ' HB1' ' CE2' ' A' ' 83' ' ' PHE . . . -59.28 -39.44 82.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.91 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.84 ' CD2' HD11 ' A' ' 122' ' ' ILE . 0.5 OUTLIER -59.78 -37.17 78.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.575 179.807 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.415 ' O ' HG22 ' A' ' 92' ' ' ILE . 67.6 mttt -56.61 -49.81 73.85 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.112 0.482 . . . . 0.0 110.189 179.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.71 -27.83 60.55 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.521 178.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.537 ' HE2' HG21 ' A' ' 146' ' ' VAL . 6.3 t80 -64.62 -47.63 77.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.814 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.57 HD12 ' CE2' ' A' ' 95' ' ' TYR . 4.8 tp -61.47 -43.97 97.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.98 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.431 ' O ' ' HB3' ' A' ' 97' ' ' LYS . 8.8 ttmm -60.17 -40.66 90.71 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.236 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.453 ' O ' ' HG3' ' A' ' 97' ' ' LYS . 9.4 t0 -73.71 -43.06 60.27 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.984 -179.227 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.57 ' CE2' HD12 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -76.82 -39.59 50.8 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.087 -179.207 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.449 ' HG2' ' O ' ' A' ' 92' ' ' ILE . 6.2 ptt? -67.72 -32.13 72.55 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.929 -0.308 . . . . 0.0 110.69 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.471 ' HG3' ' N ' ' A' ' 98' ' ' SER . 0.0 OUTLIER -70.43 -33.66 71.59 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.517 179.88 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.471 ' N ' ' HG3' ' A' ' 97' ' ' LYS . 1.5 m -62.65 -40.76 98.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.037 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.69 ' CG1' HD11 ' A' ' 8' ' ' ILE . 7.4 mt -79.86 -41.5 21.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.281 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.7 tttt -56.21 -57.15 13.42 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.442 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -59.6 -42.84 97.96 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.24 179.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.59 -36.37 83.54 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.885 0.374 . . . . 0.0 110.45 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.841 HD21 ' CB ' ' A' ' 110' ' ' ARG . 3.9 tp -72.6 -32.43 65.97 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.056 0.455 . . . . 0.0 109.9 179.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.611 ' CG ' HG11 ' A' ' 111' ' ' VAL . 69.1 mt-10 -60.62 -31.57 70.74 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.674 179.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -87.89 -21.58 24.89 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.654 -179.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -105.55 -62.42 1.36 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.78 0.324 . . . . 0.0 111.456 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.449 ' N ' ' O ' ' A' ' 103' ' ' LEU . 0.5 OUTLIER -128.54 63.56 65.04 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.96 -179.761 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.927 ' O ' HG22 ' A' ' 111' ' ' VAL . 10.3 Cg_endo -50.97 -22.66 10.67 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 123.114 2.543 . . . . 0.0 112.73 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -68.43 -12.24 60.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.606 0.241 . . . . 0.0 111.335 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.841 ' CB ' HD21 ' A' ' 103' ' ' LEU . 0.4 OUTLIER -108.03 -1.21 20.72 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -179.562 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.927 HG22 ' O ' ' A' ' 108' ' ' PRO . 22.4 m -72.71 -32.33 40.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -179.262 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.554 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 11.9 mtpt -68.99 -50.09 23.0 Favored Pre-proline 0 C--N 1.331 -0.205 0 C-N-CA 120.941 -0.304 . . . . 0.0 111.529 -179.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.554 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 24.2 Cg_exo -63.56 -29.6 70.53 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.138 1.892 . . . . 0.0 111.578 179.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.499 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 54.2 t80 -72.24 -42.31 65.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.016 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -55.48 -47.3 76.36 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.013 0.435 . . . . 0.0 110.757 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 60.1 m -76.08 -44.33 39.39 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.888 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.35 -46.81 93.1 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.774 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.4 ' O ' ' HB ' ' A' ' 122' ' ' ILE . . . -57.07 -51.82 67.77 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.028 0.442 . . . . 0.0 111.223 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.22 -28.22 67.89 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.39 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -77.72 -43.25 31.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.255 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.492 ' NE2' ' HB2' ' A' ' 24' ' ' ALA . 3.1 tp-100 -73.17 -37.83 66.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.048 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.84 HD11 ' CD2' ' A' ' 88' ' ' TYR . 0.3 OUTLIER -66.13 -46.39 87.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.299 -179.888 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.457 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 17.5 pttt -60.64 -31.88 71.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.181 179.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -66.9 -54.05 26.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.774 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.562 HG21 HD13 ' A' ' 148' ' ' LEU . 13.6 pt -61.75 -40.77 88.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.155 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.42 ' HA ' HD23 ' A' ' 126' ' ' LEU . 11.7 mt -53.85 -36.43 62.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.828 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -67.4 -13.96 62.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.191 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -141.44 36.28 1.67 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.935 0.397 . . . . 0.0 110.464 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.517 ' CE1' ' CZ ' ' A' ' 134' ' ' PHE . 4.0 t80 -49.66 -29.55 7.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.17 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 5.8 mtmp? -64.98 -21.32 66.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.192 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 32.5 m-20 -94.07 -38.02 11.33 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.287 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.409 ' CD2' ' OD1' ' A' ' 150' ' ' ASP . 4.1 m-85 -99.02 140.77 32.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.15 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.4 mm100 -118.48 145.91 44.91 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.981 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.517 ' CZ ' ' CE1' ' A' ' 129' ' ' PHE . 2.5 m-85 -82.71 122.43 28.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.945 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.43 ' CE2' ' HB2' ' A' ' 80' ' ' GLU . 28.6 m-85 -124.19 146.38 48.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.628 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.837 HD11 HG21 ' A' ' 81' ' ' THR . 0.8 OUTLIER -134.28 162.85 38.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.972 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -62.64 -164.38 0.43 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.191 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.409 ' HB3' ' HB2' ' A' ' 77' ' ' HIS . 7.5 pt-20 -72.48 -8.94 57.69 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.533 0.206 . . . . 0.0 111.476 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 19.4 m-80 -95.81 -31.49 13.14 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.647 0.26 . . . . 0.0 111.523 -179.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.454 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 32.7 mtm 56.93 41.41 27.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.885 0.374 . . . . 0.0 111.02 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . 0.404 ' ND2' ' HA3' ' A' ' 144' ' ' GLY . 15.7 p-10 -66.93 116.03 31.22 Favored Pre-proline 0 N--CA 1.451 -0.42 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.8 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 141' ' ' ASN . 24.2 Cg_exo -61.7 -27.84 81.55 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.52 2.147 . . . . 0.0 112.155 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -84.52 -4.85 59.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.018 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.404 ' HA3' ' ND2' ' A' ' 141' ' ' ASN . . . -90.1 -175.54 45.17 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.385 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -77.19 177.77 7.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.877 0.37 . . . . 0.0 110.855 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.537 HG21 ' HE2' ' A' ' 91' ' ' TYR . 47.4 t -124.34 152.5 30.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.166 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.764 ' HB1' ' HE2' ' A' ' 160' ' ' MET . . . -116.11 117.42 30.03 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.569 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.562 HD13 HG21 ' A' ' 125' ' ' ILE . 3.5 mt -91.51 108.22 19.75 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.244 -179.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.461 HD12 ' HG2' ' A' ' 160' ' ' MET . 1.3 tp -92.51 119.46 32.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.35 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.474 ' HB2' ' CZ ' ' A' ' 159' ' ' TYR . 1.0 OUTLIER -129.66 163.6 25.74 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.475 179.332 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -102.91 145.78 29.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.909 0.385 . . . . 0.0 111.052 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.17 -177.01 0.11 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.908 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -57.87 -41.31 82.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.901 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -71.51 -15.08 62.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.171 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 77.36 18.32 78.18 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.738 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 83.7 t -113.41 -73.63 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.794 0.33 . . . . 0.0 110.911 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 83.9 m -53.67 103.13 0.35 Allowed Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.235 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.798 ' HG2' HG22 ' A' ' 70' ' ' VAL . 6.0 Cg_exo -78.81 130.36 9.58 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.76 2.306 . . . . 0.0 111.952 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.474 ' CZ ' ' HB2' ' A' ' 150' ' ' ASP . 11.0 p90 -120.75 137.49 54.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.85 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' MET . . . . . 0.764 ' HE2' ' HB1' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -103.85 134.58 46.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.374 -179.373 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.558 ' HB ' ' HB2' ' A' ' 148' ' ' LEU . 51.0 mt -93.2 123.8 45.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.869 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.53 ' CE1' ' HB2' ' A' ' 147' ' ' ALA . 71.2 m-85 -129.51 126.73 39.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.182 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.431 ' CE2' ' OH ' ' A' ' 95' ' ' TYR . 4.1 m-30 -72.66 123.8 24.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.577 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.625 ' HG3' HD11 ' A' ' 29' ' ' LEU . 3.0 ttmm -60.56 -56.39 21.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.523 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.499 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 2.4 m-20 -48.63 -36.17 15.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.851 0.358 . . . . 0.0 111.286 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -94.25 28.6 10.42 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.412 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.464 HD11 ' HB3' ' A' ' 4' ' ' TYR . 1.0 OUTLIER -150.01 142.89 24.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.73 0.3 . . . . 0.0 110.837 -179.858 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.02 155.74 21.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.799 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.723 ' HB3' HD11 ' A' ' 2' ' ' ILE . 0.1 OUTLIER -121.32 145.52 47.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.931 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -157.03 131.47 8.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.881 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 2' ' ' ILE . 12.5 mttm -80.1 111.78 16.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.973 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.69 -177.05 4.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.82 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 1.5 tt 59.48 72.04 0.55 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.904 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.175 -0.917 . . . . 0.0 110.924 179.989 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.846 0.355 . . . . 0.0 111.192 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.723 HD11 ' HB3' ' A' ' 169' ' ' MET . 2.1 tt -110.11 147.82 14.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.983 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.467 HG21 ' HB3' ' A' ' 12' ' ' GLU . 16.4 mm -104.79 156.82 5.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.276 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.605 ' HE1' HG23 ' A' ' 2' ' ' ILE . 4.9 m-85 -125.75 99.14 5.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.611 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 27.1 ptt180 -113.34 147.32 37.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.136 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.542 ' OD1' HD12 ' A' ' 8' ' ' ILE . 47.3 t0 -56.95 152.16 13.43 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.8 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 61.1 tp -81.39 -20.27 40.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.377 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.542 HD12 ' OD1' ' A' ' 6' ' ' ASP . 4.0 mp -91.34 -47.31 14.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -179.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.47 -20.5 19.0 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.44 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 36.6 m80 63.96 28.93 14.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.9 0.381 . . . . 0.0 110.749 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -102.0 122.57 44.33 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.793 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.467 ' HB3' HG21 ' A' ' 3' ' ' ILE . 5.5 pm0 -57.96 92.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.251 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 9.7 mtt -72.84 -16.88 61.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.918 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.496 ' CE2' ' CD2' ' A' ' 4' ' ' TYR . 19.1 p90 -177.44 174.16 1.61 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.708 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -133.36 -172.3 2.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.863 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -92.52 17.88 9.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.099 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 46.7 pt -79.12 -15.11 13.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.967 0.413 . . . . 0.0 110.649 179.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.939 ' CE2' HG22 ' A' ' 72' ' ' ILE . 70.7 m-85 -108.07 -174.52 2.54 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.529 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.406 ' HB2' ' HB2' ' A' ' 32' ' ' GLU . 4.9 mttp -96.16 93.37 6.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.879 0.371 . . . . 0.0 110.581 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.568 HD12 ' N ' ' A' ' 20' ' ' ILE . 4.1 mp -87.81 134.62 27.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.178 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.58 122.87 37.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.838 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -77.82 116.45 18.35 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.876 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.634 HD11 HG23 ' A' ' 161' ' ' ILE . 1.4 pt -109.72 168.97 3.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.072 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.579 ' HB2' ' NE2' ' A' ' 121' ' ' GLN . . . 59.59 31.08 20.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.952 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 65.61 47.39 2.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.179 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.13 -8.23 68.06 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.809 -0.71 . . . . 0.0 113.38 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.441 ' HB3' ' HB3' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -60.94 -39.01 87.86 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.904 0.352 . . . . 0.0 111.239 -179.838 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 28.2 m -135.47 162.53 32.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.162 -179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.772 HD11 ' HG3' ' A' ' 164' ' ' LYS . 0.5 OUTLIER -126.18 132.86 51.71 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.74 179.886 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.429 ' HG3' HG12 ' A' ' 23' ' ' ILE . 18.9 mt-10 -102.19 116.24 32.23 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.257 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.4 t -90.25 112.13 24.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.706 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.406 ' HB2' ' HB2' ' A' ' 19' ' ' LYS . 18.1 mt-10 -83.55 115.16 21.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.147 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.57 -143.64 11.91 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.114 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.4 126.84 0.33 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.929 0.395 . . . . 0.0 110.955 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 42.3 mtp -70.83 115.01 9.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.626 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.491 HG23 ' CE ' ' A' ' 74' ' ' MET . 4.8 m -106.68 122.41 60.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.402 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 68.5 m -89.66 165.49 14.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.791 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.573 ' HB3' HG12 ' A' ' 67' ' ' ILE . 8.4 ttt85 -139.61 134.61 32.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.692 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.474 HG23 ' CG2' ' A' ' 62' ' ' THR . 6.3 m 59.34 25.24 13.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.859 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.83 134.28 33.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.89 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.15 28.54 33.61 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.446 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -139.27 93.91 2.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.818 0.342 . . . . 0.0 110.975 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 11.8 tt -100.26 130.72 49.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.118 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -142.62 -176.92 5.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.97 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.429 ' HB2' HD11 ' A' ' 48' ' ' ILE . 76.7 m-20 -60.64 146.72 44.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.945 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 63.0 m -101.34 -60.77 1.47 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.826 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.407 HD13 ' HA ' ' A' ' 47' ' ' LEU . 2.8 mm? -59.54 -72.59 0.1 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.157 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.429 HD11 ' HB2' ' A' ' 45' ' ' ASP . 80.1 mt 58.15 106.91 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.093 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -127.19 -80.17 0.31 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.465 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -172.18 131.89 2.26 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.461 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 14.1 p30 -169.24 177.25 4.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.825 0.345 . . . . 0.0 110.876 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.74 90.89 0.6 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.08 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.1 p -93.71 -36.82 12.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.89 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 60.0 31.49 20.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.094 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -148.08 133.07 18.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.926 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -103.92 104.12 2.41 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.401 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -67.86 119.5 6.51 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.402 2.068 . . . . 0.0 112.337 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -94.02 -34.45 13.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.917 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -105.97 -119.11 4.5 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.513 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 60.8 174.45 0.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.857 0.36 . . . . 0.0 110.857 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 164.14 -29.7 0.23 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.41 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.474 ' CG2' HG23 ' A' ' 39' ' ' THR . 2.5 m -65.87 132.34 48.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.866 0.365 . . . . 0.0 110.842 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -105.06 -75.3 0.63 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.907 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.1 t -177.32 38.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.945 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.46 HG23 ' O ' ' A' ' 65' ' ' THR . 10.5 t -106.75 117.79 34.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.987 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.764 ' C ' HD13 ' A' ' 67' ' ' ILE . 28.6 t -116.76 133.36 63.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.972 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.764 HD13 ' C ' ' A' ' 66' ' ' VAL . 0.0 OUTLIER -135.14 131.34 52.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.148 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 85.6 m -139.41 140.72 37.47 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.025 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 174.89 172.97 40.34 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.435 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.703 HG22 ' HG3' ' A' ' 158' ' ' PRO . 60.8 t -68.52 135.89 27.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.916 0.389 . . . . 0.0 110.775 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -59.23 -57.55 12.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.653 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.939 HG22 ' CE2' ' A' ' 18' ' ' TYR . 5.3 pt -53.95 -33.82 24.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.497 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.805 HG13 ' HB2' ' A' ' 78' ' ' LEU . 92.3 t -75.0 -30.87 24.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.071 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.491 ' CE ' HG23 ' A' ' 36' ' ' VAL . 1.8 mtm -78.16 -41.51 34.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.902 -179.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.428 ' OD1' ' CD2' ' A' ' 76' ' ' HIS . 15.0 p30 -82.11 -30.35 31.22 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -179.057 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.432 ' CE1' ' HA ' ' A' ' 14' ' ' PHE . 36.3 m80 -91.87 -0.13 57.5 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.856 0.36 . . . . 0.0 110.923 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 9.8 m80 55.8 34.94 24.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.256 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.805 ' HB2' HG13 ' A' ' 73' ' ' VAL . 46.5 mt -58.59 147.32 32.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.553 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -131.82 139.0 48.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.893 0.377 . . . . 0.0 111.148 -179.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.428 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 4.7 tt0 -92.68 131.89 37.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.001 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.494 HG21 HD11 ' A' ' 136' ' ' ILE . 7.8 t -122.33 151.81 40.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.768 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 62.3 m -90.47 159.01 16.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.084 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.537 ' CE2' ' HB1' ' A' ' 87' ' ' ALA . 0.2 OUTLIER -170.02 137.83 1.64 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.76 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -85.39 173.79 10.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.938 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.2 mttp -66.92 -52.31 44.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.949 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -58.46 -46.1 87.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.893 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.537 ' HB1' ' CE2' ' A' ' 83' ' ' PHE . . . -58.67 -40.75 84.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.038 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.859 ' CD2' HD11 ' A' ' 122' ' ' ILE . 0.1 OUTLIER -59.05 -36.93 75.85 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.843 179.851 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -57.39 -48.52 78.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.159 0.504 . . . . 0.0 110.354 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.8 mmtt -76.47 -27.89 56.31 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.441 178.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.583 ' HE2' HG21 ' A' ' 146' ' ' VAL . 4.6 t80 -64.99 -46.57 80.87 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.615 179.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.626 HD12 ' CE2' ' A' ' 95' ' ' TYR . 4.5 tp -61.43 -46.52 96.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.849 0.357 . . . . 0.0 110.75 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.414 ' O ' ' HB3' ' A' ' 97' ' ' LYS . 18.9 ttpp -59.25 -38.62 80.51 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.952 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.433 ' HA ' ' HG2' ' A' ' 97' ' ' LYS . 31.5 t70 -73.89 -44.98 53.56 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.054 -179.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.626 ' CE2' HD12 ' A' ' 92' ' ' ILE . 0.1 OUTLIER -76.18 -38.48 56.56 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.292 -179.236 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.42 ' HG2' ' O ' ' A' ' 92' ' ' ILE . 4.0 ptt? -67.39 -32.15 72.85 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.471 179.471 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.504 ' HG3' ' N ' ' A' ' 98' ' ' SER . 0.0 OUTLIER -70.48 -33.45 71.26 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.912 0.387 . . . . 0.0 110.482 179.681 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.504 ' N ' ' HG3' ' A' ' 97' ' ' LYS . 1.7 m -64.17 -40.51 96.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.227 179.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.523 HG23 ' HA2' ' A' ' 166' ' ' GLY . 7.9 mt -79.72 -40.4 21.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.298 179.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -56.1 -54.38 45.73 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.411 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -60.81 -45.74 95.88 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.923 179.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.69 -40.73 96.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.926 0.393 . . . . 0.0 110.207 179.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.607 HD21 ' CB ' ' A' ' 110' ' ' ARG . 3.4 tp -66.5 -36.59 83.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.029 179.224 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.619 ' CG ' HG11 ' A' ' 111' ' ' VAL . 63.2 mt-10 -58.39 -29.12 65.8 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.768 179.447 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -87.01 -20.71 26.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.503 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -106.52 -61.33 1.54 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.727 0.298 . . . . 0.0 111.633 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.439 ' N ' ' O ' ' A' ' 103' ' ' LEU . 91.7 mtm-85 -131.64 65.58 76.22 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.859 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.888 ' O ' HG22 ' A' ' 111' ' ' VAL . 9.4 Cg_endo -50.5 -23.45 10.66 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 123.105 2.537 . . . . 0.0 112.617 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -70.87 -12.06 61.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.68 0.276 . . . . 0.0 111.038 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.607 ' CB ' HD21 ' A' ' 103' ' ' LEU . 6.0 mmm180 -106.66 0.57 24.45 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.764 -179.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.888 HG22 ' O ' ' A' ' 108' ' ' PRO . 22.8 m -73.09 -33.29 41.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.547 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 12.7 mtmm -66.48 -50.02 49.4 Favored Pre-proline 0 C--N 1.332 -0.181 0 C-N-CA 121.022 -0.271 . . . . 0.0 111.583 -179.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.547 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 27.1 Cg_exo -62.18 -34.8 77.92 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.254 1.969 . . . . 0.0 111.702 179.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -68.31 -38.03 81.21 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.833 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -59.88 -47.17 86.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.021 0.439 . . . . 0.0 110.823 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 63.6 m -76.29 -44.65 36.07 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.69 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.63 -41.01 99.22 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.512 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.0 -47.2 86.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.058 0.456 . . . . 0.0 111.042 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.492 ' HB1' ' CE ' ' A' ' 123' ' ' LYS . . . -70.45 -29.87 66.55 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.188 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -73.65 -52.94 11.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.98 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.579 ' NE2' ' HB2' ' A' ' 24' ' ' ALA . 3.3 tp-100 -60.74 -45.63 93.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.932 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.859 HD11 ' CD2' ' A' ' 88' ' ' TYR . 0.3 OUTLIER -59.93 -45.4 95.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.936 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.492 ' CE ' ' HB1' ' A' ' 119' ' ' ALA . 15.1 mttm -60.49 -30.75 69.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.196 179.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -68.88 -54.46 15.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.669 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.746 HG21 HD13 ' A' ' 148' ' ' LEU . 11.6 pt -60.68 -40.5 84.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.064 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 11.5 mt -53.95 -38.59 65.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.704 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -68.52 -12.91 61.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.248 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -137.15 33.64 2.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.087 0.47 . . . . 0.0 110.503 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -49.71 -28.49 6.13 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.241 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 5.6 tttp -72.24 -20.32 61.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.341 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -94.1 -35.28 12.62 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.322 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -100.72 146.3 27.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.947 0.403 . . . . 0.0 111.283 -179.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.4 mm100 -125.38 146.22 49.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.787 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.519 ' CE1' ' CZ ' ' A' ' 88' ' ' TYR . 3.2 m-85 -81.5 129.18 34.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.958 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.449 ' O ' ' HB3' ' A' ' 147' ' ' ALA . 30.6 m-85 -133.93 136.37 44.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.678 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.494 HD11 HG21 ' A' ' 81' ' ' THR . 1.2 mt -124.65 164.92 22.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.044 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.97 -160.07 0.73 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.165 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -74.48 -8.79 57.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.467 0.175 . . . . 0.0 111.45 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -95.33 -33.31 12.58 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 111.657 0.243 . . . . 0.0 111.657 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.424 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 73.9 mtm 60.11 34.93 21.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.817 0.342 . . . . 0.0 110.841 -179.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . 0.46 ' ND2' ' HA3' ' A' ' 144' ' ' GLY . 6.4 p-10 -65.94 114.82 18.05 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.043 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -67.12 -24.89 44.17 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.669 2.246 . . . . 0.0 112.386 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -84.44 -6.5 59.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.187 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.46 ' HA3' ' ND2' ' A' ' 141' ' ' ASN . . . -85.85 -124.56 1.53 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.461 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.512 ' HE2' ' HB2' ' A' ' 163' ' ' PHE . 6.9 ptp -126.57 -177.49 4.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.81 0.338 . . . . 0.0 110.76 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.583 HG21 ' HE2' ' A' ' 91' ' ' TYR . 48.3 t -129.23 149.74 33.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.208 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.524 ' HB2' ' CE2' ' A' ' 162' ' ' PHE . . . -113.41 112.17 23.19 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.463 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.746 HD13 HG21 ' A' ' 125' ' ' ILE . 4.4 mt -86.63 106.05 17.32 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.982 -179.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.419 ' HB2' ' HE2' ' A' ' 160' ' ' MET . 1.5 tp -90.82 120.0 31.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.161 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.481 ' HB3' ' CZ ' ' A' ' 159' ' ' TYR . 29.5 t70 -133.94 165.37 25.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.429 179.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -107.99 147.27 31.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.817 0.341 . . . . 0.0 111.088 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.88 -168.7 0.1 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.863 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.87 -41.26 95.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.963 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -72.98 -15.13 61.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.311 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 65.7 28.64 73.82 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.487 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 73.6 t -112.4 -55.94 4.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.73 0.3 . . . . 0.0 111.177 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 54.5 m -85.78 111.65 39.17 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.4 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.703 ' HG3' HG22 ' A' ' 70' ' ' VAL . 88.2 Cg_endo -80.5 135.9 10.77 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.526 2.151 . . . . 0.0 111.728 179.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.481 ' CZ ' ' HB3' ' A' ' 150' ' ' ASP . 5.8 p90 -126.02 135.57 51.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.976 0.417 . . . . 0.0 111.085 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' MET . . . . . 0.448 ' CE ' HD13 ' A' ' 78' ' ' LEU . 0.8 OUTLIER -104.96 131.62 52.24 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.059 -179.741 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.634 HG23 HD11 ' A' ' 23' ' ' ILE . 67.2 mt -92.09 118.5 37.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.289 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.524 ' CE2' ' HB2' ' A' ' 147' ' ' ALA . 78.6 m-85 -117.05 163.42 16.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.703 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.512 ' HB2' ' HE2' ' A' ' 145' ' ' MET . 22.6 m-85 -100.44 122.77 43.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.905 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.772 ' HG3' HD11 ' A' ' 29' ' ' LEU . 12.4 tttt -70.06 -51.92 28.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.069 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -51.52 -29.17 15.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.162 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.523 ' HA2' HG23 ' A' ' 99' ' ' ILE . . . -105.35 24.29 27.99 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.375 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.557 HD21 ' HB3' ' A' ' 4' ' ' TYR . 0.5 OUTLIER -138.25 146.82 43.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.849 0.357 . . . . 0.0 110.812 -179.903 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -117.56 151.2 37.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.02 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.723 ' HB3' HD11 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -111.42 154.21 24.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.923 179.972 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -158.58 123.4 4.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.959 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.61 ' CG ' HD12 ' A' ' 2' ' ' ILE . 14.7 mtmm -89.88 119.05 29.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.96 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 32.8 m -111.25 150.72 29.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.933 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.88 142.43 57.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.829 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.278 -0.868 . . . . 0.0 110.855 179.911 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.5 ttt . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.844 0.354 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.616 HG22 ' HB2' ' A' ' 16' ' ' ASP . 0.8 OUTLIER -111.33 143.35 21.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.037 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.527 ' O ' ' HA ' ' A' ' 169' ' ' MET . 4.3 mm -105.69 120.47 56.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.312 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.597 ' CE1' HG23 ' A' ' 2' ' ' ILE . 25.3 m-85 -91.45 125.21 36.12 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.801 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -137.23 143.66 42.39 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.215 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -55.05 144.8 22.39 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.976 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 55.3 tp -73.58 -22.17 60.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.453 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.465 HD11 ' CG1' ' A' ' 99' ' ' ILE . 4.6 mp -91.24 -43.97 14.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.687 0.28 . . . . 0.0 111.72 -179.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.422 ' HB2' ' ND2' ' A' ' 141' ' ' ASN . 1.9 t -92.62 -27.52 17.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.378 -179.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 64.3 m-70 64.53 26.63 13.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.797 0.332 . . . . 0.0 110.773 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -103.15 129.7 50.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.718 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.422 ' HB3' ' CG2' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -57.84 95.9 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.346 -179.673 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 41.8 mtp -78.16 -16.86 57.53 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.7 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.497 ' CE2' ' CG ' ' A' ' 4' ' ' TYR . 37.8 p90 179.98 165.13 1.2 Allowed 'General case' 0 C--O 1.231 0.108 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.806 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.23 -169.93 1.98 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.563 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.616 ' HB2' HG22 ' A' ' 2' ' ' ILE . 39.4 t0 -95.67 33.78 1.59 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.02 0.438 . . . . 0.0 110.929 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.435 HG13 ' CD2' ' A' ' 18' ' ' TYR . 40.3 pt -93.33 -10.77 9.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.618 179.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.969 ' CZ ' HG22 ' A' ' 72' ' ' ILE . 51.8 m-85 -110.45 -169.32 1.44 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.686 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.0 mmtt -96.88 88.25 4.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.813 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.0 mp -87.99 124.03 40.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.982 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.0 mtt180 -119.47 126.27 50.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.163 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.799 ' HG3' HD23 ' A' ' 29' ' ' LEU . 1.0 OUTLIER -76.25 116.67 17.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.807 179.989 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.51 HD11 HG23 ' A' ' 161' ' ' ILE . 6.0 pt -114.15 170.93 4.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.204 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 56.12 28.48 13.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.286 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 63.43 41.35 7.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.218 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.1 -11.27 70.92 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.581 -0.819 . . . . 0.0 113.172 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.14 -33.87 74.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.916 0.358 . . . . 0.0 111.037 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.5 m -145.53 163.54 34.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.9 0.381 . . . . 0.0 111.158 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.799 HD23 ' HG3' ' A' ' 22' ' ' GLU . 0.4 OUTLIER -127.68 130.66 49.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.704 179.876 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -97.19 112.86 24.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.153 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' ' 159' ' ' TYR . 22.1 t -98.8 111.84 29.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.633 179.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -83.56 115.78 22.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.336 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -99.8 -137.91 10.04 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.247 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.4 ptpt -174.45 126.38 0.32 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.845 0.355 . . . . 0.0 110.959 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 23.7 mtm -72.45 121.98 20.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.758 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.446 HG23 ' CE ' ' A' ' 74' ' ' MET . 5.7 m -112.84 125.98 70.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.391 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.1 m -89.45 165.64 14.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.858 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.528 ' HB3' HG12 ' A' ' 67' ' ' ILE . 6.8 ttt180 -133.38 115.97 15.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.753 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 39' ' ' THR . 4.1 t -130.17 83.41 2.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.917 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -67.34 178.38 1.56 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.912 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -160.34 164.42 34.44 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.481 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -157.12 163.88 38.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.8 0.333 . . . . 0.0 110.819 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 15.7 tt -123.39 148.41 27.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.068 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -118.2 174.77 6.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.933 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.429 ' HB2' HG23 ' A' ' 48' ' ' ILE . 0.7 OUTLIER -89.34 -179.57 5.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.895 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.4 m -77.89 -48.9 15.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.908 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.0 mp -95.87 -69.7 0.74 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.969 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.429 HG23 ' HB2' ' A' ' 45' ' ' ASP . 18.9 tt -63.43 138.13 23.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.115 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -102.03 48.53 1.07 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.477 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.05 176.42 24.48 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.504 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -160.74 98.09 1.21 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.797 0.332 . . . . 0.0 110.96 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -171.86 75.24 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.163 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -80.32 -65.12 1.05 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.855 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -142.96 156.76 44.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.069 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 59.94 30.97 20.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.877 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -105.72 -139.46 9.69 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.476 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -67.93 139.45 47.33 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.432 2.088 . . . . 0.0 112.298 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -77.73 118.0 19.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.965 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -179.98 114.58 0.44 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.512 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -105.87 142.01 36.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.767 0.318 . . . . 0.0 110.892 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 125.67 -154.17 18.54 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.517 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.37 178.97 7.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.776 0.322 . . . . 0.0 110.91 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -71.01 -64.42 0.91 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.914 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 92.7 p -122.67 128.1 50.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.884 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 58.4 m -135.54 140.51 44.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.857 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.695 ' C ' HD13 ' A' ' 67' ' ' ILE . 41.2 t -97.06 134.62 34.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.991 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.695 HD13 ' C ' ' A' ' 66' ' ' VAL . 0.0 OUTLIER -123.96 131.88 72.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.042 -179.937 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 85.6 m -139.26 141.1 37.83 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.109 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -177.58 175.59 47.65 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.207 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.578 HG12 HG12 ' A' ' 72' ' ' ILE . 44.3 t -69.09 135.92 27.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.833 0.349 . . . . 0.0 110.901 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -62.33 -56.94 13.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.639 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.969 HG22 ' CZ ' ' A' ' 18' ' ' TYR . 7.6 pt -53.54 -33.79 22.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.36 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.785 HG13 ' HB2' ' A' ' 78' ' ' LEU . 91.4 t -73.49 -33.49 39.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.915 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.446 ' CE ' HG23 ' A' ' 36' ' ' VAL . 2.4 mtm -78.23 -39.2 41.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.614 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 19.1 p30 -82.01 -29.42 32.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.581 -179.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.436 ' CE1' ' HB ' ' A' ' 72' ' ' ILE . 26.1 m170 -91.82 -4.52 54.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.842 0.353 . . . . 0.0 110.825 179.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.476 ' HB2' ' HB3' ' A' ' 138' ' ' GLU . 28.5 m80 60.73 39.57 17.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.95 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.785 ' HB2' HG13 ' A' ' 73' ' ' VAL . 38.1 mt -70.79 140.81 51.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.796 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -116.46 132.81 56.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.734 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.435 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 0.1 OUTLIER -91.7 120.86 32.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.94 0.4 . . . . 0.0 111.183 -179.94 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.454 HG21 HD11 ' A' ' 136' ' ' ILE . 9.2 t -108.82 170.01 8.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.792 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.3 p -114.91 170.45 8.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.889 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.48 ' HB2' ' CE2' ' A' ' 134' ' ' PHE . 4.0 m-85 -171.68 152.19 3.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.074 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.405 ' H ' ' HB3' ' A' ' 87' ' ' ALA . 0.2 OUTLIER -101.44 168.49 9.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.594 179.638 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.2 mttm -54.98 -51.94 64.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.125 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.63 -42.82 73.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.238 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.405 ' HB3' ' H ' ' A' ' 84' ' ' THR . . . -60.62 -44.83 95.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.858 0.361 . . . . 0.0 111.218 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.836 ' CD2' HD11 ' A' ' 122' ' ' ILE . 0.5 OUTLIER -59.83 -34.82 73.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.89 -179.974 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 15.8 mtmt -59.69 -42.22 92.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.067 0.46 . . . . 0.0 110.5 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.6 -29.87 46.31 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.093 178.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -68.07 -46.17 71.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.743 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.818 HG22 ' O ' ' A' ' 88' ' ' TYR . 2.1 tp -64.83 -42.17 94.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.98 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.457 ' O ' ' CG ' ' A' ' 97' ' ' LYS . 3.1 ttpt -62.0 -44.89 95.76 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.792 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -67.79 -40.18 83.95 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.955 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.54 ' CD1' ' C ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -76.5 -45.11 32.34 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 121.023 -0.271 . . . . 0.0 111.022 -179.162 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.501 ' HE3' ' HB2' ' A' ' 96' ' ' MET . 20.3 ptm -59.13 -32.01 69.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.889 0.375 . . . . 0.0 110.117 179.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.457 ' CG ' ' O ' ' A' ' 93' ' ' LYS . 3.7 mmpt? -70.72 -38.71 73.64 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.449 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.3 m -58.86 -40.08 83.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.332 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.465 ' CG1' HD11 ' A' ' 8' ' ' ILE . 10.2 mt -79.85 -42.56 22.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.416 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.49 -51.71 66.07 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.411 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -63.12 -47.16 90.69 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.044 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 4.0 tppt? -61.12 -39.89 91.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.872 0.367 . . . . 0.0 110.24 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.63 ' HB3' HG12 ' A' ' 111' ' ' VAL . 5.5 tp -66.97 -36.88 83.18 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.071 179.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.685 ' HG3' HG11 ' A' ' 111' ' ' VAL . 75.8 mt-10 -57.52 -29.44 64.33 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.658 179.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -86.7 -20.81 27.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.486 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -105.77 -61.17 1.53 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.841 0.353 . . . . 0.0 111.656 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.448 ' N ' ' O ' ' A' ' 103' ' ' LEU . 22.5 mtt85 -134.06 66.81 72.7 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.863 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.88 ' O ' HG22 ' A' ' 111' ' ' VAL . 9.6 Cg_endo -50.46 -21.68 7.8 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 123.254 2.636 . . . . 0.0 112.875 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -71.15 -9.86 58.79 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.583 0.23 . . . . 0.0 111.297 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.601 ' CB ' HD21 ' A' ' 103' ' ' LEU . 8.5 mmt180 -110.34 -0.39 17.65 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.706 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.88 HG22 ' O ' ' A' ' 108' ' ' PRO . 29.6 m -71.09 -33.93 53.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -179.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.57 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 8.3 mttt -68.27 -50.07 30.6 Favored Pre-proline 0 C--N 1.332 -0.191 0 C-N-CA 121.022 -0.271 . . . . 0.0 111.62 -179.148 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.57 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 31.6 Cg_exo -58.59 -37.76 92.85 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.188 1.925 . . . . 0.0 111.956 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.449 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 69.7 t80 -68.83 -36.9 78.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.937 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.04 -47.95 79.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.803 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 60.4 m -76.41 -44.28 36.67 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.737 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.16 -42.71 99.87 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.538 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.5 -51.59 69.21 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.044 0.449 . . . . 0.0 110.975 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.6 -28.06 67.44 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.183 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -75.87 -49.48 17.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.092 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 3.3 tp-100 -65.82 -39.73 91.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.156 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.836 HD11 ' CD2' ' A' ' 88' ' ' TYR . 0.3 OUTLIER -60.64 -45.54 97.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.984 -179.877 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.435 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 30.8 mttm -60.7 -29.45 69.34 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.317 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -69.25 -53.19 21.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.75 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.763 HG21 HD13 ' A' ' 148' ' ' LEU . 12.8 pt -63.0 -41.2 91.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.333 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 11.5 mt -54.79 -37.12 65.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.82 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -71.16 -10.54 59.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.34 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -140.31 33.35 1.89 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.928 0.395 . . . . 0.0 110.66 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.511 ' CE1' ' CZ ' ' A' ' 134' ' ' PHE . 1.5 t80 -51.35 -36.41 42.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.921 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.4 -26.07 66.39 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.977 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 32.0 m-20 -94.1 -43.84 8.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.201 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -91.8 135.52 33.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.227 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.47 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 1.8 mm100 -115.07 144.13 44.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.464 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.511 ' CZ ' ' CE1' ' A' ' 129' ' ' PHE . 0.1 OUTLIER -89.22 130.76 35.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.889 0.376 . . . . 0.0 111.099 -179.638 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.536 ' HB2' ' HB3' ' A' ' 147' ' ' ALA . 17.2 m-85 -123.72 166.29 15.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.681 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.454 HD11 HG21 ' A' ' 81' ' ' THR . 0.4 OUTLIER -149.23 157.57 6.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.574 179.737 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -57.42 -172.77 0.25 Allowed Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.406 -0.902 . . . . 0.0 111.676 179.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.476 ' HB3' ' HB2' ' A' ' 77' ' ' HIS . 1.1 pt-20 -70.08 -8.94 53.54 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.587 0.232 . . . . 0.0 111.292 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -94.93 -23.4 17.44 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.697 -0.229 . . . . 0.0 111.416 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.405 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 63.7 mtp 50.95 43.36 28.8 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.824 0.345 . . . . 0.0 111.302 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . 0.426 ' ND2' ' HA3' ' A' ' 144' ' ' GLY . 17.3 p-10 -64.64 117.13 35.01 Favored Pre-proline 0 N--CA 1.451 -0.391 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.816 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -59.35 -30.88 93.91 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.409 2.073 . . . . 0.0 112.26 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -84.61 -4.01 58.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.053 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.426 ' HA3' ' ND2' ' A' ' 141' ' ' ASN . . . -81.53 -153.63 11.0 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.407 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.507 ' HE3' ' O ' ' A' ' 166' ' ' GLY . 13.2 ptp -108.59 179.15 4.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.783 0.325 . . . . 0.0 110.815 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.426 ' CG1' ' HB3' ' A' ' 134' ' ' PHE . 0.0 OUTLIER -125.15 128.43 72.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.047 179.846 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.536 ' HB3' ' HB2' ' A' ' 135' ' ' PHE . . . -89.91 109.39 20.41 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.257 0.551 . . . . 0.0 110.422 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.763 HD13 HG21 ' A' ' 125' ' ' ILE . 4.7 mt -81.85 106.29 13.66 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.349 -179.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.561 HD12 ' HG2' ' A' ' 160' ' ' MET . 2.0 tp -91.12 118.63 30.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.158 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.453 ' HB3' ' CZ ' ' A' ' 159' ' ' TYR . 34.6 t70 -130.87 164.99 24.02 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.401 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -110.49 148.81 31.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.908 0.385 . . . . 0.0 110.995 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.487 ' HG3' HG22 ' A' ' 157' ' ' THR . 5.0 mmm180 -57.42 -177.94 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.071 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -61.19 -41.27 96.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.949 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -87.41 -15.09 38.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.209 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 68.44 44.97 70.95 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.584 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 78.5 t -107.29 -20.8 5.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.743 0.306 . . . . 0.0 111.004 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.487 HG22 ' HG3' ' A' ' 152' ' ' ARG . 1.4 t -140.89 122.34 9.18 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.985 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.442 ' HB2' HD11 ' A' ' 149' ' ' LEU . 84.4 Cg_endo -78.4 130.5 10.03 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.408 2.072 . . . . 0.0 112.09 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.453 ' CZ ' ' HB3' ' A' ' 150' ' ' ASP . 8.3 p90 -123.24 138.49 54.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.969 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' MET . . . . . 0.626 ' HG3' HD11 ' A' ' 72' ' ' ILE . 30.4 mtp -105.73 140.72 38.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.042 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.51 HG23 HD11 ' A' ' 23' ' ' ILE . 59.3 mt -97.92 111.19 27.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.016 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -107.13 154.38 21.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.957 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -96.78 118.3 32.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.822 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.475 ' HD3' HD11 ' A' ' 29' ' ' LEU . 19.8 tptt -64.83 -51.54 61.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.082 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.449 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 9.0 m-20 -54.72 -32.1 59.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.151 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.507 ' O ' ' HE3' ' A' ' 145' ' ' MET . . . -103.84 17.78 48.4 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.748 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.439 HD21 ' HB3' ' A' ' 4' ' ' TYR . 7.0 tt -141.85 144.33 33.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.779 0.323 . . . . 0.0 110.808 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -130.17 150.43 51.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.689 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.527 ' HA ' ' O ' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -140.11 160.1 40.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.125 179.986 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -151.35 152.83 33.68 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.93 0.395 . . . . 0.0 111.647 -179.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.5 ' HG2' ' HB ' ' A' ' 2' ' ' ILE . 30.2 mttp -95.91 115.01 26.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.728 179.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -115.59 162.48 17.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.05 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.51 HD22 ' N ' ' A' ' 173' ' ' LEU . 3.3 mm? 60.41 87.78 0.08 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.997 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.136 -0.935 . . . . 0.0 110.922 179.987 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.835 0.35 . . . . 0.0 111.09 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.683 HG23 ' CE1' ' A' ' 4' ' ' TYR . 0.9 OUTLIER -104.34 142.47 17.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.026 179.953 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.493 ' O ' ' HA ' ' A' ' 169' ' ' MET . 7.7 mm -105.31 118.89 53.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.372 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.683 ' CE1' HG23 ' A' ' 2' ' ' ILE . 20.5 m-85 -91.32 129.27 37.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.766 179.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -138.09 148.95 45.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.078 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.418 ' O ' ' HA ' ' A' ' 10' ' ' HIS . 22.7 t0 -55.26 150.86 10.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.844 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 66.6 tp -80.05 -25.07 40.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.295 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.684 HD11 ' CG1' ' A' ' 99' ' ' ILE . 4.0 mp -91.21 -43.17 14.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.755 -179.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.5 t -91.77 -26.81 18.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.597 -179.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.418 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 0.2 OUTLIER 63.97 28.42 14.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.874 0.369 . . . . 0.0 110.832 -179.774 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -104.79 130.21 52.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.719 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.19 104.69 0.22 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.226 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 17.9 mtt -88.62 -15.67 34.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.917 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.495 ' CE2' ' CG ' ' A' ' 4' ' ' TYR . 38.2 p90 179.63 159.84 0.76 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.719 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -122.15 -169.93 1.98 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.664 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.662 ' HB2' HG22 ' A' ' 2' ' ' ILE . 36.9 t70 -93.49 28.98 2.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.989 0.423 . . . . 0.0 110.967 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.434 HG13 ' CD2' ' A' ' 18' ' ' TYR . 36.1 pt -91.46 -9.04 10.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.826 179.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.876 ' CZ ' HG22 ' A' ' 72' ' ' ILE . 57.2 m-85 -115.83 -169.74 1.65 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.789 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.0 mttt -95.78 95.06 8.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.006 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.7 mp -91.72 124.02 44.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.939 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.69 137.15 53.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.991 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.81 ' HG3' HD23 ' A' ' 29' ' ' LEU . 1.2 mp0 -83.85 114.7 21.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.818 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.622 HD11 HG23 ' A' ' 161' ' ' ILE . 5.4 pt -111.12 166.35 5.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.237 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 57.35 30.11 17.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.314 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 64.43 40.55 6.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.198 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.55 -18.5 56.96 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.007 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.33 -34.85 49.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.808 0.337 . . . . 0.0 111.041 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 35.8 m -147.9 163.63 36.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.913 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.81 HD23 ' HG3' ' A' ' 22' ' ' GLU . 0.4 OUTLIER -129.62 132.86 46.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.954 -179.832 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 73.9 mt-10 -96.26 125.25 40.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.125 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 22.4 t -102.5 111.94 34.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.732 179.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -87.08 112.54 22.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.135 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -94.17 -132.65 6.62 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.355 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.3 ptpt -174.43 123.4 0.29 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.776 0.322 . . . . 0.0 110.836 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 41.1 mtp -68.44 123.41 20.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.931 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.4 m -117.08 144.73 24.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.147 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.9 p -109.56 165.61 11.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.009 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.536 ' CB ' HG12 ' A' ' 67' ' ' ILE . 2.4 mmt180 -126.54 115.88 20.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.595 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -117.43 27.02 9.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.941 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 62.47 -80.42 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.023 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 119.72 136.63 5.3 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.391 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.0 m120 60.73 101.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.817 0.341 . . . . 0.0 110.874 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 4.3 mt -60.99 -30.79 48.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.092 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -68.81 -47.45 66.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.888 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.3 t70 60.95 59.1 2.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.875 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -105.96 -62.31 1.39 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.919 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.6 mt -59.84 -27.7 66.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.01 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -108.97 86.25 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.016 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 101.64 106.51 2.95 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.453 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -130.11 152.33 19.68 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.505 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 69.65 -65.21 0.31 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.816 0.341 . . . . 0.0 110.977 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.51 137.15 53.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.262 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.4 t 61.29 158.42 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.93 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -156.41 -65.91 0.11 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.166 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -132.29 170.47 15.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.993 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.5 159.59 29.68 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.465 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.48 178.9 4.52 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.56 2.173 . . . . 0.0 112.308 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 60.18 30.63 20.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.908 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.92 -92.23 1.62 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.41 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -82.83 150.26 26.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.841 0.353 . . . . 0.0 110.83 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 176.19 121.59 0.67 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.472 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.9 t -108.33 -26.77 10.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.694 0.283 . . . . 0.0 110.935 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 63.37 138.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.879 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.03 78.83 1.84 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.071 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 22.0 m -77.29 67.8 3.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.822 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 46.2 t -103.66 136.32 37.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.263 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.536 HG12 ' CB ' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -140.05 131.26 31.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.691 179.603 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 16.5 m -139.1 131.52 28.56 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.123 0.487 . . . . 0.0 111.253 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -170.34 -164.87 26.78 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.012 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.488 HG12 HG12 ' A' ' 72' ' ' ILE . 46.4 t -78.77 142.45 14.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.829 0.347 . . . . 0.0 110.927 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -69.99 -56.89 5.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.494 -179.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.876 HG22 ' CZ ' ' A' ' 18' ' ' TYR . 11.1 pt -53.63 -33.89 23.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.434 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.807 HG13 ' HB2' ' A' ' 78' ' ' LEU . 84.5 t -70.86 -31.43 45.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.783 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.3 mtt -78.26 -41.03 35.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.521 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.401 ' OD1' ' CD2' ' A' ' 76' ' ' HIS . 13.0 p30 -82.13 -28.51 32.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.528 -179.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.441 ' CE1' ' HA ' ' A' ' 14' ' ' PHE . 28.4 m170 -93.17 0.11 57.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.852 0.358 . . . . 0.0 110.838 179.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.487 ' HB2' ' HB3' ' A' ' 138' ' ' GLU . 13.2 m-70 56.22 27.96 12.47 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.121 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.807 ' HB2' HG13 ' A' ' 73' ' ' VAL . 43.6 mt -56.79 140.48 47.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.703 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -124.93 135.84 53.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.946 0.403 . . . . 0.0 111.279 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.421 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 0.0 OUTLIER -94.36 117.71 30.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.855 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.758 HG21 HD11 ' A' ' 136' ' ' ILE . 8.3 t -109.68 140.86 43.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.927 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 59.1 m -77.46 159.23 29.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.909 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.472 ' CE2' ' HB1' ' A' ' 87' ' ' ALA . 0.2 OUTLIER -164.23 156.13 16.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.887 -179.974 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.78 172.87 7.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.911 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.3 mttm -69.48 -52.38 27.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.893 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -62.04 -41.98 98.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.71 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.472 ' HB1' ' CE2' ' A' ' 83' ' ' PHE . . . -59.47 -42.87 93.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.076 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.893 ' CD2' HD11 ' A' ' 122' ' ' ILE . 0.1 OUTLIER -58.27 -34.49 70.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.917 -179.928 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 45.3 mttt -60.31 -48.11 83.14 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.052 0.453 . . . . 0.0 110.451 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.1 mtmt -76.69 -27.85 55.68 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.698 178.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.546 ' HE2' HG21 ' A' ' 146' ' ' VAL . 8.2 t80 -65.18 -47.49 76.78 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.777 179.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.443 ' CD1' ' CE2' ' A' ' 95' ' ' TYR . 4.7 tp -62.58 -44.2 99.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.039 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.406 ' N ' HG23 ' A' ' 92' ' ' ILE . 4.5 tttp -60.52 -40.08 90.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.139 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.492 ' HA ' ' HG2' ' A' ' 97' ' ' LYS . 26.0 t0 -75.22 -40.07 59.48 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.879 -179.257 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.465 ' CD1' ' C ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -77.95 -40.43 39.47 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 121.053 -0.259 . . . . 0.0 110.944 -179.444 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.422 ' HG2' ' O ' ' A' ' 92' ' ' ILE . 2.4 ptt? -67.64 -32.04 72.46 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.763 0.316 . . . . 0.0 110.59 179.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.492 ' HG2' ' HA ' ' A' ' 94' ' ' ASP . 1.6 ptmm? -70.47 -34.57 72.55 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.524 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.433 ' N ' ' HG3' ' A' ' 97' ' ' LYS . 2.3 m -61.09 -40.24 92.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.046 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.684 ' CG1' HD11 ' A' ' 8' ' ' ILE . 6.9 mt -79.78 -41.07 21.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.433 179.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 5.1 tttp -55.3 -53.73 52.5 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.441 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -60.56 -46.35 94.57 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.017 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 6.4 tptt -62.62 -37.1 84.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.959 0.409 . . . . 0.0 110.336 179.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.633 HD21 ' CB ' ' A' ' 110' ' ' ARG . 3.1 tp -70.41 -33.96 71.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.059 179.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.626 ' CG ' HG11 ' A' ' 111' ' ' VAL . 77.3 mt-10 -58.85 -31.63 68.7 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.634 179.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.414 ' HG3' ' HG3' ' A' ' 106' ' ' GLN . 2.2 pt-20 -86.58 -21.09 27.05 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.738 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.414 ' HG3' ' HG3' ' A' ' 105' ' ' GLU . 21.0 mt-30 -105.13 -62.53 1.33 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.74 0.305 . . . . 0.0 111.559 -179.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.441 ' N ' ' O ' ' A' ' 103' ' ' LEU . 19.6 mtt-85 -129.74 64.77 73.08 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.879 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.867 ' O ' HG22 ' A' ' 111' ' ' VAL . 9.5 Cg_endo -50.52 -22.12 8.61 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 123.192 2.595 . . . . 0.0 112.745 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -70.75 -11.88 61.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.609 0.243 . . . . 0.0 111.323 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.633 ' CB ' HD21 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -110.88 -0.26 16.92 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.342 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.867 HG22 ' O ' ' A' ' 108' ' ' PRO . 34.1 m -66.38 -36.37 77.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -179.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.591 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 1.1 mttp -69.01 -51.2 19.03 Favored Pre-proline 0 C--N 1.332 -0.194 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.457 -179.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.591 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 50.1 Cg_exo -52.45 -41.39 67.71 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.04 1.827 . . . . 0.0 111.894 179.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.435 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 78.2 t80 -67.28 -39.22 86.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.967 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 1.4 mmm -56.98 -51.22 70.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.971 0.415 . . . . 0.0 110.858 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 62.3 m -76.53 -44.62 34.23 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.758 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.28 -45.93 95.2 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.551 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.07 -51.5 69.44 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.008 0.432 . . . . 0.0 111.068 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.38 -28.11 67.66 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.225 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.423 ' O ' ' HG2' ' A' ' 123' ' ' LYS . 45.4 tt0 -71.73 -46.9 57.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.181 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -72.97 -38.43 66.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.07 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.893 HD11 ' CD2' ' A' ' 88' ' ' TYR . 0.4 OUTLIER -61.54 -46.78 95.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.147 -179.853 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.462 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 3.6 pttp -62.2 -31.74 72.3 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.099 0.476 . . . . 0.0 110.142 179.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 3.9 t-160 -67.35 -53.3 30.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.703 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.535 HG21 HD13 ' A' ' 148' ' ' LEU . 15.5 pt -61.73 -42.28 93.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.341 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.475 HD23 ' HA ' ' A' ' 126' ' ' LEU . 11.5 mt -53.87 -36.08 62.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.912 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -72.86 -10.16 59.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.173 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -141.64 33.7 1.63 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.017 0.437 . . . . 0.0 110.462 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.5 ' CE1' ' CZ ' ' A' ' 134' ' ' PHE . 11.5 t80 -50.3 -26.41 4.78 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.237 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.2 mmtt -61.76 -27.47 68.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.769 0.319 . . . . 0.0 110.945 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 22.2 m-20 -94.27 -36.75 11.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.488 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.409 ' CG ' ' OD2' ' A' ' 150' ' ' ASP . 10.8 m-85 -98.13 138.75 34.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.918 0.39 . . . . 0.0 111.25 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -122.96 144.69 49.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.951 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.51 ' CE1' ' CZ ' ' A' ' 88' ' ' TYR . 1.3 m-85 -80.52 123.81 28.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.089 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.461 ' HB2' ' HB3' ' A' ' 147' ' ' ALA . 30.3 m-85 -125.57 151.06 46.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.713 179.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.758 HD11 HG21 ' A' ' 81' ' ' THR . 0.4 OUTLIER -139.38 159.54 28.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.927 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.41 -165.12 0.3 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.403 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.487 ' HB3' ' HB2' ' A' ' 77' ' ' HIS . 5.1 pt-20 -71.52 -9.84 58.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.517 0.199 . . . . 0.0 111.467 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 -96.2 -32.03 12.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.585 0.231 . . . . 0.0 111.594 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.452 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 58.2 mtm 56.54 41.34 28.76 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.825 0.345 . . . . 0.0 111.137 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -67.02 120.44 71.91 Favored Pre-proline 0 N--CA 1.454 -0.252 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.713 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -61.8 -25.57 78.64 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.248 1.965 . . . . 0.0 111.903 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -84.79 -18.13 35.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.743 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -71.49 -161.74 4.8 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.249 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.417 ' HE1' ' O ' ' A' ' 163' ' ' PHE . 3.9 ptp -97.03 177.82 5.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.785 0.326 . . . . 0.0 110.864 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.546 HG21 ' HE2' ' A' ' 91' ' ' TYR . 41.8 t -122.62 148.01 26.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.119 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.461 ' HB3' ' HB2' ' A' ' 135' ' ' PHE . . . -112.07 115.27 28.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.845 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.535 HD13 HG21 ' A' ' 125' ' ' ILE . 4.0 mt -89.56 105.9 18.1 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.814 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.513 HD12 ' HG2' ' A' ' 160' ' ' MET . 1.1 tp -94.55 119.08 32.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.356 -179.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.545 ' HB3' ' CE1' ' A' ' 159' ' ' TYR . 0.5 OUTLIER -134.97 170.16 16.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.561 179.367 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -105.74 150.36 25.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.909 0.385 . . . . 0.0 111.151 -179.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -78.09 -172.62 2.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.814 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -57.54 -41.13 80.32 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.942 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 44.4 p-10 -69.11 -15.07 63.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.238 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 65.3 19.04 65.97 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.589 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 80.4 t -113.44 -65.36 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.904 0.383 . . . . 0.0 111.044 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 98.3 m -64.98 111.87 6.84 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.14 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -82.06 131.61 6.96 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.63 2.22 . . . . 0.0 111.903 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.545 ' CE1' ' HB3' ' A' ' 150' ' ' ASP . 6.7 p90 -125.11 139.14 54.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.96 0.41 . . . . 0.0 111.142 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' MET . . . . . 0.66 ' SD ' HD13 ' A' ' 78' ' ' LEU . 41.6 mtp -109.89 140.93 43.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.981 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.622 HG23 HD11 ' A' ' 23' ' ' ILE . 72.3 mt -97.07 116.92 40.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.337 -179.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -117.33 151.01 37.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.57 179.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.417 ' O ' ' HE1' ' A' ' 145' ' ' MET . 5.5 m-85 -100.47 124.89 46.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.955 0.407 . . . . 0.0 111.01 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.633 ' HB2' HD11 ' A' ' 29' ' ' LEU . 27.2 tttm -70.02 -45.55 66.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.275 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.435 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 15.8 m-20 -49.28 -35.6 18.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.24 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.44 ' HA2' HG23 ' A' ' 99' ' ' ILE . . . -109.26 30.71 8.3 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.509 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.502 HD21 ' HD2' ' A' ' 4' ' ' TYR . 1.5 tt -150.06 146.88 27.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.896 0.379 . . . . 0.0 110.918 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -132.06 154.09 49.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.331 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.493 ' HA ' ' O ' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -139.96 160.27 40.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.829 0.347 . . . . 0.0 111.32 -179.843 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -147.02 144.6 29.27 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.355 -179.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.485 ' N ' HD12 ' A' ' 2' ' ' ILE . 17.2 mttp -83.56 108.95 17.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.015 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 51.1 t -80.56 -36.42 32.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.848 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.419 HD23 ' N ' ' A' ' 174' ' ' GLU . 2.0 tt -99.77 144.63 28.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.928 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.419 ' N ' HD23 ' A' ' 173' ' ' LEU . 1.1 tm-20 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.207 -0.902 . . . . 0.0 110.944 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.855 0.36 . . . . 0.0 111.216 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.653 HD11 ' HB3' ' A' ' 169' ' ' MET . 1.5 tt -121.92 145.77 28.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.974 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 11.4 mm -100.11 154.18 4.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.433 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.633 ' HE1' HG23 ' A' ' 2' ' ' ILE . 3.5 m-85 -123.85 111.08 15.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.436 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.22 146.65 50.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.919 0.39 . . . . 0.0 111.215 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.496 ' OD1' HD12 ' A' ' 8' ' ' ILE . 46.1 t0 -54.67 152.16 7.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.897 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.549 HD23 HG23 ' A' ' 99' ' ' ILE . 56.2 tp -80.88 -20.36 42.43 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.484 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.592 HD11 ' CG1' ' A' ' 99' ' ' ILE . 4.1 mp -91.35 -48.28 13.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -93.79 -21.97 18.97 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 -179.157 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.454 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 3.5 m-70 63.52 31.38 14.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.884 0.373 . . . . 0.0 110.8 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -102.66 121.76 43.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.804 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -57.24 98.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.303 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.8 mtt -78.18 -18.07 55.99 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.733 179.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.643 ' CD2' HG21 ' A' ' 31' ' ' VAL . 5.7 p90 -177.37 177.42 1.19 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.778 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -133.84 -171.94 2.86 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.659 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -95.0 27.13 3.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.966 0.413 . . . . 0.0 110.876 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.418 HG13 ' CD2' ' A' ' 18' ' ' TYR . 45.6 pt -86.63 -13.83 10.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.479 179.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.914 ' CZ ' HG22 ' A' ' 72' ' ' ILE . 79.8 m-85 -106.16 -170.34 1.71 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.537 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.39 88.56 4.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.721 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.3 mp -87.97 130.65 37.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.16 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.9 mtt180 -121.73 119.12 30.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.888 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -71.4 116.07 11.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.924 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.538 HD11 HG23 ' A' ' 161' ' ' ILE . 3.6 pt -109.62 172.46 2.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.022 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.482 ' HB2' ' NE2' ' A' ' 121' ' ' GLN . . . 58.32 28.1 16.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.194 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 65.11 54.39 1.23 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.451 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.44 -3.51 72.84 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.553 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.462 ' HB3' ' HB3' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -67.48 -56.89 7.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 117.111 0.456 . . . . 0.0 110.815 179.993 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 46.9 m -120.08 168.72 10.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.747 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.523 HD21 ' HD2' ' A' ' 164' ' ' LYS . 0.5 OUTLIER -132.22 133.43 44.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.853 -179.849 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -98.42 112.84 24.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.963 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.643 HG21 ' CD2' ' A' ' 14' ' ' PHE . 22.8 t -93.63 111.98 25.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.744 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -86.87 124.7 33.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.145 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.59 -135.93 8.38 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.358 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.7 pttm -174.51 124.62 0.3 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.855 0.36 . . . . 0.0 110.881 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 62.9 mtm -69.74 121.83 17.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.75 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.1 m -111.66 127.02 69.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.342 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 78.8 p -86.77 165.69 15.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.952 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.6 ' O ' HG13 ' A' ' 66' ' ' VAL . 0.3 OUTLIER -141.35 152.99 44.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.885 -179.853 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.553 HG23 ' O ' ' A' ' 39' ' ' THR . 8.7 t -177.8 76.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.854 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -162.73 106.7 1.1 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.89 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 126.56 135.74 4.26 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.388 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.504 HD22 HG21 ' A' ' 62' ' ' THR . 1.3 t-20 -95.14 155.33 16.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.777 0.322 . . . . 0.0 110.875 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.696 HD11 ' OG1' ' A' ' 65' ' ' THR . 3.3 mp -89.38 111.59 23.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.126 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 60.5 111.07 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.921 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -68.75 159.32 32.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.935 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.34 -66.5 0.92 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.893 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -101.86 -16.23 16.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.285 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 17.9 mt 64.18 -76.9 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.064 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 159.46 -167.72 35.17 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.532 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -85.2 168.31 42.51 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.537 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 60.66 111.25 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.932 0.396 . . . . 0.0 110.867 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -122.61 111.76 17.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.033 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.02 -177.72 4.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.991 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -92.2 -37.9 12.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.051 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -86.98 79.7 8.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.875 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -173.14 103.54 0.19 Allowed Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.459 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -67.56 -175.0 0.62 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.41 2.073 . . . . 0.0 112.282 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -86.93 161.16 18.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.89 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 164.25 104.19 0.18 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.441 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -138.13 129.78 28.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.91 0.386 . . . . 0.0 110.949 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -82.44 84.56 1.51 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.47 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.504 HG21 HD22 ' A' ' 42' ' ' ASN . 0.2 OUTLIER -130.11 -177.88 4.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.776 0.322 . . . . 0.0 110.853 -179.904 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.446 ' H ' HG22 ' A' ' 62' ' ' THR . 8.7 mt-10 -131.17 113.49 13.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.889 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -170.31 153.02 4.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.829 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.696 ' OG1' HD11 ' A' ' 43' ' ' ILE . 0.2 OUTLIER 63.84 139.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.878 -179.988 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.603 ' C ' HD13 ' A' ' 67' ' ' ILE . 21.8 t -131.33 123.64 53.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.051 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.603 HD13 ' C ' ' A' ' 66' ' ' VAL . 0.0 OUTLIER -118.02 132.64 67.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.014 -179.986 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 89.0 m -139.05 140.39 38.06 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.966 0.412 . . . . 0.0 111.188 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -175.71 176.94 47.56 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.31 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.451 HG12 HG12 ' A' ' 72' ' ' ILE . 60.1 t -68.37 141.34 17.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.875 0.369 . . . . 0.0 110.852 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -67.56 -58.77 4.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.48 -179.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.914 HG22 ' CZ ' ' A' ' 18' ' ' TYR . 8.9 pt -53.72 -33.84 23.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.531 -179.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.78 HG13 ' HB2' ' A' ' 78' ' ' LEU . 58.7 t -72.26 -33.92 47.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.054 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.5 mtm -78.13 -38.89 42.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.598 -179.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.4 HD21 ' HA ' ' A' ' 72' ' ' ILE . 19.1 p30 -82.07 -28.89 32.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.565 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.423 ' CE1' ' HB ' ' A' ' 72' ' ' ILE . 26.7 m170 -93.43 -1.12 56.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.841 0.353 . . . . 0.0 110.952 179.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 57.87 30.52 19.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.07 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.78 ' HB2' HG13 ' A' ' 73' ' ' VAL . 56.9 mt -57.83 134.88 56.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.535 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -118.48 134.36 55.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.941 0.4 . . . . 0.0 111.161 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.426 ' HB2' ' CE2' ' A' ' 135' ' ' PHE . 16.0 tt0 -87.63 129.81 34.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.934 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.871 HG21 HD11 ' A' ' 136' ' ' ILE . 3.1 t -122.81 126.31 47.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.829 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.4 m -68.06 159.02 31.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.999 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -165.42 149.72 8.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.799 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.54 158.18 17.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.798 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.47 -52.5 65.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.896 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -62.35 -44.33 96.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.738 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.64 -37.9 76.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.938 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.843 ' CD2' HD11 ' A' ' 122' ' ' ILE . 2.0 t80 -59.92 -38.64 82.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.736 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.444 ' O ' HG22 ' A' ' 92' ' ' ILE . 32.6 mttt -57.46 -49.47 76.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.172 0.51 . . . . 0.0 110.483 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.2 mtmt -72.42 -27.82 62.58 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.829 178.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.476 ' HE2' HG21 ' A' ' 146' ' ' VAL . 5.0 t80 -66.84 -46.16 75.97 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.957 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.444 HG22 ' O ' ' A' ' 89' ' ' LYS . 2.9 tp -60.45 -40.79 85.29 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.172 0 CA-C-O 120.766 0.317 . . . . 0.0 110.866 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.435 ' O ' ' CG ' ' A' ' 97' ' ' LYS . 0.9 OUTLIER -61.31 -46.33 90.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.733 179.935 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -71.2 -38.96 72.04 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.846 -179.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.544 ' CD1' ' C ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -74.5 -41.64 60.33 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.739 -0.21 . . . . 0.0 110.792 -179.542 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 19.7 ptt? -64.86 -32.06 73.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.825 0.345 . . . . 0.0 110.248 179.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.435 ' CG ' ' O ' ' A' ' 93' ' ' LYS . 5.4 mmtp -64.4 -42.91 95.83 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.853 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.7 m -56.96 -43.32 81.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.82 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.592 ' CG1' HD11 ' A' ' 8' ' ' ILE . 6.3 mt -79.72 -40.92 21.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.587 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.83 -51.87 65.98 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.706 179.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -64.33 -45.39 93.55 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.014 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.88 -42.06 92.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.927 0.394 . . . . 0.0 110.447 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.528 ' HB3' HG12 ' A' ' 111' ' ' VAL . 4.1 tp -65.55 -36.49 83.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.181 179.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.613 ' CG ' HG11 ' A' ' 111' ' ' VAL . 76.9 mt-10 -58.43 -28.55 65.37 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.772 179.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -88.73 -19.23 26.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.73 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -110.39 -60.99 1.73 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.77 0.319 . . . . 0.0 111.673 -179.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 103' ' ' LEU . 1.1 mtt85 -125.59 63.17 44.35 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.93 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.86 ' O ' HG22 ' A' ' 111' ' ' VAL . 10.1 Cg_endo -50.77 -22.22 9.44 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 123.064 2.51 . . . . 0.0 112.798 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -73.44 -15.23 61.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.749 0.309 . . . . 0.0 111.253 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.543 ' C ' ' HD2' ' A' ' 113' ' ' PRO . 2.5 mmm180 -106.34 0.73 25.24 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.774 -179.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.86 HG22 ' O ' ' A' ' 108' ' ' PRO . 32.8 m -68.17 -36.66 76.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.591 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 28.4 mttt -66.79 -51.25 40.17 Favored Pre-proline 0 CA--C 1.53 0.186 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.233 -179.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.591 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 51.8 Cg_exo -53.31 -41.48 72.35 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.062 1.841 . . . . 0.0 111.821 179.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.461 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 88.2 t80 -68.35 -37.86 80.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.964 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . 0.435 ' HA ' ' HE3' ' A' ' 115' ' ' MET . 0.6 OUTLIER -53.94 -49.81 67.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.004 -179.942 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.8 m -76.61 -44.29 34.89 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.825 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.4 ' O ' ' HG2' ' A' ' 120' ' ' GLU . . . -59.09 -44.12 96.54 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.691 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.53 -45.95 92.0 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.026 0.441 . . . . 0.0 110.718 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.76 -32.6 65.76 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.67 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.4 ' HG2' ' O ' ' A' ' 117' ' ' GLY . 6.7 pt-20 -78.28 -43.07 29.09 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.731 0.3 . . . . 0.0 111.242 -179.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.482 ' NE2' ' HB2' ' A' ' 24' ' ' ALA . 9.7 tp-100 -66.26 -39.5 89.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.138 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.843 HD11 ' CD2' ' A' ' 88' ' ' TYR . 0.3 OUTLIER -63.11 -45.0 99.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.053 -179.929 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.443 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 27.0 mttt -59.51 -31.12 69.07 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.215 179.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 3.9 t-160 -68.21 -54.12 20.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.622 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.814 HG21 HD13 ' A' ' 148' ' ' LEU . 8.7 pt -61.78 -38.51 80.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.118 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.434 ' HG ' ' CD1' ' A' ' 122' ' ' ILE . 12.4 mt -53.6 -40.3 65.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.553 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.02 -19.13 60.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.766 179.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -128.91 28.94 5.28 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.392 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -48.9 -42.28 36.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.273 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 8.4 ttpp -68.67 -15.4 63.51 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.367 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -94.05 -38.54 11.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.382 -179.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.47 ' CD2' HG22 ' A' ' 125' ' ' ILE . 1.7 m-30 -97.77 153.79 18.04 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.971 0.415 . . . . 0.0 111.365 -179.386 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.447 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 4.8 mm100 -123.35 155.32 37.54 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.538 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.446 ' CE1' ' CE1' ' A' ' 88' ' ' TYR . 3.4 m-85 -93.24 133.86 36.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.876 0.369 . . . . 0.0 111.124 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.426 ' CE2' ' HB2' ' A' ' 80' ' ' GLU . 36.4 m-85 -134.25 151.29 51.21 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.491 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.871 HD11 HG21 ' A' ' 81' ' ' THR . 0.5 OUTLIER -134.61 161.44 40.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.965 179.897 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -62.19 -164.38 0.37 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.169 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -73.38 -8.93 57.95 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.552 0.215 . . . . 0.0 111.433 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -97.96 -28.7 13.69 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.668 -179.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.436 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 45.7 mtp 55.72 42.39 29.31 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.897 0.379 . . . . 0.0 111.02 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . 0.432 ' ND2' ' HA3' ' A' ' 144' ' ' GLY . 16.5 p-10 -65.03 114.78 16.34 Favored Pre-proline 0 N--CA 1.452 -0.373 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.993 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -62.19 -29.29 80.37 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.496 2.13 . . . . 0.0 112.142 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -84.64 -7.66 59.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.127 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.432 ' HA3' ' ND2' ' A' ' 141' ' ' ASN . . . -86.41 -167.67 43.9 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.436 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 1.6 ptp -84.99 -174.41 5.26 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.949 0.404 . . . . 0.0 110.794 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.476 HG21 ' HE2' ' A' ' 91' ' ' TYR . 75.6 t -130.27 155.65 41.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.067 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.573 ' HB2' ' CE1' ' A' ' 162' ' ' PHE . . . -116.56 110.84 19.08 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.473 179.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.814 HD13 HG21 ' A' ' 125' ' ' ILE . 5.0 mt -86.46 106.01 17.18 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.236 -179.174 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.537 ' HB2' ' HE2' ' A' ' 160' ' ' MET . 2.0 tp -89.69 119.77 30.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.928 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.549 ' HB2' ' CZ ' ' A' ' 159' ' ' TYR . 57.6 m-20 -131.91 161.67 32.48 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.68 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -105.3 146.6 29.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.119 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 8.7 mmt180 -59.68 -176.2 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.907 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -56.36 -41.31 75.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.951 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.488 ' OD1' HG23 ' A' ' 156' ' ' VAL . 11.1 t70 -72.61 -15.13 61.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.164 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 77.83 21.59 71.15 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.626 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.488 HG23 ' OD1' ' A' ' 154' ' ' ASP . 87.5 t -113.41 -73.01 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.772 0.32 . . . . 0.0 110.924 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 98.9 m -53.02 103.23 0.35 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.13 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -77.11 127.88 9.51 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.724 2.283 . . . . 0.0 112.069 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.549 ' CZ ' ' HB2' ' A' ' 150' ' ' ASP . 10.5 p90 -126.54 133.26 51.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.956 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' MET . . . . . 0.568 ' CE ' HD13 ' A' ' 78' ' ' LEU . 0.5 OUTLIER -103.46 140.03 38.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.055 -179.659 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.538 HG23 HD11 ' A' ' 23' ' ' ILE . 90.4 mt -95.59 113.81 30.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.888 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.573 ' CE1' ' HB2' ' A' ' 147' ' ' ALA . 47.9 m-85 -117.45 133.89 55.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.889 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -79.33 128.96 33.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.977 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.523 ' HD2' HD21 ' A' ' 29' ' ' LEU . 12.4 tttm -70.12 -52.83 20.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.101 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.461 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 19.3 m-20 -49.3 -37.83 25.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.155 -179.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -96.56 28.73 12.13 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.341 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.445 HD21 ' HB3' ' A' ' 4' ' ' TYR . 0.5 OUTLIER -146.74 145.88 30.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.75 0.309 . . . . 0.0 110.843 -179.91 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -109.84 152.61 25.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.854 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.653 ' HB3' HD11 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -124.28 138.66 54.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.935 179.982 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -149.88 130.73 14.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.962 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 17.3 mttm -83.76 116.57 22.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.899 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 1.8 t -93.2 165.3 12.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.888 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.627 HD23 ' H ' ' A' ' 173' ' ' LEU . 1.4 pt? -112.6 -33.58 6.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.964 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.185 -0.912 . . . . 0.0 110.861 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.0 ttt . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.837 0.351 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.732 HD11 ' HB3' ' A' ' 169' ' ' MET . 2.1 tt -110.08 147.81 14.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.14 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.445 HG21 ' HB3' ' A' ' 12' ' ' GLU . 19.3 mm -107.56 155.01 8.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.089 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.571 ' HE1' HG23 ' A' ' 2' ' ' ILE . 3.4 m-85 -122.2 104.47 9.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.606 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -119.19 152.19 37.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.343 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.447 ' O ' ' HA ' ' A' ' 10' ' ' HIS . 38.9 t0 -58.11 152.2 17.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.802 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.472 HD23 HG23 ' A' ' 99' ' ' ILE . 56.6 tp -81.38 -23.89 37.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.306 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.765 HD11 ' CG1' ' A' ' 99' ' ' ILE . 3.8 mp -91.18 -45.07 14.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.3 t -93.76 -25.34 17.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.781 -179.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.447 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 38.5 m80 66.47 28.84 9.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.883 0.373 . . . . 0.0 110.832 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -102.48 123.57 46.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.749 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.445 ' HB3' HG21 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -57.12 99.8 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.259 -179.746 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 33.3 mtp -80.91 -16.53 53.33 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.795 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.5 ' CE2' ' CD2' ' A' ' 4' ' ' TYR . 12.3 p90 -178.22 175.57 1.2 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.698 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -134.05 -169.85 2.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.071 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.7 p-10 -89.96 19.74 4.68 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.549 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 46.2 pt -86.15 -6.93 10.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.817 0.342 . . . . 0.0 111.266 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.861 ' CZ ' HG22 ' A' ' 72' ' ' ILE . 71.1 m-85 -116.5 168.87 9.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.748 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.403 ' HB2' ' HB2' ' A' ' 32' ' ' GLU . 2.6 mmpt? -79.71 93.34 5.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.681 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.726 HD12 ' O ' ' A' ' 18' ' ' TYR . 4.4 mp -87.78 125.66 41.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.066 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -116.97 132.14 56.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.981 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.452 ' HG3' HD23 ' A' ' 29' ' ' LEU . 5.7 mt-10 -81.52 116.11 21.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.775 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 7.7 pt -116.45 167.08 9.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.018 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 58.44 34.54 24.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.068 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 64.45 38.62 7.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.214 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.67 -10.49 74.55 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.667 -0.777 . . . . 0.0 113.182 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.417 HD21 ' HA ' ' A' ' 114' ' ' PHE . 0.1 OUTLIER -56.18 -37.64 69.86 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.901 0.35 . . . . 0.0 111.143 -179.879 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 72.0 m -136.98 169.74 17.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.139 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.496 HD21 ' HD2' ' A' ' 164' ' ' LYS . 0.3 OUTLIER -131.99 119.08 20.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.897 -179.74 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -83.09 112.94 20.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.107 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.4 HG23 ' HD2' ' A' ' 162' ' ' PHE . 30.6 t -94.74 111.92 26.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.615 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.403 ' HB2' ' HB2' ' A' ' 19' ' ' LYS . 2.0 mt-10 -82.54 118.48 23.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.205 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.4 -139.21 9.67 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.267 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.6 pttm -174.36 129.97 0.36 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.772 0.32 . . . . 0.0 110.958 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.409 ' HE2' ' O ' ' A' ' 156' ' ' VAL . 17.4 mtm -76.73 125.0 28.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.896 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.452 HG23 ' CE ' ' A' ' 74' ' ' MET . 5.0 m -118.2 134.39 61.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.216 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.695 ' CA ' HG23 ' A' ' 68' ' ' THR . 0.8 OUTLIER -93.22 165.54 12.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.957 -179.986 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.45 ' HB3' HG12 ' A' ' 67' ' ' ILE . 1.1 ttt180 -158.58 124.02 4.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.796 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.905 HG22 HG22 ' A' ' 66' ' ' VAL . 5.8 p -109.46 49.68 0.82 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.877 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -96.57 153.03 18.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.862 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 161.82 150.41 5.95 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.505 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -111.77 144.45 41.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.806 0.336 . . . . 0.0 110.878 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 6.4 tp -65.17 131.46 30.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.267 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -129.51 118.08 21.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.994 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -138.83 -178.06 5.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.89 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.5 -32.5 16.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.872 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 42.8 mt -80.05 -35.77 36.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.861 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 46.0 mm 62.76 -78.07 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.124 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 66.72 -95.17 0.26 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.574 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -59.99 114.51 6.45 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.584 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -97.67 57.23 1.34 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.876 0.369 . . . . 0.0 110.868 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -98.09 35.19 1.78 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.149 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.07 78.59 2.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.9 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -77.52 -36.66 52.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.025 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -89.67 89.15 7.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.901 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 134.9 114.33 1.41 Allowed Glycine 0 CA--C 1.521 0.417 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.627 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -60.27 -15.96 37.97 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.565 2.177 . . . . 0.0 112.454 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 77.36 99.74 0.07 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.972 0.415 . . . . 0.0 110.899 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -156.81 -45.34 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.495 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -96.76 -176.85 3.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.736 0.303 . . . . 0.0 110.925 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -87.53 -73.04 1.28 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.519 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 12.9 p 55.12 101.74 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.829 0.347 . . . . 0.0 111.004 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.05 -179.81 7.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.852 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.4 m -97.42 38.03 1.3 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.912 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.482 ' O ' HD13 ' A' ' 67' ' ' ILE . 22.0 m -86.8 147.43 25.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.008 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.905 HG22 HG22 ' A' ' 39' ' ' THR . 88.1 t -73.32 143.19 14.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.134 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.482 HD13 ' O ' ' A' ' 65' ' ' THR . 0.0 OUTLIER -122.25 126.25 74.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.696 179.67 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.695 HG23 ' CA ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -138.49 114.69 10.24 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.893 179.865 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -147.24 -176.66 21.13 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.229 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.44 HG22 ' HG3' ' A' ' 158' ' ' PRO . 59.8 t -69.73 148.28 11.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.911 0.386 . . . . 0.0 110.931 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -72.48 -57.56 4.08 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.338 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.861 HG22 ' CZ ' ' A' ' 18' ' ' TYR . 10.8 pt -53.53 -34.01 22.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.421 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.792 HG13 ' HB2' ' A' ' 78' ' ' LEU . 57.9 t -71.24 -31.88 45.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.882 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.452 ' CE ' HG23 ' A' ' 36' ' ' VAL . 2.3 mtm -78.01 -40.47 38.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.417 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.406 ' OD1' ' CD2' ' A' ' 76' ' ' HIS . 13.5 p30 -82.12 -28.77 32.06 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.51 -179.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.431 ' CE1' ' HB ' ' A' ' 72' ' ' ILE . 26.9 m170 -93.55 -0.28 56.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.753 0.311 . . . . 0.0 110.88 179.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.415 ' HB2' ' HB3' ' A' ' 138' ' ' GLU . 13.8 m-70 55.89 29.62 14.47 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.09 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.792 ' HB2' HG13 ' A' ' 73' ' ' VAL . 52.3 mt -57.09 139.84 51.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.652 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -124.44 137.38 54.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.126 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -91.59 131.86 36.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.037 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.525 HG21 HD11 ' A' ' 136' ' ' ILE . 6.2 t -118.5 170.1 9.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.872 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.3 m -107.39 165.19 11.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.955 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.493 ' CE2' ' CE2' ' A' ' 91' ' ' TYR . 2.7 m-85 -171.68 149.84 2.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.95 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.3 m -101.48 166.34 10.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.767 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.7 mtmp? -57.34 -49.86 74.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.873 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.65 -40.25 76.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.831 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.95 -43.73 94.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.101 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.851 ' CD2' HD11 ' A' ' 122' ' ' ILE . 0.6 OUTLIER -61.48 -30.74 70.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.757 179.921 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 27.7 mttm -62.98 -44.66 95.43 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.012 0.434 . . . . 0.0 110.566 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 11.3 mttm -78.56 -27.9 45.89 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.771 178.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.567 ' HE2' HG21 ' A' ' 146' ' ' VAL . 17.2 t80 -67.03 -47.32 71.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.073 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.778 HG22 ' O ' ' A' ' 88' ' ' TYR . 2.3 tp -65.06 -40.21 88.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.074 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.444 ' O ' ' CG ' ' A' ' 97' ' ' LYS . 4.9 ttpp -62.73 -45.28 93.47 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.923 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -68.76 -39.34 80.32 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.861 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.534 ' CD1' ' C ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -76.03 -43.78 42.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.712 -0.222 . . . . 0.0 110.875 -179.299 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 3.2 ptt? -62.06 -31.99 72.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.914 0.388 . . . . 0.0 110.238 179.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.444 ' CG ' ' O ' ' A' ' 93' ' ' LYS . 3.8 mmtt -66.46 -42.11 88.04 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.717 179.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.4 m -57.22 -41.72 80.0 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.657 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.765 ' CG1' HD11 ' A' ' 8' ' ' ILE . 6.6 mt -79.78 -42.26 22.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.685 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.8 tttt -53.64 -54.5 36.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.55 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -62.12 -46.4 94.07 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.126 179.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 26.0 tptt -61.08 -37.01 81.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.945 0.402 . . . . 0.0 110.406 179.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.527 HD21 ' CB ' ' A' ' 110' ' ' ARG . 6.6 tp -70.82 -32.94 70.17 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.051 179.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.605 ' CG ' HG11 ' A' ' 111' ' ' VAL . 84.0 mt-10 -60.97 -29.13 69.48 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.806 179.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -89.97 -19.58 24.32 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.423 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -106.84 -62.68 1.37 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.881 0.372 . . . . 0.0 111.472 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.428 ' N ' ' O ' ' A' ' 103' ' ' LEU . 9.7 mtt-85 -124.91 62.72 37.07 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.902 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.864 ' O ' HG22 ' A' ' 111' ' ' VAL . 10.3 Cg_endo -50.82 -24.53 13.63 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 123.091 2.528 . . . . 0.0 112.537 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -73.05 -9.46 58.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.247 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.527 ' CB ' HD21 ' A' ' 103' ' ' LEU . 58.2 mmt-85 -110.84 0.11 17.11 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.665 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.864 HG22 ' O ' ' A' ' 108' ' ' PRO . 26.5 m -71.42 -33.8 51.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.545 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 4.9 mttm -67.69 -50.4 35.22 Favored Pre-proline 0 CA--C 1.53 0.197 0 C-N-CA 120.997 -0.281 . . . . 0.0 111.681 -179.12 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.545 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 24.7 Cg_exo -63.16 -29.28 73.99 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.148 1.899 . . . . 0.0 111.67 179.478 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.481 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 89.3 t80 -72.12 -42.4 66.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.861 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 2.7 mmm -58.07 -43.83 87.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.874 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 66.2 m -76.69 -45.15 30.68 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.905 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.15 -45.83 92.69 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.775 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.402 ' O ' ' HB ' ' A' ' 122' ' ' ILE . . . -57.19 -51.76 68.02 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.045 0.45 . . . . 0.0 111.269 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.85 -28.06 63.3 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.502 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.401 ' O ' ' HG2' ' A' ' 123' ' ' LYS . 5.8 tt0 -74.13 -50.0 21.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.772 0.32 . . . . 0.0 111.474 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -67.62 -39.2 84.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.512 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.851 HD11 ' CD2' ' A' ' 88' ' ' TYR . 0.3 OUTLIER -59.5 -49.82 82.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.654 -179.458 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.481 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 9.5 ptpt -60.18 -30.64 69.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.059 0.457 . . . . 0.0 110.276 179.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -68.91 -53.26 21.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.755 179.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.503 HG21 HD13 ' A' ' 148' ' ' LEU . 16.7 pt -62.31 -42.33 95.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.309 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.498 HD21 ' CD2' ' A' ' 88' ' ' TYR . 11.3 mt -53.76 -37.18 63.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.946 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -72.89 -9.8 59.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.215 179.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 -142.24 34.44 1.51 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.983 0.42 . . . . 0.0 110.477 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.507 ' CE1' ' CZ ' ' A' ' 134' ' ' PHE . 5.4 t80 -51.95 -24.71 6.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.113 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -55.92 -37.91 69.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.979 0.418 . . . . 0.0 111.0 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 27.0 m-20 -86.25 -42.75 13.51 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.685 -179.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.443 ' HE2' HD11 ' A' ' 161' ' ' ILE . 14.1 m-85 -92.72 129.31 38.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.881 0.372 . . . . 0.0 111.394 -179.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.424 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 2.3 mm100 -114.84 145.13 42.49 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.911 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.507 ' CZ ' ' CE1' ' A' ' 129' ' ' PHE . 1.7 m-85 -79.95 127.52 32.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.174 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.422 ' CE1' ' HB3' ' A' ' 149' ' ' LEU . 48.0 m-85 -132.3 134.18 44.94 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.586 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.525 HD11 HG21 ' A' ' 81' ' ' THR . 0.7 OUTLIER -120.94 161.86 20.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.939 -179.811 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.47 -165.12 0.14 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.266 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.415 ' HB3' ' HB2' ' A' ' 77' ' ' HIS . 4.1 pt-20 -72.35 -9.18 58.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.566 0.222 . . . . 0.0 111.489 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 -97.59 -33.9 11.17 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 120.652 0.263 . . . . 0.0 111.518 -179.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.468 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 34.9 mtm 60.47 34.96 20.4 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.683 0.278 . . . . 0.0 111.335 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -64.4 123.6 83.26 Favored Pre-proline 0 N--CA 1.451 -0.392 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.732 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -61.95 -23.35 75.77 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.321 2.014 . . . . 0.0 111.822 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -84.45 -12.14 54.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.734 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -80.96 -175.54 49.96 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.258 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 1.4 ptp -85.37 -177.98 6.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.783 0.325 . . . . 0.0 110.891 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.567 HG21 ' HE2' ' A' ' 91' ' ' TYR . 43.6 t -125.88 149.04 30.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.96 0.41 . . . . 0.0 111.165 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.424 ' HB1' ' SD ' ' A' ' 160' ' ' MET . . . -113.55 112.52 23.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.649 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.532 ' HB2' ' HB ' ' A' ' 161' ' ' ILE . 4.7 mt -85.86 106.27 16.95 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.03 -179.361 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.573 HD12 ' HG2' ' A' ' 160' ' ' MET . 3.3 tp -90.75 119.19 30.77 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.381 -179.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.49 ' HB3' ' CE1' ' A' ' 159' ' ' TYR . 13.4 t70 -132.57 164.29 26.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.482 179.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -97.49 146.7 24.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.955 0.407 . . . . 0.0 111.226 -179.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.09 -176.36 0.88 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.882 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -58.96 -41.31 87.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.923 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -67.18 -15.1 63.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.132 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 75.03 11.07 84.17 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.68 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.409 ' O ' ' HE2' ' A' ' 35' ' ' MET . 73.6 t -111.89 -70.15 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.846 0.355 . . . . 0.0 110.872 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 90.5 m -55.6 108.54 1.21 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.163 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.44 ' HG3' HG22 ' A' ' 70' ' ' VAL . 88.4 Cg_endo -82.65 132.19 6.57 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.579 2.186 . . . . 0.0 112.074 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.49 ' CE1' ' HB3' ' A' ' 150' ' ' ASP . 8.1 p90 -125.28 149.15 48.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.89 0.376 . . . . 0.0 110.983 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' MET . . . . . 0.79 ' CE ' HD13 ' A' ' 78' ' ' LEU . 0.6 OUTLIER -114.52 150.76 34.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.162 -179.75 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.532 ' HB ' ' HB2' ' A' ' 148' ' ' LEU . 88.5 mt -103.44 111.95 35.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.871 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.4 ' HD2' HG23 ' A' ' 31' ' ' VAL . 90.3 m-85 -114.53 125.84 54.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.907 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.407 ' CE2' ' OH ' ' A' ' 95' ' ' TYR . 2.6 m-85 -71.06 124.68 24.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.744 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.496 ' HD2' HD21 ' A' ' 29' ' ' LEU . 6.3 tttm -66.39 -56.44 11.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.31 -179.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.481 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 0.8 OUTLIER -51.06 -34.4 29.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.238 -179.797 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.409 ' HA2' ' CG2' ' A' ' 99' ' ' ILE . . . -95.73 25.28 25.73 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.47 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.438 HD21 ' HB3' ' A' ' 4' ' ' TYR . 0.6 OUTLIER -137.74 146.99 44.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.867 0.365 . . . . 0.0 110.928 -179.91 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -119.38 136.85 54.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.79 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.732 ' HB3' HD11 ' A' ' 2' ' ' ILE . 1.6 mpp? -103.98 154.55 19.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.015 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -157.48 125.19 5.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.799 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.689 ' HG2' HD12 ' A' ' 2' ' ' ILE . 3.3 mtpp -88.22 117.81 27.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.867 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER 67.0 -74.85 0.06 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.813 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.408 ' C ' HD12 ' A' ' 173' ' ' LEU . 3.3 pp -151.93 32.07 0.55 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.89 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.922 179.986 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.1 ttp . . . . . 0 N--CA 1.486 1.375 0 CA-C-O 120.848 0.356 . . . . 0.0 111.116 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.82 HD11 ' HB3' ' A' ' 169' ' ' MET . 10.0 tt -88.84 128.93 40.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.159 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.453 HG21 ' HB3' ' A' ' 12' ' ' GLU . 19.4 mm -92.88 157.31 2.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.23 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.624 ' HB3' HD21 ' A' ' 167' ' ' LEU . 3.0 m-85 -124.54 106.7 10.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.489 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 25.0 ptt180 -121.84 148.28 44.89 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.817 0.341 . . . . 0.0 111.333 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.441 ' O ' ' HA ' ' A' ' 10' ' ' HIS . 23.3 t0 -56.57 152.21 12.27 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.808 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.634 HD11 HE22 ' A' ' 106' ' ' GLN . 61.5 tp -80.3 -24.17 40.16 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.373 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.797 HD11 ' CG1' ' A' ' 99' ' ' ILE . 4.7 mp -91.3 -44.49 14.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.823 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.402 ' HB2' ' ND2' ' A' ' 141' ' ' ASN . 28.6 p -93.1 -23.77 18.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.77 -179.185 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.441 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 5.6 m170 63.44 28.07 15.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.809 0.337 . . . . 0.0 110.817 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -102.73 121.39 42.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.734 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.453 ' HB3' HG21 ' A' ' 3' ' ' ILE . 1.0 OUTLIER -58.52 89.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.204 -179.81 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 6.4 mtt -69.32 -16.07 63.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.881 179.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.498 ' CE2' ' CD2' ' A' ' 4' ' ' TYR . 34.1 p90 -176.87 171.48 2.18 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.93 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.8 m -134.54 -169.94 2.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.005 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -87.24 12.3 12.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.525 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 46.2 pt -81.3 -3.26 6.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.884 0.373 . . . . 0.0 111.062 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.843 ' CZ ' HG22 ' A' ' 72' ' ' ILE . 65.2 m-85 -119.89 179.87 4.12 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.705 -179.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.403 ' HB2' ' HB2' ' A' ' 32' ' ' GLU . 0.1 OUTLIER -90.14 88.94 7.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.916 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.566 HD12 ' O ' ' A' ' 18' ' ' TYR . 4.4 mp -88.03 123.89 40.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.994 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.79 133.52 55.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.914 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -78.35 121.15 24.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.826 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.477 HD11 HG23 ' A' ' 161' ' ' ILE . 3.8 pt -116.44 174.59 3.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.205 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.464 ' HB2' ' NE2' ' A' ' 121' ' ' GLN . . . 57.06 24.82 10.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.393 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 65.72 57.55 0.84 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.37 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 73.56 18.95 79.62 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.756 -0.735 . . . . 0.0 113.354 179.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.522 HD21 ' O ' ' A' ' 113' ' ' PRO . 0.2 OUTLIER -92.53 -45.67 8.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.914 0.357 . . . . 0.0 110.948 179.853 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 17.0 m -130.67 171.62 12.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.054 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.75 HD11 ' HB3' ' A' ' 164' ' ' LYS . 0.5 OUTLIER -129.48 131.08 46.59 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.941 -179.926 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -97.25 112.77 24.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.798 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.6 t -92.0 111.78 24.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.726 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.403 ' HB2' ' HB2' ' A' ' 19' ' ' LYS . 8.6 mt-10 -84.19 117.57 23.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.12 -179.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -99.82 -138.37 10.26 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.319 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -174.48 124.82 0.3 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.804 0.335 . . . . 0.0 111.013 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 55.8 mtp -68.61 122.0 17.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.656 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.409 HG23 ' CE ' ' A' ' 74' ' ' MET . 17.3 m -119.08 133.81 64.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.292 -179.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.665 ' CA ' HG23 ' A' ' 68' ' ' THR . 0.9 OUTLIER -83.27 149.35 26.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.785 179.865 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.436 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 0.0 OUTLIER -132.0 115.9 16.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.858 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.3 m -74.19 -60.59 2.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.845 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -66.68 -172.51 0.17 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.872 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.99 -147.68 16.3 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.464 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -116.83 -176.24 2.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.8 0.333 . . . . 0.0 110.88 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.545 HG23 HD11 ' A' ' 48' ' ' ILE . 1.8 mt -79.59 131.88 33.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.096 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -78.11 -48.84 15.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.861 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.45 ' O ' HG22 ' A' ' 43' ' ' ILE . 1.4 m-20 -138.79 -179.09 5.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.955 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 17.3 p -90.17 -32.55 16.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.85 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 21.8 mt -85.81 -18.89 31.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.152 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.62 HD12 HG21 ' A' ' 65' ' ' THR . 38.9 mm 55.82 92.69 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.884 0.373 . . . . 0.0 111.092 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -79.66 74.9 2.19 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.506 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -97.71 -174.21 33.63 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.455 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -165.88 -48.11 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.76 0.314 . . . . 0.0 110.834 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.89 119.09 4.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.105 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.4 m -148.6 100.21 3.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.901 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -127.93 136.82 51.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.142 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -137.42 -74.26 0.42 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.843 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 148.28 -75.15 0.27 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.488 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.51 159.6 52.31 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.559 2.173 . . . . 0.0 112.343 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 60.7 157.64 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.917 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -81.69 115.32 4.0 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.517 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -105.21 138.91 40.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.756 0.312 . . . . 0.0 110.985 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 135.72 -27.6 3.06 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.503 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.414 HG22 ' H ' ' A' ' 63' ' ' GLU . 0.2 OUTLIER -141.93 -167.72 2.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.836 0.35 . . . . 0.0 110.809 -179.974 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.414 ' H ' HG22 ' A' ' 62' ' ' THR . 0.0 OUTLIER 67.48 -73.33 0.08 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.964 -179.993 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 79.4 p -117.77 154.0 32.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.983 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.62 HG21 HD12 ' A' ' 48' ' ' ILE . 2.7 m -118.91 168.58 10.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.83 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' A' ' 38' ' ' ARG . 60.8 t -86.63 137.16 21.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.201 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.433 HG13 ' HB3' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -128.19 99.88 5.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.383 179.35 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.665 HG23 ' CA ' ' A' ' 37' ' ' SER . 0.3 OUTLIER -100.84 108.87 20.77 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.035 -179.777 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -134.76 -173.63 13.17 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.143 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.447 HG12 HG12 ' A' ' 72' ' ' ILE . 47.8 t -74.22 142.66 14.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.851 0.357 . . . . 0.0 110.937 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -69.74 -57.53 5.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.399 -179.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.843 HG22 ' CZ ' ' A' ' 18' ' ' TYR . 9.1 pt -53.72 -33.92 23.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.576 -179.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.755 HG13 ' HB2' ' A' ' 78' ' ' LEU . 71.6 t -72.02 -33.75 48.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.838 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.409 ' CE ' HG23 ' A' ' 36' ' ' VAL . 3.8 mtm -78.4 -39.87 37.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.714 -179.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.41 ' OD1' ' CD2' ' A' ' 76' ' ' HIS . 18.8 p30 -82.07 -29.13 32.0 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 -179.238 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.432 ' CE1' ' HB ' ' A' ' 72' ' ' ILE . 26.3 m170 -92.98 0.25 57.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.753 0.311 . . . . 0.0 110.858 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.404 ' CD2' ' N ' ' A' ' 77' ' ' HIS . 8.4 m170 55.09 32.79 19.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.913 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.755 ' HB2' HG13 ' A' ' 73' ' ' VAL . 52.4 mt -55.92 141.58 38.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.744 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -119.81 131.25 55.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.035 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.427 ' HG3' ' CE1' ' A' ' 135' ' ' PHE . 6.5 tt0 -95.0 127.26 40.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.93 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.709 HG21 HD11 ' A' ' 136' ' ' ILE . 1.8 t -120.03 165.12 15.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.751 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.0 p -97.03 159.65 14.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.841 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.468 ' HB2' ' CE2' ' A' ' 134' ' ' PHE . 1.6 m-85 -165.6 149.62 8.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.981 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.5 m -101.43 162.94 12.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.867 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 12.7 mttm -58.32 -52.46 65.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.065 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -63.71 -44.13 94.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.82 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.58 -42.22 98.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.02 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.92 ' CD2' HD11 ' A' ' 122' ' ' ILE . 0.7 OUTLIER -61.02 -33.84 73.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.841 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 12.8 mttp -61.19 -43.55 98.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.906 0.384 . . . . 0.0 110.554 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.1 mttp -78.11 -27.82 48.46 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.843 179.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.556 ' HE2' HG21 ' A' ' 146' ' ' VAL . 7.2 t80 -67.68 -42.27 82.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.878 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.729 HD12 ' CE2' ' A' ' 95' ' ' TYR . 5.0 tp -65.73 -44.24 93.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.898 0.38 . . . . 0.0 110.972 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.472 ' O ' ' CG ' ' A' ' 97' ' ' LYS . 2.0 ttpt -61.26 -45.35 94.88 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.782 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -68.75 -40.37 79.85 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.177 -179.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.729 ' CE2' HD12 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -77.69 -44.08 29.1 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.994 -179.272 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.403 ' HG3' ' N ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -60.17 -31.59 70.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.914 0.388 . . . . 0.0 110.195 179.165 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.472 ' CG ' ' O ' ' A' ' 93' ' ' LYS . 1.6 mmpt? -66.84 -45.14 79.14 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.445 179.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -54.92 -40.65 70.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.813 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.797 ' CG1' HD11 ' A' ' 8' ' ' ILE . 11.8 mt -79.95 -42.5 22.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.532 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.63 -52.05 65.14 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.442 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -63.19 -46.86 92.18 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.363 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.97 -44.41 94.48 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.877 0.37 . . . . 0.0 110.456 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.812 HD21 ' CB ' ' A' ' 110' ' ' ARG . 3.8 tp -63.26 -37.6 87.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.285 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.773 ' HG3' HG11 ' A' ' 111' ' ' VAL . 36.8 mt-10 -57.28 -29.5 63.92 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 120.818 0.342 . . . . 0.0 110.814 179.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -86.54 -19.29 29.68 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.617 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.634 HE22 HD11 ' A' ' 7' ' ' LEU . 30.4 mt-30 -109.52 -60.72 1.74 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.803 0.335 . . . . 0.0 111.774 -179.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.435 ' N ' ' O ' ' A' ' 103' ' ' LEU . 1.7 mtt180 -132.54 66.52 76.98 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.833 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.915 ' O ' HG22 ' A' ' 111' ' ' VAL . 10.3 Cg_endo -50.56 -21.02 7.04 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 123.257 2.638 . . . . 0.0 112.879 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -69.76 -7.92 43.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.411 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.812 ' CB ' HD21 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -113.35 -2.6 13.95 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -179.517 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.915 HG22 ' O ' ' A' ' 108' ' ' PRO . 33.1 m -73.13 -30.72 32.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.557 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 2.9 mtpt -69.46 -49.74 21.58 Favored Pre-proline 0 CA--C 1.53 0.197 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.711 -179.104 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.557 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 24.7 Cg_exo -63.13 -34.76 67.98 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.118 1.879 . . . . 0.0 111.987 179.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.453 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 69.6 t80 -72.21 -36.4 69.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.949 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.6 -54.88 41.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.983 0.42 . . . . 0.0 110.713 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 75.3 m -71.58 -44.68 64.05 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.584 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -59.89 -43.06 98.38 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.412 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -55.96 -48.52 75.64 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.022 0.439 . . . . 0.0 111.082 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.74 -33.51 66.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.382 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -74.31 -39.77 62.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.849 0.357 . . . . 0.0 111.256 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.464 ' NE2' ' HB2' ' A' ' 24' ' ' ALA . 8.9 tp-100 -71.75 -35.92 70.25 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.115 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.92 HD11 ' CD2' ' A' ' 88' ' ' TYR . 0.4 OUTLIER -67.06 -45.31 87.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.303 -179.698 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.433 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 10.0 ptpt -61.84 -30.87 71.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.965 0.412 . . . . 0.0 110.23 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -67.88 -53.6 25.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.652 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.887 HG21 HD13 ' A' ' 148' ' ' LEU . 14.8 pt -62.05 -41.42 91.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.282 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 13.4 mt -53.8 -37.46 63.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.915 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -65.02 -16.55 63.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.102 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 11.4 m-80 -137.16 33.0 2.59 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.644 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.498 ' CE1' ' CE2' ' A' ' 134' ' ' PHE . 1.1 t80 -52.5 -36.74 55.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.953 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -61.13 -18.76 59.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.286 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 35.2 m-20 -92.29 -43.43 9.29 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.716 0.293 . . . . 0.0 111.306 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.427 ' CD1' ' N ' ' A' ' 132' ' ' TYR . 1.4 m-30 -94.4 163.85 13.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.909 0.385 . . . . 0.0 111.245 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.441 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 2.3 mm100 -136.35 145.67 45.67 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.88 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.498 ' CE2' ' CE1' ' A' ' 129' ' ' PHE . 1.5 m-85 -79.89 125.54 29.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.932 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.427 ' CE1' ' HG3' ' A' ' 80' ' ' GLU . 50.1 m-85 -129.45 132.42 46.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.692 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.709 HD11 HG21 ' A' ' 81' ' ' THR . 0.3 OUTLIER -120.83 158.15 23.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.576 179.914 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -56.54 -171.76 0.15 Allowed Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.447 -0.883 . . . . 0.0 112.021 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -70.02 -11.18 60.69 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.693 0.282 . . . . 0.0 111.407 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 25.0 m-80 -93.99 -25.24 17.33 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.531 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.428 ' HA ' ' HB ' ' A' ' 136' ' ' ILE . 35.6 mtm 51.33 43.91 29.16 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.806 0.336 . . . . 0.0 111.321 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . 0.402 ' ND2' ' HB2' ' A' ' 9' ' ' SER . 1.4 m-80 -66.68 120.72 73.19 Favored Pre-proline 0 N--CA 1.454 -0.267 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.766 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -61.26 -26.18 81.61 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.253 1.968 . . . . 0.0 111.893 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -84.85 -19.67 32.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.701 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -70.17 -172.84 11.16 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.316 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 5.7 ptp -90.4 -173.56 3.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.78 0.324 . . . . 0.0 110.883 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.556 HG21 ' HE2' ' A' ' 91' ' ' TYR . 58.1 t -128.88 150.65 34.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.112 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.521 ' HB1' ' SD ' ' A' ' 160' ' ' MET . . . -115.44 111.53 20.92 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.654 179.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.887 HD13 HG21 ' A' ' 125' ' ' ILE . 3.9 mt -85.59 106.23 16.74 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.129 -179.201 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.44 HD12 ' HG2' ' A' ' 160' ' ' MET . 4.2 tp -88.52 120.16 29.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.347 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.453 ' HB3' ' CE1' ' A' ' 159' ' ' TYR . 27.8 t70 -136.75 164.86 27.27 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.39 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -106.46 152.47 23.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.837 0.351 . . . . 0.0 111.13 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.25 -177.1 0.49 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.966 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.99 -37.9 75.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.835 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -76.23 -15.04 60.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.28 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 69.77 26.98 73.79 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.744 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 89.8 t -112.03 -61.89 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.848 0.356 . . . . 0.0 110.929 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 78.2 m -75.78 112.75 21.5 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.202 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -81.08 132.04 8.17 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.562 2.175 . . . . 0.0 112.065 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.453 ' CE1' ' HB3' ' A' ' 150' ' ' ASP . 9.9 p90 -127.13 142.81 51.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.957 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' MET . . . . . 0.708 ' CE ' HD13 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -109.6 145.33 36.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.003 -179.848 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.525 ' HB ' ' HB2' ' A' ' 148' ' ' LEU . 74.5 mt -98.47 118.67 45.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.064 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.464 ' CE1' ' HB2' ' A' ' 147' ' ' ALA . 96.7 m-85 -122.25 154.46 37.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.825 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -102.5 116.06 31.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.984 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.75 ' HB3' HD11 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -62.68 -40.72 97.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.104 -179.751 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.453 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 2.1 m-20 -56.73 -38.4 72.31 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.814 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -98.44 24.38 32.26 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.353 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.624 HD21 ' HB3' ' A' ' 4' ' ' TYR . 0.5 OUTLIER -137.55 146.81 44.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.829 0.347 . . . . 0.0 110.771 179.985 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.423 ' N ' ' HG ' ' A' ' 167' ' ' LEU . 6.7 tt0 -116.45 149.93 38.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.771 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.82 ' HB3' HD11 ' A' ' 2' ' ' ILE . 1.0 OUTLIER -113.79 160.0 19.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.102 -179.829 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -161.83 122.09 2.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.818 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.577 ' HG2' HD12 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -95.36 117.47 30.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.986 179.98 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' CYS . . . . . 0.675 ' C ' HD23 ' A' ' 173' ' ' LEU . 3.9 t -150.82 162.49 40.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.909 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.675 HD23 ' C ' ' A' ' 172' ' ' CYS . 0.9 OUTLIER 45.49 40.63 5.9 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.383 179.962 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.13 -0.938 . . . . 0.0 110.843 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 tpt . . . . . 0 N--CA 1.487 1.412 0 CA-C-O 120.846 0.355 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.707 HD12 ' HG2' ' A' ' 171' ' ' LYS . 2.3 tt -108.48 149.57 11.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.017 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.486 HG21 ' HB3' ' A' ' 12' ' ' GLU . 20.4 mm -111.31 159.36 11.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.378 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.506 ' CD2' ' CE2' ' A' ' 14' ' ' PHE . 5.4 m-85 -122.81 104.56 9.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.306 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 21.9 ptt180 -116.65 145.51 43.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.008 0.432 . . . . 0.0 111.415 -179.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.54 ' OD1' HD12 ' A' ' 8' ' ' ILE . 50.5 t0 -54.34 152.01 6.86 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.961 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 40.6 tp -82.47 -16.87 47.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.546 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.54 HD12 ' OD1' ' A' ' 6' ' ' ASP . 4.4 mp -91.27 -51.72 11.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -179.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.41 ' HB2' ' ND2' ' A' ' 141' ' ' ASN . 5.9 t -96.74 -16.26 20.97 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -179.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.454 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 1.8 m-70 64.39 30.08 13.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.865 0.364 . . . . 0.0 110.863 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -99.23 122.63 42.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.831 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.486 ' HB3' HG21 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -58.43 92.07 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.286 -179.739 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 35.8 mtp -70.85 -19.07 62.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.714 179.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.506 ' CE2' ' CD2' ' A' ' 4' ' ' TYR . 16.1 p90 -175.25 174.7 2.35 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.525 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.3 m -129.08 -170.53 2.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.822 0.344 . . . . 0.0 111.083 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.427 ' HB2' ' CG2' ' A' ' 2' ' ' ILE . 30.6 t0 -95.43 21.08 8.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.062 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.4 HG13 ' CD2' ' A' ' 18' ' ' TYR . 46.3 pt -87.14 -8.8 11.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.059 179.41 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.966 ' CZ ' HG22 ' A' ' 72' ' ' ILE . 84.3 m-85 -111.41 -175.99 2.84 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.899 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.1 mmmt -93.32 93.67 8.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.901 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.1 mp -88.06 123.96 40.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.985 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.405 ' NH1' ' HB3' ' A' ' 21' ' ' ARG . 9.1 mtp-105 -113.55 126.42 55.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.936 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.739 ' HG3' HD23 ' A' ' 29' ' ' LEU . 3.8 mt-10 -77.41 112.74 14.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.879 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.613 HD11 HG23 ' A' ' 161' ' ' ILE . 4.2 pt -109.69 168.46 3.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.063 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.417 ' HB2' ' NE2' ' A' ' 121' ' ' GLN . . . 57.72 30.17 18.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.152 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 63.9 40.14 7.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.29 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.7 -12.61 68.48 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.6 -0.81 . . . . 0.0 113.158 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.78 -37.4 76.24 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.824 0.345 . . . . 0.0 111.045 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 13.9 m -141.68 162.94 34.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.141 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.739 HD23 ' HG3' ' A' ' 22' ' ' GLU . 0.5 OUTLIER -128.76 135.45 49.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.703 179.894 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.403 ' OE1' ' CD2' ' A' ' 159' ' ' TYR . 64.6 mt-10 -100.7 118.13 36.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.305 -179.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.496 HG21 ' CD2' ' A' ' 14' ' ' PHE . 24.2 t -94.8 112.02 26.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.729 179.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -84.67 122.96 29.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.205 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -108.98 -138.79 8.42 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.278 179.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.9 ptpt -174.48 128.3 0.34 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.821 0.343 . . . . 0.0 111.024 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 24.4 mtp -74.17 124.9 27.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.567 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.0 m -125.28 140.12 49.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.657 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 16.9 p -91.33 165.64 13.32 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.696 179.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.769 ' O ' HG23 ' A' ' 66' ' ' VAL . 8.0 tpp180 -134.61 115.77 14.23 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.052 -179.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.65 108.97 19.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.795 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -141.04 48.5 1.69 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.003 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 122.31 172.99 14.2 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.597 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 31.8 p-10 -179.15 -39.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.827 0.346 . . . . 0.0 110.837 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 15.2 tt -90.09 159.65 2.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.01 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 64.07 44.8 4.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.867 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -155.95 26.83 0.37 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.919 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.11 -42.09 5.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.894 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.03 -30.84 68.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.933 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 34.1 mm -67.42 -63.97 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.105 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 154.01 -134.28 4.27 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.542 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 164.3 -139.44 5.85 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.5 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -115.83 56.16 0.77 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.901 0.381 . . . . 0.0 110.953 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -139.73 31.51 2.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.113 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.1 t -86.24 -31.68 21.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.796 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -138.31 80.69 1.81 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.079 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -164.48 -58.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.87 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 97.17 157.2 30.77 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.51 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -52.41 104.56 0.1 OUTLIER 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.581 2.187 . . . . 0.0 112.252 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -115.26 146.36 41.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.91 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -92.8 58.84 2.5 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.505 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -89.97 179.02 6.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.856 0.36 . . . . 0.0 110.881 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -59.93 157.09 27.33 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.482 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.7 t -64.49 119.52 10.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.852 0.358 . . . . 0.0 110.868 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.5 tt0 -175.95 126.6 0.22 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.944 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 63.1 m -132.23 -76.82 0.5 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.823 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 59.5 m -103.23 -35.02 8.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.842 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.769 HG23 ' O ' ' A' ' 38' ' ' ARG . 14.5 p -74.82 136.52 24.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.932 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.528 ' N ' HD13 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -103.37 131.62 51.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.812 0.339 . . . . 0.0 110.674 179.731 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 86.4 m -137.89 140.18 40.25 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.047 0.451 . . . . 0.0 111.243 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 179.64 -176.48 47.63 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.286 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.541 HG12 HG12 ' A' ' 72' ' ' ILE . 48.8 t -67.87 130.34 33.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.805 0.336 . . . . 0.0 110.886 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -59.68 -58.05 10.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.402 -179.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.966 HG22 ' CZ ' ' A' ' 18' ' ' TYR . 6.3 pt -53.85 -33.97 24.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.61 -179.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.768 HG13 ' HB2' ' A' ' 78' ' ' LEU . 97.0 t -72.69 -29.98 32.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.137 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 7.3 mtm -78.09 -42.58 31.64 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.664 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.44 HD21 ' HA ' ' A' ' 72' ' ' ILE . 22.0 p30 -82.25 -28.89 31.6 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -179.123 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.447 ' CE1' ' HA ' ' A' ' 14' ' ' PHE . 32.7 m170 -88.58 -8.07 55.36 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.904 0.383 . . . . 0.0 110.69 179.307 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.407 ' HB2' ' HB3' ' A' ' 138' ' ' GLU . 72.4 m-70 64.65 33.39 10.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.056 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.768 ' HB2' HG13 ' A' ' 73' ' ' VAL . 33.4 mt -64.63 142.19 58.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.537 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -129.12 146.99 50.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.909 0.385 . . . . 0.0 111.274 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.437 ' HG3' ' CE1' ' A' ' 135' ' ' PHE . 1.1 tm-20 -102.05 134.28 45.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.822 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.578 HG21 HD11 ' A' ' 136' ' ' ILE . 8.9 t -124.27 139.81 53.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.908 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 34.5 p -69.4 159.11 33.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.833 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.471 ' HB2' ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -169.48 154.22 5.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.879 -179.941 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.421 HG22 ' N ' ' A' ' 85' ' ' LYS . 14.3 m -101.52 164.05 11.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.95 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.421 ' N ' HG22 ' A' ' 84' ' ' THR . 58.1 mttt -60.74 -52.54 64.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.896 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -64.19 -42.19 96.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.616 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.29 -41.31 88.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.898 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.818 ' CD2' HD11 ' A' ' 122' ' ' ILE . 0.3 OUTLIER -57.71 -38.4 75.2 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.653 179.908 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.436 ' O ' HG22 ' A' ' 92' ' ' ILE . 21.7 mttt -58.88 -42.3 89.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.521 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 18.0 mtpt -77.27 -27.88 53.27 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.897 179.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.416 ' HB2' ' CE2' ' A' ' 83' ' ' PHE . 28.6 t80 -69.23 -45.68 69.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.565 179.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.586 HD12 ' CE2' ' A' ' 95' ' ' TYR . 6.1 tp -61.28 -39.92 84.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.071 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.501 ' O ' ' CG ' ' A' ' 97' ' ' LYS . 13.8 ttmt -62.05 -46.95 86.86 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.969 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -71.68 -36.13 70.51 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.13 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.586 ' CE2' HD12 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -78.51 -43.4 26.98 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.641 0.257 . . . . 0.0 110.735 -179.268 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.403 ' HG3' ' N ' ' A' ' 97' ' ' LYS . 0.5 OUTLIER -64.71 -31.83 73.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.841 0.353 . . . . 0.0 110.082 179.004 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.501 ' CG ' ' O ' ' A' ' 93' ' ' LYS . 9.5 mmtm -66.94 -41.37 87.08 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.549 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.7 m -55.26 -41.14 71.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.545 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.519 ' CG1' HD11 ' A' ' 8' ' ' ILE . 7.1 mt -79.78 -41.87 22.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.522 179.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 10.2 tttt -54.75 -52.61 61.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.574 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -61.6 -47.15 92.24 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.141 179.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 19.5 tptt -60.98 -40.3 92.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.841 0.353 . . . . 0.0 110.366 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.732 HD21 ' CB ' ' A' ' 110' ' ' ARG . 2.4 tp -66.96 -35.53 80.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.14 179.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.64 ' CG ' HG11 ' A' ' 111' ' ' VAL . 30.6 mt-10 -58.15 -30.15 66.13 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.607 179.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -89.43 -25.1 21.69 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.511 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -100.1 -63.55 1.12 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.858 0.361 . . . . 0.0 111.633 -179.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.441 ' N ' ' O ' ' A' ' 103' ' ' LEU . 16.0 mtm180 -130.43 65.18 75.37 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.882 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.93 ' O ' HG22 ' A' ' 111' ' ' VAL . 10.3 Cg_endo -50.86 -22.29 9.79 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 123.17 2.58 . . . . 0.0 112.831 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -66.97 -13.57 61.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.328 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.732 ' CB ' HD21 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -110.57 0.89 17.8 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.102 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.93 HG22 ' O ' ' A' ' 108' ' ' PRO . 33.9 m -70.05 -33.36 54.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.579 ' HB2' ' HD3' ' A' ' 113' ' ' PRO . 29.8 mtmt -71.1 -49.95 12.12 Favored Pre-proline 0 CA--C 1.53 0.176 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.574 -179.199 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.579 ' HD3' ' HB2' ' A' ' 112' ' ' LYS . 25.8 Cg_exo -63.06 -30.46 75.91 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.16 1.906 . . . . 0.0 111.777 179.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.459 ' CD1' ' HB2' ' A' ' 165' ' ' ASP . 88.6 t80 -72.07 -41.05 67.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.987 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 7.6 mtm -56.54 -47.88 78.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.031 0.443 . . . . 0.0 110.817 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 69.0 m -74.32 -44.36 52.83 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.659 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.27 -38.0 95.5 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.483 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.55 -51.62 68.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.921 0.391 . . . . 0.0 110.838 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.96 -28.11 65.28 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.279 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -74.81 -43.04 56.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.856 0.36 . . . . 0.0 110.982 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.417 ' NE2' ' HB2' ' A' ' 24' ' ' ALA . 3.8 tp-100 -73.31 -32.58 64.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.965 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.818 HD11 ' CD2' ' A' ' 88' ' ' TYR . 0.4 OUTLIER -71.56 -46.01 65.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.322 -179.725 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.456 ' N ' ' CG2' ' A' ' 122' ' ' ILE . 9.2 pttt -61.1 -31.54 71.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.036 0.446 . . . . 0.0 110.358 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -68.32 -53.52 23.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.77 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.822 HG21 HD13 ' A' ' 148' ' ' LEU . 16.2 pt -62.0 -42.49 95.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.304 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.46 HD23 ' HA ' ' A' ' 126' ' ' LEU . 11.7 mt -53.89 -36.99 63.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.879 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -65.46 -15.95 63.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.21 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -136.35 31.43 2.89 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.77 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.513 ' CE1' ' CZ ' ' A' ' 134' ' ' PHE . 1.8 t80 -49.5 -31.66 10.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.96 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 20.1 tptt -61.3 -21.57 64.08 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.162 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 15.0 m-20 -94.08 -47.22 6.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.429 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.479 ' CD2' HG22 ' A' ' 125' ' ' ILE . 1.0 OUTLIER -93.01 150.78 20.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.963 0.411 . . . . 0.0 111.48 -179.449 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.489 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 1.0 OUTLIER -126.6 142.95 51.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.317 179.551 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.513 ' CZ ' ' CE1' ' A' ' 129' ' ' PHE . 0.1 OUTLIER -82.49 118.27 23.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.928 0.394 . . . . 0.0 110.979 -179.704 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.437 ' CE1' ' HG3' ' A' ' 80' ' ' GLU . 20.9 m-85 -119.8 137.17 54.14 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.753 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.578 HD11 HG21 ' A' ' 81' ' ' THR . 0.8 OUTLIER -120.93 165.43 16.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.842 0.353 . . . . 0.0 110.944 179.933 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -64.59 -166.4 1.19 Allowed Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.539 -0.839 . . . . 0.0 111.981 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.407 ' HB3' ' HB2' ' A' ' 77' ' ' HIS . 12.5 pt-20 -70.98 -9.82 58.64 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.567 0.222 . . . . 0.0 111.38 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 -96.63 -29.83 13.61 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.606 0.241 . . . . 0.0 111.449 -179.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.489 ' HE2' ' HB ' ' A' ' 81' ' ' THR . 18.7 mtp 55.39 48.57 18.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.879 0.371 . . . . 0.0 111.099 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . 0.413 ' ND2' ' HA3' ' A' ' 144' ' ' GLY . 15.7 p-10 -71.84 114.8 31.89 Favored Pre-proline 0 N--CA 1.451 -0.409 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.917 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 141' ' ' ASN . 22.6 Cg_exo -63.39 -30.65 72.73 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.54 2.16 . . . . 0.0 112.214 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -84.62 -1.44 56.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.354 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.413 ' HA3' ' ND2' ' A' ' 141' ' ' ASN . . . -86.87 -115.72 1.0 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.421 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 10.7 ptp -142.27 -178.89 5.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.59 0.233 . . . . 0.0 110.769 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.504 HG11 ' HB3' ' A' ' 134' ' ' PHE . 0.0 OUTLIER -129.61 139.79 50.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.077 0.465 . . . . 0.0 111.274 179.961 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.671 ' HB2' ' CE1' ' A' ' 162' ' ' PHE . . . -103.09 110.02 21.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.224 179.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.822 HD13 HG21 ' A' ' 125' ' ' ILE . 3.8 mt -81.51 106.2 13.28 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.428 -179.051 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.526 HD11 HG21 ' A' ' 70' ' ' VAL . 1.7 tp -90.85 119.6 31.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.074 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.482 ' HB3' ' CE1' ' A' ' 159' ' ' TYR . 31.7 t70 -135.54 164.85 26.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.524 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -102.02 150.8 22.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.915 0.388 . . . . 0.0 111.189 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 16.8 mmm180 -80.59 -175.48 5.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.816 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -54.55 -40.14 68.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.011 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -66.31 -15.17 63.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.205 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 69.66 10.25 63.56 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.745 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 70.1 t -113.47 -68.19 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.843 0.354 . . . . 0.0 110.946 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 96.8 m -54.32 107.8 0.96 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.378 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -83.17 131.52 5.84 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.677 2.251 . . . . 0.0 111.965 179.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.482 ' CE1' ' HB3' ' A' ' 150' ' ' ASP . 9.5 p90 -124.1 135.58 53.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.866 0.365 . . . . 0.0 111.059 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' MET . . . . . 0.652 ' HE1' HD13 ' A' ' 78' ' ' LEU . 0.4 OUTLIER -105.09 138.7 40.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.132 -179.706 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.613 HG23 HD11 ' A' ' 23' ' ' ILE . 68.7 mt -94.96 114.41 31.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.147 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.671 ' CE1' ' HB2' ' A' ' 147' ' ' ALA . 96.6 m-85 -118.1 158.19 25.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.692 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -101.71 129.09 47.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.873 0.368 . . . . 0.0 110.803 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.519 ' HB2' HD11 ' A' ' 29' ' ' LEU . 24.3 tttt -70.09 -51.52 31.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.166 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.459 ' HB2' ' CD1' ' A' ' 114' ' ' PHE . 59.6 m-20 -52.2 -38.51 58.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.175 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.454 ' HA2' HG23 ' A' ' 99' ' ' ILE . . . -95.73 26.87 18.24 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.459 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.477 HD21 ' HB3' ' A' ' 4' ' ' TYR . 0.6 OUTLIER -144.93 143.84 30.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.778 0.323 . . . . 0.0 110.879 -179.871 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -116.88 156.61 27.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.822 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.655 ' HB3' HD11 ' A' ' 2' ' ' ILE . 3.1 mpp? -115.76 151.02 35.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.052 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -149.29 127.06 11.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.888 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.707 ' HG2' HD12 ' A' ' 2' ' ' ILE . 5.6 mttp -89.18 118.4 28.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.025 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' CYS . . . . . . . . . . . . . 1.8 m 60.7 157.61 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.037 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.588 HD23 ' O ' ' A' ' 173' ' ' LEU . 3.2 tt -132.68 16.63 4.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.142 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.314 -0.851 . . . . 0.0 111.037 179.902 . . . . . . . . 0 0 . 1 stop_ save_